<SEC-DOCUMENT>0001628280-22-006223.txt : 20220315
<SEC-HEADER>0001628280-22-006223.hdr.sgml : 20220315
<ACCEPTANCE-DATETIME>20220315152603
ACCESSION NUMBER:		0001628280-22-006223
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		102
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220315
DATE AS OF CHANGE:		20220315

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			InfuSystem Holdings, Inc
		CENTRAL INDEX KEY:			0001337013
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				203341405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35020
		FILM NUMBER:		22740730

	BUSINESS ADDRESS:	
		STREET 1:		3851 WEST HAMLIN ROAD
		CITY:			ROCHESTER HILLS
		STATE:			MI
		ZIP:			48309
		BUSINESS PHONE:		(248) 291-1210

	MAIL ADDRESS:	
		STREET 1:		3851 WEST HAMLIN ROAD
		CITY:			ROCHESTER HILLS
		STATE:			MI
		ZIP:			48309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HAPC, Inc.
		DATE OF NAME CHANGE:	20060425

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Healthcare Acquisition Partners Corp.
		DATE OF NAME CHANGE:	20050824
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>infu-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:5045cdd8-3e33-4b1e-9c96-436a6a424439,g:4f22e797-67c4-4a22-8bb5-b3bf69d58fcf,d:9e717b65c1e3405d850ef6e342b20071--><html xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:infu="http://infusystem.com/20211231" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>infu-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV80L2ZyYWc6M2U2Yjg5MmUxNmJkNDRkNGFhNDNmZmQ2ODI4ZjgxNDAvdGFibGU6OTY4NTQ2ZjdjNzc0NGRiOWIzY2E0ZWVlZWM5ZGM2MzIvdGFibGVyYW5nZTo5Njg1NDZmN2M3NzQ0ZGI5YjNjYTRlZWVlYzlkYzYzMl8zLTEtMS0xLTUwNjIy_8d4bab73-4ca6-44f4-836a-bf36cbc6765b">0001337013</ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV80L2ZyYWc6M2U2Yjg5MmUxNmJkNDRkNGFhNDNmZmQ2ODI4ZjgxNDAvdGFibGU6OTY4NTQ2ZjdjNzc0NGRiOWIzY2E0ZWVlZWM5ZGM2MzIvdGFibGVyYW5nZTo5Njg1NDZmN2M3NzQ0ZGI5YjNjYTRlZWVlYzlkYzYzMl8xOC0xLTEtMS01MDYyMg_e135dde0-358e-466a-a03c-3885cd01f475">2021</ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV80L2ZyYWc6M2U2Yjg5MmUxNmJkNDRkNGFhNDNmZmQ2ODI4ZjgxNDAvdGFibGU6OTY4NTQ2ZjdjNzc0NGRiOWIzY2E0ZWVlZWM5ZGM2MzIvdGFibGVyYW5nZTo5Njg1NDZmN2M3NzQ0ZGI5YjNjYTRlZWVlYzlkYzYzMl8xOS0xLTEtMS01MDYyMg_7cbbd274-2178-4c2f-b65a-3a99fe8bfc97">FY</ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV80L2ZyYWc6M2U2Yjg5MmUxNmJkNDRkNGFhNDNmZmQ2ODI4ZjgxNDAvdGFibGU6OTY4NTQ2ZjdjNzc0NGRiOWIzY2E0ZWVlZWM5ZGM2MzIvdGFibGVyYW5nZTo5Njg1NDZmN2M3NzQ0ZGI5YjNjYTRlZWVlYzlkYzYzMl8yMC0xLTEtMS01MDYyMg_bbcd77c3-1fd9-42d5-a838-61ca91439981">false</ix:nonNumeric><ix:nonNumeric contextRef="i936cbf63d246476db743dd2b8af1f17c_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY3ODU_89ea2bad-0ac3-4d89-9bff-0b3592eb4de5">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i29ae89039c7d4439ae9da620e9a76622_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY4ODI_16fecb86-c446-4994-8930-6e54f72298e6">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="icec29a20da85434a84ef9a1fe876a262_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzc2NzA_787bbc1d-efca-48b5-9bc6-20acf41ccb09">P15Y</ix:nonNumeric><ix:nonNumeric contextRef="icff6cc8b05334e9aa94fdb2166c5189e_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzgzMTA_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="icff6cc8b05334e9aa94fdb2166c5189e_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzODg_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i4884e729c62d490e9c7039f04d149a94_I20211231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEzNTUy_9f2fcc91-aee1-47c3-a7b5-103597d961a0">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i6cd1956173c44262a83ed2582407f25b_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8yMDUxL2ZyYWc6NTVmNTg5OWQ5MTQyNGI1MWE3NGQzMTAxYjIwYWY3NDEvdGFibGU6ZDg2YjRiZjZmZTNhNDdlMmFhYTIzYmFlZTNiYmFiZTYvdGFibGVyYW5nZTpkODZiNGJmNmZlM2E0N2UyYWFhMjNiYWVlM2JiYWJlNl8xLTEtMS0xLTg4MDQ5_51d35fd5-6d83-45bb-99b4-4ccf54d292c2">0</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="infu-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7b671a11ff144cdb841c10e00e545b2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i71d72a1442944b90bab79e5eb66f6ea8_I20220307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="iadf344ba2bca42ada453fc7ff77944bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b8b5e5eab5d411ab7c41bbd0a191163_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfdec380605a4b47bc98e52a196722c4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe974377c6e747c1a5ca843447269847_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08a5c3d39ecd4a888c2f856ced55d19a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i157f7776f6f34785bf30f4235c8d11bc_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i488a17cbb36b421597c4f159595f4b31_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67545d7705224bc6be52955d497ead2a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2affbe3d3694f7286adc05cd2ef1a5f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68d542ad3a9045d9a04429f3568a9113_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib332759d305f4dc8b9ccc96ac2c5af1a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24ee4273907446b1ba9e85ec18226b50_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc90323890a347a6a803d6e29739a07a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5306a01245a74e03ab4033c4fe19fc15_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36d6369b86a9480192a2232dd6e20776_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eec6c22b6b342eab7efdb046682bff8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i264313229b604d5dbaa260791106aae8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdf6be04bef848a3be60bd50bbe09ea3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9e4706fa4334283bce0bd814b6d4abe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7a10bd1ab424f0d9abf84a729cab56e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9fc97e52018419aac6e451ce020e3c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9f3ba1490534187962e956028423a05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibba59ce2bece4e15bb0877c92494fe88_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ef36744ffb64ea58b479667d4a1410c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffdd24f84ee6404c8449edf03c2c03b9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60447bb6297b410f8726ce5432f5690a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33bade00e83b4d3fa491f7a2b7f67333_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d0ded68cb484345bb92203314eb3670_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafc46bb5055c4ecfb796ab2b26d1f201_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9e7686a6c9a4fb996fb64830470a5d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide4509120e7e42d29953cf1e80b08d9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i954290189efa49729f89a0332d6eed3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34393106918541a2afdfacc9dc70598f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">infu:SmithsMedicalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:AmbulatoryPumpsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9f484679bbfa45cc82f4383cd151aeae_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:NPWTMedicalEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">infu:CardinalHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>infu:lease</xbrli:measure></xbrli:unit><xbrli:unit id="financialinstitution"><xbrli:measure>infu:financialInstitution</xbrli:measure></xbrli:unit><xbrli:context id="i273cf9bfb6db4d47a691a81cafdaae1a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic449570e790a4e16996815fc2fe98242_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i936cbf63d246476db743dd2b8af1f17c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3f83755b9294a7fbbea649f435470f7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29ae89039c7d4439ae9da620e9a76622_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">infu:InformationTechnologySoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff2484e23bda4759a180d34049f89085_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icec29a20da85434a84ef9a1fe876a262_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cbd2ba5629b4065967778d18fce6cc6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icff6cc8b05334e9aa94fdb2166c5189e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3805c0f8aa0b4495a88f1333effc915e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafb98485af7044f4b4e5556491802f9f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie95c2bd801aa4bb288bad94f285a3474_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ef1975dd83440c2b7903b64c216e6f5_D20211001-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00d66cb681ad4fb9820d60af76680b44_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9465d698b48a4cb89adc9870e948bf77_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie66a45b985ad4079b2542a584a5b7264_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4884e729c62d490e9c7039f04d149a94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="network"><xbrli:measure>infu:network</xbrli:measure></xbrli:unit><xbrli:context id="icf5fd049ceed45b68799835682190196_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia683a1cdfea841359642a861af2182de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibad2abb0e5fe4e9398ad4ae3632f3fbc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05190bb32cd04e68951f01b2c1a8198a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:FilAMedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1369ea7cfa4428a8a0535746cc8e915_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:FilAMedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d9edd536944e538abc2437af99d50f_I20210418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d555f047a9d4a98bcdde0ca522a6c33_D20210418-20210418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-18</xbrli:startDate><xbrli:endDate>2021-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3540294de93b4071b8f2e1e40e99745e_D20210419-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-19</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c6769d29844b238f82f52eec98cc12_I20210418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic33f271dada5450ba5170593f412ee83_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i233a685f88ec410c8dc45a29274c0b7b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9117e35a7b704846add5b6cf91320364_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ef27ca6d720458d8890b7403ee50d2f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i441702431efa453d9ae697b4ed1bf9f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac70b116e25d46d6943dcd912146fc65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if05acd9bb129444c859314fc90a675b8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee74bd21a9164ffa92cd63e1a7f77a5b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac7342c282ec477da6afb686717858a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68bd4d8cc58b4fe4b8a77002f54a62e4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44173ad083b247b4a3a2827ae4199ffe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0797ce13f2f84bccb9643bb465b72539_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b8592ae240046e2ae1d7bba300944f3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b8bca74bc6643a39beeb55eb9ee5829_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c9b6408c306478397ff75df2204b657_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i780ffb81ffd74c41a647d4101deb7fed_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55869796670c49c2b3cd162096936a33_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c13d15fc1e3436490201fc54a7ebe45_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i777a8534320c4ad2a3ca66b33e628c6d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide3e566a68504537bf76d20a1a6e221e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38bb3cacf11d424c8a9bf2b293ac90bc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i806896b65be24eb8a8d565e1ead9dfbc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94248c02936a4257911be7191534390c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie795f19734ba4ea0ad822d0aa14b10e9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0ec252312564b5b9a317bfa1d062542_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic85e0dd291c74ec88ceca6c455d9099e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2db72027cda42008cbdb85b30ce7435_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabc7ebe2911f4b8ead87bc9344dbecbf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cec8dd30c2a446b991de51c91e34f4c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93c9a20502d4745907b197f7456558c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea2e191999e8474dac4c6c90b1ebd6ea_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fca34364019406e99032d7e62aa8549_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47ce6b2f6bd4668ac4fd139af7095f7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99e9f20c6321440d8bbc7f2097999db8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24689dc260664972bc304c938065d32c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eab4726eabd4666a158889e4ca9f089_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i136bd725ae5d499aa73f5dbdcc3d0538_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1702a843f4c243c393e12054224e80e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe177a89508b4e398be3e3549eb93a26_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a29108335024c84a565385b792cd555_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fddcf470fec4bef906869caf2a1aee9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb9b60051f3d464abf97f4d754be3921_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901347f42a9240abb769c4ca3db405e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0e87b8645294c95b18cfe1e1938f796_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f56e398e372492d8641d88cd8b01cff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e2ca571a5714cb889e214a572d2aa67_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9649d301729547c5b2196154dc65a224_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b7bb29ceaad4f8da8ce9a75bfa49f10_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i680eb364512840a7b20a8bfda742ab6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i972c98c27e6f4a3999d5e2e73d5e2a77_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02810325b2664b7997154ec528092ae9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0629bca191f34f1caf750d54c8ebd131_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if63340937f6a47b08decf2e320428890_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9e0342993b94444b974026bddb99c28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45d3cf60b6544e0d862fa72ac5fa656b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i109995ede010411299c74fcc87e3829a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7678f2cb51f54e08941b9dfcf63bace0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d86c2941c0e4ddfa25d123e33722fa3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i749458dfcda84fcba057ba09cfc9c14f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec609ab7f9cc482f878e37ae4b232f06_I20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c000588f48b4e20af3b977ce4231e48_I20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6e13bc56eba44a085dd386fb4a920de_D20210205-20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i033b71a678134cd586b4202ce9eb994e_D20210205-20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2015CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28416998ed494697b9e63887fde6fd11_D20210205-20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5d269b502c94e90b66e4c4b94a9c2ed_I20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i452ae0b2df354385976aa6108ccf6fb9_I20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2015CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2da90a2b53f464d83f01bf20f29c091_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:ThreeTermNotesAssociatedWithThe2015CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9523dc8728f4f108564fbb8f67d46a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ae56ca359cf4788a118a9f206ace640_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29c501e886e64e9c963a67b76eb4cd46_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i223aaee1de9843719aacfcb115ef4cb2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32f4cc53746a4a8cba9ea7b91c877b3b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">infu:GreaterOfPrimeRateOrLIBORPlus25Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bb191034086475081b1b2d7260fba3c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">infu:GreaterOfPrimeRateOrLIBORPlus25Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib19aee4251c0421a88d27487e974e24e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86348f84097549aea76b5e34c1abceab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4249c9895bc145b5be2fa0d810ad324b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2958795320034b74ba5d1eff1f005813_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">infu:CBFloatingRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48cdf09f16b649aba0ae191e5967f0ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">infu:CBFloatingRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic70163d2c2154132b876d363ae1420b5_I20190415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8c78e4c1e864bd5a5b27f93ca59061e_D20190415-20190415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-15</xbrli:startDate><xbrli:endDate>2019-04-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b550170313246b389a63672f1b2683f_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i262345c59e314575bff01a7f8cda11fe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57c0ab7efbce44e3a190303cafd12765_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bac56a13b8a4a839f394785fb03bcca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a3117f913484a4686356512d23fcd5a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26945b82dabf4e67b225a0c6d08752e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib56fe4590048490aac40ada7ae6400c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6540674abce4c21a0ef51335bdd4b29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">infu:EquipmentLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c407a2ed2ae458a8df6a05548246659_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">infu:EquipmentLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4facded32a743d880e4713f269f8b0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">infu:The2019EquipmentLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i987ef74564c541748397735c98c6eef8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">infu:The2019EquipmentLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ab9a73eeba346ee8122c590dbcbff5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd19a01ade284855af47b1b4373ea548_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb66c8f537fd4b868b21fad8bb3d0370_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ad0860c58864013aaca9c0803749cc1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i753ef5726f0d46c09a8a2930b70f0ae4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe15e51fb3c431391c39b3871874755_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cd65086be1a4f03b35066f3c49722b5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id680c7f9eb53497f8afe704e06188d0d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id41bcfe45ebb4131bad97991e1bcf070_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie04daf42f32244b687b1b4a179069060_I20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="numberofagreement"><xbrli:measure>infu:numberOfAgreement</xbrli:measure></xbrli:unit><xbrli:context id="i3f5f66be8c4042dfbc78b5ce658083c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3212a9cabfa9493096f98169ff09dde2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i262ff830a2bd433899876342da3eb117_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15476ca71552472d8a12c8939898580d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07f3da9e713d4c489ebdd0e68b443b18_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i055937925234444eb13527b2e0cb4ae9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf34a521c00b474b8c705fb5db98af8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice5d9a455230467faf56b669a8015a3e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0c7b74dd3b642bd83f8f8f69155e38a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i856c610b2fe549e0b8bc1e612a43b96c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if64f71b0d53e48e3a2c1aa091fd31365_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i439fd912ad054d238616616e9babc7fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfedd81ba6944a6985fc391bcc412d7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2150414dae3f42f68c21d9adaf756de4_D20200415-20200415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:PaycheckProtectionProgramCaresActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-15</xbrli:startDate><xbrli:endDate>2020-04-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eb9d27f65dd4491a35f0b273d413655_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0c917cfe5e042599ce26f2256dff1ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2b9762869f5424c88544abd7900c8d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c5b6e5d34b445c1b9f13378f83a9a8b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8ac411300664a70b0331e7b8a64e151_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aecccce92b14a9c9084a4f31af83e6c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i450379ae7a724e1eb2a0f5753d483e22_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e697973a46d4d5d9d02a7da49fa4e3b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1562a53301a84c6f86d2e5026a162d32_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbca7ff14ebb4795b34515b88d7092ba_D20210518-20210518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-18</xbrli:startDate><xbrli:endDate>2021-05-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b64b934b737430092de595691e27b69_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b2880103789464c83dd09c03f90e4c9_I20140423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ee8e04870e34b48a26a7940cc7e9b5c_D20180719-20180719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-19</xbrli:startDate><xbrli:endDate>2018-07-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85e14e2aedee40cd9f3d83472a6a4224_D20190515-20190515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-15</xbrli:startDate><xbrli:endDate>2019-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93a156af54c948df8919aacc5b640f4b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idad1a9e99df642878fbca1cdddf632e2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b8108f7576e4800a4821616a2f4206c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2970496b363049a4989e1475da130d29_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2975cbac6e1d4d30a4131dcbc1127282_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a81f3c1031c41d6be1e69e4807e648a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">infu:SharebasedPaymentArrangementAchievingMinimumThresholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a5e593bf0f4482cbd136bb082362baf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">infu:SharebasedPaymentArrangementAchievingMinimumThresholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id71f0e9811ac46ee9b2694dfddb5b84c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">infu:SharebasedPaymentArrangementExceedingMinimumThresholdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i579ba4102b384a248e9ea9ecb23a50df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3deaf1a379a149fd8aca28bd274ab8e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63aa50be007746b6b60d96242969200f_D20140501-20140531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2014-05-01</xbrli:startDate><xbrli:endDate>2014-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5fd5a9607e8406696c8241935b20eea_I20140531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i337469ad875742708ce9ddae6c4a0f49_D20160901-20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-01</xbrli:startDate><xbrli:endDate>2016-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id664e22f92654bd6835e8960b88f906e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a35f534ba14f4d9e18f538cbfa8254_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec83287d77134edda3de6abc4cfa02ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e7c1a7074da4ca6b240f0057300c46c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e33f7d1e2e5453ea11e60d4febe0678_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if119c5c4f07e4e6fb8be547a3dfead4e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e5609e12fdd4bcc9d3cac4d8aa1ae1a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd1956173c44262a83ed2582407f25b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d33e010b93943a0a1b9d74ec3a67b16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8879dd04a8a42e3aa243ab1446763cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ee66b33a414ffb93ffa9dcf1afd8e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9928856516d548d1aba6381436cf7644_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b70e2ce104146f5ab103c7d119b5bb6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f6184d5208e4826bebce3c6df68d12f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bb2db6241c24063b31cb809b4d00a65_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72387201e71d4834ad096602f0745428_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i297307e995f4423482791be08ae954b0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6d80d3950ca42f0aa2a881eb9e20226_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c666a090afb4d4088d45f15b60baf48_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99dd14e3f4d04b82a5f72adea8821e1f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTUtMS0xLTY4ODc2_c111bee4-d840-4aa3-92a0-bac2910ee946 id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTctMS0xLTY4ODY5_e5423472-a3f2-41f8-bf6a-49f647b5d1ed id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTMtMS0xLTY4ODgz_40e6085e-e2f2-4deb-adba-1604628105b6" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY4_b48ecc6c-d3a8-4b35-9611-7794e88fc0c0" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTUtMS0xLTcxODU5_02a6b5f6-3c05-4ee2-b77c-626b8dbafc75 id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTctMS0xLTcxODY2_8cf1827d-43b3-49fd-9ca8-720fd3e1ef15 id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTMtMS0xLTcxODUy_6838e1f4-e58f-4c76-a61b-10f7c982034d" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY5_da598c6c-1ff0-44c6-a475-798637b014e3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTQtMS0xLTUxNTYy_85944c39-89c5-482e-9458-11163ccd9b31 id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV83LTYtMS0xLTU4NTgz_8836808c-e83c-441d-9439-13331421e05d id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTItMS0xLTUxNTYy_481006d8-1084-4727-894a-60249e6a0acf" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY3_26951cf3-5524-42c9-b7eb-b73b54eb1668" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i9e717b65c1e3405d850ef6e342b20071_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C., 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_____________________________________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDI4_62ba0d14-218d-472e-88a8-2618fe17c2a4">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________________________</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:496.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6ZDcyOGE0NTYxNGMwNGQ2N2E2ZDIxMjk4NmM0MmU0MWIvdGFibGVyYW5nZTpkNzI4YTQ1NjE0YzA0ZDY3YTZkMjEyOTg2YzQyZTQxYl8wLTAtMS0xLTYzMTUx_28023b1f-43d0-4529-9b67-90a0d4ea8fac">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MTAx_6563f86d-3451-42dd-b83d-38b1102dc05e"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MTAx_34d3a8b2-08c7-4861-9531-d3fe37ef1969">December&#160;31</ix:nonNumeric>, 2021</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:496.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YTVhMTExNjU3YTM3NDY2ZTkxNjRkNmRkZTg3NGIyOGMvdGFibGVyYW5nZTphNWExMTE2NTdhMzc0NjZlOTE2NGQ2ZGRlODc0YjI4Y18wLTAtMS0xLTYzMjU4_889806ce-8a4c-4637-bf45-bc5c6309a9bb">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the transition period from _________________ to ___________________</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDI5_80d08857-11e9-47b4-afb0-a1475f3d232f">001-35020</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________________________</span></div><div style="margin-top:10pt;text-align:center"><img src="infu-20211231_g1.jpg" alt="infu-20211231_g1.jpg" style="height:88px;margin-bottom:5pt;vertical-align:text-bottom;width:280px"/></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDI3_ba8dd0b7-5fa2-4aeb-bd6c-daa70ed56edc">INFUSYSTEM HOLDINGS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YmQwYzc1MTNiYzI2NGYzNzgyYzQ1OWExZDQ2YjM3ZjQvdGFibGVyYW5nZTpiZDBjNzUxM2JjMjY0ZjM3ODJjNDU5YTFkNDZiMzdmNF8wLTAtMS0xLTYzMTQ3_c1b3720b-7dbe-4e7b-abc9-351bc8e0594b">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YmQwYzc1MTNiYzI2NGYzNzgyYzQ1OWExZDQ2YjM3ZjQvdGFibGVyYW5nZTpiZDBjNzUxM2JjMjY0ZjM3ODJjNDU5YTFkNDZiMzdmNF8wLTEtMS0xLTYzMTQ5_ae87809f-ec33-4b64-b3a2-da3ff21c802c">20-3341405</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDMx_adffb46b-6612-431a-b04e-ffc79b5f1b2e">3851 West Hamlin Road</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDMy_05d5b741-c84b-49df-9fba-dbebef5afd24">Rochester Hills</ix:nonNumeric>, <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDM1_8db2f495-baee-4854-bd9f-fe941cf60de7">Michigan</ix:nonNumeric> <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDM3_a0bdfa05-4c0a-4984-acea-4515cbe4c5df">48309</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s Telephone Number, including Area Code:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDQ0_4f9fe551-4a89-471d-bde3-723657d638a0">(248)</ix:nonNumeric> <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDUw_73fde81e-c349-44d2-b3c0-db79c0fec568">291-1210</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Registered Pursuant to Section</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title of Each Class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name of Each Exchange on which Registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YTM5ODY2NzNhN2Y0NDY2NGI0ZDMwNTYzNDEwZDhhODcvdGFibGVyYW5nZTphMzk4NjY3M2E3ZjQ0NjY0YjRkMzA1NjM0MTBkOGE4N18xLTAtMS0xLTYzMTk1_3abcecf8-fceb-486c-8217-c908057a0342">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YTM5ODY2NzNhN2Y0NDY2NGI0ZDMwNTYzNDEwZDhhODcvdGFibGVyYW5nZTphMzk4NjY3M2E3ZjQ0NjY0YjRkMzA1NjM0MTBkOGE4N18xLTEtMS0xLTYzMTk3_4854b768-3fad-4aa9-a4e5-2fbfffdaed5c">INFU</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YTM5ODY2NzNhN2Y0NDY2NGI0ZDMwNTYzNDEwZDhhODcvdGFibGVyYW5nZTphMzk4NjY3M2E3ZjQ0NjY0YjRkMzA1NjM0MTBkOGE4N18xLTItMS0xLTYzMTk5_d0b7d2a9-258d-4e43-8501-e8b3ed6a4598">NYSE American LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Registered Pursuant to Section</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Title of Class)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________________________</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV8zMjk4NTM0ODg3NjEx_ea868d75-e1b5-4a0d-b97c-c8c8694a0d32">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV8zMjk4NTM0ODg3NjEz_51a7dd3e-e45a-4c3c-8762-a3d0b345c6d8">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods as the registrant was required to file such reports) and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDY1_b5c90036-af44-44d4-ba48-c10c62d5afbb">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDY2_f8d3e252-aaf3-49ec-a373-f71f90456d0f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:22.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6N2MzMjdhMmM4MzUwNGY3MmFjNDNjZTkyNTk1Y2IxMWEvdGFibGVyYW5nZTo3YzMyN2EyYzgzNTA0ZjcyYWM0M2NlOTI1OTVjYjExYV8wLTQtMS0xLTYzNDAx_20eb027f-2c10-4775-b6a9-27858d933ad6">Non-accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6N2MzMjdhMmM4MzUwNGY3MmFjNDNjZTkyNTk1Y2IxMWEvdGFibGVyYW5nZTo3YzMyN2EyYzgzNTA0ZjcyYWM0M2NlOTI1OTVjYjExYV8wLTctMS0xLTYzNDAz_f61c215c-aa82-47f0-99b7-c79a25c3cabe">x</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6N2MzMjdhMmM4MzUwNGY3MmFjNDNjZTkyNTk1Y2IxMWEvdGFibGVyYW5nZTo3YzMyN2EyYzgzNTA0ZjcyYWM0M2NlOTI1OTVjYjExYV8yLTEtMS0xLTYzNDA1_e5f74350-9767-4be4-a89f-d8b6b56734cc">o</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDcx_6259b3ec-9670-4d69-b6d8-d7acceb559e3">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDky_909e15e6-8f7b-4f9a-804b-5e6fbd4d9c94">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s voting equity held by non-affiliates of the registrant, computed by reference to the price at which the common stock was last sold as of the last business day of the registrants most recently completed second fiscal quarter, was $<ix:nonFraction unitRef="usd" contextRef="ib7b671a11ff144cdb841c10e00e545b2_I20210630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV8zMjk4NTM0ODg3NTk4_949184ab-2e07-4712-9d01-bd1f1c6a68ea">370,281,189</ix:nonFraction>. In determining the market value of the voting equity held by non-affiliates, securities of the registrant beneficially owned by directors and officers of the registrant and persons who hold 10% or more of the outstanding common stock of the registrant have been excluded. This determination of affiliate status is not necessarily a conclusive determination for other purposes. The number of shares of the registrant&#8217;s common stock outstanding as of March&#160;7, 2022 was <ix:nonFraction unitRef="shares" contextRef="i71d72a1442944b90bab79e5eb66f6ea8_I20220307" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV8xMDk5NTExNjMxODg5_9e38d330-024b-42f7-9f06-1529fb1f7ee5">20,547,517</ix:nonFraction>.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80Mzk4MDQ2NTE1MjI2_3dca1406-834f-4dd7-b692-64c814783bc6" escape="true">Portions of the registrant&#8217;s definitive proxy statement to be filed with the Securities and Exchange Commission in connection with the solicitation of proxies for its 2022 Annual Meeting of Stockholders are incorporated by reference in Part III of this Form 10-K.</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.954%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_13">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_16">3</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_19">Item1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_19">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_19">9</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_22">Item 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_22">20</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_25">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_25">20</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_28">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_28">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_28">20</a></span></div></td></tr><tr style="height:9pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_31">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_31">20</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_34">PART II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_37">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_37">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_37">21</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_40">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_40">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_40">22</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_43">Item 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_43">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_43">23</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_76">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_76">Quantitative and Qualitative Disclosure About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_76">34</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_79">Item 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_79">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_79">36</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_169">Item 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_169">Changes in and Disagreements with Accountants on Accounting and Financial Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_169">71</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_172">Item&#160;9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_172">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_172">71</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_175">Item 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_175">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_175">72</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_6047313954737">Item 9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_6047313954737">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_6047313954737">72</a></span></div></td></tr><tr style="height:9pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_178">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_181">Item 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_181">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_181">73</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_184">Item 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_184">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_184">73</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_187">Item 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_187">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_187">73</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_190">Item 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_190">Certain Relationships and Related Transactions and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_190">74</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_193">Item 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_193">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_193">74</a></span></div></td></tr><tr style="height:9pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_196">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_199">Item 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_199">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_199">75</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9e717b65c1e3405d850ef6e342b20071_202">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_202">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_202">80</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">References in this Form 10-K to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">we</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">us</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, or the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are to InfuSystem Holdings, Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">InfuSystem</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">) and our wholly owned subsidiaries, as appropriate to the context.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement About Forward-Looking Statements</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements contained in this Form 10-K are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). The words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;likely,&#8221; variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. In connection with the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, the Company is identifying certain factors that could cause actual results to differ, perhaps materially, from those indicated by these forward-looking statements. InfuSystem does not intend and does not undertake any obligation to update any forward-looking statement to reflect future events or circumstances after the date of such statements, except as may be required by law. Important factors that could cause our actual results and financial condition to differ materially from the forward-looking statements include, without limitation, those described in &#8220;Risk Factors&#8221; and elsewhere in this Form 10-K, and the following:</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in third-party reimbursement processes, rates, contractual relationships and payer mix;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on estimates of collectible revenue from third-party reimbursement;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with the loss of a relationship with one or more third-party payers;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with a federal government shutdown;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with the federal government&#8217;s sequestration;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with payer concentration;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">physicians&#8217;&#160;acceptance of infusion pump therapy over alternative therapies and focus on early detection and diagnostics;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on our Medicare Suppler Number, which allows us to bill Medicare for services provided to Medicare patients;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of chemotherapy drugs used in our infusion pump systems;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding enacted and potential legislative and regulatory changes impacting, among other things, the level of reimbursement received from the Medicare and state Medicaid programs including the Center for Medicare and Medicaid Services (&#8220;CMS&#8221;) competitive bidding;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence upon our suppliers;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">periodic reviews and billing audits from governmental and private payers;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain controls and processes over billing and collection and the adequacy of our allowance for doubtful accounts and customer concessions;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with state licensure laws for Durable Medical Equipment suppliers;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with our allowance for doubtful accounts and customer concessions;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to execute our business strategies to grow our business, including our ability to introduce new products and services;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">industry competition;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with regulatory guidelines affecting our billing practices;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">defective products manufactured by third-party suppliers;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to execute on acquisition and joint-venture opportunities and integrate any acquired businesses;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain relationships with health care professionals and organizations;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with changing health care regulations;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to remain in compliance with our credit agreement or future debt agreements;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic uncertainty;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in tax laws or challenges to our tax positions;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the value of our net operating loss carryforwards may become impaired if we do not generate sufficient future taxable income required to utilize all or a portion of our net operating loss carryforwards prior to their expiration;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility in the market price of our stock;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the future price of our stock may be negatively affected by not paying dividends;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential dilution to current stockholders from the issuance of equity awards;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be subject to limitations on net operating loss carryforwards and certain built-in losses following an ownership change;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the coronavirus (&#8220;COVID-19&#8221;) pandemic on our business including the impacts from the ongoing coronavirus variants, including Delta and Omicron, and other future variants;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation or other legal or regulatory proceedings in which we may be involved from time to time;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with the collection of sales or consumption taxes;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to implement, both internally and externally, information technology improvements and to respond to technological changes, interruptions and security breaches;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters, pandemics, acts of war or terrorism and other external events affecting us, our customers or our suppliers; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to hire and retain key employees.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks are not exhaustive. Other sections of this Form 10-K include additional factors which could adversely impact our business and financial performance. Moreover, we operate in a very competitive and changing environment. New risk factors emerge from time to time and it is not possible for us to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. All forward-looking statements made in this Form 10-K speak only as of the date of this report. We do not intend, and do not undertake any obligation, to update any forward-looking statements to reflect future events or circumstances after the date of such statements, except as required by law.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely upon forward-looking statements as predictions of future events. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Therefore, you should not rely on any of the forward-looking statements. In addition, with respect to all of our forward-looking statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Industry Data</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Form&#160;10-K contains market, industry and government data and forecasts that have been obtained from publicly available information, various industry publications and other published industry sources. We have not independently verified the information and cannot make any representation as to the accuracy or completeness of such information. None of the reports and other materials of third-party sources referred to in this Form&#160;10-K were prepared for use in, or in connection with, this report.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademarks and Tradenames</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a number of registered trademarks, including Ambulatory Infusion Made Easy&#174;, Biomed Made Easy&#174;, BlockPain Dashboard&#174;, EXPRESSTech&#174; and Infusion Made Easy&#174;. These and other trademarks of ours appearing in this report are our property. Solely for convenience, trademarks and trade names of ours referred to in this Form 10-K may appear without the &#174; or &#8482; symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks and trade names. This report may contain additional trade names and trademarks of other companies. We do not intend our use or display of other companies' trade names or trademarks to imply an endorsement or sponsorship of us by such companies, or any relationship with any of these companies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_16"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a Delaware corporation, formed in 2005. It operates through operating subsidiaries, including InfuSystem Holdings USA, Inc., a Delaware corporation (&#8220;Holdings&#8221;), InfuSystem, Inc., a California corporation (&#8220;ISI&#8221;), First Biomedical, Inc., a Kansas corporation (&#8220;First Biomedical&#8221;), and IFC, LLC, a Delaware limited liability company (&#8220;IFC&#8221;).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Concept and Strategy</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national health care service provider, facilitating outpatient care for Durable Medical Equipment manufacturers and health care providers. We provide our products and services to hospitals, oncology practices, ambulatory surgery centers, and other alternate site health care providers. Our headquarters is in Rochester Hills, Michigan, and we operate our business from a total of seven locations in the United States and Canada.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our services are provided under a two-platform model. Our lead platform, Integrated Therapy Services (&#8220;ITS&#8221;), provides the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex Durable Medical Equipment and services. Our second platform, Durable Medical Equipment Services (&#8220;DME Services&#8221;), supports our ITS platform and leverages strong service orientation to win incremental business from our direct payer clients. Starting in the fourth quarter of 2019, we reorganized the Company&#8217;s segment reporting to reflect this two-platform approach, and made changes to our internal reporting and the information evaluated by our chief operating decision-maker consistent with this approach.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe InfuSystem has a lot to offer the healthcare community. Over the last 30 plus years, we have developed a unique expertise and service offering that Durable Medical Equipment manufacturers and health care providers are using to reduce costs, improve service, and most importantly, provide welcome options for patients who want to continue their healthcare treatments from home. We perfected our ITS model in oncology and have proven that we can extend this model into other Durable Medical Equipment therapies. Key is the ability to leverage our existing platforms &#8211; the new therapies do not require building a new infrastructure; we simply add incrementally to the systems already in place (e.g., sales, clinical, logistics, revenue cycle management, and biomedical services).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ITS is presented as a &#8220;turnkey&#8221; solution allowing our health care provider customers to focus on the practice of medicine. InfuSystem provides the Durable Medical Equipment and treatment consumables, handles the logistics around orders and deliveries, provides 24x7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services (inspection, repair, certification and replacement) for the Durable Medical Equipment. DME Services are provided as a &#8220;concierge&#8221; offering, whereby InfuSystem leverages its strong service orientation to provide incremental services to our health care provider customers on a direct payer model. DME Services include equipment rental and sales, consumable sales, and biomedical support services.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InfuSystem competes for and retains its business primarily on the basis of its long participation and strong reputation in the Durable Medical Equipment space, its long-standing relationships with Durable Medical Equipment manufacturers and its health care provider customers, and the high levels of service it provides. Current barriers to entry for potential competitors are created by our: (i) growing number of third-party payer networks under contract, which included nearly 770</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> third-party payer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> networks for the fiscal year ended December&#160;31, 2021, an increase of 6% over the prior year period; (ii) economies of scale, which allow for predictable reimbursement and less costly purchase and management of the pumps, respectively; (iii) established, long-standing relationships as a provider of pumps to outpatient oncology practices in the U.S. and Canada; (iv) pump fleet of ambulatory and large volume infusion pumps for rent and for sale, which may allow us to be more responsive to the needs of physicians, outpatient oncology practices, hospitals, outpatient surgery centers, homecare practices, patient rehabilitation centers and patients than a new market entrant; (v) seven geographic locations in the U.S. and Canada that allow for same-day or next-day delivery of pumps; and (vi) pump repair and service capabilities at all of these facilities. We do not perform any research and development on pumps, but we have made, and continue to make, investments in our information technology.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ITS Segment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ITS segment&#8217;s core purpose is to seek opportunities to leverage our unique know-how in clinic-to-home health care involving Durable Medical Equipment, our logistics and billing capabilities, our growing network of third-party payers under contract, and our clinical and biomedical capabilities. This leverage may take the form of new products and/or services, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">strategic alliances, joint ventures and/or acquisitions. The leading service within our ITS segment is to supply electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states (&#8220;Oncology Business&#8221;). Colorectal cancer is the third most prevalent form of cancer in the United States, according to the American Cancer Society, and the standard of care for the treatment of colorectal cancer relies upon continuous chemotherapy infusions delivered via ambulatory infusion pumps. One of the primary goals for the ITS segment is to expand into treatment of other types of cancers. In 2021, our Oncology Business approximated 92% of our total ITS segment net revenues. In 2021, we generated approximately 49%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of our total ITS segment net revenues from treatments for colorectal cancer and 44% of our ITS segment net revenues from treatments for non-colorectal disease states. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of approved treatment protocols for pancreatic, head and neck, esophageal and other types of cancers, as well as other disease states which present opportunities for growth. There are also a number of other drugs currently approved by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), as well as agents in the pharmaceutical development pipeline, which we believe could potentially be used with continuous infusion protocols for the treatment of diseases other than colorectal cancer. Additional drugs or protocols currently in clinical trials may also obtain regulatory approval over the next several years. If these new drugs or protocols obtain regulatory approval for use with continuous infusion protocols, we expect the pharmaceutical companies to focus their sales and marketing efforts on promoting the new drugs and protocols to physicians.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our Oncology Business focuses mainly on the continuous infusion of chemotherapy. Continuous infusion of chemotherapy can be described as the gradual administration of a drug via a small, lightweight, portable infusion pump over a prolonged period of time. A cancer patient can receive his or her medicine anywhere from one to 30 days per month depending on the chemotherapy regimen that is most appropriate to that individual&#8217;s health status and disease state. This may be followed by periods of rest and then repeated cycles with treatment goals of progression-free disease survival. This drug administration method has replaced intravenous push or bolus administration in specific circumstances. The advantages of slow continuous low doses of certain drugs are well documented. Clinical studies support the use of continuous infusion chemotherapy for decreased toxicity without loss of anti-tumor efficacy. The 2015 National Comprehensive Cancer Network (&#8220;NCCN&#8221;) Guidelines recommend the use of continuous infusion for treatment of numerous cancer diagnoses. We believe that the growth of continuous infusion therapy is driven by three factors: evidence of improved clinical outcomes; lower toxicity and side effects; and a favorable reimbursement environment.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of continuous infusion has been demonstrated to decrease or alter the toxicity of a number of cytotoxic, or cell killing, agents. Higher doses of drugs can be infused over longer periods of time, leading to improved tolerance and decreased toxicity. For example, the cardiotoxicity (heart muscle damage) of the chemotherapy drug Doxorubicin is decreased by schedules of administration according to The Chemotherapy Source Book by Michael C. Perry. Nausea, vomiting, diarrhea and decreased white blood cell and platelet counts are all affected by duration of delivery. Continuous infusion can lead to improved tolerance and patient comfort while enhancing the patient&#8217;s ability to remain on the chemotherapy regimen. Additionally, the lower toxicity profile and resulting reduction in side effects enables patients undergoing continuous infusion therapy to continue a relatively normal lifestyle, which may include continuing to work, going shopping, and caring for family members. We believe that the partnering of physician management and patient autonomy provide for the highest quality of care with the greatest patient satisfaction.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that oncology practitioners have a heightened sensitivity to providing quality service and to their ability to obtain reimbursement for services they provide. Simultaneously, CMS and private insurers are increasingly focused on evidence-based medicine to inform their reimbursement decisions &#8212; that is, aligning reimbursement with clinical outcomes and adherence to standards of care. Continuous infusion therapy is a main component of the standard of care for certain types of cancer because clinical evidence demonstrates superior outcomes. Payers&#8217; recognition of this benefit is reflected in their relative reimbursement policies for clinical services related to the delivery of this care.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional areas of focus for our ITS segment are as follows:</span></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pain Management - providing our ambulatory pumps, products, and services for pain management in the area of post-surgical continuous peripheral nerve block.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Negative Pressure Wound Therapy (&#8220;NPWT&#8221;) - as announced in February 2020, includes providing the Durable Medical Equipment, overseeing logistics, biomedical services, and managing third-party billing of the U.S. home health care market, which as a subset of the broader NPWT market, has an estimated addressable home health care market of $600 million per year.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Acquisitions - we believe there are opportunities to acquire smaller, regional health care service providers, in whole or in part that perform similar services to us but do not have the national market access, network of third-party payer contracts or operating economies of scale that we currently enjoy. We may also pursue acquisition </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="padding-left:63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opportunities of companies that perform similar services, but offer different therapies or utilize different devices.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lymphedema Therapy &#8211; as announced in June 2021, Lymphedema therapy includes providing patient care and customer service, pneumatic compression devices and associated garments through our partnership with Bio Compression Systems, Inc. to outpatients, initially targeting our existing acute care and oncology customers, estimated to be 20% of the multi-billion-dollar Lymphedema market.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Information technology-based services - we also plan to continue to capitalize on key new information technology-based services such as EXPRESS, InfuSystem Mobile, InfuBus or InfuConnect,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pump Portal and BlockPain Dashboard&#174;.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payer environment within our ITS segment is in a constant state of change. We continue to extend our considerable breadth of payer networks under contract as patients move into different insurance coverage plans, including Medicaid and Insurance Marketplace products. In some cases, this may slightly reduce our aggregate billed revenues payment rate but result in an overall increase in collected revenues, due to a reduction in concessions. Consequently, we are increasingly focused on revenues net of concessions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DME Services Segment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our DME Services segment&#8217;s core service is to: (i) sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; (ii) sell treatment-related consumables; and (iii) provide biomedical recertification, maintenance and repair services for oncology practices as well as other alternate site settings, including, hospitals, home care and home infusion providers, skilled nursing facilities, pain centers and others. We also provide these products and services to customers in the hospital market. We purchase new and pre-owned pole-mounted and ambulatory infusion pumps from a variety of sources on a non-exclusive basis. We repair, refurbish and provide biomedical certification for the devices as needed. The pumps are then available for sale, rental or to be used within our ambulatory infusion pump management service. Our recent acquisition of FilAMed, a privately-held biomedical services company, on January&#160;31, 2021 will supplement the Company&#8217;s existing biomedical recertification, maintenance and repair services for acute care facilities and other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. Our recent acquisition of OB Healthcare Corporation (&#8220;OB Healthcare&#8221;), a privately-held biomedical services company, on April&#160;18, 2021 further develops and expands InfuSystem&#8217;s DME Services segment and complements the Company&#8217;s purchase of FilAMed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ITS Segment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our core service within our ITS segment is our Oncology Business. After providing ambulatory pumps to oncology offices, infusion clinics, and hospital and outpatient chemotherapy clinics, we then directly bill and collect payment from payers and patients for the use of these pumps. At any given time, our pumps are in the possession of these facilities, on a patient, in transit, or in our facilities for cleaning, calibration and storage as reserves for increased demand.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a physician determines that a patient is eligible for ambulatory infusion pump therapy, the physician arranges for the patient to receive an infusion pump and provides the necessary chemotherapy drugs. The physician and nursing staff train the patient in the use of the pump and initiate service. The physician bills the payers, which may include Medicare, Medicaid, third-party payer companies or patients for the physician&#8217;s professional services associated with initiating and supervising the infusion pump administration, as well as the supply of drugs. We directly bill (i) payers, (ii) facilities of our Medicare patients, and (iii) patients for the use of the pump and related disposable supplies. Billing to payers requires coordination with patients and physicians who initiate the service, as physicians&#8217; offices must provide us with appropriate documentation (patient&#8217;s insurance information, physician&#8217;s order, an acknowledgement of benefits that shows receipt of equipment by the patient, and, in some cases, physician&#8217;s progress notes) in order for us to submit a bill to the payers. We provide assistance to those that cannot afford our pumps via our financial hardship program &#8211; a program that usually matches what our physician practices provide as long as the uninsured patients meet certain criteria. This billing process is handled from our Rochester Hills, Michigan location.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to providing high quality and convenient care, we believe that our business offers significant economic benefits for patients, providers and payers.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We support our patients throughout the treatment process by providing patients with 24x7 service and support. InfuSystem Mobile provides patients with secure, two-way communication with our clinical support team, the latest infusion safety technology, and infusion therapy expertise in a convenient and easy-to-use app.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Physicians use our services to outsource the capital commitment, pump service, maintenance and billing and administrative burdens associated with pump ownership. Our services also allow the doctor to continue a direct relationship with the patient and to receive professional service fees for setting up the treatment and administering the drugs.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our clinical support team employs oncology, pain, Intravenous Certified, and Oncology Certified registered nurses trained on ambulatory infusion pump equipment who staff our 24x7 hotline to address questions that patients may have about their pump treatment, the infusion pumps or other medical or technical questions related to the pumps.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We provide methods for the physician offices to deliver the appropriate paperwork for billing through a number of electronic means including EXPRESS and InfuConnect reducing the required effort on the employees of the physician offices.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We believe our services are attractive to payers because such services are generally less expensive than hospitalization or standalone home health care.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, within ITS, we offer pain management services via electronic ambulatory infusion pumps for post-operative pain management using our pumps along with a numbing agent and a continuous nerve block catheter &#8211; continuous peripheral nerve block (&#8220;CPNB&#8221;). Using CPNB for the management of post-operative pain, which usually lasts two to three days after surgery, can result in reduced pain for the patient, increased satisfaction scores for the surgical center or hospital, and reduced need for post-operative opioid pain medication. These services include our patient care call center interaction offering support to patients and the review and collection of pain score patient outcome data for outpatient surgery centers using our proprietary BlockPain Dashboard&#174;.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DME Services Segment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other services we offer are classified under our DME Services segment and include the rental, sale or leasing and servicing of pole-mounted and ambulatory infusion pumps to oncology practices, hospitals and other clinical settings. These pumps are available for daily, weekly, monthly or annual rental periods. We also sell treatment consumables that can be used in conjunction with the pumps we sell and rent.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to sales, rental and leasing services, we also provide biomedical maintenance, repair and certification services for the devices we offer as well as for devices owned by customers but not acquired from us. We operate pump service and repair &#8220;Centers of Excellence&#8221; from all of our locations across the United States and Canada and employ a staff of highly-trained technicians to provide these services. Our main Center of Excellence for service is our Lenexa, Kansas facility.  In addition to the maintenance and repair services we perform at these facilities, we offer similar services that can be performed directly at our customer locations nation wide through our team of traveling biomedical technicians. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, our rental fleet of pole-mounted pumps, ambulatory pumps and NPWT medical equipment for both our ITS and DME Services segments had a historical cost of $91.9 million, up from $83.4 million at the end of 2020, and included approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125 makes and models</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of equipment dedicated to our rental services. Additionally, as of December 31, 2021 and 2020, we had a fleet of new and used pole-mounted pumps, ambulatory pumps and NPWT medical equipment with a historical cost of $1.8 million and $1.6 million, respectively, for sale or rental.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Technology</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Information Technology (&#8220;IT&#8221;) department is focused on not only supporting our internal IT infrastructure needs, but also supporting our revenue cycle management infrastructure including our electronic medical record technology (&#8220;EMR&#8221;) that allows medical facilities to use our infusion pumps and services via our solutions such as EXPRESS and InfuConnect. This focus has enabled current billing information to be transferred to us from participating facilities electronically and automatically. Our focus on IT solutions resulted in the development of EXPRESS, a product powered by our InfuBus data integration platform, and provides for paperless delivery of the appropriate information for InfuSystem to bill payers that:</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">eliminates all paper;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provides an enhanced visibility as a result of real time status and reporting;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduces risk of error;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">automates treatment logs, pump assignments, tracking and physician&#8217;s orders;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provides a secure scanner for easy pump assignment to patients; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">removes interruptions from physician practices&#8217;&#160;daily schedules, and standardizes data flow for clinics and hospitals with multiple locations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Relationships with Physician Offices</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had business relationships with clinical oncologists in over 2,100 outpatient oncology clinics. Although this represents a substantial number of the oncologists in the United States, we believe that we can continue to expand our network to further penetrate the oncology market. Based on our retention rates and the positive results of our professional customer satisfaction research, we believe our relationships with physician offices are strong.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, in general, we do not compete directly with hospitals and physician offices to treat patients. Rather, by providing products and services to hospitals and physician offices and other care facilities and providers, we believe that we assist other providers in meeting increasing patient demand and managing institutional constraints on capital and manpower due to the nature of limited resources in hospitals and physician offices.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physician practices in the oncology field are following the overall healthcare practices trend to consolidate. However, as of December&#160;31, 2021, we had gained more facilities than we had lost. We expect this trend to continue for the foreseeable future.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employees</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had 407 employees, including 394 full-time employees and 13 part-time or contract employees. None of our employees are unionized.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Suppliers</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We supply a wide variety of pumps and associated equipment, as well as disposables and ancillary supplies. The majority of our pumps are electronic infusion pumps. Smiths Medical, Inc. and Moog Medical Devices Group each supplied more than 10% of the ambulatory pumps purchased by us in 2021. The Company has a supply agreement in place with each of these suppliers. Certain &#8220;spot&#8221; purchases are made on the open market subject to individual negotiation. We also supply NPWT medical equipment, as well as related disposables and ancillary supplies. Cardinal Health, Inc. supplied more than 10% of the NPWT medical equipment purchased by us in 2021. The Company has a supply agreement in place with Cardinal Health, Inc.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues may be seasonal due to the impact of co-pays and deductibles for patients&#8217; insurance that traditionally reset each January. This has been further impacted by changes in the insurance industry as it responds to increased government regulation. Also, rental customers tend to make buy versus rent decisions late in the year as customer capital budgets are being finalized, impacting sales revenue in the second half of the year, predominantly in the fourth quarter. Furthermore, as the Company&#8217;s liquidity has improved, opportunistic pump purchases are made from time to time. These opportunistic pump purchases also allow for opportunistic pump sales, which could be material. The timing of such purchases and sales vary within the course of a year.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Laws</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to comply with applicable federal, state and local environmental laws regulating the disposal of cleaning agents used in the process of cleaning our ambulatory infusion pumps and NPWT medical equipment, as well as the disposal of sharps and blood products used in connection with the pumps and medical equipment. We do not believe that compliance with such laws has a material effect on our business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Customers</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have sought to establish contracts with as many third-party payer organizations as commercially practicable, in an effort to ensure that reimbursement is not a significant obstacle for providers who recommend continuous infusion therapy and wish to utilize our services. A third-party payer organization is a health care payer or a group of medical services payers that contracts to provide a wide variety of health care services to enrolled members through participating providers such as us. A payer is any entity that pays on behalf of a member patient.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had contracts with nearly 770 third-party payer networks, an increase of 6% over the prior year period. Material terms of contracts with third-party payer organizations are typically a pre-negotiated fee schedule rate or a then-current proprietary fee schedule rate for equipment and supplies provided. The majority of these contracts generally provide for a term of one year, with automatic one-year renewals, unless we or the contracted payer elect not to renew. We also contract with various other third-party payer organizations, Medicaid, commercial Medicare replacement plans, self-insured </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plans, facilities of our Medicare patients and numerous other insurance carriers. No single payer or customer represented more than 10% of net revenue in 2021, 2020 or 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competitors</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our competition primarily consists of national, regional, and hospital-owned Durable Medical Equipment providers, physician providers and home care infusion providers and the competitive products and services they offer. An estimate of the number of competitors is not known or reasonably available, due to the wide variety in type and size of the market participants described below. We are not aware of any industry reports with respect to the competitive market described below. The description of market segments and business activities within those market segments is based on our experiences in the industry.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">National Durable Medical Equipment Providers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Other national providers have offerings similar to us. These products and service offerings include, but are not limited to, third-party reimbursement, direct rental and sale of infusion electronic and disposal pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Regional Durable Medical Equipment Providers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Regional Durable Medical Equipment providers act as distributors for a variety of medical products. We believe regional Durable Medical Equipment provider sales forces generally consist of a relatively small number of salespeople, usually covering several states. Regional Durable Medical Equipment providers tend to carry a limited selection of infusion pumps and their salespeople generally have limited resources. Regional Durable Medical Equipment providers usually do not have 24x7 nursing services. We believe that Regional Durable Medical Equipment providers have relatively few third-party payer contracts, which may prevent these providers from being paid at acceptable levels and may also result in higher out-of-pocket costs for patients.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Hospital-owned Durable Medical Equipment Providers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Many hospitals have in-house Durable Medical Equipment providers to supply basic equipment. In general, however, these providers have limited capital and tend to stock a small inventory of infusion pumps. We believe that hospital-owned providers have limited ability to grow because of limited patient populations. Growth from outside of the hospital may pose a challenge because hospitals typically will not provide referrals to competitors, instead preferring to offer patients a choice of non-hospital-affiliated Durable Medical Equipment providers.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Physician Providers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: A limited number of physicians maintain an inventory of their own infusion pumps and provide them to patients for a fee. However, we believe that pump utilization in this area tends to be low and the costs associated with ongoing supplies, preventative maintenance and repairs can be relatively high. Moreover, we believe that a high percentage of Durable Medical Equipment claims by doctors are rejected by payers upon first submission, requiring a physician&#8217;s staff to spend significant time and effort to resubmit claims and receive payment for treatment. The numerous service and technical questions from patients may present another significant cost to a physician provider&#8217;s staff.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Home Care Infusion Providers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Home care infusion providers provide chemotherapy drugs and services to allow for in-home patient treatment. We believe that home care infusion treatment can be very costly and that many patients do not carry insurance coverage that covers home-based infusion services, resulting in larger out-of-pocket costs. Because home care treatments may take as long as six months, these costs can be high and can result in higher patient co-payments. We believe that home care providers may also be reluctant to offer 24x7 coverage or additional patient visits, due to capped fees.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation of Our Business</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to various regulations. Specifically, as a registered Medicare supplier of Durable Medical Equipment and related supplies, we must comply with supplier standards established by CMS regulating Medicare suppliers of Durable Medical Equipment, Prosthetics, Orthotics and Supplies (&#8220;DMEPOS Supplier Standards&#8221;). The DMEPOS Supplier Standards consist of 30 requirements that must be met in order for a DMEPOS supplier to be eligible to receive payment for a Medicare-covered item. Some of the more significant DMEPOS Supplier Standards require us to (i)&#160;advise Medicare beneficiaries of their option to purchase certain equipment, (ii)&#160;honor all warranties under state law and not charge Medicare beneficiaries for the repair or replacement of equipment or for services covered under warranty, (iii)&#160;permit CMS agents to conduct on-site inspections to ascertain compliance with the DMEPOS Supplier Standards, (iv)&#160;maintain liability insurance in prescribed amounts, (v)&#160;refrain from contacting Medicare beneficiaries by telephone, except in certain limited circumstances, (vi)&#160;answer questions and respond to complaints of beneficiaries regarding the supplied equipment, (vii)&#160;disclose the DMEPOS Supplier Standards to each Medicare beneficiary to whom we supply equipment, (viii)&#160;maintain a complaint resolution </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">procedure and record certain information regarding each complaint, (ix)&#160;maintain accreditation from a CMS approved accreditation organization, and (x)&#160;meet certain specified surety bond requirements.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to the provisions of the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), which are designed to protect the security and confidentiality of certain protected health information. Under HIPAA, we must provide patients access to certain records and must notify patients of our use of protected health information and patient privacy rights. Moreover, HIPAA sets limits on how we may use individually identifiable health information and prohibits the use of patient information for marketing purposes. The adoption of the American Recovery and Reinvestment Act of 2009 (&#8220;ARRA&#8221;) includes a new breach notification requirement that applies to breaches of unsecured health information occurring on or after September&#160;23, 2009. We are subject to regulations in the various states in which we operate. We believe we are in material compliance with all such regulations.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively the ACA, imposed a 2.3% excise tax on medical devices that applied to sales within the United States of a majority of our pump products that we purchase. This law imposed an excise tax on the first sale of medical devices by a manufacturer, producer, or importer equal to 2.3% of the sales price. This tax only applied directly to new pumps that we purchase from manufacturers. Taxable medical devices included any device as defined in Section 201(h) of the Federal Food, Drug, and Cosmetic Act intended for humans, with the exception of eyeglasses, contact lenses, hearing aids and any other device determined by the Secretary of Health and Human Services to be a type which was generally purchased by the general public at retail for individual use. On December 18, 2015, under the Consolidated Appropriations Act, 2016 (Pub. L. 114-113), a two-year moratorium on the medical device excise tax was imposed by Section 4191 of the Internal Revenue Code (the &#8220;Code&#8221;). On January 22, 2018, the H.R. 195: Extension of Continuing Appropriations Act Bill extended the then-existing suspensions of the ACA&#8217;s medical device excise tax through 2019. The Further Consolidated Appropriations Act, 2020 H.R. 1865 (Pub. L. 116-94), signed into law on December 20, 2019, repealed the medical device excise tax. As a result of the repeal and the prior moratorium, sales of taxable medical devices after December 31, 2015, are not subject to the tax. Though the repeal and prior moratorium are favorable for our Company, future legislation could have a material effect on our business, cash flows, financial condition and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Internet address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.infusystem.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On this website, we post the following filings as soon as reasonably practicable after they are electronically filed with or furnished to the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;): our Annual Reports on Form 10-K; our Quarterly Reports on Form 10-Q; our Current Reports on Form 8-K; our proxy statements related to our annual stockholders&#8217; meetings; and any amendments to those reports or statements. All such filings are available on our website free of charge. The charters of our audit, nominating and governance and compensation committees and our Code of Business Conduct and Ethics Policy are also available on our website and in print to any stockholder who requests them. The content on our website is not incorporated by reference into this Form 10-K unless expressly noted.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_19"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1A.&#160;&#160;&#160;&#160;Risk Factors.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">An investment in our securities involves a high degree of risk. You should consider carefully all of the material risks described below, together with the other information contained in this Form 10-K. If any of the following events occur, our business, financial condition, results of operations and cash flows may be materially adversely affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS RELATING TO OUR BUSINESS AND THE INDUSTRY IN WHICH WE OPERATE</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is substantially dependent on third-party reimbursement. Any change in the overall health care reimbursement system may adversely impact our business.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are substantially dependent on third-party reimbursement. We are paid directly by private insurers and, in some cases, governmental agencies, often on a fixed fee basis, for the use of continuous infusion equipment and related disposable supplies provided to patients. If the average fees allowable by private insurers or governmental agencies were reduced, the negative impact on revenues could have a material effect on our business, financial condition, results of operations and cash flows. Also, if amounts owed to us by patients and insurers are reduced or not paid on a timely basis, we may be required to increase our concessions and/or decrease our revenues.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the health care reimbursement system often create financial incentives and disincentives that encourage or discourage the use of a particular type of product, therapy or clinical procedure. Such changes may be impacted by the growth in ACOs, reduction of providers by payers, the use of lower cost rental networks and other factors. Market acceptance of continuous infusion therapy may be adversely affected by changes or trends within the health care reimbursement system. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to the health care reimbursement system that favor other technologies or treatment regimens that reduce reimbursements to providers or treatment facilities, including increasing competitive pressures from home health care and other companies that use our services, may adversely affect our ability to market our services profitably. Overall, such dependency and potential changes could materially and adversely affect our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is substantially dependent on estimates of collectible revenue from third-party reimbursement.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are substantially dependent on estimates of collectible revenue from third-party reimbursement. Due to the complex nature of third-party reimbursement for the use of continuous infusion equipment and related disposable supplies provided to patients, we must estimate, based upon historical averages, the amount of collectible revenue that may be derived from each patient treatment. If average reimbursement rates diverge from historical levels, the estimates of such revenue may diverge from actual collections.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize statistical methods to account for such changes, but there can be no assurance that the revenue reported in any period will ultimately be collected. Any recognized revenue related to third-party reimbursement from prior periods, which remains uncollected until written off from accounts receivable, will negatively impact revenues in the period in which it is written off. Thus, over time, recognized revenue net of concessions will approximate total collections.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The loss of a relationship with one or more third-party payers could negatively impact our business.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts for reimbursement with third-party payers are often for a term of one year, with automatic one-year renewals, unless we or the contracted payer elect not to renew. These evergreen contracts are subject to termination upon written notice. One or more terminations could have a material and adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any federal government shutdown may adversely impact our business.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are dependent on private insurers and governmental agencies. In the absence of any bipartisan agreement in the federal government with respect to payments from governmental agencies, our revenues could be reduced. In addition, any federal government shutdown could also have a material and adverse impact on our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business has and may continue to be adversely impacted by the U.S. federal government</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s sequestration.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2013, most agencies of the U.S. federal government automatically reduced their budgets according to an agreement made by Congress in 2012 known as &#8220;sequestration.&#8221; Originally devised as an incentive to force Congressional agreement on budget issues, the sequestration order was approved on March 1, 2013 by the President of the United States. Beginning in 2013, we were impacted by the sequestration order, which affects Medicare payments. For the years ended December&#160;31, 2021 and 2020, there was no impact on our net revenues, while for the year ended December&#160;31, 2019 there was a $0.1 million impact to our net revenues. Sequestration mainly applied to payments received from Medicare Advantage plans by the Company. As of the date of this report, it is our understanding that the mandatory payment reduction of 2% will continue until further notice, although it has currently been suspended temporarily until March 2022 by The Protecting Medicare and American Farmers from Sequester Cuts Act. Thereafter, the payment reduction sequestration will continue from April 1 through June 30, 2022 at a 1% payment reduction rate and at the full 2% payment reduction rate indefinitely thereafter until definitive action is taken by the U.S federal government on this issue.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payer concentration may adversely impact our business.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had contracts with nearly 770 third-party payer networks, an increase of 6% over the prior year period. Material terms of contracts with third-party payer organizations are typically a pre-negotiated fee schedule rate or a then-current proprietary fee schedule rate for equipment and supplies provided. The majority of these contracts generally provide for a term of one year, with automatic one-year renewals, unless we or the contracted payer elect not to renew. We also contract with various other third-party payer organizations, Medicaid, commercial Medicare replacement plans, self-insured plans, facilities of our Medicare patients and numerous other insurance carriers. No single payer represented more than 10% of net revenue in 2021, 2020 or 2019. To the extent such dependency were to occur, significant fluctuations in revenues, results of operations and liquidity could arise if any significant contracted payer reduces its reimbursement for the services we provide.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our billing process is dependent on meeting payer claims processing guidelines which are subject to change at the discretion of the payers. Such changes would materially impact our ability to bill and the timing of such billings, which could </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">materially and adversely impact our net revenues and cash flows, which impact would be even greater if such changes are made by one of our larger payers.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The continued consolidation of physician practices, outpatient infusion clinics, oncology clinics, homecare providers and hospitals, increases the concentration of decision makers whom either choose to use our ambulatory electronic pumps within our Oncology Business or directly rent, lease or purchase pumps or supplies from us.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we make every effort to benefit from such concentration, it could materially and adversely affect our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increased focus on early detection and diagnostics may adversely affect our business.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An increased focus on lowering health care spending via improved diagnostic testing (i.e., defensive medicine) and patient monitoring could materially and negatively affect our business. A large portion of our ambulatory infusion pumps are dedicated to a specific form of cancer (i.e., colorectal). As a result of rising health care costs, there may be a demand for more cost-effective approaches to disease management, specifically for colorectal cancer, as well as for emphasis on screening and accurate diagnostic testing to facilitate early detection of potentially costly, severe afflictions. Any change in the approach to treatment of colorectal cancer could have a material and adverse impact on our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If future clinical studies demonstrate that oral medications or other therapies that do not use our electronic ambulatory pumps are at least as effective as continuous infusion therapy, our business could be adversely affected.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ongoing clinical trials are currently evaluating and comparing the therapeutic benefits of current continuous infusion-based regimens with various oral medication regimens. If these clinical trials demonstrate that oral medications provide equal or greater therapeutic benefits and/or demonstrate reduced side effects compared to prior oral medication regimens, our revenues and overall business could be materially and adversely affected. Additionally, if new oral medications or other therapies that do not utilize our ambulatory electronic pumps are introduced to the market that are superior to existing oral therapies, physicians&#8217; willingness to prescribe continuous infusion-based regimens could decline, which would materially and adversely affect our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success is impacted by the availability of the chemotherapy drugs that are used in our continuous infusion pump systems.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily derive our revenues from the rental of ambulatory infusion pumps to oncology patients through physicians&#8217; offices and chemotherapy clinics. A shortage in the availability of chemotherapy drugs that are used in the continuous infusion pump system, which has occurred in the past, could have a material and adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on our Medicare Supplier Number.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to have a Medicare Supplier Number in order to have the ability to bill Medicare for services provided to Medicare patients. Furthermore, all third-party and Medicaid contracts require us to have a Medicare Supplier Number. We are required to comply with Medicare DMEPOS Supplier Standards in order to maintain such number. If we are unable to comply with the relevant standards, we could lose our Medicare Supplier Number. Without such number, we would be unable to continue our various third-party and Medicaid contracts. A significant portion of our revenues are dependent upon our Medicare Supplier Number, the loss of which would materially and adversely affect our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CMS requires that all Durable Medical Equipment providers must be accredited by a CMS-approved accreditation organization. On February&#160;17, 2009, we initially received accreditation from CHAP, and we have remained accredited to date. If we lost our accredited status, our business, financial condition, revenues and results of operations would be materially and adversely affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of United States health care reform legislation on us remains uncertain.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA has perpetuated the development of alternative provider payment models by CMS and the major national commercial payers. These payment models do not replace the current fee-for-service models nor replace current payer contracts, but rather provide additional financial incentives to certain &#8220;accountable&#8221; providers to improve quality and lower cost. The implications for the Company will come from the provider networks that are forming in order to integrate and coordinate care under these alternative models with CMS and the commercial payers. These provider networks include ACOs, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patient-centered primary care medical homes, specialty medical homes, networks accepting bundled payment programs, and other &#8220;performance&#8221; networks that contract with CMS and commercial payers under alternative payment models that financially reward improved quality and lower medical cost. The relationship between us and our provider practices and facilities that are participating in these provider networks under alternative payment models will depend on (i) the extent to which these provider networks give priority to the medical cost associated with our Durable Medical Equipment services and (ii) whether our services are seen as part of a care delivery model that delivers higher value &#8211; higher quality at a lower cost.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our failure to perform under these alternative payment models, or under similar models or conditions introduced by future legislation, could have a material adverse impact on our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on independent suppliers for our products. Any delay or disruption in the supply of products, particularly our supply of electronic ambulatory pumps, may negatively impact our operations.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our infusion pumps are obtained from outside vendors. The majority of our new pumps are electronic infusion pumps which are supplied to us by two major suppliers: Smiths Medical, Inc. and Moog Medical Devices Group. The loss or disruption of our relationships with outside vendors, including pumps, parts, or supply recall or pump end-of-life announcements or availability of related proprietary consumable supplies, could subject us to substantial delays in the delivery of pumps or services provided to customers. From time to time, we or our suppliers may experience supply chain disruptions due to circumstances beyond our or our suppliers&#8217; control, such as the 2020 outbreak of COVID-19. Significant delays in the delivery or service of pumps or related proprietary consumable supplies could result in possible cancellation of orders and the loss of customers. Our inability to provide pumps to meet delivery schedules could have a material adverse effect on our reputation in the industry, as well as on our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face periodic reviews and billing audits from governmental and private payers and these audits could have adverse results that may negatively impact our business.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our participation in the Medicaid program and our registration in the Medicare program, we are subject to various governmental reviews and audits to verify our compliance with these programs and applicable laws and regulations. We also are subject to audits under various government programs in which third-party firms engaged by CMS conduct extensive reviews of claims data and medical and other records to identify potential improper payments under the Medicare program. Private pay sources also reserve the right to conduct audits. If billing errors are identified in the sample of reviewed claims, the billing error can be extrapolated to all claims filed which could result in a larger overpayment than originally identified in the sample of reviewed claims. Our costs to respond to and defend reviews and audits may be significant and could have a material adverse effect on our business, financial condition, results of operations and cash flows. Moreover, an adverse review or audit could result in:</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required refunding or retroactive adjustment of amounts we have been paid by governmental or private payers&#894;</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state or Federal agencies imposing fines, penalties and other sanctions on us&#894;</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of our right to participate in the Medicare program, state programs, or one or more private payer networks&#894; or</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage to our business and reputation in various markets.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any one of these results could have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to maintain controls and processes over billing and collecting could have a significant negative impact on our Consolidated Financial Statements.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collection of accounts receivable is a significant challenge and requires constant focus and involvement by management and ongoing enhancements to information systems, billing center operating procedures and proper staffing levels. If we are unable to properly bill and collect our accounts receivable, our results could be materially and adversely affected. While management believes that our staffing, controls and processes are satisfactory, there can be no assurance that accounts receivable collectability will remain at current levels.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State licensure laws for Durable Medical Equipment suppliers are subject to change. If we fail to comply with any state laws, we will be unable to operate as a Durable Medical Equipment supplier in such state and our business operations will be adversely affected.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a Durable Medical Equipment supplier operating in all 50 states, we are subject to each state&#8217;s licensure laws regulating Durable Medical Equipment suppliers. State licensure laws for Durable Medical Equipment suppliers are subject to change and we must ensure that we are continually in compliance with the laws of all 50 states. In the event that we fail to comply with any state&#8217;s laws governing the licensing of Durable Medical Equipment suppliers, we will be unable to operate as a Durable Medical Equipment supplier in such state until we regain compliance. We may also be subject to certain fines and/or penalties and our business operations could be materially and adversely affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our customer concessions may not be adequate to cover actual losses.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our third-party payer contracts do not guarantee annual inflationary increases, typical of the Durable Medical Equipment payer contracting environment. Contracted reimbursement rates are either subject to increases or decreases in CMS program rates or, if not indexed to government rates, are frozen until those payer contracts are reopened and renegotiated. While we monitor reimbursement levels to identify specific payer reimbursement rates that have eroded and renegotiate such rates, we may not be able to maintain or improve overall reimbursement levels, thereby compromising the adequacy of the predicted customer concessions.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also face reduced reimbursements from private third-party payers. As a result, our customers may be unable to make timely payments to us. Although we maintain allowances for estimated losses resulting from the inability of our customers to make required payments, we cannot guarantee that we will continue to experience the same loss rates that we have in the past. If we begin to experience an increase in our loss rates in excess of our allowances, it could materially and adversely impact our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our growth strategy includes expanding into treatment for cancers other than colorectal cancer. There can be no assurance that continuous infusion-based regimens for these other cancers will become standards of care for large numbers of patients or that we will be successful in penetrating these different markets.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An aspect of our growth strategy is to expand into the treatment of other cancers, such as head, neck and gastric cancers. This population of patients will expand only if clinical trial results for new drugs and new combinations of drugs demonstrate superior outcomes for regimens that include continuous infusion therapy relative to alternatives. No assurances can be given that these new drugs and drug combinations will be approved or will prove superior to oral medication or other treatment alternatives. In addition, no assurances can be given that we will be able to penetrate successfully any new markets that may develop in the future or manage the growth in additional resources that would be required.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The industry in which we operate is intensely competitive and ever-changing. If we are unable to successfully compete with our competitors, our business operations may suffer.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The drug infusion industry is highly competitive. Some of our competitors and potential competitors, including some of the practices that we service, have significantly greater resources than we do for information technology, marketing and sales. As a result, they may be better able to compete for market share, even in areas in which our services may be superior. The industry is subject to technological changes and such changes may put our current fleet of pumps, smart pump licensing, our information technology solutions or our other technological-based solutions at a competitive disadvantage. Furthermore, the healthcare industry, in general, is experiencing market consolidation, reducing the number of decision makers. If we are unable to effectively compete in our market, our business, financial condition, results of operations and cash flows may be materially and adversely affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our industry is dependent on regulatory guidelines that affect our billing practices. If our competitors do not comply with these regulatory guidelines, our business could be adversely affected.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggressive competitors may not fully comply with rules regarding CMS and other payers&#8217; billing and documentation requirements. Competitors, who do not meet the same standards of compliance that we do with respect to billing regulations, may put us at a potential competitive disadvantage. We are a participating provider with Medicare and as of December&#160;31, 2021, we were under contract with </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nearly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 770 third-party payer networks, all of which have very stringent guidelines. If our competitors do not comply with these regulatory guidelines, we could be put at a potential competitive disadvantage and our business, financial condition, results of operations and cash flows could be material and adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Although we do not manufacture the products we distribute, if one of the products distributed by us proves to be defective or is misused by a health care practitioner or patient, we may be subject to liability that could adversely affect our financial condition and results of operations.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we do not manufacture the pumps that we distribute, a defect in the design or manufacture of a pump distributed or serviced by us, or a failure of pumps distributed by us to perform for the use specified, could have a material and adverse effect on our reputation in the industry and subject us to claims of liability for injuries and otherwise. Misuse of the pumps distributed by us by a practitioner or patient that results in injury could similarly subject us to liability. Any substantial underinsured loss could have a material and adverse effect on our business, financial condition, results of operations and cash flows. Furthermore, any impairment of our reputation could have a material and adverse effect on our revenues and prospects for future business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We intend to continue to pursue opportunities for the further expansion of our business through strategic alliances and/or joint ventures. Future strategic alliances and/or joint ventures may require significant resources and/or result in significant unanticipated costs or liabilities to us.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to pursue opportunities for the further expansion of our business through strategic alliances and/or joint ventures. Any future strategic alliances or joint ventures will depend on our ability to identify suitable partners, negotiate acceptable terms for such transactions and obtain financing, if necessary. These investments require significant managerial attention, which may be diverted from our other operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we engage in strategic acquisitions, we may experience significant costs and difficulty in assimilating operations or personnel, which could threaten our future growth.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we make any acquisitions, we could have difficulty assimilating operations, technologies and products and services. In addition, we could have difficulty integrating or retaining personnel and maintaining employee morale as we take steps to combine the personnel and business cultures of separate organizations into one and to eliminate duplicate positions and functions. It may also be difficult for us to preserve important relationships with others, such as strategic partners, customers, and suppliers, who may delay or defer decisions on agreements with us, or seek to change existing agreements with us, because of the acquisition. In addition, acquisitions may involve entering markets in which we have no or limited direct prior experience. The occurrence of any one or more of these factors could disrupt our ongoing business, distract our management&#8217;s and employees&#8217; attention from our ongoing business operations, result in decreased operating performance and increase our expenses. Moreover, our profitability may suffer because of acquisition-related costs or amortization of intangible assets. Furthermore, we may have to incur debt or issue equity securities in future acquisitions. The issuance of equity securities would dilute our existing stockholders.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to maintain adequate working relationships with health care professionals.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to maintain close working relationships with respected physicians and medical personnel in hospitals and universities. We rely on these professionals to assist us in the development of proprietary service and improvements to complement and expand our existing service and product lines. If we are unable to maintain these relationships, our ability to market and sell new and improved products and services could decrease and future operating results could be unfavorably affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with applicable governmental or accrediting bodies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">regulations, we could face substantial penalties and our business, operations and financial condition could be adversely affected.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain federal, state health care, and accreditation bodies&#8217; laws and regulations, including those pertaining to fraud and abuse and patients&#8217; rights, are applicable to our business. The laws that are applicable to our business include:</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal health care program Anti-Kickback Statute, which prohibits, among other things, soliciting, receiving or providing remuneration, directly or indirectly, to induce (i) the referral of an individual, for an item or service or (ii) the purchasing or ordering of a good or service, for which payment may be made under federal health care programs such as the Medicare and Medicaid programs;</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal false claims laws which prohibit, among other things, knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other third-party payers that are false or fraudulent, and which may apply to entities like us that promote medical devices, provide medical device management services and may provide coding and billing advice to customers;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, which prohibits executing a scheme to defraud any health care benefit program or making false statements relating to health care matters and which also imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information; and</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws that may apply to items or services reimbursed by any third-party payer, including commercial insurers, and state laws governing the privacy and security of health information in certain circumstances, many of which differ in significant ways from state to state and often are not preempted by HIPAA, thus complicating compliance efforts.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any of the laws described above or any other regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, damages, fines and the curtailment or restructuring of our operations. Any penalties, damages, fines, curtailment or restructuring of our operations could materially and adversely affect our business, financial condition, results of operations and cash flows. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. Moreover, achieving and sustaining compliance with applicable federal and state privacy, security and fraud laws may prove costly.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to protect our intellectual property could substantially harm our business and operating results.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to protect our trade secrets and other confidential information, we rely in part on confidentiality agreements with our employees, consultants and third parties with whom we have relationships. These agreements may not effectively prevent disclosure of trade secrets and other confidential information and may not provide an adequate remedy in the event of misappropriation of trade secrets or any unauthorized disclosure of trade secrets and other confidential information. In addition, others may independently discover our trade secrets and confidential information and, in such cases, we could not assert any trade secret rights against such parties. Costly and time-consuming litigation could be necessary to enforce or determine the scope of our trade secret rights and related confidentiality and nondisclosure provisions. Failure to obtain or maintain trade secret protection, or our competitors' acquisition of our trade secrets, could materially and adversely affect our competitive business position.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants in our current and any future debt agreement restrict our business.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2021 Credit Agreement contains and the agreements that govern our future indebtedness may contain, covenants that restrict our ability to and the ability of our subsidiaries to, among other things:</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engage in a transaction that results in a change of control, as defined by the 2021 Credit Agreement;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create, incur, assume or suffer to exist any lien upon any of our property, assets or revenues;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make certain investments or acquisitions;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create, incur, assume or suffer to exist certain indebtedness;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">merge, dissolve, liquidate, consolidate or sell all or substantially all of our assets;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make any disposition or enter into any agreement to make any disposition;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">repurchase outstanding stock from the open market; and</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">declare or make, directly or indirectly, any dividend or other restricted payment, or incur any obligation (contingent or otherwise) to do so.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These covenants may restrict our ability to operate our business. Our failure to comply with these covenants could result in an event of default that, if not cured or waived, could result in reduced liquidity for the Company and could have a material and adverse effect on our ability to operate our business, financial condition, results of operations and cash flows. Additionally, our ability to pay interest and repay the principal for our indebtedness is dependent upon our ability to manage our business operations, generate sufficient cash flows to service such debt and the other factors discussed in this section. Our 2021 Credit Agreement also contains certain financial covenants. As of December&#160;31, 2021, we were in compliance with all the covenants contained in the 2021 Credit Agreement, however, there can be no assurance that we will be able to manage any of the risks associated with debt agreements successfully.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic uncertainty or economic deterioration could adversely affect us.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There continues to be global economic uncertainty, as well as increased inflation. Ongoing political changes and conflicts in the U.S. and abroad continue to contribute to global economic uncertainty and volatility in the global financial markets. In February 2022, Russian forces launched significant military actions against Ukraine, which has caused significant international conflict, including sanctions, tensions and military actions. In addition, the COVID-19 pandemic continues to also contribute to economic uncertainty. Continued economic uncertainty may continue to drive stock market and interest rate </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">volatility, increased inflation and adversely impact consumer confidence, product demand, and our ability to refinance our debt. Economic conditions, along with our operating performance, may also materially and adversely impact our ability to access the financial markets. Accordingly, our future business and financial results are subject to uncertainty. If economic conditions deteriorate in the future, our future revenues and financial results could be materially and adversely affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or challenges to our tax positions could adversely affect our business, results of operations and financial condition.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes as well as non-income based taxes in federal and various state jurisdictions. Changes in tax laws, including, for example, those resulting from the U.S. federal tax legislation commonly referred to as the Coronavirus Aid, Relief, and Economic Security (CARES) Act, as well as other factors, could cause us to experience fluctuations in our tax obligations and effective tax rates in future periods and otherwise adversely affect our tax positions and/or our tax liabilities. The full impact of the CARES Act on us may change significantly as regulations, interpretations and rulings relating to the CARES Act are issued and additional changes in U.S. federal and state tax laws are made in the future. There can be no assurance that our effective tax rates, tax payments, tax credits or incentives will not be adversely affected by these or other initiatives.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to audits by tax authorities from time to time in federal and state jurisdictions. Tax authorities may disagree with certain positions we have taken and assess additional taxes and penalties. We regularly assess the likely outcomes of these audits in order to determine the appropriateness of our tax provision. However, there can be no assurance that we will accurately predict the outcomes of these audits, and the actual outcomes of these audits could have a material impact on our results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The value of our net operating loss carryforwards may become impaired if we do not generate sufficient future taxable income required to utilize all or a portion of our net operating loss carryforwards prior to their expiration.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. federal net operating loss carryforward for tax purposes was $38.2 million at December&#160;31, 2021, resulting in a federal deferred tax asset of $8.0 million. Approximately $31.3 million of the Company&#8217;s U.S. federal net operating loss carryforwards will begin to expire in various years beginning in 2029.  The Company&#8217;s realization of its deferred tax assets including the loss carryforwards is dependent upon many factors, including, but not limited to, the Company&#8217;s ability to generate sufficient taxable income in sufficient amounts.  There can be no assurance that we will generate the required amounts of taxable income before the expiration dates are reached.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS RELATING SPECIFICALLY TO OUR COMMON STOCK</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market price of our common stock has been, and is likely to remain, volatile, subject to low trading volume and may decline in value.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock has been and may continue to be volatile. Market prices for securities of health care services companies, including ours, have historically been volatile, and the market has from time to time experienced significant price and volume fluctuations that appear unrelated to the operating performance of particular companies. The following factors, among others, can have a significant effect on the market price of our common stock:</span></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements of technological innovations, new products, or clinical studies by others;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government regulation;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the coverage or reimbursement rates of private insurers and governmental agencies;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements regarding new products or services;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements or speculation regarding strategic alliances, mergers, acquisitions or other transactions;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments in patent or other proprietary rights;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the liquidity of the market for our common stock;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">news of other healthcare events or announcements;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in health care policies in the United States or globally;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">global financial conditions; and</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">comments by securities analysts and general market conditions.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The realization of any risks described in these &#8220;Risk Factors&#8221; could also have a negative effect on the market price of our common stock.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not pay dividends and this may negatively affect the price of our stock.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of our 2021 Credit Agreement, our ability to pay dividends on our common stock is limited and we do not anticipate paying dividends on our common stock in the foreseeable future. The future price of our common stock may be adversely impacted because we do not pay dividends.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted stock awards, performance-based restricted stock units and the exercise of stock options may depress our stock price and may result in dilution to our common stockholders.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a significant number of shares of restricted stock awards (&#8220;RSUs&#8221;), performance-based restricted stock units (&#8220;PSUs&#8221;) and outstanding options to purchase our stock. If the market price of our common stock rises above the exercise price of outstanding options, holders of those securities may be likely to exercise their options and sell the common stock acquired upon exercise in the open market. Sales of a substantial number of shares of our common stock in the public market by holders of options may depress the prevailing market price for our common stock and could impair our ability to raise capital through the future sale of our equity securities. Additionally, if the holders of outstanding options exercise those options, our common stockholders will incur dilution in their relative percentage ownership.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, options to purchase 2,005,110 shares of common stock were outstanding, at a weighted average exercise price of $6.90 per share, of which 1,557,127 were exercisable at a weighted average exercise price of $4.78 per share. In addition, RSUs of 290,942 shares, with a weighted average grant date fair value of $15.61 per share, were outstanding and were issuable upon the vesting of certain time restrictions and PSUs of 239,976 shares, with a weighted average grant date fair value of $14.74 per share, were outstanding and were issuable upon meeting certain performance-based vesting criteria.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to limitations on net operating loss carryforwards and certain built-in losses following an ownership change.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we experience an ownership change, either via a major transaction or a series of trades where a substantial percentage of our ownership changes, which may be less than a majority of our ownership in certain cases, we may be limited in our ability to use our net operating loss carryforwards.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to monitor shifts in past ownership (as defined under Section 382 of the Code). We are subject to an annual limitation of $1.8 million on our use of remaining pre-ownership change net operating loss carryforwards&#160;of $4.5 million (and certain other pre-change tax attributes) as of December 31, 2021. As of December 31, 2021, our U.S. federal net operating loss carryforwards of approximately $31.3 million will begin to expire in various years beginning in 2029 and $6.9 million of our U.S. federal net operating loss carryforward has an indefinite life. There can be no assurance that we will not experience an ownership change in the future, in which case we may be limited in our ability to use our deferred tax assets. At December 31, 2020, management determined that the valuation allowance against the U.S. federal and state deferred taxes was no longer required and the valuation allowance of $11.2 million was released, which is described under the heading &#8220;Income Taxes&#8221; in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_136">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_136">10</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Consolidated Financial Statements included in this Form 10-K.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL RISK FACTORS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effects of the COVID-19 pandemic could disrupt our operations and adversely affect our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The widespread continuing outbreak of COVID-19 and variants thereof has created significant volatility, uncertainty, and disruption in economic activity and financial markets globally. Although the outbreak of COVID-19 has not had any material unfavorable effect on our results of operations to date, there can be no assurance that COVID-19 will not have a material adverse effect on our future operational and financial performance. The extent to which COVID-19 could impact our operational and financial performance in future periods is currently uncertain and will depend on numerous evolving factors and future developments that we may not be able to accurately predict and to which we may not be able to respond. Such factors and developments include, but are not limited to: the duration, severity and spread of the outbreak; actions taken by government authorities to contain and mitigate COVID-19 and the effectiveness of such actions (including the efficacy and distribution of any vaccines); the effect on the U.S. and global economies and actions taken in response; the overall impact on the businesses of our customers, partners, vendors and suppliers; the health of and effect on our workforce; the future effects to our operational and financial results of the changes we have made to protect the safety and well-being of our employees and future operational disruptions or challenges we may face; increased cybersecurity and information security risk as a result of the transition of our employees to a remote work environment; and how quickly and to what extent normal economic and operating conditions may resume. Further, our management has been intensely focused on mitigating COVID-19 impacts, which has </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">required and will continue to require, a large investment of time, attention and resources. Although we have yet to experience a significant disruption of our operations as a result of the COVID-19 pandemic, a prolonged outbreak could, among other things, strain our business continuity plans, create delays in our growth and strategic initiatives, reduce our sales and marketing activities, limit our sales peoples&#8217; access to our clients, limit our access to financing on favorable terms, increase our exposure to potential impairment charges related to long-lived and intangible assets, hinder our ability to support our clients and operate our business effectively, heighten the risk of disruption to our information and reporting systems and internal controls, including those over financial reporting and other risk management systems, or require us to incur substantial costs. We cannot predict the degree to which COVID-19 will ultimately impact our operations, however, the effects of the COVID-19 pandemic, alone or taken together, could adversely affect our future business, financial condition, results of operations and cash flows, and may also heighten other risks to which the Company is subject, including other risks discussed in this annual report on Form 10-K.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to legal and regulatory proceedings that could have a material adverse impact on our business, results of operations and financial condition.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time and in the ordinary course of our business, we and certain of our subsidiaries may become involved in various legal and regulatory proceedings. All such proceedings are inherently unpredictable and, regardless of the merits of the claims, litigation and regulatory proceedings may be expensive, time-consuming and disruptive to our operations and distracting to management. If resolved against us, such proceedings could result in excessive verdicts, injunctive relief or other equitable relief that may affect how we operate our business. Similarly, if we settle such proceedings, it may affect how we operate our business. Future court decisions, alternative dispute resolution awards, business expansion or legislative activity may increase our exposure to litigation and regulatory investigations. In some cases, substantial non-economic remedies or punitive damages may be sought. Although we maintain liability insurance coverage, there can be no assurance that such coverage will cover any particular verdict, judgment or settlement that may be entered against us, that such coverage will prove to be adequate or that such coverage will continue to remain available on acceptable terms, if at all. If we incur liability that exceeds our insurance coverage or that is not within the scope of the coverage in proceedings brought against us, it could have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not collect sales or consumption taxes in some jurisdictions.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our core services are exempt from sales tax or its equivalent in many states. However, there are several states that consider pump rentals, sales and services taxable regardless of method of payment. We are collecting sales tax or its equivalent in numerous jurisdictions. A successful assertion by one or more states or localities requiring us to collect taxes where we currently do not, could result in substantial tax liabilities, including for past sales, as well as penalties and interest.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unsuccessful in our efforts to implement and support information technology improvements or respond to technological changes, our growth, prospects and results of operations could be adversely affected.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To remain competitive, we must continue to enhance and improve the functionality and features of our technology solutions and services. We have implemented a service to support EMR technology with some of our outpatient infusion practices that enables billing information to be transferred between us and medical facilities electronically and automatically, thus eliminating the current use of mail, email and/or faxes. We have also implemented a web portal that supports our rental and service customers. If these efforts cease to be successful, our reputation and ability to attract and retain customers and contributors will be adversely affected. Furthermore, we are likely to incur expenses in connection with continuously updating and improving our technology infrastructure and services. Without such improvements, our operations might suffer from unanticipated system disruptions, slow application performance or unreliable service levels, any of which could negatively affect our reputation and ability to attract and retain customers and contributors. We may face significant delays in introducing new services, products and enhancements.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If competitors introduce new products and services using new technologies or if new industry standards and practices emerge, our existing technology and systems may become obsolete or less competitive, and our business may be harmed. In addition, the expansion and improvement of our systems and infrastructure will require us to commit substantial financial, operational and technical resources, with no assurance that our business will improve.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of these factors could have a material adverse impact on our business, financial condition, results of operations and cash flows.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity risks and cyber incidents could adversely affect our business and disrupt operations.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cyber incidents can result from deliberate attacks or unintentional events. These incidents can include, but are not limited to, gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. The result of these incidents could include, but are not limited to, disrupted operations, misstated financial data, liability for stolen assets or information, increased cybersecurity protection costs, litigation and reputational damage adversely affecting customer or investor confidence. We have implemented systems and processes to focus on identification, prevention, mitigation and resolution. However, these measures cannot provide absolute security, and our systems may be vulnerable to cybersecurity breaches such as viruses, hacking, and similar disruptions from unauthorized intrusions. In addition, we rely on third party service providers to perform certain services, such as payroll and tax services. Any failure of our systems or third-party systems may compromise our sensitive information and/or personally identifiable information of our employees or patient health information subject to HIPAA confidentiality requirements. While we have secured cyber insurance to potentially cover certain risks associated with cyber incidents, there can be no assurance the insurance will be sufficient to cover any such liability.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technological interruptions or the efficiency of our website and technology solutions could damage our reputation and brand and adversely affect our results of operations.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The satisfactory performance, security, reliability and availability of our network infrastructure are critical to our reputation, our ability to attract, communicate with and retain customers and our ability to maintain adequate customer service levels. Any system interruptions, outside intrusions, or security breaches could result in negative publicity, damage our reputation and brand or adversely affect our results of operations. We may experience temporary system interruptions for a variety of reasons, including security breaches and other security incidents, viruses, telecommunication and other network failures, power failures, software errors or data corruption. We rely upon third-party service providers, such as co-location and cloud service providers, for our data centers and application hosting, and we are dependent on these third parties to provide continuous power, cooling, internet connectivity and physical security for our servers. In the event that these third-party providers experience any interruption in operations or cease business for any reason, or if we are unable to agree on satisfactory terms for continued hosting relationships, our business could be harmed and we could be forced to enter into a relationship with other service providers or assume hosting responsibilities ourselves. Although we operate two data centers in an active/standby configuration for geographic and vendor redundancy and even though we maintain a third disaster recovery facility to back up our content collection, a system disruption at the active data center could result in a noticeable disruption of our services. Because some of the causes of system interruptions may be outside of our control, we may not be able to remedy such interruptions in a timely manner, or at all.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of these factors could have a material adverse impact on our business, financial condition, results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Natural disasters, pandemics, acts of war or terrorism and other external events could significantly impact our business.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natural disasters, including hurricanes, earthquakes, floods, excessive snowfall and other unfavorable weather conditions, pandemics, such as the recent outbreak of COVID-19, acts of war or terrorism and other adverse external events may affect our operations. Such events may have a detrimental effect on our gross revenue, preventing many patients from visiting a facility to obtain our ambulatory infusion pumps or receive treatment. Similarly, such events could impact key suppliers or vendors, disrupting the services or materials they provide us. The severity of these occurrences, should they ever occur, will determine the extent to which and if our business, financial condition, results of operations and cash flows is materially and adversely affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent upon executive officers and other key personnel. The loss of any of our executive officers or other key personnel could reduce our ability to manage our businesses and achieve our business plan, which could cause our sales to decline and our operating results and cash flows to suffer.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is substantially dependent on the continued services of our executive officers and other key personnel who generally have extensive experience in our industry. Our future success also will depend in large part upon our ability to identify, attract and retain other highly qualified executive officers, managerial, finance, technical, clinical, customer service and sales and marketing personnel. Competition for these individuals is intense, more so in the current labor market. The loss of the services of any executive officer or other key employee, or our failure to attract and retain other qualified and experienced personnel on acceptable terms, could have a material and adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unresolved Staff Comments.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_25"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Properties.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not own any real property. We lease office and warehouse space at the following locations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">City</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State/Country</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rochester Hills</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lenexa</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canton</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bakersfield</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Fe Springs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mesquite</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mississauga</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ontario, Canada</span></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that such office and warehouse space is suitable and adequate for our business. All of our facilities are utilized to support both of our segments. </span></div><div id="i9e717b65c1e3405d850ef6e342b20071_28"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time in the ordinary course of our business, we may be involved in legal and regulatory proceedings, the outcomes of which may not be determinable. The results of litigation and regulatory proceedings are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable, primarily for the following reasons: (i) many of the relevant legal proceedings are in preliminary stages and until such proceedings develop further, there is often uncertainty regarding the relevant facts and circumstances at issue and potential liability; and (ii) many of these proceedings involve matters of which the outcomes are inherently difficult to predict. We have insurance policies covering certain potential losses where such coverage is cost effective.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not at this time involved in any proceedings that we believe could have a material effect on our business, financial condition, results of operations or cash flows.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_31"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;Mine Safety Disclosures.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_37"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;Market for Registrant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on the NYSE American under the symbol INFU. As of March&#160;7, 2022, we had approximately 277 stockholders of record of our common stock.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our purchases of our common stock during the three months ended December&#160;31, 2021 is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.587%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands) (b)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2021 through October 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,000,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2021 through November 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,000,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2021 through December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,469</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19,439,957</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.69&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,469</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Of the 35,370 shares of common stock presented in the table above, 1,901 shares were originally granted to employees and directors as restricted stock awards. Our stock plans allow for the withholding of shares to satisfy tax obligations due upon the vesting of restricted stock. Pursuant to our stock plans, the 1,901 shares reflected above were relinquished by employees or directors in exchange for our agreement to pay U.S. federal, state and local tax withholding obligations resulting from the vesting of the Company's restricted stock.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) On June 30, 2021, our Board of Directors approved a stock repurchase program (the "Share Repurchase Program") authorizing the Company to repurchase up to $20.0 million of the Company's outstanding common stock through June 30, 2024 (which was announced on August 12, 2021). Repurchases under the Share Repurchase Program will be subject to market conditions, the periodic capital needs of the Company's operating activities, and the continued satisfaction of all covenants under the Company's existing credit agreement. Repurchases under the Share Repurchase Program may take place in the open market or in privately negotiated transactions and may be made under a Rule 10b5-1 plan. The Share Repurchase Program does not obligate the Company to repurchase shares and may be suspended, terminated, or modified at any time. As of December&#160;31, 2021, the Company had repurchased 33,469 shares under the Share Repurchase Program.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have not declared or paid any dividends on our common stock.  Under the terms of our 2021 Credit Agreement, our ability to pay dividends on our common stock is limited, and we do not anticipate paying dividends on our common stock in the foreseeable future.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not sell any unregistered securities during the fiscal year ended December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Part III, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_187">Item 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to this Form 10-K for information relating to securities authorized for issuance under our equity compensation plans.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph shows a comparison of cumulative total shareholder return to the Company's shareholders, the corresponding returns on the Russell 2000 Index during the five-year period ended December&#160;31, 2021 assuming $100 was invested on December&#160;31, 2016 with reinvestment of all dividends.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-indent:27pt"><img src="infu-20211231_g2.jpg" alt="infu-20211231_g2.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">InfuSystem</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russell 2000 Index</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div id="i9e717b65c1e3405d850ef6e342b20071_40"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;[Reserved]</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in this Form 10-K. The forward-looking statements included in this discussion and elsewhere in this Form 10-K involve risks and uncertainties, including those set forth under</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cautionary Statement About Forward-Looking Statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Actual results and experience could differ materially from the anticipated results and other expectations expressed in our forward-looking statements as a result of a number of factors, including but not limited to those discussed in this Item and in Item 1A -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For discussion and analysis of the year ended December&#160;31, 2020 compared to the year ended December&#160;31, 2019, please refer to Management's Discussion and Analysis of Financial Condition and Results of Operations included in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on March&#160;22, 2021.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_46"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national health care service provider, facilitating outpatient care for Durable Medical Equipment manufacturers and health care providers. We provide our products and services to hospitals, oncology practices, ambulatory surgery centers, and other alternate site health care providers. Our headquarters is in Rochester Hills, Michigan, and we operate our business from a total of seven locations in the United States and Canada. We deliver local, field-based customer support as well as operate pump service and repair Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada. ISI is accredited by the Community Health Accreditation Partner (CHAP) while First Biomedical is ISO 9001 certified at our Kansas, Michigan, Massachusetts, Canada and Santa Fe Springs, California locations and also ISO 13485 certified at our Bakersfield, California location.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InfuSystem competes for and retains its business primarily on the basis of its long participation and strong reputation in the Durable Medical Equipment space, its long-standing relationships with Durable Medical Equipment manufacturers and its health care provider customers, and the high levels of service it provides. Current barriers to entry for potential competitors are created by our: (i) growing number of third-party payer networks under contract, which included </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nearly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 770 third-party payer networks for the fiscal year ended December&#160;31, 2021, an increase of 6% over the prior year period; (ii) economies of scale, which allow for predictable reimbursement and less costly purchase and management of the pumps, respectively; (iii) established, long-standing relationships as a provider of pumps to outpatient oncology practices in the U.S. and Canada; (iv) pump fleet of ambulatory and large volume infusion pumps for rent and for sale, which may allow us to be more responsive to the needs of physicians, outpatient oncology practices, hospitals, outpatient surgery centers, homecare practices, patient rehabilitation centers and patients than a new market entrant; (v) seven geographic locations in the U.S. and Canada that allow for same day or next day delivery of pumps; and (vi) pump repair and service capabilities at all of these facilities and at our customer's locations. We do not perform any research and development on pumps, but we have made, and continue to make investments in our information technology.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ITS Segment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ITS segment&#8217;s core purpose is to seek opportunities to leverage our unique know-how in clinic-to-home health care involving Durable Medical Equipment, our logistics and billing capabilities, our growing network of third-party payers under contract, and our clinical and biomedical capabilities. This leverage may take the form of new products and/or services, strategic alliances, joint ventures and/or acquisitions. The leading service within our ITS segment is to supply electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states (&#8220;Oncology Business&#8221;). Colorectal cancer is the third most prevalent form of cancer in the United States, according to the American Cancer Society, and the standard of care for the treatment of colorectal cancer relies upon continuous chemotherapy infusions delivered via ambulatory infusion pumps. One of the primary goals for the ITS segment is to expand into treatment of other types of cancers. In 2021, our Oncology Business approximated 92% of our total ITS segment revenues. In 2021, we generated approximately 49% of our total ITS segment revenues from treatments for colorectal cancer and 44% of our ITS segment revenues from treatments for non-colorectal disease states. There are a number of approved treatment protocols for pancreatic, head and neck, esophageal and other types of cancers, as well as other disease states which present opportunities for growth. There are also a number of other drugs currently approved by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), as well as agents in the pharmaceutical development pipeline, which we believe could potentially be used with continuous infusion protocols for the treatment of diseases other than colorectal cancer. Additional drugs or protocols currently in clinical trials may also obtain regulatory approval over the next several years. If these new drugs or protocols obtain regulatory approval for use with continuous infusion protocols, we expect the pharmaceutical companies to focus their sales and marketing efforts on promoting the new drugs and protocols to physicians.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our Oncology Business focuses mainly on the continuous infusion of chemotherapy. Continuous infusion of chemotherapy can be described as the gradual administration of a drug via a small, lightweight, portable infusion pump over a prolonged period of time. A cancer patient can receive his or her medicine anywhere from one to 30 days per month depending on the chemotherapy regimen that is most appropriate to that individual&#8217;s health status and disease state. This may be followed by periods of rest and then repeated cycles with treatment goals of progression-free disease survival. This drug administration method has replaced intravenous push or bolus administration in specific circumstances. The advantages of slow continuous low doses of certain drugs are well documented. Clinical studies support the use of continuous infusion chemotherapy for decreased toxicity without loss of anti-tumor efficacy. The 2015 National Comprehensive Cancer Network (&#8220;NCCN&#8221;) Guidelines recommend the use of continuous infusion for treatment of numerous cancer diagnoses. We believe that the growth of continuous infusion therapy is driven by three factors: evidence of improved clinical outcomes; lower toxicity and side effects; and a favorable reimbursement environment.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of continuous infusion has been demonstrated to decrease or alter the toxicity of a number of cytotoxic, or cell killing agents. Higher doses of drugs can be infused over longer periods of time, leading to improved tolerance and decreased toxicity. For example, the cardiotoxicity (heart muscle damage) of the chemotherapy drug Doxorubicin is decreased by schedules of administration according to The Chemotherapy Source Book by Michael C. Perry. Nausea, vomiting, diarrhea and decreased white blood cell and platelet counts are all affected by duration of delivery. Continuous infusion can lead to improved tolerance and patient comfort while enhancing the patient&#8217;s ability to remain on the chemotherapy regimen. Additionally, the lower toxicity profile and resulting reduction in side effects enables patients undergoing continuous infusion therapy to continue a relatively normal lifestyle, which may include continuing to work, going shopping, and caring for family members. We believe that the partnering of physician management and patient autonomy provide for the highest quality of care with the greatest patient satisfaction.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that oncology practitioners have a heightened sensitivity to providing quality service and to their ability to obtain reimbursement for services they provide. Simultaneously, CMS and private insurers are increasingly focused on evidence-based medicine to inform their reimbursement decisions &#8212; that is, aligning reimbursement with clinical outcomes and adherence to standards of care. Continuous infusion therapy is a main component of the standard of care for certain types of cancers because clinical evidence demonstrates superior outcomes. Payers&#8217; recognition of this benefit is reflected in their relative reimbursement policies for clinical services related to the delivery of this care.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional areas of focus for our ITS segment are as follows:</span></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pain Management - providing our ambulatory pumps, products, and services for pain management in the area of post-surgical continuous peripheral nerve block.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Negative Pressure Wound Therapy (&#8220;NPWT&#8221;) - as announced in February 2020, NPWT includes providing the Durable Medical Equipment and related consumables, overseeing logistics, providing biomedical services, and managing third-party billing of the U.S. home healthcare market, which as a subset of the broader NPWT market, has an estimated addressable home healthcare market of $600 million per year.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lymphedema Therapy &#8211; as announced in June 2021, Lymphedema therapy includes providing patient care and customer service, pneumatic compression devices and associated garments through our partnership with Bio Compression Systems, Inc. to outpatients, initially targeting our existing acute care and oncology customers, estimated to be 20% of the multi-billion-dollar Lymphedema market.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Acquisitions - we believe there are opportunities to acquire smaller, regional health care service providers, in whole or in part that perform similar services to us but do not have the national market access, network of third-party payer contracts or operating economies of scale that we currently enjoy. We may also pursue acquisition opportunities of companies that perform similar services, but offer different therapies or utilize different devices.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Information technology-based services - we also plan to continue to capitalize on key new information technology-based services such as EXPRESS, InfuSystem Mobile, InfuBus or InfuConnect,&#160;Pump Portal and BlockPain Dashboard&#174;.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payer environment within our ITS segment is in a constant state of change. We continue to extend our considerable breadth of payer networks under contract as patients move into different insurance coverage plans, including Medicaid and Insurance Marketplace products. In some cases, this may slightly reduce our aggregate billed revenues payment rate but result in an overall increase in collected revenues, due to a reduction in concessions. Consequently, we are increasingly focused on net revenues less concessions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DME Services Segment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our DME Services segment&#8217;s core service is to: (i) sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; (ii) sell treatment-related consumables; and (iii) provide biomedical recertification, maintenance and repair services for oncology practices as well as other alternate site settings, including, home care and home infusion providers, skilled nursing facilities, pain centers and others. We also provide these products and services to customers in the hospital market. We purchase new and pre-owned pole-mounted and ambulatory infusion pumps from a variety of sources on a non-exclusive basis. We repair, refurbish and provide biomedical certification for the devices as needed. The pumps are then available for sale, rental or to be used within our ambulatory infusion pump management service. Our recent acquisition of FilAMed, a privately-held biomedical services company, on January&#160;31, 2021 will supplement the Company&#8217;s existing biomedical recertification, maintenance and repair services for acute care facilities and other alternate site settings, including, home care and home infusion providers, skilled nursing facilities, pain centers and others. Our recent acquisition of OB Healthcare Corporation (&#8220;OB Healthcare&#8221;), a privately-held biomedical services company, on April&#160;18, 2021 further develops and expands InfuSystem&#8217;s DME Services segment by extending our existing biomedical service capability into our customer's locations. OB Healthcare complements the Company&#8217;s purchase of FilAMed.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_49"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Business Metrics</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management monitors a number of financial and non-financial measures and ratios on a regular basis in order to track the progress of our business and make adjustments as necessary. We believe that the most important of these measures and ratios include net revenues and our order-to-cash process, fleet utilization, operating margin, operating expenses, profitability, and debt levels including available credit and leverage ratios. These measures and ratios are compared to standards or objectives set by management, so that actions can be taken, as necessary, in order to achieve the standards and objectives.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_52"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Update</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which spread globally and throughout the United States. In response, we took a number of precautionary and preemptive steps to protect the safety and well-being of our employees while ensuring continuity of service to our clients, including, transitioning our employees to a remote work environment, suspending employee travel, canceling participation in industry events and in-person group meetings, promoting social distancing and enhanced cleaning and sanitization efforts across office locations, and implementing protocols to quarantine employees who may have been exposed to COVID-19, or show relevant symptoms. We also continued to undertake preparedness plans at our facilities to maintain continuity of operations, which provide for flexible work arrangements without any significant disruptions to our business or control processes. Our management team is continuing to actively monitor the situation and is in constant communication with our workforce as well as with our customers and vendors. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 global pandemic has caused significant disruption to the United States and global economies and has severely impacted the overall healthcare industry and the related supply chain. During 2020, the focus on preparing and treating large numbers of COVID-19 patients resulted in significant shifts in demand and related shortages in certain types of medical equipment, including infusion pumps, while at the same time reducing capacity for non-COVID-19 services such as elective surgeries. During 2020, these impacts created a significant net favorable dynamic for InfuSystem resulting in increased net revenues and margins in certain of our service lines only partially offset by reductions in others. Some of these benefits did not occur in 2021, such as elevated levels of sales of new and pre-owned medical equipment, whereas some diminished during 2021, including a portion of the increased volume of rental revenues. During 2021, outbreaks of COVID-19, including the Delta and Omicron variants, unfavorably impacted our revenue growth initiatives in certain product lines including Pain Management and NPWT,  The impacts included scattered restrictions on elective surgeries and delayed ramp-up in treatment volumes for new custom, both of which unfavorably impacted the Pain Management business, and restricted physical access to our customers facilities, which unfavorably impacted both the Pain Management and NPWT businesses. The COVID-19 pandemic continues to heighten potential risks that did not impact the Company in 2020 or 2021, but may impact the Company on a delayed basis, such as disruptions in our supply chain and increased costs of the products we sell and for our labor force. We continue to prepare for disruptions in the current and future periods, both positive and negative.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the COVID-19 pandemic has not had any material unfavorable effect on our operations to date, the extent and nature of the impact in the future, if any, will depend on future developments, which are highly uncertain, cannot be predicted and could have a material adverse impact on our financial position, operating results and cash flows. We are continuing to closely monitor the impact of the COVID-19 pandemic on all aspects of our business and may take further actions as may be required by federal, state or local authorities, or that we determine are in the best interests of our employees, customers and partners. As the conditions surrounding the COVID-19 pandemic continue to evolve, we will continue to actively manage our response in collaboration with customers, government officials and stakeholders, and assess any potential impacts to our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial position and operating results, as well as adverse developments in our business. For further information regarding the effect of the COVID-19 pandemic on the Company, please see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_163">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_163">6</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Consolidated Financial Statements included in this Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i9e717b65c1e3405d850ef6e342b20071_55"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">InfuSystem Holdings, Inc. Results of Operations for the year ended December&#160;31, 2021 compared to the year ended December&#160;31, 2020</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:28.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.768%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase/<br/>(Decrease)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;ITS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;DME Services (inclusive of inter-segment revenues)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: elimination of inter-segment revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit (inclusive of certain inter-segment allocations) (a):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;ITS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;DME Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(835)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Provision for doubtful accounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,827&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,007)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,286)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,626)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,332&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,912)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,519,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,106,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,049,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,717,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) Inter-segment allocations are for cleaning and repair services performed on medical equipment.</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Net Revenues</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues for the year ended December&#160;31, 2021 were $102.4 million, an increase of $5.0 million, or 5.1%, compared to $97.4 million for the year ended December&#160;31, 2020. The increase was due to higher treatment volumes for all three ITS Segment therapies, improved collections on billings to third party payers and additional revenue from acquisitions. These amounts were partially offset by lower equipment sales. Increased net revenues were achieved in both the ITS and DME Services segments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ITS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ITS net revenue of $65.6 million increased $4.5 million, or 7.4%, during the year ended December&#160;31, 2021 as compared to the prior year. This increase was primarily attributable to higher treatment volume and improved patient collections on </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">billings for Oncology and increased treatment volume in both Pain Management and NPWT. Pain Management net revenue for 2021 increased as compared to 2020 due to additional sites of care added during 2021 and a recovery in the elective surgeries market which was negatively impacted by COVID-19 during the second quarter of 2020. The new NPWT business was launched during the first quarter of 2020 but did not start to have measurable quarterly revenues until the second half of 2020. On a combined basis, Pain Management and NPWT net revenues increased by $1.9 million during 2021 as compared to 2020, which represented an increase of 57%.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DME Services</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DME Services net revenue of $36.8 million increased $0.5 million, or 1.3%, during 2021 as compared to the prior year. DME Services net revenue excludes inter-segment revenues for both periods. This increase was due to revenues totaling $2.1 million from FilAMed and OB Healthcare which were acquired during the first quarter of 2021 and second quarter of 2021, respectively. This increase was offset partially by a $2.4 million decrease in sales of medical equipment related to a moderation in market demand for infusion pumps which was elevated during 2020 because of the COVID-19 pandemic.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Gross Profit (inclusive of certain inter-segment allocations)</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the year ended December&#160;31, 2021 of $60.2 million increased $1.4 million, or 2.4%, from $58.8 million during the year ended December&#160;31, 2020. The increase was driven by the increase in net revenues partially offset by a lower gross profit as a percentage of net revenue (&#8220;gross margin&#8221;). Gross margin decreased to 58.8% during 2021, as compared to 60.3% during the prior year period, a decrease of 1.5%. The increase in gross profit was attributable to an increase in ITS gross profit partially offset by a decrease in gross profit for the DME Services segment. The gross margin was lower for both operating segments during 2021 as compared to 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ITS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ITS gross profit was $42.0 million, during 2021, representing an increase of $2.3 million, or 5.7%, compared to the prior year. The improvement reflected an increase in net revenues offset partially by a lower gross margin which was 64.1% during 2021, a decrease of 1.0%, from the prior year. The lower gross margin was the result of an unfavorable net revenue mix favoring lower margin therapies offset partially by improved collections on billings during 2021 as compared to 2020. Pump maintenance expenses, which include preventative maintenance, cleaning and repair services mainly performed by the DME Services segment, were unusually low during the prior year due to COVID-19 when the Company deployed a significant number of newly purchased pumps.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DME Services</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DME Services gross profit during 2021 was $18.2 million, representing a decrease of $0.8 million, or 4.4%, over the prior year. This decrease was due to lower gross margin partially offset by higher net revenue. The DME gross margin was 49.3% during 2021, which was 2.9% lower than the prior year. This decrease was the result of unfavorable net revenue mix favoring lower gross margin revenues from acquisitions, an increase in labor costs related to an increase in biomedical technicians and an increase in freight expense. The increase in biomedical technician labor resulted from an increase in team members who were hired in order to increase the capacity in biomedical services in anticipation of increased biomedical services demand. These newly hired team members mainly spent their time training during the 2021 period but will be deployed to support higher demand and related revenue volumes in future quarters.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Amortization of Intangible Assets</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets for the year ended December&#160;31, 2021 was $4.3 million representing a decrease of less than $0.1 million, or 0.5%, compared to 2020. The decrease is attributable to certain intangible assets becoming fully amortized.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Selling and Marketing Expenses</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and marketing expenses for the year ended December&#160;31, 2021 were $10.8 million, an increase of $1.1 million, compared to 2020. Selling and marketing expenses as a percentage of net revenues increased to 10.5% compared to 9.9% in 2020. This increase reflected $1.4 million in higher expenses for NPWT and Pain Management dedicated sales personnel hired during the 2021 second quarter, higher customer travel expenses and a shift in the proportion of net revenue favoring the ITS segment which has a higher commission to sales ratio than the DME Services segment. The additional sales team members represent a strategic investment to accelerate revenue growth for both the Pain Management and NPWT therapies and the expense included in selling and marketing is a portion of an overall expense increase of $2.0 million during 2021 associated with this initiative, the remainder of which is included in general and administrative expense. The higher travel expenses </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">occurred as travel restrictions related to COVID-19 were lifted during 2021. During 2020, when the COVID-19 related travel restrictions were at their peak, our sales team generally did not travel. These increases were partially offset by lower expenses associated with a management reorganization completed during the fourth quarter of 2020 and improved net revenue leverage of fixed selling and marketing expenses. Selling and marketing expenses during these periods consisted of sales personnel salaries, commissions and associated fringe benefit and payroll-related items, marketing, overall travel and entertainment and other miscellaneous expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">General and Administrative (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">G&amp;A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">) Expenses</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G&amp;A expenses for the year ended December&#160;31, 2021 were $42.3 million, an increase of 20.1% from $35.2 million for the year ended December&#160;31, 2020. G&amp;A expenses during these periods consisted primarily of accounting, administrative, third-party payer billing and contract services, customer service, nurses on staff, new product services, service center personnel salaries, fringe benefits and other payroll-related items, professional fees, legal fees, stock-based compensation, insurance and other miscellaneous items. The increase of $7.1 million was due to an increase in stock-based compensation expense of $3.8 million, $0.8 million in additional expenses related to the investments in NPWT and Pain Management. There was also additional G&amp;A and acquisition expenses for FilAMed and OB Healthcare totaling $0.6 million and other increases including higher travel, additional personnel and general business expenses totaling $2.7 million. These amounts were partially offset by lower management bonus expense of $0.8 million. The higher personnel expenses reflect higher staff levels supporting the increase in revenues and other increases. G&amp;A expenses as a percentage of net revenues for 2021 increased to 41.3% compared to 36.1% for the prior year mainly reflecting the year-over-year increases offset partially by improved net revenue leverage over fixed costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Income and Expenses</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, we incurred interest expense of $1.4 million, an increase of $0.1 million, or 9.7%, compared to the year ended December&#160;31, 2020. This was a net result of higher weighted average interest rates on our outstanding debt in 2021 as compared to 2020 and additional commitment fees on a higher unused revolving line availability during 2021. These increases were partially offset by lower interest on our decreased average outstanding borrowings during 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefit from Income Taxes</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company recorded a benefit from income taxes of $0.2 million, representing an effective tax rate of negative 12.9% on pre-tax income totaling $1.3 million. This effective tax rate for 2021 differed from the U.S. statutory rate mainly due to permanent differences in the amounts of equity compensation expense recognized for book versus tax purposes. As of December 31, 2020, the Company had generated significant pre-tax income on a three-year cumulative basis prompting management to assess available positive and negative evidence regarding the recovery of our net deferred tax assets. Due to this assessment, it was determined that it was more likely than not that the Company will recognize the benefits of its federal and state net deferred tax assets and, as a result, a previously recorded valuation allowance was released totaling $11.2 million. During the year ended December&#160;31, 2020, the Company recorded a benefit from income taxes of $9.8 million, which included the valuation allowance reversal, representing a negative effective tax rate of 130% on pre-tax income of $7.5 million. Without the valuation reserve reversal, the Company would have recorded a provision for income taxes of $1.5 million which would have represented an effective tax rate of 19.4%. This adjusted effective tax rate differed from the U.S. statutory rate mainly due to permanent differences in the amounts of equity compensation expense recognized for book versus tax purposes. On March 27, 2020, the Coronavirus Aid, Relief and Economic Securities (CARES) Act was enacted in response to the COVID-19 pandemic, which provides numerous tax provisions and other stimulus measures. The Company assessed the impact of these CARES Act provisions and the subsequently released government guidance related to the COVID-19 pandemic on our financial position and results of operations and determined their impact was not material.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div id="i9e717b65c1e3405d850ef6e342b20071_58"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated subsequent events through the date that our consolidated financial statements are issued with nothing to report. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We finance our operations and capital expenditures with cash generated from operations and borrowings under our existing credit agreements. On February 5, 2021, we and certain of our subsidiaries, as borrowers, entered into a Credit Agreement (the &#8220;2021 Credit Agreement&#8221;) with JPMorgan Chase Bank, N.A., as administrative agent, sole bookrunner and sole lead arranger, and the lenders party thereto, which replaced our then existing credit facility, dated March 23, 2015 (the &#8220;2015 Credit Agreement&#8221;). See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_130">Note 8 (Debt)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the notes to the accompanying unaudited condensed consolidated financial statements for additional information regarding the 2021 Credit Agreement and 2015 Credit Agreement. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available liquidity (in millions):</span></div><div style="margin-top:12pt;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt 0 32.57pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt 0 32.57pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Available liquidity</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity and borrowing plans are established to align with our financial and strategic planning processes and ensure we have the necessary funding to meet our operating commitments, which primarily include the purchase of pumps, inventory, payroll and general expenses. We also take into consideration our overall capital allocation strategy which includes investment for future organic growth, potential acquisitions and share repurchases. We believe we have adequate sources of liquidity and funding available for at least the next year from the filing date of this report, as well as for our currently anticipated long-term needs. However, any projections of future earnings and cash flows are subject to substantial uncertainty, including factors such as the successful execution of our business plan and general economic conditions. We may need to access debt and equity markets in the future if unforeseen costs or opportunities arise, to meet working capital requirements, fund acquisitions or investments or repay indebtedness under the 2021 Credit Agreement. If we need to obtain new debt or equity financing in the future, the terms and availability of such financing may be impacted by economic and financial market conditions as well as our financial condition and results of operations at the time we seek additional financing. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt Activities:</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement provides for a revolving credit facility (the &#8220;Revolving Facility&#8221;) of $75.0 million, maturing on February 5, 2026. The Revolving Facility may be increased by $25.0 million, subject to certain conditions, including the consent of the Agent and obtaining necessary commitments. The lenders under the 2021 Credit Agreement may issue up to $7.0 million in letters of credit subject to the satisfaction of certain conditions. On February&#160;5, 2021, the Borrowers made an initial borrowing of $30.0 million under the Revolving Facility. Proceeds from the loan, along with approximately $8.2 million in cash, were used to repay all amounts due under the Company&#8217;s then existing 2015 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement has customary representations and warranties. The ability to borrow under the facility is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations on indebtedness, liens, mergers, acquisitions, investments, asset sales, affiliate transactions and restricted payments, as well as financial covenants, including the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a minimum fixed charge coverage ratio (defined as the ratio of consolidated EBITDA (as defined in the 2021 Credit Agreement) less 50% of depreciation expense), to consolidated fixed charges (as defined in the 2021 Credit Agreement)) for the prior four most recently ended calendar quarters of 1.20 to 1.00; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a maximum leverage ratio (defined as total indebtedness to EBITDA for the prior four most recently ended calendar quarters) of 3.50 to 1.00.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement includes customary events of default. The occurrence of an event of default will permit the lenders to terminate commitments to lend under the Revolving Facility and accelerate payment of all amounts outstanding thereunder.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;5, 2021, in connection with the execution and closing of the 2021 Credit Agreement, the Company, along with its wholly owned subsidiaries as borrowers, terminated the 2015 Credit Agreement. All outstanding loans under the 2015 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit Agreement have been repaid and all liens under the 2015 Credit Agreement have been released, except that a letter of credit originally issued under the 2015 Credit Agreement in the amount of approximately $0.8 million was transferred to the 2021 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement was accounted for as a debt modification that resulted in a small increase to deferred debt issuance costs. As of December&#160;31, 2021, the Company was in compliance with all debt-related covenants under the 2021 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the 2015 Credit Agreement, which would have matured on November 9, 2024, included three term notes totaling $37.9 million, with varying required quarterly amortization payments, and an undrawn $11.8 million revolving line of credit. The availability under the line of credit was reduced by outstanding letters of credit and reserves totaling $1.0 million and was subject to a borrowing base limitation as defined by the agreement. The borrowing base was approximately $15.6 million at December&#160;31, 2020. At December&#160;31, 2020 and on the date of the refinancing, the Company was in compliance with all affirmative and negative covenants, as outlined in the agreement, which included maintenance of a maximum leverage ratio and a minimum fixed charge coverage ratio, as defined in the agreement. Interest on the facility was payable at the Company&#8217;s option as a (i) Eurodollar Loan, which bore interest at a per annum rate equal to the applicable 30-day London Inter-bank Offered Rate ("LIBOR") plus an applicable margin ranging from 2.00% to 3.00% or (ii) CB Floating Rate (&#8220;CBFR&#8221;) Loan, which bore interest at a per annum rate equal to the greater of (a) the lender&#8217;s prime rate or (b) LIBOR plus 2.50%, in each case, plus a margin ranging from -1.00% to 0.25% based on our leverage ratio. The actual Eurodollar Loan rate at December&#160;31, 2020 was 2.19% (LIBOR of 0.19% plus 2.00%). The actual CBFR Loan rate at December&#160;31, 2020 was 2.25% (lender&#8217;s prime rate of 3.25% minus 1.00%).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;15, 2019, the Company sold for $2.0 million and immediately leased back certain medical equipment in rental service to a third party specializing in such transactions. The leaseback term is 36 months. Because the arrangement contains a purchase option that the Company is reasonably certain to exercise, this transaction did not qualify for the sale-leaseback accounting under ASC 842. The medical equipment remains recorded on the accompanying condensed consolidated balance sheet and the proceeds received have been classified as an other financing liability, which is being paid off monthly over the term of the lease. The balance of other financing as of December&#160;31, 2021 was $0.4 million.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As referenced above, the Company executed and closed the 2021 Credit Agreement during the first quarter of 2021, and in connection with entering into that agreement, terminated the 2015 Credit Agreement. For the following tables, the figures related to the December&#160;31, 2021 revolving credit facility balances relate to the 2021 Credit Agreement, while the December&#160;31, 2020 revolving credit facility balances relate to the now-terminated 2015 Credit Agreement. The following table illustrates the net availability under the revolving credit facilities as of the applicable balance sheet date (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross availability</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding draws</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letters of credit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(600)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Landlord reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Availability on Revolver</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,426&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,788&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021, amounts outstanding under the Revolving Facility provided under the 2021 Credit Agreement bear interest at a variable rate equal to, at the Company&#8217;s election, a LIBO Rate for Eurodollar loans or an Alternative Base Rate for ABR loans, as defined by the 2021 Credit Agreement, plus a spread that will vary depending upon the Company&#8217;s leverage ratio. The spread ranges from 2.00% to 3.00% for Eurodollar Loans and 1.00% to 2.00% for base rate loans. The weighted-average Eurodollar loan rate at December&#160;31, 2021 was 2.11% (LIBO of 0.11% plus 2.00%). The actual ABR loan rate at December&#160;31, 2021 was 4.25% (lender&#8217;s prime rate of 3.25% plus 1.00%).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, on June 30, 2021, our Board of Directors approved the Share Repurchase Program. As of December&#160;31, 2021, the Company had repurchased approximately $0.6 million, or 33,469 shares, of the Company's outstanding common stock under the Share Repurchase Program and had approximately $19.4 million of available repurchases remaining under the program. Repurchases under the Share Repurchase Program will be subject to market conditions, the periodic capital needs of the Company's operating activities, and the continued satisfaction of all covenants under the Company's existing credit </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreement. The Share Repurchase program does not obligate the Company to repurchase shares and may be suspended, terminated, or modified at any time.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows:</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt 0 5.57pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt 0 5.57pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">In millions</span></td><td colspan="3" style="padding:0 1pt 0 5.57pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 5.57pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2020</span></td><td colspan="3" style="padding:0 1pt 0 5.57pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2021 vs. 2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 5.57pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.0)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 5.57pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(21.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash used in financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 5.57pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Cash Flow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; Net cash provided by operating activities for the year ended December&#160;31, 2021 was $18.3 million compared to $20.3 million for the year ended December&#160;31, 2020. This $2.0 million, or 9.7%, decrease was primarily attributable to the unfavorable cash flow effect of an increased amount of cash invested in working capital balances during 2021 as compared to 2020 and a decrease in net income adjusted for non-cash items of $21.0 million during 2021 as compared to $21.5 million during 2020, a decrease of $0.5 million, or 2.5%. During 2021, cash invested in working capital balances totaled $2.7 million, which included a $2.4 million decrease in accounts payable and other liabilities  and a $0.9 million increase in inventories. This amount represented a $1.4 million increase as compared to 2020 when investments in working capital balances totaled $1.3 million and included a $2.6 million increase in accounts receivable and a $0.7 million increase in other current assets.  </span></div><div style="margin-top:7pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, accounts receivable decreased by $0.8 million and increased by $2.6 million during 2020 due to a lower growth in net revenues and improved customer collections during the 2021 period as compared to the prior year period. Inventory increased by $0.9 million during 2021, which was more than the prior year when inventory increased by $0.1 million.  The higher increase during 2021 was attributable to the need to hold additional inventories related to new business lines including Pain Management and NPWT and to be more prepared for the potential disruption in the supply chain.  Accounts payable and other liabilities, net of capital items, decreased by $2.4 million during 2021 and increased by $2.4 million during 2020 resulting in a net decrease in cash flows totaling $4.8 million during 2021 as compared to the prior year.  The primary reason for this change was due to a lower management incentive bonus accrual and expense in 2021 as compared to 2020, a decrease of $2.1 million, versus a higher bonus accrual and expense in 2020 as compared to 2019, an increase of $0.7 million.  The remaining cash flow impact from accounts payable and accrued liabilities was due to timing in payments.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Cash Flow.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash used in investing activities was $21.3 million for the year ended December&#160;31, 2021 compared to $12.2 million for the year ended December&#160;31, 2020. This $9.2 million increase in net cash used was primarily due to the acquisitions of FilAMed and OB Healthcare totaling $8.0 million during 2021 and a $1.4 million decrease in proceeds from the sales of medical equipment. There were no acquisitions during 2020.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Cash Flow.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; Net cash used in financing activities for the year ended December&#160;31, 2021 was $6.5 million compared to $1.1 million for the year ended December&#160;31, 2020. The use of cash during 2021 was mainly related to the refinancing of our bank debt on February 5, 2021. Prior to that date, we operated under the 2015 Credit Agreement which included three term notes and a revolving line of credit. At the beginning of 2021, we had $9.6 million in cash on hand and no outstanding borrowings under the then outstanding revolving line of credit. The 2015 Credit Agreement was completely repaid and replaced by the 2021 Credit Agreement, which has a new $75 million revolving line of credit and no term notes. This structure allowed the Company to use a portion of its available cash, totaling $7.9 million, to reduce its overall outstanding debt on the closing date of the financing. Other amounts of cash used in financing activities during 2021 included net revolving line of credit repayments under the 2021 Credit Agreement made from our operating cash flows after the date of the February 5, 2021 refinancing totaling $3.8 million, $0.6 million used to repurchase the Company's common stock and $0.6 million in principal payments on our other financing. These amounts were partially offset by revolving line of credit borrowings totaling $8.0 million used to acquire FilAMed and OB Healthcare. Net cash used in financing activities during 2020 included $1.5 million net cash used in the Company's equity compensation plan partially offset by a $0.4 million net increase in outstanding borrowings under the 2015 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span><br/></span></div><div id="i9e717b65c1e3405d850ef6e342b20071_73"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, assumptions and judgments that affect the amounts reported in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements, including the notes thereto. We consider critical accounting policies to be those that require more significant judgments and estimates in the preparation of our consolidated financial statements, including the following: revenue recognition; leases; accounts receivable and allowance for doubtful accounts; income taxes; and long-lived asset valuations. Management relies on historical experience and other assumptions believed to be reasonable in making its judgments and estimates. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes its application of accounting policies, and the estimates inherently required therein, are reasonable. These accounting policies and estimates are periodically reevaluated, and adjustments are made when facts and circumstances dictate a change.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounting policies are more fully described under the heading &#8220;Summary of Significant Accounting Policies&#8221; in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_109">Note 2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Consolidated Financial Statements included in this Form 10-K. We believe the following critical accounting estimates are the most significant to the presentation of our financial statements and require the most difficult, subjective and complex judgments:</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 606 - Revenue from Contracts with Customers ("ASC 606") stipulates revenue recognition at the time and in an amount that reflects the consideration expected to be received for the performance obligations that have been provided. ASC 606 defines contracts as written, oral and through customary business practice. Under this definition, the Company considers contracts to be created at the time that the rental service is authorized or an order to purchase product is agreed upon regardless of whether or not there is a written contract.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three separate and distinct performance obligations offered to its customers: a rental service performance obligation, a product sale performance obligation and a service performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is defined as the unit of account for revenue recognition under ASC 606. These performance obligations are related to separate revenue streams and at no point are they combined into a single transaction. Sources of net revenues include commercial insurance payers, government insurance payers, medical facilities and patients.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue from the rental of infusion pumps to its customers and a minority of its revenue from product sales and services. For the rental service performance obligation, revenue is based on its standalone price, determined by using reimbursement rates established by third-party payer or other contracts. Revenue is recognized in the period in which the related performance obligation is satisfied, which is typically at the point in time that a patient concludes a treatment, or in certain arrangements, based on the number of pumps that a facility has onsite. The Company&#8217;s revenues related to product sales is recognized at the time that control of the product has been transferred to the customer; either at the time the product is shipped or the time the product has been received by the customer, depending on the delivery terms. The Company does not commit to long-term contracts to sell customers a certain minimum quantity of products. The Company's revenues related to services are recognized at the time that the service work has been completed.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company employs certain significant judgments to estimate the dollar amount of revenue, and related concessions, allocated to the rental service. These judgments include, among others, the estimation of variable consideration. Variable consideration, specifically related to the Company&#8217;s third-party payer rental revenues, is estimated as implied price concessions resulting from differences between the rates charged for services performed and the expected reimbursements for commercial payers and other implied customer concessions. The estimates for variable consideration are based on historical collections with similar payers, aged accounts receivable by payer class and payer correspondence using the portfolio approach, which provide a reasonable basis for estimating the variable portion of a transaction. The Company doesn&#8217;t believe it is probable that a significant reversal of revenue will occur in future periods because (i) there is no significant uncertainty about the amount of considerations that are expected to be collected based on collection history and (ii) the large number of sufficiently similar contracts allows the Company to adequately estimate the component of variable consideration.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues are adjusted when changes in estimates of variable consideration occur. Changes in estimates typically arise as a result of new information obtained, such as actual payment receipt or denial, or pricing adjustments by payers. Subsequent changes to estimates of transaction prices are recorded as adjustments to net revenue in the period of the change. Subsequent changes that are determined to be the result of an adverse change in the payer&#8217;s ability to pay are recorded as an adjustment to the allowance for doubtful accounts.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019 (the &#8220;Effective Date&#8221;), the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, Leases (Topic 842); ASU 2018-10, Codification Improvements to Topic 842, Leases; and ASU 2018-11, Targeted Improvements (collectively, &#8220;Topic 842&#8221;) using a modified retrospective transition approach, which requires Topic 842 to be applied to all leases existing at the date of initial application. Under Topic 842, lessees are required to recognize a lease liability and right-of-use asset (&#8220;ROU asset&#8221;) for all leases and to disclose key information about leasing arrangements. Additionally, leases are classified as either financing or operating; the classification determines the pattern of expense recognition and classification within the statement of operations. The Company elected to apply its lease accounting policy only to leases with a term greater than twelve months.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic 842 provides several optional practical expedients that we adopted at transition. The Company elected the &#8220;package of practical expedients&#8221;, which does not require it to reassess its prior conclusions regarding lease identification, lease classification and initial direct costs. The Company did not elect the practical expedient of hindsight to the evaluation of lease options (e.g. renewal).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic 842 also provides practical expedients for an entity&#8217;s ongoing accounting. The Company elected the &#8220;combining lease and non-lease components&#8221; practical expedient and also elected to apply the short-term lease recognition exemption to certain leases; therefore, the Company did not recognize ROU assets and lease liabilities for these leases.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In adopting Topic 842, the Company determined and will continue to determine whether an arrangement is a lease at inception. The Company&#8217;s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next ten years. The Company&#8217;s leases do not contain any restrictive covenants. The Company&#8217;s office leases generally contain renewal options for periods ranging from one to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company&#8217;s office leases do not contain any material residual value guarantees. The Company&#8217;s equipment leases generally do not contain renewal options. The Company is not reasonably certain to exercise the renewal options for those equipment leases that do contain renewal options, thus, the options are not considered in determining the lease term and payments associated with the option years are excluded from lease payments.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s equipment leases, the Company used and will use the implicit rate in the lease as the discount rate, when available. Otherwise, the Company uses its incremental borrowing rate as the discount rate. For the Company&#8217;s office leases, the implicit rate is typically not available, so the Company used and will use its incremental borrowing rate as the discount rate. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The Company&#8217;s lease agreements include both lease and non-lease components. The Company elected the practical expedient that allows it to combine lease and non-lease components for all of its leases.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments due under the Company&#8217;s operating leases include fixed payments as well as variable payments. For the Company&#8217;s office leases, variable payments include amounts for the Company&#8217;s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company&#8217;s equipment leases, variable payments may consist of sales taxes, property taxes and other fees.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Asset Valuation</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually or when events occur or circumstances change that trigger a review. Management has the option to first assess qualitative factors such as current performance and overall economic conditions to determine whether or not it is necessary to perform a quantitative goodwill impairment test. If we choose that option, then we would not be required to perform a quantitative goodwill impairment test unless we determine that, based on a qualitative assessment, it is more likely than not that the fair value of a reporting unit is less than its carrying value. If we determine that it is more likely than not, or if we choose not to perform a qualitative assessment, we will then proceed with the quantitative assessment. Under the quantitative test, if the fair value of a reporting unit exceeds its carrying amount, then goodwill of the reporting unit is considered to not be impaired. If the carrying amount of the reporting unit exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess, up to the value of the goodwill. We performed our annual impairment analysis by using a qualitative assessment as off the first day of October 2021 and determined that there was no impairment. Any changes in management's judgments could result in impairment charges in the future. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management tests indefinite life trade names for impairment annually or more frequently if deemed necessary. Management has the option of first performing the impairment test for intangible assets with indefinite lives on a qualitative basis, by evaluating factors to determine whether it is more likely than not that an impairment exists. If it is more likely than not </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that an impairment exists, then a quantitative impairment test is performed. Impairment exists when the carrying amount of the intangible asset exceeds its fair value. If the carrying value of the intangible assets exceeds the fair value, an impairment loss is recognized in an amount equal to that excess. We performed our annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that the fair value of the trade names with indefinite lives was greater than their carrying value, resulting in no impairment.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also evaluate the carrying value of other long-lived assets for impairment by analyzing the operating performance and anticipated future cash flows for those assets, whenever events or changes in circumstances indicate that the carrying amounts of such assets may not be recoverable. We evaluate the need to adjust the carrying value of the underlying assets if the sum of the expected cash flows is less than the carrying value. Our projection of future cash flows, the level of actual cash flows, the methods of estimation used for determining fair values and salvage values can impact impairment. Any changes in management&#8217;s judgments could result in greater or lesser annual depreciation and amortization expense or impairment charges in the future. Depreciation and amortization of long-lived assets is calculated using the straight-line method over the estimated useful lives of the assets.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses impairment indicators related to its internally-developed, internal-use software, specifically looking at the effectiveness and useful lives of each project and sub-project to determine if impairment indicators are present. In December 2021 and 2020, respectively, the Company assessed the impairment indicators and found none to be present.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, refer to the &#8220;Goodwill and Intangible Assets&#8221; discussion included in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_124">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_124">7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Notes to the Consolidated Financial Statements included in this Form 10-K.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_76"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7A.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosure About Market Risk.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk from changes in foreign currency exchange rates and short-term interest rates. Market risks for changes in interest rates relate primarily to our debt obligations under our 2021 Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in our functional currency which is the U.S. Dollar and include exposures primarily to the Canadian Dollar.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them.  We did not have any foreign currency derivative contracts outstanding at any time during the three-year period ended December&#160;31, 2021. The maximum length of time over which we hedge our exposure to short-term interest rate risk is equal to the remaining term for the debt obligation being hedged. We had interest rate derivative contracts with a notional value of $20.0 million as of December 31, 2021. No interest rate derivative contracts existed as of December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive loss in the consolidated balance sheet.&#160;&#160;When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive income is recorded in earnings in the consolidated statement of income on the same line as the gain or loss on the hedged item attributable to the hedged risk.&#160;&#160;We record the ineffective portion of interest rate hedging instruments, if any, to interest expense in the consolidated statements of income. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_1828">Note 9</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our consolidated financial statements for information related to the fair values of derivative instruments in our consolidated balance sheet as of December&#160;31, 2021 and 2020 and information related to the effect of derivative instruments included in our consolidated income statement and statement of comprehensive income including the amount of unrealized gain associated with our interest rate derivatives reported in accumulated other comprehensive income that was reclassified into earnings during 2021.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument&#8217;s full term.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, Financial Conduct Authority (the authority that regulates LIBOR) previously announced its intent to stop compelling banks to submit rates for the calculation of LIBOR after 2021, and the administrator of LIBOR announced its intention to cease the publication of the one week and two month USD LIBOR settings immediately following December 31, 2021, and the remaining USD LIBOR settings immediately following the LIBOR publication on June 30, 2023. The one week and two month USD LIBOR settings were last published on December 31, 2021. Additionally, it is expected that banks will no </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">longer issue LIBOR-based debt after December 31, 2021. Accordingly, there is considerable uncertainty regarding the publication of such rates beyond these dates. The Alternative Reference Rates Committee ("ARRC") has proposed that the Secured Overnight Financing Rate ("SOFR") is the rate that represents best practice as the alternative to USD LIBOR for use in derivatives and other financial contracts that are currently indexed to USD LIBOR. ARRC has proposed a paced market transition plan to SOFR from USD LIBOR and organizations are currently working on industry wide and company specific transition plans as it relates to derivatives and cash markets exposed to USD LIBOR. At this time, it is not known whether or when SOFR or other alternative reference rates will attain market traction as replacements for LIBOR. The Company's 2021 Credit Agreement, discussed in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_130">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements, and the Company's interest rate swap agreements, discussed in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_1828">Note 9</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements, are indexed to USD LIBOR and management is monitoring this activity and evaluating the related risks.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;Financial Statements and Supplementary Data.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Financial Statements</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_82">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (BDO USA, LLP; Troy, MI; PCAOB ID# <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV83OS9mcmFnOjQxMzAzZWRkMmMwMDRhMzdiZjk1MmVjN2Y1Y2Y4OGRiL3RhYmxlOmIxMDA0NzIzN2JlNTQ2OWQ4ZjMxZTE1YmNjMDI0NGQ5L3RhYmxlcmFuZ2U6YjEwMDQ3MjM3YmU1NDY5ZDhmMzFlMTViY2MwMjQ0ZDlfMS0wLTEtMS04ODUzMC90ZXh0cmVnaW9uOmNkOTRiNmViYmI0OTQxZDdiMDdhNjY0NmIzYTRiNzE5XzMyOTg1MzQ4ODM0MzY_4354a7c7-7f86-4e7c-8684-3c35ccccae2b">243</ix:nonNumeric>)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_82">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_85">Consolidated Balance Sheets as of December&#160;31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_85">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_85"> and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_85">2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_85">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Statements of Operations and Comprehensive Income for the years ended December&#160;31, 2021, 2020 and 2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_1688">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Statements of Stockholders&#8217;&#160;Equity for the years ended December&#160;31, 2021, 2020 and 2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_1715">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2021, 2020 and 2019</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_1733">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_100">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_100">44</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders and Board of Directors</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InfuSystem Holdings, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rochester Hills, Michigan</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of InfuSystem Holdings, Inc. (the &#8220;Company&#8221;) as of December&#160;31, 2021 and 2020, the related consolidated statements of operations and comprehensive income, stockholders&#8217; equity, and cash flows for each of the three years in the period ended December 31, 2021, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third-Party Payer Rental Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 2 of the Company&#8217;s consolidated financial statements, variable consideration related to third-party payer rentals is estimated as&#160;implied price concessions&#160;resulting from differences between the rates charged for services performed and the expected reimbursements&#160;for commercial payers and&#160;other&#160;implied customer&#160;concessions (&#8220;payer reimbursement rates&#8221;).&#160;Such payer reimbursement rates are based on historical collections with similar payers,&#160;aged accounts receivable by payer class and payer correspondence using the portfolio approach. For the year ended December 31, 2021, the Company&#8217;s consolidated revenues attributable to third-party payer rentals was $52.8 million.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the estimation of payer reimbursement rates used in the determination of variable consideration from third-party payer rental revenue as a critical audit matter.&#160; Significant assumptions, including rates charged and collection, are used to determine payer reimbursement rates. Auditing management&#8217;s estimates involved subjective auditor judgment due to the nature and extent of audit effort required to address these matters.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary procedures we performed to address this critical audit matter included:</span></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing the inputs to the payer reimbursement rates through tracing to source documents.</span></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing the calculation of payer reimbursement rates through checking the mathematical accuracy of the calculations.</span></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Evaluating management&#8217;s estimated payer reimbursement rates by performing a retrospective review of historical estimated payer reimbursement rates to actual reimbursements received.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84Mi9mcmFnOjA3ZjU4NzBkZTdjMjQ3ZTRiZjE3M2IzOGVkZTE2ZGQ5L3RleHRyZWdpb246MDdmNTg3MGRlN2MyNDdlNGJmMTczYjM4ZWRlMTZkZDlfMzI5ODUzNDg5MDQ3Mg_ba16c75f-ed4e-420f-a290-6467388259c6">BDO USA, LLP</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2013.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84Mi9mcmFnOjA3ZjU4NzBkZTdjMjQ3ZTRiZjE3M2IzOGVkZTE2ZGQ5L3RleHRyZWdpb246MDdmNTg3MGRlN2MyNDdlNGJmMTczYjM4ZWRlMTZkZDlfMzI5ODUzNDg5MDQ3Mw_f301903f-1042-4430-ac3e-dd9e6e0b587f">Troy, Michigan</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;15, 2022</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands, except par value and share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNC0yLTEtMS01MDYyMg_093275d1-6e89-48fe-99bd-a1d25fe21a83">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNC00LTEtMS01MDYyMg_18e0169b-2590-4d3c-9df2-b80b6e7d1c1b">9,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNS0yLTEtMS01MDYyMg_e84b0e46-8231-45ce-9949-95ff5d7ea4c4">15,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNS00LTEtMS01MDYyMg_f9a63c9a-0a8c-4df5-a488-606aa55afde9">14,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNi0yLTEtMS01MDYyMg_0abcca9e-c9cf-4d9a-8719-86c8e249c0b2">3,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNi00LTEtMS01MDYyMg_8f6b8ff6-cffc-4186-beae-3ae289ea7f5c">3,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNy0yLTEtMS01MDYyMg_4a9ae445-9af7-4db8-955a-65d852105351">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNy00LTEtMS01MDYyMg_53e016da-efb1-48af-8489-3630cc0ce9a9">2,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 5.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfOS0yLTEtMS01MDYyMg_5647e8cf-dc90-4c90-b1d8-42e56481b3e9">22,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfOS00LTEtMS01MDYyMg_903c45e7-ec4f-4536-9f6d-f338576214f9">29,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRental" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTAtMi0xLTEtNTA2MjI_61c39d96-aabc-4b31-ba61-ba8a01d1fa79">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRental" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTAtNC0xLTEtNTA2MjI_fb448d08-6852-445f-a615-73c38374c308">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service, net of accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTEtMi0xLTEtNTA2MjI_4d097177-d6b9-44ff-9208-0a60f73a36d9">39,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTEtNC0xLTEtNTA2MjI_8693f20e-3753-40ee-b99d-99474e548c72">35,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property &amp; equipment, net of accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTItMi0xLTEtNTA2MjI_5178fc56-540f-41d7-bc3e-82a4406d37fe">4,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTItNC0xLTEtNTA2MjI_d7ef229f-a0ef-4a67-8fa0-9bc3f2f91888">4,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTMtMi0xLTEtNTA3MjA_aaca9ab1-52be-41df-9b99-245acef4a960">3,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTMtNC0xLTEtNTA3MjA_e0444e23-4765-4fc4-8e6e-9b45e7aefcab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTMtMi0xLTEtNTA2MjI_58640abf-7007-4769-bd13-ebd3b0ae028a">10,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTMtNC0xLTEtNTA2MjI_351fcf0c-e6bb-45d5-8316-bfdf3b6ba479">11,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTQtMi0xLTEtNTA2MjI_4cd101b5-964c-4cab-904c-f651ea6e14d0">4,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTQtNC0xLTEtNTA2MjI_ec276d68-4c2f-48e5-9acb-58f0e630fdb0">4,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTUtMi0xLTEtNTA2MjI_90b189bb-9c0c-4b64-873a-e75d849787fd">10,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTUtNC0xLTEtNTA2MjI_1f3cd0ca-0f3d-447c-8097-c2b6613bdd3e">9,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTYtMi0xLTEtNTA2MjI_51faf067-ae29-4a01-a132-c2c028c77e2e">471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTYtNC0xLTEtNTA2MjI_5763aa8d-21df-4b16-bd89-f50cc98cc6bf">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 5.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTgtMi0xLTEtNTA2MjI_abb1b112-3439-41fa-8ff9-e37212b2e83c">97,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTgtNC0xLTEtNTA2MjI_02a0a6db-6f15-43ea-bc68-1e7309582b9f">96,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 5.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">LIABILITIES AND STOCKHOLDERS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> EQUITY</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjItMi0xLTEtNTA2MjI_0736c3ec-b0f3-4b32-8759-8011239421b9">7,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjItNC0xLTEtNTA2MjI_3420129e-8b06-4802-9b48-3f41f0fd440d">6,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjMtMi0xLTEtNTA2MjI_a55bc4c6-0876-4b4f-86a4-103c05f557fd">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjMtNC0xLTEtNTA2MjI_a96c6513-c8c9-4ba3-a418-75d5cb68b600">9,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjQtMi0xLTEtNTA2MjI_6dae1647-cc69-4b5e-94ee-2b0dc32fc980">4,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjQtNC0xLTEtNTA2MjI_5b3612bb-2735-470a-b20e-e2e37cc1f988">6,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 5.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjYtMi0xLTEtNTA2MjI_a4b30119-445f-49f0-ad0a-fea50bd20a73">12,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjYtNC0xLTEtNTA2MjI_eb86f687-47e6-4552-9fd4-edb7623f70bd">22,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Long-term debt, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjgtMi0xLTEtNTA2MjI_4690dfd2-4861-4a9d-918c-81a6bb42cc6f">32,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjgtNC0xLTEtNTA2MjI_7e2cbd28-0c16-495c-9750-972474e4df9c">29,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzAtMi0xLTEtNTA2MjI_a1f24058-9444-4037-818a-37f127e64887">3,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzAtNC0xLTEtNTA2MjI_b28d1075-d1e7-45be-8af0-c41a5a3b1708">3,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 5.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzItMi0xLTEtNTA2MjI_6b9e3dc5-cede-4b0f-a9d1-43ed1cf65b45">49,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzItNC0xLTEtNTA2MjI_48be518a-ed64-4c71-974e-baf43a42b51a">56,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 5.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODU1_77954786-1259-45f1-99c8-2b741a5d6f00"><ix:nonFraction unitRef="usdPerShare" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODU1_bac1e78b-ea5b-4f22-a5ea-65467cfcaba7">0.0001</ix:nonFraction></ix:nonFraction> par value: authorized <ix:nonFraction unitRef="shares" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODY0_b5562687-0cbb-4b5e-8f42-8adbf6a8da51"><ix:nonFraction unitRef="shares" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODY0_c588c729-d62b-41bd-b834-972d8470e362">1,000,000</ix:nonFraction></ix:nonFraction> shares; <ix:nonFraction unitRef="shares" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODc2_0c476de8-710b-406e-a3cf-2520ca5f24a1"><ix:nonFraction unitRef="shares" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODc2_f5084e4b-3175-492a-90ad-6a582d2d2888">none</ix:nonFraction></ix:nonFraction> issued</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMi0xLTEtNTA2MjI_eff1fa27-6476-441c-a360-2826ffb755a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtNC0xLTEtNTA2MjI_ca00a416-140c-4983-9c86-a6bbf8410376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDI1_1c3afd9c-7ea3-4cf8-aff4-61ddc0391dce"><ix:nonFraction unitRef="usdPerShare" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDI1_8b4915e0-1916-44a6-8b87-7abbe6514b54">0.0001</ix:nonFraction></ix:nonFraction> par value: authorized <ix:nonFraction unitRef="shares" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDM1_9d2d4457-3863-46b2-9f27-e517144a3017"><ix:nonFraction unitRef="shares" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDM1_a37638eb-ad61-47c7-a925-4ee9c0711078">200,000,000</ix:nonFraction></ix:nonFraction> shares; issued and outstanding <ix:nonFraction unitRef="shares" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDQ5_b2fc03fc-8893-4b68-a5a8-df5d9623b34e">20,699,546</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDYy_b34f4c6c-a247-49a9-bdb2-37a58cc5a8b8">20,699,546</ix:nonFraction>, as of December&#160;31, 2021, respectively, and issued and outstanding <ix:nonFraction unitRef="shares" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MTE1_cc196865-9b29-49ce-b1ec-29eb1f76fdf9">23,816,193</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MTI4_8319b14a-d35a-46d6-b4c6-5f5ea2197713">20,297,704</ix:nonFraction>, as of December&#160;31, 2020, respectively.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMi0xLTEtNTA2MjI_7e8a2f22-8f1b-499e-a3ba-361dee0c5046">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtNC0xLTEtNTA2MjI_b804fb95-5647-4f07-a64a-311429a1a88b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzctMi0xLTEtNTA2MjI_033fb916-ad73-49ce-9a2a-d3a986bbcb7e">101,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzctNC0xLTEtNTA2MjI_23160d14-eb57-4aed-aecb-c4b3c832dd20">84,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzktMi0xLTEtNTA3MzQ_6a1bea1f-d34e-49f0-a736-aa258f572bf9">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzktNC0xLTEtNTA3MzQ_3f1e7593-4c9e-4b64-8c8a-aaebb5973ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Retained deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzgtMi0xLTEtNTA2MjI_3317fe61-0cb7-44f2-9827-23e6774838ee">53,903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzgtNC0xLTEtNTA2MjI_a8e9531f-f868-495f-97c5-700609126797">44,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 5.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNDAtMi0xLTEtNTA2MjI_adc42703-ced4-41dd-ac4a-959f4baee0cd">48,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNDAtNC0xLTEtNTA2MjI_072c4e44-411c-4a76-888a-d7825f2935da">40,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 5.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNDItMi0xLTEtNTA2MjI_c69f86a8-ae12-4c26-88ca-16cb6a8df7d3">97,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNDItNC0xLTEtNTA2MjI_b19ed822-1119-4729-a71e-1cfeb3f6fec0">96,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_1688"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center;text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center;text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.156%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yLTItMS0xLTUxMDQ5_8f4167ae-94f5-4fea-960b-f34bb206e5b7">102,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yLTQtMS0xLTUxMDQ5_7d5a9fcc-74ab-4d8a-87c4-9443e2f86609">97,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yLTYtMS0xLTUxMDcy_67311fcd-34bf-4afd-9d17-955701dadb6d">81,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zLTItMS0xLTUxMDQ5_91b22a8e-7431-48f3-bb94-3cbe8ae1c443">42,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zLTQtMS0xLTUxMDQ5_a07abc2a-a01f-4f75-a9f7-4a6634a20370">38,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zLTYtMS0xLTUxMDcy_b64f3c06-fa71-4db0-9f31-8e2e5b28dc42">34,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV80LTItMS0xLTUxMDQ5_a74e55db-b59d-467d-9d64-b6861205dc84">60,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV80LTQtMS0xLTUxMDQ5_e173d8e6-6e61-4005-9036-c2764fc95896">58,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV80LTYtMS0xLTUxMDcy_bae5ca41-45c2-4888-bdad-09a6c6f0ba55">46,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling, general and administrative expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Provision for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV83LTItMS0xLTUxMDQ5_6b1b3ead-af2a-49c4-a544-c9ec6fa3fa27">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV83LTQtMS0xLTUxMDQ5_97117259-27b2-4786-8a22-dbf27acf35d2">791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV83LTYtMS0xLTUxMDg0_e00130a0-bb7b-4e8a-bd6e-adc949d53956">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV84LTItMS0xLTUxMDQ5_294d94cf-3569-4c27-9a8d-2cc9a30ed364">4,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV84LTQtMS0xLTUxMDQ5_1703ce8d-4072-4997-b31a-71cc1f536c0e">4,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV84LTYtMS0xLTUxMDg0_57bdd440-119f-48ff-8119-7a9f49b31573">4,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV85LTItMS0xLTUxMDQ5_e4b2e4c5-9638-47dd-9a5f-73c6a9303444">10,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV85LTQtMS0xLTUxMDQ5_e9bf320c-5205-4481-81db-a59c3638cc24">9,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV85LTYtMS0xLTUxMDg0_bab3228a-eb09-4c6c-90da-72767bc66c5a">9,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMC0yLTEtMS01MTA0OQ_a5726f0b-c395-46cc-a40f-072172659006">42,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMC00LTEtMS01MTA0OQ_054e7cc9-6d24-4dd6-8654-f43bc4dd7fb8">35,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMC02LTEtMS01MTA4NA_8f26fb0f-2587-4351-ba1e-446a7d193d69">28,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 28.07pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMi0yLTEtMS01MTA0OQ_97d8e2ad-a07d-4404-85a7-310b4aacfac3">57,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMi00LTEtMS01MTA0OQ_09c503f7-f85d-40a0-83a3-2cb8d07aab96">49,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMi02LTEtMS01MTA4NA_f32328ff-d81c-43a1-b62b-20a8981c888c">43,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNC0yLTEtMS01MTA0OQ_7af1dbbb-07c5-4687-b8e6-8759912b543c">2,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNC00LTEtMS01MTA0OQ_1fc2b292-3294-411a-b0bb-ec763509d3ea">8,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNC02LTEtMS01MTA5Ng_837d0480-9e38-4738-8672-5118a30d71c4">3,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNi0yLTEtMS01MTA0OQ_c2563b90-e798-4a4d-9419-8179cb740467">1,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNi00LTEtMS01MTA0OQ_b3b33301-14ad-4b8e-9136-33a86ea2d3d4">1,255</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNi02LTEtMS01MTEwNA_12c3fed8-3223-4891-8272-cf990dee4241">1,904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNy0yLTEtMS01MTA0OQ_71eccff6-f374-4bc6-87f3-16bf87b65654">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNy00LTEtMS01MTA0OQ_28383af3-5d8a-43e7-a359-d255a17ed35e">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNy02LTEtMS01MTEwNA_c3f427dc-1bd3-45e2-a311-36ce1c208134">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xOS0yLTEtMS01MTA0OQ_dd876be2-bcdb-4b88-a0ee-c9130c352ab0">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xOS00LTEtMS01MTA0OQ_fa10657e-d78a-4fa6-941a-89a3617e42b3">7,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xOS02LTEtMS01MTExOA_121a8427-e20f-4dfa-bab0-60bc668fd7a6">1,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from (provision for) income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMC0yLTEtMS01MTA0OQ_5b1585be-8e8c-48be-913a-f3388ef7ddd0">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMC00LTEtMS01MTA0OQ_d8194290-a369-4715-8e48-80523262d2ab">9,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMC02LTEtMS01MTExMQ_94666e9e-27ad-4057-9934-538f31610288">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMS0yLTEtMS01MTA0OQ_d4781426-597e-41e1-b864-6f20f3621b61">1,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMS00LTEtMS01MTA0OQ_a815cc32-ec60-4e17-93b5-ac6e9fa70de2">17,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMS02LTEtMS01MTEyNg_8fa1451b-d45b-4f62-8f18-47eef68f6c50">1,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMy0yLTEtMS01MTA0OQ_7f9718b7-56e7-4846-bfe5-9c6ab779b3fe">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMy00LTEtMS01MTA0OQ_d648fd22-7b1a-476b-a476-cd941be24b03">0.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMy02LTEtMS01MTEzOQ_56ef97a8-35d4-432c-8f0a-4fcd381b70c7">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNC0yLTEtMS01MTA0OQ_9674e000-b1d6-4841-ab97-b6b02b24000e">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNC00LTEtMS01MTA0OQ_8d8d432d-49bb-4440-bd5a-f90c0d1afa8d">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNC02LTEtMS01MTEzOQ_f75f5d29-7754-483d-8677-e90e21a42d50">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNi0yLTEtMS01MTA0OQ_975dd14a-d805-4240-8c94-8be3e35c173e">20,519,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNi00LTEtMS01MTA0OQ_45dfd4a4-afcb-42e0-baeb-d19efa2eb4eb">20,106,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNi02LTEtMS01MTEzOQ_e9aa1279-dc96-4e44-a4c5-c9176710cbde">19,731,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNy0yLTEtMS01MTA0OQ_5cb7addb-21ad-43aa-8fe9-e31b5452d7f4">22,049,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNy00LTEtMS01MTA0OQ_fe23ad67-0b82-4fc8-9f63-d3404cdc4107">21,717,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNy02LTEtMS01MTEzOQ_15841361-c812-4375-9952-7fa9701a9c74">20,839,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMC0yLTEtMS01MTA0OQ_a4cfec2f-4b96-47af-a159-7c7a8cb5a96e">1,420</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMC00LTEtMS01MTA0OQ_3fe96813-5e64-4403-9eeb-ad50bb21d896">17,332</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMC02LTEtMS01MTE0Ng_e8e0a771-b8d3-4e9e-b6ec-a31432f89568">1,361</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unrealized gain on hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMi0yLTEtMS01MTA0OQ_1c96cfb2-31e1-4326-9c13-b34351c8e759">355</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMi00LTEtMS01MTA0OQ_991bffd0-bc1d-435e-9483-e58942fcb639">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMi02LTEtMS01MTE0Ng_e598bd73-3420-4b5e-a012-5fe01fb83ea2">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Provision for income tax on unrealized hedge gain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMy0yLTEtMS01MTA0OQ_05a8a8ea-c5dc-4ec3-bc47-7497bad33555">87</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMy00LTEtMS01MTA0OQ_6afa4026-9def-42e1-9a27-e8894dbfdb10">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMy02LTEtMS01MTE0Ng_e62575ef-36c4-484a-a270-cd6e12aca43d">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zNC0yLTEtMS01MTA0OQ_0259570c-a588-4201-987e-ecf01748052a">1,688</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zNC00LTEtMS01MTA0OQ_813e118e-ed59-4c49-8312-39bde056ca12">17,332</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zNC02LTEtMS01MTE0Ng_f02f2acc-f572-4d64-af71-b207a68836f6">1,361</ix:nonFraction></span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_1715"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDERS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EQUITY</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.725%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.867%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.686%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.151%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional <br/>Paid in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained <br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balances at January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b8b5e5eab5d411ab7c41bbd0a191163_I20181231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTItMS0xLTUxMzk1_4afedbeb-31e4-436c-995c-069377ff6f3a">23,096</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8b5e5eab5d411ab7c41bbd0a191163_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTQtMS0xLTUxMzk1_f6469212-c5ca-48f7-a43f-609d4f779f3e">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfdec380605a4b47bc98e52a196722c4_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTYtMS0xLTUxMzk1_2b6a3013-7605-40cb-acb0-260d12756a9b">83,167</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe974377c6e747c1a5ca843447269847_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTgtMS0xLTUxMzk1_375ec498-ebde-4806-8dc8-5b6f63fb5f7f">62,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08a5c3d39ecd4a888c2f856ced55d19a_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTEwLTEtMS01MTM5NQ_a4037ee1-6439-485f-b763-08d6bb5cdd1f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i157f7776f6f34785bf30f4235c8d11bc_I20181231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTEyLTEtMS01MTM5NQ_ea41bfed-cba0-40e6-9aac-c9c78978f288">3,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i157f7776f6f34785bf30f4235c8d11bc_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTE0LTEtMS01MTM5NQ_4f505498-6ba5-429b-8854-5ce4196d653c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488a17cbb36b421597c4f159595f4b31_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTE2LTEtMS01MTM5NQ_0b069fa7-8930-4bb3-8ae0-5c686160b9f1">20,441</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based shares issued upon vesting - gross</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67545d7705224bc6be52955d497ead2a_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zLTItMS0xLTUxMzk1_b9b74f94-cd02-459d-8077-7a657faf897c">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2affbe3d3694f7286adc05cd2ef1a5f_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zLTYtMS0xLTUxMzk1_585158fe-cc3c-4d30-877d-6e7effdd10c5">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zLTE2LTEtMS01MTM5NQ_a6f27841-32d5-434b-840f-7f32771ff7f3">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2affbe3d3694f7286adc05cd2ef1a5f_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV80LTYtMS0xLTUxMzk1_970a8391-7ce4-4ebf-85ef-37ed78be221b">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV80LTE2LTEtMS01MTM5NQ_ffd8aaf8-a68b-4332-a921-68b1b414559e">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67545d7705224bc6be52955d497ead2a_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTItMS0xLTUxMzk1_d9f66e2b-a67a-4fab-b351-f9c6bdaa1681">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2affbe3d3694f7286adc05cd2ef1a5f_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTYtMS0xLTUxMzk1_83947b98-54bd-4b19-9452-4dbadc15f56d">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTE2LTEtMS01MTM5NQ_ebd52702-cb4e-4167-a89c-1d3b8851977b">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i67545d7705224bc6be52955d497ead2a_D20190101-20191231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTItMS0xLTUxMzk1_8f02859f-cbd3-4cc4-8ce7-a9eb4108ebf2">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2affbe3d3694f7286adc05cd2ef1a5f_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTYtMS0xLTUxMzk1_6a5b8ec2-cabf-4d95-b2b8-b0e68ab03ea0">717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTE2LTEtMS01MTM5NQ_5e9a1f86-f609-4d5c-9229-a3b6ffbad21a">717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68d542ad3a9045d9a04429f3568a9113_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV85LTgtMS0xLTUxMzk1_4f301403-aa8e-4086-b592-cbcb562b8ee6">1,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV85LTE2LTEtMS01MTM5NQ_92c7080a-057f-4c12-92f6-8b7fedaad364">1,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balances at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib332759d305f4dc8b9ccc96ac2c5af1a_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTItMS0xLTUxMjg3_e027bdfc-dca9-4c5f-98cd-da768e462cc5">23,401</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib332759d305f4dc8b9ccc96ac2c5af1a_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTQtMS0xLTUxMjg3_066ece9d-e792-4889-ae37-dac7e125818e">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ee4273907446b1ba9e85ec18226b50_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTYtMS0xLTUxMjg3_a5999d4a-a3d7-4d46-8c6b-c26fbeec155a">83,699</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc90323890a347a6a803d6e29739a07a_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTgtMS0xLTUxMjg3_59813209-afd3-4da9-9347-6f88c3b57301">61,367</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5306a01245a74e03ab4033c4fe19fc15_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTEwLTEtMS01MTI4Nw_c53854d2-8a55-49bf-921e-57adbd809ab8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i36d6369b86a9480192a2232dd6e20776_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTEyLTEtMS01MTI4Nw_dac36a93-67b2-4d0f-8b90-c0fb7a1f0292">3,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36d6369b86a9480192a2232dd6e20776_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTE0LTEtMS01MTI4Nw_fb9c24d7-cb64-4458-b565-60f62700e012">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTE2LTEtMS01MTI4Nw_d5577346-6b25-4232-93d3-931142081ac8">22,334</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based shares issued upon vesting - gross</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i264313229b604d5dbaa260791106aae8_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zLTItMS0xLTUxMjg3_1c3264f6-9e3d-4ca9-abca-6a25164158e5">505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zLTE2LTEtMS01MTI4Nw_2354db3b-90d2-496b-a6e8-e16ce50f85b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf6be04bef848a3be60bd50bbe09ea3_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV80LTYtMS0xLTUxMjg3_996405e0-2270-4660-8d36-7e2f1fe60819">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV80LTE2LTEtMS01MTI4Nw_706e931f-cad7-4914-82ad-10c84658c772">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i264313229b604d5dbaa260791106aae8_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTItMS0xLTUxMjg3_ef79705f-ff20-40f4-80e3-1636e9462b3a">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdf6be04bef848a3be60bd50bbe09ea3_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTYtMS0xLTUxMjg3_ce50a205-2d3f-409c-badc-fd19b36ef3c1">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTE2LTEtMS01MTI4Nw_72bbf9e6-d934-403d-a746-bfccba6c6567">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i264313229b604d5dbaa260791106aae8_D20200101-20201231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTItMS0xLTUxMjg3_81a23c8a-3068-4cbb-8fb5-8edb9672bbbc">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdf6be04bef848a3be60bd50bbe09ea3_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTYtMS0xLTUxMjg3_8dad3e21-fd52-457b-a900-565d080a78fb">1,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTE2LTEtMS01MTI4Nw_ce4b9b74-df06-45e1-acdd-896e0819fa50">1,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock - issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i264313229b604d5dbaa260791106aae8_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOS0yLTEtMS04ODYzNw_7fb1cb98-35e5-478f-83e3-270d66b3b395">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e4706fa4334283bce0bd814b6d4abe_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV85LTgtMS0xLTUxMjg3_9e54ad9f-a9a1-42ef-ab39-849154f7e93b">17,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV85LTE2LTEtMS01MTI4Nw_bba3dc1c-7560-409f-bccd-f50c24222760">17,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balances at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7a10bd1ab424f0d9abf84a729cab56e_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC0yLTEtMS01MTI4Nw_c86cfa6e-517e-49a7-892a-e870e0b2e894">23,816</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7a10bd1ab424f0d9abf84a729cab56e_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC00LTEtMS01MTI4Nw_4299d1c7-5e87-4540-9302-59d7e8c036aa">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fc97e52018419aac6e451ce020e3c4_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC02LTEtMS01MTI4Nw_53fde545-98a9-46e5-8d1d-a274836740a4">84,785</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9f3ba1490534187962e956028423a05_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC04LTEtMS01MTI4Nw_3fcbe3ba-7df9-4552-9699-89fd3df6feeb">44,035</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba59ce2bece4e15bb0877c92494fe88_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC0xMC0xLTEtNTEyODc_91f2153d-d658-4c23-b518-7b39550d03ff">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3ef36744ffb64ea58b479667d4a1410c_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC0xMi0xLTEtNTEyODc_c5e90422-2c90-4019-a0b5-604430e7fb47">3,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef36744ffb64ea58b479667d4a1410c_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC0xNC0xLTEtNTEyODc_96b2038c-ecf0-436f-8a63-93a1bd4e3fe5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC0xNi0xLTEtNTEyODc_1a72a6e2-b324-45a6-b87b-2ae0a22efb2a">40,752</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based shares issued upon vesting - gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMS0yLTEtMS01MTI4Nw_270e7408-a78d-4a8b-8cb2-a90623b27eee">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMS02LTEtMS01MTI4Nw_46ec49a6-acc3-4540-9e80-4e2792054b0b">812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMS0xNi0xLTEtNTEyODc_28bb7edf-fd1f-4062-a02e-887e84d50223">812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMi02LTEtMS01MTI4Nw_7d86338c-c25f-4a32-93e7-2e642ffa1382">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMi0xNi0xLTEtNTEyODc_0b294957-d43e-4320-aa60-9df33d3559e4">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMy0yLTEtMS01MTI4Nw_0dba7817-4324-46e6-b687-0f89e724d0ca">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMy02LTEtMS01MTI4Nw_aab1d31e-fa59-4049-83a4-eb90af889ba6">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMy0xNi0xLTEtNTEyODc_baeb7f61-82fd-47f1-ad77-010b4eed8395">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNC0yLTEtMS01MTI4Nw_d6e7e6f3-1b4a-4bcd-abb2-2597da47220b">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNC02LTEtMS01MTI4Nw_ccdcf8ff-b990-4723-a708-885d902b9a12">1,172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNC0xNi0xLTEtNTEyODc_c783ba63-2397-4b95-ac6c-d0c64dbe7e62">1,172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Retirement of treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yNy0yLTEtMS02ODE2Nw_ed4be597-222b-43fd-a509-d10b92959cbc">3,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yNy02LTEtMS02ODE2Nw_982fa560-b672-4fa2-bb6e-36bb75ef625f">10,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffdd24f84ee6404c8449edf03c2c03b9_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yNy04LTEtMS02ODE2Nw_f698737a-5efc-4389-9a17-a03b30fd5cae">10,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60447bb6297b410f8726ce5432f5690a_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yNy0xMi0xLTEtNjgxNjc_df477a26-686d-477a-862b-0c1c09a539e9">3,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yNy0xNi0xLTEtNjgxNjc_3804f4ae-0ee8-49b5-adf9-3cb2c9102879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Common stock repurchased as part of share repurchase program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yOC0yLTEtMS02ODE2Nw_f993c311-c277-4a90-b7f1-21a34fcf6cd9">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffdd24f84ee6404c8449edf03c2c03b9_D20210101-20211231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yOC04LTEtMS02ODE2Nw_2ff41a81-48cc-4e32-8b09-7e54ea7ef617">560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yOC0xNi0xLTEtNjgxNjc_4e83bf5d-0874-4bc4-9164-5c343394de9c">560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33bade00e83b4d3fa491f7a2b7f67333_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNi0xMC0xLTEtNTEyODc_25fb555f-3b48-4acd-ad85-0d857b03b9ad">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zMC0xNi0xLTEtNjgzMDY_5156b983-2015-4568-9e64-426b4950f01a">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffdd24f84ee6404c8449edf03c2c03b9_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNy04LTEtMS01MTI4Nw_d11958cf-c6f6-4579-a304-ff5da70dec57">1,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNy0xNi0xLTEtNTEyODc_94820500-0e26-47ee-92af-7a3425f89545">1,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d0ded68cb484345bb92203314eb3670_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC0yLTEtMS01MTI4Nw_d1bda45c-2ab4-4ee0-9315-6392cbd18f2d">20,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d0ded68cb484345bb92203314eb3670_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC00LTEtMS01MTI4Nw_8fd260d8-7e77-4f5e-9135-61cd04392246">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc46bb5055c4ecfb796ab2b26d1f201_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC02LTEtMS01MTI4Nw_524526cb-1a31-47fb-85c2-69658b37a4fe">101,905</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e7686a6c9a4fb996fb64830470a5d8_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC04LTEtMS01MTI4Nw_4a93075c-04af-4c11-b18a-c59001e85aba">53,903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide4509120e7e42d29953cf1e80b08d9a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC0xMC0xLTEtNTEyODc_bca628d4-1814-461a-bbb3-8a8c185966ac">268</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i954290189efa49729f89a0332d6eed3c_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC0xMi0xLTEtNTEyODc_25d196df-0b15-443d-b5a2-350753da4f98">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i954290189efa49729f89a0332d6eed3c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC0xNC0xLTEtNTEyODc_3f7ec1bc-74e0-44c5-b449-932926aba666">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC0xNi0xLTEtNTEyODc_52787eeb-45db-4816-a904-0bc07dff9bfe">48,272</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_1733"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yLTItMS0xLTUxNTYy_25544050-8926-4f82-9b03-4fe626bbf0ff">1,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yLTQtMS0xLTUxNTYy_98cff91f-3c75-43c6-a9a6-6c02d3de5e4a">17,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yLTYtMS0xLTUxNTgz_88517c16-1add-43b2-8114-c1bc42bda2cd">1,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Provision for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF80LTItMS0xLTUxNTYy_78fb4d16-1346-40d3-b08e-330abc6f61df">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF80LTQtMS0xLTUxNTYy_b56b39c0-8858-4f88-812a-9ca08e28ed74">791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF80LTYtMS0xLTUxNTkw_d2a703fc-e6e0-4bd1-95ea-c4e96b24feaa">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF81LTItMS0xLTUxNTYy_93c79c11-5d13-4d17-80a6-f4cc662fc372">10,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF81LTQtMS0xLTUxNTYy_91c6cf7e-b4a4-4200-8c25-00f81e3a11eb">9,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF81LTYtMS0xLTUxNTkw_c0f1a4a0-382e-4ae5-8904-a0d9100e55a6">7,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss on disposal of and reserve adjustments for medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF82LTItMS0xLTUxNTYy_b48e7b60-65b8-4d24-848a-cb16773a9bdf">1,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF82LTQtMS0xLTUxNTYy_f33f16a5-2f0c-4ce8-b8c4-afa1b482fa69">418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF82LTYtMS0xLTUxNTkw_b36f3b4a-c1d3-4f8e-a1b2-8b4ff39ee3c4">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gain on sale of medical equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF83LTItMS0xLTUxNTYy_b16c4f18-8946-40a0-95c5-7d23622b0145">2,545</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF83LTQtMS0xLTUxNTYy_53fc8f33-fbf1-47e5-94a0-eb65548fdec3">3,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF83LTYtMS0xLTUxNTk3_a6b23225-1b82-45cc-a883-eb37ea2f99a3">1,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF84LTItMS0xLTUxNTYy_e65bb164-46b7-4c3d-aa11-e150ad3f0724">4,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF84LTQtMS0xLTUxNTYy_a8dc7fb0-5313-4c01-adf8-02ba493b0c38">4,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF84LTYtMS0xLTUxNjA0_7f23c5a3-4797-4660-b79f-fc4ba41e1788">4,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization of deferred debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF85LTItMS0xLTUxNTYy_a20f9359-0d59-4318-9928-2c0058686d76">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF85LTQtMS0xLTUxNTYy_f1ff84db-7581-4f82-a354-c8c3acbb2919">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF85LTYtMS0xLTUxNjA0_22f4e59f-bf30-4b8d-9772-e592779089ce">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMC0yLTEtMS01MTU2Mg_2e6c90b8-9845-4282-aad5-99bce8a53169">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMC00LTEtMS01MTU2Mg_cab7cbf4-5656-4ea8-af29-70da4e9c7931">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMC02LTEtMS01MTYwNA_af77e871-c7ff-47a2-b282-bf62457f0d5d">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMS0yLTEtMS01MTU2Mg_242b1156-a325-4614-a59a-3c214f441a35">153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMS00LTEtMS01MTU2Mg_675a79d0-e513-4407-be20-373b45cd0afc">10,071</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMS02LTEtMS01MTYwNA_ac7cd41c-6dfa-45cb-b019-34f322ad7e45">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Changes in assets - decrease/(increase):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMy0yLTEtMS01MTU2Mg_b59968fc-f0c6-4245-aa37-db107888128f">829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMy00LTEtMS01MTU2Mg_7e20eb9c-5499-4d10-891d-a1e9b1f7f0c0">2,631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMy02LTEtMS01MTYxMQ_879dfe6b-2860-43ac-84f8-23ffb55d0803">1,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNC0yLTEtMS01MTU2Mg_a22f1c52-3f8d-4c19-80c3-7c7f3476ec34">864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNC00LTEtMS01MTU2Mg_2e2ab89d-118a-4c7d-8a55-0c4511962e61">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNC02LTEtMS01MTYxMQ_c4a12b8f-1cde-4d63-a091-ca885e6bf705">645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNS0yLTEtMS01MTU2Mg_b19cf96a-7307-4b3b-a41c-7cd95d7a0aae">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNS00LTEtMS01MTU2Mg_56c71b5c-a5f8-4411-941d-331dad1d652e">740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNS02LTEtMS01MTYxMQ_0d8d42c6-e5b2-4abe-94c0-5e30e1e9fd2c">290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNi0yLTEtMS01MTU2Mg_7ae39a6d-5933-483c-b8c2-c72f21af3387">161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNi00LTEtMS01MTU2Mg_8b7f6569-da27-47e4-b69a-2defdf8f36e1">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNi02LTEtMS01MTYxMQ_ea5e02a3-56da-424e-9c93-418b8d17ccd8">129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Changes in liabilities - (decrease)/increase:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts payable and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOC0yLTEtMS01MTU2Mg_e185e5f3-7a6c-40a9-b3b2-9462e94b2acf">2,363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOC00LTEtMS01MTU2Mg_83b28c84-2bac-4e77-b27f-827185875e4b">2,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOC02LTEtMS01MTYxOA_a939f12f-f6ef-4b11-88be-3516489e01cd">2,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET CASH PROVIDED BY OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOS0yLTEtMS01MTU2Mg_65f732d3-c4e5-4555-b81b-cbf9a6112c59">18,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOS00LTEtMS01MTU2Mg_db675857-d0a9-4234-a78d-b5a9a236b4be">20,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOS02LTEtMS01MTYxOA_795f55e3-519a-4591-bb76-23b1743fdbf2">13,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Acquisitions of businesses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMi0yLTEtMS01MTU2Mg_2710b5ca-7159-44da-aa45-a8c61d0c396e">7,976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMi00LTEtMS01MTU2Mg_08b5a472-e826-424a-9922-b9dba562610a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMi02LTEtMS01MTYyNQ_9c2f05d0-5768-4ed6-9406-040f05ee7ce5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Purchase of medical equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMy0yLTEtMS01MTU2Mg_7d0cf1c5-9123-4759-9c6f-e92a944a1cf7">15,676</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMy00LTEtMS01MTU2Mg_e0f10eed-03db-4f3a-94d2-04b6125b9543">15,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMy02LTEtMS01MTYyNQ_af741965-85a8-4ab1-b920-43bc68247e08">19,669</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Purchase of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNC0yLTEtMS01MTU2Mg_578bc7f7-0e42-429a-8f8d-12dd7083a760">980</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNC00LTEtMS01MTU2Mg_343a3050-049d-411a-af73-05d5236532c3">1,094</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNC02LTEtMS01MTYyNQ_ea94e357-1cca-42fb-93fd-edc3f23ce234">2,926</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Proceeds from sale of medical equipment, property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNS0yLTEtMS01MTU2Mg_32d53e5a-7c4d-456a-a25a-3f114ca2a535">3,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNS00LTEtMS01MTU2Mg_ae197c89-6043-45c4-b65c-32487f593ff2">4,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNS02LTEtMS01MTYyNQ_e95432c9-fa57-4147-a561-784566de7c1e">2,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">NET CASH USED IN INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNi0yLTEtMS01MTU2Mg_35614f0d-1c82-437f-bfa0-b2d9dfdabcba">21,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNi00LTEtMS01MTU2Mg_458c5aeb-ff0f-47b1-bba1-ec54fdd5f7ec">12,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNi02LTEtMS01MTYyNQ_fd6097d5-af4a-4ae6-8cdf-770214176176">19,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Principal payments on long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yOS0yLTEtMS01MTU2Mg_9dac47d7-0207-4f6c-8384-c06b43aa5c6e">81,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yOS00LTEtMS01MTU2Mg_825a167b-8ed2-4840-9acf-0cf82c2df5b7">37,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yOS02LTEtMS01MTYzMg_ae79571a-f5e7-4598-bc36-302c26f23971">4,868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash proceeds from long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMC0yLTEtMS01MTU2Mg_00135cdf-d0ec-4560-ba6a-5d49d39b4f5d">76,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMC00LTEtMS01MTU2Mg_22ad46b9-51d6-4038-a5ac-5cb3f6e8da05">37,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMC02LTEtMS01MTYzMg_4e84db69-d04e-40e9-b6f2-4524142d234e">9,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMS0yLTEtMS01MTU2Mg_9cbd051f-703c-4b0e-8b0b-8f842a0e87c5">386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMS00LTEtMS01MTU2Mg_94370ccb-6c19-4b72-8294-65296f4f4afa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMS02LTEtMS01MTYzMg_2098f6b9-2d5b-4836-a04b-8dd14183fd9d">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 35.57pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMi0yLTEtMS01MTU2Mg_3940450b-60ee-4b90-aa4f-8e7e5dcef947">1,172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMi00LTEtMS01MTU2Mg_43f326fc-5b1c-4a84-a08b-622a90759eee">1,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMi02LTEtMS01MTYzMg_a32b2167-c88f-4fea-8ef2-80b6726cfb2d">717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Common stock repurchased as part of share repurchase program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNC0yLTEtMS02ODI5MA_18529b1a-2963-430c-9a49-2312d3514800">560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNC00LTEtMS02ODI5MA_5578a8ad-0f9e-43c3-b766-a581d4cd248b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNC02LTEtMS02ODI5MA_ca9e5bab-a2d2-4a7a-b63b-7d12599958be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash proceeds from stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockPlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMy0yLTEtMS01MTU2Mg_60c9ea30-b523-4868-840d-024bc183e85f">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMy00LTEtMS01MTU2Mg_b1858c71-d3ef-41d7-8974-0aa3a9a45398">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMy02LTEtMS01MTYzMg_bddbf593-f511-43be-b9ee-979bb8527bf8">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNS0yLTEtMS01MTU2Mg_e5fe66b0-0650-4145-9523-2c56e3522682">6,463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNS00LTEtMS01MTU2Mg_5bb8d52f-9a9e-4e45-9d33-e0345ac7ff4a">1,117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNS02LTEtMS01MTYzMg_d18647fa-38cc-454e-a1b8-cca2981360c6">4,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net change in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNy0yLTEtMS01MTU2Mg_eb4727a9-fb64-4e5f-8282-71e7b3e0f86f">9,462</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNy00LTEtMS01MTU2Mg_bf058a08-8349-4845-a12d-368bb23fa1ff">7,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNy02LTEtMS01MTYzMg_5488dca5-3d21-4735-a13b-44cf1a3117ff">1,671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOC0yLTEtMS01MTU2Mg_1df5d426-7a7a-4791-83fb-03630073c4ca">9,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOC00LTEtMS01MTU2Mg_54480862-248f-4f4b-bb42-effd2aad5578">2,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488a17cbb36b421597c4f159595f4b31_I20181231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOC02LTEtMS01MTYzMg_3304fb0b-2d31-487b-9779-c0c89f7cd689">4,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash and cash equivalents, end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOS0yLTEtMS01MTU2Mg_849abb78-c52f-416e-8168-1f39fef6e29d">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOS00LTEtMS01MTU2Mg_cc764ace-773f-4332-91db-7b0338fc45b7">9,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOS02LTEtMS01MTYzMg_e494871c-251d-4d78-b323-fa92f839d77a">2,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain supplementary cash flow information:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV8zLTItMS0xLTUxNTYy_6505f19e-d837-4899-9cfe-1069e82dc01c">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV8zLTQtMS0xLTUxNTYy_081298ec-739f-4626-8aae-3adc99a264a9">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV80LTYtMS0xLTU4NTgz_9a9682b3-039f-47b3-a576-fa2bfe1940da">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV80LTItMS0xLTUxNTYy_d90a404a-8238-4db5-b4af-5b0d5bb04964">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV80LTQtMS0xLTUxNTYy_fc107106-01f2-41e1-b688-01cf431717b1">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV81LTYtMS0xLTU4NTgz_20e06869-47e5-4942-8432-b3bd01aae203">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NON-CASH TRANSACTIONS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to medical equipment and property (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTItMS0xLTUxNTYy_481006d8-1084-4727-894a-60249e6a0acf">1,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTQtMS0xLTUxNTYy_85944c39-89c5-482e-9458-11163ccd9b31">793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV83LTYtMS0xLTU4NTgz_8836808c-e83c-441d-9439-13331421e05d">2,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to contingent consideration (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTMtMS0xLTY4ODgz_40e6085e-e2f2-4deb-adba-1604628105b6">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="infu:NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTUtMS0xLTY4ODc2_c111bee4-d840-4aa3-92a0-bac2910ee946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="infu:NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTctMS0xLTY4ODY5_e5423472-a3f2-41f8-bf6a-49f647b5d1ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to cash proceeds from stock plans (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:NoncashActivitiesProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTMtMS0xLTcxODUy_6838e1f4-e58f-4c76-a61b-10f7c982034d">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="infu:NoncashActivitiesProceedsFromStockPlans" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTUtMS0xLTcxODU5_02a6b5f6-3c05-4ee2-b77c-626b8dbafc75">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="infu:NoncashActivitiesProceedsFromStockPlans" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTctMS0xLTcxODY2_8cf1827d-43b3-49fd-9ca8-720fd3e1ef15">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt 0 19pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY3_26951cf3-5524-42c9-b7eb-b73b54eb1668" footnoteRole="http://www.xbrl.org/2003/role/footnote">Amounts consist of current liabilities for medical equipment and property that have not been included in investing activities. These amounts have not been paid for as of December 31, 2021, 2020 and 2019, respectively, but will be included as a cash outflow from investing activities for purchases of medical equipment and property when paid.</ix:footnote></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY4_b48ecc6c-d3a8-4b35-9611-7794e88fc0c0" footnoteRole="http://www.xbrl.org/2003/role/footnote">Amount consists of current liabilities for contingent consideration that have not been included in financing activities. These amounts have not been paid for as of December 31, 2021, but will be included as a cash outflow from financing activities for contingent consideration when paid.</ix:footnote></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY5_da598c6c-1ff0-44c6-a475-798637b014e3" footnoteRole="http://www.xbrl.org/2003/role/footnote">Amount consists of receivables for cash proceeds from stock plans that have not been included in financing activities. These amounts have not been received as of December 31, 2021, but will be included as a cash inflow from financing activities for cash proceeds from stock plans when received.</ix:footnote></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_103"></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:BasisOfAccounting" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDMvZnJhZzo4OGUwZTEzMjZmNDk0YzY1YTViOTg2ZWI1MDQxM2RiYi90ZXh0cmVnaW9uOjg4ZTBlMTMyNmY0OTRjNjVhNWI5ODZlYjUwNDEzZGJiXzMwMzE_f3e878a6-7eda-4da9-8dbb-c55cca857cd7" continuedAt="i15401d9923274f71a894737d1b760994" escape="true">Basis of Presentation and Nature of Operations</ix:nonNumeric></span></div><ix:continuation id="i15401d9923274f71a894737d1b760994"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InfuSystem Holdings, Inc. and its consolidated subsidiaries (the &#8220;Company&#8221;) are a leading national provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from seven locations in the United States and Canada. The Company provides products and services to hospitals, oncology practices and facilities and other alternate site health care providers. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support, and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada. InfuSystem Inc. (&#8220;ISI&#8221;) and First Biomedical, Inc. ("First Biomedical") are both operating subsidiaries of the Company.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s core service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics to be utilized in the treatment of a variety of cancers including colorectal cancer, pain management and other disease states. The majority of the Company&#8217;s pumps are electronic infusion pumps. Smiths Medical, Inc. and Moog Medical Devices Group each supplied more than <ix:nonFraction unitRef="number" contextRef="i34393106918541a2afdfacc9dc70598f_D20210101-20211231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDMvZnJhZzo4OGUwZTEzMjZmNDk0YzY1YTViOTg2ZWI1MDQxM2RiYi90ZXh0cmVnaW9uOjg4ZTBlMTMyNmY0OTRjNjVhNWI5ODZlYjUwNDEzZGJiXzE0NDI_4e76d407-fd9d-43f0-bffd-43312a54a156">10</ix:nonFraction>% of the ambulatory pumps purchased by the Company in 2021. The Company has a supply agreement in place with each of these suppliers. Certain &#8220;spot&#8221; purchases are made on the open market subject to individual negotiation. The Company also supplies Negative Pressure Wound Therapy (&#8220;NPWT&#8221;) medical equipment, as well as related disposables and ancillary supplies. Cardinal Health, Inc. supplied more than <ix:nonFraction unitRef="number" contextRef="i9f484679bbfa45cc82f4383cd151aeae_D20210101-20211231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDMvZnJhZzo4OGUwZTEzMjZmNDk0YzY1YTViOTg2ZWI1MDQxM2RiYi90ZXh0cmVnaW9uOjg4ZTBlMTMyNmY0OTRjNjVhNWI5ODZlYjUwNDEzZGJiXzE4NDU_cc01f02a-bffe-49a1-8a04-364f4633a9c2">10</ix:nonFraction>% of the NPWT medical equipment purchased by the Company in 2021. The Company has a supply agreement in place with Cardinal Health, Inc.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company sells or rents new and pre-owned pole-mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. The Company also provides these products and services to customers in the hospital market.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases new and pre-owned pole-mounted and ambulatory infusion pumps from a variety of sources on a non-exclusive basis. The Company repairs, refurbishes and provides biomedical certification for the devices as needed. The pumps are then available for sale, rental or to be used within the Company&#8217;s ambulatory infusion pump management service.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;).</span></div></ix:continuation><div id="i9e717b65c1e3405d850ef6e342b20071_109"></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzU0OTc1NTgxNzQ5MjY_1e25f7ad-1d90-4864-bf65-51a63bf6afd9" continuedAt="i272642a259d64639911a607604594af1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i272642a259d64639911a607604594af1" continuedAt="i4646ca49a091469ead46600aa952549b"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODcz_5bb113f2-8e55-4e83-b13f-fa80b97b542d" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and all wholly owned organizations. All intercompany transactions and account balances have been eliminated in consolidation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODU2_d85befe6-fba2-415c-b984-87562493ca0c" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in <ix:nonFraction unitRef="lease" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzNjc_7ecdc0f5-4594-4587-ab9f-532fac70d5f8">two</ix:nonFraction> reportable segments, Integrated Therapy Services (&#8220;ITS&#8221;) and Durable Medical Equipment Services (&#8220;DME Services&#8221;) based on management's view of its business for purpose of evaluating performance and making operating decisions. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s approach is to make operational decisions and assess performance based on delivering products and services that together provide solutions to its customer base utilizing a functional management structure. Based upon this business model, the Company&#8217;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker, reviews segment financial information. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_1859">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for segment disclosures.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODc2_b69bc5a5-0f6e-4766-8e77-1807792bb13b" continuedAt="i27e620db065b4a44a31342b4dcd27c34" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates, assumptions and judgments that affect the amounts reported in the financial statements, including the notes thereto. The Company considers critical accounting policies to be those that require more significant judgments and estimates in the preparation of its consolidated financial statements, including the following: revenue recognition, leases, accounts receivable and allowance for doubtful accounts, income taxes, equity compensation valuations, and long-lived asset valuations. Management relies on </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i4646ca49a091469ead46600aa952549b" continuedAt="ifc98f7984a3242f4bff90516a63d03bd"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i27e620db065b4a44a31342b4dcd27c34">historical experience and other assumptions believed to be reasonable in making its judgments and estimates. Actual results could differ materially from those estimates.</ix:continuation></span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODU3_b19492ce-c925-45e8-a30d-ceb6629d9373" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for all business combinations using the acquisition method of accounting, which allocates the fair value of the purchase consideration to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions. The Company may utilize third-party valuation specialists to assist the Company in the allocation. For intangible assets, the Company typically uses the income approach to determine their estimated fair values.  Key estimates and assumptions in that approach include the amount and timing of projected future cash flow, the discount rate selected to measure the risks inherent in those cash flows and the assessment of the asset's useful life.  Initial purchase price allocations are subject to revision within the measurement period, not to exceed one year from the date of acquisition. Acquisition-related expenses and transaction costs associated with business combinations are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODcx_2c9ee54e-9746-49d5-8b77-b676ba4e3384" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company maintains substantially all of its cash and cash equivalents primarily with <ix:nonFraction unitRef="financialinstitution" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="INF" name="infu:NumberOfFinancialInstitutions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzQyMDg_5611fa11-29dd-4704-94aa-b444296c1876">two</ix:nonFraction> financial institutions that are insured with the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). At times throughout the year, cash and cash equivalents balances might exceed FDIC insurance limits. Accounts at banks with an aggregate excess of the amount of outstanding checks over the cash balances are included in accounts payable in current liabilities in the consolidated balance sheet.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODU4_6e7ec44b-6f35-4254-9d18-9a76f4c760c7" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts billed that have not yet been collected that also meet the conditions for unconditional right to payment are presented as accounts receivable. Accounts receivable related to rental service and delivery of products are reported at their estimated transaction prices, inclusive of adjustments for variable consideration, based on the amounts expected to be collected from payers. The Company writes off accounts receivable once collection efforts have been exhausted and an account is deemed to be uncollectible. An allowance for doubtful accounts is established as a result of an adverse change in the Company&#8217;s payers&#8217; ability to pay outstanding billings. The allowance for doubtful accounts was $<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzUxNjk_a08c18a2-0a1a-4690-8388-d573fbe2d1b0">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzUxNzY_5f46cf2d-a858-444f-8bf8-3dea97df029d">1.0</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODc0_81cbcd31-178c-4aac-a5ab-eacf6a7a167c" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s inventories consist of disposable medical supplies, replacement parts and other supplies used in conjunction with medical equipment and are stated at the lower of cost (first-in, first-out basis) or net realizable value. Cost primarily represents the purchase price paid for the items on hand. The Company periodically performs an analysis of slow-moving inventory and records an adjustment to reflect the recoverable amount.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="infu:MedicalEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODgw_ad5788c4-c033-4334-b545-29cd23add1ce" continuedAt="ib4deb6465cee4509840a03ac59a9b4a1" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Equipment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment (&#8220;Equipment&#8221;) consists of equipment that the Company purchases from third-parties and is (1) for sale or rent, and (2) used in service to generate rental revenue. Equipment, once placed into service, is depreciated using the straight-line method over the estimated useful lives of the equipment which is typically <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="infu:MedicalEquipmentInRentalServicesUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzU5Njg_7c3b36aa-fae4-40df-aa1d-3152c6dc0277">seven years</ix:nonNumeric>. The Company does not depreciate Equipment held for sale or rent. When Equipment in rental service assets are sold, or otherwise disposed, the cost and related accumulated depreciation are removed from the accounts and a gain or loss is recorded in the current period. The Company periodically performs an analysis to identify potentially missing  Equipment and records a reserve equal to the underlying net book value, which was $<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-5" name="infu:MedicalEquipmentInRentalServicesReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5MjY3MDY_647d1714-2dfb-4a3f-8a7a-32a56f9e1297">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-5" name="infu:MedicalEquipmentInRentalServicesReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5MjY2OTY_c4559a07-142b-4dce-ae94-79b4a9a97859">0.9</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively. The Company performs a similar analysis of slow-moving Equipment for sale or rent and records a reserve, which was less than $<ix:nonFraction unitRef="usd" contextRef="i273cf9bfb6db4d47a691a81cafdaae1a_I20201231" decimals="-5" name="infu:MedicalEquipmentForSaleOrRentalReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTM5OTYxOTc_0c5f62d0-07a5-4ebd-aa6d-b74c0857d21d"><ix:nonFraction unitRef="usd" contextRef="ic449570e790a4e16996815fc2fe98242_I20211231" decimals="-5" name="infu:MedicalEquipmentForSaleOrRentalReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTM5OTYxOTc_caba9030-52d8-4000-8e16-5d67b28c8472">0.1</ix:nonFraction></ix:nonFraction> million as of both December&#160;31, 2021 and 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation of Medical Equipment in the Consolidated Statements</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases medical equipment directly for sale as well as medical equipment that is purchased for either rental or sale and that is unallocated at the time of purchase (&#8220;Unallocated Assets&#8221;). Management believes that the predominant source of revenues and cash flows from the Unallocated Assets is from rentals and most equipment purchased is likely to be rented prior to being sold. The Company concluded that (i) the assets specifically supporting its two primary revenue streams should be separately disclosed on the balance sheet; (ii) the purchase and sale of Unallocated Assets should be classified solely </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="ifc98f7984a3242f4bff90516a63d03bd" continuedAt="i7b03c43c48ec4a649f41487113289fb6"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib4deb6465cee4509840a03ac59a9b4a1">in investing cash flows based on their predominant source while medical equipment purchased specifically for sales activity should be classified in operating cash flows; and (iii) other activities ancillary to the rental process should be consistently classified.</ix:continuation></span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODc3_ad923ca9-9d2b-49de-9775-7bcffd6ea217" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at acquired cost and depreciated using the straight-line method over the estimated useful lives of the related assets, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY3ODU_89ea2bad-0ac3-4d89-9bff-0b3592eb4de5">three</span> to <ix:nonNumeric contextRef="id3f83755b9294a7fbbea649f435470f7_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY3OTE_768e3bb9-c55d-4997-95c2-863efd27b36d">seven years</ix:nonNumeric>. Externally purchased information technology software and hardware are depreciated over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY4ODI_16fecb86-c446-4994-8930-6e54f72298e6">three</span> and <ix:nonNumeric contextRef="iff2484e23bda4759a180d34049f89085_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY4ODk_ffbe0b1b-6280-4203-98c4-18e6f2f98533">five years</ix:nonNumeric>, respectively. Leasehold improvements are amortized using the straight-line method over the life of the asset or the remaining term of the lease, whichever is shorter. Maintenance and minor repairs are charged to operations as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is recorded in the current period.</span></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5ODQzODM_f19a8d22-06dc-4eb0-8294-f98be21c4ef9" continuedAt="i26c6bf4e4c7340ba8bce931625d5b2f6" escape="true">Goodwill</ix:nonNumeric></span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i26c6bf4e4c7340ba8bce931625d5b2f6">Goodwill is tested for impairment annually or when events occur or circumstances change that trigger a review. Management has the option to first assess qualitative factors such as current performance and overall economic conditions to determine whether or not it is necessary to perform a quantitative goodwill impairment test. If the Company chooses that option, then the Company would not be required to perform a quantitative goodwill impairment test unless the Company determines that, based on a qualitative assessment, it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company determines that an impairment is more likely than not, or if the Company chooses not to perform a qualitative assessment, the Company will then proceed with the quantitative assessment. Under the quantitative test, if the fair value of a reporting unit exceeds its carrying amount, then goodwill of the reporting unit is considered to not be impaired. If the carrying amount of the reporting unit exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess, up to the value of the goodwill. The Company performed its annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that there was no impairment.</ix:continuation> </span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODU5_9defb300-47a8-4af0-96da-93cb1ab6d151" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of trade names, physician and customer relationships, unpatented technology, non-competition agreements and software. The Company amortizes the value assigned to the physician and customer relationships on a straight-line basis over the period of expected benefit, which ranges from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzc2NzA_787bbc1d-efca-48b5-9bc6-20acf41ccb09">fifteen</span> to <ix:nonNumeric contextRef="i9cbd2ba5629b4065967778d18fce6cc6_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzc2NzY_672f8879-b672-498f-bb01-b16be49bb636">twenty years</ix:nonNumeric>. The acquired physician and customer relationship base represents a valuable asset of the Company due to the expectation of future business opportunities to be leveraged from the existing relationship with each physician and customer. The Company has long-standing relationships with numerous oncology clinics, physicians, home care and home infusion providers, skilled nursing facilities, pain centers and others. The useful lives of these relationships are based on the expected attrition rates. Acquired software is amortized on a straight-line basis over the period of expected benefit, which ranges from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzgzMTA_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1">three</span> to <ix:nonNumeric contextRef="i3805c0f8aa0b4495a88f1333effc915e_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2NjI5OTY_d870549a-f5be-42a5-b4ad-98382c05e175">five years</ix:nonNumeric>. Acquired unpatented technology arose from recent acquisitions and is amortized on a straight-line basis over the period of expected benefit, which is <ix:nonNumeric contextRef="iafb98485af7044f4b4e5556491802f9f_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2NjM1MTA_104b8724-9ba0-4254-a9fe-6d561d45ab62">seven years</ix:nonNumeric>. This asset represents acquired knowledge of repair solutions that will be leveraged into opportunities into the acute care market. The non-competition agreements arose from recent acquisitions and are amortized on a straight-line basis over the terms of the agreements, which is <ix:nonNumeric contextRef="ie95c2bd801aa4bb288bad94f285a3474_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2NjMyNTE_769e9806-2bc9-4ecc-bfa8-d5f29a02a32b">five years</ix:nonNumeric>. Trade names associated with the original acquisition of InfuSystem are not amortized.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management tests indefinite life trade names for impairment annually or more frequently if deemed necessary. Management has the option of first performing the impairment test for intangible assets with indefinite lives on a qualitative basis, by evaluating factors to determine whether it is more likely than not that an impairment exists. If it is more likely than not that an impairment exists, then a quantitative impairment test is performed. Impairment exists when the carrying amount of the intangible asset exceeds its fair value. If the carrying value of the intangible assets exceeds the fair value, an impairment loss is recognized in an amount equal to that excess. The Company performed its annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that the fair value of the trade names with indefinite lives was greater than their carrying value, resulting in <ix:nonFraction unitRef="usd" contextRef="i1ef1975dd83440c2b7903b64c216e6f5_D20211001-20211031" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5Nzc4NjE_d0507614-480e-477b-97ee-cb16668ce6fd">no</ix:nonFraction> impairment.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:CapitalizationOfInternalCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODYy_2b57a5ed-74bd-4f78-b7f0-fcc5d846ab9a" continuedAt="ia7afe0154b63430fb1f16f3eed7ad7ea" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software Capitalization and Depreciation</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software project, external direct costs of materials and services and interest costs while developing the software. Capitalized software costs are included in intangible assets, net and are amortized using the straight-line method over the estimated useful life of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzODg_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1">three</span> to <ix:nonNumeric contextRef="i3805c0f8aa0b4495a88f1333effc915e_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzOTU_d870549a-f5be-42a5-b4ad-98382c05e175">five years</ix:nonNumeric>. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs, are </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i7b03c43c48ec4a649f41487113289fb6" continuedAt="i895cf01f281c4443b8d29beebc8ec849"><ix:continuation id="ia7afe0154b63430fb1f16f3eed7ad7ea"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expensed in the period in which they are incurred. The Company capitalized $<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQ0NzU_60966a6e-ddfb-469b-8f4c-1096c48ad32d">0.3</ix:nonFraction> million of internal-use software for the year ended December&#160;31, 2021 and did <ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5MjY2ODE_0912a9c0-f036-4709-ace8-c85991fa7065">no</ix:nonFraction>t capitalize any internal-use software for the year ended  December&#160;31, 2020. Amortization expense for capitalized software was $<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwMTYw_6ea9e547-a0bb-4137-a147-bdc205689a8a">1.6</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwMTcz_a1b35939-4b6c-4db4-9fde-ea35cce68029">1.9</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQ0Mjg_93c030f9-5b50-447a-9db7-a76fcea9786a">2.0</ix:nonFraction> million in 2019.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses impairment indicators related to its internally-developed, internal-use software, specifically looking at the effectiveness and useful lives of each project and sub-project to determine if impairment indicators are present. For the year ended December&#160;31, 2021, the Company assessed the impairment indicators and found <ix:nonFraction unitRef="usd" contextRef="i00d66cb681ad4fb9820d60af76680b44_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTQwMDg0Nzc_23cee1dc-18a6-4042-8164-900c7ddba80e">none</ix:nonFraction> to be present.</span></div></ix:continuation><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODc4_3c807485-7e39-4e7b-80aa-fb726726c33a" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets held for use, which includes medical equipment in rental service, property and equipment and amortizable intangible assets, are reviewed for impairment when events or changes in circumstances indicate that their carrying value may not be recoverable. If an impairment indicator exists, the Company assesses the asset or asset group for recoverability. Recoverability of these assets is determined based upon the expected undiscounted future net cash flows from the operations to which the assets relate, utilizing management&#8217;s best estimates, appropriate assumptions and projections at the time. If the carrying value is determined not to be recoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair market value of the asset or asset group. For the years ended December&#160;31, 2021, 2020 and 2019, respectively, the Company assessed the impairment indicators and found <ix:nonFraction unitRef="usd" contextRef="i9465d698b48a4cb89adc9870e948bf77_D20190101-20191231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5Nzc4NjQ_678dd726-f417-4588-b2c3-d3371b8d8370"><ix:nonFraction unitRef="usd" contextRef="ie66a45b985ad4079b2542a584a5b7264_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5Nzc4NjQ_6b618754-66f3-4d71-bb50-4afa9b283b11"><ix:nonFraction unitRef="usd" contextRef="i00d66cb681ad4fb9820d60af76680b44_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5Nzc4NjQ_c40aa25b-6cfd-4a60-aa5c-2b973a5989a9">none</ix:nonFraction></ix:nonFraction></ix:nonFraction> to be present.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODYz_e72c0881-06e1-4e25-a3e5-ae11f0adeb38" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019 (the &#8220;Effective Date&#8221;), the Company adopted Accounting Standards Codification ("ASC") Topic 842, Leases,("Topic 842"),  using a modified retrospective transition approach. Under Topic 842, lessees are required to recognize a lease liability and right-of-use asset (&#8220;ROU asset&#8221;) for all leases and to disclose key information about leasing arrangements. Additionally, leases are classified as either financing or operating; the classification determines the pattern of expense recognition and classification within the statement of operations. The Company elected to apply its lease accounting policy only to leases with a term greater than twelve months.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic 842 provides several optional practical expedients that the Company adopted at transition. The Company elected the &#8220;package of practical expedients&#8221;, which does not require it to reassess its prior conclusions regarding lease identification, lease classification and initial direct costs. The Company did not elect the practical expedient of hindsight to the evaluation of lease options (e.g. renewal).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic 842 also provides practical expedients for an entity&#8217;s ongoing accounting. The Company elected the &#8220;combining lease and non-lease components&#8221; practical expedient and also elected to apply the short-term lease recognition exemption to certain leases; therefore, the Company did not recognize ROU assets and lease liabilities for these leases.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In adopting Topic 842, the Company determined and will continue to determine whether an arrangement is a lease at inception. The Company&#8217;s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next <ix:nonNumeric contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2NjE1OTk_3dc77626-ad95-4441-96f8-3b58c610981e">ten years</ix:nonNumeric>. The Company&#8217;s leases do not contain any restrictive covenants. The Company&#8217;s office leases generally contain renewal options for periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEzNTUy_9f2fcc91-aee1-47c3-a7b5-103597d961a0">one</span> to <ix:nonNumeric contextRef="ic449570e790a4e16996815fc2fe98242_I20211231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEzNTU4_267a32a4-6085-44d1-a1b3-8dec2f8c4481">five years</ix:nonNumeric>. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company&#8217;s office leases do not contain any material residual value guarantees. The Company&#8217;s equipment leases generally do not contain renewal options. The Company is not reasonably certain to exercise the renewal options for those equipment leases that do contain renewal options, thus, the options are not considered in determining the lease term and payments associated with the option years are excluded from lease payments.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s equipment leases, the Company used and will use the implicit rate in the lease as the discount rate, when available. Otherwise, the Company uses its incremental borrowing rate as the discount rate. For the Company&#8217;s office leases, the implicit rate is typically not available, so the Company used and will use its incremental borrowing rate as the discount rate. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The Company&#8217;s lease agreements include both lease and non-lease components. The Company elected the practical expedient that allows it to combine lease and non-lease components for all of its leases.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments due under the Company&#8217;s operating leases include fixed payments as well as variable payments. For the Company&#8217;s office leases, variable payments include amounts for the Company&#8217;s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company&#8217;s equipment leases, variable payments may consist of sales taxes, property taxes and other fees.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i895cf01f281c4443b8d29beebc8ec849" continuedAt="i517cb935abb54eafb1fd2922c0fcaa4d"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODgx_889e03a4-0741-4ef4-afd8-a2b02ca262e0" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized at the time and in an amount that reflects the consideration expected to be received for the performance obligations that have been provided. ASC Topic 606 &#8211; Revenue from Contracts with Customers (&#8220;ASC 606&#8221;) defines contracts as written, oral and through customary business practice. Under this definition, the Company considers contracts to be created at the time that the rental service is authorized or an order to purchase product is agreed upon regardless of whether or not there is a written contract.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three separate and distinct performance obligations offered to its customers: a rental service performance obligation, a product sale performance obligation and a service performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is defined as the unit of account for revenue recognition under ASC 606. These performance obligations are related to separate revenue streams and at no point are they combined into a single transaction. Sources of net revenues include commercial insurance payers, government insurance payers, medical facilities and patients.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue from the rental of infusion pumps to its customers and a minority of its revenue from product sales and services. For the rental service performance obligation, revenue is based on its standalone price, determined by using reimbursement rates established by third-party payer or other contracts. Revenue is recognized in the period in which the related performance obligation is satisfied, which is typically at the point in time that a patient concludes a treatment, or in certain arrangements, based on the number of pumps that a facility has onsite. The Company&#8217;s revenues related to product sales are recognized at the time that control of the product has been transferred to the customer; either at the time the product is shipped or the time the product has been received by the customer, depending on the delivery terms. The Company does not commit to long-term contracts to sell customers a certain minimum quantity of products. The Company's revenues related to services are recognized at the time that the service work has been completed.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company employs certain significant judgments to estimate the dollar amount of revenue, and related concessions, allocated to the rental service. These judgments include, among others, the estimation of variable consideration. Variable consideration, specifically related to the Company&#8217;s third-party payer rental revenues, is estimated as implied price concessions resulting from differences between the rates charged for services performed and the expected reimbursements for commercial payers and other implied customer concessions. The estimates for variable consideration are based on historical collections with similar payers, aged accounts receivable by payer class and payer correspondence using the portfolio approach, which provide a reasonable basis for estimating the variable portion of a transaction. The Company doesn&#8217;t believe it is probable that a significant reversal of revenue will occur in future periods because (i) there is no significant uncertainty about the amount of considerations that are expected to be collected based on collection history and (ii) the large number of sufficiently similar contracts allows the Company to adequately estimate the component of variable consideration.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues are adjusted when changes in estimates of variable consideration occur. Changes in estimates typically arise as a result of new information obtained, such as actual payment receipt or denial, or pricing adjustments by payers. Subsequent changes to estimates of transaction prices are recorded as adjustments to net revenue in the period of the change. Subsequent changes that are determined to be the result of an adverse change in the payer&#8217;s ability to pay are recorded as an allowance for doubtful accounts.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the industry and the reimbursement environment in which the Company operates, certain estimates are required to record net revenues and accounts receivable at their net realizable values. Inherent in these estimates is the risk that the estimates will have to be revised or updated as additional information becomes available. Specifically, the complexity of many third-party billing arrangements and the uncertainty of reimbursement amounts for certain services from certain payers may result in adjustments to amounts originally recorded. Due to continuing changes in the health care industry and third-party reimbursement, it is possible that management&#8217;s estimates could change in the near term, which could have a material impact on the Company&#8217;s results of operations and cash flows.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="infu:RevenueRecognitionCostOfRevenuePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODc5_600e41fa-1e05-4014-9954-8154be5b23c9" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenues</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues include the costs of servicing and maintaining pumps, products and services sold, shipping and other direct and indirect costs related to net revenues. Shipping and handling costs incurred after control over a product has transferred to a customer are accounted for as a fulfillment cost.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODY3_5e197900-5bd5-4be2-b537-e5ef35bc7ba4" continuedAt="ifbbb31b29ffc49758dfc41ab3bcaf348" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Concentration</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had contracts with nearly <ix:nonFraction unitRef="network" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="0" name="infu:NumberOfContractsWithThirdParties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTM5OTk1MDc_dd129a3f-f07e-46bc-9d29-39ba4b336c48">770</ix:nonFraction> third-party payer networks, an increase of <ix:nonFraction unitRef="number" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="2" name="infu:PercentageIncreaseInNumberOfContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTM5OTk1NDY_68043fe9-6358-42db-a32f-812505e7458e">6</ix:nonFraction>% over the prior year period. Material terms of contracts with third-party payer organizations are typically a pre-negotiated fee </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i517cb935abb54eafb1fd2922c0fcaa4d" continuedAt="i061948ce09a243a9a418482feb08dbd1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifbbb31b29ffc49758dfc41ab3bcaf348">schedule rate or a then-current proprietary fee schedule rate for equipment and supplies provided. The majority of these contracts generally provide for a term of one year, with automatic one-year renewals, unless the Company or the contracted payer elect not to renew. The Company also contracts with various other third-party payer organizations, Medicaid, commercial Medicare replacement plans, self-insured plans, facilities of its Medicare patients and numerous other insurance carriers. No single payer or customer represented more than 10% of the Company's net revenue in 2021, 2020 or 2019.</ix:continuation></span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODY4_0545c81d-c36e-47dc-9b8c-cf2b53163715" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred&#160;income tax liabilities and assets based on (i) the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and (ii) the tax credit carryforwards. Deferred income tax (expense) benefit results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all of any deferred tax assets will not be realized.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for federal, state and foreign taxes are calculated based on reported pre-tax earnings based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities.&#160;Certain items of income and expense are recognized in different time periods for financial reporting than for income tax purposes; thus, such provisions differ from the amounts currently receivable or payable.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows a two-step approach for recognizing uncertain tax positions. First, it evaluates the tax position for recognition by determining if the weight of available evidence indicates it is more-likely-than-not that the position will be sustained upon examination. Second, for positions that are determined are more-likely-than-not to be sustained, it recognizes the tax benefits as the largest benefit that has a greater than 50% likelihood of being sustained. The Company establishes a reserve for uncertain tax positions liability that is comprised of unrecognized tax benefits and related interest and penalties. The Company adjusts this liability in the period in which an uncertain tax position is effectively settled, the statute of limitations expires for the relevant taxing authority to examine the tax position, or more information becomes available.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted Accounting Standards Update ("ASU") 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, in the fourth quarter of 2019. This guidance simplifies various aspects related to accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. The guidance was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption was permitted, including adoption in any interim period for which financial statements had not yet been issued. Certain amendments may have been applied on a retrospective, modified retrospective or prospective basis. As permitted, the Company elected to early adopt this guidance for the year ended December&#160;31, 2019. The adoption of this guidance did not have a significant impact on the Company&#8217;s financial statements and primarily resulted in the reclassification of an immaterial amount from non-income tax expense to income tax expense related to the accounting for franchise taxes, with no impact to the Company&#8217;s consolidated net income, equity or cash flows.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="infu:TreasuryStockPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODYw_601c4021-c1c2-42a1-b36d-464a98409259" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically repurchases shares of its common stock. These repurchases take place either as part of a board-authorized program, which may include open market transactions or privately negotiated transactions and may be made under a Rule 10b5-1 plan, or in targeted stock purchase agreements approved by the board. Treasury stock is accounted for using the par value method. In 2021, the Company retired the approximately <ix:nonFraction unitRef="shares" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="0" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTQwNDU5NjM_a3a0c704-5a9a-4551-998d-420d4474e76c">3,500,000</ix:nonFraction> shares that were previously held in treasury.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODY0_09597774-8c6c-402d-9899-1c61058183ca" continuedAt="i49e7a8a93d454d0abf06015a67f4690a" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Payments</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of stock option awards, restricted stock awards and stock appreciation rights (collectively, &#8220;Share-Based Awards&#8221;) on the date of grant using either the grant date price of the Company's common stock or option-pricing models which are affected by the Company&#8217;s stock price, as well as assumptions regarding a number of other inputs using the Black-Scholes pricing model. These variables include the Company&#8217;s expected stock price volatility over the expected term of the Share-Based Awards, actual and projected employee stock option exercise behaviors, risk-free interest rates and expected dividends. The expected volatility is based on the historical volatility. The expected term represents the period over which the Share-Based Awards are expected to be outstanding. The dividend yield is an estimate of the expected dividend yield on the Company&#8217;s stock. The risk-free rate is based on U.S. Treasury yields in effect at the time of the grant for the expected term of the Share-Based Awards. Forfeitures are recognized as they occur. All Share-Based Awards are amortized based on their graded vesting over the requisite service period of the awards. Compensation costs are recognized over the requisite service period using the accelerated method and included in general and administrative expenses.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i061948ce09a243a9a418482feb08dbd1" continuedAt="ic5259359d768464890ec574ca9cd1074"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i49e7a8a93d454d0abf06015a67f4690a">Additionally, the Company also determines the fair value of performance-based restricted stock units (&#8220;PSUs&#8221;) based upon the type of performance measure. These awards typically vest after the Company&#8217;s achievement of either a specific Company performance metric or when the market value of the Company&#8217;s stock meets a specific metric such as when the closing price of the Company's stock reaches a target value for a minimum number of consecutive trading days. Under Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC Topic 718, the provisions of the PSUs that vest upon achievement of a target market value are considered a market condition, and therefore the effect of that market condition is reflected in the grant date fair value for this type of award. A third-party valuation expert was engaged to complete a &#8220;Monte Carlo simulation&#8221; to account for the market condition. That simulation takes into account the beginning stock price of the Company&#8217;s common stock, the expected volatilities for the Company&#8217;s stock price and the expected risk-free rate of return. The single grant-date fair value computed by this valuation method is recognized by the Company in accounting for the awards regardless of the actual future outcome of the market condition. Compensation costs are accelerated if the market condition is satisfied prior to the end of the service period derived under the Monte Carlo simulation. The grant date fair value of the other PSUs is calculated as the closing price of the Company&#8217;s common stock on the grant date multiplied by the number of shares estimated to be delivered subject to the award terms. Company performance measure goals are considered a performance condition and the timing and amount of compensation cost for those PSUs corresponds with management&#8217;s expectation of the probable outcome of the performance conditions as of the grant date and during the vesting period.</ix:continuation></span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:DeferredChargesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODcy_8932d52b-894c-42b0-8d6d-f063a6ebe5da" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Debt Issuance Costs</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized debt issuance costs as of December&#160;31, 2021 and 2020 relate to the Company&#8217;s credit facility. The costs related to the agreement are netted against current and non-current debt. The Company amortizes these costs using the interest method through the maturity date of the underlying debt.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzQ5NDc4MDIzNjgzNTM_ba8ccc13-6407-43bc-9667-e5472a36f3a9" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its earnings per share in accordance with ASU 2017-11, Earnings Per Share (Topic 260), which requires the presentation of both basic and diluted earnings per share on the statements of operations. The diluted weighted average common shares include adjustments for the potential effects of outstanding stock options but only in the periods in which such effect is dilutive under the treasury stock method. Included in our basic and diluted weighted average common shares are those stock options and restricted stock awards due to participants granted from the 2014 and 2021 stock incentive plans. Anti-dilutive stock awards are comprised of stock options and unvested restricted stock awards, which would have been anti-dilutive in the application of the treasury stock method in accordance with ASU 2017-11, Earnings Per Share (Topic 260). In periods where the Company records a net loss, the diluted per share amount is the same as the basic per share amount.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5MjY2ODA_ec92a8bd-0c64-4295-8514-f0389d349862" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with this topic, the following table reconciles income and share amounts utilized to calculate basic and diluted net income per common share:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:58.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerator (in thousands):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income:</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzMtMS0xLTEtNjUyNTA_b35738b0-236f-4433-bfdf-3ab4cd5a5414">1,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzMtMy0xLTEtNjUyNTA_d729afd8-4474-4852-8330-1a077582085f">17,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzMtNS0xLTEtNjUyNTA_8aa93029-4fc6-4bfa-b6aa-e149d21fa771">1,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzYtMS0xLTEtNjUyNTA_15b3a122-d220-4b8d-ae9d-847a47089811">20,519,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzYtMy0xLTEtNjUyNTA_6e643be1-5cdc-4e5f-b7dd-99cccc5e01fc">20,106,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzYtNS0xLTEtNjUyNTA_1d59476e-c389-4161-bc44-7a34c4a11b08">19,731,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dilutive effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzctMS0xLTEtNjUyNTA_027e8a99-0add-4fce-aade-646cb83e52ab">1,529,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzctMy0xLTEtNjUyNTA_1f57ba60-ca18-4ec6-9aa1-27ff5d481dce">1,610,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzctNS0xLTEtNjUyNTA_d65112fb-42f5-430f-bfd3-5bda64a66bcb">1,107,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzgtMS0xLTEtNjUyNTA_a66a0a58-3e89-42da-84e1-20633897507f">22,049,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzgtMy0xLTEtNjUyNTA_d0a2862c-990a-4146-b97f-a52ef32c8119">21,717,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzgtNS0xLTEtNjUyNTA_92d3b37b-82e2-49ce-baaa-2fe648abb937">20,839,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options of <ix:nonFraction unitRef="shares" contextRef="icf5fd049ceed45b68799835682190196_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2Njc2OTQ_93b81280-56e0-4157-bfde-d980aa309589">368,056</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ia683a1cdfea841359642a861af2182de_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2MzY2NTAz_31e7ed4c-8ab3-4cf5-9bef-94abefdd5795">18,321</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ibad2abb0e5fe4e9398ad4ae3632f3fbc_D20190101-20191231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2MzY2NTEx_a31423f7-fd42-49b2-94d7-85220fc0f243">25,669</ix:nonFraction> shares were not included in the calculation for the years ended December&#160;31, 2021, 2020 and 2019, respectively, because they would have an anti-dilutive effect.</span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5MzgyOTI_3f7f5331-c418-4cd2-a2fd-14b1c0719845" continuedAt="i09ad19c1f4714dabb188194f751a0034" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes all derivative financial instruments as cash flow hedges which are shown as either assets or liabilities on the Company&#8217;s consolidated balance sheets at fair value. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in fair value of the derivative is recorded to accumulated other comprehensive income (&#8220;AOCI&#8221;) in the consolidated balance sheets. The underlying hedge transaction is realized when the interest payments </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="ic5259359d768464890ec574ca9cd1074"><ix:continuation id="i09ad19c1f4714dabb188194f751a0034"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on debt are accrued; the applicable amount of gain or loss included in AOCI is reclassified into earnings in the consolidated statements of operations on the same line as the gain or loss on the hedged item attributable to the hedged risk. The cash flows from derivatives are classified as operating activities.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a policy of requiring that all derivative instruments be governed by an International Swaps and Derivatives Association Master Agreement and settles on a net basis.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s derivative financial instruments are categorized as Level 2 of the fair value hierarchy as the values are derived using the market approach based on observable market inputs including quoted prices of similar instruments and interest rate forward curves.</span></div></ix:continuation><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODY5_882b05dc-5563-442d-a4bb-6d13b7d1c635" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported in the consolidated balance sheets as of December&#160;31, 2021 and 2020 for cash, accounts receivable, accounts payable and other current liabilities approximate fair value because of the short-term nature of these instruments (Level I). The carrying value of the Company&#8217;s long-term debt with variable interest rates approximates fair value based on instruments with similar terms (Level II).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted ASC 820, Fair Value Measurements, which defines fair value, establishes a framework for assets and liabilities being measured and reported at fair value and appends disclosures about fair value measurements.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial assets and liabilities measured at fair value on a recurring basis, fair value is the price the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction with a market participant at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value as follows:</span></div><div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Level I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;&#160;&#160;quoted prices in active markets for identical instruments;</span></div><div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Level II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;&#160;&#160;quoted prices in active markets for similar instruments, quoted prices for identical instruments in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the instrument; and</span></div><div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Level III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;&#160;&#160;significant inputs to the valuation model are unobservable.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODY1_9d6ba4b2-6e81-4ba9-9f96-e2f59dac2251" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements and Developments</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has adopted ASU 2020-04, Reference Rate Reform (Topic 848), which contains optional expedients for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Inter-bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope." This ASU clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition.  The Company has elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2016, the FASB issued ASU No. 2016-13, &#8220;Financial Instruments (Topic 326) Credit Losses&#8221;. Topic 326 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. Topic 326 was originally effective as of January 1, 2020, although in November 2019, the FASB delayed the effective date until fiscal years beginning after December 15, 2022 for SEC filers eligible as of the FASB's deferral date to be smaller reporting companies under the SEC&#8217;s definition. The Company qualified as a smaller reporting company in November 2019 when the FASB delayed the effective date of Topic 326. Early adoption is permitted. The Company is currently evaluating the impact of Topic 326 on its consolidated balance sheets, statements of operations, statements of cash flows and related disclosures.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_1765"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18zMjk4NTM0ODg4OTc0_4f67787a-bca4-41b7-98b3-464a6df342c6" continuedAt="i2e137cee20c94d77b1c5e399715e3763" escape="true">Business Combinations</ix:nonNumeric></span></div><ix:continuation id="i2e137cee20c94d77b1c5e399715e3763" continuedAt="i79db760919bf4d18a1e9cebf5d32c891"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions Accounted for Using the Purchase Method</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;31, 2021, the Company acquired the business and the majority of the assets of FilAMed, a privately-held biomedical services company based in Bakersfield, California. In becoming a part of the Company's Durable Medical Equipment Services ("DME Services") segment, this acquisition will supplement the Company&#8217;s existing biomedical recertification, maintenance and repair services for acute care facilities and other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;18, 2021, the Company acquired the business and substantially all of the assets of OB Healthcare Corporation (&#8220;OB Healthcare&#8221;), a privately-held biomedical services company based in Austin, Texas. OB Healthcare specializes in on-site repair, preventative maintenance, and device physical inventory management to hospitals and healthcare systems nationwide. The acquisition further develops and expands InfuSystem&#8217;s DME Services segment and complements the Company&#8217;s purchase of FilAMed.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FilAMed and OB Healthcare&#8217;s results of operations are included in the Company&#8217;s consolidated statements of operations from the respective closing dates. Revenues and earnings from these acquisitions have not been significant through December&#160;31, 2021.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC Topic 805, &#8220;Business Combinations,&#8221; the purchase price for each of the acquisitions was allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the respective acquisition dates. The purchase price allocations were primarily based upon a valuation using management&#8217;s estimates and assumptions. The purchase price allocation was completed for FilAMed and OB Healthcare as of December 31, 2021. <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18zMjk4NTM0ODg4OTc1_b60fe30e-f964-42f3-8acc-cf35643d7235" continuedAt="i844103e9ba864ef78193442e82965e27" escape="true"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18zMjk4NTM0ODg4OTc1_d1f721f6-1874-44eb-8b7d-e5619c53b6d4" continuedAt="i0292d51c406d4d0e8e1935f84246033e" escape="true">The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i844103e9ba864ef78193442e82965e27"><ix:continuation id="i0292d51c406d4d0e8e1935f84246033e"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">FilAMed</span></td><td colspan="3" style="padding:0 1pt 0 32.57pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consideration</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i05190bb32cd04e68951f01b2c1a8198a_D20210101-20211231" decimals="-3" name="infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8xLTEtMS0xLTUyMDAy_5fcb3dd6-78a9-44af-88d4-c0e37f3b2518">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1369ea7cfa4428a8a0535746cc8e915_D20210101-20211231" decimals="-3" name="infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8xLTMtMS0xLTUyMDAy_90cd5b35-1923-403e-811f-6ef3e6452a33">6,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8xLTUtMS0xLTUyMDAy_9baa8219-e6b3-4c7f-b1dc-36d69a5829d4">7,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Working capital adjustment, paid in cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i05190bb32cd04e68951f01b2c1a8198a_D20210101-20211231" decimals="-3" name="infu:WorkingCapital" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8yLTEtMS0xLTUyMDAy_47ed83fd-254b-47a4-9584-0898839d3014">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1369ea7cfa4428a8a0535746cc8e915_D20210101-20211231" decimals="-3" name="infu:WorkingCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8yLTMtMS0xLTUyMDAy_342a3d7f-c22f-4b90-833a-7ae750c0e78c">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:WorkingCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8yLTUtMS0xLTUyMDAy_c40748e3-2adb-47e3-8e52-6e0f44c86495">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i05190bb32cd04e68951f01b2c1a8198a_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8zLTEtMS0xLTUyMDAy_661207b1-13fb-4c6e-bc82-69784bd7bebd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1369ea7cfa4428a8a0535746cc8e915_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8zLTMtMS0xLTUyMDAy_2764d4cd-e78c-4419-8a45-85c8ebc3d101">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8zLTUtMS0xLTUyMDAy_8d3ae938-18d5-41b4-9a4a-b201ab0cb30e">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i05190bb32cd04e68951f01b2c1a8198a_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF80LTEtMS0xLTUyMDAy_5ce8c25f-ee61-4735-9bc5-426b899b78ae">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1369ea7cfa4428a8a0535746cc8e915_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF80LTMtMS0xLTUyMDAy_ce7f265f-eea0-494f-a87d-cf08b989ec9e">7,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF80LTUtMS0xLTUyMDAy_f09e5142-7237-4d9a-a519-b2127c9f319a">8,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FilAMed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8xLTItMS0xLTUyMDAy_1dc5d3c8-6456-4291-9b97-e61fd98e8638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i24d9edd536944e538abc2437af99d50f_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8xLTQtMS0xLTUyMDAy_d19772e2-1a31-4585-95ae-e36140fe94c9">725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8xLTYtMS0xLTUyMDAy_8890ee90-8ec0-4e99-9908-2e92199edb64">725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8yLTItMS0xLTUyMDAy_74b33550-d1cc-4a6b-ace3-fc3c29bcf26e">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i24d9edd536944e538abc2437af99d50f_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8yLTQtMS0xLTUyMDAy_8c51f3c2-e280-450b-87b8-c17a37990c88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8yLTYtMS0xLTUyMDAy_1f23f4b7-792b-4376-a24c-1904fc5f4458">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment held for sale or rental</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8zLTItMS0xLTUyMDAy_97f10a14-70ec-4a1a-bf16-5209383ea651">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i24d9edd536944e538abc2437af99d50f_I20210418" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8zLTQtMS0xLTUyMDAy_044b735d-a671-42a5-8472-79eba51e1018">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8zLTYtMS0xLTUyMDAy_6ac6e938-21dc-4264-bfc4-e75c9be4c4d3">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF80LTItMS0xLTUyMDAy_31c85e2b-888d-40c6-94c1-75367a1cdab4">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i24d9edd536944e538abc2437af99d50f_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF80LTQtMS0xLTUyMDAy_7ea85d0d-f822-4d00-b320-4d0b83e9ae5d">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF80LTYtMS0xLTUyMDAy_66651ff9-d725-48aa-915c-7b8e857daadf">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF81LTItMS0xLTUyMDAy_d1600d45-e446-48d0-abf6-b604b0015e38">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i24d9edd536944e538abc2437af99d50f_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF81LTQtMS0xLTUyMDAy_c496cba4-a9c1-4278-8fb9-796f5375389a">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF81LTYtMS0xLTUyMDAy_f0ecf6e1-5852-47a5-a197-2c7048226928">4,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF82LTItMS0xLTUyMDAy_27f4e346-e922-42c9-a372-293c880c35ae">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i24d9edd536944e538abc2437af99d50f_I20210418" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF82LTQtMS0xLTUyMDAy_c3c832b9-55b7-4da4-aaa7-15ca8432a7f9">3,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF82LTYtMS0xLTUyMDAy_977bfad7-df6b-427c-b30d-ebf3c35e1b6c">3,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF83LTItMS0xLTUyMDAy_3227a59d-bcee-4433-a8da-899e9dfb1dda">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i24d9edd536944e538abc2437af99d50f_I20210418" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF83LTQtMS0xLTUyMDAy_ea716fcc-50a1-4dbd-89f9-d173cc0b4b6e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF83LTYtMS0xLTUyMDAy_8df4c399-c759-44b8-84e4-65a2a53ede54">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF84LTItMS0xLTUyMDAy_2ce198d9-4bf6-43ea-8c1e-3056af0c1dc5">281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i24d9edd536944e538abc2437af99d50f_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF84LTQtMS0xLTUyMDAy_21e91e82-0b8b-4c6e-905e-695678c793a5">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF84LTYtMS0xLTUyMDAy_ec52b65e-88e9-4154-9da6-7ecabc3c98ca">288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - purchase price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF85LTItMS0xLTUyMDAy_ea3a6a45-c73c-4638-887d-88e307d6fdc4">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i24d9edd536944e538abc2437af99d50f_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF85LTQtMS0xLTUyMDAy_033951a1-fec3-491d-a86c-788c4d803a87">7,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF85LTYtMS0xLTUyMDAy_4e40b8b5-481f-49d9-959d-34d7b099e4b9">8,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of acquisition costs for both transactions was $<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xMDk5NTExNjMzMjA3_0b04c18a-6cc7-4429-be7e-f1467b1a6f3c">0.2</ix:nonFraction> million and is included in general and administrative expenses for the year ended December&#160;31, 2021.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, the Company updated the valuation of OB Healthcare based on further analysis of the final working capital with an immaterial decrease in the consideration transferred and a corresponding decrease to accounts receivable. There was no impact to the consolidated statement of operations. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i79db760919bf4d18a1e9cebf5d32c891"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company fully paid all consideration for FilAMed as of December&#160;31, 2021. On the OB Healthcare acquisition date, the Company made an initial cash payment of $<ix:nonFraction unitRef="usd" contextRef="i1d555f047a9d4a98bcdde0ca522a6c33_D20210418-20210418" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xMDk5NTExNjMzMjE0_720c5c89-8fd4-4259-b8ee-1ffa7657fdbd">6.1</ix:nonFraction>&#160;million with subsequent cash payments of $<ix:nonFraction unitRef="usd" contextRef="i3540294de93b4071b8f2e1e40e99745e_D20210419-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xNjQ5MjY3NDQ3ODE1_58e3840d-c2db-460d-8cc5-66069e97a783">0.4</ix:nonFraction> million during the year and had an additional estimated amount due to the seller for contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i40c6769d29844b238f82f52eec98cc12_I20210418" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xMDk5NTExNjMzMjU3_6c1d5187-31a7-4c57-ac0c-03e379e904fe">0.8</ix:nonFraction>&#160;million, which was recorded in the balance sheet under the heading for other current liabilities. The contingent consideration arrangement requires the Company to pay OB Healthcare $<ix:nonFraction unitRef="usd" contextRef="i40c6769d29844b238f82f52eec98cc12_I20210418" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xMDk5NTExNjMzMjY0_6c1d5187-31a7-4c57-ac0c-03e379e904fe">0.8</ix:nonFraction>&#160;million if certain customer contracts are executed by December 31, 2021. In December 2021, the Company extended this date to February 28, 2022. The Company expects to further extend this deadline and for OB Healthcare to satisfy this requirement. </span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18zMjk4NTM0ODg4OTc4_13abd2bb-8b5f-45ca-b070-5844bba57880" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the breakdown of the identified intangible assets acquired into major intangible asset classes for both acquisitions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Thousands)</span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted-Average</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization Period</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Years)</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic33f271dada5450ba5170593f412ee83_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8xLTItMS0xLTUyMDAy_d117f002-64d7-44d6-a744-06639dce2667">2,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i233a685f88ec410c8dc45a29274c0b7b_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8xLTQtMS0xLTUyMDAy_347c659a-7e86-4047-816b-88af2934353a">15</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unpatented technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9117e35a7b704846add5b6cf91320364_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8yLTItMS0xLTUyMDAy_58784513-dccf-4e8d-99dc-2dde727e66d8">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i9ef27ca6d720458d8890b7403ee50d2f_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8yLTQtMS0xLTUyMDAy_ca8433e1-5cc1-4586-8100-e9ffd74afeba">7</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i441702431efa453d9ae697b4ed1bf9f8_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8zLTItMS0xLTUyMDAy_5f86cb3a-a51b-4643-a472-1f93e9bae8ff">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ie95c2bd801aa4bb288bad94f285a3474_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8zLTQtMS0xLTUyMDAy_a2b2ad0d-0780-4181-8a80-abd0379e5f29">5</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iac70b116e25d46d6943dcd912146fc65_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV80LTItMS0xLTUyMDAy_b79ebc0b-f5a0-4393-9388-6f1ef84c620f">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i00d66cb681ad4fb9820d60af76680b44_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV80LTQtMS0xLTUyMDAy_ae3375fe-16ec-4976-a664-8e0d36662b8f">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total intangible assets (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV82LTItMS0xLTUyMDAy_29de0439-98c9-4719-87a8-0021086b608b">4,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV82LTQtMS0xLTUyMDAy_89afead1-b05a-439e-a855-354ff83d1f8c">11.2</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) There was no residual value, renewal terms or extensions associated with any intangible assets acquired.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill acquired consists of expected synergies from combining operations of FilAMed and OB Healthcare with the DME Services segment as well as their respective assembled workforce who have specialized knowledge and experience. All of the goodwill is deductible for tax purposes. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information in the table below summarizes the combined results of operations of the Company, FilAMed and OB Healthcare as though the companies&#8217; businesses had been combined as of January 1, 2020. The pro forma financial information for the year ended December&#160;31, 2021 has been adjusted by $<ix:nonFraction unitRef="usd" contextRef="if05acd9bb129444c859314fc90a675b8_D20210101-20211231" decimals="-5" name="infu:BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xMDk5NTExNjMzMzI1_ea424379-d15e-40b5-bec9-20f7a5839c65">0.5</ix:nonFraction>&#160;million for the tax effected amount of acquisition costs and non-recurring expenses directly attributable to the FilAMed and OB Healthcare acquisitions. The year ended December&#160;31, 2020 also included these charges. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place at the beginning of each period presented nor is it indicative of future results. <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18zMjk4NTM0ODg4OTc3_254651ab-16ea-49ee-8d86-5d1c470fd624" continuedAt="i9613b25ad598470e9c2813902a200ebf" escape="true">The following pro forma financial information presented also includes the pro forma depreciation and amortization charges from acquired tangible and intangible assets for the years ended December&#160;31 (in thousands):</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i9613b25ad598470e9c2813902a200ebf"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 77.57pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NzY3OGIxYTY4OGU3NDY5MDkxYjg1MWE1YTA4Njk0MGEvdGFibGVyYW5nZTo3Njc4YjFhNjg4ZTc0NjkwOTFiODUxYTVhMDg2OTQwYV8yLTUtMS0xLTUyMDAy_d5467395-74bd-49cd-902f-53dda64adfba">103,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NzY3OGIxYTY4OGU3NDY5MDkxYjg1MWE1YTA4Njk0MGEvdGFibGVyYW5nZTo3Njc4YjFhNjg4ZTc0NjkwOTFiODUxYTVhMDg2OTQwYV8yLTctMS0xLTUyMDAy_9ba357c8-3168-4009-93a5-afdb4191e82a">100,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NzY3OGIxYTY4OGU3NDY5MDkxYjg1MWE1YTA4Njk0MGEvdGFibGVyYW5nZTo3Njc4YjFhNjg4ZTc0NjkwOTFiODUxYTVhMDg2OTQwYV8zLTUtMS0xLTUyMDAy_b1d16329-83df-49d1-8ad3-389becefead4">1,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NzY3OGIxYTY4OGU3NDY5MDkxYjg1MWE1YTA4Njk0MGEvdGFibGVyYW5nZTo3Njc4YjFhNjg4ZTc0NjkwOTFiODUxYTVhMDg2OTQwYV8zLTctMS0xLTUyMDAy_15f29198-478d-4b34-996d-7fe38c1ffbd7">16,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_1749"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8zMjk4NTM0ODgzOTc3_401371c5-16b3-4939-b96b-337224f52e7d" continuedAt="iafe72937d0d1495b973606eda46ba861" escape="true">Revenue Recognition</ix:nonNumeric></span></div><ix:continuation id="iafe72937d0d1495b973606eda46ba861"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8zMjk4NTM0ODgzOTc4_eed96776-0475-40dc-9930-18d91fb9e40d" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s disaggregated revenue by offering type (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-Party Payer Rentals</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iee74bd21a9164ffa92cd63e1a7f77a5b_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTEtMS0xLTUxOTA2_387b99c4-6bca-4e12-a12c-9e1513d75ba1">52,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="iac7342c282ec477da6afb686717858a7_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTMtMS0xLTUxOTA2_2ad233b0-00b5-469e-9523-172790146e59">51.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i68bd4d8cc58b4fe4b8a77002f54a62e4_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTUtMS0xLTUxOTA2_e81a8d0e-1cff-4833-8cb6-ee842a314df6">49,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i44173ad083b247b4a3a2827ae4199ffe_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTctMS0xLTUxOTA2_1adabeee-90e5-4f95-b836-04ce5802326e">50.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0797ce13f2f84bccb9643bb465b72539_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTktMS0xLTUxOTM4_f5bf2293-7632-40ee-ac3c-71da68f0b126">40,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i0b8592ae240046e2ae1d7bba300944f3_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTExLTEtMS01MTkzOA_302c4ffd-5e4c-484d-a0a2-2ef75c03e180">49.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct Payer Rentals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9b8bca74bc6643a39beeb55eb9ee5829_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTEtMS0xLTUxOTA2_ce979eaf-ada6-4f9d-9b4e-a0ea1952d100">29,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i6c9b6408c306478397ff75df2204b657_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTMtMS0xLTUxOTA2_8984f565-2fa5-4a3b-bcb2-f774db57a22d">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i780ffb81ffd74c41a647d4101deb7fed_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTUtMS0xLTUxOTA2_efd2a237-82e9-4dfd-a4db-034c108b82a0">28,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i55869796670c49c2b3cd162096936a33_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTctMS0xLTUxOTA2_15e2074b-87c8-4be1-b8de-0c3ab1b48c8c">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8c13d15fc1e3436490201fc54a7ebe45_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTktMS0xLTUxOTM4_2a670777-5530-46cd-82ed-ab0f7b4eac47">24,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i777a8534320c4ad2a3ca66b33e628c6d_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTExLTEtMS01MTkzOA_33d6427a-05c0-424f-bfae-1ad93bd71cd8">29.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ide3e566a68504537bf76d20a1a6e221e_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTEtMS0xLTUxOTA2_3341c018-85d5-4466-8950-02267dd029ac">15,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i38bb3cacf11d424c8a9bf2b293ac90bc_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTMtMS0xLTUxOTA2_7846febe-65c2-4665-a90e-820bea8de843">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i806896b65be24eb8a8d565e1ead9dfbc_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTUtMS0xLTUxOTA2_445fa2ff-61fd-4cf9-8efc-63e6327679da">17,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i94248c02936a4257911be7191534390c_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTctMS0xLTUxOTA2_a6384071-ec26-4970-931a-066d34644ece">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie795f19734ba4ea0ad822d0aa14b10e9_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTktMS0xLTUxOTM4_051d421c-f6b5-47fb-b979-026ffe1ef3b1">14,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ib0ec252312564b5b9a317bfa1d062542_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTExLTEtMS01MTkzOA_aad25969-6921-4dcc-a0b7-1dd5a33ae8e0">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic85e0dd291c74ec88ceca6c455d9099e_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTEtMS0xLTg3NjM2_c33fea76-72dd-4364-a22b-6f273e01d6c3">4,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2db72027cda42008cbdb85b30ce7435_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTMtMS0xLTg3NjQ0_8857eb25-da31-4661-9118-94cc747678b5">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabc7ebe2911f4b8ead87bc9344dbecbf_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTUtMS0xLTg3Njgx_b579ff07-1fd0-40b4-9fa2-bcca1fd82e52">2,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8cec8dd30c2a446b991de51c91e34f4c_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTctMS0xLTg3Njgx_f09ed934-18d1-4f8f-9543-83e00ce14532">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93c9a20502d4745907b197f7456558c_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTktMS0xLTg3Njgx_5d594838-26f8-4e4e-93c1-bb063b92381a">2,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea2e191999e8474dac4c6c90b1ebd6ea_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTExLTEtMS04NzY4MQ_66479709-01de-4bcc-9776-551008a42eb0">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTEtMS0xLTUxOTA2_d10b3dfb-0419-46e9-bf14-1e67ca18c239">102,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i0fca34364019406e99032d7e62aa8549_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTMtMS0xLTUxOTA2_9d86979d-00bc-4f7e-b835-611b1e1a0b21">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTUtMS0xLTUxOTA2_506a2341-ebf2-4981-9d76-f22c30424b27">97,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="if47ce6b2f6bd4668ac4fd139af7095f7_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTctMS0xLTUxOTA2_ff6af4f8-6d02-432f-889b-d703388a0973">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTktMS0xLTUxOTM4_f497de3f-601c-48c2-989a-6963c80cea32">81,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i99e9f20c6321440d8bbc7f2097999db8_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTExLTEtMS01MTkzOA_d7f22935-3b6e-458a-88ef-3470ccca8d30">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-Party Payer Rentals are entirely attributed to revenues of the ITS segment. For the year ended December&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="i24689dc260664972bc304c938065d32c_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8zMTg_7d802c12-1ef6-4094-99e1-7d77d2cef140">12.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9eab4726eabd4666a158889e4ca9f089_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8zMjU_b03b3153-07e3-466f-9b58-f74acb579af1">16.8</ix:nonFraction> million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the year ended December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i136bd725ae5d499aa73f5dbdcc3d0538_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml80NDM_58f45648-02f4-4e77-be1f-9155ac471d90">11.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1702a843f4c243c393e12054224e80e8_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml80NTA_e3c38427-cf4c-40d3-ae78-f77c142076df">16.7</ix:nonFraction> million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the year ended December&#160;31, 2019, $<ix:nonFraction unitRef="usd" contextRef="ibe177a89508b4e398be3e3549eb93a26_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8xMDk5NTExNjI4NDEw_fafeabcf-c063-4d05-9b51-c36307d104aa">11.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2a29108335024c84a565385b792cd555_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8xMDk5NTExNjI4NDE3_b7b62a30-8a93-452c-910e-13731455e92e">13.1</ix:nonFraction> million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the year ended December&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="i4fddcf470fec4bef906869caf2a1aee9_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml82MDQ3MzEzOTUzNDY5_380c17d5-5fbd-4dfb-8ee9-39ee2d89a5aa">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifb9b60051f3d464abf97f4d754be3921_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml82MDQ3MzEzOTUzNDc4_fd58056e-fac9-4c1c-875a-947c9152a550">15.3</ix:nonFraction> million of Product Sales were attributed to the ITS and DME Services segments, respectively. For the years ended December&#160;31, 2020 and 2019 all Product Sales were entirely attributed to revenues of the DME Services segment. For the years ended December&#160;31, 2021, 2020 and 2019, all Services revenues were entirely attributed to the DME Services segment.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i9e717b65c1e3405d850ef6e342b20071_118"></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="infu:MedicalEquipmentAndPropertyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90ZXh0cmVnaW9uOjViMmEyNjc3NjYyMjQ0ZDBiNTAwZjNhYjhhNDc0ZGE4XzI1NQ_8d83cadb-83b1-42f2-9681-c6550eab6f46" continuedAt="i44e2df94255a4ecca81364f9cfc516ca" escape="true">Medical Equipment</ix:nonNumeric></span></div><ix:continuation id="i44e2df94255a4ecca81364f9cfc516ca"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="infu:ScheduleOfMedicalEquipmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90ZXh0cmVnaW9uOjViMmEyNjc3NjYyMjQ0ZDBiNTAwZjNhYjhhNDc0ZGE4XzI1Ng_b6d2078a-54af-41b1-983b-5257db3380ad" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical equipment consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment for sale or rental</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRentalGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzEtMS0xLTEtNTA2MjI_63eeca07-8ec9-475e-ae36-870e5ecba6e6">1,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRentalGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzEtMy0xLTEtNTA2MjI_f1dbc924-f541-48fa-81b7-e3efa955832d">1,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment for sale or rental - pump reserve</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:MedicalEquipmentForSaleOrRentalReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzItMS0xLTEtNTA2MjI_63195ae0-1d66-4d86-988c-7de42f52b084">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:MedicalEquipmentForSaleOrRentalReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzItMy0xLTEtNTA2MjI_3230c58c-ec9b-4654-8d41-98251dc71f51">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment for sale or rental - net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRental" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzMtMS0xLTEtNTA2MjI_e7399c0a-de67-466b-acc7-b0bd35a91dbc">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRental" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzMtMy0xLTEtNTA2MjI_feb5d2f8-30ce-4b54-b758-8271d5eede92">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment in rental service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:MedicalEquipmentInRentalServicesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzUtMS0xLTEtNTA2MjI_47bdb3a8-70ff-4bc1-902e-e8ade49ed971">91,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:MedicalEquipmentInRentalServicesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzUtMy0xLTEtNTA2MjI_3a7c7985-2f82-4565-ac5e-f72e1e8e9b64">83,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment in rental service - pump reserve</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:MedicalEquipmentInRentalServicesReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzYtMS0xLTEtNTA2MjI_2ef4c96e-b7c2-4810-8427-9167c61bbccc">1,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:MedicalEquipmentInRentalServicesReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzYtMy0xLTEtNTA2MjI_d040e948-ab0d-4e7b-9525-5bf40eee4366">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzctMS0xLTEtNTA2MjI_90010a7e-4183-4c7e-8f63-061d8c674a44">50,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzctMy0xLTEtNTA2MjI_2930ae43-934e-4c89-93e3-7d656ac14721">46,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment in rental service - net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzgtMS0xLTEtNTA2MjI_be00911d-038c-4068-b984-f973521ea465">39,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzgtMy0xLTEtNTA2MjI_fa39f253-a81a-4c56-9737-b4b490748dc3">35,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:MedicalEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzEwLTEtMS0xLTUwNjIy_9c207c3c-fedc-421e-b2bf-506ffcbe3cc9">41,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:MedicalEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzEwLTMtMS0xLTUwNjIy_7b264706-9967-47c7-b73f-07cf7a0bc4bc">37,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for medical equipment for the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-5" name="infu:DepreciationExpenseRelatedToMedicalEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90ZXh0cmVnaW9uOjViMmEyNjc3NjYyMjQ0ZDBiNTAwZjNhYjhhNDc0ZGE4XzE3Mw_f087b2a1-f738-4de7-9133-a14a3f1a7f0e">9.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-5" name="infu:DepreciationExpenseRelatedToMedicalEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90ZXh0cmVnaW9uOjViMmEyNjc3NjYyMjQ0ZDBiNTAwZjNhYjhhNDc0ZGE4XzE4MA_05040b5f-bc4c-4168-bc83-8ddc56f81451">8.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-5" name="infu:DepreciationExpenseRelatedToMedicalEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90ZXh0cmVnaW9uOjViMmEyNjc3NjYyMjQ0ZDBiNTAwZjNhYjhhNDc0ZGE4XzEwOTk1MTE2MjgxMDM_dc9ec529-55cd-43b2-9684-c099e1b5a3aa">7.5</ix:nonFraction> million, respectively, which were recorded in &#8220;cost of revenues&#8221; for each period.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90ZXh0cmVnaW9uOmE5ODM4YmFhZTg0MzRmODU5MDg3MGNjZmEwYTg0MmVlXzMwNQ_5e9b43ca-eb7c-4012-a2bd-3d6c40fbc967" continuedAt="i0c7184cfddb0482596b2d2ebe73c6264" escape="true">Property and Equipment</ix:nonNumeric></span></div><ix:continuation id="i0c7184cfddb0482596b2d2ebe73c6264"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90ZXh0cmVnaW9uOmE5ODM4YmFhZTg0MzRmODU5MDg3MGNjZmEwYTg0MmVlXzMwNg_2d98362a-0e9f-4cf1-b51c-77c74271d140" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture, fixtures, and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901347f42a9240abb769c4ca3db405e7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItMS0xLTEtNTA2MjI_89953161-4ceb-41c8-a620-d309092e2639">4,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i901347f42a9240abb769c4ca3db405e7_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItMy0xLTEtNTA2MjI_62e17b24-8a0a-4d5f-bc84-0e93a916a7af">2,528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i901347f42a9240abb769c4ca3db405e7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItNS0xLTEtNTA2MjI_e1e20b01-3516-452f-833b-1806d87a5458">2,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia0e87b8645294c95b18cfe1e1938f796_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItNy0xLTEtNTE2OTI_0ea647de-736b-4e1f-aef8-50252d94bda0">3,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia0e87b8645294c95b18cfe1e1938f796_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItOS0xLTEtNTE2OTI_d6dcd598-8c35-4609-96a6-79fd76417749">2,018</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia0e87b8645294c95b18cfe1e1938f796_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItMTEtMS0xLTUxNjky_caef10ce-ac43-42d2-bbb6-4d37bbe7132e">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Automobiles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f56e398e372492d8641d88cd8b01cff_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtMS0xLTEtNTA2MjI_fa2f0146-abdc-46c4-bff4-d72a91e58416">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9f56e398e372492d8641d88cd8b01cff_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtMy0xLTEtNTA2MjI_4a32bc1f-5c68-4243-adbb-d2f93acc4540">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9f56e398e372492d8641d88cd8b01cff_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtNS0xLTEtNTA2MjI_398d7b05-efd5-4f4c-9a1c-0c18763748d6">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1e2ca571a5714cb889e214a572d2aa67_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtNy0xLTEtNTE2OTI_ce240b04-66c9-456d-974c-0aa799a65f3e">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i1e2ca571a5714cb889e214a572d2aa67_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtOS0xLTEtNTE2OTI_52155130-e2d1-4a3c-a468-797a1a314b0d">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1e2ca571a5714cb889e214a572d2aa67_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtMTEtMS0xLTUxNjky_cf03e6e5-f130-4187-a6b2-38fe118f7935">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9649d301729547c5b2196154dc65a224_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtMS0xLTEtNTA2MjI_1a1b990c-e307-4f3c-a03e-b804bef827b4">3,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9649d301729547c5b2196154dc65a224_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtMy0xLTEtNTA2MjI_a196e61a-ea24-4941-836e-44a61753b411">1,212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9649d301729547c5b2196154dc65a224_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtNS0xLTEtNTA2MjI_a766cd9c-3232-483d-aec4-3c1e2548f575">2,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3b7bb29ceaad4f8da8ce9a75bfa49f10_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtNy0xLTEtNTE2OTI_56904136-7935-48eb-98f6-a97d2d275689">3,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3b7bb29ceaad4f8da8ce9a75bfa49f10_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtOS0xLTEtNTE2OTI_d60fc2ef-4da2-4f05-9351-2886fb4f3aae">859</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3b7bb29ceaad4f8da8ce9a75bfa49f10_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtMTEtMS0xLTUxNjky_c28515fd-cafd-4c87-b4c1-1a4adaa4c535">2,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtMS0xLTEtNTA2MjI_24b10440-db8e-4a48-ae4a-8f5dfcaeeddc">8,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtMy0xLTEtNTA2MjI_66ada9d8-4ac9-477a-9d09-9f82b9b899ee">3,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtNS0xLTEtNTA2MjI_2fc1d217-4fbd-4160-8ca6-78d44baa3bd4">4,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtNy0xLTEtNTE2OTI_a4cd9ce7-d4a0-4043-9b29-c8ad9c6c50f5">7,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtOS0xLTEtNTE2OTI_2f98f7f5-5c5a-4987-91cb-86977800fd95">2,979</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtMTEtMS0xLTUxNjky_f672b55d-fca8-42db-92b6-9d270fb46f39">4,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for property and equipment for each of the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationNonproduction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90ZXh0cmVnaW9uOmE5ODM4YmFhZTg0MzRmODU5MDg3MGNjZmEwYTg0MmVlXzE5OA_2d3788c4-e0cf-42a6-9214-1909776bb1ab">0.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationNonproduction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90ZXh0cmVnaW9uOmE5ODM4YmFhZTg0MzRmODU5MDg3MGNjZmEwYTg0MmVlXzIwNQ_da639b76-9f55-4096-ae2f-a29549816ddc">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationNonproduction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90ZXh0cmVnaW9uOmE5ODM4YmFhZTg0MzRmODU5MDg3MGNjZmEwYTg0MmVlXzEwOTk1MTE2MjgxODI_34e83340-aa5a-42de-b7c3-4ed7c4820e49">0.5</ix:nonFraction> million, respectively. This expense was recorded in &#8220;general and administrative expenses&#8221; for each period.</span></div></ix:continuation><div id="i9e717b65c1e3405d850ef6e342b20071_124"></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzkwMg_f79490bf-e5a2-4c41-9315-dcc9b4c4220f" continuedAt="iea818fd24f6145a786536873e3ceefe6" escape="true">Goodwill and Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="iea818fd24f6145a786536873e3ceefe6" continuedAt="i1c0dbb0755674641aee4a4b282b623de"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzMyOTg1MzQ4ODYzNzQ_31879b41-0b65-4efb-afc6-6e209c430757" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying value of goodwill by segment are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services (a)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i680eb364512840a7b20a8bfda742ab6c_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTplN2I0N2I1MWU3ODk0YTgwYWZmZWUyNGRjMGM5ZjU2Ni90YWJsZXJhbmdlOmU3YjQ3YjUxZTc4OTRhODBhZmZlZTI0ZGMwYzlmNTY2XzEtMi0xLTEtNTM3OTU_74c5ce8b-0bd0-401c-bbf6-190570bfbfac">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i972c98c27e6f4a3999d5e2e73d5e2a77_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTplN2I0N2I1MWU3ODk0YTgwYWZmZWUyNGRjMGM5ZjU2Ni90YWJsZXJhbmdlOmU3YjQ3YjUxZTc4OTRhODBhZmZlZTI0ZGMwYzlmNTY2XzItMi0xLTEtNTM3OTU_7999516e-ee9b-4798-95e8-1d771e0e14ec">3,710</ix:nonFraction></span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i02810325b2664b7997154ec528092ae9_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTplN2I0N2I1MWU3ODk0YTgwYWZmZWUyNGRjMGM5ZjU2Ni90YWJsZXJhbmdlOmU3YjQ3YjUxZTc4OTRhODBhZmZlZTI0ZGMwYzlmNTY2XzMtMi0xLTEtNTM3OTU_2103105e-8a1e-404f-b803-6bfe81d91e4f">3,710</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) The ITS segment has <ix:nonFraction unitRef="usd" contextRef="i0629bca191f34f1caf750d54c8ebd131_I20211231" decimals="INF" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTplN2I0N2I1MWU3ODk0YTgwYWZmZWUyNGRjMGM5ZjU2Ni90YWJsZXJhbmdlOmU3YjQ3YjUxZTc4OTRhODBhZmZlZTI0ZGMwYzlmNTY2XzUtMC0xLTEtNTM3OTUvdGV4dHJlZ2lvbjpkYzM4NDM5ZjdlMzk0MDNjYjc2NDAyMDZiNzI0YjgxOF8xMDk5NTExNjI3ODI4_cf060714-9260-4686-8b0c-838a76d05235">no</ix:nonFraction> recorded goodwill. </span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the indicators of goodwill impairment as part of its annual impairment test, as of October 1, 2021, and through December 31, 2021, by performing a qualitative assessment of goodwill. In performing the qualitative assessment, the Company evaluated events and circumstances since the last impairment analysis, recent operating performance, changes in the business climate and company-specific factors. The results of the qualitative assessment indicated that it was more likely than not that the estimated fair value of each reporting unit exceeded its carrying value amount as of the test date. </span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="infu:CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzkwMw_db56bc6b-d667-4e86-a894-adde74c37e7c" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount and accumulated amortization of intangible assets were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonamortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzMtMS0xLTEtNTA2MjI_14cf45b0-00f7-43a3-a60c-016e174e5d16">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzMtNS0xLTEtNTA2MjI_0e469b9a-6aab-456f-bc4d-c59016101850">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzMtNy0xLTEtNTE3Mzk_c8488371-4f94-4973-9679-ae886f6ec07d">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzMtMTEtMS0xLTUxNzM5_a71456cd-c970-492f-860f-5d6c542c4e0e">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63340937f6a47b08decf2e320428890_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtMS0xLTEtNTA2MjI_ba2fb6fb-110d-4d17-88d6-88095e39d5b9">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="if63340937f6a47b08decf2e320428890_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtMy0xLTEtNTA2MjI_a9a6cfeb-aefa-4f3c-87a3-5533a9de8460">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if63340937f6a47b08decf2e320428890_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtNS0xLTEtNTA2MjI_5f3630df-663e-46a8-b680-783469c49a2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib9e0342993b94444b974026bddb99c28_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtNy0xLTEtNTE3Mzk_13d836e6-eae1-4f96-8f7d-179c535935ea">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib9e0342993b94444b974026bddb99c28_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtOS0xLTEtNTE3Mzk_abae8aa5-ff09-49bd-990f-46d20f0102b7">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib9e0342993b94444b974026bddb99c28_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtMTEtMS0xLTUxNzM5_09eea431-fd6c-46ed-ba2f-d3b4ef67a336">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physician and customer relationships</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45d3cf60b6544e0d862fa72ac5fa656b_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtMS0xLTEtNTA2MjI_3809df3c-7aae-4916-89f6-d8840eaee0d6">38,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i45d3cf60b6544e0d862fa72ac5fa656b_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtMy0xLTEtNTA2MjI_271ca23b-c0a3-40cf-bf1f-b5ee201ecc7d">31,401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i45d3cf60b6544e0d862fa72ac5fa656b_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtNS0xLTEtNTA2MjI_163c110d-ac7e-43d8-afd5-63b4884976bf">7,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i109995ede010411299c74fcc87e3829a_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtNy0xLTEtNTE3Mzk_0d7ada21-dd63-461b-ad62-c925c160b393">36,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i109995ede010411299c74fcc87e3829a_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtOS0xLTEtNTE3Mzk_5c866b64-7a0a-45cf-9864-74da1df8d632">28,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i109995ede010411299c74fcc87e3829a_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtMTEtMS0xLTUxNzM5_2cf42bf6-631d-4bab-ad45-5a965fc97ec9">7,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpatented technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9117e35a7b704846add5b6cf91320364_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMS0xLTEtNTkzNDA_ff2041f4-c2fc-4fee-a233-6cf377639b3b">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9117e35a7b704846add5b6cf91320364_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMy0xLTEtNTkzNDA_0671cc2b-c64c-4443-b68b-0305a66035d8">123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9117e35a7b704846add5b6cf91320364_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNS0xLTEtNTkzNDA_7e1ad88a-9e53-4b75-bb86-3c659094a806">820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7678f2cb51f54e08941b9dfcf63bace0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNy0xLTEtNTkzNDA_4e5c134d-0f23-4365-a215-c9dee1875fca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7678f2cb51f54e08941b9dfcf63bace0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctOS0xLTEtNTkzNDA_2121c7bd-4db9-4674-9130-7e31854b500b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7678f2cb51f54e08941b9dfcf63bace0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMTEtMS0xLTU5MzQw_8af0faed-60c6-4886-81fa-26bd23d16d65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i441702431efa453d9ae697b4ed1bf9f8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMS0xLTEtNTM5OTE_aeec5ec0-98d3-409b-9625-83c5628a48fe">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i441702431efa453d9ae697b4ed1bf9f8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMy0xLTEtNTM5OTE_0faae2a5-907b-4e22-a5b6-d09dd1580612">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i441702431efa453d9ae697b4ed1bf9f8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNS0xLTEtNTM5OTE_bcceeeff-07b7-4905-aae8-01788e0bdb07">405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3d86c2941c0e4ddfa25d123e33722fa3_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNy0xLTEtNTM5OTE_5000b6ee-3d6d-42a4-b124-1e9e40207f9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3d86c2941c0e4ddfa25d123e33722fa3_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctOS0xLTEtNTM5OTE_307ec891-f757-42e8-a9b7-43de1f0b10e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3d86c2941c0e4ddfa25d123e33722fa3_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMTEtMS0xLTUzOTkx_a60a55e6-b762-47fb-beef-0cc8f4b2b888">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac70b116e25d46d6943dcd912146fc65_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMS0xLTEtNTA2MjI_aa0c409d-81fc-4c45-b894-6dfe48c8b7c1">11,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iac70b116e25d46d6943dcd912146fc65_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMy0xLTEtNTA2MjI_f95c7172-bdfc-4aac-b0f3-bf1f29742616">11,258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iac70b116e25d46d6943dcd912146fc65_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNS0xLTEtNTA2MjI_29c66d2b-beb8-4f3f-97c3-8311ed421ee8">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i749458dfcda84fcba057ba09cfc9c14f_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNy0xLTEtNTE3Mzk_7562ff30-998d-49f4-a900-c9a798b275f3">11,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i749458dfcda84fcba057ba09cfc9c14f_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctOS0xLTEtNTE3Mzk_fade2691-a868-40d0-a779-28e1bdb82d5d">9,663</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i749458dfcda84fcba057ba09cfc9c14f_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMTEtMS0xLTUxNzM5_4ecfc45c-b684-404a-9380-47dc5f0b14e7">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total nonamortizable and amortizable intangible assets</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktMS0xLTEtNTA2MjI_df254b3d-7ec2-4fe2-8aab-fb0af2aac7ff">53,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktMy0xLTEtNTA2MjI_c3528783-855e-4f9e-a153-db733a566267">42,872</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktNS0xLTEtNTA2MjI_857c20c8-b29d-415b-9767-06891fac4b0c">10,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktNy0xLTEtNTE3Mzk_95090632-50a0-478d-8788-98a52fad8e34">49,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktOS0xLTEtNTE3Mzk_f40d19de-8333-4935-b6b2-4039e587f02a">38,610</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktMTEtMS0xLTUxNzM5_2f9b9d2d-1e74-4130-92a2-c65571f285e7">11,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets for the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzEwOTk1MTE2MzA3MDk_67df1d17-5cfe-43c3-98d5-dcd159a38453">4.3</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzEwOTk1MTE2MzA3MTc_da4bafd8-7a7d-4922-8b11-4ad98a9ca9cd">4.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzEwOTk1MTE2MzA4NDg_d9e7015c-a252-482c-97bd-970486e428a1">4.4</ix:nonFraction>&#160;million, respectively, which was recorded in "amortization of intangibles expenses" for each period. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i1c0dbb0755674641aee4a4b282b623de"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzkwNA_38f57f7a-f4d0-4194-8ca3-659cf28ca241" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected remaining annual amortization expense for the next five years for intangible assets recorded as of December&#160;31, 2021 is as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2027 and <br/>thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtMS0xLTEtNTA2MjI_552a1e78-f749-4116-af37-bbd3ddd611d6">2,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtMy0xLTEtNTA2MjI_5e4f66bb-649b-4df1-b622-80d723f30da2">990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtNS0xLTEtNTA2MjI_f58d085f-46fa-4dcc-ad59-6ccf9071f813">990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtNy0xLTEtNTA2MjI_3c2cad41-739c-4c07-b778-d29bbefecfa2">810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtOS0xLTEtNTA2MjI_a54af78f-a34e-4d56-8616-1b20bd65ee39">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtMTEtMS0xLTUwNjIy_f1f6d9ab-d6de-4935-a9fd-964e08177a8b">3,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i9e717b65c1e3405d850ef6e342b20071_130"></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzY1MDg_65668fe0-2292-4cda-8b75-d592ae6ccfb1" continuedAt="ic21260f6793d4e729f4fdbefec1ae8d5" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="ic21260f6793d4e729f4fdbefec1ae8d5" continuedAt="ifa4ee76518f44436bce52eb88887d174"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;5, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company entered into a Credit Agreement (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 Credit Agreement&#8221;) with JPMorgan Chase Bank, N.A., as administrative agent (the &#8220;Agent&#8221;), sole bookrunner and sole lead arranger, and the lenders party thereto. The borrowers under the 2021 Credit Agreement are the Company, InfuSystem Holdings USA, Inc. (&#8220;Holdings&#8221;), ISI, First Biomedical, and IFC LLC (&#8220;IFC&#8221; and, collectively with the Company, Holdings, ISI and First Biomedical, the &#8220;Borrowers&#8221;).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement provides for a revolving credit facility (the &#8220;Revolving Facility&#8221;) of $<ix:nonFraction unitRef="usd" contextRef="iec609ab7f9cc482f878e37ae4b232f06_I20210205" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgxMzg_521b448c-c9f6-4d44-a530-5222828ef662">75.0</ix:nonFraction> million, maturing on February 5, 2026. The Revolving Facility may be increased by $<ix:nonFraction unitRef="usd" contextRef="iec609ab7f9cc482f878e37ae4b232f06_I20210205" decimals="INF" name="infu:LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgxNzc_28e32224-1b37-448b-8f16-ab947f3b1be8">25.0</ix:nonFraction> million, subject to certain conditions, including the consent of the Agent and obtaining necessary commitments. The lenders under the 2021 Credit Agreement may issue up to $<ix:nonFraction unitRef="usd" contextRef="i9c000588f48b4e20af3b977ce4231e48_I20210205" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgxOTc_5d8f55f7-efe4-49e3-8961-e293b885ed84">7.0</ix:nonFraction> million in letters of credit subject to the satisfaction of certain conditions. On February&#160;5, 2021, the Borrowers made an initial borrowing of $<ix:nonFraction unitRef="usd" contextRef="ib6e13bc56eba44a085dd386fb4a920de_D20210205-20210205" decimals="INF" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgyMzU_1587a1ec-a735-4297-b38b-abe521506a1b">30.0</ix:nonFraction> million under the Revolving Facility. Proceeds from the loan, along with approximately $<ix:nonFraction unitRef="usd" contextRef="i033b71a678134cd586b4202ce9eb994e_D20210205-20210205" decimals="INF" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgyNTU_64a0ed1f-f9e9-4548-8a69-ae9713a7d5a7">8.2</ix:nonFraction> million in cash, were used to repay all amounts due under the Company&#8217;s then existing credit facility dated March 23, 2015 (the &#8220;2015 Credit Agreement&#8221;).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement has customary representations and warranties. The ability to borrow under the facility is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations on indebtedness, liens, mergers, acquisitions, investments, asset sales, affiliate transactions and restricted payments, as well as financial covenants, including the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a minimum fixed charge coverage ratio (defined as the ratio of consolidated EBITDA (as defined in the 2021 Credit Agreement) less <ix:nonFraction unitRef="number" contextRef="i28416998ed494697b9e63887fde6fd11_D20210205-20210205" decimals="INF" name="infu:PercentageOfTotalDepreciationExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgyODg_c3d3e7d5-606f-4e57-b425-32ae0b20d332">50</ix:nonFraction>% of depreciation expense), to consolidated fixed charges (as defined in the 2021 Credit Agreement)) for the prior four most recently ended calendar quarters of <ix:nonFraction unitRef="number" contextRef="if5d269b502c94e90b66e4c4b94a9c2ed_I20210205" decimals="INF" name="infu:DebtInstrumentCovenantMinimumFixedCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgyODE_2c5a8fa4-9425-4719-abe8-cd1956061153">1.20</ix:nonFraction> to 1.00; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a maximum leverage ratio (defined as total indebtedness to EBITDA for the prior four most recently ended calendar quarters) of <ix:nonFraction unitRef="number" contextRef="if5d269b502c94e90b66e4c4b94a9c2ed_I20210205" decimals="INF" name="infu:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgyNzQ_ee792094-8868-4b07-987e-75e09bb14e17">3.50</ix:nonFraction> to 1.00.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement includes customary events of default. The occurrence of an event of default will permit the lenders to terminate commitments to lend under the Revolving Facility and accelerate payment of all amounts outstanding thereunder.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneous with the execution of the 2021 Credit Agreement, the Company entered into a Pledge and Security Agreement to secure repayment of the obligations of the Borrowers. Under the Pledge and Security Agreement, each Borrower has granted to the Agent, for the benefit of various secured parties, a first priority security interest in substantially all of the personal property assets of each of the Borrowers, including the shares of each of Holdings, ISI and First Biomedical and the equity interests of IFC.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;5, 2021, in connection with the execution and closing of the 2021 Credit Agreement, the Company, along with its wholly owned subsidiaries as borrowers, terminated the 2015 Credit Agreement. All outstanding loans under the 2015 Credit Agreement have been repaid and all liens under the 2015 Credit Agreement have been released, except that a letter of credit originally issued under the 2015 Credit Agreement in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="i452ae0b2df354385976aa6108ccf6fb9_I20210205" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgzMTQ_da095831-ace3-4e8e-9208-23164669a109">0.8</ix:nonFraction> million was transferred to the 2021 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement was accounted for as a debt modification that resulted in a small increase to deferred debt issuance costs. As of December&#160;31, 2021, the Company was in compliance with all debt-related covenants under the 2021 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the 2015 Credit Agreement, which would have matured on November 9, 2024, included three term notes totaling $<ix:nonFraction unitRef="usd" contextRef="id2da90a2b53f464d83f01bf20f29c091_I20201231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgzNTM_81e9088c-ecc9-4c05-82c8-0104182fca93">37.9</ix:nonFraction> million, with varying required quarterly amortization payments, and an undrawn $<ix:nonFraction unitRef="usd" contextRef="ic9523dc8728f4f108564fbb8f67d46a3_I20201231" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgzNzI_e87c02f3-f950-47ab-bc64-23103e7941bb">11.8</ix:nonFraction> million revolving line of credit. The availability under the line of credit was reduced by outstanding letters of credit and reserves totaling $<ix:nonFraction unitRef="usd" contextRef="ic9523dc8728f4f108564fbb8f67d46a3_I20201231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgzOTE_e21c2a6f-cd78-4636-bbf6-4cd73b894178">1.0</ix:nonFraction> million and was subject to a borrowing base limitation as defined by the agreement. The borrowing base was approximately $<ix:nonFraction unitRef="usd" contextRef="ic9523dc8728f4f108564fbb8f67d46a3_I20201231" decimals="-5" name="infu:LineOfCreditFacilityBorrowingBase" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg0NTM_f3f58bc6-9d32-40cd-b768-b4c5453e4737">15.6</ix:nonFraction> million at December&#160;31, 2020. At December&#160;31, 2020 and on the date of the refinancing, the Company </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="ifa4ee76518f44436bce52eb88887d174" continuedAt="i373380dd85cf4a46829b0380239483d1"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was in compliance with all affirmative and negative covenants, as outlined in the agreement, which included maintenance of a maximum leverage ratio and a minimum fixed charge coverage ratio, as defined in the agreement. Interest on the facility was payable at the Company&#8217;s option as a (i) Eurodollar Loan, which bore interest at a per annum rate equal to the applicable 30-day LIBOR plus an applicable margin ranging from <ix:nonFraction unitRef="number" contextRef="i8ae56ca359cf4788a118a9f206ace640_D20200101-20201231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1NjE_93eb789f-c0da-4329-80cc-487134fc9c29">2.00</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i29c501e886e64e9c963a67b76eb4cd46_D20200101-20201231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1Njk_33ef38f6-5652-4d81-9da7-4bf88ff715a0">3.00</ix:nonFraction>% or (ii) CB Floating Rate (&#8220;CBFR&#8221;) Loan, which bore interest at a per annum rate equal to the greater of (a) the lender&#8217;s prime rate or (b) LIBOR plus <ix:nonFraction unitRef="number" contextRef="i223aaee1de9843719aacfcb115ef4cb2_D20200101-20201231" decimals="3" name="infu:DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1Nzc_6cd182e5-013b-48dc-b332-53e31448dc5a">2.50</ix:nonFraction>%, in each case, plus a margin ranging from -<ix:nonFraction unitRef="number" contextRef="i32f4cc53746a4a8cba9ea7b91c877b3b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1ODU_98ee8b7c-450e-4725-8db6-1ffc55f9947b">1.00</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i4bb191034086475081b1b2d7260fba3c_D20200101-20201231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1OTU_5bc2f542-d220-4351-a5df-da88e835684d">0.25</ix:nonFraction>% based on the Company's leverage ratio. The actual Eurodollar Loan rate at December&#160;31, 2020 was <ix:nonFraction unitRef="number" contextRef="ib19aee4251c0421a88d27487e974e24e_I20201231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg0ODg_fdbebbd5-0b50-4de7-9f2a-40feab3dc18c">2.19</ix:nonFraction>% (LIBOR of <ix:nonFraction unitRef="number" contextRef="ib19aee4251c0421a88d27487e974e24e_I20201231" decimals="4" name="infu:LIBORRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg0ODA_0eda2429-f385-443b-a75b-718651152790">0.19</ix:nonFraction>% plus <ix:nonFraction unitRef="number" contextRef="i86348f84097549aea76b5e34c1abceab_D20200101-20201231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg0NzI_79475c80-d57e-4676-9e9b-03bb98002bf7">2.00</ix:nonFraction>%). The actual CBFR Loan rate at December&#160;31, 2020 was <ix:nonFraction unitRef="number" contextRef="i4249c9895bc145b5be2fa0d810ad324b_I20201231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1MTM_16dadeaf-d72c-4902-84b7-ab41e47deee7">2.25</ix:nonFraction>% (lender&#8217;s prime rate of <ix:nonFraction unitRef="number" contextRef="i2958795320034b74ba5d1eff1f005813_I20201231" decimals="4" name="infu:LenderPrimeRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg0OTY_a37bb903-0464-4d74-bd73-e50b6090c0e8">3.25</ix:nonFraction>% minus <ix:nonFraction unitRef="number" contextRef="i48cdf09f16b649aba0ae191e5967f0ad_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1MDQ_d6c51510-ed8f-4547-8f46-85537d35dd76">1.00</ix:nonFraction>%).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;15, 2019, the Company sold for $<ix:nonFraction unitRef="usd" contextRef="ic70163d2c2154132b876d363ae1420b5_I20190415" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg2NDQ_5c7d6919-706c-4e63-994c-a7d71156512e">2.0</ix:nonFraction> million and immediately leased back certain medical equipment in rental service to a third party specializing in such transactions. The leaseback term is <ix:nonNumeric contextRef="ia8c78e4c1e864bd5a5b27f93ca59061e_D20190415-20190415" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg2NjI_990a8158-f666-4025-861d-7ceabdcea462">36</ix:nonNumeric> months. Because the arrangement contains a purchase option that the Company is reasonably certain to exercise, this transaction did not qualify for the sale-leaseback accounting under ASC 842. The medical equipment remains recorded on the accompanying condensed consolidated balance sheet and the proceeds received have been classified as an other financing liability, which is being paid off monthly over the term of the lease. During the fourth quarter of 2021, the Company recorded an additional $<ix:nonFraction unitRef="usd" contextRef="i4b550170313246b389a63672f1b2683f_D20211001-20211231" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzMyOTg1MzQ5MDUxNTQ_db873641-438a-4b83-aced-f72f345fc375">0.2</ix:nonFraction>&#160;million of interest expense to reflect the amount expected to be paid upon the exercise of the purchase option at the end of its other financing transaction. The balance of other financing as of December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i262345c59e314575bff01a7f8cda11fe_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgwOTg_9f838c7e-c29b-44ff-8a16-f0ea7000b601">0.4</ix:nonFraction> million.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As referenced above, the Company executed and closed the 2021 Credit Agreement during the first quarter of 2021, and in connection with entering into that agreement, terminated the 2015 Credit Agreement. For the following tables, the figures related to the December&#160;31, 2021 revolving credit facility balances relate to the 2021 Credit Agreement, while the December&#160;31, 2020 revolving credit facility balances relate to the now-terminated 2015 Credit Agreement. <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzY1MDk_3785de61-e090-4a73-878d-4d70c59b700f" continuedAt="ia9b62ea545f64c3a9f691d4f3fab6ec8" escape="true">The following table illustrates the net availability under the revolving credit facilities as of the applicable balance sheet date (in thousands):</ix:nonNumeric></span></div><div style="margin-top:10pt;text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt"><ix:continuation id="ia9b62ea545f64c3a9f691d4f3fab6ec8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Facility:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross availability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzItMS0xLTEtNTA2MjI_63bf27ed-dd3e-485e-9269-2df25977bb3e">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231" decimals="-3" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzItMy0xLTEtNTA2MjI_95452266-b561-476b-9db0-af9567806115">11,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding draws</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzMtMS0xLTEtNTA2MjI_8ca2e919-63d4-45bc-9a3c-7eca771e5bb9">32,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzMtMy0xLTEtNTA2MjI_85b08632-1381-4e36-9711-9bb24d1b89ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzQtMS0xLTEtNTA2MjI_516280f7-4b77-4998-b9c1-6edc5ca01d73">600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzQtMy0xLTEtNTA2MjI_04089b18-cdc5-4f1e-b990-19312f2e3bd2">800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Landlord reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="infu:LandlordReserves" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzUtMS0xLTEtNTA2MjI_97e33960-2e7e-4622-a658-7b2b6c52dee8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231" decimals="-3" name="infu:LandlordReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzUtMy0xLTEtNTA2MjI_8747dbd0-5ca8-4177-b9cb-2c6bec2d08c4">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Availability on Revolving Facility</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzYtMS0xLTEtNTA2MjI_4f10f5fa-9232-4c8a-9691-43cb3285cb37">41,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzYtMy0xLTEtNTA2MjI_692f8705-7582-46ec-8e3d-a5b31f8772d9">10,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzY1MTA_3f8edc03-a80f-4169-9d93-69d8e752d11d" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had future maturities of its long-term debt as of December&#160;31, 2021 as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2027 and <br/>thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtMS0xLTEtNTA2MjI_b3b9aeb8-07a9-471b-9125-83fe9cc2965c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtMy0xLTEtNTA2MjI_b251681f-db78-44a8-bbf5-13c169fd1576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtNS0xLTEtNTA2MjI_998a8474-392e-4a75-90e9-7adbb3b443d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtNy0xLTEtNTA2MjI_e499a164-2522-45eb-925e-0b4ead2a9eb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtOS0xLTEtNTIzMzU_e585eca5-9cf1-4f03-89e3-b7986d5cba80">32,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtOS0xLTEtNTA2MjI_64e5aafc-2ef6-4ad7-816f-767d4f5d188f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtMTEtMS0xLTUwNjIy_862d28a3-b893-4cfa-9050-8ea15ffd3cbe">32,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtMS0xLTEtNTA2MjI_707aff14-ce8d-4225-8b73-cf1efbf16556">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtMy0xLTEtNTA2MjI_d9229e2a-e61d-46a0-b22b-cd39c2025fc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtNS0xLTEtNTA2MjI_c45a1ed2-0184-4bf7-8053-cc5f2668fa1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtNy0xLTEtNTA2MjI_18166d2b-655d-4bc1-b8e4-c8bf54fc60d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzItOS0xLTEtNTIzMzU_ed1d2de5-3e2d-4fdc-988a-628cd42bd223">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtOS0xLTEtNTA2MjI_42c73043-ac5a-4f04-91a0-8ffc139837b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtMTEtMS0xLTUwNjIy_ed0ac7b0-6595-4bb8-b7d5-d3f4f0b8b3cf">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtMS0xLTEtNTA2MjI_96d94881-a25c-4909-9e86-c744eb0b2b78">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtMy0xLTEtNTA2MjI_2de7967e-2fc9-476a-ac28-22eed10a8b45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtNS0xLTEtNTA2MjI_ad27b6e5-54c3-4d98-a597-1ecf555341b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtNy0xLTEtNTA2MjI_0255f0dd-f0ec-4bfa-97e7-154c54bbc382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzMtOS0xLTEtNTIzMzU_ac5c8e07-fdd8-41f9-b0d1-2c6a041cbd82">32,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtOS0xLTEtNTA2MjI_98fbc766-d60a-436b-a30f-2076faa81b69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtMTEtMS0xLTUwNjIy_6d28437a-38a9-48ac-adc0-77fe997a3416">33,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i373380dd85cf4a46829b0380239483d1" continuedAt="i1f441cba049d4485a05c149fe60d589f"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzY1MTE_4fe3b81e-b5d9-444e-8fc3-b973edd295b9" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a breakdown of the Company&#8217;s current and long-term debt (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMS0xLTEtNTI0NzE_696b06ae-d424-40b2-a372-f82e7007f0b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMy0xLTEtNTI0NzE_89e223b8-460a-4f2b-86d6-5cb83b70caf4">32,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItNS0xLTEtNTI0NzE_47a42365-e1f7-446c-a5d4-f7fd0c59b9f0">32,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItNy0xLTEtNTI0NzE_37b38d13-e5fe-4ff8-9baa-7dd5d20b8862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItOS0xLTEtNTI0NzE_81346e36-4f21-42dd-9a4c-35d91f58b54d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMTEtMS0xLTUyNDcx_c0c83e55-9b0a-43c2-987b-2d28d873869f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i26945b82dabf4e67b225a0c6d08752e0_I20211231" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMS0xLTEtNTA2MjI_1d3da8ff-6d5a-4ff7-b368-8060d034a0f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i26945b82dabf4e67b225a0c6d08752e0_I20211231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMy0xLTEtNTA2MjI_2d638613-a739-4dd9-94d1-5d61f0662c55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i26945b82dabf4e67b225a0c6d08752e0_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItNS0xLTEtNTA2MjI_d0a78fb6-c367-4b24-96c3-9a1368450294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib56fe4590048490aac40ada7ae6400c3_I20201231" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItNy0xLTEtNTA2MjI_addb79d8-a405-4b01-adb9-776810ed7dc7">4,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib56fe4590048490aac40ada7ae6400c3_I20201231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItOS0xLTEtNTA2MjI_6f70fbec-9674-4bbd-81ea-e3b35d086185">17,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib56fe4590048490aac40ada7ae6400c3_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMTEtMS0xLTUwNjIy_7fa4d94e-d98d-4cd3-956a-cec6e48c9d19">21,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment line</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib6540674abce4c21a0ef51335bdd4b29_I20211231" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtMS0xLTEtNTA2MjI_d662567d-e105-43a1-919b-fb147aaca962">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib6540674abce4c21a0ef51335bdd4b29_I20211231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtMy0xLTEtNTA2MjI_db276abd-04ee-4453-9cfc-c9761a98c119">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib6540674abce4c21a0ef51335bdd4b29_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtNS0xLTEtNTA2MjI_efdbaafb-3eb8-4009-a889-3ea0d37f480b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3c407a2ed2ae458a8df6a05548246659_I20201231" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtNy0xLTEtNTA2MjI_75e2e72f-515d-443c-a58e-2895f7bb73a1">1,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3c407a2ed2ae458a8df6a05548246659_I20201231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtOS0xLTEtNTA2MjI_f76ea076-0d17-4907-be56-849594c0c1fb">4,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3c407a2ed2ae458a8df6a05548246659_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtMTEtMS0xLTUwNjIy_f1ed471e-82c6-4732-82f2-802bb3e0dc21">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019 equipment line</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib4facded32a743d880e4713f269f8b0a_I20211231" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtMS0xLTEtNTA2MjI_7ae7b089-0af6-4271-9cc9-9358ffcbbd58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib4facded32a743d880e4713f269f8b0a_I20211231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtMy0xLTEtNTA2MjI_5f4f7e3d-e86c-4f37-ba75-053571d65f4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib4facded32a743d880e4713f269f8b0a_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtNS0xLTEtNTA2MjI_7cb7bb3a-99cc-4676-82de-d1cf6190ee00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i987ef74564c541748397735c98c6eef8_I20201231" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtNy0xLTEtNTA2MjI_dedd3bd6-20c7-41ac-8c52-0cb9a34b14ef">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i987ef74564c541748397735c98c6eef8_I20201231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtOS0xLTEtNTA2MjI_e91ccb56-6d4e-439a-b6e9-467973c52497">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i987ef74564c541748397735c98c6eef8_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtMTEtMS0xLTUwNjIy_a9d21d24-2cdd-4967-b30d-a7cd3c417784">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231" decimals="-3" name="infu:LongtermDebtGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtMS0xLTEtNTA2MjI_c28799ea-6c1e-4892-af3d-1b20c944331f">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtMy0xLTEtNTA2MjI_6b364d1c-a958-4370-8ef0-8216c6944197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtNS0xLTEtNTA2MjI_3e52584c-d619-4bde-8fde-b46630102949">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2ab9a73eeba346ee8122c590dbcbff5c_I20201231" decimals="-3" name="infu:LongtermDebtGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtNy0xLTEtNTA2MjI_76407969-0974-439a-ac54-ddd3a6088fe5">725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2ab9a73eeba346ee8122c590dbcbff5c_I20201231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtOS0xLTEtNTA2MjI_b2237881-257a-4452-bfce-f131523f7c7a">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2ab9a73eeba346ee8122c590dbcbff5c_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtMTEtMS0xLTUwNjIy_a20ad1fb-c447-4959-a42b-645596f0e88f">947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:LongtermDebtGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctMS0xLTEtNTA2MjI_4b271bb4-58bf-4dbe-9f09-80b4bc6bab01">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctMy0xLTEtNTA2MjI_9ccb7252-1f30-4989-be27-8788c09f0ce9">32,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctNS0xLTEtNTA2MjI_4400b7a6-50be-466b-b3af-4c54382a28b1">33,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctNy0xLTEtNTA2MjI_8c475910-0d1a-4d37-9101-b0bec29ee200">9,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctOS0xLTEtNTA2MjI_d82a92d4-f43c-4d81-941b-1c3a643edac9">29,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctMTEtMS0xLTUwNjIy_9426ed28-3423-45d6-9352-d2bad73b33b3">38,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized value of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:UnamortizedDebtIssuanceExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMS0xLTEtNTI0MzI_efa7b317-db5a-4ef4-950a-e64d709f4c10">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="infu:UnamortizedDebtIssuanceExpenseNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMy0xLTEtNTI0MzI_ca767227-b125-4b3a-9d2a-797a8baea6d5">226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktNS0xLTEtNTI0MzI_74b8bd17-de28-4d68-9caa-26e4b6d0084e">300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:UnamortizedDebtIssuanceExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktNy0xLTEtNTI0MzI_543c1855-23a8-4e16-8812-7c06f35373b2">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="infu:UnamortizedDebtIssuanceExpenseNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktOS0xLTEtNTI0MzI_c8bd6254-d9b3-4805-89d8-6dc9ff435eb9">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMTEtMS0xLTUyNDMy_38c55ac9-2e0e-477b-b2d1-fc869c51b6e1">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMS0xLTEtNTI0NTE_e91e6fc5-ae20-4faf-9e81-477f9ceb44a4">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMy0xLTEtNTI0NTE_649b8173-f726-40a8-be78-3e317ada63aa">32,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktNS0xLTEtNTI0NTE_998e4ac5-89e5-4ebf-ad8c-6d513fa1c0a8">33,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktNy0xLTEtNTI0NTE_538229fa-e5db-4497-9d10-37a0f30cf1c1">9,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktOS0xLTEtNTI0NTE_d5b28bac-0398-4fe9-b8b1-8e4e1e6a3347">29,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMTEtMS0xLTUyNDUx_d1ecc78a-e9c0-4511-80d3-838abae44dac">38,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-indent:27pt"><ix:continuation id="i1f441cba049d4485a05c149fe60d589f" continuedAt="i68cebe4df7234accaa20cebfa4b796eb"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i68cebe4df7234accaa20cebfa4b796eb">December&#160;31, 2021, amounts outstanding under the Revolving Facility provided under the 2021 Credit Agreement bear interest at a variable rate equal to, at the Company&#8217;s election, a LIBO Rate for Eurodollar loans or an Alternative Base Rate for ABR loans, as defined by the 2021 Credit Agreement, plus a spread that will vary depending upon the Company&#8217;s leverage ratio. The spread ranges from <ix:nonFraction unitRef="number" contextRef="idd19a01ade284855af47b1b4373ea548_D20210101-20211231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0NTc_62956b56-6165-4985-8ad6-23f69c0f60d0">2.00</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ifb66c8f537fd4b868b21fad8bb3d0370_D20210101-20211231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0NjU_2d772833-b3c7-4e85-a222-2a78765762fd">3.00</ix:nonFraction>% for Eurodollar Loans and <ix:nonFraction unitRef="number" contextRef="i5ad0860c58864013aaca9c0803749cc1_D20210101-20211231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0NzM_1d3117d5-6119-480e-a30e-5c7d20f8ddd9">1.00</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i753ef5726f0d46c09a8a2930b70f0ae4_D20210101-20211231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0ODE_b8f55e1f-08bf-494e-b06a-53cbab4259f7">2.00</ix:nonFraction>% for base rate loans. The weighted-average Eurodollar loan rate at December&#160;31, 2021 was <ix:nonFraction unitRef="number" contextRef="ibbe15e51fb3c431391c39b3871874755_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0MDk_9a0b416d-7664-48b3-9c12-20a46f018005">2.11</ix:nonFraction>% (LIBO of <ix:nonFraction unitRef="number" contextRef="ibbe15e51fb3c431391c39b3871874755_I20211231" decimals="4" name="infu:LIBORRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0MTc_ec4299c3-ef43-42bf-94ff-d6e20557d762">0.11</ix:nonFraction>% plus <ix:nonFraction unitRef="number" contextRef="i5cd65086be1a4f03b35066f3c49722b5_D20210101-20211231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0MjU_c7c0bfb3-1835-416e-8986-43f1d049868b">2.00</ix:nonFraction>%). The actual ABR loan rate at December&#160;31, 2021 was <ix:nonFraction unitRef="number" contextRef="id680c7f9eb53497f8afe704e06188d0d_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0NDk_39dd246e-360e-4013-94f0-3d7598f4a60d">4.25</ix:nonFraction>% (lender&#8217;s prime rate of <ix:nonFraction unitRef="number" contextRef="id680c7f9eb53497f8afe704e06188d0d_I20211231" decimals="4" name="infu:LenderPrimeRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0MzM_1a1577a1-6bae-40db-a5e0-4f60fdde6ee3">3.25</ix:nonFraction>% plus <ix:nonFraction unitRef="number" contextRef="id41bcfe45ebb4131bad97991e1bcf070_D20210101-20211231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0NDE_a7974ec5-b44b-421f-ab18-02eccc2d189a">1.00</ix:nonFraction>%</ix:continuation>).</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_1828"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGV4dHJlZ2lvbjplYjIyODYxM2Y4MjM0ODY0OTQyNWI3MzFhOGRjYzkwYV8zMjk4NTM0ODg1MzM4_e379b0cf-6177-4d13-97b5-a044ba1007c2" continuedAt="i963f91c5b5a345e2ac4f8bfd4caa2deb" escape="true">Derivative Financial Instruments and Hedging Activities</ix:nonNumeric></span></div><ix:continuation id="i963f91c5b5a345e2ac4f8bfd4caa2deb" continuedAt="iedaf93ed3b3f487b8940166782e44f9a"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company adopted a derivative investment policy which provides guidelines and objectives related to managing financial and operational exposures arising from market changes in short term interest rates. In accordance with this policy, the Company can enter into interest rate swaps or similar instruments, will endeavor to evaluate all the risks inherent in a transaction before entering into a derivative financial instrument and will not enter into derivative financial instruments for speculative or trading purposes. Hedging relationships are formally documented at the inception of the hedge and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to interest rate risk related to its variable rate debt obligations under the 2021 Credit Agreement. In order to manage the volatility in interest rate markets, in February 2021, the Company entered into <ix:nonFraction unitRef="numberofagreement" contextRef="ie04daf42f32244b687b1b4a179069060_I20210205" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGV4dHJlZ2lvbjplYjIyODYxM2Y4MjM0ODY0OTQyNWI3MzFhOGRjYzkwYV8xMTIx_4b1b9c5b-f65d-4f0d-8018-8b3ddb119802">two</ix:nonFraction> interest rate swap agreements to manage exposure arising from this risk. On a combined basis, the agreements have a constant notional amount over a 5-year term that ends on February 5, 2026. The agreements both pay the Company 30-day LIBOR on the notional amount and the Company pays a fixed rate of interest equal to <ix:nonFraction unitRef="number" contextRef="ie04daf42f32244b687b1b4a179069060_I20210205" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGV4dHJlZ2lvbjplYjIyODYxM2Y4MjM0ODY0OTQyNWI3MzFhOGRjYzkwYV8xNDQz_b753e542-9bad-40e3-856c-65debc7646cf">0.73</ix:nonFraction>%. These derivative instruments are considered cash flow hedges. The Company does not have any other derivative financial instruments.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="iedaf93ed3b3f487b8940166782e44f9a"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGV4dHJlZ2lvbjplYjIyODYxM2Y4MjM0ODY0OTQyNWI3MzFhOGRjYzkwYV80Mzk4MDQ2NTEzMTEy_0eadfba2-54a6-4a54-830a-5a072a017e5f" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the location and gross fair value amounts of the Company's derivative financial instruments and the associated notional amounts designated as cash flow hedges (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December&#160;31, 2021 (a)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair Value Derivative Assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3f5f66be8c4042dfbc78b5ce658083c7_I20211231" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6YmU0NjgwZTJjZTQyNDUwNmI1ZGY3ZjQzNmJjN2I4MTcvdGFibGVyYW5nZTpiZTQ2ODBlMmNlNDI0NTA2YjVkZjdmNDM2YmM3YjgxN180LTQtMS0xLTU0Mzc4_d139dc0f-9399-4031-8539-6904504d3d55">20,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3f5f66be8c4042dfbc78b5ce658083c7_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6YmU0NjgwZTJjZTQyNDUwNmI1ZGY3ZjQzNmJjN2I4MTcvdGFibGVyYW5nZTpiZTQ2ODBlMmNlNDI0NTA2YjVkZjdmNDM2YmM3YjgxN180LTYtMS0xLTU0Mzc4_12218d50-85d0-4b99-8e63-0cc45efcc460">355</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:40.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) No derivative instruments existed at December&#160;31, 2020.</span></div></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGV4dHJlZ2lvbjplYjIyODYxM2Y4MjM0ODY0OTQyNWI3MzFhOGRjYzkwYV8zMjk4NTM0ODg1MzM3_c1887770-e317-4803-9859-76e0024ad005" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the effect of our derivative financial instruments designated as hedging instruments in AOCI (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.100%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December&#160;31, 2021 (a)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Gain on cash flow hedges - interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3212a9cabfa9493096f98169ff09dde2_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV8zLTItMS0xLTU0Mzc4_9db9a7aa-9d66-4dbd-8cd0-3bd1a17f0bdc">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unrealized gain recognized in AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i262ff830a2bd433899876342da3eb117_D20210101-20211231" decimals="-3" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV80LTItMS0xLTU0Mzc4_e38b0ac2-34a9-4911-aa84-d8802120c9e9">249</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amounts reclassified to interest expense (b)(c)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i262ff830a2bd433899876342da3eb117_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV81LTItMS0xLTU0Mzc4_eaa2045b-9d44-4f4a-9049-507ca9a07cf8">106</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i262ff830a2bd433899876342da3eb117_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV82LTItMS0xLTU0Mzc4_7a046de8-447e-4b09-bfae-84337a3f24f2">87</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i15476ca71552472d8a12c8939898580d_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV83LTItMS0xLTU0Mzc4_b66f5f69-389c-4da6-89a6-f88ae7519342">268</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) No derivative instruments existed for the years ended December&#160;31, 2020 and December&#160;31, 2019.</span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(b) Positive amounts represented interest expense. Total interest expense as presented in the consolidated statement of operations for the years ended December&#160;31, 2021, 2020 and 2019 were $<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV8xMC0wLTEtMS01NDM3OC90ZXh0cmVnaW9uOmM1Y2Y1ZWY0YTgxMzQ4MmQ4OTkwMmYxMTc1N2EyNWE2XzE2NA_248410dd-2ce0-4c30-9330-ee08a8af9c73">1.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV8xMC0wLTEtMS01NDM3OC90ZXh0cmVnaW9uOmM1Y2Y1ZWY0YTgxMzQ4MmQ4OTkwMmYxMTc1N2EyNWE2XzE3MQ_63e7034b-ecee-45cb-a461-65b89c64228c">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV8xMC0wLTEtMS01NDM3OC90ZXh0cmVnaW9uOmM1Y2Y1ZWY0YTgxMzQ4MmQ4OTkwMmYxMTc1N2EyNWE2XzE2NDkyNjc0NDE4NzU_256f67ef-ac39-4fdc-8f51-6b9d11c6bca4">1.9</ix:nonFraction> million, respectively.</span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(c) $<ix:nonFraction unitRef="usd" contextRef="i07f3da9e713d4c489ebdd0e68b443b18_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV8xMS0wLTEtMS01NDM3OC90ZXh0cmVnaW9uOmQ3ZGVmMjZkYmQ3NDQ0YTdhYjZhNzkzYzkyZmE2NzUyXzk_d2c1ac64-f747-4ed8-95df-c10b64505aef">0.1</ix:nonFraction> million of expense is expected to be reclassified into earnings within the next 12 months.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not incur any hedge ineffectiveness during the year ended December&#160;31, 2021.</span></div></ix:continuation><div id="i9e717b65c1e3405d850ef6e342b20071_136"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwODE_9524b444-faad-4d8c-bbac-091ce1c6232c" continuedAt="ifd73adedf4d240c48bc252b0f18f1bf4" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="ifd73adedf4d240c48bc252b0f18f1bf4" continuedAt="i6f86629c24c34be29f2b243ee6133e87"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwODI_68db86da-44af-4fc5-9380-d62dd0e9f23e" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s income before income taxes (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzEtMS0xLTEtNTA2MjI_fa04d515-babf-43f8-9d77-025612edb5bb">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzItMy0xLTEtNzU2MTY_1958b3e3-a0e0-41be-a5c2-030e05ccaac2">6,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzEtMy0xLTEtNTA2MjI_e09f4b1f-c4a7-4d87-84fe-789af5bb252b">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzItMS0xLTEtNTA2MjI_75b48040-7070-4044-8c7a-7c8a06cea866">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzMtMy0xLTEtNzU2MjE_4f5f5f2c-74af-4a0d-bc67-a1b7df443e5b">920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzItMy0xLTEtNTA2MjI_8c778894-8f44-437b-863d-42fbf3d59e26">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzMtMS0xLTEtNTA2MjI_d8a7d098-722d-458e-8701-93020fa666d1">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzQtMy0xLTEtNzU2MjE_fb36b8f2-402c-4642-b825-454fecdb6985">7,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzMtMy0xLTEtNTA2MjI_27be57fe-d019-4245-8db9-049ba5402467">1,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i6f86629c24c34be29f2b243ee6133e87" continuedAt="ia64266cb2cb34207b303afee2f2c6390"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwODM_9a87d772-91eb-42d7-b858-7773521ece18" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s components of the consolidated benefit from (provision for) income taxes (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S Federal income tax benefit&#160;(expense)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzItMS0xLTEtNTA2MjI_9bf2bac8-c145-4bda-94ee-ff8342f14879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzMtMy0xLTEtNzU2Mzk_0c8080f5-b3ed-49e5-968e-79470af334b4">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzItMy0xLTEtNTA2MjI_48598244-7c15-45df-bb21-b863df4d92fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzMtMS0xLTEtNTA2MjI_f96032f7-615e-4a7b-ad65-7de5f4fdecd9">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzQtMy0xLTEtNzU2Mzk_a7686907-2ccd-4090-a238-55ca8626171b">8,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzMtMy0xLTEtNTA2MjI_5ee7f6cf-1d67-4702-a2bc-4519521cee75">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. Federal income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzQtMS0xLTEtNTA2MjI_8842f802-4f05-42f3-81fd-fd546f7bfdf4">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzUtMy0xLTEtNzU2Mzk_dd27b296-a3e2-4f30-9026-277a3ef95860">8,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzQtMy0xLTEtNTA2MjI_f3289d1a-64fe-4e36-b248-2a8d29adec30">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzYtMS0xLTEtNTA2MjI_bdc170b3-d9b3-41e0-b4c7-cbf8a5b15158">167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzctMy0xLTEtNzU2Mzk_e4178941-b667-4f25-94ec-db1bfe9737b3">66</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzYtMy0xLTEtNTA2MjI_b1d474d8-d5b7-46af-9f94-8ece2cd39a75">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzctMS0xLTEtNTA2MjI_f20a6dd3-3f43-40fa-8513-811fef9976c0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzgtMy0xLTEtNzU2Mzk_4e71b1f1-4292-489d-9958-016f22b80708">1,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzctMy0xLTEtNTA2MjI_e3ccf6aa-3d80-466a-be07-9ec070da1d03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total state and local income tax (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzgtMS0xLTEtNTA2MjI_a9e8ce2b-9fed-4589-a1e8-f4053499ebd7">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzktMy0xLTEtNzU2Mzk_3f7d39bb-d4d3-467e-a98b-4f7254eb313c">1,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzgtMy0xLTEtNTA2MjI_490aeb35-b5c8-4177-aa82-5c8fa05a2e14">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzEwLTEtMS0xLTUwNjIy_68cbb4c8-71ae-4fa2-8fda-0b848088ce89">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzExLTMtMS0xLTc1NjM5_236b1f2d-2137-45b7-bcf1-4ce58ddc235d">205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzEwLTMtMS0xLTUwNjIy_5e1652eb-8ba3-4480-97ed-47d63a5221bb">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit (expense)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzExLTEtMS0xLTUwNjIy_aeb003f4-a1b7-4b21-9bc1-56bbfe226918">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzEyLTMtMS0xLTc1NjM5_38b5a0f0-d99f-4303-8a13-55d52a4d83f2">9,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzExLTMtMS0xLTUwNjIy_8a486ae6-d554-4289-bf6b-e2d7b07c19cf">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwODQ_3fd72bfe-f04d-4d88-88b1-026983cd4b94" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity related to the Company&#8217;s valuation allowance (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance at the Beginning of Period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzEtMS0xLTEtNTA2MjI_fcfd42ee-30e0-4989-8907-7dfd7e51237e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzItMy0xLTEtNzU3MjE_52c9722e-2034-403a-aaa8-4cccb92ca00d">11,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i488a17cbb36b421597c4f159595f4b31_I20181231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzEtMy0xLTEtNTA2MjI_420176b4-fb66-4b31-b2f5-41066fd4b91b">11,370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:DeferredTaxAssetsValuationAllowanceExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzItMS0xLTEtNTA2MjI_042f341f-8f5a-46bd-a2ce-878123d1196c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="infu:DeferredTaxAssetsValuationAllowanceExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzMtMy0xLTEtNzU3MjE_d7f4f197-e766-4396-95c8-278758c61834">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="infu:DeferredTaxAssetsValuationAllowanceExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzItMy0xLTEtNTA2MjI_ab73ba97-9c96-4245-804c-6cb94df5885f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:DeferredTaxAssetsValuationAllowanceIncrease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzQtMS0xLTEtNzU3MTI_6cd5393e-4511-4564-b787-76db1380694c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="infu:DeferredTaxAssetsValuationAllowanceIncrease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzQtMy0xLTEtNzU3MjY_899563e8-c658-4808-9e23-dc4ca15eb204">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="infu:DeferredTaxAssetsValuationAllowanceIncrease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzQtNS0xLTEtNzU4Mjc_18879b2a-5ec0-4127-9045-76e03a7a1715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:DeferredTaxAssetsValuationAllowanceRelease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzMtMS0xLTEtNTA2MjI_9e7673c0-d0ae-43f2-b662-c85c2cd323e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="infu:DeferredTaxAssetsValuationAllowanceRelease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzUtMy0xLTEtNzU3MjE_d6a5381f-f156-48c4-9d7b-d496eb0e27cc">11,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="infu:DeferredTaxAssetsValuationAllowanceRelease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzMtMy0xLTEtNTA2MjI_f3b283d7-1099-4e8d-ab7c-e8f680b9f633">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance at the End of Period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzQtMS0xLTEtNTA2MjI_c14582d1-6285-479a-819e-86790e87da70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzYtMy0xLTEtNzU3MjE_8d007ecc-b87c-4b12-8b09-637f4c4a5971">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzQtMy0xLTEtNTA2MjI_5e7a28d6-7aeb-4a44-aefe-f4565461c1e5">11,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwNzk_8ca04d20-0fc8-4178-9a01-bf42db737f3f" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes a reconciliation of the Company&#8217;s effective income tax rate to the U.S. federal statutory rate:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at the statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzEtMS0xLTEtNTA2MjI_e90aa149-6e49-4e18-9100-f45002e006ad">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzItMy0xLTEtNzU4NTA_79295ec4-3091-41ff-aa3e-5c836c6ebcf2">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzEtMy0xLTEtNTA2MjI_0849c139-6fb9-4882-ab8e-75a67cffed0b">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzItMS0xLTEtNTA2MjI_3eeae136-97c0-46ce-bccd-1dc27871da32">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzMtMy0xLTEtNzU4NTA_fb9ac512-f55d-45c8-b12c-d74aafa937b7">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzItMy0xLTEtNTA2MjI_f595a02f-4f6d-43a1-bac9-2c4c89a93b00">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzMtMS0xLTEtNTA2MjI_1ae7a701-64d5-4e4c-9953-0ac351db7427">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzQtMy0xLTEtNzU4NTA_4069ac4d-a86c-465d-9a96-51f6fc35b6fa">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzMtMy0xLTEtNTA2MjI_6752f2c4-741e-4683-bdf4-dd90b6744c36">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="3" sign="-" name="infu:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzQtMS0xLTEtNTA2MjI_58f60e21-8014-449a-9332-ae0f6685a7ea">36.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="3" sign="-" name="infu:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzUtMy0xLTEtNzU4NTA_068cf96b-ad90-43ae-b7b1-1b526db80e42">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="3" sign="-" name="infu:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzQtMy0xLTEtNTA2MjI_2edeaf5b-1888-4f5c-8dc9-e2849002144f">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzUtMS0xLTEtNTA2MjI_1d36594b-fb0c-45b8-85e0-7d0382d5aa0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzYtMy0xLTEtNzU4NTA_2d8586ff-75e2-42f9-98cf-22dd2cf4265a">149.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzUtMy0xLTEtNTA2MjI_390d737f-3987-4734-91d0-15102a02e2fd">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzYtMS0xLTEtNTA2MjI_bc10a94d-6b75-459a-bc27-5428ab716f73">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzctMy0xLTEtNzU4NTA_97135bc3-8fd2-4e3f-8f5c-9e2500612901">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzYtMy0xLTEtNTA2MjI_ef14cf06-8e86-4f60-bc02-fcc1e38fd21a">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzctMS0xLTEtNTA2MjI_501de19e-32a7-401f-8f15-55a8b2fd9a2e">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzgtMy0xLTEtNzU4NTA_ce9ef043-7c89-4922-a713-f973de130f25">129.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzctMy0xLTEtNTA2MjI_66b1fb45-daff-4be7-8ad0-f85b92244f02">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="ia64266cb2cb34207b303afee2f2c6390" continuedAt="i30f1af0ff7a14dd7986c6e85147b2712"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwODA_0c477615-f797-4d4a-ad4e-e309930760e7" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the temporary differences and carryforwards that give rise to deferred tax assets and liabilities (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Federal tax assets &#8211;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt reserves</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzItMS0xLTEtNTA2MjI_0954d888-b566-45fc-b35b-00c9ea27a5d6">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzItMy0xLTEtNTA2MjI_639ba675-103c-4afb-9796-619429796e7e">1,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzMtMS0xLTEtNTA2MjI_83fb4b56-6248-489e-8cc8-28951d7cb0e8">1,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzMtMy0xLTEtNTA2MjI_9ed90dcc-3aeb-49d5-96d9-b764123d7df1">656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzQtMS0xLTEtNTA2MjI_61d539c4-5f2b-48f1-9a80-3a988a4f071c">8,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzQtMy0xLTEtNTA2MjI_c5df9217-3e4a-454a-8294-70f9013c2fc0">7,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="infu:DeferredTaxAssetsOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzUtMS0xLTEtNTA2MjI_5774628f-70e5-4305-bc0d-8822ec5f54ad">980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="infu:DeferredTaxAssetsOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzUtMy0xLTEtNTA2MjI_da429433-0992-448d-9320-bbb74dda8e53">1,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzYtMS0xLTEtNTA2MjI_717101f1-1e8c-442b-ba18-60114786523a">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzYtMy0xLTEtNTA2MjI_8b46c68b-3245-436f-b260-c6fc78909e5f">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzctMS0xLTEtNTA2MjI_d7ff6d52-48bc-42c1-b602-35affae6fd0e">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzctMy0xLTEtNTA2MjI_f8919848-640f-47ed-b9ad-c2327c33d8b8">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzgtMS0xLTEtNTA2MjI_9f87538d-cfe4-4491-b643-4c0cc7636f47">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzgtMy0xLTEtNTA2MjI_319d3673-9327-4b6a-bbd3-582d4581ad4e">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research &amp; development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzktMS0xLTEtNTA2MjI_d51e403f-980e-4945-a70b-042bd5d0dac5">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzktMy0xLTEtNTA2MjI_cc1a4bb5-8b05-4171-86a7-154af7400e3d">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzEwLTEtMS0xLTUwNjIy_5de7b75f-c09f-414a-b226-db0b481eb879">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzEwLTMtMS0xLTUwNjIy_ae0bd824-1e4b-4c33-8eb6-bdd7e3104e04">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzExLTEtMS0xLTUwNjIy_15273c46-3210-4e89-adf3-e7a82d650ba7">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzExLTMtMS0xLTUwNjIy_08c78fe3-7942-455b-b5a7-8b9cca432873">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred Federal tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzEyLTEtMS0xLTUwNjIy_63c572ea-aba8-4303-a716-1532d0626e60">13,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzEyLTMtMS0xLTUwNjIy_03500a12-5d61-40b5-96b2-4a8a8c0a0d66">12,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Federal tax liabilities &#8211;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and asset basis differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE2LTEtMS0xLTUwNjIy_048b0067-c1ce-4e75-afe5-db0e31085257">3,423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE2LTMtMS0xLTUwNjIy_d609f66d-ec0a-4948-8c27-1f08891dc9df">3,393</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="infu:DeferredTaxLiabilitiesRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE3LTEtMS0xLTUwNjIy_4fb63502-226e-476b-b2b7-6a0941a29ffe">891</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="infu:DeferredTaxLiabilitiesRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE3LTMtMS0xLTUwNjIy_c73211b8-fc66-4ecb-b04b-486d6945d5d7">937</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE4LTEtMS0xLTc3OTk3_58cf4706-173c-4389-8a5f-2ef03547c497">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE4LTMtMS0xLTc4MDA2_2143a368-2f03-4bb8-b3b4-425bd22eb448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred Federal tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE4LTEtMS0xLTUwNjIy_30071222-74b0-468c-b560-f11d17d8b133">4,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE4LTMtMS0xLTUwNjIy_9bc016ba-03c8-4167-accd-a431bb98ebe5">4,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred Federal tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE5LTEtMS0xLTUwNjIy_7a891d90-6812-4921-95f8-e67ceac0bd42">8,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE5LTMtMS0xLTUwNjIy_1c550172-3585-446c-99b1-36906b013d2b">8,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred state and local tax assets (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf34a521c00b474b8c705fb5db98af8d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzIwLTEtMS0xLTUwNjIy_659c57a5-3b45-4924-8767-0549c983c9fb">1,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice5d9a455230467faf56b669a8015a3e_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzIwLTMtMS0xLTUwNjIy_a8590ff0-a210-4165-b197-6ec346b28f56">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzIzLTEtMS0xLTUwNjIy_114166eb-ca6b-4dd7-ba41-1a5a8e40fd7a">10,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzIzLTMtMS0xLTUwNjIy_9231a49d-06d7-4a5f-ac39-a54b4a273ee4">9,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) At December&#160;31, 2021 and 2020, this includes state and local net operating losses of $<ix:nonFraction unitRef="usd" contextRef="ibf34a521c00b474b8c705fb5db98af8d_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzc5Nw_adda0269-4566-48f7-a657-d745ea20430f">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ice5d9a455230467faf56b669a8015a3e_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzgwNA_f51e51fe-f136-4417-8e2e-c59a187e4b1f">1.2</ix:nonFraction> million, respectively.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. federal net operating loss carryforward for tax purposes was $<ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzkwMg_22663f5f-b2e9-4166-a383-4c61b81598d3">38.2</ix:nonFraction> million at December&#160;31, 2021, resulting in a federal deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzk1Nw_72e862aa-f32d-4c37-9991-c52bc2646dd6">8.0</ix:nonFraction> million. Approximately $<ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-5" name="infu:OperatingLossCarryforwardsWithADefiniteLife" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzk3NQ_df4453ae-de24-4868-8d14-e7824d78a667">31.3</ix:nonFraction> million of the Company&#8217;s U.S. federal net operating loss carryforwards will begin to expire in various years beginning in 2029. $<ix:nonFraction unitRef="usd" contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231" decimals="-5" name="infu:OperatingLossCarryforwardsWithIndefiniteLife" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzEwOTg_2664e57e-9e93-4b5c-be59-e9ea66506760">6.9</ix:nonFraction> million of U.S. federal net operating loss carryforwards have an indefinite life. The Company&#8217;s state net operating loss carryforward of approximately $<ix:nonFraction unitRef="usd" contextRef="ibf34a521c00b474b8c705fb5db98af8d_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzEyNDQ_50c3c643-e04f-4f31-a7c4-06e79e6130e9">1.3</ix:nonFraction> million is comprised of various jurisdictions. These state net operating losses can be used for a period of <ix:nonNumeric contextRef="ib0c7b74dd3b642bd83f8f8f69155e38a_D20210101-20211231" name="infu:OperatingLossCarryforwardsExpirationPeriods" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzEzNDc_31a9ea0c-2750-4758-b695-44a6c7ab1ac4">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i856c610b2fe549e0b8bc1e612a43b96c_D20210101-20211231" name="infu:OperatingLossCarryforwardsExpirationPeriods" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzEzNTM_cfc51c7b-7f09-43fe-b4f8-04dcb0646cf2">20</ix:nonNumeric> years and vary by state, and if unused, begin to expire in 2022, though a substantial portion expires beyond 2022. Approximately $<ix:nonFraction unitRef="usd" contextRef="ibf34a521c00b474b8c705fb5db98af8d_I20211231" decimals="-5" name="infu:OperatingLossCarryforwardsWithADefiniteLife" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzE0Nzk_aa4afd67-75d3-4b96-b807-bfd0cf00e85f">0.1</ix:nonFraction> million of the state net operating loss carryforwards have an indefinite life. Tax benefits of operating loss and tax credit carryforwards are evaluated on an ongoing basis, including a review of historical and projected future operating results, the eligible carryforward period, and other circumstances.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to monitor shifts in past ownership (as defined under Section 382 of the Code). The Company is subject to an annual limitation of $<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-5" name="infu:NetOperatingLossCarryforwardsLimitationOnUse" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzIxMTA_6eec4ea7-7bff-4c60-b1f3-7736464199b6">1.8</ix:nonFraction> million on its use of remaining pre-ownership change net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-5" name="infu:RemainingPreownershipNetOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzIxOTQ_89faa46d-6d3d-4968-bed3-175dc623c272">4.5</ix:nonFraction> million (and certain other pre-change tax attributes).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2020, it was determined that the valuation allowance against the U.S. federal and state deferred taxes was no longer required and the valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="if64f71b0d53e48e3a2c1aa091fd31365_D20211001-20211231" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzI0MTg_b86272d9-a224-495f-8bfd-7d66c4067c78">11.2</ix:nonFraction> million that existed was released. The Company&#8217;s realization of its deferred tax assets is dependent upon many factors, including, but not limited to, the Company&#8217;s ability to generate sufficient taxable income. Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets. At December&#160;31, 2021 and 2020, cumulative income in recent years and projected future taxable income is the basis for the Company&#8217;s assessment that the deferred tax assets do not require a valuation allowance.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzMwMDA_bfc53e00-f168-4f19-a007-a980faa2ca44"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzMwMDA_ee10e418-fc4e-493d-878d-aeb61af864b6">no</ix:nonFraction></ix:nonFraction> uncertain tax positions for the years ended December&#160;31, 2021 and 2020.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to taxation for Federal and various state jurisdictions in the United States and Canada. The Federal income tax returns of the Company for the years 2018 through 2021 are open to examination by the Internal Revenue Service. The Company was under audit with the Internal Revenue Service in relation to the Company&#8217;s 2018 federal income tax return and the audit was closed on December&#160;15, 2021. The state income tax returns and other state tax filings of the Company </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i30f1af0ff7a14dd7986c6e85147b2712"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are subject to examination by the state taxing authorities, for various periods generally up to four years after they are filed. Canadian income tax returns of the Company for the years 2017 through 2021 are subject to examination by the Canada Revenue Agency.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the&#160;Coronavirus Aid, Relief, and Economic Security ("CARES") Act was enacted in response to the COVID-19 pandemic. The&#160;CARES Act among other things,&#160;allows employers to defer the deposit and payment of the employer's share of Social Security taxes. The Company, under the CARES Act, deferred paying $<ix:nonFraction unitRef="usd" contextRef="i439fd912ad054d238616616e9babc7fe_I20201231" decimals="-5" name="us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzQ1Mjc_20f1bd4c-2679-4013-8795-a32a69603e6a">0.7</ix:nonFraction> million of applicable gross payroll taxes as of December&#160;31, 2020, which was included in other liabilities. The $<ix:nonFraction unitRef="usd" contextRef="idfedd81ba6944a6985fc391bcc412d7d_I20211231" decimals="-5" name="us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzYwNDczMTM5NTgxNTc_cd80ffc1-e546-4386-acae-16babe9dd3d9">0.7</ix:nonFraction> million balance of the deferred Social Security taxes was expected to be paid in two equal annual installments during the years ending December 31, 2021 and 2022, respectively. In December 2021, the Company made the first of these two equal annual installment payments. On April&#160;15, 2020, the Company received a $<ix:nonFraction unitRef="usd" contextRef="i2150414dae3f42f68c21d9adaf756de4_D20200415-20200415" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzQ4MTk_32a775b8-aa1b-449f-ba2c-a5522b994bf3">4.1</ix:nonFraction> million loan under the Federal Paycheck Protection Program (&#8220;PPP&#8221;) created under the CARES Act. In response to revised eligibility guidelines announced by the U.S. Small Business Administration shortly thereafter, the Company repaid this loan in full on May 7, 2020.</span></div></ix:continuation><div id="i9e717b65c1e3405d850ef6e342b20071_142"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNDIvZnJhZzphODBjYWE3ZWRlZGE0ODcwYjYxMDI0MmVhMmUxMTcwYy90ZXh0cmVnaW9uOmE4MGNhYTdlZGVkYTQ4NzBiNjEwMjQyZWEyZTExNzBjXzEzMjU_54f00b79-9b73-468d-bb3e-e490ae47c787" continuedAt="i8deb46e23250408b93ce2259b420665b" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i8deb46e23250408b93ce2259b420665b"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time in the ordinary course of its business, the Company may be involved in legal and regulatory proceedings, the outcomes of which may not be determinable. The results of litigation and regulatory proceedings are inherently unpredictable. Any claims against the Company, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. The Company is not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable, primarily for the following reasons: (i) many of the relevant legal proceedings are in preliminary stages, and until such proceedings develop further, there is often uncertainty regarding the relevant facts and circumstances at issue and potential liability; and (ii) many of these proceedings involve matters of which the outcomes are inherently difficult to predict. The Company has insurance policies covering potential losses where such coverage is cost effective.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not at this time involved in any proceedings that the Company believes could have a material effect on the Company&#8217;s financial condition, results of operations or cash flows.</span></div></ix:continuation><div id="i9e717b65c1e3405d850ef6e342b20071_1842"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8zMjk4NTM0ODg0NTg5_866365c6-6f29-4b24-a20c-b703f767a9a6" continuedAt="i0b784105ee524570bc0078295383df31" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i0b784105ee524570bc0078295383df31" continuedAt="i1e7b7f6954ea4ee2bbd6d74f9e069102"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically entered into a number of lease agreements under which the Company is the lessee for equipment and office leases.</span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8zMjk4NTM0ODg0NzIz_d6fa1705-6d28-4b10-9207-55d5f19a9791" continuedAt="ie76ebe83a73e45bd86714c3b58e346e2" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s operating lease costs consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8yLTItMS0xLTU1MDk0_30516491-a31a-4e4d-a0c9-dedd272a0233">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8yLTQtMS0xLTU1MDk0_43f99280-192f-445f-95b2-70a9a6c12bfb">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8yLTYtMS0xLTU1MTEx_8800990a-2f87-4fe7-a619-f5bd9a8f576c">1,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8zLTItMS0xLTU1MDk0_676523e6-4c60-4055-907f-4d73a3336394">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8zLTQtMS0xLTU1MDk0_2a84b0bf-1631-4966-819e-1d73113ec283">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8zLTYtMS0xLTU1MTEx_21ba8e56-ce2a-47c3-93da-90856bed7bf4">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl80LTItMS0xLTU1MDk0_8ab8abab-8e31-4f3e-9711-7fb647d80d5e">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl80LTQtMS0xLTU1MDk0_15500f69-a35b-497d-8642-fd3aa44105e3">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl80LTYtMS0xLTU1MTEx_e05f6a59-59b4-4a22-979a-aebb83468af8">2,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs for the year ended December&#160;31, 2021 of approximately $<ix:nonFraction unitRef="usd" contextRef="if05acd9bb129444c859314fc90a675b8_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8zODA_670bb305-e7e5-490d-b6ce-60349f9c81af">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7eb9d27f65dd4491a35f0b273d413655_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8zODc_c4e0dd71-bc8b-4f47-9188-d4ecce5d1725">0.1</ix:nonFraction> million, were recorded to G&amp;A expenses and cost of revenues, respectively. Lease costs for the year ended December&#160;31, 2020 of approximately $<ix:nonFraction unitRef="usd" contextRef="ie0c917cfe5e042599ce26f2256dff1ae_D20200101-20201231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl81MDg_d520e842-a89f-48fb-b66e-41cd7c2f8d8f">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib2b9762869f5424c88544abd7900c8d1_D20200101-20201231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl81MTU_f8677ba2-a1ad-45b2-a1f2-08ff00ac8969">0.6</ix:nonFraction> million, were recorded to G&amp;A expenses and cost of revenues, respectively. Lease costs for the year ended December&#160;31, 2019 of approximately $<ix:nonFraction unitRef="usd" contextRef="i5c5b6e5d34b445c1b9f13378f83a9a8b_D20190101-20191231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8xNjQ5MjY3NDQyODg1_a4dff78c-ecfe-4a11-b160-6ca76eb5a414">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia8ac411300664a70b0331e7b8a64e151_D20190101-20191231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8xNjQ5MjY3NDQyODkx_7f7402e1-8510-49c2-9d1f-01419164e5a4">1.0</ix:nonFraction> million, were recorded to G&amp;A expenses and cost of revenues, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i1e7b7f6954ea4ee2bbd6d74f9e069102" continuedAt="iacb287449b614c0fa0200b0ecf5d3bc8"><ix:continuation id="ie76ebe83a73e45bd86714c3b58e346e2"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information and non-cash activity related to the Company&#8217;s leases are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities and ROU assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF8zLTItMS0xLTU1MDk0_cda39ae6-bc26-4dc9-b384-adde9def1c1a">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF8zLTQtMS0xLTU1MDk0_510ba883-937e-4a0b-9842-d4fe087f9388">1,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF8zLTYtMS0xLTU1MjI4_3dfab787-375f-4718-a20a-2b286e0ed2de">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF82LTItMS0xLTU1MDk0_619e861b-b507-4982-9ca8-e45f0adb5072">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF82LTQtMS0xLTU1MDk0_3a437f29-a8d8-4cde-9c10-faac7cb3892d">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF82LTYtMS0xLTU1MjM1_27ec2068-8936-40f8-ab8f-89ab7c0281e2">4,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions to ROU assets resulting from reductions to lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF85LTItMS0xLTU1MDk0_14538a6f-1624-41e9-bb80-5da6104e5f4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="infu:ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF85LTQtMS0xLTU1MDk0_951544c3-f8ae-42f7-92d8-9df82ea036e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="infu:ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF85LTYtMS0xLTU1MjQy_1132d890-08e8-4cdb-ab7e-375a8f660952">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease terms and discount rates for the Company&#8217;s operating leases are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6N2NmZWI1NDg1MGJhNGFmZmE2NzA2NWEyZTcwNjVmZGEvdGFibGVyYW5nZTo3Y2ZlYjU0ODUwYmE0YWZmYTY3MDY1YTJlNzA2NWZkYV8yLTItMS0xLTU1MDk0_51a99b60-3708-4e35-989f-94ab9b4986af">6.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6N2NmZWI1NDg1MGJhNGFmZmE2NzA2NWEyZTcwNjVmZGEvdGFibGVyYW5nZTo3Y2ZlYjU0ODUwYmE0YWZmYTY3MDY1YTJlNzA2NWZkYV8yLTQtMS0xLTU1MDk0_0ad9992c-9b57-450d-89b7-8e98c216315b">7.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6N2NmZWI1NDg1MGJhNGFmZmE2NzA2NWEyZTcwNjVmZGEvdGFibGVyYW5nZTo3Y2ZlYjU0ODUwYmE0YWZmYTY3MDY1YTJlNzA2NWZkYV80LTItMS0xLTU1MDk0_62a3960b-1a15-4276-bc77-81b290ac0d3c">7.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6N2NmZWI1NDg1MGJhNGFmZmE2NzA2NWEyZTcwNjVmZGEvdGFibGVyYW5nZTo3Y2ZlYjU0ODUwYmE0YWZmYTY3MDY1YTJlNzA2NWZkYV80LTQtMS0xLTU1MDk0_6b27670c-b8ad-4ce0-81f3-d124317d8f15">7.8</ix:nonFraction>%</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8zMjk4NTM0ODg0NTkz_a75043bb-26e6-4d35-902f-a2bb15a5df65" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future maturities of lease liabilities as of December&#160;31, 2021 are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:83.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl8xLTItMS0xLTU1MDk0_9fe75f7c-7839-4b75-ac0c-045c063ef653">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl8yLTItMS0xLTU1MDk0_92c1db47-ae5c-420d-8170-8e7f9058b24f">1,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl8zLTItMS0xLTU1MDk0_6638ed4f-7855-4416-826e-0833dcb91349">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl80LTItMS0xLTU1MDk0_70fcd45d-49b4-4268-b6e5-9e2c2c05c557">1,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl81LTItMS0xLTU1MDk0_dcadfe7e-021b-4929-ad3b-fe8924d6355f">941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl82LTItMS0xLTU1MDk0_50390b7a-7a50-47c3-b3b0-fdae62650ce6">1,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl83LTItMS0xLTU1MDk0_d088066f-34da-4828-ab69-171b3e83b949">7,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl84LTItMS0xLTU1MDk0_be12c1eb-c6b1-4afc-97af-d45fc984ba4e">2,434</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl85LTItMS0xLTU1MDk0_e78bad23-ba9f-4879-b76d-0a85732fcd92">4,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iacb287449b614c0fa0200b0ecf5d3bc8">The long-term portion of the lease liabilities included in the amounts above is $<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl85ODc_e8dfcab7-8667-40a4-a294-b02bfc939e77">3.7</ix:nonFraction> million with the remainder included in other current liabilities in the Consolidated Balance Sheet.</ix:continuation> </span></div><div><span><br/></span></div><div id="i9e717b65c1e3405d850ef6e342b20071_1875"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV80OTQ3ODAyMzQ2Mjk0_f90b2af8-b5ac-4b5f-8cd1-6c712fcfdc0b" continuedAt="id0ec6e45dc084950a6a0b61a69f94fdf" escape="true">Share-based Compensation</ix:nonNumeric></span></div><ix:continuation id="id0ec6e45dc084950a6a0b61a69f94fdf" continuedAt="i69de783fb94940a69c09116afe35a32e"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Incentive Plan</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various stock option and stock-based incentive plans and agreements whereby equity based awards are granted to certain employees, directors and others approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) or Compensation Committee. Grants may be made in the form of stock options, restricted stock awards ("RSUs" or "RSAs"), performance-based restricted stock units ("PSU's), unrestricted common stock, stock appreciation rights (&#8220;SARs&#8221;) in addition to other award types. Stock options are granted with an exercise price at, or above, fair market value on the date of grant, generally expire in <ix:nonNumeric contextRef="i3aecccce92b14a9c9084a4f31af83e6c_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQxOTYx_d9039ca9-1269-4dfa-b81b-afb83ab64e98">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i450379ae7a724e1eb2a0f5753d483e22_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQxOTY4_48b56d2f-2c0b-45fa-b7c4-98995ba601e3">10</ix:nonNumeric> years from the grant date and generally become exercisable over a period of up to 3 years. RSUs generally become vested over a period of up to <ix:nonNumeric contextRef="i7e697973a46d4d5d9d02a7da49fa4e3b_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQyMTEy_beb75152-75cd-4368-9ec8-4cb94b6cacf1">3</ix:nonNumeric> years. PSUs generally become vested over a period of up to <ix:nonNumeric contextRef="i1562a53301a84c6f86d2e5026a162d32_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ5MDI3_feb80639-f916-48d4-af79-2bc24e18330e">3</ix:nonNumeric> years based on the performance of a specific achievement. Awards typically vest and are issued only if the participants remain employed by the Company through the vesting date. Common stock issued under these awards are issued from shares reserved under the Company&#8217;s plan described below. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i69de783fb94940a69c09116afe35a32e" continuedAt="i9a081dfb7eb541409490c2f3622673d7"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 18, 2021, the Company&#8217;s Board adopted the 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). The 2021 Plan was approved by the Company&#8217;s shareholders at the 2021 Annual Meeting on May 18, 2021 and became effective at that time. The 2021 plan supersedes the 2014 Amended and Restated Stock Incentive Plan (the "2014 Plan"). The 2021 Plan provided for the issuance of a maximum of <ix:nonFraction unitRef="shares" contextRef="icbca7ff14ebb4795b34515b88d7092ba_D20210518-20210518" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ0ODM3_2c9c1eb9-5631-42df-b3a7-c6358fa70782">2,500,000</ix:nonFraction> shares of common stock in connection with the grant of stock-based or stock-denominated awards. As of December&#160;31, 2021, a total of <ix:nonFraction unitRef="shares" contextRef="i2b64b934b737430092de595691e27b69_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ0MzA1_b0cfc2a2-e2bf-495c-9bb4-e406df8f0598">1,766,769</ix:nonFraction> common shares remained available for future grant under the 2021 Plan.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2014, the Company&#8217;s Board adopted the 2014 Plan. The 2014 Plan was approved by the Company&#8217;s shareholders at the 2014 Annual Meeting and became effective as of the date it was adopted by the Board of Directors. The 2014 Plan provided for the issuance of a maximum of <ix:nonFraction unitRef="shares" contextRef="i0b2880103789464c83dd09c03f90e4c9_I20140423" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQzMDEw_e41724d5-39a3-414a-975a-98018100d04d">2,000,000</ix:nonFraction> shares of common stock in connection with the grant of stock-based or stock-denominated awards. On July 19, 2018, the Company&#8217;s stockholders approved the reservation of an additional <ix:nonFraction unitRef="shares" contextRef="i3ee8e04870e34b48a26a7940cc7e9b5c_D20180719-20180719" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQzMTg3_701b7060-1e73-4aeb-98c0-ea022562f9f8">1,000,000</ix:nonFraction> shares to be issued under the 2014 Plan. On May 15, 2019, the Company&#8217;s stockholders approved the reservation of an additional <ix:nonFraction unitRef="shares" contextRef="i85e14e2aedee40cd9f3d83472a6a4224_D20190515-20190515" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQzMzA5_9c23e72a-b39d-41e5-b801-21c9b2de7f35">1,000,000</ix:nonFraction> shares to be issued under the 2014 Plan. The 2021 Plan replaces and supersedes the 2014 Plan, so as of the adoption date of the 2021 Plan, no common shares remained available for future grant under the 2014 Plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation expense</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stock option awards are amortized based on their graded vesting over the requisite service period of the awards. Compensation costs are recognized over the requisite service period using the accelerated method and included in general and administrative expenses.</span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zMjk4NTM0OTA0NjQ3_286cea86-86a5-4ada-a7b9-3be58b0e9374" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total stock-based compensation expense, which is included in selling, general and administrative expenses (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8xLTItMS0xLTU1ODgw_ecccd673-8d42-4599-bd86-96d10393819c">4,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8xLTQtMS0xLTU1ODgw_4c20d863-e47a-4217-8b13-2ebd810d3314">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:RestrictedStockExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8yLTYtMS0xLTY2MzQx_05d87bb5-4489-46c1-91df-68d3fcd409d0">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option and SARs expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:StockOptionPlanExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8yLTItMS0xLTU1ODgw_dad242ca-b6c9-482a-b0b7-210b200e1256">1,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:StockOptionPlanExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8yLTQtMS0xLTU1ODgw_82e92c8a-4a2f-4d25-b0c3-64d1f68a2ad6">923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:StockOptionPlanExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8zLTYtMS0xLTY2MzQx_71adf704-5a0e-4d79-89dc-63d501e86e28">807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8zLTItMS0xLTU1ODgw_de96465c-feb6-4fea-97e6-8df94d95717b">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8zLTQtMS0xLTU1ODgw_4b0bb436-0494-4ce7-8704-5caeadf04d01">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl80LTYtMS0xLTY2MzQx_b67f8ebf-1c24-46d7-ba05-26f81b497e79">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit related to stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl82LTItMS0xLTg3ODQ3_5c401128-86fc-47dc-9dab-46219c08891f">2,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl82LTQtMS0xLTg3ODU0_f2a1afbb-294e-4490-8a45-73706bf2fbe2">1,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl82LTYtMS0xLTg3ODYx_893bcdbf-81ec-4fbc-97a6-3a550ec15033">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Forgone to Satisfy Minimum Statutory Withholdings</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021, 2020 and 2019, shares of common stock were issued to employees and directors as their restricted stock awards vested or stock options were exercised. Under the terms of the Company&#8217;s stock plans, at the election of each employee, the Company can authorize a net settlement of distributable shares to employees in order to satisfy an individual employees' tax withholding obligations. For the years ended December&#160;31, 2021, 2020 and 2019, the Company received <ix:nonFraction unitRef="shares" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8yODE0_62635520-499b-404c-8219-78d32634d336">57,067</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82NTk3MDY5Nzk4NDgz_1c848967-0174-49a6-9e1c-1ee476e14e0a">146,763</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82NTk3MDY5Nzk4NDkx_74abaf01-206c-4b2e-b2e1-17931978a9e0">121,607</ix:nonFraction> shares, respectively, from employees for tax withholding obligations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards entitle the holder to receive, upon meeting certain time-based vesting criteria, a specified number of shares of the Company&#8217;s common stock. Stock-based compensation cost of restricted stock awards is measured by the market value of the Company&#8217;s common stock on the date of grant.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i9a081dfb7eb541409490c2f3622673d7" continuedAt="i4cbcdbadd9cf45869ebd0fe953dfc56d"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zMjk4NTM0OTA0NjQ4_22c01604-8ce9-47d8-9b9e-0d40da90c068" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s restricted share activity, excluding the Company&#8217;s employee stock purchase plan:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>grant<br/>date fair<br/>value</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93a156af54c948df8919aacc5b640f4b_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF85LTEtMS0xLTU1Njg5_ce5950bb-97bf-4856-acce-07e8bde8754a">145,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i93a156af54c948df8919aacc5b640f4b_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF85LTMtMS0xLTU1Njg5_3c53ef04-73ee-4372-92fb-02b2b7f4616a">9.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMC0xLTEtMS01NTY4OQ_cb379ef2-b460-4544-9f6d-22ceaa92f592">213,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMC0zLTEtMS01NTY4OQ_f0c31bc1-78e9-4522-96f0-bc611db31ba3">18.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMS0xLTEtMS01NTY4OQ_25a024bc-c46f-4926-b748-dceb87bd953c">54,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMS0zLTEtMS01NTY4OQ_8ecf4e97-a207-4792-a060-8f243720f0a2">12.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested shares forgone to satisfy minimum statutory withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="0" name="infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMi0xLTEtMS01NTY4OQ_45895b3b-9f05-4d89-96b7-6f1c3c92b565">1,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="2" name="infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMi0zLTEtMS01NTY4OQ_de7afc32-689d-493e-9760-705f3f0ccbd4">12.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMy0xLTEtMS01NTY4OQ_91986f84-9f68-476d-9f9d-54ea090c6f31">11,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMy0zLTEtMS01NTY4OQ_0ea9787c-5048-42af-9a05-071148a4f3d3">17.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idad1a9e99df642878fbca1cdddf632e2_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xNC0xLTEtMS01NTY4OQ_85a44e17-156e-47fc-9918-079061f3ab77">290,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idad1a9e99df642878fbca1cdddf632e2_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xNC0zLTEtMS01NTY4OQ_7a1b88c3-f13b-4729-b77d-035f2f3c103a">15.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of awards granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF8xMC0xLTEtMS01NTcyOQ_f0c31bc1-78e9-4522-96f0-bc611db31ba3">18.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8b8108f7576e4800a4821616a2f4206c_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF8zLTMtMS0xLTc2MDcz_209027a8-ab41-4135-a620-ab92e7f662e9">10.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2970496b363049a4989e1475da130d29_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF8xMC0zLTEtMS01NTcyOQ_7e380e26-b1e0-43a5-bbf9-65ed2a269f77">7.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF8xMS0xLTEtMS01NTcyOQ_f3c5a2fe-4a84-46c5-8eda-276d13081f2d">920,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b8108f7576e4800a4821616a2f4206c_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF80LTMtMS0xLTc2MDc2_6765c560-536b-44bd-8fa6-a0e0a8274d61">367,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2970496b363049a4989e1475da130d29_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF8xMS0zLTEtMS01NTcyOQ_f902ccd4-d948-4e66-b029-c1cc3bad2e0d">712,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares forgone to satisfy minimum statutory withholding</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231" decimals="0" name="infu:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF80LTEtMS0xLTU1NzY4_1db1dbd9-9485-405e-aeee-e9262912e20a">32,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b8108f7576e4800a4821616a2f4206c_D20200101-20201231" decimals="0" name="infu:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF81LTMtMS0xLTc2MDc2_ab0fe384-0f13-4882-ac2d-44f2c6f6b4fd">62,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2970496b363049a4989e1475da130d29_D20190101-20191231" decimals="0" name="infu:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF80LTMtMS0xLTU1NzY1_1802e5c0-891f-427b-89fc-142880c560fd">422,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="idad1a9e99df642878fbca1cdddf632e2_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zNTMy_53b2fb5b-dbb9-40c6-b89a-25b99a9706df">2.9</ix:nonFraction> million of pre-tax total unrecognized compensation cost related to non-vested restricted stock awards, which will be adjusted for future forfeitures, if any. The Company expects to recognize such cost over a weighted average period of <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82MDQ3MzEzOTc0Nzcw_4c055a4b-1e75-4b90-b558-5690c4c50f5e">two years</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance-Based Restricted Stock Units</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company granted approximately <ix:nonFraction unitRef="shares" contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zODYx_e8c48af3-80af-4ae0-8b48-4b20efd9b77a">127,476</ix:nonFraction> PSUs. During the year ended December&#160;31, 2020, the Company granted approximately <ix:nonFraction unitRef="shares" contextRef="i2975cbac6e1d4d30a4131dcbc1127282_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ4ODEx_16112154-ed37-4027-96f6-de33efdbe506">232,500</ix:nonFraction> PSUs. PSUs entitle the holder to receive, upon meeting certain performance-based vesting criteria, a specified number of shares of the Company&#8217;s common stock. These awards typically vest after the Company&#8217;s achievement of either a Company-based performance metric, such as the achievement of a certain amount of net revenue during a specified period, coupled with a time-based vesting criteria or based on a market based metric of the Company&#8217;s stock, such as when the trading price reaches a target value for a minimum number of consecutive trading days. All of the PSUs granted in 2021 are earned based on specified Company-based performance measure conditions. Approximately three-fourths of the PSUs granted in 2020 are earned based on the market-based metric, while the other one-fourth are earned based on specified Company-based performance metric conditions. In the case of the market-based metric, awards are paid in stock immediately upon achievement of the performance condition or expire without any payment after the third anniversary of the grant date. In the case of the specified Company-based performance measure, awards can be earned at an amount that varies by award between <ix:nonFraction unitRef="number" contextRef="i4a81f3c1031c41d6be1e69e4807e648a_D20210101-20211231" decimals="2" name="infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zMjk4NTM0OTE2NjEy_5e40feeb-73d5-4468-852d-0872b3010159">93</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i8a5e593bf0f4482cbd136bb082362baf_D20210101-20211231" decimals="2" name="infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV80ODQz_e4a141f9-46dd-41f5-84b1-e2520c75f7ff">100</ix:nonFraction>% of the target number of shares for achieving a minimum threshold below the target or up to <ix:nonFraction unitRef="number" contextRef="id71f0e9811ac46ee9b2694dfddb5b84c_D20210101-20211231" decimals="2" name="infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV80OTIw_c9a0bf36-1342-4fe7-95a0-988d31125c3c">200</ix:nonFraction>% of the target number of shares for exceeding the target, with a linear adjustment between threshold and target or between target and stretch performance goals.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i4cbcdbadd9cf45869ebd0fe953dfc56d" continuedAt="i258b9ad29ceb4551b041281ee1ff0b43"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zMjk4NTM0OTA0NjQ5_a5ed2953-24f8-49eb-a003-48b9569dbf89" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s PSU activity:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>grant <br/>date fair value</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i579ba4102b384a248e9ea9ecb23a50df_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF8yLTEtMS0xLTU1Njg5_f75110c5-d0ab-41c0-bafe-446dd3789f77">232,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i579ba4102b384a248e9ea9ecb23a50df_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF8yLTMtMS0xLTU1Njg5_be310568-3cc1-463a-a70b-eacb0c702f4e">9.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF8zLTEtMS0xLTU1Njg5_9c6a8198-edc4-4f68-8a66-2e959401d269">127,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF8zLTMtMS0xLTU1Njg5_02c52769-057b-43d2-9bbc-5ee117dbb1b3">19.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF80LTEtMS0xLTcyMzc1_2c78f1f9-acad-41d6-9071-e80b0bd3b647">66,371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF80LTMtMS0xLTcyMzgy_c1593659-f2a9-4a0e-b08c-6216aa9c1880">8.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested shares forgone to satisfy minimum statutory withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" decimals="0" name="infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF81LTEtMS0xLTcyMzg5_04d11f82-b8f6-4202-aedc-c958101e4ab1">53,629</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" decimals="2" name="infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF81LTMtMS0xLTcyMzk2_d47bc040-1cfb-4f17-9899-75bbe523d9aa">8.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3deaf1a379a149fd8aca28bd274ab8e5_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF80LTEtMS0xLTU1Njg5_13ee449b-ab0c-461d-a282-56826171ff31">239,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3deaf1a379a149fd8aca28bd274ab8e5_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF80LTMtMS0xLTU1Njg5_3f3e442c-2e6e-4a92-bd3a-d57c3402a399">14.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of awards granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MDBlYWZkODI1MDg3NGJmNTkyNmJmOTIxMjVhZDhlZmMvdGFibGVyYW5nZTowMGVhZmQ4MjUwODc0YmY1OTI2YmY5MjEyNWFkOGVmY18zLTEtMS0xLTU1ODMz_02c52769-057b-43d2-9bbc-5ee117dbb1b3">19.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i579ba4102b384a248e9ea9ecb23a50df_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MDBlYWZkODI1MDg3NGJmNTkyNmJmOTIxMjVhZDhlZmMvdGFibGVyYW5nZTowMGVhZmQ4MjUwODc0YmY1OTI2YmY5MjEyNWFkOGVmY18zLTMtMS0xLTc2NjY1_be310568-3cc1-463a-a70b-eacb0c702f4e">9.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MDBlYWZkODI1MDg3NGJmNTkyNmJmOTIxMjVhZDhlZmMvdGFibGVyYW5nZTowMGVhZmQ4MjUwODc0YmY1OTI2YmY5MjEyNWFkOGVmY180LTEtMS0xLTU1ODMz_125c540f-0f77-40ca-b5d8-31cde2b84aa8">1,335,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares forgone to satisfy minimum statutory withholding</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" decimals="0" name="infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MDBlYWZkODI1MDg3NGJmNTkyNmJmOTIxMjVhZDhlZmMvdGFibGVyYW5nZTowMGVhZmQ4MjUwODc0YmY1OTI2YmY5MjEyNWFkOGVmY181LTEtMS0xLTU1ODMz_927e2e45-c8fd-4baa-b56f-6661cba29fa7">1,078,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i3deaf1a379a149fd8aca28bd274ab8e5_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82MzYz_6e1a0602-e5cc-4dfe-818a-39b561d62f0a">1.2</ix:nonFraction> million of pre-tax total unrecognized compensation cost related to non-vested PSUs, which will be adjusted for future forfeitures and changes to management&#8217;s expectations of the probable outcomes of the performance conditions, if any. The Company expects to recognize such cost over a weighted average period of <ix:nonNumeric contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ4ODQ1_605b1f67-5e42-4fe5-91a6-352da40e5165">1</ix:nonNumeric> year.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2014, the Company received approval from stockholders to adopt an employee stock purchase plan ("ESPP") effective October 2014 (collectively the &#8220;Original ESPP&#8221;). Under the Original ESPP, <ix:nonFraction unitRef="shares" contextRef="i63aa50be007746b6b60d96242969200f_D20140501-20140531" decimals="INF" name="us-gaap:EmployeeStockOwnershipPlanESOPSharesContributedToESOP" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82ODg2_541d741e-1614-4fe1-be40-5dd1d9f34e4f">200,000</ix:nonFraction> shares of common stock were authorized for purchase by eligible employees at a <ix:nonFraction unitRef="number" contextRef="ib5fd5a9607e8406696c8241935b20eea_I20140531" decimals="2" name="infu:EmployeeStockPurchasePlanDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82OTY4_fae8423a-a8bc-4f51-afdd-d65519addd57">15</ix:nonFraction>% discount through payroll deductions during the six-month offering periods. Shares were purchased in whole numbers and generally would be the last day of the offering period. In September 2016, the Company received approval from shareholders for an additional <ix:nonFraction unitRef="shares" contextRef="i337469ad875742708ce9ddae6c4a0f49_D20160901-20160930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV83MjE4_fd08c621-242a-47a7-bb39-cbeb2faa8f51">350,000</ix:nonFraction> shares. No employee may purchase more than $<ix:nonFraction unitRef="usd" contextRef="i63aa50be007746b6b60d96242969200f_D20140501-20140531" decimals="INF" name="infu:EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV83MjY0_81f706e5-d9d7-4906-af55-95ff183cd2a1">25,000</ix:nonFraction> worth of fair market value shares in any calendar year. As allowed under the ESPP, a participant may elect to withdraw from the plan, effective for the purchase period in progress at the time of the election with all accumulated payroll deductions returned to the participant at the time of withdrawal. As of December&#160;31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="INF" name="infu:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV83NTkx_41876165-dce5-4f84-9595-101456934b7c">156,052</ix:nonFraction> shares remaining available for future issuance. <ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zMjk4NTM0OTA0NjUw_f29f2708-a131-4aaa-8eb0-19d988bb580f" continuedAt="icd768d556fe94ac0a6e038b992fe00cf" escape="true">The following table summarizes the activity relating to the Company&#8217;s ESPP program:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="icd768d556fe94ac0a6e038b992fe00cf"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="0" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8xLTEtMS0xLTU1Njg5_8c9e5fdc-8a1c-486a-af57-5ba9712a816c">173,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="0" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8xLTMtMS0xLTU1Njg5_fe462af7-16a9-40bd-add9-31f527ac3170">108,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="0" name="us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8yLTUtMS0xLTY2MzY0_fcc4ec47-ccee-4be4-88d4-7d70d70a62d5">43,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of stock sold to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8yLTEtMS0xLTU1Njg5_619f8169-2637-4b74-b823-45bab25ab4ed">31,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8yLTMtMS0xLTU1Njg5_d449ac89-0f5e-40ed-a409-0cccd576bb99">30,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8zLTUtMS0xLTY2MzY0_0dd655ff-743e-4c13-8691-264c6ebe7534">33,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value per ESPP award</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="2" name="infu:EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8zLTEtMS0xLTU1Njg5_abc021b6-63bb-4793-86aa-da5c41436d46">16.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="2" name="infu:EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8zLTMtMS0xLTU1Njg5_dafb9c88-b900-446d-8782-2edd75ac8ef3">7.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="2" name="infu:EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV80LTUtMS0xLTY2MzY0_6e1e937d-51c4-479b-8337-e7fab2811886">3.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates the fair value of stock option awards using the Black-Scholes option pricing model, which incorporates various assumptions including volatility, expected term, risk-free interest rates and dividend yields. The expected volatility assumption is based on historical volatility of the Company&#8217;s common stock over the most recent period commensurate with the expected life of the stock option granted. The Company uses historical volatility because management believes such volatility is representative of prospective trends. The risk-free interest rate assumption is based upon observed interest rates appropriate for the expected life of the stock option awarded. The Company uses historical exercise data to determine the expected lives. Dividend yields have not been a factor in determining fair value of stock options granted as the Company has never issued cash dividends and does not anticipate issuing cash dividends in the future.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i258b9ad29ceb4551b041281ee1ff0b43" continuedAt="i871540f5339040f49b527a02f99fbdc9"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV81NDk3NTU4MTYwMTk4_4313e815-1bb5-48e9-b1d7-55583b5e5078" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables detail the various stock option activity:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:44.061%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2014 Plan (Options)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>of Authorized<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term (in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id664e22f92654bd6835e8960b88f906e_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF85LTItMS0xLTU1Njg5_2ecee513-33f3-4b64-9686-edf656622a5a">1,959,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id664e22f92654bd6835e8960b88f906e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF85LTQtMS0xLTU1Njg5_695e02f9-2721-418f-af3c-7b98becddd70">4.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i09a35f534ba14f4d9e18f538cbfa8254_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF85LTYtMS0xLTU1Njg5_3d14d204-0b93-400d-b6a6-19ef16e46347">4.42</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id664e22f92654bd6835e8960b88f906e_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF85LTgtMS0xLTU1Njg5_9eb49249-ca1e-43a9-a3d6-2a3dec8f209b">28,449,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xMy0yLTEtMS01NTY4OQ_d1bdb1d6-cf42-4ed9-9340-8854013edcee">56,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xMy00LTEtMS01NTY4OQ_8aad563c-5da5-440d-bc51-5bbd8995ca5b">18.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNC0yLTEtMS01NTY4OQ_f754154d-4fa3-42cc-b2f1-902f40328f16">279,904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNC00LTEtMS01NTY4OQ_73b97669-4ce0-4720-8984-6bc60a05b6d9">2.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised shares forgone to satisfy minimum statutory withholding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNS0yLTEtMS01NTY4OQ_9ad47207-4358-44e4-b002-1313501fa9a0">1,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNS00LTEtMS01NTY4OQ_bc407b7e-06ff-412a-978d-c3df0d136faa">2.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cashless exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" decimals="INF" name="infu:CashlessExerciseOfStockOptionsShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNi0yLTEtMS01NTY4OQ_70355217-6963-411a-b31e-13ac248947a3">566</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" decimals="2" name="infu:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNi00LTEtMS01NTY4OQ_066f464a-1249-4237-ad5e-0437da3f482d">2.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNy0yLTEtMS01NTY4OQ_c7deefd9-29ba-42fb-a775-d90d2548bfb2">1,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNy00LTEtMS01NTY4OQ_06034334-9981-4a07-91c0-82bdecfd28c8">18.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xOS0yLTEtMS01NTY4OQ_b9be69c2-f656-4119-85be-0d7474be8e52">1,731,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xOS00LTEtMS01NTY4OQ_67ff611d-b64d-43a8-97c6-e34d42fbd899">4.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xOS02LTEtMS01NTY4OQ_68e5dee9-b168-4385-a656-02f195823c6b">3.93</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xOS04LTEtMS01NTY4OQ_b3cd67b1-733c-424f-9fb8-a7546ab7fd45">21,051,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8yMS0yLTEtMS01NTY4OQ_04349146-b05d-42d6-99b8-2c8bcef210db">1,478,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8yMS00LTEtMS01NTY4OQ_dc292593-fd5e-4cb3-bde8-ab7cafa914a7">3.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xMS02LTEtMS03MjE1OA_5384214b-7855-4d82-814d-32c1eb63a86f">3.36</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xMS04LTEtMS03MjE4MQ_4bda2ab8-9790-4d06-92bf-98035fae4ea7">19,274,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:44.061%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 Plan (Options)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>of Authorized<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term (in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e7c1a7074da4ca6b240f0057300c46c_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xLTItMS0xLTcyMDk5_124a995a-ffdf-42ea-a94e-693a103c56d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e7c1a7074da4ca6b240f0057300c46c_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xLTQtMS0xLTcyMTA2_635119b6-cca7-4f08-a839-e6689a2b0bae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e7c1a7074da4ca6b240f0057300c46c_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xLTgtMS0xLTcyMjAy_b44fc4dd-071f-439d-9c31-8f94f92d27ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18yLTItMS0xLTcyMjA5_85ba38fb-7676-46fc-8cfc-e4e5d04410ce">288,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18yLTQtMS0xLTcyMjE2_7ff95dc1-4cd5-4e7e-b792-9003bd0aa990">19.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN182LTItMS0xLTcyMjk3_c67dd809-8a92-4ffd-8813-6a34352f3973">15,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN182LTQtMS0xLTcyMjk3_8317b9d5-1481-4bcc-94ed-c079d968f8f2">19.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021 (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b64b934b737430092de595691e27b69_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN184LTItMS0xLTcyMzA0_a86c4d17-0eae-4d0b-b973-146151d79fdd">273,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b64b934b737430092de595691e27b69_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN184LTQtMS0xLTcyMzA0_7131c675-c67c-45f3-b872-df08f05ba466">19.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN184LTYtMS0xLTcyMzA0_d2d4ea20-e0d6-4450-8498-4df0ba92bfae">9.38</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b64b934b737430092de595691e27b69_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN184LTgtMS0xLTcyMzA0_a6f8945a-3d4d-460f-a204-accf4721ec53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021 (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b64b934b737430092de595691e27b69_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xMC0yLTEtMS03MjMxMQ_33605ab8-027f-4a67-b13a-16b2ee3a88d9">78,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b64b934b737430092de595691e27b69_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xMC00LTEtMS03MjMxMQ_ce06ac0d-a282-489f-b875-73650cfbfd43">19.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xMC02LTEtMS03MjMxMQ_3873cadc-21f9-4f64-8a27-2ffdda6d9351">6.66</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b64b934b737430092de595691e27b69_I20211231" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xMC04LTEtMS03MjMxMQ_3ae7fa02-1bb9-41ee-a552-f662f0c394b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Aggregate Intrinsic Value - no options were in-the-money as of December 31, 2021</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.</span></div></ix:nonNumeric><div style="margin-top:5pt;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV81NDk3NTU4MTYwMTk2_e9f0dbfd-b2d2-478d-b098-d7845af1a90d" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the average fair value per share estimated on the date of grant and the assumptions used for options granted:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock Options:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTItMS0xLTYzNDYwL3RleHRyZWdpb246NDQxYzU2YzVhODRhNDFiOTgwYzEyYjdmNDc4ZTNmMzBfMjc0ODc3OTA2OTQ2MA_04b5923f-800c-4aab-9e41-2459fe58c70f">43</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTItMS0xLTYzNDYwL3RleHRyZWdpb246NDQxYzU2YzVhODRhNDFiOTgwYzEyYjdmNDc4ZTNmMzBfMjc0ODc3OTA2OTQ1NA_3fcc87a1-7288-4507-b21c-c6553dff5a6b">46</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTQtMS0xLTYzNDY2L3RleHRyZWdpb246MDYzZTViZjA2NTc1NGRlMjg3OGYxZGU2Y2I2ZTg5YTlfMjc0ODc3OTA2OTQ1NA_6c21b9b3-b04e-4806-bc1f-1595ca3f2a18">42</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTQtMS0xLTYzNDY2L3RleHRyZWdpb246MDYzZTViZjA2NTc1NGRlMjg3OGYxZGU2Y2I2ZTg5YTlfMTA5OTUxMTYyNzc5OQ_4d1ab108-b774-4061-bf20-de6a84838e26">51</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTYtMS0xLTY2MjU3L3RleHRyZWdpb246MDJmNWNiMWM4NTk3NDRkNGI3OTYzMDIzYmFjMmNkYjdfMTA5OTUxMTYyNzc4OA_6497b2eb-89e6-40c4-b613-301c5cc242f3">36</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTYtMS0xLTY2MjU3L3RleHRyZWdpb246MDJmNWNiMWM4NTk3NDRkNGI3OTYzMDIzYmFjMmNkYjdfMTA5OTUxMTYyNzc5Mg_87a45001-720d-483d-852c-53df7eb945bc">38</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTItMS0xLTY2MjMyL3RleHRyZWdpb246MTA3YTZhZGJjYjUyNDBkYWE1OTZjYTc2ZjAzNGE3MjlfMTA5OTUxMTYyNzc5NA_c15d17f0-8b71-4eea-ade8-03937c0f0ddb">0.31</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTItMS0xLTY2MjMyL3RleHRyZWdpb246MTA3YTZhZGJjYjUyNDBkYWE1OTZjYTc2ZjAzNGE3MjlfMTA5OTUxMTYyNzgwMg_1f00798f-6a87-4216-b130-e6ff909b71b5">0.54</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTQtMS0xLTY2MjE4L3RleHRyZWdpb246NmEyMTQxNDhiYjk3NDNhOTgyNzg3NWJkMTU1YjBjZTFfMTA5OTUxMTYyNzc5OQ_e5587c42-88ad-47d7-8751-b90b44b0a400">0.20</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTQtMS0xLTY2MjE4L3RleHRyZWdpb246NmEyMTQxNDhiYjk3NDNhOTgyNzg3NWJkMTU1YjBjZTFfMTA5OTUxMTYyNzgwNw_093c6653-9545-40ed-b24f-cd0ad8912e31">1.56</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTYtMS0xLTY2Mjc0L3RleHRyZWdpb246NzRkYWM0ZTZhMDljNGNiM2FlYmU2ZjNhYzc4YzlhZjFfMTA5OTUxMTYyNzc4OA_04e17fee-7825-4e55-b428-121c296a8f85">1.80</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTYtMS0xLTY2Mjc0L3RleHRyZWdpb246NzRkYWM0ZTZhMDljNGNiM2FlYmU2ZjNhYzc4YzlhZjFfMTA5OTUxMTYyNzc5Mg_05471f2c-7b6c-4cba-b338-d7fa56fa25e7">2.36</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected lives at date of grant (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTItMS0xLTU1Njg5_de360c18-2aa2-4693-b865-1d8ac1a40715">3.62</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTQtMS0xLTU1Njg5_d6e63691-899b-42c7-85e5-18a6b65bf9e8">3.25</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV80LTYtMS0xLTY2Mjkx_c0690c22-b8e6-498f-af71-7ef3f5cc84b4">4.63</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average fair value of options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i7e33f7d1e2e5453ea11e60d4febe0678_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV80LTItMS0xLTU1Njg5_bc6f95ed-774e-4648-938f-77bcb8a9fb88">6.56</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="if119c5c4f07e4e6fb8be547a3dfead4e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV80LTQtMS0xLTU1Njg5_12df93c9-4d0e-4ea2-b523-5485d46cc050">3.87</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i5e5609e12fdd4bcc9d3cac4d8aa1ae1a_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV81LTYtMS0xLTY2Mjk5_1438cf56-6d7b-4460-a9d7-488db605bf4e">1.61</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intrinsic value of options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV82LTItMS0xLTYzNTg5_45da3ca4-b550-4594-becf-966802c18e4b">4,248,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV82LTQtMS0xLTYzNTg5_31b2743b-05d8-4e83-bf5b-1b86e0e42bb5">3,377,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV82LTYtMS0xLTc2ODQx_a76782f2-6b47-4fa0-8c39-ec493ec3d1f5">624,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i871540f5339040f49b527a02f99fbdc9"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2021, the Company's Board of Directors approved a stock repurchase program (the &#8220;Share Repurchase Program&#8221;) authorizing the Company to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="ib7b671a11ff144cdb841c10e00e545b2_I20210630" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ5MDYw_af44981c-3d3b-456b-95cc-8a25325f556b">20.0</ix:nonFraction> million of the Company&#8217;s outstanding common stock through June 30, 2024. The Share Repurchase Program will be subject to market conditions, the periodic capital needs of the Company&#8217;s operating activities, and the continued satisfaction of all covenants under the Company&#8217;s existing 2021 Credit Agreement. Repurchases under the program may take place in the open market or in privately negotiated transactions and may be made under a Rule 10b5-1 plan. The Share Repurchase program does not obligate the Company to repurchase shares and may be suspended, terminated, or modified at any time. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had repurchased approximately $<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82MDQ3MzEzOTgwNDgw_1287e19c-ac2a-4b35-b7fc-8eb4226b58e4">0.6</ix:nonFraction> million, or <ix:nonFraction unitRef="shares" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="0" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82MDQ3MzEzOTg2MDYy_9c3f2cf7-f7e7-470e-9af3-86abd0ef5ed7">33,469</ix:nonFraction> shares, of the Company's outstanding common stock under the Share Repurchase Program.</span></div></ix:continuation><div id="i9e717b65c1e3405d850ef6e342b20071_1859"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGV4dHJlZ2lvbjoxNTA0MzEwNjkzOGY0ZTFiYTIwMTM1Yjc5NjQ4ZmM5YV80OTQ3ODAyMzI2OTMz_dc1b0542-eb96-4cf2-9399-e2f419e4a4fe" continuedAt="i0c8d3580a6504d8f99a058b16df6cd33" escape="true">Business Segment Information</ix:nonNumeric></span></div><ix:continuation id="i0c8d3580a6504d8f99a058b16df6cd33" continuedAt="i7b86ea91d03e444484ec59be5069da7c"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments are organized based on service platforms, with the ITS segment reflecting higher margin rental revenues that generally include payments made by third-party and direct payers and the DME Services segment reflecting lower margin product sales, direct payer rental and services revenues. Resources are allocated and performance is assessed for these segments by the Company&#8217;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker. The Company believes that reporting performance at the gross profit level is the best indicator of segment performance. </span></div><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGV4dHJlZ2lvbjoxNTA0MzEwNjkzOGY0ZTFiYTIwMTM1Yjc5NjQ4ZmM5YV80Mzk4MDQ2NTEyMDUy_b461644f-b970-4137-9a1f-5ee3b54a843d" continuedAt="i06424116f9294593b541587b2a2920dc" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial information summarized below is presented by reportable segment:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DME Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8yLTItMS0xLTU1NjIx_78d16ef9-8d5b-4f04-baef-e32a8dd2e949">65,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8yLTQtMS0xLTU1NjIx_23c295c6-7e53-4415-84ef-b22680bdfc25">36,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231" decimals="-3" name="infu:RevenuesExternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8yLTYtMS0xLTU1NjIx_550ba259-db5d-4361-872d-5c35b8c178d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8yLTgtMS0xLTU1NjIx_7ce9f181-852b-4d6e-913e-33a2d0dbef08">102,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231" decimals="-3" name="infu:RevenuesInternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8zLTItMS0xLTU1NjIx_4abc5cd6-258d-44f2-a5dc-045544dcfafe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231" decimals="-3" name="infu:RevenuesInternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8zLTQtMS0xLTU1NjIx_25f9cbd7-193a-4a51-b413-c180f8d9eec4">5,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231" decimals="-3" sign="-" name="infu:RevenuesInternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8zLTYtMS0xLTU1NjIx_9ba4a9c2-ffd9-49b0-ac86-7646f322bf29">5,753</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:RevenuesInternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8zLTgtMS0xLTU1NjIx_582cb305-275f-4905-8be2-56595b6ad136">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV80LTItMS0xLTU1NjIx_6026b02d-20d4-4d62-aa50-f2ab33d20f05">65,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV80LTQtMS0xLTU1NjIx_09f3d5bf-4136-4bf3-9a09-921dfdc856ee">42,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV80LTYtMS0xLTU1NjIx_974550ed-6dd0-4f4a-9063-3d03a73b8a3d">5,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV80LTgtMS0xLTU1NjIx_ecfd4df5-4be2-4196-afcd-25dc7095f914">102,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV81LTItMS0xLTU1NjIx_8d9ab61e-3414-41eb-829d-d474cfcdbef2">42,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV81LTQtMS0xLTU1NjIx_649294e5-56e0-4c66-97e9-ee2ef2bf02c1">18,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV81LTYtMS0xLTU1NjIx_86976381-7ae8-4b9e-af03-7671cd3211a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV81LTgtMS0xLTU1NjIx_7e0afd24-dbd1-443d-b4b9-0d1034379be5">60,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV83LTYtMS0xLTU1NjIx_1d26a4ae-86e7-4ca6-9531-9805720be531">57,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV83LTgtMS0xLTU1NjIx_aa1a9cbc-ca6a-4dd8-8cf1-fd8f61ff977e">57,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV84LTYtMS0xLTU1NjIx_f78b385f-352b-402e-adec-402416ff2cc6">1,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV84LTgtMS0xLTU1NjIx_b2caeaff-4830-4de6-ab46-b51f68f731a3">1,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV85LTYtMS0xLTU1NjIx_284fd301-c8de-4838-b5cf-3a215c06ef08">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV85LTgtMS0xLTU1NjIx_82f79476-b9bb-4221-93d3-49ff28467373">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xMC02LTEtMS01NTYyMQ_8c52f1c6-5703-4407-ba73-552a3f1fa38e">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xMC04LTEtMS01NTYyMQ_04f2fa41-80cf-4f65-b99f-a33be3dc1768">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xMi04LTEtMS01NTYyMQ_62c2ccc1-9c84-4527-9f78-d3030c3dda02">1,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4d33e010b93943a0a1b9d74ec3a67b16_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNC0yLTEtMS01NTYyMQ_7335b9cd-7ca2-45bd-b137-2cacbea5a493">60,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie8879dd04a8a42e3aa243ab1446763cf_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNC00LTEtMS01NTYyMQ_5ab43c45-47ad-4d4e-8313-12f77ac50ca2">34,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i90ee66b33a414ffb93ffa9dcf1afd8e9_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNC02LTEtMS01NTYyMQ_7cae8fbb-9925-4063-bad1-ff43da6ce8c9">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNC04LTEtMS01NTYyMQ_95f5d828-60ed-46ca-92eb-995e3f2aaa3b">97,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNS0yLTEtMS01NTYyMQ_c6bde9ea-d068-453a-a234-e4690440d68c">10,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNS00LTEtMS01NTYyMQ_8ce36f45-e90c-493c-8b5a-c6de0c1d589e">5,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNS02LTEtMS01NTYyMQ_327e89ba-0942-4988-83dc-1a33c23ad9e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNS04LTEtMS01NTYyMQ_01d2230a-4a63-41fa-a3ac-dbcd12255b88">15,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNi0yLTEtMS01NTYyMQ_b848f734-7c35-40dd-85cb-b20aa938701f">10,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNi00LTEtMS01NTYyMQ_e4ad0f16-9c7c-4446-811d-b404e5bf1f46">3,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNi02LTEtMS01NTYyMQ_fc3b2672-560a-4ac3-8671-8fecaba0a291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNi04LTEtMS01NTYyMQ_85ac6686-fa84-44ef-b062-64349d3db53a">14,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:10pt;text-indent:27pt"><span><br/></span></div><div style="margin-top:10pt;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i7b86ea91d03e444484ec59be5069da7c"><ix:continuation id="i06424116f9294593b541587b2a2920dc"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DME Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate/<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18yLTItMS0xLTU1NjIx_ed0a107d-a54a-40e9-a40f-f81368460569">61,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18yLTQtMS0xLTU1NjIx_3564f8cd-fc4a-458b-a05b-8f581d05debc">36,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231" decimals="-3" name="infu:RevenuesExternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18yLTYtMS0xLTU1NjIx_f131f9aa-72ff-4c48-b6eb-430edce5f5a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18yLTgtMS0xLTU1NjIx_bc49bef3-0af4-4178-ae49-93515960851d">97,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231" decimals="-3" name="infu:RevenuesInternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18zLTItMS0xLTU1NjIx_20679fbb-66e6-426c-a8b2-516846071553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231" decimals="-3" name="infu:RevenuesInternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18zLTQtMS0xLTU1NjIx_26a78f82-2771-4008-97a0-87b42e642fb3">5,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231" decimals="-3" sign="-" name="infu:RevenuesInternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18zLTYtMS0xLTU1NjIx_43f4e452-9a03-4043-a67b-c8c4da79e254">5,370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="infu:RevenuesInternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18zLTgtMS0xLTU1NjIx_14895756-2595-43e1-a24b-941aafe6bb0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY180LTItMS0xLTU1NjIx_427d358a-354d-4688-832b-03ee391e0757">61,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY180LTQtMS0xLTU1NjIx_525c44cd-2ecc-4c55-af4e-43129562eb92">41,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY180LTYtMS0xLTU1NjIx_3d4c1403-c280-4ea3-b6a5-2482f1ce3324">5,370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY180LTgtMS0xLTU1NjIx_b06a1c8e-76a6-4170-b43e-642dd30aef37">97,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY181LTItMS0xLTU1NjIx_9a76cec1-5bc3-4057-a0b2-d73d9ec5bb01">39,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY181LTQtMS0xLTU1NjIx_ef248a4e-fae9-4602-b9d0-0400adca1b72">18,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY181LTYtMS0xLTU1NjIx_7aa06f0b-72a8-41f7-9d6d-9f01f99af599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY181LTgtMS0xLTU1NjIx_2949512b-1563-447a-830e-7205c708132d">58,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY183LTYtMS0xLTU1NjIx_d99bc9bd-8817-4c56-9799-6cc48bfe6d3f">49,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY183LTgtMS0xLTU1NjIx_273d94af-c81c-4a9b-9e3d-2ff09761ad7b">49,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY184LTYtMS0xLTU1NjIx_ba4706c4-a7b2-43d6-8cdb-41501a276545">1,255</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY184LTgtMS0xLTU1NjIx_07c577db-4260-4c90-bf2b-5015143edb39">1,255</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY185LTYtMS0xLTU1NjIx_d0c0a61e-d789-4785-8f6f-8ed9e92f17f0">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY185LTgtMS0xLTU1NjIx_9c3fefbb-8751-4423-be2b-416066742d8e">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xMC02LTEtMS01NTYyMQ_76b7be42-b772-40d2-add4-c4d405187b81">9,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xMC04LTEtMS01NTYyMQ_3845aa68-dd03-4e49-bc5d-f69948eba10f">9,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xMi04LTEtMS01NTYyMQ_d4d6f888-917d-4336-a2f7-1bd3f88a79a4">17,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b70e2ce104146f5ab103c7d119b5bb6_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNC0yLTEtMS01NTYyMQ_09e843f7-114b-4745-824d-9088b952631a">68,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6184d5208e4826bebce3c6df68d12f_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNC00LTEtMS01NTYyMQ_b4f79575-d238-4960-a2e3-2b4fbc7f8bd0">26,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb2db6241c24063b31cb809b4d00a65_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNC02LTEtMS01NTYyMQ_f1652ca8-2a27-4735-9d43-1f466186d2a8">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNC04LTEtMS01NTYyMQ_7510c37f-eb98-4184-8a57-537dd6eb3a02">96,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNS0yLTEtMS01NTYyMQ_4defaf30-60b0-4d50-a350-cc448c18633c">9,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNS00LTEtMS01NTYyMQ_2fab3449-e3db-42d1-8cf4-d33bcd0cc051">6,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNS02LTEtMS01NTYyMQ_ca6f9890-0fc3-4844-a563-57065a2f492a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNS04LTEtMS01NTYyMQ_9165d76f-f72a-4eb9-9f59-d7a58f3e7ecc">15,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNi0yLTEtMS01NTYyMQ_b7b967ef-2cff-421d-934f-0f4e391c0667">10,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNi00LTEtMS01NTYyMQ_e544179c-bfdd-4a98-8eab-b83db3818c97">3,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNi02LTEtMS01NTYyMQ_8e28386f-4621-4a4c-b800-09b18082c781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNi04LTEtMS01NTYyMQ_6034b5b0-93c6-480c-91bf-dbde77a07077">14,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DME Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate/<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8yLTItMS0xLTU1NjI3_f0aef593-8b3d-42ee-aa87-f787f89e4f50">51,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8yLTQtMS0xLTU1NjI3_15b40a96-b3c8-45e1-ad05-07dc636393b9">29,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231" decimals="-3" name="infu:RevenuesExternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8yLTYtMS0xLTU1NjI3_43930026-5a8b-4966-a473-c16bf67a78c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8yLTgtMS0xLTU1NjI3_6a532e39-686c-45e6-8803-052e0de58c2d">81,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231" decimals="-3" name="infu:RevenuesInternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8zLTItMS0xLTU1NjI3_ba0b4447-c44b-4905-ac88-ec2a6908d4d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231" decimals="-3" name="infu:RevenuesInternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8zLTQtMS0xLTU1NjI3_99caa796-5451-4d47-aab3-827e3c2a5c37">3,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231" decimals="-3" sign="-" name="infu:RevenuesInternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8zLTYtMS0xLTU1NjI3_0dd2a914-1451-4814-9f81-c28efd053811">3,788</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="infu:RevenuesInternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8zLTgtMS0xLTU1NjI3_a8a0809b-807f-4ddc-819b-5e5fa26f46ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF80LTItMS0xLTU1NjI3_b37a2c6d-328d-498f-ba61-a9a0e8aaaee3">51,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF80LTQtMS0xLTU1NjI3_09756ac8-b27e-427a-8f0d-c54567e68e68">33,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF80LTYtMS0xLTU1NjI3_e25c0e5a-56e4-4bca-acea-d02ad34d62e2">3,788</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF80LTgtMS0xLTU1NjI3_7c93ab54-b4d1-4cab-9769-4b6f910aa05e">81,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF81LTItMS0xLTU1NjI3_ba6a4ee8-a40c-43d8-9d97-976ce0721dc1">33,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF81LTQtMS0xLTU1NjI3_d909ced9-7a08-4f87-9fce-14caa44e80b2">13,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF81LTYtMS0xLTU1NjI3_b1160f9f-584c-4947-9ed1-1074ed3f9d22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF81LTgtMS0xLTU1NjI3_8901b993-6ef0-4193-acd6-331431da24f2">46,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF83LTYtMS0xLTU1NjI3_89bc9737-248b-4b72-a441-97dccb3f9a58">43,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF83LTgtMS0xLTU1NjI3_7b7a8f96-b8ea-4bd4-abe8-ca06ac851740">43,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF84LTYtMS0xLTU1NjI3_b9674132-1e36-486e-971f-1d6fdfa128c8">1,904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF84LTgtMS0xLTU1NjI3_f86e6150-84b1-42c9-bfc2-8306df438189">1,904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF85LTYtMS0xLTU1NjI3_8dbe6a0c-fbb9-4ac5-a587-70661a859357">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF85LTgtMS0xLTU1NjI3_baf08796-ee45-4169-930a-b4b31620bfc5">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xMC02LTEtMS01NTYyNw_128754cc-af4f-47b1-8ffa-f28919a05954">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xMC04LTEtMS01NTYyNw_c0ff8abe-d2d0-4ecc-a3db-529ebf38bb7e">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xMi04LTEtMS01NTYyNw_7af693b9-3c83-409e-af96-9e2c1250fc06">1,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d80d3950ca42f0aa2a881eb9e20226_I20191231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNC0yLTEtMS01NTYyNw_029b9b66-e9ff-4ed0-abf3-2b1d5de0089d">54,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c666a090afb4d4088d45f15b60baf48_I20191231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNC00LTEtMS01NTYyNw_5d2e2b24-e0e7-4c92-9e7f-9a4c3f89dbfb">22,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99dd14e3f4d04b82a5f72adea8821e1f_I20191231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNC02LTEtMS01NTYyNw_fde92176-a537-4ea9-b7bd-154d89a41c18">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNC04LTEtMS01NTYyNw_df933276-3b14-40ce-bbb3-7d5ce6e9684b">79,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNS0yLTEtMS01NTYyNw_71f47965-0b2e-4f97-a1a5-3e1bb51d55ff">14,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNS00LTEtMS01NTYyNw_6a9e59c3-7cec-4671-8f51-b87bc1aa56a1">5,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNS02LTEtMS01NTYyNw_774efa56-06d8-4945-9683-211be0774ed5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNS04LTEtMS01NTYyNw_edf0465e-9eda-4004-9c10-e78b864ee9de">19,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNi0yLTEtMS01NTYyNw_32aa719d-d229-4ec0-8608-55e7be788250">9,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNi00LTEtMS01NTYyNw_549f424d-fdf0-4c51-b569-8e3e2734505a">2,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNi02LTEtMS01NTYyNw_57638886-333f-4069-8ff1-871f0ab654ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNi04LTEtMS01NTYyNw_ffb50ea0-8bed-4046-9a1d-c04bc4083831">12,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div id="i9e717b65c1e3405d850ef6e342b20071_160"></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzUwNg_b86def30-4ed0-4e15-948e-302ad3776247" continuedAt="i19cb383eb2d44e0a9e2f6e5851a1a7d1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Employee Benefit Plans and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i19cb383eb2d44e0a9e2f6e5851a1a7d1">The Company has a defined contribution plan in which the Company makes discretionary matching contributions for a certain percentage of employee contributions. For the years ended December&#160;31, 2021, 2020 and 2019, the Company&#8217;s matching contributions were $<ix:nonFraction unitRef="usd" contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzI3Mw_84614398-5d46-42bd-8024-a801201df347">0.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzI4MA_8cc27574-b754-42ee-8bf8-faf22a45c167">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzYwNDczMTM5NTM1Mjg_69138330-1496-4cad-8ee4-a8054b6d3b29">0.7</ix:nonFraction> million, respectively. The Company does not provide other post-retirement or post-employment benefits to its employees. As of December&#160;31, 2021 and 2020, accrued payroll liabilities included in Other current liabilities were $<ix:nonFraction unitRef="usd" contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzQ4Mw_e1b32cab-69b6-407c-93b4-9b3c9a4224b8">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzQ5MA_efb36ef9-feb0-4934-b196-3c48896bc73e">2.8</ix:nonFraction> million, respectively.</ix:continuation></span></div><div id="i9e717b65c1e3405d850ef6e342b20071_163"></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231" name="infu:EffectOfCovid19PandemicTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjMvZnJhZzoxN2E0NzcwOTA0NDM0NDk1OTUxMzc4NTA0MTI2OWE2NS90ZXh0cmVnaW9uOjE3YTQ3NzA5MDQ0MzQ0OTU5NTEzNzg1MDQxMjY5YTY1XzMzNDI_c6c3223c-0cd6-4f90-95c8-be020889b115" continuedAt="ib86868dbc5624a0a8164860ab1fae697" escape="true">COVID-19</ix:nonNumeric></span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib86868dbc5624a0a8164860ab1fae697" continuedAt="i3308b2cfc8704956ae8a88047494c92a">On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which spread globally and throughout the United States. With the exception of in-person visits to customer facilities by the Company's sales </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><ix:continuation id="i3308b2cfc8704956ae8a88047494c92a"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">staff, the Company continued to operate despite stay-at-home orders and other government mandated shutdowns across the United States and Canada under exceptions allowed by those orders for the healthcare industry.&#160;</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company took a number of precautionary and preemptive steps to protect the safety and well-being of its employees while ensuring continuity of service to its clients, including, transitioning employees to a remote work environment, suspending employee travel, canceling participation in industry events and in-person group meetings, promoting social distancing and enhanced cleaning and sanitization efforts across office locations, and implementing protocols to quarantine employees who may have been exposed to COVID-19, or show relevant symptoms. The Company also executed preparedness plans at its facilities to maintain continuity of operations, which provided for flexible work arrangements without any significant disruptions to its business or control processes. The Company's management team is continuing to actively monitor the situation and continuously communicates with employees, customers and vendors. Other specific actions the Company took included purchasing additional inventory of supplies and pumps, as well as purchasing personal protective equipment for employees. While the Company&#8217;s business is considered critical, the Company is unable to predict the impact that the COVID-19 pandemic will have on future periods due to numerous uncertainties. While the COVID-19 pandemic has not had any material unfavorable effects to the Company's financial results for the year ended December&#160;31, 2021, the extent of the impact in the future, if any, will depend on future developments, which are highly uncertain, cannot be predicted and could have a material adverse impact on the Company's financial position, operating results and cash flows. A prolonged outbreak could, among other things, strain the Company's business continuity plans, create delays in the Company's growth and strategic initiatives, reduce the Company's sales and marketing activities, limit the Company's access to financing on favorable terms, increase the Company's exposure to potential impairment charges related to long-lived and intangible assets, hinder the Company's ability to support its clients and operate its business effectively, heighten the risk of disruption to the Company's information and reporting systems and internal controls, including those over financial reporting and other risk management systems, or require the Company to incur substantial costs. The Company continues to closely monitor the impact of the COVID-19 pandemic on all aspects of its business and may take further actions as may be required by federal, state or local authorities, or that the Company determines are in the best interests of its employees, customers and partners. As the conditions surrounding the COVID-19 pandemic continue to evolve rapidly, the Company will continue to actively manage its response in collaboration with customers, government officials and stakeholders, and assess any potential impacts to the Company's financial position and operating results, as well as adverse developments in its business.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosures.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_172"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9A.&#160;&#160;&#160;&#160;Controls and Procedures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management, with the participation of our Chief Executive Officer (&#8220;CEO&#8221;) and our Chief Financial Officer (&#8220;CFO&#8221;), evaluated the effectiveness of our disclosure controls and procedures as of December&#160;31, 2021. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives. Based on this evaluation, management, including our CEO and CFO, concluded as of December&#160;31, 2021 that our disclosure controls and procedures were effective.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s Annual Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). The Company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (&#8220;US GAAP&#8221;).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, is a process designed by, or under the supervision of, the CEO and CFO and is effected by the Board of Directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with US GAAP. Internal control over financial reporting includes those policies and procedures that:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with US GAAP, and that the receipts and expenditures of the Company are being made only in accordance with appropriate authorization of management and the board of directors; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management conducted an evaluation of the effectiveness of internal control over financial reporting based on the framework in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our evaluation under the criteria set forth in Internal Control &#8212; Integrated Framework (2013), our management concluded that, as of December&#160;31, 2021, our internal control over financial reporting was effective.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This annual report does not include an attestation report of the Company&#8217;s independent registered public accounting firm regarding internal control over financial reporting because that requirement under Section&#160;404 of the Sarbanes-Oxley Act of 2002 was permanently removed for smaller reporting companies pursuant to the provisions of Section&#160;989G(a) set forth in the Dodd-Frank Wall Street Reform and Consumer Protection Act enacted into federal law in July 2010.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our internal controls over financial reporting as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during the quarter ended December&#160;31, 2021 identified in connection with our evaluation that has materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_6047313954737"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_181"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;Directors, Executive Officers and Corporate Governance</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Part III, Item&#160;10 is incorporated herein by reference to the sections titled &#8220;Election of Directors,&#8221; &#8220;Board of Directors and Committees of the Board of Directors,&#8221; &#8220;Executive Officers,&#8221; and &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; in our definitive proxy statement relating to the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_184"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;Executive Compensation</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Part III, Item&#160;11 is incorporated herein by reference to the sections titled &#8220;Advisory Vote Regarding Executive Compensation,&#8221; and &#8220;Executive Compensation&#8221; in our definitive proxy statement relating to the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_187"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information as of December&#160;31, 2021 with respect to compensation plans, including individual compensation arrangements, under which our equity securities are authorized for issuance:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.566%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of securities to be issued upon<br/>&#160;exercise of outstanding options and rights<br/>( a ) (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Exercise Price of options<br/>&#160;and rights<br/>( b ) (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of securities remaining available <br/>for future issuance under equity<br/>&#160;compensation plans (excluding securities reflected in column (a)) (3)<br/>( c )</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan Category:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by security holders:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 39.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Plan *</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 39.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766,769&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* As of December&#160;31, 2021, this plan is no longer in effect other than for stock options and rights that were previously granted and remain outstanding.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) This amount includes 530,918 shares of common stock issuable upon the vesting of certain restricted stock awards and performance-based restricted stock units and 2,005,110 shares of common stock issuable upon the exercise of vested stock option awards.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Excludes RSUs and PSUs, which have no exercise price.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Includes 2,500,000 shares authorized as part of our 2021 Annual Meeting of Stockholders held in May 2021, less 733,231 shares that were made available to certain employees, directors and others.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The other information required by Part III, Item&#160;12 is incorporated herein by reference to the section titled &#8220;Security Ownership of certain Beneficial Owners and Management&#8221; in our definitive proxy statement relating to the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Part III, Item&#160;13 is incorporated herein by reference to the sections titled &#8220;Election of Directors &#8211; Director Independence&#8221; and &#8220;Certain Relationships and Related Party Transactions&#8221; in our definitive proxy statement relating to the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_193"></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;Principal Accounting Fees and Services</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Part III, Item&#160;14 is incorporated herein by reference to the sections titled &#8220;Ratification of Independent Registered Public Accounting Firm&#8221; and &#8220;Independent Auditor&#8217;s Fees&#8221; in our definitive proxy statement relating to the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i9e717b65c1e3405d850ef6e342b20071_199"></div><div style="-sec-extract:summary;margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;Exhibits, Financial Statement Schedules</span></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The following documents are filed or furnished as part of this Form 10-K:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Financial Statements</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the Index to Financial Statements under Item 8, Part II hereof.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#160;Financial Statement Schedules</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Financial Statement Schedules have been omitted either because they are not required or because the information has been included in the financial statements or the notes thereto included in this Annual Report on Form 10-K.&#160;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Exhibits</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the accompanying Exhibit Index set forth below. Pursuant to the rules and regulations of the Securities and Exchange Commission, the Company has filed, furnished or incorporated by reference the documents referenced in the Exhibit Index as exhibits to this Form 10-K. The documents include agreements to which the Company is a party or has a beneficial interest. The agreements have been filed to provide investors with information regarding their respective terms. The agreements are not intended to provide any other factual information about the Company or its business or operations. In particular, the assertions embodied in any representations, warranties and covenants contained in the agreements may be subject to qualifications with respect to knowledge and materiality different from those applicable to investors and may be qualified by information in confidential disclosure schedules not included with the exhibits. These disclosure schedules may contain information that modifies, qualifies and creates exceptions to the representations, warranties and covenants set forth in the agreements. Moreover, certain representations, warranties and covenants in the agreements may have been used for the purpose of allocating risk between the parties, rather than establishing matters as facts. In addition, information concerning the subject matter of the representations, warranties and covenants may have changed after the date of the respective agreement, which subsequent information may or may not be fully reflected in the Company's public disclosures. Accordingly, investors should not rely on the representations, warranties and covenants in the agreements as characterizations of the actual state of facts about the Company or its business or operations on the date hereof. The Company will furnish to any stockholder, upon written request, any exhibit listed in the Exhibit Index upon payment by such stockholder of the Company's reasonable expenses in furnishing any such exhibit.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Index</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312514194753/d724130dex31.htm">Amended and Restated Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Company&#8217;s current report on Form 8-K (File No. 1-35020) filed on May 12, 2014).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774918013086/ex_117488.htm">Amended and Restated By-Laws (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on July 9, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312506045150/dex42.htm">Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Registration Statement on Form S-1/A (File No. 333-129035) filed on March 3, 2006).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774920006370/ex_178388.htm">Description of Securities Registered Under Section 12 of the Exchange Act (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Annual Report on Form 10-K (File No. 1-35020) filed on March 30, 2020.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312508074068/dex41.htm">InfuSystem Holdings, Inc. 2007 Stock Incentive Plan (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-8 (File No. 333-150066) filed on April 3, 2008).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312509043311/dex101.htm">Amended and Restated Registration Rights Agreement, dated as of October 17, 2007 by and among InfuSystem Holdings, Inc., Wayne Yetter, John Voris, Jean-Pierre Millon, Erin Enright, Sean McDevitt, Pat LaVecchia and Great Point Partners LLC (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Annual Report on Form 10-K (File No. 0-51902) filed on March 3, 2009).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312515183952/d922316dex101.htm">Credit Agreement by and among InfuSystem Holdings, Inc., its subsidiaries and JPMorgan Chase Bank, N.A., dated as of March 23, 2015 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on May 12, 2015).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312515183952/d922316dex102.htm">Pledge and Security Agreement by and among InfuSystem Holdings, Inc., its subsidiaries and JPMorgan Chase Bank, N.A., dated as of March 23, 2015 (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on May 12, 2015).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312515183952/d922316dex103.htm">Patent and Trademark Agreement by and among InfuSystem Holdings, Inc., its subsidiaries and JPMorgan Chase Bank, N.A., dated as of March 23, 2015 (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on May 12, 2015).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312516789780/d300464dex101.htm">First Amendment to Credit Agreement and Waiver, dated as of December 5, 2016, among the InfuSystem Holdings, Inc., and its direct and indirect subsidiaries, with JPMorgan Chase Bank, N.A. as Lender (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on December 9, 2016).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.7**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312513130501/d444466dex1016.htm">First Amended and Restated Employment Agreement by and between Jan Skonieczny and InfuSystem Holdings, Inc., effective January&#160;2, 2013 (incorporated by reference to Exhibit 10.16 to the Company&#8217;s Annual Report on Form 10-K (File No. 1-35020) filed on March 28, 2013).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.8**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312514404525/d810092dex101.htm">Form of Stock Option Award Agreement (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on November 10, 2014).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.9**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312515183952/d922316dex104.htm">Form of Restricted Stock Award Agreement (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on May 12, 2015).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.10**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312517347899/d497820dex101.htm">Employment Agreement by and between InfuSystem Holdings, Inc. and Richard DiIorio, effective November 15, 2017 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on November 20, 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.11**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312517347899/d497820dex102.htm">Stock Option Award Agreement by and between InfuSystem Holdings, Inc. and Richard DiIorio, dated as of November 15, 2017 (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on November 20, 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312517347899/d497820dex103.htm">Stock Appreciation Right Award Agreement by and between InfuSystem Holdings, Inc. and Richard DiIorio, dated as of November 15, 2017 (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on November 20, 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312517093826/d347736dex101.htm">Second Amendment to Credit Agreement by and between InfuSystem Holdings, Inc., InfuSystem Holdings USA, Inc., InfuSystem, Inc., First Biomedical, Inc., IFC LLC and JPMorgan Chase Bank, N.A. as the Lender, dated March 22, 2017 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on March 23, 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312517167426/d138062dex101.htm">Limited Waiver by and between InfuSystem Holdings, Inc., InfuSystem Holdings USA, Inc., InfuSystem, Inc., First Biomedical, Inc., IFC LLC and JPMorgan Chase Bank, N.A. as the Lender, dated May 10, 2017 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 11, 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312517203580/d408467dex101.htm">Separation Agreement and General Release by and between InfuSystem Holdings, Inc. and Eric Steen, dated June 7, 2017 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K/A (File No. 1-35020) filed on June 14, 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312517218386/d419642dex101.htm">Third Amendment to Credit Agreement by and between InfuSystem Holdings, Inc., InfuSystem Holdings USA, Inc., InfuSystem, Inc., First Biomedical, Inc., IFC LLC and JPMorgan Chase Bank as the Lender, dated June 28, 2017 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on June 29, 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312517218386/d419642dex102.htm">Patent and Trademark Security Agreement by and between InfuSystem Holdings, Inc., InfuSystem Holdings USA, Inc., InfuSystem, Inc., First Biomedical, Inc. and JPMorgan Chase Bank, N.A. as the Lender, dated June 28, 2017 (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on June 29, 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774918009798/ex_113556.htm">Employment Agreement by and between InfuSystem Holdings, Inc. and Gregory Schulte, effective May 7, 2018 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on May 14, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774918009798/ex_114009.htm">Equity Settlement Agreement by and between InfuSystem Holdings, Inc. and Christopher Downs, effective May 11, 2018 (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on May 14, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774918009798/ex_114412.htm">Inducement Stock Option Award Agreement by and between InfuSystem Holdings, Inc. and Gregory Schulte, effective May 7, 2018 (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on May 14, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774918015587/ex_120998.htm">Equity Settlement Agreement by and between InfuSystem Holdings, Inc. and Jan Skonieczny, effective June 5, 2018 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on August 14, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774918015587/ex_120999.htm">Equity Settlement Agreement by and between InfuSystem Holdings, Inc. and Trent Smith, effective June 5, 2018 (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on August 14, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774918014317/ex_119925.htm">Fourth Amendment to the Credit Agreement, dated as of July 31, 2018, among InfuSystem Holdings, Inc. and its direct subsidiaries with JPMorgan Chase Bank, N.A. as Lender (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on August 2, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774918014317/ex_119893.htm">Stock Purchase and Settlement Agreement, dated as of July 31, 2018, among InfuSystem Holdings, Inc., Ryan J. Morris and Meson Capital, L.P. (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on August 2, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.25**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774919010376/ex_145338.htm">InfuSystem Holdings, Inc. 2014 Equity Plan (as amended through May 15, 2019) (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 17, 2019).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.26</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774919002252/ex_134543.htm">Fifth Amendment to the Credit Agreement, dated as of February 5, 2019, among InfuSystem Holdings, Inc. and its direct and indirect subsidiaries with JPMorgan Chase Bank, N.A. as Lender (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on February 12, 2019).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.27**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774919019411/ex_159321.htm">Employment Agreement by and between InfuSystem Holdings, Inc. and Carrie Lachance, effective October 1, 2019 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on October 2, 2019).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774919022458/ex_164237.htm">Sixth Amendment to the Credit Agreement, dated as of November 7, 2019, among InfuSystem Holdings, Inc. and its direct and indirect subsidiaries with JPMorgan Chase Bank, N.A. as Lender (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on November 12, 2019).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.29**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774920006370/ex_178389.htm">Employment Agreement by and between InfuSystem Holdings, Inc. and Thomas Ruiz, effective January 3, 2018 (incorporated by reference to Exhibit 10.30 to the Company&#8217;s Annual Report on Form 10-K (File No. 1-35020) filed on March 30, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.31**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774920001966/ex_171722.htm">Independent Contractor Agreement, effective February 5, 2020, by and between the Company and Wesley W. Winnekins (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on February 7, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.32**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774920004612/ex_176376.htm">Separation Agreement, dated March 5, 2020, by and between the Company and Greg Schulte (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K/A (File No. 1-35020) filed on March 9, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.33**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774920004978/ex_176801.htm">Employment Agreement, effective March 11, 2020, by and between the Company and Barry G. Steele (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on March 12, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.34**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774920011856/ex_188152.htm">Form of Performance Unit Award Agreement under the 2014 Equity Plan (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 27, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.35**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774920023787/ex_212648.htm">Composite Copy of InfuSystem Holdings, Inc. Employee Stock Purchase Plan, as amended (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 1-35020) filed on November 13, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.36**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774920018661/ex_201350.htm">Amendment to Employment Agreement, dated August 24, 2020, between the Company and Richard DiIorio (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on August 25, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.37**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774920018661/ex_201351.htm">Restricted Stock Unit Agreement (Service-Based), dated August 24, 2020, between the Company and Richard DiIorio (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on August 25, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.38**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774920018661/ex_201352.htm">Restricted Stock Unit Agreement (Performance-Based), dated August 24, 2020, between the Company and Richard DiIorio (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on August 25, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.39</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921002490/ex_225362.htm">Credit Agreement dated as of February 5, 2021 among InfuSystem Holdings, Inc., InfuSystem Holdings USA, Inc., InfuSystem, Inc., First Biomedical, Inc., IFC LLC, the other Loan Parties thereto, and JPMorgan Chase Bank, N.A. as Administrative Agent, Sole Bookrunner and Sole Lead Arranger (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on February 11, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.40</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921002490/ex_225361.htm">Pledge and Security Agreement entered into as of February 5, 2021 by and among InfuSystem Holdings, Inc., InfuSystem Holdings USA, Inc., InfuSystem, Inc., First Biomedical, Inc. and IFC LLC, and JPMorgan Chase Bank, N.A., in its capacity as administrative agent for the other lenders party to the Credit Agreement (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on February 11, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.41**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921004662/ex_231141.htm">Restricted Stock Unit Agreement (Service-Based), dated March 1, 2021, between the Company and Carrie Lachance (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on March 2, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.42**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921012599/ex_250181.htm">InfuSystem Holdings, Inc. 2021 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Registration Statement on Form S-8 (File No. 333-256231) filed on May 18, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.43**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921013182/ex_252604.htm">Form of Nonqualified Stock Option Agreement (Non-employee Directors) under the InfuSystem Holdings, Inc. 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 24, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.44**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921013182/ex_252605.htm">Form of Nonqualified Stock Option Agreement (Employees) under the InfuSystem Holdings, Inc. 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 24, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.45**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921013182/ex_252606.htm">Form of Restricted Stock Unit Agreement (Time-based Vesting) under the InfuSystem Holdings, Inc. 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 24, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.754%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.46**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921013182/ex_252607.htm">Form of Restricted Stock Unit Agreement (Performance-based Vesting) under the InfuSystem Holdings, Inc. 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 24, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.47**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921013182/ex_252608.htm">First Amended and Restated Employment Agreement, dated May 24, 2021, by and between the Company and Richard DiIorio (incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 24, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.48**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921013182/ex_252609.htm">First Amended and Restated Employment Agreement, dated May 24, 2021, by and between the Company and Barry Steele (incorporated by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 24, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.49**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921013182/ex_252610.htm">First Amended and Restated Employment Agreement, dated May 24, 2021, by and between the Company and Carrie Lachance (incorporated by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 24, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.50**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921013182/ex_252611.htm">First Amended and Restated Employment Agreement, dated May 24, 2021, by and between the Company and Jeannine Sheehan (incorporated by reference to Exhibit 10.8 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 24, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.51**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774921013182/ex_252612.htm">First Amended and Restated Employment Agreement, dated May 24, 2021, by and between the Company and Tom Ruiz (incorporated by reference to Exhibit 10.9 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 24, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="infu-20211231xexx211.htm">21.1*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="infu-20211231xexx211.htm">Subsidiaries of InfuSystem Holdings, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="infu-20211231xexx231.htm">23.1*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="infu-20211231xexx231.htm">Consent of BDO USA, LLP</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="infu-20211231xexx311.htm">31.1*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="infu-20211231xexx311.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="infu-20211231xexx312.htm">31.2*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="infu-20211231xexx312.htm">Certification of&#160;Principal Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="infu-20211231xexx321.htm">32.1*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="infu-20211231xexx321.htm">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="infu-20211231xexx322.htm">32.2*</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="infu-20211231xexx322.htm">Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Management contract or compensatory plan, contract or arrangement.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_202"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;10-K Summary</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="i9e717b65c1e3405d850ef6e342b20071_205"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9e717b65c1e3405d850ef6e342b20071_7">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:50.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INFUSYSTEM HOLDINGS, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 15, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;RICHARD DiIORIO</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard DiIorio</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer and Director<br/>(Principal Executive Officer)</span></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacity and on the dates indicated.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:50.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 15, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;RICHARD DiIORIO</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard DiIorio</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer and Director<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 15, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;BARRY STEELE </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Barry Steele</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer<br/>(Principal Accounting and Financial Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 15, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;CARRIE LACHANCE</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrie Lachance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Operating Officer<br/>Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 15, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;SCOTT SHUDA </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Scott Shuda</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman of the Board<br/>Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 15, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;GREGG LEHMAN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gregg Lehman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 15, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;PAUL GENDRON</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Paul Gendron</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 15, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;DARRELL MONTGOMERY</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Darrell Montgomery</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 15, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;CHRISTOPHER SANSONE</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Christopher Sansone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Director</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>infu-20211231xexx211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i684fb90917dd4c2699a591ea152490b2_38"></div><div style="min-height:49.96pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT 21.1</font></div><div style="margin-top:9pt;text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries of the Registrant</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.279%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Jurisdiction&#160;of&#160;Organization&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">InfuSystem, Inc.</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Biomedical, Inc.</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</font></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFC, LLC</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InfuSystem&#160;Holdings&#160;USA,&#160;Inc.</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div><font><br></font></div><div style="height:61.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>infu-20211231xexx231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i71cc5308dfa24456bfd1a19df78e2b94_38"></div><div style="min-height:49.96pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT 23.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">InfuSystem Holdings, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rochester Hills, Michigan</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hereby consent to the incorporation by reference, in the Registration Statements on Form S-8 (Nos. 333-195929, 333-195930, 333-217090, 333-226872, 333-232146 and 333-256231) of InfuSystem Holdings, Inc. of our report dated </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 15, 2022,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the consolidated financial statements, which appears in this Form 10-K.</font></div><div><font><br></font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; BDO USA, LLP </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Troy, Michigan </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;15, 2022</font></div><div><font><br></font></div><div style="height:61.61pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>infu-20211231xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifa24c753474148aea6b2466f517fdc8e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION BY OFFICER</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Richard DiIorio, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this Form 10-K for the year ended December 31, 2021 of InfuSystem Holdings, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 15, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; RICHARD DiIORIO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard DiIorio</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer and Director</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>infu-20211231xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib51f46f3770a4c068f8a8f12593c10ca_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION BY OFFICER</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Barry Steele, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this Form 10-K for the year ended December 31, 2021 of InfuSystem Holdings, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 15, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; BARRY STEELE</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Barry Steele</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>infu-20211231xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibbb39c6b6ebf44a6b072b4d2d657a1e6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF OFFICER</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of InfuSystem Holdings, Inc., a Delaware corporation (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Form 10-K for the year ended December 31, 2021 (the &#8220;Report&#8221;) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 15, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; RICHARD DiIORIO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard DiIorio</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer and Director</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>infu-20211231xexx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifddddeb6c31945c79fc18654d0530989_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF OFFICER</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of InfuSystem Holdings, Inc., a Delaware corporation (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Form 10-K for the year ended December 31, 2021 (the &#8220;Report&#8221;) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 15, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; BARRY STEELE</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Barry Steele</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>infu-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5045cdd8-3e33-4b1e-9c96-436a6a424439,g:4f22e797-67c4-4a22-8bb5-b3bf69d58fcf-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:infu="http://infusystem.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://infusystem.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="infu-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="infu-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="infu-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="infu-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://infusystem.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://infusystem.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://infusystem.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002004 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementofOperationsandComprehensiveIncome" roleURI="http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome">
        <link:definition>1003005 - Statement - Consolidated Statement of Operations and Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1004006 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://infusystem.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1005007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandNatureofOperations" roleURI="http://infusystem.com/role/BasisofPresentationandNatureofOperations">
        <link:definition>2101101 - Disclosure - Basis of Presentation and Nature of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandNatureofOperationsDetails" roleURI="http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails">
        <link:definition>2402401 - Disclosure - Basis of Presentation and Nature of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesEarningsPerShareTables" roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesEarningsPerShareTables">
        <link:definition>2305301 - Disclosure - Summary of Significant Accounting Policies - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails" roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Summary of Income and Share Amounts Utilized to Calculate Basic and Diluted Net Income Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://infusystem.com/role/BusinessCombinations">
        <link:definition>2108103 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://infusystem.com/role/BusinessCombinationsTables">
        <link:definition>2309302 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsDetailsTextual" roleURI="http://infusystem.com/role/BusinessCombinationsDetailsTextual">
        <link:definition>2410404 - Disclosure - Business Combinations (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsPurchasePriceAllocationDetails" roleURI="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails">
        <link:definition>2411405 - Disclosure - Business Combinations - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>2412406 - Disclosure - Business Combinations - Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsIntangibleAssetsAcquiredDetails" roleURI="http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails">
        <link:definition>2413407 - Disclosure - Business Combinations - Intangible Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsProFormaInformationDetails" roleURI="http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails">
        <link:definition>2414408 - Disclosure - Business Combinations - Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://infusystem.com/role/RevenueRecognition">
        <link:definition>2115104 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://infusystem.com/role/RevenueRecognitionTables">
        <link:definition>2316303 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDetailsTextual" roleURI="http://infusystem.com/role/RevenueRecognitionDetailsTextual">
        <link:definition>2417409 - Disclosure - Revenue Recognition (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails" roleURI="http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails">
        <link:definition>2418410 - Disclosure - Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalEquipment" roleURI="http://infusystem.com/role/MedicalEquipment">
        <link:definition>2119105 - Disclosure - Medical Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalEquipmentTables" roleURI="http://infusystem.com/role/MedicalEquipmentTables">
        <link:definition>2320304 - Disclosure - Medical Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalEquipmentDetailsTextual" roleURI="http://infusystem.com/role/MedicalEquipmentDetailsTextual">
        <link:definition>2421411 - Disclosure - Medical Equipment (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalEquipmentSummaryofMedicalEquipmentDetails" roleURI="http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails">
        <link:definition>2422412 - Disclosure - Medical Equipment - Summary of Medical Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://infusystem.com/role/PropertyandEquipment">
        <link:definition>2123106 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://infusystem.com/role/PropertyandEquipmentTables">
        <link:definition>2324305 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentScheduleofPropertyandEquipmentDetails" roleURI="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails">
        <link:definition>2425413 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetailsTextual" roleURI="http://infusystem.com/role/PropertyandEquipmentDetailsTextual">
        <link:definition>2426414 - Disclosure - Property and Equipment (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://infusystem.com/role/GoodwillandIntangibleAssets">
        <link:definition>2127107 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>2328306 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsDetailsTextual" roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual">
        <link:definition>2429415 - Disclosure - Goodwill and Intangible Assets (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGoodwillDetails" roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails">
        <link:definition>2430416 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails">
        <link:definition>2431417 - Disclosure - Goodwill and Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1" roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1">
        <link:definition>2431417 - Disclosure - Goodwill and Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails" roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails">
        <link:definition>2432418 - Disclosure - Goodwill and Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://infusystem.com/role/Debt">
        <link:definition>2133108 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://infusystem.com/role/DebtTables">
        <link:definition>2334307 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetailsTextual" roleURI="http://infusystem.com/role/DebtDetailsTextual">
        <link:definition>2435419 - Disclosure - Debt (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" roleURI="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails">
        <link:definition>2436420 - Disclosure - Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofFutureMaturitiesofLoansDetails" roleURI="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails">
        <link:definition>2437421 - Disclosure - Debt - Summary of Future Maturities of Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofCompanysCurrentandLongtermDebtDetails" roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails">
        <link:definition>2438422 - Disclosure - Debt - Summary of Company's Current and Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofCompanysCurrentandLongtermDebtDetails_1" roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1">
        <link:definition>2438422 - Disclosure - Debt - Summary of Company's Current and Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivities" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities">
        <link:definition>2139109 - Disclosure - Derivative Financial Instruments and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivitiesTables" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables">
        <link:definition>2340308 - Disclosure - Derivative Financial Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual">
        <link:definition>2441423 - Disclosure - Derivative Financial Instruments and Hedging Activities (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails">
        <link:definition>2442424 - Disclosure - Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails">
        <link:definition>2443425 - Disclosure - Derivative Financial Instruments and Hedging Activities - Designated as Hedging Instruments in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://infusystem.com/role/IncomeTaxes">
        <link:definition>2144110 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://infusystem.com/role/IncomeTaxesTables">
        <link:definition>2345309 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://infusystem.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2446426 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeBeforeIncomeTaxesDetails" roleURI="http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails">
        <link:definition>2447427 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsDetails" roleURI="http://infusystem.com/role/IncomeTaxesComponentsDetails">
        <link:definition>2448428 - Disclosure - Income Taxes - Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesValuationAllowanceDetails" roleURI="http://infusystem.com/role/IncomeTaxesValuationAllowanceDetails">
        <link:definition>2449429 - Disclosure - Income Taxes - Valuation Allowance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveTaxRateDetails" roleURI="http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails">
        <link:definition>2450430 - Disclosure - Income Taxes - Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesCarryForwardsDetails" roleURI="http://infusystem.com/role/IncomeTaxesCarryForwardsDetails">
        <link:definition>2451431 - Disclosure - Income Taxes - Carry Forwards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://infusystem.com/role/CommitmentsandContingencies">
        <link:definition>2152111 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://infusystem.com/role/Leases">
        <link:definition>2153112 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://infusystem.com/role/LeasesTables">
        <link:definition>2354310 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetailsTextual" roleURI="http://infusystem.com/role/LeasesDetailsTextual">
        <link:definition>2455432 - Disclosure - Leases (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://infusystem.com/role/LeasesLeaseCostDetails">
        <link:definition>2456433 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowDetails" roleURI="http://infusystem.com/role/LeasesSupplementalCashFlowDetails">
        <link:definition>2457434 - Disclosure - Leases - Supplemental Cash Flow (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesWeightedAverageTableDetails" roleURI="http://infusystem.com/role/LeasesWeightedAverageTableDetails">
        <link:definition>2458435 - Disclosure - Leases - Weighted Average Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>2459436 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>2459436 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensation" roleURI="http://infusystem.com/role/SharebasedCompensation">
        <link:definition>2160113 - Disclosure - Share-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationTables" roleURI="http://infusystem.com/role/SharebasedCompensationTables">
        <link:definition>2361311 - Disclosure - Share-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationNarrativeDetails" roleURI="http://infusystem.com/role/SharebasedCompensationNarrativeDetails">
        <link:definition>2462437 - Disclosure - Share-based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationStockbasedCompensationDetails" roleURI="http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails">
        <link:definition>2463438 - Disclosure - Share-based Compensation - Stock-based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails" roleURI="http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails">
        <link:definition>2464439 - Disclosure - Share-based Compensation - Summary of Restricted Share Activity, Excluding Company's Employee Stock Purchase Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationPSUActivityDetails" roleURI="http://infusystem.com/role/SharebasedCompensationPSUActivityDetails">
        <link:definition>2465440 - Disclosure - Share-based Compensation - PSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationSummaryofActivityRelatingtoCompanysESPPProgramDetails" roleURI="http://infusystem.com/role/SharebasedCompensationSummaryofActivityRelatingtoCompanysESPPProgramDetails">
        <link:definition>2466441 - Disclosure - Share-based Compensation - Summary of Activity Relating to Company's ESPP Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensation2014and2021PlanActivityDetails" roleURI="http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails">
        <link:definition>2467442 - Disclosure - Share-based Compensation - 2014 and 2021 Plan Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails" roleURI="http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails">
        <link:definition>2468443 - Disclosure - Share-based Compensation - Schedule of Share-based Compensation Expense Based on Fair Value of Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformation" roleURI="http://infusystem.com/role/BusinessSegmentInformation">
        <link:definition>2169114 - Disclosure - Business Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationTables" roleURI="http://infusystem.com/role/BusinessSegmentInformationTables">
        <link:definition>2370312 - Disclosure - Business Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationDetails" roleURI="http://infusystem.com/role/BusinessSegmentInformationDetails">
        <link:definition>2471444 - Disclosure - Business Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandOther" roleURI="http://infusystem.com/role/EmployeeBenefitPlansandOther">
        <link:definition>2172115 - Disclosure - Employee Benefit Plans and Other</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandOtherDetails" roleURI="http://infusystem.com/role/EmployeeBenefitPlansandOtherDetails">
        <link:definition>2473445 - Disclosure - Employee Benefit Plans and Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COVID19" roleURI="http://infusystem.com/role/COVID19">
        <link:definition>2174116 - Disclosure - COVID-19</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="infu_EquipmentLineMember" abstract="true" name="EquipmentLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_PaycheckProtectionProgramCaresActMember" abstract="true" name="PaycheckProtectionProgramCaresActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_CBFloatingRateLoanMember" abstract="true" name="CBFloatingRateLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_PaymentsToAcquireMedicalEquipment" abstract="false" name="PaymentsToAcquireMedicalEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_LineOfCreditFacilityBorrowingBase" abstract="false" name="LineOfCreditFacilityBorrowingBase" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" abstract="false" name="DebtInstrumentCovenantMinimumFixedCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="infu_CreditFacilityMember" abstract="true" name="CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_The2015CreditAgreementMember" abstract="true" name="The2015CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_Covid19Abstract" abstract="true" name="Covid19Abstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_MedicalEquipmentMember" abstract="true" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_DMEServicesSegmentMember" abstract="true" name="DMEServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_RevenuesInternal" abstract="false" name="RevenuesInternal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentInRentalServicesGross" abstract="false" name="MedicalEquipmentInRentalServicesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentAndPropertyDisclosureTextBlock" abstract="false" name="MedicalEquipmentAndPropertyDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_FinancingAgreementMember" abstract="true" name="FinancingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" abstract="false" name="LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentForSaleOrRentalReserve" abstract="false" name="MedicalEquipmentForSaleOrRentalReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_OperatingLossCarryforwardsWithIndefiniteLife" abstract="false" name="OperatingLossCarryforwardsWithIndefiniteLife" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate" abstract="false" name="DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" abstract="false" name="PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_TreasuryStockPolicyPolicyTextBlock" abstract="false" name="TreasuryStockPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_DeferredTaxLiabilitiesRightOfUseAssets" abstract="false" name="DeferredTaxLiabilitiesRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_CBFloatingRateMember" abstract="true" name="CBFloatingRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_RemainingPreownershipNetOperatingLossCarryforwards" abstract="false" name="RemainingPreownershipNetOperatingLossCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_UnamortizedDebtIssuanceExpenseNoncurrent" abstract="false" name="UnamortizedDebtIssuanceExpenseNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentHeldForSaleOrRentalGross" abstract="false" name="MedicalEquipmentHeldForSaleOrRentalGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_MedicalEquipmentHeldForSaleOrRental" abstract="false" name="MedicalEquipmentHeldForSaleOrRental" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_LenderPrimeRate" abstract="false" name="LenderPrimeRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_DeferredTaxAssetsOperatingLeaseLiabilities" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_DepreciationExpenseRelatedToMedicalEquipment" abstract="false" name="DepreciationExpenseRelatedToMedicalEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_LongTermDebtGrossNoncurrent" abstract="false" name="LongTermDebtGrossNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_PercentageOfTotalDepreciationExpense" abstract="false" name="PercentageOfTotalDepreciationExpense" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_DeferredTaxAssetsValuationAllowanceRelease" abstract="false" name="DeferredTaxAssetsValuationAllowanceRelease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember" abstract="true" name="SharebasedPaymentArrangementExceedingMinimumThresholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_CashlessExerciseOfStockOptionsShares" abstract="false" name="CashlessExerciseOfStockOptionsShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="infu_DebtInstrumentCovenantMaximumLeverageRatio" abstract="false" name="DebtInstrumentCovenantMaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="infu_A2021EquityIncentivePlanMember" abstract="true" name="A2021EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_AmbulatoryPumpsMember" abstract="true" name="AmbulatoryPumpsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_A2014EquityIncentivePlanMember" abstract="true" name="A2014EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_LIBORRate" abstract="false" name="LIBORRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_RevenuesExternal" abstract="false" name="RevenuesExternal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="infu_OperatingLossCarryforwardsExpirationPeriods" abstract="false" name="OperatingLossCarryforwardsExpirationPeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="infu_EmployeeStockPurchasePlanDiscountRate" abstract="false" name="EmployeeStockPurchasePlanDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_DeferredTaxAssetsValuationAllowanceIncrease" abstract="false" name="DeferredTaxAssetsValuationAllowanceIncrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_FilAMedMember" abstract="true" name="FilAMedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_EurodollarLoanMember" abstract="true" name="EurodollarLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" abstract="false" name="BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentAbstract" abstract="true" name="MedicalEquipmentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" abstract="false" name="EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="infu_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="infu_OBHealthcareMember" abstract="true" name="OBHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_ScheduleOfMedicalEquipmentTableTextBlock" abstract="false" name="ScheduleOfMedicalEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_UnamortizedDebtIssuanceExpenseCurrent" abstract="false" name="UnamortizedDebtIssuanceExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_DeferredTaxAssetsValuationAllowanceExpense" abstract="false" name="DeferredTaxAssetsValuationAllowanceExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" abstract="false" name="CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" abstract="false" name="MedicalEquipmentInRentalServicesAccumulatedDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentPolicyTextBlock" abstract="false" name="MedicalEquipmentPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_MedicalEquipmentInRentalServicesUsefulLife" abstract="false" name="MedicalEquipmentInRentalServicesUsefulLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="infu_RevenueRecognitionCostOfRevenuePolicyTextBlock" abstract="false" name="RevenueRecognitionCostOfRevenuePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum" abstract="false" name="EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_NetOperatingLossCarryforwardsLimitationOnUse" abstract="false" name="NetOperatingLossCarryforwardsLimitationOnUse" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_OperatingLossCarryforwardsWithADefiniteLife" abstract="false" name="OperatingLossCarryforwardsWithADefiniteLife" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_LongtermDebtGrossCurrent" abstract="false" name="LongtermDebtGrossCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_The2021CreditAgreementMember" abstract="true" name="The2021CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_PhysicianAndCustomerRelationshipsMember" abstract="true" name="PhysicianAndCustomerRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_SmithsMedicalIncMember" abstract="true" name="SmithsMedicalIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_MedicalEquipmentNet" abstract="false" name="MedicalEquipmentNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="infu_ITSSegmentMember" abstract="true" name="ITSSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_MedicalEquipmentInRentalServicesReserve" abstract="false" name="MedicalEquipmentInRentalServicesReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" abstract="false" name="NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_NPWTMedicalEquipmentMember" abstract="true" name="NPWTMedicalEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_EffectOfCovid19PandemicTextBlock" abstract="false" name="EffectOfCovid19PandemicTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_GreaterOfPrimeRateOrLIBORPlus25Member" abstract="true" name="GreaterOfPrimeRateOrLIBORPlus25Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_The2019EquipmentLineMember" abstract="true" name="The2019EquipmentLineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_CorporateAndEliminationsMember" abstract="true" name="CorporateAndEliminationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_NumberOfContractsWithThirdParties" abstract="false" name="NumberOfContractsWithThirdParties" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="infu_PercentageIncreaseInNumberOfContracts" abstract="false" name="PercentageIncreaseInNumberOfContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_NoncashActivitiesProceedsFromStockPlans" abstract="false" name="NoncashActivitiesProceedsFromStockPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_CardinalHealthIncMember" abstract="true" name="CardinalHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_DirectPayerRentalsMember" abstract="true" name="DirectPayerRentalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_NumberOfFinancialInstitutions" abstract="false" name="NumberOfFinancialInstitutions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember" abstract="true" name="SharebasedPaymentArrangementAchievingMinimumThresholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_ABRLoansMember" abstract="true" name="ABRLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_InformationTechnologySoftwareMember" abstract="true" name="InformationTechnologySoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_LandlordReserves" abstract="false" name="LandlordReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember" abstract="true" name="ThreeTermNotesAssociatedWithThe2015CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_ThirdPartyPayerRentalMember" abstract="true" name="ThirdPartyPayerRentalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_WorkingCapital" abstract="false" name="WorkingCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" abstract="false" name="ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" abstract="false" name="MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance" abstract="false" name="StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>infu-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5045cdd8-3e33-4b1e-9c96-436a6a424439,g:4f22e797-67c4-4a22-8bb5-b3bf69d58fcf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://infusystem.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="infu-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_714aef45-3891-4611-abc4-97df9df09856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1bcfbe68-0210-4524-892c-c1c2c8801815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_714aef45-3891-4611-abc4-97df9df09856" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1bcfbe68-0210-4524-892c-c1c2c8801815" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_86b05583-d1e0-4d6e-9aa0-eb66a7000fad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_714aef45-3891-4611-abc4-97df9df09856" xlink:to="loc_us-gaap_AccountsPayableCurrent_86b05583-d1e0-4d6e-9aa0-eb66a7000fad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ce096f05-f5ab-4161-9db2-ef4214d13732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_714aef45-3891-4611-abc4-97df9df09856" xlink:to="loc_us-gaap_LongTermDebtCurrent_ce096f05-f5ab-4161-9db2-ef4214d13732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_06f8f3a6-0a76-4e19-9b2e-dab3f05dfa22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_9213859a-a5a3-4a19-abb1-390f87b6102f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06f8f3a6-0a76-4e19-9b2e-dab3f05dfa22" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_9213859a-a5a3-4a19-abb1-390f87b6102f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8c92fdd0-f47c-4ab1-a2a7-edd32b52e5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06f8f3a6-0a76-4e19-9b2e-dab3f05dfa22" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8c92fdd0-f47c-4ab1-a2a7-edd32b52e5c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_253381d1-a9bb-4257-ba0e-2cc7d61d7192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06f8f3a6-0a76-4e19-9b2e-dab3f05dfa22" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_253381d1-a9bb-4257-ba0e-2cc7d61d7192" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_973a6075-6774-45be-a338-c8b197b004a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06f8f3a6-0a76-4e19-9b2e-dab3f05dfa22" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_973a6075-6774-45be-a338-c8b197b004a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_c2cc9425-96a9-4e57-961e-7306cf9d58af" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06f8f3a6-0a76-4e19-9b2e-dab3f05dfa22" xlink:to="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_c2cc9425-96a9-4e57-961e-7306cf9d58af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8e569ee2-a7c0-490f-a2a2-8f97fc17278c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06f8f3a6-0a76-4e19-9b2e-dab3f05dfa22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8e569ee2-a7c0-490f-a2a2-8f97fc17278c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cfe5b018-29be-44c2-9120-6fccb719740e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06f8f3a6-0a76-4e19-9b2e-dab3f05dfa22" xlink:to="loc_us-gaap_AssetsCurrent_cfe5b018-29be-44c2-9120-6fccb719740e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental_9acad590-df69-4e8c-9996-3e60959aaaeb" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06f8f3a6-0a76-4e19-9b2e-dab3f05dfa22" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRental_9acad590-df69-4e8c-9996-3e60959aaaeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2f368bd6-fc7a-4497-a4ac-05e7602ae421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06f8f3a6-0a76-4e19-9b2e-dab3f05dfa22" xlink:to="loc_us-gaap_Goodwill_2f368bd6-fc7a-4497-a4ac-05e7602ae421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_97e287c2-56dd-44fc-978e-0c12d07b646d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_66dd37e5-4aa1-4240-90e2-7ea6caafbd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_97e287c2-56dd-44fc-978e-0c12d07b646d" xlink:to="loc_us-gaap_InventoryNet_66dd37e5-4aa1-4240-90e2-7ea6caafbd9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_3ca68d37-83ec-4ec8-8b65-031198c85d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_97e287c2-56dd-44fc-978e-0c12d07b646d" xlink:to="loc_us-gaap_OtherAssetsCurrent_3ca68d37-83ec-4ec8-8b65-031198c85d27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_eb6c41ec-fe46-4f23-ac7a-98c5d90cea41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_97e287c2-56dd-44fc-978e-0c12d07b646d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_eb6c41ec-fe46-4f23-ac7a-98c5d90cea41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_561e5bee-ed28-4a9d-8fba-fc4a30b9faf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_97e287c2-56dd-44fc-978e-0c12d07b646d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_561e5bee-ed28-4a9d-8fba-fc4a30b9faf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9341210e-ca0c-4a0d-a4b6-fe1761c9b047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b86ce997-4299-45ca-8581-3e6bdc48600e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9341210e-ca0c-4a0d-a4b6-fe1761c9b047" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b86ce997-4299-45ca-8581-3e6bdc48600e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_894508ca-3c5d-4159-a402-ff8697aa77ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9341210e-ca0c-4a0d-a4b6-fe1761c9b047" xlink:to="loc_us-gaap_LiabilitiesCurrent_894508ca-3c5d-4159-a402-ff8697aa77ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_eaadecad-b1ed-454e-b9cc-cbdf493f1d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9341210e-ca0c-4a0d-a4b6-fe1761c9b047" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_eaadecad-b1ed-454e-b9cc-cbdf493f1d82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4f7a63f7-a363-4fa4-a43f-805463911716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_950f5b9c-07d3-425a-8066-329f520e2aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4f7a63f7-a363-4fa4-a43f-805463911716" xlink:to="loc_us-gaap_StockholdersEquity_950f5b9c-07d3-425a-8066-329f520e2aad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8cbca900-8c97-47e0-b748-dc192d8c56de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4f7a63f7-a363-4fa4-a43f-805463911716" xlink:to="loc_us-gaap_Liabilities_8cbca900-8c97-47e0-b748-dc192d8c56de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1df4932a-3546-41e3-bc97-5574023783c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_458640f5-2c40-4ca9-bac9-5ca6ce58da8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1df4932a-3546-41e3-bc97-5574023783c3" xlink:to="loc_us-gaap_CommonStockValue_458640f5-2c40-4ca9-bac9-5ca6ce58da8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_8759f060-2c3d-424b-b933-aa2fcfd7327a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1df4932a-3546-41e3-bc97-5574023783c3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_8759f060-2c3d-424b-b933-aa2fcfd7327a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5b859d38-b0bf-40d1-b050-0e6f137085f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1df4932a-3546-41e3-bc97-5574023783c3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5b859d38-b0bf-40d1-b050-0e6f137085f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1c6e4c2c-c8fe-48e2-9aa4-cf8748591b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1df4932a-3546-41e3-bc97-5574023783c3" xlink:to="loc_us-gaap_PreferredStockValue_1c6e4c2c-c8fe-48e2-9aa4-cf8748591b44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_220da11e-7070-4f0f-97fd-efb49e65eae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1df4932a-3546-41e3-bc97-5574023783c3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_220da11e-7070-4f0f-97fd-efb49e65eae8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome" xlink:type="simple" xlink:href="infu-20211231.xsd#ConsolidatedStatementofOperationsandComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e6f449e0-59bd-48ac-9a6e-265f8550ac22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_fd29c63e-2606-4dea-8917-5cd21d1008fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e6f449e0-59bd-48ac-9a6e-265f8550ac22" xlink:to="loc_us-gaap_OperatingExpenses_fd29c63e-2606-4dea-8917-5cd21d1008fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c78707ae-0f74-4ad0-89fd-1c2ed1a0376a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e6f449e0-59bd-48ac-9a6e-265f8550ac22" xlink:to="loc_us-gaap_GrossProfit_c78707ae-0f74-4ad0-89fd-1c2ed1a0376a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_07dbf99c-8c34-49ba-ab91-d7384a26ca7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ce2d035-3e1e-4caa-86fc-acc43870124c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_07dbf99c-8c34-49ba-ab91-d7384a26ca7e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ce2d035-3e1e-4caa-86fc-acc43870124c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d695914d-583e-4607-872d-d939171ee681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_07dbf99c-8c34-49ba-ab91-d7384a26ca7e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d695914d-583e-4607-872d-d939171ee681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ed6bd92-b28f-43b2-ac94-92de6a5758cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2c7eb0f1-2085-4322-8e97-d7fd5d9b68ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ed6bd92-b28f-43b2-ac94-92de6a5758cc" xlink:to="loc_us-gaap_InterestExpense_2c7eb0f1-2085-4322-8e97-d7fd5d9b68ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a349f697-9dda-4eb7-9348-fd45c6b2ffdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ed6bd92-b28f-43b2-ac94-92de6a5758cc" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a349f697-9dda-4eb7-9348-fd45c6b2ffdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0b14e56b-39e4-4b2a-9053-600ef66fd6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ed6bd92-b28f-43b2-ac94-92de6a5758cc" xlink:to="loc_us-gaap_OperatingIncomeLoss_0b14e56b-39e4-4b2a-9053-600ef66fd6f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e20219d2-eec2-4b17-9f69-b26ef94aaeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6eea0336-91ea-4a0a-979b-a647b2a1ee7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e20219d2-eec2-4b17-9f69-b26ef94aaeb4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6eea0336-91ea-4a0a-979b-a647b2a1ee7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3d43ae41-cf72-4d42-a01d-52f2960dd066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e20219d2-eec2-4b17-9f69-b26ef94aaeb4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3d43ae41-cf72-4d42-a01d-52f2960dd066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_b33a8bec-3504-411e-95bd-a282f246da01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e20219d2-eec2-4b17-9f69-b26ef94aaeb4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_b33a8bec-3504-411e-95bd-a282f246da01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_8730dcc7-864c-4154-8d99-5cba7c8c0e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e20219d2-eec2-4b17-9f69-b26ef94aaeb4" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_8730dcc7-864c-4154-8d99-5cba7c8c0e0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5ddeb645-41a8-45c3-b79f-7be547da7a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6663f870-5773-4f74-a264-b5248d775d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5ddeb645-41a8-45c3-b79f-7be547da7a24" xlink:to="loc_us-gaap_NetIncomeLoss_6663f870-5773-4f74-a264-b5248d775d50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_7a618f33-28db-4126-a8be-a0e960bd92a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5ddeb645-41a8-45c3-b79f-7be547da7a24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_7a618f33-28db-4126-a8be-a0e960bd92a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_e93cc960-1714-440b-96f9-fbb68095bbb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5ddeb645-41a8-45c3-b79f-7be547da7a24" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_e93cc960-1714-440b-96f9-fbb68095bbb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d76316ac-06cf-44ff-a57a-afbe25071ead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3aece774-5b8f-47b7-80d3-5a67974158a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d76316ac-06cf-44ff-a57a-afbe25071ead" xlink:to="loc_us-gaap_Revenues_3aece774-5b8f-47b7-80d3-5a67974158a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_adbf8ef8-3acc-467b-b5a9-6db2e10f31f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d76316ac-06cf-44ff-a57a-afbe25071ead" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_adbf8ef8-3acc-467b-b5a9-6db2e10f31f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="infu-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d3d837df-edea-4922-a332-f217ee1cdc19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_c7963131-feb2-4636-aa2b-9dec84bb30fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d3d837df-edea-4922-a332-f217ee1cdc19" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_c7963131-feb2-4636-aa2b-9dec84bb30fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireMedicalEquipment_32ddd8dd-feb5-4bc8-b0e5-334b7316043e" xlink:href="infu-20211231.xsd#infu_PaymentsToAcquireMedicalEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d3d837df-edea-4922-a332-f217ee1cdc19" xlink:to="loc_infu_PaymentsToAcquireMedicalEquipment_32ddd8dd-feb5-4bc8-b0e5-334b7316043e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5e4b991c-6383-40b9-9ece-9840c9a5cf13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d3d837df-edea-4922-a332-f217ee1cdc19" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5e4b991c-6383-40b9-9ece-9840c9a5cf13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_f762a7e2-138a-4255-aaac-69418397ec15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d3d837df-edea-4922-a332-f217ee1cdc19" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_f762a7e2-138a-4255-aaac-69418397ec15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f1b5d95d-5e25-42d5-9ee7-e86e78c2c361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_04af0efb-bbda-42d4-91f2-e25319cc6c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f1b5d95d-5e25-42d5-9ee7-e86e78c2c361" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_04af0efb-bbda-42d4-91f2-e25319cc6c85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8a768360-2952-4499-8c39-8d9adf5318e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f1b5d95d-5e25-42d5-9ee7-e86e78c2c361" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8a768360-2952-4499-8c39-8d9adf5318e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cee26808-f5e7-43b9-9a98-bcb9cdd0abb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f1b5d95d-5e25-42d5-9ee7-e86e78c2c361" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cee26808-f5e7-43b9-9a98-bcb9cdd0abb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a4683975-c55e-4381-9f4d-cbd45e74b12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1b5e1561-c68d-428f-80dc-bf287d91708a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a4683975-c55e-4381-9f4d-cbd45e74b12f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1b5e1561-c68d-428f-80dc-bf287d91708a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_bf4fa799-603c-4972-9ee5-03e35d590d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a4683975-c55e-4381-9f4d-cbd45e74b12f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_bf4fa799-603c-4972-9ee5-03e35d590d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2eaa1e47-2f5c-43d7-9347-e359bccaf378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a4683975-c55e-4381-9f4d-cbd45e74b12f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2eaa1e47-2f5c-43d7-9347-e359bccaf378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_37b77d64-cf1c-471e-b41c-09f2ff43d662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a4683975-c55e-4381-9f4d-cbd45e74b12f" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_37b77d64-cf1c-471e-b41c-09f2ff43d662" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_029f89c9-b871-45cf-b912-d0b78a27f628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a4683975-c55e-4381-9f4d-cbd45e74b12f" xlink:to="loc_us-gaap_ProceedsFromStockPlans_029f89c9-b871-45cf-b912-d0b78a27f628" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_52b4e475-66dc-4523-95c3-5d1e4bb93b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a4683975-c55e-4381-9f4d-cbd45e74b12f" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_52b4e475-66dc-4523-95c3-5d1e4bb93b1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_578cbe89-76d7-478d-8f6b-61b595508390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_578cbe89-76d7-478d-8f6b-61b595508390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_030511d5-bbeb-4276-afd6-e51038e8f858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_030511d5-bbeb-4276-afd6-e51038e8f858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_300c481c-9724-4e98-9a8a-c1447aa57e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_300c481c-9724-4e98-9a8a-c1447aa57e6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_cf887d75-825c-4d10-9b4c-cdc488cd02e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_cf887d75-825c-4d10-9b4c-cdc488cd02e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_db258a09-bdc5-44d1-af87-318453facb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_db258a09-bdc5-44d1-af87-318453facb1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6219b5cf-8aba-430a-a975-582240cb96bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_Depreciation_6219b5cf-8aba-430a-a975-582240cb96bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a31b7187-be43-44d1-89c4-20efa01c571d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_ShareBasedCompensation_a31b7187-be43-44d1-89c4-20efa01c571d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_37b305ba-a1ec-4306-9ecc-6bac12574408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_37b305ba-a1ec-4306-9ecc-6bac12574408" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f71a5d61-dbae-4780-9f63-3b4499d703fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_NetIncomeLoss_f71a5d61-dbae-4780-9f63-3b4499d703fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2d7c2a67-007c-4da4-9cca-55be0795aede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2d7c2a67-007c-4da4-9cca-55be0795aede" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2a7c45a4-36f7-4f36-8c8e-f8047e652826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2a7c45a4-36f7-4f36-8c8e-f8047e652826" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_81390230-c938-460b-964a-ed2698bc3d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_81390230-c938-460b-964a-ed2698bc3d77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_cc1f2013-dc15-400a-b777-f0e1865facb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_cc1f2013-dc15-400a-b777-f0e1865facb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_1f3668c7-c728-4e1d-863a-9f2093d12beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1a49372-548c-4b98-8d73-6695bc6ebc81" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_1f3668c7-c728-4e1d-863a-9f2093d12beb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_13bf06ef-226a-420a-aa01-eae57eacb839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a91b0998-11b8-4aef-96a1-58a77176539e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_13bf06ef-226a-420a-aa01-eae57eacb839" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a91b0998-11b8-4aef-96a1-58a77176539e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7e52bc1c-e471-4f87-8d1d-09b7db499c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_13bf06ef-226a-420a-aa01-eae57eacb839" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7e52bc1c-e471-4f87-8d1d-09b7db499c49" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ecbaa6fe-732e-4ad0-ba75-e3235ef0b072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_a40273fd-ed4a-4c22-9c5a-a2b13129c20a" xlink:href="infu-20211231.xsd#infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ecbaa6fe-732e-4ad0-ba75-e3235ef0b072" xlink:to="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_a40273fd-ed4a-4c22-9c5a-a2b13129c20a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_021e41c4-db2c-402f-82b6-468721cc66c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ecbaa6fe-732e-4ad0-ba75-e3235ef0b072" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_021e41c4-db2c-402f-82b6-468721cc66c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_WorkingCapital_ad837bca-f396-4de3-ac80-d43c83a57127" xlink:href="infu-20211231.xsd#infu_WorkingCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ecbaa6fe-732e-4ad0-ba75-e3235ef0b072" xlink:to="loc_infu_WorkingCapital_ad837bca-f396-4de3-ac80-d43c83a57127" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c986bc1a-b308-4500-9b48-7a5cb02656e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_526f1290-e2f1-4ee2-9331-cbe94d1edea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c986bc1a-b308-4500-9b48-7a5cb02656e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_526f1290-e2f1-4ee2-9331-cbe94d1edea5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45b087fc-149b-4dbf-8b6b-20ba9ed15bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c986bc1a-b308-4500-9b48-7a5cb02656e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45b087fc-149b-4dbf-8b6b-20ba9ed15bb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a643ba9e-e965-4a2d-908c-b5b537cc231f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c986bc1a-b308-4500-9b48-7a5cb02656e8" xlink:to="loc_us-gaap_Goodwill_a643ba9e-e965-4a2d-908c-b5b537cc231f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e37024b3-8020-44c5-9ea2-0e6e247c6d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c986bc1a-b308-4500-9b48-7a5cb02656e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e37024b3-8020-44c5-9ea2-0e6e247c6d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c9e382cc-ccc5-4f76-870e-e47fd71168f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c986bc1a-b308-4500-9b48-7a5cb02656e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c9e382cc-ccc5-4f76-870e-e47fd71168f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_6653637e-ef6b-414e-ae4f-91e8d13609f1" xlink:href="infu-20211231.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c986bc1a-b308-4500-9b48-7a5cb02656e8" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_6653637e-ef6b-414e-ae4f-91e8d13609f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_9fc9d995-d80d-4c8a-9efa-e1000307c4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c986bc1a-b308-4500-9b48-7a5cb02656e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_9fc9d995-d80d-4c8a-9efa-e1000307c4d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_191bad2e-f374-40a4-a540-1dbed5e0286d" xlink:href="infu-20211231.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c986bc1a-b308-4500-9b48-7a5cb02656e8" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_191bad2e-f374-40a4-a540-1dbed5e0286d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#MedicalEquipmentSummaryofMedicalEquipmentDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentNet_76b45385-0347-416a-9d33-b2d850fb807c" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_2ac5a2bf-853a-4c4a-8daf-d94fe2613170" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentNet_76b45385-0347-416a-9d33-b2d850fb807c" xlink:to="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_2ac5a2bf-853a-4c4a-8daf-d94fe2613170" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental_74658060-7a40-4990-b1a0-0ce1e5240575" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentNet_76b45385-0347-416a-9d33-b2d850fb807c" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRental_74658060-7a40-4990-b1a0-0ce1e5240575" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental_10a85656-6f1c-47b2-b3db-1d0fbe47a60f" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentForSaleOrRentalReserve_ceb8f590-087e-4721-8aa9-e2882b052410" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentForSaleOrRentalReserve"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentHeldForSaleOrRental_10a85656-6f1c-47b2-b3db-1d0fbe47a60f" xlink:to="loc_infu_MedicalEquipmentForSaleOrRentalReserve_ceb8f590-087e-4721-8aa9-e2882b052410" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross_a5a7bd12-c674-4d51-a50f-cb3ec6668379" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentHeldForSaleOrRentalGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentHeldForSaleOrRental_10a85656-6f1c-47b2-b3db-1d0fbe47a60f" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross_a5a7bd12-c674-4d51-a50f-cb3ec6668379" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_b56a256c-5625-4981-8f34-a1ec02cba449" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_b7aefce8-4338-4d04-9dc8-68ac9e428584" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_b56a256c-5625-4981-8f34-a1ec02cba449" xlink:to="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_b7aefce8-4338-4d04-9dc8-68ac9e428584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesReserve_a20e22d2-9174-4a4a-befd-788c1d122664" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesReserve"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_b56a256c-5625-4981-8f34-a1ec02cba449" xlink:to="loc_infu_MedicalEquipmentInRentalServicesReserve_a20e22d2-9174-4a4a-befd-788c1d122664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesGross_f897f042-dd65-4274-aaab-6324dc54ecbf" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_b56a256c-5625-4981-8f34-a1ec02cba449" xlink:to="loc_infu_MedicalEquipmentInRentalServicesGross_f897f042-dd65-4274-aaab-6324dc54ecbf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fd5d8cca-b90a-440c-a82d-5f23418489ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_06d1ba74-c683-46cb-be83-0904f5fd2d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_fd5d8cca-b90a-440c-a82d-5f23418489ae" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_06d1ba74-c683-46cb-be83-0904f5fd2d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_760e95c6-c86c-430a-b0ee-59c1cdbdbf9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_fd5d8cca-b90a-440c-a82d-5f23418489ae" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_760e95c6-c86c-430a-b0ee-59c1cdbdbf9d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_afd50bc7-798c-4f4c-b721-3679aa45a24b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cf9a0f54-429a-4730-83d0-569ee07f0ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_afd50bc7-798c-4f4c-b721-3679aa45a24b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cf9a0f54-429a-4730-83d0-569ee07f0ed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ba9e51e1-c4d9-4f90-99c9-dd286c5853a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_afd50bc7-798c-4f4c-b721-3679aa45a24b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ba9e51e1-c4d9-4f90-99c9-dd286c5853a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_900ef290-cf6d-4113-89f4-503aee343aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_28f77b13-be65-4a61-93b6-c3dd9edf746b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_900ef290-cf6d-4113-89f4-503aee343aa5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_28f77b13-be65-4a61-93b6-c3dd9edf746b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2846c56a-6be3-4fbc-ac49-29f7bd08b68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_900ef290-cf6d-4113-89f4-503aee343aa5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2846c56a-6be3-4fbc-ac49-29f7bd08b68f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_83bc2324-4956-4cac-9eff-84a4e8d9ac13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_bdb0e0f8-5265-45e4-9749-e53d77c182a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_83bc2324-4956-4cac-9eff-84a4e8d9ac13" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_bdb0e0f8-5265-45e4-9749-e53d77c182a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7d375d4d-12cc-4c89-b80c-42f7a0a6aa74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_83bc2324-4956-4cac-9eff-84a4e8d9ac13" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7d375d4d-12cc-4c89-b80c-42f7a0a6aa74" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3ccda12f-71cb-4fba-bf0a-f626356c4b52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d7dfc4ae-f69a-4220-aeae-b034a05efdbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3ccda12f-71cb-4fba-bf0a-f626356c4b52" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d7dfc4ae-f69a-4220-aeae-b034a05efdbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7f0dc292-0492-4176-9af2-bec208388c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3ccda12f-71cb-4fba-bf0a-f626356c4b52" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7f0dc292-0492-4176-9af2-bec208388c72" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_66b46d90-67a0-4a00-9bbc-2e4a7b8f421f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_4a807290-e9e6-4800-a6fd-227bec2be5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_66b46d90-67a0-4a00-9bbc-2e4a7b8f421f" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_4a807290-e9e6-4800-a6fd-227bec2be5cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LandlordReserves_c85ccbb4-432d-4e00-8b7c-5bd7b8f8929e" xlink:href="infu-20211231.xsd#infu_LandlordReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_66b46d90-67a0-4a00-9bbc-2e4a7b8f421f" xlink:to="loc_infu_LandlordReserves_c85ccbb4-432d-4e00-8b7c-5bd7b8f8929e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_77b7b02a-1373-4b12-8d7b-e1468594cd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_66b46d90-67a0-4a00-9bbc-2e4a7b8f421f" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_77b7b02a-1373-4b12-8d7b-e1468594cd9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f51133c2-ee9a-4af2-8656-010249883391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_66b46d90-67a0-4a00-9bbc-2e4a7b8f421f" xlink:to="loc_us-gaap_LineOfCredit_f51133c2-ee9a-4af2-8656-010249883391" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofFutureMaturitiesofLoansDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9db1cd34-c3d1-4a5f-ad56-75824c0303ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_f53e7589-6f12-4a98-a1cc-a0ce6980c5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9db1cd34-c3d1-4a5f-ad56-75824c0303ab" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_f53e7589-6f12-4a98-a1cc-a0ce6980c5bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_37da445e-30d8-46b0-959e-77cddc6bd8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9db1cd34-c3d1-4a5f-ad56-75824c0303ab" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_37da445e-30d8-46b0-959e-77cddc6bd8fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4ade3ea5-107b-4d43-8afa-af311b2db39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9db1cd34-c3d1-4a5f-ad56-75824c0303ab" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4ade3ea5-107b-4d43-8afa-af311b2db39d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0a63d02f-3082-4b6f-8203-0b9f623171a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9db1cd34-c3d1-4a5f-ad56-75824c0303ab" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0a63d02f-3082-4b6f-8203-0b9f623171a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_15c258aa-538a-4aa9-bb31-02b0c3e466db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9db1cd34-c3d1-4a5f-ad56-75824c0303ab" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_15c258aa-538a-4aa9-bb31-02b0c3e466db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_84485087-4da3-41fd-aef9-16e8e52e8940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9db1cd34-c3d1-4a5f-ad56-75824c0303ab" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_84485087-4da3-41fd-aef9-16e8e52e8940" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofCompanysCurrentandLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ea43e6e3-8220-4204-b5cb-9d64a178cfb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongtermDebtGrossCurrent_26d3a629-bf1d-4f6b-9d55-45faa0c3b0a1" xlink:href="infu-20211231.xsd#infu_LongtermDebtGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtCurrent_ea43e6e3-8220-4204-b5cb-9d64a178cfb2" xlink:to="loc_infu_LongtermDebtGrossCurrent_26d3a629-bf1d-4f6b-9d55-45faa0c3b0a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_4053668d-410a-4a10-a817-fc2506760c26" xlink:href="infu-20211231.xsd#infu_UnamortizedDebtIssuanceExpenseCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtCurrent_ea43e6e3-8220-4204-b5cb-9d64a178cfb2" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_4053668d-410a-4a10-a817-fc2506760c26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_45c09244-a65f-4e6c-ac73-064dbfd0057c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongtermDebtGrossCurrent_b242d977-565c-4d4d-a73d-fc66a3566bd7" xlink:href="infu-20211231.xsd#infu_LongtermDebtGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_45c09244-a65f-4e6c-ac73-064dbfd0057c" xlink:to="loc_infu_LongtermDebtGrossCurrent_b242d977-565c-4d4d-a73d-fc66a3566bd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtGrossNoncurrent_1b8b266f-4cbd-4ce3-a7b3-c7bded52d383" xlink:href="infu-20211231.xsd#infu_LongTermDebtGrossNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_45c09244-a65f-4e6c-ac73-064dbfd0057c" xlink:to="loc_infu_LongTermDebtGrossNoncurrent_1b8b266f-4cbd-4ce3-a7b3-c7bded52d383" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_a1e28b14-14ee-4452-8348-760bb7ba5527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_ab4f9d82-3487-49c0-8ff9-3b62e0e5a7a0" xlink:href="infu-20211231.xsd#infu_UnamortizedDebtIssuanceExpenseNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense_a1e28b14-14ee-4452-8348-760bb7ba5527" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_ab4f9d82-3487-49c0-8ff9-3b62e0e5a7a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_fda68351-c826-48bd-acc7-ffa079a55ee7" xlink:href="infu-20211231.xsd#infu_UnamortizedDebtIssuanceExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense_a1e28b14-14ee-4452-8348-760bb7ba5527" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_fda68351-c826-48bd-acc7-ffa079a55ee7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e10eedb7-ef4b-4e33-97a9-554eebb7bb02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtGrossNoncurrent_d74cc599-055d-4959-9b71-2598dc9a6f71" xlink:href="infu-20211231.xsd#infu_LongTermDebtGrossNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_e10eedb7-ef4b-4e33-97a9-554eebb7bb02" xlink:to="loc_infu_LongTermDebtGrossNoncurrent_d74cc599-055d-4959-9b71-2598dc9a6f71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_a45deeab-1140-4e29-90e1-f443e0a8602a" xlink:href="infu-20211231.xsd#infu_UnamortizedDebtIssuanceExpenseNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_e10eedb7-ef4b-4e33-97a9-554eebb7bb02" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_a45deeab-1140-4e29-90e1-f443e0a8602a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_990e925e-7ec3-4ec4-b6ea-73a007dae8af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8355553c-6961-447b-8104-33a419361b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_990e925e-7ec3-4ec4-b6ea-73a007dae8af" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8355553c-6961-447b-8104-33a419361b6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_4e89ae61-fb2d-42ae-8a82-a0717e896fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_990e925e-7ec3-4ec4-b6ea-73a007dae8af" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_4e89ae61-fb2d-42ae-8a82-a0717e896fb4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofCompanysCurrentandLongtermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_46cbec99-35a2-4678-be90-0d2507b4164c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ac496d2c-bab1-41d4-bf84-0cb6032401ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_46cbec99-35a2-4678-be90-0d2507b4164c" xlink:to="loc_us-gaap_LongTermDebtCurrent_ac496d2c-bab1-41d4-bf84-0cb6032401ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_35e64644-6b61-472e-bbfb-65109fd89b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_46cbec99-35a2-4678-be90-0d2507b4164c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_35e64644-6b61-472e-bbfb-65109fd89b23" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e5277e9b-1a06-4ed7-9443-efd638764cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_62dedf0b-1f5e-4259-bfa9-3d2649b69808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e5277e9b-1a06-4ed7-9443-efd638764cb5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_62dedf0b-1f5e-4259-bfa9-3d2649b69808" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9143ac24-5a94-4b1a-a628-f2eede7103ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e5277e9b-1a06-4ed7-9443-efd638764cb5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_9143ac24-5a94-4b1a-a628-f2eede7103ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesComponentsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesComponentsDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/IncomeTaxesComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_c419aa6a-c05d-4bbc-ba25-9e8ab027d726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_05530ca3-4b33-46a2-8a8e-de49c06eb70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_c419aa6a-c05d-4bbc-ba25-9e8ab027d726" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_05530ca3-4b33-46a2-8a8e-de49c06eb70b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_136665bd-a83b-42ba-af28-d666689dd8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_c419aa6a-c05d-4bbc-ba25-9e8ab027d726" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_136665bd-a83b-42ba-af28-d666689dd8cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c664e220-58a4-461c-93e9-840197c67778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_aec954e0-d74b-47d3-ac8e-ac077ddd560c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c664e220-58a4-461c-93e9-840197c67778" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_aec954e0-d74b-47d3-ac8e-ac077ddd560c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_6deed9d8-7a8a-4582-9cb3-927a3aaae523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c664e220-58a4-461c-93e9-840197c67778" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_6deed9d8-7a8a-4582-9cb3-927a3aaae523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_8110d56e-3ab6-4aab-a815-932a1c3f8583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c664e220-58a4-461c-93e9-840197c67778" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_8110d56e-3ab6-4aab-a815-932a1c3f8583" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_92c64b40-bf7d-4476-9432-916314edf925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b8abe7aa-0087-405c-a0ec-5ab884402974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_92c64b40-bf7d-4476-9432-916314edf925" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b8abe7aa-0087-405c-a0ec-5ab884402974" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_35dd84e8-aa2c-450d-99d9-80c3a0beeb87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_92c64b40-bf7d-4476-9432-916314edf925" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_35dd84e8-aa2c-450d-99d9-80c3a0beeb87" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesEffectiveTaxRateDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a8fa48dc-20cf-45f5-aa47-0561089da64c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_8a9ee225-2ad4-43ea-9f28-4c8a0d0a0b73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a8fa48dc-20cf-45f5-aa47-0561089da64c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_8a9ee225-2ad4-43ea-9f28-4c8a0d0a0b73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_34d3c5b2-420b-4990-a08b-8d362702c8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a8fa48dc-20cf-45f5-aa47-0561089da64c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_34d3c5b2-420b-4990-a08b-8d362702c8b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_83c6e419-d5a7-40ef-8edf-b674d8dbf3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a8fa48dc-20cf-45f5-aa47-0561089da64c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_83c6e419-d5a7-40ef-8edf-b674d8dbf3f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_95d83cec-2525-46e0-93b7-f8f31dc2400b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a8fa48dc-20cf-45f5-aa47-0561089da64c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_95d83cec-2525-46e0-93b7-f8f31dc2400b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_05af14ce-e5fa-439b-8183-80f09ccead20" xlink:href="infu-20211231.xsd#infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a8fa48dc-20cf-45f5-aa47-0561089da64c" xlink:to="loc_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_05af14ce-e5fa-439b-8183-80f09ccead20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_80127815-9576-4c9f-aa1c-9338ee03eff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a8fa48dc-20cf-45f5-aa47-0561089da64c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_80127815-9576-4c9f-aa1c-9338ee03eff2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesCarryForwardsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesCarryForwardsDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/IncomeTaxesCarryForwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_53060d44-8a00-4633-92c4-55e1c982e641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_04c0eaf7-530e-4f80-b63a-abbc98ec16a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_53060d44-8a00-4633-92c4-55e1c982e641" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_04c0eaf7-530e-4f80-b63a-abbc98ec16a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_4dfac665-e8b3-4a7d-bf1f-0bbe7c34882d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_53060d44-8a00-4633-92c4-55e1c982e641" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_4dfac665-e8b3-4a7d-bf1f-0bbe7c34882d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_f2da0979-727f-4365-ab9a-d5e37898d9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_e470b95f-e036-4bf9-a3aa-afe26c703784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f2da0979-727f-4365-ab9a-d5e37898d9cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_e470b95f-e036-4bf9-a3aa-afe26c703784" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_02fdc2ef-1f66-4f77-bb16-b1ce662aa4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f2da0979-727f-4365-ab9a-d5e37898d9cb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_02fdc2ef-1f66-4f77-bb16-b1ce662aa4aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxLiabilitiesRightOfUseAssets_23432fc5-25d7-4db0-b9d5-cb7e54e2dc8c" xlink:href="infu-20211231.xsd#infu_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f2da0979-727f-4365-ab9a-d5e37898d9cb" xlink:to="loc_infu_DeferredTaxLiabilitiesRightOfUseAssets_23432fc5-25d7-4db0-b9d5-cb7e54e2dc8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_922e5953-dd83-4f35-8053-6db8c16a606d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_922e5953-dd83-4f35-8053-6db8c16a606d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_ac5bf85d-246f-4eb5-b221-a4dd9ee72d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_ac5bf85d-246f-4eb5-b221-a4dd9ee72d65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d53ecba2-65dc-49b8-839d-33b575ead684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d53ecba2-65dc-49b8-839d-33b575ead684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_dadccc17-cdb3-43a6-a7a7-592d88fa840c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_dadccc17-cdb3-43a6-a7a7-592d88fa840c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_47ad8a80-c440-48b5-b8bd-cb9c8b05360d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_47ad8a80-c440-48b5-b8bd-cb9c8b05360d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_8d17795b-d1db-46f0-8a78-c8d28f3a75b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_8d17795b-d1db-46f0-8a78-c8d28f3a75b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_ab60c9ee-015d-40ba-a07a-bc3514ec1ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_ab60c9ee-015d-40ba-a07a-bc3514ec1ff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxAssetsOperatingLeaseLiabilities_9fce15c5-ea25-4ffb-ae56-bc7556a5df25" xlink:href="infu-20211231.xsd#infu_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:to="loc_infu_DeferredTaxAssetsOperatingLeaseLiabilities_9fce15c5-ea25-4ffb-ae56-bc7556a5df25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_103a69cf-cc4d-4a7f-9417-bfec7dec6be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_103a69cf-cc4d-4a7f-9417-bfec7dec6be4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther_69b67e77-98c0-4f43-baa0-e0b31298e157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_74d73114-7606-43e7-8925-d22ac6ee45e9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther_69b67e77-98c0-4f43-baa0-e0b31298e157" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_2d6a001e-a8ff-4648-b4a6-09116fbcdabf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_b76bacd2-8679-4008-8f24-3d36d5543df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_2d6a001e-a8ff-4648-b4a6-09116fbcdabf" xlink:to="loc_us-gaap_OperatingLeaseCost_b76bacd2-8679-4008-8f24-3d36d5543df0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_9dfd5eb5-e1a5-42d9-b583-f60f62489e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_2d6a001e-a8ff-4648-b4a6-09116fbcdabf" xlink:to="loc_us-gaap_VariableLeaseCost_9dfd5eb5-e1a5-42d9-b583-f60f62489e1c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_106e0542-1453-438e-b5de-b8be3cb58780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8b499b1c-8229-4fce-9158-6a6c1db7169c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_106e0542-1453-438e-b5de-b8be3cb58780" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8b499b1c-8229-4fce-9158-6a6c1db7169c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cd108e6e-238e-4a6f-bb8b-ddf9780f1893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_106e0542-1453-438e-b5de-b8be3cb58780" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cd108e6e-238e-4a6f-bb8b-ddf9780f1893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_06e8baf5-0dc7-4193-8b4e-ba88cacbb514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_106e0542-1453-438e-b5de-b8be3cb58780" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_06e8baf5-0dc7-4193-8b4e-ba88cacbb514" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7fb9f603-66b9-452e-bed4-6f0c6efc1e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_106e0542-1453-438e-b5de-b8be3cb58780" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7fb9f603-66b9-452e-bed4-6f0c6efc1e96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8c2e63e3-9c00-4066-9a04-2bee472956f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_106e0542-1453-438e-b5de-b8be3cb58780" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8c2e63e3-9c00-4066-9a04-2bee472956f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d6519c1a-6330-4969-ba9c-12420d8bd5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_106e0542-1453-438e-b5de-b8be3cb58780" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d6519c1a-6330-4969-ba9c-12420d8bd5f6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c1fa0bb7-2c7d-487c-bac9-297f8339a5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_04fee3ea-411e-41e2-bc7b-80f0203d0d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c1fa0bb7-2c7d-487c-bac9-297f8339a5d8" xlink:to="loc_us-gaap_OperatingLeaseLiability_04fee3ea-411e-41e2-bc7b-80f0203d0d5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7017d8e5-1cb8-4cbd-838d-470abeb033fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c1fa0bb7-2c7d-487c-bac9-297f8339a5d8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7017d8e5-1cb8-4cbd-838d-470abeb033fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationStockbasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2ca4a671-ddda-41d3-ae1b-c2588a5e45a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionPlanExpense_e564b9c3-e47e-4ccd-8cef-5ea6b1bed1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_2ca4a671-ddda-41d3-ae1b-c2588a5e45a2" xlink:to="loc_us-gaap_StockOptionPlanExpense_e564b9c3-e47e-4ccd-8cef-5ea6b1bed1a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_15ff4788-4ff9-411e-b26d-73b19237b485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_2ca4a671-ddda-41d3-ae1b-c2588a5e45a2" xlink:to="loc_us-gaap_RestrictedStockExpense_15ff4788-4ff9-411e-b26d-73b19237b485" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_57185a6d-498f-426a-84c2-b3f03d05c869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesInternal_40c80ba5-6864-48a2-b6bc-ae3ded4c7ebb" xlink:href="infu-20211231.xsd#infu_RevenuesInternal"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_57185a6d-498f-426a-84c2-b3f03d05c869" xlink:to="loc_infu_RevenuesInternal_40c80ba5-6864-48a2-b6bc-ae3ded4c7ebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesExternal_aec4e93b-3b97-4ae5-96c2-a6bdec55c530" xlink:href="infu-20211231.xsd#infu_RevenuesExternal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_57185a6d-498f-426a-84c2-b3f03d05c869" xlink:to="loc_infu_RevenuesExternal_aec4e93b-3b97-4ae5-96c2-a6bdec55c530" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>infu-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5045cdd8-3e33-4b1e-9c96-436a6a424439,g:4f22e797-67c4-4a22-8bb5-b3bf69d58fcf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="infu-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i97dec5f2640c41f3b3a46d3bc07dc55f_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_75640772-5e09-40a0-a583-1bbd8d13fdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75640772-5e09-40a0-a583-1bbd8d13fdd5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b078a757-3fff-409b-98f2-14b42563842c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_SharesOutstanding_b078a757-3fff-409b-98f2-14b42563842c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9f250a88-7d2c-4144-b52f-ce6a58225af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockholdersEquity_9f250a88-7d2c-4144-b52f-ce6a58225af9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_6644e682-bc1c-4b98-a034-a6762a72cfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_6644e682-bc1c-4b98-a034-a6762a72cfe1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_fd77bee2-11d5-490c-b144-836d17fa6218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_fd77bee2-11d5-490c-b144-836d17fa6218" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ced3ce0d-f61b-4ee5-9283-886692d6ca42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ced3ce0d-f61b-4ee5-9283-886692d6ca42" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e358eddb-214f-49d1-b8dd-4c6492b7157f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e358eddb-214f-49d1-b8dd-4c6492b7157f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_ef4103c6-8227-4ab6-8a55-fc28e867ad82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_ef4103c6-8227-4ab6-8a55-fc28e867ad82" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7aa9e989-ce3e-43bb-921e-30b0853f8a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7aa9e989-ce3e-43bb-921e-30b0853f8a82" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_6f617a77-a9bd-4d48-883f-ec40cf66eeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_6f617a77-a9bd-4d48-883f-ec40cf66eeb6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_beb9e566-96f3-4862-b8e8-17342e61842b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_beb9e566-96f3-4862-b8e8-17342e61842b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_e533d6e1-5c96-48aa-b8d6-9ca6ced3a695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_e533d6e1-5c96-48aa-b8d6-9ca6ced3a695" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_56947079-2580-447a-a1c3-9bec05a8df41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_56947079-2580-447a-a1c3-9bec05a8df41" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_0dcff556-52b9-4f69-9800-a9ebd0e79fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_0dcff556-52b9-4f69-9800-a9ebd0e79fbb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e4338126-a986-428d-ad87-1e00b64538bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e4338126-a986-428d-ad87-1e00b64538bd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e18a44e5-dba1-400a-8556-76cb84573dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e18a44e5-dba1-400a-8556-76cb84573dd9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_faa536d3-4203-4932-8fcb-1730e4022df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_NetIncomeLoss_faa536d3-4203-4932-8fcb-1730e4022df4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4277d976-0e15-4756-8ed9-137842eb5586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_40106775-633c-421a-b050-6f537540dc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bcec6f2b-4152-4721-9913-a1fcff112d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_75640772-5e09-40a0-a583-1bbd8d13fdd5" xlink:to="loc_us-gaap_StatementTable_bcec6f2b-4152-4721-9913-a1fcff112d37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c4d3401b-ccd0-44ec-acac-3d9ed2d8747f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bcec6f2b-4152-4721-9913-a1fcff112d37" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c4d3401b-ccd0-44ec-acac-3d9ed2d8747f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c4d3401b-ccd0-44ec-acac-3d9ed2d8747f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c4d3401b-ccd0-44ec-acac-3d9ed2d8747f" xlink:to="loc_us-gaap_EquityComponentDomain_c4d3401b-ccd0-44ec-acac-3d9ed2d8747f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c4d3401b-ccd0-44ec-acac-3d9ed2d8747f" xlink:to="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_660d70be-fbdd-4171-82b2-0d5a782e4a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:to="loc_us-gaap_CommonStockMember_660d70be-fbdd-4171-82b2-0d5a782e4a1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f48861c7-885d-48bc-ba6b-b368eee8d325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f48861c7-885d-48bc-ba6b-b368eee8d325" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d4269ee8-2093-4250-899b-dbfea656c77e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:to="loc_us-gaap_RetainedEarningsMember_d4269ee8-2093-4250-899b-dbfea656c77e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b1e7df04-5357-4662-9360-3831972d26bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b1e7df04-5357-4662-9360-3831972d26bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_31124ad1-3dcb-4b74-9b30-bfacd7fabb94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:to="loc_us-gaap_TreasuryStockMember_31124ad1-3dcb-4b74-9b30-bfacd7fabb94" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BasisofPresentationandNatureofOperationsDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails" xlink:type="extended" id="i71da41e9a3004daf828e696e83cf0716_BasisofPresentationandNatureofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_852f10fb-82f4-4a7e-84ce-0c5c5fbfe3de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b9947507-53d5-4646-942e-09bfb62774f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_852f10fb-82f4-4a7e-84ce-0c5c5fbfe3de" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b9947507-53d5-4646-942e-09bfb62774f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_852f10fb-82f4-4a7e-84ce-0c5c5fbfe3de" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e7e07e4f-9091-4fe9-a7e4-6a1fb8ecd296" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_srt_ProductOrServiceAxis_e7e07e4f-9091-4fe9-a7e4-6a1fb8ecd296" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e7e07e4f-9091-4fe9-a7e4-6a1fb8ecd296_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e7e07e4f-9091-4fe9-a7e4-6a1fb8ecd296" xlink:to="loc_srt_ProductsAndServicesDomain_e7e07e4f-9091-4fe9-a7e4-6a1fb8ecd296_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c2525239-5b22-4c45-9ac7-32c548d57eb3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e7e07e4f-9091-4fe9-a7e4-6a1fb8ecd296" xlink:to="loc_srt_ProductsAndServicesDomain_c2525239-5b22-4c45-9ac7-32c548d57eb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_AmbulatoryPumpsMember_9f749449-e266-41a3-b8df-7399cae76399" xlink:href="infu-20211231.xsd#infu_AmbulatoryPumpsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c2525239-5b22-4c45-9ac7-32c548d57eb3" xlink:to="loc_infu_AmbulatoryPumpsMember_9f749449-e266-41a3-b8df-7399cae76399" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NPWTMedicalEquipmentMember_6e9f1a9f-24b8-41eb-b29f-2566334e3bf8" xlink:href="infu-20211231.xsd#infu_NPWTMedicalEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c2525239-5b22-4c45-9ac7-32c548d57eb3" xlink:to="loc_infu_NPWTMedicalEquipmentMember_6e9f1a9f-24b8-41eb-b29f-2566334e3bf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d6a1f649-9d8d-4ccb-ad8b-ef0a8bbefdb7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_srt_RangeAxis_d6a1f649-9d8d-4ccb-ad8b-ef0a8bbefdb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d6a1f649-9d8d-4ccb-ad8b-ef0a8bbefdb7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d6a1f649-9d8d-4ccb-ad8b-ef0a8bbefdb7" xlink:to="loc_srt_RangeMember_d6a1f649-9d8d-4ccb-ad8b-ef0a8bbefdb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_da9f472a-e260-4c5c-b3e4-5531c33cc2e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d6a1f649-9d8d-4ccb-ad8b-ef0a8bbefdb7" xlink:to="loc_srt_RangeMember_da9f472a-e260-4c5c-b3e4-5531c33cc2e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_941dc0a2-0333-4e59-9ef7-c0e15f95baa9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_da9f472a-e260-4c5c-b3e4-5531c33cc2e9" xlink:to="loc_srt_MinimumMember_941dc0a2-0333-4e59-9ef7-c0e15f95baa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2713c915-b137-4898-9832-45198eb0feaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2713c915-b137-4898-9832-45198eb0feaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2713c915-b137-4898-9832-45198eb0feaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2713c915-b137-4898-9832-45198eb0feaf" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2713c915-b137-4898-9832-45198eb0feaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c3c4f071-adf5-446e-a23d-48ae2e9295df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2713c915-b137-4898-9832-45198eb0feaf" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c3c4f071-adf5-446e-a23d-48ae2e9295df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsProductLineMember_2371890d-d7df-42c5-a46a-a4643a4a27b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c3c4f071-adf5-446e-a23d-48ae2e9295df" xlink:to="loc_us-gaap_CostOfGoodsProductLineMember_2371890d-d7df-42c5-a46a-a4643a4a27b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6f2cb98c-9cfa-4c83-8f64-fef588816eab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6f2cb98c-9cfa-4c83-8f64-fef588816eab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6f2cb98c-9cfa-4c83-8f64-fef588816eab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6f2cb98c-9cfa-4c83-8f64-fef588816eab" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6f2cb98c-9cfa-4c83-8f64-fef588816eab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_95a3d3df-9db3-450e-af24-e5dd8dfee3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6f2cb98c-9cfa-4c83-8f64-fef588816eab" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_95a3d3df-9db3-450e-af24-e5dd8dfee3be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_f56566f2-9826-4f1f-baf2-4246147747da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_95a3d3df-9db3-450e-af24-e5dd8dfee3be" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_f56566f2-9826-4f1f-baf2-4246147747da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_2d515e09-d3cc-4115-8746-72156bf84305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_2d515e09-d3cc-4115-8746-72156bf84305" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_2d515e09-d3cc-4115-8746-72156bf84305_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_2d515e09-d3cc-4115-8746-72156bf84305" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_2d515e09-d3cc-4115-8746-72156bf84305_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_5aaa71cd-cd62-4437-a9a3-97e607dcd13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_2d515e09-d3cc-4115-8746-72156bf84305" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_5aaa71cd-cd62-4437-a9a3-97e607dcd13b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SmithsMedicalIncMember_4b039092-63ab-449f-a2c1-4d93d8c716df" xlink:href="infu-20211231.xsd#infu_SmithsMedicalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_5aaa71cd-cd62-4437-a9a3-97e607dcd13b" xlink:to="loc_infu_SmithsMedicalIncMember_4b039092-63ab-449f-a2c1-4d93d8c716df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CardinalHealthIncMember_a5a1ee0b-152c-4e1f-9a31-f4ee95a15c5b" xlink:href="infu-20211231.xsd#infu_CardinalHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_5aaa71cd-cd62-4437-a9a3-97e607dcd13b" xlink:to="loc_infu_CardinalHealthIncMember_a5a1ee0b-152c-4e1f-9a31-f4ee95a15c5b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i29405977dfe7494e88f8476efeb22f5d_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_725eb5f1-2c21-408a-b3f9-aef05376baa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_NumberOfReportableSegments_725eb5f1-2c21-408a-b3f9-aef05376baa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NumberOfFinancialInstitutions_af6a5fd4-7838-4896-8873-987a4a21110c" xlink:href="infu-20211231.xsd#infu_NumberOfFinancialInstitutions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_NumberOfFinancialInstitutions_af6a5fd4-7838-4896-8873-987a4a21110c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_95fb3884-fe17-400d-a80a-cbcfa6b015a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_95fb3884-fe17-400d-a80a-cbcfa6b015a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesUsefulLife_9261097c-5551-449f-b085-cc5bf29c0c2e" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_MedicalEquipmentInRentalServicesUsefulLife_9261097c-5551-449f-b085-cc5bf29c0c2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesReserve_a8a3c286-b4a5-4d56-a82a-7d16746ab7c8" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_MedicalEquipmentInRentalServicesReserve_a8a3c286-b4a5-4d56-a82a-7d16746ab7c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentForSaleOrRentalReserve_fd09da5b-46ba-4e35-b9d8-4e4d720095ab" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentForSaleOrRentalReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_MedicalEquipmentForSaleOrRentalReserve_fd09da5b-46ba-4e35-b9d8-4e4d720095ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8d430215-1628-43d4-9dc1-af3041f05460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8d430215-1628-43d4-9dc1-af3041f05460" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3c8cf933-b0cb-4fbd-ba24-ac72afae6345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3c8cf933-b0cb-4fbd-ba24-ac72afae6345" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_3ee08e89-fd26-4356-8272-98532b6b3b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_3ee08e89-fd26-4356-8272-98532b6b3b19" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_79861b6f-8e38-4535-9a30-3b49a66de935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_79861b6f-8e38-4535-9a30-3b49a66de935" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_fab0155c-0b31-488d-8812-00118b1401a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_fab0155c-0b31-488d-8812-00118b1401a2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8ad8b780-d288-4f6c-bb94-123537ea5dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8ad8b780-d288-4f6c-bb94-123537ea5dc2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_0f91de0d-7141-4034-b792-70b67f76422c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_0f91de0d-7141-4034-b792-70b67f76422c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NumberOfContractsWithThirdParties_1191aa13-0556-4283-8928-19784194125d" xlink:href="infu-20211231.xsd#infu_NumberOfContractsWithThirdParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_NumberOfContractsWithThirdParties_1191aa13-0556-4283-8928-19784194125d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PercentageIncreaseInNumberOfContracts_18c418aa-e9ac-40ae-8b45-4a129bb7064b" xlink:href="infu-20211231.xsd#infu_PercentageIncreaseInNumberOfContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_PercentageIncreaseInNumberOfContracts_18c418aa-e9ac-40ae-8b45-4a129bb7064b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_a8abb91d-693f-42f7-82e2-11610535341a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_a8abb91d-693f-42f7-82e2-11610535341a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d819b5a5-1820-4dbd-87bc-29ab9c1cff1c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:to="loc_srt_RangeAxis_d819b5a5-1820-4dbd-87bc-29ab9c1cff1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d819b5a5-1820-4dbd-87bc-29ab9c1cff1c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d819b5a5-1820-4dbd-87bc-29ab9c1cff1c" xlink:to="loc_srt_RangeMember_d819b5a5-1820-4dbd-87bc-29ab9c1cff1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f6e6b2d-4f6a-4548-a153-907d091c36f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d819b5a5-1820-4dbd-87bc-29ab9c1cff1c" xlink:to="loc_srt_RangeMember_6f6e6b2d-4f6a-4548-a153-907d091c36f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ca16e538-33ff-49db-acb7-c6480dfc75da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f6e6b2d-4f6a-4548-a153-907d091c36f6" xlink:to="loc_srt_MinimumMember_ca16e538-33ff-49db-acb7-c6480dfc75da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d2ce17a8-dd9e-4854-89a1-33d1b6cbca85" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f6e6b2d-4f6a-4548-a153-907d091c36f6" xlink:to="loc_srt_MaximumMember_d2ce17a8-dd9e-4854-89a1-33d1b6cbca85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bb532f16-f1c5-4ca0-87e8-058e325e84b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bb532f16-f1c5-4ca0-87e8-058e325e84b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bb532f16-f1c5-4ca0-87e8-058e325e84b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bb532f16-f1c5-4ca0-87e8-058e325e84b3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bb532f16-f1c5-4ca0-87e8-058e325e84b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d0c0a3e-40ed-4960-89b7-dd8272de0857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bb532f16-f1c5-4ca0-87e8-058e325e84b3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d0c0a3e-40ed-4960-89b7-dd8272de0857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_InformationTechnologySoftwareMember_a988d447-5e99-4aa0-ad5f-44ad02314a3a" xlink:href="infu-20211231.xsd#infu_InformationTechnologySoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d0c0a3e-40ed-4960-89b7-dd8272de0857" xlink:to="loc_infu_InformationTechnologySoftwareMember_a988d447-5e99-4aa0-ad5f-44ad02314a3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_ed17a463-938e-4d44-9b25-67825961b1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d0c0a3e-40ed-4960-89b7-dd8272de0857" xlink:to="loc_us-gaap_ComputerEquipmentMember_ed17a463-938e-4d44-9b25-67825961b1b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c5a714a1-99c7-4320-a01b-02aa9fdb4c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c5a714a1-99c7-4320-a01b-02aa9fdb4c37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5a714a1-99c7-4320-a01b-02aa9fdb4c37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c5a714a1-99c7-4320-a01b-02aa9fdb4c37" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5a714a1-99c7-4320-a01b-02aa9fdb4c37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c5a714a1-99c7-4320-a01b-02aa9fdb4c37" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PhysicianAndCustomerRelationshipsMember_2fa51ed1-d4b8-4b83-aa62-ba55f3abfd89" xlink:href="infu-20211231.xsd#infu_PhysicianAndCustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:to="loc_infu_PhysicianAndCustomerRelationshipsMember_2fa51ed1-d4b8-4b83-aa62-ba55f3abfd89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_db528b97-8265-4f88-9ed0-fc6d2877c5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_db528b97-8265-4f88-9ed0-fc6d2877c5a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_fae0e8b7-c301-415e-b0c4-a3be1f27c3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_fae0e8b7-c301-415e-b0c4-a3be1f27c3b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_26e16f24-4999-4888-aff2-4655b0b9016f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_26e16f24-4999-4888-aff2-4655b0b9016f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails" xlink:type="extended" id="i929e49c6d9a342d7a609e11b37a72c6d_SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b7c031f5-9c57-40f3-9a3c-f9731d8dcf23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a402597c-6048-4880-bcf3-11de2941e621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b7c031f5-9c57-40f3-9a3c-f9731d8dcf23" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a402597c-6048-4880-bcf3-11de2941e621" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f02128e9-08e1-488b-932c-7011130f80f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b7c031f5-9c57-40f3-9a3c-f9731d8dcf23" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f02128e9-08e1-488b-932c-7011130f80f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_421a6852-8651-4d43-8ea7-29c351a4ab66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f02128e9-08e1-488b-932c-7011130f80f1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_421a6852-8651-4d43-8ea7-29c351a4ab66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421a6852-8651-4d43-8ea7-29c351a4ab66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_421a6852-8651-4d43-8ea7-29c351a4ab66" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_421a6852-8651-4d43-8ea7-29c351a4ab66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aee186d5-e9d7-4b74-becb-80f5739a8481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_421a6852-8651-4d43-8ea7-29c351a4ab66" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aee186d5-e9d7-4b74-becb-80f5739a8481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b8b69664-544f-4551-8aec-bd6d4bbff806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aee186d5-e9d7-4b74-becb-80f5739a8481" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b8b69664-544f-4551-8aec-bd6d4bbff806" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BusinessCombinationsDetailsTextual" xlink:type="extended" id="i78f9c04e42474f0ea3ae0858795a48a6_BusinessCombinationsDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_75769747-2343-4bf4-af77-415d00e5b141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_75769747-2343-4bf4-af77-415d00e5b141" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9d059d7c-5790-445a-b10e-e2e583f3c88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9d059d7c-5790-445a-b10e-e2e583f3c88a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d40cb77e-29c4-4970-93e7-ca55b9f26474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d40cb77e-29c4-4970-93e7-ca55b9f26474" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_d0754f08-246f-4fab-9bd5-b3f6e0001bd2" xlink:href="infu-20211231.xsd#infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:to="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_d0754f08-246f-4fab-9bd5-b3f6e0001bd2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f2bc0c78-cd9d-44c2-9041-b1b92c8ad3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f2bc0c78-cd9d-44c2-9041-b1b92c8ad3fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f2bc0c78-cd9d-44c2-9041-b1b92c8ad3fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f2bc0c78-cd9d-44c2-9041-b1b92c8ad3fe" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f2bc0c78-cd9d-44c2-9041-b1b92c8ad3fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fe311e1c-8404-47f8-9e4c-8f564df1c6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f2bc0c78-cd9d-44c2-9041-b1b92c8ad3fe" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fe311e1c-8404-47f8-9e4c-8f564df1c6ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e2a4476-295b-4ca4-b585-7f4a0bc337d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fe311e1c-8404-47f8-9e4c-8f564df1c6ce" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e2a4476-295b-4ca4-b585-7f4a0bc337d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_81c549a6-4269-417e-a2a6-521e91ff46b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_81c549a6-4269-417e-a2a6-521e91ff46b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c549a6-4269-417e-a2a6-521e91ff46b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81c549a6-4269-417e-a2a6-521e91ff46b1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c549a6-4269-417e-a2a6-521e91ff46b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a00c0fa4-e2fa-476c-b8b7-c0a5e44ec0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81c549a6-4269-417e-a2a6-521e91ff46b1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a00c0fa4-e2fa-476c-b8b7-c0a5e44ec0cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_d96025cf-9eb0-4f88-8dc7-16d000627355" xlink:href="infu-20211231.xsd#infu_FilAMedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a00c0fa4-e2fa-476c-b8b7-c0a5e44ec0cb" xlink:to="loc_infu_FilAMedMember_d96025cf-9eb0-4f88-8dc7-16d000627355" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_7f2c4654-10e2-4bba-801d-26566ca39939" xlink:href="infu-20211231.xsd#infu_OBHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a00c0fa4-e2fa-476c-b8b7-c0a5e44ec0cb" xlink:to="loc_infu_OBHealthcareMember_7f2c4654-10e2-4bba-801d-26566ca39939" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ee121d14-55f2-4c0f-ab68-c8588a2cab90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ee121d14-55f2-4c0f-ab68-c8588a2cab90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ee121d14-55f2-4c0f-ab68-c8588a2cab90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ee121d14-55f2-4c0f-ab68-c8588a2cab90" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ee121d14-55f2-4c0f-ab68-c8588a2cab90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b831161-f39e-4a8a-a2cd-fe8fe0e63cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ee121d14-55f2-4c0f-ab68-c8588a2cab90" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b831161-f39e-4a8a-a2cd-fe8fe0e63cf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_6dfb7ada-9b40-4b5f-af0c-465fd729d8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b831161-f39e-4a8a-a2cd-fe8fe0e63cf0" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_6dfb7ada-9b40-4b5f-af0c-465fd729d8ed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended" id="i5ac3fbc84a5f48959bd83b4905d1edd1_BusinessCombinationsPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_611e64f5-a249-4ed6-be52-0b22e0747583" xlink:href="infu-20211231.xsd#infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:to="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_611e64f5-a249-4ed6-be52-0b22e0747583" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_WorkingCapital_8e1f53ad-367f-4b7c-8da1-fb4ffa6459d5" xlink:href="infu-20211231.xsd#infu_WorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:to="loc_infu_WorkingCapital_8e1f53ad-367f-4b7c-8da1-fb4ffa6459d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_7d17acf8-b00c-4a6b-b28e-caaf154e0431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_7d17acf8-b00c-4a6b-b28e-caaf154e0431" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7fb0eb23-4604-4506-93f6-7fd867aa2913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7fb0eb23-4604-4506-93f6-7fd867aa2913" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b53b1f7a-c850-4acb-8590-2a25d4c8e682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b53b1f7a-c850-4acb-8590-2a25d4c8e682" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_946b94a1-8f39-44bc-b103-722cb6293fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b53b1f7a-c850-4acb-8590-2a25d4c8e682" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_946b94a1-8f39-44bc-b103-722cb6293fbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_946b94a1-8f39-44bc-b103-722cb6293fbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_946b94a1-8f39-44bc-b103-722cb6293fbf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_946b94a1-8f39-44bc-b103-722cb6293fbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17935322-cf52-4614-a48d-349e8ae50dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_946b94a1-8f39-44bc-b103-722cb6293fbf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17935322-cf52-4614-a48d-349e8ae50dba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_b255a394-750e-45f1-9267-2612255fec1d" xlink:href="infu-20211231.xsd#infu_FilAMedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17935322-cf52-4614-a48d-349e8ae50dba" xlink:to="loc_infu_FilAMedMember_b255a394-750e-45f1-9267-2612255fec1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_958fef5a-d2d6-486f-a626-6893571e8576" xlink:href="infu-20211231.xsd#infu_OBHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17935322-cf52-4614-a48d-349e8ae50dba" xlink:to="loc_infu_OBHealthcareMember_958fef5a-d2d6-486f-a626-6893571e8576" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="ia79c8c5c05404b6d84e1ae6efedf830d_BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d0bfea9c-45a6-4d5a-8481-25c6d24658e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d0bfea9c-45a6-4d5a-8481-25c6d24658e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_541d3c98-d50e-48a6-9c49-5ce4a8fd1441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_541d3c98-d50e-48a6-9c49-5ce4a8fd1441" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_4edf44df-fb36-4254-8ebb-4d2dd887b46a" xlink:href="infu-20211231.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_4edf44df-fb36-4254-8ebb-4d2dd887b46a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_68caacae-5e4f-4313-bd2a-ec524be6c94a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_68caacae-5e4f-4313-bd2a-ec524be6c94a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_67ca1953-8ef3-4399-85ee-39e1d7c06ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_67ca1953-8ef3-4399-85ee-39e1d7c06ca6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6a00f659-5e02-4b9f-ad5d-022bcc6cf02f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_Goodwill_6a00f659-5e02-4b9f-ad5d-022bcc6cf02f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_69e7724c-4aff-4cbb-9721-e5602fad19d3" xlink:href="infu-20211231.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_69e7724c-4aff-4cbb-9721-e5602fad19d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_2e8d4a73-f3e2-4b78-9401-d9a616c20e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_2e8d4a73-f3e2-4b78-9401-d9a616c20e3b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9e1e3c9a-0579-42ca-93a5-3efeec7c19b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9e1e3c9a-0579-42ca-93a5-3efeec7c19b3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_572ea22b-5949-4528-8e77-c68e2fa495ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_572ea22b-5949-4528-8e77-c68e2fa495ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_25200d86-774b-4eea-bb47-140d7d0f0f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_572ea22b-5949-4528-8e77-c68e2fa495ad" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_25200d86-774b-4eea-bb47-140d7d0f0f67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25200d86-774b-4eea-bb47-140d7d0f0f67_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_25200d86-774b-4eea-bb47-140d7d0f0f67" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_25200d86-774b-4eea-bb47-140d7d0f0f67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_566fef17-eb2b-4d01-8df6-b33ed59c4e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_25200d86-774b-4eea-bb47-140d7d0f0f67" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_566fef17-eb2b-4d01-8df6-b33ed59c4e88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_ceb2b008-afd2-4a68-8fdf-7f981d69c8b6" xlink:href="infu-20211231.xsd#infu_FilAMedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_566fef17-eb2b-4d01-8df6-b33ed59c4e88" xlink:to="loc_infu_FilAMedMember_ceb2b008-afd2-4a68-8fdf-7f981d69c8b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_bf413e25-1cb6-4a62-bd0c-d9ac6362eea2" xlink:href="infu-20211231.xsd#infu_OBHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_566fef17-eb2b-4d01-8df6-b33ed59c4e88" xlink:to="loc_infu_OBHealthcareMember_bf413e25-1cb6-4a62-bd0c-d9ac6362eea2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsIntangibleAssetsAcquiredDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails" xlink:type="extended" id="i536a0b2eac5c46b4988b2e061af948bb_BusinessCombinationsIntangibleAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_dc156d73-64bc-4ba9-9650-591e9279c457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_26c3e66d-7c3b-4d37-95f2-b3ed35ce5995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dc156d73-64bc-4ba9-9650-591e9279c457" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_26c3e66d-7c3b-4d37-95f2-b3ed35ce5995" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_86fe124b-d342-4239-8d76-5b78e7835dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dc156d73-64bc-4ba9-9650-591e9279c457" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_86fe124b-d342-4239-8d76-5b78e7835dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_794cc960-973b-449c-9f56-a6bb62e19f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dc156d73-64bc-4ba9-9650-591e9279c457" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_794cc960-973b-449c-9f56-a6bb62e19f4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e82b38d7-a44e-4c25-aef3-b57dbea33751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_794cc960-973b-449c-9f56-a6bb62e19f4f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e82b38d7-a44e-4c25-aef3-b57dbea33751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e82b38d7-a44e-4c25-aef3-b57dbea33751_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e82b38d7-a44e-4c25-aef3-b57dbea33751" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e82b38d7-a44e-4c25-aef3-b57dbea33751_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e82b38d7-a44e-4c25-aef3-b57dbea33751" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_261cafbd-ae8a-4478-bb29-a00e95bc9336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:to="loc_us-gaap_CustomerRelationshipsMember_261cafbd-ae8a-4478-bb29-a00e95bc9336" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6092f18a-e5c2-4eaa-9d07-d7d9de51d636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6092f18a-e5c2-4eaa-9d07-d7d9de51d636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_c0dfbb07-1df3-4fdb-8634-cadfca5ef1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_c0dfbb07-1df3-4fdb-8634-cadfca5ef1d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_1db92a94-f050-4168-94b4-ea8f0a6271ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_1db92a94-f050-4168-94b4-ea8f0a6271ad" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognitionDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#RevenueRecognitionDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/RevenueRecognitionDetailsTextual" xlink:type="extended" id="i097ee337148941b5854e984492aa7f79_RevenueRecognitionDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_95d969ef-d932-4788-a983-66d78f571913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7d78be74-2044-45d5-aa07-083d279b4759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_95d969ef-d932-4788-a983-66d78f571913" xlink:to="loc_us-gaap_Revenues_7d78be74-2044-45d5-aa07-083d279b4759" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_74f9c314-e344-4dcb-8735-1c7e2ceef515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_95d969ef-d932-4788-a983-66d78f571913" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_74f9c314-e344-4dcb-8735-1c7e2ceef515" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4635b791-abc4-4219-a8a0-170e10fa3bc4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74f9c314-e344-4dcb-8735-1c7e2ceef515" xlink:to="loc_srt_ProductOrServiceAxis_4635b791-abc4-4219-a8a0-170e10fa3bc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4635b791-abc4-4219-a8a0-170e10fa3bc4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4635b791-abc4-4219-a8a0-170e10fa3bc4" xlink:to="loc_srt_ProductsAndServicesDomain_4635b791-abc4-4219-a8a0-170e10fa3bc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f51156cc-c65f-4631-bed9-5e437c90996d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4635b791-abc4-4219-a8a0-170e10fa3bc4" xlink:to="loc_srt_ProductsAndServicesDomain_f51156cc-c65f-4631-bed9-5e437c90996d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DirectPayerRentalsMember_a57f0035-5823-4b85-a28e-f70b9559db2d" xlink:href="infu-20211231.xsd#infu_DirectPayerRentalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f51156cc-c65f-4631-bed9-5e437c90996d" xlink:to="loc_infu_DirectPayerRentalsMember_a57f0035-5823-4b85-a28e-f70b9559db2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_e432b257-3a11-4665-9b9d-88f4aa1ef1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f51156cc-c65f-4631-bed9-5e437c90996d" xlink:to="loc_us-gaap_ProductMember_e432b257-3a11-4665-9b9d-88f4aa1ef1c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e86a57ec-454d-441a-a7bf-9956f155d9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74f9c314-e344-4dcb-8735-1c7e2ceef515" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e86a57ec-454d-441a-a7bf-9956f155d9d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e86a57ec-454d-441a-a7bf-9956f155d9d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e86a57ec-454d-441a-a7bf-9956f155d9d4" xlink:to="loc_us-gaap_SegmentDomain_e86a57ec-454d-441a-a7bf-9956f155d9d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e177cadb-189f-40df-bfcf-3ac289f1b1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e86a57ec-454d-441a-a7bf-9956f155d9d4" xlink:to="loc_us-gaap_SegmentDomain_e177cadb-189f-40df-bfcf-3ac289f1b1eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_492aff3f-7d15-4072-96fc-39eee97ae8d5" xlink:href="infu-20211231.xsd#infu_ITSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e177cadb-189f-40df-bfcf-3ac289f1b1eb" xlink:to="loc_infu_ITSSegmentMember_492aff3f-7d15-4072-96fc-39eee97ae8d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_74e0d1c0-865e-4b4e-8dd2-6061ca38b9ca" xlink:href="infu-20211231.xsd#infu_DMEServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e177cadb-189f-40df-bfcf-3ac289f1b1eb" xlink:to="loc_infu_DMEServicesSegmentMember_74e0d1c0-865e-4b4e-8dd2-6061ca38b9ca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails" xlink:type="extended" id="i9ed1b367f67a49b8b44530abb2d9c7fe_RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_cadaf817-3b83-44fe-bd4d-b1f1f14031f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fa0cdf26-5926-42d5-af1d-0c112530d8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cadaf817-3b83-44fe-bd4d-b1f1f14031f5" xlink:to="loc_us-gaap_Revenues_fa0cdf26-5926-42d5-af1d-0c112530d8bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_7dffff7c-ed0f-4012-a45e-ffc7309cb3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cadaf817-3b83-44fe-bd4d-b1f1f14031f5" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_7dffff7c-ed0f-4012-a45e-ffc7309cb3e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cadaf817-3b83-44fe-bd4d-b1f1f14031f5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_89685889-1191-46aa-a8ed-e31aaa4f3f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_89685889-1191-46aa-a8ed-e31aaa4f3f04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_89685889-1191-46aa-a8ed-e31aaa4f3f04_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_89685889-1191-46aa-a8ed-e31aaa4f3f04" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_89685889-1191-46aa-a8ed-e31aaa4f3f04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_13e44f71-6653-4692-b16f-bf0e9e9bfdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_89685889-1191-46aa-a8ed-e31aaa4f3f04" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_13e44f71-6653-4692-b16f-bf0e9e9bfdd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_e17d6396-057a-45e6-a51c-d92cd5cb79d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_13e44f71-6653-4692-b16f-bf0e9e9bfdd6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_e17d6396-057a-45e6-a51c-d92cd5cb79d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_26bdaab7-d684-4d97-bc14-7070982266d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_26bdaab7-d684-4d97-bc14-7070982266d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_26bdaab7-d684-4d97-bc14-7070982266d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_26bdaab7-d684-4d97-bc14-7070982266d9" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_26bdaab7-d684-4d97-bc14-7070982266d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c3e20f67-b456-484b-ad2a-6676fc9498e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_26bdaab7-d684-4d97-bc14-7070982266d9" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c3e20f67-b456-484b-ad2a-6676fc9498e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_518c5dc1-02e2-42d3-9b20-15570c24733c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c3e20f67-b456-484b-ad2a-6676fc9498e1" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_518c5dc1-02e2-42d3-9b20-15570c24733c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c262f3b9-b852-4c26-ac4e-cf7cde36ea06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:to="loc_srt_ProductOrServiceAxis_c262f3b9-b852-4c26-ac4e-cf7cde36ea06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c262f3b9-b852-4c26-ac4e-cf7cde36ea06_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c262f3b9-b852-4c26-ac4e-cf7cde36ea06" xlink:to="loc_srt_ProductsAndServicesDomain_c262f3b9-b852-4c26-ac4e-cf7cde36ea06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c262f3b9-b852-4c26-ac4e-cf7cde36ea06" xlink:to="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ThirdPartyPayerRentalMember_c91508ee-6f57-44de-8c41-97ee8bc7f001" xlink:href="infu-20211231.xsd#infu_ThirdPartyPayerRentalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:to="loc_infu_ThirdPartyPayerRentalMember_c91508ee-6f57-44de-8c41-97ee8bc7f001" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DirectPayerRentalsMember_d7e2141a-eb70-46a4-8570-21baf5a0ee53" xlink:href="infu-20211231.xsd#infu_DirectPayerRentalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:to="loc_infu_DirectPayerRentalsMember_d7e2141a-eb70-46a4-8570-21baf5a0ee53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c6527580-f623-40da-a717-7737c926411f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:to="loc_us-gaap_ProductMember_c6527580-f623-40da-a717-7737c926411f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_5d04171e-343b-4e66-9b78-82318f686890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:to="loc_us-gaap_ServiceMember_5d04171e-343b-4e66-9b78-82318f686890" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended" id="i2325a33796bd42d1bfbc035659e93f1c_PropertyandEquipmentScheduleofPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8777fab3-048f-4ae3-a938-3e11110d719a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e40acc38-c1b6-4b42-992f-34367ff17c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8777fab3-048f-4ae3-a938-3e11110d719a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e40acc38-c1b6-4b42-992f-34367ff17c1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b54bcf08-1fdf-43da-ac5c-19c96dd46c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8777fab3-048f-4ae3-a938-3e11110d719a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b54bcf08-1fdf-43da-ac5c-19c96dd46c08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_45273ac1-4c5e-4c80-9275-339d66adc84b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8777fab3-048f-4ae3-a938-3e11110d719a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_45273ac1-4c5e-4c80-9275-339d66adc84b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6e60f0a-6ac0-4e79-b164-1007ba2fbe90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8777fab3-048f-4ae3-a938-3e11110d719a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6e60f0a-6ac0-4e79-b164-1007ba2fbe90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2f8c81ac-eced-47e6-b585-bfd182100970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6e60f0a-6ac0-4e79-b164-1007ba2fbe90" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2f8c81ac-eced-47e6-b585-bfd182100970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2f8c81ac-eced-47e6-b585-bfd182100970_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2f8c81ac-eced-47e6-b585-bfd182100970" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2f8c81ac-eced-47e6-b585-bfd182100970_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c63690b-43a2-44b6-9a26-d015287970ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2f8c81ac-eced-47e6-b585-bfd182100970" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c63690b-43a2-44b6-9a26-d015287970ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_3942bd70-c45c-47c2-9c81-f3472059ec5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c63690b-43a2-44b6-9a26-d015287970ed" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_3942bd70-c45c-47c2-9c81-f3472059ec5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_0308ef0c-6d1e-4109-aade-25f2d3a7ef5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c63690b-43a2-44b6-9a26-d015287970ed" xlink:to="loc_us-gaap_AutomobilesMember_0308ef0c-6d1e-4109-aade-25f2d3a7ef5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4e2319da-37a7-4f28-9507-a7633029619c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c63690b-43a2-44b6-9a26-d015287970ed" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4e2319da-37a7-4f28-9507-a7633029619c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual" xlink:type="extended" id="ifb13e78803dd4c83957bc0f2577e1b55_GoodwillandIntangibleAssetsDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_82627bf4-d0c3-4d62-a399-a21cbdcb1f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e94e1006-f85d-4bcb-916f-902201b55977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_82627bf4-d0c3-4d62-a399-a21cbdcb1f65" xlink:to="loc_us-gaap_Goodwill_e94e1006-f85d-4bcb-916f-902201b55977" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_362d0868-6693-47a7-b9e5-efabefd408cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_82627bf4-d0c3-4d62-a399-a21cbdcb1f65" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_362d0868-6693-47a7-b9e5-efabefd408cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_13fac265-7e71-47a8-8261-9c554466b665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_82627bf4-d0c3-4d62-a399-a21cbdcb1f65" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_13fac265-7e71-47a8-8261-9c554466b665" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cb33efa2-c559-42d5-91f7-b3e415b2277a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_13fac265-7e71-47a8-8261-9c554466b665" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cb33efa2-c559-42d5-91f7-b3e415b2277a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cb33efa2-c559-42d5-91f7-b3e415b2277a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cb33efa2-c559-42d5-91f7-b3e415b2277a" xlink:to="loc_us-gaap_SegmentDomain_cb33efa2-c559-42d5-91f7-b3e415b2277a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ee12b284-5ab4-448f-b858-1dee41699fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cb33efa2-c559-42d5-91f7-b3e415b2277a" xlink:to="loc_us-gaap_SegmentDomain_ee12b284-5ab4-448f-b858-1dee41699fc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4c5e4837-b454-441f-8124-50947c7c617e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_13fac265-7e71-47a8-8261-9c554466b665" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4c5e4837-b454-441f-8124-50947c7c617e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4c5e4837-b454-441f-8124-50947c7c617e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4c5e4837-b454-441f-8124-50947c7c617e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4c5e4837-b454-441f-8124-50947c7c617e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_84dd5b78-b295-4005-8b82-93b32581788f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4c5e4837-b454-441f-8124-50947c7c617e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_84dd5b78-b295-4005-8b82-93b32581788f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PhysicianAndCustomerRelationshipsMember_b4cd4d00-b220-4b2f-a30b-fd8347bfe197" xlink:href="infu-20211231.xsd#infu_PhysicianAndCustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_84dd5b78-b295-4005-8b82-93b32581788f" xlink:to="loc_infu_PhysicianAndCustomerRelationshipsMember_b4cd4d00-b220-4b2f-a30b-fd8347bfe197" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_50650601-1276-4158-a999-c9fd19eacff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_84dd5b78-b295-4005-8b82-93b32581788f" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_50650601-1276-4158-a999-c9fd19eacff7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended" id="i0ca95dabe40048dbaf289a85ab3cd7f7_GoodwillandIntangibleAssetsGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_bd93a71a-aaca-477e-a69c-36d053d89bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_8e1a1cd7-375b-4e5f-af33-3eb79f0dcfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_bd93a71a-aaca-477e-a69c-36d053d89bbb" xlink:to="loc_us-gaap_GoodwillRollForward_8e1a1cd7-375b-4e5f-af33-3eb79f0dcfd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_92fed940-5bd5-418c-bf23-9186d1c6a116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_8e1a1cd7-375b-4e5f-af33-3eb79f0dcfd2" xlink:to="loc_us-gaap_Goodwill_92fed940-5bd5-418c-bf23-9186d1c6a116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0d29685-c640-43c1-a5fd-4f823d03a3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_8e1a1cd7-375b-4e5f-af33-3eb79f0dcfd2" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0d29685-c640-43c1-a5fd-4f823d03a3ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_97a06f6f-6669-4836-946d-cfb9424b1d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_54601346-794d-4ccf-a5ec-2cc4596e289d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_bd93a71a-aaca-477e-a69c-36d053d89bbb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_54601346-794d-4ccf-a5ec-2cc4596e289d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_337d971c-a813-4e99-bbce-c1978a6997df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_54601346-794d-4ccf-a5ec-2cc4596e289d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_337d971c-a813-4e99-bbce-c1978a6997df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_337d971c-a813-4e99-bbce-c1978a6997df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_337d971c-a813-4e99-bbce-c1978a6997df" xlink:to="loc_us-gaap_SegmentDomain_337d971c-a813-4e99-bbce-c1978a6997df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_732bc9bd-0c54-4259-b633-60ae0094e4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_337d971c-a813-4e99-bbce-c1978a6997df" xlink:to="loc_us-gaap_SegmentDomain_732bc9bd-0c54-4259-b633-60ae0094e4d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_8c1bd309-f062-432b-9c07-3774542ae1d6" xlink:href="infu-20211231.xsd#infu_DMEServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_732bc9bd-0c54-4259-b633-60ae0094e4d5" xlink:to="loc_infu_DMEServicesSegmentMember_8c1bd309-f062-432b-9c07-3774542ae1d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_9b8b2e49-7690-4041-882e-feb2a1e5a2a3" xlink:href="infu-20211231.xsd#infu_ITSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_732bc9bd-0c54-4259-b633-60ae0094e4d5" xlink:to="loc_infu_ITSSegmentMember_9b8b2e49-7690-4041-882e-feb2a1e5a2a3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="i49f9db9f67dc4c9796f0747b331e4949_GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c7b75601-9ba3-49a5-b335-bf030a096129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c7b75601-9ba3-49a5-b335-bf030a096129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5abfab19-10a5-4acb-9eda-5b692bc30ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5abfab19-10a5-4acb-9eda-5b692bc30ce1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ed495004-04a5-462e-921e-689a420d2f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ed495004-04a5-462e-921e-689a420d2f6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4c234457-6a64-4660-8562-79e8c7bd2ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4c234457-6a64-4660-8562-79e8c7bd2ee6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5966eda3-6e32-43ba-9187-fb692cba37b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5966eda3-6e32-43ba-9187-fb692cba37b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9dbae82c-ceb1-4a75-adec-0a972ef2636d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9dbae82c-ceb1-4a75-adec-0a972ef2636d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8077f3c5-1ee4-488a-b377-d170b21a8569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8077f3c5-1ee4-488a-b377-d170b21a8569" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b87c457e-cec1-4211-8a61-6219e0dfdc41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8077f3c5-1ee4-488a-b377-d170b21a8569" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b87c457e-cec1-4211-8a61-6219e0dfdc41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b87c457e-cec1-4211-8a61-6219e0dfdc41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b87c457e-cec1-4211-8a61-6219e0dfdc41" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b87c457e-cec1-4211-8a61-6219e0dfdc41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b87c457e-cec1-4211-8a61-6219e0dfdc41" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_f7118226-ab33-41da-89b6-7b7b60344c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:to="loc_us-gaap_TradeNamesMember_f7118226-ab33-41da-89b6-7b7b60344c31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PhysicianAndCustomerRelationshipsMember_4cb89110-9174-45d7-bf36-dcad68c59a86" xlink:href="infu-20211231.xsd#infu_PhysicianAndCustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:to="loc_infu_PhysicianAndCustomerRelationshipsMember_4cb89110-9174-45d7-bf36-dcad68c59a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cedee15f-663b-4c0a-a39a-71f2d5e1a284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cedee15f-663b-4c0a-a39a-71f2d5e1a284" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_5288d7b2-d847-412b-b81e-f4cba1c84e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_5288d7b2-d847-412b-b81e-f4cba1c84e87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_41c5d0b5-39ba-4dda-a703-6e806517933e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_41c5d0b5-39ba-4dda-a703-6e806517933e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DebtDetailsTextual" xlink:type="extended" id="i385d878c1be94bd38b374da24a5d7c28_DebtDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9e11a054-00ac-46d8-8297-4fdaf52db771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9e11a054-00ac-46d8-8297-4fdaf52db771" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_3e816861-0739-4fa7-b10b-329964569b97" xlink:href="infu-20211231.xsd#infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_3e816861-0739-4fa7-b10b-329964569b97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_87e5a67b-7399-450d-a9b5-80a7ed61b6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_87e5a67b-7399-450d-a9b5-80a7ed61b6dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_2d8281a0-c068-48fe-88ef-7a471a9b2dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_2d8281a0-c068-48fe-88ef-7a471a9b2dea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PercentageOfTotalDepreciationExpense_4f73e169-49ac-46b8-b197-bc2c2072c660" xlink:href="infu-20211231.xsd#infu_PercentageOfTotalDepreciationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_PercentageOfTotalDepreciationExpense_4f73e169-49ac-46b8-b197-bc2c2072c660" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_b9cf7b0b-86c3-431a-9d1f-4a956212ff19" xlink:href="infu-20211231.xsd#infu_DebtInstrumentCovenantMinimumFixedCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_b9cf7b0b-86c3-431a-9d1f-4a956212ff19" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio_7d25f921-b664-4d12-9c7f-ca80f8978b14" xlink:href="infu-20211231.xsd#infu_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio_7d25f921-b664-4d12-9c7f-ca80f8978b14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_3d15ec88-47f7-47bc-930d-652c3facd01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_LineOfCredit_3d15ec88-47f7-47bc-930d-652c3facd01b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_34a68b8a-b267-4de8-908a-d2bb25a50bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_34a68b8a-b267-4de8-908a-d2bb25a50bde" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_aa2139f1-c603-4245-98af-6a4976cbb2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_aa2139f1-c603-4245-98af-6a4976cbb2de" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LineOfCreditFacilityBorrowingBase_e3a15bbf-d5bc-4ca6-a3b4-074db955ddcf" xlink:href="infu-20211231.xsd#infu_LineOfCreditFacilityBorrowingBase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_LineOfCreditFacilityBorrowingBase_e3a15bbf-d5bc-4ca6-a3b4-074db955ddcf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ff4178b1-5649-4e86-89e9-59d29c115e61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ff4178b1-5649-4e86-89e9-59d29c115e61" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate_457decb5-be4b-4837-a348-a547a5224074" xlink:href="infu-20211231.xsd#infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate_457decb5-be4b-4837-a348-a547a5224074" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_edc6ad82-d2ba-4caf-aefe-09bc8925b050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_edc6ad82-d2ba-4caf-aefe-09bc8925b050" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LIBORRate_5ac9add9-7abe-479c-9832-4e49756bd4e8" xlink:href="infu-20211231.xsd#infu_LIBORRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_LIBORRate_5ac9add9-7abe-479c-9832-4e49756bd4e8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LenderPrimeRate_23872cee-466f-4e5e-b29f-60038a9f8629" xlink:href="infu-20211231.xsd#infu_LenderPrimeRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_LenderPrimeRate_23872cee-466f-4e5e-b29f-60038a9f8629" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_1e7d7a02-8228-4092-9e1b-7f1976f5603c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentTerm_1e7d7a02-8228-4092-9e1b-7f1976f5603c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_bc09f762-36cb-4bbc-a38b-7465f23ce762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_bc09f762-36cb-4bbc-a38b-7465f23ce762" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_54935a22-87df-4712-88a8-932382702433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_InterestExpenseDebt_54935a22-87df-4712-88a8-932382702433" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d3f6e0de-39a3-450f-8d6c-50ef57893c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d3f6e0de-39a3-450f-8d6c-50ef57893c40" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cdfa7ebb-8d8c-40ea-88bf-4130105bd46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_DebtInstrumentAxis_cdfa7ebb-8d8c-40ea-88bf-4130105bd46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cdfa7ebb-8d8c-40ea-88bf-4130105bd46b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cdfa7ebb-8d8c-40ea-88bf-4130105bd46b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cdfa7ebb-8d8c-40ea-88bf-4130105bd46b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cdfa7ebb-8d8c-40ea-88bf-4130105bd46b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2021CreditAgreementMember_29cbfeb1-ec8a-4c10-b11d-bcb867f421a0" xlink:href="infu-20211231.xsd#infu_The2021CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:to="loc_infu_The2021CreditAgreementMember_29cbfeb1-ec8a-4c10-b11d-bcb867f421a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2015CreditAgreementMember_32de9b7f-bdad-4001-981d-38ccef68084d" xlink:href="infu-20211231.xsd#infu_The2015CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:to="loc_infu_The2015CreditAgreementMember_32de9b7f-bdad-4001-981d-38ccef68084d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember_ab617965-a656-4465-8e9d-d144e1ec0abd" xlink:href="infu-20211231.xsd#infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:to="loc_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember_ab617965-a656-4465-8e9d-d144e1ec0abd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CreditFacilityMember_2c105d2f-9c28-42e1-a684-4a1b6da3064c" xlink:href="infu-20211231.xsd#infu_CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:to="loc_infu_CreditFacilityMember_2c105d2f-9c28-42e1-a684-4a1b6da3064c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_c1b64bbd-4a73-46f9-86af-eb9a3c8016df" xlink:href="infu-20211231.xsd#infu_FinancingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:to="loc_infu_FinancingAgreementMember_c1b64bbd-4a73-46f9-86af-eb9a3c8016df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_6d9049dc-8ebb-40d7-adba-271189897929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_CreditFacilityAxis_6d9049dc-8ebb-40d7-adba-271189897929" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6d9049dc-8ebb-40d7-adba-271189897929_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_6d9049dc-8ebb-40d7-adba-271189897929" xlink:to="loc_us-gaap_CreditFacilityDomain_6d9049dc-8ebb-40d7-adba-271189897929_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6ff7cf76-485a-4e75-a23c-53db25da86b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_6d9049dc-8ebb-40d7-adba-271189897929" xlink:to="loc_us-gaap_CreditFacilityDomain_6ff7cf76-485a-4e75-a23c-53db25da86b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8fc02cfb-969b-4d3d-98eb-c570c6813c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6ff7cf76-485a-4e75-a23c-53db25da86b8" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8fc02cfb-969b-4d3d-98eb-c570c6813c0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_27055781-3e93-4638-980d-f8769a0792e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6ff7cf76-485a-4e75-a23c-53db25da86b8" xlink:to="loc_us-gaap_LetterOfCreditMember_27055781-3e93-4638-980d-f8769a0792e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_300dd64f-c6f8-4a5c-b9fe-0faf7352fa96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_srt_RangeAxis_300dd64f-c6f8-4a5c-b9fe-0faf7352fa96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_300dd64f-c6f8-4a5c-b9fe-0faf7352fa96_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_300dd64f-c6f8-4a5c-b9fe-0faf7352fa96" xlink:to="loc_srt_RangeMember_300dd64f-c6f8-4a5c-b9fe-0faf7352fa96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bd740778-19bf-4c07-b063-69084af6b0ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_300dd64f-c6f8-4a5c-b9fe-0faf7352fa96" xlink:to="loc_srt_RangeMember_bd740778-19bf-4c07-b063-69084af6b0ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_38ce1764-6775-4040-a4d0-638ba252b687" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bd740778-19bf-4c07-b063-69084af6b0ea" xlink:to="loc_srt_MinimumMember_38ce1764-6775-4040-a4d0-638ba252b687" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_73a95a16-c22d-4ce7-acda-98409bade462" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bd740778-19bf-4c07-b063-69084af6b0ea" xlink:to="loc_srt_MaximumMember_73a95a16-c22d-4ce7-acda-98409bade462" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_06fd45f1-15a3-4743-b7a5-1a6110304701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_VariableRateAxis_06fd45f1-15a3-4743-b7a5-1a6110304701" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_06fd45f1-15a3-4743-b7a5-1a6110304701_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_06fd45f1-15a3-4743-b7a5-1a6110304701" xlink:to="loc_us-gaap_VariableRateDomain_06fd45f1-15a3-4743-b7a5-1a6110304701_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_06fd45f1-15a3-4743-b7a5-1a6110304701" xlink:to="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_11101052-d092-4e2d-ae00-7dcb1a1b24d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_11101052-d092-4e2d-ae00-7dcb1a1b24d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_GreaterOfPrimeRateOrLIBORPlus25Member_b78e16df-94bb-4809-ab98-165a004508a0" xlink:href="infu-20211231.xsd#infu_GreaterOfPrimeRateOrLIBORPlus25Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:to="loc_infu_GreaterOfPrimeRateOrLIBORPlus25Member_b78e16df-94bb-4809-ab98-165a004508a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CBFloatingRateMember_58103a93-6cf4-47ad-bc7d-b63feb59436a" xlink:href="infu-20211231.xsd#infu_CBFloatingRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:to="loc_infu_CBFloatingRateMember_58103a93-6cf4-47ad-bc7d-b63feb59436a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_62e21866-6a4b-4e95-b8ab-e8fc3c8d6193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:to="loc_us-gaap_BaseRateMember_62e21866-6a4b-4e95-b8ab-e8fc3c8d6193" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7fac8303-dbd5-415b-babe-ad7598f0e1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7fac8303-dbd5-415b-babe-ad7598f0e1dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7fac8303-dbd5-415b-babe-ad7598f0e1dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7fac8303-dbd5-415b-babe-ad7598f0e1dc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7fac8303-dbd5-415b-babe-ad7598f0e1dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4a448ffb-e4c6-4f9e-8b2b-7b284992b51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7fac8303-dbd5-415b-babe-ad7598f0e1dc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4a448ffb-e4c6-4f9e-8b2b-7b284992b51a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EurodollarLoanMember_ba6181fd-677e-4f4f-b9c1-1d5f94865f9d" xlink:href="infu-20211231.xsd#infu_EurodollarLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a448ffb-e4c6-4f9e-8b2b-7b284992b51a" xlink:to="loc_infu_EurodollarLoanMember_ba6181fd-677e-4f4f-b9c1-1d5f94865f9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CBFloatingRateLoanMember_7dc7e7d4-2f2e-496e-be8c-8b0823279bf7" xlink:href="infu-20211231.xsd#infu_CBFloatingRateLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a448ffb-e4c6-4f9e-8b2b-7b284992b51a" xlink:to="loc_infu_CBFloatingRateLoanMember_7dc7e7d4-2f2e-496e-be8c-8b0823279bf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ABRLoansMember_8dea8dbf-d6a5-478e-8e06-9a0e29c6a214" xlink:href="infu-20211231.xsd#infu_ABRLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a448ffb-e4c6-4f9e-8b2b-7b284992b51a" xlink:to="loc_infu_ABRLoansMember_8dea8dbf-d6a5-478e-8e06-9a0e29c6a214" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAxis_61f9a7df-505d-4a94-9cdc-ae7339ee911e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_CollateralAxis_61f9a7df-505d-4a94-9cdc-ae7339ee911e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain_61f9a7df-505d-4a94-9cdc-ae7339ee911e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CollateralAxis_61f9a7df-505d-4a94-9cdc-ae7339ee911e" xlink:to="loc_us-gaap_CollateralDomain_61f9a7df-505d-4a94-9cdc-ae7339ee911e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain_23693c3c-5624-491f-9a2c-dc341be2bae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CollateralAxis_61f9a7df-505d-4a94-9cdc-ae7339ee911e" xlink:to="loc_us-gaap_CollateralDomain_23693c3c-5624-491f-9a2c-dc341be2bae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentMember_045d66f0-4dea-443f-96bb-6f7fd951be31" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollateralDomain_23693c3c-5624-491f-9a2c-dc341be2bae8" xlink:to="loc_infu_MedicalEquipmentMember_045d66f0-4dea-443f-96bb-6f7fd951be31" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="extended" id="ie33a46066416439b8f3cee02921f55da_DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7ee4827f-09d3-4094-9b4a-aa95f6c31dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7ee4827f-09d3-4094-9b4a-aa95f6c31dd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_6490ceef-084f-4ca1-92a1-0da7be609baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_us-gaap_LineOfCredit_6490ceef-084f-4ca1-92a1-0da7be609baf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_454d750d-6acf-4639-b1aa-cf42e7486c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_454d750d-6acf-4639-b1aa-cf42e7486c90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LandlordReserves_3f239c1b-46a9-4571-8ae2-8f6046f77993" xlink:href="infu-20211231.xsd#infu_LandlordReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_infu_LandlordReserves_3f239c1b-46a9-4571-8ae2-8f6046f77993" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_cde6ccc1-16e2-42b0-9c3c-9cfd3edda568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_cde6ccc1-16e2-42b0-9c3c-9cfd3edda568" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3108ea45-2b6c-40dc-af41-ff5d459c4710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_us-gaap_DebtInstrumentTable_3108ea45-2b6c-40dc-af41-ff5d459c4710" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_96d36da0-521f-41b9-8dd5-4db36acd544f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3108ea45-2b6c-40dc-af41-ff5d459c4710" xlink:to="loc_us-gaap_CreditFacilityAxis_96d36da0-521f-41b9-8dd5-4db36acd544f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_96d36da0-521f-41b9-8dd5-4db36acd544f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_96d36da0-521f-41b9-8dd5-4db36acd544f" xlink:to="loc_us-gaap_CreditFacilityDomain_96d36da0-521f-41b9-8dd5-4db36acd544f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b385b7f1-08ec-4d48-9dea-ca9b5afa545f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_96d36da0-521f-41b9-8dd5-4db36acd544f" xlink:to="loc_us-gaap_CreditFacilityDomain_b385b7f1-08ec-4d48-9dea-ca9b5afa545f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7d5605cd-da4c-4a12-852f-d640e7ebd0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b385b7f1-08ec-4d48-9dea-ca9b5afa545f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7d5605cd-da4c-4a12-852f-d640e7ebd0e3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofFutureMaturitiesofLoansDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="extended" id="i3ba7e4499f0943a8a650b9d1656f2406_DebtSummaryofFutureMaturitiesofLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e7411707-d327-4935-b981-c8d41a9c4f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e7411707-d327-4935-b981-c8d41a9c4f69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_715b6990-d4c3-4df7-a52a-cf71fa279316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_715b6990-d4c3-4df7-a52a-cf71fa279316" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1e46b834-3c26-43a1-88f9-5ec1eb4fdbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1e46b834-3c26-43a1-88f9-5ec1eb4fdbf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_cf68e18c-6fd6-4e59-8884-aa412dfa953f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_cf68e18c-6fd6-4e59-8884-aa412dfa953f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_f7be76e4-3cca-4f5f-9cd9-25c69f115b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_f7be76e4-3cca-4f5f-9cd9-25c69f115b90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_fa1d9694-6067-4390-b4f0-4594d4547125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_fa1d9694-6067-4390-b4f0-4594d4547125" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f999e07d-a0e4-46fb-b7e4-e35917cbf4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f999e07d-a0e4-46fb-b7e4-e35917cbf4dc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fcb27ca9-c011-42c4-887a-ad025cccc0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_DebtInstrumentTable_fcb27ca9-c011-42c4-887a-ad025cccc0e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0af42555-fe35-4f28-a93e-f7bea1acda5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fcb27ca9-c011-42c4-887a-ad025cccc0e4" xlink:to="loc_us-gaap_CreditFacilityAxis_0af42555-fe35-4f28-a93e-f7bea1acda5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0af42555-fe35-4f28-a93e-f7bea1acda5e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_0af42555-fe35-4f28-a93e-f7bea1acda5e" xlink:to="loc_us-gaap_CreditFacilityDomain_0af42555-fe35-4f28-a93e-f7bea1acda5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2f778087-317a-4b4b-b8e3-7881157b69f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_0af42555-fe35-4f28-a93e-f7bea1acda5e" xlink:to="loc_us-gaap_CreditFacilityDomain_2f778087-317a-4b4b-b8e3-7881157b69f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_22fe57aa-2f0b-4537-8555-73b905f90c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2f778087-317a-4b4b-b8e3-7881157b69f4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_22fe57aa-2f0b-4537-8555-73b905f90c47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2becea2f-336c-4e1f-81e2-4c1109281d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fcb27ca9-c011-42c4-887a-ad025cccc0e4" xlink:to="loc_us-gaap_DebtInstrumentAxis_2becea2f-336c-4e1f-81e2-4c1109281d22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2becea2f-336c-4e1f-81e2-4c1109281d22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2becea2f-336c-4e1f-81e2-4c1109281d22" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2becea2f-336c-4e1f-81e2-4c1109281d22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2bfbf283-c860-4149-b6e4-f4f567c49056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2becea2f-336c-4e1f-81e2-4c1109281d22" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2bfbf283-c860-4149-b6e4-f4f567c49056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_1081f084-217f-4fe5-9a57-16ac3d357411" xlink:href="infu-20211231.xsd#infu_FinancingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2bfbf283-c860-4149-b6e4-f4f567c49056" xlink:to="loc_infu_FinancingAgreementMember_1081f084-217f-4fe5-9a57-16ac3d357411" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofCompanysCurrentandLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="extended" id="i377c7a9e8da64a29bf7c2dcba6753116_DebtSummaryofCompanysCurrentandLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongtermDebtGrossCurrent_cfdda8c8-be92-418d-9a31-0baab39ed444" xlink:href="infu-20211231.xsd#infu_LongtermDebtGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_infu_LongtermDebtGrossCurrent_cfdda8c8-be92-418d-9a31-0baab39ed444" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtGrossNoncurrent_25ec466e-7d28-44ac-ba31-d1d6f51fbc8c" xlink:href="infu-20211231.xsd#infu_LongTermDebtGrossNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_infu_LongTermDebtGrossNoncurrent_25ec466e-7d28-44ac-ba31-d1d6f51fbc8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e8634472-f9a7-4730-8772-dac0aa1a9b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e8634472-f9a7-4730-8772-dac0aa1a9b7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_5e8a8f79-9c75-4570-b972-1b5fb06a9dd8" xlink:href="infu-20211231.xsd#infu_UnamortizedDebtIssuanceExpenseCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_5e8a8f79-9c75-4570-b972-1b5fb06a9dd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_8ce61d17-2ee5-4ca8-9411-e01673d9ef1b" xlink:href="infu-20211231.xsd#infu_UnamortizedDebtIssuanceExpenseNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_8ce61d17-2ee5-4ca8-9411-e01673d9ef1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_8872d822-69c8-4573-a4d4-deaaef26c4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_8872d822-69c8-4573-a4d4-deaaef26c4ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0d1b4d9c-1700-434a-8bc3-b4a17a96715c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_LongTermDebtCurrent_0d1b4d9c-1700-434a-8bc3-b4a17a96715c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_434f8b45-af01-4592-a765-1e9be8db95bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_434f8b45-af01-4592-a765-1e9be8db95bf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2a4dce84-ef18-46df-a646-fbf85d9cbac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_LongTermDebt_2a4dce84-ef18-46df-a646-fbf85d9cbac2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_433cd300-196d-4e0e-8e60-0affedef513e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:to="loc_us-gaap_CreditFacilityAxis_433cd300-196d-4e0e-8e60-0affedef513e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_433cd300-196d-4e0e-8e60-0affedef513e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_433cd300-196d-4e0e-8e60-0affedef513e" xlink:to="loc_us-gaap_CreditFacilityDomain_433cd300-196d-4e0e-8e60-0affedef513e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f4cba27b-442a-4206-9920-cb55caeca4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_433cd300-196d-4e0e-8e60-0affedef513e" xlink:to="loc_us-gaap_CreditFacilityDomain_f4cba27b-442a-4206-9920-cb55caeca4a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c28ff969-eb34-4aa9-90f6-c53e9b97ab49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f4cba27b-442a-4206-9920-cb55caeca4a3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c28ff969-eb34-4aa9-90f6-c53e9b97ab49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EquipmentLineMember_66bbdefb-23b2-4a21-bf66-5dac30564322" xlink:href="infu-20211231.xsd#infu_EquipmentLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f4cba27b-442a-4206-9920-cb55caeca4a3" xlink:to="loc_infu_EquipmentLineMember_66bbdefb-23b2-4a21-bf66-5dac30564322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2019EquipmentLineMember_3e7e9499-352e-492c-8f76-16fb96198024" xlink:href="infu-20211231.xsd#infu_The2019EquipmentLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f4cba27b-442a-4206-9920-cb55caeca4a3" xlink:to="loc_infu_The2019EquipmentLineMember_3e7e9499-352e-492c-8f76-16fb96198024" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3dfe716e-f547-402a-8b65-23c98ff9ad4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3dfe716e-f547-402a-8b65-23c98ff9ad4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3dfe716e-f547-402a-8b65-23c98ff9ad4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3dfe716e-f547-402a-8b65-23c98ff9ad4c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3dfe716e-f547-402a-8b65-23c98ff9ad4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eda065e4-5f64-4012-94a7-47d6e1423624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3dfe716e-f547-402a-8b65-23c98ff9ad4c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eda065e4-5f64-4012-94a7-47d6e1423624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_TermLoanMember_81467378-7985-4c3f-b4bd-a7f429906207" xlink:href="infu-20211231.xsd#infu_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eda065e4-5f64-4012-94a7-47d6e1423624" xlink:to="loc_infu_TermLoanMember_81467378-7985-4c3f-b4bd-a7f429906207" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f7172a8d-fa9c-40ca-ab8a-dcb7847182a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:to="loc_us-gaap_DebtInstrumentAxis_f7172a8d-fa9c-40ca-ab8a-dcb7847182a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f7172a8d-fa9c-40ca-ab8a-dcb7847182a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f7172a8d-fa9c-40ca-ab8a-dcb7847182a8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f7172a8d-fa9c-40ca-ab8a-dcb7847182a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_20dd9b5c-3f4f-4615-bf0c-bf3ee457b859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f7172a8d-fa9c-40ca-ab8a-dcb7847182a8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_20dd9b5c-3f4f-4615-bf0c-bf3ee457b859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_7f3eb4a9-2d40-467b-a775-ff1126c6e667" xlink:href="infu-20211231.xsd#infu_FinancingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_20dd9b5c-3f4f-4615-bf0c-bf3ee457b859" xlink:to="loc_infu_FinancingAgreementMember_7f3eb4a9-2d40-467b-a775-ff1126c6e667" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual" xlink:type="extended" id="ifd161eed8a544638b15ca96a36c2c979_DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c48686e0-74d6-4ddf-9ff3-4eadee3e46b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_397c49ff-ac18-4c6f-bd89-4f62d2800749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c48686e0-74d6-4ddf-9ff3-4eadee3e46b1" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_397c49ff-ac18-4c6f-bd89-4f62d2800749" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_7f6a5078-5b44-4ae1-8a22-693cf0f677d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c48686e0-74d6-4ddf-9ff3-4eadee3e46b1" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_7f6a5078-5b44-4ae1-8a22-693cf0f677d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_c48686e0-74d6-4ddf-9ff3-4eadee3e46b1" xlink:to="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9b435d7d-ba40-46fe-8e06-23be9e16fc05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9b435d7d-ba40-46fe-8e06-23be9e16fc05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9b435d7d-ba40-46fe-8e06-23be9e16fc05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9b435d7d-ba40-46fe-8e06-23be9e16fc05" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9b435d7d-ba40-46fe-8e06-23be9e16fc05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1e8a15f4-461a-4d66-a828-98bd14dda934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9b435d7d-ba40-46fe-8e06-23be9e16fc05" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1e8a15f4-461a-4d66-a828-98bd14dda934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_85a52c5c-0235-40f2-a15f-09899fe02c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1e8a15f4-461a-4d66-a828-98bd14dda934" xlink:to="loc_us-gaap_InterestRateSwapMember_85a52c5c-0235-40f2-a15f-09899fe02c2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0b470e93-473f-45ba-84ec-ec234b21002b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:to="loc_us-gaap_HedgingDesignationAxis_0b470e93-473f-45ba-84ec-ec234b21002b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0b470e93-473f-45ba-84ec-ec234b21002b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0b470e93-473f-45ba-84ec-ec234b21002b" xlink:to="loc_us-gaap_HedgingDesignationDomain_0b470e93-473f-45ba-84ec-ec234b21002b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_beee0ecb-41b4-45d3-b6e2-1b34501d404f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0b470e93-473f-45ba-84ec-ec234b21002b" xlink:to="loc_us-gaap_HedgingDesignationDomain_beee0ecb-41b4-45d3-b6e2-1b34501d404f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_dd423770-6787-4626-addf-cf1c79b28041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_beee0ecb-41b4-45d3-b6e2-1b34501d404f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_dd423770-6787-4626-addf-cf1c79b28041" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fdd152-9870-4336-a851-65faabc941bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fdd152-9870-4336-a851-65faabc941bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d1fdd152-9870-4336-a851-65faabc941bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fdd152-9870-4336-a851-65faabc941bc" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d1fdd152-9870-4336-a851-65faabc941bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_682c1ade-465b-4be7-8876-f8eff1421649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fdd152-9870-4336-a851-65faabc941bc" xlink:to="loc_us-gaap_HedgingRelationshipDomain_682c1ade-465b-4be7-8876-f8eff1421649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_526af988-96e7-4348-b1ac-b7d949481df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_682c1ade-465b-4be7-8876-f8eff1421649" xlink:to="loc_us-gaap_CashFlowHedgingMember_526af988-96e7-4348-b1ac-b7d949481df9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails" xlink:type="extended" id="if4f4acf11b0649d9b2a36c9f4d4e0c42_DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e94182db-18ca-4904-953c-92063c5df233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_1a82616f-58fd-4261-8a71-3b9339a82979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e94182db-18ca-4904-953c-92063c5df233" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_1a82616f-58fd-4261-8a71-3b9339a82979" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_ebc1f4ea-396d-431e-8877-e20d20163f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e94182db-18ca-4904-953c-92063c5df233" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_ebc1f4ea-396d-431e-8877-e20d20163f9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e94182db-18ca-4904-953c-92063c5df233" xlink:to="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e5beb616-9af0-4785-9958-1bdabd6ace44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e5beb616-9af0-4785-9958-1bdabd6ace44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e5beb616-9af0-4785-9958-1bdabd6ace44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e5beb616-9af0-4785-9958-1bdabd6ace44" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e5beb616-9af0-4785-9958-1bdabd6ace44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c013446c-cbd7-4a97-afa3-5388e3d0a9d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e5beb616-9af0-4785-9958-1bdabd6ace44" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c013446c-cbd7-4a97-afa3-5388e3d0a9d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_14bf0916-2649-4071-be8f-4309b0b6f7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c013446c-cbd7-4a97-afa3-5388e3d0a9d0" xlink:to="loc_us-gaap_CashFlowHedgingMember_14bf0916-2649-4071-be8f-4309b0b6f7b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f9d07c63-6c59-463a-9217-667253807a50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f9d07c63-6c59-463a-9217-667253807a50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f9d07c63-6c59-463a-9217-667253807a50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f9d07c63-6c59-463a-9217-667253807a50" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f9d07c63-6c59-463a-9217-667253807a50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_337ab2cd-db17-4e8b-a404-2e18feee049d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f9d07c63-6c59-463a-9217-667253807a50" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_337ab2cd-db17-4e8b-a404-2e18feee049d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f1ef23d1-7759-4140-b4ad-a1345d0c6133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_337ab2cd-db17-4e8b-a404-2e18feee049d" xlink:to="loc_us-gaap_InterestRateSwapMember_f1ef23d1-7759-4140-b4ad-a1345d0c6133" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6b41661b-47de-4bc2-a262-1d4b421a8b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:to="loc_us-gaap_HedgingDesignationAxis_6b41661b-47de-4bc2-a262-1d4b421a8b53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6b41661b-47de-4bc2-a262-1d4b421a8b53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_6b41661b-47de-4bc2-a262-1d4b421a8b53" xlink:to="loc_us-gaap_HedgingDesignationDomain_6b41661b-47de-4bc2-a262-1d4b421a8b53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cb39b61f-1e17-4fb2-bc7b-84d3605660ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_6b41661b-47de-4bc2-a262-1d4b421a8b53" xlink:to="loc_us-gaap_HedgingDesignationDomain_cb39b61f-1e17-4fb2-bc7b-84d3605660ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3f6865e8-81d2-4d82-bef9-6a5dabf7d3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_cb39b61f-1e17-4fb2-bc7b-84d3605660ec" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3f6865e8-81d2-4d82-bef9-6a5dabf7d3a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fdc1c066-c2f9-404a-bdc5-e990aa216cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fdc1c066-c2f9-404a-bdc5-e990aa216cd9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fdc1c066-c2f9-404a-bdc5-e990aa216cd9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fdc1c066-c2f9-404a-bdc5-e990aa216cd9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fdc1c066-c2f9-404a-bdc5-e990aa216cd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a695b079-3c9a-440d-a7e1-9d8217d8f61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fdc1c066-c2f9-404a-bdc5-e990aa216cd9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a695b079-3c9a-440d-a7e1-9d8217d8f61a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_c6ec0b87-8577-474b-b1ab-5bc0c1c6ce37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a695b079-3c9a-440d-a7e1-9d8217d8f61a" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_c6ec0b87-8577-474b-b1ab-5bc0c1c6ce37" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails" xlink:type="extended" id="i2a42ca35ab4747eaad5ee68d67c4b18c_DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6350512e-91da-4bcf-8fdb-3fcb9488bab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6350512e-91da-4bcf-8fdb-3fcb9488bab3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_32cafb3e-8bd6-4157-ba00-e0c2dc9b76dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:to="loc_us-gaap_StockholdersEquity_32cafb3e-8bd6-4157-ba00-e0c2dc9b76dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_74487dd0-e8a4-45af-a776-1d56502ffe20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_74487dd0-e8a4-45af-a776-1d56502ffe20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_39fb4594-314c-4614-b8a7-68a6d2dd0a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_39fb4594-314c-4614-b8a7-68a6d2dd0a20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_ab7cb71b-bf49-4729-b647-e3fcdadba1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_ab7cb71b-bf49-4729-b647-e3fcdadba1bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b7e165df-b28e-40c2-99db-26cd05ad83d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7c7dc01a-4067-4882-abb8-d795dfd0a8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6350512e-91da-4bcf-8fdb-3fcb9488bab3" xlink:to="loc_us-gaap_InterestExpense_7c7dc01a-4067-4882-abb8-d795dfd0a8b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_f9222efb-dea1-4db6-bc23-5c0071902e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6350512e-91da-4bcf-8fdb-3fcb9488bab3" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_f9222efb-dea1-4db6-bc23-5c0071902e9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6350512e-91da-4bcf-8fdb-3fcb9488bab3" xlink:to="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_74a9889a-1c7b-4cb2-9019-c6cdabb2148c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_74a9889a-1c7b-4cb2-9019-c6cdabb2148c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_74a9889a-1c7b-4cb2-9019-c6cdabb2148c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74a9889a-1c7b-4cb2-9019-c6cdabb2148c" xlink:to="loc_us-gaap_EquityComponentDomain_74a9889a-1c7b-4cb2-9019-c6cdabb2148c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b2e95413-29f0-409f-8e7f-4b1891b814ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74a9889a-1c7b-4cb2-9019-c6cdabb2148c" xlink:to="loc_us-gaap_EquityComponentDomain_b2e95413-29f0-409f-8e7f-4b1891b814ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15428dcd-ab90-41e0-a519-1c13c1e609bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b2e95413-29f0-409f-8e7f-4b1891b814ef" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15428dcd-ab90-41e0-a519-1c13c1e609bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_05c20d7a-cb29-41b8-b1cb-64429d473afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_05c20d7a-cb29-41b8-b1cb-64429d473afe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_05c20d7a-cb29-41b8-b1cb-64429d473afe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_05c20d7a-cb29-41b8-b1cb-64429d473afe" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_05c20d7a-cb29-41b8-b1cb-64429d473afe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_35e02f43-a73e-4a30-8b87-9918e1635530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_05c20d7a-cb29-41b8-b1cb-64429d473afe" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_35e02f43-a73e-4a30-8b87-9918e1635530" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1d1d10e9-1074-4141-9f05-987b2256ec59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_35e02f43-a73e-4a30-8b87-9918e1635530" xlink:to="loc_us-gaap_InterestRateSwapMember_1d1d10e9-1074-4141-9f05-987b2256ec59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9249678-d439-4c84-87d0-84b5e77a9c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9249678-d439-4c84-87d0-84b5e77a9c20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e9249678-d439-4c84-87d0-84b5e77a9c20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9249678-d439-4c84-87d0-84b5e77a9c20" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e9249678-d439-4c84-87d0-84b5e77a9c20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ff420689-74f3-4c12-ba3c-2f872c5c7a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9249678-d439-4c84-87d0-84b5e77a9c20" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ff420689-74f3-4c12-ba3c-2f872c5c7a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_437d5bbe-c125-4e78-8cdf-2adb3446cdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ff420689-74f3-4c12-ba3c-2f872c5c7a5b" xlink:to="loc_us-gaap_CashFlowHedgingMember_437d5bbe-c125-4e78-8cdf-2adb3446cdfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_56791a30-d028-404a-84b4-a12cf3bb4e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:to="loc_us-gaap_HedgingDesignationAxis_56791a30-d028-404a-84b4-a12cf3bb4e10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_56791a30-d028-404a-84b4-a12cf3bb4e10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_56791a30-d028-404a-84b4-a12cf3bb4e10" xlink:to="loc_us-gaap_HedgingDesignationDomain_56791a30-d028-404a-84b4-a12cf3bb4e10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f950c6ed-c5c0-424c-bd92-16e6380bcbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_56791a30-d028-404a-84b4-a12cf3bb4e10" xlink:to="loc_us-gaap_HedgingDesignationDomain_f950c6ed-c5c0-424c-bd92-16e6380bcbe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fc589750-c40e-4e4b-a486-fd0b8329d0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f950c6ed-c5c0-424c-bd92-16e6380bcbe5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fc589750-c40e-4e4b-a486-fd0b8329d0cc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i381c789e40a24408960d6bc8bf00ea52_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_54afadd0-4bfb-4700-950a-b3a6d90c772b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_OperatingLossCarryforwards_54afadd0-4bfb-4700-950a-b3a6d90c772b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f449f5bb-79b4-4010-b3f3-e3abc4f1c1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f449f5bb-79b4-4010-b3f3-e3abc4f1c1c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OperatingLossCarryforwardsWithADefiniteLife_574ebb09-826a-4213-bf6f-18ede346a5e2" xlink:href="infu-20211231.xsd#infu_OperatingLossCarryforwardsWithADefiniteLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_infu_OperatingLossCarryforwardsWithADefiniteLife_574ebb09-826a-4213-bf6f-18ede346a5e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OperatingLossCarryforwardsWithIndefiniteLife_d04dddb0-eb35-4493-bca6-d11b549bb1aa" xlink:href="infu-20211231.xsd#infu_OperatingLossCarryforwardsWithIndefiniteLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_infu_OperatingLossCarryforwardsWithIndefiniteLife_d04dddb0-eb35-4493-bca6-d11b549bb1aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OperatingLossCarryforwardsExpirationPeriods_a6147115-50bb-414d-aed9-d6ba8396533f" xlink:href="infu-20211231.xsd#infu_OperatingLossCarryforwardsExpirationPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_infu_OperatingLossCarryforwardsExpirationPeriods_a6147115-50bb-414d-aed9-d6ba8396533f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NetOperatingLossCarryforwardsLimitationOnUse_f3e7a70d-767f-47d1-bd9b-a831306d155e" xlink:href="infu-20211231.xsd#infu_NetOperatingLossCarryforwardsLimitationOnUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_infu_NetOperatingLossCarryforwardsLimitationOnUse_f3e7a70d-767f-47d1-bd9b-a831306d155e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RemainingPreownershipNetOperatingLossCarryforwards_7b4806fc-19bc-4665-88e9-fbc761b06477" xlink:href="infu-20211231.xsd#infu_RemainingPreownershipNetOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_infu_RemainingPreownershipNetOperatingLossCarryforwards_7b4806fc-19bc-4665-88e9-fbc761b06477" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_cca622b8-0878-44c3-a171-e7654a885d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_cca622b8-0878-44c3-a171-e7654a885d43" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7abd12b3-24f6-45a7-8e95-fc1b4a412a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7abd12b3-24f6-45a7-8e95-fc1b4a412a1b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_a0f9ca64-bd04-4c78-9c5a-2301c04552c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_a0f9ca64-bd04-4c78-9c5a-2301c04552c7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4825d4b2-7089-4a69-abb2-fd4cc5928bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4825d4b2-7089-4a69-abb2-fd4cc5928bdd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_61b433c6-d37e-4e47-b223-b21821b5ee81" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:to="loc_srt_RangeAxis_61b433c6-d37e-4e47-b223-b21821b5ee81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61b433c6-d37e-4e47-b223-b21821b5ee81_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_61b433c6-d37e-4e47-b223-b21821b5ee81" xlink:to="loc_srt_RangeMember_61b433c6-d37e-4e47-b223-b21821b5ee81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c3a6ba3a-afbe-41c1-9894-da20b1e5de18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_61b433c6-d37e-4e47-b223-b21821b5ee81" xlink:to="loc_srt_RangeMember_c3a6ba3a-afbe-41c1-9894-da20b1e5de18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a4dd2e9f-1f3d-4a8d-81a9-d02a9aa7d0f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c3a6ba3a-afbe-41c1-9894-da20b1e5de18" xlink:to="loc_srt_MaximumMember_a4dd2e9f-1f3d-4a8d-81a9-d02a9aa7d0f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_74a558a3-3f0e-42d8-87e9-9735a9eaa17a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c3a6ba3a-afbe-41c1-9894-da20b1e5de18" xlink:to="loc_srt_MinimumMember_74a558a3-3f0e-42d8-87e9-9735a9eaa17a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8d188a99-6387-4f60-a604-0a6ee1da217d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8d188a99-6387-4f60-a604-0a6ee1da217d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8d188a99-6387-4f60-a604-0a6ee1da217d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8d188a99-6387-4f60-a604-0a6ee1da217d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8d188a99-6387-4f60-a604-0a6ee1da217d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_049bdfaa-113e-4f3a-9e9b-2304277e156c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8d188a99-6387-4f60-a604-0a6ee1da217d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_049bdfaa-113e-4f3a-9e9b-2304277e156c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_55838384-6def-4b13-8ded-0545b7f493bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_049bdfaa-113e-4f3a-9e9b-2304277e156c" xlink:to="loc_us-gaap_OtherLiabilitiesMember_55838384-6def-4b13-8ded-0545b7f493bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_d092dcd9-5337-498a-8d2f-d38bec07efa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_d092dcd9-5337-498a-8d2f-d38bec07efa8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d092dcd9-5337-498a-8d2f-d38bec07efa8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_d092dcd9-5337-498a-8d2f-d38bec07efa8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d092dcd9-5337-498a-8d2f-d38bec07efa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d0e5a6dc-d5df-4ad0-a4be-62f0aa3ef0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_d092dcd9-5337-498a-8d2f-d38bec07efa8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d0e5a6dc-d5df-4ad0-a4be-62f0aa3ef0ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_5aaaf7d3-3d9c-44dc-9377-9bcb98912804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d0e5a6dc-d5df-4ad0-a4be-62f0aa3ef0ab" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_5aaaf7d3-3d9c-44dc-9377-9bcb98912804" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b5c32cb1-ee8d-48de-b64e-386494aa1e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d0e5a6dc-d5df-4ad0-a4be-62f0aa3ef0ab" xlink:to="loc_us-gaap_DomesticCountryMember_b5c32cb1-ee8d-48de-b64e-386494aa1e0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_47da06dc-3a0a-4812-934f-ca22e31600af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:to="loc_us-gaap_DebtInstrumentAxis_47da06dc-3a0a-4812-934f-ca22e31600af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_47da06dc-3a0a-4812-934f-ca22e31600af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_47da06dc-3a0a-4812-934f-ca22e31600af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_47da06dc-3a0a-4812-934f-ca22e31600af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8ca420ca-e9aa-4776-8269-0986139c8440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_47da06dc-3a0a-4812-934f-ca22e31600af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8ca420ca-e9aa-4776-8269-0986139c8440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaycheckProtectionProgramCaresActMember_6e6ec414-ca31-41dd-a84d-4ea203383c82" xlink:href="infu-20211231.xsd#infu_PaycheckProtectionProgramCaresActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ca420ca-e9aa-4776-8269-0986139c8440" xlink:to="loc_infu_PaycheckProtectionProgramCaresActMember_6e6ec414-ca31-41dd-a84d-4ea203383c82" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesCarryForwardsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesCarryForwardsDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/IncomeTaxesCarryForwardsDetails" xlink:type="extended" id="i37c9718dc27f442890132dfe5c9aac04_IncomeTaxesCarryForwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_143c7f53-6062-49b8-b6f1-df0007ca15b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_143c7f53-6062-49b8-b6f1-df0007ca15b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_307fc2e4-9cfe-414c-a6e3-032862f31ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_307fc2e4-9cfe-414c-a6e3-032862f31ebc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f74e9c01-3307-448e-984b-32c048a0efa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f74e9c01-3307-448e-984b-32c048a0efa7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxAssetsOperatingLeaseLiabilities_76d9f594-d64b-4e85-b62f-dcb70916a6e7" xlink:href="infu-20211231.xsd#infu_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_infu_DeferredTaxAssetsOperatingLeaseLiabilities_76d9f594-d64b-4e85-b62f-dcb70916a6e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_5716dcb7-db4d-42c0-87ee-650b59763d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_5716dcb7-db4d-42c0-87ee-650b59763d85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_dff09989-14cb-4114-91f3-e37171997a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_dff09989-14cb-4114-91f3-e37171997a20" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_4dc797c9-93b9-4677-9a63-bcc911595b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_4dc797c9-93b9-4677-9a63-bcc911595b48" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_d5d1b250-c9ed-471c-971d-e3f903196b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_d5d1b250-c9ed-471c-971d-e3f903196b6a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther_d98698f7-9d4e-45a8-a841-63e8a2a7a22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther_d98698f7-9d4e-45a8-a841-63e8a2a7a22a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_7dadeb18-5305-40ea-a34d-00b5966f09ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_7dadeb18-5305-40ea-a34d-00b5966f09ee" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_49c0b4e7-0af6-42f5-a49e-c023f49a64c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_49c0b4e7-0af6-42f5-a49e-c023f49a64c5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_effe689a-2b34-4f95-a6d7-fc687c0c7bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_effe689a-2b34-4f95-a6d7-fc687c0c7bd5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxLiabilitiesRightOfUseAssets_2ca55bce-8251-4714-b0be-55b25ef7ac60" xlink:href="infu-20211231.xsd#infu_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_infu_DeferredTaxLiabilitiesRightOfUseAssets_2ca55bce-8251-4714-b0be-55b25ef7ac60" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_8a026c25-bee5-4034-a7bd-7d2c04fa849e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_8a026c25-bee5-4034-a7bd-7d2c04fa849e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c381d071-fb92-442b-8c25-9b061b55bc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_c381d071-fb92-442b-8c25-9b061b55bc2a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_494c6e94-7fae-43a9-95f9-8da949dcc9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_494c6e94-7fae-43a9-95f9-8da949dcc9c6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_9b61522c-df7f-4633-b07c-1b2e8a676e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_9b61522c-df7f-4633-b07c-1b2e8a676e9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8ed1de6e-8974-4495-9f6b-5b5373e94e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_9b61522c-df7f-4633-b07c-1b2e8a676e9d" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8ed1de6e-8974-4495-9f6b-5b5373e94e69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_8ed1de6e-8974-4495-9f6b-5b5373e94e69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8ed1de6e-8974-4495-9f6b-5b5373e94e69" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_8ed1de6e-8974-4495-9f6b-5b5373e94e69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_298e7ed0-1a87-43d6-a2ad-371c99e867c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8ed1de6e-8974-4495-9f6b-5b5373e94e69" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_298e7ed0-1a87-43d6-a2ad-371c99e867c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_65ca1256-1d11-4a87-b4e0-4ee7dc459b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_298e7ed0-1a87-43d6-a2ad-371c99e867c5" xlink:to="loc_us-gaap_DomesticCountryMember_65ca1256-1d11-4a87-b4e0-4ee7dc459b9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_0bb296de-e944-4978-8986-11594d75ab0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_298e7ed0-1a87-43d6-a2ad-371c99e867c5" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_0bb296de-e944-4978-8986-11594d75ab0b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/LeasesDetailsTextual" xlink:type="extended" id="if58b33b5b4104db49975bcb68367f345_LeasesDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e52764ee-00e9-4c95-8df6-a6382d9f36df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_5a1e8f8a-22e1-4b13-8fda-bec046ac3fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e52764ee-00e9-4c95-8df6-a6382d9f36df" xlink:to="loc_us-gaap_LeaseCost_5a1e8f8a-22e1-4b13-8fda-bec046ac3fa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4a0c0337-7d9f-42c9-9f31-c18e86fc71ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e52764ee-00e9-4c95-8df6-a6382d9f36df" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4a0c0337-7d9f-42c9-9f31-c18e86fc71ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0343b405-5300-4709-95cb-169cf12e3d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4a0c0337-7d9f-42c9-9f31-c18e86fc71ea" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0343b405-5300-4709-95cb-169cf12e3d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0343b405-5300-4709-95cb-169cf12e3d9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0343b405-5300-4709-95cb-169cf12e3d9d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0343b405-5300-4709-95cb-169cf12e3d9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1584232c-07e7-4b5d-ad55-c5cb3e8bc950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0343b405-5300-4709-95cb-169cf12e3d9d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1584232c-07e7-4b5d-ad55-c5cb3e8bc950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e812a7ba-9a91-42ea-a7b9-c9fdc427b981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1584232c-07e7-4b5d-ad55-c5cb3e8bc950" xlink:to="loc_us-gaap_CostOfSalesMember_e812a7ba-9a91-42ea-a7b9-c9fdc427b981" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_59df98f2-41f5-4c2b-8bf5-6c35106c62d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1584232c-07e7-4b5d-ad55-c5cb3e8bc950" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_59df98f2-41f5-4c2b-8bf5-6c35106c62d0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/SharebasedCompensationNarrativeDetails" xlink:type="extended" id="i8bdea9b1fd554825b0ec483d323a6a1b_SharebasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_288fbb05-d477-4cd3-8398-91b9be0ada34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_288fbb05-d477-4cd3-8398-91b9be0ada34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_04791cf0-228e-4386-b80a-89d61a2e9f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_04791cf0-228e-4386-b80a-89d61a2e9f76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_5f92ca4b-59d5-4f72-b15b-5df7c909bf71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_5f92ca4b-59d5-4f72-b15b-5df7c909bf71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_fadfe7ce-e91c-493a-879e-79a5781ce05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_fadfe7ce-e91c-493a-879e-79a5781ce05c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e9d7f3fa-2d69-4439-9052-e327b8e3ab18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e9d7f3fa-2d69-4439-9052-e327b8e3ab18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_5fa43b9e-007f-4f3f-9cfe-19f06bebc5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_5fa43b9e-007f-4f3f-9cfe-19f06bebc5a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77f1af40-88b1-433a-9f61-d5eeb5624be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77f1af40-88b1-433a-9f61-d5eeb5624be2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b37a97a5-561e-425e-81b8-846736d99c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b37a97a5-561e-425e-81b8-846736d99c75" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d2fb54c0-0415-48d6-bc46-b61f6de15a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d2fb54c0-0415-48d6-bc46-b61f6de15a6a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned_fa0eb071-c989-43ce-988d-b43730f19580" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned_fa0eb071-c989-43ce-988d-b43730f19580" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP_feda1aa6-182d-4b52-9b5a-33f4cafa7611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP_feda1aa6-182d-4b52-9b5a-33f4cafa7611" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EmployeeStockPurchasePlanDiscountRate_d8f3fe33-08eb-4b55-ab2e-b6cdd3bf4f15" xlink:href="infu-20211231.xsd#infu_EmployeeStockPurchasePlanDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_infu_EmployeeStockPurchasePlanDiscountRate_d8f3fe33-08eb-4b55-ab2e-b6cdd3bf4f15" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum_fc256276-6c93-4528-9cd0-27debf21107c" xlink:href="infu-20211231.xsd#infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum_fc256276-6c93-4528-9cd0-27debf21107c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance_5413887c-f495-43ed-8d51-d028d25aad1d" xlink:href="infu-20211231.xsd#infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance_5413887c-f495-43ed-8d51-d028d25aad1d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0b6f6063-a9db-459b-a6c2-0e8b3f6423c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0b6f6063-a9db-459b-a6c2-0e8b3f6423c3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_161b0dd7-d75a-4512-8ca3-68ee03bb02cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_161b0dd7-d75a-4512-8ca3-68ee03bb02cd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_e2ca226c-255d-4f6f-a0f8-edc0a5e8d887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_e2ca226c-255d-4f6f-a0f8-edc0a5e8d887" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5c4cfedd-9997-49c3-aaee-9e33ebb17398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:to="loc_us-gaap_AwardTypeAxis_5c4cfedd-9997-49c3-aaee-9e33ebb17398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5c4cfedd-9997-49c3-aaee-9e33ebb17398_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5c4cfedd-9997-49c3-aaee-9e33ebb17398" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5c4cfedd-9997-49c3-aaee-9e33ebb17398_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_940606e2-8e66-40b6-9d1a-8d4bd25d7de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5c4cfedd-9997-49c3-aaee-9e33ebb17398" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_940606e2-8e66-40b6-9d1a-8d4bd25d7de5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_8448eb0d-e272-4fa4-91a2-5a0d01a324d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_940606e2-8e66-40b6-9d1a-8d4bd25d7de5" xlink:to="loc_us-gaap_RestrictedStockMember_8448eb0d-e272-4fa4-91a2-5a0d01a324d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_5ccd6954-e231-492e-b2e0-91fd9c33be0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_940606e2-8e66-40b6-9d1a-8d4bd25d7de5" xlink:to="loc_us-gaap_PerformanceSharesMember_5ccd6954-e231-492e-b2e0-91fd9c33be0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2bb93a28-c4fe-4cc1-bb16-616d582425ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_940606e2-8e66-40b6-9d1a-8d4bd25d7de5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2bb93a28-c4fe-4cc1-bb16-616d582425ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_5ad86511-66de-45ca-ba14-b99ad6b4e61d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:to="loc_us-gaap_VestingAxis_5ad86511-66de-45ca-ba14-b99ad6b4e61d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_5ad86511-66de-45ca-ba14-b99ad6b4e61d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_5ad86511-66de-45ca-ba14-b99ad6b4e61d" xlink:to="loc_us-gaap_VestingDomain_5ad86511-66de-45ca-ba14-b99ad6b4e61d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_5287df59-1e89-4415-a98f-9334b3f18ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_5ad86511-66de-45ca-ba14-b99ad6b4e61d" xlink:to="loc_us-gaap_VestingDomain_5287df59-1e89-4415-a98f-9334b3f18ca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember_ccf5f9e8-8b3c-41ba-a370-4d1dd67e5200" xlink:href="infu-20211231.xsd#infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_5287df59-1e89-4415-a98f-9334b3f18ca6" xlink:to="loc_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember_ccf5f9e8-8b3c-41ba-a370-4d1dd67e5200" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember_eb6795b5-a3bb-4941-95d9-028fcd543fd4" xlink:href="infu-20211231.xsd#infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_5287df59-1e89-4415-a98f-9334b3f18ca6" xlink:to="loc_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember_eb6795b5-a3bb-4941-95d9-028fcd543fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5632fc27-cc8a-434b-a0cc-0ce7d1f1bdd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:to="loc_us-gaap_PlanNameAxis_5632fc27-cc8a-434b-a0cc-0ce7d1f1bdd0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5632fc27-cc8a-434b-a0cc-0ce7d1f1bdd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5632fc27-cc8a-434b-a0cc-0ce7d1f1bdd0" xlink:to="loc_us-gaap_PlanNameDomain_5632fc27-cc8a-434b-a0cc-0ce7d1f1bdd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f13d4a05-d14f-4a82-9223-954cdbbcce35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5632fc27-cc8a-434b-a0cc-0ce7d1f1bdd0" xlink:to="loc_us-gaap_PlanNameDomain_f13d4a05-d14f-4a82-9223-954cdbbcce35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_A2021EquityIncentivePlanMember_cfee9923-645c-4111-b109-ba42fe2cc8a3" xlink:href="infu-20211231.xsd#infu_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f13d4a05-d14f-4a82-9223-954cdbbcce35" xlink:to="loc_infu_A2021EquityIncentivePlanMember_cfee9923-645c-4111-b109-ba42fe2cc8a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_A2014EquityIncentivePlanMember_78926923-3983-4c1c-bd8a-474b4198cf06" xlink:href="infu-20211231.xsd#infu_A2014EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f13d4a05-d14f-4a82-9223-954cdbbcce35" xlink:to="loc_infu_A2014EquityIncentivePlanMember_78926923-3983-4c1c-bd8a-474b4198cf06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd7af82b-a24f-4078-ace3-bcc04c44c423" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:to="loc_srt_RangeAxis_dd7af82b-a24f-4078-ace3-bcc04c44c423" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd7af82b-a24f-4078-ace3-bcc04c44c423_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd7af82b-a24f-4078-ace3-bcc04c44c423" xlink:to="loc_srt_RangeMember_dd7af82b-a24f-4078-ace3-bcc04c44c423_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5af31b0b-7079-4db4-9f3c-b09e46d42805" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd7af82b-a24f-4078-ace3-bcc04c44c423" xlink:to="loc_srt_RangeMember_5af31b0b-7079-4db4-9f3c-b09e46d42805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1fd28778-8285-4dbf-9e74-319eb96c1ff7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5af31b0b-7079-4db4-9f3c-b09e46d42805" xlink:to="loc_srt_MinimumMember_1fd28778-8285-4dbf-9e74-319eb96c1ff7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_35dd6e7f-b0a2-461f-b9f1-0c02a0316c81" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5af31b0b-7079-4db4-9f3c-b09e46d42805" xlink:to="loc_srt_MaximumMember_35dd6e7f-b0a2-461f-b9f1-0c02a0316c81" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails" xlink:type="extended" id="i700d73824ccf4f00b91c9c861acb4b30_SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d4e1bbb-487f-407a-82c7-59ab40c02243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d4e1bbb-487f-407a-82c7-59ab40c02243" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0748d8c3-f4f4-4d09-bb13-472f96a6ea4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0748d8c3-f4f4-4d09-bb13-472f96a6ea4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_701f9e5f-caf8-49b1-8c83-3c8e5a2186ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_701f9e5f-caf8-49b1-8c83-3c8e5a2186ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_77e958a9-c583-4ffb-8daa-6eaa9ffddd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_77e958a9-c583-4ffb-8daa-6eaa9ffddd1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod_17beb584-10b1-4b78-8844-9a7888c4a98e" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod_17beb584-10b1-4b78-8844-9a7888c4a98e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d2e44a28-60fd-4e8c-a314-04f6145e91dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d2e44a28-60fd-4e8c-a314-04f6145e91dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2d6a5c7a-5780-4595-b52e-ffc0583b7861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d4e1bbb-487f-407a-82c7-59ab40c02243" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e78f9d1f-e7c5-414f-84b8-8c9cb0877027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e78f9d1f-e7c5-414f-84b8-8c9cb0877027" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87a92321-4f38-4582-8734-a00bb6cfdbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87a92321-4f38-4582-8734-a00bb6cfdbdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8fdb47dc-8f95-421c-b7c5-f708c42fca1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8fdb47dc-8f95-421c-b7c5-f708c42fca1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue_b447db30-1e54-4cad-9ea3-01027d2ddea9" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue_b447db30-1e54-4cad-9ea3-01027d2ddea9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4cbe5f46-e343-4d5a-a2a7-8e19d96ea19a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4cbe5f46-e343-4d5a-a2a7-8e19d96ea19a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ec3dc0c4-b9ea-49e7-9d85-9c06b573ec3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e02123bd-60b6-4cef-9299-7f4e059702b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e02123bd-60b6-4cef-9299-7f4e059702b2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue_a3f1a706-00ac-4c4a-aa61-c050f530d6e4" xlink:href="infu-20211231.xsd#infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue_a3f1a706-00ac-4c4a-aa61-c050f530d6e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c16078f3-2cbd-4def-9ecb-642a04177067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d4e1bbb-487f-407a-82c7-59ab40c02243" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c16078f3-2cbd-4def-9ecb-642a04177067" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_af874197-1aa2-42fe-a5e5-847ba96db63f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c16078f3-2cbd-4def-9ecb-642a04177067" xlink:to="loc_us-gaap_AwardTypeAxis_af874197-1aa2-42fe-a5e5-847ba96db63f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af874197-1aa2-42fe-a5e5-847ba96db63f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_af874197-1aa2-42fe-a5e5-847ba96db63f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af874197-1aa2-42fe-a5e5-847ba96db63f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e572329-b984-4497-be68-e027fc5e7955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_af874197-1aa2-42fe-a5e5-847ba96db63f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e572329-b984-4497-be68-e027fc5e7955" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b9ac27c3-83d0-4a9b-be32-d75da06ed35c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e572329-b984-4497-be68-e027fc5e7955" xlink:to="loc_us-gaap_RestrictedStockMember_b9ac27c3-83d0-4a9b-be32-d75da06ed35c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationPSUActivityDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationPSUActivityDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/SharebasedCompensationPSUActivityDetails" xlink:type="extended" id="i6211c083d9454a35b5021d91175cdff1_SharebasedCompensationPSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fb3d2f4-efbb-4f4d-aa82-d35bbdceee43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fb3d2f4-efbb-4f4d-aa82-d35bbdceee43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7492e0b0-73fb-443e-88e8-f848547c4141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7492e0b0-73fb-443e-88e8-f848547c4141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_14b7178c-8206-4c5f-b92a-61d8efe76994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_14b7178c-8206-4c5f-b92a-61d8efe76994" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_66a6b053-9e68-4f42-b093-3b1f92664427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_66a6b053-9e68-4f42-b093-3b1f92664427" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone_11fdd37d-a27e-4812-80c8-6611fc5dee12" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone_11fdd37d-a27e-4812-80c8-6611fc5dee12" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6535b74a-af13-4f00-9956-36d21cb66d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fb3d2f4-efbb-4f4d-aa82-d35bbdceee43" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5e6afd48-1b3d-43cc-97dd-e9b83001bba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5e6afd48-1b3d-43cc-97dd-e9b83001bba3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_18533200-0923-4d7c-8471-87bbd0f79824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_18533200-0923-4d7c-8471-87bbd0f79824" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f1b85f0d-724d-4c24-a793-e268fcb34b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f1b85f0d-724d-4c24-a793-e268fcb34b26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue_fb256afa-f6ac-457a-8c3d-b1948c5526e7" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue_fb256afa-f6ac-457a-8c3d-b1948c5526e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1f42554f-388d-4cc2-8f3c-05df1332a05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_4304aef2-e17e-4404-8bc7-12a1d26c3518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_4304aef2-e17e-4404-8bc7-12a1d26c3518" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue_5ee7775c-9a2d-4d19-bc09-8d3a1d493725" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue_5ee7775c-9a2d-4d19-bc09-8d3a1d493725" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_04543bdd-1259-433d-bff9-2576f709fdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fb3d2f4-efbb-4f4d-aa82-d35bbdceee43" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_04543bdd-1259-433d-bff9-2576f709fdd6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8a657a70-b7e1-4c35-bdab-7ccdd8d3fba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_04543bdd-1259-433d-bff9-2576f709fdd6" xlink:to="loc_us-gaap_AwardTypeAxis_8a657a70-b7e1-4c35-bdab-7ccdd8d3fba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a657a70-b7e1-4c35-bdab-7ccdd8d3fba0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8a657a70-b7e1-4c35-bdab-7ccdd8d3fba0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a657a70-b7e1-4c35-bdab-7ccdd8d3fba0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_15cee08a-3b25-4f6f-ab0c-c99af3bc56f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8a657a70-b7e1-4c35-bdab-7ccdd8d3fba0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_15cee08a-3b25-4f6f-ab0c-c99af3bc56f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_963b28a1-64db-4855-9f6d-d4f8cbeab93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_15cee08a-3b25-4f6f-ab0c-c99af3bc56f3" xlink:to="loc_us-gaap_PerformanceSharesMember_963b28a1-64db-4855-9f6d-d4f8cbeab93d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensation2014and2021PlanActivityDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails" xlink:type="extended" id="if12e25d202384a9a94823501b744bf62_SharebasedCompensation2014and2021PlanActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91450221-21af-4122-9b70-2d2bfdf9059c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91450221-21af-4122-9b70-2d2bfdf9059c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6f896d1f-c15b-45ce-8c82-e1838d559550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6f896d1f-c15b-45ce-8c82-e1838d559550" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_496a4eaf-85a0-4e7b-baf1-1e1b5630a873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_496a4eaf-85a0-4e7b-baf1-1e1b5630a873" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_fbaca841-5961-41f7-922f-ac0c8e273976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_fbaca841-5961-41f7-922f-ac0c8e273976" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CashlessExerciseOfStockOptionsShares_f9ceac91-2709-4570-a2fe-9720162c3f48" xlink:href="infu-20211231.xsd#infu_CashlessExerciseOfStockOptionsShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_infu_CashlessExerciseOfStockOptionsShares_f9ceac91-2709-4570-a2fe-9720162c3f48" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8cc8d8d7-5351-4502-bab8-1fbacb304581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8cc8d8d7-5351-4502-bab8-1fbacb304581" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_980f9a1a-a963-418f-80c8-36e514c556fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c4fd0197-5cbb-401c-86c6-43eb45bd83e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c4fd0197-5cbb-401c-86c6-43eb45bd83e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_34c89d02-da53-4996-a86c-26396188b6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_34c89d02-da53-4996-a86c-26396188b6d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_05068ddc-5854-4b4b-8c17-4db1297e7033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_05068ddc-5854-4b4b-8c17-4db1297e7033" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d8786c91-3836-40d2-8b11-fbe9c0dcefc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d8786c91-3836-40d2-8b11-fbe9c0dcefc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_0f36144b-61b8-4138-b7a7-79c21f10958c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_0f36144b-61b8-4138-b7a7-79c21f10958c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice_833fd25f-b72a-4421-b7eb-f16c1ea8e447" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice_833fd25f-b72a-4421-b7eb-f16c1ea8e447" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_715d0efb-4b79-4fe6-9421-4645ed0784f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_715d0efb-4b79-4fe6-9421-4645ed0784f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0e52f40b-8eaa-4806-a9d9-a606219fad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_118134ac-dddf-49b9-918f-6a1d20f39b70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_118134ac-dddf-49b9-918f-6a1d20f39b70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6ba53180-fdc7-4ca9-9f6b-bdadfcff31f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6ba53180-fdc7-4ca9-9f6b-bdadfcff31f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_175b0703-db05-4add-978a-f8a8d6a6761e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_175b0703-db05-4add-978a-f8a8d6a6761e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d110d473-9320-416c-8e5d-0628d08661b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d110d473-9320-416c-8e5d-0628d08661b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6fc767bd-a641-4672-b56d-6f9cc77bc287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6fc767bd-a641-4672-b56d-6f9cc77bc287" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82800a9c-978a-4af0-811d-c90b21980155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82800a9c-978a-4af0-811d-c90b21980155" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_75b2715f-b756-4e0e-8351-082d02c85c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82800a9c-978a-4af0-811d-c90b21980155" xlink:to="loc_us-gaap_PlanNameAxis_75b2715f-b756-4e0e-8351-082d02c85c01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_75b2715f-b756-4e0e-8351-082d02c85c01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_75b2715f-b756-4e0e-8351-082d02c85c01" xlink:to="loc_us-gaap_PlanNameDomain_75b2715f-b756-4e0e-8351-082d02c85c01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4ad9dafd-f605-48e6-94cb-da0fa10fd7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_75b2715f-b756-4e0e-8351-082d02c85c01" xlink:to="loc_us-gaap_PlanNameDomain_4ad9dafd-f605-48e6-94cb-da0fa10fd7f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_A2014EquityIncentivePlanMember_1ebedee8-c34d-47b7-8ce6-bf62bf0ab968" xlink:href="infu-20211231.xsd#infu_A2014EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4ad9dafd-f605-48e6-94cb-da0fa10fd7f6" xlink:to="loc_infu_A2014EquityIncentivePlanMember_1ebedee8-c34d-47b7-8ce6-bf62bf0ab968" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_A2021EquityIncentivePlanMember_c2d3c0d7-51e5-4464-ac93-04406ac1de4d" xlink:href="infu-20211231.xsd#infu_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4ad9dafd-f605-48e6-94cb-da0fa10fd7f6" xlink:to="loc_infu_A2021EquityIncentivePlanMember_c2d3c0d7-51e5-4464-ac93-04406ac1de4d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails" xlink:type="extended" id="i33586724d296483594cba1e55b1e436f_SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0200c0f9-f2e5-4750-a66f-cc2294124b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0200c0f9-f2e5-4750-a66f-cc2294124b9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_95fae53a-726c-4c0e-be47-ca117ef6955c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_95fae53a-726c-4c0e-be47-ca117ef6955c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f7239882-583d-4d6c-a991-e896a767daa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f7239882-583d-4d6c-a991-e896a767daa0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d9d44c93-a8c0-4c6d-8ef2-e02fe374ca75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d9d44c93-a8c0-4c6d-8ef2-e02fe374ca75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1fdecbf7-7104-4e1f-9460-730d3032641b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1fdecbf7-7104-4e1f-9460-730d3032641b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_06c526f2-97fd-4a78-9098-2ae178162d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_06c526f2-97fd-4a78-9098-2ae178162d8d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_607d3cb7-98fa-4609-86ec-d8d1e1fe7b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_607d3cb7-98fa-4609-86ec-d8d1e1fe7b6f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65b045bc-5b35-4123-adb3-27595b7d98ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65b045bc-5b35-4123-adb3-27595b7d98ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1b43c5f0-9305-4cea-b5b5-fcaac89a12d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65b045bc-5b35-4123-adb3-27595b7d98ac" xlink:to="loc_us-gaap_AwardTypeAxis_1b43c5f0-9305-4cea-b5b5-fcaac89a12d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b43c5f0-9305-4cea-b5b5-fcaac89a12d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1b43c5f0-9305-4cea-b5b5-fcaac89a12d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b43c5f0-9305-4cea-b5b5-fcaac89a12d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31b6e8-0997-4288-8c07-612e849745dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1b43c5f0-9305-4cea-b5b5-fcaac89a12d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31b6e8-0997-4288-8c07-612e849745dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9d00c1c3-969d-48c9-9e9d-b87fdff666cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31b6e8-0997-4288-8c07-612e849745dd" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9d00c1c3-969d-48c9-9e9d-b87fdff666cc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="extended" id="i7baeb2387a604a5c9d8da6eb11ad7a04_BusinessSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesExternal_a1322a6f-26fa-4f27-842b-b9880dade2bb" xlink:href="infu-20211231.xsd#infu_RevenuesExternal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_infu_RevenuesExternal_a1322a6f-26fa-4f27-842b-b9880dade2bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesInternal_ddf4e378-9381-4401-87ce-b8d84571912a" xlink:href="infu-20211231.xsd#infu_RevenuesInternal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_infu_RevenuesInternal_ddf4e378-9381-4401-87ce-b8d84571912a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_44f2cd6d-235c-42d2-bde5-7621bfd4a9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_Revenues_44f2cd6d-235c-42d2-bde5-7621bfd4a9d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0bcda5ce-0f97-4d15-ae11-812e49c45e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_GrossProfit_0bcda5ce-0f97-4d15-ae11-812e49c45e2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_096a3a60-bac1-431f-97cf-3e0104e148bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_OperatingExpenses_096a3a60-bac1-431f-97cf-3e0104e148bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f8f9d114-57b2-48cf-90db-8c00fe7f87ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_InterestExpense_f8f9d114-57b2-48cf-90db-8c00fe7f87ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4ea5b936-84ac-4898-8974-34ce5207d680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4ea5b936-84ac-4898-8974-34ce5207d680" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_42939093-1b8e-4fee-a98f-0ebef7181606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_42939093-1b8e-4fee-a98f-0ebef7181606" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fd85d8cf-aa20-44c3-8a98-ac7fddfa50b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_NetIncomeLoss_fd85d8cf-aa20-44c3-8a98-ac7fddfa50b9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d4960f82-8858-4549-84cc-fd42afd16f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_Assets_d4960f82-8858-4549-84cc-fd42afd16f1d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireMedicalEquipment_6a01dc48-7bf8-4183-a783-47285f950de5" xlink:href="infu-20211231.xsd#infu_PaymentsToAcquireMedicalEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_infu_PaymentsToAcquireMedicalEquipment_6a01dc48-7bf8-4183-a783-47285f950de5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ff1ba856-c6f5-4ad8-ab13-cab601cdca79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_DepreciationAndAmortization_ff1ba856-c6f5-4ad8-ab13-cab601cdca79" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c22a99b0-e765-42bd-84f6-bce7d41cfc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c22a99b0-e765-42bd-84f6-bce7d41cfc3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_af67f85a-bbee-4cbf-b0a5-4cb21d508721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c22a99b0-e765-42bd-84f6-bce7d41cfc3a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_af67f85a-bbee-4cbf-b0a5-4cb21d508721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_af67f85a-bbee-4cbf-b0a5-4cb21d508721_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_af67f85a-bbee-4cbf-b0a5-4cb21d508721" xlink:to="loc_us-gaap_SegmentDomain_af67f85a-bbee-4cbf-b0a5-4cb21d508721_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a2ff6128-98bf-442c-867a-0cf4bebb62da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_af67f85a-bbee-4cbf-b0a5-4cb21d508721" xlink:to="loc_us-gaap_SegmentDomain_a2ff6128-98bf-442c-867a-0cf4bebb62da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_790953bf-9ef4-4db1-af09-35378e0a63a6" xlink:href="infu-20211231.xsd#infu_ITSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a2ff6128-98bf-442c-867a-0cf4bebb62da" xlink:to="loc_infu_ITSSegmentMember_790953bf-9ef4-4db1-af09-35378e0a63a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_6cb6c146-68e7-4eb2-a1c1-d61e3d4c83ca" xlink:href="infu-20211231.xsd#infu_DMEServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a2ff6128-98bf-442c-867a-0cf4bebb62da" xlink:to="loc_infu_DMEServicesSegmentMember_6cb6c146-68e7-4eb2-a1c1-d61e3d4c83ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6b93da8a-4804-476d-bc5c-2533fb934a57" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c22a99b0-e765-42bd-84f6-bce7d41cfc3a" xlink:to="loc_srt_ConsolidationItemsAxis_6b93da8a-4804-476d-bc5c-2533fb934a57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6b93da8a-4804-476d-bc5c-2533fb934a57_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_6b93da8a-4804-476d-bc5c-2533fb934a57" xlink:to="loc_srt_ConsolidationItemsDomain_6b93da8a-4804-476d-bc5c-2533fb934a57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_443663ca-019a-429c-ac2a-f51222be30d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_6b93da8a-4804-476d-bc5c-2533fb934a57" xlink:to="loc_srt_ConsolidationItemsDomain_443663ca-019a-429c-ac2a-f51222be30d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_24b227fd-99b9-4d10-883a-a10f682e9773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_443663ca-019a-429c-ac2a-f51222be30d1" xlink:to="loc_us-gaap_OperatingSegmentsMember_24b227fd-99b9-4d10-883a-a10f682e9773" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CorporateAndEliminationsMember_37c9b0f3-14c7-45fb-8773-2fcafd45582d" xlink:href="infu-20211231.xsd#infu_CorporateAndEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_443663ca-019a-429c-ac2a-f51222be30d1" xlink:to="loc_infu_CorporateAndEliminationsMember_37c9b0f3-14c7-45fb-8773-2fcafd45582d" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>infu-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5045cdd8-3e33-4b1e-9c96-436a6a424439,g:4f22e797-67c4-4a22-8bb5-b3bf69d58fcf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_e2f640fd-59e3-42c8-a949-f9047f422ac1_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses:</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2e4c4e16-9a10-4c9a-95dc-32a3d73259b5_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_4fe6535b-84fc-4b6e-8c26-c3ccbf57a597_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_92b9e83f-9367-4312-bec8-b5ed134ed307_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURES</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1bae517b-4aba-4c2b-b023-37e2e39d1717_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense at the statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_6cd63af5-a6b6-4a5c-912e-86a299ca401d_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_2ffac065-2b66-4fe2-a472-5dcb272874e6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4f5bf0e6-1687-40e1-af22-08bf933debc6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, number of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_225334c6-e1db-4374-acbe-5fa7d71150b5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_ecfe47cb-6d83-4952-8e92-64cd941a25ef_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_f6369ebc-eb96-4309-81f8-6a6074a3b329_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_a36591f8-4a54-404d-9f7d-eb191ab41113_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_655a37ed-6cda-45e9-8023-36c99ddddfd2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right of use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_964b63f0-daa5-4164-b120-b22af3e65320_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f24c0e07-a356-4237-8ced-25c4eb9f0bbc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3dc29f76-23af-4b35-b0da-11717125240d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related liabilities, current</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock_89416604-233a-4e71-994e-7f78ca3d59b9_terseLabel_en-US" xlink:label="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Medical Equipment</link:label>
    <link:label id="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock_label_en-US" xlink:label="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Medical Equipment [Table Text Block]</link:label>
    <link:label id="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock_documentation_en-US" xlink:label="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of medical equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:href="infu-20211231.xsd#infu_ScheduleOfMedicalEquipmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:to="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_c230f014-cff6-4c07-a39e-fb4c57c68960_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_The2019EquipmentLineMember_83719ebe-cc74-44e0-8a75-9aa684f8f788_terseLabel_en-US" xlink:label="lab_infu_The2019EquipmentLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2019 Equipment Line</link:label>
    <link:label id="lab_infu_The2019EquipmentLineMember_label_en-US" xlink:label="lab_infu_The2019EquipmentLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2019 Equipment Line [Member]</link:label>
    <link:label id="lab_infu_The2019EquipmentLineMember_documentation_en-US" xlink:label="lab_infu_The2019EquipmentLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding the 2019 Equipment Line.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2019EquipmentLineMember" xlink:href="infu-20211231.xsd#infu_The2019EquipmentLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_The2019EquipmentLineMember" xlink:to="lab_infu_The2019EquipmentLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_80b2bc3f-9185-4d73-9c1d-649ed44982d4_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_85d36959-c162-4526-8c3c-13cae54cf6ad_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition costs and non-recurring expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d2bfb4aa-42df-4941-84c2-9bbdb650fd8d_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_0e31f11d-2959-4e56-94f9-f9a618608c8d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_bb340251-dd40-407d-9b86-696c5be38080_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_OperatingLossCarryforwardsWithADefiniteLife_3fc41384-ed85-479f-a81d-c04c316b4396_terseLabel_en-US" xlink:label="lab_infu_OperatingLossCarryforwardsWithADefiniteLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards with a definite life</link:label>
    <link:label id="lab_infu_OperatingLossCarryforwardsWithADefiniteLife_label_en-US" xlink:label="lab_infu_OperatingLossCarryforwardsWithADefiniteLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards With A Definite Life</link:label>
    <link:label id="lab_infu_OperatingLossCarryforwardsWithADefiniteLife_documentation_en-US" xlink:label="lab_infu_OperatingLossCarryforwardsWithADefiniteLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of operating loss carryforwards that have an indefinite life.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OperatingLossCarryforwardsWithADefiniteLife" xlink:href="infu-20211231.xsd#infu_OperatingLossCarryforwardsWithADefiniteLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_OperatingLossCarryforwardsWithADefiniteLife" xlink:to="lab_infu_OperatingLossCarryforwardsWithADefiniteLife" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_bb6c8c2f-abb7-42d2-ba53-9785dd35ffe8_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_852f969f-dbc3-48c4-a6c1-ebeae73125b7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5547ef39-870f-4d06-bcd1-452c04d7931a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeitures, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_035d4ce9-a502-4d67-98bd-9b74c9489e4b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based shares issued upon vesting - gross (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d25ceabe-5408-4190-8c52-0a668cf20e67_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, number of authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6d50b99a-07cf-4428-979e-f4b18e470e2b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term:</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice_8be2d7dd-7a66-4318-ae54-bd318666eb61_terseLabel_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless exercise, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice_label_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless exercise, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average exercise price of awarded shares exercised in the period in a cashless transaction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice" xlink:to="lab_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9322c80d-a922-415b-909e-1c4a0fb0a75c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61b3a1f5-48d6-4bde-bb6b-d61c941514a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_8a68d1fb-b005-40d9-b904-ace9221fe0f2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentForSaleOrRentalReserve_f964a7ed-1a9d-488e-bdfe-a233f27743a5_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment for sale or rental, reserve</link:label>
    <link:label id="lab_infu_MedicalEquipmentForSaleOrRentalReserve_c0d6cc43-aa64-492b-8bff-c8f597125ddd_negatedTerseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment for sale or rental - pump reserve</link:label>
    <link:label id="lab_infu_MedicalEquipmentForSaleOrRentalReserve_label_en-US" xlink:label="lab_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment For Sale Or Rental Reserve</link:label>
    <link:label id="lab_infu_MedicalEquipmentForSaleOrRentalReserve_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of reserve associated with medical equipment for sale or rental, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentForSaleOrRentalReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:to="lab_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_3c0f5201-9979-443d-9abb-6559b983bff5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a9b5e174-4cce-428d-b8af-0564f2df6af3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6890ac7b-3c6f-454e-9992-31a5310d2cf0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_42d48b0e-d055-4358-a2c9-38d0d674aa19_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_025d9826-c2a5-45a6-9b32-199588b54dc7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf6a57b2-50d8-4258-aaf3-f1dd70994b8d_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_be573b36-fc72-4dcb-a3db-645d8313ec58_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember_099eb7d8-2619-4363-8f05-2517a94a284a_terseLabel_en-US" xlink:label="lab_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exceeding Minimum Threshold</link:label>
    <link:label id="lab_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember_label_en-US" xlink:label="lab_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exceeding Minimum Threshold [Member]</link:label>
    <link:label id="lab_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember_documentation_en-US" xlink:label="lab_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to exceeding the minimum threshold under the share-based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember" xlink:href="infu-20211231.xsd#infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember" xlink:to="lab_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_EffectOfCovid19PandemicTextBlock_0a448c83-6352-4049-8603-c3f5cdf5c30d_terseLabel_en-US" xlink:label="lab_infu_EffectOfCovid19PandemicTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19</link:label>
    <link:label id="lab_infu_EffectOfCovid19PandemicTextBlock_label_en-US" xlink:label="lab_infu_EffectOfCovid19PandemicTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Covid-19 Pandemic [Text Block]</link:label>
    <link:label id="lab_infu_EffectOfCovid19PandemicTextBlock_documentation_en-US" xlink:label="lab_infu_EffectOfCovid19PandemicTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for effects of COVID-19 pandemic.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EffectOfCovid19PandemicTextBlock" xlink:href="infu-20211231.xsd#infu_EffectOfCovid19PandemicTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_EffectOfCovid19PandemicTextBlock" xlink:to="lab_infu_EffectOfCovid19PandemicTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_d2edb078-98a9-46b4-8caa-df1352b65772_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f54b59f8-0b96-49fb-a9e4-77436cdd6692_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_89ad4de1-a3a9-45f9-87ad-233d4f6cb66e_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_bbdcbd1d-c473-4b8c-acc6-fd173f557dac_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_f61cc546-18fd-4193-9de0-f789113b7ffa_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of and reserve adjustments for medical equipment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_74f242a1-e8ba-44af-bfba-96a79d6195f0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_0455d0f7-c6eb-4e8c-b305-79087520786b_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_568fc4f8-9f96-4ae6-a60d-9ae7f13c7824_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate:</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a4404b17-ac71-4ee9-921a-6e6dc23df52e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e19a1831-90f3-41a0-be1e-4f17d8f7eb53_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, aggregate fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70595b33-eda3-44f7-841f-4d31edb09bce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e063d9b1-f10a-49ec-85e9-da3d89428a77_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_dbcf7d30-6543-4d28-98b0-daf42f312432_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll taxes</link:label>
    <link:label id="lab_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Payroll Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_84988e8a-77e5-4149-bef5-8947a1cd0049_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Performance Shares, Activity</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_4a44e978-1c7e-424e-8421-b09667d89175_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_SmithsMedicalIncMember_30b47e08-e00d-47da-8564-4281e0646d70_terseLabel_en-US" xlink:label="lab_infu_SmithsMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Medical, Inc.</link:label>
    <link:label id="lab_infu_SmithsMedicalIncMember_label_en-US" xlink:label="lab_infu_SmithsMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Medical, Inc. [Member]</link:label>
    <link:label id="lab_infu_SmithsMedicalIncMember_documentation_en-US" xlink:label="lab_infu_SmithsMedicalIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to Smiths Medical, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SmithsMedicalIncMember" xlink:href="infu-20211231.xsd#infu_SmithsMedicalIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_SmithsMedicalIncMember" xlink:to="lab_infu_SmithsMedicalIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_3f5f1f98-786a-4789-aa77-3baac9582761_terseLabel_en-US" xlink:label="lab_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_label_en-US" xlink:label="lab_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Permanent Differences, Percent</link:label>
    <link:label id="lab_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_documentation_en-US" xlink:label="lab_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the permanent differences.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:href="infu-20211231.xsd#infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:to="lab_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_088e2585-ca97-41ee-bc96-d1f800a80e1e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_74a37410-7006-47a4-8540-36153c935dbe_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_19316991-a0a7-4896-81e5-65dac1fd3ffd_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1cb98982-2984-4fac-8856-7efdd4f57381_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_405d8760-a2ce-42c2-be43-8cfae683b314_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e8981a3f-3353-4834-9ec0-c461fc35fe21_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e4b312f4-059e-46b5-8e1c-505bca514ee6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement, options, exercisable, number (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_69ef0e85-8606-467f-af32-39da75387fba_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_b0df3627-75f3-4a85-8f94-f790dfa1a428_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_afa77333-04c2-4513-ae08-4f329433500c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_639a6cb1-08a1-4b0c-9a2f-3ac4bc92cab1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement, equity instruments other than options, grants in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_483df9b5-4895-48d7-892e-244ec2dd014a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_e2fb0a65-019a-4d43-859b-b46ca5a7e883_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_c71dd742-d2ff-41f4-962d-5d2477742724_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8993f363-91b1-4304-ab6a-5915116ea9eb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3f0deb50-b560-4eba-9d1e-c2c050ee458c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, number of authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f1f814cf-4b42-4f15-951c-ea4203feaffb_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, number of authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_2c4c74e1-46f2-4298-ac04-8b27b701ee23_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_0b64a3ae-db27-4132-811d-780c1702cf65_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_14954cba-9062-47e8-a220-be6a24a61d35_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_NumberOfContractsWithThirdParties_78d5b8b8-bbcf-4f31-a3f8-b39e369077d3_terseLabel_en-US" xlink:label="lab_infu_NumberOfContractsWithThirdParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of contracts with third parties</link:label>
    <link:label id="lab_infu_NumberOfContractsWithThirdParties_label_en-US" xlink:label="lab_infu_NumberOfContractsWithThirdParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contracts With Third Parties</link:label>
    <link:label id="lab_infu_NumberOfContractsWithThirdParties_documentation_en-US" xlink:label="lab_infu_NumberOfContractsWithThirdParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contracts With Third Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NumberOfContractsWithThirdParties" xlink:href="infu-20211231.xsd#infu_NumberOfContractsWithThirdParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_NumberOfContractsWithThirdParties" xlink:to="lab_infu_NumberOfContractsWithThirdParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_bcbce9c6-3373-4675-a0c6-b827c2b16b5e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_69b2dae0-a6b7-4cce-92a5-d0e222cda9e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_82188751-48ad-44cc-a361-e0329b5945f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased as part of share repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_21efc9b7-7919-404e-a9e3-64d6c81ca9d6_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_20deee17-3d08-4b7a-bcd8-9631c1995d54_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3f41009b-12f0-4b59-b7c2-dd2079dc8c8a_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to medical equipment and property</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9b5336b8-676f-4839-a245-bfed630e81d5_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_6d424dbd-f248-4c71-9520-208deedf1e83_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_5b2ebf15-f18a-4da5-b7c2-7c09fcade1a9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ef657add-9fbb-4bf8-9f33-a68f34b2672d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_6f8ad11b-7472-4b06-bfd0-4d5d0ff279c6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_e0ca7c07-5751-4e6d-b36e-fa2ee83cfc77_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_3c1d46cd-9a11-4e1c-b946-0a5d8bcbe749_negatedLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_5e88b0f5-0d04-4e56-a85e-413b0260337b_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld for tax withholding obligation (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_RemainingPreownershipNetOperatingLossCarryforwards_aa4ce3b0-24e9-48c7-9421-82aeb6967e23_terseLabel_en-US" xlink:label="lab_infu_RemainingPreownershipNetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining preownership net operating loss carryforwards</link:label>
    <link:label id="lab_infu_RemainingPreownershipNetOperatingLossCarryforwards_label_en-US" xlink:label="lab_infu_RemainingPreownershipNetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Preownership Net OperatingLoss Carryforwards</link:label>
    <link:label id="lab_infu_RemainingPreownershipNetOperatingLossCarryforwards_documentation_en-US" xlink:label="lab_infu_RemainingPreownershipNetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of remaining preownership net operating loss carryforwards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RemainingPreownershipNetOperatingLossCarryforwards" xlink:href="infu-20211231.xsd#infu_RemainingPreownershipNetOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_RemainingPreownershipNetOperatingLossCarryforwards" xlink:to="lab_infu_RemainingPreownershipNetOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_3cc92f5b-d21b-476e-b8c1-3f55a66d7fdf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1da421ac-1893-40ca-b6cd-c3a29ae9329e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_3206dfc1-df68-4a27-9050-161e8098e471_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_a289478f-c5c0-4f35-9429-624d68334313_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Availability on Revolving Facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_2aff8a6f-9946-4951-88c7-829660130764_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a2c3389b-edf9-4230-8fd8-cbdde678e09f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased_b2b40ddc-e5d1-43dc-9e4c-873b6193de96_terseLabel_en-US" xlink:label="lab_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value per ESPP award (in dollars per share)</link:label>
    <link:label id="lab_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased_label_en-US" xlink:label="lab_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value per ESPP award (in dollars per share)</link:label>
    <link:label id="lab_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased_documentation_en-US" xlink:label="lab_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average purchase price of shares purchased under the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" xlink:href="infu-20211231.xsd#infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" xlink:to="lab_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_975d1e4c-15b8-4000-8180-daa46a672a5a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_OperatingLossCarryforwardsWithIndefiniteLife_f14ecae9-546d-4fe5-a812-9cf046d1cc83_terseLabel_en-US" xlink:label="lab_infu_OperatingLossCarryforwardsWithIndefiniteLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards with indefinite life</link:label>
    <link:label id="lab_infu_OperatingLossCarryforwardsWithIndefiniteLife_label_en-US" xlink:label="lab_infu_OperatingLossCarryforwardsWithIndefiniteLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards With Indefinite Life</link:label>
    <link:label id="lab_infu_OperatingLossCarryforwardsWithIndefiniteLife_documentation_en-US" xlink:label="lab_infu_OperatingLossCarryforwardsWithIndefiniteLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of operating loss carryforwards that have an indefinite life.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OperatingLossCarryforwardsWithIndefiniteLife" xlink:href="infu-20211231.xsd#infu_OperatingLossCarryforwardsWithIndefiniteLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_OperatingLossCarryforwardsWithIndefiniteLife" xlink:to="lab_infu_OperatingLossCarryforwardsWithIndefiniteLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_2f38f61d-1298-4caa-8a57-71a8dbbfae71_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_b34a5b31-2768-4fe5-bd64-86c98c2e486d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 and thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d7cc4726-9990-4591-97f3-1cab61fd2886_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, number of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72fccd4e-d76b-46ea-bf91-2d6e058464aa_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, number of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_395e83a0-22e1-4738-85c4-bcca99856353_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign income tax expense</link:label>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_55f1bb17-780f-482f-85eb-ab275d70cef6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_dde9923a-79f0-4896-ae07-73f8dd88d3b1_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized value of the debt issuance costs, total</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_06e271dd-209e-43fe-bbf9-b3c90f67f461_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_7ff8783f-b2b5-4418-aaf3-130791f8210b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_3ec53997-de92-4510-b6d3-e663426d69a7_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment in rental service, net of accumulated depreciation</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_583edda2-8195-4ea8-b684-bbeb4d435ef3_totalLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment in rental service - net</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_label_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment in rental service, net of accumulated depreciation</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents medical equipment in rental service, net of accumulated depreciation, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:to="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_892da863-a629-4729-8467-87413b460be7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionPlanExpense_a2bdacb3-2370-445f-a8a6-f48ef56bb1d5_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionPlanExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option and SARs expense</link:label>
    <link:label id="lab_us-gaap_StockOptionPlanExpense_label_en-US" xlink:label="lab_us-gaap_StockOptionPlanExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock or Unit Option Plan Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionPlanExpense" xlink:to="lab_us-gaap_StockOptionPlanExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_337345b2-c972-40f1-8440-274277548783_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LandlordReserves_09e6701d-ff02-47c7-af06-7fb026dc10e7_negatedLabel_en-US" xlink:label="lab_infu_LandlordReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Landlord reserves</link:label>
    <link:label id="lab_infu_LandlordReserves_label_en-US" xlink:label="lab_infu_LandlordReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Landlord Reserves</link:label>
    <link:label id="lab_infu_LandlordReserves_documentation_en-US" xlink:label="lab_infu_LandlordReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of landlord reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LandlordReserves" xlink:href="infu-20211231.xsd#infu_LandlordReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LandlordReserves" xlink:to="lab_infu_LandlordReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_cf2dae1c-7027-4ba5-b6f3-f50653354a00_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition date fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DeferredTaxAssetsValuationAllowanceIncrease_7181cf9f-7633-478f-8826-04b77800681f_negatedTerseLabel_en-US" xlink:label="lab_infu_DeferredTaxAssetsValuationAllowanceIncrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_infu_DeferredTaxAssetsValuationAllowanceIncrease_label_en-US" xlink:label="lab_infu_DeferredTaxAssetsValuationAllowanceIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Increase</link:label>
    <link:label id="lab_infu_DeferredTaxAssetsValuationAllowanceIncrease_documentation_en-US" xlink:label="lab_infu_DeferredTaxAssetsValuationAllowanceIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxAssetsValuationAllowanceIncrease" xlink:href="infu-20211231.xsd#infu_DeferredTaxAssetsValuationAllowanceIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DeferredTaxAssetsValuationAllowanceIncrease" xlink:to="lab_infu_DeferredTaxAssetsValuationAllowanceIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_2a78859d-4ddf-448e-8528-67d13d698854_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_f64e7584-da72-47fb-a3fd-1c77a5d36c89_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_6d2a31c2-3087-4200-9caa-de714dcb152b_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_f5440028-6bb2-46a1-b4b5-f7895a5a72b0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flow from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_207b4c05-f437-4589-a20a-682ddae4efa4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and asset basis differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_866168b5-54a0-4320-8917-25cdf7c2cdf5_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total - consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_68778215-2e92-40dd-8be5-6dc47110feda_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total U.S. Federal income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_ba6254f6-3814-4169-a678-47886ed52587_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ITSSegmentMember_2437748d-5519-4195-896c-b633784e7431_terseLabel_en-US" xlink:label="lab_infu_ITSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ITS Segment</link:label>
    <link:label id="lab_infu_ITSSegmentMember_label_en-US" xlink:label="lab_infu_ITSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ITS Segment [Member]</link:label>
    <link:label id="lab_infu_ITSSegmentMember_documentation_en-US" xlink:label="lab_infu_ITSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding the ITS segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember" xlink:href="infu-20211231.xsd#infu_ITSSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ITSSegmentMember" xlink:to="lab_infu_ITSSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LongtermDebtGrossCurrent_90f50df6-1491-4593-8fcc-f1fae1ee7ae2_verboseLabel_en-US" xlink:label="lab_infu_LongtermDebtGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Portion</link:label>
    <link:label id="lab_infu_LongtermDebtGrossCurrent_label_en-US" xlink:label="lab_infu_LongtermDebtGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Longterm Debt Gross Current</link:label>
    <link:label id="lab_infu_LongtermDebtGrossCurrent_documentation_en-US" xlink:label="lab_infu_LongtermDebtGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount, before unamortized (discount) premium and debt issuance costs, of the current portion of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongtermDebtGrossCurrent" xlink:href="infu-20211231.xsd#infu_LongtermDebtGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LongtermDebtGrossCurrent" xlink:to="lab_infu_LongtermDebtGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_6ccfa3bc-ed96-494c-93af-0fb0abaae615_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_0f598a77-3f4d-4b46-a261-21ba9be49629_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_1e3a56e1-fece-40ec-8acb-1cd55d51c831_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseCurrent_843fa085-63af-4d01-a1ba-e2a14846002f_negatedTerseLabel_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized value of debt issuance costs</link:label>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseCurrent_label_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense Current</link:label>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseCurrent_documentation_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The current portion of unamortized debt issuance expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:href="infu-20211231.xsd#infu_UnamortizedDebtIssuanceExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:to="lab_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_cd1369e5-de2b-4d18-8e66-44fa4af62eda_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_f83e408a-e9b2-49a2-9e60-4cbdd17d245f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_86ad5a56-483e-4d05-a0f1-fc1e99645fc0_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_3790e777-158d-42c6-909d-d9220cb7dd60_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_7e7d9be8-b442-41f1-a73e-d0aca7666b5b_terseLabel_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, minimum fixed coverage ratio</link:label>
    <link:label id="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_label_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Covenant Minimum Fixed Coverage Ratio</link:label>
    <link:label id="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_documentation_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The minimum fixed coverage ratio required by the debt agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:href="infu-20211231.xsd#infu_DebtInstrumentCovenantMinimumFixedCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:to="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0cc44b69-faa8-42ff-9970-3afcac313125_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_61b230b8-548c-4d53-825b-794b0ff40ec0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_CBFloatingRateLoanMember_7a7b88e1-4f91-44bf-b4e3-6b72610387f6_terseLabel_en-US" xlink:label="lab_infu_CBFloatingRateLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CB Floating Rate Loan</link:label>
    <link:label id="lab_infu_CBFloatingRateLoanMember_label_en-US" xlink:label="lab_infu_CBFloatingRateLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CB Floating Rate Loan [Member]</link:label>
    <link:label id="lab_infu_CBFloatingRateLoanMember_documentation_en-US" xlink:label="lab_infu_CBFloatingRateLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to the CB Floating Rate Loan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CBFloatingRateLoanMember" xlink:href="infu-20211231.xsd#infu_CBFloatingRateLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_CBFloatingRateLoanMember" xlink:to="lab_infu_CBFloatingRateLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_429eab2e-d6dc-4f75-be91-94c2f1495245_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_704babb0-084d-4afa-a40f-b01c8219696a_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_163c4bd2-5b24-4a0a-aa42-31ba24a3f5ac_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_ca69788d-dd7e-4591-a354-12c0f3228a93_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_e5068513-5f48-4fc3-9231-8788601ee7a4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_04075ec1-b5d1-408e-80fe-c80dbc4eb4e8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c565d593-56bf-4f1a-aaae-df34759ea679_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_17e0e713-4259-4c1e-a080-620b48360301_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangements, options, exercises in period, weighted average exercise price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_3baa7175-50d9-49c0-b3e6-02509cc64c1a_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_ee1c2997-cfc5-4723-88fc-898c21b75505_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-competition agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_f158a137-6604-4ef9-bca2-188cc279c370_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_a9dc174d-0e77-4cef-9ed4-2ca7f0fa0dba_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1f9ccf08-ff15-4c3b-a882-f45908b4a27a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_25335f2c-e284-4b14-8401-2cd73178f678_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_d3c9ff84-4cb1-48a3-af60-ce7b283fbe35_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_b96e2bc5-c438-4779-bcc3-b5728b9030ca_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance_abe42e08-625a-4c22-8a0d-78624c64657b_terseLabel_en-US" xlink:label="lab_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period shares employee stock ownership plan number of remaining shares available for future issuance (in shares)</link:label>
    <link:label id="lab_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance_label_en-US" xlink:label="lab_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Shares Employee Stock Ownership Plan Number Of Remaining Shares Available For Future Issuance</link:label>
    <link:label id="lab_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance_documentation_en-US" xlink:label="lab_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period shares employee stock ownership plan number of remaining shares available for future issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance" xlink:href="infu-20211231.xsd#infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance" xlink:to="lab_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_1ad8acc6-0972-49a6-af24-1bd55f92cb54_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income tax (expense) benefit</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_779d6271-ab95-4356-b3fb-442eafda9adc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock_033a1cec-ab5b-44cb-9e19-420a5b06f6b1_terseLabel_en-US" xlink:label="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets</link:label>
    <link:label id="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the carrying amount and accumulated amortization of identifiable intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:href="infu-20211231.xsd#infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:to="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c8192d60-d0de-4ddc-87cc-843de427256e_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d77fa14a-e05c-419b-a387-931adf3f4c1b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 and thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9dbd6b37-d680-454c-8427-997b8af32fae_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_47e34ddb-5b30-4487-9373-0e3e19c38290_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DirectPayerRentalsMember_c4e9a0f1-476f-47b4-b1a2-fa215d20a114_terseLabel_en-US" xlink:label="lab_infu_DirectPayerRentalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Payer Rentals</link:label>
    <link:label id="lab_infu_DirectPayerRentalsMember_label_en-US" xlink:label="lab_infu_DirectPayerRentalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Payer Rentals [Member]</link:label>
    <link:label id="lab_infu_DirectPayerRentalsMember_documentation_en-US" xlink:label="lab_infu_DirectPayerRentalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents direct payer rental revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DirectPayerRentalsMember" xlink:href="infu-20211231.xsd#infu_DirectPayerRentalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DirectPayerRentalsMember" xlink:to="lab_infu_DirectPayerRentalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_eb7e0a18-753c-4ff7-8b0e-f470fb53bf29_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_4af9d795-576b-4abb-8fbc-40e088429748_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5de92445-1389-445a-af1f-b96c871a8dd0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_abe4e181-97c5-434e-b7e0-1cd899289748_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_bb10666f-e35e-421e-bae2-76795d24d968_negatedLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding draws</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_The2021CreditAgreementMember_1c197095-ddca-4d9a-855a-a62f6443efb8_terseLabel_en-US" xlink:label="lab_infu_The2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2021 Credit Agreement</link:label>
    <link:label id="lab_infu_The2021CreditAgreementMember_label_en-US" xlink:label="lab_infu_The2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2021 Credit Agreement [Member]</link:label>
    <link:label id="lab_infu_The2021CreditAgreementMember_documentation_en-US" xlink:label="lab_infu_The2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the "2021 Credit Agreement".</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2021CreditAgreementMember" xlink:href="infu-20211231.xsd#infu_The2021CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_The2021CreditAgreementMember" xlink:to="lab_infu_The2021CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_d074bd1f-c612-4be3-9634-cbfe15c82160_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_83374cc2-4fd7-4d8d-9019-3a25774d1770_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_ea82ba8b-59c5-49e4-909b-f90238a98ed2_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_5018f345-e0b1-4b71-8952-56d33fbe300a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of medical equipment, property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_ba12d1d9-6bd3-4700-ab38-cda6649c9a3a_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred Federal tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_939e59f8-8233-4c20-9c39-baddcfda562e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_PhysicianAndCustomerRelationshipsMember_4a314f3f-08af-43b1-a48f-116da1ebede6_terseLabel_en-US" xlink:label="lab_infu_PhysicianAndCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician and customer relationships</link:label>
    <link:label id="lab_infu_PhysicianAndCustomerRelationshipsMember_label_en-US" xlink:label="lab_infu_PhysicianAndCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician and Customer Relationships [Member]</link:label>
    <link:label id="lab_infu_PhysicianAndCustomerRelationshipsMember_documentation_en-US" xlink:label="lab_infu_PhysicianAndCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to physician and customer relationships.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PhysicianAndCustomerRelationshipsMember" xlink:href="infu-20211231.xsd#infu_PhysicianAndCustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_PhysicianAndCustomerRelationshipsMember" xlink:to="lab_infu_PhysicianAndCustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_e5d92529-e682-48a1-a414-2e982f142f1e_verboseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_AmbulatoryPumpsMember_313ffaf5-6905-4ee2-aec1-d1f2c5e21d1f_terseLabel_en-US" xlink:label="lab_infu_AmbulatoryPumpsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ambulatory Pumps</link:label>
    <link:label id="lab_infu_AmbulatoryPumpsMember_label_en-US" xlink:label="lab_infu_AmbulatoryPumpsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ambulatory Pumps [Member]</link:label>
    <link:label id="lab_infu_AmbulatoryPumpsMember_documentation_en-US" xlink:label="lab_infu_AmbulatoryPumpsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the ambulatory pumps.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_AmbulatoryPumpsMember" xlink:href="infu-20211231.xsd#infu_AmbulatoryPumpsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_AmbulatoryPumpsMember" xlink:to="lab_infu_AmbulatoryPumpsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_58a4bfe2-86e2-4e1a-ab1a-dab1df3306a1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentNet_efa6bd99-fe74-494c-a856-c8ad03ddd3c3_totalLabel_en-US" xlink:label="lab_infu_MedicalEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_infu_MedicalEquipmentNet_label_en-US" xlink:label="lab_infu_MedicalEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment Net</link:label>
    <link:label id="lab_infu_MedicalEquipmentNet_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the net amount of medical equipment, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentNet" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentNet" xlink:to="lab_infu_MedicalEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsProductLineMember_74639456-b593-48c5-a3d6-532468da5839_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service, Product and Service Benchmark</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsProductLineMember_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service, Product and Service Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsProductLineMember" xlink:to="lab_us-gaap_CostOfGoodsProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_4c73e86d-5a36-4c07-8a26-74bf8213992c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_11cece9e-dea1-4c9d-b151-124a10b19480_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_944db6a8-465f-41b1-8d45-9bff7c78be14_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_a681bfd9-fe19-4ba1-97a2-89e63852445b_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_InformationTechnologySoftwareMember_239add7e-c636-49c8-b285-98ca0101fc38_terseLabel_en-US" xlink:label="lab_infu_InformationTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Technology Software</link:label>
    <link:label id="lab_infu_InformationTechnologySoftwareMember_label_en-US" xlink:label="lab_infu_InformationTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Technology Software [Member]</link:label>
    <link:label id="lab_infu_InformationTechnologySoftwareMember_documentation_en-US" xlink:label="lab_infu_InformationTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the external information technology software used.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_InformationTechnologySoftwareMember" xlink:href="infu-20211231.xsd#infu_InformationTechnologySoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_InformationTechnologySoftwareMember" xlink:to="lab_infu_InformationTechnologySoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_1505c9f0-17b1-4f63-9487-7a5b6c715725_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_9b914fa7-5024-4baa-a6a9-740ac57e907d_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_2c0d86d3-9c9a-493d-9809-dd08a61eae6d_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_7db47ec0-91ce-44a6-9982-9da156f4b730_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement, options, exercisable, weighted average exercise price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_87f9fe1d-92c1-49e0-9cc4-ac355cef3101_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_aad4c867-03e9-49e3-af93-7077f1ffb81f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_42f74c79-9ce2-47cd-b9a9-33a63ad7f5a6_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_2cf3cf08-82c6-48dc-baa8-b25b63773e0f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_6e081479-78f2-4ae8-b087-69305ef17817_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e7c0e5ed-521c-48cb-a8dd-5cff35b6c5c8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_eb4ac3ba-f85e-464c-b983-cbda9b3e3346_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f64dfa89-74b7-4457-9c24-426d5b67a42a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_a6114bad-b65f-403d-8c38-be37e8aa44af_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LineOfCreditFacilityBorrowingBase_63df7bd8-9343-4038-abca-6b9badcde4ac_terseLabel_en-US" xlink:label="lab_infu_LineOfCreditFacilityBorrowingBase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, borrowing base</link:label>
    <link:label id="lab_infu_LineOfCreditFacilityBorrowingBase_label_en-US" xlink:label="lab_infu_LineOfCreditFacilityBorrowingBase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Borrowing Base</link:label>
    <link:label id="lab_infu_LineOfCreditFacilityBorrowingBase_documentation_en-US" xlink:label="lab_infu_LineOfCreditFacilityBorrowingBase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of money that a lender is willing to loan a company calculated as the sum of the company's eligible accounts receivable and eligible inventory as define by the credit agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LineOfCreditFacilityBorrowingBase" xlink:href="infu-20211231.xsd#infu_LineOfCreditFacilityBorrowingBase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LineOfCreditFacilityBorrowingBase" xlink:to="lab_infu_LineOfCreditFacilityBorrowingBase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_6623e828-1047-4fe0-b9ad-bf93da12f88e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4465f216-c28c-42f1-be50-e2ecc206b902_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_7839efde-5f2d-48bc-8832-3fad51691fa7_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_81abecc1-7c71-498a-8e7a-a9c6d9fa4a4a_negatedLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5ac0003d-4708-4657-a39c-1a0d80f8e401_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_968be566-00ca-4c32-b725-6ecc8e68b8c3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value: authorized 200,000,000 shares; issued and outstanding 20,699,546 and 20,699,546, as of December&#160;31, 2021, respectively, and issued and outstanding 23,816,193 and 20,297,704, as of December&#160;31, 2020, respectively.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_07ef929d-3e38-4503-a4d8-f41d7fec33f0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2b22484b-9ef0-4bec-8db7-b4ee07907f4f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost not yet recognized, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b1a730d0-e13d-4107-8048-81c660b29372_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c2c98074-8e12-48d1-832e-282021c6daf1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_de93c252-025a-4b94-bed5-cf4ea3e16918_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_a4b364b1-9f16-4dda-9c7f-5c33369775be_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_cab4f568-041f-4ff7-ab8a-4d9c67719c16_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_ddd763d9-c852-4ea1-9e5c-b4a546ac63bc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_66dfd551-9ce8-474c-82ee-0cd946a50caa_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6ec919d0-3506-4464-bf00-0a8082dbd386_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_205f96de-4449-4ecc-88fd-4698ea7f22d0_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for credit loss, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_NetOperatingLossCarryforwardsLimitationOnUse_2eafc21b-5aeb-48e4-8d3e-6073148589a3_terseLabel_en-US" xlink:label="lab_infu_NetOperatingLossCarryforwardsLimitationOnUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards limitation on use</link:label>
    <link:label id="lab_infu_NetOperatingLossCarryforwardsLimitationOnUse_label_en-US" xlink:label="lab_infu_NetOperatingLossCarryforwardsLimitationOnUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryforwards Limitation On Use</link:label>
    <link:label id="lab_infu_NetOperatingLossCarryforwardsLimitationOnUse_documentation_en-US" xlink:label="lab_infu_NetOperatingLossCarryforwardsLimitationOnUse" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The annual limitations on use applicable to net operating loss carryforwards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NetOperatingLossCarryforwardsLimitationOnUse" xlink:href="infu-20211231.xsd#infu_NetOperatingLossCarryforwardsLimitationOnUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_NetOperatingLossCarryforwardsLimitationOnUse" xlink:to="lab_infu_NetOperatingLossCarryforwardsLimitationOnUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_d846dca4-4dab-4180-8e0b-301ecf6ba59d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_EurodollarLoanMember_34908c27-eefe-4a4a-8b93-015a201d097d_terseLabel_en-US" xlink:label="lab_infu_EurodollarLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar Loan</link:label>
    <link:label id="lab_infu_EurodollarLoanMember_label_en-US" xlink:label="lab_infu_EurodollarLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar Loan [Member]</link:label>
    <link:label id="lab_infu_EurodollarLoanMember_documentation_en-US" xlink:label="lab_infu_EurodollarLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to the Eurodollar Loan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EurodollarLoanMember" xlink:href="infu-20211231.xsd#infu_EurodollarLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_EurodollarLoanMember" xlink:to="lab_infu_EurodollarLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_37826cac-add7-483b-ab1b-e0409bcb918c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock_723cecf4-4654-4303-b8ab-7c8ca7fef9ea_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:label id="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock_label_en-US" xlink:label="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment and Property Disclosure [Text Block]</link:label>
    <link:label id="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for medical equipment and property.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentAndPropertyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:to="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_a731c777-8eea-4322-8b2b-4c9255546beb_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_88b3be66-73e4-4df1-993d-ccbebef5b54a_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8e63c0ab-4dbd-412e-aa17-ed17a392008f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_36c8d6a1-21d7-4af4-a613-a89e2bdc3181_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod_a4e757d2-f4a2-489d-9d5c-3ef53ce58371_negatedTerseLabel_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested shares forgone to satisfy minimum statutory withholding, number of shares (in shares)</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expirations In Period</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod_documentation_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of equity-based payment instruments, excluding stock (or unit) options, that expired during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod" xlink:to="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_6b641ff0-6bdd-4138-9fea-81d28abbd980_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_55a0c31c-cc72-4502-86f5-24e34e1a4444_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_bcdaf991-e56c-4f0c-bf9c-33f7bdf9fcdc_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of common stock equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_43a1a068-94b5-4598-a9e2-a46246fe4308_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_CashlessExerciseOfStockOptionsShares_88d516be-7a83-4735-866a-e2050678d98f_negatedLabel_en-US" xlink:label="lab_infu_CashlessExerciseOfStockOptionsShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless exercise, number of authorized shares (in shares)</link:label>
    <link:label id="lab_infu_CashlessExerciseOfStockOptionsShares_label_en-US" xlink:label="lab_infu_CashlessExerciseOfStockOptionsShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless Exercise Of Stock Options Shares</link:label>
    <link:label id="lab_infu_CashlessExerciseOfStockOptionsShares_documentation_en-US" xlink:label="lab_infu_CashlessExerciseOfStockOptionsShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of shares exercised in a cashless transaction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CashlessExerciseOfStockOptionsShares" xlink:href="infu-20211231.xsd#infu_CashlessExerciseOfStockOptionsShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_CashlessExerciseOfStockOptionsShares" xlink:to="lab_infu_CashlessExerciseOfStockOptionsShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_dfe3f7fa-4147-4f82-b13d-58b29e9d90f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d61f90b9-67b8-41f4-9b13-c187fe4c9c1b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_50f63c4c-0b89-4bef-bbef-4fec8f37c7a6_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_dc93b887-270b-4a93-86c9-95eea94f5c03_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_EquipmentLineMember_33560f52-b8be-4487-93ca-0e37f7b34bc9_terseLabel_en-US" xlink:label="lab_infu_EquipmentLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Line</link:label>
    <link:label id="lab_infu_EquipmentLineMember_label_en-US" xlink:label="lab_infu_EquipmentLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Line [Member]</link:label>
    <link:label id="lab_infu_EquipmentLineMember_documentation_en-US" xlink:label="lab_infu_EquipmentLineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the equipment line.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EquipmentLineMember" xlink:href="infu-20211231.xsd#infu_EquipmentLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_EquipmentLineMember" xlink:to="lab_infu_EquipmentLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_09fc1873-cd8b-4a6e-b2d1-1cb5a0c6b577_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DepreciationExpenseRelatedToMedicalEquipment_25280ece-8df7-4462-a90f-edd5aefdb4cd_terseLabel_en-US" xlink:label="lab_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense related to medical equipment</link:label>
    <link:label id="lab_infu_DepreciationExpenseRelatedToMedicalEquipment_label_en-US" xlink:label="lab_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation Expense Related To Medical Equipment</link:label>
    <link:label id="lab_infu_DepreciationExpenseRelatedToMedicalEquipment_documentation_en-US" xlink:label="lab_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of depreciation expense related to medical equipment recorded during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:href="infu-20211231.xsd#infu_DepreciationExpenseRelatedToMedicalEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:to="lab_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_be464d4a-1c37-4850-9ab8-49533f45bcd0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, shares purchased for award (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesReserve_b7327e14-d1ec-4647-9f0e-4d1cc32c3058_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment in rental services reserve</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesReserve_58afa4a9-de73-454a-8840-267b9948731f_negatedTerseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesReserve" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment in rental service - pump reserve</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesReserve_label_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment In Rental Services Reserve</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesReserve_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of medical equipment in rental services reserve, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesReserve" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentInRentalServicesReserve" xlink:to="lab_infu_MedicalEquipmentInRentalServicesReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_66106890-d691-4517-92e9-5a2b008d6619_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6b442c57-bad7-437f-bb15-22a9f7972d63_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRental_d5df968d-9785-4a19-9872-b322cea75583_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment for sale or rental</link:label>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRental_e07ea747-7eca-4a49-ab5d-bd7b043f2392_totalLabel_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment for sale or rental - net</link:label>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRental_label_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment for sale or rental</link:label>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRental_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents medical equipment held for sale or rental as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentHeldForSaleOrRental" xlink:to="lab_infu_MedicalEquipmentHeldForSaleOrRental" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_410e6ad8-0d4c-444a-a6c5-f696683593b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets - decrease/(increase):</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e8c1f681-192e-4f00-94a9-d946bfc0d2ed_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_7bcfc208-2b26-4a2a-b2e7-23f8d9fa8f17_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_3172c530-84d0-4d69-8b82-634cfae22492_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9a67df1e-7f44-4544-bfe0-ced259b9d7cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_23db7387-98c6-48d4-9c60-681e47a3c95d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_A2014EquityIncentivePlanMember_0d297e4b-b0d8-4fd7-95ff-a182e9568943_terseLabel_en-US" xlink:label="lab_infu_A2014EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Equity Incentive Plan</link:label>
    <link:label id="lab_infu_A2014EquityIncentivePlanMember_label_en-US" xlink:label="lab_infu_A2014EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_infu_A2014EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_infu_A2014EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_A2014EquityIncentivePlanMember" xlink:href="infu-20211231.xsd#infu_A2014EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_A2014EquityIncentivePlanMember" xlink:to="lab_infu_A2014EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_ad48613b-ff6b-46bc-ab03-8a4ff5bb714c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_dde417ca-e1ca-4e19-805c-509da6b95e98_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_dd131f63-f621-4c48-8798-d5d8ce908a0f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_dd162203-8bf4-4d5b-bb20-a25e7a747593_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_19f43438-d5aa-4e2f-ae66-3912ca721f71_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_9b277736-c529-4844-b622-c5c3837955dc_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0382fb72-d555-42fe-9a3a-8b75b5f4badb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c449875c-3c8c-413c-b524-0b72b078b771_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_TermLoanMember_fb85beb8-e411-49b4-a8eb-aa5b110c6748_terseLabel_en-US" xlink:label="lab_infu_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_infu_TermLoanMember_label_en-US" xlink:label="lab_infu_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_infu_TermLoanMember_documentation_en-US" xlink:label="lab_infu_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to the Term Loan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_TermLoanMember" xlink:href="infu-20211231.xsd#infu_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_TermLoanMember" xlink:to="lab_infu_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_9e4d6894-ca35-4e1d-b3df-d7de4c1c23ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_0dd3cf44-a2b1-4b95-b8b8-69990a47f67c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1a7f722c-c9b7-431c-bd1a-73de60859ba4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_19e8ed4b-0c6a-4dbe-a52a-d8092c9e8592_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_8218825d-fb92-407b-a4c1-a1e20a52e7dd_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_b48ef4b4-97c0-4c61-b598-5dffd7e93273_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpatented technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_The2015CreditAgreementMember_8484e9f5-6385-46d9-a91b-f91aaff9fa6e_terseLabel_en-US" xlink:label="lab_infu_The2015CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2015 Credit Agreement</link:label>
    <link:label id="lab_infu_The2015CreditAgreementMember_label_en-US" xlink:label="lab_infu_The2015CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2015 Credit Agreement [Member]</link:label>
    <link:label id="lab_infu_The2015CreditAgreementMember_documentation_en-US" xlink:label="lab_infu_The2015CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the "2015 Credit Agreement".</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2015CreditAgreementMember" xlink:href="infu-20211231.xsd#infu_The2015CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_The2015CreditAgreementMember" xlink:to="lab_infu_The2015CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_b2638fb4-2d98-4860-a355-f030bcc9291c_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_5b554200-77a5-4b58-af7a-3d52cc3b40db_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_7096eb53-6f09-41bd-b99f-b886bbfa940e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_CardinalHealthIncMember_38f05dd5-88e6-4af5-8ea7-02585b191a70_terseLabel_en-US" xlink:label="lab_infu_CardinalHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health, Inc.</link:label>
    <link:label id="lab_infu_CardinalHealthIncMember_label_en-US" xlink:label="lab_infu_CardinalHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health, Inc. [Member]</link:label>
    <link:label id="lab_infu_CardinalHealthIncMember_documentation_en-US" xlink:label="lab_infu_CardinalHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to Cardinal Health, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CardinalHealthIncMember" xlink:href="infu-20211231.xsd#infu_CardinalHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_CardinalHealthIncMember" xlink:to="lab_infu_CardinalHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollateralDomain_43c54da8-69f8-46ec-ae48-20e1b0534fa9_terseLabel_en-US" xlink:label="lab_us-gaap_CollateralDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Domain]</link:label>
    <link:label id="lab_us-gaap_CollateralDomain_label_en-US" xlink:label="lab_us-gaap_CollateralDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollateralDomain" xlink:to="lab_us-gaap_CollateralDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_AuditInformationAbstract_label_en-US" xlink:label="lab_infu_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_infu_AuditInformationAbstract_documentation_en-US" xlink:label="lab_infu_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_AuditInformationAbstract" xlink:href="infu-20211231.xsd#infu_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_AuditInformationAbstract" xlink:to="lab_infu_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_WorkingCapital_287b6a48-8e53-4f28-a553-21b45d8ce558_terseLabel_en-US" xlink:label="lab_infu_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital adjustment, paid in cash</link:label>
    <link:label id="lab_infu_WorkingCapital_label_en-US" xlink:label="lab_infu_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital</link:label>
    <link:label id="lab_infu_WorkingCapital_documentation_en-US" xlink:label="lab_infu_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of working capital adjustments incurred by the acquirer as part of consideration transferred in a business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_WorkingCapital" xlink:href="infu-20211231.xsd#infu_WorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_WorkingCapital" xlink:to="lab_infu_WorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_4837ccbf-2382-4914-a83f-f94f709c7899_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross_3925650f-367d-4ab1-8bd1-01cde88e2b39_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment for sale or rental</link:label>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross_label_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment Held For Sale Or Rental Gross</link:label>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents medical equipment held for sale or rental as of the balance sheet date, before reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentHeldForSaleOrRentalGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:to="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c298e05f-583c-41e6-b27e-b08a6e554e99_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_1aff6970-8788-45a9-bf39-546d485ad198_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased as part of share repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_930794f4-533d-4e5a-a67e-aae76182c9b5_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c63693fc-e2d1-4114-9d1d-92be99c83ca1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_fff9aa61-61b4-4d65-b56f-ad6a623ac664_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_4f0a6972-f367-423e-a8f2-f95c439ba645_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination</link:label>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_d21c92d9-9775-4172-8989-5f363e8c917b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions by employer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_3279373d-77c2-4225-81ef-53fee9b99b18_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3935f6c6-6cff-414a-b929-c799779ae251_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_1bcb5106-9866-47c1-b740-7b051cdc9365_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_c27ed103-c15e-4dd8-99d4-1c8ada0751b2_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4a4554ff-9e2a-4994-b577-2b1fd189ccce_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a928b515-735a-4876-99ef-04215052c96c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangements, options, grants in period, weighted average exercise price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock_1ad46b2f-8127-48d8-a3df-944c73b07da7_terseLabel_en-US" xlink:label="lab_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenues</link:label>
    <link:label id="lab_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock_label_en-US" xlink:label="lab_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Cost of Revenue [Policy Text Block]</link:label>
    <link:label id="lab_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock_documentation_en-US" xlink:label="lab_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for the cost of revenue for servicing and maintaining products sold including shipping and handling costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock" xlink:href="infu-20211231.xsd#infu_RevenueRecognitionCostOfRevenuePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock" xlink:to="lab_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07bb5104-59b3-476f-8650-f46e3a73a8cd_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a7befd24-a20b-4452-aea9-e0bccd20ad59_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_94c0b281-bf22-442c-98cd-354c50efb553_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised shares forgone to satisfy minimum statutory withholding, number of authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2371813c-57af-4f4a-acf9-84431129f1a9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_9538a9d0-7516-4be5-a6fd-3d4e12f29a36_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f6fd35f2-6210-42cb-974e-e49d4d2501db_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_17426338-2675-4b14-a017-508bf8d87a2b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a9689aaa-8613-46b1-ac68-04b1996c7685_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_5fefbda4-984c-4fad-a327-f97d42c5ba81_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, total</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_443a6b32-c419-493e-b921-a5f109d6083d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_48790ce1-7128-483b-b9d0-b346e9ad34b3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_015b6636-e1ba-4d4f-869c-2ba25bd53045_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_RevenuesInternal_d04ff8cd-db5a-4d24-bca7-9cd09bd27b32_terseLabel_en-US" xlink:label="lab_infu_RevenuesInternal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues - internal</link:label>
    <link:label id="lab_infu_RevenuesInternal_label_en-US" xlink:label="lab_infu_RevenuesInternal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues - internal</link:label>
    <link:label id="lab_infu_RevenuesInternal_documentation_en-US" xlink:label="lab_infu_RevenuesInternal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of internal net revenues recognized during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesInternal" xlink:href="infu-20211231.xsd#infu_RevenuesInternal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_RevenuesInternal" xlink:to="lab_infu_RevenuesInternal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_94051096-68ee-452a-bf7c-0f19ac758106_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_989b68fc-f641-413a-8481-192e5229e7da_terseLabel_en-US" xlink:label="lab_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to contingent consideration</link:label>
    <link:label id="lab_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_label_en-US" xlink:label="lab_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration</link:label>
    <link:label id="lab_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_documentation_en-US" xlink:label="lab_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:href="infu-20211231.xsd#infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:to="lab_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_73e1eefe-6f52-46e4-a7ba-2a1620927c51_terseLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S Federal income tax benefit&#160;(expense)</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_b3f54bbc-623f-4d9f-9c06-ad866fb2a325_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_aa8fe352-e443-4c9d-ba78-5842ab1e1be5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_58ce2cfb-6fd6-4f59-abd9-0a24c67573f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased as part of share repurchase program</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_85e3c513-8a29-41a0-9ab5-abd4cd254761_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesUsefulLife_576a7f1e-b51f-4a73-91ea-3893005fa10d_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment in rental services, useful life</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesUsefulLife_label_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment In Rental Services Useful Life</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesUsefulLife_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesUsefulLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the useful life of medical equipment in rental services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesUsefulLife" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentInRentalServicesUsefulLife" xlink:to="lab_infu_MedicalEquipmentInRentalServicesUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_78ecc0ab-ad01-4ed3-bf14-f12b07921a5c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LongTermDebtGrossNoncurrent_8979b788-f5d6-45c2-8c0d-23b47b1d56e5_verboseLabel_en-US" xlink:label="lab_infu_LongTermDebtGrossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Portion</link:label>
    <link:label id="lab_infu_LongTermDebtGrossNoncurrent_label_en-US" xlink:label="lab_infu_LongTermDebtGrossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term Debt Gross Noncurrent</link:label>
    <link:label id="lab_infu_LongTermDebtGrossNoncurrent_documentation_en-US" xlink:label="lab_infu_LongTermDebtGrossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt, excluding the current portion. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtGrossNoncurrent" xlink:href="infu-20211231.xsd#infu_LongTermDebtGrossNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LongTermDebtGrossNoncurrent" xlink:to="lab_infu_LongTermDebtGrossNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_563472a9-506d-427c-b015-9fa55edc5ab6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_29afe7ae-3e52-4d11-9be8-48cdb4e2f18d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations_ab0bd162-fd1b-4626-acf4-345d0ad52446_terseLabel_en-US" xlink:label="lab_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations_label_en-US" xlink:label="lab_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions to ROU assets resulting from reductions to lease obligations: Operating leases</link:label>
    <link:label id="lab_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations_documentation_en-US" xlink:label="lab_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of reductions to right-of-use assets resulting from reductions to lease obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" xlink:href="infu-20211231.xsd#infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" xlink:to="lab_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_2d954f30-5343-4cec-a863-a167f93305dd_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3bb68099-fce3-41ea-9510-d32b3d91459f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b6d1794b-01be-405f-8c53-8f7f7ca53b8d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_91d25939-1566-4ab7-863c-d7f916bc420b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:to="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_94dfa73b-bf70-4aae-8710-77009a6b2de3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_b8467546-6519-4bd6-848d-095b6ab4a9d7_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_de58fea0-642f-45df-bdae-ba455507fa3c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d8a078cd-fec5-46d6-8e6a-77fb4b66aeed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, effective percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2e92e942-f762-48a5-85a4-3e16405c1788_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7e5f4779-f9f2-44bc-a8b3-031e8ed7d986_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total - purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_52dac363-c9cb-4585-9cdd-f2f0370cc393_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit related to stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_a95e0ba3-8744-4242-a45a-f55ed277412d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_cb9ba7fb-5f14-4fa6-98e1-80bea752fc61_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_011159ae-536f-4f92-9ea0-b7cbf88612e7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, operating lease, expiration</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f58d7a19-c69f-49ce-8475-d09693789a76_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b9dffdd9-a2c5-470e-b13a-d7955aec87ba_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ba72de62-06f8-4c96-a751-01974c40f766_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0e49fdd7-b908-4f43-ba74-4f7bbe1eb857_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_022c9d74-6f73-4406-ae93-b69f59dd05e1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of stock sold to employees (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_334d978c-3758-4dbb-bd0b-7fc966042665_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_CorporateAndEliminationsMember_64ebac9e-c6a2-4699-9bb9-366d71805b16_terseLabel_en-US" xlink:label="lab_infu_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Eliminations</link:label>
    <link:label id="lab_infu_CorporateAndEliminationsMember_label_en-US" xlink:label="lab_infu_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Eliminations [Member]</link:label>
    <link:label id="lab_infu_CorporateAndEliminationsMember_documentation_en-US" xlink:label="lab_infu_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding corporate and eliminations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CorporateAndEliminationsMember" xlink:href="infu-20211231.xsd#infu_CorporateAndEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_CorporateAndEliminationsMember" xlink:to="lab_infu_CorporateAndEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LIBORRate_9bccb9c5-b0b2-48f1-bfda-c9ac3e48055e_terseLabel_en-US" xlink:label="lab_infu_LIBORRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR rate</link:label>
    <link:label id="lab_infu_LIBORRate_label_en-US" xlink:label="lab_infu_LIBORRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR Rate</link:label>
    <link:label id="lab_infu_LIBORRate_documentation_en-US" xlink:label="lab_infu_LIBORRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the LIBOR rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LIBORRate" xlink:href="infu-20211231.xsd#infu_LIBORRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LIBORRate" xlink:to="lab_infu_LIBORRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_8f9a424f-b549-44e2-be36-b7f0c274e870_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred Federal tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_497cee45-3b70-43a6-883f-dabefbbb3ae4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_bcabcff8-8a80-4671-9f34-cae497500a79_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income tax on unrealized hedge gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_cac0d645-a22c-4367-8d5f-585dcb9f0965_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_553b8f0e-033b-47a5-97a0-24e8bd0d92e8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_ada03f3b-b91d-48c5-ab72-53a4bc6e3779_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_a5e9eb94-c795-4ee8-83ee-e249af323c37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_TreasuryStockPolicyPolicyTextBlock_6cda8ae2-ae7b-4c89-b0b0-ee0260064edb_terseLabel_en-US" xlink:label="lab_infu_TreasuryStockPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_infu_TreasuryStockPolicyPolicyTextBlock_label_en-US" xlink:label="lab_infu_TreasuryStockPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Policy [Policy Text Block]</link:label>
    <link:label id="lab_infu_TreasuryStockPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_infu_TreasuryStockPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for policy of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_TreasuryStockPolicyPolicyTextBlock" xlink:href="infu-20211231.xsd#infu_TreasuryStockPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_TreasuryStockPolicyPolicyTextBlock" xlink:to="lab_infu_TreasuryStockPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DeferredTaxLiabilitiesRightOfUseAssets_fb586825-47ab-4284-859c-f599a867002b_negatedTerseLabel_en-US" xlink:label="lab_infu_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_infu_DeferredTaxLiabilitiesRightOfUseAssets_label_en-US" xlink:label="lab_infu_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Right Of Use Assets</link:label>
    <link:label id="lab_infu_DeferredTaxLiabilitiesRightOfUseAssets_documentation_en-US" xlink:label="lab_infu_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred tax liability attributable to right-of-use assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxLiabilitiesRightOfUseAssets" xlink:href="infu-20211231.xsd#infu_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="lab_infu_DeferredTaxLiabilitiesRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_81a25bf3-85fb-4d33-abb5-b1f453655fb1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_0051a9d1-3fe6-41bb-8195-9fda0f112bbf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_25be374a-151c-4568-8af6-5ff9b5f0cb29_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_703c9e27-e0da-4ba1-9a8a-5362976189aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangements, options, forfeitures in period, weighted average exercise price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c960bfa1-514e-417e-8cb3-5ba8a49cb833_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3a33b273-1169-4383-af22-5e3b9bcddff9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from (provision for) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0af2e3b3-628d-475b-bc9c-6afaf5cc35ef_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9187b971-2b4e-46a2-a946-10f5a51889a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_bad4ebbb-eb8b-424c-983c-6c79fe517706_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ef138e70-628b-453f-8f46-4f6cd4255e28_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_00e4b10e-5a29-4c88-8d83-73776aa21928_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_447dc491-83fc-41d4-bfac-c830bba9bbc8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds from long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_63eca47e-fd33-429b-b9ea-b65defe40079_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_EmployeeStockPurchasePlanDiscountRate_5dc748ec-791e-4297-a30d-ea1cab65a83c_terseLabel_en-US" xlink:label="lab_infu_EmployeeStockPurchasePlanDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan discount rate</link:label>
    <link:label id="lab_infu_EmployeeStockPurchasePlanDiscountRate_label_en-US" xlink:label="lab_infu_EmployeeStockPurchasePlanDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Discount Rate</link:label>
    <link:label id="lab_infu_EmployeeStockPurchasePlanDiscountRate_documentation_en-US" xlink:label="lab_infu_EmployeeStockPurchasePlanDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The discount rate applied to an employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EmployeeStockPurchasePlanDiscountRate" xlink:href="infu-20211231.xsd#infu_EmployeeStockPurchasePlanDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_EmployeeStockPurchasePlanDiscountRate" xlink:to="lab_infu_EmployeeStockPurchasePlanDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d799f17f-3d36-4799-9c15-0a72cc8fa9a4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_NPWTMedicalEquipmentMember_73ab0e7a-fcf7-4074-af1a-9226d9a063ca_terseLabel_en-US" xlink:label="lab_infu_NPWTMedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPWT Medical Equipment</link:label>
    <link:label id="lab_infu_NPWTMedicalEquipmentMember_label_en-US" xlink:label="lab_infu_NPWTMedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPWT Medical Equipment [Member]</link:label>
    <link:label id="lab_infu_NPWTMedicalEquipmentMember_documentation_en-US" xlink:label="lab_infu_NPWTMedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the NPWT medical equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NPWTMedicalEquipmentMember" xlink:href="infu-20211231.xsd#infu_NPWTMedicalEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_NPWTMedicalEquipmentMember" xlink:to="lab_infu_NPWTMedicalEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_bcd20a7a-5d38-4de0-b31e-78c9b0831afb_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_57dcdca9-2de2-4278-9d45-bb06a839d7d9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_90f9600d-5f1c-4fdc-be69-7eaadd38c6f1_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d61104ee-2910-4d22-8abe-08643e9a3845_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_4c6ca2f9-d3dc-4c85-9f42-c5c35f713590_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_413a11ac-82a7-4fd7-aa4a-783cc4fa882a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3b3fd4ba-91b6-4db3-b0cb-afbd5c537202_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeitures, number of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_3672ae78-33ab-4746-ac3c-dc7790e0e759_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_55623bc8-1513-4e81-8910-c73a2ac9297c_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_169496c9-e143-429f-8e39-3b5295ecdc9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d095a33a-fc95-41a9-a60d-48d3f288912b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payments</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_48578931-05d9-4bc2-974f-258a80853e20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_a090dad4-84df-4d9a-88d9-db4e420686d3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_8d685ba7-a5d5-45ae-9c97-aef6075dfd0c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangements, options, expirations in period, weighted average exercise price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_41c9bc1d-b1a7-47e2-a114-ef7dbfbf685a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_f0ffcf18-6f5b-43ef-b660-c9f9af3a5e79_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_274eb97d-a6ef-499e-8b30-0afc8d51c1af_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance, deferred tax asset, increase (decrease), amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_6421c206-ddff-41fa-80a0-06c7c9161448_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_59cc9512-2fad-4b34-8bbd-d2900e88d2f0_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_a44950af-239b-4769-a1c4-36dd42dfa0d5_terseLabel_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpatented technology</link:label>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpatented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpatentedTechnologyMember" xlink:to="lab_us-gaap_UnpatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_006881b5-fffb-45c4-845c-ed11453e864f_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_392bf8c1-6e4e-42ee-80c3-9f5e3ac208fa_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccounting_3f434a84-5138-40aa-ac4b-3c1737fadf6d_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Nature of Operations</link:label>
    <link:label id="lab_us-gaap_BasisOfAccounting_label_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_70142bc2-18aa-450d-8d05-294da663a624_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_24d4bc5d-599d-4b9f-bae2-f312ee33336b_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_052e7190-884b-4bca-8696-d16fc8918390_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4b5f3bf6-d7ca-4521-a829-71d94571a1c3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested award, excluding option, cost not yet recognized, amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f74e8c17-483a-43d2-bfa0-ff0d0921379d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_e2a3f04d-1cb6-4ac3-b5e0-39b04c58725d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based shares issued upon vesting - gross</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_2d72661c-5cec-438a-8d73-a723215a1b4b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_abd47323-e096-4bcc-b5f6-6c9bc029542c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_NoncashActivitiesProceedsFromStockPlans_2013f44d-13c6-448c-b7d0-82635405ba4e_terseLabel_en-US" xlink:label="lab_infu_NoncashActivitiesProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to cash proceeds from stock plans</link:label>
    <link:label id="lab_infu_NoncashActivitiesProceedsFromStockPlans_label_en-US" xlink:label="lab_infu_NoncashActivitiesProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Activities, Proceeds from Stock Plans</link:label>
    <link:label id="lab_infu_NoncashActivitiesProceedsFromStockPlans_documentation_en-US" xlink:label="lab_infu_NoncashActivitiesProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Activities, Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NoncashActivitiesProceedsFromStockPlans" xlink:href="infu-20211231.xsd#infu_NoncashActivitiesProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_NoncashActivitiesProceedsFromStockPlans" xlink:to="lab_infu_NoncashActivitiesProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureTextBlockAbstract_cd9cf6ed-205a-433b-836c-0eebf25efe37_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureTextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes to Financial Statements</link:label>
    <link:label id="lab_us-gaap_DisclosureTextBlockAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureTextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Text Block [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureTextBlockAbstract" xlink:to="lab_us-gaap_DisclosureTextBlockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_c2fa941d-48c4-486c-a95a-d648a42d03ce_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_bacd2276-ead1-40a6-9466-03ef34aa7b63_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of medical equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember_d9d80998-ac5a-401a-a5dc-3eb72b641a55_terseLabel_en-US" xlink:label="lab_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Term Notes Associated With the 2015 Credit Agreement</link:label>
    <link:label id="lab_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember_label_en-US" xlink:label="lab_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Term Notes Associated With the 2015 Credit Agreement [Member]</link:label>
    <link:label id="lab_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember_documentation_en-US" xlink:label="lab_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding three term notes associated with the 2015 Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember" xlink:href="infu-20211231.xsd#infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember" xlink:to="lab_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1b03d93f-b2a2-46a8-bbd9-41f1ad29f6c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_3b547e37-dc36-4a62-b403-3e70a272c075_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_RevenuesExternal_b4af44f7-f5cf-40dc-985b-8ac444eb9954_terseLabel_en-US" xlink:label="lab_infu_RevenuesExternal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues - external</link:label>
    <link:label id="lab_infu_RevenuesExternal_label_en-US" xlink:label="lab_infu_RevenuesExternal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues - external</link:label>
    <link:label id="lab_infu_RevenuesExternal_documentation_en-US" xlink:label="lab_infu_RevenuesExternal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of external net revenues recognized during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesExternal" xlink:href="infu-20211231.xsd#infu_RevenuesExternal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_RevenuesExternal" xlink:to="lab_infu_RevenuesExternal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e2514c14-066e-4a06-aa35-d0b9c7479ba0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_77a877b0-2b1f-4baa-a4bc-6932ebffe152_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b054ea1b-1c2a-4627-bdfc-089daf97fd20_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5c0aeb64-8c82-4282-94e0-060d938e8213_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total nonamortizable and amortizable intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_7bfb4de4-5702-4d7a-a8d6-e95f24153a8b_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f3dad156-697d-452c-bdc0-29e5f91f7e1d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cbf6945e-bb87-4d66-a375-86b705519abd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_de20538d-c8cc-4e70-ab53-f867d558ca52_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance at the Beginning of Period</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_aa287001-db39-4a40-98ee-74b4a487dba2_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance at the End of Period</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_a4dbf905-229e-4755-ab9c-fb18f920cb2f_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_041d3f0b-30c9-4d3a-a7e4-c1dff367f979_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DeferredTaxAssetsValuationAllowanceRelease_50d27e95-35d9-413e-b803-b3f9b2ff7a3e_terseLabel_en-US" xlink:label="lab_infu_DeferredTaxAssetsValuationAllowanceRelease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Release of valuation allowance</link:label>
    <link:label id="lab_infu_DeferredTaxAssetsValuationAllowanceRelease_label_en-US" xlink:label="lab_infu_DeferredTaxAssetsValuationAllowanceRelease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance, Release</link:label>
    <link:label id="lab_infu_DeferredTaxAssetsValuationAllowanceRelease_documentation_en-US" xlink:label="lab_infu_DeferredTaxAssetsValuationAllowanceRelease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of decrease in the valuation allowance for deferred tax assets due to the release of valuation allowance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxAssetsValuationAllowanceRelease" xlink:href="infu-20211231.xsd#infu_DeferredTaxAssetsValuationAllowanceRelease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DeferredTaxAssetsValuationAllowanceRelease" xlink:to="lab_infu_DeferredTaxAssetsValuationAllowanceRelease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_5afb372b-6204-4f91-aa44-ba7d90128fb1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_0ba89c1b-4629-41ea-ba10-6a2a12940496_terseLabel_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right of use assets</link:label>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Asset</link:label>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of operating lease right of use asset recognized as of the acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:href="infu-20211231.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:to="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_66dc7773-863c-457a-a523-c55b2148c2d0_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plans and Other</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_3ca33690-8b3d-4dda-90cf-e9ff102e9e63_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0f138714-269a-43e8-8e2f-0e18e4269a9b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement, options, grants in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_96dad784-97ce-41cb-898b-230814bb95db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_826ce375-e6cf-4124-8786-12103b116a05_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DeferredTaxAssetsOperatingLeaseLiabilities_79c67360-9b47-4c08-bf67-04b626160b76_terseLabel_en-US" xlink:label="lab_infu_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_infu_DeferredTaxAssetsOperatingLeaseLiabilities_label_en-US" xlink:label="lab_infu_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:label id="lab_infu_DeferredTaxAssetsOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_infu_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to operating lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="infu-20211231.xsd#infu_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="lab_infu_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_815fa5d4-2445-4ae2-842a-fee0cd603ccf_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d35012b8-8993-47ab-81aa-ddb4d6ec8170_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum_30231405-a141-468e-b2ce-165f6875e1f8_terseLabel_en-US" xlink:label="lab_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESOP purchase per employee maximum</link:label>
    <link:label id="lab_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum_label_en-US" xlink:label="lab_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan ESOP Purchase Per Employee Maximum</link:label>
    <link:label id="lab_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum_documentation_en-US" xlink:label="lab_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum threshold, per employee, of purchases made in the employee stock ownership plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum" xlink:href="infu-20211231.xsd#infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum" xlink:to="lab_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_a0b006db-e430-49eb-bc50-27bc3b404c07_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_18ef9260-17d5-4907-8255-50ab5520c83b_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total state and local income tax (expense) benefit</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_87436531-22f2-4d7c-98ec-bcf4829e9e0e_negatedLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified within twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_c9c56e92-81db-43e4-99ee-6773bdb642e9_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a0893121-e1af-488f-9b20-96f6fe83a5cd_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_f0359996-4c65-4a5f-9b6f-477ddcaf9bc2_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_1ed2451d-402b-4a76-a4f6-c1843a3f95c9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_f984dfa8-63b3-4cc4-8604-183709835346_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock,, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_2949bf91-f830-4217-b318-b6f4ae0d671d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_e0ab184c-4a5d-4c46-bd4c-49143e473482_terseLabel_en-US" xlink:label="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma acquisition cost and non-recurring expense</link:label>
    <link:label id="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_label_en-US" xlink:label="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Pro Forma Acquisition Cost And Nonrecurring Expense</link:label>
    <link:label id="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_documentation_en-US" xlink:label="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The pro forma acquisition cost and non-recurring expense for a period as if the business combination or combinations had been completed at the beginning of the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:href="infu-20211231.xsd#infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:to="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_97556b7c-8f29-499d-b6f3-1c608ad81855_verboseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_9ea7b63b-32c4-4950-8bdd-1784eb8d6d65_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_401f14fd-bef9-44e7-bd81-a4b90a40a88f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_8cacf5b5-b12a-4a84-843f-a422f98605e6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_6636bf09-46c0-4a37-a8ce-476af17345a3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_c3a3c70f-9d67-40e2-8fb0-2eaddcb264fb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_137db0e6-0b59-4bd5-af43-0d33526395d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_a5bb054c-578c-44d3-8ba4-b844e51daaf4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0ea6e6cd-904e-4fe3-a79b-96dca65233dd_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_b2ac3025-81d9-481a-97a6-1387422292fb_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_03d883ef-1516-4f7b-93ef-354002567138_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH PROVIDED BY OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_7afb4306-6d7d-47e9-9d27-9cfe3423de9e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_952af3bf-bcc8-44e5-b8b0-2de55fa5f137_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures, and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_f77750fc-2f74-4fea-a26f-506008074b29_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_62bcb37a-2cfe-447e-81ca-78755eacebd9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_PercentageOfTotalDepreciationExpense_80febdd5-cc39-4ce9-a1ca-f49114cde49e_terseLabel_en-US" xlink:label="lab_infu_PercentageOfTotalDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total depreciation expense</link:label>
    <link:label id="lab_infu_PercentageOfTotalDepreciationExpense_label_en-US" xlink:label="lab_infu_PercentageOfTotalDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Total Depreciation Expense</link:label>
    <link:label id="lab_infu_PercentageOfTotalDepreciationExpense_documentation_en-US" xlink:label="lab_infu_PercentageOfTotalDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of total depreciation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PercentageOfTotalDepreciationExpense" xlink:href="infu-20211231.xsd#infu_PercentageOfTotalDepreciationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_PercentageOfTotalDepreciationExpense" xlink:to="lab_infu_PercentageOfTotalDepreciationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_4c392d2e-6062-4468-9ce5-5186ab2766eb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember_9b2c42b8-4fc1-4760-9a19-c9f92aa0d093_terseLabel_en-US" xlink:label="lab_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Achieving Minimum Threshold</link:label>
    <link:label id="lab_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember_label_en-US" xlink:label="lab_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Achieving Minimum Threshold [Member]</link:label>
    <link:label id="lab_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember_documentation_en-US" xlink:label="lab_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to the achievement of minimum threshold under the share-based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember" xlink:href="infu-20211231.xsd#infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember" xlink:to="lab_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_100e9ec6-acf7-41cb-8aa7-6e20ad14ee25_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_3421ab49-5b62-4763-a8b3-5f6f191dc43d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_ad630843-8d59-4d47-8872-6c3f7d1d4fed_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_60915e75-37ec-472b-af31-dc5291aad0d2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_441f2c24-b1ba-403c-8af2-16f145a1d03c_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_2ed89b8a-de6a-43c6-8a3d-f7c9073eef3f_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_68233944-a851-47ea-b0af-da41e3c998e9_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_002c1392-a2a6-4477-8f50-04b908db481e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_6b57673e-7122-4c38-ae86-6f43385b5dad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate_c9d323ae-942e-49cc-ab5b-95c68655f56e_terseLabel_en-US" xlink:label="lab_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate, before margin rate</link:label>
    <link:label id="lab_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate_label_en-US" xlink:label="lab_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Basis Spread On Variable Rate Before Margin Rate</link:label>
    <link:label id="lab_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate_documentation_en-US" xlink:label="lab_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage points, excluding the margin rate, added to the reference rate to compute the variable rate on the debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate" xlink:href="infu-20211231.xsd#infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate" xlink:to="lab_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentAbstract_label_en-US" xlink:label="lab_infu_MedicalEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Abstract]</link:label>
    <link:label id="lab_infu_MedicalEquipmentAbstract_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAbstract" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentAbstract" xlink:to="lab_infu_MedicalEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e680444a-a035-4597-9b1e-2a32f658d258_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8f529796-fef5-45b5-9925-f5334a989570_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6ae85b94-e9a7-4c63-b150-1fd49241a0d7_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total nonamortizable and amortizable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_8ebf1f2b-cf61-43f5-9bd6-aa8efb4ad896_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther_39821bfe-82f0-4efc-ada9-345be57f007b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e4675807-d6da-4934-a72c-50fe2570f07b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizationOfInternalCostsPolicy_a71927a8-fa09-4ae1-b054-f75f696906ec_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizationOfInternalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Capitalization and Depreciation</link:label>
    <link:label id="lab_us-gaap_CapitalizationOfInternalCostsPolicy_label_en-US" xlink:label="lab_us-gaap_CapitalizationOfInternalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalization of Internal Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfInternalCostsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizationOfInternalCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizationOfInternalCostsPolicy" xlink:to="lab_us-gaap_CapitalizationOfInternalCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ee46f45d-6fab-4bd3-93f6-607247c24093_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_aa033f51-abbe-407b-8d08-e20d61b92b8a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b81cc47f-5fd6-4bfe-9d6d-6810a70e29ef_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_593d2194-0c19-4e6e-99dd-93975e077793_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_PaymentsToAcquireMedicalEquipment_02727992-7fc0-4901-a9b6-c10b352f2b57_negatedLabel_en-US" xlink:label="lab_infu_PaymentsToAcquireMedicalEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of medical equipment</link:label>
    <link:label id="lab_infu_PaymentsToAcquireMedicalEquipment_6ac1728d-67de-478a-b65d-a37bbbb96330_terseLabel_en-US" xlink:label="lab_infu_PaymentsToAcquireMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of medical equipment</link:label>
    <link:label id="lab_infu_PaymentsToAcquireMedicalEquipment_label_en-US" xlink:label="lab_infu_PaymentsToAcquireMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Medical Equipment</link:label>
    <link:label id="lab_infu_PaymentsToAcquireMedicalEquipment_documentation_en-US" xlink:label="lab_infu_PaymentsToAcquireMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of cash paid during the period to acquire medical equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireMedicalEquipment" xlink:href="infu-20211231.xsd#infu_PaymentsToAcquireMedicalEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_PaymentsToAcquireMedicalEquipment" xlink:to="lab_infu_PaymentsToAcquireMedicalEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent_4be64021-5a24-43f1-9425-71ccb3b65f85_negatedTerseLabel_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized value of the debt issuance costs, long-term debt</link:label>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent_label_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense Noncurrent</link:label>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent_documentation_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The noncurrent portion of unamortized debt issuance expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:href="infu-20211231.xsd#infu_UnamortizedDebtIssuanceExpenseNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:to="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_67dc1a35-a081-47e5-83d2-539b6cfa893d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_d04ef015-342b-40a7-8fad-bbc70f938265_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_1ab3ab7c-8c93-4c9f-b738-b6d3d45c99e4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_00425b90-132e-4976-b322-b7ccadb78fb8_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets held-for-use</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue_700609b6-f8e2-40d0-b0b0-c9bc31534b2e_terseLabel_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested shares forgone to satisfy minimum statutory withholding (in shares)</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Shares Forgone, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Shares Forgone, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue" xlink:to="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollateralAxis_eb5a1e48-e797-4d93-a0e4-07214c90cdac_terseLabel_en-US" xlink:label="lab_us-gaap_CollateralAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Axis]</link:label>
    <link:label id="lab_us-gaap_CollateralAxis_label_en-US" xlink:label="lab_us-gaap_CollateralAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollateralAxis" xlink:to="lab_us-gaap_CollateralAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_47421db1-0117-447c-a1a6-351d66f6d439_terseLabel_en-US" xlink:label="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_label_en-US" xlink:label="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Business, Excluding Working Capital Adjustments</link:label>
    <link:label id="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_documentation_en-US" xlink:label="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Business, Excluding Working Capital Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:href="infu-20211231.xsd#infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:to="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d2aaf14e-12a2-43bc-a600-1cc81579eef9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_412ccc88-887a-45ee-becc-fb78fa085a37_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_6851913c-7f0c-449a-a850-f70a284757cf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_015482f3-de27-4735-a184-fedaaca86db4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_A2021EquityIncentivePlanMember_730c160c-0212-49d4-ba9f-5b002fe24a06_terseLabel_en-US" xlink:label="lab_infu_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:label id="lab_infu_A2021EquityIncentivePlanMember_label_en-US" xlink:label="lab_infu_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_infu_A2021EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_infu_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_A2021EquityIncentivePlanMember" xlink:href="infu-20211231.xsd#infu_A2021EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_A2021EquityIncentivePlanMember" xlink:to="lab_infu_A2021EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_1a040465-6f5f-4c48-a4bc-6afa4b86add5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_CreditFacilityMember_f657b4fb-497c-466d-88e2-2ec5e305f9f2_terseLabel_en-US" xlink:label="lab_infu_CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_infu_CreditFacilityMember_label_en-US" xlink:label="lab_infu_CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Member]</link:label>
    <link:label id="lab_infu_CreditFacilityMember_documentation_en-US" xlink:label="lab_infu_CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information about credit facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CreditFacilityMember" xlink:href="infu-20211231.xsd#infu_CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_CreditFacilityMember" xlink:to="lab_infu_CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c069ec75-bb58-487e-bd36-d6296965bbab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP_b87770a0-1e2f-4d2f-a58c-c76f61ad6702_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock ownership plan (ESOP) (in shares)</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Shares Contributed to ESOP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationNonproduction_7732021d-575d-49d6-8451-e06083a214b6_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationNonproduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, nonproduction</link:label>
    <link:label id="lab_us-gaap_DepreciationNonproduction_label_en-US" xlink:label="lab_us-gaap_DepreciationNonproduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationNonproduction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationNonproduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationNonproduction" xlink:to="lab_us-gaap_DepreciationNonproduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_1d436ee3-6279-4203-b05f-2ddc2e7b1152_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_369849f6-8a70-45d0-a13a-6d3d0cd190b9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_47a2bfab-78e1-4a08-9a49-60a402c82f27_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_bfeb268d-f803-411e-aa1a-8a5c3cabe963_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares, retired (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentPolicyTextBlock_6f960830-7c76-4b1f-be1b-54ff7977e0c0_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:label id="lab_infu_MedicalEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_infu_MedicalEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Policy Text Block]</link:label>
    <link:label id="lab_infu_MedicalEquipmentPolicyTextBlock_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for medical equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentPolicyTextBlock" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentPolicyTextBlock" xlink:to="lab_infu_MedicalEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_GreaterOfPrimeRateOrLIBORPlus25Member_b324b03f-9b38-48f8-a87b-fcc6c2cad45a_terseLabel_en-US" xlink:label="lab_infu_GreaterOfPrimeRateOrLIBORPlus25Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater of Prime Rate or LIBOR Plus 2.5%</link:label>
    <link:label id="lab_infu_GreaterOfPrimeRateOrLIBORPlus25Member_label_en-US" xlink:label="lab_infu_GreaterOfPrimeRateOrLIBORPlus25Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater of Prime Rate or LIBOR Plus 2.5% [Member]</link:label>
    <link:label id="lab_infu_GreaterOfPrimeRateOrLIBORPlus25Member_documentation_en-US" xlink:label="lab_infu_GreaterOfPrimeRateOrLIBORPlus25Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to the greater of prime rate or LIBOR plus 2.5%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_GreaterOfPrimeRateOrLIBORPlus25Member" xlink:href="infu-20211231.xsd#infu_GreaterOfPrimeRateOrLIBORPlus25Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_GreaterOfPrimeRateOrLIBORPlus25Member" xlink:to="lab_infu_GreaterOfPrimeRateOrLIBORPlus25Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_98dcecd0-e484-4fce-a930-5f2df94c843c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_cead0b96-a0a1-4bac-9629-81f8fb56162b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_814fc047-4d88-4534-8133-9d60a4b29d41_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_9efab3a6-cd1f-4447-aef1-b6167fdc3136_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_db3d25c4-8713-4a3e-995c-0a96b8df22f8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_3bfeee0b-cf16-4650-885c-1f84952ea119_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_OperatingLossCarryforwardsExpirationPeriods_b7f87b69-7562-4d0b-ba32-9d3ebc3ddb36_terseLabel_en-US" xlink:label="lab_infu_OperatingLossCarryforwardsExpirationPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards expiration periods</link:label>
    <link:label id="lab_infu_OperatingLossCarryforwardsExpirationPeriods_label_en-US" xlink:label="lab_infu_OperatingLossCarryforwardsExpirationPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards Expiration Periods</link:label>
    <link:label id="lab_infu_OperatingLossCarryforwardsExpirationPeriods_documentation_en-US" xlink:label="lab_infu_OperatingLossCarryforwardsExpirationPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The duration of operating loss carryforwards before expiration begins.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OperatingLossCarryforwardsExpirationPeriods" xlink:href="infu-20211231.xsd#infu_OperatingLossCarryforwardsExpirationPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_OperatingLossCarryforwardsExpirationPeriods" xlink:to="lab_infu_OperatingLossCarryforwardsExpirationPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d9ad857c-a9f2-4074-a41b-533b1f765c58_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockExpense_432b5dac-2696-4a28-9cb2-4d803b5d49f2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share expense</link:label>
    <link:label id="lab_us-gaap_RestrictedStockExpense_label_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock or Unit Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockExpense" xlink:to="lab_us-gaap_RestrictedStockExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_f1ad4f5b-4934-4c90-bf3d-5e3f0eb24345_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1520e83c-0624-4596-96b6-07f0adb0d5ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Authorized Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_895f8710-2d8e-423d-8af9-7a41485f916e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income tax expense</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_07a36169-cca3-40ec-a6d6-f6169bf0a720_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_5e2e0b51-bea5-4b8b-9755-a2cc3ee276f5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, cost, total</link:label>
    <link:label id="lab_us-gaap_LeaseCost_a2665045-a6f1-4cbd-acf5-a5f33b818ee4_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_20c4485d-9a68-40aa-8258-9c1fa800e321_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_5cf04487-6af5-46bd-86d8-15c002afb705_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research &amp; development credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_8305253c-c8c0-45a9-9995-05d922cfe387_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_921ac2c9-8963-464e-b5c0-7ea2e454a8ab_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_402dd4ab-aae9-4765-a6df-57d6f0cc7ee2_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NON-CASH TRANSACTIONS</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_115c0c9c-883f-4761-b545-11769fba87ca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_edd02598-d87d-477a-8c02-8be91a7dcfa2_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_06db7022-c84f-4a74-aa63-ad77822edea9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property &amp; equipment, net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_19654dec-9aab-4793-b4bd-dca25f472816_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_390a23f8-f183-4b36-a018-454139e810f5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_41db4099-b32b-4aa9-a338-c572385f77e3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_cbfe0fad-921d-4a88-87c0-b5240bb8b159_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_06af0ee3-d03a-40a6-9f9a-6f0cca323e86_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computer software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0eea1967-6d0a-4634-a918-bd47a3928ec3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_ab94b142-aada-4f7d-9f2d-792cc63c7e9a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_cc766a28-0749-45b7-a627-ce49b5f58638_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0ed73cec-d5ba-4452-9f8b-f720260f5e2b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio_d67aca86-b725-454e-83a4-751cf6b14920_terseLabel_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, maximum leverage ratio</link:label>
    <link:label id="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio_label_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Covenant Maximum Leverage Ratio</link:label>
    <link:label id="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio_documentation_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum leverage ratio required by the debt agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:href="infu-20211231.xsd#infu_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:to="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_1021b5d7-43ab-4da7-aebb-b15cdda8c5be_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_f1d44324-9c31-4dce-9c13-a7d691d847d5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DMEServicesSegmentMember_8cfeda3f-5b3b-4993-862d-988c8bd449ca_terseLabel_en-US" xlink:label="lab_infu_DMEServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DME Services Segment</link:label>
    <link:label id="lab_infu_DMEServicesSegmentMember_label_en-US" xlink:label="lab_infu_DMEServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DME Services Segment [Member]</link:label>
    <link:label id="lab_infu_DMEServicesSegmentMember_documentation_en-US" xlink:label="lab_infu_DMEServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding the DME Services segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember" xlink:href="infu-20211231.xsd#infu_DMEServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DMEServicesSegmentMember" xlink:to="lab_infu_DMEServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_f7290428-8943-452e-87eb-abb5bcc31562_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_66e95cb1-6e36-47d2-901e-49f6b3ae034c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_f48ded11-ebd7-416e-9c22-50eb5c11c370_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_382cbcac-7ba6-4d47-b235-6f2c1a87a88a_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_af4b84e5-59cf-4a96-8dcf-a60fe27b609a_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_5a890f3e-60cf-406c-954c-54d461d8a2e7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_80a4764b-2d98-49fd-8419-b06e2e9bf560_totalLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross availability</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_25caf13b-ec25-4908-b08e-6654dca01563_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue_23fcad9c-71c1-4e13-87e8-2be3104b416b_terseLabel_en-US" xlink:label="lab_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested shares forgone to satisfy minimum statutory withholding, aggregate fair value</link:label>
    <link:label id="lab_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue_label_en-US" xlink:label="lab_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Expiration In Period Fair Value</link:label>
    <link:label id="lab_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue_documentation_en-US" xlink:label="lab_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of share-based awards expired during the period, to receive or retain shares or units, other instruments, or cash.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" xlink:href="infu-20211231.xsd#infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" xlink:to="lab_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_e81d9bc3-7505-4b06-a14f-700dd4d2a751_terseLabel_en-US" xlink:label="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_label_en-US" xlink:label="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Additional Borrowing Capacity Subject To Certain Conditions</link:label>
    <link:label id="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_documentation_en-US" xlink:label="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional borrowing capacity under the credit facility subject to certain conditions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:href="infu-20211231.xsd#infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:to="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c14453fd-7c0c-4d9e-9aef-c6a410959559_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40d4bac7-4647-4120-9bf1-96ccd0b155f4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_NumberOfFinancialInstitutions_1961838d-7f18-4e39-9dd1-dacf60047b0f_terseLabel_en-US" xlink:label="lab_infu_NumberOfFinancialInstitutions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of financial institutions</link:label>
    <link:label id="lab_infu_NumberOfFinancialInstitutions_label_en-US" xlink:label="lab_infu_NumberOfFinancialInstitutions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Financial Institutions</link:label>
    <link:label id="lab_infu_NumberOfFinancialInstitutions_documentation_en-US" xlink:label="lab_infu_NumberOfFinancialInstitutions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of financial institutions where the entity maintains its cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NumberOfFinancialInstitutions" xlink:href="infu-20211231.xsd#infu_NumberOfFinancialInstitutions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_NumberOfFinancialInstitutions" xlink:to="lab_infu_NumberOfFinancialInstitutions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_f142fd08-20f8-4795-90ee-dbf6454de32b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_d7e757ce-e523-4d9c-a2e0-0c2de37b6eb3_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_f27c8307-14b2-4302-9018-85da557b729a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_32109816-8c71-4cd0-8a79-330ab6dd2d7b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value of options granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b04240cf-fe44-4553-b027-9179cbca298c_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_8313465e-877b-48f5-8760-8ee2fa4db768_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_21a5ec7b-6f6a-409b-a88d-aa7b782d0f0b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, Weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_93331e7e-730a-4b90-864a-5cb3d9260555_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_be924e2e-616b-4b2d-9580-2a5e2a567cb7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_88ff905d-a547-43e0-9b9a-9c49cac491c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c7ba9f15-a3c3-441e-a685-3ffd81a17b86_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone_05a34adf-db56-4893-8460-5f3addd8eea1_negatedTerseLabel_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested shares forgone (in shares)</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone_label_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Shares Forgone</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone_documentation_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Shares Forgone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone" xlink:to="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8e0fefb6-f91f-4f01-a3a5-c3b5cd7c021e_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_504125b3-a295-4100-8a6d-9fc6785c0864_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_PaycheckProtectionProgramCaresActMember_848cb7a5-9893-4acc-877e-e2e56121d1c0_terseLabel_en-US" xlink:label="lab_infu_PaycheckProtectionProgramCaresActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program CARES Act</link:label>
    <link:label id="lab_infu_PaycheckProtectionProgramCaresActMember_label_en-US" xlink:label="lab_infu_PaycheckProtectionProgramCaresActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program CARES Act [Member]</link:label>
    <link:label id="lab_infu_PaycheckProtectionProgramCaresActMember_documentation_en-US" xlink:label="lab_infu_PaycheckProtectionProgramCaresActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents loan designed to provide funds for small businesses to keep their employees on the payroll.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaycheckProtectionProgramCaresActMember" xlink:href="infu-20211231.xsd#infu_PaycheckProtectionProgramCaresActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_PaycheckProtectionProgramCaresActMember" xlink:to="lab_infu_PaycheckProtectionProgramCaresActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_8363eac6-2b3a-4d02-9d8c-95d5f2cde8b6_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_6df0c64a-3e48-4772-841a-7f88d0d307a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Before Income Tax, Domestic and Foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned_21b63f25-d482-4b47-87bb-383e6f210080_terseLabel_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award percentage of target number of shares to be earned</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned_label_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Percentage of Target Number of Shares to Be Earned</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned_documentation_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of target number of shares to be earned under share based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" xlink:to="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_4ddf50ac-e7ce-42d1-a24c-2235a945ccc2_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_83363424-d95f-499a-bc14-c64c53a51974_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_e5b204a7-1c73-4e0b-bdfd-745a2c171270_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_32f3bc3e-f991-48d9-ab14-d092b207b619_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_2d40b84f-0d98-4508-baaa-f3869d8094a4_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangible assets, gross assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ABRLoansMember_4a05d1db-67bb-44c4-a8a9-0b8d27ebffe8_terseLabel_en-US" xlink:label="lab_infu_ABRLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABR Loans</link:label>
    <link:label id="lab_infu_ABRLoansMember_label_en-US" xlink:label="lab_infu_ABRLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABR Loans [Member]</link:label>
    <link:label id="lab_infu_ABRLoansMember_documentation_en-US" xlink:label="lab_infu_ABRLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the ABR loans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ABRLoansMember" xlink:href="infu-20211231.xsd#infu_ABRLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ABRLoansMember" xlink:to="lab_infu_ABRLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_311de2bb-ed45-4eb9-ba3e-7a2faeb41f39_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_5ed889d8-83ba-4905-8115-40b4569cff51_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_ed43253d-14f8-419b-b218-173106da17d9_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computer software, amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0495a875-cbe4-4105-85a2-e42b2625dbca_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_Covid19Abstract_label_en-US" xlink:label="lab_infu_Covid19Abstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covid-19 [Abstract]</link:label>
    <link:label id="lab_infu_Covid19Abstract_documentation_en-US" xlink:label="lab_infu_Covid19Abstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covid-19</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_Covid19Abstract" xlink:href="infu-20211231.xsd#infu_Covid19Abstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_Covid19Abstract" xlink:to="lab_infu_Covid19Abstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_dec62ac0-f9ba-44d6-b7f3-ce1b6b03facf_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_59f419cd-73be-4fe0-8dcd-c0291f46e94a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in liabilities - (decrease)/increase:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_bd0dbb32-b5c7-49a6-ad23-88f46c302a78_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to interest expense</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f74b80f6-7943-4435-90c2-f7312f355919_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a14a1e25-6e77-4c20-84ac-d80facc6a26f_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, number of authorized shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue_0f5bc508-51a3-4700-8179-3e14cd497ac3_terseLabel_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares forgone to satisfy minimum statutory withholding</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue_label_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value Shares Forgone, Fair Value</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue_documentation_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value Shares Forgone, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue" xlink:to="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_28f3d500-db0c-45aa-ba62-5314fafb04cc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_151090ed-206a-4017-8c71-da30e37975ca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fa5bba4e-ccb8-4e98-b719-a17fb674beeb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_973cb341-7f66-4e32-a366-c36b6e3f2ba2_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a40cce6b-aa79-48fc-a239-f962b69f67fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue_4cc6f29a-5957-46dd-9944-f5a3730e12f2_terseLabel_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested shares forgone to satisfy minimum statutory withholding, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expirations Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The weighted average fair value at grant date for nonvested equity-based awards expired during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue" xlink:to="lab_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ac34e4a3-6988-47b0-aedb-f6be104ea734_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationTable_d16d0288-0c79-44f8-9859-3103ba2476a4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationTable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Segment Allocation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:to="lab_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2c199140-6895-4355-9bf7-a3b005de383d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4d009e0e-36b8-4615-b244-e6ba63c87e32_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8db67ccc-f6db-4a5f-88c7-f7790945247e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_08ba8fdc-2a84-424c-a2cd-84411fc5a8a8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e619dfc3-1c59-4b5d-bafb-3d90dd3654be_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_FilAMedMember_7209dda6-7644-47ec-aa94-a9e080deafd7_terseLabel_en-US" xlink:label="lab_infu_FilAMedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FilAMed</link:label>
    <link:label id="lab_infu_FilAMedMember_label_en-US" xlink:label="lab_infu_FilAMedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FilAMed [Member]</link:label>
    <link:label id="lab_infu_FilAMedMember_documentation_en-US" xlink:label="lab_infu_FilAMedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to FilAMed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember" xlink:href="infu-20211231.xsd#infu_FilAMedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_FilAMedMember" xlink:to="lab_infu_FilAMedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_3b35e4c8-4be1-482f-b4a5-fa46a6f350be_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_30eef826-52ec-4bcb-85dc-30549197c6cb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_0999fca4-0b43-4639-915d-f22879e06115_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_fc87823e-d916-4b94-9f12-8454a656c0a2_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_8d53c9cd-f394-4b2e-a46e-c30d8c6e8be2_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_0e2595b8-0ce0-4a96-8b35-20b10272923e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_05946239-f58f-4f7e-9b91-fd16f3ef7af6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_7c9ed658-0581-491e-be5f-2f67392a8a4b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_fa667722-5b0e-43c2-96fe-1f2037792687_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a053f1d5-6a1f-4b02-b594-5be24b32fcba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_5c4ebf90-4c37-45b9-b4ac-0fdb7c0e3d0f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b182bfa6-b0e6-45d1-8219-9f51ec8cce11_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1a7ea269-315d-4d5f-92f6-bbd7dadf1d67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_32669811-f9c5-46b9-8877-a1d374a19f8c_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_d15d69da-4ad5-41c6-a365-d491d16cd612_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_13df39dc-5d32-4657-a83d-9832bdccdb81_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_fab05c1c-e7b0-490d-966f-ed791d782d11_terseLabel_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment held for sale or rental</link:label>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_label_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Medical Equipment Held For Sale Or Rental</link:label>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_documentation_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of medical equipment in rental service recognized as of the acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:href="infu-20211231.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:to="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a5cbd38e-3752-4552-9dfd-3d8238938b73_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected lives at date of grant (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1888af22-eac3-4d23-9360-068e8960b2dc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c2659bac-f8d0-4856-9505-ab88cb92abc0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_258f0848-93ae-4f99-9dff-ef41e251ede2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_71521ad1-e88a-43b0-9bbe-dfef1fd8a3d6_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses, gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_16335981-4cfd-4cbb-8c2a-77001b89f40a_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_968149cf-0580-44e0-ae47-299b754ccee5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_e2cf9bf2-d179-4d21-b0c6-4a781333cb60_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3d62baaa-ecb1-4a2f-90e4-68ea686dd3a3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LenderPrimeRate_dafdcefb-316d-4805-8401-5df92efd7e45_terseLabel_en-US" xlink:label="lab_infu_LenderPrimeRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender prime rate</link:label>
    <link:label id="lab_infu_LenderPrimeRate_label_en-US" xlink:label="lab_infu_LenderPrimeRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Prime Rate</link:label>
    <link:label id="lab_infu_LenderPrimeRate_documentation_en-US" xlink:label="lab_infu_LenderPrimeRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the lender's prime rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LenderPrimeRate" xlink:href="infu-20211231.xsd#infu_LenderPrimeRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LenderPrimeRate" xlink:to="lab_infu_LenderPrimeRate" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_OBHealthcareMember_62fe5849-fa75-422c-80cc-8d20f7d4cdeb_terseLabel_en-US" xlink:label="lab_infu_OBHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OB Healthcare</link:label>
    <link:label id="lab_infu_OBHealthcareMember_label_en-US" xlink:label="lab_infu_OBHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OB Healthcare [Member]</link:label>
    <link:label id="lab_infu_OBHealthcareMember_documentation_en-US" xlink:label="lab_infu_OBHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding the acquisition of OB Healthcare Corporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember" xlink:href="infu-20211231.xsd#infu_OBHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_OBHealthcareMember" xlink:to="lab_infu_OBHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_209fa5d2-6173-4847-b128-dafe309dd342_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_42bb5120-d5fd-4c5a-863f-166e4f2488d4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds from stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_7bcd8b3b-07c0-4f32-9f84-296db8892d36_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_6a3a87e8-5a62-48d1-bebb-886a43b6fcdb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_ca782283-2b76-48c8-b4ed-e99782bd019e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1bf10075-7113-44d1-b64e-6681a18d577e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements and Developments</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_7db959f5-8369-4ca4-9d06-0cb54524cdc4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_1f319eba-5d3e-41fd-96b2-b01f427c3c03_negatedTerseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_label_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment In Rental Services Accumulated Depreciation</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of accumulated depreciation related to medical equipment in rental services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:to="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_d617fc59-0d45-4ddb-baea-97cb7c1108f7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesGross_021cb938-db73-4cc3-ae9a-e4a8a585f5c7_verboseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment in rental service</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesGross_label_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment In Rental Services Gross</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesGross_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the gross amount of medical equipment in rental services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesGross" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentInRentalServicesGross" xlink:to="lab_infu_MedicalEquipmentInRentalServicesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_35dbf842-05ea-4cbf-99b0-871472f023ae_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_f8a6993e-98ca-4de4-ac89-39e2ceae76c1_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e4de57f2-b3a5-4190-a1d2-e571b2118544_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_bdae3084-a4cf-4b4a-a53d-bcb5ada38eb7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_adda17ee-8c08-49a2-8f68-99b2592e5b6d_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_1cae7f56-70dc-4cfa-8106-74e04863ddef_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_690739bd-0fca-4ebe-a260-4f49e9fef77d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_fe2baaee-0aee-4cca-ac54-d8366d8733bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_CBFloatingRateMember_40818f04-61e3-4f42-8987-17d54beb8d12_terseLabel_en-US" xlink:label="lab_infu_CBFloatingRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CB Floating Rate</link:label>
    <link:label id="lab_infu_CBFloatingRateMember_label_en-US" xlink:label="lab_infu_CBFloatingRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CB Floating Rate [Member]</link:label>
    <link:label id="lab_infu_CBFloatingRateMember_documentation_en-US" xlink:label="lab_infu_CBFloatingRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding the CB Floating Rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CBFloatingRateMember" xlink:href="infu-20211231.xsd#infu_CBFloatingRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_CBFloatingRateMember" xlink:to="lab_infu_CBFloatingRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c10c585f-9f30-4305-8701-8555808d7a35_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign income tax</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_fe392397-1003-4ac7-86cb-a17f16089f1f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentMember_2093580d-f270-4adf-af05-c3b9f1a06b75_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:label id="lab_infu_MedicalEquipmentMember_label_en-US" xlink:label="lab_infu_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:label id="lab_infu_MedicalEquipmentMember_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents medical equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentMember" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentMember" xlink:to="lab_infu_MedicalEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_2d11680f-7253-4065-86b4-5f1d876cfdf7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_91657217-f785-4832-a423-19a8978b9dc4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_fa483e3c-a357-4c4a-9655-d82ddec640a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6110e18d-92fd-4b84-a73a-67492d98bc98_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_ee942a3b-5161-459a-a2fb-8bcca6731473_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DeferredTaxAssetsValuationAllowanceExpense_45fe0ffe-5383-44bc-9855-0cbf93b41aec_negatedLabel_en-US" xlink:label="lab_infu_DeferredTaxAssetsValuationAllowanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_infu_DeferredTaxAssetsValuationAllowanceExpense_label_en-US" xlink:label="lab_infu_DeferredTaxAssetsValuationAllowanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Valuation Allowance Expense</link:label>
    <link:label id="lab_infu_DeferredTaxAssetsValuationAllowanceExpense_documentation_en-US" xlink:label="lab_infu_DeferredTaxAssetsValuationAllowanceExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase in the valuation allowance for deferred tax assets charged to income tax expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxAssetsValuationAllowanceExpense" xlink:href="infu-20211231.xsd#infu_DeferredTaxAssetsValuationAllowanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DeferredTaxAssetsValuationAllowanceExpense" xlink:to="lab_infu_DeferredTaxAssetsValuationAllowanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ThirdPartyPayerRentalMember_c33b0e19-29b5-450e-87b0-2bc812e66a55_terseLabel_en-US" xlink:label="lab_infu_ThirdPartyPayerRentalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Payer Rentals</link:label>
    <link:label id="lab_infu_ThirdPartyPayerRentalMember_label_en-US" xlink:label="lab_infu_ThirdPartyPayerRentalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Payer Rental [Member]</link:label>
    <link:label id="lab_infu_ThirdPartyPayerRentalMember_documentation_en-US" xlink:label="lab_infu_ThirdPartyPayerRentalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents third-party payor rental.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ThirdPartyPayerRentalMember" xlink:href="infu-20211231.xsd#infu_ThirdPartyPayerRentalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ThirdPartyPayerRentalMember" xlink:to="lab_infu_ThirdPartyPayerRentalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_95ceefdc-b069-46bd-b762-6b40839fb7ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_392c0a5b-2b42-4965-87d5-b4fc0a6ea330_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_FinancingAgreementMember_d0414451-6436-4c68-b664-259c16dd0011_terseLabel_en-US" xlink:label="lab_infu_FinancingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing</link:label>
    <link:label id="lab_infu_FinancingAgreementMember_label_en-US" xlink:label="lab_infu_FinancingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Agreement [Member]</link:label>
    <link:label id="lab_infu_FinancingAgreementMember_documentation_en-US" xlink:label="lab_infu_FinancingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to the financing agreement (the "Financing Agreement").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember" xlink:href="infu-20211231.xsd#infu_FinancingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_FinancingAgreementMember" xlink:to="lab_infu_FinancingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_14a65b0e-5543-4f6c-9183-5b23e089a534_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_6242f3fe-3ce3-41e3-bfdd-12a8ed0eb62e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b633a018-e613-4dc4-88c5-3d0b28a937f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_PercentageIncreaseInNumberOfContracts_33e45071-cc31-4ef6-bdf6-f13dbe3524e0_terseLabel_en-US" xlink:label="lab_infu_PercentageIncreaseInNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage increase in number of contracts</link:label>
    <link:label id="lab_infu_PercentageIncreaseInNumberOfContracts_label_en-US" xlink:label="lab_infu_PercentageIncreaseInNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Increase in Number of Contracts</link:label>
    <link:label id="lab_infu_PercentageIncreaseInNumberOfContracts_documentation_en-US" xlink:label="lab_infu_PercentageIncreaseInNumberOfContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Increase in Number of Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PercentageIncreaseInNumberOfContracts" xlink:href="infu-20211231.xsd#infu_PercentageIncreaseInNumberOfContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_PercentageIncreaseInNumberOfContracts" xlink:to="lab_infu_PercentageIncreaseInNumberOfContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AutomobilesMember_7a9ea626-a4fd-42e9-b4c8-e304412f449e_terseLabel_en-US" xlink:label="lab_us-gaap_AutomobilesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Automobiles</link:label>
    <link:label id="lab_us-gaap_AutomobilesMember_label_en-US" xlink:label="lab_us-gaap_AutomobilesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Automobiles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AutomobilesMember" xlink:to="lab_us-gaap_AutomobilesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_7222029e-2755-4f12-8244-68a9e87d3022_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>infu-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5045cdd8-3e33-4b1e-9c96-436a6a424439,g:4f22e797-67c4-4a22-8bb5-b3bf69d58fcf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://infusystem.com/role/Cover" xlink:type="simple" xlink:href="infu-20211231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cf8a0229-1bce-4275-ab77-8dc13810c8fb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_DocumentType_cf8a0229-1bce-4275-ab77-8dc13810c8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_077a76e0-9d3d-4116-b9db-da9633789845" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_DocumentAnnualReport_077a76e0-9d3d-4116-b9db-da9633789845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_90d55f38-aef7-421f-b067-774c2e5445db" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_DocumentPeriodEndDate_90d55f38-aef7-421f-b067-774c2e5445db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2e34da3b-4cb2-435e-9ea7-49245fdf49e9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_CurrentFiscalYearEndDate_2e34da3b-4cb2-435e-9ea7-49245fdf49e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_64ab936c-470a-4c2c-b3d6-436f8227d087" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_DocumentTransitionReport_64ab936c-470a-4c2c-b3d6-436f8227d087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_62efb344-b838-4104-8afa-5d87542c43e4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityFileNumber_62efb344-b838-4104-8afa-5d87542c43e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0f917862-a970-4910-a9f4-1e8766ff0a23" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityRegistrantName_0f917862-a970-4910-a9f4-1e8766ff0a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_46b3254e-8a25-4fcd-aa5d-72739ddf8833" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityIncorporationStateCountryCode_46b3254e-8a25-4fcd-aa5d-72739ddf8833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0ebfa128-c1fd-4776-bf50-0d2b554278ba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityTaxIdentificationNumber_0ebfa128-c1fd-4776-bf50-0d2b554278ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b9aec34d-5116-4f3b-a7fa-1c38b2220e71" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityAddressAddressLine1_b9aec34d-5116-4f3b-a7fa-1c38b2220e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5d6e1375-1976-4d0d-b258-5939ef08ba06" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityAddressCityOrTown_5d6e1375-1976-4d0d-b258-5939ef08ba06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ab26e30e-a6d3-4f6a-b3ef-f78913113f99" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityAddressStateOrProvince_ab26e30e-a6d3-4f6a-b3ef-f78913113f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_add6a744-0190-445d-825c-17d5bc450a98" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityAddressPostalZipCode_add6a744-0190-445d-825c-17d5bc450a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0d00397b-bc57-4cdb-9dfc-5164292bdd24" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_CityAreaCode_0d00397b-bc57-4cdb-9dfc-5164292bdd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e75f61e6-dc5d-43eb-a488-74edb99bf194" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_LocalPhoneNumber_e75f61e6-dc5d-43eb-a488-74edb99bf194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b453dad6-40c9-4ddc-b605-2256337a11f5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_Security12bTitle_b453dad6-40c9-4ddc-b605-2256337a11f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_16d7df90-5fae-4c26-8381-0b040361e326" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_TradingSymbol_16d7df90-5fae-4c26-8381-0b040361e326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_58ea280b-b68a-4275-b267-4cb7a69f0005" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_SecurityExchangeName_58ea280b-b68a-4275-b267-4cb7a69f0005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_1c31d0fb-045b-43e8-a8ce-b5b3e073c1ff" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_1c31d0fb-045b-43e8-a8ce-b5b3e073c1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_ad1dcb19-c2d2-4957-9514-10fa455c248c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityVoluntaryFilers_ad1dcb19-c2d2-4957-9514-10fa455c248c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c933aa9d-b2ee-49f2-9a6e-4b6290201d46" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityCurrentReportingStatus_c933aa9d-b2ee-49f2-9a6e-4b6290201d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_2643fac4-3785-4a93-9905-b9333fea9f5d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityInteractiveDataCurrent_2643fac4-3785-4a93-9905-b9333fea9f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d8420f0e-787d-46f7-9207-05c430a055df" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityFilerCategory_d8420f0e-787d-46f7-9207-05c430a055df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_310b2914-c020-4472-94de-a91a2d05aa59" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntitySmallBusiness_310b2914-c020-4472-94de-a91a2d05aa59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_62a40ab5-0e47-4107-a445-bfe44a4f92ee" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityEmergingGrowthCompany_62a40ab5-0e47-4107-a445-bfe44a4f92ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_882871c5-c03a-40fb-9f85-fe64f91e738d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_IcfrAuditorAttestationFlag_882871c5-c03a-40fb-9f85-fe64f91e738d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_72512eb3-42d8-41bf-8401-03023411082e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityShellCompany_72512eb3-42d8-41bf-8401-03023411082e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_98c95bae-768e-42a2-81f2-2580391cee5b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityPublicFloat_98c95bae-768e-42a2-81f2-2580391cee5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_ac650741-5656-4a2c-9c6e-be1e1a8039a5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_ac650741-5656-4a2c-9c6e-be1e1a8039a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_b237638b-2026-49a8-b50a-1d9dd62848e8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_b237638b-2026-49a8-b50a-1d9dd62848e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cd7d5c4c-39ce-4499-bdef-c966bb690818" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_EntityCentralIndexKey_cd7d5c4c-39ce-4499-bdef-c966bb690818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d59abc85-bb67-41bd-8238-0a5dfbeb275b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_DocumentFiscalYearFocus_d59abc85-bb67-41bd-8238-0a5dfbeb275b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_97509071-a686-4cfd-9bda-a587133ea206" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_DocumentFiscalPeriodFocus_97509071-a686-4cfd-9bda-a587133ea206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_55b0fe72-5b6b-4f36-a79f-ca55f64f2fb0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1429237f-93ff-4003-9491-5bd7b80b1732" xlink:to="loc_dei_AmendmentFlag_55b0fe72-5b6b-4f36-a79f-ca55f64f2fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/AuditInformation" xlink:type="simple" xlink:href="infu-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_AuditInformationAbstract_3f633b6a-b6e7-4f25-94e5-29076ca377a4" xlink:href="infu-20211231.xsd#infu_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_f655b4d6-6f7e-4a42-828c-9532f35c8f97" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_AuditInformationAbstract_3f633b6a-b6e7-4f25-94e5-29076ca377a4" xlink:to="loc_dei_AuditorName_f655b4d6-6f7e-4a42-828c-9532f35c8f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_7bd2bd83-3374-45bf-a5ed-455ec9ffd141" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_AuditInformationAbstract_3f633b6a-b6e7-4f25-94e5-29076ca377a4" xlink:to="loc_dei_AuditorLocation_7bd2bd83-3374-45bf-a5ed-455ec9ffd141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_9f70f6c2-cca7-421e-9169-32ba586dbd7e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_AuditInformationAbstract_3f633b6a-b6e7-4f25-94e5-29076ca377a4" xlink:to="loc_dei_AuditorFirmId_9f70f6c2-cca7-421e-9169-32ba586dbd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="infu-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4dad0d1e-961f-4a7e-b6d2-29bca6b8ec7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4dad0d1e-961f-4a7e-b6d2-29bca6b8ec7c" xlink:to="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f8ede5f5-b2d0-4f51-a482-aa9f1def6f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f8ede5f5-b2d0-4f51-a482-aa9f1def6f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_72aac787-18c4-435c-9fff-24d6f7b459fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8ede5f5-b2d0-4f51-a482-aa9f1def6f7a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_72aac787-18c4-435c-9fff-24d6f7b459fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_39885217-d7c4-4b73-a1d8-973d19a0ed4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8ede5f5-b2d0-4f51-a482-aa9f1def6f7a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_39885217-d7c4-4b73-a1d8-973d19a0ed4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_93a847d6-10b9-45d2-8015-b9782fcd6cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8ede5f5-b2d0-4f51-a482-aa9f1def6f7a" xlink:to="loc_us-gaap_InventoryNet_93a847d6-10b9-45d2-8015-b9782fcd6cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_666c9c34-e72a-465a-ae63-2283657ab4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8ede5f5-b2d0-4f51-a482-aa9f1def6f7a" xlink:to="loc_us-gaap_OtherAssetsCurrent_666c9c34-e72a-465a-ae63-2283657ab4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bef117ca-ec51-47ba-abe3-154e403cfa0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f8ede5f5-b2d0-4f51-a482-aa9f1def6f7a" xlink:to="loc_us-gaap_AssetsCurrent_bef117ca-ec51-47ba-abe3-154e403cfa0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental_d03fd2d0-840e-47d4-8683-1407ad4357aa" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRental_d03fd2d0-840e-47d4-8683-1407ad4357aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_983080ec-6333-4bf1-82a9-58bc5257e879" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:to="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_983080ec-6333-4bf1-82a9-58bc5257e879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6368fbd4-8c3c-48d1-9e50-a17a43e3246b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6368fbd4-8c3c-48d1-9e50-a17a43e3246b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_374cd7e1-b180-486f-9d59-af0ba86fb8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:to="loc_us-gaap_Goodwill_374cd7e1-b180-486f-9d59-af0ba86fb8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f2296741-323b-40b1-b351-fac5a97baca3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f2296741-323b-40b1-b351-fac5a97baca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_77f095dd-73cd-4556-984c-3c8e4a49366b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_77f095dd-73cd-4556-984c-3c8e4a49366b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_8004551f-44d1-46b0-acd0-dff8cd86e16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_8004551f-44d1-46b0-acd0-dff8cd86e16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2b53d123-efbc-4261-8b0c-aa22aaa04251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2b53d123-efbc-4261-8b0c-aa22aaa04251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_88265266-9c13-45b2-b383-e21c3a9c9209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_77e3991f-36d2-4546-a6ba-25a466c62842" xlink:to="loc_us-gaap_Assets_88265266-9c13-45b2-b383-e21c3a9c9209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d3bd1d-4811-42c2-945f-795bbb4b00e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4dad0d1e-961f-4a7e-b6d2-29bca6b8ec7c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d3bd1d-4811-42c2-945f-795bbb4b00e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3784c5e2-90aa-491b-86cf-7d017bc04187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d3bd1d-4811-42c2-945f-795bbb4b00e9" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3784c5e2-90aa-491b-86cf-7d017bc04187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d5acd2fd-5fa3-47c0-9cbb-34484dd435a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3784c5e2-90aa-491b-86cf-7d017bc04187" xlink:to="loc_us-gaap_AccountsPayableCurrent_d5acd2fd-5fa3-47c0-9cbb-34484dd435a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_966de4c6-30ed-4022-8d4b-8986d5e742e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3784c5e2-90aa-491b-86cf-7d017bc04187" xlink:to="loc_us-gaap_LongTermDebtCurrent_966de4c6-30ed-4022-8d4b-8986d5e742e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_3c7a8d33-a87f-4078-831c-538c01eb3cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3784c5e2-90aa-491b-86cf-7d017bc04187" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_3c7a8d33-a87f-4078-831c-538c01eb3cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_38404a9a-af3d-40fa-9c30-4e9753675136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3784c5e2-90aa-491b-86cf-7d017bc04187" xlink:to="loc_us-gaap_LiabilitiesCurrent_38404a9a-af3d-40fa-9c30-4e9753675136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_eb7139f3-98b6-46f1-80cd-a3b741b40c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d3bd1d-4811-42c2-945f-795bbb4b00e9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_eb7139f3-98b6-46f1-80cd-a3b741b40c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0b2437ac-1e2d-4458-b315-75a8dd677e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d3bd1d-4811-42c2-945f-795bbb4b00e9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0b2437ac-1e2d-4458-b315-75a8dd677e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b06cf515-ff6f-45b8-92c1-440ce33649ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d3bd1d-4811-42c2-945f-795bbb4b00e9" xlink:to="loc_us-gaap_Liabilities_b06cf515-ff6f-45b8-92c1-440ce33649ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_ba9c7657-da03-45a3-99ca-5817978a5d39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d3bd1d-4811-42c2-945f-795bbb4b00e9" xlink:to="loc_us-gaap_StockholdersEquityAbstract_ba9c7657-da03-45a3-99ca-5817978a5d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b6a401b6-0e09-4f3d-881a-8c34ce7cd5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba9c7657-da03-45a3-99ca-5817978a5d39" xlink:to="loc_us-gaap_PreferredStockValue_b6a401b6-0e09-4f3d-881a-8c34ce7cd5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8861c5f0-4492-4d5c-8576-c3ff0fa7844b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba9c7657-da03-45a3-99ca-5817978a5d39" xlink:to="loc_us-gaap_CommonStockValue_8861c5f0-4492-4d5c-8576-c3ff0fa7844b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_24bfd764-d49f-40f0-8681-b45e55ab2d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba9c7657-da03-45a3-99ca-5817978a5d39" xlink:to="loc_us-gaap_AdditionalPaidInCapital_24bfd764-d49f-40f0-8681-b45e55ab2d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9a9fd3e6-2ce8-4e49-a19f-bde2f1b53124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba9c7657-da03-45a3-99ca-5817978a5d39" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9a9fd3e6-2ce8-4e49-a19f-bde2f1b53124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f3703826-3eb3-447a-ab7f-f918d9a4d282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba9c7657-da03-45a3-99ca-5817978a5d39" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f3703826-3eb3-447a-ab7f-f918d9a4d282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_64d6a531-f375-4fd0-ae19-ce36b15018c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_ba9c7657-da03-45a3-99ca-5817978a5d39" xlink:to="loc_us-gaap_StockholdersEquity_64d6a531-f375-4fd0-ae19-ce36b15018c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1165abe3-e492-4083-8426-f8c124094261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c4d3bd1d-4811-42c2-945f-795bbb4b00e9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_1165abe3-e492-4083-8426-f8c124094261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="infu-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7599bd88-2e55-410a-b51d-e1606d401481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_fcf8d38f-afde-4349-ad82-6360d58708e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7599bd88-2e55-410a-b51d-e1606d401481" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_fcf8d38f-afde-4349-ad82-6360d58708e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b1d8d151-db9b-4bda-9a43-cb3426294faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7599bd88-2e55-410a-b51d-e1606d401481" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b1d8d151-db9b-4bda-9a43-cb3426294faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_132a3bd1-f7e1-440b-a969-1af389515741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7599bd88-2e55-410a-b51d-e1606d401481" xlink:to="loc_us-gaap_PreferredStockSharesIssued_132a3bd1-f7e1-440b-a969-1af389515741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0f48547f-f913-417d-a8f7-03b50336ccc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7599bd88-2e55-410a-b51d-e1606d401481" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0f48547f-f913-417d-a8f7-03b50336ccc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4da74a0e-cb62-451f-ab31-57aafc502d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7599bd88-2e55-410a-b51d-e1606d401481" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4da74a0e-cb62-451f-ab31-57aafc502d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e94823c5-3498-41c8-945a-3388284a02c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7599bd88-2e55-410a-b51d-e1606d401481" xlink:to="loc_us-gaap_CommonStockSharesIssued_e94823c5-3498-41c8-945a-3388284a02c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_793565dd-c404-4faa-b4ca-2117489af723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7599bd88-2e55-410a-b51d-e1606d401481" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_793565dd-c404-4faa-b4ca-2117489af723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome" xlink:type="simple" xlink:href="infu-20211231.xsd#ConsolidatedStatementofOperationsandComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_282c65bc-e850-4792-a7f2-2f34a554b7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_Revenues_282c65bc-e850-4792-a7f2-2f34a554b7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ec9c0bee-b8e8-4187-968a-a31c62c6396e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ec9c0bee-b8e8-4187-968a-a31c62c6396e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_241eea37-20b4-415b-a0e0-6a0923ad9035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_GrossProfit_241eea37-20b4-415b-a0e0-6a0923ad9035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_ca0f0f06-099c-4891-ab11-f7e505bf4586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_ca0f0f06-099c-4891-ab11-f7e505bf4586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_bee1b5da-768f-4d45-8df0-8752e1051d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_ca0f0f06-099c-4891-ab11-f7e505bf4586" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_bee1b5da-768f-4d45-8df0-8752e1051d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_899281b8-7368-4a48-8524-81bbad191aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_ca0f0f06-099c-4891-ab11-f7e505bf4586" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_899281b8-7368-4a48-8524-81bbad191aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_e138b0c3-d401-4078-b252-397030ae084c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_ca0f0f06-099c-4891-ab11-f7e505bf4586" xlink:to="loc_us-gaap_SellingAndMarketingExpense_e138b0c3-d401-4078-b252-397030ae084c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c4329d1a-c060-46e4-9528-ac1306231bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_ca0f0f06-099c-4891-ab11-f7e505bf4586" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c4329d1a-c060-46e4-9528-ac1306231bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_bc1688c6-6023-4b63-b1b8-abbef4fd373a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_ca0f0f06-099c-4891-ab11-f7e505bf4586" xlink:to="loc_us-gaap_OperatingExpenses_bc1688c6-6023-4b63-b1b8-abbef4fd373a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1b416cc1-3efd-4258-aed0-cec2cc1360b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_OperatingIncomeLoss_1b416cc1-3efd-4258-aed0-cec2cc1360b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_78c4b53b-0999-41b3-aa5b-cf2587f70268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_78c4b53b-0999-41b3-aa5b-cf2587f70268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ab770c52-9347-48c2-a1f0-e217e4a7ca6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_78c4b53b-0999-41b3-aa5b-cf2587f70268" xlink:to="loc_us-gaap_InterestExpense_ab770c52-9347-48c2-a1f0-e217e4a7ca6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0481ccd4-a612-40d6-b443-c6d2c32fdf9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_78c4b53b-0999-41b3-aa5b-cf2587f70268" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0481ccd4-a612-40d6-b443-c6d2c32fdf9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_737b3424-c145-4369-a299-d87dc55d1bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_737b3424-c145-4369-a299-d87dc55d1bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7fdcad97-30f7-4517-b23b-4eca74f89c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7fdcad97-30f7-4517-b23b-4eca74f89c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_639b6426-9d77-4e89-b328-4bfae47627ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_NetIncomeLoss_639b6426-9d77-4e89-b328-4bfae47627ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3dd6a412-2526-44fd-8105-126c2392b1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3dd6a412-2526-44fd-8105-126c2392b1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6f83eac2-9e8f-4e61-ac70-4d0276a3e866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3dd6a412-2526-44fd-8105-126c2392b1c9" xlink:to="loc_us-gaap_EarningsPerShareBasic_6f83eac2-9e8f-4e61-ac70-4d0276a3e866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6e791df1-7591-439f-8ea7-e9ef392f6dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3dd6a412-2526-44fd-8105-126c2392b1c9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6e791df1-7591-439f-8ea7-e9ef392f6dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e38f75d0-4003-43e8-83ad-db292ee6e5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e38f75d0-4003-43e8-83ad-db292ee6e5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fdb1de45-6c03-46ee-bc8a-705ca50c995b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e38f75d0-4003-43e8-83ad-db292ee6e5a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fdb1de45-6c03-46ee-bc8a-705ca50c995b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_71c4b1ec-2ad2-4a45-b165-f0959e8d0dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e38f75d0-4003-43e8-83ad-db292ee6e5a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_71c4b1ec-2ad2-4a45-b165-f0959e8d0dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_060c1580-60f1-47b9-aa1f-e60c4424ee67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d476c6f0-bf7f-4608-9953-c308fc2c7a16" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_060c1580-60f1-47b9-aa1f-e60c4424ee67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3c619379-6093-45f5-abad-8dcb77f3d444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_060c1580-60f1-47b9-aa1f-e60c4424ee67" xlink:to="loc_us-gaap_NetIncomeLoss_3c619379-6093-45f5-abad-8dcb77f3d444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_32bfb997-67e5-432e-9b8c-67fdb83e4c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_060c1580-60f1-47b9-aa1f-e60c4424ee67" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_32bfb997-67e5-432e-9b8c-67fdb83e4c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_b4e1d200-4dec-419c-a347-6006a30644b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_32bfb997-67e5-432e-9b8c-67fdb83e4c8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_b4e1d200-4dec-419c-a347-6006a30644b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_c1230538-1db8-44d7-88f5-fdb4124ca8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_32bfb997-67e5-432e-9b8c-67fdb83e4c8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_c1230538-1db8-44d7-88f5-fdb4124ca8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d55e683c-2f76-4ff6-a76f-7f539e0e7c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_060c1580-60f1-47b9-aa1f-e60c4424ee67" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d55e683c-2f76-4ff6-a76f-7f539e0e7c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="infu-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_72b5f5f2-7109-4494-a5cd-22eba43094ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bcec6f2b-4152-4721-9913-a1fcff112d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_72b5f5f2-7109-4494-a5cd-22eba43094ee" xlink:to="loc_us-gaap_StatementTable_bcec6f2b-4152-4721-9913-a1fcff112d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c4d3401b-ccd0-44ec-acac-3d9ed2d8747f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bcec6f2b-4152-4721-9913-a1fcff112d37" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c4d3401b-ccd0-44ec-acac-3d9ed2d8747f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c4d3401b-ccd0-44ec-acac-3d9ed2d8747f" xlink:to="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_660d70be-fbdd-4171-82b2-0d5a782e4a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:to="loc_us-gaap_CommonStockMember_660d70be-fbdd-4171-82b2-0d5a782e4a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f48861c7-885d-48bc-ba6b-b368eee8d325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f48861c7-885d-48bc-ba6b-b368eee8d325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d4269ee8-2093-4250-899b-dbfea656c77e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:to="loc_us-gaap_RetainedEarningsMember_d4269ee8-2093-4250-899b-dbfea656c77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b1e7df04-5357-4662-9360-3831972d26bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b1e7df04-5357-4662-9360-3831972d26bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_31124ad1-3dcb-4b74-9b30-bfacd7fabb94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_446d99c6-0c12-447b-834d-a2c95b3f5843" xlink:to="loc_us-gaap_TreasuryStockMember_31124ad1-3dcb-4b74-9b30-bfacd7fabb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_75640772-5e09-40a0-a583-1bbd8d13fdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bcec6f2b-4152-4721-9913-a1fcff112d37" xlink:to="loc_us-gaap_StatementLineItems_75640772-5e09-40a0-a583-1bbd8d13fdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75640772-5e09-40a0-a583-1bbd8d13fdd5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b078a757-3fff-409b-98f2-14b42563842c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_SharesOutstanding_b078a757-3fff-409b-98f2-14b42563842c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9f250a88-7d2c-4144-b52f-ce6a58225af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockholdersEquity_9f250a88-7d2c-4144-b52f-ce6a58225af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_6644e682-bc1c-4b98-a034-a6762a72cfe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_6644e682-bc1c-4b98-a034-a6762a72cfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_fd77bee2-11d5-490c-b144-836d17fa6218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_fd77bee2-11d5-490c-b144-836d17fa6218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ced3ce0d-f61b-4ee5-9283-886692d6ca42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ced3ce0d-f61b-4ee5-9283-886692d6ca42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e358eddb-214f-49d1-b8dd-4c6492b7157f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e358eddb-214f-49d1-b8dd-4c6492b7157f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_ef4103c6-8227-4ab6-8a55-fc28e867ad82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_ef4103c6-8227-4ab6-8a55-fc28e867ad82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7aa9e989-ce3e-43bb-921e-30b0853f8a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7aa9e989-ce3e-43bb-921e-30b0853f8a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_6f617a77-a9bd-4d48-883f-ec40cf66eeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_6f617a77-a9bd-4d48-883f-ec40cf66eeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_beb9e566-96f3-4862-b8e8-17342e61842b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_beb9e566-96f3-4862-b8e8-17342e61842b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_e533d6e1-5c96-48aa-b8d6-9ca6ced3a695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_e533d6e1-5c96-48aa-b8d6-9ca6ced3a695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_56947079-2580-447a-a1c3-9bec05a8df41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_56947079-2580-447a-a1c3-9bec05a8df41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_0dcff556-52b9-4f69-9800-a9ebd0e79fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_0dcff556-52b9-4f69-9800-a9ebd0e79fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e4338126-a986-428d-ad87-1e00b64538bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e4338126-a986-428d-ad87-1e00b64538bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e18a44e5-dba1-400a-8556-76cb84573dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e18a44e5-dba1-400a-8556-76cb84573dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_faa536d3-4203-4932-8fcb-1730e4022df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_NetIncomeLoss_faa536d3-4203-4932-8fcb-1730e4022df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4277d976-0e15-4756-8ed9-137842eb5586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_SharesOutstanding_4277d976-0e15-4756-8ed9-137842eb5586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_40106775-633c-421a-b050-6f537540dc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_310b0954-ccc2-45ec-9b4b-c74e9874847b" xlink:to="loc_us-gaap_StockholdersEquity_40106775-633c-421a-b050-6f537540dc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="infu-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1003ee52-dedc-463d-a057-dc8a7899a0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa303603-77d5-4143-9322-d7eb1b8279bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1003ee52-dedc-463d-a057-dc8a7899a0dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa303603-77d5-4143-9322-d7eb1b8279bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_434403c0-a460-46a8-a54d-1d78974ba1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa303603-77d5-4143-9322-d7eb1b8279bd" xlink:to="loc_us-gaap_NetIncomeLoss_434403c0-a460-46a8-a54d-1d78974ba1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6eba6345-5001-4a42-a5e0-8aaf46a36052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa303603-77d5-4143-9322-d7eb1b8279bd" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6eba6345-5001-4a42-a5e0-8aaf46a36052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_a8c246ec-97f1-491b-b52b-bf09b75420ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6eba6345-5001-4a42-a5e0-8aaf46a36052" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_a8c246ec-97f1-491b-b52b-bf09b75420ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c8972800-4ad1-4067-850c-aee322be220c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6eba6345-5001-4a42-a5e0-8aaf46a36052" xlink:to="loc_us-gaap_Depreciation_c8972800-4ad1-4067-850c-aee322be220c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2a27a78c-8daf-45f2-b9f1-03f16b4b2de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6eba6345-5001-4a42-a5e0-8aaf46a36052" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2a27a78c-8daf-45f2-b9f1-03f16b4b2de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_ee652446-fbc6-4198-aac1-271073f457e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6eba6345-5001-4a42-a5e0-8aaf46a36052" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_ee652446-fbc6-4198-aac1-271073f457e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ff0326fb-17df-453e-9f3d-76000c98c3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6eba6345-5001-4a42-a5e0-8aaf46a36052" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ff0326fb-17df-453e-9f3d-76000c98c3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_fa5bae0e-4d54-4238-9c72-6492d475b559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6eba6345-5001-4a42-a5e0-8aaf46a36052" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_fa5bae0e-4d54-4238-9c72-6492d475b559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2bc0d96a-7dfe-4f10-bd17-ce967350174d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6eba6345-5001-4a42-a5e0-8aaf46a36052" xlink:to="loc_us-gaap_ShareBasedCompensation_2bc0d96a-7dfe-4f10-bd17-ce967350174d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2256bbb7-6647-4eee-89d6-db6dd9a33f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6eba6345-5001-4a42-a5e0-8aaf46a36052" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2256bbb7-6647-4eee-89d6-db6dd9a33f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_322732f8-f5a1-473a-9c3e-44ef532d1a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa303603-77d5-4143-9322-d7eb1b8279bd" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_322732f8-f5a1-473a-9c3e-44ef532d1a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6d613fb4-5769-4ff8-9064-575d559e033c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_322732f8-f5a1-473a-9c3e-44ef532d1a88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6d613fb4-5769-4ff8-9064-575d559e033c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_32adb8b3-868b-443c-abda-599f4104a732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_322732f8-f5a1-473a-9c3e-44ef532d1a88" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_32adb8b3-868b-443c-abda-599f4104a732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_9251cf47-e5b2-4e2e-9a1d-ed627bc67973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_322732f8-f5a1-473a-9c3e-44ef532d1a88" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_9251cf47-e5b2-4e2e-9a1d-ed627bc67973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_1d6c8ecb-9184-432f-8e76-5c942c12b4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_322732f8-f5a1-473a-9c3e-44ef532d1a88" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_1d6c8ecb-9184-432f-8e76-5c942c12b4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_dfe41085-cd4a-4889-acad-8b8c57074427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa303603-77d5-4143-9322-d7eb1b8279bd" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_dfe41085-cd4a-4889-acad-8b8c57074427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_a6385c2e-723d-4f79-9b14-2a248bbd7910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_dfe41085-cd4a-4889-acad-8b8c57074427" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_a6385c2e-723d-4f79-9b14-2a248bbd7910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_66e652c4-0c29-45e4-82e5-be8a56889a35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fa303603-77d5-4143-9322-d7eb1b8279bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_66e652c4-0c29-45e4-82e5-be8a56889a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_622cd58a-c926-4d1a-b164-8b60799b61ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1003ee52-dedc-463d-a057-dc8a7899a0dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_622cd58a-c926-4d1a-b164-8b60799b61ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8c27668a-e868-4076-8840-b6e7cb7e0174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_622cd58a-c926-4d1a-b164-8b60799b61ba" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8c27668a-e868-4076-8840-b6e7cb7e0174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireMedicalEquipment_aa850078-3589-439a-8285-ba8326820e7f" xlink:href="infu-20211231.xsd#infu_PaymentsToAcquireMedicalEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_622cd58a-c926-4d1a-b164-8b60799b61ba" xlink:to="loc_infu_PaymentsToAcquireMedicalEquipment_aa850078-3589-439a-8285-ba8326820e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b91b2025-15e3-4a5a-833a-28769762dd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_622cd58a-c926-4d1a-b164-8b60799b61ba" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b91b2025-15e3-4a5a-833a-28769762dd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_09788ffe-7a9d-4015-84ad-63b2a303f7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_622cd58a-c926-4d1a-b164-8b60799b61ba" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_09788ffe-7a9d-4015-84ad-63b2a303f7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a6384a8b-5e7c-4b09-b4b7-7d3bd9ff470d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_622cd58a-c926-4d1a-b164-8b60799b61ba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a6384a8b-5e7c-4b09-b4b7-7d3bd9ff470d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94e90185-6251-44da-b5c4-ec30a35d77e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1003ee52-dedc-463d-a057-dc8a7899a0dc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94e90185-6251-44da-b5c4-ec30a35d77e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_7859554f-0a25-4c9d-8419-cb078e755aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94e90185-6251-44da-b5c4-ec30a35d77e0" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_7859554f-0a25-4c9d-8419-cb078e755aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_892bedc5-b051-4266-aec0-b66e469734a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94e90185-6251-44da-b5c4-ec30a35d77e0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_892bedc5-b051-4266-aec0-b66e469734a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_988807a9-6666-43ae-aca5-c3aedd1cc423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94e90185-6251-44da-b5c4-ec30a35d77e0" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_988807a9-6666-43ae-aca5-c3aedd1cc423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_59f1dfac-2de4-4f31-97a8-1b327055e82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94e90185-6251-44da-b5c4-ec30a35d77e0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_59f1dfac-2de4-4f31-97a8-1b327055e82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7ce76dc1-34f5-4131-9e05-98784e15200a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94e90185-6251-44da-b5c4-ec30a35d77e0" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7ce76dc1-34f5-4131-9e05-98784e15200a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_1c94fef7-f5f1-4f90-a8b4-b45f52850e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94e90185-6251-44da-b5c4-ec30a35d77e0" xlink:to="loc_us-gaap_ProceedsFromStockPlans_1c94fef7-f5f1-4f90-a8b4-b45f52850e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e94a8627-22fc-4108-a33a-e1de75ce36e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_94e90185-6251-44da-b5c4-ec30a35d77e0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e94a8627-22fc-4108-a33a-e1de75ce36e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1307a9b2-f63c-4132-88d3-6a044a48f603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1003ee52-dedc-463d-a057-dc8a7899a0dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1307a9b2-f63c-4132-88d3-6a044a48f603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_906263ca-742f-43c6-a7a2-f474b0e2a492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1003ee52-dedc-463d-a057-dc8a7899a0dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_906263ca-742f-43c6-a7a2-f474b0e2a492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1af2110c-dcad-48f1-a164-5f4fd36c292a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1003ee52-dedc-463d-a057-dc8a7899a0dc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1af2110c-dcad-48f1-a164-5f4fd36c292a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_ee553b1b-7037-4482-a822-f370c0245e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1003ee52-dedc-463d-a057-dc8a7899a0dc" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_ee553b1b-7037-4482-a822-f370c0245e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_b5f38d4e-ad5a-45fa-bb0d-c947e40dedcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ee553b1b-7037-4482-a822-f370c0245e35" xlink:to="loc_us-gaap_InterestPaidNet_b5f38d4e-ad5a-45fa-bb0d-c947e40dedcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_b9e7c604-ece7-4e98-844d-de50a8684c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ee553b1b-7037-4482-a822-f370c0245e35" xlink:to="loc_us-gaap_IncomeTaxesPaid_b9e7c604-ece7-4e98-844d-de50a8684c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3c4b567-b900-44f2-b503-ee5b37ae4ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1003ee52-dedc-463d-a057-dc8a7899a0dc" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3c4b567-b900-44f2-b503-ee5b37ae4ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_18ef7baa-1c98-4445-b765-f1b96d19adcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3c4b567-b900-44f2-b503-ee5b37ae4ab9" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_18ef7baa-1c98-4445-b765-f1b96d19adcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_891090c7-6f67-4476-8458-809bea4ee549" xlink:href="infu-20211231.xsd#infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3c4b567-b900-44f2-b503-ee5b37ae4ab9" xlink:to="loc_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration_891090c7-6f67-4476-8458-809bea4ee549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NoncashActivitiesProceedsFromStockPlans_5b1241c7-9d79-46f5-a5e7-c587971c2675" xlink:href="infu-20211231.xsd#infu_NoncashActivitiesProceedsFromStockPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e3c4b567-b900-44f2-b503-ee5b37ae4ab9" xlink:to="loc_infu_NoncashActivitiesProceedsFromStockPlans_5b1241c7-9d79-46f5-a5e7-c587971c2675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BasisofPresentationandNatureofOperations" xlink:type="simple" xlink:href="infu-20211231.xsd#BasisofPresentationandNatureofOperations"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BasisofPresentationandNatureofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_50f039c7-2953-4fd2-930c-5c3589d44d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_e875bdd1-8310-4c83-aef9-8337604aa0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_50f039c7-2953-4fd2-930c-5c3589d44d2f" xlink:to="loc_us-gaap_BasisOfAccounting_e875bdd1-8310-4c83-aef9-8337604aa0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BasisofPresentationandNatureofOperationsDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09b0724c-6c5d-4dd4-8c9a-aa773f5ef0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09b0724c-6c5d-4dd4-8c9a-aa773f5ef0ff" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e7e07e4f-9091-4fe9-a7e4-6a1fb8ecd296" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_srt_ProductOrServiceAxis_e7e07e4f-9091-4fe9-a7e4-6a1fb8ecd296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c2525239-5b22-4c45-9ac7-32c548d57eb3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e7e07e4f-9091-4fe9-a7e4-6a1fb8ecd296" xlink:to="loc_srt_ProductsAndServicesDomain_c2525239-5b22-4c45-9ac7-32c548d57eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_AmbulatoryPumpsMember_9f749449-e266-41a3-b8df-7399cae76399" xlink:href="infu-20211231.xsd#infu_AmbulatoryPumpsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c2525239-5b22-4c45-9ac7-32c548d57eb3" xlink:to="loc_infu_AmbulatoryPumpsMember_9f749449-e266-41a3-b8df-7399cae76399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NPWTMedicalEquipmentMember_6e9f1a9f-24b8-41eb-b29f-2566334e3bf8" xlink:href="infu-20211231.xsd#infu_NPWTMedicalEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c2525239-5b22-4c45-9ac7-32c548d57eb3" xlink:to="loc_infu_NPWTMedicalEquipmentMember_6e9f1a9f-24b8-41eb-b29f-2566334e3bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d6a1f649-9d8d-4ccb-ad8b-ef0a8bbefdb7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_srt_RangeAxis_d6a1f649-9d8d-4ccb-ad8b-ef0a8bbefdb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_da9f472a-e260-4c5c-b3e4-5531c33cc2e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d6a1f649-9d8d-4ccb-ad8b-ef0a8bbefdb7" xlink:to="loc_srt_RangeMember_da9f472a-e260-4c5c-b3e4-5531c33cc2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_941dc0a2-0333-4e59-9ef7-c0e15f95baa9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_da9f472a-e260-4c5c-b3e4-5531c33cc2e9" xlink:to="loc_srt_MinimumMember_941dc0a2-0333-4e59-9ef7-c0e15f95baa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2713c915-b137-4898-9832-45198eb0feaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2713c915-b137-4898-9832-45198eb0feaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c3c4f071-adf5-446e-a23d-48ae2e9295df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2713c915-b137-4898-9832-45198eb0feaf" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c3c4f071-adf5-446e-a23d-48ae2e9295df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsProductLineMember_2371890d-d7df-42c5-a46a-a4643a4a27b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c3c4f071-adf5-446e-a23d-48ae2e9295df" xlink:to="loc_us-gaap_CostOfGoodsProductLineMember_2371890d-d7df-42c5-a46a-a4643a4a27b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6f2cb98c-9cfa-4c83-8f64-fef588816eab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6f2cb98c-9cfa-4c83-8f64-fef588816eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_95a3d3df-9db3-450e-af24-e5dd8dfee3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6f2cb98c-9cfa-4c83-8f64-fef588816eab" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_95a3d3df-9db3-450e-af24-e5dd8dfee3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_f56566f2-9826-4f1f-baf2-4246147747da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_95a3d3df-9db3-450e-af24-e5dd8dfee3be" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_f56566f2-9826-4f1f-baf2-4246147747da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_2d515e09-d3cc-4115-8746-72156bf84305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_2d515e09-d3cc-4115-8746-72156bf84305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_5aaa71cd-cd62-4437-a9a3-97e607dcd13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_2d515e09-d3cc-4115-8746-72156bf84305" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_5aaa71cd-cd62-4437-a9a3-97e607dcd13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SmithsMedicalIncMember_4b039092-63ab-449f-a2c1-4d93d8c716df" xlink:href="infu-20211231.xsd#infu_SmithsMedicalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_5aaa71cd-cd62-4437-a9a3-97e607dcd13b" xlink:to="loc_infu_SmithsMedicalIncMember_4b039092-63ab-449f-a2c1-4d93d8c716df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CardinalHealthIncMember_a5a1ee0b-152c-4e1f-9a31-f4ee95a15c5b" xlink:href="infu-20211231.xsd#infu_CardinalHealthIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_5aaa71cd-cd62-4437-a9a3-97e607dcd13b" xlink:to="loc_infu_CardinalHealthIncMember_a5a1ee0b-152c-4e1f-9a31-f4ee95a15c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_852f10fb-82f4-4a7e-84ce-0c5c5fbfe3de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_03971145-76ed-4d6c-827a-13309e078118" xlink:to="loc_us-gaap_ProductInformationLineItems_852f10fb-82f4-4a7e-84ce-0c5c5fbfe3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b9947507-53d5-4646-942e-09bfb62774f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_852f10fb-82f4-4a7e-84ce-0c5c5fbfe3de" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b9947507-53d5-4646-942e-09bfb62774f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="infu-20211231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6af30a73-ffba-46f9-80e2-4a4ca0950354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_cadf994a-9dcf-4527-99de-8a35ee059a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6af30a73-ffba-46f9-80e2-4a4ca0950354" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_cadf994a-9dcf-4527-99de-8a35ee059a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="infu-20211231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_aafb775a-47ef-45d8-aa20-7edc05395736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_aafb775a-47ef-45d8-aa20-7edc05395736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_6309889c-e3a5-4493-b778-03b2d83fe4da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_6309889c-e3a5-4493-b778-03b2d83fe4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_349199a9-ba90-4e4f-9fec-a0316a6d9526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_UseOfEstimates_349199a9-ba90-4e4f-9fec-a0316a6d9526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_2ba2a714-4f59-4378-9545-f218102cf021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_2ba2a714-4f59-4378-9545-f218102cf021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_148984ec-84d1-4412-ab77-9c57326d18f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_148984ec-84d1-4412-ab77-9c57326d18f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_a94355c7-c21f-4e98-bd6a-55043b1ba1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_a94355c7-c21f-4e98-bd6a-55043b1ba1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_9017af59-75a3-407e-8e4f-bc991b48dfef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_9017af59-75a3-407e-8e4f-bc991b48dfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentPolicyTextBlock_4a509683-2215-4b21-8e67-ac91f1d510c5" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_infu_MedicalEquipmentPolicyTextBlock_4a509683-2215-4b21-8e67-ac91f1d510c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_634d7ae7-0557-4cd4-b83e-49a02ba6c25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_634d7ae7-0557-4cd4-b83e-49a02ba6c25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_d05a9e0a-f992-4970-8658-967fea3604e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_d05a9e0a-f992-4970-8658-967fea3604e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_01216119-2ecb-464a-a126-73d1a298b2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_01216119-2ecb-464a-a126-73d1a298b2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfInternalCostsPolicy_74a1ddff-63b1-4318-80ca-08aa15b1dbad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizationOfInternalCostsPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_CapitalizationOfInternalCostsPolicy_74a1ddff-63b1-4318-80ca-08aa15b1dbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_5ea69a7e-a201-41df-aee6-8d56c1e2e4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_5ea69a7e-a201-41df-aee6-8d56c1e2e4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_1cfc677f-f310-423b-b1cf-b2b12b928e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_1cfc677f-f310-423b-b1cf-b2b12b928e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_55dbcb56-555b-4ef5-99c1-d9fa526b59cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_55dbcb56-555b-4ef5-99c1-d9fa526b59cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock_e5fa2b14-941c-4943-ba2a-9843c4e8a345" xlink:href="infu-20211231.xsd#infu_RevenueRecognitionCostOfRevenuePolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock_e5fa2b14-941c-4943-ba2a-9843c4e8a345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_f0e297e3-018e-44e2-8ae2-582d752d0d39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_f0e297e3-018e-44e2-8ae2-582d752d0d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_f9c148c8-e89b-4ad9-950e-3e1411ea79b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_f9c148c8-e89b-4ad9-950e-3e1411ea79b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_TreasuryStockPolicyPolicyTextBlock_ce9dc4e7-678e-4a7c-8123-b19b98818fe7" xlink:href="infu-20211231.xsd#infu_TreasuryStockPolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_infu_TreasuryStockPolicyPolicyTextBlock_ce9dc4e7-678e-4a7c-8123-b19b98818fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_80da609e-1778-44cb-a55a-63cd452d6458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_80da609e-1778-44cb-a55a-63cd452d6458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_39fb74bc-50fa-4cdc-b81a-d11c63fc5fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_39fb74bc-50fa-4cdc-b81a-d11c63fc5fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_a1df7734-93e1-494c-9474-2f7f0299241f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_a1df7734-93e1-494c-9474-2f7f0299241f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_fcb16872-ef9c-4a20-8e2d-8378cb48e1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_fcb16872-ef9c-4a20-8e2d-8378cb48e1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b51b785c-fd75-429b-8300-82c0d1f194d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b51b785c-fd75-429b-8300-82c0d1f194d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6e157eaa-d0b8-43cc-a838-88da11547e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_03721b11-dfea-4ec1-be01-f9e4c51004a4" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6e157eaa-d0b8-43cc-a838-88da11547e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesEarningsPerShareTables" xlink:type="simple" xlink:href="infu-20211231.xsd#SummaryofSignificantAccountingPoliciesEarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesEarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c2a74bf2-6ea1-488f-b726-580fd619708b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_918529bd-ea85-4f4e-86eb-8e5b34571216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c2a74bf2-6ea1-488f-b726-580fd619708b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_918529bd-ea85-4f4e-86eb-8e5b34571216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_04776953-760b-4e8d-906c-52b0b7225596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_04776953-760b-4e8d-906c-52b0b7225596" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d819b5a5-1820-4dbd-87bc-29ab9c1cff1c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:to="loc_srt_RangeAxis_d819b5a5-1820-4dbd-87bc-29ab9c1cff1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f6e6b2d-4f6a-4548-a153-907d091c36f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d819b5a5-1820-4dbd-87bc-29ab9c1cff1c" xlink:to="loc_srt_RangeMember_6f6e6b2d-4f6a-4548-a153-907d091c36f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ca16e538-33ff-49db-acb7-c6480dfc75da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f6e6b2d-4f6a-4548-a153-907d091c36f6" xlink:to="loc_srt_MinimumMember_ca16e538-33ff-49db-acb7-c6480dfc75da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d2ce17a8-dd9e-4854-89a1-33d1b6cbca85" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f6e6b2d-4f6a-4548-a153-907d091c36f6" xlink:to="loc_srt_MaximumMember_d2ce17a8-dd9e-4854-89a1-33d1b6cbca85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bb532f16-f1c5-4ca0-87e8-058e325e84b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bb532f16-f1c5-4ca0-87e8-058e325e84b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d0c0a3e-40ed-4960-89b7-dd8272de0857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bb532f16-f1c5-4ca0-87e8-058e325e84b3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d0c0a3e-40ed-4960-89b7-dd8272de0857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_InformationTechnologySoftwareMember_a988d447-5e99-4aa0-ad5f-44ad02314a3a" xlink:href="infu-20211231.xsd#infu_InformationTechnologySoftwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d0c0a3e-40ed-4960-89b7-dd8272de0857" xlink:to="loc_infu_InformationTechnologySoftwareMember_a988d447-5e99-4aa0-ad5f-44ad02314a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_ed17a463-938e-4d44-9b25-67825961b1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d0c0a3e-40ed-4960-89b7-dd8272de0857" xlink:to="loc_us-gaap_ComputerEquipmentMember_ed17a463-938e-4d44-9b25-67825961b1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c5a714a1-99c7-4320-a01b-02aa9fdb4c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c5a714a1-99c7-4320-a01b-02aa9fdb4c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c5a714a1-99c7-4320-a01b-02aa9fdb4c37" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PhysicianAndCustomerRelationshipsMember_2fa51ed1-d4b8-4b83-aa62-ba55f3abfd89" xlink:href="infu-20211231.xsd#infu_PhysicianAndCustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:to="loc_infu_PhysicianAndCustomerRelationshipsMember_2fa51ed1-d4b8-4b83-aa62-ba55f3abfd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_db528b97-8265-4f88-9ed0-fc6d2877c5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_db528b97-8265-4f88-9ed0-fc6d2877c5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_fae0e8b7-c301-415e-b0c4-a3be1f27c3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_fae0e8b7-c301-415e-b0c4-a3be1f27c3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_26e16f24-4999-4888-aff2-4655b0b9016f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_debe1e44-5953-422a-80b1-843b203db2e7" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_26e16f24-4999-4888-aff2-4655b0b9016f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbce494f-dadc-40ab-b8cc-ff7e392d8bef" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_725eb5f1-2c21-408a-b3f9-aef05376baa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_NumberOfReportableSegments_725eb5f1-2c21-408a-b3f9-aef05376baa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NumberOfFinancialInstitutions_af6a5fd4-7838-4896-8873-987a4a21110c" xlink:href="infu-20211231.xsd#infu_NumberOfFinancialInstitutions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_NumberOfFinancialInstitutions_af6a5fd4-7838-4896-8873-987a4a21110c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_95fb3884-fe17-400d-a80a-cbcfa6b015a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_95fb3884-fe17-400d-a80a-cbcfa6b015a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesUsefulLife_9261097c-5551-449f-b085-cc5bf29c0c2e" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_MedicalEquipmentInRentalServicesUsefulLife_9261097c-5551-449f-b085-cc5bf29c0c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesReserve_a8a3c286-b4a5-4d56-a82a-7d16746ab7c8" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_MedicalEquipmentInRentalServicesReserve_a8a3c286-b4a5-4d56-a82a-7d16746ab7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentForSaleOrRentalReserve_fd09da5b-46ba-4e35-b9d8-4e4d720095ab" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentForSaleOrRentalReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_MedicalEquipmentForSaleOrRentalReserve_fd09da5b-46ba-4e35-b9d8-4e4d720095ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8d430215-1628-43d4-9dc1-af3041f05460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8d430215-1628-43d4-9dc1-af3041f05460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3c8cf933-b0cb-4fbd-ba24-ac72afae6345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3c8cf933-b0cb-4fbd-ba24-ac72afae6345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_3ee08e89-fd26-4356-8272-98532b6b3b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_3ee08e89-fd26-4356-8272-98532b6b3b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_79861b6f-8e38-4535-9a30-3b49a66de935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_79861b6f-8e38-4535-9a30-3b49a66de935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_fab0155c-0b31-488d-8812-00118b1401a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_fab0155c-0b31-488d-8812-00118b1401a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8ad8b780-d288-4f6c-bb94-123537ea5dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8ad8b780-d288-4f6c-bb94-123537ea5dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_0f91de0d-7141-4034-b792-70b67f76422c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_0f91de0d-7141-4034-b792-70b67f76422c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NumberOfContractsWithThirdParties_1191aa13-0556-4283-8928-19784194125d" xlink:href="infu-20211231.xsd#infu_NumberOfContractsWithThirdParties"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_NumberOfContractsWithThirdParties_1191aa13-0556-4283-8928-19784194125d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PercentageIncreaseInNumberOfContracts_18c418aa-e9ac-40ae-8b45-4a129bb7064b" xlink:href="infu-20211231.xsd#infu_PercentageIncreaseInNumberOfContracts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_infu_PercentageIncreaseInNumberOfContracts_18c418aa-e9ac-40ae-8b45-4a129bb7064b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_a8abb91d-693f-42f7-82e2-11610535341a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5e1049c2-7c51-4ab7-b280-b2b66f21fde5" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_a8abb91d-693f-42f7-82e2-11610535341a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f2f086ec-7e0b-4a15-9132-541913c78e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d010115b-81dd-4a70-b57b-4c8fc7e5d990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f2f086ec-7e0b-4a15-9132-541913c78e10" xlink:to="loc_us-gaap_NetIncomeLoss_d010115b-81dd-4a70-b57b-4c8fc7e5d990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_21ca4e92-4731-46a8-9f69-1c14c619f1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f2f086ec-7e0b-4a15-9132-541913c78e10" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_21ca4e92-4731-46a8-9f69-1c14c619f1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0f2501db-a803-4740-b9f7-315ff8be11df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_21ca4e92-4731-46a8-9f69-1c14c619f1f7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0f2501db-a803-4740-b9f7-315ff8be11df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fb045295-4f12-4568-baa9-916f808c75fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_21ca4e92-4731-46a8-9f69-1c14c619f1f7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fb045295-4f12-4568-baa9-916f808c75fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6bf1dc5e-55f5-4280-a058-bc7109a3b3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_21ca4e92-4731-46a8-9f69-1c14c619f1f7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6bf1dc5e-55f5-4280-a058-bc7109a3b3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f02128e9-08e1-488b-932c-7011130f80f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f2f086ec-7e0b-4a15-9132-541913c78e10" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f02128e9-08e1-488b-932c-7011130f80f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_421a6852-8651-4d43-8ea7-29c351a4ab66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f02128e9-08e1-488b-932c-7011130f80f1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_421a6852-8651-4d43-8ea7-29c351a4ab66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aee186d5-e9d7-4b74-becb-80f5739a8481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_421a6852-8651-4d43-8ea7-29c351a4ab66" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aee186d5-e9d7-4b74-becb-80f5739a8481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b8b69664-544f-4551-8aec-bd6d4bbff806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_aee186d5-e9d7-4b74-becb-80f5739a8481" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b8b69664-544f-4551-8aec-bd6d4bbff806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b7c031f5-9c57-40f3-9a3c-f9731d8dcf23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f02128e9-08e1-488b-932c-7011130f80f1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b7c031f5-9c57-40f3-9a3c-f9731d8dcf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a402597c-6048-4880-bcf3-11de2941e621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b7c031f5-9c57-40f3-9a3c-f9731d8dcf23" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a402597c-6048-4880-bcf3-11de2941e621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinations" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a566ba2e-df41-4f87-ad37-427838656425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_96f45fa5-2c5e-4ea1-9f04-4db730154f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a566ba2e-df41-4f87-ad37-427838656425" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_96f45fa5-2c5e-4ea1-9f04-4db730154f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cbde39f7-c52b-4cbb-9bd5-853ed0934c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_56e35e6b-23c3-4033-84f2-985deba9cf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cbde39f7-c52b-4cbb-9bd5-853ed0934c41" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_56e35e6b-23c3-4033-84f2-985deba9cf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_29060c3f-f95e-4188-9bbc-cc93e60808a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cbde39f7-c52b-4cbb-9bd5-853ed0934c41" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_29060c3f-f95e-4188-9bbc-cc93e60808a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_07e9f8be-89eb-4a02-bed0-c642b9c2da43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cbde39f7-c52b-4cbb-9bd5-853ed0934c41" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_07e9f8be-89eb-4a02-bed0-c642b9c2da43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_688b7be7-d4ff-4fbe-a6f6-28867bdfce12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cbde39f7-c52b-4cbb-9bd5-853ed0934c41" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_688b7be7-d4ff-4fbe-a6f6-28867bdfce12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0c81a67a-359d-4aab-b408-4ff98b1fde6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0c81a67a-359d-4aab-b408-4ff98b1fde6b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f2bc0c78-cd9d-44c2-9041-b1b92c8ad3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f2bc0c78-cd9d-44c2-9041-b1b92c8ad3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fe311e1c-8404-47f8-9e4c-8f564df1c6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f2bc0c78-cd9d-44c2-9041-b1b92c8ad3fe" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fe311e1c-8404-47f8-9e4c-8f564df1c6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e2a4476-295b-4ca4-b585-7f4a0bc337d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fe311e1c-8404-47f8-9e4c-8f564df1c6ce" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e2a4476-295b-4ca4-b585-7f4a0bc337d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_81c549a6-4269-417e-a2a6-521e91ff46b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_81c549a6-4269-417e-a2a6-521e91ff46b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a00c0fa4-e2fa-476c-b8b7-c0a5e44ec0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81c549a6-4269-417e-a2a6-521e91ff46b1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a00c0fa4-e2fa-476c-b8b7-c0a5e44ec0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_d96025cf-9eb0-4f88-8dc7-16d000627355" xlink:href="infu-20211231.xsd#infu_FilAMedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a00c0fa4-e2fa-476c-b8b7-c0a5e44ec0cb" xlink:to="loc_infu_FilAMedMember_d96025cf-9eb0-4f88-8dc7-16d000627355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_7f2c4654-10e2-4bba-801d-26566ca39939" xlink:href="infu-20211231.xsd#infu_OBHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a00c0fa4-e2fa-476c-b8b7-c0a5e44ec0cb" xlink:to="loc_infu_OBHealthcareMember_7f2c4654-10e2-4bba-801d-26566ca39939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ee121d14-55f2-4c0f-ab68-c8588a2cab90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ee121d14-55f2-4c0f-ab68-c8588a2cab90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9b831161-f39e-4a8a-a2cd-fe8fe0e63cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ee121d14-55f2-4c0f-ab68-c8588a2cab90" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9b831161-f39e-4a8a-a2cd-fe8fe0e63cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_6dfb7ada-9b40-4b5f-af0c-465fd729d8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9b831161-f39e-4a8a-a2cd-fe8fe0e63cf0" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_6dfb7ada-9b40-4b5f-af0c-465fd729d8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7841c3de-aaeb-4721-b851-9fea0d429f07" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_75769747-2343-4bf4-af77-415d00e5b141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_75769747-2343-4bf4-af77-415d00e5b141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9d059d7c-5790-445a-b10e-e2e583f3c88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9d059d7c-5790-445a-b10e-e2e583f3c88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d40cb77e-29c4-4970-93e7-ca55b9f26474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d40cb77e-29c4-4970-93e7-ca55b9f26474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_d0754f08-246f-4fab-9bd5-b3f6e0001bd2" xlink:href="infu-20211231.xsd#infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_31953477-3f95-4669-b424-e09be8d7ed2c" xlink:to="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_d0754f08-246f-4fab-9bd5-b3f6e0001bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3d441f08-477d-447d-85c2-1c4e3412fa53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b53b1f7a-c850-4acb-8590-2a25d4c8e682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3d441f08-477d-447d-85c2-1c4e3412fa53" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b53b1f7a-c850-4acb-8590-2a25d4c8e682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_946b94a1-8f39-44bc-b103-722cb6293fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b53b1f7a-c850-4acb-8590-2a25d4c8e682" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_946b94a1-8f39-44bc-b103-722cb6293fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17935322-cf52-4614-a48d-349e8ae50dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_946b94a1-8f39-44bc-b103-722cb6293fbf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17935322-cf52-4614-a48d-349e8ae50dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_b255a394-750e-45f1-9267-2612255fec1d" xlink:href="infu-20211231.xsd#infu_FilAMedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17935322-cf52-4614-a48d-349e8ae50dba" xlink:to="loc_infu_FilAMedMember_b255a394-750e-45f1-9267-2612255fec1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_958fef5a-d2d6-486f-a626-6893571e8576" xlink:href="infu-20211231.xsd#infu_OBHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17935322-cf52-4614-a48d-349e8ae50dba" xlink:to="loc_infu_OBHealthcareMember_958fef5a-d2d6-486f-a626-6893571e8576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b53b1f7a-c850-4acb-8590-2a25d4c8e682" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_611e64f5-a249-4ed6-be52-0b22e0747583" xlink:href="infu-20211231.xsd#infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:to="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_611e64f5-a249-4ed6-be52-0b22e0747583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_WorkingCapital_8e1f53ad-367f-4b7c-8da1-fb4ffa6459d5" xlink:href="infu-20211231.xsd#infu_WorkingCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:to="loc_infu_WorkingCapital_8e1f53ad-367f-4b7c-8da1-fb4ffa6459d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_7d17acf8-b00c-4a6b-b28e-caaf154e0431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_7d17acf8-b00c-4a6b-b28e-caaf154e0431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7fb0eb23-4604-4506-93f6-7fd867aa2913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8a499e67-4174-49c1-b487-ca0ab4598c9e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7fb0eb23-4604-4506-93f6-7fd867aa2913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_632b51a7-64a5-401d-b994-c470055e1f55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_572ea22b-5949-4528-8e77-c68e2fa495ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_632b51a7-64a5-401d-b994-c470055e1f55" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_572ea22b-5949-4528-8e77-c68e2fa495ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_25200d86-774b-4eea-bb47-140d7d0f0f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_572ea22b-5949-4528-8e77-c68e2fa495ad" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_25200d86-774b-4eea-bb47-140d7d0f0f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_566fef17-eb2b-4d01-8df6-b33ed59c4e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_25200d86-774b-4eea-bb47-140d7d0f0f67" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_566fef17-eb2b-4d01-8df6-b33ed59c4e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_ceb2b008-afd2-4a68-8fdf-7f981d69c8b6" xlink:href="infu-20211231.xsd#infu_FilAMedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_566fef17-eb2b-4d01-8df6-b33ed59c4e88" xlink:to="loc_infu_FilAMedMember_ceb2b008-afd2-4a68-8fdf-7f981d69c8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_bf413e25-1cb6-4a62-bd0c-d9ac6362eea2" xlink:href="infu-20211231.xsd#infu_OBHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_566fef17-eb2b-4d01-8df6-b33ed59c4e88" xlink:to="loc_infu_OBHealthcareMember_bf413e25-1cb6-4a62-bd0c-d9ac6362eea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_572ea22b-5949-4528-8e77-c68e2fa495ad" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d0bfea9c-45a6-4d5a-8481-25c6d24658e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d0bfea9c-45a6-4d5a-8481-25c6d24658e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_541d3c98-d50e-48a6-9c49-5ce4a8fd1441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_541d3c98-d50e-48a6-9c49-5ce4a8fd1441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_4edf44df-fb36-4254-8ebb-4d2dd887b46a" xlink:href="infu-20211231.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_4edf44df-fb36-4254-8ebb-4d2dd887b46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_68caacae-5e4f-4313-bd2a-ec524be6c94a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_68caacae-5e4f-4313-bd2a-ec524be6c94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_67ca1953-8ef3-4399-85ee-39e1d7c06ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_67ca1953-8ef3-4399-85ee-39e1d7c06ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6a00f659-5e02-4b9f-ad5d-022bcc6cf02f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_Goodwill_6a00f659-5e02-4b9f-ad5d-022bcc6cf02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_69e7724c-4aff-4cbb-9721-e5602fad19d3" xlink:href="infu-20211231.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_69e7724c-4aff-4cbb-9721-e5602fad19d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_2e8d4a73-f3e2-4b78-9401-d9a616c20e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_2e8d4a73-f3e2-4b78-9401-d9a616c20e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9e1e3c9a-0579-42ca-93a5-3efeec7c19b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f3f376f9-5e95-460e-824d-a1e9d80b3c86" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9e1e3c9a-0579-42ca-93a5-3efeec7c19b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsIntangibleAssetsAcquiredDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_803d83d5-9e3f-4494-b705-90632e4637d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_794cc960-973b-449c-9f56-a6bb62e19f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_803d83d5-9e3f-4494-b705-90632e4637d6" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_794cc960-973b-449c-9f56-a6bb62e19f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e82b38d7-a44e-4c25-aef3-b57dbea33751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_794cc960-973b-449c-9f56-a6bb62e19f4f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e82b38d7-a44e-4c25-aef3-b57dbea33751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e82b38d7-a44e-4c25-aef3-b57dbea33751" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_261cafbd-ae8a-4478-bb29-a00e95bc9336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:to="loc_us-gaap_CustomerRelationshipsMember_261cafbd-ae8a-4478-bb29-a00e95bc9336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6092f18a-e5c2-4eaa-9d07-d7d9de51d636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6092f18a-e5c2-4eaa-9d07-d7d9de51d636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_c0dfbb07-1df3-4fdb-8634-cadfca5ef1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_c0dfbb07-1df3-4fdb-8634-cadfca5ef1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_1db92a94-f050-4168-94b4-ea8f0a6271ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e8cd99d9-dcef-475a-93dd-7cbe925c1b89" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_1db92a94-f050-4168-94b4-ea8f0a6271ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_dc156d73-64bc-4ba9-9650-591e9279c457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_794cc960-973b-449c-9f56-a6bb62e19f4f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_dc156d73-64bc-4ba9-9650-591e9279c457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_26c3e66d-7c3b-4d37-95f2-b3ed35ce5995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dc156d73-64bc-4ba9-9650-591e9279c457" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_26c3e66d-7c3b-4d37-95f2-b3ed35ce5995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_86fe124b-d342-4239-8d76-5b78e7835dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dc156d73-64bc-4ba9-9650-591e9279c457" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_86fe124b-d342-4239-8d76-5b78e7835dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessCombinationsProFormaInformationDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9417c191-675b-4bc6-9cb1-e8324015a2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_acbb56d7-f0d7-41e0-92d0-d3ac48cf11dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9417c191-675b-4bc6-9cb1-e8324015a2ae" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_acbb56d7-f0d7-41e0-92d0-d3ac48cf11dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_ed811431-9f2e-4024-a37f-2558fdd67955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9417c191-675b-4bc6-9cb1-e8324015a2ae" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_ed811431-9f2e-4024-a37f-2558fdd67955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognition" xlink:type="simple" xlink:href="infu-20211231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_665200a3-9234-481c-ad99-2c87f22a8908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1cc7cd90-5f82-4822-b315-e7a6dd05dd47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_665200a3-9234-481c-ad99-2c87f22a8908" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1cc7cd90-5f82-4822-b315-e7a6dd05dd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="infu-20211231.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_3aa4387c-3cce-4842-a7f1-0ed19a1c7160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e510c0f1-9f71-4e62-9786-eb912650ed29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_3aa4387c-3cce-4842-a7f1-0ed19a1c7160" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e510c0f1-9f71-4e62-9786-eb912650ed29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognitionDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#RevenueRecognitionDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/RevenueRecognitionDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_3cf3e791-d80b-4488-94fb-ac357cbc3553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_74f9c314-e344-4dcb-8735-1c7e2ceef515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_3cf3e791-d80b-4488-94fb-ac357cbc3553" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_74f9c314-e344-4dcb-8735-1c7e2ceef515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4635b791-abc4-4219-a8a0-170e10fa3bc4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74f9c314-e344-4dcb-8735-1c7e2ceef515" xlink:to="loc_srt_ProductOrServiceAxis_4635b791-abc4-4219-a8a0-170e10fa3bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f51156cc-c65f-4631-bed9-5e437c90996d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4635b791-abc4-4219-a8a0-170e10fa3bc4" xlink:to="loc_srt_ProductsAndServicesDomain_f51156cc-c65f-4631-bed9-5e437c90996d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DirectPayerRentalsMember_a57f0035-5823-4b85-a28e-f70b9559db2d" xlink:href="infu-20211231.xsd#infu_DirectPayerRentalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f51156cc-c65f-4631-bed9-5e437c90996d" xlink:to="loc_infu_DirectPayerRentalsMember_a57f0035-5823-4b85-a28e-f70b9559db2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_e432b257-3a11-4665-9b9d-88f4aa1ef1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f51156cc-c65f-4631-bed9-5e437c90996d" xlink:to="loc_us-gaap_ProductMember_e432b257-3a11-4665-9b9d-88f4aa1ef1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e86a57ec-454d-441a-a7bf-9956f155d9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74f9c314-e344-4dcb-8735-1c7e2ceef515" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e86a57ec-454d-441a-a7bf-9956f155d9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e177cadb-189f-40df-bfcf-3ac289f1b1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e86a57ec-454d-441a-a7bf-9956f155d9d4" xlink:to="loc_us-gaap_SegmentDomain_e177cadb-189f-40df-bfcf-3ac289f1b1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_492aff3f-7d15-4072-96fc-39eee97ae8d5" xlink:href="infu-20211231.xsd#infu_ITSSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e177cadb-189f-40df-bfcf-3ac289f1b1eb" xlink:to="loc_infu_ITSSegmentMember_492aff3f-7d15-4072-96fc-39eee97ae8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_74e0d1c0-865e-4b4e-8dd2-6061ca38b9ca" xlink:href="infu-20211231.xsd#infu_DMEServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e177cadb-189f-40df-bfcf-3ac289f1b1eb" xlink:to="loc_infu_DMEServicesSegmentMember_74e0d1c0-865e-4b4e-8dd2-6061ca38b9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_95d969ef-d932-4788-a983-66d78f571913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74f9c314-e344-4dcb-8735-1c7e2ceef515" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_95d969ef-d932-4788-a983-66d78f571913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7d78be74-2044-45d5-aa07-083d279b4759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_95d969ef-d932-4788-a983-66d78f571913" xlink:to="loc_us-gaap_Revenues_7d78be74-2044-45d5-aa07-083d279b4759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_0ebba1d3-2b7f-4f5a-8ce4-cc1990ed84b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_0ebba1d3-2b7f-4f5a-8ce4-cc1990ed84b2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_89685889-1191-46aa-a8ed-e31aaa4f3f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_89685889-1191-46aa-a8ed-e31aaa4f3f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_13e44f71-6653-4692-b16f-bf0e9e9bfdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_89685889-1191-46aa-a8ed-e31aaa4f3f04" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_13e44f71-6653-4692-b16f-bf0e9e9bfdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_e17d6396-057a-45e6-a51c-d92cd5cb79d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_13e44f71-6653-4692-b16f-bf0e9e9bfdd6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_e17d6396-057a-45e6-a51c-d92cd5cb79d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_26bdaab7-d684-4d97-bc14-7070982266d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_26bdaab7-d684-4d97-bc14-7070982266d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c3e20f67-b456-484b-ad2a-6676fc9498e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_26bdaab7-d684-4d97-bc14-7070982266d9" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c3e20f67-b456-484b-ad2a-6676fc9498e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_518c5dc1-02e2-42d3-9b20-15570c24733c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c3e20f67-b456-484b-ad2a-6676fc9498e1" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_518c5dc1-02e2-42d3-9b20-15570c24733c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c262f3b9-b852-4c26-ac4e-cf7cde36ea06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:to="loc_srt_ProductOrServiceAxis_c262f3b9-b852-4c26-ac4e-cf7cde36ea06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c262f3b9-b852-4c26-ac4e-cf7cde36ea06" xlink:to="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ThirdPartyPayerRentalMember_c91508ee-6f57-44de-8c41-97ee8bc7f001" xlink:href="infu-20211231.xsd#infu_ThirdPartyPayerRentalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:to="loc_infu_ThirdPartyPayerRentalMember_c91508ee-6f57-44de-8c41-97ee8bc7f001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DirectPayerRentalsMember_d7e2141a-eb70-46a4-8570-21baf5a0ee53" xlink:href="infu-20211231.xsd#infu_DirectPayerRentalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:to="loc_infu_DirectPayerRentalsMember_d7e2141a-eb70-46a4-8570-21baf5a0ee53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c6527580-f623-40da-a717-7737c926411f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:to="loc_us-gaap_ProductMember_c6527580-f623-40da-a717-7737c926411f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_5d04171e-343b-4e66-9b78-82318f686890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_19096e32-e321-4927-8079-4736981af86b" xlink:to="loc_us-gaap_ServiceMember_5d04171e-343b-4e66-9b78-82318f686890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_cadaf817-3b83-44fe-bd4d-b1f1f14031f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80b2a389-3cf7-40a1-9b5d-d3d97cd85e6e" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_cadaf817-3b83-44fe-bd4d-b1f1f14031f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fa0cdf26-5926-42d5-af1d-0c112530d8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cadaf817-3b83-44fe-bd4d-b1f1f14031f5" xlink:to="loc_us-gaap_Revenues_fa0cdf26-5926-42d5-af1d-0c112530d8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_7dffff7c-ed0f-4012-a45e-ffc7309cb3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cadaf817-3b83-44fe-bd4d-b1f1f14031f5" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_7dffff7c-ed0f-4012-a45e-ffc7309cb3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/MedicalEquipment" xlink:type="simple" xlink:href="infu-20211231.xsd#MedicalEquipment"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/MedicalEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAbstract_c36b3b62-764b-43a4-b222-6298290fe2c1" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAndPropertyDisclosureTextBlock_eb4627f9-6fa1-4563-a6c9-a867c68ffd5a" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentAndPropertyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_c36b3b62-764b-43a4-b222-6298290fe2c1" xlink:to="loc_infu_MedicalEquipmentAndPropertyDisclosureTextBlock_eb4627f9-6fa1-4563-a6c9-a867c68ffd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/MedicalEquipmentTables" xlink:type="simple" xlink:href="infu-20211231.xsd#MedicalEquipmentTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/MedicalEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAbstract_80a82a4c-6953-487b-9647-a1e7766d0a44" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ScheduleOfMedicalEquipmentTableTextBlock_b2362985-1fc5-4d01-abc0-caa07b82ddfd" xlink:href="infu-20211231.xsd#infu_ScheduleOfMedicalEquipmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_80a82a4c-6953-487b-9647-a1e7766d0a44" xlink:to="loc_infu_ScheduleOfMedicalEquipmentTableTextBlock_b2362985-1fc5-4d01-abc0-caa07b82ddfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/MedicalEquipmentDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#MedicalEquipmentDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/MedicalEquipmentDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAbstract_a287f27f-7036-4e6b-89a4-f9793ba78022" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DepreciationExpenseRelatedToMedicalEquipment_6c6472b9-9a1b-4850-8cb1-f365993634a6" xlink:href="infu-20211231.xsd#infu_DepreciationExpenseRelatedToMedicalEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_a287f27f-7036-4e6b-89a4-f9793ba78022" xlink:to="loc_infu_DepreciationExpenseRelatedToMedicalEquipment_6c6472b9-9a1b-4850-8cb1-f365993634a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#MedicalEquipmentSummaryofMedicalEquipmentDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAbstract_6ec67cd5-84a9-4dc8-8a47-f526a51b1b07" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross_bfc5db69-88bd-453e-827c-e1c72d68bf0b" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentHeldForSaleOrRentalGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_6ec67cd5-84a9-4dc8-8a47-f526a51b1b07" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross_bfc5db69-88bd-453e-827c-e1c72d68bf0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentForSaleOrRentalReserve_8ba4b8e5-ab02-46c8-becb-1e8b546f21ac" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentForSaleOrRentalReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_6ec67cd5-84a9-4dc8-8a47-f526a51b1b07" xlink:to="loc_infu_MedicalEquipmentForSaleOrRentalReserve_8ba4b8e5-ab02-46c8-becb-1e8b546f21ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental_33cfab2e-3e36-4708-aab2-303b08ae4a2b" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_6ec67cd5-84a9-4dc8-8a47-f526a51b1b07" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRental_33cfab2e-3e36-4708-aab2-303b08ae4a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesGross_fec42307-3bde-4e73-987f-ba354af79e25" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_6ec67cd5-84a9-4dc8-8a47-f526a51b1b07" xlink:to="loc_infu_MedicalEquipmentInRentalServicesGross_fec42307-3bde-4e73-987f-ba354af79e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesReserve_b1516518-cc5a-4f8a-819e-199e356c2944" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_6ec67cd5-84a9-4dc8-8a47-f526a51b1b07" xlink:to="loc_infu_MedicalEquipmentInRentalServicesReserve_b1516518-cc5a-4f8a-819e-199e356c2944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_dddd88e1-b035-4279-8885-7fc1ed6b0db0" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_6ec67cd5-84a9-4dc8-8a47-f526a51b1b07" xlink:to="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_dddd88e1-b035-4279-8885-7fc1ed6b0db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_7317957b-696e-4455-8799-22062bc7f1df" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_6ec67cd5-84a9-4dc8-8a47-f526a51b1b07" xlink:to="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_7317957b-696e-4455-8799-22062bc7f1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentNet_6a2cfe0f-fdbc-4d35-92df-b208282280ac" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_6ec67cd5-84a9-4dc8-8a47-f526a51b1b07" xlink:to="loc_infu_MedicalEquipmentNet_6a2cfe0f-fdbc-4d35-92df-b208282280ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="infu-20211231.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_23b23fa6-56eb-488b-8d37-d34b2047c3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_e37a5b7d-1978-4f35-b095-a0f26ba54143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_23b23fa6-56eb-488b-8d37-d34b2047c3fc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_e37a5b7d-1978-4f35-b095-a0f26ba54143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="infu-20211231.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_11b094bb-5f91-4219-9f88-2eb5b32e6484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_123a831e-882b-482d-aec0-fd765157cde9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_11b094bb-5f91-4219-9f88-2eb5b32e6484" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_123a831e-882b-482d-aec0-fd765157cde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6df66e63-4706-4edf-83da-575ce616b237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6e60f0a-6ac0-4e79-b164-1007ba2fbe90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6df66e63-4706-4edf-83da-575ce616b237" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6e60f0a-6ac0-4e79-b164-1007ba2fbe90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2f8c81ac-eced-47e6-b585-bfd182100970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6e60f0a-6ac0-4e79-b164-1007ba2fbe90" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2f8c81ac-eced-47e6-b585-bfd182100970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c63690b-43a2-44b6-9a26-d015287970ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2f8c81ac-eced-47e6-b585-bfd182100970" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c63690b-43a2-44b6-9a26-d015287970ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_3942bd70-c45c-47c2-9c81-f3472059ec5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c63690b-43a2-44b6-9a26-d015287970ed" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_3942bd70-c45c-47c2-9c81-f3472059ec5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_0308ef0c-6d1e-4109-aade-25f2d3a7ef5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c63690b-43a2-44b6-9a26-d015287970ed" xlink:to="loc_us-gaap_AutomobilesMember_0308ef0c-6d1e-4109-aade-25f2d3a7ef5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4e2319da-37a7-4f28-9507-a7633029619c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1c63690b-43a2-44b6-9a26-d015287970ed" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4e2319da-37a7-4f28-9507-a7633029619c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8777fab3-048f-4ae3-a938-3e11110d719a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6e60f0a-6ac0-4e79-b164-1007ba2fbe90" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8777fab3-048f-4ae3-a938-3e11110d719a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e40acc38-c1b6-4b42-992f-34367ff17c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8777fab3-048f-4ae3-a938-3e11110d719a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e40acc38-c1b6-4b42-992f-34367ff17c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b54bcf08-1fdf-43da-ac5c-19c96dd46c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8777fab3-048f-4ae3-a938-3e11110d719a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b54bcf08-1fdf-43da-ac5c-19c96dd46c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_45273ac1-4c5e-4c80-9275-339d66adc84b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8777fab3-048f-4ae3-a938-3e11110d719a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_45273ac1-4c5e-4c80-9275-339d66adc84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipmentDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#PropertyandEquipmentDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/PropertyandEquipmentDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f24b062e-dd84-44a0-b396-8c822c6eff54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationNonproduction_c162d34f-ceaa-48b9-a705-e7b95791077b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationNonproduction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f24b062e-dd84-44a0-b396-8c822c6eff54" xlink:to="loc_us-gaap_DepreciationNonproduction_c162d34f-ceaa-48b9-a705-e7b95791077b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f076eec3-256e-4760-9226-076635974dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_153a0880-3b5e-4996-94f8-2f00589555cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f076eec3-256e-4760-9226-076635974dae" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_153a0880-3b5e-4996-94f8-2f00589555cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ed3bf21-60d0-4461-9b1f-674b50e36681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_34ced926-d7cb-4f61-a1d6-580146e06b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ed3bf21-60d0-4461-9b1f-674b50e36681" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_34ced926-d7cb-4f61-a1d6-580146e06b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock_c207f9a9-3907-4f54-859c-81c1525eadbd" xlink:href="infu-20211231.xsd#infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ed3bf21-60d0-4461-9b1f-674b50e36681" xlink:to="loc_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock_c207f9a9-3907-4f54-859c-81c1525eadbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5a8636e1-9989-4777-b146-7cf88d534484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ed3bf21-60d0-4461-9b1f-674b50e36681" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5a8636e1-9989-4777-b146-7cf88d534484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6cad48dd-d89a-468e-8cd2-0a73fb8b84d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_13fac265-7e71-47a8-8261-9c554466b665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6cad48dd-d89a-468e-8cd2-0a73fb8b84d7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_13fac265-7e71-47a8-8261-9c554466b665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cb33efa2-c559-42d5-91f7-b3e415b2277a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_13fac265-7e71-47a8-8261-9c554466b665" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cb33efa2-c559-42d5-91f7-b3e415b2277a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ee12b284-5ab4-448f-b858-1dee41699fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cb33efa2-c559-42d5-91f7-b3e415b2277a" xlink:to="loc_us-gaap_SegmentDomain_ee12b284-5ab4-448f-b858-1dee41699fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4c5e4837-b454-441f-8124-50947c7c617e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_13fac265-7e71-47a8-8261-9c554466b665" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4c5e4837-b454-441f-8124-50947c7c617e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_84dd5b78-b295-4005-8b82-93b32581788f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4c5e4837-b454-441f-8124-50947c7c617e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_84dd5b78-b295-4005-8b82-93b32581788f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PhysicianAndCustomerRelationshipsMember_b4cd4d00-b220-4b2f-a30b-fd8347bfe197" xlink:href="infu-20211231.xsd#infu_PhysicianAndCustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_84dd5b78-b295-4005-8b82-93b32581788f" xlink:to="loc_infu_PhysicianAndCustomerRelationshipsMember_b4cd4d00-b220-4b2f-a30b-fd8347bfe197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_50650601-1276-4158-a999-c9fd19eacff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_84dd5b78-b295-4005-8b82-93b32581788f" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_50650601-1276-4158-a999-c9fd19eacff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_82627bf4-d0c3-4d62-a399-a21cbdcb1f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_13fac265-7e71-47a8-8261-9c554466b665" xlink:to="loc_us-gaap_GoodwillLineItems_82627bf4-d0c3-4d62-a399-a21cbdcb1f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e94e1006-f85d-4bcb-916f-902201b55977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_82627bf4-d0c3-4d62-a399-a21cbdcb1f65" xlink:to="loc_us-gaap_Goodwill_e94e1006-f85d-4bcb-916f-902201b55977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_362d0868-6693-47a7-b9e5-efabefd408cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_82627bf4-d0c3-4d62-a399-a21cbdcb1f65" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_362d0868-6693-47a7-b9e5-efabefd408cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a7e9bbde-79e8-4d2f-b0b5-2392e60a4c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_54601346-794d-4ccf-a5ec-2cc4596e289d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a7e9bbde-79e8-4d2f-b0b5-2392e60a4c87" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_54601346-794d-4ccf-a5ec-2cc4596e289d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_337d971c-a813-4e99-bbce-c1978a6997df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_54601346-794d-4ccf-a5ec-2cc4596e289d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_337d971c-a813-4e99-bbce-c1978a6997df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_732bc9bd-0c54-4259-b633-60ae0094e4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_337d971c-a813-4e99-bbce-c1978a6997df" xlink:to="loc_us-gaap_SegmentDomain_732bc9bd-0c54-4259-b633-60ae0094e4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_8c1bd309-f062-432b-9c07-3774542ae1d6" xlink:href="infu-20211231.xsd#infu_DMEServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_732bc9bd-0c54-4259-b633-60ae0094e4d5" xlink:to="loc_infu_DMEServicesSegmentMember_8c1bd309-f062-432b-9c07-3774542ae1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_9b8b2e49-7690-4041-882e-feb2a1e5a2a3" xlink:href="infu-20211231.xsd#infu_ITSSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_732bc9bd-0c54-4259-b633-60ae0094e4d5" xlink:to="loc_infu_ITSSegmentMember_9b8b2e49-7690-4041-882e-feb2a1e5a2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_bd93a71a-aaca-477e-a69c-36d053d89bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_54601346-794d-4ccf-a5ec-2cc4596e289d" xlink:to="loc_us-gaap_GoodwillLineItems_bd93a71a-aaca-477e-a69c-36d053d89bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_8e1a1cd7-375b-4e5f-af33-3eb79f0dcfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_bd93a71a-aaca-477e-a69c-36d053d89bbb" xlink:to="loc_us-gaap_GoodwillRollForward_8e1a1cd7-375b-4e5f-af33-3eb79f0dcfd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_92fed940-5bd5-418c-bf23-9186d1c6a116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8e1a1cd7-375b-4e5f-af33-3eb79f0dcfd2" xlink:to="loc_us-gaap_Goodwill_92fed940-5bd5-418c-bf23-9186d1c6a116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0d29685-c640-43c1-a5fd-4f823d03a3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8e1a1cd7-375b-4e5f-af33-3eb79f0dcfd2" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0d29685-c640-43c1-a5fd-4f823d03a3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_97a06f6f-6669-4836-946d-cfb9424b1d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_8e1a1cd7-375b-4e5f-af33-3eb79f0dcfd2" xlink:to="loc_us-gaap_Goodwill_97a06f6f-6669-4836-946d-cfb9424b1d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_971426d8-6c8f-454c-b903-aface86feb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8077f3c5-1ee4-488a-b377-d170b21a8569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_971426d8-6c8f-454c-b903-aface86feb8e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8077f3c5-1ee4-488a-b377-d170b21a8569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b87c457e-cec1-4211-8a61-6219e0dfdc41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8077f3c5-1ee4-488a-b377-d170b21a8569" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b87c457e-cec1-4211-8a61-6219e0dfdc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b87c457e-cec1-4211-8a61-6219e0dfdc41" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_f7118226-ab33-41da-89b6-7b7b60344c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:to="loc_us-gaap_TradeNamesMember_f7118226-ab33-41da-89b6-7b7b60344c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PhysicianAndCustomerRelationshipsMember_4cb89110-9174-45d7-bf36-dcad68c59a86" xlink:href="infu-20211231.xsd#infu_PhysicianAndCustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:to="loc_infu_PhysicianAndCustomerRelationshipsMember_4cb89110-9174-45d7-bf36-dcad68c59a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cedee15f-663b-4c0a-a39a-71f2d5e1a284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cedee15f-663b-4c0a-a39a-71f2d5e1a284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_5288d7b2-d847-412b-b81e-f4cba1c84e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_5288d7b2-d847-412b-b81e-f4cba1c84e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_41c5d0b5-39ba-4dda-a703-6e806517933e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_353b558c-20f1-4930-ae7f-4e22051ef39f" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_41c5d0b5-39ba-4dda-a703-6e806517933e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8077f3c5-1ee4-488a-b377-d170b21a8569" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c7b75601-9ba3-49a5-b335-bf030a096129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c7b75601-9ba3-49a5-b335-bf030a096129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5abfab19-10a5-4acb-9eda-5b692bc30ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5abfab19-10a5-4acb-9eda-5b692bc30ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ed495004-04a5-462e-921e-689a420d2f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ed495004-04a5-462e-921e-689a420d2f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4c234457-6a64-4660-8562-79e8c7bd2ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4c234457-6a64-4660-8562-79e8c7bd2ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5966eda3-6e32-43ba-9187-fb692cba37b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_5966eda3-6e32-43ba-9187-fb692cba37b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9dbae82c-ceb1-4a75-adec-0a972ef2636d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ab622468-2f04-4853-9c4e-2343123b24ad" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9dbae82c-ceb1-4a75-adec-0a972ef2636d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88586500-6219-43ca-a6c3-86b88c724b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b6b70796-7703-41e2-861a-61f2a0075fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88586500-6219-43ca-a6c3-86b88c724b3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b6b70796-7703-41e2-861a-61f2a0075fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7f3ec27d-dea4-4de3-9a22-9bd462d04454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88586500-6219-43ca-a6c3-86b88c724b3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7f3ec27d-dea4-4de3-9a22-9bd462d04454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_89b544fd-bb08-49ce-b13c-0d932da7ef90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88586500-6219-43ca-a6c3-86b88c724b3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_89b544fd-bb08-49ce-b13c-0d932da7ef90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1b4645e2-5492-472c-97c7-c03912061dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88586500-6219-43ca-a6c3-86b88c724b3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1b4645e2-5492-472c-97c7-c03912061dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c6d12fa7-338d-4edc-8f53-bfa3be7a67a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88586500-6219-43ca-a6c3-86b88c724b3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c6d12fa7-338d-4edc-8f53-bfa3be7a67a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_968427f3-4256-4090-8839-b0eb8d2f44fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_88586500-6219-43ca-a6c3-86b88c724b3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_968427f3-4256-4090-8839-b0eb8d2f44fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/Debt" xlink:type="simple" xlink:href="infu-20211231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_991b2cbc-dde4-49f2-bc7c-9f2e2d8877d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_25b76de4-2977-41a3-8b02-565633cf93eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_991b2cbc-dde4-49f2-bc7c-9f2e2d8877d1" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_25b76de4-2977-41a3-8b02-565633cf93eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtTables" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_279c4aa9-0132-42d1-b876-308789f92cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_0c2c25f4-bbbc-473a-b9be-51596f472e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_279c4aa9-0132-42d1-b876-308789f92cab" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_0c2c25f4-bbbc-473a-b9be-51596f472e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_3ac66b1a-f521-470e-b64e-b5fc28fc2cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_279c4aa9-0132-42d1-b876-308789f92cab" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_3ac66b1a-f521-470e-b64e-b5fc28fc2cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_3b09d6da-40e6-4fbe-abbc-b1fbc235ffa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_279c4aa9-0132-42d1-b876-308789f92cab" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_3b09d6da-40e6-4fbe-abbc-b1fbc235ffa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5cb8692d-a0f3-45f9-9dff-a30755539e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5cb8692d-a0f3-45f9-9dff-a30755539e30" xlink:to="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cdfa7ebb-8d8c-40ea-88bf-4130105bd46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_DebtInstrumentAxis_cdfa7ebb-8d8c-40ea-88bf-4130105bd46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cdfa7ebb-8d8c-40ea-88bf-4130105bd46b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2021CreditAgreementMember_29cbfeb1-ec8a-4c10-b11d-bcb867f421a0" xlink:href="infu-20211231.xsd#infu_The2021CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:to="loc_infu_The2021CreditAgreementMember_29cbfeb1-ec8a-4c10-b11d-bcb867f421a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2015CreditAgreementMember_32de9b7f-bdad-4001-981d-38ccef68084d" xlink:href="infu-20211231.xsd#infu_The2015CreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:to="loc_infu_The2015CreditAgreementMember_32de9b7f-bdad-4001-981d-38ccef68084d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember_ab617965-a656-4465-8e9d-d144e1ec0abd" xlink:href="infu-20211231.xsd#infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:to="loc_infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember_ab617965-a656-4465-8e9d-d144e1ec0abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CreditFacilityMember_2c105d2f-9c28-42e1-a684-4a1b6da3064c" xlink:href="infu-20211231.xsd#infu_CreditFacilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:to="loc_infu_CreditFacilityMember_2c105d2f-9c28-42e1-a684-4a1b6da3064c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_c1b64bbd-4a73-46f9-86af-eb9a3c8016df" xlink:href="infu-20211231.xsd#infu_FinancingAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c11a7b18-e375-4425-a2bd-bb6673436ef2" xlink:to="loc_infu_FinancingAgreementMember_c1b64bbd-4a73-46f9-86af-eb9a3c8016df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_6d9049dc-8ebb-40d7-adba-271189897929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_CreditFacilityAxis_6d9049dc-8ebb-40d7-adba-271189897929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6ff7cf76-485a-4e75-a23c-53db25da86b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_6d9049dc-8ebb-40d7-adba-271189897929" xlink:to="loc_us-gaap_CreditFacilityDomain_6ff7cf76-485a-4e75-a23c-53db25da86b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8fc02cfb-969b-4d3d-98eb-c570c6813c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6ff7cf76-485a-4e75-a23c-53db25da86b8" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8fc02cfb-969b-4d3d-98eb-c570c6813c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_27055781-3e93-4638-980d-f8769a0792e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6ff7cf76-485a-4e75-a23c-53db25da86b8" xlink:to="loc_us-gaap_LetterOfCreditMember_27055781-3e93-4638-980d-f8769a0792e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_300dd64f-c6f8-4a5c-b9fe-0faf7352fa96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_srt_RangeAxis_300dd64f-c6f8-4a5c-b9fe-0faf7352fa96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bd740778-19bf-4c07-b063-69084af6b0ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_300dd64f-c6f8-4a5c-b9fe-0faf7352fa96" xlink:to="loc_srt_RangeMember_bd740778-19bf-4c07-b063-69084af6b0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_38ce1764-6775-4040-a4d0-638ba252b687" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bd740778-19bf-4c07-b063-69084af6b0ea" xlink:to="loc_srt_MinimumMember_38ce1764-6775-4040-a4d0-638ba252b687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_73a95a16-c22d-4ce7-acda-98409bade462" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bd740778-19bf-4c07-b063-69084af6b0ea" xlink:to="loc_srt_MaximumMember_73a95a16-c22d-4ce7-acda-98409bade462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_06fd45f1-15a3-4743-b7a5-1a6110304701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_VariableRateAxis_06fd45f1-15a3-4743-b7a5-1a6110304701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_06fd45f1-15a3-4743-b7a5-1a6110304701" xlink:to="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_11101052-d092-4e2d-ae00-7dcb1a1b24d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_11101052-d092-4e2d-ae00-7dcb1a1b24d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_GreaterOfPrimeRateOrLIBORPlus25Member_b78e16df-94bb-4809-ab98-165a004508a0" xlink:href="infu-20211231.xsd#infu_GreaterOfPrimeRateOrLIBORPlus25Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:to="loc_infu_GreaterOfPrimeRateOrLIBORPlus25Member_b78e16df-94bb-4809-ab98-165a004508a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CBFloatingRateMember_58103a93-6cf4-47ad-bc7d-b63feb59436a" xlink:href="infu-20211231.xsd#infu_CBFloatingRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:to="loc_infu_CBFloatingRateMember_58103a93-6cf4-47ad-bc7d-b63feb59436a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_62e21866-6a4b-4e95-b8ab-e8fc3c8d6193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4144380d-6111-4939-add5-f878f81925d9" xlink:to="loc_us-gaap_BaseRateMember_62e21866-6a4b-4e95-b8ab-e8fc3c8d6193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7fac8303-dbd5-415b-babe-ad7598f0e1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7fac8303-dbd5-415b-babe-ad7598f0e1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4a448ffb-e4c6-4f9e-8b2b-7b284992b51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7fac8303-dbd5-415b-babe-ad7598f0e1dc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4a448ffb-e4c6-4f9e-8b2b-7b284992b51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EurodollarLoanMember_ba6181fd-677e-4f4f-b9c1-1d5f94865f9d" xlink:href="infu-20211231.xsd#infu_EurodollarLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a448ffb-e4c6-4f9e-8b2b-7b284992b51a" xlink:to="loc_infu_EurodollarLoanMember_ba6181fd-677e-4f4f-b9c1-1d5f94865f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CBFloatingRateLoanMember_7dc7e7d4-2f2e-496e-be8c-8b0823279bf7" xlink:href="infu-20211231.xsd#infu_CBFloatingRateLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a448ffb-e4c6-4f9e-8b2b-7b284992b51a" xlink:to="loc_infu_CBFloatingRateLoanMember_7dc7e7d4-2f2e-496e-be8c-8b0823279bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ABRLoansMember_8dea8dbf-d6a5-478e-8e06-9a0e29c6a214" xlink:href="infu-20211231.xsd#infu_ABRLoansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a448ffb-e4c6-4f9e-8b2b-7b284992b51a" xlink:to="loc_infu_ABRLoansMember_8dea8dbf-d6a5-478e-8e06-9a0e29c6a214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAxis_61f9a7df-505d-4a94-9cdc-ae7339ee911e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_CollateralAxis_61f9a7df-505d-4a94-9cdc-ae7339ee911e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain_23693c3c-5624-491f-9a2c-dc341be2bae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollateralAxis_61f9a7df-505d-4a94-9cdc-ae7339ee911e" xlink:to="loc_us-gaap_CollateralDomain_23693c3c-5624-491f-9a2c-dc341be2bae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentMember_045d66f0-4dea-443f-96bb-6f7fd951be31" xlink:href="infu-20211231.xsd#infu_MedicalEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollateralDomain_23693c3c-5624-491f-9a2c-dc341be2bae8" xlink:to="loc_infu_MedicalEquipmentMember_045d66f0-4dea-443f-96bb-6f7fd951be31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4e668bae-c91c-4b94-bd0d-400beafd7d44" xlink:to="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9e11a054-00ac-46d8-8297-4fdaf52db771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9e11a054-00ac-46d8-8297-4fdaf52db771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_3e816861-0739-4fa7-b10b-329964569b97" xlink:href="infu-20211231.xsd#infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_3e816861-0739-4fa7-b10b-329964569b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_87e5a67b-7399-450d-a9b5-80a7ed61b6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_87e5a67b-7399-450d-a9b5-80a7ed61b6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_2d8281a0-c068-48fe-88ef-7a471a9b2dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_2d8281a0-c068-48fe-88ef-7a471a9b2dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PercentageOfTotalDepreciationExpense_4f73e169-49ac-46b8-b197-bc2c2072c660" xlink:href="infu-20211231.xsd#infu_PercentageOfTotalDepreciationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_PercentageOfTotalDepreciationExpense_4f73e169-49ac-46b8-b197-bc2c2072c660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_b9cf7b0b-86c3-431a-9d1f-4a956212ff19" xlink:href="infu-20211231.xsd#infu_DebtInstrumentCovenantMinimumFixedCoverageRatio"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_b9cf7b0b-86c3-431a-9d1f-4a956212ff19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio_7d25f921-b664-4d12-9c7f-ca80f8978b14" xlink:href="infu-20211231.xsd#infu_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio_7d25f921-b664-4d12-9c7f-ca80f8978b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_3d15ec88-47f7-47bc-930d-652c3facd01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_LineOfCredit_3d15ec88-47f7-47bc-930d-652c3facd01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_34a68b8a-b267-4de8-908a-d2bb25a50bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_34a68b8a-b267-4de8-908a-d2bb25a50bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_aa2139f1-c603-4245-98af-6a4976cbb2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_aa2139f1-c603-4245-98af-6a4976cbb2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LineOfCreditFacilityBorrowingBase_e3a15bbf-d5bc-4ca6-a3b4-074db955ddcf" xlink:href="infu-20211231.xsd#infu_LineOfCreditFacilityBorrowingBase"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_LineOfCreditFacilityBorrowingBase_e3a15bbf-d5bc-4ca6-a3b4-074db955ddcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ff4178b1-5649-4e86-89e9-59d29c115e61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ff4178b1-5649-4e86-89e9-59d29c115e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate_457decb5-be4b-4837-a348-a547a5224074" xlink:href="infu-20211231.xsd#infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate_457decb5-be4b-4837-a348-a547a5224074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_edc6ad82-d2ba-4caf-aefe-09bc8925b050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_edc6ad82-d2ba-4caf-aefe-09bc8925b050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LIBORRate_5ac9add9-7abe-479c-9832-4e49756bd4e8" xlink:href="infu-20211231.xsd#infu_LIBORRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_LIBORRate_5ac9add9-7abe-479c-9832-4e49756bd4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LenderPrimeRate_23872cee-466f-4e5e-b29f-60038a9f8629" xlink:href="infu-20211231.xsd#infu_LenderPrimeRate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_infu_LenderPrimeRate_23872cee-466f-4e5e-b29f-60038a9f8629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_1e7d7a02-8228-4092-9e1b-7f1976f5603c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentTerm_1e7d7a02-8228-4092-9e1b-7f1976f5603c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_bc09f762-36cb-4bbc-a38b-7465f23ce762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_bc09f762-36cb-4bbc-a38b-7465f23ce762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_54935a22-87df-4712-88a8-932382702433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_InterestExpenseDebt_54935a22-87df-4712-88a8-932382702433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d3f6e0de-39a3-450f-8d6c-50ef57893c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_80b299da-21c8-479e-86fb-db989bc67842" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d3f6e0de-39a3-450f-8d6c-50ef57893c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_af035135-2780-47df-bf8c-9caf03917b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3108ea45-2b6c-40dc-af41-ff5d459c4710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_af035135-2780-47df-bf8c-9caf03917b23" xlink:to="loc_us-gaap_DebtInstrumentTable_3108ea45-2b6c-40dc-af41-ff5d459c4710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_96d36da0-521f-41b9-8dd5-4db36acd544f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3108ea45-2b6c-40dc-af41-ff5d459c4710" xlink:to="loc_us-gaap_CreditFacilityAxis_96d36da0-521f-41b9-8dd5-4db36acd544f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b385b7f1-08ec-4d48-9dea-ca9b5afa545f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_96d36da0-521f-41b9-8dd5-4db36acd544f" xlink:to="loc_us-gaap_CreditFacilityDomain_b385b7f1-08ec-4d48-9dea-ca9b5afa545f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7d5605cd-da4c-4a12-852f-d640e7ebd0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b385b7f1-08ec-4d48-9dea-ca9b5afa545f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7d5605cd-da4c-4a12-852f-d640e7ebd0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3108ea45-2b6c-40dc-af41-ff5d459c4710" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7ee4827f-09d3-4094-9b4a-aa95f6c31dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7ee4827f-09d3-4094-9b4a-aa95f6c31dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_6490ceef-084f-4ca1-92a1-0da7be609baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_us-gaap_LineOfCredit_6490ceef-084f-4ca1-92a1-0da7be609baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_454d750d-6acf-4639-b1aa-cf42e7486c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_454d750d-6acf-4639-b1aa-cf42e7486c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LandlordReserves_3f239c1b-46a9-4571-8ae2-8f6046f77993" xlink:href="infu-20211231.xsd#infu_LandlordReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_infu_LandlordReserves_3f239c1b-46a9-4571-8ae2-8f6046f77993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_cde6ccc1-16e2-42b0-9c3c-9cfd3edda568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3caf4236-4845-407f-85e4-b4b6911425aa" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_cde6ccc1-16e2-42b0-9c3c-9cfd3edda568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofFutureMaturitiesofLoansDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dcff5991-c177-4ecc-9fd5-f8e34e95fb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fcb27ca9-c011-42c4-887a-ad025cccc0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dcff5991-c177-4ecc-9fd5-f8e34e95fb1d" xlink:to="loc_us-gaap_DebtInstrumentTable_fcb27ca9-c011-42c4-887a-ad025cccc0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0af42555-fe35-4f28-a93e-f7bea1acda5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fcb27ca9-c011-42c4-887a-ad025cccc0e4" xlink:to="loc_us-gaap_CreditFacilityAxis_0af42555-fe35-4f28-a93e-f7bea1acda5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2f778087-317a-4b4b-b8e3-7881157b69f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0af42555-fe35-4f28-a93e-f7bea1acda5e" xlink:to="loc_us-gaap_CreditFacilityDomain_2f778087-317a-4b4b-b8e3-7881157b69f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_22fe57aa-2f0b-4537-8555-73b905f90c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2f778087-317a-4b4b-b8e3-7881157b69f4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_22fe57aa-2f0b-4537-8555-73b905f90c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2becea2f-336c-4e1f-81e2-4c1109281d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fcb27ca9-c011-42c4-887a-ad025cccc0e4" xlink:to="loc_us-gaap_DebtInstrumentAxis_2becea2f-336c-4e1f-81e2-4c1109281d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2bfbf283-c860-4149-b6e4-f4f567c49056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2becea2f-336c-4e1f-81e2-4c1109281d22" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2bfbf283-c860-4149-b6e4-f4f567c49056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_1081f084-217f-4fe5-9a57-16ac3d357411" xlink:href="infu-20211231.xsd#infu_FinancingAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2bfbf283-c860-4149-b6e4-f4f567c49056" xlink:to="loc_infu_FinancingAgreementMember_1081f084-217f-4fe5-9a57-16ac3d357411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fcb27ca9-c011-42c4-887a-ad025cccc0e4" xlink:to="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e7411707-d327-4935-b981-c8d41a9c4f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e7411707-d327-4935-b981-c8d41a9c4f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_715b6990-d4c3-4df7-a52a-cf71fa279316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_715b6990-d4c3-4df7-a52a-cf71fa279316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1e46b834-3c26-43a1-88f9-5ec1eb4fdbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1e46b834-3c26-43a1-88f9-5ec1eb4fdbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_cf68e18c-6fd6-4e59-8884-aa412dfa953f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_cf68e18c-6fd6-4e59-8884-aa412dfa953f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_f7be76e4-3cca-4f5f-9cd9-25c69f115b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_f7be76e4-3cca-4f5f-9cd9-25c69f115b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_fa1d9694-6067-4390-b4f0-4594d4547125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_fa1d9694-6067-4390-b4f0-4594d4547125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f999e07d-a0e4-46fb-b7e4-e35917cbf4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73297d3d-f139-4b9c-995f-9c3dc83dbe7a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f999e07d-a0e4-46fb-b7e4-e35917cbf4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofCompanysCurrentandLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_17cf3989-b59b-40b9-875c-0e54087b76a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17cf3989-b59b-40b9-875c-0e54087b76a2" xlink:to="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_433cd300-196d-4e0e-8e60-0affedef513e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:to="loc_us-gaap_CreditFacilityAxis_433cd300-196d-4e0e-8e60-0affedef513e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f4cba27b-442a-4206-9920-cb55caeca4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_433cd300-196d-4e0e-8e60-0affedef513e" xlink:to="loc_us-gaap_CreditFacilityDomain_f4cba27b-442a-4206-9920-cb55caeca4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c28ff969-eb34-4aa9-90f6-c53e9b97ab49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f4cba27b-442a-4206-9920-cb55caeca4a3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c28ff969-eb34-4aa9-90f6-c53e9b97ab49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EquipmentLineMember_66bbdefb-23b2-4a21-bf66-5dac30564322" xlink:href="infu-20211231.xsd#infu_EquipmentLineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f4cba27b-442a-4206-9920-cb55caeca4a3" xlink:to="loc_infu_EquipmentLineMember_66bbdefb-23b2-4a21-bf66-5dac30564322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2019EquipmentLineMember_3e7e9499-352e-492c-8f76-16fb96198024" xlink:href="infu-20211231.xsd#infu_The2019EquipmentLineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f4cba27b-442a-4206-9920-cb55caeca4a3" xlink:to="loc_infu_The2019EquipmentLineMember_3e7e9499-352e-492c-8f76-16fb96198024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3dfe716e-f547-402a-8b65-23c98ff9ad4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3dfe716e-f547-402a-8b65-23c98ff9ad4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eda065e4-5f64-4012-94a7-47d6e1423624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3dfe716e-f547-402a-8b65-23c98ff9ad4c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eda065e4-5f64-4012-94a7-47d6e1423624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_TermLoanMember_81467378-7985-4c3f-b4bd-a7f429906207" xlink:href="infu-20211231.xsd#infu_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eda065e4-5f64-4012-94a7-47d6e1423624" xlink:to="loc_infu_TermLoanMember_81467378-7985-4c3f-b4bd-a7f429906207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f7172a8d-fa9c-40ca-ab8a-dcb7847182a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:to="loc_us-gaap_DebtInstrumentAxis_f7172a8d-fa9c-40ca-ab8a-dcb7847182a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_20dd9b5c-3f4f-4615-bf0c-bf3ee457b859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f7172a8d-fa9c-40ca-ab8a-dcb7847182a8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_20dd9b5c-3f4f-4615-bf0c-bf3ee457b859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_7f3eb4a9-2d40-467b-a775-ff1126c6e667" xlink:href="infu-20211231.xsd#infu_FinancingAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_20dd9b5c-3f4f-4615-bf0c-bf3ee457b859" xlink:to="loc_infu_FinancingAgreementMember_7f3eb4a9-2d40-467b-a775-ff1126c6e667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_48698571-c5ff-4573-abdc-2e86ee5fb8f2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongtermDebtGrossCurrent_cfdda8c8-be92-418d-9a31-0baab39ed444" xlink:href="infu-20211231.xsd#infu_LongtermDebtGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_infu_LongtermDebtGrossCurrent_cfdda8c8-be92-418d-9a31-0baab39ed444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtGrossNoncurrent_25ec466e-7d28-44ac-ba31-d1d6f51fbc8c" xlink:href="infu-20211231.xsd#infu_LongTermDebtGrossNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_infu_LongTermDebtGrossNoncurrent_25ec466e-7d28-44ac-ba31-d1d6f51fbc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e8634472-f9a7-4730-8772-dac0aa1a9b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e8634472-f9a7-4730-8772-dac0aa1a9b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_5e8a8f79-9c75-4570-b972-1b5fb06a9dd8" xlink:href="infu-20211231.xsd#infu_UnamortizedDebtIssuanceExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_5e8a8f79-9c75-4570-b972-1b5fb06a9dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_8ce61d17-2ee5-4ca8-9411-e01673d9ef1b" xlink:href="infu-20211231.xsd#infu_UnamortizedDebtIssuanceExpenseNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_8ce61d17-2ee5-4ca8-9411-e01673d9ef1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_8872d822-69c8-4573-a4d4-deaaef26c4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_8872d822-69c8-4573-a4d4-deaaef26c4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0d1b4d9c-1700-434a-8bc3-b4a17a96715c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_LongTermDebtCurrent_0d1b4d9c-1700-434a-8bc3-b4a17a96715c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_434f8b45-af01-4592-a765-1e9be8db95bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_434f8b45-af01-4592-a765-1e9be8db95bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2a4dce84-ef18-46df-a646-fbf85d9cbac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2211138a-40cb-49fe-a95d-fa1fa6158bd1" xlink:to="loc_us-gaap_LongTermDebt_2a4dce84-ef18-46df-a646-fbf85d9cbac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1" xlink:type="simple" xlink:href="infu-20211231.xsd#DebtSummaryofCompanysCurrentandLongtermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="infu-20211231.xsd#DerivativeFinancialInstrumentsandHedgingActivities"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2b73d1b7-3c6a-49a7-ae07-3508b49caf84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5ddb243d-f3bf-4fec-a02e-47ef953a69b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2b73d1b7-3c6a-49a7-ae07-3508b49caf84" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5ddb243d-f3bf-4fec-a02e-47ef953a69b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="infu-20211231.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1602a69d-cb3a-4d0c-b724-b5f628c8d1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f5aa6805-ce21-4255-ba47-54f85582746d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1602a69d-cb3a-4d0c-b724-b5f628c8d1c5" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f5aa6805-ce21-4255-ba47-54f85582746d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_71f4a8f6-e876-41c7-abdb-563bb214b8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1602a69d-cb3a-4d0c-b724-b5f628c8d1c5" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_71f4a8f6-e876-41c7-abdb-563bb214b8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d479ccaa-aa90-46fa-846f-d760b93cabb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d479ccaa-aa90-46fa-846f-d760b93cabb2" xlink:to="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9b435d7d-ba40-46fe-8e06-23be9e16fc05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9b435d7d-ba40-46fe-8e06-23be9e16fc05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1e8a15f4-461a-4d66-a828-98bd14dda934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9b435d7d-ba40-46fe-8e06-23be9e16fc05" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1e8a15f4-461a-4d66-a828-98bd14dda934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_85a52c5c-0235-40f2-a15f-09899fe02c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1e8a15f4-461a-4d66-a828-98bd14dda934" xlink:to="loc_us-gaap_InterestRateSwapMember_85a52c5c-0235-40f2-a15f-09899fe02c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0b470e93-473f-45ba-84ec-ec234b21002b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:to="loc_us-gaap_HedgingDesignationAxis_0b470e93-473f-45ba-84ec-ec234b21002b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_beee0ecb-41b4-45d3-b6e2-1b34501d404f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0b470e93-473f-45ba-84ec-ec234b21002b" xlink:to="loc_us-gaap_HedgingDesignationDomain_beee0ecb-41b4-45d3-b6e2-1b34501d404f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_dd423770-6787-4626-addf-cf1c79b28041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_beee0ecb-41b4-45d3-b6e2-1b34501d404f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_dd423770-6787-4626-addf-cf1c79b28041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fdd152-9870-4336-a851-65faabc941bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fdd152-9870-4336-a851-65faabc941bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_682c1ade-465b-4be7-8876-f8eff1421649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fdd152-9870-4336-a851-65faabc941bc" xlink:to="loc_us-gaap_HedgingRelationshipDomain_682c1ade-465b-4be7-8876-f8eff1421649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_526af988-96e7-4348-b1ac-b7d949481df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_682c1ade-465b-4be7-8876-f8eff1421649" xlink:to="loc_us-gaap_CashFlowHedgingMember_526af988-96e7-4348-b1ac-b7d949481df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c48686e0-74d6-4ddf-9ff3-4eadee3e46b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_24784938-b913-4dd6-844b-6ccbd905a9d5" xlink:to="loc_us-gaap_DerivativeLineItems_c48686e0-74d6-4ddf-9ff3-4eadee3e46b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_397c49ff-ac18-4c6f-bd89-4f62d2800749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c48686e0-74d6-4ddf-9ff3-4eadee3e46b1" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_397c49ff-ac18-4c6f-bd89-4f62d2800749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_7f6a5078-5b44-4ae1-8a22-693cf0f677d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c48686e0-74d6-4ddf-9ff3-4eadee3e46b1" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_7f6a5078-5b44-4ae1-8a22-693cf0f677d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3abeb89b-697d-4814-95dc-809f33739889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3abeb89b-697d-4814-95dc-809f33739889" xlink:to="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e5beb616-9af0-4785-9958-1bdabd6ace44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e5beb616-9af0-4785-9958-1bdabd6ace44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c013446c-cbd7-4a97-afa3-5388e3d0a9d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e5beb616-9af0-4785-9958-1bdabd6ace44" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c013446c-cbd7-4a97-afa3-5388e3d0a9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_14bf0916-2649-4071-be8f-4309b0b6f7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c013446c-cbd7-4a97-afa3-5388e3d0a9d0" xlink:to="loc_us-gaap_CashFlowHedgingMember_14bf0916-2649-4071-be8f-4309b0b6f7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f9d07c63-6c59-463a-9217-667253807a50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f9d07c63-6c59-463a-9217-667253807a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_337ab2cd-db17-4e8b-a404-2e18feee049d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f9d07c63-6c59-463a-9217-667253807a50" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_337ab2cd-db17-4e8b-a404-2e18feee049d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f1ef23d1-7759-4140-b4ad-a1345d0c6133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_337ab2cd-db17-4e8b-a404-2e18feee049d" xlink:to="loc_us-gaap_InterestRateSwapMember_f1ef23d1-7759-4140-b4ad-a1345d0c6133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_6b41661b-47de-4bc2-a262-1d4b421a8b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:to="loc_us-gaap_HedgingDesignationAxis_6b41661b-47de-4bc2-a262-1d4b421a8b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cb39b61f-1e17-4fb2-bc7b-84d3605660ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_6b41661b-47de-4bc2-a262-1d4b421a8b53" xlink:to="loc_us-gaap_HedgingDesignationDomain_cb39b61f-1e17-4fb2-bc7b-84d3605660ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3f6865e8-81d2-4d82-bef9-6a5dabf7d3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_cb39b61f-1e17-4fb2-bc7b-84d3605660ec" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3f6865e8-81d2-4d82-bef9-6a5dabf7d3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fdc1c066-c2f9-404a-bdc5-e990aa216cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fdc1c066-c2f9-404a-bdc5-e990aa216cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a695b079-3c9a-440d-a7e1-9d8217d8f61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fdc1c066-c2f9-404a-bdc5-e990aa216cd9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a695b079-3c9a-440d-a7e1-9d8217d8f61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_c6ec0b87-8577-474b-b1ab-5bc0c1c6ce37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a695b079-3c9a-440d-a7e1-9d8217d8f61a" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_c6ec0b87-8577-474b-b1ab-5bc0c1c6ce37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e94182db-18ca-4904-953c-92063c5df233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_81700f5b-b62c-4005-9d93-86b2225c3d54" xlink:to="loc_us-gaap_DerivativeLineItems_e94182db-18ca-4904-953c-92063c5df233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_1a82616f-58fd-4261-8a71-3b9339a82979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e94182db-18ca-4904-953c-92063c5df233" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_1a82616f-58fd-4261-8a71-3b9339a82979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_ebc1f4ea-396d-431e-8877-e20d20163f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e94182db-18ca-4904-953c-92063c5df233" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_ebc1f4ea-396d-431e-8877-e20d20163f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f58e4d85-5cd8-455e-a5d8-f9bc2fc33664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f58e4d85-5cd8-455e-a5d8-f9bc2fc33664" xlink:to="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_74a9889a-1c7b-4cb2-9019-c6cdabb2148c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_74a9889a-1c7b-4cb2-9019-c6cdabb2148c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b2e95413-29f0-409f-8e7f-4b1891b814ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74a9889a-1c7b-4cb2-9019-c6cdabb2148c" xlink:to="loc_us-gaap_EquityComponentDomain_b2e95413-29f0-409f-8e7f-4b1891b814ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15428dcd-ab90-41e0-a519-1c13c1e609bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b2e95413-29f0-409f-8e7f-4b1891b814ef" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15428dcd-ab90-41e0-a519-1c13c1e609bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_05c20d7a-cb29-41b8-b1cb-64429d473afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_05c20d7a-cb29-41b8-b1cb-64429d473afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_35e02f43-a73e-4a30-8b87-9918e1635530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_05c20d7a-cb29-41b8-b1cb-64429d473afe" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_35e02f43-a73e-4a30-8b87-9918e1635530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1d1d10e9-1074-4141-9f05-987b2256ec59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_35e02f43-a73e-4a30-8b87-9918e1635530" xlink:to="loc_us-gaap_InterestRateSwapMember_1d1d10e9-1074-4141-9f05-987b2256ec59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9249678-d439-4c84-87d0-84b5e77a9c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9249678-d439-4c84-87d0-84b5e77a9c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ff420689-74f3-4c12-ba3c-2f872c5c7a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9249678-d439-4c84-87d0-84b5e77a9c20" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ff420689-74f3-4c12-ba3c-2f872c5c7a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_437d5bbe-c125-4e78-8cdf-2adb3446cdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ff420689-74f3-4c12-ba3c-2f872c5c7a5b" xlink:to="loc_us-gaap_CashFlowHedgingMember_437d5bbe-c125-4e78-8cdf-2adb3446cdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_56791a30-d028-404a-84b4-a12cf3bb4e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:to="loc_us-gaap_HedgingDesignationAxis_56791a30-d028-404a-84b4-a12cf3bb4e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f950c6ed-c5c0-424c-bd92-16e6380bcbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_56791a30-d028-404a-84b4-a12cf3bb4e10" xlink:to="loc_us-gaap_HedgingDesignationDomain_f950c6ed-c5c0-424c-bd92-16e6380bcbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fc589750-c40e-4e4b-a486-fd0b8329d0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f950c6ed-c5c0-424c-bd92-16e6380bcbe5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fc589750-c40e-4e4b-a486-fd0b8329d0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6350512e-91da-4bcf-8fdb-3fcb9488bab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_88c8f720-4e83-42f9-8e06-746f3c2208c5" xlink:to="loc_us-gaap_DerivativeLineItems_6350512e-91da-4bcf-8fdb-3fcb9488bab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6350512e-91da-4bcf-8fdb-3fcb9488bab3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_32cafb3e-8bd6-4157-ba00-e0c2dc9b76dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:to="loc_us-gaap_StockholdersEquity_32cafb3e-8bd6-4157-ba00-e0c2dc9b76dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_74487dd0-e8a4-45af-a776-1d56502ffe20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_74487dd0-e8a4-45af-a776-1d56502ffe20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_39fb4594-314c-4614-b8a7-68a6d2dd0a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_39fb4594-314c-4614-b8a7-68a6d2dd0a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_ab7cb71b-bf49-4729-b647-e3fcdadba1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_ab7cb71b-bf49-4729-b647-e3fcdadba1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b7e165df-b28e-40c2-99db-26cd05ad83d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba2cbc7e-7ad2-4755-8fa6-e81ec859b597" xlink:to="loc_us-gaap_StockholdersEquity_b7e165df-b28e-40c2-99db-26cd05ad83d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7c7dc01a-4067-4882-abb8-d795dfd0a8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6350512e-91da-4bcf-8fdb-3fcb9488bab3" xlink:to="loc_us-gaap_InterestExpense_7c7dc01a-4067-4882-abb8-d795dfd0a8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_f9222efb-dea1-4db6-bc23-5c0071902e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6350512e-91da-4bcf-8fdb-3fcb9488bab3" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_f9222efb-dea1-4db6-bc23-5c0071902e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxes" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_42971325-a28e-480c-bdfa-4fd8f377f485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_307c28e8-3e3b-4714-a4ab-ab89c6e9ce61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_42971325-a28e-480c-bdfa-4fd8f377f485" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_307c28e8-3e3b-4714-a4ab-ab89c6e9ce61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1fbe624f-d66d-4bf1-9b4b-0fc907057856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b17a48c3-6eff-4be9-8436-42c90ffffde6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1fbe624f-d66d-4bf1-9b4b-0fc907057856" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b17a48c3-6eff-4be9-8436-42c90ffffde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_287c4bdb-bb4a-4209-a998-4b194ef3d99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1fbe624f-d66d-4bf1-9b4b-0fc907057856" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_287c4bdb-bb4a-4209-a998-4b194ef3d99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_2e398082-5d82-48d1-b79b-ae0984f0c285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1fbe624f-d66d-4bf1-9b4b-0fc907057856" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_2e398082-5d82-48d1-b79b-ae0984f0c285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8c02c47a-26ec-4487-8877-212cd836b526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1fbe624f-d66d-4bf1-9b4b-0fc907057856" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8c02c47a-26ec-4487-8877-212cd836b526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ebe717c0-e859-47d8-888e-925c938fa42a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1fbe624f-d66d-4bf1-9b4b-0fc907057856" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ebe717c0-e859-47d8-888e-925c938fa42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7ef3cc19-4510-40ea-a650-5e2d44d8545b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7ef3cc19-4510-40ea-a650-5e2d44d8545b" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_61b433c6-d37e-4e47-b223-b21821b5ee81" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:to="loc_srt_RangeAxis_61b433c6-d37e-4e47-b223-b21821b5ee81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c3a6ba3a-afbe-41c1-9894-da20b1e5de18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_61b433c6-d37e-4e47-b223-b21821b5ee81" xlink:to="loc_srt_RangeMember_c3a6ba3a-afbe-41c1-9894-da20b1e5de18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a4dd2e9f-1f3d-4a8d-81a9-d02a9aa7d0f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c3a6ba3a-afbe-41c1-9894-da20b1e5de18" xlink:to="loc_srt_MaximumMember_a4dd2e9f-1f3d-4a8d-81a9-d02a9aa7d0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_74a558a3-3f0e-42d8-87e9-9735a9eaa17a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c3a6ba3a-afbe-41c1-9894-da20b1e5de18" xlink:to="loc_srt_MinimumMember_74a558a3-3f0e-42d8-87e9-9735a9eaa17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8d188a99-6387-4f60-a604-0a6ee1da217d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8d188a99-6387-4f60-a604-0a6ee1da217d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_049bdfaa-113e-4f3a-9e9b-2304277e156c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8d188a99-6387-4f60-a604-0a6ee1da217d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_049bdfaa-113e-4f3a-9e9b-2304277e156c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_55838384-6def-4b13-8ded-0545b7f493bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_049bdfaa-113e-4f3a-9e9b-2304277e156c" xlink:to="loc_us-gaap_OtherLiabilitiesMember_55838384-6def-4b13-8ded-0545b7f493bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_d092dcd9-5337-498a-8d2f-d38bec07efa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_d092dcd9-5337-498a-8d2f-d38bec07efa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d0e5a6dc-d5df-4ad0-a4be-62f0aa3ef0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_d092dcd9-5337-498a-8d2f-d38bec07efa8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d0e5a6dc-d5df-4ad0-a4be-62f0aa3ef0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_5aaaf7d3-3d9c-44dc-9377-9bcb98912804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d0e5a6dc-d5df-4ad0-a4be-62f0aa3ef0ab" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_5aaaf7d3-3d9c-44dc-9377-9bcb98912804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b5c32cb1-ee8d-48de-b64e-386494aa1e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d0e5a6dc-d5df-4ad0-a4be-62f0aa3ef0ab" xlink:to="loc_us-gaap_DomesticCountryMember_b5c32cb1-ee8d-48de-b64e-386494aa1e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_47da06dc-3a0a-4812-934f-ca22e31600af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:to="loc_us-gaap_DebtInstrumentAxis_47da06dc-3a0a-4812-934f-ca22e31600af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8ca420ca-e9aa-4776-8269-0986139c8440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_47da06dc-3a0a-4812-934f-ca22e31600af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8ca420ca-e9aa-4776-8269-0986139c8440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaycheckProtectionProgramCaresActMember_6e6ec414-ca31-41dd-a84d-4ea203383c82" xlink:href="infu-20211231.xsd#infu_PaycheckProtectionProgramCaresActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8ca420ca-e9aa-4776-8269-0986139c8440" xlink:to="loc_infu_PaycheckProtectionProgramCaresActMember_6e6ec414-ca31-41dd-a84d-4ea203383c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_9243f46f-1a34-4871-8787-b71de7eb16d7" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_54afadd0-4bfb-4700-950a-b3a6d90c772b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_OperatingLossCarryforwards_54afadd0-4bfb-4700-950a-b3a6d90c772b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f449f5bb-79b4-4010-b3f3-e3abc4f1c1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f449f5bb-79b4-4010-b3f3-e3abc4f1c1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OperatingLossCarryforwardsWithADefiniteLife_574ebb09-826a-4213-bf6f-18ede346a5e2" xlink:href="infu-20211231.xsd#infu_OperatingLossCarryforwardsWithADefiniteLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_infu_OperatingLossCarryforwardsWithADefiniteLife_574ebb09-826a-4213-bf6f-18ede346a5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OperatingLossCarryforwardsWithIndefiniteLife_d04dddb0-eb35-4493-bca6-d11b549bb1aa" xlink:href="infu-20211231.xsd#infu_OperatingLossCarryforwardsWithIndefiniteLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_infu_OperatingLossCarryforwardsWithIndefiniteLife_d04dddb0-eb35-4493-bca6-d11b549bb1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OperatingLossCarryforwardsExpirationPeriods_a6147115-50bb-414d-aed9-d6ba8396533f" xlink:href="infu-20211231.xsd#infu_OperatingLossCarryforwardsExpirationPeriods"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_infu_OperatingLossCarryforwardsExpirationPeriods_a6147115-50bb-414d-aed9-d6ba8396533f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_NetOperatingLossCarryforwardsLimitationOnUse_f3e7a70d-767f-47d1-bd9b-a831306d155e" xlink:href="infu-20211231.xsd#infu_NetOperatingLossCarryforwardsLimitationOnUse"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_infu_NetOperatingLossCarryforwardsLimitationOnUse_f3e7a70d-767f-47d1-bd9b-a831306d155e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RemainingPreownershipNetOperatingLossCarryforwards_7b4806fc-19bc-4665-88e9-fbc761b06477" xlink:href="infu-20211231.xsd#infu_RemainingPreownershipNetOperatingLossCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_infu_RemainingPreownershipNetOperatingLossCarryforwards_7b4806fc-19bc-4665-88e9-fbc761b06477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_cca622b8-0878-44c3-a171-e7654a885d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_cca622b8-0878-44c3-a171-e7654a885d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7abd12b3-24f6-45a7-8e95-fc1b4a412a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7abd12b3-24f6-45a7-8e95-fc1b4a412a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_a0f9ca64-bd04-4c78-9c5a-2301c04552c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_a0f9ca64-bd04-4c78-9c5a-2301c04552c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4825d4b2-7089-4a69-abb2-fd4cc5928bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_81f15494-17f7-4f85-b7da-6616435f3401" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_4825d4b2-7089-4a69-abb2-fd4cc5928bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d01c7b13-ada1-4708-80e7-05a9f21f18fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7525f284-4d7d-48bb-876b-e2777209fa47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d01c7b13-ada1-4708-80e7-05a9f21f18fe" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7525f284-4d7d-48bb-876b-e2777209fa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7e74c9ba-98ce-40c8-8876-47bc7803b1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d01c7b13-ada1-4708-80e7-05a9f21f18fe" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7e74c9ba-98ce-40c8-8876-47bc7803b1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_53111792-7f3d-42d1-83a3-fcfcc9e7556d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d01c7b13-ada1-4708-80e7-05a9f21f18fe" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_53111792-7f3d-42d1-83a3-fcfcc9e7556d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesComponentsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesComponentsDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/IncomeTaxesComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fa977575-be68-4aee-bc56-6a883adba8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_30133e37-782d-43d6-ac59-56a9b86cf448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fa977575-be68-4aee-bc56-6a883adba8f5" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_30133e37-782d-43d6-ac59-56a9b86cf448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_718d9884-f9c6-4893-9080-51f52f14cb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_30133e37-782d-43d6-ac59-56a9b86cf448" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_718d9884-f9c6-4893-9080-51f52f14cb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d85cb7d6-7f7d-47e4-9cb4-e20e0f179f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_30133e37-782d-43d6-ac59-56a9b86cf448" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d85cb7d6-7f7d-47e4-9cb4-e20e0f179f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_9eef0a9b-9ec7-4a18-9912-b15f051e34a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_30133e37-782d-43d6-ac59-56a9b86cf448" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_9eef0a9b-9ec7-4a18-9912-b15f051e34a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_32f6e32b-8262-422d-ad82-5c1e1d1ea5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fa977575-be68-4aee-bc56-6a883adba8f5" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_32f6e32b-8262-422d-ad82-5c1e1d1ea5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_5adcb1b4-0c95-46bc-a99e-50c9b386909f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_32f6e32b-8262-422d-ad82-5c1e1d1ea5f9" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_5adcb1b4-0c95-46bc-a99e-50c9b386909f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_026e6872-7e16-49cc-bb97-12887e09946b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_32f6e32b-8262-422d-ad82-5c1e1d1ea5f9" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_026e6872-7e16-49cc-bb97-12887e09946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_165764a2-ed04-4783-a322-7f632e51794e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_32f6e32b-8262-422d-ad82-5c1e1d1ea5f9" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_165764a2-ed04-4783-a322-7f632e51794e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_d10909b9-e26f-4608-8fc7-7c08a9bf14e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fa977575-be68-4aee-bc56-6a883adba8f5" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_d10909b9-e26f-4608-8fc7-7c08a9bf14e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9f22cb08-96e9-48d0-b053-fa465f1b7275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_d10909b9-e26f-4608-8fc7-7c08a9bf14e3" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9f22cb08-96e9-48d0-b053-fa465f1b7275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d4326ab9-a447-4d2f-b964-8835d882d59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fa977575-be68-4aee-bc56-6a883adba8f5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d4326ab9-a447-4d2f-b964-8835d882d59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesValuationAllowanceDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesValuationAllowanceDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/IncomeTaxesValuationAllowanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0e05cde0-f4f0-4086-9bef-ab6988a020cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_682d8d8c-2560-4b11-bbd3-d96b2f3c0142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0e05cde0-f4f0-4086-9bef-ab6988a020cf" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_682d8d8c-2560-4b11-bbd3-d96b2f3c0142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxAssetsValuationAllowanceExpense_7019e33c-db8a-4a42-8de2-ad24a85e9268" xlink:href="infu-20211231.xsd#infu_DeferredTaxAssetsValuationAllowanceExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0e05cde0-f4f0-4086-9bef-ab6988a020cf" xlink:to="loc_infu_DeferredTaxAssetsValuationAllowanceExpense_7019e33c-db8a-4a42-8de2-ad24a85e9268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxAssetsValuationAllowanceIncrease_de7b1327-5dc8-4cf8-aa18-c855bd5d39d8" xlink:href="infu-20211231.xsd#infu_DeferredTaxAssetsValuationAllowanceIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0e05cde0-f4f0-4086-9bef-ab6988a020cf" xlink:to="loc_infu_DeferredTaxAssetsValuationAllowanceIncrease_de7b1327-5dc8-4cf8-aa18-c855bd5d39d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxAssetsValuationAllowanceRelease_681fb7ed-b0fd-4bd5-8e01-fe1bcd12607a" xlink:href="infu-20211231.xsd#infu_DeferredTaxAssetsValuationAllowanceRelease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0e05cde0-f4f0-4086-9bef-ab6988a020cf" xlink:to="loc_infu_DeferredTaxAssetsValuationAllowanceRelease_681fb7ed-b0fd-4bd5-8e01-fe1bcd12607a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5c2bb2ed-2911-462e-a124-425c16d2dffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0e05cde0-f4f0-4086-9bef-ab6988a020cf" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5c2bb2ed-2911-462e-a124-425c16d2dffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesEffectiveTaxRateDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f8785e60-ebf3-4da9-990e-3eb43d851339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_f6ca194f-087a-4905-8cfc-357b52513f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8785e60-ebf3-4da9-990e-3eb43d851339" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_f6ca194f-087a-4905-8cfc-357b52513f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b973fc93-f00b-418a-b5d5-c3391ccc406e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8785e60-ebf3-4da9-990e-3eb43d851339" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b973fc93-f00b-418a-b5d5-c3391ccc406e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_93a9ee71-69a1-4b2a-a389-57ba9101063e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8785e60-ebf3-4da9-990e-3eb43d851339" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_93a9ee71-69a1-4b2a-a389-57ba9101063e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_33f5c26b-9d29-462e-b77e-af0030fab059" xlink:href="infu-20211231.xsd#infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8785e60-ebf3-4da9-990e-3eb43d851339" xlink:to="loc_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_33f5c26b-9d29-462e-b77e-af0030fab059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_9d87d223-e288-4c6e-9905-33b89b7b1b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8785e60-ebf3-4da9-990e-3eb43d851339" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_9d87d223-e288-4c6e-9905-33b89b7b1b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2a289ad5-e4e0-430f-95d5-45e8e2326c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8785e60-ebf3-4da9-990e-3eb43d851339" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2a289ad5-e4e0-430f-95d5-45e8e2326c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1b2ea27c-c4fd-4e58-b2a1-ccb6042204db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8785e60-ebf3-4da9-990e-3eb43d851339" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1b2ea27c-c4fd-4e58-b2a1-ccb6042204db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesCarryForwardsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#IncomeTaxesCarryForwardsDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/IncomeTaxesCarryForwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f75baeb5-f81d-4e61-a1a6-2d242dd32c16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_9b61522c-df7f-4633-b07c-1b2e8a676e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f75baeb5-f81d-4e61-a1a6-2d242dd32c16" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_9b61522c-df7f-4633-b07c-1b2e8a676e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8ed1de6e-8974-4495-9f6b-5b5373e94e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_9b61522c-df7f-4633-b07c-1b2e8a676e9d" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8ed1de6e-8974-4495-9f6b-5b5373e94e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_298e7ed0-1a87-43d6-a2ad-371c99e867c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8ed1de6e-8974-4495-9f6b-5b5373e94e69" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_298e7ed0-1a87-43d6-a2ad-371c99e867c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_65ca1256-1d11-4a87-b4e0-4ee7dc459b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_298e7ed0-1a87-43d6-a2ad-371c99e867c5" xlink:to="loc_us-gaap_DomesticCountryMember_65ca1256-1d11-4a87-b4e0-4ee7dc459b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_0bb296de-e944-4978-8986-11594d75ab0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_298e7ed0-1a87-43d6-a2ad-371c99e867c5" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_0bb296de-e944-4978-8986-11594d75ab0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_9b61522c-df7f-4633-b07c-1b2e8a676e9d" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_143c7f53-6062-49b8-b6f1-df0007ca15b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_143c7f53-6062-49b8-b6f1-df0007ca15b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_307fc2e4-9cfe-414c-a6e3-032862f31ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_307fc2e4-9cfe-414c-a6e3-032862f31ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f74e9c01-3307-448e-984b-32c048a0efa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f74e9c01-3307-448e-984b-32c048a0efa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxAssetsOperatingLeaseLiabilities_76d9f594-d64b-4e85-b62f-dcb70916a6e7" xlink:href="infu-20211231.xsd#infu_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_infu_DeferredTaxAssetsOperatingLeaseLiabilities_76d9f594-d64b-4e85-b62f-dcb70916a6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_5716dcb7-db4d-42c0-87ee-650b59763d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_5716dcb7-db4d-42c0-87ee-650b59763d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_dff09989-14cb-4114-91f3-e37171997a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_dff09989-14cb-4114-91f3-e37171997a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_4dc797c9-93b9-4677-9a63-bcc911595b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_4dc797c9-93b9-4677-9a63-bcc911595b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_d5d1b250-c9ed-471c-971d-e3f903196b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_d5d1b250-c9ed-471c-971d-e3f903196b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther_d98698f7-9d4e-45a8-a841-63e8a2a7a22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther_d98698f7-9d4e-45a8-a841-63e8a2a7a22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_7dadeb18-5305-40ea-a34d-00b5966f09ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_7dadeb18-5305-40ea-a34d-00b5966f09ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_49c0b4e7-0af6-42f5-a49e-c023f49a64c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_49c0b4e7-0af6-42f5-a49e-c023f49a64c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_effe689a-2b34-4f95-a6d7-fc687c0c7bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_effe689a-2b34-4f95-a6d7-fc687c0c7bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DeferredTaxLiabilitiesRightOfUseAssets_2ca55bce-8251-4714-b0be-55b25ef7ac60" xlink:href="infu-20211231.xsd#infu_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_infu_DeferredTaxLiabilitiesRightOfUseAssets_2ca55bce-8251-4714-b0be-55b25ef7ac60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_8a026c25-bee5-4034-a7bd-7d2c04fa849e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_8a026c25-bee5-4034-a7bd-7d2c04fa849e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c381d071-fb92-442b-8c25-9b061b55bc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_c381d071-fb92-442b-8c25-9b061b55bc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_494c6e94-7fae-43a9-95f9-8da949dcc9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_416a113a-faae-4655-aa35-8fb9e99fc42d" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_494c6e94-7fae-43a9-95f9-8da949dcc9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="infu-20211231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a4599b60-08be-47e1-8f92-6a480d0ba06f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65b92e17-b9e3-42b3-86d6-b4d78fda4a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a4599b60-08be-47e1-8f92-6a480d0ba06f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65b92e17-b9e3-42b3-86d6-b4d78fda4a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/Leases" xlink:type="simple" xlink:href="infu-20211231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1ab741c5-a34b-4215-b179-bfb15386048d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_3554a30e-b8ab-40f0-82f2-0780a4e80c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1ab741c5-a34b-4215-b179-bfb15386048d" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_3554a30e-b8ab-40f0-82f2-0780a4e80c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesTables" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a71d62e7-6383-49ff-ac5c-41952d49bbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_255e894a-b40a-477d-9bbb-9310342b2bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a71d62e7-6383-49ff-ac5c-41952d49bbb4" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_255e894a-b40a-477d-9bbb-9310342b2bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8cdca6f5-a6b8-43ac-afb0-09fe106264f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a71d62e7-6383-49ff-ac5c-41952d49bbb4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8cdca6f5-a6b8-43ac-afb0-09fe106264f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesDetailsTextual" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7a9a0363-fc46-4e17-a865-40be81fcf8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4a0c0337-7d9f-42c9-9f31-c18e86fc71ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7a9a0363-fc46-4e17-a865-40be81fcf8ce" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4a0c0337-7d9f-42c9-9f31-c18e86fc71ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0343b405-5300-4709-95cb-169cf12e3d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4a0c0337-7d9f-42c9-9f31-c18e86fc71ea" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0343b405-5300-4709-95cb-169cf12e3d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1584232c-07e7-4b5d-ad55-c5cb3e8bc950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0343b405-5300-4709-95cb-169cf12e3d9d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1584232c-07e7-4b5d-ad55-c5cb3e8bc950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e812a7ba-9a91-42ea-a7b9-c9fdc427b981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1584232c-07e7-4b5d-ad55-c5cb3e8bc950" xlink:to="loc_us-gaap_CostOfSalesMember_e812a7ba-9a91-42ea-a7b9-c9fdc427b981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_59df98f2-41f5-4c2b-8bf5-6c35106c62d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1584232c-07e7-4b5d-ad55-c5cb3e8bc950" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_59df98f2-41f5-4c2b-8bf5-6c35106c62d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e52764ee-00e9-4c95-8df6-a6382d9f36df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4a0c0337-7d9f-42c9-9f31-c18e86fc71ea" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_e52764ee-00e9-4c95-8df6-a6382d9f36df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_5a1e8f8a-22e1-4b13-8fda-bec046ac3fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e52764ee-00e9-4c95-8df6-a6382d9f36df" xlink:to="loc_us-gaap_LeaseCost_5a1e8f8a-22e1-4b13-8fda-bec046ac3fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5f660394-f562-450a-a0ae-3756ca194476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_8994f86d-accf-4080-a117-fa5bbad1b1db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5f660394-f562-450a-a0ae-3756ca194476" xlink:to="loc_us-gaap_OperatingLeaseCost_8994f86d-accf-4080-a117-fa5bbad1b1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_4328baad-2d3b-47ac-98ec-657251463e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5f660394-f562-450a-a0ae-3756ca194476" xlink:to="loc_us-gaap_VariableLeaseCost_4328baad-2d3b-47ac-98ec-657251463e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_af55c2e4-4639-46ba-8bb9-661e76bc671f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5f660394-f562-450a-a0ae-3756ca194476" xlink:to="loc_us-gaap_LeaseCost_af55c2e4-4639-46ba-8bb9-661e76bc671f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesSupplementalCashFlowDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesSupplementalCashFlowDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesSupplementalCashFlowDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ad5fec87-6664-4342-ae81-4716f2f16489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_bb9f120a-d06d-4f86-a50d-ebcd030d4842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ad5fec87-6664-4342-ae81-4716f2f16489" xlink:to="loc_us-gaap_OperatingLeasePayments_bb9f120a-d06d-4f86-a50d-ebcd030d4842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_47cd538e-40c4-4125-b733-a7e9f750e44d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ad5fec87-6664-4342-ae81-4716f2f16489" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_47cd538e-40c4-4125-b733-a7e9f750e44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations_49148aeb-ffcc-4c08-a4df-e499694b2523" xlink:href="infu-20211231.xsd#infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ad5fec87-6664-4342-ae81-4716f2f16489" xlink:to="loc_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations_49148aeb-ffcc-4c08-a4df-e499694b2523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesWeightedAverageTableDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesWeightedAverageTableDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesWeightedAverageTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3866fcd0-a6bf-456b-9cae-3761bc50a8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f683d6a4-a908-4034-bf88-f9d01fd3f5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3866fcd0-a6bf-456b-9cae-3761bc50a8ce" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f683d6a4-a908-4034-bf88-f9d01fd3f5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_88c51455-aa13-43f9-ab93-ffa3e2965f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3866fcd0-a6bf-456b-9cae-3761bc50a8ce" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_88c51455-aa13-43f9-ab93-ffa3e2965f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bbec2cdb-a0b9-4c74-9261-1da809311f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_dbd3c94d-1fb4-44b3-aaf1-6a087fd4b4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbec2cdb-a0b9-4c74-9261-1da809311f3e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_dbd3c94d-1fb4-44b3-aaf1-6a087fd4b4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a70217ef-e8df-4297-892d-e98297a89068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbec2cdb-a0b9-4c74-9261-1da809311f3e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a70217ef-e8df-4297-892d-e98297a89068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_66e03c87-e677-4516-a883-c4a844685b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbec2cdb-a0b9-4c74-9261-1da809311f3e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_66e03c87-e677-4516-a883-c4a844685b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_54e8bf58-09f8-4248-9f8f-885670ac5bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbec2cdb-a0b9-4c74-9261-1da809311f3e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_54e8bf58-09f8-4248-9f8f-885670ac5bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6ea9e0e7-5c92-4990-8ab2-0c9809a4acbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbec2cdb-a0b9-4c74-9261-1da809311f3e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6ea9e0e7-5c92-4990-8ab2-0c9809a4acbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_feb7c68c-c272-42bd-8c5c-9a6a9450b52d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbec2cdb-a0b9-4c74-9261-1da809311f3e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_feb7c68c-c272-42bd-8c5c-9a6a9450b52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6b03562-0119-446d-8070-1aa265fad2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbec2cdb-a0b9-4c74-9261-1da809311f3e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c6b03562-0119-446d-8070-1aa265fad2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_28bddbf7-fb05-4056-98d6-89fe8888e767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbec2cdb-a0b9-4c74-9261-1da809311f3e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_28bddbf7-fb05-4056-98d6-89fe8888e767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_798d4ed6-95c5-4282-bbf2-9b95f71bade7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bbec2cdb-a0b9-4c74-9261-1da809311f3e" xlink:to="loc_us-gaap_OperatingLeaseLiability_798d4ed6-95c5-4282-bbf2-9b95f71bade7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="infu-20211231.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensation" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensation"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SharebasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_66a2bb5e-8d46-4ab5-959f-319cb8624ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_cb8b14f1-00ed-423e-b073-feb99b167129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_66a2bb5e-8d46-4ab5-959f-319cb8624ce2" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_cb8b14f1-00ed-423e-b073-feb99b167129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationTables" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SharebasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f75584fd-408c-4669-a363-0c72c755e101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_4c715b97-17b3-4538-8954-4aa5cf358937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f75584fd-408c-4669-a363-0c72c755e101" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_4c715b97-17b3-4538-8954-4aa5cf358937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_0c38368a-3266-491a-b0dc-91f30071dbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f75584fd-408c-4669-a363-0c72c755e101" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_0c38368a-3266-491a-b0dc-91f30071dbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_82e7a435-befd-4c9f-bb10-c747cd2dcaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f75584fd-408c-4669-a363-0c72c755e101" xlink:to="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_82e7a435-befd-4c9f-bb10-c747cd2dcaf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_bb3aaa88-2a28-4914-a974-469f2e795194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f75584fd-408c-4669-a363-0c72c755e101" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_bb3aaa88-2a28-4914-a974-469f2e795194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_683b04a9-b8ac-4aea-b870-dd4a03a43cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f75584fd-408c-4669-a363-0c72c755e101" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_683b04a9-b8ac-4aea-b870-dd4a03a43cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_34c59d68-4505-46c3-b982-f29f5a62ae95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f75584fd-408c-4669-a363-0c72c755e101" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_34c59d68-4505-46c3-b982-f29f5a62ae95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SharebasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_de5d8804-b035-4714-a472-8ee41eb87dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_de5d8804-b035-4714-a472-8ee41eb87dae" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5c4cfedd-9997-49c3-aaee-9e33ebb17398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:to="loc_us-gaap_AwardTypeAxis_5c4cfedd-9997-49c3-aaee-9e33ebb17398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_940606e2-8e66-40b6-9d1a-8d4bd25d7de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5c4cfedd-9997-49c3-aaee-9e33ebb17398" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_940606e2-8e66-40b6-9d1a-8d4bd25d7de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_8448eb0d-e272-4fa4-91a2-5a0d01a324d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_940606e2-8e66-40b6-9d1a-8d4bd25d7de5" xlink:to="loc_us-gaap_RestrictedStockMember_8448eb0d-e272-4fa4-91a2-5a0d01a324d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_5ccd6954-e231-492e-b2e0-91fd9c33be0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_940606e2-8e66-40b6-9d1a-8d4bd25d7de5" xlink:to="loc_us-gaap_PerformanceSharesMember_5ccd6954-e231-492e-b2e0-91fd9c33be0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2bb93a28-c4fe-4cc1-bb16-616d582425ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_940606e2-8e66-40b6-9d1a-8d4bd25d7de5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2bb93a28-c4fe-4cc1-bb16-616d582425ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_5ad86511-66de-45ca-ba14-b99ad6b4e61d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:to="loc_us-gaap_VestingAxis_5ad86511-66de-45ca-ba14-b99ad6b4e61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_5287df59-1e89-4415-a98f-9334b3f18ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_5ad86511-66de-45ca-ba14-b99ad6b4e61d" xlink:to="loc_us-gaap_VestingDomain_5287df59-1e89-4415-a98f-9334b3f18ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember_ccf5f9e8-8b3c-41ba-a370-4d1dd67e5200" xlink:href="infu-20211231.xsd#infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_5287df59-1e89-4415-a98f-9334b3f18ca6" xlink:to="loc_infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember_ccf5f9e8-8b3c-41ba-a370-4d1dd67e5200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember_eb6795b5-a3bb-4941-95d9-028fcd543fd4" xlink:href="infu-20211231.xsd#infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_5287df59-1e89-4415-a98f-9334b3f18ca6" xlink:to="loc_infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember_eb6795b5-a3bb-4941-95d9-028fcd543fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5632fc27-cc8a-434b-a0cc-0ce7d1f1bdd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:to="loc_us-gaap_PlanNameAxis_5632fc27-cc8a-434b-a0cc-0ce7d1f1bdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f13d4a05-d14f-4a82-9223-954cdbbcce35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5632fc27-cc8a-434b-a0cc-0ce7d1f1bdd0" xlink:to="loc_us-gaap_PlanNameDomain_f13d4a05-d14f-4a82-9223-954cdbbcce35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_A2021EquityIncentivePlanMember_cfee9923-645c-4111-b109-ba42fe2cc8a3" xlink:href="infu-20211231.xsd#infu_A2021EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f13d4a05-d14f-4a82-9223-954cdbbcce35" xlink:to="loc_infu_A2021EquityIncentivePlanMember_cfee9923-645c-4111-b109-ba42fe2cc8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_A2014EquityIncentivePlanMember_78926923-3983-4c1c-bd8a-474b4198cf06" xlink:href="infu-20211231.xsd#infu_A2014EquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f13d4a05-d14f-4a82-9223-954cdbbcce35" xlink:to="loc_infu_A2014EquityIncentivePlanMember_78926923-3983-4c1c-bd8a-474b4198cf06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd7af82b-a24f-4078-ace3-bcc04c44c423" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:to="loc_srt_RangeAxis_dd7af82b-a24f-4078-ace3-bcc04c44c423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5af31b0b-7079-4db4-9f3c-b09e46d42805" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd7af82b-a24f-4078-ace3-bcc04c44c423" xlink:to="loc_srt_RangeMember_5af31b0b-7079-4db4-9f3c-b09e46d42805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1fd28778-8285-4dbf-9e74-319eb96c1ff7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5af31b0b-7079-4db4-9f3c-b09e46d42805" xlink:to="loc_srt_MinimumMember_1fd28778-8285-4dbf-9e74-319eb96c1ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_35dd6e7f-b0a2-461f-b9f1-0c02a0316c81" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5af31b0b-7079-4db4-9f3c-b09e46d42805" xlink:to="loc_srt_MaximumMember_35dd6e7f-b0a2-461f-b9f1-0c02a0316c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ae3eb7c-67b4-427a-984c-950ecfd24710" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_288fbb05-d477-4cd3-8398-91b9be0ada34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_288fbb05-d477-4cd3-8398-91b9be0ada34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_04791cf0-228e-4386-b80a-89d61a2e9f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_04791cf0-228e-4386-b80a-89d61a2e9f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_5f92ca4b-59d5-4f72-b15b-5df7c909bf71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_5f92ca4b-59d5-4f72-b15b-5df7c909bf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_fadfe7ce-e91c-493a-879e-79a5781ce05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_fadfe7ce-e91c-493a-879e-79a5781ce05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e9d7f3fa-2d69-4439-9052-e327b8e3ab18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e9d7f3fa-2d69-4439-9052-e327b8e3ab18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_5fa43b9e-007f-4f3f-9cfe-19f06bebc5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_5fa43b9e-007f-4f3f-9cfe-19f06bebc5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77f1af40-88b1-433a-9f61-d5eeb5624be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77f1af40-88b1-433a-9f61-d5eeb5624be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b37a97a5-561e-425e-81b8-846736d99c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b37a97a5-561e-425e-81b8-846736d99c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d2fb54c0-0415-48d6-bc46-b61f6de15a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d2fb54c0-0415-48d6-bc46-b61f6de15a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned_fa0eb071-c989-43ce-988d-b43730f19580" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned_fa0eb071-c989-43ce-988d-b43730f19580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP_feda1aa6-182d-4b52-9b5a-33f4cafa7611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP_feda1aa6-182d-4b52-9b5a-33f4cafa7611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EmployeeStockPurchasePlanDiscountRate_d8f3fe33-08eb-4b55-ab2e-b6cdd3bf4f15" xlink:href="infu-20211231.xsd#infu_EmployeeStockPurchasePlanDiscountRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_infu_EmployeeStockPurchasePlanDiscountRate_d8f3fe33-08eb-4b55-ab2e-b6cdd3bf4f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum_fc256276-6c93-4528-9cd0-27debf21107c" xlink:href="infu-20211231.xsd#infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum_fc256276-6c93-4528-9cd0-27debf21107c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance_5413887c-f495-43ed-8d51-d028d25aad1d" xlink:href="infu-20211231.xsd#infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance_5413887c-f495-43ed-8d51-d028d25aad1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0b6f6063-a9db-459b-a6c2-0e8b3f6423c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0b6f6063-a9db-459b-a6c2-0e8b3f6423c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_161b0dd7-d75a-4512-8ca3-68ee03bb02cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_161b0dd7-d75a-4512-8ca3-68ee03bb02cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_e2ca226c-255d-4f6f-a0f8-edc0a5e8d887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_085f04fe-d6e2-4d6b-b6a2-5cbb767e6461" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_e2ca226c-255d-4f6f-a0f8-edc0a5e8d887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationStockbasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8a6ad516-b183-4986-8a79-29b3f36a5234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_a307083b-edd5-4366-a8a4-539368bdf7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8a6ad516-b183-4986-8a79-29b3f36a5234" xlink:to="loc_us-gaap_RestrictedStockExpense_a307083b-edd5-4366-a8a4-539368bdf7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionPlanExpense_2c046548-e0a7-46c5-9f6e-4d8ea799c210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8a6ad516-b183-4986-8a79-29b3f36a5234" xlink:to="loc_us-gaap_StockOptionPlanExpense_2c046548-e0a7-46c5-9f6e-4d8ea799c210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9231acc4-1147-4852-9944-d8f1f5f5fda0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8a6ad516-b183-4986-8a79-29b3f36a5234" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9231acc4-1147-4852-9944-d8f1f5f5fda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_90d9e212-1351-4d5e-940d-ac2cc57885dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8a6ad516-b183-4986-8a79-29b3f36a5234" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_90d9e212-1351-4d5e-940d-ac2cc57885dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6ec93740-72c1-4471-aac4-1b9f5621135b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c16078f3-2cbd-4def-9ecb-642a04177067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6ec93740-72c1-4471-aac4-1b9f5621135b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c16078f3-2cbd-4def-9ecb-642a04177067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_af874197-1aa2-42fe-a5e5-847ba96db63f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c16078f3-2cbd-4def-9ecb-642a04177067" xlink:to="loc_us-gaap_AwardTypeAxis_af874197-1aa2-42fe-a5e5-847ba96db63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e572329-b984-4497-be68-e027fc5e7955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_af874197-1aa2-42fe-a5e5-847ba96db63f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e572329-b984-4497-be68-e027fc5e7955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b9ac27c3-83d0-4a9b-be32-d75da06ed35c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e572329-b984-4497-be68-e027fc5e7955" xlink:to="loc_us-gaap_RestrictedStockMember_b9ac27c3-83d0-4a9b-be32-d75da06ed35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d4e1bbb-487f-407a-82c7-59ab40c02243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c16078f3-2cbd-4def-9ecb-642a04177067" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d4e1bbb-487f-407a-82c7-59ab40c02243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d4e1bbb-487f-407a-82c7-59ab40c02243" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0748d8c3-f4f4-4d09-bb13-472f96a6ea4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0748d8c3-f4f4-4d09-bb13-472f96a6ea4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_701f9e5f-caf8-49b1-8c83-3c8e5a2186ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_701f9e5f-caf8-49b1-8c83-3c8e5a2186ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_77e958a9-c583-4ffb-8daa-6eaa9ffddd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_77e958a9-c583-4ffb-8daa-6eaa9ffddd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod_17beb584-10b1-4b78-8844-9a7888c4a98e" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod_17beb584-10b1-4b78-8844-9a7888c4a98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d2e44a28-60fd-4e8c-a314-04f6145e91dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d2e44a28-60fd-4e8c-a314-04f6145e91dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2d6a5c7a-5780-4595-b52e-ffc0583b7861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_406cb35c-d75a-48b5-a7b8-b6ecf02e9a20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2d6a5c7a-5780-4595-b52e-ffc0583b7861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d4e1bbb-487f-407a-82c7-59ab40c02243" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e78f9d1f-e7c5-414f-84b8-8c9cb0877027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e78f9d1f-e7c5-414f-84b8-8c9cb0877027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87a92321-4f38-4582-8734-a00bb6cfdbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87a92321-4f38-4582-8734-a00bb6cfdbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8fdb47dc-8f95-421c-b7c5-f708c42fca1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8fdb47dc-8f95-421c-b7c5-f708c42fca1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue_b447db30-1e54-4cad-9ea3-01027d2ddea9" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue_b447db30-1e54-4cad-9ea3-01027d2ddea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4cbe5f46-e343-4d5a-a2a7-8e19d96ea19a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4cbe5f46-e343-4d5a-a2a7-8e19d96ea19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ec3dc0c4-b9ea-49e7-9d85-9c06b573ec3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ec3dc0c4-b9ea-49e7-9d85-9c06b573ec3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e02123bd-60b6-4cef-9299-7f4e059702b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e02123bd-60b6-4cef-9299-7f4e059702b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue_a3f1a706-00ac-4c4a-aa61-c050f530d6e4" xlink:href="infu-20211231.xsd#infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_dc63e931-8b9a-49b1-80ec-108b9a41ea2c" xlink:to="loc_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue_a3f1a706-00ac-4c4a-aa61-c050f530d6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationPSUActivityDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationPSUActivityDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SharebasedCompensationPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f65ca709-690b-4b6f-bd6d-6a2e70142be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_04543bdd-1259-433d-bff9-2576f709fdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f65ca709-690b-4b6f-bd6d-6a2e70142be5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_04543bdd-1259-433d-bff9-2576f709fdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8a657a70-b7e1-4c35-bdab-7ccdd8d3fba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_04543bdd-1259-433d-bff9-2576f709fdd6" xlink:to="loc_us-gaap_AwardTypeAxis_8a657a70-b7e1-4c35-bdab-7ccdd8d3fba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_15cee08a-3b25-4f6f-ab0c-c99af3bc56f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8a657a70-b7e1-4c35-bdab-7ccdd8d3fba0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_15cee08a-3b25-4f6f-ab0c-c99af3bc56f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_963b28a1-64db-4855-9f6d-d4f8cbeab93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_15cee08a-3b25-4f6f-ab0c-c99af3bc56f3" xlink:to="loc_us-gaap_PerformanceSharesMember_963b28a1-64db-4855-9f6d-d4f8cbeab93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fb3d2f4-efbb-4f4d-aa82-d35bbdceee43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_04543bdd-1259-433d-bff9-2576f709fdd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fb3d2f4-efbb-4f4d-aa82-d35bbdceee43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fb3d2f4-efbb-4f4d-aa82-d35bbdceee43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7492e0b0-73fb-443e-88e8-f848547c4141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7492e0b0-73fb-443e-88e8-f848547c4141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_14b7178c-8206-4c5f-b92a-61d8efe76994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_14b7178c-8206-4c5f-b92a-61d8efe76994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_66a6b053-9e68-4f42-b093-3b1f92664427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_66a6b053-9e68-4f42-b093-3b1f92664427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone_11fdd37d-a27e-4812-80c8-6611fc5dee12" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone_11fdd37d-a27e-4812-80c8-6611fc5dee12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6535b74a-af13-4f00-9956-36d21cb66d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_857f53f6-2ada-497d-a2f2-5af891160dea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6535b74a-af13-4f00-9956-36d21cb66d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5fb3d2f4-efbb-4f4d-aa82-d35bbdceee43" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5e6afd48-1b3d-43cc-97dd-e9b83001bba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5e6afd48-1b3d-43cc-97dd-e9b83001bba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_18533200-0923-4d7c-8471-87bbd0f79824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_18533200-0923-4d7c-8471-87bbd0f79824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f1b85f0d-724d-4c24-a793-e268fcb34b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f1b85f0d-724d-4c24-a793-e268fcb34b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue_fb256afa-f6ac-457a-8c3d-b1948c5526e7" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue_fb256afa-f6ac-457a-8c3d-b1948c5526e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1f42554f-388d-4cc2-8f3c-05df1332a05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1f42554f-388d-4cc2-8f3c-05df1332a05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_4304aef2-e17e-4404-8bc7-12a1d26c3518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_4304aef2-e17e-4404-8bc7-12a1d26c3518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue_5ee7775c-9a2d-4d19-bc09-8d3a1d493725" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_c70c0c2f-86cd-4a57-905a-a1058d467df1" xlink:to="loc_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue_5ee7775c-9a2d-4d19-bc09-8d3a1d493725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationSummaryofActivityRelatingtoCompanysESPPProgramDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationSummaryofActivityRelatingtoCompanysESPPProgramDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SharebasedCompensationSummaryofActivityRelatingtoCompanysESPPProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_049c4031-e48a-439b-95ba-37fcae093c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_862bf5f1-c5b7-4d8c-a3da-a36a4a49426f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_049c4031-e48a-439b-95ba-37fcae093c9a" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense_862bf5f1-c5b7-4d8c-a3da-a36a4a49426f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e26be702-94ac-4597-a744-2741448590b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_049c4031-e48a-439b-95ba-37fcae093c9a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e26be702-94ac-4597-a744-2741448590b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased_05e59e8f-ad78-43fd-bc14-180e9df579f6" xlink:href="infu-20211231.xsd#infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_049c4031-e48a-439b-95ba-37fcae093c9a" xlink:to="loc_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased_05e59e8f-ad78-43fd-bc14-180e9df579f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensation2014and2021PlanActivityDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72ca1b40-52d6-4f73-ae2e-e933593ca901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82800a9c-978a-4af0-811d-c90b21980155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_72ca1b40-52d6-4f73-ae2e-e933593ca901" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82800a9c-978a-4af0-811d-c90b21980155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_75b2715f-b756-4e0e-8351-082d02c85c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82800a9c-978a-4af0-811d-c90b21980155" xlink:to="loc_us-gaap_PlanNameAxis_75b2715f-b756-4e0e-8351-082d02c85c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4ad9dafd-f605-48e6-94cb-da0fa10fd7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_75b2715f-b756-4e0e-8351-082d02c85c01" xlink:to="loc_us-gaap_PlanNameDomain_4ad9dafd-f605-48e6-94cb-da0fa10fd7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_A2014EquityIncentivePlanMember_1ebedee8-c34d-47b7-8ce6-bf62bf0ab968" xlink:href="infu-20211231.xsd#infu_A2014EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4ad9dafd-f605-48e6-94cb-da0fa10fd7f6" xlink:to="loc_infu_A2014EquityIncentivePlanMember_1ebedee8-c34d-47b7-8ce6-bf62bf0ab968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_A2021EquityIncentivePlanMember_c2d3c0d7-51e5-4464-ac93-04406ac1de4d" xlink:href="infu-20211231.xsd#infu_A2021EquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4ad9dafd-f605-48e6-94cb-da0fa10fd7f6" xlink:to="loc_infu_A2021EquityIncentivePlanMember_c2d3c0d7-51e5-4464-ac93-04406ac1de4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82800a9c-978a-4af0-811d-c90b21980155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91450221-21af-4122-9b70-2d2bfdf9059c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91450221-21af-4122-9b70-2d2bfdf9059c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6f896d1f-c15b-45ce-8c82-e1838d559550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6f896d1f-c15b-45ce-8c82-e1838d559550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_496a4eaf-85a0-4e7b-baf1-1e1b5630a873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_496a4eaf-85a0-4e7b-baf1-1e1b5630a873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_fbaca841-5961-41f7-922f-ac0c8e273976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_fbaca841-5961-41f7-922f-ac0c8e273976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CashlessExerciseOfStockOptionsShares_f9ceac91-2709-4570-a2fe-9720162c3f48" xlink:href="infu-20211231.xsd#infu_CashlessExerciseOfStockOptionsShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_infu_CashlessExerciseOfStockOptionsShares_f9ceac91-2709-4570-a2fe-9720162c3f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8cc8d8d7-5351-4502-bab8-1fbacb304581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8cc8d8d7-5351-4502-bab8-1fbacb304581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_980f9a1a-a963-418f-80c8-36e514c556fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6aff1c77-54a9-4230-84a1-63816fc896e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_980f9a1a-a963-418f-80c8-36e514c556fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c4fd0197-5cbb-401c-86c6-43eb45bd83e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c4fd0197-5cbb-401c-86c6-43eb45bd83e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_34c89d02-da53-4996-a86c-26396188b6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_34c89d02-da53-4996-a86c-26396188b6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_05068ddc-5854-4b4b-8c17-4db1297e7033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_05068ddc-5854-4b4b-8c17-4db1297e7033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d8786c91-3836-40d2-8b11-fbe9c0dcefc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d8786c91-3836-40d2-8b11-fbe9c0dcefc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_0f36144b-61b8-4138-b7a7-79c21f10958c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_0f36144b-61b8-4138-b7a7-79c21f10958c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice_833fd25f-b72a-4421-b7eb-f16c1ea8e447" xlink:href="infu-20211231.xsd#infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice_833fd25f-b72a-4421-b7eb-f16c1ea8e447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_715d0efb-4b79-4fe6-9421-4645ed0784f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_715d0efb-4b79-4fe6-9421-4645ed0784f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0e52f40b-8eaa-4806-a9d9-a606219fad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0942e1f7-7bf4-46e2-a2b7-0f78e24afb01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0e52f40b-8eaa-4806-a9d9-a606219fad8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_118134ac-dddf-49b9-918f-6a1d20f39b70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_118134ac-dddf-49b9-918f-6a1d20f39b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02e8b775-39ec-422a-9682-bf2c39ebd175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6ba53180-fdc7-4ca9-9f6b-bdadfcff31f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6ba53180-fdc7-4ca9-9f6b-bdadfcff31f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_175b0703-db05-4add-978a-f8a8d6a6761e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_175b0703-db05-4add-978a-f8a8d6a6761e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d110d473-9320-416c-8e5d-0628d08661b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d110d473-9320-416c-8e5d-0628d08661b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6fc767bd-a641-4672-b56d-6f9cc77bc287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_73161b73-753e-4a7f-b3ad-4bf8b57f9be5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6fc767bd-a641-4672-b56d-6f9cc77bc287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6bdf666f-21c8-416d-9d88-eb2652fd42ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65b045bc-5b35-4123-adb3-27595b7d98ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6bdf666f-21c8-416d-9d88-eb2652fd42ff" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65b045bc-5b35-4123-adb3-27595b7d98ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1b43c5f0-9305-4cea-b5b5-fcaac89a12d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65b045bc-5b35-4123-adb3-27595b7d98ac" xlink:to="loc_us-gaap_AwardTypeAxis_1b43c5f0-9305-4cea-b5b5-fcaac89a12d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31b6e8-0997-4288-8c07-612e849745dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1b43c5f0-9305-4cea-b5b5-fcaac89a12d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31b6e8-0997-4288-8c07-612e849745dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9d00c1c3-969d-48c9-9e9d-b87fdff666cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31b6e8-0997-4288-8c07-612e849745dd" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9d00c1c3-969d-48c9-9e9d-b87fdff666cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65b045bc-5b35-4123-adb3-27595b7d98ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0200c0f9-f2e5-4750-a66f-cc2294124b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0200c0f9-f2e5-4750-a66f-cc2294124b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_95fae53a-726c-4c0e-be47-ca117ef6955c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_95fae53a-726c-4c0e-be47-ca117ef6955c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f7239882-583d-4d6c-a991-e896a767daa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f7239882-583d-4d6c-a991-e896a767daa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d9d44c93-a8c0-4c6d-8ef2-e02fe374ca75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d9d44c93-a8c0-4c6d-8ef2-e02fe374ca75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1fdecbf7-7104-4e1f-9460-730d3032641b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1fdecbf7-7104-4e1f-9460-730d3032641b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_06c526f2-97fd-4a78-9098-2ae178162d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_06c526f2-97fd-4a78-9098-2ae178162d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_607d3cb7-98fa-4609-86ec-d8d1e1fe7b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3fd6d3c9-57a3-4cf0-abeb-80d479a2a0d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_607d3cb7-98fa-4609-86ec-d8d1e1fe7b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessSegmentInformation" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessSegmentInformation"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessSegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_552dc68b-a61c-497c-8c05-b8430da70819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_b10365b8-8c15-4df3-8b65-b057ca255523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_552dc68b-a61c-497c-8c05-b8430da70819" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_b10365b8-8c15-4df3-8b65-b057ca255523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessSegmentInformationTables" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessSegmentInformationTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessSegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e47e1dfc-fc1a-46b8-b3d2-594f3444414a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ed5ed4ec-1c02-4e27-b34a-a03dd67ad349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e47e1dfc-fc1a-46b8-b3d2-594f3444414a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ed5ed4ec-1c02-4e27-b34a-a03dd67ad349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#BusinessSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_34ab29e4-42ec-487d-88a1-3f6fb0fc305f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c22a99b0-e765-42bd-84f6-bce7d41cfc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_34ab29e4-42ec-487d-88a1-3f6fb0fc305f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c22a99b0-e765-42bd-84f6-bce7d41cfc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_af67f85a-bbee-4cbf-b0a5-4cb21d508721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c22a99b0-e765-42bd-84f6-bce7d41cfc3a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_af67f85a-bbee-4cbf-b0a5-4cb21d508721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a2ff6128-98bf-442c-867a-0cf4bebb62da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_af67f85a-bbee-4cbf-b0a5-4cb21d508721" xlink:to="loc_us-gaap_SegmentDomain_a2ff6128-98bf-442c-867a-0cf4bebb62da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_790953bf-9ef4-4db1-af09-35378e0a63a6" xlink:href="infu-20211231.xsd#infu_ITSSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a2ff6128-98bf-442c-867a-0cf4bebb62da" xlink:to="loc_infu_ITSSegmentMember_790953bf-9ef4-4db1-af09-35378e0a63a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_6cb6c146-68e7-4eb2-a1c1-d61e3d4c83ca" xlink:href="infu-20211231.xsd#infu_DMEServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a2ff6128-98bf-442c-867a-0cf4bebb62da" xlink:to="loc_infu_DMEServicesSegmentMember_6cb6c146-68e7-4eb2-a1c1-d61e3d4c83ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6b93da8a-4804-476d-bc5c-2533fb934a57" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c22a99b0-e765-42bd-84f6-bce7d41cfc3a" xlink:to="loc_srt_ConsolidationItemsAxis_6b93da8a-4804-476d-bc5c-2533fb934a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_443663ca-019a-429c-ac2a-f51222be30d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_6b93da8a-4804-476d-bc5c-2533fb934a57" xlink:to="loc_srt_ConsolidationItemsDomain_443663ca-019a-429c-ac2a-f51222be30d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_24b227fd-99b9-4d10-883a-a10f682e9773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_443663ca-019a-429c-ac2a-f51222be30d1" xlink:to="loc_us-gaap_OperatingSegmentsMember_24b227fd-99b9-4d10-883a-a10f682e9773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CorporateAndEliminationsMember_37c9b0f3-14c7-45fb-8773-2fcafd45582d" xlink:href="infu-20211231.xsd#infu_CorporateAndEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_443663ca-019a-429c-ac2a-f51222be30d1" xlink:to="loc_infu_CorporateAndEliminationsMember_37c9b0f3-14c7-45fb-8773-2fcafd45582d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c22a99b0-e765-42bd-84f6-bce7d41cfc3a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesExternal_a1322a6f-26fa-4f27-842b-b9880dade2bb" xlink:href="infu-20211231.xsd#infu_RevenuesExternal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_infu_RevenuesExternal_a1322a6f-26fa-4f27-842b-b9880dade2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesInternal_ddf4e378-9381-4401-87ce-b8d84571912a" xlink:href="infu-20211231.xsd#infu_RevenuesInternal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_infu_RevenuesInternal_ddf4e378-9381-4401-87ce-b8d84571912a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_44f2cd6d-235c-42d2-bde5-7621bfd4a9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_Revenues_44f2cd6d-235c-42d2-bde5-7621bfd4a9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0bcda5ce-0f97-4d15-ae11-812e49c45e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_GrossProfit_0bcda5ce-0f97-4d15-ae11-812e49c45e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_096a3a60-bac1-431f-97cf-3e0104e148bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_OperatingExpenses_096a3a60-bac1-431f-97cf-3e0104e148bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f8f9d114-57b2-48cf-90db-8c00fe7f87ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_InterestExpense_f8f9d114-57b2-48cf-90db-8c00fe7f87ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4ea5b936-84ac-4898-8974-34ce5207d680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4ea5b936-84ac-4898-8974-34ce5207d680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_42939093-1b8e-4fee-a98f-0ebef7181606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_42939093-1b8e-4fee-a98f-0ebef7181606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fd85d8cf-aa20-44c3-8a98-ac7fddfa50b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_NetIncomeLoss_fd85d8cf-aa20-44c3-8a98-ac7fddfa50b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d4960f82-8858-4549-84cc-fd42afd16f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_Assets_d4960f82-8858-4549-84cc-fd42afd16f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireMedicalEquipment_6a01dc48-7bf8-4183-a783-47285f950de5" xlink:href="infu-20211231.xsd#infu_PaymentsToAcquireMedicalEquipment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_infu_PaymentsToAcquireMedicalEquipment_6a01dc48-7bf8-4183-a783-47285f950de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ff1ba856-c6f5-4ad8-ab13-cab601cdca79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_16f991c8-f88a-43ac-938e-b0b29bc90899" xlink:to="loc_us-gaap_DepreciationAndAmortization_ff1ba856-c6f5-4ad8-ab13-cab601cdca79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/EmployeeBenefitPlansandOther" xlink:type="simple" xlink:href="infu-20211231.xsd#EmployeeBenefitPlansandOther"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/EmployeeBenefitPlansandOther" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureTextBlockAbstract_41aa4696-d4b2-459c-a271-92557f83aaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_83c50c5f-8bbf-4a0e-bf15-5cdf1873656a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureTextBlockAbstract_41aa4696-d4b2-459c-a271-92557f83aaf2" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_83c50c5f-8bbf-4a0e-bf15-5cdf1873656a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/EmployeeBenefitPlansandOtherDetails" xlink:type="simple" xlink:href="infu-20211231.xsd#EmployeeBenefitPlansandOtherDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/EmployeeBenefitPlansandOtherDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureTextBlockAbstract_7f43a0f8-709c-4d60-b64f-5b22a47fb04f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_605bf742-2fd0-488d-93dc-178eaa1a224c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureTextBlockAbstract_7f43a0f8-709c-4d60-b64f-5b22a47fb04f" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_605bf742-2fd0-488d-93dc-178eaa1a224c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b687e87a-ee5f-4463-970f-81567331f042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureTextBlockAbstract_7f43a0f8-709c-4d60-b64f-5b22a47fb04f" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b687e87a-ee5f-4463-970f-81567331f042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/COVID19" xlink:type="simple" xlink:href="infu-20211231.xsd#COVID19"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/COVID19" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_Covid19Abstract_754a003a-ea59-4e04-a96e-d221e4a08450" xlink:href="infu-20211231.xsd#infu_Covid19Abstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EffectOfCovid19PandemicTextBlock_b1f0d9e8-e77d-421d-9618-bf9d82fa18b7" xlink:href="infu-20211231.xsd#infu_EffectOfCovid19PandemicTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_Covid19Abstract_754a003a-ea59-4e04-a96e-d221e4a08450" xlink:to="loc_infu_EffectOfCovid19PandemicTextBlock_b1f0d9e8-e77d-421d-9618-bf9d82fa18b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>infu-20211231_g1.jpg
<DESCRIPTION>LOGO
<TEXT>
begin 644 infu-20211231_g1.jpg
M_]C_X1$817AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    D    <@$R  (    4
M    EH=I  0    !    K    -@ +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-#(#(P,3<@*$UA8VEN=&]S:"D ,C Q.3HQ,#HP-" P.3HR.3HU
M-      #H $  P    '__P  H ( !     $   <7H , !     $   (]
M      8! P #     0 &   !&@ %     0   28!&P %     0   2X!*  #
M     0 "   " 0 $     0   38" @ $     0  #]H         2     $
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M<W'J]M&740W_ (JP[W!O_%/993_Q:VFX^%TOZIQU&HV"\"RRL2";;(=4W?\
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M.$))300Z      $/    $     $       MP<FEN=$]U='!U=     4
M4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN
M=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    6 $@ 4  @
M $\ 9@!F &D 8P!E &H 90!T "  4 !R &\ (  X #8 ,0 P       /<')I
M;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M   *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E
M8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC
M<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X
M0DE- ^T      ! !+     $  0$L     0 !.$))300F       .
M     #^    X0DE-! T       0   !:.$))3009       $    'CA"24T#
M\P      "0           0 X0DE-)Q        H  0         !.$))30/U
M      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(
M   ! %H    &       ! #4    ! "T    &       !.$))30/X      !P
M  #_____________________________ ^@     ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@  #A"24T$         @  .$))300"
M   "   X0DE-!#        $! #A"24T$+0      !@ !     CA"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  .7    !@             "/0  !Q<    Q $D ;@!F '4 4P!Y ', = !E
M &T 7P!3 $$ 1@!% "X 4P!- $$ 4@!4 "X 5 !2 %4 4P!4 $4 1  N %\
M4 !- %, 0P!? %, = !A &, :P!E &0 7P Q #  +0 Q #D    !
M                  $             !Q<   (]
M  $                         $     $       !N=6QL     @    9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M  !,969T;&]N9P          0G1O;6QO;F<   (]     %)G:'1L;VYG   '
M%P    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M!W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN
M96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E
M96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG   "/0    !29VAT;&]N9P  !Q<    #=7)L5$585
M  $       !N=6QL5$585     $       !-<V=E5$585     $       9A
M;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L
M;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R
M>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V56
M97)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L
M:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M  IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M   +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
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MP  1"  S * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
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M5)+-\WZ>_P#E/FZ)A\H^7_!V?__9.$))300A      !=     0$    / $$
M9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    %P!! &0 ;P!B &4 ( !0
M &@ ;P!T &\ <P!H &\ <  @ $, 0P @ #( ,  Q #<    ! #A"24T$!@
M    !P ( 0$  0$ _^% J&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M86(@!]  !P :  4 *0 U86-S<$%04$P     041"10
M  $  /;6  $     TRU!1$)%
M                           *9&5S8P   /P   !T8W!R=    7     K
M=W1P=    9P    403)",    ;   *(&03)",@   ;   *(&03)",0  H[@
M *(&0C)!,  !1<   CBT0C)!,0 #?G0  CBT0C)!,@ %MR@  CBT9V%M=  '
M[]P  )"19&5S8P         :52Y3+B!796(@0V]A=&5D("A35T]0*2!V,@
M
M                                          !T97AT     $-O<'ER
M:6=H=" R,# P($%D;V)E(%-Y<W1E;7,L($EN8RX  %A96B        "U6@
MO&<  )(P;69T,@     $ PD   $                    !
M         0   0   @   B0$'07:!VD(V0HV"X4,QPW_#S$07A&+$K<3XA4+
M%C(75QAY&9@:M1O2'.\>)1]9((<ALB+:(_\E(R9$)V8HABFG*L<KZ"T(+B@O
M2#!I,8DRIC/"--XU^S<8.#4Y43IM.XD\I3W"/MX_^$$10BE#0D1<175&CT>I
M2,-)W4KW3!)-+$Y#3UE0;U&&4IQ3LE3)5=]6]E@-62-:.EM17&9=>%Z*7YM@
MK6&^8L]CX&3Q9@)G$F@C:3-J0FM2;%YM9VYQ;WIP@W&,<I1SG'2C=:IVL7>W
M>+UYPWK(>\U\SGW-?LQ_RX#)@<>"Q8/"A+^%NX:WA[.(KHFIBJ2+GHR8C9&.
MAH][D'"19))8DTR40)4SEB:7&9@,F/^9\IKDF]:<R)V[GJV?GZ".H7RB:J-7
MI$6E,Z8@IPZG_*CJJ=>JQ:NSK*&MCZY]KVNP6;%'LC:S)+02M0"U[;;:M\BX
MM;FCNI"[?KQKO5F^1[\UP"+!$,'^PNS#VL3'Q;7&H\>1R'[);,I9RT3,+LT8
MS@'.Z\_5T+[1I]*0TWG48=5)UC'7&-@ V.;9S=JRVYC<?=UBWD??+. 0X/3A
MV.*[XY[D>^57YC/G#N?HZ,'IFNIQZTCL'>SP[</NEN]V\%7Q,_(/\NKSP_2<
M]7/V2?<>]_/XQOF5^F'[*?OK_*?]7/X+_K3_6O__   !Z .G!2P&A >_".<*
M! L6#!P-'@X<#QD0%Q$4$A 3"Q0$%/P5\Q;F%]@8S!G6&MX;X1SA'=\>VQ_6
M(-$ARR+$([XDN"6S)JXGJBBF*:(JH"N>+)TMFBZ5+Y$PC3&),H8S@S2!-7\V
M?S=_.( Y@CI_.WX\?#U\/GP_?4!_08)"A4.)1(U%DD:81YI(FTF=2I]+HTRF
M3:I.KT^T4+I1P%+'4\Y4U5775ME7VUC>6>!:XUOG7.I=[5[Q7_5@^&'\8P!D
M V4!9?]F_&?Z:/AI]6KS:_!L[FWK;NAOY7#A<=YRVG/6=,UUPW:Y=Z]XI7F;
M>I![A7QZ?6]^9']8@$V!08(U@RF$'(40A?Z&[8?;B,J)N(JFBY6,@XUQCF"/
M3I ]D2R2&Y,*D_J4Z979ELF7NIBGF9.:@)MMG%J=2)XVGR6@%*$$H?6BYJ/8
MI,JEO::QIZ:HFZF1JH>K?ZQWK6^N9Z]@L%JQ5+)/LTRT2;5&MD6W1+A%N4:Z
M2+M*O$Z]4KY7OUW 8\%JPG+#>\2$Q8K&D,>6R)W)I<JMR[;,O\W(SM+/W-#F
MT?'2^]0&U1+6'M<JV#?91-I1VU[<:]UYWH;?E."<X:+BJ..MY++EMN:ZY[WH
MP.G#ZM3KY>SU[@3O$O @\2SR./-#]$[U6?9C]VKX;OEO^FS[9/Q6_43^+_\7
M__\   (% ]@%: ;&" 8),@I2"V4,<@UX#GH/>A!Z$7D2=1-P%&@57A92%T48
M-QDI&C0;/1Q '3\>.A\T("PA(R(9(P\D!"3Y)>XFXR?8*,PIP2JV*ZLLGRV3
M+H<O?#!P,60R63---$$U-C8K-R$X%CD+.@ Z]COM/.,]VS[3/\M Q$&]0K=#
MLD2L1:9&H4><2)=)E$J02XY,BTV*3HE/B%"(48E2B%.(5(A5B%:)5XI8BUF-
M6H];D5R3799>F%^;8)UAGV*@8Z%DHV6D9J9GIVBH::EJJFNJ;*MMJVZK;ZMP
MJ7&H<J5SHW2@=9UVF7>5>)%YC'J'>X)\?'UV?F]_:8!A@5J"48-(A#Z%-88K
MAR&(%XD,B@**]XOMC.*-V([-C\.0N9&ODJ63G)22E8F6@)=XF'"9:IICFUZ<
M69U5GE*?4*!/H4^B4*-2I%6E6:9?IV:H;JEXJH*KCJR<K:NNNZ_,L-^Q\[,)
MM""U.+91MVRXA[FDNL*[X;T!OB&_0\!EP8?"JL/.Q/'&%<<YR%[)@LJFR\K,
M[<X0SS+05-%TTI33LM3/U>O7!M@>V3;:3-MAW'3=A]Z8WZ?@L^&^XL?CS>31
MY=+FT.?,Z,3INNJLZYOLA^UO[ECO7/!;\5;R3/,]]"KU$O7V]M;WL_B-^6+Z
M+_KT^['\9OT1_;/^3?[A_W'__P   =D#C04)!E0'?PB6":$*I N?#),-@@YP
M#U\03!$W$B$3"1/P%-85NQ:?%X,8@1E]&G0;9AQ5'4$>+!\7(  @ZB'3(KTC
MIB20)7HF9"=.*#DI)2H0*OTKZBS7+<0NL2^>,(PQ>3)G,U4T1#4R-B(W$3@!
M./$YXCK3.\0\M3VF/I@_BD!]06]"8D-51$E%/$8P1R-(%TD+2?]*\TOH3-Q-
MT$[%3[E0K5&A4I53B%1Z56U67U=16$-9-5HF6QA<"5SZ7>M>W%_,8+UAK&*;
M8XED>&5F9E1G0F@P:1YJ"VKX:^5LTFV^;JIOEG""<6QR5G- ="EU$G7[=N1W
MS7BV>9YZAGMN?%9]/GXE?PU_](#;@<*"J(.-A'*%5X8[AR"(!8CJB<^*LXN8
MC'V-8HY'CRV0$I#XD=Z2Q).JE)&5>)9@ET>8+YD8F@&:ZIO4G+^=JIZ6GX.@
M<:%?HD^C/Z0PI2*F%:<(I_VH\ZGJJN*KVZS5K="NRZ_'L,2QPK+!L\&TPK7%
MMLBWS;C3N=NZX[OMO/B^!+\1P"#!,,) PU+$9L5ZQH_'ILB^R=;*\<P,S2K.
M1\]CT(#1G]*_T^#5 ]8GUTS8<]F;VL3;[]T:WD;?<^"AX<_C N1-Y9GFY^@V
MZ8;JV.PK[8#NU_ Q\9#R[_1-]:KW!/A:^:OZ]OPZ_7O^N____P"  (  Y;1_
MS7]4S#]_I7[#LHQ_E'YIF']_GGY,?>-_P7YC8D%__GZ21&& ?W\%'V2!_H <
M_+A^=(MYY ]^5XFRRMM^3X@4L3Y^7(:TER]^@H6;?)-^OH2Z8.E_#X/T0P!_
MEH-X':* Y(/?^J-])9<(XDA]')0QR5A])9%ZK\Y]2X\>E=9]AHT->TY]UXL\
M7[1^-XF)0<M^P(@M' 1_SX@1^+]\%Z*PX()\%Y[)Q[)\*YL4KD5\6Y>CE'-\
MJY2F>@Y]#)'F7I5]=X]/0+9]_XTM&HQ^Q(O)]PE[1ZYUWMI[1*EZQAM[7:3$
MK-)[EJ!FDQ![ZIQ:>-I\6YB[78A\SY5-/[E]4I*+&3Q]QH[P]85ZJKI=W5EZ
MG[1(Q*=ZLZZ+JWQZ\*D]D>)[3*1.=[)[P)^Z7(M\/9N//M-\O)AV&!=\VY!)
M]#AZ+\9RW UZ&[\[PV)Z)[ASJDUZ9+(VD-]ZR:QQ=M)[1*<06ZY[P*(P/@Q\
M.Y\/%QQ\!X^@\QUYT=+(VO%YM,IAPDEYN,*-J3]Y\+MAC^=Z6;3.=@9ZW:[&
M6P9[7JF'/6-[T*33%DE[4H\1\BIYC-^$V?UY9M73P55Y8,SNJ%9YE,3BCQ-Y
M_KV2=4MZAK<'6FE[#+'</-I[>JDE%9YZR(Z=[>V)$WXKUGZ( 'VQOLV'!7U7
MIK6&,'TSCAJ%A'U(=-"$_'V,6FN$FWWH/8Z$GWZ+&(N&>H !Z\F'KHD(U0"&
MHX=]O8V%N88AI7Z$^(4#C-"$9(0J<WV#](.(60^#J(,'/#F#N(+@%OF%=X0#
MZ?N&<)/XTU.%=Y%UO!"$G(\9I!2#]8T3BXF#=8M6<E6#%XG55_^"V(A\.RR"
MZX>4%8B$>X>HZ%*%<Y[XT;*$@YN!NG^#LI@[HJ&##I4ZBCB"H)*A<2F"4)!#
M5O>"&XX<.C2"+HR6%#B#B8K)YLB$JJH8T#*#NZ6MN0:"\:&"H3^"59VDB.Z!
MXYH2< N!HY;G5@*!=9/_.5.!AI(,$Q6"FHSGY6.$#+5BSM:#'; #M[6"4JKJ
MH 6!N:8NA]6!3J'&;OV!"9V\51^ XYHS.(F \Y@X$A^!O(Q!Y"^#B\#:S:R"
MG+J"MI*!SK1ZGO2!-J[?ANB TZFP;C& DZ3M5%R 9:#8-]V =)Y8$52! XNW
MXRF#),R5S*^"-L4[M9B!9;Y#G@. RK?+A@F :;'=;7> ,ZR-4\: "*A6-TV
M"J-<$*Z ;(M'XDZ"T-B[R]J!YM!.M,2!$\AAG36 =,$4A4Z $KIZ;-5_W[3-
M4SQ_NK!(-M%_O*40$"I_](KNW3R287R8QVN0>GQ#L5:.LGP0FL>-&GP1@Y>+
MMWQ):YZ*@GRQ4G6)B'TR-HZ))WX!$3*+UG_>VT:1+8;+Q@6/0H6$L"J-@X1O
MF;*+_(.0@H.*K8+R:HR)C8*(45Z(HX) -7J(28)@$ 2*F(.&V;.0 )$DQ)V.
M(H[MKOV,8XS?F("*\8LF@56)LXFR:6J(IHA\4$J'RX=V-':'>8<%#OJ)5H:[
MV$>/")N2PRZ-,IA[K8&+AI67EQZ*$Y+]@!>(Z)"^:%.'YHZ\3UN'$XS_,YV&
MPHP=#A2(*(F$UNF.2J85P=&,>*(FK"2*U)YSE=*):)L*?N:(,I?J9TN'/I4M
M3GV&;Y+,,MF&')'!#4Z')8C_U:>-L;#'P)N+XJP JO:*/J=WE+2(UJ-!?>*'
MI)]<9EB&IYO:3;6%W9CY,BR%BI?R#*B&2XB/U)"-,[NEOY*+9[8%J?*)PK"F
MD[Z(6ZND?0J',*<(99Z&-J+G30R%7Y^O,9V%"YT_#!Z%EX@QTZ.,R\;'OK.+
M \!)J1:)7KH4DN>']+1)?$*&S*\$9/:%W*IW3(>%!:=E,22$HJ$Z"ZZ%!(?F
MTN",<M)7O?N*L,KQJ%V)#</ADC&'H[U3>YV&>K=\9&F%B[+'3 V$O:YG,+>$
M7*#P"U6$CH>IS/N;\GM;N).91WLAH_:6N'L)CMZ48'LF>16217MX8FF097OY
M2G*.VGR3+V..-7U^"GZ0'W_ RSJ:XH3]MV:8(X/GHP&5F8+\C?J338)+>"N1
M0X'887R/=8&:27Z-]X&!+GF-5X'C"<^.FX,(R=.9WXZMMAR7)8S"H>64F(KX
MC.&26XF)=R&07HA48(..GH=>2)B-*H:@+:>,C(:="36-1X7HR*B8YYB.M..6
M/97.H*>3O9,TB[N1<I#M=@./AH[_7W^-THU21[&,9HO[+-Z+S(O-"*^,'X7?
MQWR8+**&L\:5A)[ZGWN3"YNLBH20TIBJ=.R.V97T7H^-,9.@1NZ+Q9'$+#N+
M)Y&^"#R+(861QE^7FZRELK*4]:A9GFR2?J1*B8202J"-= &.4YTC7;B,G9HG
M1D&+-)?W*ZZ*E)<[!]N*3(50Q6:7)K;LL<F4@+'>G8F2"*T.B*J/U:B:<T"-
MY:2/71.,,*$31;&*M)[3*SJ*$IO(!XN)FX4:Q)*6P\%XL0>4'KNEG,F1I[86
MA^Z/<K#N<H^-A:Q57'V+VJB913Z*7*9!*MF)J)SY!TJ)"X3NP^*6;LQYL&>3
MRL78G"B15K^%ATZ/([FS<?Z--K2J7 .+C;$31-6*&JQ"*GR):9RZ!Q:(F83+
MO3^ET'IZJARB:'I-EM&?''I%@Q2<"'IR;IV9.'K462R6LGMD0E.4HGP*)_.3
M\WS]!*J3?W^FN[.DXH.4J2JA6H*<EA6>"H'0@F":_8$^;=N8.H#K6&.5PH#.
M08*3O(#;)S23"X%U!&B2 X*:NHBCZXS"J!>@:(L!E22=%8EN@6N:%X@I;/&7
M78<G5XJ4[X9F0+R2[H7H)HZ2.(9;!"^0M(+4N7RC&Y7UIOV?HY-ZD_^<69$Y
M@%^93H\S:_66G8V15JV4-(PQ0 *2-(LY)?F1=XO9 _V/DH*RN):B59]HI@J>
MZ9PSDOZ;JID_?U:8II:+:P25V)0N5=F3?)(_/U*1?I#L)6Z0OY%6 ]..F8*6
MMZ.AR*D"I36>5:45DBZ;$:%K?H*8$9X9:CF55ILB52*2ZYBL/L.0[)<_)0&0
M)Y8+ Z^-R()]MLNA5[*]I&V=X:X>D6R:G:G&?<J7H*71:9:4ZZ)25):2@)^#
M/D^0;)Y4)*R/H)C, Y&-&H)IM@^@_KRVH\:=@K=AD,J:/;)<?2R7/ZW,:0&4
MCJG@5!>2+:<-/>^0$J3#)&6/,)B; WF,C8)9M7&@K\<LHSR=+<$7D$&9ZKM?
M?*66\+8_:(B40+(24[.1X*]'/9N/TJFH)!^.])AL V6,'8),KAZO_GGDG"FK
MWGFVBA"GWGFR=XJD%WGF9$>@F'I03_F=<WKF.A^:]GN-("F:F'QQ  "5TW_*
MK,ZO*(*#FVBJY(&9B7ZFVH#@=ONC$X!C8ZB?FX F3U.<?X C.72:!8!,'Z&9
MEH$7  "4CH  J]^N/8LNFHJI_HF-B+VE[8@:=C&B,(;[8N2>O(8@3I^;IH6.
M.-69+(5+'RZ8JX9&  "3<(  JQ*M:I/GF:JI-Y&:A\RE,(^$=5"A:(V]8A*=
M_(Q13>B:Z(LX.$&8:HJB'LJ7UXNS  "2>(  JD&LRIRTF-JHF)G"AO.DE)<7
M='6@SY3 84V=2Y*P34*:/9$H-[^7N)!K'G67%)!A  N1DH 'J9"L+*7,F"^G
M_*(QADBC^9[B<\J@-9OO8*J<LIE<3*^9CY=K-TV7"I;E'BB67Y18 !N0Q( 2
MJ.*KN:\#EZ*G?:JXA<*C<J;#<T"?K*-#8"F<-J!/3$&9')X[-O:6@)U]'?.5
MR)1  "B0&8 ;J$*K8;ATEQFG&[-[A4.C#:[G<LB?2*KD7[N;UJ>I2^&8Q:7C
M-K"6(Z+K'<R53Y0F #./CX BI[FK%<)>EJ:FQ+RKA-:BMK=Q<F*>]K+Z7V.;
MAJ^Z2YR8=:T?-GN5W:36':>5"90- #R/(( HG["ZA'ETCM6UJWDZ?=&P_'DR
M;&2LBWEG6CBH9'G41N^DKGIJ,>NAYGL'%_"B<GN^  "1*(  GJ:YMH&DCD*T
MPH"]?6*P!8 -:_.KC'^>6;BG9']R1FRCKG^#,6R@WG_!%["A.X"Z  "0;H
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M1*>E>IBL@J03:2^H!*$%5R6CU)Z71#F@")U)+\2<\)PG%Q6<J(^;  "."H
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M"(<G<5ZXGH7<8-NS=83S3Z&NGX19/5*J6H09*2.G2H1.#Z^H3X3N  ",P8
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MH:R3;_:U'ZC+7XVOXZ783G>K":0:/&^FO*+_*+.C4YN%$&RC1(L;  "+_X
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M;(T99B#!<HMG5G:[FXH:1B2V*(E(-+6Q9HC^(2RN28GD"5VMFX95  "*18
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MQ;#J9F2]DZSR5O*WHZIF1L*R):C?-8BM5J0R(F6IVY=!"T>HL(>@  "*B(
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M-92:?ZF?PI)_;@*<B)"?6YR9B8[V2"R6_8V_,R:5 HTO&<B5+8SM  ")KX
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MN'0W=I"LHG3"9>^HQ75L5&>E*W8Q0:*B"'<#+/"?^'>L$FZB''>L  ")?H
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M9II+<]2H.)?58R^D096M4<Z@E)/E/V:=69+#*T";"Y,3$A";\HPV  "&LX
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M"'K4:JZU/'JL6O2PJWJV2D^L;GKN.%^HU7M#)#2FQWN!"I^H+GQB  "%MH
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MVI]D:/6P[YRN63FL/IIK2,*G[)C;-SFD+)BJ([JAF):C"YRAE(?9  "$FH
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MGH#87T>^/8 /4$ZY"W^@0'VT.G]M+U"P1W]W&WVNDG^K!)>L28!U  "#(8
M>W#'Z(D4;7W"<X>>7Q>]$89G4"6WU(6%0%ZS 84"+TJO H3?&ZVM'86$!1*J
MFX-N  "#'X  >UO&[)!E;67!<(Z 7OZ\!(SH4 *VPHNE0$^QWXK/+U"MW(JL
M&]^KT(LP!8&I)(.Y  "#'H  >SG&)9?D;53 FI607O>['Y..4 .UU9'V0$^P
M[I#L+V&LTI$!'!6JII +!>2GX8/[  "#'8  >Q?%A)]U;4>_ZIRS7O>Z8)I'
M4 JU#)AF0%NP)9==+WFL )=Y'$NIHY,A!CNFSH0W  "#'8  >O;%!J<P;3^_
M6Z/]7ORYP:$L4!:T89\40&>O=9Y9+XVK5IS3''BHX)- !H>EZX1J  "#'(
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MUA5_#G&VP>5_$'+*K/1_'7//EQ]_-731@'5_5G7=:.Y_B';V4#%_SW@(-)J
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M"8#*A>F3VX!E<^V1Y8 <8060'7_Q30&.F'_?-V.-@7_6'7>-_G_S  "'<H
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M,:P+@:N0!ZA&;\>.!*2G72V,1*&*2::*SY]D-+2)F)W9&XN)AY*?  ""_8
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M8X=$>1B;AH93:$Z8V86$5H"6<X3C0Y.49(1J+MZ2_X0K%0>4/H2   "#*(
MEWZ@?)#=B$.=?(]">$>:H8V]9W27]XQ85=&5@8L:0OR3>XHU+FR2#(G1%,J3
M&XE   "";(  EM>?L)FKAY><N9=Z=Y>9WY579LF7+Y-352^4MY&-0GN2FY!
M+@R1)Y .%)*2%(U&  "!SH  ED:?'**/AQB<*)_/=Q691)T-9CF6BIIT5)V4
M%9A!0?^1_);)+;20;9:%%&&1.(W(  "!2X  E<Z>L:N7AIV;O:A.=I*8TJ3Y
M9;:6#J'75!Z3E9]108>1@IX0+5B/Z9O@%#F0A(VL  " X(  E76>8K3PACN;
M:[$I=B*8>*U&94&5JJFN4[23*J<.02^1$J4Z+0Z/?9YV% *0#(V'  " BX
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M38T-;1ZCP8NT74&@8HJ!3(F=3(F).HV:P8CL)I29,8C_#3^:7(<]  " &H
MBA"J09;$>ZZFEI3-;)BC!9+L7+J?H9$Y3 F<A8_1.C*9W8[T)EN8/X];#4*9
M)XCW  "  (  B:BIGI\@>T"E^)RK;":B9)I&7$B>_9@82Z&;WI9<.>.9+I6&
M)C:77I3<#4J8$8C\  "  (  B4NI-*>G>P6EBJ2]:^>AY*'.6_B>8I\C2TJ;
M.9TY.8J8F9RL)?.6RYER#4J7.8C\  "  (  B0.HZ+"">KRE,ZTJ:Y6A@JG
M6Z.=]J:]2O^:Q:3Z.4Z8'Z+$)<B649F,#4.6H(CW  "  (  ?W*Y_VUL<>&U
MP&YI8[&QO6]Q5*NMZ7" 1)FJ8'&-,P&GDW)X'KNFT7+!!;VG/W-M  "  (
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MK9) 8@BL<9"74P*H8H\F0R6DJHX2,?ZAG8VU'H&@(XW@!R&>HX32  "  (
M?9^T:9OF< NP$IFV8<:KR9>94KZGKY7$0N*C]I2",=*@WI1Z'GZ?+I*G!TZ=
M>(3Q  "  (  ?6JSZ:/E;]BOCJ%089"K/9[-4H:G&YRI0JRC7)MP,9R@2IKB
M'F:>?)2-!WF<=H4.  "  (  ?3:SFZQ';]"O*ZE6882JP:9=4F2F@J/K0I"B
MK:+#,92?CY_S'G:=R929!Z";Q84H  "  (  <J_%2&S>9:7 K&VT6!V\.6Z?
M2=.W[&^5.G6T 7"!*5.Q-'$M%):QZ7"X  "K*71[  "  (  <J+$=W1P9<._
ML72+6#J[!'352?&VAG5 .I:R=G6_*8VO?W8A%16OQ'6[  ^IZ7CG  "  (
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M8I;@5ZZU?Y4*26.PSY.-.C^LD)+"*;:I.),'%F"H+8\A D>AM(&*  "  (
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M^I=^AH&#,)5<=&^"@),S88R!\9$P3:J!AH]X.$6!18Y2'K6!6(W=  " ((
MIN*$'*,RELB#1:"(A:V"=IVL<YF!PIK*8,2!-Y@F30" S97R-\> =I2Z'E&
M;))7  "  (  IDJ#CZT(EB."OJFZA/B!YZ8F<N&!)J*,8!* EY]63%. .9S9
M-S=_WYNU'?A_IY1$  "  (  I>.#+;<:E:2"8+,SA%Z!?*[K<CR J:J@7WR
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M6ITP>GF*S9JU:7J)7I@]5ZV((98*1-6'')1;,%Z&5Y/T%O^&LH^-  "  (
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MNGH2<GV7;7I-8F"54WJ543V3:GKI/LN1X7M *EF1''MQ$ :3+WLE  "  (
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M4J)#;P"3 Y^37O:0S9SQ3AV.W)K4/":-3YG<*&N,.)@:#TN,K(I7  "  (
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M.H  9E^?3G^V5TZ<C'^"1QR:&']I-8N8*7]?(:&7=7]8"*Z7BW^3  "  (
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MMZ;L9"Z;IJ0R5/J8K:&E10*6#: M,]F3_)Y\()F2V)8*"..1.X8"  "  (
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M6(4N6P6GSX2'3+>D;8/S/7*A9(./+)"?,H-K&-F>]X._ NV:.X'[  "  (
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M0&@.4..WEFEP0R.T!6K&-"JPZ&OT(Q^O/FRB#B&Q2&OC  "?!'.P  "  (
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M'(G)4$2Q (C<0IZM#8@0,_RID8>2(YVG.H? #^:GJX:X  "9D(    "  (
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M-<""?74X&\B#;W5F  "  'JYH(N!V7;5D6:!B'>+@5V!.W@K<!*! WC 7<"
MWGE52CB UWGD-06 \WI/&S>!FGHL  "  'XZGV: &8 ED#-_W8 B@!=_IX #
M;Q-_>7_>7-M_9'_"28!_9G^M-'A_?G^4&LI_X7]7  "  (  GCM^L(E]CR1^
M?8C/?P=^4(?_;>1^*X<=6]9^'H9*2)%^,H69,[)^0H4-&CE^684,  "  (
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MG67Q=_",>6@@9Y^+B6HG5AN*NVP50SV**FWA+G:**6]'$\B,FV\4  "  'I
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M2HZR<T.%8(UW8R*$A8PG4B2#S(KP/_*#1(H *]*"_8F>$A^#9X@Z  "  (
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M'VT":YF3:6YG7$61VV^_2[R0>W$&.;Z/@7(G)7B/=G+("RZ1&')%  "  (
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MW9/P9[R-.Y)B6(:+J)#%2&N*38]H-Q2)0HZ8(YZ(LH[&"L:('8=)  "  (
M@K&/UIW.=7:.0IP%9SJ,EYGO6 2*]I?,1^J)DY8:-H^(C)5K(S2'Z905"K:'
M$(<^  "  (  @EJ/9*:$=1:-SJ1;9LN,%Z''5Y&*9Y\O1X2(]YU2-CR'Y9QP
M(NZ'.9>>"I6&1H<H  "  (  >I"BI6)P;A.@)F258*N=[F:@4B";YVB*0EB:
M'FI.,.*8_FO#'(&9P6P_ ]^8H6R^  "  '_0>?RA06I[;:">S&OB8#2<?VU!
M4;F:76Z50@&8@&_2,*.72G#4'&:7SW$'!""6$''2  "  (  >6N?HG)8;.Z=
M0G,A7YV:]'/F42&8T72L08*6\G5H,$25L77^'#:6!77[!%*3Q7=-  "  (
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M!IB#7-V5KI;+3G.3894,/QZ199/6+F./^Y/2&S"/C)$]!-6,'(-%  "  (
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M WA34_VC+'B<1FJ@>GCO-XF>,WE!)MV<W'EL$I>>,GCU  "4,'QC  "  (
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MI)RH4IF>F)KW1-B;HIE6-C.9%YC/)?R7:I;G$JJ7J8R>  N/BH (  "  (
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MK'R_2+ZL77RM.[FI-'R<+8ZFE7RB'1FECGR9">JEB'T9  ".P8    "  (
M8"ZQVH/Q5,>N@8.72*.K)(,J.YNG\8+!+6^E2(*#'26D$(*@"B>CS((Y  "-
MXX    "  (  7_VP_(L45+6MC8I]2)BJ'XF\.XNFX8D(+5VD,8BV'2NBWHD@
M"F6B2H:(  "-,X    "  (  7]FP5Y)&5+*LRY%^2)BI2)!V.X6E^8^)+4NC
M08]E'1BA[(Z\"GRA'X<7  ",G(    "  (  7\&OW9F@5+NL+)B]2*.HD9>!
M.X>E-):$+5*B;98M'3.A 9-."I*@(H<F  ", (    "  (  P1-G%5_MKM-I
M.6*TF^UK/F5@B")M)&?N<VEN^&II7;=PN6S11L=R16\0+,]S)G#="@1V*G$4
MOR!D)6K1K4MFBFR%FHYHOVXLANAJTF_+<D9LSW%@7*ANL7+K1<EP2713*^AP
M\75="6UT:'5KO4EAE76GJX9D('9.F0=F?7;SA7-HLW>E</AJTGA<6X%LT'D1
M1,IN<'FO*P]NV7H*".ERW'HMNW=?2X!=J;AA]8 /ET-D;'_(@^YFP7^-;Y=I
M 7]I6E)K&']-0\]LOG\I*D)LY'[M"'9QLWZ&N<Q=58L$J"!@%XG<E;)BIHBU
M@FEE#(>7;E)G8H:.635ID(6G0N=K.83-*8EK&80:"!1R68(_N'%;P)6SIM1>
MDI.[E'!A+9&U@3%CHH^V;2UF XW46#QH-XP=0AIIXXJ@*.5I?HFQ!\%RY84^
MMUQ:>:!CI<Q=5IV>DVI?]9JZ@#%B<)?>;#UDWI4Q5VIG&I+ 07%HNY"O*&!H
M%X_*!WQS6840MHY9?ZL.I05<8J=\DIQ>_J.^?U]A=J (:VYCYYR95JUF+)F/
M0-9GR9<G)^QFXI4B!T1SN(3JM@I8U+6LI'Y;M;$_D@->1*RE?KI@L:@A:L]C
M':0#5A]E8*!^0$UF\)X?)VYER)E?!QAT X3,LS=N[%]'HIEP3V(QD0YQIV3I
M?FAR]F=W:K1T/VGM5>EU@6Q-/[QVI&YW)@)W6F_\!#)["7$2L<)L+&FKH7MM
MSVN,D !O4&U0?6MPO6[_:<-R('"?50YS>'(R/OATH'.:)5=U#W1X ^%Y<G7)
ML#%IM7/TG\UK?G3?CGMM('6X>_9NK7:,:'IP,'=@4^UQH7@N/?YRR7C<)(=R
MYGDF YEYZWI&KI)G@GX?GB9I9GXMC-IK(7XN>I5LQWXI9SAN:7XP4MEO[GX[
M/1QQ%WX\(])PX7X0 UMZ4WXKK1!EGXA'G+-GF(>+BVQI:8:Z>2YK((7A9A-L
MT8454==N;(1G/$MODH/'(S!O!H-3 R9ZK8&"J]9D&))]FX!F'Y#\BD%G^H]9
M> YIOXVO905K>HP:4/9M%HJO.Y1N.HF((J!M78D? OIZ^8(#JMQBW)RUFHED
M[)IRB4MFRY?^=Q]HE96%9"5J7),U4#9K_I$F.O]M$H^/(B]KZH[< M5[-X'J
MJB-A[*;MF<QC_J/IB(1EV:"H=E9GGYUB8V!I:IIA3X!K%)?1.FYL(986(<EJ
MJI.0 K=[:H'6J:UA1;$?F49C5*U;A^AE(JE-=;%FW*5%8L5HHJ&D3OIJ2IZV
M.>MK2ISZ(4]IBI:% I][DX'%I:1W%5[#EGIWKV&ZAC1X7&1T=*=Y%&;[8?!Y
MTVEG3@9ZFVNW.(M[9FV_'LM\.V[3  "  ')@I'AT>6B-E5IU5&J.A0%V)6QI
M<XMV]FXG8.YWRV_532)XHW%L-\-Y9G+''BAYV'-1  "  '<%HS9R%W)0E )S
M'W-N@^1T#G1T<FAT^'5F7^QUX'933$9VQW<V-Q%WA7?M'9UWDG@'  "  'L8
MH<1O]7OWDHUQ%WQ/@EAR'WR,<1ES'GRY7KAT)7SI2SQU'GT8-C5UU7TV'/-U
M=WT#  "  'ZBH&QN)H6<D3AO6H4[@0AP=82W;]1Q@X0?7;1RE(.02E5SGX,7
M-7QT38*M'&ISA8)O  "  (  GU!LKX]6D"!M[XX^?_AO$XSW;LUP+(N=7+UQ
M18I528UR3(DV--MR\HAC&^]QRXA+  "  (  GFUK@)D3CSQLR)='?Q1M[I4_
M;?!O"Y,G6^YP+I$T2-QQ-X^(-%EQQ8YQ&Y!P78U8  "  (  G<1JEJ+3CHIK
MXZ!7?EAM!9V1;35N'9J\6S9O0I@K2#!P4I89,]%PU)4?&SIO-9%Z  "  (
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M*GIR=Y=YA7K;9WEYX7LY5A!Z3GN.0W%ZP'O<+PE[&WP*%69['7NF  "  (
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MCZ6*<WUS]**38U5T49^/4E-TQIS]0#-U.9MJ+&QU,YF,$XMTM(TW  "  (
MBRR(?EWP?A&'K6#';].''6-J8$>&N&7;3W2&<6@G/2N&9FH[*+R&[6NY#@:(
M_FM'  "  'G3BE&&-&:M?3J%I&BU;NR%+6J:7W.$SFQB3KJ$BFX//(^$?&^/
M*$"$WW"/#=>&26_U  "  'U8B5Z$!V]3?!V#I'"C;>V#0G';7G>"\W+Z3=^"
MNW0+.]B"L73Z)[."]W6'#9Z#YW3O  "  (  B$^"%'?H>OJ!Q7B7;+B!>'DJ
M782!,GFH30"!#7H>.R.!!WJ!)RR!,GJK#6:!T7I=  "  (  ATJ 5H"+>?V
M&X"C:\)_WX"67(M_IH!N3&=_>X!).JA_?8 M)MQ_CH 0#5)__G_H  "  (
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M%H7[8%Z'*H6'4@N&0H3X0KJ%?(1Q,?*$]X0@'FZ$^80[!I&$/(+;  "  (
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M1V9O6+26HFA 2N&5(VGX.[:3ZFN#*J^3;FRK%C"5%VR4 "^0OFZV  "  (
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MU8JA552/18GD1[.-OXD5.0:,=HAV*,^+G8A1%76+XX@$ 0.'WX"O  "  (
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MN&NX31F>E&SQ/_B<FFX>,7^;$6\:(-":P6^5#'V<;&\&  "*>W>B  "  (
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M2HZ;2M.8'(V^/=B5_8S;+ZZ41(QV'XN3?HRO#(F3)8AZ  "%(8    "  (
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M)F_]05>GJ'"Y-.>E57%M)M^CO''L%@JD3G&K!(2A7'+\  "%07Z*  "  (
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M>I(B0*>ANI%5-"Z?(Y"D)F>=+Y"9%B:<]HWD!6J8<(.I  "!@(    "  (
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M9I#8=D9F-H]F9B%G[8WB50UIDHQ]0M9J](M6+Q5K:HJL%IUK(XG'  "  (
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M6)9$:Y5L?)2!7%UMB9*I3"-NCI$/.JIO6X_V)X!O)X_L#P!Q4(HE  "  (
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M#7+W9)9Z:'0%5BYZNW3W1EM[('73-1=[AW:((71[U';0"+)]<'<+  "  (
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M)YK]8/-SFYD04I-S\I<.0S5T296!,G1T>I42'X%SMI+6""QW"H6&  "  (
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M'7B160Z ZGDB2UV MWF8/)F DWG\*^B J7I"&$B _WH3 FZ!1'O   "  (
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M,'U+3@"(9WU[00F'GWV-,MZ'!'V9(MF&S'VC#PN'$GVU  " &X    "  (
M9%J(B(2+65*'YH1W36B'((0O0':&5(/0,EJ%L(.*(H"%6(.)#S.%(8-'  "
M (    "  (  8]Z'@(Q%60V&[XOE32^&'XLD0#^%+(H[,B^$9XFP(C:$!HH!
M#N6#H(?R  "  (    "  (  8WR&L9096*V&(9-\3,N%39)3/^&$3Y$&,>.#
M<Y!N(@*"[9 J#MN"78H+  "  (    "  (  7.">\57?4D*=65B?1L"<"%M%
M.?F:^UVX*XF:?5^^&DF;S6"X!H2<2F$$  "#HVU)  "  (  7 :<W5T=4:R;
M65]51C>9]&%Y.968P&-R*U&8%&4,&E"9$66T!M^8W67C  ""$'(Q  "  (
M6U^:A61#4/69&V7\19^7O6>B.066A&DF*NJ5Q6I6&B:6AVJU!Q>5G&KD  "
MEW<4  "  (  6K:80&M:4#B6YVR>1-&5EVW..&J486[C*FJ3GV^Q&=V4,V_.
M!RZ2L7 C  "  'ME  "  (  6@R63'*!3Y*5!'-;1#"3MW0<-\:2?'2W*@*1
MJW4M&922''4A!S&0*G7>  "  '\N  "  (  67.4MWG(3P:3?7I#0[&2+GJ5
M-U&0Z7K#*9B0!'K?&7&0+7K,!SN-^'O1  "  (    "  (  6/"3:X$33I:2
M/H$[0TR0ZH$C-NV/EX#L*2Z.I8#.&2".J8#K!U",'(#@  "  (    "  (
M6(B27(A@3B^1.H@[0N>/YH?$-I".AH<V*-R-?H<&&+>-<X='!RN*HX39  "
M (    "  (  6#>1CH_E3@F0<H^C0L./%8[.-F^-D(W;*.*,5XW"&/F,"(RA
M!W*)5(4)  "  (    "  (  4*:J851-1F*HF%;2.TVG#5D]+NREY%MI((:E
MV5SW#I>HHUT(  "@"&!\  "  '$N  "  (  3\:HE%LJ1<2FS%TW.K^E'E\R
M+H6CP6#W(%NC;6(K#L>ELF('  "=;&45  "  '7X  "  (  3SVF4V'O12VD
MEF...D&BZV48+A&A?F9Y(!.A!V=6#M&BX6<*  ":WFGN  "  'H\  "  (
M3L>D"VBG1*.B66G>.:2@MFL!+:&?26P '\">OVR1#L:@/VPH  "8=V\K  "
M 'W_  "  (  3DNB"V]Q1"N@:W!..3.>Q7$1+2N=3'&D'XR<I7'V#L"=V7&.
M #66 '4)  "  (    "  (  3=>@:G9@0\J>TW;P..2=*'=5+.N;GG>1'UB:
MUW><#MB;J7=> '&3VGI4  "  (    "  (  37.?$WU50W^=@WVB.*N;SWVP
M++>:-WV>'R:977V,#M&9Y7VU +"2"7[.  "  (    "  (  322> X190TJ<
M<X1Q.(&:MH0R+)F9"(/?'PJ8$H/D#JJ8=X-[ +60F8![  "  (    "  (
M3/&=*8N/0RB;E(N&.&29T(L(+(:8$(J.'Q.6\XJO#MF7'HA$ -V/9X"6  "
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M:H(';J)>\H'?7V5A1H&@3R=C9X%D/9UE"X$[*DUE)($L$>9H]X$[  "  (
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M6H?*9 ]D3(<T5:YF#8:&1CUGF(7K-7!HDX6"(J1GI(6*"LMNSX1#  "  (
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M0XRQ67AJEHO-2^1KL(K./2ALDXH&+-QLWXFZ&BMK]HG,!)EX.H,<  "  (
M<15F<96-981H&I2.6/=I<),B2V5J@Y&>/+UK6)" +(IKA9!?&=!JM(Z(!&QX
MAX+]  "  (  ;,6"V5)[88*"S57G54B"]%DL1\N#.5P].-:#H5\!)]F$>&$L
M$O2&NV&5  "#.F6N  "  'P#:Y9_A%I.8)!_P5TA5&: !U_01Q" 56)3.$.
MN620)W2!:V9$$M>"^V9?  "!"6IB  "  '\V:H1\4V(C7V]\RV1>4W9],F9\
M1BY]D&AN-XM]^&HG)NI^BFMG$I1_B6L_  "  &]Z  "  (  :6UY9FGX7DYZ
M!&NA4E%ZA6TM14MZ]VZ8-K][:&_.)DQ[VW"A$CE\CW!(  "  '3^  "  (
M:&-VU7'3751WD'+U45UX)7/U1%%XHG31-B-Y"W6-)<AY8'8#$?5Y^'6>  "
M 'GB  "  (  9W-TH'G%7'!U>'IB4(AV'GK50YIVG7LE-7]V_WMD)7UW'WN2
M$==WN7M@  "  'X)  "  (  9JYRR(&S6\MSO8';3_9T:X'%0PMTXX&,-.EU
M.8%C)/=U+X%D$:EUVH&)  "  (    "  (  9A)Q28F:6S1R38E53V)S 8B]
M0H)S=(@%-&=SNX>+)')SB8>;$4MT:H;!  "  (    "  (  99AP%I&&6KYQ
M*)#J3NMQX(_;0A-R2XZS- MR?HX")"]R(8XV$1%S/XKP  "  (    "  (
M8*:,;U&85@>+[53<2G>+J5?]/9R+E5KD+QJ+UUUE'@B-*5[Z"8".:E\I  "
M &EI  "  'YP7X^)4EC^52N)$5N[2:J(WEY5//6(Q&"\+J&([F+&'<F)^6/X
M":2*J&/]  "  &XI  "  (  7I^&06!C5"V&,6*82->&%V2O/"^&!&:6+@6&
M)&@I'6*&]6C]":.'46CK  "  '-D  "  (  7;"#:&?)4S*#=VEZ1]6#<6L-
M.V>#:FQZ+56#B6V<'..$)&X8"8:$9VX,  "  'A;  "  (  7,: Z&\]4DZ!
M$G!Q1O2!''&%.HN!%7)O+,"!)W,M'&>!CG-C"6&!XW.*  "  'RL  "  (
M6_1^QW;$48A_"G>%1CU_'W@<.=U_%WB.+"-_%'CB'"5_*'CQ"5I_M'F9  "
M (    "  (  6SQ\\'X]4-=]3WZ219E];WZT.4=]9'ZW*YM]3WZZ&]%])'[$
M"8U]TG\S  "  (    "  (  6JQ[>87+4'1[^87.149\&X5X.09[\83]*V][
MMH3#&XU[6H4;"5)\7(/?  "  (    "  (  6CMZ2HUL4 5ZUXTK1-EZ_XQM
M.*=ZS8N2*R=Z=8M(&V)YV8LR"4Q[*H9)  "  (    "  (  5*66W% ]2HR5
M\5-5/XF53U9*,R:5 ECZ),^5=UL6$N^84ENH 8*4I5V-  "  &T4  "  (
M4YZ3_5<_2;R31%G@/L62IUQ=,HB21%Z;)&>2B&!/$MB4YV"9 =21"F)I  "
M ''X  "  (  4LN1#%X_2-R0>6!G/@J/[&)M,=B/AV0Y(^2/KV6'$IN1I&6.
M @:-RV=G  "  ';D  "  (  4@".0F5 2 :-R&;Q/2B-2VB!,2^,Z6GA(U2-
M 6K0$DJ.DVJ= A^*\&RD  "  'L\  "  (  43F+R&Q51T2+:6V6/&N*]VZU
M,'2*CV^>(N.*BG ]$?Z+OF_F BV(>'):  "  '\&  "  (  4(*)JW. 1IF)
M9W1<.]*(_74-+^J(C'6/(FF(:'77$>*)'W6( D6&57A*  "  (    "  (
M3^*'XGJI1@R'N'LM.UB'5'MU+X"&U7N7(@2&DWNF$:B&Y7N+ G"$@GU7  "
M (    "  (  3V"&8X'$18B&4H'P.MB%]H'7+PR%<(&G(9N%$8&F$2^%&('#
M F&#$8%U  "  (    "  (  3OB%-(DS15J%1HE .KF$\XB]+Q"$.(@4(>V#
M@X@:$>2#'8<D M>!M('L  "  (    "  (  2%BB<4Y?/M^A/%%"-&F@9U/V
M*%F@*%9.&<.A<U>_"*.C&UAE  "1E%_D  "  '!Z  "  (  1T>?YE3^/?B>
M[%=W,WB>&EG%)X^=KUN\&46>H5S8"*>?<UU9  ".W&1^  "  '51  "  (
M1IN=#5N=/32<+5VL,L*;;U^.)MN:^6$D&,.;O6'J")>;SF)0  ",0VE1  "
M 'FI  "  (  1@>:/&(Z/(29;V/<,?:8O&56)D"81V:+&$>8[6<&"("83&=?
M  ")WFY\  "  'V   "  (  1627N&CH.]V7#&HI,5Z66&M ):B5TFP*%_N6
M3&Q+"'65#VRO  "'QG0O  "  (    "  (  1,65DV^^.TJ5"G"G,.246W%?
M)4R3OG'3%[B4 ''0")*2*7)D  "&$'EG  "  (    "  (  1#N3PG:<.L^3
M6G<Y,(*2KG>6)/B2 7>\%VB2'G>9"(*/TGB;  "$LGW*  "  (    "  (
M0\F207V0.FV1]GWM,#*13WWX),.0B'W:%T*0<WW("%*-\'YX  "#18    "
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M#)@6;59'BI7U7H9+DI/R3J!/"I)%/8)119$=*N%0K9$3$]]>:8U   "  (
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M]'.J9T%7*72Y6-1:#W6R25Q<GW:=.$Q>2W=Q)6==@W@)#7YI,7@Z  "  (
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M:7G'7+!;*WI.3Q%=EGJ\0%1?B7LB, =@6'N#'4]@B7N[!M9T<GSJ  "  (
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MXW[T4AM@'W\,139A\G\+-QMC*W\3)T=BWG\O%'%FNW]F 21^$W_Z  "  (
M:"59 X; 741;NX:/47E>"X871*!?XX6)-HEA"(4I)K1@884F% 9E5(5$ 3!]
M_H#.  "  (  9YY7+8[&7,5: (XS4/=<7HTV1")>,HPB-B!?/XMJ)F=>88N)
M$[!D.(GS 0]^-8"X  "  (  9.-Z#$U:6=QZN%#X3@=[B%2"00-\9%?=,G1]
M3%K;(91^@%T-#,R H%UX  "  &6=  "  'NT8T5UPE3?6*AVP5@"3/UWNEL%
M0"IXI%W8,<AY@F!3(1QZ9V(1#+1\K&(]  "  &I(  "  '[T8?%QIUR#5UUR
M[E\72^YT$F&0/R]U#V/7,/IUYF70((%V>&<>#'QY06<:  "  &]6  "  (
M8+!MU60R5AMO468T2K!PEV@=/C=QK&G?,!YR?FM9']5RLVP_##!V6&P@  "
M '31  "  (  7X1J7&OH50-L!&U?2:1M:6Z\/2QNBV_S+WAO3W#Y'TMO'7&(
M"_YST'%N  "  'FR  "  (  7G9G1G.R5 9I&72D2+YJG'5T/&IKQW8B+L]L
M=':P'P-KVW;]"_1QF7<?  "  'W3  "  (  79ADDWMX4TMFE7OS2!MH,WPZ
M.])I7WQB+C-IZ'R+'GII'7RL"]=OPGT]  "  (    "  (  7.=B2H,R4J1D
M;8-!1WUF(8,'.T-G3(*S+:MGLX**'>QFZH*W"XIN7()[  "  (    "  (
M7&)@;8KL4B9BJHJE1O]D;HGU.LQEE8DM+4MEV(C,':AE)HDJ"UEM/H:J  "
M (    "  (  6/.#7$Q@3JN#ED_=0X2$!%,^-PJ$FE9A*+R%@%D"%U:'B5I<
M!'&'U5NB  "  &DU  "  'X:5WA_3E-\381_U5:*0GF 8%EQ-BR \5P;*!.!
ML5Y)%O&#,U]#!(V$"&!N  "  &WQ  "  (  5DA[6EJS3%1\'UU 07M\R5^J
M-3Y]7V'7)U-^ F.1%FM^^V0O!(J MF56  "  ',D  "  (  52MWHF'U2S%X
MDF/]0%9Y567D-%AY]V>:)HAZ?VCF%=-Z^&DO!'-]W&IO  "  '@@  "  (
M5!IT.6E'2BEU4FK./U5V+VPV,V)VT&UL)>)W-VY8%4=WA&Y>!%I[:6_C  "
M 'QR  "  (  4R9Q+'"K24-R;W&[/H1S9'*F,J%T!G-G)3=T/7/K%05TAW/3
M!&)Y0W7?  "  (    "  (  4E%N=W@*2'-OYWBI/<1P]GD:,?5QEGEK)*%Q
MFWF?%*)R)GF !)!X2GMS  "  (    "  (  4:9L)W]T1^]MS'^X/5AN]W^Q
M,:AOB7^-)&5O4G^)%$)P.G^P!%QXHH G  "  (    "  (  425J/X;R1V]L
M 8;I/-QM089X,3EMSH7S)!%M9(7;%!!NI(6X!%%XM8+K  "  (    "  (
M3.^-H$K70V"-:DXV.-6-@U%I++V-_U1$'E6/7U97#("1W5;V  ")BEPT  "
M &RM  "  (  2Y.)RU&40CB)YE2+-[6*%U=0*\6*?UF^'9F+F%ML##F-%5O6
M  "&3F#?  "  '&.  "  (  2H6%^EAG01R&2UKI-KR&E%T\*M>&\U\['-R'
MU&"$"^2(GF"_  "#5&6Z  "  ':(  "  (  28V"5%]'0!>"R&%/-:N#(V,K
M*@&#@62_'""$,66K"XB$MV7"  " JFK>  "  'KK  "  (  2)M^\68\/R=_
MCV?.-,)__FDW*1Z 3VI7&Y6 P6KX"SN!8&K]  "  '!Y  "  'Z^  "  (
M1[I[XFU,/DU\L&YP,_Y]-F]H*'%]?7 B&OM]IG!L"Q-^AG"'  "  '95  "
M (    "  (  1OAY,71=/95Z+74=,UQZRW6G)^9[!78#&G)ZYW83"M1\-G9L
M  "  'M'  "  (    "  (  1D]VT'ML/.MX WO0,KUXO'OX)UUX[7P &?IX
MA'O["FUZ;WRM  "  ']X  "  (    "  (  1=-TVX*\/(=V1(+@,F]W((*?
M)SIW.8)+&B1V<H);"LYXM8(&  "  (    "  (    "  (  0)F914BK-[*8
MK4OE+:.8E$[4(:J945$[$GF<,E)3 U*9OE1@  "$LE^*  "  ' -  "  (
M/S>5O$\$-E25CE'9+"R5F51B($N60%9F$6Z8H5<O PF5%5D_  "!KF1   "
M '4!  "  (  /D&2%E5X-3J2&5?A*QZ2/EH"'SJ2UUN@$*"4PUP? M*0SUXN
M  "  &DC  "  'ET  "  (  /6^.?5O]-%".GUWV*AB.U5^I'F>/9&#H#_^0
MUV$J JJ-!F,Z  "  &Y6  "  'U8  "  (  /)J+%&*:,W2+:60F*42+K65T
M'9F,(F9+#Z>-$&9G IF)Q6B'  "  '0$  "  (    "  (  .\N'\FE=,J:(
MAVJ!*)"(Y6MK'0:)0FOQ#S^)I&O6 J:' VXP  "  'D[  "  (    "  (
M.Q6%*7 I,?2%_G#O)_B&=W%Y'(V&OW&T#N>&KG&& I:$Q713  "  'V8  "
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M?CQ\/7P^?#]]0']!@D*%0XE$C4621IA'FDB;29U*GTNC3*9-JDZO3[10NE'
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M&IV$F AI(YEFE(585I51D05( I$PC6LX6HSPB:\J#8ANA=2KGJGOJUZ;1*6
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M:K2(B$!3'ZU<AOI&,*7PA=<Y]YXLA,4NN98%@]TE&XV-@QJ)(\A"E%![@L&
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M@.<F>HHI@1"8(J^6BWN)R:KTB=M[+J9:B&)L6:''AQM=8IT_A@-.DIBAA0%
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MAKIGQK;2A71;*;!0A'1.K*FB@[1"A:*W@Q4W%IM]@HHLGI/P@B4CP(PS@=^
M^\)3CJ]T6[PJC*-GL+77BL];#*]6B2U.H*BFA[E"B:'-AF4W+YJDA1@LUI,P
M@^8D'(N8@M: W,&4E1]T2[M@DGYGJK4$D E;#:Z!C<).H*?6BYA"E*#\B8,W
M2IGFAW4M!Y*,A7LD:(L6@ZJ O<#YFV)T0+JZF"-GJK13E05;$ZW.DA!.J:<K
MCS5"I*!:C&0W99E#B9<M,Y(!AMTDIXJLA%R G\!^H7)T.;HSG8QGK[/"F;M;
M'*TUE@Y.LZ:7DH%"LI_7COHW?)C*BWDM6)&0B XDVHI5A.^ A\ 9IU!T.+G
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MIV*<[8 $HO:)^7^7GG%VYW]7F?)CY7\ZE651+G\SD*T^MW]>BYTM$'^@A@G
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MD@%=E(2MCN%,)(.WBZD[%8+9B#0K"8( A&VSDHIVIU6C&(CWHX>1_X>,GXR
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MKWK8I.ZF$GKDH7^4R7KRG<V"^WL;F?=Q 'MNEAU?!GOFDC%-97QXCAX\%7U
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M&F'WN>NQ]&1@M%*?&6:?KE>+V&CHJ"UXD6MKH@=E;6XIF]!2IW$5E5Q /W1
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MKX.(;E.6E8,2;^^'C(*O<71WQH)<<O9G?H(8=(A7#8'E=C1&ZH'!=_PW(X'
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M?(<F/H,'?=V6(HDC?AJ(^8@0?D=[)H<,?E]LV880?G%>$H4N?H]/2H1;?KA
MYH.1?NHR_8+C?R4F6())?V:5-8?+AE>($(;(A=)Z1X72A2ML H3EA&Y=?(0,
M@[%.VX-6@P- GH*K@E RX((?@9,F;H&F@,B4:X;)CH^'8X71C5IYH(3>B^QK
M28/VBE9<SX,IB+Q.6H)\ARE 1X'JA8XRN8%Y@]0F@($<@@"3QX7[EI^&MX4-
ME+9X]809DGIJIH,SD I<-X)QC9--XX'0BQA "(%#B) RH(#LA=TFCX"I@PR3
M1X5?GH&&,H1YF^)X:(.!F--J'X*3E7Y;N8'4DB%-;H%&CKP_N(#&BTHRBH!X
MAZDFG(!+@^^2[(3OICJ%R80.HN5W[X,-GO=II8(3FJ];4X%/EF1-(X#'DA0_
M@X!9C;4R;8 >B2TFIH  A*F,*)<#9*V 'I309R!S69+4:8-EWY#H:^-8!([K
M;E=*&8SA</8\H(K-<\ OG(B\=M\CS(:W>F.+CI5X;,)_D9-N;F!RP9%W;_UE
M68^'<:97DHV/<V=)PHN7=4P\9XF8=U,OE8>A>9DD#H6U?"&*YI/:=*1^Q)'P
M=8ER$) &=F]DK(XE=V%7!8Q >&M)6HIA>9 \*8A]>LTOC8:C?#(D2(33?;N*
M'I)7?%U]Z9!\?)YQ)XZG?-5C]HS4?1)6:8L+?5Y(ZHE&?;P[YX=^?B8O@(7"
M?J4D>80.?S&)59$6A )]*8]'@Z5P:XU[@S%C-XNU@K%5YXGR@C-(A8A)@<<[
MK8:;@5@O=X3Z@.PDI(-E@'Z(K9 /BZI\@HY.BJEOR(R)B7UBI(K#B#)59HD)
MAN1(.X=CA9\[@87.A%HO;81-@P,DR(+6@:*()8]'DRU\#(V2D8QO5(O'CYYB
M)XG[C8%4ZXA*BV)'VH:TB44[584CAR,O9(.ZA.0DY8)@@IV'N8ZSFGY[GHT!
MF#ANX8LQE85ANHE>DI%4A8>OCYI'?(8GC*$[&82BB:4O78-"AHDD_8( @V^'
M:(Y&H9Y[1HR5GK)N?XJ\FS)A68C?EUU4-(<LDX='0H6IC[$Z\80SB]@O38+G
MA^HE$(&SA!N 0J ,9%MT]ITX9K]I))J":2%<RY?":XU0+93=;A5#E)';<,LW
M@(Z_<ZLL XN5=MXAV(AN>F1_NIZZ:_UTD)OT;9EHO9DR;T%<=I9D</]/ZY-_
M<MQ#:I"*=.(W<XV =PHL)(IM>7,B.(=??!)_-ITR<V-S\9J#=%-H.I?'=4Y;
M^)4"=F%/B9(L=Y%#*X]->.,W6XQ;>DXL/HEC>^4BC(9R?9Q^GINU>IMS29D3
M>O-GAY9H>TQ;<).P>[5/%Y#R?#1"X(XK?,DW.XM3?6\L3XAX?C BU86D?O]^
M!)IV@<%RL9?@@8AF[Y4]@4):W)*-@/9.LX_9@+M"EHTJ@) W&HII@&HL7(>I
M@% C$H3U@#M]?9E^B-UR-);QB!)F>)1/AR)::)&@AA].38[PA1Y"98Q A"@W
M!XF7@S@L:8;U@D$C1H1A@4Y]$IBNC\YQQY8JCFQF"Y.)C,U: )#;BPQ-]8XR
MB4A"+8N,AX8W HC?A<<L>899@_TC<(/G@CE\O9@=EI5QEY6>E*AEVY+ODDY9
MQI JC[5-NHU]C2)![HKMBI@VV(A5B!4L@(7;A8$CDH.$@OU\?)>TG2AQ5Y4L
MFJ9EE9)SEXQ9?X^FE"%-@8SVD+Y!QXIJC64VPX?BBA<L@85]AL,CKH,U@YUT
MZZE08^AJ3Z7C9CU?8*)R:*%4'Y[0:QY(N9KN;;X];Y;9<) ROI*?<XPHP(Y(
M=MD@(HGX>F)T=:@U:R-J$*2X;+I?+:$D;FY3_YUJ<$1(J9F#<D(]=)5Y=&XR
MW9%/=KTI!XT.>4P@GHC;? -T%::\<A1IGZ-)<PU>V9^U=!Q3L9O]=5-(=)@C
M=JT]7Y0N># RZY :><XI0HOV>YLA"H?B?7YSK*4\>-%I)Z'4>3]>5YY,>;E3
M5IJB>D](+9;<>P4].I+^>]8R[H\$?+PI<(K]?<$A9X<+?M-S0*/V?WQHP*"7
M?V==\)T6?T]2[9ER?SI'[I6V?T$]%)'O?UXR[(X.?X4IEHHD?[XAM895?_]R
MX:+[AAYH;I^@A85=HYP=A,]2HYAYA Y'KY3"@UH\^)#_@K@R[(TS@B IM(EH
M@8XA]X6\@01RDJ(WC(]H+Y[;BW5=:IM2BAQ2:)>JB*9'=I/ZASH\V9!!A=DR
M](QVA(,ITHC&@RHB+84]@>%R6:&9DL5G^YX\D2)=,IJOCR12,9<"C/9'1)-4
MBL\\J8^KB*\RY8ODAJ$I\(@_A) B6837@IER*Z$PF-5G_9W(EKU=+YHFE 12
M')9@D/Q'.Y*FC@P\M(\#BS0R]HM>B'4J!(?:A;DB?(2%@R]J";+78VI?_*[H
M9:E5X:JY: U+L*8D:IM!@*$K;5@WB9OH<$TN/99T<VLEO9#9=M,>H(M<>F!I
MF+'R:D!?UZW2:\M5UJEI;8E+NJ2Q;WA!G)^N<9LWN9IT<_,NA94/_^+_XDE#
M0U]04D]&24Q%  ()=G F*(^->2@?-HHP>_5I6["$<,)?DZQ@<;M5K*?R<MM+
MF:,U=#=!DIX\=<$WRYD5=WHNN)/'>5$F@HYC>U8?MXDK?61I)*[Y=PA?3ZK;
M=X-57Z9V>!I+:Z'(>-]!=ISA>= WS9?2>N,NW9*?? XFS(U<?5L@)XA+?JIH
MZJVB?3E?'*F+?4%5+:4I?51+-*"!?7=!9)NH?<0WSI:P?BXN_)&7?J<G"XQV
M?S8@A8>-?\IHMZR9@V-? *AZ@OE5%Z05@GM+'I]O@?Y!3YJ?@9<WU)6P@4PO
M&9"P@1,G08NP@.8@TX;N@,)HCJO*B5M>\:>>B'Y5#J,PAVI+$IZ+AD5!0YG$
MA3$WUY3BA#$O-X_I@T0G<HL)@F(A%(9K@9-H;JLOCQM>[Z;PC<E5#Z)UC!M+
M#9W*BD5!.)D(B($WS90YAM O08]/A3<GF(I_@ZLA2(8!@D%H6JJ^E*%>]J9B
MDME5%Z'8D(A+#YTGC?U!/)AGBX,WVY.CB20O3([-AM\GJHH4A+8A<H6M@LW"
MSV@.8."Q2FI.8[^?46QY9HR,PFZ9:4UYPW##;!-FEG,(;O!3GW5R<?) Z'@@
M=3PO"'LL>0+ [F5%:W^OTV?(;46>!FHJ;P>+GVR <,QXO&[C<IIEKG%D=']2
MV'0*=GQ 57;U>+$NP7H]>SF_*6+8=@2N(F6&=K><E6@8=VR*16J;>#9WCVTP
M>1!DL6_F>?Q2$7+$>O<_S'7G?!$N@7EE?5.]:6"P@%FL:F.#@ Z:ZF8V?\R(
MW6CC?Y9V4FNI?WECKFZ0?V=13G&A?UD_2W3X?U,N2GBE?TR[SU[9BHRJYF')
MB5F9<62;B"6'=F=FAO1U+VI/A<YBO&UFA+M0FW"E@YT^V70H@F\N&G?^@1RZ
M@5U>E*NIJ6!CDI>80V-(D&R&5F8KCCMT*6DPC ]AZ&QDB>=/_F_,A[4^='-W
MA5LM\G=N@K^Y=UPMGJ:HKE]!FZZ736(PF(F%:V4CE5-S4VA!DB%A-VN1CN=/
M?&\4BY(^(W+AB LMT';VA#"XL5M$J&ZG\%YAI(R6BV%3H&B$JF1,G"5RFV=[
ME^=@F&KEDY]/!VZ"CRT]W')FBG8MM7:2A6VX,UJDL>JG<%W"K0N5^V"NI]R$
M$F.DHHUR#6;8G4-@(&I2E^M.GVX"DF(]D7'^C(XMGW9"AG>U?F^N8%ZEHW$F
M8V.5%G*=9D*#QW08:0MQ]76C:]I?]'=);L5.,7D1<=@\N'L6=3@L+7UP>1>T
M&&T3:GFDE&[.;'"4&7!T;E*"WG(8<"]Q'W//<A5?.W6H=!1-GG>G=C(\5'GI
M>(DL!'Q^>S:RF6J_=&ZB_&RF=6:2K6YT=E2!B7!%=T9O_'(K>$9>2G0X>5I,
MXG9K>G\[VWC@>\4KX'NF?3:Q#&BO?C2A;&JV?D:1*&RF?DR 1FZ9?E%NWW"P
M?F5=97+J?H9,.G5-?JT[<W?T?M\KP'KF?Q2OFV;JA^&@#6D,AQJ/TFL9ACQ^
M_VTJA5)MWF]?A&Y<CW''@YA+H'15@KH[%W<F@<\KI7I @,FN;V5^D7^>ZF>R
MC^".O&G1CAA]^&OYC#IL\&Y(BEM;U7#*B'Y+&7. AIDZQG9WA(\KCGFR@E&M
M@618FOF> 6::F'^-UVC"E<=]'VKYDO!L+&UAD!9;-V_^C31*K'+*BCHZAG7C
MAQ,K>WD[@ZBLT&-XI$"=3V7 H.>-'6?LG3E\:&HHF6!K@&R@E85:H6]8D9]*
M0G(]C9@Z3G5IB50K:WC9A,ZL7V+>K3^<T&4FJ/Z,C6=*I%)[TFF#GW)J^&P"
MFI-:-&['E:=)XW'"D)0Z"G4'BT$K7WB*A<.HAW>(8 ::+G@P8QN*^'CO9@-Z
MXGG":-%J/WJF:Z=9;7NC;IY(Y7R]<< XL'X-=34I?7^D>2FG:G41:829'W7^
M:YZ)W';H;9YYX7??;Y1I7GCL<958LWH6<[)(5GM@=>TX6GSD>&4I<GZM>S&F
M.'+3<NV7VW/Q=!R(U'4"=3MXVW8==E-H?W=.=WE8 7BE>+5'V'H?>@4X$GO7
M>W@I:'W2?1FDVG#3?"J6?7(1?(B'9G-#?,YWK71^?0IG='7??5%7*W=C?:1'
M/7D*?@$WNWKN?FHI8'T0?MVCDF\CA4Z5/7!XA.*&,7'%A%-VB7,;@ZYFE'26
M@PM6<G9%@G)&NW@4@=8W='HA@3 I67QI@'BBA6W'CF>4-V\MC2^%-G")B\-U
MG7'UBC9EP'.(B*55TG5-AQ-&2W= A7PW-WER@\4I4WO:@>:AKVRMEUN386X@
ME56$96^%DP5TUW#^D(QE#G*HC@M5172%BX%%\':,B.0W"'C>AAXI3GMC@R6A
M#VO4H!V2NVU/G42#N&ZWF@MT,' TEIQD<7'MDR54O'/DCZ-%DG8"C 8VW7AD
MB#4I2GL!A#:@I6L\J)R20FRYI.V#+6X;H,-SHV^5G%=C]7%3E^946W-7DVA%
M/G6*CLLVHW@$B?PI1WJSA1>;Z'^=7]&.PW]Z8N. OG^#9<QQVG^I:)]B;7_>
M:WY2UH D;H%#EX!_<;$TN8$&=3<F^('$>3>:^GU':+^-TWUK:NE_OWV?;/IP
M\WWB;P5AIGXX<1Y2-WZE<U1#(W\J=:LT@'_>>$$G#(#&>RJ9\'LF<8>,I'M[
M<N!^O'O.="9O^GPR=6=@V7RK=K11F'U!>!9"N'WQ>8\T3G[2>RXG'7_E?/N8
MSWDV>C^+=WFM>M-]C'HA>TQO&'J?>\%@%'L_?#E1!7O\?,!"6GS5?5(T)7WC
M??4G+'\??J:7KW>8@MV*?'@E@KI\DGBQ@FYN$'E(@@E?2GH @:9077KF@4Q!
MYGOE@/$S[GT7@)(G.7YU@"F6OW9.BV^)BW;JBHU[JG>#B7%M.7@KB#)>BGCX
MANQ/TGGQA:=!B'L1A%XSP7QF@OPG0WWD@8"5_W5!D]B(S'7JDC5Z\7:*D$5L
MBG<^CB9=[7@>B_U/6'DLB<Q!0GI<AXTSHWO0A2LG3'UL@JF5;'1QG ^(-74C
MF:EZ577%EMYK]G9[D]==8W=HD,5.WGB/C:9 \'G2BG8SA7M5AQLG4WT)@Z65
M!G/:I :'P722H-YYU'4PG3%K=G7BF3I<]G;2E3A.BW@$D2I J7E<C08S5WKW
MB+TG67RZA'6/EX?O7ZF#=X<18J]VB(9I999HS87;:&]:F(52:UA,183/;FD^
M6X17<:8PY8/]=3PDI8/+>4*.RX7):!""LH4N:D!UN(2F;%YH%H0L;GM9_X.Z
M<*I+T8-8<OH^#X,#=6PPT(+1>" DUH+#>R&-Z8/ <%&!K(-6<<!TU8+K<R%G
M/(*-=(%938([=?%+2X']=WD]NH'/>1HPMH'$>N4E 8':?-R,[8'O>'" HH&>
M>2YSP8%0>=AF:H$(>GE8F(#:>R5*QH#!>]X]:8"X?*8PG(#4?8,E)X$.?G*+
M^H!0@(%_NX 9@)1RY7_B@(5EE7^S@%Y8''^4@#M*;7^@@"$].7^\@ HPDW__
M?_4E1H!??]^+*'\9B(]_!G[RA_5R.G[#AR-DZ7Z;ABM7;'Z1A2Y)\'ZNA#@\
MYG[H@T P<W],@C8E87_+@2"*?WX:D&Y^6GW_CR5QE'W4C8MD3GVUB\%6W7V[
MB>Y)@WWIB!<\L'XQACDP8WZRA#\E=W]0@C6)^GU4F!9]U7U"EAQQ#GT8D[AC
MT'SXD1)6:'T(CF))&7U,BZH\;7VDB.HP57XTA@DEB7[L@QZ)F'S#GX1];'RV
MG-QPG'R(F:5C8'QCEAQ6#'QSDHA(UGS!CNX\-WTMBT@P-WW4AXHEEWZ<@]Z#
MI9"<7W-X6H\*8F-L9XVK949?RXQ::"E2T(K]:R%%R(F:;D0Y.X@W<90M/(;E
M=3XBB86O>4N"[8ZM9UAWO(U/:81KQXP!:ZU?18JX;=]298EK<"=%?X@D<I0Y
M%X;?=28M2H6P=_TBUH2;>Q>",8R^;Q5VY8N+<)!K$XI4<@E>FXDA<XE1X(?O
M=1Y%(H;(=L\XZ(6F>)TM4(2;>IHC&H.H?+^!8(KV=JYV"(G;=XAJ+XB^>%9=
M](>@>2=15(:/>@)$Q(6*>O$XN82,>_(M4X.F?1 C58+5?D& DXEQ?C!U48AH
M?G)I@X=<?IE=0H92?JY0[85-?L=$>H1K?O(XEX..?R(M6H+,?UPCAX(@?YE_
MWH@YA:UTIH=#A4QHX88_A+U<NH4XA U0>81"@UA$2X-H@K4X?X*L@A@M78(/
M@7(CL(&(@,=_3(=&C05T-89>C IH=X5:BK]</X1/B4!/_8-GA\%#Z8*AADXX
M6H'OA-\M6H%Q@U<CTX$*@<I^V(:,E"=SP86KDI!H H2ED(5;U(.7CC1/G(*S
MB^9#BX(!B9XX((%>AUXM68#NA0$C[X"C@J-^?X8!FQ1S984BF.1GGX07EA);
M=8,#DN9/3X(<C\%#5X%QC*4X X#@B8\M4X"(AF8D!8!1@U5X,YEF7REMOY<R
M8@ABP94A9.E7.I,%9]9+;Y#$:MX_KXYL;A<T?8P(<7TIZ8FJ=3T@JH=H>5!W
MCI>X9I]M1I6E:,5B3I.0:O=6XI%M;3Q+,H\S;Y\_D(SQ<BPT?HJG=-\J%XAI
M=]HA$H9&>PUV]Y7A;>%LF9/O;V5API'K</!68(_6<I%*TXVS=$H_6(N.=B@T
M<HEE>",J/(=*>E,A;85(?*1V3I0@=/EKXI)!=>EA I!4=MA5THY6=]-*88Q1
M>. _$HI+>@<T68A$>T,J589,?*,ANX1M?A-UII*G? !K0)#9?&%@98[Y?+-5
M.XT'?/U)_XL4?5<^S8DO?<0T/(=&?CTJ9H5N?L@A_H.Q?UIU$Y%^@OQJN8^^
M@L]?Z8WC@GM4Q8OV@A!)F8H.@:H^HH@O@54T*X9D@0LJ=82N@, B-8,4@'=T
MFY"&B<IJ0X[4B0M?=XS]B Q468L4AN=)/8DVA<,^9X=GA*HT*X6?@YLJB(0)
M@H$B8X*2@6IT/(_1D&QJ"(XICRA?/XQ*C714'HI/BWU)"8AOB9(^+8:WA[8T
M X4&A>DJE(.!A LBB((H@C5S\H])EM9IP8V>E0A>]8NYDII3V8FYC]=(TX?8
MC2(^"X8EBG\S]H2&A^PJFX,9A5(BIH'3@MMM0J)O7K!C>)^D88!96IS69&-.
MYIG:9V)$3):B:H<YT9-!;>(O]8_)<6DFSXQ+=4(?!XCR>51LJ:#\9;UC')XT
M9^)9#YM0:B-.MIA$;(-$-I4,;PHYV)&\<<$P'(Y;=)XG'XK[=[X?B(?">P)L
M,9\Z;(UBF9R%;AU8K)FL;\).7I:I<8E#_I.%<W YQ9!/=8$P,8T,=[$G88G/
M>A0?]X:Y?(IKM9U\<S!B$9K8=#E8'9@1=4Q-_)4B=G=#M)(9=[XYHH\!>2,P
M.8O>>J GE8C%?$$@5X75?>IK.)P ><-AG)EL>DI7K9:O>LQ-C9/+>U!#=I#3
M>^XY?HW:?*4P.8K5?6HGO8?>?D4@J843?R)JRIK6@$MA/9A,@%)76)62@#I-
M0)*R@!1#-H_$?_PY:(S3?_PP/(GK@ @GWH<6@!L@[81P@#!J;9GIAJ1@\Y=F
MABQ7%Y2JA71- 9')A)Y"^8[E@],Y1HP#@QDP1XDA@FXG_H9K@;\A)8/I@15J
M)YDJC+]@LI:LB\-6UI/PBFE,QI$-B-]"QXXMAUXY%8M=A>LP-XB$A(XH'H7=
M@RLA4H-\@=1I[YBBDK)@IY8BD4E6RY-9CSM,LI!@C-Q"Q8UUBIDY*HJMB',P
M4(?TAF<H-H5OA%HA=H,E@G!BK*O*7AI9?:AS8-=0-Z3C8[U&T:#Q9M ]:9RE
M:ADT.)@=;9TKM9-W<4TC^H['=44=E8I4>55B%:J09,%9+Z<B9N%0!*-G:3!&
MO9]<:Z\]<9L*;F(T7Y:.<4LK_)'[=%HD:(UH=Z,>+8D6>OAAO:C>:R18U*5T
M;+Q/Q:' ;GA&BYVX<&H]79EW<H<T;943=-4L,9"<=T DQ8PL>=D>L(@"?'-A
M<*<:<598?:.\<G-/:: 5<ZE&4YPC=0D].Y?Z=I(T;9.U>#TL5X]?>@$E$8L5
M>^8?((<5?<5A(Z62=WA8.*)!>"%/*9ZB>--&$YJY>90])9:E>GXT;))]>X8L
M=HY'?)TE48HC?<H??X9+?N]@W:1=?9)8"J$.?<I/!IUQ?>U%])F-?A ]#96$
M?DHT=9%I?J0LE8U1?PXEB(E2?X(?SX6C?_!@HZ-F@WI7ZJ 5@T%.\)QU@M%%
MX)B4@D\\^Y26@>$T=9"+@8DLM(Q^@44EN8BB@08@$(48@,I@=J*HB2I7V)]/
MB(!.Y9NHAWA%UI?$ADH\[I/,A2\T:(_7A"HLO(O;@SXEX(@1@E<@1(2H@7]@
M6:(8CJ17TYZOC8=.XIK_B^%%TY<7B@ \\Y,AB#0T>8\WAH,LRHM0A.TE]8>?
M@VD@;H1.@A&W66*W6NFF]V5>7EB6*V?V8;F$SFJ-90UR_FTZ:&=A ' -:]M/
M1G,-;WD]W'9;<V@M<7H*=^.U<E]J952E?F)D9[F4X&5#:A>#K&@>;'5Q^VL1
M;MM@'VXM<5M.C'%X<_L]7743=N M1GD.>BRSJ5R!;Z2CSE^Y<0&3<6+5<ER"
M5F7K<\5PTVD;=3Q?*VQZ=LA-TG *>&P\YW/M>D M(7@K?%6QY%GI><:B&5U6
M>BN1S6"A>I6 ^6/K>P=OHF=:>XU>-FKV?"--'F[&?,4\>7+I?8(M '=C?ENP
M05>K@\2@EUM%@T208%Z\@L%_GV(O@D!NE&7,@<E=5FFD@61,?6VM@/X\&7((
M@)TLY':T@#>NY573C:F?6UF/C$B//5TFBM9^DV"^B5UMH62!A^A<G&A_AGM+
M]&R]A0L[Q7%)@X<LS'8?@>.MSE1/EV:>75@GE1^.4UO4DK=]NU^'D$-LW6-M
MC=-;^V>0BU]+AFOQB-H[A'"HAC0LN76B@UNL^U,AH.>=G%<+G;*-FEK&FD]]
M#5Z(EMML/&*'DVU;;6;-C_9+'FM0C&,[3' CB)LLJ74[A)ZL<U))J@R=&%8\
MI=B-$UGXH7-\B%V_G0%KQ6'+F)A;#68FE")*RFK#CX8[#V^UBJTLG'3HA:RJ
MW&H,6JR;^FO]7C6,=FWQ89Y\/&_N9/-KA'($:%!:H70_:\M*"W:D;W0YTGE3
M<W4JKGQ:> "I6F;P9).:W6DT9QR+=VMD:9-[6VV9; )JO&_H;GI9^G)D<0Y)
MC'4/<\8YA7@*=L<JGWM:>C"GS&0E;E:906:F;^N*#6D-<75Z"FMZ<O]IGVX&
M=)=9$G#"=D1(WG.N> PY'W;I>@4JD7IV?#^F-V&H=^V7L619>*&(C6;N>4EX
MTFF*>>UHCFQ1>I]8.F](>V%(17)Q?#(XR'7I?1\JA7FL?BFDOU^!@6F64V):
M@4>'/V49@0]WE6?=@,MGGFK/@(Y7=&W^@&!'NW%>@#4X?74+@ \J>GC]?^FC
MBEV\BM&5,6"SB=B&,F.0B+MVG&9WAXMFOVF-AEM6SVSAA3)'1G!QA @X/'1-
M@LXJ<GAH@7JBE%Q)E ^42%]8DCN%5F))D#1UT&5*CA-F"&B"B_)6/6OYB<U&
MZF^HAYTX"G.MA4\J:W?K@MBAW%LHG1&3E5Y%FE^$I&%"EVAU*&12E%!E:V>C
MD3E5M&L[CAQ&BV\+BNHWWG,JAXPJ97>%A 2A8UI9I;V3%5U\HBB$&F!ZGCMT
MH&..FBED]6;LEAQ56&J9D@=&.FZ#C=8WIG+ B74J8'<SA/Z>I7&86HZ1(G+-
M7A^"VW0888ISQ'5W9-]D*';N:#U49'B':[]$^7I&;W(U]7Q)<X$H%GZ9>!J=
M8FZE8]J0!G L9GZ!OW&O:0IRR7-!:XQC4G3N;AI3N';#<,=$>WC <YDULWL%
M=K0H(7V3>C&<&FOU;16.N6V\;M> MV]R<(IQS'$S<C1B@',2<^Q3%G4A=;U$
M#W=;=ZDU?WG@><@H*WRJ?">:L&F/=B:-5FN$=QI_3&UG=_EPIF]3>,YA?W%M
M>:Q23'.T>IQ#@G8H>YTU.'CD?+LH,WO=??>986> ?QR,%6F9?TI^&FNB?U=O
MB6VU?U!@K6_U?TU1H')Q?UA##W48?VDU 7@&?X$H.GLL?YV83&7/B *+#F@#
MAV9])FHFAIMNIFQ:A;1?XVZ\A,I1$7%9@^9"KG0M@P0TT7=(@A4H0'J5@167
M;V1LD+V*.6:TCU5\6FCKC:QMZFLVB]]?.VVXB@Y0CG!UB#M"8G-EAF$TKW:G
MA&TH17H8@EN6R6-5F3R)DV6LEP=[LV?NE'QM36I&D<%>J&S?CP50#F^]C$1"
M#7+*B74TCW8DAH$H27FQ@W&666**H6Z)&63IGFM[+F<LFO=LR6F)ETQ>.6PM
MDZ!/NF\>C_!!PW)&C"PT776]B$4H37E?A%B2KGEA6HB&37G<7A!Y(GI_87=K
M*GL[9,Q<LGP+:"].&GSU:[H_Z'W];W8R+'] <Y(EJ8#">"^1EW:48T2%37=A
M9?-X(W@Y:(MJ27DA:QY;]WH?;;]-B7L^<($_AGQ_<VLR!GW\=I\ESW^S>C"0
M>'0&:^.$%740;<=W'G84;YMI5G<H<6A;,WA6<T-,]WFK=3<_*7LC=TDQY7S9
M>8\E\'[#? ^/17&T='*"WG+M=95U[W0;=J%H>W55=ZA:>7:U>+-,<G@\>=$^
MW'GI>P,QRWO6?%4F#'WQ?<:.&F^]?.>!VW$8?5-T\')H?9UG='/$?=!9LW5(
M?@A+SG<#?DT^;WC@?IHQGWKY?O,F)7T]?U2-(FXAA4B Z6^3A/IT#7#\A'EF
MI')U@]A8_W07@S1+4W7N@I@^('?U@?\Q?WHZ@5XF.7RC@+.,6FS.C7R *6Y4
MC')S5F_-BR%E^W%:B:=8:7,9B"A*X74.AJ<]Y7<MA20Q:WF7@XTF2GPD@>2+
MP6O"E79_D&U7DZ]RO6[:D8IE;7!RCR]7Y7)&C,]*;G19BFP]FW:2B (Q5WD1
MA7LF6'N\@N:+5&KZG29_'6R9FJ9R06X?EZAD]&^[E&=7@7&7D2)*)'.\C=H]
M6W80BH8Q+WBLAQLF8WMI@[N&\(%M6H1[@H$X7?QO7($R85QB?H%$9+55+X%>
M:"!'SH&(:[8ZX8'';WXN@((R<Z8C;(+/>$&%^7[08KAZJ7[H96ENAW\.: MA
MR7]!:JY4GW^";6-'9G_:<#TZIH!*<T N?(#J=HXCK(&U>BZ$_GQ@:M)YEWRS
M;,AMH'T";K1@\WU<<)U3\WW(<IE&Z7Y1=+$Z7G[T=N@N<'_%>54CXX"]>_:#
M\WHN<LMXB7JH=!1LCWL>=4U@+GN8=GY32WPT=[I&='SL>0HZ'WV_>FXN9W[!
M>_4D$W_D?9>"\GA$>KUWD'C@>UEKIGEU>]A?57H/?$52R'K'?+I&$WNN?3LY
M[7RM?<@N8WW=?F8D/'\J?PZ"%7:\@IYVV'=Q@I%K '@9@E->J7C)@?52)GF<
M@9A%J7J=@48YJGO#@/DN4'T;@*HD7WZ-@%B!875ZBDYV)G9!B95J5W;VB)1>
M#W>XAVI1G'BCACQ%0GF^A1(Y?'KY@^HN2'QU@K,D>WX+@72 U71YD<!UGG5/
MD%MIT78-CI5=E';7C)A1+'?4BI9$WWD*B)0Y0'I<AI(N07OMA'PDDGVA@F2
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M=U0Q.HX2>/HJ&XK=>JTCNX?2?'8>E(4>?BQ91IM4=_112YCQ>+Y))98X>7Q
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M<?$FV7VB=RN3YF>C7FJ'8FG789!Z"&P)9*-L#FY,9[!=F7"Q:LE/"'-);@1
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M34UQ8XN0DU'Y9BB";59W:,-SEUL+:V)D7E_5;@Y5!F3J<-A&'6I$<\HWR'
M=PLJUW7X>K&<=TF#;56.XDY\;P6 UE-8<+IR5%A(<G)C2%UY=#A4+V+R=A=%
MC&BS>!4W@&[4>D\JWG4B?,Z:M$7^=ON-8$M@=\E_@E"<>)MQ&E7@>6UB;5MF
M>DM3?6$_>SQ%$V=;?#\W1&W3?6HJXW1J?KV9*D+N@':,&4BO@&5^>$Y @%1P
M/%/7@$)AJ%FG@#12_%_)@#1$MV8W@#PW%6SZ@%,JZ'/-@'F7XD!,B;V+#49A
MB,)]I$P^A\EOD5(;AM%A#U@QA=Q2@UZ5A.I$=&5!@_<V\VQ#@OPJ['-*@?Z6
MWSX?DK.*.41ZD,9\_4J6CN!O#U"KC0-@HE;ZBRM2'UV9B4Q$+&1]AV(VV&NM
MA5XJ[W+>@TN6*#QUFR&)GD, F#M\@4E'E6INLD^&DK)@857^D -1]%S'C4-$
M!&/7BFLVNVLTAVHJ\G*(A&&79%UE3_Z*&6!A5&E\;6-S6-%N.V:I73=?G&H0
M8:M0W6VV9D5"B7&9:Q@TM'7<<%8H+WIG=C"5>EC'66J(QUQ)7/][6U_-8(]M
M6V-K9!Y>XF<[9[503&M.:VY")F^A;U@TBW18<Z@H3'E/>'V3NE2:8LR'&%B2
M98-Y[EQ\:#9L#6!]:NI=S&2S;:I/<FDQ<(I!CVWP<Y(T1G,-=NPH97A7>J:2
M"%#2;!"%?U4R;>QX<UEW;\AJZ5W1<:1<TF)K<XI.M6=+=8M!%&QM=ZLT$''F
M>@@H>W=]?*:0=DUU=3>$'%(P=C]W,U;.=T-IP5M[>$-<"&!H>4U.$V6D>FQ
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M,8%L?ODQ)($/?S K5(#*?WPF*("6?]$AFH">@!L>!8#$@%0  /__  #__P
M__\  &UF=#$      P0A   !                     0
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MYO^F.3+_HD9*_:!-8/&D3'+FITR$VJA0EL^F6:;'I62QQ*=OML&G>+N]IX'
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M<)1WSW27=<YWF'/->9IRS7N;<<Q]FW#+?YQORX"=;\N G6_+@)UORX"=;\N
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MTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BT_^C.2K_GT9
M_YU05?J@4&7OHU%UY*13AMJB6Y;0H&6DR)UPL,6<>[7"G(.YOYJ)OKR5B\*Z
MD(S%N(R/R;:(DLRSA)?/LH&?TJU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_
MHM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BT_^C.2K_GT9 _YU0
M5?J@4&7OHU%UY*13AMJB6Y;0H&6DR)UPL,6<>[7"G(.YOYJ)OKR5B\*ZD(S%
MN(R/R;:(DLRSA)?/LH&?TJU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M
M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BT_^C.2K_GT9 _YU05?J@
M4&7OHU%UY*13AMJB6Y;0H&6DR)UPL,6<>[7"G(.YOYJ)OKR5B\*ZD(S%N(R/
MR;:(DLRSA)?/LH&?TJU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3
MK7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BT_^C.2K_GT9 _YU05?J@4&7O
MHU%UY*13AMJB6Y;0H&6DR)UPL,6<>[7"G(.YOYJ)OKR5B\*ZD(S%N(R/R;:(
MDLRSA)?/LH&?TJU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^B
MTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BT_^C.2K_GT9 _YU05?J@4&7OHU%U
MY*13AMJB6Y;0H&6DR)UPL,6<>[7"G(.YOYJ)OKR5B\*ZD(S%N(R/R;:(DLRS
MA)?/LH&?TJU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_
MHM.M?Z+3K7^BTZU_HM.M?Z+3K7^BT_^C.2K_GT9 _YU05?J@4&7OHU%UY*13
MAMJB6Y;0H&6DR)UPL,6<>[7"G(.YOYJ)OKR5B\*ZD(S%N(R/R;:(DLRSA)?/
MLH&?TJU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M
M?Z+3K7^BTZU_HM.M?Z+3K7^BT_^C.2K_GT9 _YU05?J@4&7OHU%UY*13AMJB
M6Y;0H&6DR)UPL,6<>[7"G(.YOYJ)OKR5B\*ZD(S%N(R/R;:(DLRSA)?/LH&?
MTJU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3
MK7^BTZU_HM.M?Z+3K7^BT_^C.2K_GT9 _YU05?J@4&7OHU%UY*13AMJB6Y;0
MH&6DR)UPL,6<>[7"G(.YOYJ)OKR5B\*ZD(S%N(R/R;:(DLRSA)?/LH&?TJU_
MHM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^B
MTZU_HM.M?Z+3K7^BT_^C.2K_GT9 _YU05?J@4&7OHU%UY*13AMJB6Y;0H&6D
MR)UPL,6<>[7"G(.YOYJ)OKR5B\*ZD(S%N(R/R;:(DLRSA)?/LH&?TJU_HM.M
M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_
MHM.M?Z+3K7^BT_^C.2K_GT9 _YU05?J@4&7OHU%UY*13AMJB6Y;0H&6DR)UP
ML,6<>[7"G(.YOYJ)OKR5B\*ZD(S%N(R/R;:(DLRSA)?/LH&?TJU_HM.M?Z+3
MK7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M
M?Z+3K7^BT_^C.2K_GT9 _YY/5/JA3F3OI$]UY:91A=JE6)71HF*CR9]MK\6?
M=[7"GH"YOYV(OKR9B<.YE(O'MH^-R[.*D,^QAI;4KH.@UZ>!H=6G@:'5IX&A
MU:>!H=6G@:'5IX&AU:>!H=6G@:'5IX&AU:>!H=6G@:'5IX&AU:>!H=6G@:'5
MIX&AU?^C.2K_H$9 _YY.5/JB363PI4YTY:A/A-NG5932I5^ARJ-IK<6B=+3"
MH7VYOZ"%OKN=B,.XF(G(M9.+S;&.CM.NB9;8IX6=VJ&%H-:AA:#6H86@UJ&%
MH-:AA:#6H86@UJ&%H-:AA:#6H86@UJ&%H-:AA:#6H86@UJ&%H-:AA:#6H86@
MUO^C.2K_H$9 _Y]-5/NC3&3PITQTYJE.@]RJ4Y+2J5N@RZ9FJ\:E<+/#I7JX
MOZ2"O;NBA\.XG8?)LYB)S["4CM6KDI?:H(J<W)N)G]B;B9_8FXF?V)N)G]B;
MB9_8FXF?V)N)G]B;B9_8FXF?V)N)G]B;B9_8FXF?V)N)G]B;B9_8FXF?V/^C
M."K_H$5 _Z!,5/ND2V/QJ$MSYJM,@]VM4)'4K%B>S*IBJ<>J;+'$JG:VP*I^
MO+RHA,*XI(;)LZ&(SZR<C=6CEI3:FI&<W):.GMB6CI[8EHZ>V):.GMB6CI[8
MEHZ>V):.GMB6CI[8EHZ>V):.GMB6CI[8EHZ>V):.GMB6CI[8EHZ>V/^D."K_
MH$5 _Z!+4_NE2F/QJ4ERYZU*@=ZP39#5L%6<SK!>I\FP:*_&LG.SP[)\N+VP
M@,&VK(+)KJ>%SZ6ABM6<G)':E9F<W)&4GMF1E)[9D92>V9&4GMF1E)[9D92>
MV9&4GMF1E)[9D92>V9&4GMF1E)[9D92>V9&4GMF1E)[9D92>V?^D."K_H$5
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M_YI12O^=4EGWGU1I[:!7>..?7(?:G&>5TIEPH<R6>ZO&E(2SQ).+ML*/C[K
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MA*>2SX"FG-" HZ7/@*&FSH"AILZ H:;.@*&FSH"AILZ H:;.@*&FSH"AILZ
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MW)9QDM63>YS/D(2DRXZ,J\B*D+#%AY2TPX28M\*!F[G!?YZZP7VBN\![IKS
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M;W^LHG6*I)Q\DYR8@YJ5E(J@CY&2I8J.FZB&C:2K@XROK(&-O:R"C+^K@XK
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M8]^!U&/?@=1CWX'48]^!U&/?@=1CWX'48]^!U&/?@?]U) ;_=C40_W=#'/^
M2B?_A5(S_X99/O^%8$C_@6A2_WQO6OQW>6+W<X-H]&^,;O%LDW+O:IIU[6>@
M>.QEI7KK9*I\ZF*O?>EAM7[H8+M_Z%_#@.=?RX'F7M6!X&#;@==BWH'48]^!
MU&/?@=1CWX'48]^!U&/?@=1CWX'48]^!U&/?@?]V) ;_=S40_WE"'/^"22?_
MAU$R_XA8/?^'7TC_@V91_WYN6OMY=V+W=8)I]'&*;O%MDG/N:YEV[&B?>>MF
MI'OJ9*I]Z6.O?^ABM8#G8;R!YV#$@N9?SH+C7]>#W&';@])CW8//9-V#SV3=
M@\]DW8//9-V#SV3=@\]DW8//9-V#SV3=@_]W) ;_>#40_WQ!'/^%2"?_BD\R
M_XQ6/?^+74?_AV11_X)L6OM\=&+W>']I\W2(;_!PD'3M;)=XZVJ>>^EGI'[H
M9JJ YV2P@N9BMH/E8;Z$Y6#'A>5@TX7=8MF%TV3<A<QEVX;)9=N&R67;ALEE
MVX;)9=N&R67;ALEEVX;)9=N&R67;AO]X) ;_>#40_WY &_^(1R;_C4XQ_X]5
M//^.6T;_BV)0_X9I6?R <6+W>WMI\W:%<.]RCG7L;I5YZFN<?>AIHX#G9JF"
MY66PA.1CMX7D8L"'XV'+A]]BU8?59-J'S679B,9GV8G$9]B)Q&?8B<1GV(G$
M9]B)Q&?8B<1GV(G$9]B)Q&?8B?]Y(P;_>300_X _&_^*1B;_D$TP_Y)3._^1
M6D7_CV!/_XIG6?R$;F'W?GAI\GF"<.]TBW;K<)-[Z6V;?^=JHH+E9ZF$Y&6P
MAN-DN8CB8L.)XF+0BMADV(K.9MB*QV?7B\!HUHR^:=:,OFG6C+YIUHR^:=:,
MOFG6C+YIUHR^:=:,OFG6C/]Y(P;_>C00_X,^&_^-127_DTPO_Y51.O^45T3_
MDEU._XYE6/R(:V'W@G1I\GQ_<.YWB';K<Y%\Z&^9@.9KH83D:*F'XF:QB>%D
MNXO@8\>,W&/4C,]FUHS':-6-P&G4CKIJU(ZX:]2.N&O4CKAKU(ZX:]2.N&O4
MCKAKU(ZX:]2.N&O4CO]Z(P;_>S00_X4]&O^/1"3_EDHN_Y=../^75$+_E5I,
M_Y)A5OR.:5_VAW!H\H%Z<.U[A7?J=HY\YG&7@>-MGX;@:JB)W6>PC-IFNXW6
M9<>.T6;4C\=HTX^_:M.0N6O2D;-LTI&R;=*1LFW2D;)MTI&R;=*1LFW2D;)M
MTI&R;=*1LFW2D?][(P;_?#01_X@\&O^20R3_F$@M_YI,-_^:4D'_F5A*_)=?
M5/:39EWPC6YFZX=W;^: @7;A>XM]W'63@]=QG(?2;J2+SVNLCLQIM9'):,"2
MQVC/D[]KT9.X;-"3LFW0E*UOT).K;]&3JV_1DZMOT9.K;]&3JV_1DZMOT9.K
M;]&3JV_1D_]\(P;_?301_XH[&?^402/_FD8L_YQ+-?^=4#__G59(^)M=4?&8
M8UOKDVMDY(UU;=Z&?G78@(=\T7J/@\QVEXG'<I^-Q&^GD<!ML).^;+N5NVO(
MEK9MSY:P;\Z6JW#/EJ9QSY6E<L^5I7+/E:5RSY6E<L^5I7+/E:5RSY6E<L^5
MI7+/E?]\(P;_?301_XPZ&?^70"+_G$4K_Y])-/^@3CS[H51%]*!:3NR=85CE
MF6EAWI-S:M6,>W3.A8-]R'^+A,)ZDXJ^=IN/NG.CD[9QJY:S;[:8L6_"F*UP
MS9BH<LV8I'/-F*!TSI>?=,Z7GW3.EY]TSI>?=,Z7GW3.EY]TSI>?=,Z7GW3.
ME_]](P;_?S,1_XXY&/^9/R'_GD,I_Z%',O^C3#KXI5)#\*182^BC7U3AGVA=
MUYAP:,Z1>'3&BH!]P(2(A;I_CXNU>Y>0L7>?E*UUIY>J<[&9IW.]FZ5SRYN@
M=<N:G7;,FIIWS9F9=\V8F7?-F)EWS9B9=\V8F7?-F)EWS9B9=\V8F7?-F/]^
M(@;_@#(0_Y X&/^;/R#_H$(H_Z1&,/ZF2SCTJ%! [*E71^2I75#<I69:T)UN
M:,>5=7._CGU]N8F$A;.#C(RM?Y.1J7R;E:1YI)FA=ZV;GG>YG)QWR)R9>,J<
MEWG+FY5ZS)J4>LR9E'K,F91ZS)F4>LR9E'K,F91ZS)F4>LR9E'K,F?]^(@;_
M@C(0_Y(W%_^</1__H4 G_Z9$+ONI237QK$\\Z:Y50^&O74O5J&19RZ%K9\*9
M<W.YDWI]LHV!A:R(B8RFA)"1H8"8EIU]H)J9?*J<EGNVG91[Q)Z2?,J=D7W*
MG(]]RYN/?<R:CWW,FH]]S)J/?<R:CWW,FH]]S)J/?<R:CWW,FO]_(@;_A#$0
M_Y,V%_^>/![_HS\E_ZA"+/BM1S+OL$TYYK14/]VS6TG0K&)9QJ1J9KR=<7*T
MEW=\K)%^A::,AHR@B(V1FH65EI:"GIJ2@*>=CW^RGHV P9Z,@,F>BX#*G8J
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M5T#]IEA _*E80/RI6$#\J5A _*E80/RI6$#\J5A _*E80/RI6,:X! "VQ 0
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M7NAQV%[H<=A>Z''87NAQV%[H<?]K(P3_:C$*_W$\%/]Z0QW_@$LH_X%3,O^
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M?=1BX7W*8^!^PV3@?[UFWX"W9]^ MV??@+=GWX"W9]^ MV??@+=GWX"W9]^
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M9TCFWV=*X.QG2M_L9TK?[&=*W^QG2M_L9TK?[&=*W^QG2M_L9_^<#0#;L08
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M=%.UY'14L.=U5JSG=5:LYW56K.=U5JSG=5:LYW56K.=U5JSG=?^#$@'_EA$
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M44#M\5% [?%10.WQ44#M\5% [?%10.WQ4=2E  #$L@, MKP# *O)!0"@V @
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M3$;<WDQ&VNU,1-CY3T/8^T]#V/M/0]C[3T/8^T]#V/M/0]C[3]N:  #*J0(
MN[," +"] P"ER04 F]8) )3H% &,Z24$A.@S"WOH/!1SZ$0;:^A+(F3G4BA>
MYUDM6>=@,E7G:#52YV\X3^=W.TSG@#U)YXD_1^B4043HGT)"Z:Q#0>FZ1$#J
MS41 ZN1$0.CU1$#G^$- Y_A#0.?X0T#G^$- Y_A#0.?X0\VC  "]K@$ L+@!
M *3$ @"9T 4 C^$* (GQ&@&!\2@%>/(R#'#R.Q-I\D,98O)*'USS4"-6\U<G
M4O->*T_S92U,]&PP2?1S,D;T>S1#](0V0?6.-S[UF3D]]J0Z._:P.SKWOSPY
M^,\\./?H/#CW[#PX]^P\./?L/#CW[#PX]^P\./?L/+^J  "QLP  I+\  )C*
M 0",V 0 A/H. 'S[&P)T^R8%;/PP"F7\.!!>_4 56/Y'&5/^31U/_U0@2_]:
M(DC_825%_V<F0O]M*$#_=2H]_WTK.O^&+3C_D2XV_YLO-/^F,#/_LC$R_[XR
M,?_0,C'_UC(Q_]8R,?_6,C'_UC(Q_]8R,?_6,K*O  "EN@  F,8  (O2  !_
MWP( >?\1 6__&0)G_R($8/\L!UK_- Q4_SP/3_]#$TK_215'_T\70_]5&4#_
M6QL^_V$<._]F'CG_;1\V_W0@-/]](3'_AB,O_Y$D+?^;)2S_I28K_Z\F*O^[
M)RG_OB<I_[XG*?^^)RG_OB<I_[XG*?^^)Z:V  "8P@  B\X  '[;  !U^0<
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M5!W_5V D_U1K*O]0>"__380S_TJ/-O]'F3G_1J$[_T6I//]$L#[_0[<__T+
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M(P/_B"L%_8TT"?.0.P[JD$,4XH]*&MJ*5"70@UTPR7YG.L-X;T*^='A(N7&
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M5C!ZMETX<[1D/VZR:D1HL7%)9+!Y35^N@5%;K8I46*V55U2LH5E2K*];4*S
M6U"LVEI/J^Y;3ZKZ6U&F^EM1IOI;4:;Z6U&F^EM1IOI;4:;Z6_^ "0#AD@$
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M*EO49R]7U&XS4]-V-E#3?SE,TX@[2M.4/D?3H#]%U*Y 1-2_04/5V$!$T^Q
M0M+V0D'1_D1!T?Y$0='^1$'1_D1!T?Y$0='^1-&8  ##I0  M:X  *FX  ">
MPP( E,T& (K9"@"$XQ@!?>0F W7D,@ANXSP/9^-%%6'C31M<XU4@5^-=)%3C
M9"=0XFLJ3>)S+4KC?#!(XX8R1>.0-$/CG#5!Y*DV0.2X-S_ERS<_Y>0W/^/S
M-CWB^S@]XOLX/>+[.#WB^S@]XOLX/>+[.,:A  "WJP  JK0  )Z^  "3R0(
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M2WTI_TB(+/]&DB[_19LP_T2B,O]#J3/_0K T_T*W-?]!OS;_0<DV_T#7-_]
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M6"Z(FU\U@IEF/'V6;4%XE'1&<Y)[2V^0@T]KCXQ29XZ6562-HEAAC*]97XS
M6E^,V5E?C.Y97XS[6&&*_5=AB?U788G]5V&)_5=AB?U788G]5_]O# #_?PD
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M24BP_TI(L/]*2+#_2DBP_TI(L/]*2+#_2N*&  #.E   PJ$  +:I  "KL0
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M(S3K^",TZ_@C-.OX([.E  "FK0  F;<  (W!  " RP  ==4! &GA!@!D\Q$
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M4&YWV5!N=^]/;G?\3FYW_TUO=_],;W?_3&]W_TQO=_],;W?_3/]D#0#_<@H
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M2E>._TI8CO])6([_25B._TE8CO])6([_2?]Q 0#@@   SXP  ,26 @"[G@(
MLJ0  *FJ!0"BK!4 FZPF I2K- >,JC\/A:A(%WZF4!YXI%@E<Z)>*VZA93!J
MGVPT99YS.6&=>SQ>FX1 6IJ.0U>9FD54F:='4IFV2%&9RDA1F.9(49?U2%&7
M_T=1EO]'49;_1U&6_T=1EO]'49;_1_9W  #8A0  R9$  +^; 0"TH@  JZ@
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M-T"W_S= M_\W0+?_-\Z+  "_F   LJ$  *>I  "<L   D;@  (;  @![R <
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M&P!6XR<!4N0R D[D/ 1*Y$0&1^5-"$7E50I"Y5P,0.5D#C[F;! [YG82.>:
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M1'UFV41\9^]#?&?\07QH_T!\:/] ?&C_/WQH_S]\:/\_?&C_/_];# #_9PD
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M0V9X_T)F>/]!9GC_0&9X_T!F>/] 9GC_0/]D P#N<0  V'P  ,N% @##C ,
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M/$^1_SQ/D?\\3Y'_/.1T  #/@0  PHP  +B6  "MG   HZ$  )BH  "0J@T
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M)+V1  "PFP  I*(  )BJ  ",L0  @+D  '6_  !JQ@0 7LP( %G/$@!7T"$
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M!R7PIP@D\;@((_',""+RY0@B\/,((N_U""+O]0@B[_4((N_U")ZF  "1KP
MA+@  '?!  !JR0  7=   %'7  !&W0  /^H% #SV#@ Y]A< -O<@ #/W*  Q
M^#  +ODV 2OY/0$I^D0!)_I* B7[4@(C^UH"(/QC Q[\;@,<_7L#&_Z)!!G^
MF 08_Z@$%_^W!!;_R 06_^ $%O_D!!;_Y 06_^0$%O_D!).N  "%MP  >,
M &K)  !=T@  4-D  $3?   ZY   -?<# #+_#  N_Q( *_\: "C_(0 F_R<
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M-)!6W32.5_ TC5?],XQ8_S.,6/\RC%C_,8Q8_S&,6/\QC%C_,?]1# #_6PD
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M.')G_S=R:/\V<FC_-7)H_S5R:/\U<FC_-?]9 @#V90  W6X  ,]V 0#'>P,
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M-5YX_S5>>/\U7GC_-?5D  #<<   RGH  ,"#  "VB0  KHT  *2/  "=D1
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M%S>]M1@VO<H8-[SG%S6[]ADUNO\:-+G_&S2Y_QLTN?\;-+G_&[B/  "JF
MGY\  ).F  "'K   >[,  &^Y  !CO@  6,0$ %#(# !-R!< 3,DE $K*,0!'
MRCL!1<I$ D/*3 -!RE0$/LI<!CS*9 <ZRVX).,MX"C;+A0PTRY(-,LNB#C'+
ML@\PS,</,,OE#B_)]0\NR/T1+L?_$B['_Q(NQ_\2+L?_$JZ7  "AG@  E:4
M (FM  !\M   <+L  &3!  !9Q@  3LL# $70"  ^U0X /=4: #S6)@ [US$
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M A#[Q@(0^]T"$/OI A#[Z0(0^^D"$/OI H^K  "!M   <[T  &;&  !9S0
M2],  $#9   UW@  +.,  ";Q   D_@H (?\0 !__%@ <_QP &?\B !?_*  5
M_RX $_\U !+_/  0_T, #O],  W_5@ +_V( "?]O  C_?P$'_Y !!?^@ 03_
MK@$$_[P! __' 0/_QP$#_\<! __' 8.T  !UO0  9\8  %K/  !+U0  /]P
M #/A   IY0  (>P  ![]   :_P4 %_\, !7_$  2_Q0 $/\9  [_'@ -_R,
M"_\H  C_+@ &_S4  _\]  #_1@  _U$  /]=  #_:P  _WL  /^+  #_F0
M_Z4  /^L  #_K   _ZP  /^L /\G+ '_*BH!_RLJ ?\J+@'_)C0"_R4_ O\C
M2P/_(5@#_R!D!/\>< 3_'7L$_QV%!?\=C@7_'98%_QV<!O\=H@;_'*@&_QRN
M!_\<M ?_'+L'_QS#!_\<S@?_'=\'_QWK!_P=]0?Y'?X&]Q[_!_<=_PCV'?\)
M]AW_"?8=_PGV'?\)]AW_"?\I*@'_+"<!_RXG ?\M*@'_+#(!_RL] O\I20/_
M)U4#_R5A!/\C;03_(G@%_R*"!?\ABP;_(9,&_R&:!_\AH ?_(:4'_R&K"/\A
ML0C_(;@(_R'!"/\ARPC\(=P(^2'I"/8A] CS(OT'\B+_"?$B_PKQ(?\+\"'_
M"_ A_POP(?\+\"'_"_\L)@'_,"0!_S$C ?\Q)@'_,B\!_S$Z O\O1@/_+5(#
M_RM>!/\I:07_*'4%_R=_!O\GB ?_)I '_R:6"/\FG0C^)J,)_2:I"?PFKPG[
M)K8)^B:^"?@FR GV)MD)\B;H">\G\PGM)_T*ZR;_"^HF_PWI)O\-Z";_#N@F
M_P[H)O\.Z";_#O\O(P'_,R !_S4? ?\W(P'_."P!_S@W O\V0@+_-$X#_S):
M!/\P907_+G &_BU[!_PMA CZ+(P)^"R3"?<LF0KV*Z *]"NF"O,KK OR*[,+
M\2N["^\KQ@ON+-0+ZBSF"^8L\@OD+/P-XBS_#^$L_Q#@+/\0WRS_$=\L_Q'?
M+/\1WRS_$?\S'P'_-QL!_SH: ?\]( '_/R@!_S\R ?\]/@+_.TD#_SE5!/LW
M80;W-6P']31V"/(S?PGP,H<*[S*/"^TRE@OL,9P,ZC&B#.DQJ0SH,; -YC&Y
M#>4QPPWC,M$-WS+E#-PR\0_8,?P1U3'_$M(Q_Q/1,?\4T#'_%- Q_Q30,?\4
MT#'_%/\W&P'_.Q< _S\6 /]#' #_1B0!_T8N ?]$.0+\0D0#]C]0!/$]7 ;M
M/&<'ZCMQ">@Z>@KE.8,+XSB+#.(XD@W@-YD-WS>?#MTWI@[;-ZT/V3:V$-<V
MP1#5-LX0T3?C$<TW\1/*-_L5R#?_%L8W_Q?%-_\8Q#?_&,0W_QC$-_\8Q#?_
M&/\[%P#_0!, _T43 /])& #_3"  _TPI ?I+,P'R2#X"[$9*!.=$5@;C0V((
MWT%L"MQ =0S9/WX-U3Z&#],]C1#1/901SSR;$LT\HA/,/*D4RCNQ%,@[NQ7'
M.\@6Q3S<%L$\[1>^//D9NSS_&KH\_QNY//\;N#S_&[@\_QNX//\;N#S_&_\^
M% #_1!  _TH1 /]/% #_41L ^U(C /%1+0'I3S@!XDU% ]Q+407625P(T4=F
M"\Y&< [+17@0R$2 $L9#AQ3$0HX5PT*5%L%!G!>_0:08O4"L&;Q MAJZ0,(:
MN$#2&[5!Z!NR0?8=L$'_'JY!_QZM0?\>K$'_'JQ!_QZL0?\>K$'_'O]"$0#_
M1PT _T\. /]3$0#_5A4 \U<< .A6)0#@53$!UU,_ L]23 7*4%<)QDYA#<-,
M:A# 2G(2O4EZ%;M(@A:Y1XD8MT>0&;5&EQNS1I\<L46G';!%L1ZN1;P?K$7,
M'ZI%XR"G1O,AI4;_(:-&_R*B1O\AHD;_(:)&_R&B1O\AHD;_(?]%#@#_2PH
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M*X!8_RJ 6/\J@%C_*8!8_RF 6/\I@%C_*?]/ @#]60  XF   -5G  #,:@,
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M*VIG_RMJ9_\K:F?_*_Y8  #A8P  SVP  ,1S  "[>   LWH  *MZ! "D>Q(
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M(T24LR-#E,@C0Y3E(T.2]21#D?\D0Y#_)$.0_R1#D/\D0Y#_),IU  "[@0
ML(L  *21  ":E0  CYD  (.=  !TH@  ;J,+ &JD%P!FI24 8Z4Q 5^D.P-;
MI$0%6*1+"%6C4PM2HUH-3Z)A$$VB:!-*H7$51Z![&$2@AAI"GY,<0)^B'3Z?
MLAX]G\8>/9_C'3V=]!X]G/\?/)O_'SR;_R \F_\@/)O_(,)\  "UB   J9
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M""K$\ @IPOL)*,'_"BC!_PLHP?\+*,'_"ZB5  "=FP  D:(  (2I  !XKP
M:[4  %^[  !4OP  2<,  #_(!  VS0D ,\X1 #+/'  QSR< ,- Q "_0.@ N
MT4, +=%, "O250 JTE\!*--I 2?3=@$ETX0")-24 B+4I@(AU;D"(=72 B#3
MZP(@TO8#']'_!!_1_P0?T?\$']'_!)^;  "4H@  AZD  'FQ  !MN   8+X
M %3#  !)QP  /LL  #70 0 MU08 )=L+ "3>$@ CWAP (M\E "'@+@ @X#<
M'^%  ![A2@ =XE, '.-> !OC:@ :Y'@ &.2( 1?EF@$6YJP!%>;  13GW0$3
MY>\!$^/Z 1/C^@$3X_H!$^/Z 9:B  ")J0  >[$  &ZY  !AP   5,8  $C*
M   ]SP  ,],  "K9   BW@( 'NL* !SL$  ;[1< &>T? !?N)@ 5[BT %.\U
M !/P/0 1\$8 $/%0  _R6P .\FD #?-X  STB@ +]9P "O6N  GVP@ )]MD
M"/7M  CU[0 (]>T "/7M (NI  !]L@  ;[H  &+"  !5R0  1\X  #O2   Q
MV   )]T  !_A   9Z   %O@& !3Z#0 2^Q( $/P7  [\'0 -_2, #/TI  K^
M,  (_S@ !O]!  /_3   _U@  /]F  #_=P  _XD  /^;  #_JP  _[L  /_.
M  #_SP  _\\  /_/ '^R  !QN@  8\,  %;+  !(T0  .M8  "_=   EX0
M'.4  !3I   1]P  #_\!  W_"0 +_PT "/\0  ;_%  #_Q@  /\>  #_(P
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M"<DQZ@K&,?<,PS'_#L$Q_P_ ,?\/OS'_#[\Q_Q"_,?\0OS'_$/\V$P#_.0\
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M')5&_QN41O\;DT;_&Y-'_QN31_\;DT?_&_]"!0#_2@$ \E   .%4 0#95@4
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M(758_R%U6/\A=5C_(?]-  #E5P  TU\  ,AD  "_9P  MV@  +%G!P"I:!0
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M:0  O'(  +)X  "I?0  GW\  ))^  "*?P< A( 3 ("!(0![@2X!=X Y W*
M0@5N?TH(:WY1"VA]6 YD?%\18GMF%%]Z;1=<>74967A_'%=XBAY4=Y8A4G:D
M(E%VLR-0=L8D4';C(U!U]2-1=?\B473_(5%T_R%1=/\A473_(=AC  #%;0
MN'8  *Y]  "E@@  FH,  (V#  "$A , ?840 'F&'@!UARL!<8<V FV&/P1I
MA4<'981/"F*#5@U?@UP/7()C$EJ!:Q57@',85']]&E%_B!Q/?I0?37ZB($M]
ML2%*?<0B2GWA(4M\]"%+>_\@2WO_($M[_R!+>_\@2WO_(-!G  # <@  M'L
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M%3F8[Q8YE_P6.);_%SB5_Q<XE?\7.)7_%[MZ  "OA0  I(P  )B1  "-E0
M@9H  '6=  !HH   6Z0  %:E# !3IA< 4:<C $^G+P!,IS@!2J=! 4BG20)&
MIU $0Z=8!4&G7P8_IF@(/:9R"CJF?0LXIHH--J69#C2EJ0\SI;L/,Z74#S.D
M[@\RHOL0,J'_$3*A_Q$RH?\1,J'_$;2"  "HC   G9(  )*7  "&G   >:$
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M 1C*_P(8RO\"&,K_ IN9  "/GP  @J8  '6M  !HLP  7+D  %"]  !$P0
M.<0  ##(   HS $ (- & !G5"P 6UQ  %=@9 !79(@ 4V2L $]HT !/:/0 2
MVT@ $=Q3 !'=7P 0W6T $-Y^  [?D0 .X*0 #>"X  S@T@ +W^T #-[W  S=
M^P ,W?L #-W[ )*?  "%IP  =ZX  &JU  !=O   4,$  $3%   XR0  +LT
M "71   >U0  %MH! !'>!@ 0YPT #N<2  WH&0 ,Z"$ "^DI  KJ,0 )ZCL
M!^M%  7K40 $ZUX  ^MN  'K@   ZI0  .JG  #KO   Z](  .OI  #L[P
M[.\  .SO (>G  !YKP  :[<  %Z^  !1Q0  0\D  #?-   MT0  (]8  !O;
M   3WP  #N,   SN @ *]@H !_8.  7V$@ #]A@  /4>  #U)0  ]2X  /4W
M  #V0@  ]DX  /9=  #V;@  ]H$  /:5  #WIP  ][<  /C'  #XT   ^-
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M ?\.A '_#HL!_PZ2 ?\.F '_#IT!_PZC ?X.J '\#JX!^PZU /H.O@#X#LD
M]0[; /(.Z@#N#O4 [ [_ >L/_P'J#_\!ZA#_ >D0_P'I$/\!Z1#_ ?\B'P#_
M(AP _R$< /\?( #_'RD _QPT /\:0 #_%TP!_Q58 ?\48P'_$VX!_Q-W ?X3
M@ '\$X@!^A*. ?D2E0'X$IH!]A*@ ?42I@'T$JP!\Q*S ?$2O 'P$L<![1+8
M >D3Z 'F$_4!Y!3_ >(4_P+A%?\"X17_ N 5_P+@%?\"X!7_ O\E&P#_)A<
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M"K P_PNN,/\+KC#_"ZTP_PNM,/\+K3#_"_\S# #_-@8 _SP) /\^# #]/1
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M%85'_Q6%1_\5A4?_%?\_  #L2   W4\  ,]3  #&50  P%,# +M1# "S4AD
MK5,I *A3-@&C4D("GU%+!)Q05 :93UP(EDYC"I1-:@R13'$.CTMX#XU+?Q&+
M2H<2B4J0%(=)FA6%2:47@TFQ&())P!B!2M89?TKM&'Y+_!A^2_\7?4O_%WU+
M_Q9]2_\6?4O_%O]#  #F3   UE,  ,E8  # 60  NE@! +16"0"L5Q8 IE@E
M *%8,@&=5SX"F%9(!)5540:25%@(CU)?"HQ29@R*46T.B%!T$(5/>Q*#3X03
M@4Z-%7].EQ=]3J$8>TVN&7I.O1IX3M$:=T[K&G=/^AEV3_\9=D__&'9/_Q=V
M3_\7=D__%_A&  #B4   T%<  ,1<  "[7@  M%T  *Y:!@"F6Q, H%PB )M<
M+P"76SL"DEI% X]930:+6%4(B%=<"H968PR#56H.@51Q$'Y4>!)\4X 4>E*)
M%GA2E!AV4I\9=%*K&G)2NAMQ4LT<<%+H&W!3^1IP4_\:<%/_&7!3_QAP4_\8
M<%/_&.])  #=4P  RUH  ,!?  "W8@  KV$  *A> @"A7Q  FV > )9@+ "1
M8#@!C5Y" XE=2P6%7%('@EM9"H!:8 Q]66<.>UAN$'A8=1)V5WT4=%>'%G)6
MD1AO5IP:;E:I&VQ6N!QK5LL=:E;F'&I7]QMJ5_\::E?_&6M7_QEK5_\9:U?_
M&>M,  #85@  R%X  +QB  "S90  JV4  *-B  "<8@X EF,< )%D*0",8S4!
MB&(_ X1A2 6 8% '?5]7"7I>70MW760-=5QK$'-<<A)P6WL4;EN$%VQ:CQAJ
M6IH::%JG'&9:MAUE6L@=95KD'65:]AQE6O\;95K_&F5:_QEE6O\995K_&>A/
M  #360  Q&$  +EF  "P:   IVD  )YE  "79@T D6<9 (QH)P"'9S(!@V8]
M G]E1@1[9$T&>&-4"75B6PMR86$-<&%I#VU@<!)K7WD4:5^"%F=>C1EE7I@:
M8UZE'&%>M!U@7L<=8%[C'6!>]1Q@7O\;8%[_&F%>_QIA7O\:85[_&N12  #/
M7   P&0  +9I  "L;   HVP  )EI  "2:@L C&H6 (=K) "":S !?FHZ GII
M0P1V:$L&<V=2"'!G60IM9F -:V5F#VAD;A%F9'849&. %F)CBQA@8I<:7F*D
M'%QBLAU;8L4=6V+A'5MB]!Q;8O\;7&+_&EQB_QI<8O\:7&+_&N!5  #+7P
MO6<  +)L  "I<   GV\  )1L  ",;0@ AFX3 ()O(0!];RT!>6\X G5N00-R
M;4D%;FQ0!VMK5PII:UX,9FIE#F1I;!%A:7037VA^%EUGB1A;9Y4:66:B&U=F
ML!Q69L,=5F;?'59F\QQ79O\;5V;_&E=F_QI79O\:5V;_&MM9  #'8@  NFH
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M&49W[QA'=OP81W;_&$=U_Q='=?\71W7_%\EE  "Z;P  KG<  *1]  "8?P
MBW\  'Y_  !S@0  ;(,) &B$$P!EA2  8H8L %^&-@%<AC\"685& U>%3@54
MA54'4H1<"4^#8PM-@VL-2X)T#TB"?Q%&@8P31(&:%4* J19!@+H60(#2%D%_
M[19!?OL607W_%D%]_Q9!??\607W_%L)J  "U=0  JGT  )^"  "2@P  A80
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M"BV;_PHMF_\*+9O_"J^   "CB0  EXX  (V3  !_E0  <I@  &:<  !;H
M3Z0  $6G   ^J0P /*H4 #JJ'P YJBD .*LR #>K.P UJT, -*Q+ #*L4P$Q
MK%P!+ZQF BVL<0(KK'\#*JR. RBLG@0GK+ $)JS%!":KY ,EJ?4$):C_!26G
M_P4EI_\%):?_!:>)  ";CP  D90  (29  !XG@  :Z(  %^F  !3J@  2*T
M #VP   TLP, +[4. "VU%@ LM2  *[8I "JV,@ IMSH *+=# ">W3  FN%4
M)+A? ".X:P BN'@!(+B( 1^XF0$=N:L!'+G  1RXWP$<MO(!&[7\ ANT_P(;
MM/\"&[3_ I^/  "4E0  B)L  'NA  !NI@  8JL  %:P  !*LP  /[8  #6Y
M   LO   )+\& !_"#0 =PA0 ',(> !O#)@ :PR\ &<0X !C$00 7Q$H %L55
M !7%80 4QF\ $\9_ !+&D0 1QZ0 $,>Y  _'U  0QNX $,3Z !##_P 0P_\
M$,/_ )>6  "+G   ?J(  '&I  !DKP  6+0  $NX  ! NP  -;X  "O!   C
MQ0  &\D! !3,!@ 0T L #M$1  W1&0 -T2$ #-$J  S1-  +TCX "M))  G3
M50 )TV( "--R  ;4A  %U)@ !-2K  /5P  !U=P  =7M  '5]@ !U?8  =7V
M (Z=  " I   <ZL  &:Q  !9N   3+T  #_    TPP  *L<  "'*   9S@
M$M(   W6 0 )VP4 !MP-  3<$0 #W1@  =X@  #>*   WS$  . \  #A1P
MXE0  .-C  #C=   Y(@  .2;  #EK@  Y<$  .75  #FYP  YN<  .;G (.D
M  !UK   :+,  %J[  !-P0  0,0  #/(   HS   ']   !?4   0V0  "]T
M  7A    Y    .4'  #F#0  YQ$  .@6  #I'0  ZB4  .LN  #M.0  [T4
M /!3  #Q9   \78  /**  #SG   \ZT  /2[  #TR   ],@  /3( '>M  !J
MM0  7+T  $_$  ! R0  ,\T  "?1   =U@  %-P   [@   (XP   >8   #J
M    [@   .X   #O!   \ H  /$.  #S$@  ]!@  /8@  #X*@  ^C4  /U#
M  #^4@  _V,  /]V  #_B0  _YH  /^F  #_L   _[   /^P /\6(P#_%2$
M_Q$A /\-) #_"2L _P8W /\#1 #_ %$ _P!= /\ : #_ '( _P![ /\ @P#_
M (H _P"1 /\ E@#_ )P _P"A /T I@#[ *P ^0"S /< NP#U ,4 \P#1 /(
MY #Q /$ [P#Z .X _P#N /\ [0#_ .T _P#M /\ [0#_ /\9( #_&!T _Q4=
M /\0'P#_#BD _PPT /\*00#_!TT _P59 /\$9 #_!&X _P-W /\#@ #_ X<
M_P.- /T"DP#[ ID ^0*> /<"I #U JH \P&P /$!N #O <( [0'/ .L!XP#J
M >\ Z +[ .<$_P#F!?\ Y@;_ .8&_P#F!O\ Y@;_ /\<&P#_&QD _Q<8 /\5
M'0#_$R4 _Q$P /\0/0#_#DD _PQ5 /\+8 #_"VH _0MS /L+? #Y"H, ]PJ*
M /4*D #T"I8 \PJ; /$*H0#O":< [0FN .L)M@#H"<  Y@G- .0)X@#B"O
MWPO[ -X,_P#<#?\ W W_ -L-_P';#?\!VPW_ ?\?%P#_'A, _QL2 /\<&0#_
M&R( _Q@L /\5. #_$T0 _A)0 /D16P#U$&8 \Q!O / 0=P#N$'\ [!"& .H0
MC #I$)( Z!"8 .8/G@#E#Z4 XP^L .$/M #@#[X W@_, -H0X0#5$?  TA+[
M ,\2_P'.$_\!S1/_ <T3_P',$_\!S!/_ ?\B$@#_(@\ _R$/ /\B% #_(AP
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M")PQ_PB<,?\(G#'_"/\P  #_-0  [S@  .(Z  #;.00 UC4) ,XT$P#&-B(
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M  #93   R%,  +U7  "T6   K%<  *52 0">4P\ F%0< )-4*0"/5#4 BU-
M 8A32 *%4E $@E%7!7]07@9]4&0(>T]K"7E/<@MW3GL-=4Z$#G--CA!Q39D1
M;TVE$VU-LQ1L3<44:T[A%&M.]!-K3O\2:T[_$FM._Q%K3O\1:T[_$>A&  #3
M4   Q%8  +E:  "P7   IEH  )]6  "85@T DE<9 (Y8)@")6#( AE@] 8)7
M10)_5DT#?%54!7E46P9W5&$(=5-H"7-3< MQ4G@-;U*!#VU2BQ!K49<2:5&C
M$V=1L11F4<,595+>%652\A1E4O\395+_$F52_Q)E4O\295+_$N1*  #/4P
MP%H  +5>  "L8   HEX  )I9  "26@L C5L6 (A<(P"$7"\ @%LZ 7U;0P)Y
M6DL#=EE2!'186 9Q6%\';U=F"6U7;0MK5G4-:59^#V=6B1%E59428U6A%&)5
MKQ5A5<$68%7;%F!6\15@5OX48%;_$V%6_Q)A5O\285;_$N!-  #+5@  O5T
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M%5%A[1528?L44F'_$U-A_Q)38?\24V'_$M%6  # 7P  LV8  *EK  "<:P
MD&H  (5G  !]:0  =VH- '-K%P!O:R0 ;&PO &EL. %F:T$"8VM) V%K4 1>
M:E<&7&I=!UII90E8:6T+56AV#5-H@0]19XT13V>:$DYGJ11-9[D43&?/%$QF
MZQ1-9OL336;_$DYE_Q).9?\23F7_$LQ:  "\8P  L&H  *5O  "8;@  C&T
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M#CQX_PX]=_\./7?_#KQH  "O<@  I'D  )9Z  "(>@  ?'H  '!\  !C?P
M7((  %>$"P!3A10 488@ $^&*@!.AS0 3(<\ 4J'1 %(ATL"1H=3 D2&6@-"
MAF($0(9L!CZ%=@<[A8,(.861"CB$H LVA+$+-H3&"S:#Y LV@O8+-H'_##:
M_PPV@/\,-H#_#+9O  "J>   GW\  )!^  "#?P  =X   &N"  !>AP  58H
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M J*&  "7C   BX\  'V1  !OE   8Y@  %>=  !-H0  0Z4  #BH   PJP
M**X' "2O$  CKQ< (:\A ""P*0 ?L#$ 'K Z !VQ0@ <L4P &[%6 !JQ80 9
MLF\ &+)^ !:RD  5LJ( %+*V !.RS@ 3L>L $Z_Y !.N_P$3KO\!$Z[_ 9J-
M  "0D@  A)<  '6:  !HGP  6Z,  %"H  !%K   .[   #&R   GM0  (+@
M !BZ!P 4O X $[P5 !*\'@ 1O28 $;TN !"]-P 0OD$ #KY,  Z^5P -OF4
M#+]T  N_A@ *OID "+ZL  >^P@ 'OM\ "+[P  B]^@ (O?P "+W\ ).4  "'
MF0  >I\  &RE  !@J@  4Z\  $>S   \M@  ,;@  ">[   ?O@  %\$  !'$
M 0 ,R @ ",D.  ?)%  &R1P !<DD  3*+  #RC8  LI   #+3   RUD  ,MH
M  #+>0  S(P  ,N?  #+LP  R\@  ,SB  #,[P  S/$  ,SQ (J:  !\H0
M;Z<  &*M  !5LP  2+@  #N[   PO@  )L$  !W$   5R   #\L   K.   $
MT@(  -,*  #3#P  U!0  -4:  #6(@  URH  -DT  #:/P  W$L  -Q:  #=
M:@  W7T  -V1  #=I   WK8  -[(  #>W@  WN(  -[B '^B  !QJ0  9+
M %:W  !)O   /,   "_$   DQP  &\L  !//   -T@  !]8   #;    W@
M -\#  #@"0  X0X  .(2  #C%P  Y1X  .8G  #H,0  ZCT  .Q+  #L6@
M[6P  .Z   #NE   [J4  .ZT  #NP@  [L8  .[& '2J  !FL@  6+D  $O
M   ]Q0  +\D  "3-   9T0  $=8   O;   #W@   .$   #E    Z    .D
M  #J    ZP8  .T+  #O#P  \!,  /(:  #T(P  ]RX  /D[  #[2@  _%L
M /UM  #]@   _I,  /ZB  #^K0  _J\  /ZO /\0'P#_#AT _PH= /\!( #_
M "@ _P U /\ 00#_ $X _P!: /\ 90#_ &X _P!W /\ ?P#^ (8 _ ", /L
MD@#Y )< ^ "< /< H@#V *< ]0"M /, M0#R +T \0#) .\ W #N .L [0#W
M .P _P#K /\ Z@#_ .H _P#J /\ Z@#_ /\3' #_$1D _PT9 /\&' #_ R4
M_P Q /\ /@#_ $H _P!6 /\ 80#_ &L _0!S /H >P#W (, ]0") /0 CP#R
M )0 \0"9 /  GP#N *0 [0"K .P L@#J +H Z #& .< U@#E .@ Y #U .,
M_@#B /\ X0#_ .$ _P#A /\ X0#_ /\5& #_$Q0 _P\4 /\-&0#_"R( _P@M
M /\$.0#_ 48 _P!1 /X 7 #Z &8 ]@!O /( =P#O 'X [0"% .L BP#J )$
MZ "6 .< G #F *$ Y "H ., KP#A +@ WP## -T T0#; .8 V0#S -< _0#5
M O\ U +_ -0#_P#4 _\ U /_ /\8$P#_%1  _Q(/ /\2%0#_$1T _PXH /\,
M- #_"D$ ^0A, /4&5P#Q!F$ [09J .D%<@#F!7H Y 6! .(%AP#@!HT WP:2
M -T&F #;!IX V0:E -<&K0#4!K4 T@;  - 'SP#.".4 S GT ,H+_P#(#/\
MQPS_ ,<,_P#&#/\ Q@S_ /\;#@#_&0P _Q@- /\8$0#_%Q@ _Q0B /L1+@#S
M$#H [0Y& .@-4@#E#5P X0UE -X-;0#;#74 V U\ -4-@@#3#8D T0V/ - -
ME0#.#9P S0ZC ,L.JP#)#K0 R [  ,8.SP##$.8 P!'U +T2_P"\$O\ NQ+_
M +H2_P&Z$O\!NA+_ ?\?"@#_' 0 _Q\( /\?#0#_'1( ^!H; .X6)@#F%#,
MX!,_ -H32P#4$U8 T!-? ,X4: #+%&\ R11W ,<5?0#&%80 Q!6* ,,5D0#!
M%I@ P!:? +X6IP"\%[  NQ>\ +D7RP"W&.( LQGR ;$:_P&O&_\!KAO_ :X;
M_P&M&_\!K1O_ ?\B! #_(@  _R4" /PD!P#W(0P [!T2 .$:' #8&BH T!LX
M ,L=10#''5  PQY: , >8@"^'FH O!]Q +H?> "Y'WX MQ^% +8?C "T'Y,
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M!?\M  #J-0  W#H  ,X]  #&/   P#<" +LS#0"S-!D KC8G *DW- "E-T
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M"G= L@IU0,,+=$#="W-!\0MR0?\*<D'_"G)!_PER0?\)<D'_">D\  #510
MQ4L  +I.  "P3@  ITL  *)&  ";1@X ED<: )%()P".2#, BD@] (='1@&$
M1TX!@D95 H!&7 -^16($?$5I!'I%< 5X1'@&=D2!"'1$BPER1)8*<$2B"V]$
MKPQN1, ,;479#6Q%[PQK1?T+:T;_"VM&_PIK1O\*:T;_"N5   #/20  P4\
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M#UI1Z@Y;4?H-6U'_#%M1_PQ;4?\+6U'_"]9*  ##4P  MED  *M<  ">6@
MDUD  (M4  "$5@, ?E80 'I7&@!V5R8 <U@Q '!7.@!M5T(!:E=) FA64 )F
M5E<#9%9>!&)5905@56T'7E5V"%U5@0I;58T+652:#5A4IPY65;@/5E7,#U95
MZ0Y65?D-5E7_#5=4_PQ75/\,5U3_#-%-  # 5@  LUP  *=>  ":70  CUP
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M#$A@_PM)8/\+26#_"\18  "U8   JF8  )MF  "-9@  @F4  '9D  !N90
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M!K!L  "D=0  E'4  (9U  !Y=@  ;G<  &-Y  !7?0  3X$  $>$  !"A@P
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M !J?C0 8GY\ %Y^R !:?R0 6GN@ %ISW !:;_P$7F_\!%YO_ 9V#  "/A@
M@H8  '2'  !GBP  6X\  %"3  !&F   /)P  #.@   KHP  (Z8  !RH"P :
MJ1$ &*D8 !>I(0 6JBD %:HQ !2J.0 3JD, $ZM- !*K6  1JV4 $*MT  ZK
MA@ .JYD #:NL  RKP0 ,JM\ #*GR  VH_  -J/\ #:C_ ):*  ")C   >HT
M &R1  !@E0  5)H  $F?   _HP  -:<  "NJ   CK@  &[   !2S 0 /M0H
M#;80  RV%@ +MA\ "K8G  FV+P (MCD ![=#  :W3P $MUL  [=J  *W>P
MMXX  +>A  "VM   MLL  +;E  "U\0  M?<  +7W (^1  "!E   <I<  &6<
M  !8H0  3*8  $&K   WKP  ++(  ".U   :N   $[L   Z]   )P 4  \$-
M  #!$0  P1<  ,(>  #")@  PB\  ,,Y  #$1   Q%   ,1>  #%;P  Q8$
M ,65  #%J   Q;P  ,31  #$Y@  Q.X  ,3N (:8  !YG@  :Z,  %VI  !0
MK@  1+,  #>V   LN0  (KP  !F_   1P@  #,4   ;(    RP   ,P'  #,
M#0  S1$  ,T6  #.'0  SR0  - M  #2.   U$0  -12  #580  U7,  -:'
M  #6FP  UJT  ->_  #8S@  V-T  -C= 'N@  !NI@  8*T  %.S  !%N
M.+P  "N_   AP@  %\8  !#)   *S    M    #4    UP   -@   #:!0
MVPL  -P.  #>$P  WQD  .$A  #C*@  Y38  .=#  #G4P  Z&0  .EW  #I
MC   ZI\  .JN  #JN@  ZL,  .K# '"H  !BKP  5;8  $>\   YP   +,0
M "#(   6S   #M    ?4    V0   -T   #A    XP   .0   #F    YP$
M .D'  #K#   [!   .X5  #P'0  \R<  /8S  #W0P  ^%0  /EF  #Y>@
M^HX  /J>  #[J0  ^[   /NP /\+&P#_!QD _P 9 /\ ' #_ "4 _P R /\
M/P#_ $L _P!7 /\ 8@#_ &L _P!S /T >P#[ (( ^@"( /@ C0#W )( ]@"8
M /4 G0#T *( \P"I /$ L #O +@ [@## .P T0#K .8 Z0#S .@ _@#H /\
MZ #_ .@ _P#H /\ Z #_ /\.& #_"A4 _P$4 /\ & #_ "( _P N /\ .P#_
M $< _P!3 /T 7@#Z &< ]P!O /4 =P#S 'X \@"$ /  B0#O (\ [@"4 .P
MF@#K )\ Z0"E .@ K #F +0 Y "_ ., S #A .( WP#P -X ^P#> /\ W0#_
M -T _P#< /\ W #_ /\0$P#_#1$ _P80 /\"%0#_ !X _P I /\ -@#_ $(
M^@!. /0 60#Q &( [@!K .P <@#J 'D Z !_ .< A0#E (L Y "0 .( E@#A
M )P WP"B -T J0#: +$ V "[ -4 R #2 -T T0#M -  ^0#/ /\ S@#_ ,T
M_P#- /\ S0#_ /\1#P#_#@T _PP- /\+$@#_!QD _P(D /\ , #V #P [P!)
M .H 4P#G %T Y !F .$ ;0#? '0 W0![ -L @0#9 (8 U@", -0 D@#2 )@
MT "> ,X I@#, *X R@"X ,@ Q #& -< Q0#J ,, ]P#" /\ P0'_ , "_P#
M O\ P +_ /\4"P#_$ 8 _Q ) /\0#@#_#A0 _PH> /4&*0#K!#8 XP-" -\#
M3@#;!%< U@1@ -,$: #0!&\ S@5V ,P%? #*!8( R06( ,<%C@#&!90 Q 6;
M ,(%HP# !JL O@:U +T&P@"["-0 N@GI +<+^ "U#/\ M S_ +0,_P"T#/\
MM S_ /\7! #_%   _Q8# /\4"0#_$0X \@X5 .@,(0#>"BX U@L[ - ,1P#,
M#%$ R0Q: ,8-8@#$#6H P@UQ , -=P"_#7T O0Z# +P.B@"Z#I$ N0Z8 +<.
MH "V#JD M ^T +(/P0"Q$-0 KA'K *L2^@"I$O\ J!/_ *<3_P"G$_\ IQ/_
M /\:  #_&P  ^1L  .L9  #E% 8 Y1 . -D.%P#/$28 R!(T ,030 "_%$L
MO!14 +D570"W%60 M15K +05<0"R%7@ L19^ *\6A0"N%HP K!:4 *L7G "I
M%Z8 IQBP *88O0"D&,\ HAKG )\:]P"=&_\!G!O_ 9P;_P&;&_\!FQO_ ?\=
M  #W(0  Z"0  -TE  #4(0$ SQL( ,H7$0#"&B  O!PM +<=.@"S'D4 L!Y/
M *T>5P"K'E\ J1]F *@?; "F'W, I1]Y *,?@ "B'X< H""/ )\@F "=(*(
MFR"L 9HAN0&8(<H!EB+D 90C]0&2(_\!D2/_ 9 C_P&0(_\!D"/_ ?\B  #K
M*0  W2X  ,\O  #'+0  P2<# +TB#0"V(QH L"4H *PF- "H)D  I2=) *(G
M4@"@)UH GB=A )PG9P";)VT F2=T )@G>P&6)X(!E2>+ 9,GE &1*)X!D"BI
M 8XHM0*-*<8"BRG? HDJ\@*'*O\"ABK_ H8J_P*&*O\"ABK_ O0H  #C,0
MT38  ,4X  "\-@  MC   +(K"0"K+!0 IBTB *(N+P">+CH FRY$ )@O30"6
M+U4 E"Y< )(N8@"0+FD!CRYO 8TN=@&,+GX!BBZ& H@NCP*'+IH"A2^E X,O
ML@."+\(#@3#: W\P[P-],?X#?3'_ WPQ_P-\,?\#?#'_ ^TO  #;-P  R3T
M +X^  "S/   K#@  *<S! "B,A$ G30= )DU*@"5-34 DC5  (\U20"--5
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M1@  G4,  )<_  "2/@L C3\5 (D_(0"%0"T @D W '] 0 !]0$@ >T!/ 7E
M5@%W/UT!=3]C G,_:@)Q/W(#<#]Z VX_A 1L/Y %:S^<!FD_J09H/[@'9T#,
M!V9 Z =F0/D&94#_!F5 _P9E0/\%94#_!=P^  #'1@  N4L  *Q,  "@2@
MET<  )%#  "+0P@ AD,2 ()$'@!^1"D >T4T 'E%/0!V144 =$1, 7)$4P%P
M1%D!;D1@ FQ#9P)K0V\#:4-W!&=#@05F0XT&9$.9!F)#IP=A1+8(8$3*"&!$
MY@A?1?@'7T7_!V!%_P9@1/\&8$3_!M9!  ##20  MDX  *=/  ";30  DDL
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M!U%/_P=13_\&44__!LE+  "Y4P  JU<  )Q6  "/50  A50  'Q0  !U40
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M!KE9  "K80  FF$  (MA  !_80  =&$  &EA  !?8@  660  %1F"0!19Q$
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M BUYD@(K>*,"*GBU BIXS (J=^H"*G;Y RIU_P,J=/\#*G3_ ZIJ  ":;0
MB6P  'QM  !P;0  9FX  %MQ  !0=0  2'@  $%[   Z?@4 -G\. #2 %@ S
M@2  ,H$H #"!,  O@C@ +H)  "V"2  L@E  *X): "J"9  H@G  )H)_ 26"
MCP$D@J !(X*R 2*"R0$B@><!(G_W 2)^_P(B??\"(GW_ J5Q  "3<0  @W$
M '9Q  !L<@  8'4  %9X  !,?   0X   #N#   SA@  +8D* "J*$0 IBQD
M)XLB ":+*@ EC#$ )(PY ".,0@ BC4H (8U4 ""-7@ ?C6L '8UY !R-B@ ;
MC9P &8VN !B,Q  8C., &8KU !F)_P$9B/\!&8C_ 9UW  ",=@  ?78  ')W
M  !E>0  6GP  %"   !&A   /(D  #2,   MD   )9," !^5#  =EA( ')8:
M !N7(@ :ERH &9<R !B8.@ 7F$, %IA- !686  4F&0 $YAS !&8A  0F)8
M$)BI  Z8OP .E]T #Y;R !"5_  0E/\ $)3_ )5]  "%?   >'P  &M^  !?
M@0  5(8  $J*  ! CP  -I,  "V7   FF@  'IT  !>@ P 2H@P $*,2 !"C
M&0 /HR$ #J0I  ZD,0 -I#H #*1%  ND4  *I%P ":1J  >D>P &HXX !*.A
M  *CM  #HLL  Z+F  .A\P #H?L  Z'[ (V#  !_@@  <80  &2'  !8C
M39$  $*6   XF@  +YX  ":B   >I0  %Z@  !&K   ,K@< !Z\-  .O$@ "
MKQD  :\A  "O*0  L#(  + \  "P1P  L%,  +!A  "P<0  L(,  *^7  "O
MJ@  K[\  *[9  "NZP  KO0  *[T (>)  !XB@  :HX  %V3  !1F   19T
M #NB   PI@  )ZH  !ZN   6L0  $+0   NV   %N0,  +H*  "Z#@  NA,
M +L9  "[(0  O"@  +PQ  "]/   OD@  +Y6  "^90  OG<  +Z,  "^GP
MO;,  +['  "^W@  O>L  +WK '^2  !PE0  8IH  %6?  !)I0  /:L  #*O
M   HM   'K8  !6Y   .O   ";\   +"    Q    ,4$  #&"@  Q@X  ,<2
M  #(&   R1\  ,HG  #,,   SCP  ,Y)  #/60  SVH  ,]^  #/DP  SZ8
M ,^X  #/R   S]L  ,_; '><  !HH0  6Z<  $ZN  !!M   -+<  "BZ   =
MO0  $\    W$   &QP   ,H   #.    T    -$   #2 @  TP@  -4,  #6
M$   V14  -L<  #=)   X"\  .(\  #C2P  Y%P  .1O  #E@P  Y9@  .6I
M  #EM@  Y<,  .7# &RE  !?K   4;(  $2Y   UO   *,   !S$   2R
M#,L   //    TP   -@   #<    WP   -\   #A    XP   .0#  #F"
MZ T  .D1  #L&   [B(  /$N  #S/   ]$T  /5?  #V<P  ]X<  />9  #X
MI0  ^+   /BP /\#%P#_ !4 _P 5 /\ & #_ ", _P O /\ / #_ $@ _P!4
M /\ 7@#_ &< _0!O /L =@#Y 'T ^ "# /8 B #U (X ] "3 /( F #Q )X
M\ "D .X JP#M +, ZP"] .H RP#H .$ YP#Q .8 _0#E /\ Y #_ .0 _P#D
M /\ Y #_ /\'$P#_ !$ _P 1 /\ %0#_ !\ _P K /\ -P#_ $0 _@!/ /H
M6@#W &, ] !K /( <@#P 'D [P!_ .T A #K (H Z@"/ .@ E #G )H Y0"@
M .0 IP#B *\ X "Y -X Q@#< -H V@#L -@ ^0#6 /\ U@#_ -< _P#8 /\
MV #_ /\*$ #_ PX _P - /\ $@#_ !H _P F /P ,@#W #\ ] !* /$ 50#M
M %X Z@!F .@ ;@#E '0 XP!Z .( @ #@ (4 W@"+ -P D #; )8 V "< -4
MHP#3 *L T0"U ,X P0#, -$ RP#G ,D ]0#( /\ R #_ ,@ _P#( /\ R #_
M /\,# #_!@@ _P(* /\ #P#_ !4 _  @ /$ + #L #D Z0!% .4 3P#A %D
MW@!A -L : #7 &\ U !U -( >P#0 (  S@"& ,P C #+ )( R0"8 ,< H #%
M *@ PP"Q ,$ O "_ ,L O0#C +P \@"[ /T NP#_ +H _P"Z /\ N@#_ /\.
M!0#_"0  _PD% /\&"P#_ 1  \  9 .8 )0#A #( W  _ -8 20#1 %, S@!;
M ,L 8P#( &H Q@!P ,4 =@## 'L P0"! ,  AP"^ (X O "4 +L G "Y *0
MMP"N +4 N0"S ,@ L0#? + ![P"O ?L K@+_ *T#_P"M _\ K0/_ /\0  #_
M#@  _PT  /8+ P#R!PH X@$1 -L"'0#2 RL S ,W ,@$0P#$!$T P016 +X%
M70"\!60 N@5K +@%<0"W!78 M05\ +,&@P"R!HD L :1 *\'F0"M!Z$ JP>K
M *D(MP"H"<8 I@K= *4+\ "C#/T H@W_ *$-_P"A#?\ H W_ /\1  #\$@
M[!,  .(3  #;#P, U@D+ ,X(% #&"B( P PP +P-/ "X#48 M0U/ +(.5P"P
M#E\ K@YE *T.:P"K#G$ J@YX *@.?@"G#X4 I0^- *0/E@"B$)\ H!"I )\0
MM0"=$<4 FQ'> )D2\0"7$_\ EA3_ )44_P"5%/\ E!3_ /\5  #M&P  X!\
M -(?  #)&P  Q!0% ,$0#@"Z$AL M!,I + 4-0"L%4  J15) *854@"D%ED
MHA9@ *$69@"?%FP GA9R )P6>0";%X  F1>( )@7D0"6&)L E!BF ),9L@"1
M&<$ D!K8 (T;[@"+'/T BAS_ (H<_P")'/\ B1S_ /0=  #D)0  TRD  ,<J
M  "\)@  MB   +09"P"N&A4 J!PC *0=+P"A'CH GAY$ )L>3 "9'E0 EQ];
M )4?80"4'V< DA]M )$?= "/('P CB"$ (P@C0"*()< B2&B (<AK@"&(KT
MA2+1 8(CZP&!)/L!@"3_ 7\D_P%_)/\!?R3_ >PE  #;+0  R3$  +PQ  "Q
M+@  JRD  *<D!0"C(Q$ GB0= )HE*@"6)C4 DR8_ )$F1P"/)D\ C296 (LG
M7 "))V( B"=I (8G;P"%)W< @R=_ ($GB0& *),!?BB> 7TIJP%[*;D!>BG-
M 7@JZ %W*_D!=BO_ 78K_P%U*_\!=2K_ >4L  #0-   P3@  +,X  "H-0
MHC$  )TM  "9*@X E"L8 ) L) "-+3  BBTZ (<M0P"%+4H @RU1 ($N6 "
M+EX ?BYD 'TN:P![+G,!>2Y[ 7@NA0%V+H\!="^; 7,OJ )Q+[8"<##) F\P
MY0)N,?<";3'_ FTQ_P)M,?\";3'_ M\R  #).0  NSX  *P]  "A.@  FC<
M )4S  "0,0H C#$4 (<R( "$,RL @3,U '\S/@!],T8 >S-- 'DS5 !W,UH
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M UD__P-9/_\#63__ \P_  "\1@  JT@  )Q'  "11@  B$0  ()   !\/P
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M [U,  "N4@  G%$  (U1  "!40  =U   &Y,  !G3@  8D\  %U0#0!:4!0
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M CE=DP(X7:,#-UVU S9=RP,V7.@#-USY S=;_P,X6_\#.%K_ [)7  "@6@
MCUD  (%9  !U60  :UD  &!:  !66P  45T  $Q> @!(8 T 16 4 $1A'@!"
M8B8 0&(N #]B-@ ^8SX /6-% #QC30 [8U4 .6-> #AC: $V8W0!-6.! 3-C
MD0(R8Z$",6.S C%CR (Q8N<",6'X C%A_P(R8/\",F#_ JY<  ";70  BET
M 'Q=  !P70  9ET  %Q>  !28   3&(  $5E  !!9@H /F<1 #QH&@ [:"(
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M !I[OP :>]X &GGR !MX_@ ;=_\!&W?_ 9EI  "(:0  >6D  &UI  !C:@
M66P  $]O  !%<P  /7<  #5Z   N?0  )X$# "*##0 @A!( 'X0: !V$(@ <
MA2H &X4Q !J%.0 9A4( &(9, !>&5@ 6AF, %89Q !2&@0 2AI, $8:F !&%
MNP 0A=8 $8/O !&"^P 2@O\ $H'_ )%N  "!;0  =&X  &EN  !=<   4W,
M $EW  ! ?   -X   "^#   GAP  (8H  !J-!@ 5CPT $Y 3 !*0&@ 2D"(
M$9 J !"1,@ 0D3L #Y%$  Z13P -D5P #)%J  N1>@ *D8T ")"?  >0LP '
MC\D !X_F  >.]  (C?P "(W_ (ES  ![<P  ;W,  &-U  !7>   37T  $.!
M   YA@  ,(H  "B.   AD0  &I4  !.7   .F@@ "YP.  F<$P (G!H !YPB
M  :<*@ $G#,  YP]  *=2   G50  )UB  "<<@  G(0  )R7  ";J@  F[\
M )K;  ":[   FO4  )GX ()Y  !V>0  :'H  %Q^  !1@@  1H<  #R,   R
MD0  *94  "&9   9G0  $J    ZC   )I@4  Z<,  "G$   IQ4  *@<  "H
M(P  J"L  *DT  "I/P  J4L  *E9  "I:   J7H  *F.  "IH0  J+4  *C+
M  "GY   I^\  *?S 'V   !O@0  880  %6)  !)C@  /I0  #29   JG@
M(:(  !FF   2J0  #:P   >O    L@   +,'  "S#   LQ   +05  "T&P
MM2(  +8K  "W-0  MT   +A.  "X70  N&X  +B"  "XEP  N*H  +>^  "W
MT@  M^8  +?J ':(  !GBP  6I   $Z6  !"G   -Z(  "RG   BJP  &:\
M !&S   +M@  !+D   "\    O@   +X   "_!@  P L  ,$/  #"$P  PQD
M ,0@  #%*0  QS0  ,A"  #)40  R6(  ,EU  #)B@  R9\  ,JQ  #*P0
MR=$  ,G9 &Z3  !@F   4YX  $:D   ZJP  +[   "2U   9N   $+P   J_
M   !P0   ,0   #(    R@   ,H   #,    S0,  ,X(  #0#0  T1   -,6
M  #6'@  VB@  -TT  #>0P  WU0  -]G  #@?   X)$  ."D  #@L@  X+X
M .## &:?  !9I@  3*T  #^T   RN   )+P  !B_   0PP  ",<   #*
MS0   -$   #5    V    -D   #;    W0   -\   #A!   XPH  .4.  #G
M$P  ZAP  .TG  #P-0  \48  /)8  #S:P  \X   /24  #THP  ]*X  /2R
M /\ $P#_ !$ _P 1 /\ %0#_ !\ _P L /\ .0#_ $4 _P!0 /\ 6@#^ &,
M^P!K /D <@#W '@ ]0!^ /0 A #R (D \0". /  DP#N )D [0"? .P I@#J
M *X Z "X .8 Q0#E -L XP#M .( ^P#B /\ X0#_ .$ _P#A /\ X0#_ /\
M$ #_  X _P - /\ $@#_ !L _P H /\ - #^ $$ ^P!, /< 5@#T %\ \0!F
M .\ ;0#L '0 Z@!Z .D ?P#G (4 Y@"* .4 CP#C )4 X0"; .  H@#> *H
MVP"T -D P #6 -  TP#H -( ]P#1 /\ T0#_ -  _P#0 /\ T #_ /\ #0#_
M  D _P * /\ #P#_ !8 ^P B /< +P#T #L \ !' .T 40#I %H Y0!B .(
M:0#@ &\ W@!U -P >@#: (  V "% -4 BP#3 )$ T0"7 ,\ G@#- *8 RP"O
M ,D N@#' ,D Q0#B ,0 \@## /X P@#_ ,$ _P#" /\ P@#_ /\#!@#_  $
M_P & /\ # #Y !$ \0 = .L *0#G #8 XP!! -\ 2P#; %0 U0!< -( 8P#/
M &H S0!P ,L =0#) 'L R "  ,8 A@#% (P PP"3 ,$ F@"_ *( O0"K +L
MM@"Y ,0 MP#: +8 [0"T /H M #_ +0 _P"T /\ M #_ /\$  #_    _P
M /\ !@#L  T Y0 6 -X (@#7 "\ T0 [ ,T 10#* $X Q@!7 ,0 7@#! &0
MOP!J +T < "\ '4 N@![ +D @0"W (< M0". +, E0"R )X L "G *X L@"L
M +\ J@#1 *@ Z "H /< IP#_ *< _P"F /\ I@#_ /\&  #_!0  \0,  .@
M  #A  < U0 0 ,T &P#' "< PP S +\ /@"\ $@ N0!1 +8 6 "T %\ L@!E
M +  :@"O '  K0!V *P ? "J (( J0") *< D0"E )H HP"D *$ K@"@ +L
MG@'- )T"Y@"<!/0 FP3_ )H%_P":!?\ F07_ /\*  #Q#@  Y!   -D/  #.
M"P  R ,+ ,( $P"\ A\ MP,L +,$-P"P!4( K09* *H&4@"H!UD I@=? *4'
M90"C!VL H@AQ * (=P"?"'X G0B% )L)C@":"9< F JA )8*K "5"[H DPO,
M )(,Y0"0#?8 CP[_ (X._P".#O\ C0[_ /81  #F%P  UAL  ,<9  "^%0
MN1   +<*#0"Q"Q< K TD *@., "E#CL H@Y$ )\/3 "=#U, FP]: )H/8 "8
M$&8 EQ!L )40<@"3$'D DA"! ) 0B@"/$90 C1&? (L1J@"*$K@ B!++ (83
MY@"%%/< @Q7_ (,5_P""%?\ @A7_ .T:  #<(0  RB4  +LB  "Q'P  JQH
M *D4!@"E$A$ H!0> )P5*@"9%34 EA8^ )061P"2%DX D!95 (X76P",%V$
MBQ=G (D7;0"(%W0 AAA\ (48A@"#&9  @1F; ( :IP!^&K4 ?1O' 'P<X@!Z
M'?4 >1W_ '@=_P!X'?\ >!W_ .4B  #0*0  ORP  + J  "G)P  H",  )T?
M  ":&@X E1P8 )$=) ".'B\ C!XY (D>00"''TD A1]0 (,?5@""'UP @!]B
M '\?:0!]('  ?"!X 'H@@0!Y(8P =R&7 '4BI !T(K( <R/# '(CWP!P)/,
M;R3_ &\D_P!N)/\ ;B3_ -TI  #(,   MS(  *@P  ">+@  ERH  ),G  "0
M(PH C",3 (@D'P"$)2H @B4T ( F/0!])D0 ?"9+ 'HF4@!X)E@ =R9> '4F
M90!T)VP <B=T '$G?0!O*(@ ;BB4 &PHH0!K*:\!:BG  6DJVP%G*O$!9RO_
M 68K_P%F*O\!9BK_ =0O  #"-@  KS8  *$U  "6-   D#   (HM  "'*@8
M@RD0 '\J&@!\*R4 >2LO '<L. !U+$  <RQ' '$L30!P+%0 ;BQ: &TL80!K
M+6@ :BUP &@M>@!G+H4 92Z1 60NG@%B+ZP!82^] 6$PU0%@,.\!7S#] 5\P
M_P%?,/\!7S#_ <TT  "\.P  J3H  )LZ  "0.   B34  (,R  !_, $ >R\.
M '<P%@!T,"$ <3$K &\Q- !M,3P :S%# &HQ2@!H,E  9S)7 &4R70!D,F4
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M < _  "N0P  G$,  (Y#  ""0@  >D   ',]  !M/   :#T% &0]#@!A/A<
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M 4))D@%!2:("0$FS C]*QP(_2N4"/TGW D!)_P) 2/\"0$C_ ;9)  "B2@
MD4H  (-*  !W2@  ;DD  &5%  !>1P  64@  %5)" !12A  3TH8 $Q*(0!*
M2RD 24LQ $=+. !&3#\ 14Q& $1,3@!#358 0DU? $%-: ! 370!/DV! 3U-
MD $\3: !.TZQ CI.Q@(Z3N0".TWV CM-_P$[3/\!/$S_ ;--  ">3   C4P
M '],  !T3   :DP  &!*  !92P  5$P  %!-!0!,3@X 24\5 $=/'@!%3R8
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M 2I=OP$I7=X!*ESR 2I;_@$K6_\!*UK_ :-5  "/50  ?U4  ')5  !G5@
M7E8  %17  !,60  15L  #]=   Z7P0 -F - #1A$P R8AP ,6(C #!B*P O
M8S( +F,Z "UC0@ L8TH *F13 "ED70 H9&D )V1V "9DA@ E9)< )&2I "-D
MO0 B9-H (V/Q "-B_0$D8?\!)&'_ 9Q8  ")6   >ED  &Y9  !C60  6EH
M %!<  !(7@  06   #IC   T9@  +V@* "QI$  J:1< *6H? "AJ)@ G:BX
M)FLU "5K/0 D:T8 (VM/ ")L60 @;&4 'VQR !YL@@ =;)0 '&RF !MKN@ :
M:]0 &VKN !QI_  <:/\ '&C_ )5<  "#7   =5P  &E=  !?70  5EX  $QA
M  !#9   /&<  #5J   O;0  *' $ "-R#0 A<A( (',: !]S(0 ><R@ '70P
M !QT.  ;=$  &G1* !ET5  7=6  %G5N !5U?@ 4=9  $W2B !)TM@ 1=,\
M$G/L !)R^@ 3<?\ $W'_ (Y@  !]8   ;V$  &5A  !;8@  460  $AG   ^
M:P  -VX  #!Q   I=0  (G@  !Q[!P 7?0X %GT3 !5]&P 4?B( $WXJ !)^
M,0 1?CH $7Y$ !!_3@ /?UH #G]H  U_>  ,?XH "WZ=  I^L  )?<8 "GWD
M  I\]  +>_T "WK_ (9E  !W90  :F4  &%F  !6:   3&L  $)O   Y<P
M,7<  "IZ   C?@  '($  !6$   0AP@ #8D.  R)%  ,B1L "XDC  J)*P )
MB3, "(D]  :)2  %B50 !(EA  *)<0 !B8,  (F6  "(J0  A[X  (?:  "&
M[   AO4  (;Z 'YJ  !Q:@  9VL  %ML  !0<   1G0  #QX   S?0  *H$
M ".%   <B   %8P  !"/   ,D@8 !I,,  *3$0  E!8  )0=  "4)   E2P
M )4U  "50   E4P  )99  "6:0  E7H  )6.  "4H0  E+4  )/,  "2Y@
MDO(  )+W 'AP  !M<   8'(  %1U  !)>0  /WX  #6#   LB   (XT  !N1
M   4E   #Y<   J:   $G0,  )X)  "?#@  GQ(  * 7  "@'0  H24  *(M
M  "B-P  HT,  *-0  "C7P  HW$  *.$  "BF0  HJT  *'"  "AW   H>L
M *#R '-V  !F=P  67L  $V   !"A0  .(L  "Z0   DE0  &YH  !2>   .
MH0  ":0   *G    J@   *L$  "K"@  K T  *T1  "M%@  KAP  *\D  "P
M+0  L3D  +%&  "R50  LF8  +)Y  "RC@  L:,  +*W  "QR@  L>   +'I
M &Q^  !?@@  4H<  $:-   [DP  ,)D  ":>   <HP  $Z<   VK   'K@
M +(   "U    MP   +@   "Y @  N0@  +H,  "[$   O!0  +T;  "_(P
MP2T  ,(Z  #"20  PUH  ,-L  #$@@  Q)<  ,2K  #$O   Q,L  ,3: &6)
M  !8C@  2Y4  #^;   SH@  **@  !VM   4L0  #;8   :Y    O    +\
M  ##    Q    ,4   #&    QP   ,D$  #*"0  RPT  ,T1  #/&   TB$
M -4M  #6/   V$T  -E?  #:<P  VHH  -N>  #;K@  V[H  -S# %Z6  !1
MG   1*,  #BJ   LL0  (+<  !6[   -O@  !,(   #%    R0   ,T   #0
M    T@   -(   #5    U@   -D   #;    W@4  . *  #B#P  Y18  .@@
M  #L+0  [3X  .U1  #N90  [WH  .^/  #PGP  \*L  /"S /\ $ #_  X
M_P . /\ $@#_ !T _P I /\ -0#_ $$ _P!- /X 5@#[ %\ ^ !F /8 ;0#T
M '0 \@!Y /$ ?P#P (0 [@") .T CP#K )4 Z@"; .@ H@#F *H Y0"S .,
MP #A -( X #J -\ ^0#= /\ W0#_ -T _P#> /\ W@#_ /\ #0#_  H _P )
M /\ #P#_ !@ _P D /X ,0#[ #T ^ !( /0 4@#P %H [0!B .L :0#I &\
MYP!U .4 >@#C '\ X@"% .  B@#> )  W "6 -H G0#8 *4 U0"O -( N@#0
M ,H S@#C ,T ] #+ /\ RP#_ ,L _P#+ /\ RP#_ /\ " #_  , _P % /\
M# #\ !0 ]P ? /( *P#O #< ZP!" .< 3 #D %4 X != -T 9 #: &H V !P
M -4 =0#2 'H T "  ,\ A0#- (L RP"2 ,D F0#' *$ Q0"J ,, M0#! ,,
MOP#: +X [@"] /P O #_ +P _P"\ /\ O #_ /\   #_    _P   /D !P#Q
M !  Z@ : .0 )0#? #$ VP \ -< 1P#2 %  S@!7 ,L 7@#) &4 Q@!J ,4
M< ## '4 P0!Z ,  @ "^ (8 O "- +H E "Y )P MP"E +4 L "S +T L0#/
M *\ Z "N /@ K@#_ *T _P"M /\ K0#_ /\   #_    _0   .X  0#C  P
MV@ 4 -$ 'P#, "L R  V ,4 0 #" $H OP!2 +P 60"Z %\ N !E +8 :@"T
M &\ LP!U +$ >@"P ($ K@"( *T CP"K )@ J0"A *< JP"E +@ HP#( *(
MX@"A /, H #^ *  _P"@ /\ H #_ /\   #V    Z@   .    #3  8 R0 /
M ,( & "] "0 N0 O +8 .@"T $, L0!, *X 4P"L %D J@!? *D 9 "G &H
MI@!O *0 =0"C 'L H0"" *  B@"> ), G "= )H IP"8 +0 E@## )4 W "4
M .\ DP#[ ), _P"3 /\ D@#_ /D%  #J"P  W T  ,L*  #"!0  O  * +8
M$0"Q !P K@ H *H ,P"G #T I !% *( 30"@ %, G@!9 )P 7P"; &0 F@!J
M )@ < "7 '8 E0!^ ), A@"2 8\ D &9 (X"I ", K$ BP/  (D%U@"(!NT
MB ?Z (<(_P"&"/\ A@C_ .\/  #>%   RA4  +P2  "S$   K@P  *L&#0"G
M Q4 H@4@ )\'+ "<"#8 F0@_ )<)1P"5"4X DPE4 )$*6@"0"E\ C@IE (T*
M:P"+"G( B@MY (@+@@"'"XP A0R7 (,,H@"!#;  @ W  '\-V !]#N\ ? _]
M 'L/_P![$/\ >Q#_ .87  #1'@  O1T  *\<  "F&0  H14  )X0! "=#0\
MF X9 )0.)0"1#R\ CQ Y (P000"*$$@ B!!/ (<050"%$%L A!%A ((19P"
M$6X ?Q%U 'T1?@!\$H@ >A*4 '@2H !W$ZX =1.^ '04U0!S%>X <1;] '$6
M_P!Q%O\ <!;_ -P?  #&)0  LR4  *4C  "<(0  EAX  )(9  "1% L C104
M (D5'P"&%BD @Q8S ($7/ " %T, ?A=* 'P74 !Z%U8 >1A< '<88@!V&&D
M=!AQ ',9>@!Q&80 ;QJ0 &X:G0!L&ZL :QR[ &H<T !I'>P :![[ &@>_P!G
M'O\ 9Q[_ -$F  "]*@  JRH  )TJ  "3*   C24  (@B  "&'08 @QL0 '\<
M&@!\'20 >ATN '<>-@!V'CX =!Y% '(?2P!Q'U$ ;Q]8 &X?7@!L'V4 :R!M
M &D@=@!H(8$ 9B&- &4BF@!C(J@ 8B.X &$CS0!@).D 8"3Z %\D_P!?)/\
M7R3_ ,HL  "V+P  I"\  )8O  ",+0  A2H  ( H  !])   >B(- '8C%0!S
M(R  <20I &\D,@!M)#H :R5! &HE1P!H)4T 9B54 &4E6@!D)F$ 8B9I &$F
M<@!?)WT 7B>* %THEP!;*:4 6BFU %HJR@!9*N< 6"KX %@J_P!8*O\ 6"K_
M ,4Q  "O,P  GC,  ) S  "&,@  ?R\  'DM  !U*@  <B@* &\H$@!K*1L
M:2DE &<J+0!E*C4 8RH] &(J0P!@*DH 7RM0 %XK5P!<*UX 6RQF %DL;P!8
M+7H 5RV' %8NE0!4+J, 4R^S %,OQP!2+^4 4B_W %(O_P!2+_\ 4B__ ,$V
M  "J-@  F38  (LV  "!-0  >3,  ',Q  !O+P  :RX& &@M$ !D+A@ 8BXA
M & O*@!>+S$ 7"\Y %LO0 !9+T8 6"]- %<P4P!6,%L 5#%C %,Q; !2,G<
M43*$ $\SD@!.,Z$ 33.Q $TTQ0%,-.,!3#3V $PT_P!,-/\ 3#/_ +LY  "F
M.0  E3D  (<Y  !\.0  =#<  &XT  !I,P  93(" &$R#0!>,A0 7#,> %HS
M)@!8,RX 5C,U %4T/ !3-$, 4C1* %$T4 !0-5@ 3C5@ $TV:@!,-G4 2S>"
M $HWD !).)\ 2#BP 4<XPP%'..$!1SCU 4<X_P%'./\!1SC_ ;<[  "B/
MD3P  (,\  !X/   <#H  &HW  !D-@  8#8  %PV"P!9-Q( 5C<: %0W(P!2
M-RL 4#<R $\X.0!-.$  3#A' $LX3@!*.54 23E> $@Z: !'.G, 1CN  $4[
MC@!$/)X 0SRN 4(\P@%"/=\!0CSS 4(\_P%"//\!0CO_ ;,]  ">/@  C3X
M '\^  !U/@  ;#T  &8Z  !@.0  6SH  %<Z" !3.Q  43L8 $X[( !,.R@
M2SLO $D\-@!'/#T 1SQ$ $8]2P!%/5, 1#Y< $,^9@!"/W$ 03]^ $ _C0 _
M0)P /D"M 3U P $]0-T!/4#R 3U _P$^/_\!/C__ :Y   ":0   B4$  'Q!
M  !Q00  :$   &$\  !;/0  5CX  %(^!0!./PX 3#\5 $D_'0!'0"4 1D L
M $1 ,P!#0#H 0D%" $%!20! 05$ /T): #Y"8P ]0V\ /$-\ #M#BP Z1)L
M.42K 3E$O@$X1-L!.43Q 3E#_@$Y0_\!.4/_ :I"  "60P  AD,  'A#  !N
M0P  94,  %U   !60   44(  $U" @!)0PP 1D,2 $1$&@!"1"( 040J #]%
M,0 ^13@ /44_ #Q&1P [1D\ .D97 #E'80 X1VP -T=Z #9(B0 U2)D -$BJ
M #1(O0 S2-D -$CP #1'_0 T1_\ -4;_ *9$  "210  @D8  '5&  !J1@
M844  %E$  !11   3$8  $A'  !$1PH 04@0 #])&  ]22  /$DG #I*+@ Y
M2C8 .$H] #=+1  V2TP -4M5 #1,7P S3&H ,DQW #%,A@ P3)< +TVH "Y-
MNP N3=4 +DSO "],_0 O2_\ ,$O_ *%'  ".2   ?D@  '%(  !F20  74@
M %5(  !,20  1TH  $)+   _3 8 .TT. #E.%0 W3AT -D\D #5/*P S3S,
M,E Z #%00@ P4$H +U%2 "Y17  M46< +%%U "M1A  J4I4 *5*F "E2N0 H
M4M( *5'N "E0_  J4/\ *D__ )Q*  ")2@  >DL  &U+  !C3   6DP  %%,
M  !(30  0T\  #U0   Y4@( -5,, #-4$@ Q5!D ,%4A "Y5*  M52\ +%8W
M "M6/@ J5D8 *59/ "A760 G5V0 )E=R "57@0 D5Y( (U>D ")7MP B5\\
M(E?L "-6^@ C5?\ )%7_ )9-  "$3@  =4X  &E.  !?3P  5D\  $U0  !%
M4@  /U,  #E6   S6   +UH( "M;#P J6Q4 *%P= "=<)  F7"L )5PS "1=
M.@ C74, (EU, "%=5@ @7F$ 'UYN !Y>?@ =7H\ '%ZA !M>M  :7<P &UWI
M !M<^0 <6_\ '%O_ )!1  !^40  <%$  &12  !;4@  4E,  $I4  !!5P
M.UD  #5;   N7@  *& # "1B#  B8Q$ (6,8 !]D(  >9"< '60N !QD-@ ;
M93X &F5' !EE40 895T %V5J !9E>@ 598L %&6> !-EL0 29<@ $F3G !-C
M]P 48O\ %&+_ (E4  !X50  :U4  &!6  !75@  3U<  $99   ]7   -E\
M #!B   I9   (V<  !UJ!P 9; X &&P3 !9M&@ 5;2$ %&TI !1M,  3;3D
M$FY" !%N3  0;E@ #VYE  YN=0 -;H< #6Z:  QMK0 +;<( "VS@  QK\P -
M:_T #6K_ ()9  !R60  9ED  %Q:  !46@  2EP  $%?   Y8P  ,68  "II
M   D;   '6\  !=R   2=0D #W</  YW%  .=QL #7<C  QW*@ +=S, "G<\
M  EW1P (=U( !W=?  5W;P $=X   W>4  %VIP  =KL  775  %TZP "=/8
M G3\ 'M=  !M70  8EX  %E>  !.8   16,  #QG   S:P  *VX  "1R   >
M=0  %WD  !)\   -?P8 "8$,  6!$0 #@18  H$=  &!)   @2T  ((V  ""
M0   @DP  ()9  "":   @GD  (*-  "!H   @+0  (#+  !_YP  ?O(  '[Y
M '1B  !H8@  7F(  %-D  !)9P  /VL  #9P   M=   )7@  !Y\   7@
M$8,   V&   (B00  HL*  "+#@  BQ,  (P8  ",'P  C28  (TO  "..0
MCD0  (Y1  ".8   CG$  (Z%  ".F0  C:T  (S#  ",WP  B^X  (OV &YH
M  !D9P  6&D  $UL  !"<0  .'8  "][   F?P  'H0  !:(   0C   #(\
M  :2    E0   )8'  "7#   EP\  )@3  "9&   FA\  )LF  ";,   G#L
M )Q(  "<5P  G&@  )Q[  "<D   FZ4  )NZ  ":T   FN<  )KQ &IM  !>
M;P  47(  $9W   [?   ,8(  ">'   >C   %I$  !"5   *F0  !)P   "@
M    H@   *,!  "C!@  I L  *4.  "F$@  IQ<  *@>  "J)@  JS$  *L^
M  "L30  K%T  *QP  "LA0  K)L  *NO  "KPP  J]D  *KH &1U  !7>0
M2WX  #^$   TB@  *9   !^6   6FP  $)\   FC   !IP   *H   "N
ML    +    "Q    L@,  +0(  "U#0  MA   +<5  "Y'0  NR8  +PS  "]
M00  O5(  +UD  "^>0  OI   +VD  "]MP  O<8  +W7 %Q_  !0A0  1(L
M #B2   LF0  (9\  !>D   0J0  ":X   "R    M@   +D   "]    OP
M +\   #     P0   ,,   #$!0  Q@H  ,<.  #)$P  RQP  ,XF  #0-0
MT44  -)7  #2:P  TX(  -.7  #3J0  TK@  -+$ %6,  !)DP  /9H  #"B
M   EJ   &JX  !&T   )N0   +T   #!    Q    ,@   #+    S0   ,T
M  #/    T    -(   #4    V    -H&  #=#   X!$  .,:  #F)P  YS@
M .A*  #I70  ZG(  .N(  #KFP  [*@  .RR /\ #0#_  L _P + /\ $ #_
M !H _P F /\ ,@#_ #T _P!( /L 4@#X %H ]@!B /, :0#Q &\ \ !U .X
M>@#L '\ ZP"$ .D B@#H )  Y@"6 .0 G0#B *4 X0"O -\ NP#= ,L VP#F
M -D ]P#8 /\ V #_ -< _P#7 /\ U #_ /\ " #_  0 _P $ /\ #0#_ !4
M_@ A /H + #W #@ ] !# /  30#M %4 Z@!= .< 9 #D &H X@!P .  =0#>
M 'H W0!_ -L A0#9 (L U0"1 -, F0#1 *  SP"J ,T M0#+ ,0 R0#= ,@
M\0#' /\ Q@#_ ,8 _P#& /\ QP#_ /\   #_    _P   /\ "@#X !$ \0 <
M .P )P#I #( Y@ ] .( 1P#= %  V0!8 -4 7P#2 &4 T !J ,X < #, '4
MR@!Z ,D ?P#' (4 Q0", ,, E #! )P OP"E +T L "[ +T N@#0 +@ ZP"W
M /L M@#_ +8 _P"V /\ M@#_ /\   #_    _0   /, !0#I  X X0 6 -L
M(0#5 "T T0 W ,X 00#* $H QP!2 ,0 60#" %\ P !E +X :@"\ &\ NP!T
M +D >@"W (  M@"' +0 C@"R )< L "@ *X J@"M +< JP#( *D XP"H /4
MIP#_ *< _P"G /\ I@#_ /\   #^    \0   .4   #7  H S0 1 ,< ' #"
M "8 OP Q +P .P"Z $0 MP!, +0 4P"R %D L0!? *\ 9 "M &D K !O *H
M= "I 'H IP"! *8 B0"D )$ H@"; *  I0"> +( G0#! )L V@": .\ F0#]
M )@ _P"8 /\ F #_ /T   #P    X0   -$   #&  0 O0 - +< %0"S "
ML  K *T -0"K #X J !& *8 30"D %0 HP!9 *$ 7P"@ &0 G@!I )T ;@";
M '4 F@![ )@ @P"6 (P E0"6 ), H0"1 *T CP"[ (T SP", .D BP#X (P
M_P", /\ C #_ /,"  #B!P  S <  +\$  "W    L0 ( *L $ "G !D I  D
M *  +@"> #< G !  )H 1P"8 $X E@!4 )4 60"3 %X D@!D )  :0"/ &\
MC0!V (L ?@"* (@ B "2 (8 G0"% *D @P"X ($ R@"  .4 @ #U '\ _P!_
M /\ ?P#_ .@-  #0$   OA   +$.  "H#0  HP@  * "# "< !, F  = )4
M)P"2 #$ D  Y (X!00", 4@ B@). (D"5 "' ED A@)? (0#9 "# VL @0-R
M ( $>@!^!(0 ?06. 'L%F@!Y!J< > :U '8'R !U"., =0GT '0*_P!S"O\
M<PK_ -T5  #$%P  L1<  *46  "<$P  EA$  )0-! "3" T C@<5 (L)( "(
M"2H A0HS (,+.P"!"T( @ M) 'X+3P!]#%0 >PQ: 'H,8 !X#&< =PQN '4-
M=@!T#8  <@V, ' -F0!O#J8 ;0ZU &P.R0!K#^8 :A#W &D0_P!I$/\ :1#_
M - =  "Y'@  J!X  )L=  "2&P  BQD  (@5  "'$0< A0X0 ($/&@!^$"0
M>Q M 'D0-@!W$3T =A%$ '012@!S$5  <1%6 ' 17 !N$F( ;1)J &L2<P!I
M$WT :!.) &83E@!E%*, 8Q6S &(5Q@!B%N, 81;V & 7_P!@%_\ 8!?_ ,<B
M  "P(P  GR0  )(C  ")(@  @B   'X=  !\&0  >A4- '<5%0!T%A\ <18H
M &\7, !N%S@ ;!<_ &L710!I&$L :!A1 &886 !E&%X 8QEF &(9;P!@&7D
M7QJ% %T;D@!<&Z$ 6QRP %H<PP!9'>  6![T %@>_P!8'O\ 6![_ +\G  "I
M*   F2@  (LH  "")P  >R4  '8C  !S(   <1P) &X<$0!K'!H :1TC &<=
M+ !E'3, 8QXZ &(>00!@'D< 7QY- %X>5 !<'UL 6Q]B %D@:P!8('8 5B&"
M %4AD !4(IX 4R*N %(CP !1(]T 423R %$D_P!1)/\ 42/_ +DK  "C+
MDRP  (8M  !\+   ="H  &\H  !K)0  :2(% &8A#@!C(A8 82(? %\C)P!=
M(R\ 7",V %HC/0!9)$, 5R1* %8D4 !5)%< 4R5? %(E: !1)G, 3R9_ $XG
MC0!-*)P 3"BL $LIO@!+*=H 2BGQ $HI_P!+*?\ 2RG_ +,N  ">+P  CC
M ($P  !W+P  ;RX  &HK  !E*@  8R<! %\G# !<)Q, 6B<; %@H) !6*"L
M52@R %,H.0!2*4  4"E& $\I30!.*50 32I< $PJ90!**W  22M\ $@LBP!'
M+9H 1BVJ $4NO !%+M8 12[O $4N_@!%+O\ 12W_ *XQ  ":,@  B3,  'PS
M  !R,P  :S$  &4O  !@+0  72P  %DL"0!6+!  5"P8 %(L( !0+"@ 3BTO
M $TM-@!,+3P 2BU# $DM2@!(+E$ 1RY9 $8O8P!%,&T 0S!Z $(QB0!!,9@
M03*H $ RNP _,M, /S+N $ R_0! ,O\ 0#+_ *HS  "6-0  AC4  'DV  !N
M-0  9C4  &$R  !<,   5S   %0P!@!1, X 3C 5 $PQ'0!*,24 2#$L $<Q
M,@!&,3D 1#%  $,R1P!",D\ 03-7 $ S8  _-&L /C5X #TUAP \-I8 .S:G
M #LVN0 Z-M$ .C;M #LV_  [-O\ .S;_ *8V  "2-P  @C@  '4X  !K.
M8S<  %TV  !7,P  4S0  $\T P!+- P 2302 $8U&@!%-2( 0S4I $$U+P!
M-38 /S8] #XV1  ]-TP /#=5 #LX7@ Z.&D .3EV #@YA0 W.I4 -SJE #8Z
MN  U.L\ -CKL #8Z^P V.?\ -SG_ *(X  "..0  ?CH  '([  !H.P  7SH
M %DY  !3-@  3C<  $HX  !&. H 1#D0 $$Y%P _.1\ /CDF #PY+0 [.C0
M.CH[ #D[0@ X.TH -SM3 #8\7  U/&< -#UT #,]@P S/I, ,CZD #$^M@ Q
M/LT ,3[J #$^^@ R/?\ ,CW_ )X[  "+/   >SP  &X]  !D/0  7#T  %4\
M  !..@  23L  $4\  !!/0< /CT. #P]%0 Z/AP .3XC #<^*@ V/S$ -3\X
M #0_0  S0$@ ,D!0 #% 6@ P064 +T%R "Y"@0 M0I$ +4*B "Q"M0 K0LL
M+$+I "Q"^0 M0?\ +4'_ )D]  "'/@  =S\  &L_  !A0   63\  %(_  !)
M/@  1#\  $!    \000 .4(- #="$@ U0QD ,T,A #)#*  Q1"\ ,$0V "]$
M/0 N144 +45. "Q%6  K1F, *D9O "E&?@ H1H\ )T>A "9'LP F1\D )D;G
M "=&^  H1?\ *$7_ )5   ""00  <T(  &="  !>0@  54(  $Y"  !%0@
M/T0  #M%   W1@  -$<* #%($  O2!8 +DD> "Q))0 K22P *DDS "E*.@ H
M2D( )TI+ "9+50 E2V  )$MM "-+?  B2XT (4R? "%,L0 @3,< ($OF "%+
M]P B2O\ (DK_ )!#  !^1   ;T0  &1%  !:10  4D4  $I&  !!1P  /$@
M #=)   R2P  +DT' "M.#@ I3A, )T\: "9/(0 E3R@ )$\P "-0-P B4#\
M(5!( "!04@ ?45T 'E%J !U1>0 <48H &U&< !I1KP 94<4 &5'D !I0]@ ;
M3_\ '$__ (I&  !Y1P  :T<  &!(  !62   3D@  $=)   ^2P  .4P  #-.
M   N4   *%," "14"P B51  (%46 !]6'@ >5B0 '58L !Q6,P ;5SL &E=$
M !E73@ 85UD %UAF !58=0 46(< %%B: !-7K  25\( $E?A !-6]  45?\
M%%7_ (1)  !T2@  9DL  %Q+  !32P  2TP  $1-   \3P  -5$  "]4   I
M5@  )%D  !Y;!P :70T &%T2 !==&0 67B  %5XG !1>+@ 37C< $EY  !%?
M2@ 17U4 $%]B  ]?<0 .7X, #5^6  U?J0 ,7KX #%[:  U=\  -7/P #ES_
M 'Y-  !N3@  8DX  %A/  !/3P  2%   $!2   X5   ,%<  "I:   D70
M'U\  !EB 0 390D $68/ !!F%  /9AL #F<B  UG*0 -9S( #&<[  MG10 *
M9U  "6==  =G;  &9WT !6>0  1FHP "9K<  V7/  1EZ0 $9/4 !&3\ '=1
M  !I4@  75(  %12  !,4P  0U4  #M8   S6P  *UX  "5A   ?9   &6<
M !-J   /;08 "W ,  AP_^+_XDE#0U]04D]&24Q%  0)$0 '<!8 !7 =  1P
M)  #<"P  G U  !P/P  <$H  '!7  !P90  <'8  '"*  !OG@  ;[(  &[(
M  !MY0  ;?(  &WY '!6  !C5@  658  %%7  !'6   /EL  #9?   N8@
M)F8  !]J   9;0  $W    YS   +=@0 !7@+  %X#P  >1,  'D9  !Y'P
M>B8  'HO  !Z.0  >D0  'I0  !Z7P  >G   'J#  !ZF   >JP  'G"  !X
MWP  >.\  '?W &I;  !?6P  5EL  $Q<  !"8   .6,  #!H   H;   ('
M !ET   3=P  #GL   E^   $@0(  (((  "##0  @Q   (04  "%&0  AB
M (8H  "',0  ASP  (=)  "'5P  AV@  (=[  "'D   AJ4  (6Z  "%TP
MA.H  (3T &5@  !<8   46$  $9D   \:0  ,FT  "ER   A=P  &7L  !*
M   -@P  "(<   **    C0   (X$  "."0  CPT  ) 0  "1%   DAD  ),@
M  "4*0  E3,  )5   "63@  EE\  )5R  "5B   E9T  )2R  "4R   D^(
M )/N &%E  !69@  2FH  #]N   U=   *WD  "%_   9A   $8D   R-   &
MD0   )0   "8    F@   )L   "< @  G0<  )X+  "?#@  H1(  *(8  "C
M(   I2D  *8V  "F1   IE4  *9H  "F?0  II0  *6I  "DO0  I-$  *3D
M %ML  !/<   0W4  #A[   M@0  (X<  !F-   1D@  "Y<   2<    H
M *,   "F    J    *D   "J    K    *T$  "N"0  L T  +$1  "S%P
MM2   +8K  "W.@  MTL  +A<  "X<0  N(@  +B=  "XL0  M\(  +?0 %1V
M  !(?   /((  #&)   FD   &Y<  !*=   ,H@   Z<   "K    K@   +(
M  "V    N    +@   "Z    NP   +T   "^    P 4  ,$+  ##$   QA8
M ,D@  #*+@  RSX  ,Q0  #,9   S7H  ,V1  #-I   S;0  ,W  $V#  !!
MB@  -9$  "F9   >H   $Z8   RL   #L0   +8   "Z    O@   ,(   #&
M    R    ,@   #*    RP   ,T   #.    T    -(!  #5"   V0X  -T5
M  #A(0  XC$  .1#  #E5@  YFL  .:"  #GE@  YZ4  .:P /\ "0#_  4
M_P & /\ #@#_ !8 _P A /\ +0#_ #@ _0!# /D 30#U %4 \@!= /  8P#N
M &D [ !O .H = #I 'H YP!_ .8 A0#D (L XP"1 .$ F0#? *$ W "J -H
MM@#7 ,8 U0#A -, ] #2 /\ T0#_ -$ _P#/ /\ R@#_ /\  0#_    _P !
M /\ # #_ !( ^@ = /8 * #S #, \  ^ .P 2 #H %  Y0!8 .( 7@#? &0
MW0!J -L ;P#9 '0 U@!Z -0 ?P#2 (4 T ", ,X DP#, )P R0"E ,< L #&
M +X Q #4 ,( [@#! /X P #_ ,  _P"_ /\ O@#_ /\   #_    _P   /H
M!P#Q  \ ZP 8 .8 (P#B "X X  X -L 0@#5 $L T0!2 ,X 60#+ %\ R0!E
M ,< :@#& &\ Q !T ,( >@#! (  OP"& +T C@"[ )8 N0"@ +< J@"V +<
MM #* +( Y@"Q /@ L #_ *\ _P"O /\ L #_ /\   #_    ]P   .H  @#A
M  P UP 3 -  '0#, "@ R0 R ,8 / #" $4 OP!- +P 4P"Z %D N !? +<
M9 "U &D M !N +( = "Q 'H KP"  *T B "L )$ J@": *@ I0"F +$ I #!
M *, W "A /( H0#_ *  _P"@ /\ H0#_ /\   #W    Z    -D   #+  @
MPP 0 +T & "Y "( M@ L +0 -@"R #\ KP!' *P 30"K %0 J0!9 *< 7@"F
M &, I0!H *, ;@"B '0 H !Z )X @@"< (L FP"5 )D GP"8 *P E@"Z )0
MSP"3 .L D@#[ )( _P"2 /\ D0#_ /<   #G    TP   ,8   "[  ( LP ,
M *T $@"J !P IP F *0 , "C #@ H !  )X 1P"< $X F@!3 )D 6 "7 %T
ME@!C )4 : "3 &X D@!T )  ? "/ (4 C0"/ (L F@"* *< B "U (8 QP"%
M .0 A #U (0 _P"# /\ @P#_ .P   #3    P0$  +0   "L    I@ ' *
M#@"= !8 F@ @ )< *0"5 #( DP Z )$ 00"/ $@ C0!- (P 4P"+ %@ B0!=
M (@ 8P"' &D A0!O (, =P"" (  @ "* 'X E@!] *, >P"P 'H P@!Y -T
M> #Q '< _0!X /\ > #_ -X*  #$"P  L@P  *8+  "="   F00  )4 "@"1
M !$ C@ 9 (L (P") "P AP T (4 .P"# $( @@!( (  3@!_ %, ?0!8 'P
M7@![ &0 >0!J '@ <@!V 'L = "& ', D@!Q )\ < "M &X O@!M =8 ;0+M
M &P#^@!L _\ ; /_ ,X0  "W$0  IA(  )H1  "1$   BPX  (D+ P"'!0P
MA $3 ($!' !^ B4 ? ,N 'H#-@!X!#P =P1# '4%2 !T!4X <P54 '$%60!P
M!E\ ;@9F &T&;@!K!W@ :@># &@(D !G"9T 90FL &0)O !C"M0 8POL &(,
M^@!B#/\ 8@S_ ,,6  "M%P  G1@  ) 8  "'%@  @10  'T1  !\#@8 ? H.
M '@*%@!U"Q\ <@LH ' ,, !O##< ;0P^ &P,1 !K#4H :0U/ &@-50!G#5P
M90UC &,.:P!B#G4 8 Z! %\.C@!=#YP 7!"K %L0O0!:$-8 61'P %D1_0!9
M$?\ 61'_ +D;  "E'0  E!X  (@>  !^'0  >!L  '08  !Q%0  <1$) &\0
M$0!L$!D :1 B &<1*@!F$3( 9!$Y &,1/P!B$44 8!)+ %\240!=$E@ 7!)?
M %H3: !9$W( 5Q1] %84BP!4%9D 4Q6I %(6N@!1%M( 41?M %$7_0!1%_\
M41?_ +(@  ">(@  CB(  ($C  !W(@  <"$  &P>  !I&P  9Q@$ &85#@!C
M%A4 818> %\6)@!=%BT 7!<T %H7.P!9%T$ 6!A' %8830!5&%0 4QA< %(9
M9 !1&6X 3QIZ $X;B !-&Y< 2QRF $H<N !*'<\ 21WK $D=^P!)'?\ 2AW_
M *PD  "8)0  B"8  'LG  !Q)@  :B4  &8C  !B(0  8!X  %X<"P!;&Q(
M61P: %<<(@!5'"D 5!PP %,=-P!1'3T 4!U# $\=2@!-'E$ 3!Y8 $L?80!)
M'VL 2"!W $<@A0!&(90 1"*D $0BM@!#(LP 0R/I $,C^@!#(_\ 0R+_ *8G
M  "3*0  @RH  '8J  !M*@  92D  & G  !<)0  62,  %<A!P!5(0\ 4B$6
M % A'@!.(24 32(L $PB,P!*(CD 22)  $@B1@!'(TT 12-5 $0D7@!#)&D
M0B5U $ F@P _)I( /B>C #XGM  ])\H /2CH #TH^0 ])_\ /B?_ *(J  ".
M*P  ?RT  '(M  !H+0  82P  %PK  !8*   5"8  %$F! !.)0T 3"43 $HF
M&@!()B( 1R8I $4F+P!$)C8 0R<\ $$G0P! )TL /RA3 #XI7  ]*68 /"IR
M #LJ@0 Z*Y  .2NA #@LL@ W+,@ -RSF #@L^  X+/\ ."S_ )TL  "*+@
M>R\  &\P  !E,   72\  %@N  !3*P  4"H  $PJ  !)*@L 1BH1 $0J%P!"
M*A\ 02HE #\J+  ^*S, /2LY #PK0  [+$@ .BQ0 #DM60 X+F0 -RYP #8O
M?P U+X\ -#"? #,PL0 R,,< ,C#E #,P]P S,/\ -"__ )DO  "',0  =S(
M &LR  !B,@  6C(  %0Q  !/+P  2RT  $<N  !$+@@ 02X. #\N%  ]+AP
M.RXB #DO*0 X+R\ -R\V #8P/@ U,$8 -3%. #0Q5P S,F( ,C)N #$S?0 P
M,XT +S2> "XTL  M-,4 +33C "XT]@ O,_\ +S/_ )4Q  "#,P  =#0  &@U
M  !>-0  5S0  %$T  !+,@  1C$  $(R   _,@4 /#(- #DS$@ X,QD -C,@
M #0S)@ S,RT ,C0T #$T.P P-4, ,#5, "\V50 N-F  +3=L "PW>P K-XL
M*CB< "DXK@ H.,, *#CB "DX]0 J-_\ *C?_ )(T  !_-0  <38  &4W  !;
M-P  5#<  $TV  !'-@  0C4  #TV   Z-@( -S<+ #0W$  R-Q8 ,3@= "\X
M)  N."L +3DR "PY.0 K.4$ *CI) "HZ4P I.UX *#MJ "<[>0 F/(D )3R;
M "0\K0 C/,( (SS@ "0\]  E._\ )3O_ (TV  !\.   ;3D  &(Y  !8.@
M43D  $HY  !$.0  /3D  #DZ   U.P  ,CL( "\\#@ M/10 +#T: "H](0 I
M/2@ *#XO "<^-@ F/CX )3]' "0_4  C0%L (D!H "% =@ @0(< 'T&9 !]!
MJP >0<  'D'> !] \P ?0/X (#__ (DY  !X.@  :3L  %X\  !5/   33P
M $<\  ! /   .#T  #0^   P0   +4$% "I"#  G0A$ )D,8 "1#'@ C0R4
M(D,L "%$,P @1#L 'T1$ !Y%3@ =15D '$5E !M%=  :184 &4:7 !E&J0 8
M1KX %T7< !A%\0 91/T &D3_ (0\  !S/0  9CX  %L_  !2/P  2C\  $0_
M   ]0   -D$  #%#   L1   )T8! "1'"@ A2 \ ($D4 !Y)&P =22( '$DI
M !M*,  :2C@ &4I! !A*2P 72U4 %DMB !5+<0 42X( $TN4 !)+IP 22[P
M$4O9 !)*\  32OP %$G_ '\_  !O0   84$  %="  !.0@  1T(  $%"   Z
M0P  ,D4  "U'   H20  (TL  !Y-!@ ;3PT &% 1 !=0%P 64!X %5 E !10
M+  3430 $E$] !%11P 145( $%%?  ]2;0 .4GX #5&1  U1I  ,4;@ #%'1
M  U0[  -4/H #D__ 'E#  !J1   740  %-%  !+10  1$4  #Y&   V2
M+TH  "E,   D3P  'U$  !I3   45@D $5<. !!8$P 06!D #U@@  Y8*  -
M6#  #5@Y  Q80P +6$X "EA:  A8:  '6'D !EB,  58GP $6+, !%?*  57
MY@ %5_, !E;\ '-&  !D1P  64@  %!(  !(2   04D  #I*   R30  *U
M "52   @50  &E@  !5:   0708 #& ,  I@$  )8!4 "& <  =@(P %8"L
M!& T  -@/0 !8$D  &!5  !@8P  8',  &"&  !?F@  7ZX  %_$  !>X@
M7O   %[X &Q*  !?2P  54L  $Q,  !%3   /4X  #50   N4P  )U8  "!9
M   :7   %5\  !!B   -900 "&<+  -G#@  :!,  &@8  !H'P  :28  &DN
M  !I.   :4,  &E/  !I70  :6T  &F   !IE   :*D  &B_  !GW   9NX
M &;W &9/  !:3P  44\  $I/  !!40  .%0  #!7   H6P  (5X  !IB   4
M90  $&@   QK   ';@,  7 )  !P#0  <1   '$4  !R&@  <R$  ',H  !S
M,0  <SP  '1(  !S5@  <V8  '-Y  !SC@  <Z,  '*Y  !QT@  <>L  '#T
M &%3  !64P  3U,  $55   [6   ,EP  "I@   B9   &V@  !1L   /;P
M"W(   9V    >0   'H&  !Z"@  >PX  'P1  !]%0  ?AL  '\B  " *@
M@#4  (!!  " 3P  @%\  (!Q  " A@  @)T  '^R  !^R@  ?N4  'WQ %Q8
M  !46   25H  #]=   U80  +&4  "-J   ;;P  %',   YW   )>P   W\
M  ""    A    (8!  "&!@  B H  (D-  "*$   BQ4  (P;  ".(@  CRP
M (\X  "/1@  CU8  (]H  "/?@  CY4  (ZK  "-P0  C=P  (SK %E=  !.
M7P  0V(  #AF   N;   )'$  !QW   4?   #H$   B%    B0   (T   "0
M    D@   ),   "4    E@,  )<(  "8#   F@\  )L3  "=&@  GR,  * N
M  "@/   H$P  *!>  "@=   GXP  )^B  "?MP  GLL  )[@ %-D  !':
M/&T  #%S   G>0  '7\  !2%   -BP  !I    "4    F    )P   "?
MH0   *(   "D    I0   *<   "H!   J@D  *P-  "M$@  L!D  +(C  "R
M,0  LD(  +)4  "R:0  LH   +*8  "QK   LK\  +'. $QN  ! <P  -7H
M "J!   ?B   %8X   Z5   &F@   )\   "D    J    *P   "O    L0
M +$   "S    M0   +8   "X    N@   +P&  "^#   P!$  ,,9  #%)@
MQ3<  ,9)  #&70  QW(  ,>*  #(GP  R*\  ,B\ $9Z   Y@0  +HD  "*0
M   7F   #Y\   >E    J@   *\   "S    MP   +P   "_    P0   ,(
M  #$    Q0   ,<   #)    RP   ,T   #/ P  T@H  -80  #<&@  W2H
M -X\  #?4   X&4  .%[  #AD0  XJ(  .*M /\  @#_    _P # /\ # #_
M !, _P = /\ * #^ #, ^P ^ /< 2 #S %  \ !7 .T 7@#K &0 Z !I .<
M;P#E '0 XP!Y .( ?P#@ (4 W@", -P DP#9 )P U@"F -, L0#1 ,  SP#:
M ,X \0#, /\ RP#_ ,L _P#& /\ P0#_ /\   #_    _P   /\ " #[ !
M]@ 9 /( ) #O "X [0 Y .@ 0@#C $L X !2 -T 60#9 %\ U@!D -, :0#1
M &X SP!T ,X >0#, '\ R@"& ,@ C@#& )8 Q "@ ,( JP#  +D O@#- +P
MZ@"[ /P N@#_ +H _P"Z /\ M@#_ /\   #_    _@   /0 ! #K  T Y  4
M -\ 'P#; "D V  S -, /0#. $4 R@!- ,< 4P#% %D PP!? ,$ 9 "_ &D
MO0!N +L <P"Z 'D N "  +8 B "T )  L@": +$ I0"O +( K0#$ *P X0"K
M /8 J@#_ *H _P"J /\ J@#_ /\   #]    [@   .(   #5  H S0 1 ,<
M&0#$ ", P0 M +\ -P"[ #\ MP!' +4 3@"R %, L !9 *\ 7@"M &, K !H
M *L ;0"I ', J !Z *8 @0"D (H HP"4 *$ GP"? *P G@"[ )P T@"; .X
MF@#_ )H _P"9 /\ F0#_ /X   #N    W@   ,L   #!  4 N0 - +0 % "Q
M !X K@ G *L , "J #D IP!! *0 2 "B $T H0!3 )\ 6 "> %T G0!B )L
M9P": &T F !S )< >P"5 (0 E ". )( F0"0 *8 C@"T (T R ", .8 BP#Y
M (H _P"* /\ BP#_ /    #;    QP   +H   "P    J  * *0 $ "@ !@
MG0 A )L *@": #, F  [ )8 00"4 $@ D@!- )$ 4@"/ %< C@!< (P 80"+
M &< B@!N (@ =0"' 'X A0"( (, E "" *  @ "O '\ P !^ -T ?0#R 'T
M_P!] /\ ?0#_ .    #&    M0   *H   "B    FP % )4 #0"2 !, D  <
M (T ) "+ "T B@ T (@ .P"& $( A0!' (, 30"" %( @0!7 '\ 7 !^ &(
M?0!H 'L < !Z 'D > "# '8 CP!U )P = "J '( N@!Q -$ < #L '  ^P!P
M /\ < #_ ,T$  "W!@  IP<  )L&  "3!   C@   (H " "&  \ A  6 ($
M'@!_ "< ?0 N 'P -@!Z #P >0!" '< 1P!V $P =0!2 ', 5P!R %T <0!C
M &\ :P!N '0 ; !^ &L B@!I )@ : "F &< M@!F ,L 90#G &4 ]P!E /\
M90#_ , ,  "K#0  FPX  (\.  "&#0  @0L  'X' 0!\ 0L >0 1 '< & !U
M "$ <P I '$ , !O #8 ;@ \ &P 0@!K $< :@!- &D 4@!H %@ 9@!? &4
M9P!C '  8@%Z & !AP!? I4 7@*C %P#LP!< \< 6P3D %L%] !;!OX 6P;_
M +40  "A$@  D1,  (43  !\$@  =A$  ',.  !R# 0 <0<- &X$$@!L!!L
M:04C &<%*@!F!C$ 9 8W &,&/0!B!T, 80=) %\'3@!>"%4 70A< %L)8P!:
M"6T 6 IX %<*A0!6"Y, 5 NB %,+LP!2#,< 4@SD %$-]0!1#?\ 40W_ *T5
M  "9%P  B1@  'T9  !T&   ;1<  &H4  !G$0  9PX' &8,#@!C#!4 80P=
M %\,)0!=#2P 7 TS %L-.0!:#3\ 6 U% %<-2P!6#E$ 50Y9 %,.80!2#FL
M4 ]V $X0@P!-$)( 3!"B $L0L@!*$<@ 21'E $D1]P!)$O\ 21'_ *49  "2
M'   @QT  '8>  !M'0  9AP  &(:  !?%P  7A0! %X1"@!;$!$ 61$8 %<1
M( !5$2< 5!$N %,1- !1$3L 4!)! $\21P!.$DX 3!)5 $L37@!)$V< 2!1S
M $84@ !%%8\ 1!6? $,6L !"%L4 0A?C $(7]@!"%_\ 0A?_ )\=  ",(
M?2$  '$B  !H(@  82$  %P?  !9'   5QD  %46!@!4%0X 4144 $\6' !.
M%B, 3!8J $L6, !*%C< 21<] $<70P!&%TH 11A2 $,86@!"&60 01EP #\:
M?0 ^&XT /1N= #P<K@ [',, .QSA #L=]0 ['/\ /!S_ )HA  "'(P  >"0
M &PE  !C)0  7"0  %<C  !3(   41X  $\< @!-&PP 2QH1 $@;& !'&R
M11LF $0;+0!#'#, 0APY $ <0  _'4< /AU/ #T>6  \'F( .A]M #D?>P X
M((L -R&; #8AK0 U(<$ -2'? #4A\P V(?\ -B'_ )8C  "#)@  ="<  &@H
M  !?*   6"<  %,F  !/)   3"(  $D@  !'( D 1!\/ $(?%0! (!P /R C
M #X@*0 \("\ .R$V #HA/0 Y(40 ."), #<B50 V(U\ -"-K #,D>0 R)8D
M,26: # EJP P)K\ +R;< # F\@ P)O\ ,27_ )$F  !_*   <2H  &4J  !<
M*@  52H  $\I  !+*   2"4  $0D  !!) 4 /R0- #TD$@ [)!D .20? #<D
M)@ V)"P -24S #0E.@ S)D$ ,B9* #$G4P P)UT +RAI "XI=P M*8< +"F8
M "LJJ@ J*KT *BK: "LJ\0 K*OX +"G_ (TH  !\*@  ;2P  &(M  !9+0
M42T  $PL  !'*P  0R@  #\H   \* ( .2@+ #<H$  U*!8 ,R@< #(H(P P
M*"D +RDP "\J-P N*C\ +2M' "PK40 K+%L *BQG "DM=0 H+84 )RV7 "8N
MJ  E+KP )2[8 "8N\  F+OT )RW_ (HK  !X+0  :BX  %\O  !6+P  3B\
M $@N  !#+0  /RP  #LL   W+   -"P) #(L#@ P+1, +BT: "TM(  K+2<
M*BXM "HN-0 I+ST *"]% "<P3@ F,%D )3%E "0Q<P C,8, (C*5 "$RIP A
M,KL (#+4 "$R[P B,?P (C'_ (8M  !U+P  9S   %PQ  !3,0  2S$  $4Q
M  ! ,   .S   #8P   S,   ,#$& "TQ#0 K,1$ *3(7 "@R'@ G,B0 )3,K
M "4S,@ D,SH (S1# "(T3  A-5< (#5C !\U<0 >-H$ '3:3 !PVI0 ;-KD
M&S;2 !PV[0 =-OL '37_ ((P  !Q,@  8S,  %DT  !0-   230  $(S   ]
M,P  -S,  #$T   N-0  *S4" "@V"P E-Q  )#<5 "(W&P A."( (#@H !\X
M,  >.#< '3E  !PY20 ;.E0 &CI@ !DZ;@ 8.G\ %SN1 !<[I  6.[< %3O0
M !8Z[  7.OH &#G_ 'TR  !M-   8#4  %4V  !--@  1C8  $ V   Z-@
M-#8  "XX   J.0  )CH  ",["  @/ X 'CT2 !T]&  </1\ &SXE !H^+0 9
M/C0 %SX] !8_1P 5/U$ %#]> !0_;  30'P $D"/ !% H@ 10+8 $$#. !$_
MZP 2/_D $C[_ 'DU  !I-P  7#@  %(Y  !*.0  0SD  #TY   W.0  ,3H
M "L\   G/0  (C\  !Y!!  :0@L &$,0 !=#%0 51!L %$0B !-$*0 31#$
M$D0Z !%%0P 014X $$5;  Y%:0 .17D #46,  U%GP ,1;( "T7)  Q%Y0 -
M1/8 #43_ '0Y  !E.@  6#L  $\[  !'/   0#P  #H\   T/   +CX  "A
M   C0@  'T0  !I&   52 @ $DH- !%*$@ 02A@ #TL>  Y+)0 -2RT #4LV
M  Q+0  +2TH "DM6  E+9  (2W0 !TN'  5+F@ $2ZX !$K$  5*X  %2O
M!DGZ &X\  !@/0  5#X  $L^  !$/@  /3X  #<_   Q0   *D(  "1%   ?
M1P  &DD  !5,   13@4 #E$+  M1$  *410 "5$;  A1(@ '42D !5$R  12
M.P #4D8  5)2  !27P  4F\  %*!  !1E@  4:D  %&_  !0W   4.X  %#W
M &A   !;00  4$$  $A!  !!00  .T(  #1#   M10  )D@  "!+   ;30
M%E   !%3   .500 "E@*  98#@ "6!(  %D7  !9'0  624  %DM  !9-@
M64$  %E-  !:6@  6FD  %E\  !9D   6:4  %BZ  !8U0  5^P  %?V &-$
M  !610  344  $5%   _10  -T<  "])   H3   (D\  !M2   650  $5@
M  U:   )70, !%\)  !@#0  8!   &$4  !A&0  8B   &(G  !B,0  8CL
M &)'  !B50  8V0  &)V  !BBP  8J   &&V  !ASP  8.H  &#U %U(  !2
M20  2D@  $-(   Z2@  ,DT  "I0   C4P  '%<  !9:   170  #6    AC
M   #9@$  &<&  !H"P  :0X  &H1  !K%0  ;!L  &TB  !M*@  ;30  &U
M  !M3@  ;5T  &UO  !MA   ;)H  &RP  !KR   :^8  &KS %A-  !.30
M2$P  #Y.   U40  +%0  "18   =7   %F   !!D   ,9P  !VL   %N
M<    '(#  !R!P  <PL  '4.  !V$0  =Q8  '@<  !Y(P  >BT  'HY  !Z
M1P  >E8  'EH  !Z?   >90  'BJ  !XP0  =]\  '?O %11  !,40  0E(
M #A5   O60  )EX  !YB   69P  $&L   MO   %<P   '<   !Z    ?
M 'X   !_ @  @ 8  ($*  "##0  A!$  (85  "('   B24  (HP  "*/@
MB4T  (E?  ")<P  B(L  (BB  "'N0  A]$  (;H %)6  !'5P  /%H  #)?
M   H9   'VD  !9O   0=   "GD   )]    @0   (4   "(    B@   (P
M  "-    CP   ) $  "2"   DPP  )40  "7%0  F1T  )LG  ";-   FT0
M )I6  "::@  F8(  )J:  "8L   F,<  )?> $M<  ! 8   -64  "MJ   A
M<0  %W<  !!]   )@P   8@   ",    D0   )4   "8    F@   )L   "=
M    GP   *    "B    I 4  *8*  "H#@  JA0  *T=  "M*@  K3D  *U+
M  "M7P  K7<  *R0  "KIP  J[H  *O+ $5F   Y:P  +G$  "-X   9?P
M$(8   F-    DP   )@   "=    H0   *4   "H    JP   *L   "N
MKP   +$   "S    M0   +<!  "Y!P  O T  +\3  #"'P  PBX  ,)   #"
M5   P6L  ,&#  # FP  P:T  ,&\ #YR   R>   )X   !R(   2D   "I<
M  "=    HP   *@   "M    L@   +8   "Y    NP   +P   "^    P
M ,(   #$    Q@   ,@   #+    S@4  -$-  #6%   UR,  -@U  #920
MVEX  -MU  #;C   W)\  -RK /\   #_    _P   /\ "0#_ !  _P 9 /X
M) #\ "\ ^0 Y /0 0P#P $L [0!2 .H 60#G %\ Y !D .( :0#@ &X W@!S
M -P >0#: '\ UP"& -0 C@#1 )8 SP"A ,P K #* +L R #2 ,8 [@#& /\
MQ0#_ ,4 _P"_ /\ N@#_ /\   #_    _P   /X !0#W  X \@ 5 .X 'P#K
M "H Z0 T ., /0#> $4 V0!- -0 4P#1 %D S@!> ,P 8P#* &@ R0!M ,<
M<P#% 'D PP"  ,$ B "_ )  O0"; +L I@"Y +0 MP#( +8 Y@"U /L M #_
M +0 _P"S /\ K@#_ /\   #_    ^    .T   #E  L W0 1 -< &@#2 "0
MSP N ,L -P#' $  PP!' ,  3@"^ %, O !9 +H 7@"X &, M@!H +4 ;0"S
M ', L0!Y *\ @0"M (H JP"4 *D H "H *T I@"^ *4 VP"D /0 I #_ *,
M_P"C /\ H@#_ /\   #V    Y@   -<   #+  8 Q  . +X %0"[ !\ N0 H
M +< ,0"T #H L !! *T 2 "K $X J0!3 *< 6 "F %P I !A *, 9P"A &P
MH !S )X >@"= (, FP". )D F0"7 *8 E@"V )4 S "4 .L DP#] ), _P"3
M /\ DP#_ /<   #D    T    ,$   "W  ( KP + *L $0"G !D I0 B *,
M*P"B #, GP [ )P 0@"; $@ F0!- )< 4@"6 %< E0!; ), 80"2 &8 D !M
M (\ = "- 'T C "' (H DP"( *  AP"O (4 P@"% .( A #W (0 _P"$ /\
MA #_ .4   #-    O    *\   "F    G@ ' )H #@"6 !0 E  = )( )0"1
M "T D  U (T / ", $( B@!' (@ 3 "' %$ A@!6 (0 6P"# &  @0!G (
M;@!^ '< ?0"! 'L C0!Z )H > "I '< N@!V -, =@#O '8 _@!U /\ =0#_
M -    "[    JP   )\   "7    D  " (L "P"( !  A@ 7 (0 ( "" "<
M@0 O '\ -0!] #P ? !! 'L 1@!Y $L > !0 '< 50!V %L = !A ', :0!Q
M '$ < ![ &X AP!M )4 :P"C &H M !J ,D :0#H &D ^0!I /\ :0#_ ,
M  "L    G (  ) "  "(    @P   '\ !@![  T >0 2 '< &@!V "( =  I
M ', , !Q #8 <  \ &\ 00!M $8 ; !+ &L 4 !J %8 : !< &< 9 !E &P
M9 !V &, @@!A )  8 "? %\ KP!> ,, 7@#A %X ] != /\ 70#_ +0'  "@
M"0  D L  (0+  !\"@  =P<  '0$  !Q  D ;P / &T %0!K !P :0 C &@
M*@!G #$ 90 V &0 / !C $$ 8@!& &  3 !? %( 7@!8 %T 7P!; &@ 6@!R
M %@ ?@!7 (P 5@"; %4 JP!4 +X 5 #: %, [P!4 /L 5 #_ *D-  "6#@
MAQ   'H0  !R$   ; X  &D,  !G"0, 9@0+ &0 $ !B !< 8  > %X )0!=
M "L 7  Q %H -P!9 #P 6 !" %<!1P!6 4X 50)4 %,"7 !2 V4 40-O $\$
M>P!.!(H 3069 $P%J0!+!;P 2@;4 $H'[0!*!_D 2@?_ *$0  ".$@  ?A0
M ',4  !J%   9!,  & 1  !>#P  70T% %T)#0!:!A( 6 <9 %8'( !5!R<
M4P<M %((,P!1"#@ 4 @^ $\)1 !."4H 3 E1 $L*60!*"F( 2 MM $<+>@!&
M#(@ 1 R8 $,,J0!"#;P 0@W5 $(-[@!"#?L 0@W_ )H4  "'%@  >!@  &P9
M  !C&0  71@  %D6  !6$P  5!$  %0." !3#0X 40T4 $\-&P!-#2( 3 TH
M $L-+@!*#30 20TZ $<.00!&#D< 10Y/ $0.5P!"#V$ 01!L #\0>0 ^$(@
M/1&8 #L1J0 [$;P .A'6 #H1\  Z$OT .Q'_ ),8  "!&@  <QP  &<=  !>
M'0  6!P  %,;  !0&   3A8  $P3 P!,$0L 2A 0 $@1%P!&$1X 11$D $01
M*@!"$3  01$W $ 2/0 _$D0 /1), #P35  [$UX .11I #@4=@ W%84 -A66
M #06IP T%KH ,Q;3 #,6[@ T%OP -!;_ (X;  !\'0  ;A\  &,@  !:(
M4R   $X>  !*'0  2!H  $88  !%%@< 0Q4. $$5$P _%1H /A4@ #T5)P [
M%2T .A8S #D6.@ X%D$ -Q=) #4740 T&%L ,QEF #(9<P P&H, +QJ4 "X;
MI0 M&[@ +1O0 "T;[  N&_L +AO_ (H>  !X(   :B(  %\C  !6(P  3R(
M $HA  !&(   0QX  $$;   _&@, /1H, #L9$0 Y&18 -QH= #8:(P U&BD
M-!HP #,;-@ Q&SX ,!Q& "\<3P N'5D +1UD "P><0 K'X$ *A^2 "D?I  H
M(+< )R#. "<@ZP H(/H *1__ (8@  !T(P  9R0  %PE  !3)0  3"4  $<D
M  !"(P  /R$  #T?   Z'@  -QX) #4>#@ S'A, ,1X: # >(  O'B8 +A\M
M "T?,P L(#L *R!# "HA3  I(58 *")B "8B;P E(W\ )".0 ",CH@ B)+4
M(B3, "(DZ0 C)/D )"/_ ((C  !Q)0  8R8  %DG  !0*   22<  $,G   _
M)@  .R0  #@B   U(@  ,B(& # B#0 N(A$ +"(7 "HB'0 I(B, *",J "<C
M,0 F)#@ )25! "0E2@ C)E0 (B9@ "$G;0 @)WT 'R>/ !XHH0 >*+0 '2C*
M !THZ  >*/@ 'R?_ 'XE  !N)P  8"D  %8I  !-*@  1BH  $$I   \*
M-R<  #0F   P)@  +28# "LG"P H)Q  )R<4 "4G&@ D)R$ (R@G "(H+@ A
M*38 ("D^ !\J2  >*E( '2M> !PK:P ;*WL &BR- !DLGP 8++( &"S) !@L
MYP 9*_< &BO_ 'HG  !J*@  72L  %,L  !*+   0RP  #XK   Y*P  -"H
M # J   K*@  *2L  "8K"  C+ X (BP2 " L&  ?+!X 'BTE !TM+  <+3,
M&RX\ !HN10 9+U  &"]< !<O:0 6,'D %3"+ !0PG@ 4,+$ $S#' !,PY0 4
M,/8 %2__ '8J  !G+   6BT  % N  !(+@  02X  #LN   V+0  ,2T  "PM
M   G+P  )"\  "$P!0 ?,0P '#$0 !LR%0 :,AP &3(B !@R*0 7,S$ %C,Y
M !4S0P 4-$T $S19 !(T9P 1-7< $36) ! UG  0-;  #C7&  \TY  0-/4
M$#3_ '(L  !C+@  5S   $TP  !%,   /C   #@P   S,   +S   "DQ   D
M,@  (3,  !TU @ :-@D %S<. !4W$P 4.!D $S@? !(X)@ 2."X $3DV ! Y
M0  0.4L #CE7  XZ9  -.G0 ##J&  PZF0 +.:P "CG!  HYW@ +.?$ ##C\
M &XO  !?,0  4S(  $HS  !",P  .S,  #8S   Q,@  +#,  "<T   A-@
M'3@  !DY   5.P8 $CT, ! ^$  0/A4 #CX<  X^(P -/BH ##XS  P^/  +
M/T< "C]2  @_8  '/V\ !C^!  4_E  $/Z@  SZ\  0^UP %/NP !3[W &DS
M  !;-   4#4  $<U   _-0  .34  #0U   N-0  *3<  ",X   >.P  &CP
M !8_   2000 #D,*  Q$#@ *1!, "409  A$(  '1"< !D0O  5$.  #14(
M D5.  !%6P  16H  $5\  !%D   1*0  $2Y  !$T0  1.H  $/U &0V  !7
M-P  3#@  $,X   \.   -S@  #$X   K.0  )3L  " ]   :0   %D(  !)$
M   .1P0 "TD)  =*#0 $2Q$  4L6  !+'   2R,  $LK  !+-   2SX  $Q)
M  !,5P  3&8  $QW  !+C   2Z$  $NU  !*S@  2ND  $KU %\Z  !2.P
M2#L  $ [   Z.P  -#L  "X\   G/@  (D$  !Q#   61@  $DD   Y+   +
M3@, !U (  )1#   41   %(3  !3&   4Q\  %,F  !3+P  4SD  %-%  !3
M4@  4V$  %-R  !3AP  4IP  %*Q  !1R@  4><  %'T %D^  !./@  13X
M #X^   X/@  ,$   "E"   C1   '4<  !=*   230  #E    M3   &50(
M %<'  !8"P  60X  %H1  !:%0  6QH  %PA  !<*@  7#0  %P_  !<30
M7%L  %QL  !<@0  6Y<  %NM  !:Q0  6N0  %GS %1"  !*0@  0D(  #Q"
M   T0P  +$8  "5)   >3   %T\  !)3   .5@  "ED   5;    7@   & $
M  !A"   8@P  &,.  !D$0  918  &8<  !G(P  9RT  &<Y  !G1@  9U4
M &=F  !G>@  9I$  &6H  !EP   9-X  &3P $]&  !'1@  0$4  #='   O
M2@  )DT  !]1   850  $ED   U<   (8    F,   !F    :    &H   !K
M!   ; @  &T,  !O#@  <!(  '(7  !S'0  ="8  '0R  !T/P  =$X  '-?
M  !T<@  <XH  '*A  !QN   <=0  '#L $Q*  !%2@  .TL  #).   I4@
M(%8  !A;   27P  #60   =H    :P   &\   !R    =0   '8   !W
M>0(  'H&  !\"@  ?@X  ( 1  ""%@  A!X  (0I  "$-@  A$4  (16  "#
M:@  @X$  (*9  "!L0  @,D  (#E $I.   _4   -5,  "M7   B7   &6(
M !)G   ,;   !7$   !U    >0   'T   "!    @P   (4   "&    B
M (D   "+!   C0@  (\-  "2$   E!8  )8@  "6+   ECL  )9,  "58
ME78  )20  "3IP  DKT  )+5 $15   Y60  +UT  "1C   ::0  $F\   QU
M   $>P   (    "%    B0   (T   "1    DP   )0   "6    F    )H
M  "<    G@   * &  "B"P  I1   *@7  "I(P  J3$  *E#  "I5@  J&T
M *:'  "GG@  IK,  *7' #Y>   R8P  )VH  !UP   3>   #'\   .%
MBP   )$   "6    FP   )\   "B    I    *4   "G    J0   *L   "M
M    L    +(   "U @  MPD  +L0  "^&   OB8  +XX  "^2P  O6$  +QZ
M  "[E   NJD  +JY #=J   K<   ('@  !:    -B   !8\   "6    G
M *(   "G    K    +    "S    M@   +<   "Y    NP   +T   "_
MP@   ,4   #(    R@   ,X(  #2$   U1L  -4L  #40   U%<  --N  #4
MA@  U)L  -.K /\   #_    _P   /\ !0#_  X _P 5 /P ( #Y "H ]@ T
M /$ /0#M $8 Z0!- .8 4P#D %D X0!> -X 8P#< &@ V0!N -4 <P#3 'D
MT "  ,X B #+ )$ R0"< ,8 IP#$ +< P@#, ,  [ "_ /\ O@#_ +T _P"W
M /\ L@#_ /\   #_    _P   /H  0#S  L [0 2 .@ &P#E "4 Y  N -\
M. #8 $  T@!' ,X 3@#+ %0 R !9 ,8 7@#$ &, P@!G ,  ;0"_ ', O0!Z
M +L @0"Y (L M@"5 +0 H0"R *\ L #" *X XP"N /H K #_ *T _P"I /\
MI@#_ /\   #_    \@   .8   #=  < T@ . ,T %@#* "  R  I ,4 ,@#
M #H O !" +D 2 "W $X M0!3 +, 6 "Q %T L !B *X 9P"L &P J@!S *D
M>P"G (0 I0". *, F@"A *@ GP"Y )X T@"= /( G #_ )T _P"< /\ F0#_
M /P   #N    W0   ,P   #!  ( N@ , +8 $@"R !H L  C *\ + "M #0
MJ0 \ *8 0@"D $@ H@!- *  4@"> %< G0!; )P 8 ": &8 F0!L )< = "5
M 'T DP"' )$ DP"0 *$ C@"Q (T Q@", .@ BP#] (P _P", /\ C #_ .T
M  #8    Q0   +<   "L    I@ ( *$ #@"? !4 G0 > )L )@": "X EP U
M )4 / "3 $( D0!' )  3 ". %$ C0!5 (L 6@"* &  B0!F (< ;0"% '8
MA "  (( C "  )H ?P"I 'T O !\ -P ? #U 'P _P!\ /\ ? #_ -D   #!
M    L0   *0   "<    E  # )  # "- !$ BP 8 (D ( ") "@ AP O (4
M-@"# #P @@!! (  1@!_ $L ?0!/ 'P 5 ![ %H >0!@ '@ 9P!V '  =0!Z
M ', A@!Q ), < "B &\ M !N ,P ;@#M &X _@!N /\ ;@#_ ,0   "O
MH    )0   ",    A@   ($ " !^  X ?  4 'L &P!Y "( >  I '< , !U
M #8 =  [ '( 0 !Q $4 < !* &\ 3P!M %0 ; !; &L 8@!I &H : !T &8
M@ !E (X 8P"= &( K0!A ,( 80#D &$ ^ !A /\ 80#_ +0   "@    D0
M (8   !^    >0   '4  P!Q  L ;P 0 &T %@!L !T :P D &L *@!I #
M:  V &8 .P!E $  9 !% &, 2@!A $\ 8 !6 %\ 70!= &4 7 !O %H >@!9
M (@ 6 "8 %< J !6 +L 5@#8 %8 \0!6 /\ 5@#_ *@!  "4!0  A0<  'H'
M  !R!@  ; 0  &D!  !G  < 9  - &, $0!A !@ 8  ? %\ )0!> "L 70 P
M %L -@!: #L 60!  %@ 10!7 $L 5@!1 %4 6 !3 &$ 4@!J %  =@!/ (0
M3@"3 $T I !, +8 3 #- $P ZP!, /H 3 #_ )T)  "+"P  ? T  ' -  !H
M#0  8@P  %\*  !=!@$ 7 $) %H #@!8 !, 5P 9 %8 ( !5 "8 4P K %(
M,0!1 #8 4  [ $\ 00!. $< 30!- $L 50!* %T 20!G $< <P!& (  10"0
M $0 H0!# +( 0P#( $, Y@!# /4 0P#_ )4-  "##P  =!   &D1  !@$0
M6A   %8.  !4#0  4PH$ %,&"P!1 Q  3P$5 $X!&P!, 2$ 2P$G $H"+ !)
M C( 2 (W $<#/0!% T, 1 -* $,$40!"!%H 0 5D #\%<  ^!GX /0:. #P'
MGP [![$ .@?& #H'XP Z!_, .@C\ (X0  !\$@  ;A0  &(5  !:%0  5!0
M % 3  !-$0  2PX  $L-!@!*"@P 20@1 $<(%@!%"!T 1 @C $((* !!"2X
M0 DS #\).0 ^"D  /0I' #P*3P Z"U@ .0MC #@,;P V#'X -0R. #0-GP S
M#;$ ,@W' #(-XP R#?0 ,@W^ (@3  !W%0  :1<  %X8  !5&   3Q@  $H6
M  !'%0  11,  $,0 @!##@@ 0@T. $ -$@ _#1@ /0T? #P-)  [#2H .0TP
M #@.-P W#CT -@Y% #4.30 S#U< ,@]B #$0;@ O$'T +A". "T1H  L$;(
M*Q'( "L1Y@ K$?8 +!'_ (,6  !R&0  9!H  %D;  !1&P  2QL  $8:  !"
M&   /Q<  #X4   \$@0 .Q$* #H0$  X$!4 -Q ; #41(0 T$2< ,Q$M #(1
M,P P$3H +Q)" "X22P M$U0 *Q-? "H4;  I%'L *!2, "<5G@ F%;  )17&
M "45Y  E%?8 )A7_ 'X9  !N&P  8!T  %8>  !-'@  1QX  $(=   ^'
M.AH  #@8   W%@  -14' #04#0 R%!( ,!07 "\4'0 M%", +!4J "L5,  J
M%3< *18_ "@62  G%U( )AA= "08:@ C&7D (AF* "$9G  @&:\ 'QG$ !\9
MX@ @&?0 (!G_ 'H;  !J'@  71\  %,@  !*(   1"   #X?   Z'@  -QT
M #0<   R&0  ,!D$ "X8"P L&!  *A@4 "D8&@ G&"  )ADF "49+0 D&C4
M(QH] "(;1@ A&U  (!Q; !\=:  >'7< '1V( !P>FP ;'JT &A[# !H>X  :
M'?, &QW_ '<=  !G(   6B$  % B  !((@  02(  #LB   W(0  ,R   # ?
M   M'0  *QT  "@="  F'0X )1T2 ",=%P A'1T (1TD " >*@ ?'C( 'A\Z
M !T?0P <($T &R%9 !HA9@ 9(74 &"*' !<BF0 6(JP %2+! !4BWP 5(?(
M%B'^ ',@  !D(@  5R,  $TD  !%)0  /B0  #DD   T(P  ,"(  "PB   I
M(0  )B$  "0A!@ B(0P ("$0 !XA%0 =(AL &R(A !LB*  :(R\ &2,X !@D
M00 7)$L %B57 !4E9  4)G, $R:% !(FF  1)JL $2;  ! FW0 1)?$ $B7]
M ' B  !A)   5"8  $HF  !")P  /"8  #8F   Q)0  +24  "DD   F)
M(B4  !\E P =)@H &R8. !DG$@ 8)Q@ %R<? !8G)0 5*"T %"@U !,I/@ 2
M*4D $2E5 !$J8@ 0*G$ #RJ#  XJE@ .*JD #2J]  TJUP -*NX #BG[ &PD
M  !=)@  42@  $@H  ! *0  .2@  #0H   O*   *R<  "<G   B*   'BD
M !LJ   8*P< %BL- !0L$0 3+!8 $BP< !$M(P 0+2H $"TR  \N/  .+D8
M#2Y2  TN7P ,+VX "R]_  HOD@ )+Z4 "2ZY  @NT  )+ND "B[W &@G  !:
M*0  3BH  $4K   ]*P  -RL  #$J   M*@  *2H  "0J   @*P  &RT  !@N
M   5+P0 $C$* ! R#@ /,A, #C(9  TR(  -,B< ##(O  LS.  *,T( "3-.
M  @S6P &-&H !31[  0SC@ #,Z(  C.V  (SS0 #,^< !#+S &0J  !6+
M2RT  $(M   Z+0  -"T  "\L   K+   )BP  "(M   =+P  &3$  !4R   2
M- , #S8)  PX#0 *.!$ "3@6  @X'0 '."0 !C@L  0X-  #.#X  CE*   Y
M5P  .64  #EW   YBP  .)\  #BS   XR@  ..8  #?R %\M  !2+@  2"\
M #\P   X+P  ,B\  "TO   I+P  )#   !\Q   :,P  %34  !(W   /.0,
M##L(  @]#0 %/A   SX4   ^&@  /B$  #XH   ^,0  /SL  #]&   _4P
M/V$  #]S   _AP  /IP  #ZP   ]QP  />0  #WR %HP  !.,@  1#(  #PR
M   U,@  ,#$  "LQ   F,@  (#0  !LV   6.   $CL   \]   ,/P, "$$(
M  1##   0PX  $02  !%%@  11T  $4D  !%+0  1C8  $9"  !&3@  1ET
M $9N  !%@@  19@  $2M  !$Q   0^,  $/R %4T  !*-0  034  #DU   S
M-   +C0  "@U   B-P  '3H  !<\   2/P  #T$   Q$   (1@$  T@&  !)
M"@  2@T  $L0  !,%   31D  $X@  !.*   3C(  $T]  !.2@  3E@  $UI
M  !-?0  3)0  $RJ  !+P0  2^$  $KR % X  !&.   /3@  #<X   Q-P
M*CD  "0[   >/0  &$   !-#   /1@  "TD   =+   "3@   % $  !1"
M4@L  %,.  !4$0  514  %8;  !7(P  5RP  %<X  !71   5U(  %9C  !6
M=P  5HX  %6E  !4O0  4]T  %/P $L\  !"/   .SL  #4[   M/   )C\
M !]"   910  $T@   Y+   +3P  !5$   !4    5P   %@!  !:!0  6P@
M %P,  !=#@  7Q$  & 6  !B'0  8B8  &(Q  !B/@  84P  &%=  !A<
M8(@  &"@  !?MP  7M0  %WN $=    _/P  .C\  #%    I0P  (48  !I*
M   33@  #E$   I5   $6    %L   !>    80   &,   !D 0  900  &<(
M  !H"P  :@X  &P2  !N%P  ;R   &\J  !O-@  ;D4  &Y5  !N:   ;7\
M &V8  !LL   :\H  &KH $1$   ^0P  -40  "M'   C2P  &T\  !-4   .
M6   "%P   )@    9    &<   !K    ;0   &\   !P    <@   '0"  !U
M!@  =PH  'D.  !\$@  ?A@  '\B  !_+@  ?ST  'Y-  !]80  ?7<  'R0
M  ![J   >L   'G? $-'   Y20  +TP  "50   <50  %%L   Y@   '90
M &H   !N    <@   '8   !Y    ?    'X   !_    @0   (,   "%
MAP,  (H(  ",#0  CQ$  )(9  "2)0  DC,  ))$  "15P  D&T  (^&  ".
MGP  C;4  (S- #U.   R40  *%8  !Y<   58@  #F@   =N    =    'D
M  !^    @@   (8   ")    C    (X   "0    D@   )0   "6    F
M )L   ">!@  H0P  *01  "F&P  IBD  *8Z  "E30  I6(  *1[  "CE
MH:L  *&_ #97   L7   (6(  !=I   /<   !W<   !^    A    (H   "/
M    E    )@   ";    G@   )\   "B    I    *8   "H    JP   *T
M  "P    LP0  +<,  "[$@  NQ\  +LP  "[0P  NE@  +EP  "WBP  MZ$
M +>S #!B   E:0  &G   !!X   )@    (@   "/    E@   )L   "A
MI@   *H   "N    L    +$   "T    M@   +@   "[    O0   ,    ##
M    QP   ,L#  #/#   TQ4  -(E  #2.   T4X  -!E  #/?@  S98  ,RI
M /\   #_    _P   /\  P#_  L _  1 /D &P#W "4 \P O .X . #I $
MY@!( .( 3@#? %0 W !9 -D 7@#5 &, TP!H -  ;0#. ', RP!Z ,@ @@#&
M (P PP"7 ,  HP"^ +( O #( +H Z@"Y /\ N #_ +$ _P"J /\ IP#_ /\
M  #_    ^P   /8   #M  < YP / .( %@#? "  W@ I -D ,P#1 #L S !"
M ,@ 2 #% $X P@!3 ,  6 "^ %T O !B +H 9P"Y &T MP!T +4 >P"R (4
ML "0 *X G "L *H J0"] *< W@"F /D I0#_ *, _P"= /\ FP#_ /T   #V
M    ZP   -\   #1  , R@ , ,4 $@## !L P  D +X + "Y #4 M@ \ +,
M0P"P $@ K@!. *P 4@"K %< J0!< *< 80"F &< I !M *( = "@ 'T G@"(
M )P E0": *, F "T )8 S0"5 /$ E #_ )4 _P"0 /\ C@#_ /,   #F
MT0   ,(   "X    L0 ( *T #P"J !8 J  > *@ )P"F "\ H@ V )\ / "=
M $( FP!' )D 3 "7 %$ E@!5 )0 6@"3 &  D0!F )  ;@". '8 C "! (H
MC0"( )L A@"L (4 P0"$ .8 @P#] (0 _P"# /\ @0#_ .0   #+    N@
M *P   "B    G  $ )@ # "6 !$ E  9 ), (0"2 "@ CP P (T -@"+ #P
MB0!! (@ 1@"& $L A0!/ (0 5 "" %H @0!@ '\ 9P!^ &\ ? !Z 'H A@!X
M )0 =P"D '4 MP!T -0 <P#T '0 _P!T /\ = #_ ,L   "V    I@   )H
M  "2    B@   (8 " "#  X @0 4 ($ &P"  ", ?P J 'T , ![ #8 >@ [
M '@ 0 !W $4 =0!) '0 3@!S %0 <0!: '  80!N &D ;0!S &L ?P!I (T
M: "= &< K@!F ,< 90#J &8 _P!F /\ 9P#_ +@   "D    E0   (H   "!
M    ?    '8 ! !T  P <@ 0 '$ %@!P !T <  D &X *@!M #  :P U &H
M.@!I #\ : !$ &< 20!E $X 9 !4 &, 6P!A &, 8 !M %X >0!= (< 6P"6
M %H J !9 +T 60#? %D ^ !: /\ 6@#_ *@   "5    AP   'L   !S
M;@   &H  0!G  @ 90 . &0 $@!C !@ 8P ? &( )0!A "H 7P P %X -0!=
M #H 7  ^ %L 1 !9 $D 6 !/ %< 5@!6 %X 5 !H %, <P!1 ($ 4 "1 $\
MH@!. +4 3@#0 $X \ !. /\ 3P#_ )P   ")    >P,  ' #  !H P  8@$
M %\   !=  0 6P + %D #P!8 !0 5P 9 %< ( !6 "4 50 J %, , !2 #0
M40 Y %  /P!/ $0 3@!+ $T 4@!+ %H 2@!C $D ;P!' 'P 1@", $4 G0!%
M +  1 #' $0 Z !$ /H 10#_ )($  " !P  <0H  &8*  !>"@  60D  %4'
M  !4!   4@ ' %  # !/ !  3@ 5 $T &P!, "  2P F $H *P!) #  2  U
M $< .@!& $  10!& $, 3@!" %8 00!? $  :P ^ '@ /0"( #P F0 \ *L
M/ #! #L X  [ /0 .P#_ (D*  !X#   :@X  %\.  !7#@  40X  $T,  !+
M"P  2@@" $D$"0!(  T 1@ 1 $4 %@!$ !P 0P A $( )@!! "L /P Q #X
M-@ ] #P / !# #L 2@ Z %( .0!< #@ :  V '4 -0"% #0 E@ T *@ ,P"\
M #, V  S .\ ,P#[ ((-  !Q#P  9!   %D1  !1$0  2Q$  $<0  !$#@
M0@T  $$+!0!!!PL /P4. #X#$@ \ A@ .P(= #H#(@ Y R@ . ,M #<#,@ V
M!#D -00_ #0%1P S!5  ,09: # &9@ O!W, +@># "T'E0 L!Z< *P>Z "L'
MT@ K!^L *P?W 'T0  !L$0  7Q,  %04  !,%   1A0  $(3   ^$@  /!
M #H. 0 Z#08 .@H, #@)$  V"!0 -0@9 #0)'P R"20 ,0DI # )+P O"C8
M+@H] "T*10 L"TX *PM9 "D,90 H#', )PR# "8-E0 E#:< ) V[ ",-T@ C
M#>L (PWW '@2  !H%   6Q8  %$7  !(%P  0A8  #T6   Y%0  -Q,  #41
M   S$ , ,PX( #(-#0 P#1$ +PT6 "T-&P L#2$ *PTG "H-+0 I#C0 * X[
M "<.1  E#DX ) ]9 ",090 A$', (!"$ !\0E@ >$*D '1"] !P0V  =$.X
M'1#Y ',4  !D%@  5Q@  $T9  !%&0  /QD  #H8   U%P  ,A8  # 5   N
M$P  +1$$ "P0"@ K$ X *1 2 "@0&  F$!X )1 D "00*@ C$3$ (A$Y "$1
M0@ @$DL 'A)6 !T38P <$W$ &A." !D4E0 8%*< %Q2[ !<3U  7$^X &!/Z
M ' 6  !@&0  5!H  $H;  !"'   /!L  #8;   R&@  +QD  "P8   J%@
M*!0! "83!P E$PP (Q,0 "(3%0 @$QH 'Q,A !X4)P =%"X '!4V !L5/P :
M%DD &194 !@780 6%W  %1B! !08DP 3&*8 $ABZ !(7T@ 2%^P $Q?Z &P9
M  !=&P  41T  $<=   _'@  .1T  #0=   O'   *QL  "@:   F&0  )!@
M "(7!  @%PH 'A<. !P7$@ :%Q< &1@> !D8)  8&2P %QDT !8:/0 5&D<
M%!M2 !,;7P 2'&X $1Q_ ! <D@ 0'*4 #QRY  X<T  .&^H #QOX &D;  !:
M'0  3A\  $4?   ](   -A\  #$?   M'@  *1T  "4=   C'   (!L  !T;
M 0 ;&P< &1P- !<<$  6'!4 %1P; !0=(@ 3'2D $AXQ !$>.@ 1'T4 $!]0
M  \@70 .(&P #2!\  T@CP ,(*( "R"U  L@R@ +(.4 #!_T &4=  !7'P
M3"$  $(A   Z(0  -"$  "\A   J(   )A\  ",?   @'@  '1X  !D@   6
M( 0 %" + !(A#@ 1(1, $2(9 ! B'P /(B8 #B,O  XC-P -(T$ #"1-  LD
M60 *)&< "21X  @DBP '))X !R2Q  8DQP &(^, !R/Q &(?  !4(0  22,
M $ C   X(P  ,B,  "PC   H(@  )"$  "$A   >(0  &B$  !8C   3) ,
M$24(  \F#0 .)Q$ #2<6  PG'0 +)R, "B<K  DH-  (*#X !RA)  8H50 %
M*60 !"ET  ,IAP "*9L  2BO   HQ0 !*.$  2?P %XB  !1)   1B4  #TE
M   U)0  +R4  "HD   F)   (B,  !\C   ;)   &"4  !0F   1* , #RD(
M  PL#  *+!  ""P4  <L&@ &+"$ !2PH  ,M,  "+3H  2U%   M4@  +F
M "YQ   MA   +9D  "VM   LP@  +.   "SP %HD  !-)@  0R<  #HG   S
M)P  +2<  "@F   D)@  (28  !TF   9)P  %2D  !$K   /+ , #2X'  DP
M#  &,0X  S$2  $R%P  ,AX  #(E   R+0  ,C8  #-"   S3@  ,UT  #-M
M   S@0  ,I8  #*K   QP0  ,=\  #'P %8G  !**0  /RH  #<J   P*@
M*RD  "<H   C*   'BD  !HJ   6+   $BX   \P   -,0( "C0'  4U"P "
M-@X  #<0   X%   .!H  #@B   X*@  .3,  #D^   Y2@  .5D  #EI   Y
M?0  .),  #BH   WOP  -]X  #;P %$K  !&+   /"P  #0L   N+   *BL
M "4K   @+   &RT  !<O   3,0  $#,   TU   )-P( !3H&  $["@  / T
M #T/   ^$@  /Q<  $ >  ! )0  0"\  $ Z  ! 1@  0%0  $!E   _>
M/X\  #ZF   ^O0  /=P  #WP $TN  !"+P  .2\  #(O   M+@  *"X  "(O
M   =,   &#(  !,U   0-P  ##H   D\   %/@   $$$  !""   0PL  $0-
M  !&$   1Q0  $@9  !((0  2"H  $@U  !(00  2$\  $A@  !'<P  1XH
M $:B  !%N0  1=D  $3P $@R   ^,@  -C(  # Q   K,0  )3(  !\T   9
M-@  $SD  ! \   ,/P  "$(   -$    1@   $@"  !*!0  2P@  $P+  !.
M#@  3Q$  %$5  !2'   4B4  %(P  !2/   44H  %%:  !1;0  4(0  $^=
M  !.M0  3=(  $WN $,V   [-@  -#4  "\T   G-0  (3@  !H[   4/@
M$$$   Q$   '1P   DH   !-    3P   %$   !3 @  5 4  %4(  !7"P
M60X  %L1  !=%P  71\  %TJ  !=-@  7$0  %Q4  !;9P  6WX  %J7  !9
MKP  6,L  %?J #\Y   X.0  ,S@  "LY   C/   '#\  !5#   01P  "TH
M  5.    40   %0   !7    6@   %P   !=    7P   & $  !B!P  9 L
M &8.  !H$@  :QD  &LC  !J+@  :CP  &I-  !I7P  :'4  &>/  !FJ
M9<(  &3C #T]   W/   +CT  "5    =1   %DD  !!-   *40  !%4   !:
M    70   &    !C    9@   &@   !J    :P   &T   !O @  <08  '0*
M  !V#@  >1,  'L;  ![)P  >C4  'E%  !X60  >&T  '>&  !VGP  =;<
M '32 #Q!   R0@  *$4  "!*   73@  $%0   I9   "7@   &,   !G
M:P   &\   !R    =0   '<   !Y    >P   'T   !_    @@   (0#  "'
M"0  B@X  (X3  "/'@  CBL  (X[  "-3@  BV,  (I\  "*E0  B*T  (?%
M #9'   L2P  (D\  !E5   06P  "F$   %G    ;0   '(   !W    >P
M '\   "#    A@   (@   "*    C0   (\   "1    E    )<   ": 0
MG0<  *$-  "E%   I"$  *0Q  "C1   HED  *!P  "?BP  G:(  )VW #!0
M   E50  &UL  !)B   +:0   7    !W    ?0   (,   "(    C0   )$
M  "5    F    )H   "<    GP   *$   "C    I@   *D   "L    L
M +0'  "X#@  NA@  +HG  "Y.0  N$X  +=E  "V?@  M98  +.K "E;   >
M8@  %&D   QQ   ">0   ($   ")    CP   )8   ";    H    *0   "H
M    JP   *P   "O    L@   +0   "V    N0   +P   #     Q    ,@
M  #-!P  TA   -(=  #1+P  T$0  ,];  #-<P  RXT  ,JA /\   #_
M^P   /H   #\  @ ^  / /4 %P#T "  \0 J .L ,P#F #L X@!# -X 20#:
M $\ U@!4 -, 60#0 %X S@!C ,L : #) &X Q@!U ,, ?0#! (8 O@"2 +L
MG@"Y *X M@## +0 Z "S /\ KP#_ *4 _P"> /\ FP#_ /T   #W    \@
M /    #G  , X0 , -P $@#8 !L U@ D -( +0#, #8 Q@ ] ,( 0P"_ $D
MO !. +H 4P"X %@ M@!= +4 8@"S &< L0!N *\ =@"L '\ J@"* *@ EP"E
M *8 HP"Y *$ V0"@ /D G@#_ )@ _P"2 /\ CP#_ /,   #L    XP   -,
M  #(    P0 ) +T #P"[ !8 N0 ? +< )P"S "\ KP W *P /0"J $, J !(
M *8 30"D %( HP!6 *$ 6P"? &$ G@!G )P ;P": '@ EP"# )4 D "3 )X
MD0"P )  R ". /  C0#_ (H _P"% /\ @@#_ .<   #=    Q@   +@   "N
M    J  $ *4 # "A !( H0 9 *  (@"? "D FP P )@ -P"6 #T DP!" )(
M1P"0 $L CP!0 (T 50", %H B@!A (@ : "' '  A0![ (, B "! )8 ?P"G
M 'T O !\ ., ? #] 'P _P!X /\ =@#_ -8   #     KP   *,   "9
MDP   (\ "0"-  X BP 4 (H ' "* ", B  J (4 , "# #8 @@ [ (  0 !_
M $4 ?@!* 'P 3P![ %0 >@!: '@ 80!V &D =0!S ', @ !Q (X ;P"? &X
ML@!M ,\ ; #T &P _P!K /\ :0#_ ,    "K    FP   (\   "'    @
M 'P ! !Z  P >  1 '@ %P!X !X =P D '4 *@!S #  <0 U '  .@!N #\
M;0!$ &P 20!K $X :@!4 &@ 6P!G &, 90!M &0 > !B (< 8 "7 %\ J@!>
M ,( 7@#I %X _P!> /\ 70#_ *P   "9    B@   '\   !W    <0   &T
M  !J  @ :0 . &@ $@!G !@ 9P ? &< )0!E "H 8P O &( - !A #D 8  ^
M %\ 0P!> $@ 70!. %L 50!: %T 6 !G %< <@!5 ($ 5 "1 %, HP!2 +@
M40#< %$ ^0!2 /\ 4@#_ )T   "+    ?    '$   !I    9    &    !>
M  4 7  + %L #P!; !0 6@ 9 %H 'P!9 "4 5P J %8 +P!5 #0 5  X %,
M/0!2 $, 4 !) $\ 4 !. %@ 30!B $L ;0!* 'H 20"+ $@ G0!' +$ 1P#,
M $8 \ !' /\ 1P#_ )    !^    <    &8   !>    60   %8   !3  $
M4@ ( %  #0!/ !  3P 5 $X &@!. "  30 E $P *@!* "X 20 S $@ . !'
M #X 1@!$ $4 2P!$ %, 0P!= $$ : !  '4 /P"% #X EP ] *L /0## #T
MY@ ] /L /@#_ (<   !U P  : 8  %T'  !5!@  4 8  $P$  !* 0  20 $
M $< "@!&  X 10 1 $4 %@!$ !L 0P @ $( )0!! "H 0  O #\ -  ^ #H
M/0!  #L 1P Z $\ .0!9 #@ 9  W '$ -@"! #4 DP T *8 - "[ #0 W0 T
M /4 -0#_ 'X&  !M"0  8 L  %8,  !.#   2 L  $0*  !""   0 4! #\!
M!P ^  L /0 . #P $@ [ !< .P < #H (0 Y "4 -P J #8 ,  U #4 -  \
M #, 0P R $P ,0!5 #  8  O &T +@!] "T CP L *( + "V "P T  L .X
M+ #\ '<*  !G#   6@X  % .  !)#@  0PX  #X-   [#   .0L  #@) P W
M!0@ -@(- #4!$  T !, ,P 8 #( '0 Q "( ,  G "\ +  N #( +0 X "P
M0  K $D *@!2 "D 70 H &L )P%Z "8!C  E )\ )0"R "4 R@ E .@ )0#W
M '(-  !B#@  5A   $P1  !$$0  /A$  #D0   V#P  ,PX  #$- 0 P"P4
M, @* "\&#0 N!1$ + 04 "L#&0 J QX *0,C "@$*0 G!"\ )@4U "4%/0 D
M!48 (P90 "(&7  A!VD ( =Y !\'BP >!YT '@>P !T&Q@ =!N, '07S &T.
M  !>$0  4A(  $@3  ! $P  .A,  #42   Q$0  +A   "P/   J#@, *@T'
M "D+"P H"0X )PD1 "4(%@ D"!L (PD@ "())@ A"2P ( HS !\*.P >"T0
M'0M/ !P,6P ;#&D &@QY !@,BP 8#)X %PRP !8,Q0 6#.$ %@OP &D0  !:
M$@  3A0  $45   ]%0  -Q4  #$4   M$P  *A(  "@1   F$ $ )! $ ",.
M"  C#0P (@P/ " ,$P ?#!@ '@T= !T-(P <#2H &PTR !H..@ 8#D0 %PY0
M !8/7  5#VH $Q![ !(0C0 1$*  $1"S ! /R0 0#^0 $0_R &42  !7%
M2Q8  $(7   Z%P  -!<  "\6   J%0  )Q0  "03   B$P  (!(# !X1!@ =
M$ D '! - !L/$  9$!4 &! ; !<0(0 6$"@ %1$P !01.0 3$4, $A). !$2
M6@ 0$FD $!-Y  X3C  .$YX #1.Q  T2Q0 ,$N$ #1+Q &(4  !4%@  21@
M #\9   W&0  ,1D  "P8   H%P  )!8  "$6   ?%0  '!0" !H3!  9$@8
M%Q(+ !42#@ 4$A( $Q,8 !(3'P 1$R8 $10M ! 4-@ /%4$ #A5,  X65P -
M%F4 #!=U  L7AP *%YH "1:M  @6P0 (%MT "17N %\6  !1&   1AH  #T:
M   U&P  +QH  "H:   E&0  (A@  !\8   <%P  &18! !<6 P 5%@0 $Q8)
M !$6#0 0%Q$ #Q<6  X7'  .&", #1@J  P9,P ,&3P "QI'  H:4P )&F$
M!QMQ  8;@P %&Y< !!JJ  ,:OP #&=H !!GL %P8  !.&@  0QP  #H<   S
M'   +!P  "<<   C&P  (!H  !T9   :&0  %Q@! !48 @ 2&00 $!L'  X;
M#  -'!  #!P3  L<&0 *'!\ "1TG  @=+P ''CD !AY#  0>4  #'UX  A]N
M  $?@   'Y4  !ZI   >O0  '=@  !WL %@:  !+'   01X  #@>   P'@
M*AX  "4=   A'   'AP  !L;   8&P  %AL! !,; @ 1' 0 #AX'  P?"P *
M( X "" 2  8A%P %(1T !"$D  (B+  !(C4  ")    C30  (UH  "-K   C
M?@  (Y,  "*G   BO   (=<  "'M %4=  !('P  /B   #4@   N(   *"
M ",?   @'@  '1T  !H=   6'0  $QX  !$? @ .( 0 #2('  HD"P &)0T
M!"40  (F%   )AH  "8A   G*0  )S(  "<]   G20  *%<  "AG   G>P
M)Y   ">E   FNP  )M8  "7M %$@  !%(0  .R(  #(B   L(@  )B$  "(A
M   >(   &Q\  !@@   4(   $2(   \C   -)0, "B8&  8H"@ #*0T  "L/
M   L$@  +!<  "P>   L)@  +2\  "TY   M1@  +50  "UD   M=P  +(T
M "RD   KN@  *]8  "KN $TB  !!)   ."0  # D   I)   )",  "$B   =
M(@  &2(  !4C   2)   #R8   TH   **@( !BP%  (N"0  +PL  # .   R
M$   ,Q4  #,;   S(@  ,RL  #,V   S0@  ,U   #-@   S<P  ,HH  #*A
M   QN   ,-8  ##O $DE   ^)@  -"<  "TG   H)@  (R4  !\D   ;)0
M%B8  !(H   0*@  #2P   HN   &, $  C($   T!P  -0H  #<,   X#@
M.A(  #H7   Z'P  .B<  #HR   Z/@  .DP  #I<   Z;P  .88  #B>   X
MM@  -]0  #;O $0I   Z*0  ,2D  "LI   F*   (B<  !TH   8*0  $RL
M ! N   -,   "3(   4U   !-P   #D"   [!0  / @  #X+   _#0  01
M $,4  !#&P  0R,  $,N  !#.0  0T<  $)7  !":@  08$  $":   _L@
M/L\  #[O #\L   V+   +RP  "HK   E*@  'RL  !DM   4+P  $#(   TU
M   (.   !#H    \    /P   $$   !# @  104  $8(  !("P  2@X  $P1
M  !-%@  31X  $TH  !--   3$(  $Q1  !+9   2WL  $J4  !)K0  2,H
M $?L #LP   S+P  +2\  "@M   B+P  &S$  !4T   0-P  #3H   @]   "
M0    $,   !&    2    $H   !,    3@$  $\$  !1!P  4PL  %4.  !8
M$@  61D  %@B  !8+@  5SP  %=+  !67@  5G,  %6-  !4IP  4L(  %+F
M #@S   Q,@  +#$  "4R   =-0  %C@  !$\   ,0   !T0   !'    2@
M $T   !0    4P   %4   !7    60   %H   !< P  7@<  &$+  !D#@
M9A,  &<<  !F)P  9C0  &5$  !D5P  9&L  &*%  !AGP  8+D  %[< #4W
M   P-0  *#<  " Z   8/0  $4(   Q&   &2@   $\   !3    5@   %D
M  !<    7P   &$   !D    90   &<   !I    ; $  &X&  !Q"P  = \
M '<5  !W(   =BT  '8]  !U3P  =&,  '-[  !RE0  <*\  &_) #4Z   K
M.P  (C\  !I#   22   #$T   52    5P   %P   !@    9    &@   !K
M    ;@   '$   !S    =0   '<   !Z    ?    '\   ""!   A@H  (H/
M  ",%P  BR0  (HS  ")10  AUL  (9R  "%BP  @Z4  (*\ "]    E1
M'$D  !-.   -5   !%H   !A    9@   &L   !O    =    'D   !]
M@    (,   "%    AP   (H   ",    CP   )(   "6    F0(  )X)  "B
M$   HAH  *$I  "@.P  GU   )UG  ":@0  FID  )FO "E)   ?3@  %50
M  Y;   %8@   &D   !P    =P   'T   ""    A@   (L   "/    DP
M )4   "7    F@   )T   "@    HP   *8   "J    K@   +(   "W"@
MNQ$  +H?  "Y,   MT4  +5<  "T=   L8X  *^D ")4   86P  $&(   =J
M    <P   'L   ""    B0   )    "5    F@   )\   "C    I@   *@
M  "K    K@   +    "S    M@   +H   "]    P@   ,<   #, 0  TPL
M -05  #3)@  T3H  -!1  #-:   RX$  ,J6 /P   #V    \@   /$   #S
M  4 ]  , /( $P#P !P [0 E .@ +@#B #8 W@ ^ -D 1 #4 $H T0!/ ,X
M5 #+ %D R0!> ,8 8P#$ &D P0!P +X > "\ ($ N0"- +8 F@"S *L L0#
M *\ Y@"N /\ I0#_ )H _P"4 /\ CP#_ /0   #L    Z    .<   #?
MV0 ) -( $ #/ !< SP @ ,P * #& #  P  W +P /@"Y $0 MP!) +4 3@"S
M %, L0!7 *\ 70"M &( JP!I *D <0"G 'H I0"% *( DP"@ *( G0"V )L
MU "9 /D E@#_ (T _P"( /\ A #_ .@   #?    V0   ,D   "_    N  $
M +4 #0"S !( L0 : +  (@"M "H J0 Q *8 . "D #T H@!# *  2 "> $P
MG !1 )L 5@"9 %P EP!B )4 :0"3 '( D0!] (\ BP"- )H BP"L (D Q0"(
M .X A@#_ '\ _P!Z /\ > #_ -D   #-    NP   *X   "E    GP   )P
M"0"9  \ F0 5 )D '0"8 "0 E  K )$ ,0". #< C  \ (L 00") $8 B !+
M (8 4 "% %4 @P!; (( 8@"  &L ?@!U 'P @@!Z )( > "C '< N0!V .
M=0#_ '( _P!N /\ ; #_ ,<   "U    I0   )D   "/    B0   (4 ! "$
M  P @@ 1 (( %P"" !X @  E 'X *P!\ #$ >@ V 'D .P!W $  =@!$ '4
M20!S $\ <@!5 '  7 !O &0 ;0!N &P >@!J (H : "; &< KP!F ,P 90#U
M &0 _P!A /\ 8 #_ +0   "@    D    (4   !]    =P   ',   !P  @
M;P . &\ $@!O !@ ;P ? &T )0!K "H :0 P &@ - !G #D 9@ ^ &4 0P!C
M $@ 8@!. &$ 50!? %X 7@!G %P <P!; (( 60"3 %@ I@!7 +\ 5P#J %<
M_P!6 /\ 5 #_ *$   ".    ?P   '4   !L    :    &0   !A  0 8  +
M %\ #P!? !, 7P 9 %\ 'P!= "4 7  J %L +P!9 #, 6  X %< /0!6 $,
M50!) %, 4 !2 %@ 40!A %  ;0!. 'L 30", $P GP!+ +4 2@#< $H ^@!*
M /\ 2@#_ )(   "     <@   &<   !?    6@   %<   !5  $ 4P ' %(
M# !2 !  4@ 4 %( &@!1 !\ 3P D $X *0!- "X 3  S $L . !* #T 20!#
M $@ 2@!& %( 10!< $0 9P!# '4 0@"& $$ F !  *X 0 #+ #\ \@!  /\
M0 #_ (4   !T    9P   %T   !5    3P   $P   !*    2  $ $< "@!'
M  T 1@ 1 $8 %0!& !H 10 ? $0 ) !# "D 0@ M $$ ,P _ #@ /@ ^ #T
M10 \ $X .P!7 #H 8@ Y &\ . "  #< DP V *< -@#  #8 Z  V /X -@#_
M 'P   !K    7@(  %0#  !- P  1P,  $,!  !!    /P ! #X !P ]  L
M/0 . #P $0 \ !8 /  : #H 'P Y "0 .  I #< +@ V #, -0 Z #0 00 S
M $D ,@!3 #$ 7@ P &L +P![ "X C@ M *( +0"X "T W0 M /@ +@#_ ',!
M  !D!0  5P<  $T(  !&"   0 @  #L'   X!0  -P,  #8 !  U  @ -  ,
M #0 #P T !( ,P 6 #( &P Q "  ,  D "\ *0 N "\ +0 V "P /0 K $4
M*@!/ "D 6@ H &< )P!W "8 B0 F )T )0"S "4 SP E /  )@#_ &T&  !>
M"0  4@L  $@,  ! #   .@L  #8+   R"@  , @  "X& @ N P8 +0 * "P
M#0 L !  *P 3 "H %P I !P *  @ "< )0 F "L )0 R "0 .0 C $( (@!+
M "( 5P A &0 ( !S !\ A0 ? )D '@"N !X QP > .D 'P#Z &@)  !9#
M30T  $,.   \#@  -@X  #$-   M#0  *@P  "@+   G"00 )@8( "8$"P E
M PX ) $0 "0!%  B 1@ (0$= "$ (@ @ "@ 'P N !X!-@ = 3\ ' %) !L!
M5  : 6$ &@%P !D!@@ 8 )8 & "J !@ P0 8 .$ & #T &,,  !5#@  20\
M $ 0   X$   ,A   "T/   I#@  )@X  ",-   B# , ( L& " )"0 ?!PP
M'@8. !X%$0 <!14 &P4: !H%'P :!24 &04K !@%,P 7!CP %@9& !8&4@ 5
M!U\ % =N !,'@  2!Y0 $@:G !(%O  2!-D $@/O %\.  !1#P  1A   #P1
M   U$0  +Q$  "H1   F$   (A   " /   =#@( ' T% !H-!P :"PH &0H-
M !@)$  7"1( %@D7 !4)'  4"2( % HI !,*,0 2"CH $@M% !$+40 0#%\
M#PQN  X,@  .#)0 #0NG  T+N@ -"M( #0KJ %P/  !.$0  0Q(  #H3   R
M$P  +!,  "<2   C$0  'Q$  !P0   :$ ( & \$ !8.!P 5#@D % T+ !,,
M#0 2#!  $@P4 !$,&@ 1#2  $ TH  \-,  .#CL #0Y&  T.40 ,#UX "P]M
M  H/?P )#Y, "0^F  @.N0 (#M  !P[H %@1  !+$@  0!,  #<4   P%
M*10  "44   A$P  '1(  !H2   7$0( %1$% !,0!P 2$ D $0\* ! .#  .
M#@X #@\2  T0&  -$!X #! E  P0+0 +$38 "A%!  D130 ($EH !Q)J  82
M?  %$I  !!*D  ,1N  #$<\  A'H %42  !)%   /A4  #46   M%@  )Q8
M "(5   >%   &Q0  !@3   5$@, $Q(% !(1!P 0$0D #Q$*  T1"P ,$@X
M"Q(1  H2%0 )$QL "1,B  @3*@ '%#, !10^  052@ #%5@  A5G  $5>@
M%8X  !6C   4MP  %,\  !/I %(4  !&%@  .Q<  #(7   K%P  )1<  "$6
M   <%@  &14  !84 0 4$P0 $A,& !$2"  /$@@ #A,)  P4"@ *%0T "!80
M  86$P %%AD !!<?  ,7)P "&#   1@[   91P  &54  !ED   9=P  &8P
M !BB   8MP  %\\  !?J $\6  !#&   .1D  # 9   I&0  (QD  !\8   ;
M%P  &!8  !45 @ 3%04 $10& ! 4!@ .%0< #!8(  H7"@ '&0P !!H.  (;
M$@ !&Q8  !L=   <)   '"T  !PX   =1   '5(  !UB   ==0  '8H  !R@
M   <M@  &]   !KK $P8  ! &@  -AL  "T;   F&P  (1H  !T9   9&0
M%Q@  !07 P 2%@0 $!<$  X7!  ,&04 "AH'  <<"0 #'0L  !\-   @$
M(!0  "$:   A(@  (2H  "$U   B00  (D\  ")?   B<@  (8@  "&?   @
MM@  ']$  !_M $@:   ]'   ,QT  "L=   D'0  (!P  !P;   8&@  %AD!
M !,9 0 1&0$ #AH!  P< @ *'0, !Q\%  ,A"   (@H  "0,   F#@  )A(
M "88   G'P  )R<  "<R   G/@  )TL  "=<   G;@  )H4  ":=   EM
M)-$  "/N $0=   Y'P  ,!\  "@?   C'@  'AT  !L<   8&P  %!P  !$<
M   .'0  #1\   HA   &(@$  R0$   F!@  * @  "H+   K#0  +1   "T5
M   M'   +20  "XN   N.@  +D@  "U8   M:@  +8$  "R:   KL@  *M
M "GO $ @   V(0  +2$  "8A   A(   '1\  !H>   6'@  $A\   \A   -
M(@  "B0   8F   "*    "L"   M!   +P8  # )   R#   - X  #42   U
M&   -2   #4J   U-@  -4,  #53   T9@  -'P  #.6   RKP  ,<T  ##O
M #PC   R)   *B0  "0C   @(@  '"$  !<A   3(P  $"4   TG   )*0
M!2L   $N    ,    #(    T 0  -@0  #@&   Z"0  / T  #X0   ^%
M/AP  #XF   ^,0  /C\  #U.   ]80  /'<  #N1   ZJP  .<D  #CM #<G
M   O)P  *"8  ",E   ?)   &24  !0F   0*   #2L   DN   %,    #,
M   U    .    #H    \    /@$  $ #  !"!P  1 H  $8-  !)$0  21<
M $@A  !(+   1SH  $=)  !&6P  17$  $2+  !#I0  0L,  $'H #0J   L
M*@  )R@  "(G   <*   %BH  !$M   -,   "3,   ,V    .0   #P    ^
M    00   $,   !&    2    $H   !, P  3@8  % *  !3#@  5!,  %0<
M  !3)P  4S0  %-#  !250  46H  %"#  !/G@  3;D  $S@ # M   K+
M)BL  !\L   8+@  $C(   TU   (.0   CT   !     0P   $8   !)
M3    $X   !1    4P   %4   !7    60$  %P&  !?"@  8@X  &,5  !C
M'P  8BP  &$\  !@3@  7V(  %Y[  !<E@  6[   %G/ "\P   J+P  (C
M !HS   3-P  #CL   @_   !1    $@   !,    3P   %(   !5    6
M %L   !=    8    &(   !D    9@   &D   !M!0  < L  '00  !T&
M<R4  '(T  !R10  <%D  &]Q  !MBP  :Z8  &K  "XS   E-0  '3@  !0\
M   .00  !T<   !,    40   %4   !9    70   &$   !E    :    &L
M  !M    ;P   '(   !T    =P   'H   !^    @@0  (8+  "*$0  B1P
M (@K  "&/0  A%(  (-G  "!@0  ?YL  'ZR "DZ   @/0  %D(   ](   (
M3@   %0   !:    8    &0   !I    ;@   '(   !V    >@   'T   "
M    @@   (4   "(    BP   (X   "2    E@   )L#  "@#   HA,  * A
M  "?,P  G4<  )I>  "8=P  EX\  )6G "-#   92   $4X   E5    7
M &,   !J    <0   '8   ![    @    (8   "*    C@   )$   "3
ME@   )D   "<    H    *,   "G    JP   +    "V!   O T  +H7  "Y
M*   MSP  +12  "R:@  KX4  *V< !Q.   35   "UP   %D    ;    '0
M  !\    @P   (D   "/    E    )H   "?    H@   *0   "G    J@
M *X   "Q    M    +@   "\    P0   ,<   #-    U 4  -@0  #5'@
MTS$  -!(  #-7P  RW8  ,B.                       ! P0%!@@)"@L-
M#@\1$A,4%A<8&AL<'1\@(2(D)28H*2HK+2XO,#(S-#8W.#D[/#T^0$%"1$5&
M1TE*2TU.3U!24U155UA96UQ=7F!A8F-E9F=I:FML;F]P<7-T=7=X>7I\?7Z
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M________________________________________________
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M^/GZ^_S]_O]M9G0Q      ,$(0   0                    $
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MI9>2YJ67DN:EEY+FI9>2YJ67DN;:RPD;Z,T..NG,$&#<R Z2R[HRK,:W4+3
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MT86FB-&%IHC1A::(T86FB-',T D8RM0*/L73"FVXQ1:EKKE$M:>U7KNCLG#
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M@:6-TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]*
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MF;"$PI2OA,.0KX7$C:Z%Q8JNAL:(K8;&AZV'QH6MB,>#K8G'@:V+QX"LB\>
MK(O'@*R+QX"LB\> K(O'@*R+QX"LB\> K(O'@*R+QX"LB\> K(O'@*R+QX"L
MB\?5Q@@)V<P*(.7/#4#8U0M?O=8+B*7$-*:<MUJXF;5KNY>T=[V6LW^^E;*%
MP)&QA<&.L87!B["&PHFPA\*(L(?#AK"(PX6OB<.#KXK$@J^+Q(&OB\2!KXO$
M@:^+Q(&OB\2!KXO$@:^+Q(&OB\2!KXO$@:^+Q(&OB\2!KXO$@:^+Q(&OB\32
MR @'T\\*'=74"SW"V0MCJ]X0@YO.,YF4Q%.FD;YGKY"Z=+20MWVYD;6$O(ZS
MAKZ,LH:_BK*'P(BRB,"&L8C!A;&)P82QBL&"L8O!@;&,PH"QC,* L8S"@+&,
MPH"QC,* L8S"@+&,PH"QC,* L8S"@+&,PH"QC,* L8S"@+&,PH"QC,+.R@@&
MSM$*',;7"D&OZ@YAG>8<>)#:,HB+TDR4B<M?G(C&;J.(PWBHA<!\JX._?ZZ
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ME7*PQ95]M<.7A;C!EXN[OY.,O;Z/CL"\C(_"NXF2Q+J&E,6Y@Y;&N8&9Q[B
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MSWVGFL__N0\'_[H7'/^Y(CG_M2U:[+,P>MW 'Y#)PR&HM;I(M*NU8KRFLG/
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M=5/HCG53Z(YU4^B.=5/HCG6\R04 J]L!")K_"Q:/_QDCA?\K+7[_.3=X_T9
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MS(R-JL>*D;'$B)2VPX66N,*#F;G"@9NYP7^>NL%]H;O!>Z2[P'JGN\!YJKS
M>*Z\P'>TN[QXM+N\>+2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[O'BTN[QX
MM+O_H!@#_Z(L$/^@.R7_G$D\_Y=74_B29&?LD&QYXH]UB=F.?I?1C8>BS(R-
MJL>*D;'$B)2VPX66N,*#F;G"@9NYP7^>NL%]H;O!>Z2[P'JGN\!YJKS >*Z\
MP'>TN[QXM+N\>+2[O'BTN[QXM+N\>+2[O'BTN[QXM+N\>+2[O'BTN[QXM+O_
MH1@#_Z,K$/^@.B7_G$@\_Y=64_B38VCLDFEZX9%SBMB/?)C0CH2DRHZ,K<:-
MD+3$BI.WPX:5N,*$F+G!@9NZP7^=N\!]H+S >Z2\P'JGO<!YK+W >+"]O7BS
MO+AXL[RX>+.\N'BSO+AXL[RX>+.\N'BSO+AXL[RX>+.\N'BSO+AXL[S_H1@#
M_Z,J$/^A.27_G4@]_YA55/>486GKE&9[X))OC-:1>)K.D(*FR(^)L,2/C[;#
MBY&WPHB4N<&$E[K @IJ\P'^=O;]]H+Z_>Z2^OGJHO[YXK;^]>+&^N'BROK1Y
ML[VT>;.]M'FSO;1YL[VT>;.]M'FSO;1YL[VT>;.]M'FSO;1YL[W_HA@#_Z0I
M$/^A."7_G4<]_YE55/>67FGKE6-[X)1LC=62=9S-D7^HQY&'LL21CK;#C9"X
MP8F3NL"&EKR_@IF]OW^<OKY]H+^]>Z7 O7FJP+UXL,"X>;# M'FQOZ]ZLKVO
M>K*]KWJRO:]ZLKVO>K*]KWJRO:]ZLKVO>K*]KWJRO:]ZLKW_HQ@#_Z0I$/^B
M."7_GD8]_YE45?>77&GKEV!\WY9IC=63<IW,DGRJQ9*%M,22C+;"CX^YP8N2
MN\"'E;V^@YB_O8"<P+U]H,&\>Z7"O'FKPKEYK\*T>:_!L'JPP*Q[LKZL>[*^
MK'NROJQ[LKZL>[*^K'NROJQ[LKZL>[*^K'NROJQ[LK[_HQ@"_Z4H$/^B-R7_
MGT8]_YI35?>96FGKF5Y\WY=ECM25;YW+E'FKQ9."M,24BK?"D8ZYP(R0O+^(
MD[Z]A)? O(";PKM]H,.[>Z;$NGJMQ;1ZKL2O>J_"K'NPP*A\L;^H?+&_J'RQ
MOZA\L;^H?+&_J'RQOZA\L;^H?+&_J'RQOZA\L;__I!@"_Z4H$/^C-B7_GT4]
M_YI35?>:5VGKFUM\WYEBCM27:Y[+E7:LQ92 M,.5B+?!DXVZP(Z/O;Z)DL"\
MA97"NX&:Q+E]H,:Y>ZC'M'JKQZ][K<6K>Z[#IWROP:1]L;^D?;&_I'VQOZ1]
ML;^D?;&_I'VQOZ1]L;^D?;&_I'VQOZ1]L;__I!@"_Z8G$/^C-B7_H$0]_YM2
M5O><56GKG%A\WYM>CM299Y[*EW.LQ99\M,.7A;?!EHN[OY&-OKV+D,&[AI3$
MN8&9Q[=^H,FV?*G*KGNJR*I\K,:F?:W$HWZOP:!^L;^@?K&_H'ZQOZ!^L;^@
M?K&_H'ZQOZ!^L;^@?K&_H'ZQOZ!^L;__I1@"_Z8F#_^D-27_H$0]_YQ15O>>
M4VGKGE5[WYY:C=2;9)[*F6^LQ9AYM,.9@KC!F8J[OI2,O[R.CL.YB)+'MX*8
MR[5^H<VO?*?-J7VIRJ5^J\>B?ZW$GW^OPIV L;^=@+&_G8"QOYV L;^=@+&_
MG8"QOYV L;^=@+&_G8"QOYV L;__IA@"_Z<F#_^D-27_H$,^_YU05?>?46CK
MH%-[X*!7C=2>7Y[*FVNLQ9MUM,.;?KC FX>\O9>*P+J1C,6WBI#*M(27S[*
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M+23_JS8[_[8O2//$*%'@UB96S.0B<;O:*(BJS$&;G\-7J9F\:;*6MW:YE+2
MO9&RA<"+L8;!AK"(PX&OB\1^KH_%>ZZ4Q7JOFL1XKZ#$=:^GQ'2MKL-TK:[#
M=*VNPW2MKL-TK:[#=*VNPW2MKL-TK:[#=*VNPW2MKL/_K!0"_ZT?#O^L*R3_
ML"\W^K\E0>31($7.Y!U;O>DB=*W:+(F?SD69E\9:I)/ :JV1NW:SD+A_MXVV
MA+N)M(:]A;*(OX*QB\%_L8[!?+&2PGJQEL%YL9O!>+*AP'2QI\%TL:?!=+&G
MP72QI\%TL:?!=+&GP72QI\%TL:?!=+&GP72QI\'_KA(!_Z\=#?^N*"3_N"0Q
MZLL:-=#B%T._\!U>K^@E=:#;,8>6T4B4D,I<GHW%:J6+P7:JB;Y]KX6\@+*"
MNH.T?KF&MGRXB;=YMXRX=[>/N7:VD[IUMI>Z=+:=NG.WI+ESMZ2Y<[>DN7.W
MI+ESMZ2Y<[>DN7.WI+ESMZ2Y<[>DN7.WI+G_L! !_[$:#?^Q)2/SQ!<GU-\0
M*\'O%TBP]R!@H>HK<Y7?.8*-UTR-B-%=E8;,:IN$R72@@,9YI'W$?:9ZPH"I
M=\&#JG7 AJQSOXJM<;^-KF^^D*]NOI2O;+Z9KVN^H*]KOJ"O:[Z@KVN^H*]K
MOJ"O:[Z@KVN^H*]KOJ"O:[Z@KVN^H*__LPX!_[06#/R\%QK6U@L6P^T0,++\
M&4JB^25>ENTS;HSE07J%WD^#@=E>BG_5:H]ZTG"3=L]UEW/.>9EQS'V;;\N
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M."__LCHN_\ [+O_3.RW_ZSPM_^L\+?_K/"W_ZSPM_^L\+?_K/"W_ZSRXL
MJ+P  )K)  ",V0  @?4# 'G_$ %N_Q8#9?\?!E[_)PM7_S /4?\W$TO_/A=&
M_T490?],&SW_4ATY_U@?-O]?(33_9B(Q_VXD+_]W)2W_@"8K_XPH*?^7*2C_
MHBHG_ZTK)O^Y+";_R2TF_\DM)O_)+2;_R2TF_\DM)O_)+2;_R2VJMP  FL4
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M)@3ML2D%XKHO!M:_-@_*ND0@O[1/,;2N6$"JJ&!.H:-G6IB>;V2/FG=MB):
M=8"2BWMZCY: =(ZDA'&-MH5OCM&%<8O=@W.)WX%UA^!^=H7A?7>$XWMW@^1Z
M=X/D>G>#Y'IW@^1Z=X/D>G>#Y'K_;!0!_W,6 O^%$P'_E!8!_Z(> ?6M( +G
MN"$"W<,F M##- W$OD(>N;E-+ZZS5CZDKEY,FJEE5Y&E;6*)H75K@)U^<GF:
MB'EREY1^;9:B@FF5LX1GELV#:9/>@FR/WX!OC.%^<(KB?'*(XWIRA^1Y<H?D
M>7*'Y'ERA^1Y<H?D>7*'Y'G_;1,!_W83 ?^($@'_F!, _Z<9 >^S%@'BP!4
MU<H> <G',@R^PT <L[Y++*BZ5#R>M5Q)E+!C58JL:U^!J7)H>:5[;W*CA79K
MH)%[9I^??V*?L8%@G\J 8IS@?V67X7YHD^)\:I#C>VR-Y'EMC.5X;8SE>&V,
MY7AMC.5X;8SE>&V,Y7C_;A,!_WL1 ?^-$ #_G1  ^JP1 -J["P#5R0L S<X;
M <+,+PJWR3T9K,5)*:' 4CB7O%I&C;AA48.U:%MZLG!D<J]Y:VNL@W%DJX]V
M7ZF>>ENIKWQ9JLE\6J?B>UZ@XWMAF^-Z8Y?D>6:4Y7=FDN9W9I+F=V:2YG=F
MDN9W9I+F=V:2YG?_<!(!_X . ?^2#@#RHPL V;,) ,^^"0#+S D Q-,7 +K2
M+ >PSSL6I<Q&)IK(4#6/Q%A!A<%?37R^9U9SO&]>:[EW962X@FM>MHYP6;6=
M<U6UKG54MLAU4[/G=E>KYG9:I.9V7*#G=5^<YW1@FNAT8)KH=&":Z'1@FNAT
M8)KH=&":Z'3_<A(!_X8, /N8"0#9J08 SK4' ,;!!P# SPD NML3 +':*06G
MV#<2G-1$(9+133"'SE4\?<M=1W3)95!LQVU79<5V7E[$@6-9PXYH5,.=:U'#
MKFQ/Q,AM3L+M;5"XZV]3L.MP5:OJ<%BFZW!9H^MP6:/K<%FCZW!9H^MP6:/K
M<%FCZW#_=P\!_XT( -Z@ @#/K@4 Q+D% +O%!@"UTPH KN$6 :;A*0:=X#<1
MD]Y"'8G<3"E_VE0U===</VW59$AETVQ/7])V5%G2@5E4T8Y=4-&=8$W2L&)+
MT\EB2M+M8DO(\F9-O_%H3[CP:5&R\&E2K^]I4J_O:5*O[VE2K^]I4J_O:5*O
M[VG_?PH [98  -*F 0#$L@, N;P# +#)!@"IV H H><9 IGG*@F0YS<4A^9"
M'WWE2BETY%$S:^-9.F3B84%>XFM'6.)U2U/A@$]/XHU32^*;54GCK%='Y,17
M1N/I5T;=]EE'T/=<2<CW7DK!]F!+O?9@2[WV8$N]]F!+O?9@2[WV8$N]]F#_
MB0  V9X  ,>L 0"YM@( KL$# *7.!@"<Y P E>\= XWO+ N%[SD5?.]!'G/O
M22=J[E O8NY7-5SN7SI6[F@_4NYQ0DWO?$9)[XE)1O"62T/PIDU \;E./_+;
M3S[P]TY"YOM/0]W[4434_%-%S_Q41<_\5$7/_%1%S_Q41<_\5$7/_%3AE0
MRZ8  +NP  "NNP$ HL@" )C5!0"0^ \!B?@@!(+X+@MY^3<3</D_&VCY1B)@
M^DTH6OI4+53Z7#%/^V4U2_MM.$?\=SM#_(,]/_V0/SS]GT$Z_J]#./_&1#?_
MZD4V_/U%._+_1#[J_T0^YO]&/N;_1C[F_T8^YO]&/N;_1C[F_T;0GP  O:P
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M'AS_YA\;__ ?&__P'QO_\!\;__ ?&__P'QO_\!^DM0  E<(  (;/  !WW@
M:_0  &+_ P!9_PL!4?\1 4K_%P)$_Q\#/_\F!#K_+04V_S0&,O\Z!R[_0 @K
M_T8(*/],"27_4@DB_UD*(/]B"QW_:PP:_W8-%_^$#A7_D@\4_Z 0$_^M$1/_
MNA$3_\,2$__#$A/_PQ(3_\,2$__#$A/_PQ*7O@  ALP  '?;  !IYP  7/T
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M74NY]U].L?9@4:KV8%.E]F!5H?9@5:'V8%6A]F!5H?9@5:'V8%6A]F#_=P@
MZXP  -.;  #&J ( N[$" +*[ @"JQP8 HM,* )W6&@&5UBP&C-0Z$8/21AUZ
MT$\G<LY8,6K-8#ADRV@_7LIR15C*?$E4R8A-3\F544S)I5-*R;E42<K<4T?(
M]U5(P/Q82KC[64RR^UI.K?I:3JWZ6DZM^EI.K?I:3JWZ6DZM^EK_?P  W),
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M-#?L_S8YY?\X.>7_.#GE_S@YY?\X.>7_.#GE_SC(G@  MJD  *BR  ";O0
MC\@  (/4  !YZ < <_P2 6O]'0)D_2<$7OXQ"%C^.PU3_T,13?]+%4G_4QA%
M_UH:0?]C'3[_;!\[_W8A-_^"(S3_D"4R_Y\G,/^P*"[_R"DM_^HJ+/__*BS_
M_RHO^?\J+_G_*B_Y_RHO^?\J+_G_*B_Y_RJYI@  JJX  )RY  ".Q0  @=$
M '7>  !M^@D 9?\1 5[_&@)7_R,#4O\L!4S_- =(_SP*0_]$##__3 X\_U,0
M./];$C7_8Q0R_VP6+_]W%RS_A!DI_Y,:)_^B'"7_M!TD_\P>(__M'B+__1\B
M__\?(O__'R+__Q\B__\?(O__'R+__Q^LJP  G;8  (_"  " S@  <]P  &?I
M  !?_P8 6/\. %'_%0%+_QT"1O\F T'_+00\_S4%./\\!C3_0@<Q_TD(+O]0
M"2O_5PHH_U\*)?]I#"/_= T@_X(.'?^2#QO_HA :_[(1&?_($AC_Y1,7__H4
M%__Z%!?_^A07__H4%__Z%!?_^A2?LP  D+\  (#,  !RV@  9.0  %CU  !1
M_P$ 2O\+ $3_$ $^_Q<!.?\> C3_)0(P_RP#+/\R!"C_. 0E_SX%(O]$!1__
M2@4<_U$&&O]9!A?_8P<4_VX'$O]\"!#_C @/_YP(#O^L"0[_NPD-_],)#?_3
M"0W_TPD-_],)#?_3"0W_TPF1O   @<D  '+7  !DY   5.L  $O_  !$_P
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M8%V3[5]>D/A>88SY7&.*^EMDA_M:98;[666&^UEEAOM998;[666&^UG_9@T
M_W<# ..'  #3DP$ RIX$ ,*G! "[KP0 M;8- *ZW(0*EMC()G;,_%92P2B",
MK5,KA*I;-'VH8SQVI6I#<*-R2FJA>T]EH(948)Z16%N=GUM8G;!=5IW'75:=
MZUQ7FOI;6I7Z6ER1^UE>COQ87XW\5U^-_%=?C?Q77XW\5U^-_%?_:@H _WP
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M2D>S_TM)K?],2JO_3$JK_TQ*J_],2JO_3$JK_TSI?P  T9   ,*>  "UIP
MJJ\  *"X  "6P0( C,L' (35#0" U1X!>=4N!7+4/ QLTT<49=)0&U_162%:
MT6(G5=!K+%'0=3!-SX$T2<^.-T;/G3E$T*X[0M#&.T/0ZCI S?T^/LO_0$##
M_T)!O?]#0KG_1$*Y_T1"N?]$0KG_1$*Y_T3=B   QY@  +BC  "KJP  H+0
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M'2KW_QTJ]_\=*O?_'2KW_QVSHP  I*L  )>V  ")P0  >\L  &_6  !CWP
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M5FYZYE5N>OQ3;WG_47!W_T]Q=O]-<77_3'%U_TQQ=?],<77_3'%U_TS_6PX
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M35B0_TQ9C?]+6XK_2EN*_TI;BO]*6XK_2EN*_TK_:   Y7D  -&'  #%D@
MNYP  +&B  "IJ0  H;$" )NS%0"5LR@"CK(V"8:P0A)_KDP;>*Q4(W*J7"IL
MJ&0Q9Z=L-F*E=3M=I'] 6:.*0U6BET=1H:=)3Z&Z2DZBV4E.H/5)3I__25"9
M_TE2EO](5)+_1U22_T=4DO]'5)+_1U22_T?_;@  WG\  ,J-  "^F   LZ
M *JG  "AK@  E[8  )&Z$ ",NB,!A;DR!GZX/@YWMDD7<;52'FNS6B5ELF(K
M8+%J,%NP<S57KWTY4ZZ)/4^MED!,K:5"2JVY0TFNV$)(J_5#1ZK_1$FE_T1+
MH/]$39S_1$V<_T1-G/]$39S_1$V<_T3J=0  TH8  ,.3  "WG0  K*0  **K
M  "8LP  CKL! (7!# "!PAT >\(M W7!.@EOP$41:;]/&&.^5QY>O5\C6;QH
M*%6[<2U1NWLP3;J'-$JZE3='NJ4Y1;JX.D2ZUSE#N/4[0K;_/4*S_SY$KO\^
M1:G_/D6I_SY%J?\^1:G_/D6I_S[@?0  R8T  +N:  "NH@  HZD  )BQ  ".
MN0  A,$" 'G)!P!TRQ0 <,PF 6O+-05ERT *8,I+$%O*5!97R5T:4LEE'T[(
M;R-+R'HF1\B&*43(E"Q"R*0N0,BX+S_)UR\_Q_4P/<3_,SO#_S4\OO\V/;C_
M-SVX_S<]N/\W/;C_-SVX_S?1A@  P)4  +*?  "EIP  FJ\  (ZW  "#OP
M>,<# &[/!P!EUPT 8]@= &#8+0);V#H$5]A&"5/84 U/V%D12]=B%4?7;!A$
MUW<;0=>$'C[8DR \V*,A.]FW(CK:U2(ZUO(C-]3_)S;2_RDTT?\K-LK_+3;*
M_RTVRO\M-LK_+3;*_RW%D   MIT  *BE  "<K0  C[8  (.^  !WQP  ;,\"
M &+6!P!:Y X 6.0< %3D*0%0Y#4#3.4_!4CE20=%Y5,*0N9<#3_F9@\\YG$2
M.N=^%#?GC!8UYYP7,^BN&3+IQADRZ.H9,>7^&2_D_QPNY/\>+>+_("WB_R M
MXO\@+>+_("WB_R"ZF@  JJ,  )VK  "0M   @[T  '?&  !KSP  7]8  %3>
M! !1\!  3? ; $KP)@%&\3 "0O(Z S[R0P0[\TL%./-4!S;T70@S]&@),/5T
M"R[U@0PL]I$.*O:B#RCWMQ G^-81)_;T$2;S_Q$F\?\1)?'_$R7Q_Q,E\?\3
M)?'_$R7Q_Q.MH0  H*D  )*S  "$O   =L8  &G/  !=V   4=\  $GN! !&
M_ X 0OT7 #[^(0 [_BH!-_\S C3_.@(P_T(#+?]* RO_4P0H_UP%)?]F!2+_
M<P8@_X,''_^4"!W_I@@<_[P(&__B"1K_^0D:__\)&?__"1G__PD9__\)&?__
M"1G__PFBIP  D[$  (6[  !VQ@  :=   %O:  !.X   0^4  #[[ 0 Z_PP
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M1W]FX4=_9_A%?FC_0WYH_T%]9_\_?&?_/GQG_SU\9_\]?&?_/7QG_SW_4@X
M_UT# /UI  #A<@  UGH" ,Y_!0#*@P@ Q882 +R')@&UAC8&KH-##Z> 3ABA
M?%@@FWE@)Y9W:2V2=' SCG)Y-XIP@3R&;HL_@VV50W]LH45\:ZY'>FN_2'AK
MW4AX;/9&>&S_1'=L_T)W:_] =VK_/W=J_SYW:O\^=VK_/G=J_S[_5 P _U\
M /)L  #==@  T'T" ,F#! #$AP8 OXH0 +>,(P&PBC0%J8A!#J*%3!><@54?
MEG]>)I%\9BV,>6XRB'=V-X1U?SN =(@_?'*20WAQGD9U<*Q(<V^]27%PV4EQ
M</1'<7'_1')P_T)R;_]!<F[_/W)N_SYR;O\^<F[_/G)N_S[_5@H _V(  .9O
M  #7>0  S($! ,6' P"_BP0 N8X. +*0( &KCS$%I(P_#9V*2A:6AU,>D81<
M)8N!9"R&?VLQ@GUS-GY[?#MZ>88_=G>00G)VG$5O=:E(;'6Z26MUU$EK=?)'
M:W7_16QU_T-M<_]!;7+_/VUR_S]M<O\_;7+_/VUR_S__60< _V4  .)R  #1
M?   QX0  ,"* @"YCP( LY(, *R4'0"FDR\$GI$\"YB/2!21C%$<BXE:)(:'
M8BJ!A6DP?()Q-7B!>CIT?X,^<'V.0FQ\FD5I>Z='9GJX2&1[T$AD>_!'97O_
M1&9Z_T-G>/]!:';_/VAV_S]H=O\_:';_/VAV_S__6P0 ]VD  -UV  #-@
MPX@  +N.  "TDP$ K9<) *>8&@"@F"P#F98Z"I*411*,DD\:AH]7(H"-7RA[
MBV<N=HEO,W*'=SAMA8$\:82+0&:"ET-B@:5&8(&V1UZ!S4=>@>]&7X'_1&!_
M_T)A??]!8GO_/V-Z_S]C>O\_8WK_/V-Z_S__7@  Z6T  -9Y  #(A   OHP
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M.U"/_SM0C_\[4(__.U"/_SOK;0  TWP  ,.)  "WDP  K)H  **?  "9I0
MCJL  (6P"P"!L1L ?+$K G>P. =QKT,-:ZY-%&:M51EAK%T>7:ME(UFJ;B=5
MJ7<K4:B"+TVGCS)*IYXU2*>O-D>GQC9&INDV1:3^-T6C_S=&H/\W2)S_-TF:
M_S=)FO\W29K_-TF:_S?B=   RH,  +R/  "PF   I9X  )ND  "0JP  A;$
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M(2_(_R&^CP  KYH  **A  "6J0  BK   'VX  !QOP  9L8  %O, @!0T@<
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M Q?_G@,5_[,$%/_3!!3^] 03_/\#$_K_ Q/Y_P,3^?\#$_G_ Q/Y_P.=I0
MCZX  ("X  !RP@  9,L  %;3  !)V@  /M\  #3D   N]   *_\* "C_$  E
M_Q< (O\? !__)@ <_RT &?\T !?_/  4_T0!$O]. 1#_60$._V<!#/]W 0O_
MB@(*_Y\""?^U @C_U0('__0"!___ @?__P('__\"!___ @?__P*1K0  @K@
M '/"  !DS   5M4  $C=   [X@  ,.<  "?N   C_P  (/\$ !S_#  9_Q$
M%O\6 !/_&P 1_R$ #O\G  W_+@ *_S8 !_\^  3_2   _U0  /]B 0#_<P$
M_X<! /^= 0#_L@$ _\H! /_J 0#_\P$ __,! /_S 0#_\P&$MP  =,$  &7,
M  !6V   1]\  #GE   MZ@  (^X  !S]   8_P  %?\  !'_!  /_PL #?\.
M  G_$0 &_Q4  _\:  #_(   _R8  /\N  #_-P  _T$  /]-  #_7   _VT
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MXCJV%N [PA;?.](6VCOH%]0Z]AK0.O\<S3K_'LLZ_Q[*.O\?Q#O_'\ \_Q[
M//\>P#S_'L \_Q[_.1L!_T 5 /]%$0#_2A, _TX9 /]0(@'_4"P!_4XW O9+
M0P3P25 'ZTA="N=&:0WC1700X$1^$]U#AQ7;0I 7V$&8&-5 H!G30*D;T4"R
M',] O1W-0,P=RD'D'L9 ]"#"0/\BOT#_([U _R.[0/\CMD'_([-"_R*S0O\B
MLT+_(K-"_R+_/1< _T01 /]*#@#_4!  _U05 /]6'0#]5B8!\U4Q >M3/0/E
M4DL&WU!8"MI.8P[43&X3T$IX%LU)@1G+2(H;R$>2'<9'FA_$1J,APD:L(L!%
MMR.^1<4DO$7<)+A&\"6U1O\GLD;_)[!&_R>N1O\GJD?_)J=(_R:G2/\FITC_
M)J=(_R;_0!0 _T@. /]."P#_50X _UD1 /]<%@#T71\ ZEPJ >);-P+:6D8%
MTE=3"\Q57A#(4V@5Q%%R&<%0>QR^3X0?O$V,(KE-E22W3)TFM4NG)[-+L2FQ
M2K\JKTK1*JQ+ZRNI2_PLIDO_+*5,_RNC3/\JGTW_*IU-_RF=3?\IG4W_*9U-
M_RG_0Q$ _TL, /]3" #_6@L _UX- /E@$ #K818 X6(A -9B,0'.84$%QU].
M"\)<61&]6F07N5AM&[96=A^S57XBL%.'):Y2CRBK49@JJ5"B+*=0K"VE3[DO
MHT_++Z!0YB^>4/DPG%#_+YI1_RZ84?\MEE+_+)12_RN44O\KE%+_*Y12_RO_
M1A  _TX) /]6!0#^7@8 [V(' .=E"@#D9@X UF<9 ,UH+0'%9ST%OV5*"[EC
M51*T8%\7L%YI'*Q<<2&I6GHDIEF"**18BRNA5I0MGU6=+YQ5J#&:5+0SF%3%
M,Y94X3235?8SDE7_,I%6_S&/5O\PC5;_+HQ7_RV,5_\MC%?_+8Q7_RW_20X
M_U$% /]: 0#N8@  WV<# -AJ!@#5:PH S6T5 ,5N*0&^;3D$MVM'"[%H4A&L
M9EP8J&1E':1B;2*A8'4FGEY^*9M=ABV87(\OE5J9,I-9I#206; VCEG -HQ9
MVS>*6?,VB5K_-(A;_S.'6_\QAEO_,(5;_R^%6_\OA5O_+X5;_R__2PP _U0
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M.'-H_S9S:/\U<V?_,W-F_S)S9O\R<V;_,G-F_S+_400 _UP  .)G  #2<
MQW8  ,!Z  "Z?0( M'\, *V!'0"G@2X"H'\\")I]1P^5>E$6D'A:'(MV8B&'
M=&DF@W)Q*W]Q>B]\;X,R>&Z--75MF#AR;*4[<&NT/&YKR3QM:^D[;6S^.6UL
M_S=N;/\U;FO_-&YJ_S)N:O\R;FK_,FYJ_S+_4P  ]%\  -YJ  #-<P  PWH
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M-%]W_S-?=_\S7W?_,U]W_S/^7   X6H  ,UU  # ?@  MH8  *Z+  "EC@
MFY$  )63$0"0E"(!BY,Q X62/0E_D4@/>H]1%G6-61MQC& @;(IH)6B)<"ED
MAWDM88:#,5V%CS1:A)PV5X.L.%6#OSE5@^$X58+Y-U:"_S56@?\T6'__,UE]
M_S)9??\R67W_,EE]_S+O8   VVX  ,=Z  "[@P  LHL  *B0  "?DP  E)8
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M*T27_RO7<@  PX   +:,  "JE   GYD  )2>  ")HP  ?J@  '"N  !JL X
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M#C'(M0\PR-,/,,;T$"[$_Q,MPO\5+,'_%BO _Q<KP/\7*\#_%RO _Q>XC0
MJI<  )Z>  "1I0  A*P  'BR  !KN0  8+\  %3#  !*R ( 0,T' #K2#@ Y
MTAL .-,H #?3-0 VU$  --5+ 3/550$QUF "+]9L RW7>@0KV(L%*MB=!2C9
ML08GVLT&)]?O!B;4_PDETO\+)-'_#"/0_PTCT/\-(]#_#2/0_PVNE@  H)T
M )2D  "&K   >;0  &R[  !@P@  5,8  $C+   ^T   -=4$ "W="@ LX1,
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M  #_R@  __   /__  #__P  __\  /__  #__P"-JP  ?;4  &Z_  !@R
M4M   $/7   WW0  *^(  "+F   9Z@  %?D  !+_   0_P@ #O\.  S_$0 )
M_Q8 !O\<  /_(@  _RH  /\S  #_/0  _TD  /]7  #_:0  _WX  /^5  #_
MK   _\<  /_H  #_^@  __H  /_Z  #_^@" M0  <+\  &')  !2TP  0]L
M #7A   IY@  'NH  !7N   0^   #O\   O_   (_P  !/\&  #_"@  _PX
M /\1  #_%0  _QL  /\C  #_*P  _S8  /]#  #_4P  _V4  /]Z  #_D0
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M&K-!YAJO0?<<K4'_':M!_QVI0?\<J4'_'*9!_QNE0?\;I4'_&Z5!_QO_/1
M_T() /](!0#_30@ _U + /E1#P#K4!4 X4\@ -A0,0#/4$$"R4].!<1.6@G
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M*H-6_RB#5O\G@E;_)8%6_R2!5O\D@5;_)(%6_R3_1P, _T\  .=8  #98
MS60  ,9F 0#!9@0 NV8. +1I( "N:3$"J&@_!:-F2@J?950/FF-=%)=A91B3
M8&T<D%YU'XY=?2*+7(8EB%N0*(5:FBJ#6:8L@%FT+7]9QRY]6>8M?%KZ+'M:
M_RI[6_\H>UO_)WM:_R9Z6O\E>EK_)7I:_R7_20  ^U(  .-<  #28P  QV@
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M*6IF_RAJ9O\G:F;_)VIF_R?_4   YUL  --F  #%;@  NW,  +-W  "K>0
MI'@# )UZ% "8>R4!DWLT XYZ0 >)>$H-A'93$H!U6Q=\<V(;>')J'W5Q<B)R
M;WLF;VZ%*6QMD"QI;)PN9FRJ,&1LO#%C;-DP8VST+V-L_RUD;/\K9&O_*65J
M_RAE:O\H96K_*&5J_RC]4P  XU\  ,YI  #!<0  MW<  *][  "G?0  GGT
M )A^$0"3@"( CH Q HE_/@:$?4@,?WQ1$7MZ619W>6 :<W=H'F]V<"%L=7@E
M:72"*&9SCBMC<IHN8'&H+UYQNC!=<=0P77'R+EYQ_RQ></\K7W#_*6!O_RA@
M;O\H8&[_*&!N_RCQ50  WF(  ,IM  "]=0  LWL  *N   "B@@  F($  )&#
M#P"-A1\ B(4N H.$.P5^@T4*>H%.#W6 5A1Q?UX8;GUF'&I\;2!G>W8C8WJ
M)V!YBRI=>)@L6G>F+EAWN"]7=]$O5W?Q+EAV_RQ8=O\J677_*5IT_RA:=/\G
M6G3_)UIT_R?M60  UV8  ,5Q  "Y>@  KX   *:$  "=A@  D8<  (J)# "&
MBAL @HLK 7V*. 1XB4((=(A,#6^'5!)LA5L6:(1C&F2#:QYA@G0A78%])%J
MB2A7?Y8J57ZD+%)^MBU1?LXM47WO+%)]_RM2?/\I4WO_*%1Z_R=4>O\G5'K_
M)U1Z_R?H7@  T&L  ,!V  "T?@  JX4  *&)  "7BP  B8T  (./" !^D!<
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M'T":L" _FL@@/YGK'S^8_R ^EO\A/I7_(3^4_R$_E/\A/Y3_(3^4_R'-<
MO'T  +"(  "DCP  F90  (Z8  "#G0  =Z   &FD  !@IP@ 7:@4 %NI) !9
MJ3$!5JD\ E.I1010J$X&3:A7"4JH7PQ'IV@.1*=S$4&F?Q0^IHT6/*:=%SJF
MKQ@YIL<8.:7J&#BC_QHWH?\;-Z#_'#>?_QPWG_\<-Y__'#>?_QS$>   M84
M *F/  "=E0  DIH  (:?  !ZHP  ;J@  &*L  !5L   4+(. $ZR&P!-LR@
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M A_-^@,>R_\$'LK_!1W)_P8=R?\&'<G_!AW)_P:HE   G)H  )"A  ""J
M=*\  &>V  !;O   3L   $/#   YQP  +\P  "?0!  ?U@H &]H0 !O;&@ :
MVR8 &MPQ !G=/  8W4@ &-Y5 !??8@ 6X'( %>"% !3AF@ 3XK$ $N// !+@
M]  2WO\!$=W_ 1';_P(1V_\"$=O_ A';_P*>F@  DJ$  (2I  !VL0  :+@
M %N_  !.Q   0L@  #?,   MT   )-4  !S;   5WP4 %.D. !+J%  1ZQT
M$.LF  [L,  .[3H #>Y&  ON4P *[V( "?!T  CQB0 '\J  !?*Z  3QY  "
M\?T  N__  /M_P #[?\  ^W_  /M_P"5H0  AJD  'BR  !IN@  6\(  $W(
M  ! S   --$  "K6   AVP  &>   !+D   /\ $ #?D*  OZ#P )^Q4 !_L<
M  3\)  !_"P  /PW  #\0@  _%   /QA  #]=0  _(P  /RD  #\P0  _.L
M /S_  #]_P  _?\  /W_  #]_P")J0  >;(  &J[  !<Q   3LP  #_1   R
MUP  )]T  !WA   5Y0  #N@   KQ   (_0  !?\#  '_"0  _PX  /\2  #_
M%P  _Q\  /\G  #_,0  _SX  /]-  #_7P  _W4  /^-  #_I@  _\(  /_G
M  #__   __\  /__  #__P!\LP  ;+P  %W&  !.SP  /]8  #'=   EX@
M&N8  !'J   ,[@  !?(   #_    _P   /\   #_    _P4  /\*  #_#@
M_Q(  /\8  #_(0  _RL  /\Y  #_2@  _UT  /]S  #_C   _Z0  /^Y  #_
MU   _]X  /_>  #_W@#_&"P _QDI /\9* #_%2L _Q P /\+. '_ T0!_P!1
M ?\ 7@'_ &P!_P!X ?\ @@'_ (P!_P"4 ?\ G #_ *( _P"H /\ KP#_ +8
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M M@DZ@/2)/D%SR7_!LTE_P?+)?\(RB7_",HD_PC*)/\(RB3_",HD_PC_+A0
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M%YI!_Q>80?\7F$'_%I=!_Q670?\5ET'_%9=!_Q7_.P8 _S\  /E&  #E2P
MW$X  ---! #12@D RDH4 ,)-)P"\3C<!MTY% K)-4 6O3%H(JTMC"JA*; VF
M270/I$E\$:%(A!.?1XP5G4>5%YM&GQB91JH9ET:X&I9&RAN31N8;D4?Y&X]'
M_QJ.1_\9CD?_&(U'_QB-1_\7C4?_%XU'_Q?_/@( _T,  .M+  #=40  T50
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M'796_QQV5O\;=E;_&W96_QO_10  [$X  -I8  #)7@  OV(  +=D  "Q8P
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M'F!F_Q[O3P  VEP  ,9E  "Z;0  L'(  *=U  "==   E',  (UT#0")=AP
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M(4]YKB).><,B37CE(DUW^R%.=_\?3G;_'D]U_QU/=?\=3W7_'4]U_QW?7
MR&@  +ER  "N>@  I8   )J"  ".@@  @(,  'F% @!TAA$ <8@@ &Z(+@%J
MB#D"9X=#!6.'3 A@AE,+785;#EJ$8Q%7A&L45(-U%U&"@!I.@8T<2X&;'DF!
MK!](@,$@1X#C'T=_^AY(?O\>2'W_'4E\_QQ)?/\<27S_'$E\_QS680  PFX
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M#S2=]Q SG/\2,YK_$C.9_Q,SF?\3,YG_$S.9_Q.]=P  KX,  *.+  "8D0
MC94  (&9  !SG   9Y\  %NB  !/I@  1ZD( $2J$@!#JA\ 0:LK $"K-P _
MK$$ /:Q* 3NL4P(YK%P#-ZQG!#6L<P4RK($&,*R1!RZLHP@MK+@)+*S9""RJ
M]0HKJ/\+*J;_#"JE_PTJI?\-*J7_#2JE_PVU@   J(L  )R1  "1E@  A9P
M 'B@  !KI0  7Z@  %.L  !(KP  /;(  #:U"P TM14 ,[8A #*V+  QMS<
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M  O2_P +TO\!"]+_ 0O2_P&:F   CI\  ("F  !RK0  9+0  %>Z  !)OP
M/<(  #+&   HR0  '\T  !?1   1U@  #-L%  C>"P &WQ$ !=\:  3@)  "
MX2X  >(Z  #C1P  Y%8  .1G  #E>P  YI(  .:J  #GR   Y_   .C_  #H
M_P  Z/\  .C_  #H_P"1GP  @J<  '2O  !EMP  5[X  $G#   \QP  ,,L
M "7/   <U   %-D   [=   )X0   N4   #I!@  Z0T  .D1  #J&   ZR$
M .TK  #O-P  \44  /)6  #S:   \WX  /27  #UL   ]M   /?S  #W_P
M]_\  /?_  #W_P"%IP  =K   &:X  !8P0  2L@  #O,   NT0  (]8  !G<
M   1X   #.,   3G    Z@   /4   #T    ]04  /4+  #V#P  ]A0  /@=
M  #Z)P  _#0  /]#  #_50  _VD  /^!  #_F@  _[(  /_/  #_[0  __D
M /_Y  #_^0!XL   :+H  %G#  !+RP  .]$  "W8   AW0  %N(   [F   (
MZ@   .T   #P    ^    /\   #_    _P   /\   #_!@  _PP  /\0  #_
M&   _R(  /\P  #_0   _U,  /]I  #_@0  _YD  /^O  #_PP  _]4  /_5
M  #_U0#_$R@ _Q,E /\1)0#_#2< _P8M /\ -0#_ $$ _P!/ /\ 7 #_ &D
M_P!T /\ ?@#_ (@ _P"0 /\ EP#_ )T _P"D /\ J@#_ +  _P"W /\ P #_
M ,P _P#? /\ [ #_ /@ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_%B4 _Q8B /\4(0#_$", _PHH /\ , #_ #T _P!+ /\ 6 #_ &0 _P!P
M /\ >@#_ (0 _P", /\ DP#_ )H _P"@ /\ I@#_ *T _P"T /\ O #^ ,@
M_0#9 /L Z0#Z /8 ^0#_ /@ _P#X /\ ^ #_ /@ _P#Y /\ ^0#_ /D _P#_
M&B( _QH> /\8'0#_$QX _PXB /\*+ #_!SD _P-& /\ 4P#_ &  _P!K /\
M=@#_ '\ _P"( /\ CP#_ )8 _P"= /\ HP#^ *D _ "P /H N0#W ,0 ]0#2
M /, Y@#R /0 \0#_ /  _P#O /\ [P#_ .\ _P#P /\ \ #_ /  _P#_'AT
M_QX9 /\<%P#_%Q@ _Q,> /\1* #_#C0 _PQ! /\*3@#_"%L _P=F /\&<0#_
M!GH _P:# /X&BP#\!I( ^@:9 /@&GP#V!J8 ] :M /(&M0#P!<  [07. .L%
MY #I!O, Y@C_ .4*_P#D"_\ Y O_ >0+_P'D"_\!Y O_ >0+_P'_(1@ _R$3
M /\@$0#_&Q( _QP: /\:) #_%B\ _Q,\ /\120#_$%4 _ YA /D.:P#V#G4
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M!+@E_P6V)?\%M27_!K4E_P:U)?\%M27_!;4E_P7_+ T _RT% /\N 0#_,04
M_S$+ /TO$ #Q*Q@ YRDE -\H,P#8*$( T2I/ ,TK6@#)*V4!QRMN <0L=@+"
M+'X"P"R& [XLC@.]+)8#NRR>!+DLIP2X++$%MBR_!;4MT06Q+>H&KB[[!ZLN
M_PBI+O\(J"[_"*@M_PBH+?\(J"W_"*@M_PC_+P@ _S$  /\U  #V-P  ZC8"
M .<S" #D+P\ V2X; ,\Q+ #),SP Q#1) , U50&\-5\"NC5H K<U< .U-'@$
MLS2 !;$TB :P-) &KC29!ZPTH@BK-*P)J32Y":<TR@JE->4*H37X"Y\U_PR=
M-?\,G37_"YPU_PN<-?\+G#7_"YPU_PO_,P( _S4  /8Z  #E/@  W$   -0]
M! #2-PD RS@5 ,,Z)@"]/38 N#Y$ ;0^4 &Q/5H#KCUC!*P]:P6I/',&ISQ[
M"*8\@PFD.XL*HCN4"Z [G0R>.Z@-G3NT#IL[Q0Z9.^ .ECOT#Y0\_P^2//\/
MDCS_#I$\_PV1//\-D3S_#9$\_PW_-0  _SD  .I!  #=1@  T$<  ,E&  #&
M004 P$ 1 +E"(0"S1#( KT5  :M%2P*G154#I$1>!:%$9@>?0VX(G4-V"IM"
M?@N90H8-ET&/#I5!F0^30:01D4&P$I!!P!*.0=D2BT'Q$HE"_Q*(0O\1B$+_
M$(="_Q"'0O\/AT+_#X="_P__.   \ST  .-'  #23   R$X  ,!-  "[2@(
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M%&M5_Q3R0P  WT\  ,M8  "]70  LV$  *MB  "B8   FUP  )5>$ "08!\
MC&$N (AA.@*$8$4$@6!.!GY?5@E[7ET+>%UE#G9<;!!S7'03<%M]%6Y:B!=K
M6I09:5FA&V=9L!QE6<,<9%GC'&19^AID6?\89%G_%V59_Q5E6?\495G_%&59
M_Q3O1@  VE(  ,9;  "Z80  L&4  *9F  "=8P  E6$  (]B#@"+9!P AV4K
M (-E-P%_94(#?&1+!GAC4PAU8UL+<V)B#G!A:A!M8'(3:V![%6A?AA=F7I$9
M8UZ?&V%=KAQ@7<$<7UWA'%]=^!I?7?\87UW_%V!=_Q9@7?\58%W_%6!=_Q7K
M2@  U%8  ,->  "V90  K&D  *)I  "89P  CV4  (EF# "%:!D @6DH 'YJ
M-0%Z:3\#=FE)!7-H40AP9UD*;6=@#6MF9Q!H97 2961Y%6-D@Q=@8X\97F*=
M&UQBK!Q:8K\<66+?'%EB]QI:8O\96F'_%UMA_Q9;8?\56V'_%5MA_Q7G30
MSUD  +]B  "S:   J6T  )YM  "3:P  B6D  (-K"0!_;14 ?&XE 'AN,@%U
M;CT"<6Y&!&YM3P=K;%8):&Q>#&5K90]C:FT18&EV%%UI@19;:(T86&>;&E9G
MJAM59[T<5&?<'%1G]AI49O\856;_%U5E_Q969?\55F7_%59E_Q7B40  RET
M +MF  "O;   IG$  )EP  ".;P  @VX  'UP!0!X<A( =7,A ')S+P%O<SH"
M;'-$!&ER3 9F<E0(8W%;"V!P8PU=<&L06V]T$UAN?Q55;HL74VV9&5%MJ!I/
M;;L;3FW9&DYL]!E/:_\83VO_%U!J_Q90:O\54&K_%5!J_Q7=50  Q6$  +=J
M  "L<0  HG4  )1T  ")=   ?',  '9U  !Q=Q  ;W@= &QY*P!I>3<!9GE
M V-Y205@>%$'77=8"5MW8 Q8=F@.575Q$5)U?!-0=(@63727%TMSIAA)<[D9
M2'/5&4ER\QA)<?\72G'_%DIP_Q5+</\42W#_%$MP_Q346@  P&8  +-O  "H
M=@  G7D  (]X  "$>   =WD  &]\  !J?0T 9WX9 &1_)@!B@#(!7X ] ER
M1@-:?TX%5W]5!U1^70E2?64,3WUO#DQ\>1%*?(831WN4%45[I!9$>[<60WO2
M%D-Z\A9#>?\50WC_%$1W_Q1$=O\31';_$T1V_Q/-7P  NVL  *YT  "D?
MEWX  (I]  !_?@  <G\  &:#  !AA @ 7H83 %R'(0!:ARX 6(<X 56'0@)3
MATH#4(=2!4Z&6@=+AF()285L"T:%=PU#A(,/0822$3^$HA(]A+43/(3/$SR"
M\!(\@?\2/8#_$CU__Q(]?O\1/7[_$3U^_Q'%9@  M7$  *I[  "?@@  DH(
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M!B2?_P8DGO\'))[_!R2>_P>O?@  HX@  )>.  "-DP  ?I4  '"8  !CFP
M5Y\  $RB  !"I@  .*D  "^L P JK@X *:X8 "BO(P GKRT )K W "6P00 D
ML$L ([%6 "*Q8P AL7$ '[&" !ZRE $<LJD!&[+! 1NQYP$;K_X"&JW_ AJL
M_P,:J_\#&JO_ QJK_P.HB   FX\  )&4  "$F@  =I\  &BB  !;I0  3ZD
M $2M   YL   +[,  ":V   >N04 &+L. !>[%@ 7O"  %KPJ !6]-0 4O4
M$[Y+ !*^6  2OF< $;]X !"_C  0P*( #L"Z  [ X0 /O?L #[S_ !"Z_P$0
MNO\!$+K_ 1"Z_P&?CP  E)4  (>;  !YH0  :Z<  %ZL  !2L0  1;0  #JV
M   ON0  );P  !V_   5PP  #\8%  O*#0 )RA0 ",H=  ?*)P 'RC( !LL^
M  7+2P $S%H  \QJ  +,?@ !S)0  ,RK  #-R   S.T  ,S_  #+_P !RO\
M <K_  '*_P"7E@  BIP  'RC  !NJ@  8+   %*V  !%N0  .;P  "Z_   C
MPP  &\8  !/*   -S0  "-$   '4"0  U X  -45  #6'@  V"<  -DQ  #;
M/@  W$L  -U;  #>;@  WH0  -^;  #?M   WMD  -_W  #?_P  W_\  -__
M  #?_P"-G0  ?Z4  '"L  !ALP  4[H  $6_   XP@  +,8  "')   8S0
M$-$   O5   $V@   -X   #@ 0  X0D  .(.  #D$P  Y1L  .<D  #I+P
MZSP  .U+  #N70  [G$  .^)  #PH@  \+P  /#C  #O^0  \/\  /#_  #P
M_P"!I0  <JT  &.U  !4O0  1L0  #?(   JS   ']   !75   .V@  !]X
M  #B    Y@   .D   #J    [    .X%  #O#   \1   /,7  #U(   ^"L
M /LY  #]2@  _EX  /]T  #_C0  _Z8  /_   #_X0  __4  /_U  #_]0!T
MK@  9;<  %;   !'R   .,T  "K2   =V   $]T   SB   #Y@   .D   #L
M    \    /,   #T    ]@   /@   #Z    _0<  /\-  #_$@  _QL  /\H
M  #_-P  _TH  /]>  #_=@  _X\  /^F  #_N@  _]$  /_1  #_T0#_#R0
M_PXB /\+(0#_ R0 _P I /\ ,@#_ #X _P!, /\ 60#_ &4 _P!P /\ >@#_
M (0 _P", /\ D@#_ )D _P"? /\ I0#_ *L _P"R /\ N@#_ ,4 _P#3 /\
MYP#_ /0 _P#_ /X _P#_ /\ _@#_ /X _P#^ /\ _@#_ /X _P#_$2$ _Q >
M /\-'0#_!Q\ _P C /\ +0#_ #H _P!( /\ 50#_ &$ _P!L /\ =@#_ '\
M_P"' /\ C@#_ )4 _P"; /\ H0#_ *< _@"N /T M@#\ ,  ^P#- /D X@#X
M /  ]P#\ /8 _P#U /\ ]0#_ /4 _P#U /\ ]0#_ /4 _P#_%1T _Q,: /\0
M&0#_"QD _P = /\ *0#_ #8 _P!# /\ 4 #_ %P _P!G /\ <0#_ 'H _@"#
M /P B@#Z )$ ^0"7 /@ G0#W *, ]0"J /0 L@#R +L \0#( .\ W #N .P
M[0#Z .L _P#J /\ Z@#_ .H _P#J /\ Z@#_ .H _P#_&!D _Q85 /\3$P#_
M#A, _PL: /\') #_ C  _P ^ /\ 2P#_ %< _P!B /P ; #X '4 ]0!^ /(
MA0#Q (P [P"3 .X F0#L *  ZP"F .D K@#G +< Y@## .0 U #B .D X0#W
M -\ _P#= /\ W0#_ -T _P#= /\ W0#_ -T _P#_&Q, _QH0 /\6#@#_$@X
M_Q(5 /\/'P#_#"L _PDX /\&10#[ U$ ]P)< /("9@#N G  Z@)X .<"@ #F
M X< Y .. .(#E0#A YP WP2C -T$JP#;!+0 V 7  -8%T #3!N< T CX ,X*
M_P#,"_\ RPS_ ,L,_P#+"_\ RPO_ ,L+_P#_'Q  _QX+ /\:!P#_&0L _Q@1
M /\6&0#_$B0 ^A P /,./@#N#4H Z0Q6 .4,80#B#&H W@US -L->P#9#8,
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M!*$F_P.A)O\#H2;_ Z$F_P/_*0  _R@  /8M  #G,   WR\  -DK! #6(@H
MSB,6 ,8F)P# *#8 NRI$ +@K3P"U+%D LBQB ; L:@&N+7(!K"UZ JHM@0*I
M+8H"IRV2 Z4MFP.D+:4$HBVQ!* MP 2?+=@$G"[O!9DN_P:7+_\&EB__!I4N
M_P65+O\%E2[_!94N_P7_+   _RX  .HU  #=.0  T3D  ,HV  #'+P8 P2T1
M +HP(0"T,C$ L#0^ *PU2@"I-50!IS5= :0U90*B-6T"H#5T Y\U? 2=-80$
MFS6-!9HTEP:8-*$&EC2M!Y0UNPB3-= (D#7L"(XV_@B,-O\(BS;_"(LV_P>*
M-?\'BC7_!XHU_P?_+P  \C0  .(\  #200  QT(  ,!   "[.@$ MC8. + Y
M' "J.RP ICPZ *,]1@"?/5 !G3U9 IH]80.8/6@$ECQP!90\=P:2/( 'D3R(
M!X\[D@B-.YT)BSNI"HD[MPN(.\H+A3SH"X,\^PN"//\*@3S_"H$\_PF!//\(
M@3S_"($\_PC_,P  [#H  -I#  #*1P  OTD  +='  "Q0@  K3X* *9 %P"B
M0B< GD,U )I$0@&71$P!E$15 I%#70./0V0%C4-K!HM"<P>)0GL(AT*$"H5!
MC@N#09D,@4&E#7]!LPY^0<8.?$'D#GI"^0UY0O\,>$+_"WA"_PMX0O\*>$'_
M"GA!_PKV-@  YD   -%(  ##30  N4X  +%-  "I20  I$4& )]&$P":2",
MEDDR ))*/@&/2D@"C$I1 XI)602'26 %A4EH!X-(;PB!2'<*?T> "WU'B@UZ
M1Y4.>$:B#W9&L!!U1L(0<T;@$')']P]Q1_\.<4?_#7%'_PQQ1_\+<4;_"W%&
M_POS.0  X$0  ,Q,  "^40  M%,  *I2  "B3@  G4H! )=+$0"332  CT\N
M (Q/.@&(3T4"A4]. X-/5@2 3ET&?DYD!WQ-; EY370+=TQ]#'5,APYS3)(/
M<4N?$6]+K1)M2[\2;$O<$FM,]1%J3/\/:DS_#FI+_PUJ2_\,:DO_#&I+_PSP
M/0  VT@  ,=0  "Z50  L%@  *56  "<4P  ET\  )%0#@",4AP B50K (54
M-P""5$(!?U1+ WQ44P1Z4UH&>%-B"'52:0ES4G$+<5%Z#6Y1A ]L4) 0:E"<
M$FA0JQ-F4+P395#8$V10\Q)D4/\09%#_#V10_PYE3_\-94__#&5/_PSL00
MU$P  ,-4  "V60  K%P  *!:  "75P  D50  (M5# "&5QD @U@G (!9- !]
M63\!>EE( W=84 1T6%@&<E=?!V]79@EM5FX+:U9W#6A5@0]F58T19%2:$F)4
MJ1-@5+H47U33%%Y4\A->5/\17U3_#U]4_PY?4_\-7U/_#5]3_PWG1   SU
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M$T]B[1)/8?\13V'_$%!@_PY08/\.4&#_#5!@_PW93P  PUH  +1C  "I:0
MFV@  (]G  "$9P  >64  '-G  !O:0X ;&H; &EK* !G;#0 9&P] 6)L1@)?
M:TX$76M6!5IJ70=8:F4)5FEN"U-I> U1:(0/3FB2$$QGH1)+9[(226?)$DEG
MZQ))9O\02F;_#TIE_PY+9?\-2V3_#4MD_PW15   OEX  +%G  "F;0  EVP
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M"S=Y_PHX>/\*.'C_"CAX_PJ^9   L&\  *5X  "6>0  AWD  'MY  !P>@
M9'P  %B   !0@P  2X4* $B&% !'AR  18@K $2(-0!#B#X 08E' 4")3P$^
MB%@"/(AA SJ(; 0WB'@%-8B'!C.(F <RAZH',(C !S"'Y <PA?L(,(/_"#""
M_P@P@?\(,('_"#"!_PBW:P  JG8  *!_  "0?@  @GX  '9_  !J@   7H,
M %.'  !*BP  08X" #V0#@ [D!@ .I$C #F1+0 XDC< -Y)  #:220 TDU(
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M 1.D_P&CA@  EXP  (V1  !]D@  ;94  &"8  !4G   2*   #ZD   TIP
M*JL  "&N   9L0  $K,'  ^U$  .M1< #K4A  VU*P -M38 #+9!  NV3@ *
MMEP ";9L  BV?P 'MI0 !K:J  6VQ0 &MNH ![7_  BT_P (L_\ ";+_  FR
M_P":C0  D),  (28  !TG   9:   %>D  !+J   0*P  #6P   JLP  (;4
M !BX   1NP  #+X"  ; "P "P!$  <$9  #!(@  PBL  ,(V  ##0@  PU
M ,1?  #$<0  Q(<  ,2=  #$M0  Q-H  ,3V  ##_P  P_\  ,/_  ##_P"3
ME   AYH  'B@  !JI@  7*P  $^Q  !!M0  -;<  "FZ   ?O0  %L   !##
M   *Q@   \H   #,!0  S P  ,T1  #.&   SB$  - J  #1-0  TT,  -12
M  #48P  U7@  -6/  #5IP  UL(  -;I  #6_0  UO\  -;_  #6_P"*FP
M>Z(  &RI  !>L   4+8  $*Z   TO0  *,$  !W$   4QP  #<L   ;.
MT@   -<   #9    V@4  -P+  #=$   WQ4  .$=  #C)P  Y3,  .="  #H
M5   Z&<  .E^  #IEP  ZJ\  .K.  #K[P  Z_X  .O_  #K_P!]HP  ;JL
M %^R  !1N@  0L   #3#   GQP  &\L  !+/   +TP   M@   #=    X0
M .0   #E    YP   .D   #K!P  [0T  .\1  #Q&0  ]"0  /<Q  #Y00
M^E4  /IJ  #[A   ^YT  /RV  #\T@  _>T  /WT  #]] !QK   8;4  %*]
M  !$Q   -,D  ";-   :T@  $-@   C=    X0   .4   #H    [    .\
M  #Q    \P   /4   #W    ^0$  /L(  #^#@  _Q4  /\A  #_+P  _T$
M /]6  #_;0  _X<  /^@  #_M@  _\H  /_4  #_U #_"R  _P<> /\ '0#_
M "  _P E /\ +@#_ #L _P!) /\ 5@#_ &( _P!M /\ =@#_ '\ _P"' /\
MC@#_ )0 _P": /\ H #_ *8 _P"M /\ M0#_ +X _P#+ /\ X0#_ /  _@#]
M /T _P#] /\ _0#_ /T _P#\ /\ ^0#_ /D _P#_#1T _PL: /\$&0#_ !H
M_P ? /\ *@#_ #< _P!% /\ 40#_ %X _P!H /\ <@#_ 'H _P"" /\ B0#_
M )  _P"6 /\ G #^ *( _ "I /L L #Y +D ^ #& /8 V0#U .L ] #Y /,
M_P#R /\ \P#_ /, _P#S /\ \P#_ /, _P#_$!D _PX5 /\(% #_ !0 _P 9
M /\ )0#_ #( _P!  /\ 3 #_ %D _P!C /X ;0#\ '4 ^@!] /D A #W (L
M]@"1 /0 EP#S )X \@"D /  K #N +0 [0#  .L SP#I .8 Z #U .8 _P#G
M /\ Y@#_ .4 _P#E /\ Y0#_ .4 _P#_$A0 _Q 0 /\,#P#_ Q  _P 5 /\
M( #_ "P _P Z /\ 1P#Z %, ]P!> /0 9P#Q '  [P!X .T ?P#K (8 Z@",
M .@ DP#G )D Y0"@ ., IP#A +  WP"Z -T R0#; .  V #P -< _@#5 /\
MU #_ -, _P#3 /\ TP#_ -, _P#_%1  _Q(, /\."0#_"PP _PD2 /\#&@#_
M "8 _0 S /0 0 #O $T ZP!8 .@ 80#E &H X@!R .  >@#> (  W "' -H
MC@#8 )4 U "< -( HP#0 *P S@"V ,P Q #* -D R #M ,< ^P#% /\ Q '_
M ,,!_P#$ ?\ Q '_ ,0!_P#_& L _Q4% /\0  #_$ 8 _P\- /\,% #\!Q\
M\0,K .< .0#B $8 W@%1 -H"6P#5 F0 T@-L ,\#= #-!'L RP2" ,H$B0#(
M!9  Q@68 ,0%H #"!JD P0:T +\&P0"]"-4 NPGL +@+_0"V#/\ M0W_ +0-
M_P"T#?\ M W_ +0-_P#_&P4 _Q@  /\7  #_%@  ^Q,& /H0#@#N#!8 XPDB
M -H), #3"CX S@M* ,H,50#'#5X Q0UG ,(.;P#!#G8 OPY^ +T/A0"\#XT
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M HXG_P+_)@  \BD  .,Q  #2-   R#0  , P  "[*0( N",. +$F' "L*"L
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M!WD[K =W.[P(=CS5"'0\\0AS//\'<CS_!G(\_P5R//\%<CO_!7([_P7Q,@
MWCT  ,E$  "\2   L$D  *9&  "?00  FST! )4]$ "1/QT C4$K (I". "'
M0T( A$-+ 8)#4P& 0UL"?D)B WQ":01Z0G$%>$)Z!G9!A =T08\(<D&;"'!!
MJ0EO0;D*;4'0"FQ![@EK0O\(:D+_!VI!_P9J0?\&:D'_!6I!_P7M-P  UD(
M ,1)  "W30  JTT  *!*  "81P  DT(  (Y##0")11H AD8H (-'- " 2#\
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M#5E/Z Q83_T+6$__"5E/_PA93O\'64[_!UE._P??0P  QTT  +A4  "L60
MG5<  )%5  "(5   @5   'M2! !W4Q$ =%0> '%5*P!O5C8 ;%9  6I62 %H
M5E "9E97 V167@1B568%8%5O!UU5> A;5(0*6521"U=4H Q54[ -5%/%#5-3
MY@Q34_P+4U/_"512_PA44O\(5%+_!U12_P?:1@  PU   +58  "H6P  F5H
M (U8  "$5P  >U0  '96 0!Q5P\ ;ED; &Q:* !I6C, 9UL] 65;10%C6TT"
M85I5 U]:7 1=6F0%6UEL!EA9=@A668()5%B/"U)8G@Q06*X-3UC##4Y8Y Q.
M6/L+3U?_"4]7_PA/5O\(4%;_!U!6_P?32@  P%0  +)<  "C7@  E5T  (E<
M  !_6P  =ED  '!:  !K7 T :%T8 &9>) !D7S  8E\Z &!?0P%>7TL"7%]2
M EI?6@-87V$%55YJ!E->= =177\)3UV-"DU=G M+7:P,2EW!#$E=XPQ)7/H*
M25O_"4I;_PA*6O\(2EK_!TI:_P?.3@  O%@  *Y@  "?80  D6   (5?  ![
M7P  <%T  &I?  !E80H 8F(4 &!C(0!>9"T 7&0W %ID0 %89$@!5F10 E1D
M5P-29%\$4&1G!4YC<09,8WT(26*+"4=BF@I&8JH+1&*_"T1BX0M$8?D*1&#_
M"41@_PA%7_\'15__!T5?_P?(4@  N%P  *MD  ";9   C&,  (!C  !V8P
M:F(  &-D  !?9@8 6V<1 %EH'0!7:2D 5FHS %1J/ !2:D4!4&I, 4YJ5 ),
M:EP#2FIE!$AI;P5&:7H'1&F("$)HF E :*D*/VB]"CYHW@D^9_<)/F;_"#]E
M_P<_9?\'/V3_!S]D_P?#5P  LV$  *=I  "6:   AV<  'MG  !Q9P  96@
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M RE[_P.Q:@  I70  )5V  "%=0  >'4  &UU  !A=P  5WH  $Q^  !#@0
M.X4  #6("0 RB1$ ,8D; #"))0 OBB\ +HHX "V+00 LBTH *HM4 "F+7P H
MBVL )HMZ 22+BP$CBYX!(HNS 2&,S@$ABO$!((C_ B"&_P(@A?\"(87_ B&%
M_P*K<@  H7P  (][  " >@  <WH  &9\  !;?P  4((  $:&   \B@  -(T
M "R1   FDPP ))03 ".4'  BE28 (94O ""5.  ?ED( 'I9, !V66  <EF0
M&I=T !F7A@ 8EYD %Y>N !67R0 6E>X %I/_ 1:2_P$6D?\!%I#_ 1:0_P&E
M>P  F8,  (F!  ![@   ;((  %^$  !4B   28L  #^0   UE   +9<  "6:
M   =G@$ %J , !2A$@ 4H1L $Z$E !*A+@ 1HC@ $:)# !"B3P /HEP #J-K
M  VC?0 -HY( #*.G  JBP  +HN8 #*#^  V?_P -GO\ #9W_  V=_P">A
MDHD  (.(  !SB   98L  %B.  !,D@  09<  #>;   NG@  )*(  !RE   5
MJ   #ZL$  JN#  'K1( !JT;  6M)  $KBX  JXY  &N10  KE(  *YA  "N
M<P  KH<  *Z=  "NM   KM4  *WT  "M_P  K/\  *O_  "K_P"6BP  C)
M 'N0  !KD@  798  %":  !$GP  .:,  "^G   EJP  '*X  !2Q   .M
M";<   &X"0  N X  +D4  "Y'   NB4  +HO  "[.@  O$<  +Q6  "\9P
MO'L  +R1  "\J0  O,0  +SK  "[_@  N_\  +O_  "[_P"0D@  @Y@  '.;
M  !CGP  5:,  $>H   [K0  ,+$  "6T   ;MP  $KH   R]   %OP   ,,
M  #$ @  Q0H  ,4.  #&%   QQL  ,@D  #*+@  S#H  ,U)  #-60  S6P
M ,Z#  #.FP  S;4  ,[:  #.]@  S?\  ,W_  #-_P"&F0  =Z   &FF  !:
MK   3+(  #ZV   PN0  )+P  !F_   1P@  "L4   +)    S    -    #1
M    T@$  -,(  #5#0  UQ$  -H8  #<(0  WRP  .$Z  #B2@  XUT  .1R
M  #DBP  Y:4  .7   #EY@  Y?@  .7_  #E_P!ZH0  :ZD  %RO  !-M@
M/[P  #"_   CPP  %\<   _*   'S@   -$   #6    W    -\   #@
MX@   .0   #F P  Z D  .D.  #L%0  [AX  /$K  #T.@  ]4T  /9A  #W
M>0  ^),  /BM  #YQ@  ^>0  /GS  #Y\P!MJ@  7K(  $^Z  ! P0  ,<4
M "+)   6S@  #=(   38    W0   .$   #D    Z    .L   #M    [P
M /$   #S    ]@   /@#  #Z"P  _1$  /\;  #_*0  _SL  /]/  #_9@
M_W\  /^9  #_KP  _\,  /_6  #_U@#_!!P _P 9 /\ &0#_ !P _P B /\
M*P#_ #@ _P!& /\ 4P#_ %X _P!I /\ <@#_ 'H _P"" /\ B0#_ (\ _P"5
M /\ FP#_ *$ _P"H /\ KP#_ +D _P#% /\ V0#^ .P _0#[ /L _P#[ /\
M^P#_ /H _P#T /\ \ #_ /  _P#_!Q@ _P$5 /\ % #_ !8 _P ; /\ )@#_
M #0 _P!" /\ 3@#_ %H _P!D /\ ;0#_ '4 _P!] /\ A #_ (H _0"0 /P
ME@#Z )T ^0"C /@ JP#W +0 ]0"_ /0 S@#S .8 \0#V /  _P#O /\ [P#_
M .X _P#N /\ Z@#_ .H _P#_"Q0 _P81 /\ $ #_ !  _P 6 /\ (@#_ "X
M_P \ /\ 20#_ %0 _@!? /L : #Y '  ]P!X /4 ?P#S (4 \@"+ /  D@#O
M )@ [0"? .P I@#J *X Z "Y .< QP#E -X XP#P .( _@#@ /\ X #_ .$
M_P#A /\ X0#_ .$ _P#_#1  _PD- /\!# #_  P _P 2 /\ ' #_ "@ _  V
M /D 0P#V $X \@!9 .\ 8@#L &L Z@!R .@ >0#F (  Y "& .( C #A ),
MWP": -T H0#; *H V "T -4 P #2 -, T #J ,X ^@#- /\ S0#_ ,T _P#,
M /\ S #_ ,P _P#_$ P _PP' /\# @#_  @ _P . /\ %@#V "( \  O .P
M/ #I $@ Y0!3 .$ 7 #> &4 VP!L -< <P#4 'H T@"  -  AP#. (X S "5
M ,H G0#( *4 Q@"O ,0 NP#" ,L P #E +X ]0"] /\ O #_ +P _P"\ /\
MO #_ +P _P#_$04 _PX  /\*  #_" $ _P0* /@ $ #I !H XP H -X -0#9
M $$ TP!, ,\ 5@#+ %\ R0!F ,8 ;@#$ '0 P@![ ,$ @@"_ (D O0"0 +P
MF "Z *$ N "K +8 MP"T ,< L@#@ +$!\@"O O\ K@/_ *T$_P"M!/\ K03_
M *T$_P#_%   _Q   /\/  #R#0  Z@H  .D#"0#= !( U  ? ,T!+0#( CH
MQ -% , #4 "]!%D NP5A +D%: "W!F\ M09V +0'?0"R!X0 L0B, *\(E0"M
M"9X JPFH *H*M0"H"L4 I@O? *0-] "B#O\ H [_ )\._P"?#O\ GP[_ )\.
M_P#_%P  _Q,  .\8  #D&0  VQ8  -(0 @#/"0L R @6 ,$*) "\##( MPT^
M +0.20"Q#E, KQ!; *T08P"K$&H J1%Q *@1> "F$8  I1&( *,2D0"A$IL
MH!.F )X3LP"<$\, FQ3> )<6] "5%O\ E!?_ ),7_P"2%_\ DA;_ )(6_P#_
M&@  ]!T  .4C  #5)0  RB0  ,(=  "^%@0 NQ 0 +03'0"O%2L JQ8X *<8
M0P"E&4T HAE6 * :70">&V4 G1ML )L<<P":''L F!R# )<=C0"5'9< DQZB
M )(>KP"0'K\ CQ_8 (P@\0&)(/\!B"#_ 8<@_P&'(/\!AB#_ 88@_P'Z'@
MZR8  -HM  #*,   OBX  +4H  "P(@  KAL, *@=%P"C'R8 GR$S )PB/@"9
M(T@ ER11 )4D60"3)6  DB5G ) F;@".)G8 C29_ (LFB &*)Y,!B">> 88G
MJP&$)[L!@RC1 8 H[@%^*?\!?2G_ 7PH_P%\*/\!?"C_ 7PH_P'U)   XRX
M ,\U  #!.   M#8  *LQ  "E+   HB8& )XF$P"9*"$ E2HN )(K.0"/+$0
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M!64\Y05D//H$9#S_ V,[_P-C._\#8SO_ F,[_P+E-0  S3\  +U&  "N1P
MGT4  )5#  ".0   B3P  (0\"@" /10 ?3XB 'H_+@!X0#@ =4%" '-!2@!R
M05$!<$%9 6Y!8 )L06<":D%P VA!>0-G080$94&1!6-!GP5A0:X&8$'"!EY!
MX@9>0?D%74'_!%U _P-=0/\#74#_ UU _P/?.0  R$,  +E*  "I2P  FTD
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M!4U-_P1-3?\$3DS_ TY,_P/.1   O$X  *Y4  "<4P  CE(  (-1  !Z4
M<DT  &Q/  !H4 L 95$5 &-2(0!A4RP 7U,V %U4/P!;5$< 6E1. 5A45@%6
M5%T"5%1F U)3;P-04WL$3E.(!4Q3EP9+4Z<'25.Z!TA3U0=(4O,&2%+_!4A1
M_P1)4?\$25#_ TE0_P/*2   N5(  *I7  "85@  BE4  ']4  !V4P  ;%$
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M SE>_P.\50  K5\  )Q@  "+7P  ?5\  ')?  !H7P  76   %5B  !/9
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M "9ZAP$E>ID!(WJL 2)ZQ0$B>>D!(G?_ 2)V_P$B=?\"(G3_ B-T_P*L:
MG6X  (IM  ![;   ;VP  &5L  !:;@  4'$  $5U   ]>   -GP  "Y_ @ I
M@0T )X(4 ":"'@ E@B< )((O ".#.  B@T( (8-+ ""$5@ ?A&( 'H1Q !R$
M@@ ;A)4 &H2I !B$P0 8@^8 &('] !F _P$9?_\!&7[_ 1E^_P&F<   E7,
M (1R  !V<0  :W$  %YS  !4=@  27D  #]]   W@0  +X0  ">(   @BP4
M&XT. !J-%0 9C1X &(XG !>.,  6CCD %8Y# !2/3P 3CUL $H]J !&/>P 0
MCX\ #X^D  Z/NP -C^  #HWZ  ^+_P 0BO\ $(G_ !")_P"A>@  CGD  'YW
M  !R=P  9'@  %A[  !-?@  0H(  #F&   OB@  )XX  ""1   8E0  $I@%
M  Z:#@ -FA0 #)H=  N:)@ +FC  "IH[  F:1@ (FE, !IMA  6:<@ $FH8
M IJ;  ":L0 !F<\  IGP  *8_P $E_\ !9;_  66_P"9@0  AW\  'I^  !K
M?@  78$  %"%  !%B0  .XT  #&2   HE@  'YD  !B=   1H   #*,"  :E
M"@ !I1   *46  "F'P  IB@  *8R  "G/0  ITH  *=8  "G:   IWP  *>1
M  "FJ   IL,  *7I  "E_   I?\  *3_  "D_P"1AP  @H8  '*&  !CB
M58P  $F1   ]E@  ,IH  "B>   ?H@  %Z8  !"I   +K   !*\   "Q!@
ML0P  +(1  "R%P  LQ\  +,H  "T,@  M3\  +5-  "U70  M7   +6&  "U
MG0  M;8  +7<  "T]P  M/\  +3_  "T_P"+CP  >HX  &J1  !;E0  39H
M $"?   UI   *J@  ""L   6L   #[0   FW   !N0   +T   "^    O@8
M +\,  # $   P18  ,(=  ##)P  Q3(  ,9   #&40  QV,  ,=X  #'D0
MQZD  ,?'  #'[   Q_X  ,?_  #'_P"#EP  <9H  &&>  !2HP  1:D  #BN
M   LLP  (+<  !:Z   .O0  !L    ##    QP   ,D   #*    S    ,T#
M  #."0  T X  -(3  #4&P  V"4  -LR  #=0@  W50  -YI  #>@0  WIP
M -^U  #?V0  W_,  -__  #?_P!WGP  :*8  %FM  !*LP  .[@  "V[   ?
MOP  %,(   S&   #R0   ,P   #0    U0   -D   #:    W    -X   #@
M    X@4  .0+  #G$   ZA@  .TD  #P,@  \40  /)8  #S;P  ](H  /2D
M  #TOP  ]-\  /3S  #T] !JJ   6Z\  $RW   ]O0  +<$  !_&   3R@
M"\X   #2    UP   -P   #@    Y0   .<   #I    ZP   .T   #O
M\0   /,   #V!P  ^0X  /P6  #_(@  _S,  /]'  #_70  _W8  /^1  #_
MJ0  _[X  /_8  #_VP#_ !@ _P 6 /\ %0#_ !@ _P > /\ )P#_ #8 _P!#
M /\ 3P#_ %H _P!D /\ ;0#_ '4 _P!] /\ A #_ (H _P"0 /\ E@#_ )P
M_P"C /\ JP#_ +0 _@"_ /T SP#[ .< ^@#X /D _P#Y /\ ^0#_ /4 _P#N
M /\ Z0#_ .< _P#_ !0 _P 1 /\ $0#_ !( _P 7 /\ (P#_ #$ _P ^ /\
M2@#_ %8 _P!@ /\ : #_ '  _P!X /T ?@#\ (4 ^@"+ /D D0#X )@ ]P">
M /4 I@#T *X \@"Y /$ QP#O .  [@#R .P _P#L /\ [ #_ .L _P#E /\
MX #_ -X _P#_ Q  _P . /\ #0#_  T _P 3 /\ '@#_ "L _P X /\ 10#^
M %  ^P!: /@ 8P#U &L \P!R /$ >0#O '\ [@"& .P C #J )( Z0"9 .<
MH #F *D Y "S .$ P #@ -, W@#K -P ^P#; /\ V@#_ -H _P#9 /\ U #_
M -( _P#_!PT _P ) /\ !@#_  D _P / /\ & #[ "4 ^  R /4 /P#R $H
M[0!4 .H 70#G &4 Y !L .( <P#@ 'H W@"  -P A@#: (T UP"4 -0 FP#2
M *0 SP"M ,T N0#+ ,D R0#D ,@ ]@#& /\ Q0#_ ,8 _P#' /\ QP#_ ,<
M_P#_"@8 _P$  /\   #_  0 _P + /0 $@#O !\ Z@ L .4 . #B $, W0!.
M -D 5P#4 %\ T0!G ,X ;0#, '0 R@!Z ,@ @ #& (< Q0". ,, E@#! )X
MOP"H +T LP"Z ,( N0#; +< \ "U /\ M@#_ +4 _P"U /\ M0#_ +4 _P#_
M#   _P0  /\   #^    ]@ # .@ #0#@ !< V0 D -$ ,0#- #P R@!' ,8
M40## %D P !@ +X 9P"\ &X N@!T +D >P"W (( M0") +, D0"R )H L "D
M *X KP"L +T J@#0 *@ ZP"G /L I@#_ *8 _P"E /\ I0#_ *4 _P#_#0
M_P<  /0)  #J"0  X@0  -H !P#/ !$ R  < ,( *0"^ #4 NP!  +< 2@"T
M %, L@!; +  8@"N &@ K !O *L =0"I 'T J "$ *8 C0"D )8 HP"@ *$
MJP"? ;D G0/, )P$Z ":!OD F0?_ )@(_P"7"/\ EPC_ )<(_P#_$   ]Q
M .@4  #<%0  SA$  ,8-  #"! L O  4 +<!(0"R RX K@4Z *L&1 "H"$T
MI@A5 *0)7 "B"F, H IJ )\+<0"="W@ G N  )H,B0"9#), EPR> )4-J@"4
M#;@ D@W, ) .Z@".$/P C!#_ (L0_P"+$/\ BQ#_ (H0_P#[$P  [1H  -T@
M  #,(0  OQT  +<7  "S$0  L@L- *L-&0"G#B8 HP\S )\0/@"=$4< FA%0
M )@25P"6$EX E1-E ),3; "2$W, D!1\ (\4A0"-%8\ BQ6: (H5IP"(%K4
MAA;) (07YP""&/L @!G_ '\9_P!_&?\ ?QC_ '\8_P#U&@  Y",  ,\I  #
M*@  LR8  *HB  "E'   I!4( * 4$P";%B$ EQ@M )09. "1&D( CQM+ (T<
M4@"+'%D B1U@ (@=9P"&'F\ A1YW (,?@ ""'XL @!^7 'X@HP!](+( >R#%
M 'DAY !W(OD =B+_ '4B_P!T(?\ ="'_ '0A_P#O(0  VRL  ,<Q  "V,0
MJ2X  * J  ";)@  F"$! )4>$ "0(!L C2$H (DC,P"')#T A21& (,E3@"!
M)E4 ?R9< 'XF8P!\)VL >R=S 'DG? !X*(< =BB3 '0HH %R**\!<2G! 6\I
MX %M*?<!;"G_ 6LI_P%K*?\!:RC_ 6LH_P'H*   T#(  , X  "N-P  H34
M )@R  "2+0  CBD  (LG# "'*!< @RHC ( K+P!^+#D ?"Q" 'HM2@!X+E$
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M TQ%S -+1>T#2T3_ DM$_P)+0_\"3$+_ DQ"_P+*/P  N4@  *9*  "520
MAT@  'U'  !U10  ;D(  &E#  !E1 D 8D43 %]&'@!=1R@ 7$@R %I(.P!9
M24, 5TE* %9)4@!425D!4TEA 5%):P%/278"34F" DM)D0-*2:$#2$FS T=)
MR@-&2>P#1DC_ D9(_P)'1_\"1T;_ D=&_P+&0P  MDP  *),  "13   A$L
M 'E*  !P20  :48  &1'  !?208 7$H0 %I+&P!83"4 5DPO %5-. !334
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M C=5_P(W5/\"-U/_ CA3_P*Z3P  J58  )55  "%5   >%0  &U4  !D5
M6%0  %)6  !.5P  2ED) $=:$0!&6AL 1%LE $-;+@!"7#8 05P^ #]<1@ ^
M74\ /5U7 #M=80 Z76P!.%UY 39=B $T79D",UVK C%=P@(Q7.4",5O\ C%:
M_P(Q6?\",EG_ 3)8_P&V5   I%D  )!8  " 6   <U<  &E7  !@6   5%D
M $Y;  !(70  0U\$ $!@#@ ^81< /6$@ #MB*0 Z8C( .6(Z #AC0@ W8TL
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M 1MM_P&F9@  D64  ']D  !Q9   9F0  %UD  !29@  2&D  #]L   W;P
M,',  "EV   B>0@ 'WL0 !Y[%P <>Q\ &WLH !I[,  9?#D &'Q# !=\3@ 6
M?%H %7QG !1]>  2?8L $7V? !!]M0 /?=4 $'OU !%Y_P 1>/\ $G?_ !)W
M_P">:P  BFH  'II  !M:0  8FD  %=J  !,;0  0W   #ET   Q>   *7L
M ")_   ;@@  %(4) !&&$  1AA< $(<? !"'*  .AS$ #H<[  V'1@ ,AU,
M"X=A  J'<0 )AX0 !X>8  :&K@ %ALD !H7L  >$_P (@_\ "8+_  F"_P"5
M<0  @V\  '1N  !I;@  7&\  %!R  !&=0  /'D  #)]   J@0  (H4  !N)
M   4C   #X\#  J2"P &DA$ !)(8  *2(  !DBD  )(S  "3/@  DTL  )-9
M  "3:0  DWL  )*0  "2I@  D;\  )'E  "0^@  C_\  (__  "/_P"-=P
M?74  '!T  !B=0  57@  $E\   _@   -(0  "N)   BC0  &I$  !.4   .
MEP  "9L   &="   G0X  )T3  ">&@  GB(  )\K  "?-0  H$(  *!0  "@
M7P  H'$  *"'  "?G0  G[4  )[:  "=]@  G?\  )S_  "<_P"&?0  >'P
M &E\  !;?P  3H,  $&(   VC   +)$  ".6   :F@  $IX   VA   &I
M *<   "I P  J0H  *H.  "K$P  K!D  *TB  "N*P  KS<  *]%  "O5
MKV8  *][  "NE   KJL  *[)  "N[P  K?\  *W_  "M_P"!A   <80  &&'
M  !3BP  1I   #F6   NFP  (Z   !JD   2J   #*P   2O    L@   +8
M  "W    MP(  +@(  "Y#0  NA(  +L8  "](0  OBL  , X  # 2   P%H
M ,%N  #!A@  P:   ,&Z  #!XP  P/D  ,#_  # _P!YC0  :)   %F4  !+
MF@  /:   #&E   EJP  &J\  !&S   +N    KL   "^    P0   ,0   #%
M    Q@   ,<   #(!0  R@L  ,P/  #.%0  T!\  -,K  #5.@  U4P  -9@
M  #8=P  V)(  -BL  #9R0  V>P  -G[  #8_P!PF0  8)X  %&D  !#J@
M-;   "BV   <N@  $;X   G!    Q0   ,@   #+    SP   -(   #3
MU@   -@   #;    W0   -\'  #B#0  Y1,  .@=  #L*@  [3P  .U1  #N
M9P  [X$  .^<  #PMP  \-,  /#L  #P] !GI@  6*T  $FT   ZN@  *KX
M !S"   0Q@  !\H   #.    T@   -8   #<    X    .,   #D    Y@
M .@   #K    [0   .\   #R @  ]0H  /@1  #\'   _RP  /\_  #_50
M_VX  /^*  #_I   _[H  /_1  #_X0#_ !0 _P 2 /\ $@#_ !0 _P 9 /\
M)0#_ #( _P _ /\ 2P#_ %8 _P!@ /\ : #_ '  _P!X /\ ?P#_ (4 _P"+
M /\ D0#_ )@ _P"> /X I@#] *X _ "Y /H R #Y .( ^ #T /< _P#V /\
M]@#_ .\ _P#G /\ X@#_ -X _P#_ !$ _P . /\ #@#_  \ _P 4 /\ ( #_
M "T _P Z /\ 1@#_ %$ _P!; /\ 8P#^ &L _ !S /H >0#Y (  ]P"& /8
MC #U )( \P"9 /( H #P *D [@"S .T P0#K -8 Z@#N .D _@#G /\ YP#_
M .4 _P#= /\ U0#_ -$ _P#_  T _P * /\ " #_  D _P 0 /\ &P#_ "@
M_P U /\ 0 #Z $L ]@!5 /, 7@#Q &8 [@!M .P = #K 'H Z0"  .< A@#F
M (T Y "3 .( FP#@ *, W@"M -P N0#: ,H UP#F -0 ^ #2 /\ T@#_ -(
M_P#. /\ R0#_ ,8 _P#_  @ _P # /\   #_  , _P - /P %@#W "( \P N
M .\ .@#L $4 Z !/ .0 6 #A &  W@!G -L ;0#9 '0 U0!Z -, @ #1 (<
MSP". ,T E0#+ )X R0"G ,< LP#% ,( PP#< ,$ \0"_ /\ OP#_ +X _P"^
M /\ O0#_ +L _P#_    _P   /\   #_    ]@ ( .X $0#G !L X0 G -T
M,P#9 #X TP!) ,\ 4@#+ %D R !A ,8 9P#$ &T P@!S ,  >@"_ (  O0"(
M +L D "Y )@ N "B +4 K0"S +L L0#. +  Z@"O /P K0#_ *T _P"N /\
MK@#_ *X _P#_ @  _P   /T   #R    Z    -X # #3 !4 S  A ,@ + #$
M #@ P0!" +T 2P"Z %, N !: +8 80"T &< L@!M +  = "O 'H K0"" *P
MB@"J ), J "= *8 J "D +4 H@#& *$ XP"? /8 G@#_ )X _P"> /\ G@#_
M )X _P#_!@  ^P   .X%  #B!   U0   ,L !@##  \ O0 9 +@ )0"T #$
ML0 [ *X 10"L $T J0!5 *< 6P"E &( I !H *( ;@"A '4 GP!\ )X A0"<
M (X F@"8 )@ I "6 +  E0#! ), W "2 /( D0#_ )  _P"0 /\ CP#_ (\
M_P#]"@  \ X  .$1  #.$   P@T  +L'  "W  H L0 2 *P '@"H "D I0 T
M *( /@"? $< G0!/ )L 5@"9 5P EP%C )8":0"4 G  DP-X )$#@ "0!(H
MC@25 (P%H0"*!:X B0:^ (<(V "&"?  A K_ (,+_P"#"_\ @PO_ (,+_P#V
M$   YA<  -(<  # &@  LQ8  *P2  "H#0  I@<- *(%%@"=!R( F0DN )8*
M. "4"T$ D@Q* ) ,40".#5@ C U> (L-90")#6P B YT (8.?0"%#H< @PZ3
M ($/GP" $*T ?A"^ 'T0VP!Z$?0 >!+_ '<2_P!W$O\ =Q+_ '<2_P#O%P
MVR$  ,8D  "T(P  J"   * <  ";%P  F1$$ )@.$ "3$!L CQ$G (P2,@")
M$SP AQ-$ (443 "#%%, @15: ( 58 !^%F@ ?19O 'L6> !Y%X, >!>/ '88
MG !T&*H <QF[ '(9U !O&O$ ;AO_ &T;_P!M&O\ ;1K_ &T:_P#G(   T"D
M +PK  "K*@  GB@  )8D  "0(   C1P  (P7# "(&!8 A!HB ($;+0!^'#<
M?!U  'H=2 !Y'D\ =QY5 '8?7 !T'V, <Q]K '$@= !P('\ ;B&+ &PAF !K
M(:< :2*X &@BSP!F(NX 92/_ &0C_P!D(O\ 9"+_ &0A_P#@)@  R"\  +0Q
M  "C,   EBX  (TK  "'*   A"0  ((@" !^(!( >R(> '@C*0!U)#, <R4\
M '$E0P!P)DL ;B92 &TG60!K)V  :B=H &DH<0!G*'L 92B( &0IE0!B*:0
M8"FU %\IRP!>*NP 7"K_ %PI_P!<*?\ 7"G_ %PH_P#8+   PS4  *TU  "=
M-   D#,  (8Q  " +0  ?"L  'DH P!V)Q  <BD: ' J)0!M*R\ :RPX &HL
M0 !H+4< 9RU. &4N50!D+ET 8RYE &$O;@!?+W@ 7B^$ %POD@!:+Z$!62^R
M 5@PR %6,.D!53#^ 54O_P!5+_\ 52[_ %4N_P#0,0  O3H  *@Y  "7.
MBC<  ( V  !Z,@  =3   '(N  !N+@T :R\6 &DP(0!F,2L 9#(T &,R/0!A
M,T0 8#-+ %\T4@!=-%H 7#1B %HT:P!9-74 5S6" %4UD %4-9\!4C6P 5$U
MQ@%0-><!3S7] 4\U_P%/-/\!3S3_ 4\S_P'+-@  N#T  *,\  "2/   A3L
M 'LZ  !T-P  ;S4  &PS  !H- H 9343 &(V'@!@-R@ 7C<Q %TX.@!;.$$
M6CE( %DY4 !7.5< 5CI? %0Z: !3.G, 43I_ 4\ZC0%..IT!3#JN 4LZPP%*
M.N4!23K\ 4DY_P%).?\!23C_ 4HX_P''.@  LT   )X_  "./P  @3X  '<]
M  !P.P  :C@  &8X  !B.0< 7SH1 %P[&P!:.R4 63PN %<]-P!6/3X 5#Y&
M %,^30!2/E4 43Y= $\_9@!-/W  3#]] 4H_BP%(/YL!1S^L 44_P0%$/^,!
M1#[[ 40^_P%$/?\!1#W_ 44\_P'#/@  KT,  )I"  "*0@  ?4$  '-   !K
M/P  93P  & \  !</@0 63X/ %<_& !50"( 4T$K %)!- !00CP 3T)# $Y"
M2P!-0U( 2T-: $I#9 !(0VX 1T-[ 45#B0%#0YD!0D.K 4!#P $_0^$!/T/Y
M 3]"_P$_0?\!0$'_ 4! _P&_00  JD4  )9%  "&10  >40  &]$  !G0@
M8#\  %M!  !70@  5$,- %%$%0!/11\ 3D4H $Q&,0!+1CD 2D=! $E'2 !(
M1U  1D=8 $5'80!#2&P 0DAX 4!(AP$^2)<!/$BI 3M(O@$Z2-\!.D?X 3I&
M_P$Z1?\!.T7_ 3M$_P&[10  ID@  ))'  ""1P  =D<  &M'  !C1@  6T,
M %9%  !21P  3D@* $Q)$@!*21P 2$HE $=*+@!&2S8 14L^ $-+1@!"3$T
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M 2I2_P&O40  F%$  (51  !V4   :E   &!0  !840  3E(  $=3  !!50
M.U@  #A9"@ U6A$ -%H: #-;(@ R6RL ,5LS "]<.P N7$, +5Q, "Q<5@ K
M76  *5UM "A=?  F78X )%VA "-=M0 B7=( (ESS ");_P C6O\ (UG_ "18
M_P"H50  DE0  (!4  !Q5   9E0  %Q4  !450  2E8  $-8   \6P  -ET
M #!@!0 M80X *V$5 "IB'0 I8B4 *&(N "=C-@ F8SX )6-' "-C40 B9%P
M(61I !]D>0 >9(H '&2> !MDLP 99,X &F/Q !MA_P ;8/\ '&#_ !Q?_P"A
M60  C%@  'M8  !M6   8E@  %E8  !060  1UL  #Y>   W8   ,6,  "IF
M   D:0D (6H0 "!J%P ?:B  'FLH !UK,  <:SD &VM" !IL3  9;%@ %VQE
M !9L=  4;(8 $VR: !)LKP 1;,H $6OO !)I_P 3:/\ $VC_ !-G_P"970
MA5T  '5<  !H7   7EP  %5<  !+7@  0F$  #ED   R9P  *VH  "1M   >
M< $ %W,+ !5T$0 4=!@ $W0A !)U*0 1=3( $74[ !!U1@ /=5( #G5?  UU
M;@ ,=8$ "W65  IUJ@ (=,, "73G  IS_0 +<?\ #''_  QP_P"18@  ?V$
M '!A  !D80  6F$  $]B  !%90  /&@  #-L   K;P  )'(  !UV   7>0
M$7P$  U_#  +?Q( "G\9  E_(@ (?RH !G\T  5_/P $?TL  G]8  %_9P
M?WD  '^.  !_HP  ?KL  'W@  !]]P  ?/\  'O_  ![_P")9P  >&<  &MF
M  !A9@  5&<  $EI   _;0  -7$  "QU   D>0  '7P  !:    0@P  #(8"
M  :)"@ !B0\  (D4  "*&P  BB,  (LL  "+-P  BT,  (M0  "+7P  BW$
M (N&  "+G   BK,  (G3  "(\P  B/\  (?_  "'_P"";0  <VP  &AL  !:
M;0  3F\  $)S   X=P  +GL  "6    =A   %8@  !",   +CP  !)(   "4
M!@  E0P  )40  "6%0  EQP  )@D  "8+@  F3D  )E'  "95@  F6@  )E]
M  "9E   F*L  )?(  "6[@  EO\  )7_  "5_P![=   ;W,  &%S  !3=@
M1GH  #M_   PA   )H@  !V-   4D@  #I8   F9   !G    *    "A
MH@8  *(,  "D$   I10  *4<  "G)   J"\  *@]  "I3   J5X  *ER  "H
MB0  J*(  *B\  "GY0  IOL  *;_  "E_P!W>P  :'L  %E^  !+@@  /H<
M #*-   GD@  '9<  !2<   .H   !Z0   "H    JP   *X   "O    L
M +$$  "S"@  M X  +43  "V&P  N"0  +HQ  "Z0   NE(  +ME  "[?0
MNI<  +JQ  "ZT@  NO,  +G_  "Y_P!O@P  7X8  %&+  !#D   -I<  "J=
M   ?H@  %:<   VL   %L    +0   "W    NP   +X   "_    P    ,$
M  ## 0  Q <  ,4-  #'$0  RAD  ,TD  #.,P  ST0  -!8  #0;@  T8@
M -"D  #0P0  T>8  -'X  #1_P!GCP  5Y0  $F:   [H0  +J<  "&M   6
MLP  #K@   :\    P    ,,   #&    RP   ,T   #.    T    -$   #4
M    U@   -H"  #<"0  WP\  .,7  #F)   YS8  .A)  #I7P  ZG@  .N4
M  #KKP  Z\P  .SH  #L]@!?G@  4*0  $*K   TL@  )KD  !F^   .P@
M!,4   #*    S0   -$   #8    VP   -\   #@    X@   .0   #F
MZ0   .L   #N    \04  /4-  #Y%@  _"4  /TY  #^3P  _V<  /^"  #_
MG0  _[4  /_+  #_Y #_ !$ _P / /\ #P#_ !$ _P 6 /\ (@#_ "\ _P [
M /\ 1P#_ %( _P!; /\ 9 #_ &P _P!S /\ >@#_ (  _P"& /\ C #^ ),
M_0"9 /L H0#Z *D ^ "T /< P@#V -H ]0#Q /0 _P#S /\ \P#_ .D _P#@
M /\ V #_ -, _P#_  X _P + /\ "@#_  L _P 1 /\ '0#_ "H _P V /\
M00#_ $P _P!6 /X 7P#[ &8 ^0!M /< = #U 'H ] "  /( A@#P (T [P"4
M .T FP#L *0 Z@"N .D N@#G ,T Y0#I .0 ^P#C /\ X@#_ -X _P#1 /\
MS #_ ,@ _P#_  D _P $ /\  0#_  0 _P . /\ & #_ "0 _0 P /L .P#W
M $8 \P!0 .\ 60#L &  Z@!G .< ;@#F '0 Y !Z .( @ #@ (< W@". -P
ME0#: )X U@"H -0 LP#1 ,, SP#? ,X ] #, /\ RP#_ ,L _P#% /\ OP#_
M +P _P#_  ( _P   /\   #_    _0 + /< $P#Q !X [0 J .H -0#G $
MX@!* -T 4@#9 %H U0!A -( 9P#0 &T S@!S ,P >@#* (  R "' ,8 CP#$
M )@ P@"A ,  K0"^ +L O #0 +H [0"Y /X N #_ +@ _P"W /\ LP#_ +
M_P#_    _P   /\   #Y    [@ % .4 #@#> !@ V  C -( +@#/ #D RP!#
M ,< 3 #$ %0 P0!; +\ 80"\ &< NP!M +D <P"W 'H M0"! +0 B0"R )(
ML "; *\ IP"L +0 JP#& *D Y "G /@ I@#_ *8 _P"E /\ I0#_ *0 _P#_
M    _P   /4   #J    W@   -  "@#( !( P@ = +X * "[ #, N0 ] +4
M1@"R $T L !5 *T 6P"L &$ J@!G *@ ;0"G ', I0!Z *0 @@"B (P H "6
M )\ H0"= *X FP"^ )D V "7 /$ E@#_ )8 _P"7 /\ EP#_ )< _P#_
M]0   .<!  #4    R0   ,  ! "X  X LP 6 *\ (0"K "P J  V *8 /P"C
M $< H0!/ )\ 50"= %L FP!A )H 9P"8 &X EP!U )4 ?0"4 (8 D@"1 )
MG ". *D C "X (L S0") .L B #] (@ _P"( /\ B #_ (@ _P#Y!@  Z0P
M -0.  ###   MPD  + "  "K  D I@ 0 *( &@"> "4 FP P )@ .0"6 $$
ME !) )( 4 "0 %8 C@!< (T 8@"+ &D B@!P (@ > "' ($ A0", (0 F ""
M *4 @ "T 'X R !] >< ? +Y 'L#_P![!/\ >P3_ 'L$_P#Q#@  WA4  ,45
M  "T%   J1$  *$.  ">"@  FP,, )< $P"3 !X D $I (T",P"* SP B 1#
M (8%2P"%!E$ @P97 (('7@" !V0 ?PAL 'T(= !\"'X >@F) '@)E@!W"J,
M=0JS ',+QP!R#.8 < W[ ' -_P!O#?\ ;PW_ &\-_P#H%@  T!X  +D=  "I
M'   G1H  )46  "0$P  CPX# (X*#@")"Q< A@PC (,-+0" #38 ?@X^ 'P.
M1@![#DT >0]3 '@06@!V$&$ =1!H ',0<0!Q$7L <!&' &X1E !L$:( :Q*R
M &D2QP!H$^< 9A/] &44_P!E%/\ 91/_ &43_P#?'@  QB0  + D  "@(P
ME"$  (L?  "&&P  @Q<  ((2" !_$1( ?!(= 'D4* !V%#$ =!4Z '(600!Q
M%D@ ;Q=/ &X75@!L%UT :QAD &D8;0!H&7< 9AF# &09D !C&I\ 81JO & :
MQ !>&^0 71S[ %P<_P!<&_\ 7!O_ %P;_P#5)0  O2H  *@I  "8*0  C"@
M (,E  !](@  >1\  '@; P!V&0\ <AH8 &\<(P!M'2T :QTU &D>/0!H'D0
M9A]+ &4?4@!C(%D 8B!A &$@:0!?(7, 72%_ %PAC0!:(IP 62*L %<BP !6
M(^$ 52/Y %0C_P!4(O\ 5"+_ %0B_P#-*P  MBX  *(N  "2+@  A2T  'PK
M  !V*   <B8  &\C  !M(0P :B(5 &<C'P!E)"D 8R0Q &(E.0!@)D$ 7R9(
M %TF3P!<)U8 6R== %DG9@!8*'  5BA\ %0HB@!3*9D 42FJ % IO@!/*=X
M3BGW $TI_P!-*?\ 32C_ $XH_P#(,   L#(  )PR  ",,@  @#$  '8P  !P
M+0  :RL  &@I  !F* D 8R@1 & I' !>*B4 7"LN %LK-@!9+#T 6"Q$ %<M
M3 !5+5, 5"U; %,M8P!1+FX 4"YZ $XNB !,+Y< 2R^H $DONP!(+]L 2"_V
M $<O_P!'+O\ 1RW_ $@M_P#$-   JS4  )<U  "'-0  >S4  '(T  !K,@
M9B\  &(N  !?+04 7"X0 %HO& !8,"( 5C K %4Q,P!3,3H 4C)" %$R20!0
M,E  3C-8 $TS80!+,VL 2C-W $@TA0!'-)4 132F $,TN0!"--8 0C3T $(T
M_P!",_\ 0C+_ $(R_P# .   IS@  ),X  "#.   =S@  &TW  !F-@  83,
M %TR  !9,@( 5S,- %0T%0!2-1\ 434H $\V, !.-C@ 3#<_ $LW1@!*-TX
M23A6 $<X7P!&.&D 1#AU $,X@P!!.9, 0#FD #XYN  ].=, /#GS #PX_P ]
M-_\ /3?_ #TV_P"[.P  HCL  (\[  !_.P  <SL  &HZ  !B.0  73<  %@V
M  !4-P  43@+ $\Y$P!-.1P 2SHE $HZ+0!(.S4 1SL\ $8\1 !%/$L 1#Q3
M $(\7 !!/6< /SUS #X]@0 \/9$ .CVC #D]M@ X/=$ -SWR #<\_P X._\
M.#O_ #@Z_P"V/0  GCX  (L^  !\/@  ;SX  &8]  !>/0  6#L  %,Z  !/
M.P  3#P( $D]$0!'/AD 1C\B $0_*@!#/S( 0D Z $% 00! 0$D /D%1 #U!
M6@ \060 .D%P #A!?P W08\ -4*A #1"M  R0LX ,D'P #) _P S0/\ ,S__
M #0^_P"Q0   FD   (=   !X00  ;$$  &)   !;0   5#\  $X_  !*0
M1D$% $1"#@!"0Q8 0$,? #]$)P ^1"\ /$0W #M%/@ Z148 .45. #A&6  V
M1F( -49N #-&?  Q1HT ,$:? "Y&LP M1LP +4;O "U%_P N1/\ +D/_ "Y#
M_P"L0P  ED,  (-#  !T0P  :$,  %]#  !70P  4$,  $A#  !$10  048!
M #Y'#  \2!, .D@< #E))  X22P -DDT #5*.P T2D, ,TI, #)*50 P2U\
M+TMK "U+>@ L2XL *DN= "A+L0 G2\H )TOM "=*_P H2?\ *$C_ "E'_P"G
M1@  D48  ']&  !P1@  948  %M&  !41@  3$<  $1(   _2@  .TL  #=,
M"0 U31  ,TX8 #).(  Q3R@ ,$\P "]/.  N3T  +%!( "M04@ J4%P *%!H
M "=0=P E4(@ )%"; ")0KP A4,@ (%#K "%/_P B3O\ (DW_ "--_P"A20
MC$D  'I)  !L2@  84H  %A*  !02@  24L  $!,   [3@  -5   #%2!  M
M4PT +%04 "I4'  I520 *%4L "=5,P F53P )59% "163@ B5ED (59E !]6
M=  >5H4 '%:8 !M6K  95L4 &5;I !I5_P ;5/\ &U/_ !Q2_P";30  ADT
M '5-  !H30  74T  %1-  !-3@  14\  #Q1   V4P  ,54  "M8   F6@D
M(UL0 ");%P A7!\ (%PG !]<+@ =7#< '%U  !M=2@ :754 &%UA !==<  5
M78$ %%V5 !-=J@ 17<( $5WG !);_@ 36O\ $UK_ !19_P"440  @%$  '!1
M  !D40  65$  %%1  !)4@  05,  #A6   R60  *UL  "5>   ?80, &F,,
M !AD$0 79!D %F0A !5D*0 493$ $V4Z !)E1  195  $&5=  ]E:P .97T
M#661  QEI0 *9+P "F3@  MC^0 ,8O\ #6'_  UA_P"-50  >E4  &M5  !?
M50  5E4  $Y5  !$5P  /%D  #1<   L7P  )F(  !]E   9:   $VL% !!M
M#0 .;A( #6X:  QN(@ ,;BL "VXT  IN/@ (;DH !VY7  9N90 $;G8  FZ*
M  !MGP  ;;8  &S6  !L\P !:_\  FK_  -J_P"%6@  =%H  &9:  !<60
M4UD  $A:   _70  -F   "YC   F9P  'VH  !EM   3<0  #G0#  IW"@ %
M=Q   7<5  !W'   =R0  '@M  !X-P  >$,  'A0  !X7@  >&\  'B$  !X
MF0  =[   ';-  !U\   =?\  '3_  !T_P!^7P  ;E\  &)>  !97@  35\
M $)B   Y90  ,&@  "=L   ?<   &'0  !)W   ->P  "'X   * "   @0T
M ($1  ""%P  @QX  (,F  "$,   A#L  (1(  "$5P  A&@  (1\  "$DP
M@ZH  (+%  "!ZP  @?X  (#_  " _P!W90  :60  %]C  !29   1V<  #QK
M   Q;P  *',  "!W   8?   $7\   R#   &AP   (H   ", P  C D  (T.
M  ".$0  CQ<  ) >  "1)P  DC(  )(_  "23@  DE\  ))S  "2BP  D:(
M )&\  "0Y0  C_P  ([_  "._P!Q:P  9FH  %AK  !+;0  /W$  #1V   J
M>P  ((   !>%   0B0  "XT   21    E0   )@   "9    F@,  )L(  "<
M#0  GA$  )\6  "@'@  HB@  *(U  "C1   HU4  *-I  "B@   HIH  *&S
M  "@V   H/8  )__  "?_P!N<0  7W(  %%U  !$>0  -WX  "R$   AB@
M%X\  !"4   *F0   9T   "@    I    *<   "H    J0   *H   "L!@
MK0L  *\0  "P%0  LAX  +0I  "T.0  M$H  +5=  "U<P  M8X  +6H  "T
MQ@  L^T  ++_  "R_P!F>@  5WT  $F"   \AP  +XX  ".4   8F@  $)\
M  FD    J0   *T   "P    M    +<   "X    N0   +L   "\    O@(
M , (  #"#@  Q!0  ,<>  #(+   R3T  ,I0  #*9@  RG\  ,J;  #*N
MRMT  ,KU  #*_P!>A@  3XL  $&1   SF   )Y\  !NE   1JP  ";    "U
M    N0   +T   #!    Q@   ,@   #)    RP   ,P   #.    T    -(
M  #4!0  V0P  -T2  #A'@  XBX  .-"  #D5P  Y6\  .:,  #FJ   Y<4
M .7G  #F]@!6E   2)L  #JB   LJ0  '[   !.V   +O    ,$   #%
MR0   ,T   #2    U@   -H   #;    W@   .    #B    Y    .<   #I
M    [0   / *  #T$0  ^!\  /DR  #Z2   ^U\  /QZ  #]EP  _:\  /W'
M  #]Y #_  X _P - /\ # #_  X _P 3 /\ '@#_ "H _P V /\ 0@#_ $T
M_P!7 /\ 7P#_ &< _P!N /\ = #_ 'H _P"! /T AP#\ (T ^@"4 /D G #W
M *4 ]0"O /0 O #S ,\ \0#L /  _@#O /\ [P#_ ., _P#7 /\ S@#_ ,H
M_P#_  H _P & /\ ! #_  @ _P 0 /\ &0#_ "4 _P Q /\ /0#_ $< _@!1
M /L 60#Y &$ ]@!H /0 ;@#S '0 \0!Z .\ @0#N (< [ ". .H E@#H )\
MY@"I ., M0#B ,8 X #C -\ ^ #= /\ W0#_ -0 _P#) /\ P@#_ +X _P#_
M  , _P   /\   #_  $ _P - /\ % #] "  ^@ K /< -@#S $$ [P!+ .P
M5 #H %L Y@!B ., : #A &X WP!T -P >@#: ($ V "( -0 D #2 )@ SP"B
M ,T K@#+ +P R0#3 ,< \ #& /\ Q #_ ,0 _P"[ /\ M@#_ +, _P#_
M_P   /\   #_    ]P ( /  $ #K !H YP E .0 , #A #L W !% -4 30#1
M %4 S@!; ,L 8@#) &< QP!M ,4 <P## 'H P0"! +\ B0"] )( NP"< +D
MIP"W +4 M0#( +, Y@"R /L L0#_ +  _P"N /\ J@#_ *< _P#_    _P
M /X   #Q    Y0 " -P #0#3 !0 S0 ? ,H *@#' #0 Q  ^ ,  1P"\ $X
MN@!5 +< 6P"U &$ LP!G +( ;0"P ', K@!Z *P @@"J (L J "5 *< H "E
M *T HP"^ *$ VP"@ /0 GP#_ )X _P"? /\ G0#_ )L _P#_    _    .X
M  #@    T    ,4 " "^ !  N0 9 +4 (P"S "X L  W *T 0 "J $@ J !/
M *4 50"C %L H@!@ *  9@"? &P G0!S )L >P": (0 F ". )8 F@"5 *<
MDP"W )$ S "0 .P CP#_ (X _P". /\ C@#_ (\ _P#\    [P   -L   #)
M    O0   +4  @"N  P J0 3 *4 '0"B "< H  Q )T .@": $( F !) )8
M3P"4 %4 DP!; )$ 8 "0 &< C@!M (T =0"+ 'X B0") (@ E0"& *( A0"Q
M (, Q "! .0 @ #Y '\ _P"  /\ @ #_ (  _P#T @  X D  ,<(  "W!P
MK ,  *8   "@  < FP / )@ %P"5 "$ D@ J (\ ,P"- #P BP!# (D 20"'
M %  A@!5 (0 6P"# &$ @0!H (  < !^ 'D ? "$ 'L D !Y )T > "L '8
MO@!U -T <P#T ', _P!S /\ <P#_ ', _P#I#0  SQ   +D0  "I$   G@X
M )<+  "3!@  D  + (P $0") !H A@ D (, +@"! #8 ?P ^ 'T 1 !\ $L
M>@!1 'D 5P!W %T =@!D '0 ; !S 74 <0&  &\"C0!N IH ; .J &L#NP!I
M!-8 : ;Q &@'_P!G!_\ 9P?_ &<'_P#?%   PQ<  *X7  ">%@  DQ4  (L2
M  "&$   A P" (,&#0"  Q0 ? 4> 'D'* !W"#  =0@X ',)0 !R"48 < I,
M &\*4P!M"UD ; MA &H+:0!I#'( 9PQ^ &8,BP!D#9D 8@VI &$-NP!@#=@
M7@[S %T._P!=#O\ 70[_ %T._P#4'   N1T  *0>  "5'0  B1P  ($:  ![
M%P  >!,  '@0!@!W#0\ <PX8 ' .(@!N#RL ;! S &H0.P!I$$( 9Q%) &81
M3P!D$58 8Q)= &$29@!@$F\ 7A)[ %P3B !;$Y< 61.G %<4N@!6%-4 517S
M %05_P!4%?\ 5!7_ %04_P#*(@  L"(  )TC  "-(P  @2(  'DA  !S'@
M;QL  &X7  !M$PP :A04 &<5'@!E%B< 8Q8O &$7-P!@%SX 7AA% %T82P!<
M&5( 6AE: %D98@!7&FP 5AIW %0:A0!2&Y0 41ND $\;MP!.&]  31SQ $P<
M_P!,'/\ 31S_ $T;_P##)@  JB<  )8G  "'*   >R<  '(F  !L)   :"$
M &8>  !D&P@ 8AL1 %\<&@!='2, 6QXK %H>,P!8'SH 5Q]! %8@2 !4($\
M4R!7 %$A7P!0(6D 3B%T $TA@@!+(I$ 22*B $@BM !'(LT 1B/O $4C_P!%
M(O\ 1B+_ $8A_P"\*@  I"L  )$K  ""+   =BL  &TJ  !F*0  8B8  %\D
M  !=(@0 6R$. %@B%@!6(Q\ 5"0H %,D, !2)3< 4"4^ $\F10!.)DP 3"94
M $LG7 !))V8 2"=Q $8G?P!%*(\ 0RB@ $$HL@! *,L /RCM #\H_P _*/\
M0"?_ $ G_P"W+0  GRX  (PO  !]+P  <2\  &@N  !A+0  72L  %HH  !7
M)P  5"<, %(H$P!0*1P 3BDE $TJ+ !+*C0 2BL[ $DK0@!(+$D 1BQ1 $4L
M6@!$+&0 0BUO $ M?0 _+8T /2V> #PML  Z+<@ .BWK #HM_P Z+?\ .BS_
M #HL_P"R,   FS$  (@R  !Y,@  ;3(  &0R  !=,0  6"\  %4L  !1+
M3RT) $PM$0!*+AD 22\B $<O*@!&,#$ 13 X $,P/P!",4< 03%/ $ Q5P ^
M,6$ /3)M #LR>P Y,HL .#*< #8RKP U,L< -#+I #0R_P U,?\ -3'_ #4P
M_P"M,P  EC0  (0U  !U-0  :34  & U  !9-   5#,  % P  !,,0  23$&
M $<R#P!%,Q8 0S,? $(T)P! -"X /S4V #XU/0 ]-40 /#9, #HV50 Y-E\
M-S9K #8V>  T-XD ,C>: #$WK0 O-\4 +S?H "\V_@ P-?\ ,#7_ # T_P"I
M-@  DC8  ( W  !R.   9C@  %TW  !6-P  4#8  $LT  !'-0  1#8# $$W
M#0 _.!0 /C@< #PY)  [.2P .CDS #DZ.@ X.D( -CI* #4Z4P T.UT ,CMH
M # [=@ O.X< +3N9 "P[K  J.\, *3OF "HZ_0 J.O\ *SG_ "PX_P"D.
MCCD  'PZ  !N.@  8SH  %HZ  !3.@  33H  $8X  !".@  /SL  #P\"P Z
M/!$ .#T9 #<](0 V/BD -#XP #,^-P R/S\ ,3]' # _4  N/UH +4!F "M
M=  I0(0 *$"7 "9 J@ E0,$ )$#E "0__  E/O\ )CW_ "8]_P"?.P  BCP
M '@]  !J/0  7ST  %8]  !//0  23T  $(]   \/@  .3\  #9!"  T00\
M,D(6 #%"'@ O0R4 +D,M "U#-  L1#P *T1$ "I$30 H1%@ )T5C "5%<0 C
M18( (D65 "!%J  ?1;\ 'D3C !]$^P ?0_\ ($+_ "%!_P":/@  A3\  '1
M  !G0   7$   %-   !,0   1D   #Y!   X0P  -$4  #!& P M1PT *T@2
M "I(&@ I2"( *$DI "=),0 E23D )$E! "-*2@ B2E4 ($IA !]*;P =2G\
M&TJ2 !I*I@ 82KT %TK@ !A)^@ 92/\ &D?_ !I'_P"50@  @$(  '!#  !C
M0P  6$,  %!#  !)0P  0D0  #M%   U1P  ,$D  "M+   F30D )$X0 ").
M%@ A3QT ($\E !]/+  >3S4 '4\] !Q01P :4%$ &5!= !=0:P 64'P %%"/
M !-0I  14+H $5#> !%/^  23O\ $TW_ !1-_P"/10  >T8  &M&  !?1P
M54<  $U'  !&1P  /T<  #=*   Q3   *TX  "90   @4P, '%4, !I6$0 9
M5A@ %U8@ !96)P 55C  %%8Y !-70@ 25TT $5=9 !!7:  /5WD #E>,  U7
MH  +5[8 "U;4  M6]  ,5?\ #53_  Y3_P"(20  =DH  &=*  !;2@  44H
M $I*  !#2@  .TP  #-.   L40  )E0  "%6   ;60  %5P' !%>#0 07A,
M$%X:  Y>(@ .7BH #5XS  Q>/0 +7D@ "EY4  A>8@ '7G, !5Z&  ->FP "
M7K$  EW,  )=[@ #7/\ !%O_  5;_P"!3@  <$X  &).  !73@  3DX  $=.
M   ^3P  -E$  "Y4   G5P  (5H  !M=   58   $&,#  QF"P (9Q  !F<5
M  5G'  $9R0  F<M  %G-P  9T(  &=.  !G7   9VT  &>   !FE0  9JP
M &7'  !EZP  9/P  &3_  !C_P!Z4@  :E,  %U2  !44@  2U(  $)3   Y
M50  ,%@  "A;   A7P  &F(  !1E   0:   #&L!  9N"0  ;PX  &\2  !O
M&   <!\  ' G  !Q,   <3L  '%(  !Q5@  <68  '%Y  !QCP  <*<  &_!
M  !OYP  ;OP  &W_  !M_P!S6   95<  %I7  !15@  1E<  #Q:   R70
M*F$  ")D   ::   %&P   YO   *<@  !'8   !X!0  > L  'D.  !Z$P
M>QD  'P@  !]*0  ?3,  'U   !]3@  ?5X  'UR  !]B   ?*$  'RZ  ![
MX@  >OH  'G_  !X_P!M70  8%P  %=<  !+70  0%\  #5C   K9P  (VL
M !IO   3<P  #G<   A[   "?@   ((   "# 0  A 8  (4+  "&#P  B!,
M (D9  "*(0  BRL  (LW  ",1@  BU8  (MI  "+@   BYD  (JS  ")V
MB/<  (C_  "'_P!H8P  7F(  %%B  !$90  .&D  "YN   D<P  &G@  !-]
M   -@0  !H4   ")    C0   )    "2    D@   )0%  "5"@  EPX  )@2
M  ":&   FR$  )PM  "=/   G4P  )Q?  "<=@  FY$  )NK  ":R0  FO
M )G_  "8_P!E:0  5VD  $EL   ]<0  ,'8  "5\   ;@0  $H<   R,   $
MD0   )4   "9    G0   *    "A    H@   *0   "E 0  IP<  *D,  "J
M$0  K1@  *\B  "O,   KT$  *]4  "O:P  KH4  *ZA  "NO@  K>8  *S\
M  "L_P!><0  3W0  $)Y   U?P  *(4  !V,   3D@  #)@   .=    H@
M *8   "J    K@   +    "Q    LP   +0   "V    N    +H$  "\"@
MOA   ,$7  ##)   PS4  ,1)  #$7@  Q7<  ,63  #%KP  Q=$  ,/R  ##
M_P!6?   1X(  #J(   LCP  ()8  !2=   -HP   ZD   "N    L@   +<
M  "[    OP   ,(   #"    Q0   ,8   #(    R@   ,T   #/    T@@
M -4.  #;&   W2<  -XZ  #?4   X&@  ."$  #AH0  X;T  .'B  #@] !.
MBP  0)(  #*9   EH0  &*@   ZO   %M0   +H   "_    Q    ,@   #.
M    T0   -0   #5    V    -H   #=    WP   .(   #D    YP   .L%
M  #O#@  ]!D  /4K  #V00  ]U@  /AR  #YD   ^:L  /C$  #XX0#_  L
M_P ( /\ "0#_  P _P 2 /\ &@#_ "8 _P R /\ /@#_ $@ _P!2 /\ 6@#_
M &( _P!I /\ ;P#_ '4 _@![ /P @0#[ (@ ^0"/ /< EP#U *  \P"J /(
MMP#O ,D [0#F .P ^P#K /\ ZP#_ -T _P#. /\ Q@#_ ,( _P#_  0 _P
M /\   #_  4 _P - /\ %0#_ "$ _P L /\ . #_ $, _0!, /D 5 #W %P
M] !C /( :0#P &\ [@!U .P >P#J (( Z ") .< D0#D )H X@"D .  L #=
M ,  V@#< -@ ] #5 /\ TP#_ ,L _P#! /\ NP#_ +< _P#_    _P   /\
M  #_    _P * /T $0#Y !L ]@ G /0 ,@#P #P [ !& .@ 3@#D %8 X0!<
M -X 8P#< &@ V0!N -4 = #2 'L T "" ,T B@#+ ), R "= ,8 J #$ +<
MP0#, ,  ZP"^ /\ O0#_ +T _P"T /\ K@#_ *L _P#_    _P   /\   #Z
M    \@ % .H #@#E !8 X  A -T *P#; #8 TP _ ,X 2 #* $\ QP!6 ,0
M7 #" &$ P !G +X ;0"\ ', N@!Z +@ @@"V (L M "6 +( H0"P *\ K@#!
M *T X "K /< J@#_ *D _P"F /\ H0#_ )\ _P#_    _P   /<   #H
MW    -  "@#* !$ Q0 ; ,( )0"_ "\ O  X +@ 00"U $@ L@!/ +  50"N
M %L K !A *H 9@"H &P IP!S *4 >P"C (0 H0". )\ F@"= *< FP"X )H
MT "9 .\ F #_ )< _P"6 /\ E #_ )( _P#_    ]@   .0   #2    Q0
M +L !0"U  X L  5 *P 'P"J "D J  R *4 .@"B $( H !) )X 3P"< %4
MF@!: )@ 8 "6 &8 E0!L ), = "2 'T D "' (X DP", *$ BP"P (H Q0"(
M .8 AP#[ (8 _P"' /\ AP#_ (8 _P#X    Y0   ,T   "]    LP   *H
M  "C  H GP 1 )L &0"9 ", EP L )4 - "2 #P D !# (X 20", $\ B@!4
M (D 6@"' &  A@!F (0 ;@"# '< @0"! '\ C0!^ )L ? "J 'L O !Z -L
M> #U '@ _P!X /\ > #_ '@ _P#M    T0(  +L"  "L 0  H@   )L   "6
M  4 D0 - (T % "+ !T B  F (8 +@"$ #8 @@ ] (  0P!^ $D ?0!/ 'P
M50!Z %L >0!A '< :0!U '$ = !\ '( B !Q )8 ;P"E &X M@!M ,X ; #N
M &L _P!K /\ :P#_ &L _P#?"P  P@P  *X,  ">#   DPL  (P'  "( @
MA0 ) ($ $ !_ !< ?  @ 'H * !X #  =@ X '0 /@!S $0 <0!* '  4 !N
M %8 ;0!= &P 9 !J &T : !W &< A !E )( 9 "A &, L@!A ,D 8 #I &
M_ !@ /\ 8 #_ &  _P#0$   MA$  *(2  "3$@  B!$  ( /  !\#0  >0D!
M '@#"P!U !$ <P : '  (P!N 2L ; $S &H".0!I T  9P-& &8$3 !E!%(
M8P59 &(%80!@!6H 7P9T %T&@0!<!X\ 6@>? %D'L !7!\8 5@GG %8*^P!5
M"O\ 50K_ %8*_P#&%0  K1<  )D8  "*&   ?Q<  '86  !Q$P  ;A   &T-
M!0!M"0T :@D4 &<*'0!E"B8 8PLN &(,-0!@##P 7PQ" %X-2 !<#4\ 6PU6
M %D-7@!8#F@ 5@YS %4.@ !3#H\ 40Z? % .L0!.#L@ 31#J $T0_0!-$/\
M31#_ $T0_P"\&P  I1P  )(=  "#'@  =QT  &\<  !I&@  9A<  &04  !D
M$ @ 8@\0 %\0& !=$"$ 6Q$I %H1,0!8$C@ 5Q(^ %8210!4$DP 4Q-3 %$3
M6P!0$V4 3A1P $P4?0!+%(P 212< $<5K@!&%<4 117H $46_@!%%O\ 117_
M $45_P"U'P  GB$  (LB  !\(@  <2(  &@A  !B'P  7QT  %P:  !;%P(
M6A4- %<6% !5%AT 5!<E %(8+0!1&#0 3Q@[ $X90@!-&4@ 2QI0 $H:6 !(
M&F( 1QIM $4;>@!#&XD 0AN: $ ;K  _&\( /ASE #T<_  ^'/\ /AO_ #X;
M_P"O(P  F"0  (8E  !W)@  ;"8  &,E  !=)   62(  %8?  !4'0  4QP+
M %$<$@!.'1H 31TB $L>*0!*'C$ 21\W $<?/@!&($4 12!- $,@50!"(%\
M0"%J #\A=P ](8< .R&8 #DAJ@ X(L  -R+C #<B^P W(O\ ."'_ #@A_P"J
M)@  E"<  ($I  !S*0  9RD  %\I  !8*   5"8  %$C  !/(@  3"(' $HB
M$ !((A< 1R,? $4D)@!$)"X 0B0T $$E.P! )4, /R5* #TF4P \)EP .B9G
M #DF=0 W)X0 -2>6 #0GJ  R)[X ,2?A #$G^0 R)O\ ,B;_ #,E_P"E*0
MCRH  'TL  !O+   9"T  %LL  !5*P  4"H  $PH  !*)@  1R<$ $0G#0!"
M*!0 02@< #\I(P ^*2L /2DR #PJ.0 [*D  .2I( #@K4  V*UH -2ME #,K
M<@ Q*X( ,"R4 "XLIP L++P *RS> "PL^  L*_\ +2K_ "TJ_P"A+   BRT
M 'DN  !K+P  8"\  %@O  !1+@  3"X  $@L  !%*P  02L  #\L"P ]+!$
M.RT9 #HN(0 Y+B@ -RXO #8O-@ U+SX -"]% #,O3@ Q,%@ ,#!C "XP<  L
M,(  *C"2 "DPI0 G,+H )C#< "8P]P G+_\ *"__ "@N_P"<+@  AS   '8Q
M  !H,@  73(  %4R  !.,0  2#$  $0P  ! +P  /#   #HQ"0 W,1  -C(6
M #4R'@ S,R4 ,C,L #$S,P P-#L +S1# "TT3  L-%8 *C5A "DU;@ G-7X
M)360 ",UHP B-;D (379 "$T]@ B-/\ (S/_ ",R_P"8,0  @S,  '(T  !E
M-   6C4  %$U  !+-   130  $ T   Z,P  -S0  #0U!@ R-@X ,#<3 "\W
M&P N-R( +3@I "LX,0 J.#@ *3E  "@Y20 F.5, )3E? ",Y;  A.GP (#J.
M !XZH@ <.K< &SG5 !PY]0 =./\ '3C_ !XW_P"3-   ?S8  &XW  !A-P
M5S<  $XW  !(-P  0C<  #PW   U.   ,CD  "\Z @ L.PL *CP1 "D\&  H
M/1\ )CTF "4]+@ D/34 (SX] "(^1@ @/E  'SY< !T_:0 ;/WD &C^, !@_
MH  6/[4 %3[2 !8^\P 7/?\ &#S_ !@\_P".-P  >C@  &HY  !>.@  4SH
M $LZ  !%.@  /SH  #DZ   R/   +CX  "E    F00@ )$(. ")"%  A0AL
M($,C !]#*@ >0S( '$,Z !M$0P :1$T &$19 !=$9P 51'< $T2* !)$G@ 1
M1+, $$30 !!#\@ 10O\ $D+_ !-!_P").P  =CP  &8]  !:/0  4#T  $@]
M  !"/0  /#T  #8^   O0   *D(  "5$   A1@, '4@, !M)$0 921< &$D>
M !=))@ 622X %4HV !1*0  32DH $4I6 !!*9  /2G0 #DJ'  U*FP ,2K
M"DK*  M)[  ,2/\ #4?_  U'_P"#/@  <3\  &)   !60   34   $5    _
M0   .4$  #)"   K10  )D<  "%)   <2P  %DX' !-0#@ 24!, $5 9 !!0
M(0 /4"D #E Q  U0.P -448 "U%1  I17P )46\ !U"!  50E@ #4*L  E#%
M  -/Z  #3_L !4[_  9-_P!]0@  :T,  %U$  !21   2D0  $-#   \1
M-44  "Y'   G2@  (4P  !Q/   740  $E0#  Y7"@ +6!  "E@5  A8'  '
M6"0 !E@L  58-@ #6$   5A,  !86@  6&D  %A\  !8D0  5Z<  %?   !6
MY0  5OD  %7_  !5_P!V1P  9D<  %E(  !/1P  1T<  $!'   X2   ,$H
M "E-   B4   '%,  !95   16   #5L"  E>"0 $7PX  %\2  !?&   8!\
M & G  !@,   8#L  &!'  !@5   8&,  &!V  !@BP  7Z(  %^[  !?X@
M7OD  %W_  !=_P!O2P  84P  %5,  !,2P  1$L  #M,   R3@  *U$  "-4
M   <5P  %EL  !%>   -8   "&,   )F!P  9PP  &</  !H$P  :1D  &HA
M  !J*0  :C0  &I   !J30  :ET  &IO  !JA0  :IT  &FV  !HW0  :/<
M &?_  !F_P!I40  7%   %)0  !*3P  /U   #53   M5@  )%D  !U=   6
M8   $&0   QG   &:@   &X   !O P  < @  '$-  !R$   =!0  '4;  !V
M(P  =RP  '<X  !V1@  =E8  '9H  !V?@  =I<  '6Q  !TTP  <_4  '/_
M  !R_P!C5@  6%4  %!4  !$50  .5@  "];   F7P  '6,  !5G   0;
M"G    1S    =@   'H   !\    ? ,  'X(  !_#   @1   ((4  "$&P
MA20  (8O  "&/0  ADT  (5?  "%=0  A8\  (2I  "#R0  @O$  ('_  "
M_P!?6P  5EH  $E;   ]7@  ,F$  "=F   >:P  %7    YU   )>0   7X
M  "!    A0   (@   "*    BP   (T!  ".!@  D L  )$/  "3%   E1L
M )<F  "7-   ET0  )=6  "6;   E88  )6B  "4P0  D^H  )+_  "2_P!=
M80  3V$  $)D   V:0  *FX  !]T   5>0  #G\   >$    B0   (X   "2
M    E@   )@   ":    FP   )T   "?    H0,  *,(  "E#0  IQ,  *D<
M  "J*   JCD  *I+  "J80  J7H  *B9  "HM0  I]T  *?X  "F_P!6:
M2&P  #IP   N=@  (GT  !>$   .B@  !Y    "6    F@   )\   "C
MIP   *H   "K    K0   *\   "Q    LP   +4   "X!0  N@P  +T2  #
M'   P"T  ,!   "_50  OVX  +Z+  "^J   OLD  +WO  "\_@!.=   0'D
M #)_   EAP  &8X  !"5   'G    *(   "G    K    +    "U    N0
M +P   "]    OP   ,$   ##    Q@   ,@   #*    S0(  - +  #5$@
MUB$  -<T  #820  V6   -I\  #:F@  V[4  -O9  #;\@!&@@  .(D  "N0
M   =F   $J    JG    K@   +0   "Y    O@   ,(   #(    RP   ,X
M  #/    T@   -0   #6    V@   -T   #?    X@   .8   #J"@  [Q,
M / E  #R.@  \U$  /1K  #TB0  ]:4  /6_  #UW0#_  8 _P # /\ !0#_
M  L _P 0 /\ %P#_ "( _P M /\ .0#_ $0 _P!- /\ 50#_ %T _P!D /\
M:@#_ '  _0!V /L ? #Y (, ]P"* /4 D@#S )L \ "F .X LP#K ,0 Z0#D
M .< ^0#F /\ Y0#_ -, _P#' /\ OP#_ +L _P#_    _P   /\   #_  (
M_P + /\ $@#_ !T _P H /\ ,P#_ #X _ !' /@ 3P#T %< \0!= .X 8P#L
M &D Z@!O .@ =0#F 'P Y "# .( BP#? )4 W "? -D JP#5 +L T@#4 ,\
M\@#- /\ S #_ ,4 _P"Z /\ M #_ +  _P#_    _P   /\   #_    _P &
M /D #P#U !< \P B /$ +0#M #< YP!  .( 20#? %  VP!7 -< 70#4 &,
MT0!H ,\ ;@#, '4 R@!\ ,@ A #% (T P@"8 ,  I "] +( NP#& +D Z "X
M /T MP#_ +8 _P"M /\ IP#_ *, _P#_    _P   /\   #U    ZP ! .0
M# #> !, V0 < -, )@#1 #  S  Z ,@ 0@#$ $H P !0 +T 5@"[ %P N0!A
M +< 9P"U &T LP!T +$ ? "O (4 K0"0 *H G "H *H I@"[ *4 V@"C /4
MHP#_ *( _P"> /\ F@#_ )< _P#_    _@   .\   #?    T    ,< !P#!
M  \ O  7 +D ( "W "H M0 S +  .P"M $, JP!) *@ 3P"F %4 I !: *,
M8 "A &8 GP!M )T = "< 'T F@"( )@ E "6 *( E "R )( R0"1 .L D0#_
M )  _P"0 /\ C #_ (H _P#\    [    -D   #'    N@   +$  @"K  P
MIP 2 *0 &P"A "0 H  L )X -0"; #P F !# )8 20"4 $\ D@!4 )  6@"/
M %\ C0!F (L ;0") '8 B "  (8 C "$ )H @@"J ($ O@"  .  @ #Y '\
M_P!_ /\ ?P#_ 'X _P#Q    V    ,(   "S    J    *    "9  < E0 .
M )( %0"0 !X C@ F (T +@"* #8 AP ] (4 0P"$ $D @@!. ($ 5 !_ %D
M?@!@ 'P 9P!Z &\ >0!Z '< A@!U )0 = "C '( M0!R ,\ <0#Q '  _P!P
M /\ < #_ '$ _P#A    Q    +    "B    EP   )$   "+  ( A@ + (,
M$0"! !@ ?P A 'T *0!\ #  >0 W '@ /0!V $, = !) ', 3@!R %0 < !:
M &\ 8@!M &H :P!T &H @ !H (X 9P"= &4 KP!E ,8 9 #H &0 _0!C /\
M8P#_ &0 _P#/!0  M@<  *,(  "4"   B0<  ((#  !^    >P & '< #@!U
M !, <@ ; '$ (P!O "L ;0 R &P . !J #X :0!$ &< 20!F $\ 90!6 &,
M70!B &4 8 !O %\ >P!= (D 7 "9 %L J@!9 +\ 60#A %@ ^ !8 /\ 6 #_
M %D _P#"#   J@T  )<.  ")#@  ?0X  '8-  !Q"@  ;P8  &T "@!K !
M:0 6 &< '@!E "8 8P M &$ ,P!@ #D 7P _ %T 10!< $L 6P!2 %H 60!8
M &( 5P!L %4 > !3 (8 4@"6 %$ IP!0 +L 3P'; $X"] !. _\ 3@3_ $X#
M_P"X$   H1(  (X3  !_$P  =!,  &P2  !G$   90X  &,+ P!C!@P 8001
M %X#&0!<!"$ 6P4H %D&+P!8!C4 5@<[ %4'0@!4!T@ 4PA/ %$(5@!0"5\
M3@EI $T)=@!+"H0 20J4 $@*I@!'"KH 1@K8 $4+\P!%#/\ 10S_ $4,_P"P
M%   F18  (<8  !X&0  ;1@  &47  !?%@  7!,  %H1  !:#@8 6@P- %<,
M% !5#!P 4PTD %(-*P!0#3$ 3PXX $X./@!-#D4 2PY- $H.50!(#UX 1P]H
M $4/=0!#$(0 01"5 $ 0I@ ^$+L /1#< #T1]@ ]$?\ /1#_ #X0_P"I&0
MDAL  ($<  !R'0  9QT  %\<  !9&P  51D  %,6  !2$P  4A$* % 0$ !.
M$1@ 3!$@ $H2)P!)$BX 2!,T $<3.P!%$T( 1!-) $,44@!!%%L /Q1E #X5
M<@ \%8$ .A62 #@5I  W%;D -178 #46]0 V%O\ -A;_ #<5_P"C'   C1X
M 'L@  !M(0  8B$  %HA  !4'P  4!X  $T;  !,&0  2Q8& $D6#@!'%Q4
M11<< $08) !"&"H 01@Q $ 9.  _&3\ /1E& #P:3P Z&E@ .1IC #<;;P U
M&WX ,QN0 #(;H@ P&[< +QO3 "\<\P O&_\ ,!O_ # ;_P"='P  B"(  '<C
M  !I)   7B0  %8D  !0(P  2R(  $@@  !&'0  11P" $,<# !!'!( /QT9
M #X=(0 \'B< .QXN #H?-0 Y'SP -Q]$ #8?3  T(%8 ,R!@ #$@;0 O('P
M+2&. "PAH  J(;4 *2'0 "DA\@ I(?\ *B#_ "L@_P"9(@  A"4  ',F  !E
M)P  6R<  %,G  !,)@  1R4  $0D  !"(0  /R$  #TA"0 [(1  .2(6 #@B
M'@ V(R4 -2,K #0D,@ S)#D ,B1! # D2@ O)5, +25> "LE:P J)7H *"6,
M "8EGP D);, (R7. ",E\  D)?\ )23_ "4D_P"4)0  @"<  &\I  !B*@
M5RH  $\J  !)*0  1"@  $ G   ])@  .B4  #<F!@ U)@X -"<4 #(G&P Q
M*"( ,"@I "\H,  M*3< +"D_ "LI1P I*5$ *"I< "8J:0 D*G@ (RJ* "$J
MG0 ?*K( 'BK, !XJ[P ?*?\ ("G_ "$H_P"0*   ?"H  &PK  !?+   5"P
M $PL  !&+   02L  #PK   X*@  -2H  #(K P P*PP +BP1 "TL&  L+!\
M*BTF "DM+0 H+30 )RX\ "8N10 D+D\ (RY: "$O9P ?+W8 '2^( !POFP :
M+[  &"_* !@N[0 9+O\ &RW_ !LM_P",*P  >"T  &@N  !;+P  42\  $DO
M  !#+P  /BX  #DN   T+@  ,"X  "TO   K, H *3$0 "<Q%0 F,1P )3(C
M "0R*@ C,C$ (3,Y " S0@ ?,TP '3-7 !LS9  :-'0 &#2& !8TF@ 4,ZX
M$S/( !,S[  4,_\ %3+_ !8Q_P"'+@  ="\  &4Q  !8,0  3C(  $8R  !
M,0  .S$  #8Q   Q,0  *S,  "@T   E-08 (S8- "$V$@ @-QD 'S<@ !XW
M)P =."X &S@V !HX/P 9.$D %SE5 !4Y8@ 4.7$ $CF$ !$YF  0.:T #CC'
M  XXZP 0./\ $#?_ !$V_P"#,0  <#(  &$T  !5-   2S0  $0T   ]-
M.#0  #,T   M-0  *#<  "0Y   @.@( '3L+ !L\$  9/14 &#T< !<](P 6
M/2L %3XS !0^/  2/D8 $3Y2 ! ^7P //F\ #CZ!  P^E0 +/JD "C[!  H]
MY  +/?L ##S_  T[_P!]-   :S8  %TW  !1-P  2#<  $$W   [-P  -3<
M # W   J.0  )3L  " ]   </P  %T$& !1##0 20Q( $4,8 !%#'P 01"<
M#T0O  Y$.0 -1$, #$1.  M$6P )1&H !T1\  9$D  $0Z4  D.]  -#X  #
M0_8 !$+_  9!_P!X.   9SD  %DZ  !..@  13H  #XZ   X.@  ,SH  "T[
M   G/0  (4   !Q"   71   $T8#  ])"@ -2@\ #$H4  M*&P )2B, "$HK
M  =*-  %2CX !$I)  )*5@  2F4  $IW  !*BP  2J$  $FY  !)W0  2?4
M $C_  !(_P!R/   8CT  %4^  !*/@  0CT  #P]   V/0  +SX  "E    C
M0@  '44  !='   32@  #TP"  M/"0 '4 T  U$1  !1%P  41X  %$F  !1
M+P  43D  %%$  !240  4F   %%R  !1AP  49T  %&U  !0V   4/4  $__
M  !/_P!L0   74$  %%!  !'00  0$   #E    R00  *D,  "1&   >2
M%TL  !).   .40  "U,!  96!P  5PP  %@0  !8$P  61D  %HA  !:*0
M6C,  %H_  !:3   6EH  %IL  !:@0  69D  %FQ  !8T0  6/0  %?_  !7
M_P!E10  6$4  $U%  !%1   /D0  #5%   M1P  )4H  !Y-   84   $E,
M  Y6   *60  !%P   !>!   7PD  & -  !A$   8A4  &,;  !D(P  9"T
M &0X  !D10  9%0  &1F  !D>P  8Y,  &.M  !BS   8?(  &'_  !@_P!?
M2@  4TH  $I)  !#2   .4D  "],   G3P  'U(  !A5   260  #5T   A@
M   "8P   &8   !H 0  :04  &H*  !K#0  ;1$  &X6  !P'0  <28  '$Q
M  !P/@  <$X  '!?  !P<P  ;XT  &^G  !NQ@  ;>\  &S_  !L_P!:3P
M4$X  $A-   ]3@  ,U$  "E4   @6   &%P  !%@   ,9   !F@   !K
M;P   '(   !T    =0   '<$  !X"0  >@T  'P0  !]%@  ?QX  ( H  "
M-0  @$4  ']6  !_:P  ?X0  'Z@  !]O@  ?.D  'O_  !Z_P!65   3E,
M $)4   W5@  +%H  ")?   88P  $6@   MM   #<@   '8   !Z    ?0
M (    "#    A    (8   "' @  B0<  (L,  "-$   D!8  )(?  "2+
MDCL  ))-  "18@  D7H  (^7  "/M   CN$  (S[  ",_P!560  2%H  #M=
M   O80  )&8  !EL   1<@  "G<   )]    @@   (8   "+    C@   )$
M  "3    E0   )<   "9    FP   )T$  "?"@  H@\  *06  "F(0  IC$
M *9#  "E5P  I'   *..  "CJP  H=   *#U  "?_P!.80  0&0  #-I   G
M;@  &W4  !%\   +@P   (D   ".    DP   )@   "=    H0   *0   "E
M    IP   *D   "K    K0   +    "R    M0@  +@.  "\%@  O"4  +PW
M  "[3   NF0  +F!  "WH@  M\   +?J  "W_ !&:P  .7   "MW   ??P
M$X8   N.   !E0   )L   "A    I@   *L   "P    LP   +<   "W
MN@   +P   "_    P0   ,0   #'    R@   ,T%  #1#@  U!D  -0K  #4
M0   TU@  --T  #3D@  TK   -+3  #2\@ ^>0  ,8   ".(   7D0  #9D
M  .@    IP   *X   "S    N    +T   #"    Q@   ,H   #*    S0
M ,\   #2    U0   -D   #=    WP   .,   #G!0  ZP\  .P?  #M,P
M[DL  .]D  #O@@  \)\  /&Y  #QV #_    _P   /\ ! #_  D _P . /\
M%0#_ !X _P I /\ - #_ #\ _P!( /\ 4 #_ %@ _P!> /\ 90#] &L ^P!Q
M /D =P#X 'X ]@"% /, C0#Q )< [@"B .L KP#H ,  Y@#@ ., ^ #B /\
MVP#_ ,L _P#! /\ N0#_ +0 _P#_    _P   /\   #_    _P ) /\ $ #_
M !D _P C /\ +@#] #D ^0!" /4 2@#R %( [@!8 .L 7@#I &0 Y@!J .0
M< #B '8 WP!] -T A@#9 (\ U0": -$ IP#. +8 RP#. ,D \ #' /\ Q0#_
M +L _P"T /\ K0#_ *D _P#_    _P   /\   #_    ^P " /8 #0#Q !,
M[0 > .P * #I #( XP [ -T 1 #8 $L TP!1 -  6 #- %T RP!C ,D : #&
M &\ Q !V ,( ?@"_ (< O "2 +H GP"W *T M0#! +( Y "Q /T KP#_ *P
M_P"E /\ H #_ )P _P#_    _P   /L   #N    Y    -P " #3 !  SP 8
M ,L (@#) "L Q@ T ,$ /0"] $0 N@!+ +< 40"U %8 L@!< +  80"N &<
MK !N *H =@"H '\ I@"* *, E@"A *4 GP"V )T T0"< /, FP#_ )P _P"6
M /\ DP#_ )  _P#_    ]@   .<   #3    Q@   +T  P"X  T LP 3 +$
M' "O "4 K@ N *D -@"F #T HP!$ *$ 2@"? $\ G0!5 )L 6@": &  F !F
M )8 ;@"4 '< D@"! )  C@". )P C "M (H PP") .@ B #_ (D _P"' /\
MA0#_ (( _P#S    XP   ,P   "\    L    *<   "A  @ G@ / )L %@"9
M !\ F  G )8 +P"3 #< D0 ] (X 0P", $D BP!. (D 5 "' %D A0!@ (0
M9P"" &\ @ !Z 'X A@!\ )0 >@"D 'D N !X -@ =P#W '@ _P!X /\ =P#_
M '4 _P#F    RP   +<   "H    G@   )8   "/  0 BP , (@ $@"' !D
MA0 A (0 *0"" #  ?P W 'T /0!\ $, >@!( 'D 30!W %, =@!9 '0 80!R
M &D <0!S &\ ?P!M (T ; "= &H KP!I ,@ : #M &D _P!I /\ :0#_ &D
M_P#2    N    *4   "7    C0   (8   "!    ?  ( 'D #@!W !0 =@ <
M '0 (P!S "L <0 Q &\ -P!N #T ; !# &L 2 !J $X : !4 &< 6P!E &,
M8P!M &( > !@ (< 7P"6 %T J != +X 7 #D %P ^P!< /\ 7 #_ %P _P#"
M    J@$  )@#  ")!   ?P(  '@   !T    <  $ &T # !K !$ :0 7 &@
M'@!F "4 90 L &, ,@!B #@ 8  ] %\ 0P!> $D 7 !/ %L 5@!: %X 6 !H
M %< <P!5 ($ 5 "1 %( HP!1 +< 40#6 %$ ]0!1 /\ 40#_ %( _P"V!P
MGPD  (T+  !^#   <PL  &P*  !H!P  90,  &, !P!A  T 7P 3 %T &@!<
M "$ 6P G %D +0!8 #, 5@ Y %4 /P!4 $4 4P!+ %$ 4@!0 %H 3P!D $T
M;P!, 'T 2@"- $D GP!( +( 1P#, $< [P!& /\ 1P#_ $< _P"L#   E0X
M (,0  !U$   :Q   &,/  !>#@  6PP  %H) @!9! H 5P / %4 %0!3 !P
M4@ C %$ *0!/ "\ 3@ U $T!.P!, 4$ 2@)( $D"3P!( E< 1@-A $4#;0!#
M WH 0@.+ $ #G  _ Z\ /@/( #T$Z@ ]!?P /0;_ #X&_P"D$   CA(  'P3
M  !N%   9!0  %P3  !6$@  4Q$  %$.  !0# 4 4 D, $\'$0!-!Q< 2P@?
M $D()0!("2L 1PDQ $8). !$"CX 0PI% $(*30! "U4 /PM? #T+:P \"WD
M.@R* #@,G  W#*\ -0S' #4,Z0 U#?T -0W_ #8,_P"=$P  AQ4  '87  !I
M&   7A@  %88  !0%P  314  $H3  !)$0  20X' $@-#@!&#1, 1 T: $,.
M(0!"#B@ 0 XN #\.-0 ^#SP /0]# #L02P Z$%0 .!!> #80:P T$'D ,A"*
M #$0G  O$+  +1#) "T1[  M$?\ +A'_ "\0_P"7%@  @AD  '$;  !D'
M61P  %$<  !,&P  1QH  $08  !#%0  0A," $$2"P! $1  /A(7 #P2'@ [
M$R4 .A,K #@3,@ W$SD -A1  #042  S%%$ ,11< # 5:  N%7< +!6( "H5
MF@ H%:X )Q7' "85Z@ G%?\ *!7_ "D5_P"1&@  ?1P  &T>  !@'P  5A\
M $X?  !('@  0QT  $ <   ^&@  /1@  #L7!P Y%@X .!<4 #87&P U&"(
M,Q@H #(8+P Q&38 ,!D] "X91@ M&D\ *QI9 "H:9@ H&G0 )AJ& "0:F0 B
M&JT (1K% " :Z  A&OX (AK_ ",:_P"-'0  >1\  &DA  !<(@  4B(  $HB
M  !$(0  /R$  #P@   Y'@  .!L  #4<!  T' T ,AP2 # =&  O'1\ +ATE
M "T>+  K'C, *AX[ "D?0P G'TT )A]7 "0?9  B'W( (!^$ !\?EP ='ZL
M&Q_# !L?YP ;'_T '1__ !X>_P")(   =2(  &4C  !9)   3R4  $<E  !!
M)   /",  #@C   U(@  ,R   # @ 0 N(0H +"$0 "LA%0 J(AP *"(C "<B
M*0 F(S  )2,X ",C00 B)$H (215 !\D80 =)'  &R2" !DDE0 7)*H %B3!
M !4DY0 6)/P %R/_ !DC_P"%(@  <20  &(F  !6)P  3"<  $0G   ^)P
M.28  #4F   Q)0  +B0  "LE   I)0< )R8. "4F$P D)QD (R<@ "(G)P A
M*"X ("@V !XH/@ =*$@ &RE3 !DI7P 8*6X %BF  !0IE  2*:@ $2G  !$H
MY  1*/L $RC_ !0G_P" )0  ;B<  %\H  !3*0  22H  $(I   [*0  -BD
M #(H   N*   *B@  "8I   D*@0 (BL, " K$0 ?+!8 '2P= !PL)  ;+2L
M&BTS !@M/  7+44 %BY0 !0N70 2+FP $2Y^ ! ND@ .+J< #2V]  TMWP -
M+?D #BS_ ! L_P!\*   :BH  %LK  !0+   1BP  #\L   Y+   -"L  "\K
M   K*P  )BP  "(N   ?+P  '# ) !HQ#@ 9,1, %S$: !8R(0 5,B@ %#(P
M !,R.0 2,T, $3-. ! S6P .,VD #3-Z  PSC@ *,Z( "#*Y  @RV0 (,O0
M"C'_  LQ_P!W*P  9BT  %@N  !-+P  0R\  #PN   V+@  ,2X  "TN   I
M+@  (S   !\R   ;,P  %S4% !0V#  2-Q$ $3<6 !$W'0 0."0 #S@L  XX
M-0 -.#\ ##A*  LX5P ).&4 !SAV  4XB@ #.)\  3>U  $WTP "-_$  S;_
M  4V_P!S+@  8C   %0Q  !),0  03$  #DQ   T,0  +S   "LP   E,@
M(#,  !LV   7.   $SH" ! \"0 -/0X ##T3  L]&0 */2$ "3TI  @],0 &
M/CL !3Y&  ,^4@ !/F$  #YR   ^A@  /9P  #VR   ]T   //   #S_   \
M_P!M,@  73,  % T  !&-   /C0  #<T   R,P  +3,  "<T   B-@  '3@
M !@Z   4/0  $#\"  U!"  )0PT !D01  -$%@ "1!T  $0D  !$+0  1#8
M $1!  !$3@  1%P  $1M  !$@0  1)@  $.O  !#S0  0O   $+_  !"_P!H
M-@  6#<  $PX  !#.   .S<  #4V   P-@  *3<  ",Y   >.P  &#T  !-
M   00@  #44!  A'!P #20P  $D/  !*$P  2QD  $L@  !+*   2S(  $L]
M  !,20  3%<  $MH  !+?0  2Y0  $JL  !*R@  2>\  $G_  !)_P!B.@
M5#L  $D[  ! .P  .3H  #,Y   L.@  )3P  !\_   900  $T0  !!'   ,
M20  "$P   )/!0  4 H  % -  !1$   4A4  %0;  !4(P  5"P  %0W  !4
M1   5%(  %1C  !4=P  5(\  %.H  !2Q@  4NT  %'_  !1_P!</P  3S\
M $4_   ^/@  -ST  "\^   G0   ($,  !E&   320  #TP   M/   &4@
M %0   !7 @  6 <  %D+  !:#@  6Q$  %T6  !>'0  7R8  %\Q  !>/0
M7DP  %Y=  !><0  78D  %VC  !<P0  6^L  %K_  !:_P!61   2T,  $-"
M   \00  ,D(  "E%   A2   &DL  !-.   .4@  "E4   -9    6P   %X
M  !@    8@(  &,&  !E"@  9@X  &@1  !J%P  :Q\  &LI  !K-@  :T4
M &M6  !J:@  :H(  &F=  !HNP  9^<  &;_  !E_P!12   2$@  $%&   W
M1P  +$H  "--   ;40  $U4   Y9   (70   6$   !D    9P   &H   !L
M    ;@   '    !R!0  <PD  '4-  !W$0  >A@  'LA  ![+@  >CT  'I.
M  !Y8@  >7D  'B6  !WLP  =>   '3\  !S_P!.30  1TP  #M-   P3P
M)E,  !Q8   37   #6$   9F    :@   &\   !R    =@   'D   !\
M?0   '\   "!    @P(  (8'  "(#   BQ$  (X8  ".)   CC,  (U$  ",
M6   BV\  (J,  ")J@  B,\  (;W  "%_P!-40  05,  #15   I6@  'E\
M !1E   -:@  !7    !V    >P   '\   "#    AP   (H   "-    C@
M )$   "3    E0   )@   ":!0  G0P  * 1  "C&@  HR@  *(Z  "A3@
MH&4  *"!  ">H   G<$  )ON  ":_P!&60  .5P  "UA   A9P  %FX   YU
M   %>P   ($   "'    C0   )(   "6    F@   )T   "?    H0   *0
M  "F    J    *L   "N    L0,  +0+  "X$0  N1X  +DO  "X0P  MUH
M +5V  "TEP  M+4  +'B  "P_  _9   ,6D  "5O   8=P  #W\   :'
MC@   )0   ":    H    *4   "J    K@   +$   "R    M0   +<   "Z
M    O    +\   ##    Q@   ,D   #."@  TA,  -(C  #1-P  T$\  ,YJ
M  #-B@  RJL  ,O+  #+[P W<0  *7@  !V    1B0  ")$   ":    H0
M *<   "M    LP   +D   "^    P@   ,4   #&    R0   ,P   #.
MT@   -4   #:    W@   .$   #E    Z@L  .L7  #J*P  ZD,  .I>  #J
M>@  ZYD  .NU  #KU0#_    _P   /\  0#_  < _P - /\ $@#_ !L _P E
M /\ +P#_ #H _P!# /\ 2P#_ %, _P!: /T 8 #[ &8 ^@!K /@ <@#V '@
M] "  /$ B0#O )( [ "= .D J@#F +P XP#< -\ ]P#= /\ S #_ +X _P"U
M /\ L #_ *T _P#_    _P   /\   #_    _P & /\ #0#_ !0 _P ? /\
M*0#[ #, ]P ] /, 10#O $T [ !3 .@ 60#E %\ XP!E .  :@#= '$ V@!X
M -8 @ #2 (H SP"5 ,P H@#( +( Q0#) ,( [0#  /\ NP#_ +  _P"H /\
MI #_ *$ _P#_    _P   /T   #Z    ^    /  "0#L !$ Z  9 .< (P#E
M "T W@ V -8 /@#1 $8 S0!, ,H 4@#( %@ Q0!= ,, 8P#  &D O@!P +P
M> "Y ($ MP"- +0 F@"Q *D K@"\ *P X0"J /P J #_ *  _P"9 /\ E@#_
M )0 _P#_    ^0   /(   #G    VP   -$ ! #*  T QP 4 ,0 '0#" "8
MOP O +L -P"W #\ M !% +$ 2P"N %$ K !6 *H 7 "H &$ I@!H *, < "A
M 'D GP"$ )T D0": *  F "Q )8 S "5 /$ E #_ )$ _P"+ /\ B #_ (8
M_P#W    [    -X   #)    O    +0   "O  H JP 0 *D %P"H "  IP H
M *( , "? #@ G  ^ )H 1 "8 $H E@!/ )0 50"3 %H D0!A (\ : "- '$
MBP![ (D B "' )< A0"H (, O@"! .0 @ #_ (  _P!\ /\ >P#_ 'D _P#I
M    UP   ,$   "Q    I@   )T   "7  4 E  - )( $@"0 !H CP B (X
M*@"+ #$ B0 X (< /@"% $, @P!( ($ 3@!_ %0 ?@!: 'P 80!Z &D > !S
M '8 ?P!U (X <P"? '$ LP!P -  ;P#V &\ _P!O /\ ;0#_ &P _P#:
MOP   *P   ">    DP   (P   "%    @@ ) '\ #P!^ !4 ?0 < 'P ) !Z
M "L =P Q '4 -P!T #T <@!" '$ 2 !O $T ;@!3 &P 6@!K &( :0!L &<
M> !F (8 9 "7 &( J@!A ,( 8 #K &$ _P!A /\ 80#_ &  _P#%    K0
M )L   "-    @P   'P   !W    <@ % '  # !N !$ ;  7 &P '@!K "4
M:0 L &< ,0!F #< 9  ] &, 0@!B $@ 8 !. %\ 50!= %T 7 !F %H <@!9
M (  5P"0 %8 HP!5 +D 5 #> %0 ^P!4 /\ 50#_ %4 _P"V    GP   (T
M  !_    =0   &X   !I    9@ ! &, "0!A  X 8  3 %\ &0!> "  70 F
M %L + !: #( 6  W %< /0!6 $, 50!) %, 4 !2 %@ 40!A $\ ; !. 'H
M3 "* $L G !* +$ 20#. $D \P!) /\ 20#_ $H _P"J 0  E 4  (('  !T
M"   :@@  &,&  !>!   6P   %D !0!7  P 5@ 0 %0 %0!3 !L 4@ B %$
M* !0 "T 3@ S $T . !, #X 2P!% $H 3 !( %0 1P!= $8 : !$ '4 0P"%
M $$ F !  *L 0 #% #\ Z@ _ /\ 0 #_ $  _P"@"   B@L  'D-  !L#0
M80T  %H-  !5"P  4@D  % &  !/ @@ 3@ - $P $@!+ !< 2@ > $D (P!'
M "D 1@ O $4 - !$ #H 0@!! $$ 2 !  %  /@!: #T 9  \ '( .@"" #D
ME  X *< -P"^ #8 XP V /D -@#_ #< _P"8#0  @PX  '(0  !E$0  6Q$
M %,0  !.$   2@X  $@-  !'"@, 1P<* $4$#@!$ A, 0@(: $$"( !  R4
M/@,K #T$,0 \!#< .P0^ #H%10 Y!4X -P57 #8%8@ T!G  ,@:  #$&D@ P
M!J4 +P6[ "X%W0 N!O4 +0?_ "X'_P"1$   ?1$  &P3  !?%   510  $X4
M  !($P  1!(  $$0  ! #@  0 T& $ *#  ^"1  / D6 #L*'  Y"B( . HH
M #<++@ V"S4 -0L[ #,+0P R#$P , Q6 "\,80 M#&\ *PQ_ "H,D@ H#*4
M)PR[ "4,W0 E#?4 )@W_ "<-_P"+$@  =Q0  &<6  !;%P  41@  $D7  !#
M%P  /Q4  #P4   Z$@  .1$! #D/"  X#@T -PX2 #4.&  T#A\ ,@XE #$/
M+  P#S( +Q Z "T00@ L$$L *A!5 "@080 F$&\ )!"  ",0DP A$*< 'Q"]
M !X0X  >$?< 'Q#_ " 0_P"&%   <Q<  &,9  !7&@  31L  $4:  ! &@
M.QD  #@8   U%@  -!0  #,2!  R$@L ,1(0 "\2%0 M$AP +!,B "L3*0 J
M$S  *!,W "<4/P F%$@ )!13 "(47P @%6T 'Q5^ !T5D0 ;%:4 &16[ !@5
MW@ 8%?@ &13_ !H4_P""%P  ;QH  %\<  !3'0  2AT  $(=   \'0  -QP
M #0;   Q&@  +QD  "X6   L%P@ *Q8. "D7$P H%QD )Q@@ "48)@ D&"T
M(Q@T "(9/0 @&48 'AE1 !T970 ;&FL &1I\ !<:CP 5&J, %!FZ !(9VP 3
M&?8 %!G_ !48_P!]&@  :QT  %P?  !0(   1R   #\@   Y'P  -!\  #$>
M   M'0  *QP  "D;   G&P4 )1L, "0<$0 B'!8 (1P= " =(P ?'2H 'ATR
M !P>.@ ;'D0 &1Y. !<>6P 6'FD %!]Z !(>C0 1'J( $!ZX  X>V  /'O4
M$!W_ !$=_P!Z'0  9Q\  %DA  !-(@  1"(  #PB   V(@  ,B$  "XA   J
M(   )R   "0?   B( ( (" * !XA#P =(10 '"$: !LB(0 9(B< &"(O !<B
M.  5(T$ %"-, !(C6  1(V< $"-X  XCBP -(Y\ #".T  LCT  +(O  #"+_
M  TA_P!V'P  9"(  %8C  !+)   020  #HD   T)   +R,  "LC   H(P
M)",  " C   =)   &R4' !DF#0 7)A$ %B87 !4G'@ 4)R4 $R<L !(G-0 1
M*#\ $"A*  XH5@ -*&0 #"AT  HHAP )*)L !R>Q  4GS  &)^P !R;^  @F
M_P!Q(@  8"0  %,F  !()P  /R<  #<F   Q)@  +28  "DE   E)0  (B4
M !TG   9*   %BH$ !0K"P 2+!  $2P4 ! L&P 0+"( #BPI  XM,@ -+3L
M"RU&  HM4@ (+6  !BUP  0M@P "+9@  "RN   LR0  +.L  2O\  (K_P!M
M)0  72<  $\H  !%*0  /"D  #4I   O*   *R@  "<G   C)P  'R@  !LJ
M   7+   $RX" ! P"  .,0T #3$2  PQ%P +,1X "C$F  @R+@ ',C< !3)"
M  ,R3@ !,EP  #)L   R?P  ,I4  #&L   QQP  ,.H  ##\   P_P!H*0
M6"H  $PK  !!+   .2P  #(K   M*P  *2H  "4J   @*P  '"P  !<N   3
M,   $#("  XT!P *-PP !S<0  4W%  #-QL  C<B   W*@  .#,  #@^   X
M2@  .%@  #AH   X?   -Y(  #>I   VQ0  -NH  #;]   U_P!C+   5"X
M $@O   ^+P  -BX  # N   K+0  )RT  "(M   =+P  &#$  !0S   0-0
M#C<!  HZ!P &.PL  CP.   ]$@  /A<  #X>   ^)@  /B\  #XZ   ^1@
M/E0  #YD   ^=P  /H\  #VG   ]PP  /.D  #S]   [_P!>,   4#$  $0R
M   [,@  -#$  "XP   I+P  )#   !XR   9-   %#8  ! Y   -.P  "CT
M  5 !0  00H  $(-  !#$   1!0  $4:  !&(@  1BL  $8U  !&00  1D\
M $9?  !&<P  18H  $6D  !$P   0^@  $/^  !"_P!8-   2S4  $$U   Y
M-0  ,C0  "TS   F-   (#4  !HX   4.@  $#T   U    )0@  !$4   !'
M P  2 <  $H+  !+#@  3!$  $X5  !/'   3R4  $\O  !//   3TH  $]:
M  !.;0  3H4  $V@  !,O   2^<  $O^  !*_P!3.0  1SD  #XY   W.
M,3<  "DW   A.0  &SP  !4_   00@  #$4   =(   "2@   $T   !/
M400  %('  !4"P  50X  %<1  !9%P  6A\  %DI  !9-@  640  %E4  !8
M9P  6'\  %>:  !6MP  5>,  %3]  !4_P!./0  0ST  #P\   U.P  +#P
M "0^   <00  %40  !!(   +2P  !4X   !1    5    %<   !9    6P
M %T"  !>!@  8 L  &(.  !D$@  9Q@  &<B  !F+@  9CP  &9-  !E8
M97<  &23  !CL0  8=T  &#\  !?_P!)0@  04$  #H_   P0   )D,  !Y&
M   52@  $$X   I2   #5@   %H   !=    8    &,   !E    9P   &D
M  !K 0  ;04  &\*  !R#@  =1(  '<;  !V)@  =C4  '5&  !T60  =&\
M '.+  !RJ0  <,T  &_W  !N_P!&1@  0$4  #5&   J2   ($P  !=1   0
M5@  "5H   %?    8P   &@   !K    ;P   '(   !U    =P   'D   ![
M    ?0   ( #  "#"   A@T  (D3  "*'0  BBL  (D\  "(3P  AF8  (6!
M  "$H   @L(  ('P  !__P!&2P  .DP  "Y/   C4P  &%@  !!>   )9
M &D   !O    =    '@   !\    @0   (0   "'    B    (L   ".
MD    ),   "6    F0<  )T-  "A%   H"$  * Q  ">1   G5L  )QV  "9
ME@  F;4  );E  "5_@ _4@  ,E4  "9:   ;8   $6<   EM    =    'L
M  "!    A@   (L   "0    E    )<   "9    G    )\   "A    I
M *<   "J    K0   +$&  "U#0  N!8  +<F  "V.0  M5   +1J  "RB0
ML*H  *[/  "M]0 W7   *V$  !YH   3<   "W@   "     AP   (X   "5
M    F@   )\   "D    J    *P   "M    L    +,   "U    N    +L
M  "_    PP   ,<   #+!0  T0X  -$;  #0+@  ST4  ,U?  #+?@  R9X
M ,B^  #%Z0 O:0  (W   !9Y   -@0   8L   "3    FP   *(   "H
MK@   +0   "X    O0   ,    #"    Q0   ,@   #+    S@   -$   #6
M    VP   -\   #D    Z 8  .L1  #J(P  ZCH  .E4  #G<@  Y9,  ..S
M  #CU #_    _P   /\   #_  0 _P + /\ $ #_ !< _P A /\ *P#_ #4
M_P ^ /\ 1P#_ $X _P!5 /P 6P#Z &$ ^ !F /8 ;0#T ', \@![ .\ A #M
M (X Z@"9 .8 IP#C +D WP#5 -L ]P#6 /\ P #_ +( _P"J /\ I0#_ *(
M_P#_    _P   /X   #\    _  # /X "P#_ !$ _P : /T ) #Y "X ]  X
M /  0 #L $@ Z0!. .8 5 #B %H WP!? -P 90#8 &L U !R -  >P#- (4
MR@"1 ,< G@## *X P #% +T ZP"[ /\ L #_ *0 _P"< /\ F #_ )4 _P#_
M    ^@   /0   #Q    \@   .H !0#G  X X@ 5 .$ '@#A "@ V  Q -
M.0#+ $  R !' ,4 30#" %, OP!8 +T 7@"[ &0 N0!K +8 <P"T 'P L0"(
M *X E0"K *0 J "X *8 W "C /L GP#_ )4 _P"/ /\ BP#_ (D _P#Y
M[P   .<   #?    SP   ,@   #!  H OP 1 +P & "[ "$ N0 J +0 ,@"Q
M #H K@!  *L 1@"H $P I@!1 *, 5@"A %P GP!C )T :@"; ', F0!^ )8
MC "4 )L D@"M )  QP". /  C0#_ (8 _P"  /\ ?0#_ 'P _P#M    X
M -$   "_    LP   *H   "F  4 H@ - *$ $P"@ !L GP C )L *P"8 #(
ME0 Y ), /P"1 $0 CP!* (X 3P", %4 B@!; (@ 8P"& &L A !V (( @@"
M )( ?@"C 'P N@!Z .$ >0#_ '< _P!R /\ < #_ &\ _P#=    RP   +8
M  "G    G0   )0   ".  $ BP * (D $ "( !4 AP = (< )0"$ "P @@ R
M '\ . !] #T >P!# 'D 2 !X $X =@!4 '4 6P!S &, <0!N &\ >@!M (D
M; ": &H K@!I ,P : #V &< _P!E /\ 9 #_ &, _P#*    M    *$   "3
M    B0   ((   ![    >  % '8 # !U !$ =  8 ', 'P!R "4 <  L &X
M,@!L #< :@ \ &D 0@!H $@ 9@!. &4 50!C %T 8@!F &  <@!> (  70"2
M %L I0!: +X 60#I %D _P!9 /\ 6 #_ %@ _P"Y    H@   )    "#
M>0   '$   !M    :0 ! &8 "0!E  X 9  3 &, &0!C "  80 F &  + !>
M #$ 7  W %L / !: $( 6 !( %< 3P!6 %< 5 !@ %, ; !1 'D 4 "* $\
MG@!. +0 30#: $T ^P!- /\ 30#_ $T _P"J    E    ((   !U    :P
M &0   !@    70   %H !0!8  P 5P 0 %8 %0!6 !L 50 A %, )P!2 "P
M40 Q $\ -P!. #T 30!# $P 2@!* %( 20!; $@ 9@!& ', 10"$ $0 EP!#
M *P 0@#) $( \0!" /\ 0P#_ $, _P">    B0   '@#  !J!   800  %H#
M  !5 0  4@   %   @!.  D 30 - $P $0!+ !< 2@ < $D (@!( "< 1P M
M $4 ,@!$ #@ 0P ^ $( 10!! $T /P!6 #X 80 ] &X .P!^ #H D0 Y *8
M. "_ #@ Z  X /\ .0#_ #D _P"5 P  @ <  &\)  !B"@  6 L  %$*  !,
M"   208  $<#  !&  8 1  + $, #P!" !, 00 8 $$ '@ _ ", /@ I #T
M+@ [ #0 .@ Z #D 00 X $D -P!2 #8 70 T &H ,P!Z #( C  Q *$ , "X
M "\ W@ O /D +P#_ #  _P","0  > P  &@-  !<#@  4@X  $L.  !%#0
M00P  #\*   ^" ( /00( #P!#0 [ !  .@ 5 #D &@ X "  -@ E #4 *P T
M #  ,P W #( /@ Q $8 +P!0 "X 6@ M &< *P!W "H B0 I )T * "S "<
MT0 G /( )P#_ "< _P"&#   <@X  &,0  !6$0  31$  $41  ! $   / \
M #D.   W#0  -@L$ #8("@ U!@X - 42 #($%P Q!1P , 4B "\%*  N!BX
M+08T "L&/  J!D0 *0=. "<'60 F!V4 ) =U ",'AP B!YL ( :P " &RP ?
M!>T 'P;^ !\'_P" #@  ;1$  %X2  !2$P  2!,  $$3   [$P  -Q(  #01
M   R$   , \! # -!@ P"PL +PH0 "T*%  L"QD *@L? "D+)0 H#"L )PPR
M "8,.@ D#$, (PQ- "$-6  @#64 '@UU !P-B  :#9P &0VQ !@,R@ 7#.L
M%PW\ !@,_P![$0  :1,  %H5  !.%@  118  #T6   X%0  ,Q4  # 4   M
M$P  *Q(  "H0 P J#P@ *0X- "@.$0 F#A8 )0\= "0/(P C#RD (1 Q " 0
M.0 >$$( '1!, !L06  9$&8 %Q!V !40B0 4$)X $A"S !$0S@ 1$.X $A#^
M !(0_P!W$P  914  %<7  !+&   0AD  #H9   T&   ,!<  "P7   I%@
M)Q4  "84 0 E$@0 (Q(+ "(2#P A$A0 (!(: !X3(  =$R< '!,N !H3-@ 9
M%$  %Q1* !845@ 4%&0 $A1T !$4AP 0%)P #A2Q  T4R@ -%.L #A/^  X3
M_P!S%0  81@  %,:  !(&P  /QL  #<;   R&@  +1H  "D9   F&   )!@
M "(7   @%@$ 'A8( !T6#0 ;%Q( &A<7 !D7'0 8&"0 %A@K !48-  4&#T
M$AE( !$95  0&6( #AER  T9A  ,&9@ "AFM  D8Q@ )&.< "1CZ  H7_P!O
M&   7AH  % <  !%'0  /!T  #4=   O'0  *AP  "8;   C&P  (1H  !X:
M   <&@  &AL% !@;#  6'!  %1P5 !0<&P 3'"( $ATI !$=,0 0'3L #AU%
M  T>40 ,'EX "AYM  D>@  ''I0 !1VJ  ,=P@ #'>8 !!SX  4<_P!K&@
M6QT  $T>  !"'P  .A\  #(?   M'P  *!X  "0>   A'0  'AT  !P=   8
M'@  %1\" !,@"0 2(0X $"$2 ! A&  .(1\ #B(F  TB+@ ,(C< "B)!  DB
M30 '(EH !2)I  ,B?  !(I$  "*H   AP   (>4  "#X   @_P!G'0  5Q\
M $HA  ! (0  -R(  # A   J(0  )B   "(@   ?'P  '!\  !D@   6(0
M$B," ! D!P .)@P #"80  LF%0 *)AP "28B  @F*@ &)S, !"<]  ,G20 !
M)U8  "=F   G>0  )X\  ":F   FOP  )>0  "7Y   D_P!C(   5"(  $<C
M   ])   -"0  "XC   H(P  )"(  "$B   >(0  &B(  !<C   3)   $"8"
M  XH!P +*@L ""L.  8K$P $*Q@  BL?  $L)P  +#   "PZ   L10  +%,
M "QC   L=@  +(P  "ND   KO@  *N0  "KZ   I_P!?(P  4"4  $0F   Z
M)@  ,B8  "LF   F)0  (R0  !\D   ;)   %R4  !0G   1*0  #BL"  LM
M!@ '+PL !# .   P$0  ,14  #$<   Q(P  ,BP  #(V   R0@  ,D\  #)?
M   R<@  ,8D  #&B   PO   ,.0  "_[   O_P!:)P  3"@  $ I   W*0
M+RD  "DH   E)P  (28  !PG   8*   %"H  !$L   .+@  "S !  <R!0 #
M- D  #4,   V#P  -Q(  #@8   X(   ."@  #@R   Y/0  .4L  #E;   X
M;@  .(4  #>?   WN@  -N0  #7\   U_P!5*@  2"P  #TL   T+   +2L
M "@J   D*0  'BH  !DK   4+0  $2\   TQ   *-   !S8   (X!   .@<
M #L*   ]#0  /A   $ 4  ! &P  0"0  $ N  ! .0  0$<  $!6  ! :0
M0(   #^;   ^MP  />,  #S\   \_P!0+P  0R\  #DO   R+P  +"T  "<L
M   @+0  &B\  !4Q   1,P  #38   DX   %.P   #T   !  0  000  $,'
M  !%"P  1@X  $@1  !*%@  2AX  $HH  !*-   24(  $E1  !)9   2'L
M $B7  !'M   1N   $7\  !$_P!*,P  /S,  #8S   P,0  *C   ",Q   <
M,P  %C4  !$X   -.P  "#X   -!    0P   $8   !(    2@   $P$  !.
M!P  3PL  %$.  !4$@  51D  %4B  !4+@  5#P  %1+  !37@  4W0  %*0
M  !1K@  4-<  $_[  !._P!%-P  /#<  #4V   O-   )C4  !XW   7.@
M$3T   Q!   '1    $@   !*    30   %    !3    50   %<   !8 @
M6P8  %T+  !?#@  8A,  &(;  !B)P  8C0  &%%  !@5P  8&T  %^)  !=
MIP  7,P  %KX  !9_P!!/   .CL  #0Y   J.@  (3P  !A    10P  #$<
M  9+    3P   %,   !6    60   %P   !?    80   &,   !E    9P$
M &H%  !M"@  < X  ',5  !R(   <BT  '$]  !P3P  ;V4  &Z   !MGP
M:\$  &GQ  !H_P _0   .3X  "X_   D0@  &D8  !)*   ,3P  !%0   !8
M    70   &$   !E    :    &L   !N    <0   ',   !U    >    'L
M  !^ P  @0H  (4/  "'%P  AB0  (4T  "$1@  @ET  (%V  !_E@  ?K8
M 'SG  !Z_P _1   ,T4  "A(   =3   $U(   Q7   #70   &,   !H
M;0   '$   !V    >@   'X   "!    @P   (8   ")    BP   (X   "2
M    E0$  )D)  ">$   GAH  )TI  "</   FE(  )AL  "6BP  E*H  )+4
M  "0^@ X2P  +$X  "!3   560  #6    -G    ;@   '0   !Z    @
M (0   "*    C@   )(   "5    EP   )H   "=    H    *,   "G
MJP   *\   "T"0  N!   +<>  "U,   LT8  +%@  "O?@  K*   *O!  "I
M[@ Q50  )%L  !AA   .:0  !7$   !Y    @0   (@   "/    E    )H
M  "?    I    *@   "I    K    *\   "S    M0   +D   "]    P0
M ,8   #+    T0H  -,4  #1)0  T#L  ,U4  #*<0  R)(  ,6S  ##W@ I
M8@  '&D  !%Q   '>P   (0   "-    E0   )T   "C    J0   *\   "T
M    N0   +P   "^    P@   ,4   #(    S    -    #4    V@   -\
M  #D    Z@   .X,  #M&@  ["\  .I)  #H90  YH8  .2E  #BQ@#_
M_P   /\   #\  $ _  ( /X #@#_ !0 _P = /\ )@#_ #  _P Z /\ 0@#_
M $D _@!0 /L 5@#Y %P ]@!B /0 : #R &\ \ !V .T ?P#J (D YP"5 .0
MHP#@ +4 VP#0 -4 ]@#* /\ M@#_ *@ _P"? /\ F@#_ )8 _P#_    ^P
M /8   #S    \P   /8 "0#Z  X _0 6 /L ( #W "H \@ S .T .P#I $,
MY@!) .( 3P#> %4 VP!; -8 8 #2 &< SP!N ,P =@#) (  Q@", ,( F@"_
M *H NP#! +@ Z0"V /\ IP#_ )H _P"2 /\ C0#_ (H _P#Z    \0   .H
M  #G    YP   .0  0#@  L VP 1 -H &@#; ", T0 L ,H - #& #L P@!"
M +\ 2 "\ $X N@!3 +@ 60"V %\ LP!F +$ ;@"N '< K "# *D D0"F *$
MHP"U *  V "> /L E0#_ (L _P"% /\ @ #_ 'X _P#O    XP   -H   #3
M    Q@   +\   "Y  8 MP . +0 % "T !T LP E *X +0"K #0 IP [ *0
M00"A $8 GP!, )T 40"; %< F0!> )< 90"5 &X DP!Y )  AP". )< C "I
M (D Q "( .\ A0#_ 'P _P!V /\ <P#_ '( _P#@    T    ,8   "V
MJ0   *$   "=  $ F0 * )@ $ "8 !8 EP > )0 )@"1 "T CP T (P .@"*
M #\ B !% (< 2@"% %  @P!6 ($ 7@"  &8 ?@!Q 'P ?0!Y (T =P"@ '4
MM@!S -\ <@#_ &X _P!I /\ 9P#_ &4 _P#,    O@   *L   "=    DP
M (H   "%    @@ % (  #0!_ !$ ?P 8 (  ( !] "8 >@ M '< ,P!U #@
M=  ^ '( 0P!P $D ;P!/ &T 5@!L %X :@!H &@ =0!G (0 90"6 &0 JP!B
M ,D 80#V &  _P!< /\ 6P#_ %H _P"]    J0   )<   ")    ?@   '@
M  !S    ;P ! &T "0!L  X :P 3 &L &0!J "  :  F &8 + !E #( 8P W
M &( / !@ $( 7P!( %T 3P!< %< 6@!A %D ;0!7 'L 5@". %4 H@!3 +L
M4@#I %( _P!0 /\ 3P#_ $\ _P"M    F    (8   !X    ;@   &<   !C
M    8    %T !0!<  L 6P 0 %L %0!; !L 6@ A %@ )@!6 "P 5  Q %,
M-@!2 #P 40!" $\ 20!. %$ 30!; $L 9@!* '0 20"% $@ F0!' +$ 1@#8
M $8 _ !% /\ 10#_ $4 _P"?    B0   '@   !L    8@   %L   !6
M4P   %$  @!/  @ 3P - $X $0!. !8 30 < $P (0!* "8 20 L $@ ,0!'
M #< 10 ] $0 1 !# $P 0@!5 $  8  _ &X /@!^ #T D@ \ *D .P#' #L
M\P [ /\ .P#_ #P _P"3    ?@   &X   !A    6    %$   !,    20
M $<   !%  4 1  + $, #@!# !( 0P 7 $( '0!  "( /P G #X +  ] #(
M.P X #H /P Y $< . !0 #< 6P U &@ - !X #, C  R *( ,0"\ #$ YP Q
M /\ ,@#_ #, _P")    =@,  &8%  !9!P  4 <  $D&  !#!0  0 ,  #X!
M   \  , .P ( #H #0 Z !  .0 4 #D &0 W !X -@ C #4 *  T "X ,P T
M #( .P P $, +P!, "X 5P M &0 + !S "L AP J )P *0"U "D W  I /L
M*0#_ "H _P"!!   ;@@  %\*  !3"P  2@L  $(+   ]"@  .0D  #8(   U
M!0  - (& #, "@ R  X ,0 1 #$ %0 P !H +P ? "X )  L "H *P P "H
M-P I #\ * !) "< 5  F &  ) !O ", @@ B )< (0"N "$ S  A /, (0#_
M "( _P!["0  : P  %H-  !.#@  10X  #T.   X#0  ,PT  # ,   N"P
M+0D# "T&"  L! P *P(/ "H!$@ I 1< * $< "< (0 F "< )0 M "0 -  C
M 3T (@%& "$!40 ? 5T '@%L !P!?P ; )0 &@"J !H Q0 : .L &0#_ !H
M_P!U#   9 X  %4/  !*$   0!   #D0   S$   +P\  "P.   I#@  )PT!
M "<,!0 G"@H )@@- "4'$  D!A0 (@89 "$&'P @!R0 'P<K !X',@ =!SH
M' A$ !H(3P 9"%P %PAK !8(?0 5!Y$ % >G !,&OP 2!>0 $@7Z !(%_P!Q
M#@  7Q   %$1  !&$@  /1(  #82   P$@  *Q$  "@1   E$   (Q   "(.
M!  A#0< (0P+ " +#@ ?"Q( '0L7 !P,'  ;#"( &@PI !D,,0 8##D %@U#
M !4-3P 3#5P $@UK ! -?@ /#9( #@VG  T,O@ -#.  #0SU  T,_P!M$
M7!$  $X3  !#%   .A0  #(4   M%   *!,  "43   B$@  (!$  !X1 P <
M$ 4 ' \( !L/#  :#A  &0\4 !</&@ 6#R$ %1 H !00,  2$#D $1!$ ! 0
M4  .$%T #1!K  P0?  +$)  "1"E  @0O  '$-\ !Q#T  </_P!I$0  6!0
M $L5  ! %@  -Q8  # 6   J%@  )A4  "(5   ?%   '1,  !H3 @ 9$@0
M%Q(& !82"@ 5$@X %!(2 !(2&  1$QX $1,E ! 3+@ .$S< #11   P42P +
M%%@ "11G  <4>  &%(T !!2C  ,3NP "$]T  1+T  (2_P!E$P  518  $@7
M   ]&   -!@  "T8   H&   (Q<  " 7   =%@  &A4  !@5 @ 6%00 %!4%
M !(6"  1%@T $!<0  X7%0 .%QL #1<B  P7*0 +&#( "1@\  <81P %&%0
M!!AC  (8=0 !&(L  !>A   7N0  %]T  !;U   6_P!A%@  4A@  $4:   [
M&@  ,AH  "L:   E&@  (1D  !X8   ;&   &!<  !87 @ 4%P, $A@% ! 9
M!P .&PL #!L/  L;$P *&Q@ "!P?  <<)@ %'"\ !!PX  (<1   '5$  !U@
M   =<@  '(@  !R@   ;N0  &]X  !KV   :_P!>&   3QH  $(<   X'
M+QT  "D<   C'   'QL  !P:   9&0  %QD! !09 @ 2&@, $!L$  X=!P ,
M'@L "1\.  8@$0 %(!8  R <  $A(P  (2L  "$U   A0   (4X  "%=   A
M;P  (88  "">   @N   ']X  ![X   >_P!:&P  2QT  #\>   U'P  +1\
M "<>   B'0  'AT  !L<   8&P  %1L  !(<   0'0( #A\$  PA!@ )(@H
M!2,-  (D$   )1,  "49   F(   )B@  "8R   F/0  )DH  "9:   F;
M)H,  "6<   EMP  )-\  "/Y   C_P!5'@  1R   #PA   R(0  *R$  "4@
M   @'P  '1X  !H=   6'@  $QX  ! @   .(0  #","  @E!0 %)PD  "@+
M   J#@  *Q$  "P6   L'0  +"4  "PN   L.@  +$<  "Q6   L:0  +(
M "N:   JM0  *=\  "G[   H_P!1(@  1",  #@D   O)   *",  ",B   ?
M(0  '"   !<@   3(0  $",   XD   +)@  ""@   0J!   + <  "X)   P
M#   ,0\  #,3   S&0  ,R$  #,J   S-0  ,T,  #-2   S90  ,GL  #*7
M   QLP  ,-X  "_[   N_P!,)0  /R8  #4G   M)@  )R4  "(D   >(P
M&2,  !0D   1)@  #B@   LJ   '+    R\    Q @  ,P0  #4'   W"@
M.0T  #H0   [%0  .QT  #LF   [,0  .SX  #M.   [8   .G<  #F2   X
ML   -]L  #;\   U_P!'*0  .RH  #(J   K*0  )2<  "$F   ;)P  %2@
M !$J   .+   "B\   8Q   !-    #8    X    .P$  #T$   _!P  00H
M $,.  !%$0  11@  $4A  !%+   1#D  $1(  !$6P  0W$  $*-  !!JP
M0-(  #_Z   ^_P!"+0  ."X  "\M   I*P  )"H  !TJ   7+   $2X   TQ
M   )-   !#<    Z    /    #\   !!    1    $8   !( P  2@<  $P+
M  !.#@  4!,  % <  !0)P  3S0  $]#  !/50  3FH  $V&  !,I   2LH
M $GX  !(_P ^,@  -3$  "XO   I+@  ("X  !DQ   2,P  #C<   DZ   "
M/0   $    !$    1P   $D   !,    3P   %$   !3    50$  %@&  !:
M"P  70X  %\5  !>(   7BP  %T\  !<3@  6V,  %I^  !8G0  5\   %7R
M  !4_P Z-@  ,S0  "TR   D,P  &S8  !,Y   ./0  "$$   !%    20
M $P   !0    4P   %8   !9    6P   %T   !@    8@   &4   !H!0
M:PL  &\0  !O&   ;B4  &TT  !M1@  :UL  &IU  !HE   9K8  &3I  !B
M_P X.0  ,C<  "@Y   >.P  %3\   Y$   '20   $T   !2    5@   %H
M  !>    8@   &4   !H    :P   &T   !P    <P   '8   !Y    ?00
M ($+  "%$0  A!T  ((L  " /@  ?E0  'YK  ![B@  >JH  '?6  !U_0 X
M/0  +#X  ")!   71@  #TL   =1    5P   %P   !B    9@   &L   !O
M    =    '@   ![    ?@   (    "#    A@   (H   "-    D0   )8#
M  ";#   G1,  )LA  ":,P  ETD  )1B  "3?P  D*   ([%  ",\P Q1
M)4@  !I-   04P  "%H   !A    :    &X   !T    >0   '\   "$
MB0   (T   "1    DP   )8   "9    G0   *    "D    J    *P   "R
M P  MPT  +<7  "U*   LCX  +!6  "L<P  JI0  *FT  "EY0 J3P  'E0
M !);   *8@   &H   !S    >P   ((   ")    C@   )0   ":    GP
M *0   "F    J0   *T   "P    LP   +<   "[    P    ,4   #+
MT00  -4.  #3'0  T#(  ,U+  #*9@  QH<  ,*I  #!RP B6P  %F(   QK
M   !=    'T   "'    D    )<   ">    I    *L   "Q    M@   +H
M  "\    P    ,0   #(    RP   ,\   #4    V@   .    #F    ZP
M /$&  #P$P  [B<  .P_  #J6P  YWH  .2;  #@NP#_    ^P   /8   #S
M    ]  % /8 # #Z !$ _P 9 /\ (@#_ "P _P U /\ /0#_ $4 _ !, /H
M4@#W %@ ]0!> /, 9 #Q &H [@!R .P >@#I (4 Y0"1 .$ H #= +( V #.
M -( ]@#! /\ K0#_ )X _P"6 /\ D #_ (P _P#Z    \@   .P   #I
MZ0   .P !0#R  P ^  2 /< &P#U "4 \  N .L -P#F #X X@!% -T 2P#8
M %  TP!6 -  7 #- &( R@!J ,@ <@#% 'P P@"( +X E@"Z *@ MP"_ +0
MZ "N /\ G0#_ )  _P"( /\ @P#_ (  _P#P    Y0   -X   #:    VP
M -P   #8  < T0 . -$ %0#2 !X RP G ,4 +P#  #< O0 ] +H 1 "W $D
MM0!/ +( 50"P %L K@!A *P :0"I ', IP!_ *0 C0"A )X G@"R )L U0"9
M /P C #_ (( _P![ /\ =@#_ '0 _P#B    TP   ,H   #'    O    +8
M  "P  $ KP + *P $0"M !@ K0 @ *@ * "D "\ H  V )T / "; $( F0!'
M )< 30"5 %, DP!9 )$ 80"/ &H C !U (H @P"( )0 A@"G (, P@"" /
M? #_ ', _P!M /\ :@#_ &@ _P#/    P0   +D   "M    H    )@   "4
M    D0 & )  #0"0 !( CP 9 (X (0"+ "@ B  O (8 -0"$ #H @@!  (
M10!^ $L ? !2 'H 60!X &( =@!L '0 >0!R (D <0"= &\ M !M -\ ; #_
M &4 _P!@ /\ 7@#_ %P _P"^    L0   *    "2    B0   ((   !\
M>@ ! '@ "0!W  X >  4 '< &@!T "$ <@ G '  +0!N #, ;  X &L /@!I
M $0 : !* &8 40!D %H 8P!D &$ < !? '\ 7@"3 %T J0!< ,@ 6P#W %<
M_P!4 /\ 4@#_ %$ _P"P    GP   (T   !_    =    &X   !J    9@
M &4 ! !C  L 8P 0 &, %0!C !L 80 A %\ )P!= "P 7  R %H -P!9 #T
M5P!# %8 2P!5 %, 4P!< %( : !0 '< 3P") $X GP!- +H 3 #I $L _P!)
M /\ 1P#_ $< _P"B    C0   'P   !N    90   %X   !9    5P   %4
M 0!4  < 4P - %, $0!4 !8 4@ ; %$ (0!/ "8 3@ K $P ,0!+ #< 2@ ]
M $D 1 !' $P 1@!6 $0 80!# '  0@"! $$ EP!  *\ /P#7 #\ _P ^ /\
M/0#_ #X _P"4    ?P   &\   !C    60   %$   !-    2@   $@   !'
M  0 1P * $8 #@!& !$ 1P 6 $4 ' !$ "$ 0@ F $$ *P!  #$ /@ W #T
M/@ \ $< .@!0 #D 6P X &D -P!Z #8 CP U *< -0#& #0 ]0 T /\ - #_
M #4 _P"(    =    &4   !8    3P   $@   !#    /P   #T    \  (
M/  ' #L #  [  \ .P 2 #H %P Y !P -P A #8 )@ U "P -  R #, .0 Q
M $$ , !+ "\ 5@ N &, +0!S "P B  L *  *P"[ "L Z@ K /\ *P#_ "P
M_P!_    ;    %T!  !1 @  2 ,  $ #   [ @  -P   #0    S    ,@ %
M #( "0 R  T ,0 0 #$ $P P !@ +P = "T (@ L "@ *P N "H -0 I #T
M* !& "< 40 F %X )0!N "0 @@ C )D (P"S "( W@ B /\ (P#_ "0 _P!W
M    900  %8&  !+!P  0@@  #H(   U!P  , 8  "T%   L P  *P # "H
M!P I  L *0 . "D $0 H !4 )P 9 "8 '@ E "0 )  J ", ,0 B #D (0!#
M "  3@ ? %H '@!I !T ?  < ), &P"L !L S0 ; /8 &P#_ !P _P!P!0
M7P@  %$*  !&"P  /0L  #4+   P"P  *PH  "@)   E"   ) <" ",$!@ C
M @D (@$, "( #P A !( (  6 !\ &P > "  '0 F !P +@ ; #8 &@ _ !D
M2@ 8 %< %P!F !8 >  5 (\ %0"F !0 PP 4 .X % #_ !4 _P!K"   6PL
M $T,  !"#0  .0T  #$-   L#0  )PT  ",,   A#   'PL! !X*!0 =" @
M'08+ !P%#0 <!!  &P04 !D$&  9!!X & 0C !<$*P 6!#, %00\ !0$1P 3
M U0 $@-C !$#=0 0 HH $ &B  \ O  / .4 #P#^ !  _P!G"P  5PT  $D.
M   ^#P  -0\  "X/   H#P  ) X  " .   =#@  &PT! !D-!  8# < & L)
M !<)#  7"0X %@D2 !4)%@ 4"1L $PDA !()*  2"3  $0DZ ! )10 /"5(
M#@EA  T)<P ,"(@ "PB?  H'MP *!ML "@7V  H$_P!C#0  4PX  $80   [
M$0  ,A$  "L1   E$   (1   !T0   :#P  & \! !8.!  5#@< % T) !,-
M"P 3# T $@P0 !$,%  0#!D $ P?  \,)P .#2\ #0TY  P-10 +#5$ "0U@
M  @-<0 &#88 !0V=  0,M  ##-(  @SQ  (+_P!?#@  4!   $,1   X$@
M+Q(  "@2   C$@  'A$  !L1   8$0  %1 " !00!0 2$ < $0\) ! /"@ 0
M#@P #@X.  X/$@ -#Q< #! =  P0)  *$"P "1 V  @000 &$$X !1!=  ,0
M;P !$(0  !"<   /M   #M0   [S   ._P!<$   31(  $ 3   V%   +10
M "84   A$P  '!,  !D2   6$@  %!$# !(1!@ 1$0@ $! *  X0"P -$0L
M#!$-  L2$0 *$A4 "1(:  @2(0 &$RD !1,S  ,3/@ "$TL  !-:   3;
M$X(  !*;   2M   $=<  !'U   1_P!8$@  210  #T5   S%@  *Q8  "05
M   ?%0  &A0  !<4   4$P$ $Q($ !$2!P 0$@D #A()  T2"0 +$PH "10-
M  <5#P &%A, !!88  ,6'P "%B<  !<P   7.P  %T@  !=8   7:@  %H
M !:9   5M   %=D  !3W   3_P!5%   1A8  #H7   P&   *!@  "(7   =
M%@  &18  !85   3% , $A,& ! 3!P /$P< #10'  L5"  )%@D !A@,  ,:
M#@ !&A$  !H6   ;'   &R0  !LM   ;.   &T8  !Q5   ;9P  &WT  !N7
M   :LP  &=L  !CY   7_P!1%@  0Q@  #<9   N&@  )AH  " 9   ;&
M&!<  !46 0 3%04 $14$  \5!  -%@0 "Q<%  D9!@ &&@@  AP*   >#0
M(!   " 3   @&0  ("$  "$J   A-0  (4(  "%2   @9   ('H  !^5   ?
ML0  'ML  !WZ   <_P!-&0  /QL  #0<   K'   )!P  !X;   :&@  %Q@
M !07 @ 2%P( $!@!  T9 0 +&@( "!P#  4=!  "'P8  "$(   C"P  )0X
M "81   F%@  )AX  "<G   G,@  )S\  "9.   F8   )G<  "62   DKP
M(]H  "+[   A_P!('0  /!X  #$?   H'@  (AX  !T<   9&P  %AH  !(:
M   0&P  #1P   L=   ('P  !"$   $C @  )00  "<&   I"0  + P  "X/
M   N$P  +AH  "XC   N+@  +CL  "Y*   M7   +7(  "R.   KK   *M0
M "G[   H_P!$(   ."$  "XA   F(0  ("   !P>   8'0  %!T  ! >   .
M'P  "R$   <C   #)0   "<    I    + $  "X#   P!@  ,PH  #4-   V
M$0  -A<  #8?   V*0  -C8  #9%   U5P  -6T  #2)   RJ   ,<\  ##Z
M   O_P _)   -"0  "LD   D(P  'R$  !L@   6(   $2$   XC   *)0
M!B@   (J    +0   "\    R    -    #<    Y P  .P8  #X*  ! #@
M01(  $$:  ! )0  0#$  $!    _4@  /F<  #V"   \H@  .L<  #GX   X
M_P Z*   ,"@  "DG   C)0  'R,  !@D   2)0  #B@   HJ   %+0   #
M   S    -@   #@    [    /@   $    !"    10(  $<&  !*"@  30X
M $T5  !,'P  3"L  $LZ  !*3   26$  $A\  !'FP  1;\  $/S  !"_P V
M+   +2L  "<I   C)P  &R@  !0J   .+0  "C    0S    -P   #H    ]
M    0    $,   !&    2    $L   !-    4    %,!  !6!@  60L  %L0
M  !;&0  6B4  %DT  !81@  5UH  %5T  !4DP  4K4  %#J  !/_P S,
M+"X  "<L   >+0  %B\  ! R   *-@   SH    _    0@   $8   !)
M3    $\   !2    50   %@   !:    70   &    !C    9P8  &L,  !L
M$@  :QX  &LL  !I/0  9U(  &9J  !DB0  8:L  %_<  !=_P Q,P  +#$
M "(R   9-0  $3D   H]   "0@   $<   !,    4    %0   !8    6P
M %\   !B    90   &@   !K    ;@   '$   !U    >0   'T&  ""#0
M@A8  ( D  !^-0  ?$D  'MA  !X?P  =I\  '/&  !P]P Q-@  )C@  !P[
M   20   "T4   )+    40   %8   !;    8    &4   !I    ;@   '(
M  !V    >0   'P   !^    @@   (4   ")    C@   ),   "8!@  G X
M )L:  "8*P  ED   ))9  "1<P  C94  (NU  "(Z  K/@  ($$  !5'   -
M30   E0   !;    80   &@   !N    <P   'D   !^    @P   (@   ",
M    CP   )(   "5    F0   )T   "A    I0   *H   "P    MP<  +@1
M  "U(0  LC4  *]-  "J:0  J(@  *:H  "BT0 C2   &$X   Y4   $7
M &0   !M    =0   'P   "#    B0   (\   "5    FP   *    "C
MI@   *D   "M    L0   +4   "Y    O@   ,0   #*    T@   -H*  #6
M%@  TBD  ,Y!  #*7   Q7P  ,*=  #!O0 <50  $5P   =E    ;@   '<
M  !_    B    )    "8    GP   *4   "M    LP   +@   "Z    O@
M ,(   #&    R@   ,X   #3    V@   .    #G    [0   /,   #T#@
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M_____________________________________________________P
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M]/7V]_CY^OO\_?[_;69T,0     #!"$   $                    !
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M ,;4"0"X]Q0$J_\I#I[_-!B0_SHAA/]!*7K_23!R_U(V;/]>.FC_:#UD_V]
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MC340_Y@[%_^@1"'_IDXM_Z=9//^E9$S_H6Y;]YMX:NZ5@7?GCHF"X8:/B]R
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M6_B;7EOXFUY;^)M>6_B;7EOXFUY;^)M>6_B;7EOXFUY;^)M>^KD. ,W+"0#
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M7C'_B6L\_X5W1O^!@T[_?8]6_WF87/QUH&'Y<J9E]V^M:?5LLVSS:KEO\FC
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M8E#VRF)0]LIB4/;*8E#VRF)0]LIB4/;*8E#VRF)0]LIB_Z,+ -:X!@#&Q <
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MD]B)_WP8 O^$' /_E1\#_Z,E!/^O+ ;WNC,)[,0[#^+.0AC3SD@LQL=20+G
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M?E3#X7U4P^%]5,/A?53#X7U4P^%]5,/A?53#X7U4P^%]_X<3 ?^<$@'_KA$
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M_ZD8 ?:X&P'GQQH!V]D< <W6, O TC\=M,U*+ZC(4C^=PUI-DK]A6(F[9V*
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M_%BW8_Q8MV/\6+=C_%BW8_Q8_V,? _]F(P3_<B($_WTG!O^%+@G_BC<._XU
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M,=*:7D#(DV=-P(QO6+F'=V&S@G]HKGV';JEZCG.D=Y9XH'2?>YUSJ'Z:<;2
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M:EVD[VI=I.]J7:3O:EVD[VI=I.]J_WD1 ?^,#@#_G@T W*X( -*["0#,R D
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MEQLP_Z$;+_^J'"__M1PN_[\<+O^_'"[_OQPN_[\<+O^_'"[_OQPN_[\<J;4
M )K"  ",SP  ?]X  ';_!0!L_PX!8O\4 EK_&P-3_R0%3?\K!T?_,PE#_SH*
M/_]!"SO_1PPX_TT--?]3#C/_6 \Q_UX/+_]D$"W_:Q$K_W,1*?]\$B?_AA(E
M_Y 3)/^9$R/_HQ0B_ZL4(O^K%"+_JQ0B_ZL4(O^K%"+_JQ0B_ZL4G+X  (W+
M  !^V@  <.8  &?_  !=_PH!5/\0 4W_%0)'_QT#0?\D!#S_*P4W_S(&-/\X
M!S#_/0@M_T,(*O]("2C_30DF_U(*)/]7"B+_70L@_V,+'O]K"QS_<PP:_WP,
M&/^$#!?_C@T5_Y4-%?^5#17_E0T5_Y4-%?^5#17_E0T5_Y4-_U(E _]-+P3_
M43(&_U<U!_]:/ K_6T4._UI/$_]971?_6&T;_U9['_]5B2+_4Y4E_U*@)_]1
MJ"G_4+$J_U"X*_]/P2S_3\HM_T[6+O].Y"[_3NTO_T[S+_]-^##_3?PP_TS_
M,/Q,_S#Y3/\O^$S_+_A,_R_X3/\O^$S_+_A,_R_X3/\O_U,D _]-+P3_5# %
M_UDT!_]=.@K_7T,._UY.$_]=6AC_6VH<_UIY(?]8AB3_5I(G_U6=*?]4IBO_
M4ZXM_U*V+O]2OB__4<<P_U'2,?]0X3+_4.LR_T_R,_]/]S/_3OPT^T[_-/A-
M_S3U3O\R]$[_,O1._S+T3O\R]$[_,O1._S+T3O\R_U,D _].+@3_5B\%_UPR
M!_]@. K_8D$._V),$_]@6!C_7V@=_UUV(O];@R;_68\I_UB:+/]6HR[_5:PP
M_U6S,?]4NS/_4\0T_U/.-?]2WC;_4NDW_U'Q-_]1]CC[4/LX]T__./1/_S?Q
M4/\U\%#_-/!0_S3P4/\T\%#_-/!0_S3P4/\T_U0C _]0+03_62T%_U\P!_]C
M-@K_9D ._V9*$_]E51G_8V4>_V%S(_]>@"C_7(PL_UN7+_]9H3'_6*DT_U>P
M-?]6N#?_5<$X_U7+.?]4VCK_5.<[_U/P//M2]CWV4?L]\E'_/>]2_SOL4O\X
MZU+_..M2_SCK4O\XZU+_..M2_SCK4O\X_U4C _]2*P3_7"L%_V,N!_]G- K_
M:CX._VM($_]J4QG_:&$?_V9P)?]C?2K_8(@O_UZ3,_]<G3;_6Z4X_UJM.O]8
MM3S_5[T^_U?'/_]6TT'\5>1"^57N0_54]D3P4_Q$[%3_0>E5_S_F5?\\Y57_
M.^55_SOE5?\[Y57_.^55_SOE5?\[_U8B _]5*03_7R@%_V<K!O]L,@G_;SP-
M_W!&$_]P4!G_;ET@_VMK)_]H>2W_980R_V*/-_]@F3O^7J$^_5RI0?M;L4/Z
M6;E%^5C"1_=7SDCU5N!*\5;L2^Y5]DSI5OQ*Y5?_1N)8_T/>6?] W5G_/]U9
M_S_=6?\_W5G_/]U9_S_=6?\__U<B _]9)P3_8R8$_VLH!O]Q, C_=#D-_W5#
M$_]U31G_=5DA_W%G*?]M=##]:H V^F:*//ACE$#V89Q$]%ZD2/)<K$OQ6[1-
M[UF]4.U8R5+K5]I3YU;I5>17]53A6?U/VUK_2]5;_TC07/]$SUS_1,]<_T3/
M7/]$SUS_1,]<_T3/7/]$_U@B _]<) /_9B,$_V\F!?]V+@C_>C<,_WM!$O][
M2QG_>U4A_G=C*OES;S+V;GLZ\FJ%0>]FCT?L8Y=,ZF"?4.A=IU3E6Z]7XUFX
M6N%7PUW?5])>VE;F7M99\UK27/Q5S5[_4,E>_TS%7_])Q%__2,1?_TC$7_](
MQ%__2,1?_TC$7_](_UDA O]?(@/_:B$$_W0D!?][+ ?_?S4+_X$^$?^"2!G]
M@E(A]WY?*_)Y:S7M<W4^Z6Z 1N5IB4WA99%4WF&96=I?HES67:I?TURS8=!;
MOF+.6\QCRUKB8\A<\6#&7_I:P6#^5;UA_U&Z8O]-N6+_2[EB_TNY8O]+N6+_
M2[EB_TNY8O]+_UDA O]B( /_;A\#_W@C!/]_*P;_A#,*_X<\$/Z(11?WB$XA
M\(1;*^I^9C;D>'!!WW)Z2]EM@U+3:8Q8SV:57,QDG5_)8J5BQF"N9,-?N&;!
M7L1GOU[8:+Q?ZV:Z8_=?MF3[6;-E_E6P9?]0KV7_3Z]E_T^O9?]/KV7_3Z]E
M_T^O9?]/_UH@ O]E'@/_<1P#_WPB _^$*07_B3$)_XPZ#OF.0Q;QCDP@ZHI8
M*^.$8C?;?FQ#TWAV3,US?U/(;X=9Q&N07L!IF&*]9J!ENF6H:+=CLFJU8KYK
MLV+.;+!BY6NO9O1DK&?X7:EH_%BG:?]3IFG_4J9I_U*F:?]2IFG_4J9I_U*F
M:?]2_UL@ O]G' +_=!H"_W\@ _^()P3_CB\'_9(W#/240!3LE4D>Y)!5*MN*
M7S?1A&E#RGUR3,1X>U2_=(-:NG&+7[9NDV2S:YMGKVFD:JUGK6RJ9KANJ&;'
M;Z5FWV^E:O%HHFOV8:!L^5N>;/U6GFS^59YL_E6>;/Y5GFS^59YL_E6>;/Y5
M_UP? O]J&@+_=QD"_X,? _^,)03_DBT&^9<U"^^9/A+GFT8<WI92*=*07#?*
MB69"PX-O3+Q^=U2W>7];LG6'8*YRCV6J<)=HIFV?;*-LJ6Z@:[1PGFK"<9QJ
MUW&<;NYKFF_S9)EO^%Z7</Q8EW#]5Y=P_5>7</U7EW#]5Y=P_5>7</U7_UX>
M O]L&0+_>A@"_X8= O^/(P/_EBL%]9LS">N?.Q#BH$49UYM0*,R46C;$C6-"
MO(AL3+6"=%2P?GQ;JWJ$8*9WBV6B=)-IGG*<;9MPI7"8;[!RE6Z]<Y-OT'.4
M<NMNDW/R9I)S]F"0<_I:D'/[69!S^UF0<_M9D'/[69!S^UF0<_M9_U\= O]N
M%P+_?1<"_XD< O^2(@+]FBD$\: P!^>D.0W>I4,7T9].)\>86#6^DF%!MHQI
M2Z^'<52I@GE;I'^ 8)]\B&6;>9!JEW:9;9-UHG&0<ZQSC7.Z=(MSRW6,=N=P
MC'?P:(MW]6**=_E<BG?Z6HIW^EJ*=_I:BG?Z6HIW^EJ*=_I:_V$; O]Q%@+_
M?Q8!_XL: ?^5( +YGB8#[:0N!>.I-@K8J4 6S*-,)L*<5C2YEE] L9!G2JJ+
M;U.DAW9:GH-^8)F A664?8UJD'N6;HQYGW&)>*ITAG>V=81WQW:%>N1RAGOO
M:H5[]&2%>_A=A7OY7(5[^5R%>_E<A7OY7(5[^5R%>_E<_V,: O]S% '_@14!
M_XX9 ?^9'@'VH2,"ZJDJ!."O,@?2K#X5QZ9+)+V@53.TFEX_K)5E2J60;5*>
MC'19F(A[8).%@V6.@HMJBH"3;H9^G7&"?:=T?WRT=GU\Q79]?N!S?W_N:W]_
M\V5_?O=>?W[X77]^^%U_?OA=?W[X77]^^%U_?OA=_V48 O]U$P'_A!0!_Y$7
M ?^<&P'RI2 !YJXF MNT+@;.KST4PZI)([FD4S&OGEP^IYED2:"4:U&9D')9
MDXUY7XZ*@&2)AXAIA(61;H"#FG%\@J5T>8&R=G>!PG9V@MUT>83M;'F#\F9Z
M@O=?>H+X7GJ"^%YZ@OA>>H+X7GJ"^%YZ@OA>_V<7 O]W$0'_AQ,!_Y05 /Z?
M& #NJAP!XK,A =6W*@7)LSL3OJY((K2H4C"KHUH]HIYB1YN9:5"4E7!8CI)W
M7HB/?F2#C89I?HN/;7F)F'%VAZ-S<H:O=7"&OW9OA]=U<XGM;7.(\F9TA_9@
M=(?W7W2']U]TA_=?=(?W7W2']U]TA_=?_VD5 ?]Z$ '_BA$ _Y<2 /FC% #J
MKA4 W;D7 ,^Z* 3$MSD1N;)&(*^L4"^FIU@[G:-@1I6?9T^.FVY6B)AU78*5
M?&-]DX1H>)&,;'./EG!OCJ!R;(VM=&J-O75IC=)U;)#M;6V.\6=NC/9@;HSW
M7VZ,]U]NC/=?;HSW7VZ,]U]NC/=?_VP3 ?]]#P'_C1  _YL0 /2H#P#EM0T
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MLSA"\,0X0?#?.4'O[SA [?TX0.S_.$#L_SA [/\X0.S_.$#L_SA [/\XRZ
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M%BC_LQ8G_\(6)__'%B?_QQ8G_\<6)__'%B?_QQ8G_\<6I+0  );   "'S
M>MH  &WK  !D_P4 7/\. 53_% %-_QP"2/\D!$+_+ 4^_S,&.O\Y!S;_0 @S
M_T4(,/]+"2[_40HK_U<**?]="R?_9 LD_VP,(O]V#2#_@ T>_XP.'?^7#AS_
MH0X;_ZP/&_^N#QO_K@\;_ZX/&_^N#QO_K@\;_ZX/E[P  (C)  !YU@  :^,
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M5L57[%7#6_E/PE[_2L!?_T:]8/]"NF#_0+I@_T"Z8/] NF#_0+I@_T"Z8/]
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M47Y]_U%^??]1?GW_47Y]_U%^??]1_V,4 ?]R#P'_@1  _XT1 /R8$@#LH1,
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MH?]0_W<' /")  #6F   RZ0# ,&M! "YM@, LL $ *O%% "CQ2@$F\(W#I'
M0QF)O4PD@+I5+GFX7#9RMF,];;1J0V>S<4ABL7E,7K"!4%JOBU16KY=64ZZC
M6%"NLEE/KL993Z[D6%&N]E13KO]05*S_352L_TU4K/]-5*S_352L_TU4K/]-
M_WT  -^/  #.G0  PZ@" +FP @"PN@( J,0% *',#P";S","DLHS"HG(/Q6!
MQDD?><12*'+"6C!KP6$W9K]H/&&^<$%<O7A%6+R!252\BTQ1NY9/3KNC44R[
MLU)*N\922KOD44R[]DY-NO]+3KG_24ZY_TE.N?])3KG_24ZY_TE.N?])[X4
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M+CWJ[RX]Z/PN/>?_+3WG_RT]Y_\M/>?_+3WG_RT]Y_\MQ9\  +6I  "HL0
MG+P  )#'  "$T@$ >M\& '3T$P!M]" "9O0J!%_T- A:]3T+5/5%#T_U3!),
M]5442?9=%T;V91A$]FX:0?9W'#_W@1T]]XT?._>9(#GXIB$X^+4B-_G((C;Y
MXR(V^/,B-O?\(C;W_"(V]_PB-O?\(C;W_"(V]_PBMZ8  *FN  "<N0  D,0
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M"A3_LPH4_[,*%/^S"A3_LPH4_[,*D[L  (3'  !UTP  9^$  %CH  !.^P
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M_W(9 ?]Y'P+_?B<#^8 P!?"!.0KG@$,1X'Q0&M9W6R3/<F8NR6UO-<1J>#O
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M&0'[AR ![XPG N2., 7:C3T,SX=*&,>"52._?5\MN7AH-;-T<#RO<7A"JVZ
M1J=LB$JD:9!.H&B849UFH5.;9:M5F&2X5Y9DR%B49.%8E6CT4)9K_TJ7;/]%
MEFW_099M_T"6;?] EFW_0)9M_T"6;?] _UD5 ?]F$ '_<A  _WT2 /^%%@#V
MC!L!ZI$B =^4*P/3D3H+R8Q'%\"'4R*Y@EPLLGUE-:UY;3RH=75"HW-]1Z!P
MA$N<;HQ.F6R54I5KGE22::A7D&FT68YHPUF,:-Q:C6SR4X]N_TR0</]'CW'_
M0X]Q_T&/<?]!CW'_08]Q_T&/<?]!_UL4 ?]H#P#_=0\ _X 1 /^)$P#RD!<
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M14FV\D-*M?]!2[7_/DNT_SU+M/\]2[3_/4NT_SU+M/\]XH,  ,V2  #!GP
MM*<  *JO  "@N   EL # (S*!P"&S10 @<TF GK,-0ASRT$/;,I*%V;)4QUA
MR%LC7,=B*%C&:BQ4QG(P4,5\,TW%AC9*Q)(Y1\2?.T7$KCQ$Q<$\0\7?/$3$
M\SM$P_\Y1<+_-T7!_S=%P?\W1<'_-T7!_S=%P?\WU8L  ,6:  "WI   JZP
M *"T  "6O@  B\<$ ('0" !XV0X ==D@ 6_8+P1IV#P)8]9&$%[64!59U5@:
M5=1@'U'4:").U'$F2]-[*4C3A2M%TY(N0M2?+T'4KS _U<(Q/]7A,#_3\C _
MTOTO/]'_+C_0_RX_T/\N/]#_+C_0_RX_T/\NRI0  +NA  "MJ0  HK$  ):[
M  "+Q   @,T# '78" !OY!$ :N0@ 63D+0->Y#@'6>1!"U7D2P]1Y%023>1=
M%DKD91A'Y&X;1>1W'4+D@A] Y(XA/N6;(SSEJB0[YKPD.N;3)#GE[B0YX_HC
M.>+_)#GB_R0YXO\D.>+_)#GB_R0YXO\DOYX  *^F  "CK@  E[@  (K"  !^
MS   <]8" &GE"0!D[Q0 7_ @ 5GP*P-4\#4%3_ ^!TOQ1@I'\4X,1/%7#D+Q
M7Q _\F<2/?)P%#KR>Q4X\X<6-O.4&#7THADS]+$9,O7%&C'UXAHQ]/$9,?'^
M&3'Q_QDQ\?\9,?'_&3'Q_QDQ\?\9LJ0  *6K  "8M@  B\   '[*  !QU0
M9=X  %[U"@!9_!, 4_P> 4[\)P)*_3 #1?TY!4']0 8^_D@'._Y/"3C_5PHV
M_UX+,_]G##'_< TN_WP.+/^)#RO_EA I_Z00*/^T$2?_QQ$G_^$1)O_R$2;_
M]A$F__81)O_V$2;_]A$F__81IZD  )FS  "+O@  ?LD  '#3  !DW@  6.<
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M2U>2[T=:DOU"7)/_/EV3_SM=D_\[79/_.UV3_SM=D_\[_VX  .!^  #.BP
MQ)4  +J=  "QHP  J:D  *&N"P";KQT!E*XN!(RL.PR%JD85?JA.''BF5B-R
MI%TJ;:)D+VFA:S1DGW,X8)Y[/%R=A3]9G(]"59N<15.;JD=1F[I'4)O11U&;
M[D13F_Q 59O_/%:;_SI6F_\Z5IO_.E:;_SI6F_\Z\70  -F#  #(D   OIH
M +.A  "JIP  H:X  )>U!@"2MA@ C+4J X6T-PE^LD(1=[!,&'&N5!]LK5LE
M9ZMB*F*J:2]>J7$S6JAZ-U:G@SI3IHX]4*:;0$VEJ4%+I;I"2Z;10DNE[3]-
MI?P\3J3_.4^D_S=/I/\W3Z3_-T^D_S=/I/\WY'H  ,^)  #"E0  MI\  *RE
M  "BK   F+,  (Z[ @"(O1( @[TE 7R\,P9VNS\-;[I)%&JX41IEMUD?8+9@
M)%RU9RE8M&\L5+-X,%&S@C--LHTV2K*:.$BQJ#I&LKDZ1;+1.D:Q[3E'L/PV
M1[#_-$BO_S-(K_\S2*__,TBO_S-(K_\SVX(  ,>0  "[G   KJ,  *2J  "9
ML0  C[D  (3  P![Q@T >,8> '/&+@-MQ3H(9\1%#F+#3A-=PU886<)>'57!
M9B%1P6XD3L!W*$O @2M(OXPM1;^:+T._J#%!O[HQ0<#2,4&^[C!!O?TO0;S_
M+D&\_RU!O/\M0;S_+4&\_RU!O/\MSHH  +^8  "QH   IJ@  )NP  "0N
MA;\  'K'! !OSPD :]$5 &?1)@%CT30$7M! "%G02@Q5SU,04<];%$[/8QA+
MSFL;2,YU'D7.?R!"SHPB0,Z9)#[.J"8\SKHF/,_4)CS-[R4[S/LE.\O_)3O*
M_R4[RO\E.\K_)3O*_R4[RO\EPY,  +6>  "HI@  G:X  )&V  "%OP  ><<
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M"B#\_ H@_/P*HJ<  )6Q  "'NP  ><8  &S/  !?V0  4M\  $CH  !#_P@
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M169Y[D!H>_TZ:GO_-FM\_S)K?/\R:WS_,FM\_S)K?/\R_V$  .IO  #9>@
MS(0  ,.+  "[D0$ M)4! *R7#@"EER$!GI8Q!9>3/@R0D$@4BHY1&X2+62%_
MB6 G>X=G*W>%;C!SA'4T;X)]-VN!ASMH@)$^97^<06)^J4-@?KE$7W[/1&!_
M[$!B@/PZ9(#_-F6!_S-F@?\R9H'_,F:!_S)F@?\R_V0  .5R  #3?@  QX<
M +Z/  "VE0  KID  *:;# "@G!X F9LN!)*9.PJ+ED82A91/&7^15Q]ZCUXE
M=8YE*G&,;"YMBG,R:8E[-F:(A#EBAH\]7X6:/UR%J$%:A;="687,0EJ%ZC]<
MAOLZ7H;_-E^'_S)?A_\R7X?_,E^'_S)?A_\R_6@  .!V  #-@@  PHP  +F3
M  "PF0  J)T  )^@"0"9H1H DZ K XR?. B%G4,0?YI,%WF85!UTEUPB<)5C
M)VN3:BQGDG$P9)%Y,V"/@C=<CHTZ68V9/5>-IC]4C;9 4XW+0%2-Z3U6C?HY
M5XW_-5F._S)9CO\Q68[_,5F._S%9CO\Q[6T  -E[  #(AP  O9   +28  "J
MG0  H:$  )>F! "1IQ4 C*<G H6F-09_I$ ->:)*%'.@4AINGUD?:9U@)&6<
M9RAAFV\L7IIW,%J8@#-6EXLV4Y>7.5&6I3M/EK0\3I;)/$Z6Z#I/EODV49;_
M,U*6_S!2EO\P4I;_,%*6_S!2EO\PYG(  -"   #"C   N)8  *V<  "CH0
MF:8  (ZM  "(KA$ @ZXB 7VM,01WK#T*<JI'$&RI3Q9GJ%<;8Z=>'U^F921;
MI&TG6*1U*U2C?RY1HHDQ3J&6-$NAI#9)H;0V2*'(-TB@YS5)H/DR2I__,$N?
M_RY+G_\M2Y__+4N?_RU+G_\MW7D  ,F&  "\D@  L9H  *:@  "<I@  D:P
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M'#;$_QPVQ/\<OI$  +";  "DHP  F*H  (RR  " N0  =,   &C'  !=S04
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M> (1_X@"$/^: A#_JP,._[X##O_5 P[_[0,.__ ##O_P P[_\ ,.__ #DZX
M (2X  !VP@  9\P  %K5  !,W   /^$  #7F   M]   *O\" ";_"P C_Q$
M(/\7 !W_'0 9_R, %O\I !3_+P 2_S4 $/\]  [_10$,_TX!"O]8 0?_90$%
M_W0! _^% 0+_E@$!_Z8! /^U 0#_Q@$ _\H! /_* 0#_R@$ _\H!AK<  '?!
M  !HS   6M<  $O>   ^Y   ,ND  "?M   C_P  '_\  !O_!0 7_PP %/\0
M !'_%  /_Q@ #?\=  O_(@ (_R@ !?\N  +_-0  _ST  /]'  #_4@  _UX
M /]M  #_?@$ _XX! /^; 0#_J0$ _ZL! /^K 0#_JP$ _ZL!_RHM ?\N*P'_
M,"L!_S N O\N-0+_*3T#_R5)!/\C5P3_(60%_Q]R!O\=?P;_'8H&_QV4!O\=
MG ?_'*,'_QRJ!_\<L0?_'+@&_QR_!O\<R0;_'-8&_QWE!O\=[P;_'?D%_QW_
M!?\=_P7_'?\%_QW_!?\=_P7_'?\%_QW_!?\=_P7_'?\%_RPK ?\P* '_,R@!
M_S,K O\Q,0+_+3H#_RM'!/\H5 7_)F$%_R1O!O\B? ?_(H<'_R*1!_\AF0?_
M(:$(_R&G"/\AK@C_(;4(_R&\"/\AQ@?_(=$'_R'B!_\B[0?_(O<'_R+_!OTB
M_P;\(O\&_"+_!OPB_P;[(O\&^R+_!OLB_P;[(O\&_RXH ?\S)0'_-B4!_S<G
M ?\U+0+_-#@#_S)$!/\O407_+%X&_RIK!_\I=P?_*(,(_R>-"/\GE@G_)YT)
M_R>D"?\GJPG_)[()_R>Y"?\GP@G_)\T)_R?>"?\GZPG\)_8(^2C^"/<H_PCV
M*/\(]2C_"/4H_PCU*/\(]2C_"/4H_PCU*/\(_S(E ?\W(@'_.B$!_SLC ?\[
M*0+_.S0"_SE !/\V307_-%H&_S%F!_\P<PC_+G\)_RZ)"O\ND@K_+9D+_RVA
M"_\MIPO_+:X+_RVU#/\MO@S^+<D,^RW9#/@MZ OT+O0+\2[^"^\N_PON+O\+
M[2[_"^PN_PKL+O\*["[_"NPN_PKL+O\*_S4B ?\['@'_/QT!_T ? ?]")@'_
M0C$"_T \ _\^2 7_.U4&_SEB"/\W;@K_-GD+_S6$#/TTC0W\-)4-^C2<#ODS
MHP[W,ZH/]C.R#_4SN@_S,\4/\C/2#^XSY0_J-/(/YS3]#^4T_P_D-/\.XC7_
M#N(U_PWA-?\-X37_#>$U_PWA-?\-_SD> ?\_&@'_0Q@!_T8: ?])(P'_22T"
M_T@X _]%1 7_0U '_T!="?L^:0OX/70-]3Q_#O,[B _Q.Y 0[SJ8$>TZGQ+L
M.:83ZCFN$^DYMA3G.<$4YCG.%>(YXQ7>.?$5VSK\%-@Z_Q/5._\2TSO_$M([
M_Q'2._\0TCO_$-([_Q#2._\0_ST; ?]#%@#_2!0 _TP7 ?]/'P'_4"@!_T\S
M O]-/P3[2DH&]4=7"?%&9 SM1&\.Z4-Y$>="@Q/D08L4XD"3%N _FQ??/Z(8
MW3ZJ&=L^LQK8/KT:UC[*&](^WQO./N\;RS_[&LE _QC'0/\7QD'_%<5!_Q3$
M0?\4Q$'_%,1!_Q3$0?\4_T$7 /]'$@#_3!  _U(4 /]6&P#_5R0!_U8N OA4
M.0/Q444&ZT]2">9-7@SA2VD0W4ET$]E(?1;51H88TD6.&M!%EAS.1)T=S$2E
M'LI#K1_(0[8@QD/#(<5#TR'!0^DAOD3W'[Q%_QVZ1O\;N4?_&;A'_QBX1_\7
MN$?_%[A'_Q>X1_\7_T04 /]+$ #_40X _U<1 /];%@#_71X ^5TH >];,P+G
M63\$X%=-"-I460W34F02SE!N%LI.=QG'3( <Q4N('L)*D"# 2I<AODF?([Q(
MIR2Z2+ EN$B\)K=(RR>T1^,GLDGS);!*_R*N2_\?KDS_':U,_QNM3?\:K4W_
M&JU-_QJM3?\:_T<1 /]/#0#_5@P _UP. /]@$@#]8A@ \&,A .9B+ '>8#H#
MU%Y(!\U;5 W'6%\3PU9I%[]4<AN\4GH>N5&"(;90BB.T3Y$ELDZ9)[!-HBBN
M3:LJK$RV*ZI,Q"RH3-LLIDWO*J1/_2:D4/\CHU'_(*-2_QZB4O\=HE+_':)2
M_QVB4O\=_TH/ /]2"@#_6@D _V + /]E#@#U9Q$ Z&@8 -UG) #29C4"RF1$
M!\-A4 V]7EL3N5QD&+5:;1RQ6'4@KE=](ZQ5A"6I5(PHIU.4*J52G2RC4J8M
MH5&Q+Y]1OC"=4=$PFU'J+YI3^BJ:5?\FF5;_(YE6_R&95_\?F5?_'YE7_Q^9
M5_\?_TT- /]5!@#_704 ^V0' .]I"0#I:PP X6P0 --M'@#);#$"PFI ![MG
M3 VU9%<3L&%@&:Q?:1VH77$AI5QX)*):@">@68<JG5B0+)M7F"Z95J(PEE6L
M,I15N3.35<HSD57E,Y%7]RV16?\ID5K_)9%;_R.16_\AD5O_(9%;_R&16_\A
M_T\+ /]7 @#_80( ZF@! -YM! #8< @ U7 + ,MR&P#"<2X"NF\]!K1L20VN
M:503J6==&:1D91VA8FTAG6%T)9I??"B87H,KE5V++9);E#"06YXRC5JH-(M9
MM36*6<8VB%GA-HA<]#"(7?\KB5[_*(E?_R6)7_\CB5__(XE?_R.)7_\C_U$)
M /]:  #U9   X&P  -=Q P#0= 8 S74) ,1V%P"\=BH!M'0Z!:YQ1@RG;E$2
MHFM:&)YI8AV:9VDAEF5Q)9-D>"B08H KC6&(+HM@D3&(7YHSAEZE-8->LC>"
M7L(W@%[<.(!?\C.!8?\M@F+_*8)C_R:"9/\E@F3_)8)D_R6"9/\E_U,& /]=
M  #G9P  VV\  -!T @#*> 4 QGD' +YZ%0"V>B@!KW@W!:AV1 NB<TX2G'!7
M&)AM7QV4:V<AD&IN)8UH=2B*9WTKAV6%+H1DCC&!8Y<T?V*B-GQBKSAZ8KXY
M>6+5.7EC[S1Z9?XO>V;_*WQG_RA\9_\F?&?_)GQG_R9\9_\F_U4# /]@  #C
M:@  U7(  ,QX 0#%>P, P'T% +E^$@"Q?B4!JGTU!*-Z00J==TP1EW15%Y)R
M71R.<&0@BFYK)(=L<BB$:WHK@6J"+GYIBS%[9Y4T>&>@-G9FK#AT9KPY<V;1
M.G-G[39T:?TP=6K_+'9K_REW:_\G=VO_)W=K_R=W:_\G_U<  /9C  #?;0
MT74  ,A[  #!?P( NX # +2!$ "L@B,!I8$R!)Y^/PF8>TH0DGE3%HUV6QN)
M=&(@A7)I)(%Q<"=^;W<K>VY_+GAMB#%U;)(T<VN>-W!JJCEN:KDZ;6K..FUK
MZS=O;?PQ<&[_+7%N_RIQ;_\H<6__*'%O_RAQ;_\H_UD  .ME  #;<   S7@
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MB@  K(P  *.."@"=CAH EXXK I",. :*BD,,A(=,$G^%51AZA%P==H)C(7.
M:B5O?W$I;'YY+&A]@B]E?(PR8GN8-5]ZI#==>K,X7'K'.5QZY3=>>_@R7WO_
M+F!\_RMA?/\I87S_*6%\_REA?/\I]6(  -YO  #,>@  P(,  +>)  "OC@
MII$  )V2!@"7DQ< D9,H 8N2-@6%D$$+?XY*$7J,4A9UBEH;<8AA'VV':"-J
MAF\G9H1W*V.#@"Y@@HHQ78&6-%J!HS98@+(W5H#%-U: XS98@?<Q68'_+5N"
M_RI;@O\I6X+_*5N"_RE;@O\I[&8  -AS  #'?@  O(<  +..  "ID@  H)4
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M)$>:_R1'FO\DU'<  ,*$  "VCP  JY8  *&<  "6H   BZ4  '^J  !TK@4
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MF DMTZD)+-.^"BS3WPDKT?,**L_^"RG._PPIS?\-*<W_#2G-_PTIS?\-KI@
M **?  "6I@  B:X  'RV  !OO0  8\,  %?(  !,S0  0M(# #G9"0 UWQ
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M 0G_I@$(_[H!!__4 0?_ZP$&__8!!O_V 0;_]@$&__8!CZP  ("V  !ROP
M8\D  %;1  !(V   .]T  ##B   FY@  '_   !S_   9_PD %O\. !3_$P 1
M_QD #_\>  W_)  +_RL "?\R  ;_.P #_T0  /]/  #_7   _VL  /]]  #_
MD   _Z,  /^T  #_Q@  _]8  /_6  #_U@  _]8 @K4  '._  !DR0  5M,
M $?;   ZX   +N4  "/I   :[0  %?T  !+_   0_P( #O\)  O_#0 (_Q
M!/\3  '_&   _QX  /\D  #_*P  _S,  /\]  #_20  _U8  /]F  #_>
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M+(-7[RF#6/XD@UG_((1:_QZ$6O\<A%K_'(1:_QR$6O\<_TX! /]7  #E7P
MV&8  ,YJ  #'; , PVL% +QL$@"T;24 K6PU Z=J0@>A9TT,G&56$9AC7A64
M8F48D6!L&XY?=!Z,7GLAB5V#)(9<C":$6Y4H@5J@*G]:K"Q]6KLM?%K/+GM;
M["M\7/PF?%W_(GU>_Q]]7O\=?5[_'7U>_QU]7O\=_U   /59  #A8P  TFH
M ,EN  #"< $ O7 # +9P$ "N<2( J' R J%N/P:<;$H+EVI3$))H6Q2.9F(8
MBV5I&XAC<!Z%8G@A@F& )(!@B29]7Y(I>UZ=*WA>J2UV7K@N=5[,+W1>Z2UU
M8/HG=F'_(W=B_R!W8O\>=V+_'G=B_QYW8O\>_U(  .Q<  #<9@  SFT  ,1R
M  "]=   MW0! +!T#@"I=1\ HG0O IQR/067<$<*D6Y1#XUL612):F 7A6EG
M&X)H;AY_9G4A?65])'IDAB=W8Y I=6.;+')BIRYP8K8O;V+)+VYBYBYO9/DH
M<&7_)'%F_R%Q9O\?<6;_'W%F_Q]Q9O\?_U0  .A?  #7:0  RG   ,!U  "Y
M>   LG@  *MX#0"D>1T GG@M 9=W.@62=44*C').#HAP5A.$;UX7@&UD&GUL
M:QUZ:W,@=VI[(W1I@R9R:(TI;V>9+&QFI2YJ9K,O:6;&,&AFY"]J:/<I:VG_
M)6QI_R)L:O\@;&K_(&QJ_R!L:O\@_U<  .1B  #2;   QG,  +UX  "U>P
MK7P  *5\"@"??1H F7PJ 9-[. 2->4,)B'=,#H-U5!)_<UL6>W)B&7AP:1UU
M;W @<FYX(V]M@29L;(LI:FR7+&=KHRYE:[(O9&O$,&)KX2]D;/8J9FW_)F9M
M_R-G;O\@9V[_(&=N_R!G;O\@]ED  .!E  #.;P  PG8  +E\  "Q?P  J8
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M(%=\_R!7?/\@Y60  ,]P  #!>@  MH,  *V)  "CC   F8X  (V/  "&D X
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MEQH]HZ<;/*.Y'#NCTAL[HN\;.Z#^&CN?_QD\G_\8/)__&#R?_Q@\G_\8Q'P
M +:)  "JD@  GY<  )6<  ")H0  ?:8  '&J  !DK@  6K$( %>Q% !5LB,
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M!"7-S@0ER^X$),G\!B/(_P<CQ_\'(\?_!R/'_P<CQ_\'J98  )Z=  "2HP
MA:L  'BR  !KN   7[X  %+"  !'Q@  /<H  #3/!  KU D )MD/ "79&0 E
MVB4 )-HP "/;.P CVT4 (MQ0 "'=6P @W6@ 'MYV !W>AP$<WYD!&M^L 1G?
MQ $8WN<!&-SX 1C;_P(7VO\"%]K_ A?:_P(7VO\"H)P  )2C  "'JP  >;,
M &RZ  !?P0  4L8  $;*   [S@  ,=,  "G9   AW@4 'N@. !WH%0 ;Z1X
M&>DG !CJ,  6ZCD %>M# !3L3@ 2[%H $>UG !#N=P 0[HH #N^>  [PLP -
M\,T #._L  SM_  ,Z_\ #.O_  SK_P ,Z_\ EZ,  (FK  ![M   ;;P  %_$
M  !2R@  1<X  #G3   OV   )=T  !WA   8[ ( %O<+ !3W$0 1^!< $/@>
M  [Y)0 -^2T "_HU  G[/P '^TH !/Q7  /]9@ "_G<  /V+  #]GP  _+4
M /S1  #\[0  _/P  /S]  #\_0  _/T BZL  'VT  !NO0  8,8  %+-  !$
MT@  -]@  "S=   BX0  &>4  !/J   0^@  #O\&  W_#  *_Q  !_\4  3_
M&@ !_R   /\G  #_,   _SH  /]%  #_4P  _V(  /]U  #_B@  _Y\  /^S
M  #_QP  _^4  /_E  #_Y0  _^4 ?[0  '"]  !AQP  4]   $/6   VW0
M*N(  !_F   6Z@  $.T   SZ   )_P  !O\   +_!   _PD  /\-  #_$
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M.-<0M3CL$+(Y^P^P.O\.KSK_#:XZ_PRM.O\+K3K_"ZTZ_PNM.O\+_SP- /]
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M&IM$\Q>91?\5F$;_$YA&_Q&81O\0ET;_$)=&_Q"71O\0_T(% /]'  #W3P
MY5,  -U5 0#7508 U5(+ ,M3&0##5"L O%0[ ;922 2Q45('K5!<"JE.9 VF
M36P/I$QT$:%+>Q.?2H(5G4J*%YM)DQB929P:ETBF&Y5(LAR42,$=DDC8'9!)
M[QN/2OX8CTO_%HY+_Q2.3/\2CDS_$HY,_Q*.3/\2_T4  /]+  #I4P  WE@
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M&W=9_QEW6?\7=UG_%G=9_Q9W6?\6_TP  .E6  #97P  RV4  ,%H  "Z:0
MM&@  *UG#0"F:!P H&@M 9IG.@.5944&D&-."HQB5PV)85X0AE]E$X->;!:
M77,8?EQ[&GM<@QUY6XT?=EJ8(71:I"-R6K(D<5K$)6]:X25P6_8@<5S_''%=
M_QIQ7?\8<5W_%W%=_Q=Q7?\7_4\  .59  #38@  QV@  +UL  "V;0  KVP
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M&6)H_QEB:/\9[%<  -EB  #':P  O'(  +-W  "J>0  H7D  )=W 0"0>!$
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MEAY,?Z4@2G^V(4E_S"%)?NL?2G[\'$M^_QI+?O\93'[_&$Q^_QA,?O\8U6<
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M$S>>R!,WG>@2-IOZ$C::_Q(VF?\1-YG_$3>9_Q$WF?\1OGL  +&'  "ECP
MFY0  )"8  "$G   =Z   &ND  !?IP  4JH  $VK#@!+JQH 2JLG $BK,P!&
MJST!1*M& 4*K3@) JU8#/JM?!3NK: 8YJG,(-ZJ "32JCPLRJI\,,:JP##"J
MQPPPJ><,+Z?Z#2^F_PTOI?\-+Z7_#2^E_PTOI?\-MH0  *J.  ">E   E)D
M (>>  ![HP  ;Z@  &.L  !7KP  2[(  $&U!@ ^MA$ /;8> #NV*0 ZMS0
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M !#3_P 0TO\!$-'_ 1#1_P$0T?\!G)H  )&A  "#J   =;   &BW  !;O0
M3L$  $+%   WR   +<P  "30   <U0  %=H% !#B"P 0XQ$ #N0:  [D(P -
MY2T #.4W  OF0@ *YD\ ">==  CG;0 &YH  !>:5  3FJP "YL0  >;F  #G
M^0  Y_\  .;_  #F_P  YO\ DZ$  (6I  !WL0  :;D  %O   !.Q@  0<H
M #7.   JT@  (=8  !G;   2WP  #>,   OQ"  )\PX !_,3  3R&@ "\B(
M /(J  #R-   \C\  /),  #R7   \FT  /*"  #RF   \ZT  //&  #TY0
M]/8  /3[  #T^P  ]/L AZD  'FR  !JN@  7,(  $[)  ! S@  ,],  "C8
M   >W0  %>$   _D   *Z   !?,   /] 0  _ @  /L-  #[$0  ^Q8  /P>
M  #\)@  _#   /T\  #^20  _EH  /YM  #_@@  _Y@  /^L  #_P   _]@
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M ,( _P#- /\ WP#_ .P _P#X /\ _P#] /\ _0#_ /T _P#] /\ _0#_ /T
M_P#] /\ _Q\C /\?(0#_'B$ _QDC /\3*0#_#C( _PQ  /\)30'_!UH!_P1G
M ?\#<P'_ WT!_P.' ?\#CP#_ I8 _P*< /\"H@#_ J@ _P*O /\!M@#_ ;X
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M!;HK^0:X+/\&MBS_!;4L_P6T+/\%M"S_!;0L_P6T+/\%_S0, /\V!0#_.0,
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M$(E&_PZ(1O\-B$;_#8A&_PV(1O\-_T   /)'  #C3P  U%,  ,M5  #$5
MP% $ +E/$0"R4"( K%$R *=1/P*B4$H#GD]3!9M.7 B836,*E4QJ#)-+<0V1
M2GD/CDJ $8Q)B1**29(4B$B<%89(J!:%2+47@TC'&(%(Y!B!2O<5@$K_$H!+
M_Q" 2_\/@$O_#H!+_PZ 2_\._T,  .Q+  #=4P  SE@  ,1:  "]6@  N%<!
M +%4#@"J5AX I58N )]6.P&;548#EU10!9-36 B04E\*C5%F#(M0;0Z(3W00
MAD]\$H1.A1."3HX5@$V9%WY-I!A\3;(9>DW#&GE-WQIX3O07>$__%'A/_Q)X
M4/\0>%#_#WA0_P]X4/\/_48  .=/  #65P  R%P  +]?  "W7P  L5P  *I9
M# "D6AH GELJ )E;. &46D,#D%E,!8Q850B)5UP*AE9C#(-5:@Z!5'$0?U-Y
M$GU3@11Z4HL6>%*5&'91H1ET4:\;<U' &W%1VQQQ4O(9<5/_%7%4_Q-R5/\1
M<E3_$')4_Q!R5/\0\T@  .-3  #06P  Q&   +IC  "S8P  K&$  *1>"0"=
M7Q< F%\G )-?-0&.7D #BEU*!89<4@>#6UD*@%I@#'U99PY[6&X0>%AU$G97
M?A1T5H@7<E:3&&]6GQIN5:P;;%6]'&M6U1UK5O ::U?_%VM8_Q1L6/\2;%C_
M$6Q8_Q%L6/\1\4L  -]6  #,7@  P&0  +=G  "N:   IV8  )]B!@"88Q0
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MEAI89Z0<5F>T'55GRAU59^@;5F?[&%=G_Q97:/\46&?_$UAG_Q-89_\3X5@
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M=   JWL  *)_  "7@0  C($  'I^  !S?P( ;G\1 &N '@!H@"P 98 W 6*
M0 -??T@$7'Y0!EE^5PA7?5X+5'QF#5%\;@]/>W@13'N#%$IZD19(>I\71GJO
M&$5ZQ!A$>N0817GX%D9Y_Q1&>/\21WC_$4=X_Q%'>/\1S64  +UP  "Q>0
MIX   )R$  "2A@  AH8  '>&  !KA@  9H<- &.'&0!@B"< 7H@S 5N(/ )8
MAT4#5H=-!%.&5 90AEL(3H5C"DN$; Q)A'8/1H.!$42#CQ-"@YT40(*N%3^#
MPA4^@N(5/X'W$S^!_Q) @/\10(#_$$" _Q! @/\0QFL  +=V  "L?P  HH4
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M!RFA_P<IH/\(*9__""F?_P@IG_\(L8(  *6+  ":D0  D)8  (.:  !VGP
M:J(  %ZF  !2J0  1JL  #RM   UKPP ,[ 5 #*P(0 QL"L +[ U "ZQ/@ M
ML4@ ++%1 "NQ6P IL6<!)[%T 2:Q@P$DL90"([&F B*RNP(ALML"(:_S R"N
M_P,@K?\$'ZS_!!^L_P0?K/\$JHL  )V1  "3EP  AYP  'JB  !MIP  8*L
M %6O  !)L0  /K0  #.W   JN@, )+P- "*]%0 AO2  (;TJ ""],P ?OCT
M'KY' !V^4@ <OUX &K]L !F_?  8OXX %\"A !; M@ 4P-, %;[Q !6\_P$5
MN_\!%+K_ A2Z_P(4NO\"H9(  ):8  "*G@  ?:0  &^J  !BKP  5K0  $JW
M   ^N@  ,[T  "K    AQ   &<<% !/+"P 1S!( $<P; !#,)0 /S2\ #LTZ
M  [-1@ -S5( #<Y@  S.<  +SH, "LZ7  G.K  (SL8 ",[H  C-^P )R_\
M"<O_  G+_P )R_\ F)@  (V>  !_I0  <:P  &2S  !7N0  2KT  #[    R
MPP  *,8  !_*   7S0  $=$   S6!0 (V0P !MD2  7:&P $VB0  ]LN  ';
M.0  W$4  -U2  #>8@  WG,  -Z(  #?G0  W[,  -_.  #@[@  W_H  -__
M  #?_P  W_\ CY\  (&F  !SK@  9;4  %B]  !*P@  /<4  #')   FS
M'=   !34   .V0  "=T   /A    XP<  .,-  #D$@  Y1D  .8B  #G*P
MZ38  .M#  #L4@  [&(  .UV  #NC   [J$  .^W  #OT0  [^L  /#V  #P
M]@  \/8 A*<  '6O  !GMP  6;\  $O&   \R@  +\X  "32   :V   $MP
M  S@   %XP   .<   #K    ZP   .T%  #N"P  \!   /$5  #S'@  ]"<
M /<S  #Y0   ^E$  /MC  #\=P  _8T  /VC  #^M@  _LD  /_?  #_WP
M_]\ =[   &BY  !:P0  3,H  #S/   NU   (MH  !?>   0X@  ">8   #I
M    [    /    #V    ]@   /<   #X    ^@<  /L-  #]$0  _QD  /\C
M  #_+P  _SX  /]/  #_8@  _W<  /^-  #_GP  _ZX  /^Z  #_N@  _[H
M_Q8C /\5(0#_$B$ _PXD /\&*@#_ #, _P!! /\ 3@#_ %P _P!H /\ = #_
M 'X _P"' /\ CP#_ )8 _P"< /\ H@#_ *@ _P"N /\ M0#_ +T _P#' /\
MU@#_ .< _@#S /X _@#] /\ _ #_ /L _P#[ /\ ^P#_ /L _P#[ /\ _QH@
M /\9'@#_%AX _Q @ /\*)0#_!#  _P ] /\ 2P#_ %@ _P!D /\ < #_ 'H
M_P"# /\ BP#_ )( _P"8 /\ G@#_ *0 _P"J /\ L0#] +D ^P## /H T #X
M ., ]P#Q /8 _ #T /\ ] #_ /, _P#S /\ \P#_ /, _P#S /\ _QT< /\<
M&0#_&1D _Q0; /\._^+_XDE#0U]04D]&24Q%  @)(0#_#"P _PDY /\%1@#_
M E, _P!? /\ :P#_ '4 _P!^ /\ A@#_ (X _P"4 /X FP#\ *$ ^@"G /@
MK@#U +4 \P"_ /$ RP#P -\ [@#N .P ^0#K /\ Z@#_ .H!_P#I ?\ Z0'_
M .D!_P#I ?\ _R 7 /\?% #_'!, _Q<5 /\6'0#_$R@ _Q T /\-00#_#$X
M_PE: /\(9@#_"'  _@=Y /P'@0#Z!XD ^ >0 /8&E@#S!IT \0:C .\&J@#M
M!K( Z@:[ .@&R #F!MP Y ;L .((^@#@"O\ W@O_ -T+_P#=#/\ W S_ -P,
M_P#<#/\ _R,2 /\C$ #_(0X _QX0 /\>& #_'", _Q@O /\4.P#_$DD _!!5
M /@/8 #T#VH \0]T .\.? #M#H0 ZPZ+ .D.D@#G#ID Y@Z@ .0.IP#B#J\
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M /\O  #_,@  _S," /DR" #W+PX ZRL6 .$G(@#8)S( T"E! ,LJ3@#&*ED
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M"Y$YY0N/.O<*C3K_"8P[_PB,._\'C#O_!XP[_P>,._\'_S@  /$^  #C10
MU$D  ,M*  #%1P  P4$$ +H_$0"S02$ K4(Q *A#/@"D0TD!H$)3 IU!6P.;
M06($F$!J!99 <0:4/W@'DC]_") _B J//I$+C3Z;#(L^I@V)/K,-B#[$#H8_
MX Z$/_0-@T#_"X- _PJ"0/\)@D'_"()!_PB"0?\(_SP  .M#  #<2@  S$\
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M$&Q/_PYL3_\,;$__"VQ/_PML3_\+[D4  -Q0  #)5P  O5P  +1>  "L7@
MI%L  )Q6! "55A( D%<A (M8+P"'5SL!@U9$ G]630-\550%>E1;!G=48@AU
M4V@)<U-P"W%2> UO4H(/;5&-$6M1F1)I4:849U&V%691RQ5E4ND495+[$693
M_P]F4_\-9E/_#&93_PQF4_\,ZDD  -53  #%6@  NE\  +!B  "H8@  GU\
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M#5=>_PU77O\-WE,  ,A=  "[9   L&H  *9M  "=;@  DVT  (5G  !^9PD
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M' !F<B@ 8W(T &!R/0%><D4"6W%- UEQ5 57<%L&5'!C"%)O:PI0;W0,36Z
M#DMNC1!);IL11VVK$D9NOA-%;MP21FWT$49M_P]';?\.1VS_#4=L_PU';/\-
MS%\  +QI  "P<0  I7<  )Q[  "1?   AGL  '5X  !K=P  97<, &%X%P!?
M>"0 77DP %IY.@%8>4("5GA* E-X4011=U@%3W=@!TQV: A*=G(*2'5]#$5U
MB@Y#=9D/0G6I$$!UO!! ==D00'3S#T!T_PY!<_\-07/_#$%S_PQ!<_\,QF0
M +=N  "K=@  HGP  )=_  ",@0  @8$  '*   !E?P  77\( %E_$P!7@"
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M!BV2MP8LDM$&+)'O!BN/_P8KCO\&*XW_!RN-_P<KC?\'LW@  *>"  "<B
MD8P  (>0  !ZDP  ;94  &&7  !5F0  29L  #^< 0 YG0X -YT7 #:>(@ T
MGBP ,YXU #*>/@ QGD< ,)]0 "Z?6@ MGV0!*Y]Q 2F>?P(GGI ")IZA B2>
MM0(CGLX"(YWN R.;_@,BFO\$(IG_!"*9_P0BF?\$K($  *"(  "5C@  BY(
M '^6  !RF@  99T  %F@  !.HP  0J0  #>F   NJ 4 *:D/ "BI&  GJB(
M)JHL "6J-0 DJC\ (ZI( "*K4P AJUX (*MJ !ZK>0 =JXL &ZN= !JKL0 9
MJ\H &:KL 1FH_0$8I_\"&*;_ ABF_P(8IO\"I8D  )F/  "/E   @YD  '6>
M  !HH@  7*8  %"I  !$K   .:X  "^P   FLP  'K4& !FW#P 8MQ< %[<A
M !:W*@ 5MS0 %+@^ !.X20 2N%0 $KEB !&Y<0 0N8, #[F7  ZYK  -N<0
M#;CG  ZV^P .M?\ #K3_  ZT_P .M/\ G)   )*5  "&FP  >:   &NF  !>
MJP  4J\  $:R   ZM0  +[<  "6Z   =O0  %<   !##!@ +Q@X "L45  G%
M'@ (Q2@ !\4R  ;&/0 %QDD !<97  /&9@ "QG<  <:+  #&H   Q;8  ,;2
M  #%[P  Q?P  ,7_  #%_P  Q?\ E98  (F<  ![HP  ;:D  &"O  !3M
M1K@  #J[   NO@  ),$  !O$   3QP  #LH   C. 0 !T H  - 0  #0%@
MT1X  -(G  #3,0  U#P  -5)  #66   UFD  -9\  #6D@  UJ<  -:_  #6
MX   UO,  -;^  #6_P  UO\ C)T  'ZD  !OJP  8;(  %2Y  !&O0  .<$
M "W$   BQP  &<L  !'.   ,T@  !=4   #;    W ,  -T*  #>#P  WQ0
M .$<  #B)   Y"X  .8Z  #G20  Z%D  .AK  #I@0  Z9@  .FM  #IQ0
MZ>(  .GR  #I]0  Z?4 @*4  '&M  !CM0  5;P  $?"   YQ@  +,H  "#.
M   6T@  #]8   C;    WP   .,   #E    YP   .@!  #J!P  ZPT  .T1
M  #O&   \2$  /,K  #V.   ]T@  /A:  #Y;0  ^H0  /J;  #ZKP  ^L(
M /K:  #ZWP  ^M\ =*X  &6V  !6O@  2,8  #G+   KT   ']0  !3:   -
MWP  !>,   #F    Z0   .T   #O    \0   /,   #U    ]@(  /@)  #Z
M#@  _1,  /\<  #_*   _S8  /]'  #_6@  _VX  /^%  #_F@  _ZL  /^Y
M  #_O   _[P _Q$@ /\0'@#_#!X _P0A /\ )P#_ #  _P ^ /\ 3 #_ %D
M_P!E /\ < #_ 'H _P"# /\ BP#_ )( _P"8 /\ G@#_ *0 _P"J /\ L #_
M +@ _P#" /\ S@#_ .( _@#P /T ^P#[ /\ ^P#_ /L _P#Z /\ ^@#_ /H
M_P#Z /\ _Q0< /\2&@#_#AH _P@< /\ (0#_ "T _P Z /\ 2 #_ %4 _P!A
M /\ ; #_ '8 _P!_ /\ AP#_ (X _P"4 /\ F@#^ *  _0"F /P K #[ +0
M^0"] /@ R0#W -P ]0#L /, ^ #S /\ \@#_ /$ _P#P /\ \ #_ /  _P#P
M /\ _Q<8 /\5%@#_$14 _PP7 /\%'0#_ "@ _P V /\ 0P#_ %  _P!< /\
M9P#_ '$ _P!Z /P @@#Z (D ^ "0 /< E@#U )P ] "B /, J #Q +  \ "X
M .X PP#L -, Z@#G .D ]0#G /\ Y@#_ .4 _P#E /\ Y0#_ .4 _P#E /\
M_QH3 /\8$0#_%!  _P\1 /\-&0#_"B0 _P4P /\!/@#_ $L _P!7 /X 8@#Z
M &P ]0!U /( ?0#P (0 [@"+ .P D0#K )< Z0"> .< I #F *P Y "T .(
MOP#@ ,T W@#C -P \@#: /T V #_ -8 _P#5 ?\ U0'_ -4"_P#5 O\ _QX0
M /\<#0#_%PL _Q4. /\4%0#_$1\ _PXJ /\+. #]"$4 ^ 91 /0$7 #N!&8
MZ@1O .8#=P#D!'\ X@2& . $C #>!), W06: -L%H #8!:@ U06Q -(%NP#0
M!LD S@?@ ,P(\0#)"O\ QPO_ ,8,_P#%#/\ Q0S_ ,4,_P#%#/\ _R$, /\@
M!@#_' , _QT* /\;$ #_&!@ _Q0C /81, #O#CX Z@Y* .4-5@#A#6  W0UI
M -D-<0#5#7D TPV! -$-B #/#8\ S0Z6 ,L.G0#*#J4 R ZN ,8/N0#$$,@
MPA#? +X1\@"[$O\ N1/_ +<3_P&V$_\!MA/_ ;83_P&V$_\!_R4& /\C  #_
M(P  _R0# /\A"@#]'1$ \1H; .@6)P#A%#4 VA-# -,43P#.%5D RQ5C ,@6
M:P#%%G, PQ=[ ,$7@@# &(D OAB0 +P8F "[&:  N1FI +<9M "U&L( M!K6
M + ;[0&M'/P!JQW_ :D=_P&I'?\!J!W_ :@=_P&H'?\!_R@  /\G  #^*@
M[RH  .<G 0#G(@D Y!T0 -D;'0#/'2T R1X\ ,0@20"_(%, O"%= +DA90"W
M(FT M2)T +,B? "Q(H,!L"** :XBD@&L(YL!JR.D :DCKP&G([P!IB3. :,D
MZ *@)?D"GB7_ ITE_P*<)?\"FR7_ ILE_P*;)?\"_RP  /\M  #M,@  XC0
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M!WP[_P9\._\%?#O_!7P[_P5\._\%]#<  .5   #21P  Q4H  +Q+  "U20
MKT,  *D^"P"B/Q< G4 F )A!- "403\ D4%) 8Y!40&+0%D"B4!@ X= 9P.%
M/VT$@S]U!8$_?09_/H<'?3Z1"'L^G EZ/JD)>#ZX"G<_S0IU/^H*=$#\"'1
M_P=T0/\&<T#_!G- _P9S0/\&\3L  -]%  #,3   OT\  +90  "N3P  ITH
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M"&!._PA@3O\(XT<  ,U0  "^5P  LUL  *I=  "A70  F%H  (U3  "&4@P
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M'P!N7"L :UPV &A;/P%E6T<!8UM. F%:50-?6EP$75IC!5M::P99674(5UF
M"E59C M469H-4EFJ#E%9O Y06=@.4%GR#5%9_PM16?\*45G_"5%9_PA16?\(
MU%$  ,):  "T80  JF8  *!H  "7:0  C&<  'U@  !U7P, ;U\0 &M?' !H
M8"@ 9F S &-@/ %A8$0!7U], EQ?4P-;7UH$65]A!5=>:0957G,(4UY^"5%=
MB@M/79D,35VH#4Q>N@Y+7M0.2U[Q#$Q>_PM,7?\*3%W_"4Q=_PA,7?\(SU0
M +Y>  "Q90  IVH  )UM  "4;0  B6P  'AE  !O9   :60. &5D&0!B9"4
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M"3MPM0H[<,T*.F_L"3MN_@@[;O\(.VW_!SMM_P<[;?\'OV(  +%K  "F<P
MG7D  ))[  "'?   >WP  &UZ  !@>   5G<! %!W#@!.>!@ 3'@D $MY+@!)
M>3< 2'E  $9Y2 %$>4\!0GE7 D%Y8 (_>&D#/'AT!#IX@@4X>)$&-WBA!S5X
MLP<T>,L'-'?K!S1V_0<T=?\'-77_!C5T_P8U=/\&N6@  *UQ  "B>0  F'X
M (V   ""@0  =H(  &F!  !;@0  48$  $B "@!%@1, 0X$> $*"*0!!@C(
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M 1R5^@$;E/\!&Y/_ AN3_P(;D_\"IW\  )R&  "1BP  AX\  'J2  !ME0
M89@  %6;  !)G0  /9X  #.?   JH0  (:,* !^C$0 >HQH ':0D !RD+0 ;
MI#8 &J0_ !FD2@ 8I%4 %J5A !6E<  4I8$ $Z64 !*EJ  1I;\ $*3B !&B
M^  1H?\ $:#_ 1&@_P$1H/\!H(8  )6,  ",D0  ?Y4  '&:  !DG@  6*$
M $RD  ! I@  -:<  "JI   BK   &:X  !*P"0 0L1  $+$8  ZQ(@ .L2L
M#;$U  VQ0  ,L4L "[%8  JQ9P (L7@ ![&+  6QH  $L+4 !+#0  2P[P %
MK_X !J[_  :N_P &KO\ F(X  (^3  ""F   =9T  &>B  !:IP  3JL  $&M
M   UKP  *[$  "&T   8M@  $;D   V\ P 'O@P  [T2  &]&0  OB(  +XK
M  "^-@  OD$  +].  "_7   OVT  +^   "^E0  OJH  +["  "]Y   O?8
M +W_  "]_P  O?\ DI0  (6:  !XH   :J8  %RK  !/L   0K,  #6V   J
MN   (+L  !>^   0P0  "\0   3'    R0<  ,D-  #)$@  RAD  ,LB  #+
M*P  S34  ,Y!  #.4   SV   ,]R  #/AP  SYT  ,^S  #/S@  S^L  ,[X
M  #._@  SOX B)L  'JB  !LJ   7J\  %"U  !"N0  -;P  "F_   >P@
M%<8   [)   (S    -    #3    U0   -8&  #8#   V1$  -L6  #<'P
MWB@  . T  #B00  XE$  .-C  #C=P  Y(X  .2D  #DN@  Y=0  .7J  #E
M\P  Y?, ?*,  &ZJ  !@L@  4;D  $.^   UP@  *,8  !S)   3S0  #-$
M  35    V@   -X   #A    X@   .0   #E P  YPD  .D.  #K$@  [1H
M .\D  #R,0  ]$$  /13  #U9@  ]7P  /:3  #VJ0  ][P  /?.  #WWP
M]]\ <*P  &&T  !3NP  1<,  #;'   GS   &]   !'5   *VP   -\   #B
M    Y0   .D   #L    [0   /    #Q    \P   /4$  #W"@  ^A   /P6
M  #_(0  _RX  /]   #_4P  _V@  /^   #_E@  _Z@  /^V  #_OP  _[\
M_PT< /\*&P#_ AL _P > /\ ) #_ "X _P \ /\ 2@#_ %8 _P!C /\ ;0#_
M '< _P!_ /\ AP#_ (X _P"4 /\ F@#_ *  _P"F /\ K #_ +0 _P"] /\
MR0#^ -T _0#M /P ^@#[ /\ ^@#_ /D _P#Z /\ ^@#_ /H _P#Z /\ _Q 9
M /\-%P#_!A8 _P 8 /\ '@#_ "H _P W /\ 10#_ %( _P!> /\ :0#_ '(
M_P![ /\ @@#_ (D _P"0 /X E@#] )P _ "A /L J #Y *\ ^ "X /8 PP#T
M -( \P#G /( ]@#P /\ [P#_ /  _P#O /\ [P#_ .X _P#N /\ _Q(4 /\/
M$@#_"Q( _P 2 /\ &@#_ "4 _P S /\ 0 #_ $T _P!9 /\ 9 #] &T ^P!V
M /D ?0#W (0 ]0"+ /0 D0#S )< \0"= /  HP#N *H [ "S .H O0#H ,L
MYP#A .4 \0#C /T XP#_ .( _P#A /\ X0#_ .  _P#@ /\ _Q00 /\1#@#_
M#0T _P</ /\"%0#_ "  _P M /\ .@#_ $< ^0!3 /4 7@#R &@ \ !P .T
M> #K '\ Z0"% .@ C #F )( Y0"8 ., GP#A *8 WP"N -P N #: ,4 U@#9
M -0 [ #2 /D T0#_ ,\ _P#. /\ S@#_ ,X _P#. /\ _Q<, /\4" #_#P4
M_PX+ /\,$0#_!QH _P$F /P - #T $$ [0!- .D 6 #F &( XP!J .  <@#>
M 'D VP"  -D A@#6 (T TP"3 -$ F@#/ *$ S0"J ,L LP#) +\ Q@#0 ,4
MZ ## /8 P0#_ , "_P"_ _\ OP/_ +\#_P"_ _\ _QL& /\7  #_%   _Q,%
M /\1#0#_#A0 ^0H? / &+ #F SD X -& -P#40#6!%L T@1D ,\%; #,!7,
MR@5Z ,@%@0#&!8< Q0:. ,,&E@#!!IT OP:F +T&L "[![P N0C- +@*Y0"U
M"_< LPW_ +$-_P"P#?\ L [_ *\._P"O#O\ _QX  /\;  #_&P  ^AH  /46
M!0#V$0T ZPX5 .(+(@#8"S$ T P^ ,L-2@#'#54 Q Y> ,$.9@"_#FT O0YT
M +L/>P"Y#X( MQ"* +80D0"T$)H LA"C + 1K0"O$;H K1'* *H2Y0"G%/<
MI17_ *,5_P"B%?\ HA7_ *(5_P"B%?\ _R(  /\@  #P(P  YB0  . A  #<
M&04 VQ , - 1&0#($RD PA4W +T61 "Y%TX M1=7 +,88 "P&&< KAAN *P9
M=0"K&7P J1F$ *@:C "F&I0 I!J> *,;J "A&[0 GQS% )X<WP":'?,!F![_
M 9<>_P&6'_\!E1__ 94?_P&5'_\!_R8  /0G  #F+0  VB\  ,\M  #*)P
MQQ\( ,$<$P"Z'B( M!\Q *\@/0"K(4@ J")2 *8B6@"C(V( H2-I * C;P">
M(W< G"-^ )LCA@"9)(\!ER29 98DHP&4)+ !DB6_ 9$EU@&.)N\!C"?_ HLG
M_P**)_\"B2?_ HDG_P&))_\!^BD  .PP  #=-@  S3@  ,0W  "^,@  NBL"
M +4E#@"N)QT J"DK *0J. "@*D, G2M, )HK50"8*UP EBMC )0K:@&2*W$!
MD"QX 8\L@0&-+(H!BRR4 HHLGP*(+*L"ABRZ H4MS@.#+NH#@2[\ X N_P)_
M+O\"?R[_ GXN_P)^+O\"]"X  .0W  #2/0  Q3\  +L_  "T/   KS4  *DO
M"P"C+Q< GC$F )DR,P"6,CX DC-( ) S4 "-,U@ BS-> 8DS90&',VP!AC-S
M 80S? *",X4"@#./ W\SF@-],Z<#?#.U!'HSR01Y-.8$=S7Y!'8U_P-U-?\#
M=37_ W4U_P-U-?\#\#,  -T]  #*0P  OD4  +5&  "M0P  ICT  * V!@"9
M-A, E#@A ) Y+@",.3D B3E# (<Y3 "$.5,!@CE: 8 Y80%^.6@"?#EO GHY
M=P)Y.8 #=SF+!'4YE@1T.:,%<CFQ!7$YQ 9O.N(&;CKW!6X[_P1M._\$;3O_
M VTZ_P-M.O\#ZCD  -5"  #$2   N4L  *]+  "G20  GT0  )@^ 0"1/!
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M(@!V2"X <T@X '%(00!N2$D!;$A0 6I(5@%H2%T"9D=D F5'; -C1W8$84>
M!6!'C09>1YH'7$>I"%M(NPA:2-0(6DCQ!UI)_P9:2?\%6DC_!5I(_P1:2/\$
MVT0  ,9-  "X4P  K5<  *-9  ":6   D50  (9.  !]2P@ =TL2 '-,'P!P
M3"L ;4PU &M,/@!H3$8 9DQ- 61,4P%B3%H"84QB E],:@->3',$7$M^!5I+
MB@982Y@'5TRG"%9,N0E53-$)5$SO"%1-_P953/\&54S_!55,_P553/\%U4@
M ,)1  "U5P  JEL  *!<  "77   C5D  (%3  !W3P0 <4\0 &Y0' !J4"@
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M!T=9LPA&6<H(15GJ"$99_09&6/\&1EC_!4=8_P5'6/\%QU(  +A;  "K80
MH68  )AH  ".:0  @V<  ')@  !H7@  85T) %Q=$P!:71X 5UTI %9>,P!4
M7CL 4EY# %%>2@%/7E(!3EY9 DQ>80)*7FH#2%YU!$9>@@5$79 &0UZ@!T%>
ML0= 7L@'0%[H!T!=_ 9!7?\%05W_!4%<_P5!7/\%PU8  +1?  "H9@  GFH
M )5M  "*;0  ?VP  &]G  !D9   6V(% %9B$ !48AL 4F,E %!C+P!.9#@
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M RYQ^ ,N</\#+F__ RYO_P,N;_\#LV8  *=O  "==@  DWH  (A\  !^?0
M<GT  &1\  !7>P  3'H  $)Y P \>0X .GH7 #EZ(0 X>BH -WLS #9[.P T
M>T0 ,WM, #)[50 P>U\ +WMJ 2U[=P$K>X<!*GN8 BA[J@(G>[\")GOA B9Z
M]P(F>/\")GC_ B=W_P(G=_\"KFP  *-V  "9?   CG\  (2"  !X@P  ;(0
M %^$  !1A   1X0  #R$   SA D ,(01 "^$&@ MA"0 +(4M "N%-0 JA3X
M*85' "B&4  GAEH )H9F "2&<P CAH, (8:5 ""&IP$>AKP!'H;> !Z$]0$>
M@O\!'H+_ 1Z!_P$>@?\!J'0  )Y]  "3@@  B84  'Z(  !QB@  98L  %B,
M  !,C0  0(X  #:.   LCP  )9 , ".0$P BD!P (9 E ""1+@ ?D38 'I%
M !V120 <D50 &I%@ !F1;@ 8D7X %I*0 !62I  4D;D $Y'8 !./]  4CO\
M%(W_ !2,_P$4C/\!HWT  )B#  ".B   A(P  '>/  !ID0  79,  %"5  !%
MEP  .9@  "Z9   EF@  '9L" !:=#  5G1, %)T; !.=)  2G2T $9XW !&>
M00 0GDP #YY8  Z>9P -GG< #)Z*  N=G@ *G;( "9W,  F<[  *F_X "YK_
M  N9_P +F?\ G(0  )&*  "(C@  >Y(  &V6  !@F0  5)P  $B?   \H
M,*$  ":C   =I0  %:<  !"I!0 +JPT "*H3  >J&P &JB0 !:HN  2J.  "
MJD0  :I0  "J7@  JFX  *J!  "JE0  J:H  *G!  "HY   J/8  *?_  "G
M_P  I_\ E8L  (R0  !_E0  <9H  &.>  !6H@  2J8  #VH   QJ@  )JL
M !VM   4L   #K(   FU 0 "M@H  +8/  "V%0  MQT  +<E  "W+P  N#D
M +A&  "X5   N&0  +AV  "XBP  MZ   +>V  "WTP  MN\  +;\  "V_P
MMO\ CY(  (*7  !TG0  9J(  %BG  !+K   /J\  #&Q   FLP  '+8  !.X
M   -NP  !KX   #!    P@0  ,(+  ##$   Q!4  ,0<  #%)   QBX  ,@Z
M  #)1P  R5<  ,EI  #)?0  R90  ,BJ  #(PP  R.0  ,CT  #(_0  R/T
MA9D  '>?  !HI@  6JL  $VQ   _M0  ,;@  "6Z   :O0  $<    O#   #
MQP   ,H   #-    S@   ,\#  #0"0  T0X  -,2  #5&0  UR(  -HM  #=
M.0  WDD  -Y:  #?;@  WX4  -^<  #?L@  WLL  -[F  #?]   W_0 >:$
M &NH  !<KP  3K4  $"[   QO@  ),$  !G%   0R   "<P   #/    TP
M -D   #<    W0   -\   #A    X@4  .0+  #F$   Z!8  .H@  #M*P
M\#H  /%+  #Q7@  \G,  /.+  #SH@  \[8  //)  #SX0  \^$ ;:H  %ZQ
M  !0N0  0;\  #+$   DR   %\P   [0   &U0   -H   #>    X@   .8
M  #I    Z@   .P   #N    \    /(   #T!@  ]@P  /D2  #\'   _RD
M /\Z  #_30  _V(  /]X  #_D   _Z,  /^S  #_P0  _\$ _P<9 /\!%P#_
M !< _P : /\ (0#_ "L _P Y /\ 1P#_ %0 _P!? /\ :@#_ ', _P![ /\
M@P#_ (H _P"0 /\ E@#_ )L _P"A /\ J #_ *\ _P"X /\ Q #^ -4 _ #J
M /L ^ #Z /\ ^0#_ /@ _P#X /\ ]@#_ /, _P#Q /\ _PL5 /\%$P#_ !,
M_P 4 /\ &@#_ "< _P T /\ 0@#_ $\ _P!; /\ 90#_ &X _P!V /\ ?@#_
M (4 _@"+ /T D0#[ )< ^@"= /@ HP#W *L ]@"S /0 O@#S ,P \0#C .\
M\P#N /\ [0#_ .P _P#K /\ [ #_ .P _P#K /\ _PT1 /\)$ #_  \ _P 0
M /\ %@#_ "( _P O /\ /0#_ $H _P!5 /T 8 #Z &D ^ !Q /8 >0#T '\
M\P"& /$ C #O )( [@"8 .P GP#K *8 Z0"N .< N #E ,4 XP#: .$ [0#?
M /L W@#_ -T _P#= /\ W0#_ -T _P#= /\ _P\- /\,"P#_ PD _P , /\
M$@#_ !T _P I /L -P#X $0 ]0!0 /( 6@#N &, [ !K .D <P#G 'H Y0"
M ., A@#A (P WP"3 -T F0#; *$ V0"I -4 L@#2 +X T #. ,X Y@#, /8
MR@#_ ,H _P#) /\ R #_ ,@ _P#( /\ _Q$( /\- @#_!P  _P4( /\ #@#_
M !8 ]P B .\ , #K #T Z !) .0 5 #@ %T W0!E -D ;0#5 ', T@!Z -
M@ #. (< S "- ,H E #( )L Q@"D ,0 K0#" +@ P #' +T WP"\ /$ NP#^
M +D _P"X /\ N #_ +@ _P"X /\ _Q0  /\/  #_#0  _PP  /\'"0#X 1
MZ  : ., * #= #8 V !" -( 30#. %< R@!? ,< 9@#% &T PP!T ,$ >@"_
M ($ O0"( +L CP"Y )< MP"? +4 J "S +, L0#" *\ V "N NT K /[ *L%
M_P"J!O\ J0;_ *D&_P"I!O\ _Q8  /\2  #W$@  [!$  .8.  #E!@@ W0,2
M -0#( #-!"T R 0Z ,,%1@"_!5  O 98 +D&8 "W!V< M0=N +,'=0"Q"'L
MKPB" *X)B@"L"9( J@F; *@*I0"F"K  I0N_ *,,U "A#>T GP[^ )T._P"<
M#_\ FP__ )L/_P";#_\ _QH  /<9  #J'@  WQX  -4:  #0$P( S@P+ ,<+
M%@# #24 N@XR +8./P"R#TD KQ!2 *P06@"J$&$ J!%H *81;P"D$78 HA%]
M *$1A0"?$HX G1*7 )P2H@":$ZT F!.\ )<4T "4%>P DA;] ) 7_P"/%_\
MCA?_ (X7_P".%_\ ^AT  .XC  #?*   T"H  ,<G  #!(0  O1D% +D2$ "R
M%1X K18L *@7. "D&$, H1E, )\95 "<&EP FAIB )D::0"7&W  E1MW )0;
M?P"2'(@ D!R2 (\<G0"-':D BQVW (H>R@"('^< AB#Z (0@_P&#(/\!@R#_
M 8(@_P&"(/\!]20  .4L  #3,0  QC,  +PQ  "V+0  L"4  *P=# "F'A@
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MC )E.)D#9#FH V(YN0-A.M #8#KN V Z_P-?.O\"7SK_ E\Z_P)?.O\"W3L
M ,=#  "Y20  KDL  *1,  ";2@  DD4  (D_  "!.@D >SH4 '<[( !T/"L
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M!%!'L01/1\<$3D?G!$Y'^P1.1_\#3D?_ T]'_P-/1_\#S$8  +M.  "O5
MI%<  )I8  "15P  AE0  'M.  !P2@  :4@- &5(%@!B22$ 7TDK %U)- !;
M23P 64E# %=)2@!625( 54I9 51*80%22FH!44IU D]*@0-.2H\#3$N?!$M+
ML 1*2\4$24OF!$E+^@1)2_\#2DO_ TI+_P-*2_\#R$D  +A1  "L5P  H5L
M )A<  ".7   @UD  '93  !K3@  9$T* %],$P!<31X 6DTH %A-,0!633H
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M SI8]P,Z6/\#.U?_ SM7_P,[5_\#O%0  *Y<  "C8P  F6<  )!I  "%:0
M>6<  &MB  !@8   55T  $Y;# !+6Q0 25P? $=<* !&73$ 15TY $-=00!"
M74@ 05Y0 $!>6  ^7F$!/%YL 3M>> (Y7H<"-UZ7 C9>J0,U7KT#-%_= S1>
M]0,U7?\"-5W_ C5<_P(U7/\"N%D  *IA  "@9P  EFP  (QN  "!;@  =FP
M &=I  !<9@  460  $AB"0!$8A$ 0F(; $%C)  _8RT /F,U #UD/0 \9$4
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M 2!Q_P$@<?\!J6L  )YS  "4>0  BGP  (!^  !T?P  9W\  %I_  !-?@
M0WX  #A]   O?0( *'T- "9]%  D?1P (WXE ")^+0 A?C8 (7X_ !]_2  >
M?U( '7]> !Q_:P :?WH &7^, !=_GP 6?[, %7_. !5^[P 6?/\ %GO_ !9[
M_P 7>_\ I'(  )IZ  "/?P  A8(  'N$  !MA@  8(<  %2'  !(B   /(@
M #*(   HB   ((@% !J)#@ 9B14 &(D= !>*)@ 6BBX %8HW !2*00 3BDP
M$HM8 !&+90 0BW4 #XN'  Z*FP -BJ\ #(K(  R)Z@ -A_P #H?_  Z&_P .
MAO\ GWL  )2!  "*A0  @(@  '.+  !EC0  68\  $R0  !!D@  -)(  "J2
M   ADP  &90  !*6!@ .EPX #9<5  R7'0 ,ER8 "Y<O  J7.0 )ET0 ")=0
M  :77@ %EVX  Y:   &6E   E:@  )6^  "4X   E/0  )/_  &2_P !DO\
MF((  (Z(  "%C   =X\  &J2  !=E0  4)@  $2:   XFP  +)P  "*=   9
MG@  $J    VB @ 'HPL  :,0  "C%P  HQ\  *,G  "C,0  I#P  *1(  "D
M5@  I&4  *-W  "CBP  HZ   **V  "AT@  H?   *#[  "@_P  H/\ D8H
M (F.  ![D@  ;9<  &";  !3G@  1J$  #FC   MI   (Z8  !FH   1J@
M#*P   6N    KP<  *\-  "O$0  L!@  + @  "Q*   L3(  +(^  "R3
MLEL  +)L  "R@0  L9<  +&L  "PQ@  L.@  *_W  "O_P  K_\ C)   '^5
M  !QF@  8Y\  %6D  !'J   .JH  "VL   BK@  &+   !"S   *M0   K@
M  "[    NP   +P'  "\#0  O1$  +X6  "_'@  P"<  ,$R  #"0   PT\
M ,-@  ##=   PXL  ,.A  ##N   PM<  ,+O  #"^@  P?X @9<  '.=  !E
MHP  5Z@  $FM   [L0  +;,  "&V   6N0  #KL   >^    P0   ,4   #'
M    R    ,D   #*!0  RPL  ,T/  #.%   T!P  -,F  #6,@  V$$  -A3
M  #99@  V7P  -F4  #9JP  V<,  -GA  #9\   V?0 =I\  &>F  !9K
M2[(  #RW   NN@  (;T  !7    -Q   !<<   #*    S@   -(   #5
MU@   -D   #;    W0   -\'  #A#   XQ$  .89  #I)   [#(  .U#  #N
M5@  [VL  .^$  #OG   [[(  ._&  #OW0  [^0 :J@  %NO  !,M@  /KP
M "_    @Q   %,@   S,   "T    -0   #9    W@   .(   #E    Y@
M .@   #I    [    .X   #P @  \@D  /4/  #X%P  _",  /\S  #_1@
M_UH  /]Q  #_B0  _Y\  /^Q  #_P   _\8 _P 5 /\ % #_ !0 _P 7 /\
M'0#_ "@ _P W /\ 1 #_ %$ _P!< /\ 9@#_ &\ _P!W /\ ?@#_ (4 _P"+
M /\ D0#_ )< _P"= /\ I #_ *L _P"T /X OP#] ,X ^P#F /D ]@#X /\
M]P#_ /< _P#W /\ \ #_ .P _P#I /\ _P,2 /\ $ #_ !  _P 1 /\ %P#_
M "0 _P R /\ /P#_ $P _P!7 /\ 80#_ &H _P!R /\ >0#] (  _ "& /H
MC #Y )( ^ "8 /8 GP#U *8 ] "N /( N0#P ,8 [@#> .T \ #K /X Z@#_
M .D _P#I /\ YP#_ ., _P#@ /\ _P<. /\ #0#_  L _P , /\ $P#_ !\
M_P L /\ .@#_ $8 _@!2 /L 7 #X &4 ]0!L /, = #Q 'H [P"! .X AP#L
M (T Z@"3 .D F@#G *$ Y@"I ., LP#A +\ WP#0 -T Z0#: /D V0#_ -<
M_P#5 /\ U0#_ -4 _P#4 /\ _PD* /\!!0#_  , _P ) /\ $ #_ !D ^P F
M /< - #T $  \@!, .X 5@#J %\ YP!G .0 ;@#B '0 X ![ -X @0#< (<
MV@"- -8 E #4 )L T0"C ,\ K0#, +@ R@#' ,@ X #& /, Q0#_ ,, _P##
M /\ PP#_ ,, _P## /\ _PL! /\#  #_    _P # /\ "P#S !( [@ ? .H
M+0#F #H X@!% -X 3P#9 %@ U !@ -$ : #. &X S !T ,H >P#( ($ Q@"'
M ,0 C@#" )8 P "> +X IP"[ +( N0#  +< U "U .P LP#[ +, _P"R /\
ML@#_ +$ _P"Q /\ _PT  /\&  #_ P  ]P   /0  P#G  T X  8 -H )0#3
M #( S@ ^ ,H 20#& %( PP!: ,  80"^ &@ O !N +H = "X 'L M@"! +0
MB "R )  L "9 *X H@"L *T J@"Z *@ RP"F .8 I0#W *0 _P"C /\ H@#_
M *( _P"B /\ _Q   /L,  #O#@  Y@T  -\)  #:  8 T  1 ,D '0#$ "H
MOP W +L 0@"W $L M !4 +( 6P"O &( K0!H *L ;@"I '4 J ![ *8 @P"D
M (L H@"4 *  G@"> :@ G *U )L#Q@"9!>( F ;T )8(_P"5"?\ E G_ )0)
M_P"4"?\ _!$  /$5  #C&0  UAD  ,P5  #'$   Q <* +T#% "W!"$ L@8N
M *X(.@"J"40 IPE- *0*50"B"EP H IB )X+:0"<"V\ FPMV )D,?@"7#(8
ME@R0 )0,F@"2#:8 D0VS (\-Q0"-#N( BQ#V (D0_P"($?\ AQ'_ (<1_P"'
M$?\ ]AD  .<@  #6)   R"4  +\B  "Y'   M!0! +$-#@"J#AD I0\G *$0
M,P"=$3X FA%' )@23P"5$E8 DQ)< )$28P"0$VD CA-P (P3> "+$X$ B12+
M (<4E@"&%:( A!6P (,6P0"!%]T ?QCT 'T9_P!\&?\ ?!G_ 'L9_P![&?\
M[R$  -TI  #*+0  OB\  +4L  "N)P  J"   *,7" ">%A, F1<A )09+0"1
M&C@ CAI! (L;20")&U  AQM7 (4<7@"$'&0 @AQK ( <<P!_'7P ?1V& 'P>
MD0!Z'IX >!^K '<?O !V(-0 ="'P '(A_P!Q(O\ <2'_ '$A_P!Q(?\ Z"@
M -(P  #"-0  MS<  *TU  "E,0  GBL  )@C @"2'A  C2 ; (DA)P"&(C(
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M 5PSL0%;-,8!6C3F 5DU^P%9-?\!633_ 5DT_P%9-/\!TC@  ,!   "S10
MJ$@  )Y(  "51@  BT   (([  !Y-00 <S,0 &\T&@!L-"4 :34O &<U-P!E
M-C\ 8S9& &(V30!@-E0 7S9; %TW8P!<-VL 6S=V 5DW@@%8.(\!5CB> 54X
MKP)4.<,"4SGD E,Z^0%3.?\!4CG_ 5,Y_P%3.?\!S3P  +Q$  "O20  I$P
M )I,  "12P  AT8  'U   !S.P  ;#@- &@Y%P!E.2( 8SHK & Z- !>.CP
M73I# %LZ2@!:.U  6#M8 %<[8 !6.V@ 53QS 5,\?P%2/(T!4#V< 4\]K ).
M/L$"33[A DT^^ )-/O\!33[_ 4T]_P%-/?\!R4   +A(  "L30  H5   )=1
M  ".3P  A$L  'E%  !N0   9CT+ &(]% !?/1X 7#XH %H^,0!8/C@ 5SY
M %4_1@!4/TT 4S]5 %) 70!00&8 3T!P 4Y ? %,08H!2T&: DI!JP))0KX"
M2$+> DA"]@)(0O\"2$+_ 4A!_P%(0?\!Q40  +5+  "I4   GE0  )54  "+
M4P  @%   '5*  !J1@  84(( %Q!$0!90AL 5T(E %5"+@!30C4 44(] $]"
M0P!/0TL 3D-2 $U$6@!+1&, 2D1N 4E%>@%'18@!1D68 D5&J0)$1KT"0T;<
M D-&]0)#1O\"0T;_ 4-%_P%#1?\!P4<  +)/  "F5   G%<  ))8  "(6
M?E4  '%/  !F2@  7$8% %=&#P!41A@ 448B $]&*P!.1C, 3$<Z $M'00!*
M1TD 24A0 $A(6 !'2&$ 14EL $1)> %"288!04F6 4!*IP(_2KL"/DO8 CY*
M\P(^2O\"/DG_ 3])_P$_2?\!O4H  *]2  "C6   F5L  )!=  "&7   >UD
M &U3  !B3P  5TP! %%*#0!.2A4 3$L? $I+* !)2S  1TLX $9,/P!%3$8
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M 2Y7_P$N5O\!LE<  *5?  ";90  D6D  (=J  !\:@  <6@  &-E  !88@
M35\  $-= @ \6PT .EP4 #A<'0 W7"8 -5TN #1=-@ S73X ,EU& #%>3@ P
M7E< +UYB "U>;@ L7WT *E^. "E?H  H7[,!)U_, "=?[0$G7O\!)UW_ 2A=
M_P$H7/\!K5P  *)D  "8:@  CFX  (-O  !Y;P  ;FX  &!K  !4:0  26<
M #]E   U8PD ,F,1 #!C&0 O9"$ +F0I "UD,0 L9#D *V5" "IE2@ H950
M)V5? "9F:P D9GH (V:+ ")FG0 @9K$ 'V;) !]FZP @9?X (&3_ "!C_P$A
M8_\!J6(  )YJ  "5<   BG,  (!U  !U=0  :70  %QR  !/<0  1&\  #IN
M   P;0, *6P- "=L%  F;!P )6TD "1M+  C;30 (FT] "%N1@ @;E  'FY;
M !UN9P <;G8 &FZ' !EOF@ 8;ZX %F_& !9NZ0 7;?P &&S_ !AK_P 8:_\
MI&D  )IQ  "0=@  AGD  'Q[  !Q>P  9'L  %=Z  !*>0  /W@  #5X   K
M=P  (G8' !UV#P <=Q8 &W<> !IW)@ 9=RX &'<W !=X0  5>$H %'A6 !-X
M8P 2>'( $7B# !!XEP />*L #GC#  YWY@ .=OH #W7_ !!U_P 0=/\ GW$
M )5X  "+?   @G\  '>!  !J@@  78(  %""  !$@@  .((  "Z"   D@@
M'((  !2""0 1@Q  $(,6 !"#'@ .@R< #H,P  V#.0 -@T0 #(-0  N#70 )
M@VP "(-^  :#D0 %@J4  X*[  2!VP $@?( !8#_  9__P &?_\ FGD  )!^
M  "&@P  ?84  &^'  !BB0  58H  $F+   ]C   ,8P  ":,   =C0  %8X
M  ^/ P *D P !I 1  2/&  #CR   8\I  "/,@  D#T  )!)  "/5@  CV4
M (]V  "/B@  CI\  (ZT  "-SP  C.X  (S[  "+_P  B_\ E(   (N%  ""
MB0  =(P  &:/  !9D0  3),  $"5   TE@  *)8  !Z7   5F   #YH   J;
M   "G D  )P.  "<$P  G!H  )PB  "=*P  G34  )U   "=3@  G5P  )UN
M  "<@0  G)<  )RL  ";Q@  FN@  )GY  "9_P  F/\ CH@  (:,  !XD
M:I0  %R7  !/F@  0IT  #:>   IGP  'Z$  !6B   .I   "*8   "H
MJ00  *D*  "I#@  J1,  *H:  "J(@  JRL  *PV  "L1   K%,  *QC  "L
M=P  JXX  *ND  "KO   JMX  *GT  "I_0  J?\ B8X  'N3  !MEP  7YP
M %&@  !$I   -J8  "JH   >J0  %*L   VN   &L    +(   "U    M0
M +4#  "V"0  MPX  +@2  "X&0  NB$  +LK  "\.   O4<  +U8  "]:P
MO8$  +V9  "]L   O<P  +SJ  "\]P  N_X ?I4  '";  !BH   4Z4  $:J
M   XK0  *J\  !ZQ   3M   #+<   .Y    O    +\   #"    P@   ,,
M  #$    Q@8  ,<,  #($   RA8  ,P@  #/*P  T#H  -%+  #17@  TG,
M -*+  #2I   T[L  -/8  #3[0  T_8 <YT  &2C  !6J0  1Z\  #FS   J
MM@  ';D  !*\   *OP   ,,   #&    R0   ,T   #/    T    -(   #4
M    U@   -D"  #;"   W@X  .$3  #D'0  Z"H  .@\  #I3P  Z60  .I\
M  #KE0  ZZP  .O"  #LU0  [.4 9J8  %BL  !)LP  .[D  "N\   =P
M$<0   G(    S    ,\   #3    V0   -T   #@    X0   .,   #E
MYP   .H   #L    [@0  /$+  #U$@  ^!P  /LK  #]/@  _E,  /YJ  #_
M@P  _YL  /^N  #_O@  _\H _P 2 /\ $ #_ !$ _P 3 /\ &0#_ "8 _P T
M /\ 00#_ $T _P!8 /\ 8@#_ &L _P!S /\ >@#_ ($ _P"' /\ C0#_ ),
M_P"9 /\ H #_ *< _@"O /P N@#Z ,D ^0#A /@ \P#W /\ ]@#_ /4 _P#Q
M /\ Z0#_ .0 _P#A /\ _P / /\ #0#_  T _P . /\ % #_ "$ _P N /\
M/ #_ $@ _P!3 /\ 70#_ &8 _@!M /P =0#[ 'L ^0"" /@ B #W (X ]@"4
M /0 FP#S *( \0"J .\ M #M ,$ ZP#5 .H [ #H /P YP#_ .4 _P#F /\
MX #_ -D _P#4 /\ _P + /\ " #_  8 _P ) /\ $ #_ !P _P I /\ -@#_
M $( ^P!. /< 5P#T &  \@!H .\ ;P#M '8 [ !\ .H @@#H (@ YP". .4
ME0#C )P X0"D -\ K@#= +D V@#* -< Y #4 /8 T0#_ -  _P#0 /\ SP#_
M ,L _P#' /\ _P # /\   #_    _P $ /\ #0#Z !8 ]@ C /, , #P #P
M[0!' .D 40#E %H X@!B -\ :0#= &\ V@!V -@ ? #4 (( T@"( -  CP#-
M )8 RP"> ,D J #' +, Q0#! ,( V #  .\ OP#^ +X _P"] /\ O #_ +P
M_P"\ /\ _P(  /\   #_    _P   /0 !P#M !$ Z  < ., *0#? #4 VP!!
M -8 2P#1 %0 S0!< ,H 8P#( &D Q@!O ,, =0#! 'L OP"" +X B "\ )
MN@"8 +@ H@"U *P LP"Y +$ RP"O .< K@#X *P _P"K /\ K #_ *P _P"K
M /\ _P0  /\   #V    [@   .<   #?  P U@ 5 ,\ (@#* "X QP Z ,,
M1 #  $T O !5 +D 7 "W &, M0!I +, ;P"Q '4 KP![ *T @@"K (H J0"2
M *< G "E *8 HP"S *$ PP"? -X G@#R )T _P"< /\ G #_ )L _P"; /\
M_P<  /8)  #I"P  WPH  -4$  #.  4 Q@ 0 ,  &@"[ "< MP R +, /0"P
M $8 K0!/ *H 5@"H %P I@!C *0 : "B &\ H0!U )\ ? "= (0 FP"- )D
MEP"7 *( E0"N ), O0"1 -, D #M (\ _ ". /\ C0'_ (T!_P"- ?\ ^0X
M .H2  #<%0  S14  ,01  "^#   N@(* +0 $@"N !X J@ J *8 -0"B #\
MH !( )T!4 "; E8 F0)< )<#8P"5 VD DP-O )$$=@"0!'\ C@6( (P%D@"*
M!IX B :J (8'N@"%",\ A KK ((+_ "!#/\ @ S_ ( ,_P" #/\ \14  . =
M  #-(   P2$  +@=  "Q%P  K!   *@)#0"B!Q8 G0DC )D*+@"5"S@ DPQ!
M ) ,20".#5  C U7 (H-70"(#6, APUJ (4.<0"##GH @@Z$ ( .CP!^#YL
M? ^H 'L0N !Z$,X >!'L '82_P!U$O\ =!/_ '03_P!T$_\ Z!X  -,F  ##
M*@  N"H  *XH  "G(P  H!P  )L3 P"6#Q  D! ; (P1)P")$C( AA,[ (03
M0P""%$L @!11 'X45P!\%%X >Q5E 'D5; !W%70 =A9^ '06B@!R%Y8 <1>D
M &\8M !N&,D ;1GH &L:_ !J&_\ :AO_ &H;_P!J&_\ X"8  ,HM  "\,0
ML#,  *<Q  "?+   ER8  ) ?  "*%PP A1@6 ($9(@!^&BP >QLV 'D;/@!W
M'$4 =1Q, ',<4P!Q'5D <!U@ &X=9P!M'G  :QYZ &H>A0!H'Y( 9Q^@ &4@
ML !D(<4 8R'D &(B^@!A(O\ 82+_ &$B_P!A(O\ URP  ,,T  "V.   JCD
M *$X  "8-0  D"\  (@H  " (0@ >R 2 '<A'0!T(B< <2(Q &\C.0!M(T$
M:R-( &DC3@!H)%4 9B1; &4D8P!C)6L 8B5U &$E@0!?)HX 7B:= %TGK0!;
M*,$ 6RC@ %HI]P!9*?\ 62G_ %DI_P!9*/\ SS(  +XY  "Q/0  IC\  )P_
M  "3/   BC8  ($P  !Y*@, <B8/ &XG&0!K*", :2@L &8I-0!E*3P 8RE#
M &$J2@!@*E$ 7BI7 %TJ7P!<*V@ 6BMR %DL?0!8+(L 5BV: %4MJ@!4+KT
M4R[< %(O]0!2+_\ 4B[_ %(N_P!2+O\ RC8  +H]  "M0@  HD0  )A$  "/
M00  A3P  'LW  !R,0  :RP, &<M%0!D+1\ 82XH %\N,0!=+CD 7"]  %HO
M1@!8+TT 5R]4 %8P7 !5,&0 4S%N %(Q>@!1,8@ 4#*7 $XRJ !-,[L 3338
M $PT\P!,-/\ 3#3_ $PS_P!,,_\ QCH  +9"  "I1@  GDD  )5)  "+1P
M@4(  '<]  !M-P  9#() & R$@!=,AP 6C(E %@S+0!6,S4 53,\ %,T0P!2
M-$H 4311 % T60!/-6$ 335L $PV=P!+-H4 2C>5 $@WI@!'.+@!1SC3 48X
M\0%&./\!1CC_ $8X_P!&-_\ P3X  +)%  "F2@  G$T  ))-  "(2P  ?D<
M '-"  !I/0  7S<& %HV$ !7-Q@ 5#<B %(W*@!0-S( 3S@Y $TX0 !,.$<
M2SA. $HY5@!).5\ 2#II $<Z=0!%.X, 1#N3 $,\I %"/+8!03W0 4$]\ %!
M/?\!03S_ 4$\_P%!//\ OD(  *])  "C3@  F5   (]1  "%4   >TP  &]&
M  !E0@  6CT" %0[#@!1.Q4 3SL? $T[)P!+.R\ 23PV $<\/0!'/$0 1CU+
M $4]5 !$/EP 0SYG $(_<P! /X$ /S^1 #Y H@ ]0+4!/$'. 3Q![@$\0?\!
M/$#_ 3Q _P$]/_\!ND4  *Q,  "A40  EU0  (U5  "#5   >%$  &Q+  !A
M1P  5D(  $] # !,/Q, 24 < $= ) !&0"P 1$ S $- .@!"04( 04%) $!"
M40 _0EH /D-E #U#<0 [0W\ .D2/ #E$H  X1;,!-T7+ 3=%[ $W1?\!-T3_
M 3A$_P$X0_\ MTD  *E0  ">50  E%@  (M9  " 6   =E8  &A0  !=3
M4T@  $I%"0!&1!$ 1$09 $)$(@!!12D /T4Q #Y%.  ]13\ /$9' #M&3P Z
M1U@ .4=B #A(;@ V2'P -4B- #1)G@ S2;$ ,DG) #%)ZP R2?X ,DC_ #)(
M_P S2/\ M$P  *=4  "<60  DEP  (A=  !^70  <UH  &55  !;4@  4$X
M $9*!0! 20X /DD6 #U)'@ [2B8 .DHN #E*-0 X2ST -TM$ #9+30 T3%8
M,TQ@ #),;  Q37H ,$V+ "Y-G  M3J\ +$[' "Q.Z0 L3?T +4W_ "U,_P M
M3/\ L%   *18  "970  CV$  (9B  ![80  <%\  &);  !86   3E4  $-1
M 0 [3PP .$\3 #9/&P U3R, -% K #-0,@ R4#H ,5!" #!12@ N45, +5)=
M "Q2:0 K4G@ *5*( "A3F@ G4ZT )E/% "93YP F4_P )U+_ "=1_P G4?\
MK%4  *!<  "68@  C68  (-G  !X9@  ;64  &!A  !57@  2EL  #]8   U
M5@@ ,540 #!6%P N5A\ +58G "Q6+P K5S8 *E<^ "E71P H5U  )EA: "58
M9P D6'4 (UF& "%9F  @6:L 'UG" !]9Y0 ?6/H (%C_ "!7_P A5_\ J%H
M )UB  "39P  BFL  ']L  !U;   :FL  %UH  !190  1F,  #M@   Q7@,
M*ET- "A=$P F71L )5XC "1>*@ C7C( (EXZ "%>0P @7TP 'U]7 !Y?8P <
M8'$ &V"" !E@E0 88*D %V#  !9@X@ 77_D &%[_ !E>_P 97?\ I&   )EH
M  "0;@  AG   'QR  !R<@  9G$  %AN  !,;   06L  #9I   M9P  (V8(
M !]F#P =9A4 '&8= !MF)0 :9BT &6<U !AG/@ 79T@ %F=3 !5H7P 3:&X
M$FA_ !%HD@ 0:*8 #VB]  YHX  09_< $&;_ !%E_P 19?\ GV<  )9O  ",
M<P  @G8  'AX  !M>   8'<  %-V  !&=   .W,  #%R   G<0  'G$  !9P
M"@ 3<!  $W 7 !)P'P 1<2< $'$O !!Q.  .<4( #G%.  UQ6P ,<6D "W%Z
M  IQC0 (<:$ !G&V  9PT@ '<.\ "&__  EN_P );O\ FV\  )%U  "'>0
M?GP  '1^  !F?@  67X  $U^  ! ?0  -7T  "I\   A?   &'P  !%\!  ,
M? P "GP1  E\&0 (?"$ !WPI  9\,@ $?#T  WQ(  %\50  ?&,  'QT  !\
MAP  >YP  'NQ  !ZRP  >>L  'GZ  !Y_P  >/\ EG<  (Q\  "#@   >8,
M &R$  !>A0  488  $6'   YAP  +8<  ".'   :AP  $H<   V( 0 &B0H
M 8D/  ")%   B!L  (@C  ")+   B38  (E"  "(3@  B%T  (AM  "(@0
MAY4  (>K  "&Q   A>8  (3X  "$_P  A/\ D'X  (>#  !^AP  <8D  &.+
M  !6C0  28\  #R1   PD0  ))$  !J2   2DP  #90   :5    E@8  )8,
M  "5$   EA4  )8=  "6)   EBX  )8Y  "61@  EE4  )9E  "6>   E8X
M )6D  "4O   D]\  )/U  "2_P  DO\ BX8  (.*  !UC0  9Y   %F4  !,
MEP  /YD  #*:   FFP  &YP  !*=   ,GP  !*    "B    HP$  *,'  "C
M#   HQ   *05  "D'   I24  *8O  "F/   IDL  *9;  "F;@  I80  *6;
M  "DLP  H]   */O  "B_   HO\ AHT  'B1  !JE0  7)D  $Z=  !!H
M,Z(  ":C   ;I0  $:<   JI   !JP   *T   "O    L    +    "P!0
ML0L  +(/  "S%   M!L  +4D  "W,   MS\  +=0  "W8@  MW@  +>0  "V
MJ0  ML(  +;D  "V]0  M?X >Y,  &V8  !?G0  4*(  $*F   TJ0  )JL
M !JM   0KP  ";(   "T    MP   +H   "\    O0   +X   "^    P (
M ,$(  #"#0  Q!(  ,89  #))   RC(  ,M#  #+50  S&H  ,R#  #,G
MR[4  ,S.  #,Z0  S/8 <)L  &&A  !2I@  1*L  #:P   GL@  &K4  !"X
M   'NP   +X   #!    Q    ,@   #+    RP   ,T   #.    T    -(
M  #5 P  V H  -L0  #>&   XB0  .,U  #D2   Y5P  .9S  #FC0  YJ4
M .:\  #FTP  Y^< 8Z0  %6J  !&L   .+4  "BY   :O   #\    7$
MQP   ,L   #/    U    -@   #<    W0   -\   #A    XP   .4   #H
M    Z@   .T&  #Q#@  ]18  /@E  #Y.   ^4T  /IC  #[?   _)4  /RJ
M  #\NP  _<L _P / /\ #@#_  X _P 0 /\ %@#_ ", _P P /\ /0#_ $D
M_P!4 /\ 7@#_ &8 _P!N /\ =@#_ 'P _P"" /\ B0#_ (\ _P"5 /X FP#]
M *, ^P"K /H M0#Y ,, ]P#; /8 \ #T /\ \P#_ /( _P#L /\ X@#_ -P
M_P#6 /\ _P , /\ "0#_  @ _P * /\ $@#_ !X _P K /\ . #_ $0 _P!/
M /\ 60#^ &$ _ !I /H < #X '< ]P!] /8 @P#T (D \@"/ /$ E@#O )T
M[0"E .P KP#J +P Z #- .8 Z #D /H XP#_ .( _P#@ /\ U0#_ ,X _P#+
M /\ _P & /\  0#_    _P $ /\ #@#_ !D _P E /T ,@#[ #X ]P!) /,
M4P#P %P [@!C .P :@#J '$ Z !W .8 ?0#D (, X@") .  D #> )< W "?
M -D J0#6 +0 TP#$ -  W@#. /, S #_ ,L _P#* /\ R #_ ,( _P"^ /\
M_P   /\   #_    _P   /L "P#V !, \0 @ .T + #J #@ YP!# ., 30#@
M %8 W != -D 9 #5 &L T@!Q -  =@#. 'P S "# ,H B0#( )$ Q@"9 ,0
MHP#! *T OP"[ +T SP"[ .L N0#\ +< _P"W /\ M@#_ +0 _P"Q /\ _P
M /\   #_    ]@   .X !0#G  \ X0 9 -L )0#5 #$ T@ \ ,X 1@#* $\
MQP!7 ,0 7@#! &0 OP!J +T < "[ '8 N0!\ +@ @P"V (H LP"3 +$ G "O
M *< K0"S *L Q0"I .$ IP#U *8 _P"E /\ I #_ *0 _P"D /\ _P   /P
M  #Q    Z    .    #4  L S  3 ,< 'P#" "H OP U +P /P"X $@ M0!0
M +, 5P"P %X K@!D *P :0"K &\ J0!U *< ? "E (0 HP", *$ E@"? *$
MG0"M )H O "8 -( EP#N )4 _@"4 /\ E0#_ )4 _P"5 /\ _ $  / %  #C
M!P  U04  ,P   #%  0 O@ . +@ %P"S ", KP N *L . "I $$ I@!* *,
M40"A %< GP!= )T 8P"; &D F@!O )@ =@"6 'T E "& )( D "0 )L C@"G
M (P M@"* ,D B #G (< ^0"' /\ A@#_ (8 _P"& /\ ] P  .00  #1$@
MQ1$  +T.  "V"   L0 ( *L $0"F !L H0 F )X ,0": #H F !# )4 2@"3
M %$ D0!7 (\ 70". &, C !I (H < "( '< A@"  (0 BP"" )8 @ "C 'X
ML0!] ,0 >P+A 'H#]0!Z!?\ >07_ '@&_P!X!O\ ZA,  -8:  #&'0  NAP
M +$9  "J$P  I T  )\%# "9 !0 E0 ? )$"*0"- S, BP0\ (@%1 "&!DL
MA 91 (('5P"!!UT ?P=C 'T(:@!["'( >@A\ '@)A@!V"9( = J@ ',*KP!Q
M"\$ < S? &\-]@!N#O\ ;0[_ &T._P!M#O\ X1P  ,LC  "\)@  L28  *@D
M  "@'@  F1@  ),0 @"."PX B L7 (0,(@"!#2P ?@TU 'P./0!Z#D4 > Y+
M '<.40!U#U@ <P]> '$090!P$&X ;A!W &P0@@!K$(\ :1&= &@1K0!F$L
M91+? &03]@!C%/\ 8Q3_ &(4_P!B%/\ UB0  ,,J  "U+@  JB\  * M  "8
M*   D"(  (D;  ""$P@ ?1$2 'D2' !V$R< <Q0P '$4. !O%3\ ;15& &P5
M3 !J%E, :!99 &<680!E%FD 9!=R &(7?@!A&(L 7QB9 %X9J0!<&;P 7!K8
M %H;\P!:'/\ 61S_ %D<_P!9'/\ S2H  +TQ  "O-0  I#8  )LT  "2,0
MB2L  ($E  !Y'0, <Q@. &\9& !L&B( :1LK &<;,P!E'#L 9!Q! &(=2 !@
M'4X 7QU5 %T=7 !<'F0 6QYN %D?>0!8'X< 5B"6 %4@I@!4(;@ 4R'2 %(B
M\0!2(_\ 4B/_ %(B_P!2(O\ R"\  +@V  "K.@  H#P  )8[  "-.   @S(
M 'HM  !R)@  :B , &8@$P!C(1T 82$F %\B+P!=(C8 6R(] %HC1 !8(TH
M5R-1 %4C6 !4)&$ 4R1J %$E=@!0)8, 3R:3 $XGHP!,)[4 3"C. $LH[@!+
M*?\ 2RC_ $LH_P!+*/\ PS0  +,[  "G/P  G$$  ))   ")/@  ?SD  '4S
M  !L+0  8R<( %XF$0!<)AD 62<B %<G*P!5*#( 5"@Y %(H0 !1*$8 4"E-
M $XI50!-*5T 3"IG $LJ<P!)*X  2"N0 $<LH0!&+;, 12W+ $4N[ !$+O\
M1"[_ $4M_P!%+?\ OC@  + _  "D0P  F44  (]%  "%0P  >SX  '$Y  !G
M-   7BX$ %@K#@!5*Q8 4BP? % L)P!/+"\ 32TV $PM/ !*+4, 22U* $@N
M4@!'+EH 1B]D $4O< !#,'X 0C"- $$QG@! ,K$ /S+( #\SZ@ _,_X /S+_
M #\R_P _,O\ NSP  *U#  "A1P  EDD  (Q)  "#2   >$0  &T^  !C.0
M6C0  %(P# !/,!, 3# < $HP) !),2L 1S$R $8Q.0!$,4  0S)' $(R3P!!
M,U@ 0#-B #\T;0 ^-'L /36+ #PVG  [-J\ .C?& #DWZ  Y-_P .C?_ #HV
M_P Z-O\ MT   *I&  ">2P  E$T  (I.  " 3   =4@  &I#  !@/@  5CD
M $TU"0!)-!$ 1S49 $4U(0!#-2@ 034O $ U-@ _-CT /C9% #TW30 \-U4
M.SA@ #HX:P Y.7D .#F) #<ZFP U.JT -3O$ #0[Y@ T._L -3O_ #4Z_P U
M.O\ M$,  *=*  "<3@  DE$  (A2  !^4   <TT  &=(  !<1   4C\  $@Z
M!@!$.0\ 03D6 #\Y'@ ^.28 /#DM #LZ-  Z.CL .3M" #@[2@ W/%, -CQ=
M #4]:0 T/7< ,SZ' #$^F0 P/ZL +S_" "\_Y  O/_H ,#__ # ^_P P/O\
ML4<  *1-  "94@  CU4  (96  !\50  <5(  &1,  !920  3T4  $5  P _
M/@T /#X3 #H^&P Y/B, -SXJ #8_,0 U/S@ -#]  #- 2  R0%$ ,4%; #!!
M9P N0G4 +4*% "Q#EP K0ZH *D/  "E$X@ J0_D *D/_ "M"_P K0O\ KDH
M *%1  "75@  C5D  (-:  !Y6@  ;E<  &%2  !73@  34L  $-'   Z0PH
M-D,1 #1#&  S0R  ,D0G #%$+P P1#8 +T4] "U%1@ L14\ *T99 "I&9  I
M1W( *$># "9'E0 E2*@ )$B^ "-(X  D2/< )4?_ "5'_P F1_\ JD\  )]5
M  "46@  BUX  (%?  !W7@  :UP  %]8  !550  2U$  $!-   U2@< ,$D.
M "Y)%0 M21T +$DD "M**P J2C, *$H[ "=+0P F2TP )4M6 "1,8@ C3'
M(4R  "!-DP ?3:8 'DV[ !U.W0 >3?8 'DS_ !],_P @2_\ IU,  )Q:  "2
M7P  B&,  'YD  !T8P  :6$  %Q>  !26P  1U@  #Q5   R4@( *E , "=/
M$@ F4!D )5 @ "10*  C4"\ (E$W "%10  @44D 'E)3 !U27P <4FT &E-]
M !E3D  84Z0 %E.Y !53V0 64_0 %U+_ !A1_P 94?\ HUD  )A@  "/90
MA6@  'MI  !Q:0  9F<  %ED  !-80  0E\  #A<   N6@  )5@( "!7#@ >
M5Q0 '5<< !Q8(P ;6"L &E@S !E8/  86$4 %EE0 !596P 466D $UIZ !):
MC0 16J$ $%JW  Y:U0 06?, $%G_ !%8_P 16/\ GU\  )5F  ",:P  @FT
M 'AN  !N;P  8FT  %5J  !(:   /F8  #-E   I8P  (&$! !A@"P 58!
M%& 7 !-@'@ 28"8 $F N !%A-P 084  #V%+  YA6  -868 #&)V  MBB0 *
M89T "6&R  AARP (8>L "6#]  I?_P +7_\ FV8  ))M  "(<0  ?G,  '5U
M  !J=   7',  $]R  !#<   .&\  "UN   D;   &VL  !-K!  .:@P #6H2
M  QJ&0 +:B$ "FHI  EJ,@ (:CP !VM'  5K4P $:V$  FMQ  !JA   :I@
M &JM  !IQ@  :><  &GX  !H_P  :/\ EVT  (US  "$=P  >WH  '![  !C
M>P  5GH  $EZ   ]>0  ,7@  "=W   ==@  %78   ]V @ )=@H !'8/  !V
M%0  =AP  '8D  !U+   =38  '5!  !U3@  =5P  '5L  !U?@  =),  '2H
M  !SP   <^,  '+W  !R_P  <?\ DG4  (EZ  " ?@  =H   &F!  !;@@
M3H(  $&"   U@P  *8(  !^!   6@0  $((   J"   "@P<  ((-  ""$0
M@A<  ((>  "")@  @B\  (([  ""1P  @E4  (%E  "!>   @8T  ("B  !_
MN@  ?]T  '[T  !]_P  ??\ C7P  (2!  ![A   ;H8  &"(  !2B@  18L
M #F,   LC   (8P  !>,   0C0  "8X   */    D ,  (\)  "/#@  CQ(
M ) 8  "0'P  D"@  ) R  "0/P  D$T  )!=  "/<   CX4  (Z<  ".LP
MC=   (SP  "+_@  B_\ B(0  ("(  !RBP  9(T  %:0  !(DP  .Y4  "Z6
M   BE@  %Y<   ^8   (F0   )L   "=    G0   )T#  "="0  G0T  )X1
M  ">%P  GQ\  )\I  "@-0  H$,  *!4  "@9@  GWL  )Z3  ">JP  G<8
M )WI  "<^0  G/\ @XL  '6.  !GD@  698  $N9   ]G   ,)X  ".?   7
MH   #J(   >D    I@   *@   "J    J@   *H   "K 0  JP<  *P,  "M
M$   KA8  *\>  "Q*0  L3@  +%(  "Q6@  L6\  +&(  "QH   L+H  *_=
M  "O\@  K_T >)$  &J6  !<F@  39\  #^C   QI@  (Z<  !>I   .JP
M!:X   "P    L@   +4   "W    MP   +@   "Y    N@   +P#  "]"0
MO@X  , 4  ##'@  Q2L  ,4\  #&3@  QF(  ,9Z  #&E   QJT  ,;(  #%
MY0  Q?, ;)D  %Z>  !/I   0:@  #*L   DKP  %K$   VT   #MP   +H
M  "]    P    ,0   #&    Q@   ,@   #)    RP   ,P   #.    T 8
M -,-  #8$P  W!X  -XM  #?0   X%0  .%K  #AA0  X9\  .&W  #ASP
MX>8 8*$  %*G  !#K0  -+(  "6U   7N0  #;P   &_    PP   ,<   #*
M    SP   -,   #6    UP   -H   #<    WP   .$   #C    Y@   .D!
M  #L"P  \!(  /,?  #T,0  ]D8  /=<  #X=   ^(\  /FF  #YN   ^,D
M_P - /\ "P#_  L _P . /\ $P#_ !\ _P L /\ .0#_ $4 _P!0 /\ 60#_
M &( _P!J /\ <0#_ '< _P!^ /\ A #^ (H _0"0 /P EP#Z )X ^0"G /<
ML0#V +X ]0#2 /, [ #Q /X \ #_ /  _P#F /\ W #_ -( _P#- /\ _P '
M /\ ! #_  ( _P & /\ $ #_ !L _P G /\ ,P#_ #\ _P!* /X 5 #[ %T
M^0!D /< :P#U '( \P!X /( ?@#P (0 [P"* .T D0#L )D Z@"A .@ JP#F
M +8 Y #' .( XP#@ /< W@#_ -T _P#9 /\ S #_ ,4 _P#! /\ _P   /\
M  #_    _P ! /\ #0#_ !8 _  B /D +@#V #D \P!% .\ 3@#L %< Z0!>
M .8 90#D &P X@!R .  =P#? 'X W0"$ -L BP#8 )( U0"; -( I #/ *\
MS0"^ ,L U0#) .\ QP#_ ,4 _P#$ /\ O@#_ +@ _P"U /\ _P   /\   #_
M    _@   /< "0#Q !$ ZP < .< * #D #, X0 ^ -T 2 #8 %$ TP!8 -
M7P#. &4 S !K ,H <0#( '< Q@!] ,0 A #" (P P "4 +X G@"[ *@ N0"V
M +< R "U .8 LP#Z +$ _P"P /\ L #_ *P _P"I /\ _P   /\   #Z
M\0   .@  P#@  T V  6 -$ (@#- "T R@ W ,8 00#" $H OP!2 +T 60"Z
M %\ N !E +< :@"U '  LP!V +$ ?0"O (4 K0"- *L EP"I *$ IP"N *4
MO@"B -@ H #R )\ _P"> /\ G@#_ )X _P"< /\ _P   /<   #K    X0
M -8   #+  D Q0 1 +\ &P"[ "8 MP Q +0 .@"Q $, K@!+ *L 4@"I %@
MIP!> *8 9 "D &D H@!P *  =@"> 'X G "& )H D "8 )L E@"G )0 M@"2
M ,H D #I (\ _ ". /\ C0#_ (P _P"- /\ ^    .D"  #; P  S $  ,0
M  "]  ( M@ - +  %0"K "  IP J *0 - "A #P G@!$ )P 2P": %( F !8
M )8 70"5 &, DP!I )$ < "/ '< C0"  (L B@") )4 AP"A (4 KP"# ,$
M@0#@ (  ]0!_ /\ ?P#_ '\ _P!_ /\ [@H  -P.  #*$   O@X  +4+  "O
M P  J0 ' *, $ "> !@ F0 C )8 + "3 #4 D  ^ (X 10", $L B@!1 (@
M5P"& %T A0!C (, :@"! '$ ?P!Z 'T A ![ (\ >0"< '< J@!U +L = #4
M '( \ !R /\ <@#_ '$ _P!Q /\ XQ$  ,T7  "_&0  LQD  *H5  "C$
MG0H  )<!"@"1 !( C0 ; (D )0"% "\ @P W (  /@!^ $4 ?0!+ 'L 40!Y
M %< > != '8 9 !T 6L <@%T ' "?P!N HL ; .8 &L#I@!I!+< : 7. &<'
M[ !F"/T 9@G_ &4)_P!E"?\ UAH  ,0@  "V(P  JR,  *$@  "9&P  DA0
M (P. 0"&!PT @ 04 'P&'@!Y!R@ =@@P '0(. !R"3\ < E% &\*3 !M"E(
M; I8 &H+7P!H"V< 9PMP &4,>@!C#(< 8@R5 & -I !?#;8 7@W. %P.[0!<
M#_\ 6Q#_ %L0_P!;$/\ S2$  +PH  "O*P  I"L  )HI  "2)   B1\  ((8
M  ![$04 =0T/ '$-%P!N#B$ :PXJ &D/,@!G$#D 91!  &001@!C$$T 81!3
M %\16@!>$6( 7!%K %L1=@!9$H, 6!*2 %83H@!5$[0 5!/+ %,4[ !2%?\
M4A;_ %(5_P!2%?\ QB@  +8N  "I,@  GS(  )4Q  ",+0  @R<  'HA  !R
M&@  :Q,+ &<3$P!D%!P 810E %\5+0!=%30 7!4[ %L60@!9%D@ 6!9/ %87
M5@!5%UX 4Q=G %(8<@!0&'\ 3QF. $X:GP!,&K  2QO' $L;Z0!*'/T 2AS_
M $H<_P!*'/\ P2T  +$T  "E-P  FC@  ) W  "'-   ?2\  '0I  !L(P
M9!P' %X9$ !;&A@ 61LA %<;*0!5&S  5!PW %(</0!1'$0 3QU+ $X=4@!-
M'5H 2QYC $H>;@!)'WP 1Q^+ $8@G !%(:X 1"'$ $,BY@!#(OP 0R+_ $,B
M_P!#(O\ O#(  *TX  "A/   ESX  (T]  "#.@  >34  &\P  !F*@  7B0"
M %<@#0!4(!0 42 = $\A)0!.(2P 3"$S $LB.@!)(D  2")' $<B3@!&(U<
M1"-@ $,D:P!")'D 026( #\FF0 ^)JL /2?! #TGXP ]*/H /2C_ #TG_P ]
M)_\ N#8  *H]  ">0   E$(  (I"  " /P  =CL  &PV  !B,   62H  %$E
M"P!-)1$ 2R49 $DE(0!')B@ 128O $0F-@!#)CT 0B=$ $$G2P _*%0 /BA=
M #TI:0 \*78 .RJ& #DKEP X*ZD -RR_ #<LX  W+/@ -RS_ #<L_P X+/\
MM3H  *=   "<1   D48  (=&  !]1   <T   &@[  !?-@  53$  $PK!P!'
M*0\ 12H6 $,J'@!!*B4 /RHL #XK,P ]*SD /"M! #LL2  Z+%$ .2U; #@N
M9@ V+G, -2^# #0OE0 S,*< ,C"] #$QW@ Q,?< ,C'_ #(P_P S,/\ L3X
M *1$  "92   CTH  (5*  ![20  <$4  &5   !;.P  4C8  $@Q! !"+@T
M/RX3 #TN&P [+B( .2\I #@O+P W+S8 -C ^ #4P1@ T,4\ ,S%9 #(R9  Q
M,G$ ,#.! "\TDP N-*8 +#6[ "PUVP L-?4 +37_ "TT_P N-/\ KD$  *)(
M  "73   C4X  (-.  !Y30  ;DH  &)%  !80   3CP  $4W   ],PL .3,1
M #<S&  V,Q\ -#,F #,S+0 R-#0 ,30\ # U1  O-4P +C96 "TV8@ L-V\
M*S=_ "HXD0 H.*0 )SFY "8YV  G.?0 *#G_ "@X_P I./\ JT4  )]+  "4
M3P  BU(  (%3  !W4@  ;$\  %])  !61@  3$(  $(]   X. @ -#@/ #(X
M%0 Q.!T +S@D "XX*P M.3( +#DY "LZ00 J.DH *3M4 "@[7P G/&T )3Q]
M "0]CP C/:( (CVW "$^U  A/O, (CW_ ",]_P C//\ J$D  )U/  "24P
MB58  ']7  !U5@  :E,  %U/  !33   2D@  $!$   V0 4 +ST- "T]$P K
M/1H *CXA "D^*  H/B\ )SXW "8_/P D/T@ (T!2 ") 70 A06H ($%Z !Y!
MC0 =0J  '$*U !M"T0 ;0O$ '$+_ !U!_P >0?\ I4T  )I3  "06   AEL
M 'U<  !R6P  9U@  %M4  !14@  2$X  #U*   S1P  *D,+ "9#$  E0Q8
M)$,> "-$)0 B1"P (40T "!%/  >144 '45/ !Q&6@ ;1F@ &49X !A'B@ 7
M1YX %D>S !1(S@ 51^\ %D?_ !=&_P 71O\ HE(  )=8  "-70  A&   'IA
M  !P8   95X  %E:  !/6   1%0  #E1   O3@  )DL& "!*#@ >2A, '4H:
M !Q*(0 ;2R@ &DLP !E+.  72T( %DQ, !5,5P 43&4 $TUU !)-B  139P
M$$VQ  Y.S  /3>X $$W_ !%,_P 13/\ GE<  )1=  "+8@  @64  '=F  !M
M9@  8V0  %9A  !*7@  /UL  #58   K5@  (E0! !I2"@ 64A  %5(6 !12
M'0 34B0 $E(L !%2-  14CX $%-(  ]35  .4V( #51R  Q4A  +5)@ "52M
M  A4Q0 )5.< "E/[  M2_P +4O\ FUT  )%D  "(:   ?FL  '1L  !K;
M7VH  %)G  !%9   .F(  #!@   F7@  '5T  !5;!0 06@P #EH1  Y:&  -
M6R  #%LG  M;,  *6SH "5M%  =;40 &6UX !%MM  -;@  !6Y0  %NH  !;
MP   6N(  %KV  %:_P "6?\ EV0  (YK  "$;@  >W   ')R  !G<0  67
M $QN  ! ;   -6L  "II   A9P  &&8  !%F 0 ,90H !V4/  1E%  #9!L
M F0C  !D+   9#4  &1   !D3   9%H  &1I  !D>P  9(\  &.D  !CNP
M8MT  &+T  !B_P  8?\ DVP  (EQ  " =0  >'<  &UX  !@=P  4G8  $9U
M   Y=   +G0  "-R   :<0  $G$   UQ   &<0@  ' -  !P$@  <!<  &\?
M  !O)@  ;S   &\[  !O1P  ;U0  &]D  !O=0  ;HH  &V@  !MM@  ;-8
M &OR  !K_P  :_\ CG,  (5X  !]>P  <WT  &5^  !8?@  2WX  #Y^   R
M?@  )GT  !Q\   3?   #7P   9]    ?04  'P+  !\#P  ?!,  'P9  !\
M(0  ?"D  'PT  ![0   >TX  'M>  ![;P  >H0  'J:  !YL0  >,X  '?O
M  !V_@  =O\ B7H  (%_  !X@@  :X,  %V%  !/A@  0H<  #6(   IAP
M'8<  !2'   -B   !HD   "*    B@   (D&  ")#   B0\  (D3  ")&@
MBB(  (HL  "*.   BD8  (E6  "):   B7P  (B4  "'JP  AL8  (7J  "%
M^P  A/\ A8(  'V&  !OB   88L  %.-  !%CP  .)$  "N1   ?D@  %)(
M  V3   $E    )8   "7    F    )<   "7!0  EPL  )@.  "8$P  F1H
M )DB  ":+@  FCT  )E-  "97@  F7,  )B+  "8HP  E[P  );B  "6]P
ME?\ @(D  '*,  !DCP  5I,  $B6   ZF0  +)H  !^;   4G   #)X   .?
M    H0   *,   "E    I0   *4   "E    I@(  *<(  "G#0  J!$  *D9
M  "K(P  JS$  *M!  "L4P  K&<  *N   "JF@  JK,  *K0  "I[P  J?L
M=8\  &>4  !9F   2IP  #R?   MH@  (*,  !.E   +IP   :D   "K
MK@   +$   "R    L@   +,   "T    M0   +8   "X!   N0L  +L0  "]
M&   OR0  +\U  # 1P  P%L  ,!R  # C0  P:8  ,#!  "_XP  OO, :I<
M %N<  !-H0  /J4  "^I   AJP  $ZT   NP    LP   +4   "X    O
M +\   #!    P0   ,,   #$    Q@   ,<   #)    RP   ,X(  #1#P
MU1@  -@G  #9.0  VDT  -MD  #;?@  W)D  -RP  #<R0  W., 79\  $^E
M  ! J@  ,J\  "*R   4M0  "K@   "[    OP   ,,   #&    RP   ,X
M  #1    T0   -0   #6    V0   -L   #>    X    .0   #G!@  ZPX
M .\9  #P*@  \C\  /-5  #T;0  ](@  /2A  #TM@  ],< _P ) /\ !@#_
M  < _P , /\ $0#_ !P _P H /\ - #_ $$ _P!, /\ 50#_ %T _P!E /\
M; #_ '( _@!X /P ?@#[ (0 ^@"+ /D D@#W )D ]@"B /0 K #S +D \0#+
M /  Z #N /L [0#_ .P _P#A /\ T@#_ ,D _P#$ /\ _P ! /\   #_
M_P $ /\ #@#_ !< _P C /\ +P#_ #L _0!& /H 4 #W %@ ] !? /( 9@#P
M &P [P!R .T > #L 'X Z@"% .D C #G ), Y0"< ., I@#A +$ WP#! -T
MW0#; /0 V0#_ -8 _P#/ /\ Q #_ +T _P"Y /\ _P   /\   #_    _P
M /\ "P#\ !, ]P > /0 *@#R #4 [@!  .D 2@#F %( XP!9 .  8 #> &8
MW !L -H <@#7 '@ U !^ -( A0#0 (T S@"5 ,P GP#) *H QP"X ,4 S0##
M .L P #^ +\ _P"^ /\ M@#_ +  _P"M /\ _P   /\   #_    ^0   /(
M!@#K  \ Y@ 9 .$ ) #> "\ V@ Y -, 0P#/ $P S !3 ,D 6@#' &  Q0!F
M ,, :P#! '$ OP!W +T ?@"[ (8 N0". +< F "U *, LP"P +$ P@"N .
MK #W *L _P"J /\ J #_ *, _P"@ /\ _P   /\   #U    ZP   .$   #6
M  P SP 3 ,H '@#& "D P@ S +\ /0"[ $4 N !- +8 5 "S %H L0!? +
M90"N &H K !P *L =P"I '\ IP"' *4 D0"C )P H "I )X N "< ,X F@#N
M )D _P"7 /\ E@#_ )8 _P"3 /\ _0   /$   #E    V0   ,T   #$  8
MO0 / +< & "S "( L  L *T -@"I #X IP!& *0 30"B %, H !9 )\ 7@"=
M &0 FP!J )H < "8 '< E@"  )0 B@"1 )4 CP"B (T L "+ ,, B0#C (@
M^0"& /\ A@#_ (8 _P"& /\ \P   .,   #1    Q0   +T   "V    K@ +
M *@ $@"D !P H  F )P +P": #< EP _ )4 1@"2 $P D0!2 (\ 6 "- %T
MBP!C (H :@"( '$ A@!Y (0 @P"" (\ ?P"; 'X J0!\ +L >@#5 '@ \@!X
M /\ =P#_ '< _P!W /\ YP<  -$,  ###0  N P  *X(  "H    H@ % )L
M#@"6 !4 D@ ? (X * "+ #$ B  Y (8 0 "$ $8 @@!, (  4@!_ %< ?0!=
M 'L 8P!Z &L > !S '8 ?0!T (@ <0"5 '  I !N +0 ; #* &L Z@!J /P
M:@#_ &H _P!J /\ VA   ,84  "X%@  K14  *02  "<#@  E@<  )  "0"*
M !  A0 8 ($ (0!^ "H >P R 'D .0!W $  =0!& ', 3 !R %$ < !7 &X
M7@!M &4 :P!N &D =P!G (, 90"1 &, GP!B *\ 8 #$ %\ Y !? ?@ 7@+_
M %X"_P!> O\ SA@  +T=  "P(   I1\  )L<  "3%P  BQ$  (0,  !^! L
M>0 2 '4 &P!R ", ;P K &T!,P!K 3H :0)  &<#1@!F TP 9 12 &,$60!A
M!&  7P5I %X%<P!<!G\ 6@:- %D'G !7"*T 5@C! %4)X0!4"_8 5 O_ %0+
M_P!4"_\ QA\  +8E  "I*   GB@  )0E  "+(0  @QL  'L4  !T#@, ;@D-
M &D(% !F"1T 9 HE &(*+0!@"S0 7@LZ %T+0 !;#$< 6@Q- %@,5 !7#5P
M50UD %0-;P!2#7L 4 Z* $\.F@!.#JP 3 _" $P0XP!+$/D 2Q#_ $L1_P!+
M$/\ OR8  + K  "D+P  F2\  (\M  "&*0  ?20  '0>  !L%P  91$' %\.
M$ !<#Q< 6A ? %@0)P!6$"X 5! U %,0.P!2$4( 4!%( $\14 !.$5< 3!)@
M $L2:P!)$G@ 2!.' $83EP!%%*D 1!2^ $,5WP!#%O@ 0Q;_ $,6_P!#%O\
MNBL  *LQ  "@-   E34  (LT  "!,0  >"L  &\F  !F(   7AD! %<4#0!4
M%!, 410; $\5(P!.%2H 3!4Q $L6-P!)%CX 2!9$ $<73 !%%U0 1!== $,8
M9P!!&'0 0!F# #\:E  ]&J8 /!N[ #L;VP ['/8 /!S_ #P<_P \'/\ M3
M *@V  "<.0  D3L  (<Z  !^-P  <S(  &HM  !A)P  62$  %$;"0!,&1
M2AH7 $@:'P!&&B8 11LM $,;,P!"&SH 01Q! $ <2  ^'%  /1U9 #P>9  [
M'G$ .1^  #@?D@ W(*0 -B"X #4AU@ U(?0 -2+_ #4A_P V(?\ LC0  *0Z
M  "9/@  CS\  (4_  ![/   <#@  &<R  !=+0  5"@  $PB!0!&'PX 0Q\4
M $$?&P _'R( /B I #T@,  [(#8 .B$] #DA10 X(DT -R)7 #8C8@ T(VX
M,R1^ #(DCP Q):( +R6V "\FT@ O)O( +R;_ # F_P P)O\ KS@  *(^  "6
M0@  C$,  ()#  !X00  ;CT  &,X  !:,P  42X  $@H 0! ) P /2,1 #LD
M&  Y)!\ ."0F #8D+  U)3, -"4Z #,F0@ R)DH ,2=4 # G7P O*&P +BA[
M "PIC0 K*J  *BJT "DJSP I*_  *BO_ "HJ_P K*O\ K#P  )]"  "41@
MBD<  (!'  !V10  ;$(  &$]  !7.   3C,  $0N   \*0D -R@0 #4H%0 S
M*!P ,B@C # H*0 O*3  +RHW "XJ/P M*T@ +"M2 "LL70 J+&H *"UY "<M
MBP F+IX )2ZS "0OS0 D+^X )2__ "4O_P F+O\ J3\  )U%  "220  B$L
M 'Y,  !T2@  :D<  %Y"  !4/0  2SD  $$T   X+P8 ,BT- # M$P N+1D
M+2T@ "LM)P J+BX *2XU "DO/0 H+T8 )S!/ "4P6P D,6@ (S%W "(RB0 A
M,IT 'S.Q !XSRP >,^T 'S/_ " S_P A,O\ ID,  )I)  "030  AD\  'Q0
M  !S3P  :$P  %Q&  !20P  23\  #\[   V-@( +C(, "LR$0 I,A< *#(>
M "8R)  E,RL )#,R ",T.@ B-$, (35- " U6  ?-F4 'C9U !PWAP ;-YL
M&C>O !DXR  9..L &CC_ !LW_P ;-_\ HT<  )A-  ".40  A%,  'M4  !Q
M4P  9E   %I,  !020  1T4  #U!   S/0  *CD) "4W#@ C-Q0 (C@; "$X
M(@ @."@ 'S@P !XY.  =.4$ '#I+ !HZ5@ 9.V, &#MR !8[A0 5/)D %#RM
M !,]Q@ 3/>D %#S] !4\_P 6._\ H$L  )51  "+50  @E@  'E9  !N6
M9%8  %A1  !.3P  14L  #I'   P0P  )T % " ^#0 =/A$ '#X7 !L^'@ :
M/B4 &3XM !@_-0 6/SX %3]( !1 4P 30&  $D%P !%!@@ 009< #T&L  Y"
MQ  .0N< #T'\ !!!_P 00/\ G5   )-6  ")6@  @%T  '9>  !L70  8EL
M %97  !,50  05$  #9.   L2P  (T@  !M%"0 71 \ %404 !1%&P 312(
M$D4I !%%,0 113L $$9%  ]&4  .1UX #4=M  Q'?P +1Y, "4>G  A'O@ (
M1^  "4?V  I&_P +1O\ FE4  )!;  "'8   ?6(  '-C  !J8@  8&$  %->
M  !'6@  /%<  #)5   H4@  'U   !=.!  13 P #TP1  Y,%P .3!X #4TE
M  Q-+@ +33< "DU"  E-30 '3EH !DYI  1.>P "3H\  4ZD  !-N@  3=L
M 4WR  %-_P "3/\ EEL  (UB  "$9@  >F@  '%I  !H:0  7&<  $]D  !"
M80  -U\  "U<   C6@  &E@  !)7 0 -5@D "54.  =5$P &51H !%4B  -5
M*@ "530  %4^  !52@  5E<  %9E  !5=P  58L  %6@  !5M@  5-0  %3Q
M  !3_0  4_\ DV(  (IH  " ;   =VX  &]O  !C;@  5FP  $EJ   ]:
M,F8  "=E   =8P  %6(   YA   )8 @  V -  !?$0  7Q<  %\>  !?)@
M7R\  %\Z  !?10  7U,  %]A  !><@  7H<  %V<  !=L@  7,\  %SO  !;
M_0  6_\ D&H  (9O  !]<@  =70  &IU  !==   3W,  $)R   V<   *V\
M "!N   7;0  $&P   IL   ":P8  &L+  !J#P  :A0  &H:  !J(0  :2H
M &DT  !I0   :4X  &E<  !I;0  :((  &B8  !GK@  9LH  &7M  !E_
M9/\ BW$  ()V  !Z>0  <'L  &)[  !5>P  2'H  #MZ   O>@  (WD  !EX
M   1=P  "G<   -W    =P(  '<(  !V#0  =A   '85  !V&P  =B,  '8N
M  !U.@  =4<  '56  !U:   ='P  '22  !SJ@  <L0  ''I  !P^P  </\
MAGD  ']]  !V?P  :($  %J"  !,@@  /X,  #*$   E@P  &H,  !&#   *
M@P   H,   "$    A0   (0#  "#"   @PT  (,0  "#%0  A!P  (0F  "$
M,@  A#\  (-/  "#8   @G4  (*,  "!I   @+T  '_C  !^^0  ?O\ @H
M 'J$  !LA@  7H@  %"*  !"BP  -8T  ">-   ;C0  $8X   J.    CP
M )$   "2    D@   )(   "2 0  D@<  )(,  "2$   DQ4  ),=  "4*
ME#8  )1%  "35P  DVL  )."  "2G   D;8  )#8  "/\P  C_\ ?H<  '"*
M  !AC0  4Y   $63   WE0  *98  !R7   1F   "9D   ";    G    )X
M  "@    H    *    "@    H0   *$$  "B"0  HPX  *04  "E'0  IBH
M *8Z  "F3   I6   *5X  "ED@  I*P  *3)  "CZP  HOH <XX  &21  !6
ME0  1YD  #F<   JG@  ':   !&A   (HP   *4   "G    J0   *P   "N
M    K@   *X   "O    L    +$   "R    LP8  +4-  "W$P  N1X  +DN
M  "Z0   NE0  +MJ  "ZA0  N:$  +F[  "ZW@  N?( 9Y4  %B9  !*G@
M.Z(  "RF   =J   $:H   >L    KP   +$   "T    N    +L   "\
MO    +X   "_    P    ,(   #$    Q@   ,@#  #+"P  SQ(  -$@  #1
M,@  TD8  --=  #4=@  U)(  -6K  #5Q   U.( 6YT  $RB   ]IP  +ZP
M !^O   1L0  ![4   "X    NP   +X   #"    QP   ,H   #,    S
M ,X   #0    T@   -4   #8    VP   -\   #B    Y@L  .L3  #L)
M[3@  .Y.  #O9P  \((  /"<  #PL@  \<4 _P # /\  0#_  0 _P ) /\
M#P#_ !@ _P D /\ , #_ #P _P!' /\ 40#_ %D _P!@ /T 9P#\ &T ^@!S
M /D >0#X '\ ]@"% /4 C #S )0 \@"= /  IP#N +, [ #$ .L X0#J /@
MZ0#_ .< _P#9 /\ RP#_ ,( _P"] /\ _P   /\   #_    _P   /\ # #_
M !0 _P @ /\ *P#^ #< ^@!" /8 2P#R %, \ !; .X 80#L &< Z@!M .@
M<P#G 'D Y0!_ ., A@#A (X WP"6 -T H #; *P V "[ -0 T0#3 /  T #_
M ,X _P#( /\ O0#_ +8 _P"R /\ _P   /\   #_    _P   /T " #W !
M\P : .\ )@#M #$ Z  [ ., 10#@ $T W !5 -D 6P#6 &$ TP!G -$ ; #/
M '( S0!X ,L ?P#) (< QP"0 ,4 F@## *4 P "R +X Q0"\ .4 N@#[ +@
M_P"W /\ L #_ *D _P"E /\ _P   /\   #^    ]0   .P  P#E  T WP 5
M -H ( #4 "H T  U ,L /@#( $< Q0!. ,( 50#  %L O@!A +P 9@"Z &P
MN !R +8 > "U (  LP"( +$ D@"N )X K "J *D NP"H -4 I@#S *0 _P"C
M /\ H0#_ )L _P"8 /\ _P   /L   #P    Y0   -@   #.  D QP 1 ,(
M&@"^ "0 NP N +< . "T $  L0!( *X 3@"L %0 J@!: *D 7P"G &4 I0!K
M *0 <0"B '@ H "! )X BP"< )8 F0"C )< L@"6 ,< DP#H )( _@"1 /\
MD #_ (T _P"+ /\ ^0   .L   #=    SP   ,8   "\  0 M0 - +  %0"L
M !X J  H *4 ,0"B #D GP!! )T 2 "; $X F0!3 )< 60"6 %X E !D )(
M:@"0 '$ C@!Z (P @P"* (\ B "< (8 J@"$ +P @@#< ($ ]@"  /\ ?P#_
M '\ _P!^ /\ [    -H   #)    O@   +8   "N    IP ) *$ $ "< !@
MF  B )4 *@"2 #( D  Z (T 00"+ $< B0!- (< 4@"& %@ A != (( 9 "!
M &L ?P!S 'T ?0![ (@ > "5 '8 HP!U +0 <P#, '$ [0!P /\ < #_ '
M_P!P /\ WP4  ,H*  "\"P  L0D  *@$  "A    FP # )0 # "/ !, B@ ;
M (< ) "$ "P @0 S '\ .@!] $$ >P!' 'D 3 !W %( =@!7 '0 70!R &0
M< !M &\ =@!L (( :@"/ &D G0!G *X 90## &0 Y !C /H 8P#_ &( _P!C
M /\ T X  +\2  "R$P  IQ(  )T0  "5"P  CP,  (D !P""  X ?@ 5 'H
M'@!V "4 =  M '$ - !O #H ;@!  &P 1@!J $P :0!2 &< 6 !F %\ 9 !G
M &( <0!@ 'P 7@") %P F !; *D 60"\ %@ W !8 /0 6 #_ %< _P!7 /\
MQA8  +8:  "J'0  GQP  )49  "-%   A0\  'X)  !W 0H <@ 0 &X %P!J
M !\ :  G &4 +@!D #0 8@ [ &  0 !? $8 70!, %P 4P!: %H 6 !B %<
M; !5 '< 4P"% %( E !0 :4 3P&X $X"T@!-!/  307_ $T%_P!-!?\ OQT
M + B  "C)0  F24  (\B  "%'0  ?1@  '42  !N#0( 9P8, &,#$0!? AD
M70,A %L$* !9!"\ 5P4U %8%.P!4!D$ 4P9' %$&3@!0!U4 3@=> $T(9P!+
M"', 20F! $@)D@!'"J, 10JV $0+T !$#.\ 0PW_ $,-_P!$#?\ N20  *HI
M  ">+   E"P  (HJ  " )@  =R$  &X;  !F%   7P\% %D+#0!5"A, 4PL;
M %$+(@!/#"D 30PO $P,-@!+#3P 20U" $@-20!&#5$ 10Y: $0.9 !"#G
M0 Y_ #\/D  ^$*( /!"V #L0T0 [$?$ .Q'_ #L1_P \$?\ M"D  *8O  ":
M,@  D#(  (8Q  !\+0  <B@  &DC  !A'0  618  %$1" !,#Q  2A 6 $@0
M'0!&$"0 11 K $,1,0!"$3< 01$^ $ 110 ^$DT /1)6 #P280 Z$VT .1-\
M #<4C0 V%)\ -16S #05S0 S%NX -!;_ #06_P T%O\ KRX  *(T  "7-P
MC#@  ((V  !X-   ;BX  &4J  !<)   5!X  $P8! !&% T 0A02 $ 4&0 _
M%"  /14G #P5+0 [%30 .18Z #@60@ W%DH -A=3 #477@ S&&H ,AEY # 9
MB@ O&IT +AJQ "T;R@ M&^P +1S_ "X;_P N&_\ K#(  )\X  "4.P  BCP
M ( \  !V.0  :S0  &(O  !9*@  4"4  $<?  ! &@H /!D0 #H9%@ X&1T
M-AHC #4:*0 T&C  ,QHW #(;/@ Q&T< +QQ0 "X=6P M'6< +!YV "H>B  I
M'YL *!^N "<@QP F(.H )R#^ "@@_P H(/\ J38  )T\  "2/P  AT$  'U
M  !T/@  :3H  %\U  !6,   32L  $0E   [( < -AX. #,>$P R'AD ,!X@
M "\>)@ N'RT +1\T "P@.P K($0 *B%. "DA6  G(F4 )B)T "4CA0 C(YD
M(B2M "$DQ0 A)>@ (B7] "(D_P C)/\ ICH  )H_  "/0P  A44  'M$  !R
M0P  9S\  %TZ  !3-@  2C$  $$L   X)@, ,2,, "XB$0 L(A8 *B(= "DB
M(P H(RH )R,Q "8D.0 E)4$ )"5+ ",F5@ B)F, (2=R !\G@P >*)< '2BK
M !LIPP ;*>8 '"G[ !TI_P >*/\ HSX  )A#  "-1P  @TD  'I)  !P1P
M9D0  %H_  !1.P  1S<  #XR   U+0  +"@) "@G#P G)Q0 )2<: "0G(0 C
M*"< (B@N "$I-@ @*3\ 'RI) !XJ5  =*V  &RMO !HL@0 9+)4 %RVI !8M
MP0 6+>0 %RWZ !@M_P 9+?\ H4$  )5'  "+2P  @DT  'A-  !N3   9$D
M %A$  !/0   1CT  #TX   S-   *B\& "0L#0 A+!( ("P8 !\M'@ >+24
M'2TL !PN-  ;+CP &B]& !@O40 7,%X %C!M !4Q?P 3,9, $C&H !$ROP 1
M,N( $C+Y !,Q_P 3,?\ GD4  )-+  ")3P  @%$  '92  !M4   8DX  %9)
M  !-1@  1$,  #L_   Q.@  )S8# !\R"P <,A  &S(5 !DR&P 8,B( %S,I
M !8S,0 5-#H %#1$ !,T3P 2-5P $35K ! V?0 /-I$ #C:F  TWO  --]T
M#3;V  XV_P /-O\ FTD  )%/  "'4P  ?E8  '56  !J50  8%,  %5/  !,
M3   0DD  #A%   N00  )#T  !PZ"  6. X %3@2 !0X&  3.1\ $CDF !$Y
M+@ 0.3< #SI!  XZ3  -.UD #3MH  L[>@ *.XT "3RB  <\N  '/-4 "#SP
M  D[_P *._\ F$X  (Y4  "%6   ?%L  ');  !H6@  7E@  %-5  !)4@
M/DX  #1+   J1P  (40  !A" P 20 L $#\0  X_%0 ./QP #4 C  Q *P +
M0#0 "D ^  E!2@ '058 !D%E  1!=@ #08H  4&?  !!M   0=   4'N  %!
M_  "0/\ E50  (Q9  "#7@  >6   '!@  !F8   75X  %%;  !%5P  .E0
M "]1   E3P  '$P  !1*   .2 @ "T<.  A'$@ '1QD !D<@  5(*  #2#$
M D@[  !(1P  2%,  $AB  !(<P  2(8  $B;  !(L0  1\P  $?M  !'^P
M1_\ DEH  (E@  " 8P  =V4  &YF  !E9@  660  $Q@  ! 70  -5L  "I9
M   @5P  %U4  !!3   +4@< !5$-  %0$0  4!8  % =  !0)0  4"X  % X
M  !00P  4%   %!>  !0;P  4(,  $^8  !/K@  3LD  $[K  !-^P  3?\
MCV$  (9F  !]:0  =&P  &QM  !A:P  4VD  $9G   Z9   +V,  "1A   :
M7P  $EX   Q<   &7 8  %L+  !:#P  6A,  %H9  !9(0  62D  %DS  !9
M/P  64P  %E:  !9:P  6'X  %B4  !7JP  5\4  %;I  !5^P  5?\ C&@
M ()M  !Z<   <G(  &=R  !:<0  3'   #]N   S;0  *&L  !UJ   4:
M#6<   =G    9@,  &8)  !E#0  91$  &05  !D'   9"0  &0N  !D.@
M8T<  &-5  !C9@  8WH  &*0  !AIP  8,$  %_F  !?^@  7O\ AV\  ']T
M  !X=P  ;G@  &!X  !2=P  17<  #AV   K=@  ('0  !9S   .<P  !W(
M  !R    <@   '$%  !Q"@  <0X  ' 1  !P%P  <!X  ' G  !P,P  ;T
M &]0  !O8   ;G0  &Z+  !MH@  ;+P  &OB  !J^   :?\ @W<  'Q[  !S
M?0  97X  %=_  !)?P  /'\  "^    B?P  %WX   ]^   '?@   '\   !_
M    ?P   'X   !^!0  ?@H  'X-  !^$0  ?A<  'X@  !^*P  ?3D  'U(
M  !]60  ?&T  'R$  ![G   >K8  'G:  !X]0  =_\ @'\  '>"  !I@P
M6X4  $V&   _B   ,HD  "2)   8B0  #XD   >*    BP   (P   "-
MC0   (P   ",    C ,  (P(  "-#0  C1$  (T7  ".(@  CB\  (X_  "-
M4   C60  (Q[  ",E0  BZX  (K-  ")[P  B?\ >X4  &V(  !>B@  4(T
M $*/   TD0  )I(  !F3   .E   !I4   "6    F    )H   ";    FP
M )L   ";    FP   )P   "=!0  G0L  )X0  "?%P  H"0  * T  "@1@
MH%D  )]P  "?B@  GJ4  )["  "=Z   G/D <(P  &&/  !3D@  1)8  #:9
M   GFP  &9P   ^=   %GP   *$   "C    I0   *@   "I    J0   *D
M  "J    JP   *P   "M    K@$  + )  "R#P  LQ@  +0G  "T.0  M4T
M +1D  "T?@  LYH  +.T  "SU0  L_  9),  %67  !'FP  .)\  "FB   :
MI   #J8   2H    JP   *T   "P    M    +8   "X    N    +D   "Z
M    O    +T   "_    P    ,,   #%!P  R0\  ,H:  #++   S$   ,U6
M  #.;P  S8L  ,RH  #,P@  S.( 6)L  $F@   ZI0  +*D  !RK   /K@
M!+$   "T    MP   +H   "^    PP   ,8   #(    R    ,H   #+
MS0   ,\   #2    U0   -D   #=    X04  .8/  #G'@  Z#(  .E(  #J
M8   ZWL  .N7  #LK@  [,( _P   /\   #_    _P & /\ #0#_ !4 _P A
M /\ + #_ #@ _P!# /\ 3 #^ %0 ^P!; /H 8@#X &@ ]@!N /4 = #T 'H
M\@"  /$ AP#O (\ [0"7 .L H0#I *T YP"] .4 V #D /, X@#_ .  _P#0
M /\ Q #_ +P _P"V /\ _P   /\   #_    _P   /\ "0#_ !$ _P < /T
M)P#Y #( ]0 ] /$ 1@#M $\ ZP!6 .@ 7 #F &( Y !H ., ;@#A ', WP!Y
M -T @ #: (@ V "1 -0 FP#2 *8 SP"T ,P R0#) .D R #_ ,< _P#! /\
MMP#_ *\ _P"K /\ _P   /\   #_    _P   /@ !0#R  X [@ 7 .H (@#F
M "P X0 W -T 0 #8 $D TP!0 -  5@#. %P S !B ,H 9P#( &T Q@!S ,0
M>0#" ($ P "* +X E "\ )\ N0"L +8 O@"T -T LP#W +$ _P"P /\ J #_
M *( _P"> /\ _P   /\   #Y    [P   .8   #?  L U@ 2 -  ' #, "8
MR  P ,0 .@#  $( O0!* +L 4 "X %8 M@!; +4 80"S &8 L0!L +  <@"N
M 'H K "" *D C "G )@ I0"E *, M "@ ,L GP#N )T _P"< /\ F0#_ )0
M_P"1 /\ _P   /8   #J    W0   ,\   #'  8 P  / +L %P"W "  LP J
M +  ,P"M #L J@!# *< 20"E $\ HP!5 *( 6@"@ %\ G@!E )T :P"; '(
MF0![ )< A0"4 )  D@"= )  K ". +\ C #B (L ^@") /\ B0#_ (8 _P"#
M /\ ]    .0   #4    R    +\   "U  $ K@ + *D $@"E !L H0 C )X
M+ "; #0 F  \ )8 0P"4 $D D@!. )  4P". %D C0!> (L 9 ") &L AP!S
M (4 ?0"# (@ @0"5 '\ I !] +4 >P#/ 'D \0!X /\ =P#_ '< _P!U /\
MY0   -$   ##    N    *\   "H    H  & )H #@"5 !4 D0 > (X )@"+
M "T B  U (8 / "$ $( @@!' (  30!_ %( ?0!8 'L 7@!Y &4 > !M '8
M=@!S ($ <0". &\ G0!M *X ; #$ &H YP!I /T : #_ &@ _P!I /\ U0,
M ,,'  "V"   JP8  *(   ";    E    (T "@"( !  @P 8 '\ ( !\ "<
M>@ N '< -0!U #L = !! '( 1P!P $P ;P!2 &T 6 !K %\ :0!F &< < !E
M 'L 8P"( &( EP!@ *< 7@"[ %T W !< /8 7 #_ %L _P!; /\ R0T  +D0
M  "L$0  H1   )<-  "/"   B    (( !0![  T =P 2 ', &@!O "$ ;  H
M &H +P!H #4 9P [ &4 00!C $8 8@!, &  4@!? %D 70!A %L :@!9 '4
M5P"" %4 D0!4 *( 4P"U %$ SP!0 .\ 4 #_ %  _P!0 /\ OQ0  + 8  "D
M&@  F1D  (\6  "'$0  ?PT  '<&  !Q  @ :P . &< % !D !L 80 B %X
M*0!= "\ 6P U %D .P!8 $$ 5@!& %4 30!3 %0 4@!< %  90!. '  3 !]
M $L C0!) )X 2 "P $< QP!& .D 1@#[ $8 _P!% /\ N!L  *H@  ">(@
MDR(  (D?  " &@  =Q4  &\0  !H"P  800* %T $ !9 !8 5@ = %0 (P!2
M "H 4  P $\ -0!. #L 3 !! $L 2 !) $\ 1P%7 $8!80!$ FP 0P)Y $$#
MB0!  YH /@2M #T$Q  \!>4 / ?X #P'_P \!_\ LB(  *4G  "9*0  CBD
M (0G  ![(P  <1X  &D8  !A$@  6@T# %,(# !/!1$ 3 47 $H&'@!(!B0
M1P8J $4', !$!S8 0P@] $$(0P! "$L /@E3 #T)70 ["F@ .@IV #@+AP W
M"YD -0NL #0,P@ S#.0 ,PWY #,-_P T#?\ K2<  * L  "5+P  BR\  ( N
M  !W*@  ;24  &0@  !<&@  5!0  $P/!@!&# T 0PP2 $$,&  _#!\ /@PE
M #P-*P [#3( .@TX #@-/P W#D< -@Y0 #0.6@ S#F8 ,0]T # /A0 N$)@
M+1"K "P0PP K$>4 +!'Z "P1_P M$?\ JBP  )TQ  "2-   AS4  'TT  !T
M,0  :BL  & G  !8(0  3QL  $<6  ! $0D .Q / #D0%  W$!L -A A #00
M)P S$2T ,A$T #$1.P P$4, +A)- "T25P L$F, *A-Q "D3@@ G%)4 )A2I
M "45P  D%>, )1;Z "86_P F%?\ IC$  )HV  "/.0  A3H  'LY  !Q-@
M9S$  %TM  !4*   3"(  $,=   [%P4 -10- #(3$0 Q%!< +Q0= "X4)  L
M%"H *Q4Q "H5.  I%D  *!9* "<75  F%V  )!AO ",8@  A&9, (!FG !\9
MO@ >&N  'QKX " :_P @&O\ HS0  )@Z  "-/0  @SX  'D]  !O.P  93<
M %LR  !2+0  22@  $ C   X'@$ ,!D* "P8#P J&!0 *1@: "<8(  F&2<
M)1DM "0:-0 C&CX (AM' "$;4@ @'%X 'QUL !T=?@ <'9$ &AZE !D>O  8
M']T &1_V !H?_P ;'O\ H3@  )4]  "+00  @4(  '="  !M0   8SP  %DW
M  !/,P  1BX  #TI   U)   +2 ' "<=#0 E'1( (QT7 "$='0 A'20 (!XK
M !\>,@ >'SL '1]% !P@3P :(5P &2%J !@B>P 6(H\ %2*C !0CN@ 3(]H
M%"/U !4C_P 6(_\ GCP  )-!  ")1   ?T8  '5&  !L1   8D$  %<\  !-
M.   1#0  #PP   S*P  *B8# ",B"P @(1  'B$5 !PB&P ;(B$ &B(H !HC
M,  9(S@ &"1" !8E30 5)5D %"9H !,F>0 2)HT $2>B ! GN  .)]8 $"CT
M !$G_P 1)_\ G$   )%%  "'2   ?4H  '1*  !J20  8$8  %5!  !,/@
M0SH  #HV   Q,@  *"T  " I"0 ;)PX &2<2 !@G&  6)Q\ %2@E !0H+0 3
M*#8 $BE  !(I2P 1*E< $"IF  XK=P .*XL #2R?  PLM0 ++,\ #"SO  TL
M_P -*_\ F40  (])  "%3   ?$X  '-/  !I3@  7DL  %-'  !*1   0D
M #D]   O.   )30  !TP!0 6+0P %"P0 !,M%0 2+1P $2TC ! M*@ /+C,
M#BX]  TO2  -+U4 ##!C  HP=  ),(@ "#&<  8QL0 &,<L !C'K  <P_  (
M,/\ ET@  (U-  "#40  >E,  '%4  !G4@  75   %),  !)2@  0$8  #5"
M   K/@  (CH  !HW 0 2- D #S,.  XS$P -,QD #3,@  PT*  +-#$ "C4[
M  @U1@ '-5( !39@  0V<0 "-H0  #:9   VKP  -L@  #;H   V^0 !-?\
ME$T  (I2  "!5@  >%@  &]9  !E6   6U4  %%2  !'3P  /$P  #%(   G
M1   'D$  !8_   0/ < "SH-  DZ$0 (.Q< !CL>  4[)@ $.RX  CLX  $\
M0P  /$\  #Q>   \;@  /($  #R7   \K   .\4  #OG   [^   ._\ D5(
M (A8  !_7   =ET  &U>  !C70  6EP  $Y8  !"5   -U$  "U.   C2P
M&DD  !)&   -1 8 !T,,  -#$   0Q4  $,;  !#(P  0RL  $,U  !#0
M0TT  $-;  !#:P  0WX  $.4  !"J@  0L,  $'F  !!^0  0?\ CE@  (9>
M  !]80  <V,  &MD  !B8P  5V$  $E=   ]6@  ,E@  "=5   >4P  %5$
M  Y/   )304  DT+  !,#@  3!,  $L8  !+'P  2R@  $LR  !+/0  2TD
M $M7  !+9P  2GL  $J0  !)IP  2<   $CD  !(^   1_\ BU\  (-D  !Z
M9P  <6D  &EJ  !>:0  4&8  $-D   W80  +%\  "%=   86P  $%D   I8
M   #5P,  %<)  !6#0  51   %45  !4&P  5",  %0M  !4.0  5$4  %13
M  !49   4W<  %.-  !2I   4;T  %#B  !0^   3_\ B&<  ']K  !W;@
M;W   &5P  !7;@  2FP  #UK   P:0  )6@  !IF   19   "V,   1B
M8@$  &$&  !@"P  8 X  %\2  !?%P  7QX  %XH  !>,P  7D   %Y/  !>
M7P  77(  %V(  !<H   6[D  %K?  !9]P  6/\ A&X  'QR  !U=0  :W8
M %UU  !/=   0G,  #5S   H<@  '7   !-O   ,;@  !&X   !N    ;@
M &P"  !L!P  :PL  &L.  !K$@  :AD  &HB  !J+0  :CH  &E)  !I6@
M:6P  &B#  !GFP  9K4  &78  !D]0  9/\ @'4  'IY  !P>P  8GL  %1\
M  !&?   .7P  "Q\   ?>P  %'H   UZ   $>@   'H   !Z    >@   'D
M  !Y 0  > 8  '@+  !X#@  >!,  '@:  !X)0  >#(  '=!  !W4@  =V4
M '9\  !UE0  =*\  '/.  !R\0  <?\ ?GT  '6   !G@0  6((  $J#   \
MA   +H4  "&%   5A0  #84   .%    A@   (<   "(    B    (<   "'
M    AP   (<$  "'"0  APX  (@3  "('   B"D  (@X  "'2@  AUT  (9S
M  "&C0  A:<  (3%  "#[   @OX >(0  &J&  !<B   38H  #^,   QC@
M(X\  !:/   -D    I$   "2    DP   )4   "6    E@   )8   "6
ME@   )<   "7    EP<  )@-  "9$P  FA\  )HM  ":/P  FE(  )IH  "9
M@P  F9\  )BZ  "7X@  EO@ ;8H  %^-  !0D   09,  #.6   DEP  %I@
M  V9   !FP   )T   "?    H0   *0   "E    I    *4   "E    I@
M *<   "H    J0   *H$  "L#   KA,  *XA  "N,P  KD<  *Y=  "N=@
MKI,  *ZN  "MS0  K.\ 89$  %.5  !$F   -9P  ":?   7H0  #:,   "E
M    IP   *H   "L    L    +(   "T    LP   +0   "U    MP   +@
M  "Y    NP   +T   "_ 0  PPL  ,45  #%)0  QCD  ,=/  #':   QH4
M ,:B  #&O   QMX 59D  $>=   XH@  *:8  !FH   -JP   *T   "Q
MM    +<   "Z    OP   ,$   #$    PP   ,4   #&    R    ,H   #-
M    SP   -(   #6    VP   . ,  #A&   XRL  .1!  #E6@  YG0  .:1
M  #EK   Y<0 _P   /\   #_    _P ! /\ "@#_ !( _P = /\ * #_ #0
M_P ^ /T 2 #Z %  ]P!7 /4 70#T &, \@!I /  ;P#O '0 [0![ .L @0#I
M (D Z "2 .8 G #D *@ X@"W -\ S0#< .X V0#_ -D _P#* /\ O@#_ +4
M_P"P /\ _P   /\   #_    _P   /\ !@#_  \ _  8 /@ (P#T "X \  X
M .L 0@#H $H Y0!1 .( 6 #@ %T W@!C -P : #9 &X U@!T -0 >P#1 ((
MSP"+ ,T E0#* *$ R "O ,4 P0#" ., P #[ ,  _P"[ /\ L #_ *@ _P"D
M /\ _P   /\   #_    ^P   /,  0#M  P Z  3 ., '@#@ "@ V@ R -,
M/ #/ $0 S !+ ,D 40#& %< Q != ,( 8@#! &< OP!M +T = "[ 'L N0"$
M +< C@"T )D L@"G *\ MP"M -  JP#R *H _P"I /\ H0#_ )L _P"7 /\
M_P   /\   #T    Z0   .    #5  @ S@ 0 ,D & #% "( P0 K +P -0"Y
M #T M@!% +, 2P"Q %$ KP!6 *X 6P"L &$ J@!F *D ;0"F '0 I !\ *(
MA@"@ )( G@"? )P K@"9 ,, EP#G )8 _P"5 /\ D@#_ (T _P"* /\ _
M /    #C    U    ,@   "_  , N0 - +, $P"O !P K  E *D +@"E #8
MHP ^ *  1 "> $H G0!0 )L 50"9 %H EP!? )8 9@"4 &P D@!U )  ?@".
M (H BP"7 (D I@"' +@ A0#6 (0 ]@"" /\ @0#_ 'X _P!\ /\ [0   -T
M  #,    P0   +@   "N    IP ) *( $ "> !< F@ ? )< )P"4 "\ D0 W
M (\ /0"- $, BP!) (D 3@"( %, A@!9 (0 7P"" &4 @ !M 'X =P!\ ((
M>@"/ '@ G@!U *\ <P#' '( [ !Q /\ < #_ '  _P!N /\ W0   ,D   "\
M    L0   *D   "A    F0 # ), # ". !( B@ 9 (< (0"$ "D @0 P '\
M-P!] #T >P!" 'D 2 !X $T =@!2 '0 6 !R %\ <0!G &\ < !L 'L :@"(
M &@ EP!F *@ 90"\ &, X0!B /H 80#_ &$ _P!A /\ S0$  +P%  "O!0
MI0(  )P   "4    C0   (8 " "!  X ?  4 '@ &P!U ", <@ I '  , !N
M #8 ;0 \ &L 00!I $< : !, &8 4@!D %D 8P!@ &$ :0!? '0 70"! %L
MD !9 *$ 5P"T %8 T !5 /( 50#_ %0 _P!5 /\ P0P  +(.  "F#P  FPX
M )(+  ")!0  @@   'L  @!U  L <  0 &P %@!H !T 9@ C &, *@!A #
M8  V %X .P!= $$ 6P!& %H 3 !8 %, 5@!; %0 9 !2 &X 40![ $\ B@!-
M )L 3 "N $L Q@!* .H 20#^ $D _P!) /\ N1(  *H6  ">%P  E!8  (H3
M  "!$   >0L  '$#  !K  8 90 - &$ $0!= !@ 6@ > %@ ) !6 "H 5  P
M %, -@!1 #L 4 !! $X 1P!- $X 2P!6 $D 7P!' &D 1@!V $0 A0!# )<
M00"I $  OP _ .( /P#X #X _P _ /\ LAD  *0>  "8'P  CA\  (0<  !Z
M&   <A(  &H.  !B"   7 $( %< #@!3 !, 4  9 $X 'P!, "4 2@ K $@
M, !' #8 1@ \ $0 0@!# $D 00!1 #\ 6@ ^ &4 / !R #H @0 Y ), . "E
M #8 N@ V -L -0#T #4 _P U /\ K"   )\D  "4)@  B28  '\D  !U(
M;!L  &05  !<$   5 P! $X&"@!* @\ 1P 4 $0 &@!" "  0  E #\ *P ^
M 3$ / $W #L"/@ Y D4 . -- #8#5@ U!&$ ,P1N #$%?@ P!9  +P6C "T&
MN  L!M0 + ?P "P(_P L"/\ J"4  )LJ  "0+   ABT  'LK  !R)P  :"(
M %\=  !7%P  3Q(  $@.! !!"@L /@<0 #L&%0 Y!QL . <A #8()@ U""P
M,P@R #().0 Q"4$ +PE) "X*4P L"EX *PML "D+?  H#(\ )@RB "4,MP D
M#-, (PWP "0-_P E#?\ I"H  )@O  "-,@  @S(  'DQ  !O+@  92D  %PD
M  !3'P  2QD  $,3   \$ 8 -0T, #,,$0 Q#!8 +PP< "X-(@ M#2@ *PTN
M "H--0 I#3T )PY& "8.4  D#EP (P]J "(/>P @$(X 'Q"B !T0MP <$-0
M'1'R !T1_P >$?\ H2\  )4S  "*-@  @#<  '8V  !M,P  8R\  %DJ  !0
M)0  2"   #\:   X%0  ,!$( "P0#@ J$!( *! 8 "<0'@ E$"0 )! J ",1
M,@ B$3H (1%# " 23@ >$EH '1-H !L3>  :$XL &!2@ !<4M0 6%-$ %A7Q
M !<5_P 8%/\ GC,  ),W  "(.@  ?CL  '0[  !K.   830  %<O  !.*P
M128  #TA   T'   +1<% "83#  C$Q  (A,5 " 3&@ ?$R$ 'A0G !T4+P <
M%3< &Q5! !H62P 9%E< %Q=E !87=@ 4&(D $QB> !(8LP 1&<X $1GO !(9
M_P 3&?\ G#8  )$[  "&/@  ?#\  ',_  !I/0  7SD  %4U  !,,   0RP
M #HG   R(@  *AX! "(9"0 >%PX '!<2 !H7%P 9&!X &1@D !@9+  7&30
M%AH^ !4:20 3&U4 $AMC !$<=  0'(< #QV<  X=L0 -'<L #1WL  X=_P /
M'?\ F3H  (\_  "$0@  >T0  '%#  !H0@  7CX  %,Z  !*-@  03(  #DM
M   Q*0  *"4  " @!@ :'0P %QP0 !4<%0 4'1L %!TB !,=*0 2'C( $1\\
M ! ?1@ 0(%, #B!A  TA<0 ,(84 "R*9  HBK@ )(L< "2+G  HB^P +(?\
MESX  (Q#  "#1@  >4@  '!(  !G1@  7$0  %(_  !).P  0#@  #@T   O
M,   )RP  !XG P 6(PH $B$. !$A$P 0(AD $"(@  \B)P .(R\ #20Y  PD
M1  +)5  "B5>  DF;P ')H( !B:6  0FK  #)L0 !";E  0F]P &)O\ E4(
M (I'  "!2@  >$P  &],  !E2P  6T@  %!$  !'00  /SX  #<[   M-@
M)#$  !LM   3*@< #R@-  TG$0 -*!8 #"@=  LH)0 **2T "2DW  <J0@ &
M*DX !"M<  ,K;  !*W\  "N4   KJ0  *\$  "OC   K]@  *O\ DD8  (A+
M  !_3P  =E$  &U1  !C4   6DT  $]*  !'1P  /D0  #-    I/   (#@
M !<T   1,04 #"\,  DN$  '+A4 !B\;  4O(P #+RL  C U   P/P  ,$P
M #%9   Q:0  ,7P  #&1   QIP  ,+\  ##A   P]0  +_\ D$L  (90  !]
M5   =58  &M6  !B50  6%,  $Y0  !%30  .DD  "]%   E0@  '#X  !0[
M   ..04 "3<+  0V#P !-A,  #89   V(   -BD  #8R   W/0  -TD  #=7
M   W9P  -WD  #>/   VI0  -KT  #;@   U]0  -?\ C5   (16  !\6@
M<EL  &E;  !@6P  5UD  $Q6  ! 4@  -4X  "I+   @2   %T8  !!#   +
M000 !$ *   _#@  /A$  #X6   ^'0  /B8  #XO   ^.@  /D8  #Y4   ^
M9   /G8  #V,   ]HP  /+L  #S>   []0  ._\ BE<  ()<  !Y7P  <&$
M &AA  !?80  5%X  $=;   Z5P  +U4  "52   ;4   $DT   Q+   &2@,
M $D)  !(#0  1Q   $<4  !&&@  1B(  $8L  !&-P  1D,  $91  !&8
M17,  $6)  !$H   1+@  $/<  !"]0  0O\ B%T  ']B  !W90  ;F<  &=H
M  !;9@  3F,  $%A   T7@  *5P  !]:   55P  #E8   =4    4P$  %(&
M  !1"P  40X  % 1  !/%@  3QX  $\G  !/,@  3S\  $]-  !.70  3F\
M $Z%  !-G0  3+4  $O8  !*]0  2O\ A64  'QI  !T;   ;6X  &)M  !4
M:P  1VD  #IG   M90  (F0  !AB   08   "5\   !>    7@   %T#  !<
M"   6PP  %H/  !:$P  61D  %DB  !9+0  63H  %E(  !86   6&L  %>!
M  !7F0  5K(  %72  !4]   4_\ @6P  'EP  !S<P  :',  %IR  !,<0
M/W   #)O   E;@  &FP  !%K   ):@   &H   !I    :0   &@   !G P
M9@@  &8,  !F#P  910  &4<  !E)P  9#0  &1#  !D4P  9&4  &-[  !B
ME   8:T  &#-  !?\0  7O\ ?70  '=W  !N>0  7WD  %%Y  !#>0  -G@
M "EX   <=P  $78   IU    =0   '4   !V    =0   '0   !T    <P(
M ','  !S#   <A   '(5  !R(   <BP  '([  !Q3   <5\  '%T  !PC@
M;Z@  &[&  !L[0  :_\ >WL  ')^  !D?@  57\  $>    Y@0  *X(  !Z!
M   2@0  "H$   "!    @@   (,   "#    @P   ((   ""    @@   ((
M  ""!0  @@H  ((/  ""%P  @B,  ((R  ""0P  @58  (%L  " A@  ?Z$
M 'Z]  !]Y@  ?/P =H(  &B#  !9A0  2X<  #R)   NB@  ((L  !.+   *
MBP   (P   "-    CP   )$   "2    D0   )$   "1    D0   )$   "2
M    D@(  ),)  "4#P  E!D  )0G  "4.   E$P  )-B  "3?   DY@  )*S
M  "1V   D/8 :H@  %R*  !-C0  /Y   #"2   AE   %)4   J6    EP
M )D   ";    G0   )\   "@    H    *    "@    H0   *(   "C
MI    *4   "F!P  J!   *@<  "H+0  J4   *E6  "I;P  J8L  *BH  "G
MQP  INP 7X\  %"2  !!E@  ,YD  ".<   4G0  "I\   "A    HP   *8
M  "H    K    *X   "O    KP   +    "P    L@   +,   "T    M@
M +<   "Z    O0<  +\0  "_'P  P#,  ,!)  # 8@  P'X  ,";  # MP
MO]@ 4Y<  $2;   UGP  )J,  !:E   +IP   *H   "M    L    +,   "V
M    NP   +T   #     OP   ,$   #"    Q    ,8   #(    R@   ,P
M  #/    TP   -H'  #;$P  W24  -X[  #?4P  X&X  -^,  #=J0  W<(
M_P   /\   #_    _P   /\ !P#_ !  _P 9 /\ ) #_ "\ _  Z /D 0P#U
M $L \P!2 /$ 60#O %X [0!D .L :0#I &\ YP!U .8 ? #D (0 X@"- .
MEP#= *( V@"Q -4 Q0#2 .@ T #_ ,\ _P#$ /\ N #_ *\ _P"I /\ _P
M /\   #_    _P   /\  @#[  T ]P 5 /, 'P#O "D Z@ T .8 /0#B $4
MW@!, -L 4P#8 %@ U !> -( 8P#0 &D S@!N ,P =0#* 'T R "% ,8 D #"
M )L P "I +X N@"[ -D N0#W +@ _P"T /\ J0#_ *( _P"= /\ _P   /\
M  #_    ]@   .X   #G  H X0 1 -P &@#7 ", T  N ,L -P#' #\ Q !&
M ,$ 30"_ %( O0!8 +L 70"Y &( N !H +8 ;@"T '4 L0!^ *\ B "M ),
MJ@"A *@ L0"F ,@ I #M *( _P"B /\ FP#_ )4 _P"1 /\ _P   /P   #N
M    XP   -@   #-  4 Q@ . ,$ %0"] !X N0 G +4 , "R #@ KP!  *P
M1@"J $P J !1 *< 5@"E %L HP!A *$ 9P"? &X G@!V )L @ "9 (P EP"9
M )0 J "2 +P D #? (X ^P". /\ BP#_ (8 _P"# /\ ^    .D   #<
MS    ,$   "X    L@ * *P $0"H !@ I0 A *( *0"> #( G  Y )D /P"7
M $4 E0!* )0 4 "2 %4 D !: (\ 8 "- &< BP!O (D > "& (0 A "1 ((
MH "  +( ?0#, 'P \0![ /\ >@#_ '< _P!U /\ Y@   -,   #&    NP
M +$   "G    H0 % )L #0"7 !, DP ; )  (P", "L B@ R (@ . "& #X
MA !$ (( 20"! $X ?P!3 'T 60![ &  >0!H '< <0!U 'P <P") '  F !O
M *D ;0"_ &L Y@!J /\ :0#_ &D _P!G /\ TP   ,,   "U    JP   *,
M  ";    D@   (P "@"' !  @P 6 '\ '0!] "0 >@ K '@ ,@!V #@ =  ]
M '( 0@!Q $@ ;P!- &T 4P!L %D :@!A &@ :@!F '0 9 "! &$ D0!? *(
M7@"V %P U0!; /< 6P#_ %H _P!: /\ Q0   +8"  "I @  GP   )8   ".
M    AP   (  !0!Z  P =0 1 '$ & !N !X :P E &D *P!G #$ 9@ W &0
M/ !C $$ 80!' %\ 30!> %, 7 !; %H 9 !8 &X 5@![ %0 B@!2 )L 40"N
M %  R !/ .X 3@#_ $X _P!- /\ NPH  *P-  "@#0  E0P  (P(  "# @
M?    '4   !N  @ :0 . &4 $P!B !D 7P ? %T )0!; "L 60 Q %@ -@!6
M #L 50!! %, 1P!1 $X 4 !5 $X 7@!, &@ 2@!U $@ A !' )4 10"H $0
MOP!# .0 0@#\ $( _P!" /\ LA$  *44  "9%0  CA,  (01  ![#0  <P@
M &P   !E  , 7P + %L #P!7 !0 5  : %$ 'P!/ "4 3@ K $P , !+ #8
M20 \ $@ 0@!& $@ 10!0 $, 60!! &, /P!O #X ?@ \ )  .P"C #H N  Y
M -D . #U #@ _P X /\ K!<  )\;  "3'0  B1P  '\9  !U%0  ;!   &0,
M  !=!@  5@ & %$ # !- !  2@ 5 $< &@!% "  1  F $( *P!! #$ /P V
M #X /0 \ $0 .P!+ #D 5  W %\ -@!K #0 >@ R (P ,0"> #  LP O ,X
M+P#O "X _P N /\ IQX  )HB  "/)   A"0  'HA  !Q'0  9Q@  %\3  !7
M#@  4 H  $D#" !%  T 00 1 #X %@ \ !L .@ A #D )@ W "P -@ R #0
M.  S #\ ,0!' #  4  N %L +0!G "L =@ J (@ * "< "< L  F ,D )0#J
M "4!^P E ?\ HB,  )8H  "+*@  @2H  '<H  !M)0  9"   %L;  !2%0
M2Q   $,, @ ]!PD .0,. #8!$@ S 1< ,0$< # !(@ O B< +0(M "P#-  J
M SL *01# "@$30 F!5@ )05E ",&=  B!H8 ( :: !\'K@ >!\8 '0?G !T(
M^  ="?\ GR@  ),M  "(+P  ?B\  '0N  !J*P  828  %@A  !/'   1Q<
M #\2   X#@0 ,0L* "X(#@ K!Q( *0<7 "@('0 G"", )0@I "0),  C"3<
M(0I  " *2@ ?"U4 '0MB !L,<@ :#(4 & R9 !<,K0 6#,8 %0WF !4-^0 6
M#?\ G"T  ) Q  "&-   ?#0  '(S  !H,0  7RP  %4G  !,(P  1!T  #P8
M   T$P  +1 & "8-"P D# \ (@P3 "$,&0 ?#!\ '@TE !T-+  ;#30 &@X]
M !D.1P 7#E, %@YA !0/<0 3$(0 $A"8 !$0K@ 0$,8 $!#H ! 0^P 1$/\
MF3$  (XU  "$.   >CD  ' X  !G-@  73(  %,M  !**   0B0  #D?   Q
M&@  *A4! ",1!P =$ T &P\0 !D/%0 8$!L %Q A !80*0 5$#$ %!$Z !,1
M10 2$E$ $1)? ! 2;P .$X( #A.6  T3JP +$\( "Q3C  P4^@ -$_\ ES4
M (PY  ""/   >#T  &\]  !E.@  6S<  %(R  !)+@  0"H  #<E   O(0
M*!P  " 8 P 9% H %1(. !02$@ 3$Q@ $A,? !$4)@ 1%"X $!0X  \50@ .
M%D\ #19<  P7;  +%W\ "1B3  @8J  &&+\ !QC@  <8]0 )&/\ E3@  (H]
M  " 0   =T$  &U!  !D/P  6CP  % X  !',P  /C   #8K   N)P  )R,
M !\?   7&@@ $A<- ! 7$0 /%Q8 #A@<  X8(P -&2P #!HU  L:0  *&TP
M"1M:  <<:0 %''P !!V1  (=I@ !';P  AS=  (<\@ #'/\ DSP  (A!  !_
M1   =44  &Q%  !C1   64$  $\]  !&.0  /C8  #4R   N+@  )2H  !TE
M   4(00 #QT+  T=$  ,'10 "QT:  H>(@ ('BH !Q\S  8@/@ $($H  R%7
M  $A9P  (7D  "&.   AI   (;H  "';   A\@  (/X D$   (9%  !]2
M=$H  &M*  !B20  6$8  $Y"  !%/P  /3P  #4Y   K-   (B\  !DK   2
M* 0 #20*  DC#@ &(Q( !2,9  0D(  ")"@  24Q   E/   )4@  "95   F
M90  )G<  ":,   FH@  )KD  ";9   E\@  )?X CD4  (1)  ![30  <T\
M &I/  !@3@  5TL  $U(  !$10  /$(  #$]   G.0  'C4  !4R   /+@,
M"BP*  4K#@ !*A$  "H6   J'@  *B8  "LO   K.0  *T4  "Q3   L8@
M+'4  "R*   KH   *[<  "O6   J\@  *O\ C$D  ().  !Z4@  <50  &A4
M  !?4P  5E$  $Q.  !#2P  -T<  "U#   C/P  &CP  !(X   ,-@, !C,)
M   R#0  ,A   #$4   Q&P  ,2,  #$L   R-P  ,D,  #)0   R8   ,G(
M #*'   QG@  ,;4  ##4   P\@  +_\ B4\  (!4  !X5P  ;UD  &99  !>
M60  55<  $E3   ^3P  ,DP  "A(   >10  %4(   Y    (/0(  3P(   [
M#   .@\  #D2   Y&   .2   #DI   Y-   .4   #E.   Y70  .6\  #B%
M   XG   -[,  #?2   V\@  -?\ AU4  ']:  !V70  ;5\  &5?  !=7P
M4EP  $18   X50  +5(  ")/   83   $$H   I(   #1@$  $4&  !$"@
M0PT  $(0  !!%0  01T  $$F  !!,0  03T  $%*  !!6@  06P  $"!   _
MF0  /[$  #[0   ]\@  //\ A%P  'Q@  !S8P  ;&4  &1F  !99   2V$
M #Y>   R6P  )ED  !Q6   25   #%(   11    3P   $X#  !-"   3 P
M $L.  !+$@  2AD  $HB  !*+   2CD  $I'  !*5@  26@  $E^  !(E@
M1Z\  $;-  !%\0  1/\ @6,  'EG  !R:@  :VP  &!K  !2:0  1&8  #=D
M   J8@  'V   !5>   -70  !EL   !:    60   %@   !7!   5@@  %8,
M  !5$   5!0  %0=  !4)P  5#0  %1"  !34@  4V0  %)Y  !2D@  4:L
M %#*  !/[P  3O\ ?FH  '=N  !P<0  9G$  %AP  !*;P  /&T  "]L   B
M:@  %VD   YG   &9@   &4   !E    90   &,   !B    8@0  &$(  !A
M#0  8!   & 7  !@(0  7RX  %\\  !?30  7EX  %YT  !=C0  7*<  %O%
M  !:[0  6?\ >W(  '5V  !K=P  778  $]V  !!=0  ,W4  "9T   9<P
M$'(   =Q    <0   '$   !Q    <0   &\   !O    ;@   &X"  !N"
M;0P  &T1  !M&@  ;28  &PU  !L1@  :U@  &MM  !JA@  ::$  &B^  !G
MZ   9OX >7H  '!\  !A?   4WT  $1]   V?@  *'X  !M]   0?0  !WT
M  !]    ?0   'X   !_    ?@   'T   !]    ?    'P   !\    ? 8
M 'P,  !\$@  ?!T  'PL  !\/   ?$\  'ME  ![?@  >IH  'FV  !XWP
M=_H <X   &6!  !6@P  2(0  #F&   KAP  '8<  !&'   'B    (@   ")
M    B@   (P   "-    C0   (P   ",    C    (P   ",    C0   (T$
M  ".#   CA,  (\A  ".,@  CD8  (Y;  "-=   C9   (RM  "+S@  BO,
M:(8  %J(  !+BP  /(T  "V/   >D   $9$   >2    DP   )4   "7
MF0   )L   "<    FP   )L   "<    G    )T   ">    G@   )\   "A
M P  H@P  *(6  "C)@  HSH  *-/  "C:   HH8  **B  "BP   H>@ 7(T
M $V0   _DP  ,)8  "&9   2F@  !YL   "=    H    *(   "D    J
M *H   "K    J@   *L   "L    K0   *X   "O    L0   +(   "T
MMP$  +D-  "Y&@  NBT  +I#  "Z6P  NG<  +N4  "[L0  N=( 4)4  $&8
M   RG   (Z   !.B   (I    *<   "J    K    *\   "R    MP   +D
M  "[    N@   +P   "]    OP   ,    #"    Q    ,8   #)    S0
M -(!  #4#P  U1\  -<U  #830  V&D  ->&  #7HP  UKT _P   /\   #_
M    _P   /\  P#_  T _P 5 /\ ( #\ "L ^  U /0 /P#P $< [@!. .L
M5 #I %H YP!? .4 9 #C &H X0!P -\ =@#= 'X VP"' -@ D0#3 )T SP"K
M ,T O0#+ .  R0#[ ,< _P"] /\ L0#_ *D _P"C /\ _P   /\   #_
M_P   /P   #V  L \0 1 .T &P#I "4 Y  P -\ .0#: $$ U0!( -$ 3@#/
M %0 S0!9 ,L 7@#) &, QP!I ,4 ;P## '< P !_ +X B@"[ )4 N "C +8
MM "T ,T L@#R +  _P"L /\ HP#_ )P _P"7 /\ _P   /\   #Z    \0
M .@   #@  8 V0 . -( %@#. !\ R  I ,0 ,@#  #H O0!! +H 2 "X $T
MM@!3 +0 6 "R %T L !B *X :0"L &\ J@!X *@ @@"F (X I "; *$ JP"?
M ,  G0#F )L _P": /\ E #_ (X _P"* /\ _P   /8   #H    W    ,X
M  #&  $ OP + +H $0"V !H L@ B *X *P"J #0 J  [ *4 00"C $< H0!,
M )\ 40"> %8 G !< )H 8@"9 &@ EP!P )4 >@"2 (8 D "3 (T H@"+ +4
MB0#3 (< ]P"& /\ A #_ '\ _P!\ /\ \@   .,   #2    Q0   +H   "Q
M    JP ' *4 #@"A !0 G@ < )H )0"7 "T E  T )( .@"0 $  C@!% (T
M2@"+ %  B0!5 (@ 6P"& &$ A !I (( <@!_ 'T ?0"+ 'L F@!X *L =@#$
M '0 ZP!S /\ <P#_ '  _P!N /\ WP   ,P   "_    M    *L   "A
MF@ " )0 "P"0 !  C  7 (@ '@"% "8 @P M ($ ,P!_ #D ?0 _ 'L 1 !Y
M $D > !. '8 5 !T %H <P!B '  :P!N '4 ; "# &H D@!H *, 9@"X &0
MW@!C /L 8@#_ &( _P!@ /\ S    +P   "O    I0   )T   "4    C
M (8 !P"!  T ?  2 '@ &0!U !\ <P F '$ +0!O #( ;0 X &L /0!J $(
M: !( &< 3@!E %0 8P!; &$ 9 !? &X 70![ %L B@!9 )L 5P"O %8 RP!5
M /( 5 #_ %0 _P!4 /\ O@   +    "D    F0   )    "(    @0   'D
M @!S  H ;P / &L % !G !H 90 @ &, )@!A "P 7P R %X -P!< #P 6P!"
M %D 1P!7 $X 5@!5 %0 7@!2 &@ 4 !T $X @P!, )4 2@"H $D P !( .@
M1P#_ $< _P!' /\ M D  *8+  ";#   D H  (8%  !^    =@   &\   !H
M  4 8P , %\ $ !; !4 6  : %8 (0!4 "8 4P L %$ ,0!0 #8 3@ \ $T
M0@!+ $@ 20!0 $@ 6 !& &( 1 !N $( ?0!  (X /P"B #T N  ] -T / #X
M #P _P \ /\ K!   )\2  "4$@  B1$  '\/  !V#   ;@4  &8   !@  $
M60 ( %4 #0!1 !$ 3@ 6 $L &P!) "$ 2  F $8 *P!% #$ 0P V $( / !
M $, /@!+ #T 4P [ %T .0!I #< >  V (D - "< #, L0 R ,X ,@#Q #$
M_P Q /\ IA8  )H9  ".&@  A!H  'H6  !P$@  : X  %\*  !8 P  40 $
M $P "@!(  X 1  2 $$ %@ _ !L /0 A #P )@ Z "P .0 Q #< -P V #X
M- !& #, 3P Q %D +P!E "X <P L (4 *P"8 "H K0 I ,8 * #J "@ _@ H
M /\ H1P  )4@  "*(0  ?R$  '4?  !L&@  8Q8  %H1  !2#0  2P<  $0
M!@!   L /  / #@ $@ V !< -  < #, (0 Q "< ,  L "X ,P M #H *P!"
M "H 2P H %4 )@!A "4 <  D ($ (@"5 "$ J0 @ ,$ ( #D !\ ^0 ? /\
MG2(  )$F  "&*   ?"<  '(E  !I(@  7QT  %<8  !.$P  1@X  #\+   X
M!0< -  , #$ $  N !, +  8 "H '0 I "( )P H "8 +@ D #8 (P ^ "(
M1P @ %( 'P!> !T ;0 < 'X &@"2 !D IP 8 +T %P#? !<!]0 7 O\ FB<
M (XK  "$+0  >2T  ' K  !F*   720  %0?  !+&@  0Q0  #L0   T#0(
M+0D) "D%#0 F Q  ) $3 "("&0 A AX ( (D !X#*@ = S( &P0Z !H%1  9
M!4\ %P9< !8&:@ 4!WP $P>0 !('I0 1![L $ ?; ! (\@ 0"?\ ERL  (PO
M  "!,0  =S(  &XQ  !D+@  6RH  %$E  !)(   0!L  #@6   Q$@  *0X$
M ",,"0 ?"0T '0<0 !L'%0 9"!H & @@ !<))P 6"2X %0HW !,*00 2"TT
M$0M: ! +:0 .#'L #@R0  T,I0 ,#;L "PW9  L-\0 ,#?\ E2\  (HS  !_
M-@  =C8  &PU  !C,P  62\  % K  !')@  /B$  #8=   N&   )Q,  " 0
M!0 9#@H %0P. !0,$0 3#!8 $@P< !$-(P 0#2L #PTT  X./P -#DH # ]8
M  L/9P *$'D "!"-  <0H@ &$+@ !1#4  40[P &$/\ DC,  (@W  !^.@
M=#L  &LZ  !A.   6#4  $XP  !%+   /2<  #4C   M'P  )AH  !X6 0 7
M$P8 $1 +  X.#@ .#Q, #1 9  T0(  ,$"@ "Q$R  H1/  ($D@ !Q)5  83
M90 $$W8  Q.+  $4H   $[8  !/1   3[@  $_L D#8  (8[  !\/@  <S\
M &H_  !@/0  5SD  $TV  !$,0  /"X  #0J   L)@  )2(  !X>   6&@(
M$!4)  P3#@ *$Q( "107  @4'P '%28 !A4O  06.@ #%D8  1=3   78@
M&'0  !B)   8GP  &+4  !?0   7[0  %_L CCH  (0_  ![0@  <D,  &A#
M  !?0@  5C\  $P[  !#-P  .S0  #,P   L+   )"D  !LD   3'P( #1L)
M  D9#0 &&1$ !!D6  (9'0 !&B0  !HM   ;.   &T0  !Q1   <8   '7(
M !V'   <G0  '+,  !S.   ;[0  &_P C#X  ()#  !Y1@  <$@  &A(  !>
M1@  540  $M   !#/0  .SH  #,W   J,@  ("T  !<I   0)0( "R()  4@
M#0 !'Q   !\4   ?&P  ("(  " K   A-@  (4$  "%/   A7@  (G   "*%
M   AFP  (;(  "'-   @[0  '_P BD,  (!(  !X2P  ;TP  &9-  !=2P
M5$D  $I&  !"0P  .D   "\[   E-P  '#,  !,O   -+ ( !RD(  $G#
M)@X  "42   F&0  )B$  "8I   F,P  )S\  "=-   G7   )VT  ">"   G
MF0  )K   "7,   E[@  )/T B$@  '],  !V4   ;E$  &52  !<40  4T\
M $I,  !!20  -40  "M    A/   %SD  ! V   *,@$  S '   O"P  +@X
M "T1   M%@  +1X  "TG   M,0  +3T  "U*   M60  +6L  "V    LEP
M+*\  "O+   J[@  *OX A4T  'U2  !U50  ;%<  &-7  !;5@  4U4  $=1
M   [30  ,$D  "5&   <0P  $S\   T]   &.@   #@%   W"0  -@T  #4/
M   T%   -!L  #0D   T+@  -#H  #1'   T5P  -&@  #1]   SE0  ,JT
M #'*   Q[@  ,/\ @U,  'M8  !S6P  :ET  &)=  !;70  3UH  $)6   V
M4@  *D\  "!,   620  #D<   A$    0@   $$#   _!P  /@L  #T.   ]
M$0  /!@  #PA   \*P  /#<  #Q$   \4P  /&4  #MZ   ZD@  .JL  #G(
M   X[0  -_\ @5H  'E>  !Q80  :6,  &)D  !78@  25X  #Q;   O6
M)%4  !E3   040  "D\   %-    3    $H   !)!   2 @  $<,  !&#P
M1A0  $4<  !%)P  13,  $5   !%4   1&$  $1V  !#CP  0J@  $'&  !
M[   /_\ ?F$  '9E  !O:   :&H  %UI  !/9@  0F0  #1A   H7P  '5T
M !);   +60   E@   !6    5@   %0   !3    4@0  %$)  !0#0  4!
M $\8  !/(@  3RX  $\\  !/2P  3ET  $YR  !-BP  3*4  $O"  !)Z@
M2/\ >VD  '1L  !N;P  9&\  %5M  !';   .6H  "QI   @9P  %&4   UD
M   #8@   &(   !A    8    %\   !>    70   %P$  !<"0  6PT  %L2
M  !;'   6B@  %HV  !:1@  65@  %EM  !8A0  5Z   %:]  !5Z   4_X
M>7   '-T  !I=0  6W0  $QS   ^<P  ,'(  "-Q   6;P  #6X   1M
M;0   &T   !M    ;    &L   !J    :0   &D   !I P  : D  &@.  !H
M%0  9R$  &<O  !G/P  9E(  &9F  !E?P  9)H  &.W  !BX0  8?P =W@
M &UZ  !?>@  4'H  $)Z   S>P  )7L  !AZ   .>0  !'D   !Y    >0
M 'H   !Z    >@   '@   !X    =P   '<   !W    =P$  '<(  !W#@
M=Q@  '<F  !V-@  =DD  '5?  !U=P  =),  '.O  !RTP  <?< <7X  &-_
M  !4@   18(  #:#   HA   &H0   Z#   $A    (0   "%    A@   (@
M  ")    B    (<   "'    AP   (<   "'    B    (@   "(!P  B1
M (D<  ")+   B#\  (A5  "(;0  AXD  (:G  "%QP  A.\ 9H0  %>&  !(
MB   .8H  "J,   ;C0  #XT   2.    D    )$   "3    E0   )<   "8
M    E@   )<   "7    EP   )@   "8    F0   )H   ";    G0<  )T1
M  "=(0  G3,  )U)  "<8@  G'\  )R<  "<N0  F^( 6HL  $N.   \D0
M+9,  !Z5   0E@  !)@   ":    G    )X   "A    I    *8   "G
MI@   *<   "G    J    *D   "J    K    *T   "O    L0   +,)  "S
M%0  M"<  +0]  "U50  M7   +2.  "TK   M,P 39(  #^6   OF@  ()T
M !&?   %H0   *,   "F    J0   *P   "O    LP   +4   "W    M@
M +<   "X    N@   +L   "]    OP   ,$   #$    QP   ,L   #-#
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M^_S^______________________________________________________\
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M\/'R\_3U]O?X^?K[_/W^_VUF=#$      P$A   !
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M___________;D%L]9:CV__________________________________Z\=30
M5)OK_________________________________].4?DDL3IKL____________
M____________________V-3*LWYE;:7Y____________________________
M________],6NK\G_____________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________#6QNS____________________________________FNY%T
M8ZOW________________________________]L2:<T4F-'W,____________
M____________________M8!5, H &6"R____________________________
M___/=#4+    "E*G______________________________^6-        $^G
M______________________________9I'0  "0P&"5*Q________________
M_____________\L[#A,U3%M-3%[#_____________________________ZE@
M-F"&G[:LJ;C9_____________________________^"7C;[E____________
M___________________________M^?______________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________Z]G*O,?_____________
M_____________________\^:@6U:1HCJ____________________________
M____Q'P^)A   %2P_______________________________@@SP      "Z'
M[?____________________________^L4Q       !=MUO______________
M______________N ,0        EAS/___________________________]):
M @        !=S/___________________________Z@U          !<T___
M_________________________WT-          !4UO__________________
M________[GU%          !$U/___________________________*ID+P(
M  0B-TE8SO___________________________^FD:T$H/V-_E:>ZVO______
M________________________U;*LLLSD^O__________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________Y;N7=V+(_________________________________]N>9S8*  *,
M________________________________R'\_!0    !>S_______________
M_______________9@3D        \JO____________________________^>
M3          CD/___________________________]QO&@         0??G_
M_________________________Z](            ;^[_________________
M_________X03            9.;_________________________[%$
M        5][_________________________N!4             2-;_____
M____________________=!0             .,______________________
M___YHEH3            (\7_________________________WYM<+
M    #;K__________________________^^Q?54Y(A$' 0(1(K+_________
M_____________________]^_I9F8FJ"LO=K_________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________^.^G8!\^_______________
M__________________*WA%<P#@ =K/______________________________
MTHI,%0      <O/____________________________6?S8         2\G_
M__________________________J1/@          +ZO_________________
M_________\!:            &I7__________________________XTD
M        "(3_________________________YUX              '?_____
M____________________M"4              &K_____________________
M____?0               %OT_______________________]*P
M     $SK______________________^E                 #SA________
M______________\P#                "W9_____________________YF*
M82<              "?7_______________________MOHE5)P
M "7<__________________________[*G79=2CPR+2PP.4?>____________
M___________________]YMW6TM#3V>3_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________[]2[UO_________________________________GN(]J2R\5;___
M____________________________Y*%G- <     /,G_________________
M___________6@CL         $I?__________________________^V%,0
M         &___________________________Z9"             %#A____
M____________________[&D              #?)____________________
M____LR\              "*V________________________>0
M     !"G_______________________R-                 "9________
M______________^I                  ",______________________]&
M                  !______________________]\
M  !T_____________________Y<                   !J____________
M_________\X                   !C______________________\I(@$
M              !A______________________^YHX!7-Q<           !H
M___________________________ZTZZ4AGQU<7!R=X&4________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________]NZG8)I:=/______________________________\B3
M93T9    '9[____________________________;CDP3         &[_____
M_____________________]M\+            $77____________________
M_____XLJ             "*T________________________PD0
M      .7________________________?0$               !_________
M_______________G-@                !J______________________^=
M                  !8______________________]&
M  !'^/___________________^D                    UZ?__________
M_________Y8                    EV____________________[P
M               8SO___________________^L                    /
MPO____________________\                    *N?______________
M______\G                   *M?____________________]P
M           -N?_____________________@G(QP54(S)AL4#PT.$AHFO___
M__________________________GDV-+.S,O,S];@_/__________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________________________^O3O./_____
M___________________________2J85E2"P2 87_____________________
M_______QJW$\#P       $_@_________________________]5_-0
M     !^R________________________XW4=              ")________
M________________D",               !G_______________________5
M0P                !(]O____________________^*
M   NW?____________________\X                   7R/__________
M_________[X                    $MO___________________YP
M                I?___________________[H
MD____________________]P                     @O______________
M______\                     =/____________________\3
M            :/____________________]"                    8/__
M__________________]Z                    7?__________________
M___1                    8?______________________)
M        9O______________________R:R9B7UV<6QI9V9G:W!ZC/______
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________________________________^+%
MJI%Y87?_____________________________W:9W4"P,     #'$________
M_________________^"23A,           "/________________________
MTG =              !@_______________________N;P\
M   WXO____________________^6'                  4P/__________
M__________]                     H____________________ZX
M                B?___________________YX
M<O___________________[P                     7_______________
M_____]H                     3?____________________H
M            ._____________________\.                    *OG_
M__________________\S                    &^G_________________
M__]>                    #]O___________________^/
M        !M#____________________0                     ,K_____
M________________*P                   ,C_____________________
M@                    ,O_____________________]Q8!!04# 0
M 08-&,O_______________________SKX=C/S,W/T-+4U]SBZO__________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________QVL;_________________________
M______'&HX1H33(8 !6K__________________________^Y?$88
M  !Q________________________UWPO               [X___________
M___________?9 D                ,M?____________________]T P
M                C?___________________\45
M:O___________________YD                     2_______________
M_____[8                     ,/W__________________]<
M            &>?___________________8                     !=/_
M__________________\.                     ,'_________________
M__\O                     *____________________]2
M         )[___________________]Y                     ([_____
M______________^E                     (#____________________8
M                     '3_____________________-@
M     &W_____________________?                    &G_________
M____________UPT                  &C______________________W
M                 &'_______________________]0/$9.5%E=861H;'!V
M?HG_________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________^_5NZ.+<UJ5____________
M_______________XOXYD02$%      !2_/______________________]YU6
M&              7P?_____________________E;!8
MC?____________________]C                    7O______________
M_____YT                     -?S__________________Z$
M            $=G__________________\H                      +O_
M_________________^X                      *'_________________
M__\,                     (K___________________\M
M         ';___________________]-                     &3_____
M______________]O                     %+___________________^4
M                     $#___________________^\
M     ##____________________J#@                   "+_________
M____________1                    !7_____________________@0
M                  OU____________________R L
M  +L_____________________UX                   #E____________
M_________\D<                  #:______________________^= 0
M           '#A?%________________________U;F\P<?.U=OAYNWT^___
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________^-_/_____________________________^S&I8AM5#LA!P R
MWO_______________________]>262D             H/______________
M________B38                 9_____________________]F
M            ,O;__________________Y4                      \C_
M_________________Z<                      *#_________________
M_]<                      'S___________________\
M         %[___________________\E                     $/_____
M______________](                     "S___________________]J
M                     !C___________________^+
M      7S__________________^O                      #A________
M___________5                      #/____________________)
M                  "^____________________5
M  "N____________________BP                    "?____________
M________RPX                   "2_____________________U<
M              "&_____________________ZH*                  !Y
M______________________]M                  !F________________
M_______W50                !%_________________________VHC*S4_
M2E5@:G5^AY&<________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________HS[:=@VE.N?_________________________LLH-<
M.AT"        >_______________________Q6TI                0/__
M__________________^#&P                  !\O_________________
M_Y(                      )C__________________Z0
M         &K__________________]T                      $'_____
M______________\.                     !W___________________\Y
M                      #H__________________]@
M      #.__________________^%                      "W________
M__________^H                      "C___________________+
M                  "0___________________O%@
M  !]____________________/@                    !L____________
M________:0                    !:____________________F0
M              !)____________________TA8                    Y
M_____________________U@                    I________________
M_____Z(                    9______________________56
M           $______________________^[+P                  ^/__
M____________________JRD                 S___________________
M_____\E'      <3("X^4FB$[?__________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________________________________________________35R?__
M__________________________K2L))W74(H#   2O__________________
M_____\5]11<             $=C____________________$4
M         )___________________Z(,                     &C_____
M_____________Y0                      #;__________________]H
M                      ?L__________________\5
M      #$__________________](                      "B________
M__________]U                      "#__________________^=
M                  !I___________________#
M  !2___________________G#P                     ^____________
M________,P                     K____________________6
M               8____________________@0                     %
M____________________K                       ________________
M____WB(                     \O___________________UP
M            W____________________Y\                     S/__
M_________________^A*                    M___________________
M__^@%@                  G/______________________>@(
M        =________________________WH+               %3/______
M__________________^B5VAT@(V<J[S0Y___________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______MX___________________________TJ-Z6#HI(QP6#@8  )______
M________________K%(.                 &G__________________^1#
M                     #3__________________WD
M      #C_________________\T                       "R________
M__________\3                      "%__________________]/
M                  !=__________________^#
M   Z__________________^R                       <____________
M_______; P                     "____________________*@
M                ^___________________3P
MY___________________=                       U/______________
M____FP                      P/__________________Q <
M            K?__________________\#,                     FO__
M_________________V<                     AO__________________
M_Z,                     <O___________________^-$
M        7/____________________^1!@                  0?______
M_______________K7P                  '?______________________
MRDL                  /_______________________\M7   ,&"0Q/TY@
M=(NGQ___________________________U^?R________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________Z]3-Q\*^NK>S
ML*VIJ*7____________________=?E,_,",9$0D"          #;________
M_________W8                       "G_________________[H
M                  !U__________________\'
M  !&__________________].                       :____________
M______^,                        _?_________________!
M                V__________________Q&0
MOO__________________1                       I/______________
M____:P                      C?__________________D0
M            >?__________________MP                      9O__
M________________WB$                     4___________________
M_TH                     /____________________W<
M        *____________________ZP*                    %O______
M_____________^=%                     /____________________^*
M                     /_____________________630
M     /W_____________________IRX                  -7_________
M_____________Y@J           &&"U%8.#_______________________^H
M8W2!CYRKN\WB^O______________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________Y\NWJ9V5CHF$@'QX='!L
M:&60_________________[QJ2"T9"@                 Q____________
M______\                        #__________________]"
M                W/________________^.
MLO_________________.                        C?______________
M____*0                      :___________________6@
M            3O__________________A@                      -/__
M________________K@                      'O__________________
MU!<                     "O__________________^CT
M         /___________________V4                      /______
M_____________XX                      /___________________[P9
M                     .____________________%.
M     -C___________________^+                     +__________
M___________,0P                   *'_____________________D1D
M                 'K_____________________\G0*
M$5_______________________^AT$Q\L.$538G*%F[32]?______________
M____________U^CT____________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___[]_/Q[NSKZ^SQ___________________9LIF'>6UD75912T9!/#@R+2@C
MQ/________________]+)0L                     DO______________
M__^(                        9O_________________7
M            /?__________________,P                      &/__
M________________;                        /__________________
MG0                       /__________________R0P
M         /;_________________\34                      -______
M_____________UL                      ,O__________________X(
M                     +?__________________ZD&
M     */__________________],O                     (W_________
M__________]>                     '?___________________^3!P
M                 %[____________________-0P
M $#_____________________AQ                   !S_____________
M________V%X                   #______________________[].
M   .'"P^4FJ&I<C________________________"?(R:I[;%UNC]________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________________NX=?/R<.^
MNK:QK:FGIJ:GKO________________^^AFU;3$ W+R@B'!80"P0     %/__
M_______________7!0                       /__________________
M-                        /;_________________=@
M         -+_________________L                        ++_____
M____________X20                      );__________________U$
M                     'S__________________WD
M     &;__________________Z                       %'_________
M_________\<C                     #S__________________^Y+
M                 "?___________________]T
M !#___________________^C%@                    #_____________
M_______83                     #_____________________B \
M              #_____________________RU,                   #_
M_____________________Z4X           )'31.:XS_________________
M______^9.4-17VY]CJ"UR^7_____________________________Z_G_____
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________Z\RYK*&9D8N&@7QX
M='!K:&9F:/'_________________844R(Q@.!@               )[_____
M____________?@                       '7_________________PP
M                     %+_________________^S<
M     #+__________________VH                      !;_________
M_________Y8                       #__________________[\;
M                  #__________________^9"
M  #___________________]I                      #_____________
M______^0 @                    #___________________^Y+
M              #T___________________H7                     #9
M____________________D1@                   "\________________
M____RE,                   "=_____________________Y@N
M     ! I1F;$_____________________^Y_'0P:*#=&5VE^E:_,[O______
M___________________GH*JYR-CI_/______________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__WU\.OFXM_;V-32T=#2U^#_________________SIZ*?'%I85M644Q(0SXZ
M-C(O+C'_________________TB41 P                    #_________
M_________T(                       #__________________WT
M                  #__________________[ +
M  #V_________________]TY                      #<____________
M______]B                      #%__________________^)
M              "O__________________^O(@                    "9
M___________________62                     ""________________
M____<@                    !I____________________H2@
M          !.____________________TUP                    S____
M_________________Y8N               5,E)W____________________
M_^!R$P   0\?+T)8<(NHR.S________________________*;VY^CIZPP]CO
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________________________________________________G@TLC
MNK6PK*BEHI^=FYN<H*?__________________X)D5DM#/#8P*R<B'1@3#@D$
M  #4_________________Y(                       "M____________
M_____\P>                      "+__________________M2
M              !M__________________^                       !1
M__________________^I&P                     Z________________
M___00@                     C___________________U:
M           ,____________________CQ0                     ____
M________________N#X                     ____________________
MY6T#                    _____________________Y\W
M   0+U!T_____________________]UR%      &%RI!6G64MMK_________
M______________^\6$149'6&FJ_(X_______________________________
MTLWA\?______________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________/OZ^_W______________________^ZYJ)V6CXJ&
M@G][>'9T<G-U>'^0_________________^M/.C H(1L5$ L' @         C
M__________________]I                        ________________
M__^;"@                      ___________________(.0
M            ___________________P8P                      ____
M________________B@X                     ____________________
ML#0                     ____________________U5L
M        _____________________X4:                   #[/______
M_____________[%)               8.5V!_____________________^5[
M'@      #"$X4F^/L]G_______________________^[6"DY25IL@)>PS>W_
M____________________________LYZTQ=?K________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____^N_GX=S9UM32T-#0T=/9X.OW__________________^XBGYW<6QH9&%>
M6UE85U=97F5Q__________________^_,1\6$ H%                ____
M_______________M5@                      Z/__________________
M@@0                     S/__________________JR\
M        L___________________TE<                     F_______
M____________]WP0                    A?___________________Z(W
M                  4KE/___________________\MA @            PL
M4':>T?____________________6-,       #2,[5W:9ON7_____________
M___________#8Q@J.TQ?=(VGQN?_____________________________J'^6
MJ+O0Y_____________________________________W_________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
MW<[%O[RYMK2SL;*RM;G R=7C____________________EVQD7EE544],2DA'
M1DA+4%EFH?__________________IR8.!P(                 5O______
M____________SE                      .O__________________]'D+
M                    (?___________________Y\R
M    #O___________________\18                "#%:A/__________
M_________^E_'P          !B=+<9K"Z?____________________^G20
M   "%R]*:(JNU?S________________________3=1XF.$I>=8^KR^______
M________________________KG*%F*S"V_;_________________________
M_________]_O________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________________________________[^R
MJJ:CH:"?GZ&CIJRTP,W=[/___________________XI:4T]+2$9$0T)!0D-'
M3EEI??___________________YXN!@                   /__________
M_________\-6                   50?___________________^=[&@
M           )-&"+M/____________________^?/P         $)4IQF<+K
M_______________________&9@\    3*D1B@Z?-]?__________________
M_______KCC4K/E%H@9V\WO______________________________OG9_E*G!
MW/G__________________________________]+8\___________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________]O+P[^_O\?/X_?____________________________BPGYJ7
MEI:6F)N?I*RVPM'A[O____________________Z.4$I'141$1$5&1TM16FB#
MJ?____________________^F00$           <V8X^ZX?______________
M_______&90H       0G3'.<Q.S________________________EB"\  !,J
M1&*"ILST____________________________JU V2F%[EK36^O__________
M____________________TH=\F+'+Z?______________________________
M_____]3.[?__________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________[>7CX^3FZ.WQ^?_____________________________]L922DI69
MG:.ILKS0[?__________________________G5-'24U15F!SBJ_6_/______
M____________________LE8 &C50;8NNTO?_________________________
M____S6\^7WN9M]?Y________________________________[I^#IL+A____
M_________________________________^/.Z_______________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________P
M
M
M                    ________________________________________
M____________________________________________________________
M____________________________________________________________
M__________\   #_[@ A061O8F4 9$     " P 0 P($"
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M-R];E_@
M
M                               "[77[W6VJT&;T]L8H\M\3)KHUCH57
M\<_& !2/)P<N-/=H_>PXJ,?]/ 6K1?V<$*K&?7\?ZX_T
M
M
M !S?'TSHQ\N\SKQZN\\GN]9JPR\QY6+N%$ !=#@[O7S7IDB\O8S1Y;X>R2BR
M_P .J/CFXP  "@^7J\VK:NPNH-.TB@%36![=+[@
M
M                                                     !6="JC?
M/KLS$;[]=&8[)6U<\ %*5BG(DNYS6RTS9SXM@  KKB[/#M[CT]IO=!&[A4O6
M_%V>$   Z?[\_P!U85V%5#HHE-LZMM+V.CV0
M
M                                                #<A@[E"E*ZBM
MA*_-NYB   *=J?10%?1MIM8VW2@@   N;P=S@D 1.Z5&[/Z',_     HSDZ_
M+H0E=L*PU+2""U'_
M
M                            !7% JR6/IMV/-S^"N4X     BQ[>=>:/
M[LBPP    !M)H4TI^1!$+L474?QR\8   &M2M0_W8Y,QM+6]*<G!R
M
M
M  &0-MIHFCZ)=J+-:P]U@     $8C;)@$CL;-\(0    !EW3Z]YLH.#7GH&Y
MW#W.N   !BAWZ'Z,7*<V7K^U_/TNP
M
M                                    !DI:R=INV@O;*R4M7.P
M'6Y>-!"]#FG]A/?JU      #(_IU?HRIH'>RWUU^#O=8   #&CNT?OQ3YY9&
MX5NN;J<X
M
M              7C@\H3E?/UMP936AN&      ZO-QHNVV[7TCZ;)\+0
M  !E!T:UT)6<#O=;RN>+L\(   &$E3CGJQ7YW92X/G?OQ^@
M
M                                                   #U>GV4V_0
M?MA;&L8+X@    "W,HH;4)FKC.T'[&,-V"60UH         9XTJ3>1*-@UZ;
M?][\^OX   !H]D]MZLT:RBVU6
M
M                              $FC5'GPD;:P,XP   'Y_36YE)8EHBV
M&X@-1>:>-*EZM3P          ;H(W<*E]]D4N?1X   'C?7'^X>UQ+!W+LKV
M:=V@
M
M       ,Y<?KN)U/GNV\O0ZW,  #@Y/EI^S9QD1R]G^#C!V_]I
M   <C]2C(->B@,_*3*/&    T<R>V]6:.91;:K
M
M                                         #^_A. T#;:6QW%Z^0
M-=>3=D$6';WKR8)Y"V@              !>'K=_K2\[?7YMM7'%V>$   U>U
MR&>_&UF=H:Y
M
M              -GN)F0";#H7VM@ *+KM*1>=MNOQHAV'8?.'[^0
M       &V:@3FG)$T/NQ10  !HZD]MZLT<2BVU6
M
M                                          $T+11M/;7,.\C !B1>
M>VJ&MO)U=,0;UVS                 '*_4H&#WFH#8-2)5XP %N^;J<\1"
MX-A[D6F['1[(          !=>'2-E?9RXRZ$2D#GX_M1];IBPMQ8<Q=NY;YY
MW9X
M                                                 %ZX%*WT)/-5
MNJ=_K<P-=63ED$,/>GJR6REE                   !4'QR_C?1%;G4AM=H
M$XIVHOCE_&%=3COJ1[)=:NM,7^]1>^         !W.#E;Q]?V6[?;KIS&9M6
M$NPY/G]  !HRV"8C(EVY?6Z
M
M         WD:_<N$M;3-LC!KQR9LDA1[Y=4RBZ[2@
M =O\^OYZ/Y]?GP_KC_8          5)2^\F6Z--H[:;B'D,    "/YLCPP19
M-O&O,                  %:\78XLTJ;(O+R>Z-9\^[?7[_ %O<^>7\^)]<
M7ZM=S]+L8Z=VD][#2HQ[T[2]CH]D
M                                                )=FEG9:W98%9
M7,8[L0!!5]".H9:>91P         !N(PBR>2>=3.?P  */K=,0+O11IV
M              !*2U&;"4@S6OFD     (W>TC!9&EVIX&@
M   #.&ER3R=RT<N#3&P*D2GQO3_/O\@   ?D8@5&@>GJ0D$%J/5K7(54'F_7
MQ^@
M                     GD^=S<,S"LE<Y!L] FH]@/D99L          &\3
M #+9+:TQ[)0  417Z2^<QZ?-'0                 "Z\.D;Z$OFHW5JBIG
M=     $7K;9K\1YME^$X               "X'#VN&1#$+KT5LKHLP\(
M   #'/N4GO1SIC:6ML,*E'O4
M                                          ^C#YAMX;1?L&Q$1;MN
M>O<           ;Q, ,MDMK3'LE  !1%?I+YS'I\T=
M-S.#&4B8+I+V;@  #^#':YT(6_DE%9(6NG2+EMPU\-%&PK$(
M   7?Z_?ZTJ:"7MM[D/TZKT@        "C.3K\L.FXM@;FV\YNIS
M
M        !ZW3[+Z)/F3W<OGY^DG2^M9+XZ           -XF &6R6UICV2@
M HBOTE\YCT^:.@                 $F?5)GND;ZO\ .0  %)5FFH5&^/5.
MURY/V.!ZO3[*LZ%5%MY30@              >Q\\GYEB0&^-NLL.A7/.
M     //_ 'Y_48^;V;KS7G5XI[0                           &UV@SB
MG=D5%EWA@ !KCK,2]S4Y7X-40
M        %44BH)/>IG/]%<V^Z\            &\3 #+9+:TQ[)0  417Z2^
M<QZ?-'0                 "6GIGV1MY>OS+@  &D;/G$Y$:W1:U0
M           &ZJ-7$I;?%%;FT@         <;\1Q9E:6N-6-=A-0
M                    !OQBESZ/W-QNX5+@ !IKD=OJGT#RRU]8@
M                                    <OQ],X+ W:8-9 VC
M    ;Q, ,MDMK3'LE  !1%?I+YS'I\T=                  )?.E'9DW2X
M)94@  C';8,!$=+9W@^                 ._\ GU_)E=N,@K872X.[UP
M"U_/TNQJKKL)J'#FI1_TZ,Y.ORW<Z_?ZV<5,DGD[,J),?!JWCY^,-!<KM?6.
MF>26^J<                             WXQ2Y]'[FXW<*EP  TUR.WU3
MZ!Y9:^L0                                       ,HNC6O/NKU^[P
M=3]_'9?O\P/JL9]CB?@ #*3HUKS\A>G5>ECYW*7W<6>]1/0         -XF
M&6R6UICV2@  HBOTE\YCT^:.@                 $O[2?LT;H,%,IP  1<
M-N6O='PV4X6                 #-.FR+RI7,"O?;P   PKJ4=]6+].+,U]
M1'+UN4  +E\'<X)',.NW1&,'>HW?T-2JV-7@
M     ;\8I<^C]S<;N%2X  ::Y';ZI] \LM?6(
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MCX;*<+                 !N[C%QZ4WHQ>Y5)   $-VXV/]SK*]FG=H
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MU@YQ   U-9E8X(MFW37L#='&KATOOIBMSJ/   -"LKMC6&EV26\J@
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M_K\J\6]FMN+L\4U:VN1%K    (3MR\=;J4KR<'(       ;Q, ,MDMK3'LE
M !1%?I+YS'I\T= "X,:K3Z+OF)W@@  P/R(L^B:[D];Z:WH:VM+OPF3
MQ&O1;5!_W]:EUFIS%@3$=(FSMN-P?R@        417Z2^<QZ?-'3=!@IE.E_
M:3]F@  -9V5EA4)+??J>   $@_6MFFE'ZC=A   -+^=>+"(#NPUE@V04:7>'
M)LA-XZ#   .G^_/]TC2:W-5Z8Y);VJ*4Y.#D      V:T28^#)7A=X*%   (
MC=P+$W(Q7[]$]    #8W1I;XDG&$WDH(  +#]JF=R'A<6P5S.)^,TJ;(?+DN
M0J\-"7>Z_?ZP     %)\G!R1]);:NL]55>A-0[CHY<"F-_T3NC1P
M6JY^EV(9%R,>[H  !GQ291X\B"(76HJ^G5J?4      L-VJ9W(R\VLY7F*G?
MHGH  !*&@UYZ V#4F5>,  $1&X-A[D[^HG=&CL]*5)_'    #&_N4CO14YY9
M*X5NN;J<\E2%W?H79;19AX0    >5]?'ZC/36SM=ZZ:Q$_;#)[HUGH78Z_>Z
MW6_?S^\C]8)56,^OQOQZ/S]_F;I;+(VU7._?X   1![A6&N5C7W:/W@
M #>)@!ELEM:8]DH  *(K])?.8]/FCH 7!C5:?1=\Q.\$  &)EY;<*KH]19$6
MRFP     #4=FAC6AI;R]7 )B.D39VW&X/Y0        *(K])?.8]/FCIN@P4
MRG2_M)^S0  &L[*RPJ$EOOU/   "0?K6S32C]1NP@  &E_.O%A$!W8:RP5QQ
M=GBF:6XR#M?4'QR_@   "C.3K\NMBM1#W=<59B/MX'U6,^O37WP\@   'H?G
MU_)B]N;_ -LKR]>H=4  -/DB@-2Q]I;:RLP   ))4,N[0VT*AS3P   T52FV
ME6Z2)-;FJ\I>A6O/E?P*^-NZH^.;C       ,<>Y2.]$DN!8NX^VN/SJF]_T
M3NC1P        6JY^EV(9%R,>[H  ;EHY<&F-^$3N?1_,_?X       41R];
MEBF3RR-P\7>]1?0  E#0:\] ;!J3*O&  # FJQCV,]J5)_'      UY5>*>U
MB-4*%Z6\:,7(I,     "C>3K\L/^X=A+E6E['1[(    3%;=7^MG??JU/I@
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MDMY5       !O$P RV2VM,>R4  %$5^DOG,>GS1T +@QJM/HN^8G>"
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M8.]1N^$H:#7GH#8-295XP  >#]<7[B W#L+<JQ_:IO;  DG0N[U#;/J),_
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M,-NY0X  ?P0T+CX^W/M'V.AV0  F(6[O[;._G4JG3  "+M.++U_K\J\6]D
M  +^=2J=.7_;R_5M?1_/O\@ !'JEUJJTU$2&!U(      &\3 #+9+:TQ[)0
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M55HCE5LZN"4-!KST!L&I,J\8  -$<IMG5VD^36ZJH  ,\:5)O(E-P6]=O@
MM1S]'L0RKD8^70   ):$ OG;K+RGU[S   C#S>S5>ZZZQ$_;     )!<1NI1
MFX&/3VF@  P:JD:]:*Q.[)W"      #>)@!ELEM:8]DH  *(K])?.8]/FCH
M7!C5:?1=\Q.\$   ?.>]/&CU04CHP  ,O;*7,3X?.?N/  !;^245\Z'T[Z/@
M  2_M)^S1N@P4RG  !%PVY:]T?#93A8  #=!@IE.E_:3]F@  -9V5EA4)+??
MJ>   $@_6MFFE'ZC=A   -+^=>+"(#NPUE@       .1^MI-"FE/R&8A=:BZ
MF^.;C   (B=P;#W)Q?[U&[X<_P"?O\F!6\OW;7(/J57I  !&#F]F:^UWUB*>
MU[OQR?B9_;?(6U]8<?8X@ ,(ZG'/5BGSRR-PP -W,9N-2F].+7+I(
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M<T\  "B>3K\L,RY&/=T*<^^+]@  &1/3JW2V[1Z>4WL=H\M\.^'5J74
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M0  :7\Z\6$0'=AK+  !M&H<TI^_'4J?4T@R>W%5@   !DMTJQT)>UO;\VV
M (H$]L?<3#*I1[U  -_D3NC1VY".7 I@  -'$GMM5FY>.7!IBL./L<0 &HJ0
M02I(]$OM36@     %\.K4NIF33I!YF:%-D/E[#*/*_%OOU:GTP  #%_O4;T(
MB=P;#W(  WXQ2Y]'[FXW<*EP  U"2&!U+'NEUJJS   -F5$F/@R6H7>"A0
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M2GQI/$(O+07I?GW^=3=?@U1Z$)7;"L*&Y>MR@ !7'%V>*3O"+RT#F[3)'Y0
M =;]_/["RN3CQ=*B>7K<H %^NI4^G,)MW?VVG9?O\  \O]^/UZGY]_D  (E,
M_L7<;$FH4+T@   ,A.G5>E8WM4WM^;]?'Z  YOS]_F\J+W)I/=Y&;CTH  %&
M\G7Y84MR\=KI@ ;\8I<^C]S<;N%2X  8'U6,^O%CG5E+@@  %P^'M\,S>V^0
M=K_2_/O\@ >']<?[B!W#L)<JQ?:IO;   .Y^?7\W"QV?4SJ1D$$J2G/OB_8
M !*&@UYZ V#4F5>,  $=:86GK;4Y7X-40  9QTN2>3*I@E[;>@ !CEW*3WH@
M%P["7*   )9L OG;K+^GU[S   C$3>S5>ZZJQ$_;       .[^?7\D:PZ[5$
M;2J%-:? .,19IU92X."%5C/K@   !O$P RV2VM,>R4  %$5^DOG,>GS1T +@
MQJM/HN^8G>"   /G'^H'1LI&M4T  &7-E[E)\OG,W(@  M_)**^=#Z=]'P
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M7MMZ  &.7<I/>B 7#L)<H   EFP"^=NLOZ?7O,  ",1-[-5[KJK$3]L
M  #E?K>5%[DTENXC%QJ5Y7[_  +2=CH]F)//[%7&M-V.CV0   -XF &6R6UI
MCV2@  HBOTE\YCT^:.@!<&-5I]%WS$[P0  !\X_U Z-E(UJF@  RYLO<I/E\
MYFY$  %OY)17SH?3OH^  !+^TG[-&Z#!3*<  $7#;EKW1\-E.%@  /[^'T)O
M-1NL7WMY+P          :7\Z\6$0'=AK+!DCTJOT96\#O?;RXG#V^
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MV^4O1K7G@   >!]<7[AG7(Q]N?0?+U>8  *IX^;CE202]MO<OZ?7O-
M  ".O,+3UMJ;K\&J( #-.FR+RY7,"O?;L     "U7/TNQ#(N1CW=  VT4"<T
MY(DA]V**          CQR^U-:ZCY!!*C )0T&O/0&P:DRKQ@  CK3"T];:G*
M_!JB  #..ER3R95,$O;;T  ,<NY2>]$ N'82Y0  !+-@%\[=9?T^O>8  $8B
M;V:KW756(G[8         %5\?/Q[HXW<.EMQL<G],UCQ]CBQ(J%"]*+[.+,5
M]:SGZ78  #>)@!ELEM:8]DH  *(K])?.8]/FCH 7!C5:?1=\Q.\$   ?./\
M4#HV4C6J:  #+FR]RD^7SF;D0  6_DE%?.A].^CX  $O[2?LT;H,%,IP  1<
M-N6O='PV4X6   #)^TMP$]?SJ;BU44FH      -9.5]@FS;%"_H  -+^=>+"
M(#NPUEKC</;X),\)O%0F;],DGD@         8CU"A>E%CG5E+@4/R];F
M#:]0)Q3LBZ'W9HD   #5U7(74$;B9VBK@   D?PV[E#[3:%-:?        #!
MVJ1OUHL,ZLI<'I_OS_0 /V)9$!OE;K,&G5_S     "U7/TNQ#(N1CW=  #<]
M&[A4OOIBESJ0Y7[_         #6M6HA[L;"9V@KGR_KX_0!*&@UYZ V#4F5>
M,  $=:86GK;4Y7X-40  9QTN2>3*I@E[;>@ !CEW*3WH@%P["7*   )9L OG
M;K+^GU[S   C$3>S5>ZZJQ$_;           *VXNSQ;3:%-:>V?T.9^#>#K]
M_JQPIE:2N,&JI&O6  WB8 9;);6F/9*  "B*_27SF/3YHZ %P8U6GT7?,3O!
M   'SC_4#HV4C6J:  #+FR]RD^7SF;D0  6_DE%?.A].^CX  $O[2?LT;H,%
M,IP  1<-N6O='PV4X6    -U&!^5:7-I=V5/0ZW,    #4EF=C:CK[-\(4Y7
MS];<   :7\Z\6$0'=AK+!W?SZ_FZ.-7#I;=O&;C4K4OQS<8      !^1JKKT
M(J&/G+;65G2O)P<@    ![WQR_B9);G("V-RN'N<   !%8G=D[A8-52->L
M 7RZM2ZDD:&7=H?-2FR+R@      #6G6H?[L<V8VEK>D>3@Y   "_/4J?3E3
MP2]MOKV=:H]0    +5<_2[$,BY&/=T   S_I,I\:0]#[K47>_K5+J      4
MW]\/)HWE%MJLTRR.WU3\/[^?T "4-!KST!L&I,J\8  (ZTPM/6VIROP:H@
MSCI<D\F53!+VV]  #'+N4GO1 +AV$N4   2S8!?.W67]/KWF  !&(F]FJ]UU
M5B)^V             7 X>UPY?T^O^;BUWJ)Z%I>QT>P ;B,(LGDGG4SG\
M"CZW3$"[T4:=@!7$?JR>3YW-PP   @3>BS3FI>KT\  &4%I+@)L.A?:X  "A
MY!2$#;T1Z>@  2F=1&PMMHPSR1  !''V@X--&VP+$@    &Q3&.]Z39JASY;
M&<8;XN7X^@ %@;CPU'9V;X0M"&Q?#AF-8^Z"9AHRVD   U+YF8W(LVW?7H
MNOU^]U]PD>GU,[3*%-:?O+UJAU0    \+ZX_WKLK$3]O3/)+>U/AW4:!Z8
M    !O5BURZ2W;QFXU*  !C_ -NE]V'O<2P=R^-^    .0;$J/+/$VR4"<T[
MG=2I-Y%2?'-Q@  %$\O7Y=?]6BWLZBY! ZDP=JD;]8     N!P]KAW<QFX]*
M;4*%-:?N'P]O@   ,3^_0_1B1W L5<<   ]OYY/QM-H,VI_:G0IM3V8].K_F
M=K\^OX  %E.S3NWJ_KD,][3U(H#4UH^QT.R   2,8==JB<XZ7)/)  #0_*K9
M5?K+K<.]T  ,Q:=7_,DGPN[]#  !83MTSN19IU92X   !)NA%XZ#RFZ-;\\
M ([<PM/6N!]5C/K@
M       7G@LJ9IV(NHN["I*\[M<+%V[=OF$U^[3NIS<8         _8R;Z-9
MZ&7-/KWFWZZE3Z=?\7;X>[^?O\I7[X>2SG9I_9Q?[U%]##6I1_TZ9^^'D
M     #=;&KBTMO?BMS*0  #1#*;9U=I1DUNJJ      #TOG[_.1O3JW2O;UJ
MEU*QXN?BZ_[^?VA.7K<UC>U3>W8#MTKN=;]_/Z       !V_SZ_F2G2J_1OK
MU:GTZJX^?CZ?[\_VWW-U.?'ON4KN62[-.[8     %8<?8XLG.C6>A=SK][K>
MK\\GYH?EZW-CIW*1W;#=NF=S^
M
M             #F_/U,(MY?RV=_NI5.F !T?WY_L-RXV/USK2=CH]D
M
M
M                   V)4>6>+)ZA%Y:!  #756(G[<8B;V:KT
M
M
M               NUU^]UI6T#O?;R_G4JG3  ",--[-5[KLK$3]L
M
M
M              -[\5N92/;_ #Z_GJ?/W^;K<'>Z^P*D2GQ:VX^SQ  !9OLT
M_M0X[BV N;T_WY_H
M
M                                      3=[8Y'6I]7\^_R     :&)
M5;&K]+4EMY5(
M
M                                  !-WMCD=:GU?S[_ "    %GNQT.
MU#]N'82Y5+<G!R
M
M                                     $W>V.1UJ?5_/O\ (   'C?7
M'^HN4YLO<#!FJ1KU@
M
M                                        )N]L<CK4^K^??Y   ,8N
M]1N_'AE]J:UPNJ4=]0
M
M                                          )"T0NK1?=_/K^!^!2O
M)P<MD>U3NUAI48]ZF(M1H/I?@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M  '+\?3*RSUQ57T6IL8;LP!;V2T0   !^OS]71B,@4E6J:IFJ]    >]3NXK
M6@U4  %LY707!R?  K"B5-4=+[P #B^_E;&64          <OQ],K+/7%5?1
M:FQANS %O9+1   >GU.PN!&ZRH:04AXO?ZH "XL8K;K<OPH.14<   !<B+5U
MY7<ZRC*[2P  !Z/5YUPHU6@!U^7X6XE%#<?U\@  NG$)"   */K=,4Y5.B
M    #T.MS+AQFM@  "WTEHKS>UP "O8Y6'K=/L@"CJY3%.U/H@  "Y\2K[H]
MCB6^DM%!R_'TN=$Z^\.H=11%?I(  *DI?>9:69N2\KN==BI>"W3Q^]U0 %84
M2IJCI?>  !T>QQ+=2>A@#M</(N3%JZ  "C:[2U/5+I #F^/I<V)U\'Y_?Q0<
MBI#RNYU@  !=N&21<Z)R!:>8QQ;^245=&(R%9V<1<
M   &3=J)\F<Z+=IC,JQMT0>?V>%JGS"QT0[=W>L13=5Z   -FF*-_$VK0EM?
M:D\S<;4,W>=JV   &ZG _*M+UTJ;,   ?/'],6DU9F<Q8 2K-/NQ-ORUS9D
M +:RJA/G5^G'2"        #)NT\^3.=%VTQF58VZ(//[/"U39A8Z(=V[S6&I
MNJ=$ ;,L4K]IMFA'; TSYS8MH?.[760 ,UK#763LO/3M\:[\FK)(0^_74T
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M*]&NT9@!DA9EU^7C4]4^DWKZ],O4"CT5Z='X^OP
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M7J4                      F/Z/-H+;WA3DRBE[A]=#3MF[C"M%-8T
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MQV[UIRS@Q?0[MW>L0 !(.UK9J)0FI38$[G!RJ.KE+:5<\,547C;;KZ4'(J.
M #8MC%>].(T [;$9[:Q@4CA;0\&0  9*6LG;Z!7FWW0   ^=IZ;-(JUDOCP
MNG$)"^B7YD]W32_G7BPB [L-98 ^B/YE=W#&ZZ4%02?0QJ!
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MZ4=F;='@EE0^?SZ1=,+&>ZT" $B_6'G"DWZH,^@  8\W,A+Y_GI#TQ/*[G7
M&ZG _*M+UTJ;,$1/=-K3:3<]<4    $JS3[L3;\M<V9" AZ.--3%"\=N0  !
M5E&J2HJ9W5L990     !5]$J;8MC'?!J\RVQ]?G]_$OS2ALS;HL$\J'S]_2-
MI@8TW5@8 E4Z?MB3?KKES)0+O1/IV4O5Z>GG>=G<0TEY[8H(H&XW7(F2Z.-H
MC;SA7DN^=EZ;=(BUTNCX V[X5Y+ID^CC:(  "G*IT7S[O27I=65GD4 &>&.]
MX4Z[SV;>D<O9]@ZC*[7<!DP[2-LZ;C<'LH$(;?MJ9:W<I+%@  "7]I/V:-T&
M"F4[YWWIGTDK132- "N(_5G9XN1;Z2T4      $^_P X^Y5[=/[;Y^OI(TO@
M  ";+H5VNMF&*=^GS:O4MHH9TX^7>3K_ #U;>VK'+W'E"UWMZK   3Y/.;N0
M7RM_+D!ST8Z;UC+@Q%MUPMR63*=&VT5']V188HL>WG7D  S(L==!XO?ZK%&\
M5N7I=7G?0N\T>Z]9V;Q= A]%^G$  &Q;&*]Z<1H!VV(SVUC I'"VAX,@  R4
MM9.WT"O-ON@:*-A6(2)QN1UP@   +IQ"0OHE^9/=TTOYUXL(@.[#66O)!Y0D
MQ:IL]F]C7KEZB^;:]?J/)LPPF!>&$2=;:4T)X_>ZH
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MP\LK -".Q?#EY/<ZP  ,J;/W$2*-9&;S49FEC2U0YBXY@  NU#)(D[ZF\_@
M :D<S\;&IS,C'  5G0JHE/:A=AP/Q]?*U4PCK6;E981J\RWQ^<?U\@KF/U=+
MFTN;*FJ',;')H^S]Q+
M
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M?(K!3Y:3(L$'!4C9#:$*EAJNP$==@(Z[ 1UN#A! WSAVWRY<9H=@(Z[ 1UV
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M*F4G 'VH,2@6B)<[QA;W[2%9[MA3OWT2KWA"A=W\R<I5254FHM/C_K22?D=
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M4L2+0/6BH-Y8BUTT9&\'Y530QM;?=,YWZAN38.TUV9/+;?11]72Q7O-:4OK
MB[J@U[CPYE>FK6VI^RAOIT2UC_8I0OZZ/XV73K^-ETZ_C9=.FVE5H3=XW!\
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M45WR>=+YN7['AOU)A7^XO;,/Z?RVMAS3,55*/M=%%0E:<2H3R,1U1))P1U_
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M&_4F%?[BXMOQ%'>+)='8)ERWKNBZQ15-2&K0KCOUM"V=RG^-GHLJTB2E:#5
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M->*2>U35373RUE(+K),T6&)F." HS2U24Y3E!.4IR62$TQ3X@A5CC%"]!0K
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M<YU3@9G<,+][UA:'B*%>[EB:_<,+U[]]E+'CI.8#Q7 I'C8!ROCBDX4%MO\
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MIGR1E-/<<*B_X%]9"CS%O/CU=2FY#-T((&$'?JZ%=S'KB\+[RRXE%(M X50
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MB[%#CCFA]8B86OS*1=LS8FU]@FKRGNQ&=<EMYF[<*[9POK9SZE<Z^W1"'$_
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MO)OMT0@P.W$J&F7+F #8'-S<S[;E@D]<7%ARK''; ]($.\!Z@H=MSUI0Y?\
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M+\S?1]%L[?\ 'Q712)1_#?M^ZELX;?DIV(PSQBQH,ZWULHT5ZO."TW2O=/\
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M9_?@R29X5B]ZK$*ZQE*54M<3<G\>F=E%9)RMY6:+CX_U[DKW:7K=,4:CF?\
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MPU555U<MM&IRKY#B ]V>B; GXA?XD)10+0J)8A 3F &!RU9%Q2GJ@2@6CB9
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M% G2>*B!UA"0@&!RU9=RUTRH<*=5*IP)M,AW-+\#1TR<JXAB"!5IJ\&/"O\
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M'<-Q+#PU/A.;@N(UWRW-S"6@]K$YX,C?] \7M\15 "Z(Q6>('5SMO($GBJ=
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M^M@CFAV3WLOS0[)[V6B->R?[,J*%7B&GMDCM9;<S%CPYR0#UQT\6LGL9!5T
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MW,/^F6WQF7VYA_TRV^,R^W,/^F6WQF7VYA_TRV^,R6*+&K!G8@*HO+<DDF@
M DJ23H &DGT TLK!54$DD@  :223H  TDG5DUMBW2K#5D70R1W,<[J1N,L!D
M93P, >#(10]*[($_ZC21#W4L:*.4Y&?HIBMGB: 5)M;F&X '#S3O3EIG/?8E
M-';P1T+22NL:+4@#:=B%%20!4BI(&LY?;F'_ $RV^,R^6X1<Q74))'.0R)*E
M1K&TA9:C=%:C->SOL7LH9HSLO')=0(ZL-896D#*1O$ Y+8X5BEI=3M4B.*YA
MD<@"I(1'+&@!)H- %3UA[2[QBQBEB8JZ/=P*Z,IHRLK2 JRD$$$ @Z#DUM@N
M(VMY(J[12"XBE8*"!M%8W8A:D"I%*D#61GO>XA,D$,8J\DCJB**TJSL0JBI
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MQQ>RFFD(5$CNH'=F.H*JR%F)W  3F/=W;K%%$K.[NP5$102S,Q("JH!+,2
M"2:9?;F'_3+;XS+[<P_Z9;?&9?;F'_3+;XS+[<P_Z9;?&9?;F'_3+;XS)KG!
M;N&\C5MDO!*DJAJ [):-F :A!H36A!U$9C33,$1 69F( 4 5)).@ #22= &7
MVYA_TRV^,R^W,/\ IEM\9ELKC=@3P7EO\9ES^'3QSI[*-U=>RI(STONF^+6N
M%QR5$?/RJC2$4J(HZ\Y(5J*A%:E=-,EPWHWTEL;BYD-$B,PBED)U"..;FWD/
M @8\&46(=-<3M\+@G?FXWN)%C5W"EME2VL[()IO#*'$</E6>WN$22*1&#))&
MZAD=&%0RLI#*P-""",K;#.EV,6N'7%Y^8CGF6-Y1M!*HI-2-HA0:4)T#4?Z$
MGZ9=)"9"#S5M;H0)+JX8$I"A-0HHI>20@B.-6:C,%1I).D]^\5@6K'86[-':
M1K7P08P?AG'^K.9'J3LE5HHZB7N'RO!-&:I)&S(ZD;JLI#*>$$'*'#\?F/27
M#ZA3#=L3= $T^!O &F+G0 )Q<+N*H)KE:8K<VLMC)<PQRM;S[//0,Z!C%+L,
MZ"2,G9<*Q 8'3G7L%C)L8CCE;"VH:,JRJ?E,PW1S=OMJKC2DLD1ZD71W$)-C
M#^DBK9O4T5;H$M92'A,C-;C<'RDDZL^R\\6OU2_SNCOFRP^JQ9G1[S<_UF3-
MP?Y]:?6(^OS],>D9,A!YNVMU($EU<,"4B0FH44!>20@B.-6:C-LHTDG2>_>*
MP+5CL+=FCM(UK508P?AG'^K.9'J3LE5HHZB7N'RO!-&:I)&S(ZD;JLI#*>$$
M'*'#L?F/27#ZJIANV)N@":? W@#3%SH $XN%W%52:Y6F*W-K+8R7,,<K6\^S
MST#.@8Q2[#.@DC)V7"L0&!TYG2! :&9K",<N(6K'LJC#J?\ P#I%-LX+CTBJ
MK,:);7QHD4NG0J3C9@F.JO,NQ5(VKU;KI+57Q*XK;X?"VGG+IU-'9=V*!:S2
MZ@0HCV@TB5GQ7$Y6GN;F1Y99'.T\DDC%W=B=)9F)8G=)RZ.5-%E^71G\;#KO
M9_OA<_%^G5S0O9PGF$;5)=2$1VT=-9#3,FW2I6,.U**<IL2Q"1II[AWED=C5
MGDD8L[L=UF8DD[I.6$],68BT63F+P"OA6<]$FJ!ZHQ@B=%W9(DR6>%@Z. RL
MI!#*14$$:""-((T$9W2KYJOUB'-6\Z$8S=8<5-=B.5N9<Z_A+=MJ"4<$D;#@
MRCZ"=/8X[+'RIYB6/P;>_P!@58*I)YFY"@N8P2D@#-'L4YH9C^,>[G8_YS'U
M6'KG2OYB_OTS^B_Z"?ZY<YF/^)A__3K7,2\L)7@FC-5>-F1U.^K*0P/"#E#A
M_3*XDZ18/4*Z7#;=Y$NHO!=-X;LHTB.X:2-@-A6A)VQ9]+^BMPMU87R"2)QH
M.LAD=3I22-@R2(U&1U92*C-Q7YY<^7?+HO\ IY_J=SU<9^8W?U>3J-YLN_*6
M^:O1'HBL=UTCNH]OP_"AL86J%EE4$;<ST)AA) H.=E\#829L<Z:8E/B5TQ/A
MS2%@@)KLQ)HCB3>CB5$&XHZHQ3HAB5SAMP*>';320EJ;C[# .N^KAE(T$$'*
MQ_EITTP[_>9+JH6^ME2&>%$&T\UW&-BW>% /">,0N- "SR,J-U>CWFY_K,F=
MT2\XP>^S.F/F/%OJ%QG8QYXE^I6.9CGF^\^K29@O,+N)+:9=4D3M&XXF0AAR
M'*.*[Q(X[9*1M6^(DSL5U'8NJBY1J>IK(\8-"8VU$V^%,;#&(4VIL/G8&0*-
M<D#@*MQ"#H+JJNFCG8H]I=K,Q*T_GM<W=M@D-SS1: %I(K)8-JSYI=ER(7+1
MR3&*-W(DF=%,K5RM,1_E5THDEC@DCDNK5;B*=Y+<,"Z&)UAN[1Y!51,X95KH
MB)&71+ [11'$MQ<["#4J000QJ!P*) !EB?\ *[^85Q\DGZ+Q3W,3SDJ5L(23
M<Q/M>%M6,E?!]4(75%79A.5Q_,^\CD2T:XYJQ5@=F*WM2K1P ^IYP+(LTP4_
MG9V;0'&0=34$5'$?Z#M^AVV1:X):142NCY1=@3RR<;0_)TX-CA.0514G0 -9
M.5OB?\UL6N8KR=%=K.QYE/D^T*B.2XFCG$DBC1)L1(JM54>0 .Q7"L5Q:VEI
MH9Y;29*[[)\DC8\DBY28IT+FCZ26D8)*0H8+T*-)(MG9UEIJ AFDE8ZHLC_-
MKI[:-%:X7,R6%O,A5I;V)BKSNC@$):."J C3= FH-N5;.GP.PDV\.Z.AK**A
MJK7&T#>R#AYT" D:"MNC#7U$NK9S')&P=&4D,K*0592-(((!!&D$5RPGIJ&'
MRF:(1W:B@V+N'X.X%!ZD,XYV,?Z4B'=SK+SQ:_5+_J7'3).D PH6][+9\R;$
MW.US<-O-SG.?*X*5Y_9V-@TV*[1VJ#[YK_"3_P!RR^^:_P )/_<LOOFO\)/_
M '++#NCIDY[Y!:V]MSFSL;?,1)%M[.TVSM;.UL[34K3:-*YG1[S<_P!9DZF$
M=-1TK%J,5M(+KF?]M,G-<_&LFQSGR^/;V=JFUL+6E=D:LOOFO\)/_<LOOFO\
M)/\ W+*SQD],%D^23PS;'^UE=KFI%?9VO]Q;9VMFE:&E:T.KK\'0[;(M<#M(
MJ)71\HNP)Y9*;[1&W3@YOA.01!4G0 -)).X,K?$_YJXM<Q7DZ*[6ECS*"WVA
M41R7$T<XDD4:)-B)%5JJCN ')7"L5Q:VEIH9Y;29*[[)\DC8\DB]Z3%.ADT?
M22TC!)2%#!>A1I)%L[.LM-0$,TDK'5%D?YM=/+1HK7#)F2PMYD*M+>1,5>X=
M' (2T<%4!&FY!-0;<ALR2"O[1B%G'QTYV7_VJ]2HR&"X[-MX]@:I#<ECX=Q!
M2D%WITLS!>;G.D\\A=MD3(.I)=W;K%%$K.[N0JHB@LS,QH%50"22: "IRFQ.
MS=A@^'[5OAT9J!S0;P[@J:4DNG D-0&6,11-4QUZG12>M-J^2/\ 7*\7;VZ9
M^&_RCPR2L6'@7MZ =!N)4*VT;;QB@9I2-1%RAUKU;?!K^3;Q'HZ5L9JFK- %
MK9RG=H808*DU9[=V.O.Z5?-5^L0]3%[9,8&$?[4ELU3:_*N=^4&84I\HM]C8
MYG75MK:W*:?OFO\ "3_W+)FPKI=#-,!X*RX>\*$[@+I=SLHX1&U-XY2=$.FM
MN(;E%$B.C;<,\+$A9H)*+MQL58:55U961U5U*BWQK"96@NK25)H9$-&CEC8.
MCJ=]6 (XLL%Z:H IQ.S@G=1J21XU,J#@CEVT_%S"_P#\S45)/V4=W_\ V67W
MS7^$G_N6470I\2&*&2TBNN>%O\FISLDT>QS?/3UV>9KM;>G:ILBE3E88^.EZ
MP_+K:"XV/]K+;'/1+)L;7^X+M;.U3:V5K2M!JR^^:_PD_P#<LL0Z.OBHQ;Y=
M="YYP6WR;8I$D6QL\_<;7J-K:VEUTV=%3UO%N@BW7R(XI 8>?YOG>;JRG:YO
M;CV]6KG%UZ\OOFO\)/\ W++[YK_"3_W++%^A1N/E1PJ[GM>>V.;YWF)&CV^;
MVY-C:V:[.VU*TVCKRP?H<)ODQQ:^M++GMCG.:^53QP<YS>TFWL;>UL;:;5*;
M2UJ/OFO\)/\ W++[YK_"3_W++"_Y?M=_+SAJ2)S_ #7,\YMS235YKG)=BG.;
M-.<:M*U%:#JX_P")A_\ TZUR":JD#LY??-?X2?\ N66CIFO\*/\ W+*?I?AU
MW#CF&VB[=PT*/#<0QCU4SV[%PT2#2[1S.R+5V01JSC+&OY6WDA:WEA_W&V4G
M1'+&\<%PJ_I4DA<C4.9)&DM7,Q7YY<^7?+HO^GG^IW/5QGYC=_5Y.HWFR[\I
M;YADD-%4$D[P&DG+%NFN)L6EQ*YEFH3781F(BB'M8H@D2#<5 -S*RZ"=&=@7
M-V6)DD)$<,4:EY99" 3LH@)H 6=ME%!9@,E7I'C.)WMS0;30-;6T1.Z5B:"Y
M<<%9FR8]$,?O[.:FCY6EO=QUWJ1)9N =5=IB-=#J+7V)6(Q+#0:"\L=N>,5-
M%YZ/96: FH%9(Q$6(5)'.7^]=((A_P#(L717N20"UK#H:.R4[A70]P1H:;P:
MLL,;9F'X^F/#"?D%LUOL&R-SMUE:3;VOE5OL^JIL[+:JUW,OOFO\)/\ W++$
M_P"8;=)Q?C#5A;Y.,.,'.<[<0V].=^72[&SSNW^;:NSLZ*U&6,3)C0PC_:6M
M5H;3Y5SORD7!K^TV^QL<Q[?:VO6[.G[YK_"3_P!RRPCIR>E0O!A=S'<<S_MI
MBYW8-=CG/E\FQ7V6PU-XYG3'S'BWU"XZE[T73%!A/R.T-USIMOE.W2:&'8V.
M?M]G\[M;6T?4TV=-1]\U_A)_[EE]\U_A)_[EE]\U_A)_[EE>=%'Q08M\KO&N
M^=%O\FV=J""'F]CG[C:IS.UM;8]539T5/5QSS?>?5I.I+T*3$AA9CM);KGC;
M_*:\U)#'L<WST%-KGJ[6WHV:;)K45BZ9(QWCA;*.R,0;N9/=]&+VQQH("1$K
MO:W#>*LZ\Q[JY7@KE-@'2>SFL+V TDAG1HY%WCLL!56&E6%5=2&4D$'*VZ1=
M';E[2]LY%EAFC-'1UU$;A!TAE(*NI*L"I(-MTIHL6(0'Y/?PKJCN45260$DB
M*9666/2=D,8RS-&QS/\ ^._YOW-K;XU;0(RW+R-:O LA9EA:^79B5@I$HM[E
MR@659%0EB<L(Q_\ D1TP&)S%I)1S-Q!<3V+Q%.;+7-I2%UF#LO-/&C;*,'$B
M.:?R[N<2CYFZN;*[N9H@"-B6>+#2R4.D;#AU U[F6&]/>@ML[KTA:*PN(H*U
M_P!Q=!%'H6@V;Z,;+#U)F20N:S 9= >B=KLO<0R8D]Y,H_/7EQ'8M,]: E5Y
ML115H>9BC!T@G+#;ZM>>M;>2OCQ(WI_T'+C,JGFL6LK6>-J:"84^2.M?9+S"
MDC6 ZG41D)$-&4@@C6"-1'%E;X5_-F.3"<0151[N*-I[.9@ .<*Q!IX&<Z2G
M-21KI/.@>"!-T-QFSQ+14K;W$4DBCV\:MSB'@=5(WNL8MTR# 721\S9J:>%>
M3_!P:#ZH1L3,Z[L<3Y-<3L7=R69F)+,S&I8DZ2234DZ2=.737%;N(.T-@;3#
MRPT?[BY%TCJ=PQ?)XHWTCX.Z8::Y&.0%64D$$4((T$$'2"#K&5__ "JQ.2EO
MC"FYM 3H%Y GPJ*-^>V4L3OVR*-+9UEYXM?JE_U,1\]77U+#NL='O-S_ %F3
MJ=$HI;N%67";$$&5 01;I4$%J@C>.7[9!^NC_*R_;(/UT?Y61CL[B.5@*D(Z
ML0- K1232I KPCK\V,RJ>:Q:RM)XVW"8H_DCK7V2F $C6 ZG4PR$B&C*001K
M!&D$<65OA7\V8Y,)Q!%57NXXVGLYF  ,A6(-/ SG24YJ2-=)YT#P0)NAN,V>
M):*E;>XBDD4>WC5N<0[X=5(WL_"+$'3-C$3<8CL[VO;=3R=2*6>-D6=2\9((
M#H'>,LA/JE$D;H2*C:1EUJ1E8].,(JZP-L7,(-!<6LA FA.Y5E :,FH29(Y*
M'8IE9]*>CTPN+*_B2:&0>N1Q45&M672KH?"1PRL P(R7^3?1J:E]BB"3$&0Z
M8;,GP+>HU/=$5<5J+=2K*5N%/4$5U&T;%4<!@5)21%DC8 ^M>-E=#J96#"H(
M.71*\)H$QC#2?%-Y"&_NDYV(=+<;?8M,.@EN)3NE8D+;*UUN] J+K9R%&DY8
METRQIMJZQ*XDG?22%YQB5C6OK(UV8T&XBJ-S);+'8>>PO#[6XN+I2/!?:3Y/
M"E=(#<[,LJC=$+;V6)]#L3_/X9<S6S&E W-2,@<>UD4!U.ZK C0<K.UOY-C#
ML= L+BIHJO(P^2RG<&Q<;*%CH2*64YW2KYJOUB'J=+_T6&^_O>KT9P.T96O[
M.VNY+@"A98KA[<6RO34:PSN%.D*X:E'!.71:.YKM&VE85]@]U.\?)L,M.#.M
M?-%K]8O.I@'FZQ^K1>@>E_G>_P#K$F70[SYA/U^WS\?\3#_^G6N2>,.[U<;Q
MGI&RK8P65R9MNE&4Q,O-T/JFE+"-$UN[*H!) ZD4D-=F+#[QI/$(C05X-MTY
M:9N*_/+GR[Y=%_T\_P!3N>KC/S&[^KR=1O-EWY2WS'@D]2ZE3Q$4/:RO^C6)
MJ5N,/N)K:4$4H\,C1MVU-.#*RZ>X)$EQ);;:20R$A)H95*2QEA4H2IJC@'8D
M56*NH*-'%BE^V WC ;4-^I2,-N[-VFU;E =32O"Q&DQKI 7$< O(+ZW;5+;R
MQS1GB>-F4\AZQTG\2S_ZC9]3ICX^%^]O\[ICYCQ;ZA<=3&I+R5(E.$N 795!
M/RRT- 6(T\&7[9!^NC_*R_;(/UT?Y67[9!^NC_*R#H:@Z01I!!U$',QSS?>?
M5I.I=>:+KZQ9]6ZGMH%_W["XI)["95'..4!=K1CK:.X *JI-$F*2#4P;*YZ%
MR/\ \MCUI( E=!N;,-<1M3540?*E.Z=H:=%,R?I+?17.&XC=,9)I[*8)STAU
MO)%/'/#M'6QC2-G))8EC7*''L0>\QJ2W8/'%>20_)@RFJL\,,,9EH179D=HF
MU-&1HRP[%NF%S?0OA:.D2VLL$:,)'5VYP2VTY)J@'@LNC<KIR F17"L&&T :
M,IJK"NIE.D$:0=(RL<,Z8SW<"8?))+$;22&-BTBA&#F:"<%:*"  IKNG5E9X
M#9L[PV,$5NC2$%V2&-8U+E552Y506(5036B@:/Z#7#H9$ML8P\O+87#@[ 9@
M!)!-0%A!.%0,R@M&Z1R!7"M&\O1KIK82X?>15\&1?!=:T$D4@K'-$:>#)&S(
M=(!J".HMQ;.T<B$%64E64C4584((W"#7**WO+\X[ARD!K;$&:5MG=$5T:W$9
M T)M/)$NCX%@*9-B71ES!>VX7Y58RD<_;EM3:-$L+$'FYDT'4ZQR509ME_*W
M#)*VV"()[H Z&O;A 44[A,%L5V2-(:XE4BJ]3!L,N$V+N_0XA<Z*'G;L!T5A
MN-%;B"%AOQG+&+*!-BTQ)AB-MHH.;NRS2*HU!8[D3Q*!J5!JU"PZ5X(_-W>'
M3Q7$3;FW$X<!@-:M39==3*2IT$Y8;TTP4UML2MXYT%:E"Z^'&Q'KXGVHWWG1
MAFV7GBU^J7_4;#.B6/XEA=L[F5HK2^NK:)I&55:0QPRHA<JB*7(VBJJ":**?
M?''/XM?_ +QE]\<<_BU_^\9='L%Z1=)<5O[.<WO.07.(W<\,FSAUVZ[<4LS(
M^RZJZ[2FC*K#2 <WH]YN?ZS)FXMYEG^O8?U]<.AD2VQC#R\MA<.#L!F $EO-
M0%A!/LIM,H+1ND<@#A6C>7HUTUL);"\B)\&1?!=:T$D4@K'-&?6R1LR'<-0>
MHMQ;.T<B$%64E64C4584((W"#7*.WO+\X]ARD!K;$&:5]G=$5T:W$9 T)M/)
M$NCX%@*9-B71ES!>6X7Y592D<_;LVIM&B6%B#S<R>"VIUCD#(,SHOA]?SMW=
M24_10Q+_ .]V^IT;Z<X'#MXQ@"XG,0HJ\]B<3O3/%HTLT( N(P:T"S(H+2]3
M&.A_3 /<6<4,MWABBI(N_76=0#S<5RQ$@>@2)Q*Q#&71?=+ND<IGO<0F::5]
MS:8Z%45.S&BT2-!H2-50: ,K/HRZL,-@(N<0D%1L6L;#:0,-4D[%8(Z:07,E
M"L;4Z18?91K##%_MZQH@"JB?[79;*JHH JK0 #4!3+",0K3F+VUDKXD\;>EG
M8?\ RGPR2D^+,+N\ .D6D#_ HPWI[E=L?-2#H;J773B[39N.D%P2A(T_)+0O
M#%KTC:G-RV\RF,Z10Y6?3VT2EOC]N!(0-'RNS"1/6F@;=N;8BNEF60Z:'(.A
M((-01H((U$'?RPOI1.X>^B3Y+?;XN[<*LC-O&=2EP!N+,HW,WI5\U7ZQ#U+V
M?^7UZMFV(")9RT$$^V(3(8Z<]')LT,C^II6NFM!E]MQ?0+']WR:V;I#S*N*$
MQ65C&].!Q;;:GA1E(W#E-C&-W,MY=W#%Y9IG:261CK9W<EF.Y4DZ !JRL.A/
M1N,R7=_*L8-"5C37)-)35'#&&DD.XJFE30'#^BN%"EMAMM#;15U[$$:QJ3OL
M0M6.Z23G6OFBU^L7G4P#S=8_5HO0/2_SO?\ UB3+H=Y\PGZ_;Y^/^)A__3K7
M(,NL:<OMN+Z!8_N^5/\ >XA_^@L/W?);;IYC<]] C!E@ C@M]H:F,%ND4+.M
M2%=D+ $T.DURQ#^;.-1&)\606MB&%&-HCAYIM/K)YDC6/546Y<55T.;BOSRY
M\N^71?\ 3S_4[GJXS\QN_J\G4;S9=^4M\V7^:_\ +&#G[]U'R^Q0>'<<VH47
M-L/7S[ "RPCPIMD/&&F++(]G>1M%+$Q5T=2KHRFC*RL 58$4((!!T'J+BG1B
M_N,.N5U2VTTD$FC<VHV4D<!-#NC*'"/YL1?[UAY(4W4:I'?0KJVB%V(;D*/6
MLL<ITL9F.@VO2KHI=)>V%XFW%*A-"-15@0&1T8%7C<*Z."KJ&!&=TG\2S_ZC
M9]3ICX^%^]O\[ICYCQ;ZA<9V!^;[/ZM'F8YYOO/JTG4NO-%U]8L\S'<+M12*
MVQ"]B0#4%CN944#B &716:$D$WFQH]C+#+&W(5<@\']&G!>FF&V^)6QJ0D\:
MOL$BFU&Q&W$]-3QLKC<;)[GH7B-Y@<C5I&VS>VR[P"2M'<>ZNFT=N2^Z/K!T
M@MDJ?^48I<A1NFVF"ECO)!).YW!E)8W\3P3PL4DCD5D='4T971@&5E.@JP!!
MT$96'3C G.W:R 31@T6XMV($]N^X5D2H!-=APDBT=%(ML9PY^<M[N*.:)O91
MRH'1N56!S,3Z;XR?^7PVWDF85H7912.)2=&W-(4B3V[KE?=*,:DYV[Q">6XF
M;?DE<NU!N*":*NI5  T#+"O_ )U,8,'6YB>\8(\A-NC!Y$"1JSDRJO- A3LE
MPQT Y!5Q:< : !87E -X? Y81B_02_>?%\-EDB9'M;B'G+29=IJR21JI,,T:
M%%)&B64C3H.6)?RAQ.2LED3?60)UP2,%NHEWA',R3 "I)N)3J7-LO/%K]4O^
MI+THZ#6L$]I#</;,TES%"PE2.*5@%<@D;$R':U$DC<.7V?:_3K?\K+[/M?IU
MO^5E@G3;I79V\6'V)NC*R74,C#G;*Y@2B*Q9JR2H#34"3J&;T>\W/]9DZF%=
M-+?I';6\>*VL%TL36LK-&)HUD"%A* Q4-0D  [V7WIM?HDWQV7WIM?HDWQV5
MYTMQ'&8<12ZL9+01QP/$RL]Q;3;99G8$ 0%:4K5@:Z/0!P7IIAMOB5L:D)/&
MK[!.C:C8C;B>FIXV5QN-D]ST+Q&\P.1JTC;9O;9=X!)6CN/=73:.W)?='U@Z
M06R5/_*,4N0HW3;3!2QWD@DG<[@RDL;^)X)X6*21R*R.CJ:,KHP#*RG05(!!
MT$96'3C G.U:R 31@T6XMF($]N^X5D2M"0=B0)(M'12+;&,.?G+>[BCFB;V4
M<J!T;E5@<SH?AX/J$Q.0_CM8J.QL-V3U.B\+"H:"=B#NB2\N7[>UD]W@T6S@
M6,EY[,@>!"]09[/@YEF#1#_0>,59D<C)8(%+NY"JJ@EF8F@  TDDZ !I)T#*
M*VQ*,#&L4V+G$&T51ROP5J"/6VR,5-"09FF=3LN ,;D_U8K!^Q8VZ?X,EFC-
M&0@CC!J.WE'=1^ID56'$P!':.9)>7;B.*%6=W8T5$4%F9B= "@$DG4!7+%NF
M\A;F+B8I:JU1S=I#\';K3UI,:AY -!E=VUDY)%,XB1F4,Y!(120"Q"@L0HTD
M*"32@!.6']$\'Q6=;7#;>&VB_P"0O*E(45 S? Z6:FTYUEB2=)RGZ/X'B<KX
MM:3175EMV5T@,J$I)&9&B 42022@;1"\X(RWJ:C*Y_ESB4FS9]($K#4^"M];
MJS)2NA>?AYQ#NO(D"Z33-Z5?-5^L0]2>/H7A-WBK6P0S"U@DG,8DV@A?FU;9
M#;#;-:5V334<ONAB_P! N/B\FAF4HZ$JRL""I!H00=((.@@Z0<L,Z'W%_%AB
MXC.D N9PS1QM)H3:":27?9C6I5=MEVW1-IPZX$&O,3N5"W-_,JB:1:@\W$HJ
ML$&T W-*6+$*99)2BD9UKYHM?K%YU, \W6/U:+T#TO\ .]_]8DRZ'>?,)^OV
M^?C_ (F'_P#3K7*@UG+[H8O] N/B\H#TUP>\PH76WS/RJWD@$O-[.WL&15VM
MC;7:I6FTM=8ZD'\S>F&(C$+:*=XSAD(9 DT3 [%[*2&(9"DHAA"AD="TQ!:/
M*.SLXUBAA541$4*B(H"JB*H"JJJ %4     4S<71Q0K>W0/&)Y,NBS.:#Y1,
M.4VEP .4D#JXT[F@%A=DG> MY*GJ.1N87=D_K+8=TC.,G37!X9[DB@NHZP78
MH*+\/"4=POK4E,D8]AD\_0#I%-;G25AOX4F4\'RB#F64#?\ D\AIKJ=)DQ/'
M\-%WAT52UY9,;B!0-;2#92>%!H\.:&-*D ,3HZG_ /&-_*6PS'@YB0GP8;Z*
M,NCK70O/Q1M"X \-^8)/@:<WI/XEG_U&SZG3'Q\+][?YW3'S'BWU"XZEYT8P
M[$(\.>SM3=&22)I0P$T46P%5E(-90U:TH"*:<OO3:_1)OCLOO3:_1)OCLOO3
M:_1)OCLK#!)'$C6=M! 7 H&,42QE@#4@,5J!717,QSS?>?5I.I=>:+KZQ9]6
M[Q_%I!%:V,,L\SG4L4*-([<BJ3E>XY<"DE[/-.PUT::1I"*\;'+H^$6L=F;F
MZD/L5AM9M@GCF:)?QOZ,N^DW2&=;:RL8GFFE;4J(*G1K9CJ55!9V(506(!;"
M[Z?_ &#$.<98X;YT1)TVB(VBN=$)D9=G:A<I(')2,3*-LAE-0=((U$=2V'1Y
MHGOXK)$Q$Q;)I,)).:68KH-PL.R'VO#$?,JVA0!ET1@O*B1<'PT$'6/^4AHI
MX5% >+,PS^4&%R>'<D7]\ ?\I&9+2)J:P\HDF930@PPMJ;.PGIW9U*V,ZF9%
MURVT@,=S%O5>%G"UT*^RVM1E!BN'2":WN8TEBD4U5XY%#HZG=#*0P.\<RR\\
M6OU2_P"IB/GJZ^I8=UCH]YN?ZS)U.B'FBP^KQYYQ7I+?6^'6JFAFN9HX(@36
M@,DK(@)H:"M33)VZ'XQ98KS7J_DEU!<%*ZML1.Y6NYM 5ZU=])ND,ZVUE8Q/
M--*VI405.C6S'U*JH+.Q"J"Q +87?3_[!B!=EC@OG1$F3:(C:*YT0EV79VH7
M*2!R4C$JC;(934'2"-WJ6PZ.M$]_%9(F(F+9-)A))S2S%=!N%AV0^UX8CYE6
MT* ,NB,%[42K@^&A@=8_Y.&BGA44!X1F='L/K^:PZ22GZ6YD7_V>UU.B45*5
MPZ!_UH,G;V\KWH5B6S',XYVTG(J;>[C!YF7?V34QR@:6A>110D$7?1O'H6M[
MVQE>&:-M:21L58;Q%156%592&4D$'(_S<Z30UP[!Y-FR1QX,]\H!YT ZTM 0
MP.HW#1[)K#(O4FE_U["R?L"2/_V^I@F(5KS]A9R5\>WC;T\Q^B^'R;&(=)&:
MT6AHRVB@->OQ,C);'@N"1ZG.M,?PB0PW=E-'/#(-:2PN)(V'$R@Y85T[PN@C
MQ&W21E!KS<HJD\).Z89EDB)W2E<SI5\U7ZQ#U.E_Z+#??WO4_P#G&#Q;.%](
MR\QV1X,5\M#<IHU":HN4K3:9YE4;,>0930C2"-8.^,HFQ67;QK"-BUO@3X4A
M"GF+H\%RBDN= Y])@ %"USK7S1:_6+SJ8!YNL?JT68,1Z68E:X9;D[(DN[B*
MW0M[$-*Z*6X 2>#)KSHCBMIBD49 9[2YAN%0G4&,3N%)H=#4.@]<Z7^=[_ZQ
M)ET.\^83]?M\_'_$P_\ Z=:Y)XP[O4O>C]J@.)VG_-V#:*_*8E;X*NXMQ&7@
M-3LAG20U,8R:&92CH2K*P(*D&A!!T@@Z"#I!R3!L:FV,$QXI;W&T:)!/4BVN
MM.A0KL8I6J (9&=J\THSNDV!SH47Y?/<1:*#F+MOE4--P@13**C=!&@@@89T
MRPL W&&7,-RBDT5S$X<QL1IV9 "C4T[+'*#I9T.NEGAE5><CJ.>MI2*M!<1@
MDQR(:BA\%Q1XR\;*QRQ#H)AURDN/8W ]LL",&>VMIU*3W$P!K'M0LR0 T=Y'
M#H"D;D98_P!-74\S9V26:L1H,EU,DQV3NE$M/"IJ$@KZH9L72#'(S=W-U*L5
MM:(X26<@J9G#$,%2&,[3.5*[9CCJ&E4Y)/T-Q.-KDK5[*8B*\BT5(:!C5@N[
M)"9(MZ0]2:XQ)TCMT1FE:4JL:Q@$N9&:BA M2Q8[(%:Z,L=EZ'!1A+8A>&S"
MBB?)C<2&#8&@A.;V=@$5"T!TY=$8[.NV,4M6-/8)('EY.;5Z\%<[I/XEG_U&
MSZG3'Q\+][?YW3'S'BWU"XZF->:'^N6G6,<\WWGU:3J77FBZ^L6?4>YZ7XU9
MX>$!)6:XC60TW$BVN=D;VJ(S'<&4O\N?Y9"2/!Y&'RN\D4QR7@1@RQ11FCQ6
MVT [F0++,0$*1QAQ+EB7\W<6B*-B(^16.T*$V\;A[F8;ZR3I'$I%#6WDUA@>
MJMATLQ[#L,G8 B.ZO;>"0@ZFV)9%;9]M2G#E'B>$7$5U;2BJ2PR++&XU521"
MRL*[H)']$#^36&QS6F'6/-SW3.CQ?+9V&U%L;0!DM8!I1A5)9]IAM"&)SDMK
MT5Z0XA80KJBANYTA'_!#\U_<R:RQ'I7B;1,*,J74D08'6&YHH6!W020=T9%W
M)9F-23I))UDG=)RM.BUA&XLD=9;^< [-O:*PYPEM0DD ,<"ZVD8>L5V6.TM4
M$<42JB*HH%50%50-P   #>ZMQC&*2"&VM(I)I9&]2D42%Y';@55+'@&6+=.[
MZH^7SLT2$Z8K=*1V\6]6.!$4D:&8%M9.6&]#<%6MSB5Q% AH2%YQ@&D:GK(U
MVI'.XBL=S)(I<(FE=5 9S?7H+D  L0LZJ"QTD* H)T #1E]B2_3[[]XR^Q)?
MI]]^\981TJ_EY:O;X5=[=K<(TLLPCNEVI8GVYG=QS\7.+L[6RIMZ@5<UR?H1
MB,FU?=&W$2U/A-93;36S:=?-,);>@%$CCBJ:L,RR\\6OU2_ZF(^>KKZEAW6.
MCWFY_K,G4$<=Q(JJ* !V  W@ = R_:9?UC]_+]IE_6/W\OVF7]8_?RPTG23:
MV_D4ZN-VF*3/\DP6[N,/M(*GFXDM9# [JFK;GDC:61SX3;2K781%6TZ6]%;E
MK6]LI \;J2 :'PHW (#Q2"J21M570E6!!RL,>"<V+VW@N-@ZUYZ)9-D^+M4Y
M.LC^3>&QS6F&V/-SW3.CQ?+9V&U'L;0!DM8!ZAAX$L^TXVA#$_46UZ*](<0L
M(5U10W<Z0C_@A^:_N9-98CTKQ-HG%&5+J2(,-T-S10L#N@D@[HR+N2S,:DG2
M23K).Z3E9]%K"-Q9(ZRW\X!V;>T5ASA+:A)( 8X%UM(P/J%=ECM+5!'%$JHB
MJ*!54 *H&X   !O9EE;@Z+?![5*<+75[)W''8'4Z)6I%"F#88#XWR*':[=>I
MA73/H1S=O>3R16N*%BJCY,-"7H!*\Y+;H#$\8)>5.950.;)-AT-Z-Q<S98?$
ML42Z*D#2SN0!M22.6DD:E7D9F.D]3#;D#1-@UN?QEO+]3_=V>IT1NB:DX/AP
M)]LEI$C?WE.9?S64FWAV$5L+2AJK+ S<],*:#SUP9&5QZJ(1 UV1DMO I=W(
M554$LS,:!0!I))- !I)RPR'IOALEUC'R>,WD@O+J-3<,NU*JI%,D82-B8T*J
M-I4#'PB3E]B2_3[[]XR^Q)?I]]^\9#IU_*ZQDM7PZ=/EJ&>></;3$1B0":20
MJ89C'78H"DCL^A!3+%/Y08I)KK?V(8[O@QW<*UX.:F1!O7#TUG,Z5?-5^L0]
M3I?^BPWW][U,1Z%S!1<NO/6<C?Y5Y$"86KN*Y+0RD:>9ED TD93X9B,30W%M
M(\4L;BC1R1L4=&&XRL"I&X0<K3I+(S'#;BEMB$8J=JUD8;4@4:Y+=@LT=-+%
M#'4+(V45]92++#,BR1NA#*Z. R.K#0592""-!!!&=:^:+7ZQ>=3 /-UC]6BS
M,6Q['9G9(KF:"UB).Q;VT4C)%$BZE\$!I" -N4N[:6.5CTTZ.3-'+:R*9$5B
M%N(-H<[;RC4T<J@J0?4MLNI5U5@"-WK?2_SO?_6),NAWGS"?K]OGX_XF'_\
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M"S.5BB<J=#"-Y%<J=!"D'0<IL6Q>=[FZN7:2665B\DCL:L[NQ)9B=)).4/\
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MISE)_,+^84D38NT30VUM"W.):I)02R22@!7G=1S:K'M1I&S^'(T@$?\ 7?\
M_]H " $# @8_ /0_P<+MQ*Q[@RJ+68_\)_R<JFUF'_"?\G+X6)UXU8=T?UN4
M,T4(WY'"]K2>U3AR!FOEF.]$R =FK$]@956W5CON2_:8D=K*D$:IXJ@=P9OP
M\:/XR@]T'*K6ZJ=]"4[2D#M9$V<[(=Y@&'9&R1V\BT:"91NH:GW)HW8!R,<R
ME&&L,"#V#_6B(XP69B  !4DG4 !I).X,EEL,'FAB;_,N=FV6AW0)BCL.%$:N
ML9;>)8E8VY/K4,\I' ?@HQ7B+#AR,N%WME>4]9MRQ.>!=N(Q^ZD4<.0M.E>'
MRV98D*S &)R-?-S(6BDIN[#FF[3,_P"6F=. ,0.Q6G:R G*S#VRT/96G;!R"
MWBM V_ZI>R!7LK3AR$MLZR*=U2".UG\U=QK(OM@#3B.L<8ID9,-D,3>Q:K+R
M'U0Y=K*EY$0NXPTJ?QAHY#0\']9J85@5K+=W,GJ8XD9V.^:*#11ZYC15&DD#
M*/$/YB7?R1#0_);8J\W%).0T49WQ&LU0=#J<@G1C#8;>0"AF*\Y.V_M3R;4M
M#[$,%%="@:,R3"L:MX[JVF%'CE4.C#A!!%1K!&E30@@@')NE714/-@TC .A)
M9[-F-%5FUM Q(6.1O"5B(Y"6*N^;SUI(T;;ZFE>,:B. U&0BQ9*C_40:?QEU
M'C6G IR$]HXD0[H/:(U@\!H<\HX!!T$'2#QC(S8<>8D]CKC/)K7DJ/:Y<S>Q
ME#N'6&X5(T'TMVA_K*BQKI27PK#&HR@K_P U.NNL<;"D2,-4LHTZ&2.137+_
M &SHK9I;(:;;@;4LI'KI96J[G60"=E:T15&C/GPK$XEFM[E&CD1A571P593Q
M@\8UC3EB'168EDMY*Q.=;P2 /"YIHVC&RAZ: X9=S/$]G(4;=IJ(WB-1' <A
M;W](9CH!]8QX"?4G@)XB3HZP;>Z0.AW#W1N@[Q&D9&YPNLL>LIK=>+V0_O<!
MTG^L>'!,!MWNKJ<[*1H*D[Y.XJJ-+.Q"JH+,0 3E%T@Z7A,0Q8494(VK>U;6
M-A2/A95_U7%%-.;4%><;K.#8Z@HUU;2PL=_Y/(K@GAI<TKO #<ZRMKB!,D&H
M'6R<7LE&]K U'10K/;L'1A4$:C^&Z-PZ#U@W5G2*XUG<5_&WC[8<M=8:WN5*
M.N@@_AI&\1H.L?UB1X!T;AVY#IDD:HB@CK0R2O0[*C<&EG-%168@9?)<+7G[
MV4#Y1=NH$DIU[*Z^;B!]3$IIH!<N_A'K71_"P?#ABNY2/:S/ BGE,#=@]:\#
MPXF/A(=1X1O-P[NHUT46ZM&VE/9!W01N$?VBHH>L;,G@RJ/ <#2. [Z\'**'
M)K2[798=@C<*G=!_L-""/ZPH^C^ I[::9@>;@BK0R2$=A$'A.U%&Z0F ]'X]
MYIIF YV>2E#)(>SL(/!1="C63UIIYV"(@+,S$!54"I))T  :23H RO<>MB3:
M(1;VU?\ 0AJ%;3I'.N7FH=(YRAU=;Y^ U4^K0ZF'I$;AW.$5!6[M6JIUC=4[
MJD;A']HJ"#UCF9O!==*/NJ?3!W1N\! (:TNEV77L$;A!W0=SO_U@6_1KH_%S
MEQ.=9J$C0>KED8 [,:#2QTDZ%4%F53'@.#+M2-1KB<@"2XEI0NVNBC2(XZD(
MNBI8LS=::>=@B("S,Q 55 J22:  #22= &O*;H)T#EVK-JK=7:U G&[# =?,
MG5))_G#P5^"),O7!-'X4;4#IN,/28;AY-1.2W5LVTCBH/=!WB#H(W^L50 3Q
MCP&W_:'@.YO'3JK4Q2 JRD@@ZP1K!_J^BL+&-I9IG5(T4$L[N0JJH&DEB0 -
MTG(&["R8M>!6NI10[.ZMO&?]..OA$?G)*N?!"*O6?E_2.]ALH=-&FD6/:IN*
M&(+MO*H+'<&3V_1:VGQ645 <CY/;D[^W(#,:;W, '<85KDUKB]R+>Q)J+2WK
M'#H-1SFDO,1H/PC,H(JBKU_FYB3;R'PA[$^S'"-T;HX0,A)&0RL 01J(.D$<
M?6/]XMAO"4#L!^XIY#OG^KX?S/Z0Q?"256P1AZE-*O=4.Z^E(3N)MN 0\;#/
MJ<GM6N_]QNUJ.8L]F6C;SR[0A2AT,-LR+I^#.K)[;HTD>#6YJ 8Z37!'#-(N
MRO 8XD8>S.38AC%S+=SOZJ2:1I'/&SDL>SZ"&$7C>"Q^")W"?6<1];PZ-T4S
MVAE&TK@@@[H(H1E)9/ZPZ#OJ=*GE&OAJ/ZO(<(D!%C;TFO'&BD*D?!@[CS-2
M-=T LX!"'*.SM$6.*)51$4 *J* JJH&@*H   T "F<TLK!54$DDT  TDDG0
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M!1550%50%4!0!_0.TA(.^-&5)'+<9)[OH*'"<*B:>YN'6..-!5G=C0 <NZ:
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M%&HU*D:A$4<2@#K6!6OL(+AO=R1C_!Z*%M:(7<[@W!ODZ@!OG(3WE)IM>D>
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M\FWHW'\68:7>UA4[VPL[L.7;2O$,ZXQO%9!%;6L;2R.?6H@+$TUDT% !I8T
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M5W,H(\*D,MPK$! C@E6&G2R@:"H.DZ!4Y+@%NP:0G;N&&K:W(P=T+N\(&HU
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M@'6^:NTJ1ZEAH9>(^D:@[HRV9?"C;U+C4> [S;X[!(SH_&?WQSKB"!2SO,X
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MGP3R,:?C<'6\0\V2_6K3.O?T$WDVS+#YS!Y5<^[_ $TOOVSNCWS^V\HN=?\
MS:?R39T_G"?R-MG8)\VG\JN=*-^PN!_ZMN?2SL>A45V;<2<D4L<I/($KGX_B
MI&B66UB!X8DF=A_ZRUY,Z#SA!Y&Y] 12IK5U(XP0<]QO(G<KZ>8EU":-&P8<
MAKV#J/!E'=P^ID4,.7<XQJ/#FF.055@01O@Z",I;)_\ +8@<(UJ>52#RY&[8
M>%.U?Q5\$=O:/$<V2[E]3&I8\@U<9U#AR>XE-6=BQXR:G/\ ^4D(7=0Z4/(=
M7&*'AR"8C$8S[)/"7L'PAR;60^2SHQ.Y6C>Y-&[76XL4C&D'8?BTE3R:17A
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MZU<?HY/>G-7#L4;P-22'UN\K>UWFW-1T:0&4U!Z\;2S(>X/*(^%M]MY>5M%
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M-1^'!N==J<FM\-I-+JVM:+R^N/ -&^=S)KBY8N[:23^&K> T#4.M+/$:,A#
M[Q!J,HKR+5(H/$=T<AJ.3/DV35(?@U_%]4>5JZ=ZF?S]HU*^J4^I8;Q'<.L;
MAR$8/-S;J,=?BG4P[>^.NFWLB)I]6C2BGVQ&L^U'*1DUS<L7=C4D_AH W -
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MX-P<)/\ 6TO$.YGGY3("^XBZ7/)N<;$#+8;X.$'0@/;8^N/:&X-W^ML*89=
M U)^5E^9E["?E9?F9>PGY67YF7^Y^5E\';.>-@.X&R_Y:!$\8LW<V,BLDY53
MN)1!V5H3RDY5/_V=H1Q@LS&@ %22=0 W2<A-A^ WK(VD,\#Q*1OJTH0$<()&
M6W)@%T1[0(Y[".Q[67-8_87%DQT 3PR0D\7.*M>3K%!I)R^R[OZ--^1DJ8G;
M2VQ>I42QO&6 UD!P*TW:9YM\-@DN) -HK$C2,%! )HH)H"0*TI4C?R^R[OZ-
M-^1E]EW?T:;\C+[+N_HTWY&7V7=_1IOR,OLN[^C3?D9-%*I5E)!!!!!!H00=
M((.@@Z0<QI<,M)KA5-"8HGD .NA**0#330Y?9=W]&F_(R^R[OZ--^1E]EW?T
M:;\C+[+N_HTWY&1DDPVZ55!))MY@ !I))*: -T^@!'&"S,:  5))U #=)R$V
M'X#>LC:0SP/$I&^K2A 1P@D9;<F 71'M CGL(['M9<UCUA<63'0!/#)"3Q<X
MJUY,Y;6RC>:5Z[*(I=FH"315!)H 2:#4"<OLN[^C3?D9?)L0AD@DH#L2(R-0
MZCLL :'<-,U;FUP^YEC<55D@E96&^&"$$<(.1NK^QN((EI5Y(9$45-!5F4 5
M.@:=)ZPMQ;X==21N RLMO*RLI%0RD(001I!!H1I&0GQ*SGMT8[(:6*2-2U":
M NH!- 3370$[F>MK9QM+(^A412S,== J@DZ-X9?9=W]&F_(R^R[OZ--^1E]E
MW?T:;\C(R2X;=*HUDV\H Y2F11P01H(.@@\.=]F7?T:;\C+[+N_HTWY&7V7=
M_1IOR,OLN[^C3?D9?9=W]&F_(R^R[OZ--^1DL6)V\MNS"H$L;1DBM*@. 2*Z
M*C17KBVUI&TLCFBHBEF8[P4 DG@ R^R[OZ--^1E]EW?T:;\C+[+N_HTWY&7V
M7=_1IOR,OLN[^C3?D9?9=W]&F_(R:UO(VAE3U2.I5EJ*Z58 C00=(U',6ZL;
M&XFB:M'CAD=30D&C*I!H00:'001E]EW?T:;\C+[+N_HTWY&7V7=_1IOR,@N(
M6\L!.H21LE?= 9X=,-NBI%01;S$$'40=C2#DUU>6%S#$GJG>"557332S* -)
M TG6>J(XP69B  !4DG0  -9.X,OLN[^C3?D9?*,1LI[>.H&U)#(BU.H;3*!4
MT-!6N<++";>6ZF;5'#&\CGB5 S'L9"2' +L _P"H@B/N961ARC(R7. 7I U\
MW"TWDMO)K7$(7@E76DB,C#C5@".49K2X9:37"J:$Q1/( =="44@&FFAR^R[O
MZ--^1E]EW?T:;\C+[+N_HTWY&7V7=_1IOR,OLN[^C3?D9-<W6'W,<:"K,T$J
MJH&LEB@ '"3F+;VZEY'(554%F9F- J@5)))H -).@9?9=W]&F_(R^R[OZ--^
M1E]EW?T:;\C+[+N_HTWY&7V7=_1IOR,A!B5O);NPV@LJ-&Q6I%0' )%01754
M$;F8(XP69B  !4DG0  -)).H9?9=W]&F_(R^R[OZ--^1E4X9=C_]--^1ES5Y
M$\3;SJRGL, <]K7HQA\]\Z4V^:C9E2NK;>FPE=S:85W,FO<9P2ZBA05:01F1
M%&^[Q[:H.%B!E):=&;&:^EB7;=84+E5J%VB!J%2!7?RDL[Q&BEA9D=&!5D=2
M596!TAE(((.D$4RGO>CV'3WD-M^=>*-G5-!:C$"@.R":;VG^A(NCF#40$;<T
MS E((00&D8"E34A40$%W*K515@B8':+)=@4>[E >X<TTD.1\$I_TX@BZJAFJ
MQZC6UW&LL;BC(ZAE8;Q5@01P$927F$Q#!+RA/.6X @)I_F6Q(C"C6>:YEMTL
M0*97%A!.ETD,CHLT6US<H1BHD3:"ML.!M+50:$:,ZVENDVK/"Z7<U1X)*,.8
MC.X=N79)4^JC20=1\8M$VKO!B;A:#28" +E.((%F/Z$ :\^Y\W3_ %BUSL8^
M?7?EY,S%_GB^03-Q'YK<>2?K\71S!@$%-N:9@2D$((#2-36:D*B @NY"U JP
M1,#M%DNP*/=R@/<.::2'(^#4_P"G$$754$U8]1K:[C66-Q1D=0RL-XJP((X"
M,I+S"8Q@EW0GG+< 0$T_S+8D1A1K/-&$[I8@4RN+""=+I(9'19HMKFY0K%1(
MFT%;8>FTM5!H1HS,(8Z1$+ISR6<ZC^\PZG_RW!X]K$L)1BP4>%/:BK21[Y:(
MUEC&]SJ@%G6G5@P6C+90TFNY!HV(%(JH.Y)*:1IK()+T*HV45A8QK%# BQQH
MHHJ(@"JJC<"J  -X98S36GR5Q^+>6]?[M<_#^BT%0MS*.=8>L@3PYGKJ!$:M
MLUT%RJZR,H[*T01Q0JJ(JZ J( JJ!N   #@&5_T<50;@ISML3ZVXB\**AW-L
MUB8[B2-DT4H*LI(((H01H((.H@Z",[ ?T[>1DS6MND^&P7@(IM.@YU?$F6DL
M9X4=3D_2KHF[W.$U'.H_A36NT: E@!SD))"AZ!D)4/M5VSF+Q#N9V$_,3Y>7
MKF ?.E]ZV?COZ6+ZM#F83XUW]<GS&M[N-98W%&5U#*1O%2"".,927G1N%,'Q
M&A*M"NS;2-N++ O@J"?7PA&!.T1)39-QT>QZ$P75JVRZ'LAE.ID=2&1AH92"
M-!S;#YM!Y)<L=_11?68>KAOSJW\JG47Y];^\FS6Z0](6>#!H'V?!\&2ZD7U4
M<;>MC75)(--3S<?A;31KA?1JRBLH%IX,2!2Q'KG;U<C;[NS,=TGJFQZ0V4%[
M$?6S1I(!7=7:!*G>9:$'2#7*ZZ;=&KS_ &U(*$VLS-)%(S&BQV[G:F61CZE7
M,BG=:)%+#JXO\\7R"9W2#YG+W,SHYYTP_P"MQ9V'>;H_K-UF87\[MO+)F&VO
MXDGC.M9%5U/&K @]C)WM[(85=&M);.D2@[FU!3F&%==$5R- <:\A-?@7>'2-
MLQ7<2D(3N)*AJ89"-(4EE;3L.]&IF65Q_*J&WFQ22'G )2 DER9=FYYQMI*R
M( Z1AW51L1JQ""F5Q9]/<#2-Y4=()VA>)4F*G98.IDM[A4/A&-2I.Z],ND&*
M7!+R&&':8ZRTLLCL3PDH3E8].>B$/RB+'7BA=8M(-W( (9%IHV;I*:=1D4LQ
MK*,HN@]LZ-<"+G+IAKDFG#*\I&O8+(T<1(_-Q!=)4Y%6T$:/Z#FZ1[(Y_$[A
MZMN\U;DQ(G$).>;\?@RVFT 936/0*P@DMXF*K<77.-SM#3;2*-XMA#K3:=F*
MT+*I)4 W]AA\\>Z%CN(VY&^4.!RH<DL>DL;X+</0!I&$ML2?_/559.$R1(BC
M7)E__'_12X5Y[Z-6NIHF#".VD%5B5E)&U<*0S$'1 1K$P*YT6*7:;-YC)%R]
M1I$-*6R<7-DR[X,S#<ZC03J'1P592*AE(H00=!!&@@ZQEB'1D@\S')MVY/KK
M>3PX37=*J=AS[-&&YG7/FZ?ZQ:]2'HVV$&_YVV2XYP77,TVY)H]C8^3RUIS5
M=K:%=JE!2I^[9^GC]RR^[9^GC]RR^[9^GC]RRO,8"<W\KGEFV*[6SSLC/L[5
M%VMG:I6@K2M!JS,7^>+Y!.IB'1DX 9_D%Q+!SGRT)M\TY3:V/DC[.U2NSM-3
M54Y?=L_3Q^Y9?=L_3Q^Y97.'?_'2GRB*2/:^7 [.VA7:I\C%:5K2HKJJ.OR]
M(]D<_BEP]6W>:MR8D3B$@F;\?@R+,: :SE+8] L/@DMHF*K<77.-SM#3;2*-
MXMA#K3;=F*T+*A)4 W]AA\\>Z%CN(VY&^4.!RH<DL>DL;X+</0!I&$ML2?\
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MQ)5*O);K)SQ4BA"R22.$J-&TBJXUJX.5YA_1V&UD6^96D:>.5V!164;!CFB
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M9D]39RR*G*!><Q*4=4P&V&_DMF5%>=C28SK;\>0PXME]A]E8<:>9=;(4E:5
M*2I)!!&(X[1K1NZH1HNL]GTYIFO1'5-L+O"EQ@&&;PI37 +6H94U)IL>I/'.
M$H:>; W+@U&ORIHIEO6]$4^Z<4*F5&8OH0:/2HZBGKI<IS*TPT",5'%12@*4
MF[]4;F]2G7-4B[$IR'2['HE%BMB'1*)%60G%$6,AMHKR@N*"G5#.M7R&@Z9Z
M0:FW^TXHI$FS[&N:XH:<#E4IV;2HSK2$I/IE+6 .<C9IVG^;I<4%IT!6:Y+F
ML&TUMI/.[%N:K1'AA]3U>;O;!;VG5HT]1PQ:EZF66M:<>4DP)3Z>'/@KP;')
M8EDR>EABSJ5:B01ACF'E#S?#YO>V4XG0IFJM(QS+I&I>E,E> ^IBNUMMY6/U
MK1V=>N+S9M8T1F I3\RC635[I@L(1Q4Z_/M9N:RA ^K4L)[^S]+K=+J-&J<9
M6633JK"DT^='5]2_$EI0X@]Y21\J'2;1V!UR3J!?%#H50D1QB[3Z"Y*$FY:L
M@8'\#IS<J4>'(V=J;1:1#8I])H\"'2Z73XJ W&@TZGQTQ(4..V/2H::0E"!S
M  =D4]A,&\=;[FISKUCZ>B0KJ8;"RJ.W=MZ.1E!R-2VG$J#;25)>F.)4RP4I
M2_(CUS4W5>Z:A=UXU][/+J,Y82S%BH43$I-(@M!+,.%'"BB/$CH2VV/2IQ))
M^3:3=EH5JHV[<E"F-SZ16:5(7%G0938*<[3J.5*DE2'&U I6@J0M*D*(-/M;
MSB6$V7<[:&HJ;]I4)^3:%;6/4TR*O3H:7'Z8^LX9RVV[%)S+*HR,&PW6;)NN
MW+NI+J4*14;;K5.K</!8Q2%2*<XXE)Y<4J((.((Q&SLB2\U'CLH4X\^^XAEE
MIM(Q4XZZX0E*0.4DX;3&/RQAZAW8RA:8UI:?RHM>>5) (2W5*['4JGPDI5@'
M0[(+R024,.$9=FJG=\ANCVM27GE6K8E)>=-#H2'1U:I3RW E4R<M'!V:\D$X
ME+2&6B&Q\@0J72H,RIU.HRF(-/IU/C/39\^;*=#$6'"AQDJ<==<6I*&VT)*E
M*( !)VIMX><?7W]%+3EI9E,V53H\:J:IU&*O!66H-2<T&AE:"%)\I$J2A0*'
MH31VAN6?HI;%;K\0(7^6&H49%_7.N4CAY=&EW(EYB"Z0,#[&1HR>7!(Q.+;+
M+:&66D);:::0EMMIM"<J&VT(P"4@   # #>TO28L4U27KW06VIJH[*IK=-C:
M?W([+BM22,Z6UO*CK6@*P)2DD8@?*AOS5J;&ZZ!H_I\N)37BC'R6[-19*Z-3
MWDN'@,:5%K;9 XG... (/8'D8I]R:UWE"E-Z<60\Z5LL!),=V\[J;84EQNE1
M',0E 4ER8\GR=E24ID/Q[CU%U$N*H75>=V5)ZK5ZNU-T.29DI[!*4(0@);99
M:0$,QX[*$M,M)0TTA#:$I'Z@(ETZ;+I\IO'))A27HLA&/+D>84E0\1V2U6;A
MKE7:24E+53JT^>VDI]*4HE.+ (YN'R%;]DV71)]R79=56A4.WZ%3&2_.JE5J
M#XCQ(D='  J41F6HA*4XJ6I*02*;?%[1*5>WG#U6 ERKW2ZRF92[#$QC"3;=
MA(?&#>0%3,JJY0_)Z826HZ^I[3YO]'S8>7ZF7)4\F/IO8FUA%S8=[RW#Q_)W
ML;8%D77>DX*2ER/;% JE;6QFXYI1I[3@:2!Q*W"E('$D#9EZH6K;EA17PE3;
M][73 9<"#],[3K;%3EMGZQV.E7>V;5=VN5NTE? NL6Y9E2N%)/.AN54YU,/@
M46?\79(JVL=\S5@=-5.H5 I:5'GRHDF81XU';\YNJV;$\>MM###F&'L9^SLH
M4O6*^X:R.BJ?1+?J20>ZI$?R0G]L-EKM?7BDSU$$MQZ_8<RD)2>9*YE.JDW'
MOJ# \&SKM$AV)?S:,5(;M>[6X,I2!Q&9F\F*4@*PY4I=5QX G9Q6HFE][6G%
M:7U9JE4M^>BAN+QRY8]>90N$[Q_T;ZN;N_K[NK4&1'R5#5+5.M2(\G+EZ^W+
M-IT>W*:WCRJZNH"KG''#I888@X[7!JS>[B9DE@>Q5F6HU)1'J5ZWA+96NE4"
M"I044(Z"GYDC(H,1VW7<JU)2VNZ=6]3JRNLW9=<Y4F0I.=NGTJ"T.JIM!HD1
M2E"/!ALA+$9D*)"1F6I;BEK5\@:BV]JGI[96I%!@Z#W#685%OJUZ+=E*B5=C
M4&VH+-4C4^NLOM(D(9D/M)>2@+"'%I!P4H'XJGFZ? OIW_1VWQ5/-T^!?3O^
MCMOBJ>;I\"^G?]';?%4\W3X%]._Z.V^*IYNGP+Z=_P!';7Q-A>:YYO<29#L^
MYI425&T<T^8D1I,>BONL2([S=/"D+0H!2%)(((!!Q^3G_.ZOVDI<NN]6ZC0]
M(8\UC%= LQIU=.KMV,-NC%$FK/(=B1W D*3";6I"U-3E#M7FHT=*L>OEZTU)
MU /I?)&;6BQU$=_KG0/ ?DR%6VJ,C3ZQ)?5NIO&]69,%,^(OI%^W:"E/EDX%
M/%IW(U&7R>4 X[1)]V4R9J]<K&1QR=>>5NW$/I],8=FP5>2J:5_HJ@N9AQZ7
M)A&I%OTBET*DPT=7$I=&@1*93HJ/J(T*$A#2!WDI':%M.H0ZTZA3;C;B4K;<
M;6G*M"T*Q!!!(((P(VE2*SIS3[6KTD+/Y3Z?]7:-60\OTTI^- 08$IT\ZYL)
MX]_:97-'JS%U8H#*7'S0W6V:#?,5E(*RAF$\X8=0R)'+'?;><. ;BDG#:;1:
M_2JC1*S37UQ:C2:O"DTVI0)+?IX\R#,2AUI8YT+2".Y^OCS9J"EGJ#,TOI%X
MNMX95!_41]Z_WU+',HKJ9*@>(/ [56X*]48=(H="ILZL5FK5!]N+ IE*ID54
MVH5";)=(2VRRRA;CBU$!*02> VJ%PPY$V)I-93DZW=);>D=8R&:'UX$VZ:A$
M. 34*PMM$A_$9FFDQXQ4H1PM7R#J?_=TN;])=J;VH/M(NO\ $,CY-TRTAHBG
M&JAJ)>E M?RMM'6&FPJE/0W5:PX@\K<*+UTMWZQM7 [6U9-KP&J5;5H4&D6S
M;],8&#,"BT* W3*9#;[S;+2$X\^&)[5YMU'S8^0V3?U2R8^E]EJ[3XN;#O\
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M"3UJ2E;55MVX*;+H]=H=0ETJKTJ>RN/-I]1@OJC2X<IE?%*VUI*5#O=NU/\
M[NES?I+M3>U!]I%U_B&1\FW%[_%\>Y.WM[S=?>_O+W1QODS5*YU(S*HFFT>B
MMDIQ#:[CN:++*DD\BLM-4D'EP*AR$[^JM1DR7':=:=PS-/+>CE94Q#I-E27*
M,XF+CR(D3$2YI[JWU$<" -^GUV@52H42M4F4S.I=6I,R13ZE3IL=>=B7"FQ5
M(<:<01BE:% CF.RW75K===6IQQQQ2EN..+5F6M:U8DDDDDDXD_J?K?[:[0_%
M$O>T6]N5S?B1G]7?.AO: 2U6=0KVTXT>:G(X/1**UGN6X(K2^9$V,ZJ.^G$Y
MDY>&(!V\WGW\M)O=[3]KUTFHE8I] J=T.6RN-5:JS)?@Q10KM@W$\'VH@+AS
MMQ%-IRC@I0)X8[4/5N[-3:57G;8A5QJDT*W*34(K4N97:-(H#KM3GSW$GJ6F
M)+JTLH9)4YD)6D((7:&B%BUNGW5.MJ['+NO&K4B0U-I5(J4&DRJ'3* S46"I
MI^1EFRG)B6E$,E#:%'K"M#?G)Z13/5:-J1YN=]RDQE<6D779*$5JTZJI!Q!5
M%4N2I'#'%0P([+^OUR4]"[MU"3+I]H*DM8NT2QX<HQGI4=*P"AVJ26EK4O#C
M&:8*%!+S@5NT#SCK8@)9<G2HEH:DHC- )?DE@IM6YI 3R**&E4Z0X>7"(D#'
M,3VW4_\ NZ7-^DNU-[4'VD77^(9';E4C2[3>^=1*DVI"'XEEVK6[E=B]9Z5<
MWV(8=#",.)<=*4@8DD $[-2EZ-1[3AO92A^\KXLFD/8*XDNTIF>_.;PYPY%2
M>YCQP"W)VBL57#U)^_*RIP<.<QJ.XG_*V4N'0]-+@4E)4&J1J)!9<6</2)->
M8A)Q^R4!W]GGZ[YMM^5!AA*G%.64:'J,5-IXE:&+ F5)WDXX%O,.<#:11+HH
M59MNM1"!+I%?IDVCU2*3R"1 J*&W4'A],@=JN+W^+X]R=O;WFZ^]_>7NCC?)
MGG$/G#.W$TK93P&.1]ZXEKP/A;3COZW46<A:)$+5:_<"L$%Z-(N:3*A2ACQR
MO,K;=2><*!_4EE^R=(=0[AAOA):JD*U*P*,H+XH)K4AI$1./*,SPQ''DV0Z]
MIM H#+@!0NNWK9S*\#SKBP)LE]'@6T#WM@IR1I?%4?\ -OW=45+'A,:FN)]!
M6V9DZ:SC@3DBWA*0K'ZG&= 93CX\._LMU.EC-:8;!*G:'>5DS%</J(;U0:D*
MQY@ED[.O7GI#J-;T1D*+E2J%HUM-) 1Z<IK#;*HJL.4Y7C@./:M;_;7:'XHE
M[VBWMRN;\2,]O,*RK-NJ\)B5)0J+:]O5>OR4K5Z5*F*4RZH$\P(V0[ T4N"
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M8T2&P[)E2'5>E:8CLA2UJ/,E()V9?H&B%Z-1WTA;,FY8T*RF'&CQ#K;MY/0
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M$;^NU/U9TTL74J#1;(M291X=\VM1KHC4N7*KS[$F3 8K++R6G'$)2E:T $@
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MQ)4_%3&EH;3@$B-(6>*CO7MIO70GV,O.VZI07GB@.*A/38RD0JFR@\.MBO\
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M_5JG_P ?*_=[?]6J?_'ROW>Q2JJU(@@@@SI1!!X$$%78N+WA[X]UEO;VO/\
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M:0IJFT:FM+4J%1*'!*E)CQ(X40VV"225..*6ZMQQ7948[[S!4 %%EU;14!Q
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M"90:$"HXGJK>M\Q8*.X,L<<.&WE0K]:$H',)(JDX/A6..;KNLS8X\<<=HK]
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M=:Q)03OPJ52X4JHU.I2XT"G4^"P[*FSITQX1XD.'%8"EN.NN*2AMM"2I2B
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M?HHKN]K][U5Y?B9W?T/]K=2]U$_>N'VFV3^*?D-JY-.[ON"S:VWE29] J4F
MN0TE6;R:<TTKJY#)/IF'T+;5],D[1:7K59=+O^"@(:=N>V%,VO= 2/3R9E,R
MJILM?<;81"3W5=V,Q3]2H%H5F0$ T'45 LZ:VXOTC J,]1ICSA/1"(T]TD\
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M6GUD3 XRY:5C*DTY,Z(OH]37:\M:ITP*3T76@ZW'7SQQVJ'>>FUTU.U+AA]
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M%29<8I(Z3*@<-A7-4KVK%T/M..+@4]]U$6A4<.<%-T:@00W#C C!*E-,A:\
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M;)3,NZUJ^4C KJUC6ZRI??4*$U"'[4#8)72=)9!&.*WK3KR5*X8<0Q6$#O\
M ;*2U#TMAE7(N-:-44I'##HB74W1W^(.RFXVH=(H25XA7L-8UG9\I^E2[584
MI:?"E0/?V<:K^N6I+T=X%+T.FW-/M^ ^E7*AZ!;ZHK*T_6J;([VSTR?*DS9D
MA9<D2I;[LF2^X>5;S[Q4I1[ZB3VYB?39LNG3HRPY&FP9#T27'< P#C$F.4K0
MKOI(.S35!UROMQED ,L7%4&;SCM(3P2VVQ>+4] 0.0("<H' #9(F7%9U>*0
M556R*0RI9PY5>P?D0Q^Q V*54?21PGZ==J7 %#CCP#=92.]R;*#+&F$ D8!4
M2T:@M2>&&*?+JB\._P 0=EMLZF0:&TX"E3=$LFRF58$88(DSH$AY'>*'0>_L
MZS=^LFHU:AO!0=IKMV5>-2%A7IL:-!=:B\>3]YY.')MB>)/$D\I/:C+L:][N
MLV2I86M^UKDK%ONK6. 4XNE/-%7#AQQX<-D-0]9JO4F$  M7)1;6N9;B4\@7
M,KD%^3X2EX$\YV2F2_IU5BD %=0LY;:ED<I4*5,C#CSX ;94TC25H_5MVI7R
MH\O,[6%#YFRT0KUMVVPO'I4.Q[9<6E)Y4H77F)Q'AY1S''9YF[M:-0ZG#D I
MD4MFY:A2:,\%<H=HE%5'B*[G%G8J42I2B2I1))))Q))/RI&(L5EV1)DO-QX\
M=AM3KS[[RPVRRRT@$J4I1"4I Q). VT[TW+3:*K2:&U.NAQO*KRB[*THU:XE
MEY/[XEN2\MAE1/[TVV.   W*C6*K*:@TNDP9=3J4V0K(Q#@0(ZI4R4\KF0VV
MA2U'N#;4+5"H%U)NVY)LZGQWSF=@4)@B!;M,4<2,8T!F,P2.4HQY_EN4Z\*M
M!+UDZ0+AW=5'76\T:9<Z75&S:.%$$%?E+:IZTD$%N*I"L.L3CNU*UJ=+ZBY-
M79PLJ&EM>60W;B6Q.O&6$\[:HH13W?Y8DX<X^6W"LC3>@2*O4GUM+J-06EQJ
MB6[3EN9':Q<-3"5(C1V^)Q.*W".K90XZI*%4?3FVE"=*;4JJ73<2V$L2KFN:
M6TA%0JKS0*NK; 0AB*SF5U;#;:"I:PI:MVIVO3I?7VUI%#-D0DMKS,.7%UHF
M7E,">9Q,LII[G=$-)PYS\M>%,5KE<;9EQ(TDH%E4Q007V4NE 4:AQPQPQV_/
MI<G]2:9_2&R34-9;XE-@])$.@4&"LCZUQ]4@#QI.T>57)NI5[=4H*>@5VYZ?
M3J7(P^D4BUH$"4E)YP)F/?YMFK8T[M&@V=0FE!PT^A4]B$B0_ER&5.>0.LD/
MD !3\A:W%<ZCO:@:H3U,ERV*!)=H\5XC)4;DG$4ZVZ:4\I2].>80X4@E*"I>
M&"3M/JU3E/3:E4YDJHU";(5G?ESIKZI,N4^L\JW'%*6H\Y)^6Q1O^U4__E$=
MJM/S>Z#-"XMN=1>M^I8<Q!KD^*IFUJ-(RX$*CPW79KB#BE0E1U<%-\/EL4;_
M +53_P#E$=INK4ZZ'$*C4*$I%*I?6I:DW!<,L%JB4&%CB2N0]@%J2D]6T''E
M#(VHBY;ZNF8J?<5V5JH5VKRCF"%S*C(5(<;8;).1IO$-LM X(;2E">"1\MFC
M?]JI_P#RB.T56YKFJT"A6_0X3]2J]8J<EN) I\&,C.](DR'2$I2!XR<  20-
MFX=!5,I^DUF2)+%FTI\+8>K$M?J,N\*Q&/(_(2,D9I?&.QT< XX^5_+9HW_:
MJ?\ \HC?E)OB\(LRZ&FE*BV';2V*U>$MW)G:;>IK*PB$A8XI?J#K#9P.52E=
M$FER_P#^#M,H,L2*/8-+EN/,R'6E$QZG=%1"6S/E)Y6P6T,L_P"::2LK<7\M
MJ!#<TYU:4Y%A18RU(AV=D4MAA+2E(S5<' D<,1M^;?5W_@[-_I?;\V^KO_!V
M;_2^Q+>FNK2U_2I7&LYM)/?6FJJ(_:G99HFBEWU!8!ZM-5NFBT9*CS9UQ(\\
MI\23LZFRM(;&MPKS!MRY*S7;N6T", H"G"C)*AR@E.&/*DCAM(A5K56L4*D2
M I"J-8[4:S8G4KX.1W9="2U-?;4."D29;@(X'APV<==<6ZZZM3CKKBE+<<<6
MK,MQQ:L222222<2?_P"7::C1F79$B0XAEAAAM;KSSSJ@AMIIIL%2E*) 2D D
MG@-F9]L>;7J_)@24)<BSZG9M4MN#+:6,R'HDRY41&G4$<BVU%)[NRI,KS9M2
M'6T)"BFF1*96GR",>C%HTI]TGO!!.R(>IFFE_P"GLEQQ333%[V?<-K./+3Q*
M6$UR.QGX#$%&.(XCAVA*$)4M:U)0A"$E2UK4<$I2D<22>  V_,[JG\'MV^L]
MHK%X6E<UJ/SFW'83-RT&JT)V8TRH(><BMU1IHN)05 ** 0"0#R[ZZ7:=N5ZZ
M*FW&<FN4ZW:/4*W.;AM.(:=EKB4UMUP-)6XVE3A3E!4D$XD;?F=U3^#V[?6>
MWYG=4_@]NWUGM^9W5/X/;M]9[?F=U3^#V[?6>WYG=4_@]NWUGM(A38[\.9#?
M>BRXDIER/)BR8[A:?CR&'0%H<0L%*T* ((((!&Y(F6A8UX75$B/B-+E6W;-:
MKD:+)4V'4QY#]+8=2A920H(40<#CAAM^9W5/X/;M]9[?F=U3^#V[?6>WYG=4
M_@]NWUGM^9W5/X/;M]9[/29.D>IT:-&:<?D2'["NIEAAAE!<=>>=<B!*4)2"
MI2E$  8GA\@,QHS+LB1(=0RQ'8;6Z\^\ZH(;:9:;!4I2B0$I2"2> V9GVQYM
M>K\F!)0ER+/J=FU2VX,MI8S(>B3+E1$;=00>"VU%)[NRI,KS9M2'6T)"BFF1
M*96GR",>C%HTI]TGO!!.R8>IFFE_Z>RG'"TTQ>UGW!:SCRT\2EA-<CL9^ Q!
M1CB.(X;T6C6_2:G7:Q.4XB%2J/ E5.I3%M-*?=3%@PD+=<*6T*6H(0<$@D\
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M\W>_#</'V"" 00001B"#P((.SMW672O)=%M8I51N"T41&<L"T[D#@D7/8IR
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M+>>9+IU(AJ1>U"9*05J$FE]=(;80"79,:,D#'>\VOV[S/<M4.QYK/_?-7?\
MD+=[/G#7E4XTUBR;KNVPZ3:;DA+K<6;6K4IM57=TN ES +2$5"F,./(Q!6V6
M\<S2@-O.2?IY0IA%W4:&X4$%/EU.LJET^I@X<XDM.A7?QQWKB]_B^/<G;W8U
MM]]W4GW93?D'S6?>'TQ]R<7;SKO[M>NGZ+ZIOZ)_]RU4_2U6]I7\F?\ O1[.
MD%IV!'FR+QK&HUH-4$P$NF1#F,5MF6:JIQKBTU"0VN6^^<$M--K<40E!(VJ3
M,LH#]1U3T]ATP*("E3D.2Z@X&\>4^3,2#PY@=W3/WO[-]SD;;SC_ &M6U^D"
MD=G2CWRK%]U$7L1_?FL+\5U;<BS&" _$D,RF2H8I#L=P.MD@8<,0.?:R]0K>
M?1)H-\VK;]W4=]M8<2Y3;BI356AG,.<-NI"N<'$$ [7=HI>%1GT.'</L?.I=
MQ4MMJ1/MVX:+-14:/5VHD@I0^A#B.KD1U*1UK*W&TN-+4EU$^1;=EQ=;+3CK
M<5%K^F$MN?5G(V)+ EV/4"S5DR"D8N-0X\IM*NB'U\"7J#>]J7)9U=CX]?1;
MJH=4MZK,8'*>NIU7:9>3Q!'20.T>;K_W+4#]$M?['FH_]MUI_P":M;>\U'^\
MIH7^E"E]C21BE4V?4WF]=(#KC-/AR)CK;0L"NH+BVXR5$)Q(&)&&) V_\3N7
M^8JI_NMO_$[E_F*J?[K;_P 3N7^8JI_NMEM.H6VXVM3;C;B2A;:T'*M"T*P(
M((P(/)N:.^^GI[[K8?8MWW^+']R=P]FVX=0K4DZ+:C5RF6YJ=;TF0X:3!8J3
MZ:?"OR(PHE+,RE+6AYUU"<ST5+T<XE3:F]J#J['B)->T6OBEK>GAM*G$6??[
M[5KU>&I8X@+J9HKB23@,BAABK$=FB:>T>IV;J#85MPF:7;MMZBV\_.5;]*8!
M2S3Z37+<E4R?U38Z++<N0^AM("&TI0 G:J650HFG^D=/K<)^GU2MV!3*[^5[
ML*6V6)<:#7K@J$Q,,.()2'H<9N0C'%M]"L"+^M?2JW]-:K#U%FT^?7)=[T2Y
M*I48SU,@/4^(FEO42KTUMM(2^XHAUIPYL#B!P+JHDJ1%4_'?B/JC/.,*>B2F
MRS*BNEHC,VX@E#B#P4"001M>=Q:44>PZS,OFD4RBUEB_*37JM#:C4F:N=$>@
M-T&ITQ:'<SBTJ4XXL93@$@\=KKO6JL08M4O"Y:[=-2BTQIYBFQI]P51VK3&*
M>S)<><0PAQY26DN.K4$@!2U'$G]0I%>E0IUQ:57RQ!HNIUJ07&TSGH<)];E*
MN>A)?4AHU*F%Y\LMNK2A]IU]A2VRXA]JGZ@Z0WK1;WM:H)0/+*3)!E4Z4IL.
MKI=<I;P1)@3&P1UD28TVZG$$IP()VD0*A$C3H,ME<>7#F,-2HLIAU.5QF1'?
M"D+0H<%)4"".4;5"=2K*CZ+WW(0XN+>&ED2+0X1F*&*'*U9#0329;:E])\ML
M1Y+G'"4@G-M'M_4.(Q6;2KSDE5D:D4)I\VS=4>-@IV,0]BN%4&4*29-/D'.C
M'.TM]@H>7NW?YR-PT_JKAU?G.6S9CC[>#\73NU9ZFI\N.I6"DIJ=8;=#B2"%
M(@1W$G!?8U:N&#,\LM>RJBC2NSE)<#K'L)8;CE-G28;HX*9F5552J#2AP*'Q
MR\ITJK$V9Y7=&G\)>DUX%3G6OBJV*PU"I,F2X>DMV71W*9-=6H8EQY?+AF-Z
M:9WA$$ZV+\MBM6I7(XR]8:?6X"X#[T9:P<CS07UK#H&*'$I6G!20=M0=(KN;
MR7!I]=-6MJ<Z&U-,ST0))3 K$1"\3Y/-CEF9&)Y6G4'GW;O_ +OMZ^[FV.PQ
M<6J&B.D6I%P1:<S1XM=OW3:S+PK,:D1I+LR/2V*G<,*0^B,V](?=0PE80E;C
MB@D*6HGXJ/FU_ 7I?_1>WQ4?-K^ O2_^B]M=KNL/S>]#[)NRD1]/%4FY[1TG
ML*V[BI9FZLT&FS#3JU1H#,E@O1WGF'>J=3G;6M"L4J4#N:Y^^[3O<;$W=,/[
MQ=L_HTNOM\BO2X4ZXM*KY8@T;4ZU8+B$SG8<)];E*NB@I?4AHU*F%Y\LMNJ2
MA]IU]A2VBXA]JG:@Z17K1;WM:HH1A-I,D*DTZ4IL.+IE<I;P3)@3&P1UL28T
MVZG$$HP()VD0*A$C3H,ME<>7#F,-2HLIAU.5QF1'?"D+0H<%)4"".4;5"=2K
M*CZ+7W(0ZY%N_2R)%H<(S%#,ARM60V$TF6VI?3?+3$>2YQPE()S;1[?U#B1Z
MS:=><DJLC4BA-/FV;JCQL%.QR'AGA5!E*DF53Y!SHQSM+>8*'E[GG&US+C['
M6)8]*SX>E]F;@F3,N/?\@Q\78\X#1J\JMY-I9K=*T<M]ER8^40;9U*9T8MV/
M;%9!=.5IJH+<52992$A2EQ'7%!N,>QI5JII4JG4*[*E7:)8VLTU\L,MN6&DG
MR34 ,K4WY3.H["%Q%, ER4TN*VE2$QN-G:6V#3$4>S[&H4*WZ'!3E4YY-$1Z
MK+F/)">ME272Y)EOJ&9UYQQQ6*ED[77J&S(BKOZM(7:.EE)?ZMU4Z]JM&6(M
M1=B+QZR+2VDNU&4% )6EI+!4E;[>.@]=J\Z55*M4U:J2JG4IS[LJ;/J"M:;C
M$R9+DODK<==<"EK6HDJ42>?;5&AY<_LSIU>U*R88Y_9&VI4/+AW\^&]?'G.7
M#3\]&TRB/6/8+K[6+3]]W+3\UQ5&*Y]73:.Z(ZP?_P#9)4.*.&UMZ.4N9UU#
MT,M-MJI--K"FORZOUMBOUHXHZ*NJIK='9P.)0X'D\#F&UTZ)U29UM=T0NIQZ
MD,N.8N&Q+_>?KE-#86<R^HJK=70O+B&T+83PQ3BMIU"'&G$*;<;<2%MN-K&5
M:%H5B""#@0>7;4G3>%#7%LVH3A>^FZLBDL.6)=;SDVE0XZE<5BG/)DTE:SZ9
MR*M7(1N^;7[=YGN6J'8M*'KG:4VZH]CR*S)MM$.Y[EMLPGK@;C-513BK=E12
M]UB8;  =*@G*<N&96/YH*Y\*.IO]+;,5%&A:JJ]&<2ZRS7-0]3:I SI.(#]-
M?K'D[R>ZA]M:3S@[4JU+/H%&M:V*%$1 HMO6]38='HU*A-DE$6GTV AMEI )
M)RH0!B23Q).U[:OZ@3VX-M6519-3?;ZUMN55I^'4TFWZ6ES@N9/DJ:B14<A<
M<3FP2%$7UJ7<JT.7!?\ =UQ7E62V5=2FI7)5G:O+:CA7$-(6\4-)^E2 !P&]
M<7O\7Q[D[>[&MOONZD^[*;\@^:S[P^F/N3B[>==_=KUT_1?5-_1/_N6JGZ6J
MWLMM8Q0M*D*&)&*5#*H8CO;?F@KGPHZF_P!+; G1^MJ ()2=4=3L% 'D.6K
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M@5JB5)" \PYE#K$B.^R5-2([[:D/1I3"UM/-*2XTM2%!1W?-U_[EJ!^B6O\
M8\U'_MNM/_-6MO>:C_>4T+_2A2][6+WT]0O=;,W-'??3T]]UL/L6[[_%C^Y.
MX=S1FY*DXMVHW#I1IW7)[KA*EN3:M:$.?*<65<25+<423MYR\64E"VFM/Q4D
MAPX)$FC5Z%6(:A]<EYA"D]\#]36[NTCU NK3ZX4!#;M0MBKRJ=Y=';7UB856
MB-GJ)L?-Q5&EM.-$\J#M#I^KEAV#K%!CA"7ZK%$C3J[Y@ "5KD3Z,W*I./#$
M!JB-\<<3AAA"HU\OW1H9<$M2&0J^X3,^SERG" EMF\;?4\AEL?32*G%AMIPX
MJ'#&!6:)4H%8H]5B,3Z95J5,CU"FU&#*;#T:; G1%+:>:<00IMQM92H$$$C:
M]]&[TC,&-<E,>70:PXREV5:MVPVE.6Y=-.5Z9+L204E801UK*G6%XMNK2;@M
M.O1C"KML5NJV[6H:CF5$JU%GN4VHQE*'*6WFEH)[VYIUH]::":YJ%=5+MV/(
MZI3S=-BRGL]6K<IM&!+$"(A^;(PXAII9&UG:<VA"%/M>QK:HMJ4&(,I4U2Z%
M3VZ=$ZY:0,[JD-A;KA&*UE2U<23MJ5_[,TENM:K2+/K4'3^$]4J=2&$7348B
MJ?2:D_4*JXRPAN$XZ)JPMQ.=+10DYE)V6XYIC;CCCBE+<<7JA8"UK6LYE+6I
M50Q))XDG;5*U]:+(IM(TMOZBTRM0IT"][3N!5+ONWI7DD9**92)CKR6Y\"4^
MF0\E!Z46,E7#B-M/O.FMVGY8-W,L::ZCN,-8)1<M'B.3++K4I202I<NG-R8"
MUJ(2E,&.@=)SCN7?_=]O7W<VQV*;IQK)<EQTBZ:K:T"\H<:D6A6J]&70JE5)
MM'BOKF4Y"D)67Z?)26R<P !/!0V_\YO?X-;I_P!UM_YS>_P:W3_NMM7]'],[
MKNJI7O>#-DHH<*HV/7Z1#>51-1Z/<E0ZZHS6TM-Y8L-]2<QZ2@$CB1NZY^^[
M3O<;$[&I>D<[02[Z[-TVO:X[*E5F)>E%AQ:H_;M4<ICL^/$>A+6VATME:4*6
M2 <"3M\6^]_Z^T'UAM\6^]_Z^T'UAM:FE]!TFN*PI=N:F4J_7:M5[EIE9C2H
MU.M:KV\JG-QH49E25J54T.APJ( 01AB01V]N[M(]0+JT^N% ;0[/MFK2J<)[
M#:^L3#JT-L]1-CYN)C2VG&B>5!VAT_5RPK!UB@QPA+]5B"1IU=\P !*UR)]&
M;E4G'AB U1&^..)PPP@T6^9%T:&7!+4VR%7W"9GV<N4X0$MLWE;ZGT,MCZ:1
M4XL-M.'%0X8P*S1*E K%'JD1B?3*K2ID>H4VHP938>C38$Z(I;3S3B"%-N-J
M*5 @@D;7OHW><:.8]QTQYR@5AQD.RK5NZ&TIRV[IIRO3)=B2""M*".M94ZPO
M%MU:37[4KT8PJY;%:JMO5F&HA2HE6HLYRFU&,I0Y2V\TM!/>W/.KKBDX^53]
M&Z4TLCTOL?'N:7(2D]_REHGP#L><;+;<4E;%T6S$0X@E"T+I5@4BGI*5#B"D
ML\".YM$I=V5-,C6C25FG6OJ"A]T&;<4#J"U;5_!*CBKV0::6U-4.2:R^K*AM
MUD':1,F2&(D2(P[)E2I+K;$:-&8;+K\B0^Z0E"$)!4M:B  "2<-JE4*!.>7I
M#IN9UHZ60\SB8\^"B2!7+V6PO#!ZLOM(=02A*DQ&XC2TA;:B=(&,<?8RN:HP
M</J>LU-JM2P__48[2(KZ<[$EAV.\CZIIYLMN)\8)&TZG/_O\"9*A/<,/58KZ
MF'.![Z3N0*32XDBH5.J3(M.IT"(TM^5-G37TQHD2,RV"I;CCBDH0E(Q)( VT
MOT=8;C^S-"H3=1O2;'R+34[[KRO9:[)8D)XNMHENKC15J)(CM,HY$@;3)$2&
MY494>+(>C4]IZ/'=G2&F2MF&T_*4AI"G5 (2MQ:4 G%1 !.U]:GW5II;3]Q7
M_==>NZL*3JC8*FFYM>J3E1=C1@NH=%EGK TP@8!#:4I   &U&OB\=.Z/#TRN
M>@5JRM1E0M0[)J3S%'GM)J5(JK%,ASEN.N1*G%AK/5H4YU)?2@8K(.U U]M^
MG]==6AM1+%PJCM9I$W3:ZY34.H+=R#.Y[&U'R.2@'HM,.S'#@,QW?-K]N\SW
M+5#L49_5W4^QM-6;A<G,T)V]KEI5N-U=VF):74&Z<JJ.MAXL!]DNA&.7.G'#
M,-OC3:#_  G6GZZV8EQ'V9464RU(C28[J'X\B.^@.LOL/-$I6A:2%)4DD$$$
M'#;4+56#9=<U#>L&VI]S+L^W'XD:L5>'3$AZH&,_-.1*8[ <E/%*7'.J;7U3
M3KN1I<1=Z.QK4TZH,QV7:6EUO2)"Z#2I"T*835ZQ,?"7*G4^J4IHS'D(0A*E
MIC,1TNN)7O7%[_%\>Y.WNQK;[[NI/NRF_(/FL^\/IC[DXNWG7?W:]=/T7U3?
MT3_[EJI^EJM[%2B$I2"I2B< $@8DDG;XTV@_PG6GZZVK(TBU5L'4I5NB":\F
MR;IH]QKHXJG6BG*J2*6ZX60_U#X:*P KJUX8Y3AM6/-WTJL%^QZ_4;<IM68U
MGN!Z+4'9]!KL92%3].:&TE3+;C,AN1"5/GN.*;>9=2B(E26W]IU6JTZ94ZK5
M)DFHU*I5"2]-GU"H37E29DZ=,DJ4XZ\ZXI3CCCBBI2B5*)))W=+WFE!;;NG=
ME.MJ'(I#EM1E(4/"#MYR"&D*6H6M;[I2D8D-L7W27WE^!*$J4>\.SI(RTA3C
MKNIMA-MMI&*EN+NJ(E"$CG)) '8B)4H N:T6&A /TRA2*NX4C_%23XMYN/I#
MJO7Z-;R7E/O635BQ<MCR%.+ZR24VO7D/QH[CQ_?9$)++YX>J@@$186N&@U!K
MJ,$(E7#IA<$VW9*$IX*>%K7.*@V\M0XD"J,)QY !P$"W;)O]=L7Y42AN'I[J
M/"1:=SS7W,,D2D.J=?IM1?4<<(].J#[V *BV$\>P/.*HE-99U#T4=IS59GQV
MDB57]-:W5D4R?39A0 7#3)LIFH1EK40RT9H )=Q&[YNO_<M0/T2U_L>:C_VW
M6G_FK6WO-1_O*:%_I0I?8M746OV-5K]C73>[%E,TRCUB'17XC[]!G5T3W)$U
MEY*D!,)3>0)!Q4#C@,#\6^]_Z^T'UAM\6^]_Z^T'UAM\6^]_Z^T'UAM>UX,1
M7(+%UW=<ERLPG7$O.PVJ[67JHW%=>0 %J;#H0I0 !(Q &YH[[Z>GONMA]BW?
M?XL?W)W#V;7L>V(3E1N.\+AHUKT& T%*<F5BO5%NETV,D)!/3>=0GDY]K3LV
M"LN0K2MF@VS#<*0@KBT&EM4J.LH')BAH'#FVUP+KR&YMUL6E9=):40#+E5^\
MX"9S*,>=-/;FO>!L_J9;&GEBT67<-WWC6H- M^C0D@O3:C/>#+*5+40AMM&)
M<>><4EMIM*G'%)0E2@Q<E'HW_O98R:9#E5>XM-J;4)U2MR>8B'*K&K5HX.3Q
M%9>ZT-U&.AUA3*4NOF*M992IMQ*D.(4I"T+24K0M)RJ2I*N((/ @]BX57W'K
M42R:CJ-/J.DK-<3);+EOR*1%]G)M!;E<12WJ@'%L%L!I4CRIQ&)6I2MO.BF4
MDMJI\CS@=7G&'&2"R_C?L\/26BG@4NKS.)(Y0<=S43SI[C@8Q;>;>TQTV7(:
MQ2JM5&.U/OBN12O A4>&N)3VG48I4)4MLX*0=[5#1>JB.V]>%MR$6]4)*<44
M:\*8M-6M&L%205!$>H,1UOA&!6SUC>."SM6;;K\"12J[;U5J-#K5+EHZN53:
MM29:X%2@26_I7&7FUMK',0=R[_[OMZ^[FV.Q8?\ =TLS](EV=HUS]]VG>XV)
MV/.F]_C4[W62M]JVM/;,NN^[C?;4\S0+-MZKW/6G66U!+CS=+HK+[Y0DJ2%*
M",!B,3QVAHU5TIU&TV-1*DTXWW95QVHW45(3G6(#M<C,)?RCTW5%6'''D[5:
M^GEB465<-X7C685 M^CPT@O3:C/=#325+60AMI Q<?><4EMIM*W'%)0E2@S<
M='HW_O98R:9#E5:X]-J;4)M2MV<8B5U2-6K1(<GIC,N];U=0CH=84RE+KYBK
M664J0M*D+0I2%H6DI6A:3@I*DGB"#P(/8N!5^1ZU%LFH:C5"H:2,UQ,EM3EO
M2*1%]G)E!;E<12WJ@'5L%L!I4CRIQ&)6I2MO.AF4@MJI\GS@=7W8[C)267PJ
M_I_62&2C@4.+S.)(Y01N:ZUS+A[(ZMTRE9\/3>PUG1IF7'O>7X^/L><]*"LW
M5:MW+3<<<<#1WDT@I\748>+:T=7J!Y3-I,5XT6_+;8=#:+KL2J/-BO4968A'
M7)"&Y<%:^BW*986H%*5)5:^H%DU>-7K2O*ATZXK>J\0DLSJ75(R945W(K!2%
MA*LKK2P%MK"D+2E:2 WYK>GE7ZJ_M5*296H\V"__ !BV=,Y"U,>PBUMG%N37
MUI6RM!.(@H?"T 2F5]BE10K'V'U1U"II'U)=?BU?+_\ JL?'V-7Z'ER>PVJ-
M_P!*R889/8Z[)</+AWLF&Y%U&KM/\JL?S?HL2^)BGFL\25?<QUR+I[3E$C@M
MJ0U(JZ"#P5 "3P7@=VYK(NF U5;9O"@5BV+@ICW[U/HM=I[E,J<-9Y@XRZM.
M(XC'$<=M3-%[CZU<^P;IG4B--=;ZHUBA.99]M5]#8PP14*<]%F(','0#Q!W/
M-K]N\SW+5#L>:S_WS5W_ )"W>P='+KJ?E&HV@3-/H+)DNYI=<TSDA35FU).<
M@K-/#;E(?" <C;,1;BL\@8K;<0EQMQ*D.-K2%H6A8RJ0M*N!!' @[5-NVZ:J
M-I%JD9]YZ9N--E,*DH<D@W)9#:N0*I$EU"6$8DB&]$4I16I>&]<7O\7Q[D[>
M[&MOONZD^[*;N+H.F6G]ZZB5MID2'J18]KUNZZDQ'*LOE+\*A,/N(;QY7%I"
M1SG:-2M4M-K\TXJ4U"W84&^K1KUIR9K+1 <>A,UV.P7D#,G%;84GB./$=L\U
MGWA],?<G%V\Z[^[7KI^B^J;^B?\ W+53]+5;VE?R9_[T>Q:%\5&8\UIW<ZDV
M-JE%25J:-H5N4V%5OJ$XYG:3*0Q4494YU(:=920'E8L2XC[,J+*9:D1I,=U#
MT>1'>0'&7V'FR4K0M)"DJ22"""#AM*NVT:5Y7J]HJS4[LM-,5G//N2VBREV\
M;,2$ K=6\PRF;!;"5*5*CH9;RB0X3N^;O>4.2B4^-,;;M>M+2O.M-R6-#%EW
M$EY)XI4J9 ><"5?2J21B""=1-)KD6XU1-1+.K]HSY3*$N2("*W37(353B(60
M"]%<4B0SB<,Z$X\-JUIEJO;DRC56G2I/L35O)W_8"[J,V\6XER6M4W$A$J&^
MG*H%)SM*)9?0V\AQM.UCZT5^WY],T4TAN2!>4BY*C%=C0+NO"VI:9]M6M;SC
MP"9A;GML2:DIL*::8:4TZI+K[*5[:(Z0-24&K77J+4=0),9M8+S5'LBW9% :
M5)0.*6WY%<!:S>F4PO#'(<-RH6-9LUBV:#;M$DUN\+\J5/D5"C6TVXRXU0(3
MT9AQHO2:C+0&66$.A?5)?D *1'6#*A:LZ>U.-;R))8IVH= :D5S3VM(4YD8<
MA7-&;#;*W>!3$GICR@/3,)X=BEP+?BU*=7IE0AQJ+"HS$J35I55>D);@1Z9'
MA!3RY"W2E+*&@5E> 2,<-M&8VJZY#FIT?2RP6-05S70].5>35K147&:@^DJ"
MY/E8=\H6DE*G,Q2<"-O.B?JI;$5>B][PVB[ER^R51I*Z?1@,WTQF.L!'/FPP
MX[WFZ_\ <M0/T2U_L>:C_P!MUI_YJUM[S4?[RFA?Z4*7V-(??XI_Z/J]VC1W
MWT]/?=;#[%N^_P 6/[D[A[$:GZ6:1:A7T[*6A")5O6K5YE)8"S@EZ?7 T(45
MK'E>DR$('.H;4_7WSB%TB?JM C/"QK!I<EBKTK3Y^='5&EUVMU9@JCS*N&EN
M,1T15.1HH4IU+S[ZFE1=K \UNV*BB4Q8CR=1-2O)W@MIFZZK35PK/H+Z4D97
MX=-D2IKR3B"F<QA@I"AV7ZWIAHGJQJ'18SCC+]8LG3R[;HI3;[7!R,JHT6(\
MSUH_T6?-WMIUO730JQ;5?ICO45*AW!3)M&K%/?RA?4SJ944-O-+P(.5Q .!!
M_4AWSLK@GV_<]_7E[*VY946FU"!61IS;D=TPZQY<J&MQ,6MU(C!]E6#T:%D;
M)0J5):&SM2U+T+THO:KODEVN7!8EN3J^LD8'&O+C^6<>&(#_ ##N#9FKT+S9
M]&V*C&<2]&E3K(H]:7%>0<S;\5-;;D);<2>*5H 4D\00=FV66T-,M(0TTTTA
M+;;3;:<J&VT)P"4I    P VNG4FMSH*[MEPIM&TQM=YQ!F75?$F*4TN.W$QS
M*B1%*3+J3P&#;"%#$N+:0N=5*E)>FU&I3),^?,D++DB7-F/*D2I+[AXJ6XM2
MEJ)Y22>S0K5MRGOU:X;FK-,M^A4N*D+E5*LUF:BG4R!'2<,7'GW$-H&/*1MI
MAHM1>H=%E6S%BUFH1T%"*S=4]2JK=E;&8!6$NHOR7FTJQ*$*0C'!(VO_ %9N
MYWJK>T^M6L7144!Q#;TP4R(IZ-2X:E\#(F/=7%C)^F=<0D<3M+DQ=4[>IT:1
M*D/QZ>QIEIV\Q!8==+C4-EZ93''EH:20A*G7%+(&*E*5B3^=^A_!=IE_1.WY
MWZ'\%VF7]$[:I:::[7%3:[J9;"8-ZVI4HE$HENKJMDR2W1:W ]CJ"Q&8)IDX
MQ7"Z6NL6)P!)2T,-HVL- I_D]F:_P'Z[*4PUEC0M1J"&H5XQB$ A)FMN0JIF
M6<77GY648-G<N_\ N^WK[N;8[%A_W=+,_2)=G:-<_?=IWN-B=AQ]^B4A]YU:
MG'7GJ;"<==<4<5+<<6@E1)XDD[?^/T/^:8'^[V_\?H?\TP/]WM_X_0_YI@?[
MO;4!*0$I3>UUI2E( 2E(KKX  '(!V='ZG;=*@"Z-6[$M75*^;G2PT:O7:C>E
M';N.FT^9- SF/3(LMN%%C@AM&1QP)ZUYY:[GTOU*H$.Y+/NVF/TVIP);3:W&
M2Z@B-4Z:^M*E1YL5S*_$E-X.,NI2X@A21M>ME+EIGJL^[;CM=4Y "43%6_6'
MJ29:$I) #G4YP 3R\O:7?.RK\^W[GOZ\_96W+*BTVH0*R-.+;CO&'6!.5#6X
MF+6ZD1@^RK!Z-"R-'(J5):&SU2U+T+THO6K/DJ>KE?L2W)U?62,#C7EQ_+./
M/@_QX=S9FKT'S9]'&*E&<2]%E3;)H]:7%>0<R'XJ:VW(2VXD\4K0 I)X@@[-
MLLMH:9:0AIIII"6VVFVTY4-MH3@$I2   !@!M=.I%:G0E7=+@S:+IA;#SB%3
M+IOB3%4FEL-Q,<RHD12DRZB[AE;80H8EQ;2%S:G49+TVH5&7)GSYDA9<D2YD
MQY4B5)?<5Q4MQ:E*4H\I).Y=TY2<%5S7V\YR5D<5,QK+MRDH2#W N.YAWR>Q
MYT%3"LR)GG":R.LGE_B__N'44QACWFPD=C4K276(5BN6K1:16;TT5CPF94M]
M-WO8NS]-UO,H=$2'59*TS&)3B4LQG?*UN%1D( O/5C4&I*JMWWU7)=<K$GII
M8:6^0W$IM/96I1:B0V$M1(; 40TRVVV."1V+_@*5BNE><)=B$)^IC3-/[8E-
MGQN%[T.QYT=.",C;7G :NOL(PPRQ9U]SIT5(\#;J,-RR8E8I_D=^ZH)1JE?7
M6M9)D:5<D-I5NT*1G&=!@4I$1IUA1P1)5)( *U;29LV0S$APV'I4N5)=0Q'C
M1H[9>?D2'G"$H0A *EJ40  23AMJ%*T=U!I%M:5FZZLQI_2)&GUCU64U:D.2
M8='ES)U;I[\I3\MEM,M]+KJLCCJD)P0E('YWZ'\%VF7]$[?G?H?P7:9?T3L[
MHQYQ]XTJXHU]VW/.G4Z/:]L6PN!>-OH55WJ2XNWHL1+J)]/1+*2^5D/,,MM
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M.L1^SA\MSRQI/JK"?5 .5;/+CX4\O@Q[@WY,DCA@EA![O'.Y_P"GY;A!&(/
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M$E3GI >XGEV_"A]R?_<[?A0^Y/\ [G;\*'W)_P#<[?A0^Y/_ +G;\*'W)_\
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MIWD?PKOVW;,#Q!X$'GV,F.G&,H]- _S"B>3[$\W<Y.YNF(ZK!J0H=63R(?Y
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M>#BGQ=H0T@8K<6E"1W5*.4#9IA'I6FTH'?P'%1[Y/$[RW75!#:!F4H\@'^'
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M(/U?3<P[S:3\\C8*0CK'1QZYW!2@?K!R)\7'O]M9F)'IO47<!SC%3:CXL0?
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>2\O[!*&_MLVP*8Z%J'TSN+IQ[N"\0/$/_P"M.__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>infu-20211231_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 infu-20211231_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBN'^*G[3'[._P-N8K'XQ?'#PKX9N9U#06FM:[!;S
M2*?XEC=@Q7W Q0!W%%<I\+OCK\%OC?82ZG\'?BSX<\40P8^TOH.LPW1@)Z!Q
M&Q*'V;%=5)(D2-+*X55!+,QP /4T +1110 4444 %%0:KJNF:'IESK>MZC!9
MV5G \]W=W4RQQ01(I9W=V("JH!)).  2:J>$/&7A#X@^';?Q?X"\5Z;K>DW>
M_P"R:II%]'<V\VQV1MDD9*MAU93@\%2.H- &E1110 45YU=_M?\ [)=A=2V-
M]^U%\.H9X9&CFAE\;6"O&X."K RY!!X(-:G@S]H?X ?$?55T+X>?'/P=KU\P
M)6ST7Q-:74IP,G"12,?TH [&BBB@ HHHH **Y'XL?'WX(? BRMM0^-'Q:\/>
M%HKUV2R;7=6BMC<%<;A&'8%\9&< XR,UM>"_&W@_XC^%K+QOX \3V.LZ/J,7
MFV&IZ9=+-!<)DC<CJ2&&01QW!% &I1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD?M)_!7Q+JGA6]\09U"T\1^!KT):WDC,<SF"12%).<^68B3DGDDD P_VEO\
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M+PS^TEX$URQ_9AT/QE<6&N7NCW!B.N74M]<W32S$?.T,32% JC!,$H5O-QL
M/V'_ &6OVL/AW^U]X-NOB+\)] \11:!#=M;6FK:WI/V2+4&4D.UN&8M(JD8+
M8 R=O56"^GUE^"--\':/X.TK2_AY9V%OH,&GPKHT.E*BVRVNP>6(@GR[-N,8
MXQBM2@#\L?\ @D[^Q3^R[^U&OQ@\1?'OX1V?B.]TOXCSVUA/<WEQ$88FW,5
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MNN_\%QOV&M&O/#.GVU]XJU.?Q-;QS)#I>A+*^GAY"B+<+YH(=L;@D8D;:RG
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MMO\ [/O[,'Q#\.?#CXT>)9](G\36%[>66HR6^;2&&UC,DIEDSE3@850K%F(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
MH4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_O
MI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V
M**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$E
MU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (27
M5_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+
MW_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4
M+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^
MEH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:
M/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_
M (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?
M_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU
M?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]
M_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W
M_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -B
MBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^
M$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_
M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
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M (275_\ H4+W_OI:M:5JM[J$CI=:)/:A5R&E(PWMQ0!>HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU_@FG\_T-VBBBO<.@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%OVZ?A1J^V+Q)IFIZ1(?O.\(GB'XH=Q_[XKTCPM\7OA?XTVKX9\=Z9=2/]V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHHHKL- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<9Q?N0ZI[<TK?@OF^B.'*<IG3FJU96:V7ZL****_>#Z0**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'AC1W^*OC&)WUK64+VWVC)>"!CNW'/\ ')U)ZXQZL*\_^'=NW[2_QIN?B?\
M$>9(-"TV4?9K&9LJP4YCMQZ@?><]R<?Q<?30\8>%P,#6H/SK\WR&E4XOSO\
MM_$+_9Z5XX:+Z])56N[M:/;U2;\K#)X[$?69?"M(+\Y?Y&G16;_PF/AC_H-0
M?]]4?\)CX8_Z#4'_ 'U7Z6>L:5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &
ME16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/A
MC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^
M@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4
M:5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^
M&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_
MZ#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &
ME16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/A
MC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^
M@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4
M:5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^
M&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU5C3];TG57:/3K^.9D&6"'H* +5%%%
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M^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\
MGQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH
MA_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'
M_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^S
MM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQ
MA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_
ML[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_O
MT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/
M_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_
M[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[
M3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*
MFHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\
M^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]
M"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_
M /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FH
MH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?
M&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C
M^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\
MGQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH
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M_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\
MY\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ*
M(?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_
M +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L
M[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA
M_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?
M[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[
M]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3
M_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?
M^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.
MT_\ Y\8?^_0I\5M;0$F"W1">I1 ,T^B@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ K%^(7CO0_AMX0O?&/B&;;;VD>1&#\TSGA8U]V.!
M^O0&MHD*"S$  <DU\N?$WQ#K/[6'QHM?ACX-NV7P]I4K--=IRA"G$EP>Q_N(
M.^<\;CCY7BSB">18",</'GQ-9\E*'>3ZO^['=]-E=7./&XIX:E:"O.6D5Y_\
M M_LZ^!-<^.WQ+O/C_\ $B'S+6"[SIUNX^229?NJH/\ RSB&/JV.N&KZ8JCX
M:\.:/X1T"T\,Z!9K!9V4 BMXE[ =SZDGDGN235ZMN%N'X</99[*4N>M-N=6?
M6<WN[]ELO+7=L>#PJPM'E;O)ZM]V%%%%?2'6%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% $=U=6UC:R7M[.D4,,9>661L*B@9)
M)/0 <U\MW\^K?MD?'-;"T>:+PIHA.7&1B'/+>TDI&!W"CI\ISTW[7/Q:U36=
M1@^ 'P\WW%_J$J)JGV<_,=Q&RW![9X9O08!X+5ZE\$/A+I?P=\"V_AFUV27<
MG[W4[M1_KIB.<?[(^ZH]!GJ37YEFLI<;9_\ V12?^QX=IUVMIS6L:2\EO/[M
M&E?R*S>88GV"_AP^+S?2/^9U6G:=8Z180:5IEJD%M;1+%!#&N%1%& H'H *F
MHHK],C&,(J,59(]=))604444P"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\_-]PHHHKVSH"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKS+]I_XWQ_"+P6;/
M1[A?[<U16CT]1R8%Z-,1[9P/5B.H!KSLVS3!Y+EU3&XJ5H05WY]DO-O1+NS*
MO6AAZ3J3V1YW^T]\1M;^+/CJT_9W^&S></M:KJDB-\LDPYV$C^", LWN/]GG
MW'X7_#K1/A7X+M/!NA)E(%W7$Y7#7$I^_(WN3^0 ':O._P!D?X(2> _#C>/_
M !5;,=<UF/<HF&7MK<_,%.>0[<,W?[HX(->R5\GP?E>,Q%:IG^9QMB,0O=C_
M ,^J7V8+S>\O/>SN<6!HU)2>)K?%+9=H]%_F%%%%?>GI!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV5.%.Q2%)4$@D UZM0 4444 17EK'?6KVDS,%D7#%&P?P-9G_"#Z1_S\WO\
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
M\(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D
M?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^
MD?\ /S>_^!;5:TK0++1Y'DM99V+K@^;,6'ZU>HH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)62/5V"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
M"#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\
M_-[_ .!;5L44 8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?
M\_-[_P"!;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO
M_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _
M-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;
M5L44 8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!
M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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M[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
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M59)*R1ZD*<*4%&"LD8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L45TEF/\
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MDKRD^MEY=6[)=7JCZY_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ_//PK_P4O\
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MXHOYN];FG_\ !)_X!08;4?&_BVX([)=VT:G\/()_6C^RN :7Q9C4G_AHM?\
MI3#^UO$&K\.6TX?XJR?_ *2CU34/VS/V6],!-S\;M#;'_/O.TW_H -8>H?\
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M_P"(@82I_ P.*J?X:+_5H^TJ*^+/^&?O^"GOB?\ Y"WQM.G;NO\ Q4K18_\
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M8/\ 5KC"K_'SF7_;M&G'\;L^+?\ AI+_ (*:>)_^03\!/[.W=/\ BE9X<?\
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M+LORZ#AA*,::>ZC%17X)!1117&=@4444 %%%% !1110 4444 %%%% !1110
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M/^&?OVN/&7S>+?BU]DB;[\+:S,?_ !R)=A_.N!_X;D_;PTS_ )#O[*^W'?\
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MN:Z<?QW6M7;?H)0OZ5T7[,W[,W@K]F;P4_ASPY*U[J%ZRR:OJ\T862ZD P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &;X=\'^%O"/VK_A&=!MK'[=<M<7?V>,+YLAZL?\.@K2HHK.E1I4*:A3
MBHQ71*R^Y"C&,59*R"BBBM!A1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%?+W_!3GXS?%+P+HOPU^#/PI\?/X.NOBE\0;7P]J'C.)09=*M7^^82<!
M9GW *V00%;!!(90#Z<M;ZQO6E2SO(IC!*8IQ%(&,;@ E6QT."#@\\BI:_.OX
M%?LK?M0_"WXA^+OB'^R5\?O%VNWGAGXY2Z1XJ\,>.O$XGLO$&EBPL9)KJ8NH
M_P!,S*5\T#<5V8QLPWMG[7OQ>^-OQ$_:K\&?L%_L]?$63P9<ZQX?G\2^.?&%
MG:)/=V.E1R-%'#;!P522252I?JNY".,@@'U117Q]X3\8?'W]BG]L;P/^SW\6
MOCSJWQ&\ _%>UO8?#FK^)X(O[2T;5K5%D,3S1*/-BE#(JY'#.,!0C%_L&@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
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M[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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M?&^M2[V\-V5O'!'"+:W',\[J9 I(V+Y/S;=RL #V?1O$GAWQ&;L>'M?LK_\
ML^]>SO\ [%=)+]FN4QOADVD[)%R,H<$9&1S5"Z^)OPWLKF2RO?B#H<,T+E)8
MI=6A5D8'!4@MD$'C%?)O_!#[1;OPW^SA\0/#M_K=QJ<]A\:=<MIM1NV)ENG2
M*T4RN222S$%CDGDGDUO_ +2/_!/'_@F/X(\,^,OVF?C;\!+9TMUO-<\17_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\A?\
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M+61ACT-RG/;K72?\%#/#_P"RQ_PZ_P#%'D:=X;C\)6WA 2^ GL8XA!'=E ;
MVI'1FD*#Y>64OG(+5]1ZYH6B^)]%N_#GB32;:_T^_MWM[VQO(%EAN(G4JT;H
MP(92"001@@U\_>%?^"4'[!_@[QG:>-=)^"GFMIUZ;O3=)O\ 7+VYTZTGSGS$
MM99FBZY."I4=@,# !Z+^Q]_PG'_#*/PU_P"%EF<Z_P#\(+I7]K_:\^=Y_P!D
MCW>9GGS,_>S_ !9KT:BB@ HHHH **** "BBB@ HHHH *^0O^")__ ":%JW_9
M2M<_]')7U[7(?!/X#?"?]G3PA-X"^#?A3^Q])GU*?4);3[=/<;KF8@R/NG=V
M&2!QG [ 4 ?+O[07[3WQ1_:Z^,VN?L7?LB^.K3PGH>@2_9/BC\6+BX56L225
MDL-.4L"]Q\KJT@(VD, 4P'/L'A;1?V>OV OV0M>@^#R6*Z+X'\.7FK706\2:
M>_N$A+F6=UY>65E5<\#E54!0JCD-1_X(S?\ !-G5]0GU74OV<FFN;J9I;B9_
M&>LEI'8DLQ_TSJ22:V/#O_!*K]AKP7X'\3_#WP+\(KG1M-\8VMM:^(TM/$^H
MR/=P07"SI'NGGDV+O09VX+ E22#B@#+_ &8]1@_8B_X)G:-\3_B)X<UC5[K3
M_#3^*?%EMI%O')?37%[(;NX8K(Z*3'YYW$L,+$>N #=^-O@/]A7]KO\ 9=N_
MVFOB9X.\,3Z3JO@K[;#XXN;.!-2TR 1,Z!+M?WD4D4C$>6&QY@92#D@_1,UA
M87%@VEW%E"]J\)B>V>,&-HR,%"IX*XXQTQ7SC+_P2+_8#F\2-KS?!%EMGO?M
MC: GB"^72S/G._[()O*Q_L;=F.-N.* )?^"2OC/XJ>/OV ? /B;XP7]Y>:K+
M;74=O?:BS-/<V<=U+';R.6Y;]TJ@,>64*V3G)Y"]_P"4YEI_V;B?_3N]?6^F
MZ;IVC:=;Z/H]A!:6EI"D-K:VT0CCAC4!51%4 *H   '  KEW^ OPGD^.:?M)
MOX4SXUC\-_V"FM?;I^-/\XS>3Y._R?\ 6$MOV;^V['% 'BOQG_XO'_P4F^%?
MPF0>9IWPU\+:EXXUJ,\HUU.?[/L5;T="9Y0.N!GIU^F:Y+PQ\$O 'A+XM^*/
MC?I-A.?$7B^UL;;5[N>Y9U\FT1DACB0\1+\[,P7[S')Z"NMH ^0O^"-?_)&_
MBI_V7KQ%_P"@VM5?^"K4MU\8?&'P3_8<L[F1+7XF^/!=>)EA<AGTG3@DT\9
M['>''^U /2OICX-? ;X3_L_:-JOA_P"$7A3^R+/6]>N=:U.'[=/<>=?3[1++
MF9W*[MB_*I"C' '-,\2_ #X1^,/C'X;^/_B3PE]I\7>$;6YMO#NK&_G7[''<
M1M',!$L@B<LCL,NC$9X(XH ZZSL[33K2+3["UC@@@C6."&) J1HHP%4#@
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M001D$\@YH ^9_P#@C+_RC3^&7_7#5/\ T[7E>;_$[X[>/?\ @I1\1==_9T^
M/Q&A\%_!S0KYM.^('Q&2\C2\\02#_6Z?INX\1D'#S="K9.4(2;ZW^%WP%^%/
MP6^$%K\!OAEX8;2O"EE;7%O:Z8FHW$C1QSR222@322-+DO*YSOR-W!&!CPG_
M (<J_P#!,S_HVK_R\M9_^3* -_XY>(/A-^Q#_P $_/%L7P"M[&PT_P )^%9;
M/P]:Z9<"5DOKD^1;LQ!+/(]Q,K,Q.YB6.<FG6_B[PA_P3*_X)_\ AJ_\:>$-
M9U/3O _A[3K/6X/#MO%+,+B4HDTY$DB+L-Q(S,<Y&_H:L^#_ /@F3^Q?\.O"
M<_@;X??"J?2-)O/$>FZWJ-E#XAOIUO+JP=I+82?:)I"8U9R2@P&XSG KW#Q!
MX?T+Q7H=YX8\3Z/:ZCINH6SV]_87L"RPW$+J5>-T8$,I!(((P0: /EW_ (*#
M_!_]B_XC?LD>-/VGO$'A[PO#J<WA4ZOX<^(^G6\4.HRWB6P_L]H[Q )9-S+!
M&L98AAA<>GJ?[!GBCXE>-OV-?AMXL^+\UQ+XBO\ PG:S:A<7@/G3@K^[EDSR
M7>/8[$\DL2:XC0/^"27[!'A[Q/;>)+;X*/<Q65W]JL=$U'Q!?76FV\V22RVL
MLS1$9)^5E*\]*^D41(T$<:!54855& !Z4 ?(?P&_Y3'_ !V_[)_X?_\ 1,-=
M*I_X71_P519O]=I?P3^&P'_7#6M:DS_Z10?7Y_3K[3H/P&^$_ACXR:]^T!H?
MA3R/%WB;3[>QUO5OMT[?:8( HB3RF<Q)M"CE$4G')-.^'?P2\ ?"_P 7>+O'
M7A6PG75?&^KIJ/B&[N;II6FE2)88U7=]Q$10%4<#GUH Z?4O^0=<?]<'_D:^
M3O\ @AU_RC?\&?\ 82U?_P!.$]?6LL:31M#(N592&&>H-<G\#O@3\*OV;OAO
M9?"/X+>%O[%\/:?)-)9Z?]NGN?+:61I'/F3N[G+LQY8XS@8'% 'R;\+_ -F/
MX2?'+XE_$+XJ_L2_M=^/_A?%)XNNK#XE>%-)@BCB75(S^^E2&X7-LS%FQ)AA
MD-MP%VBO_P $EOACX'TO]H?]H/XH_"*>\O/!4OB#3?#^@:W>WS74FKW-E _V
M^[:=O]>TL\BRF0<,9B1@8%>W_&7_ ()H_L;_ !W\?WOQ.\=_"Z9-9U50NMW.
MC:[>:>NJ*!C%PEO*BR$C@L1N/<FO7?AO\-/ /P?\$Z?\./AAX3LM#T/2X?*L
M--T^$)'$N22?4L22Q8Y+$DDDDF@#<HHHH **** "BBB@ HHHH **** /D+XM
M?\II?A1_V2+5?_1L]>F?MP_MI:)^R+X.TJST?PVWB3QWXOO?[.\#>$X9@AOK
MD[09)7)_=P1ETWM_M*,C)9?0M7^ WPGUWXTZ3^T/JOA3S?&.AZ1+I>EZQ]NG
M7R+24L7C\H.(FR6;YF0L,\$5QG[1W[ O[)G[6_B:P\8?M"?"MO$.H:98?8["
M8^(-0M5BAWLY4);3QH268DL06/ S@   \[_8_P#V7X/"/Q!N?VK?VKOBWHWC
M'XR:];^3]H@OHS8^&[9L@6&GQY^4 ,5:0#+98#[SM)=^&/\ Q>3_ (*<_$/X
MA-^\TWX4^"-/\)Z83S&;^^8WUW(O^VD:P1-Z X]:3P__ ,$<_P#@G#X6UZQ\
M3Z#^SIY%]IUY%=64_P#PEVL-Y<L;AT;:UV0<, <$$'N*]M^%'P2\ ?!B7Q+<
M>![">.;Q=XINO$&NSW5TTKSWUP$#L"WW4 10J#Y5 P!0!P7AKXZ?L\?M:_$O
MXB?LF>-OANE[?^ M0MUUKP[XUTFUF@U%&^>*[@A9I!+""$8.R@C?&2!N%>#?
MLOZ)X7^#O_!6CX@? S]F61;;X>'X>1:GXN\-Z;*3INCZZ;B-56) =D,C1$$Q
MKC[[C&(P%^@OVA/V#?V7OVGO$MIXY^*WP\=_$%E!Y%OX@T?5+C3[WRN?W;2V
M[H9%&3@/NQDXQDUT?[/G[,'P)_99\*3>#?@3\/+30K2ZG\Z_D222:XO)?[\T
M\K-)*1DXW,0N3@ &@#P__@MM_P HU?B!_P!?&C_^G6TKNOVU_BW>_!/]@WQ9
MXXT9G_M5_"<>FZ(L7^L:^O%2TM]@ZEA),K8']TUZ3\;O@?\ "_\ :,^&FH?!
M_P",OAC^V?#NJ-"U_IWVV>W\TQ2I-'^\@=)%Q)&C<,,XP<@D5#\4_@1\.?C)
MHF@>&_'6FSSV'AOQ%8ZUIUI%=NB-<VC%H!)@_O8PV"4;(8J,YQ0!Q%CK_P +
M?^"=G[$FCS?$?4Q:Z+X \)V=I=O;J&DO+E8U0K$N1OEFF)P,@9?)( )'@_P:
M^%WBS]NSQ_HO[6?[<VM:5I7A?39EO_AI\&QJ<;0V8/,=]J62/.G*X(C(XSA@
MHW1GZD_:'_9F^"7[5O@:#X;?'OP:VNZ);ZE'?Q6*ZI=6@^T(DB*Y:VEC9@%D
M?Y22N2#C(!'BO_#E7_@F9_T;5_Y>6L__ "90!SO[?.I:7\.OVV_V7?VE-9U&
M&+PS9^(=7T'4M6>4"WMY-0M%BMF:3[JJW[TEB< (3TIW_!96ZL_&WPA^'_[-
MVBW*3^(_B#\4-)M-,TV-@96@C=FFN-O41H3&&;H-XSWKZ(U+]E[X!ZU\!K?]
MF/6_AM9WW@6TTV*PMM!O999EB@B \L+*[F4.N 1)OW@C(;/-<A\!/^"=_P"R
M7^S9XV7XD_#+X;2C7XK4VMEJVLZS=:A-90$$&. W$CB$8)7*@,0Q&<$B@#VV
MBBB@ HHHH **** "BBB@ HHHH \J_;L_Y,C^,/\ V2[7_P#TW3UC_P#!/6^L
MM+_8"^%.IZE=Q6]M;_#S3Y;B>:0*D:+;J69F/   ))/0"O6/'?@CPO\ $SP1
MK'PY\;Z9]MT;7]+N-.U:S\YX_/MIXVCECWQLKKN1F&Y2&&<@@\UB6GP&^%-A
M\#?^&;K/PNT7@O\ X1UM"_L=-1N ?[/:(PF'SO,\[F,E=V_=S][/- 'QWK'Q
M&\7?\%9O%5]X2T+QR/ _[.FD:FUMJFI"^6WU3QY+$WS11!B#!9Y')(RW?+96
M+UK]NO6_"OP;_8"U;X3?L^VNG6C:]#9^!?!VF:3(OEI-J$B6HB4J20PADE?/
M+$KDY)S5/_ARK_P3,_Z-J_\ +RUG_P"3*[CP#_P3L_9(^%>C:#X:^''PVGTG
M3/#GC5/%NG:>FNWEQ&=72 0)<O\ :)9&8K& %7.T$9QG)H E^,/QP^$__!.W
M]G[P:GBK0=8G\+Z==:7X5BN]*MHG338_*\J.YN=\B[(5$6&9=QW,H"G->*_\
M%9/@O^ROX8_93\2_M+Z9X>T#PSX\M[BWU'PGXY\.Q16>J7FIO*ACVW$.V2Y+
MJ6SDMA<N,;=P^O/'G@+P9\4/!^H> /B'X8LM9T75;<P:AIFH0"2*=#S@J?0@
M$'J" 000#7AWPZ_X)5_L-_#'QGI_CG0/A!+=W>CS^=H=OK>OWM_:Z<^0088+
MB5XP00""02" 001F@#USX#:KXWUWX&^#-;^)MNT/B2\\)Z=/X@B>/8R7SVT;
M3J5_A(D+C':OF[]@+_D^W]K7_L<-"_\ 2:ZKZ]KD/ 'P&^$_PN\=^+?B9X%\
M*?8=;\=7D%UXJO?MT\OVZ:%62-MDCLD6%=AB-5!SR#Q0!XM\$_\ B\?_  4B
M^*_Q<?\ >:=\./#.F^!M$E'*-<S'^T+\CT=&:",GK@8Z5RW[47[6WQ3^-'QK
MU']AG]C/Q/8:'JNGPJ/B1\3]0G40>&(7ZP6P)'FWA&0,'Y#D##*[Q?2GPB^"
M7@#X(VFO6O@*PGB/B;Q/>>(-:FN;III+F_NF4RR%FZ [5 4< * *\6\6_P#!
M(#_@G9X[\5ZGXW\6?L^->ZKK.H37VIWC^,-85I[B5S))(0MV "S,3@ #G@4
M>@?LC?L]_ G]ESX9Q?";X+ZA;WC;VO-:U26]2>]U2Z; DNKAU.68G _NJ,
M"O&/^"Y__*.;Q5_V&-)_]+8J]7_9S_X)\?LA?LF>,[OX@_L_?"/^P-8OM+?3
MKJ[_ +?U"[WVS21RM'LN9Y%&7BC.0 ?EQG!(/;_'3X#?"?\ :4^'-W\)?C7X
M4_MKP]?312W6G_;I[;>\3B1#YD#HXPR@\,,XYR* .OHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN^*G[3W_  GGV[_A9D&D1_V'_9?E?V;]AMA!GSO-;SM^-WW$V]/FZT >/_\
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M9@2.2!QT K@/V:_V(OBQ\=O$-K=:QH%[H?AE9%:^U>^@,1DCSRL"N,R,1P&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '%_"7]G3X$_ >;4[KX-_";0O#<VLS^;JL^DZ
M>D4ETV21O8#) +,0N<#<< 9-=I110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
/!1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248727256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 07, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INFUSYSTEM HOLDINGS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-3341405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3851 West Hamlin Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rochester Hills<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">48309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">291-1210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INFU<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370,281,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,547,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s definitive proxy statement to be filed with the Securities and Exchange Commission in connection with the solicitation of proxies for its 2022 Annual Meeting of Stockholders are incorporated by reference in Part III of this Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001337013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246486456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">BDO USA, LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Troy, Michigan<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248320696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">$ 9,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">15,405<span></span>
</td>
<td class="nump">14,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">3,939<span></span>
</td>
<td class="nump">3,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">2,535<span></span>
</td>
<td class="nump">2,402<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">22,065<span></span>
</td>
<td class="nump">29,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentHeldForSaleOrRental', window );">Medical equipment for sale or rental</a></td>
<td class="nump">1,742<span></span>
</td>
<td class="nump">1,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation', window );">Medical equipment in rental service, net of accumulated depreciation</a></td>
<td class="nump">39,871<span></span>
</td>
<td class="nump">35,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property &amp; equipment, net of accumulated depreciation</a></td>
<td class="nump">4,523<span></span>
</td>
<td class="nump">4,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,710<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">10,930<span></span>
</td>
<td class="nump">11,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets</a></td>
<td class="nump">4,241<span></span>
</td>
<td class="nump">4,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">10,033<span></span>
</td>
<td class="nump">9,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">471<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">97,586<span></span>
</td>
<td class="nump">96,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,862<span></span>
</td>
<td class="nump">6,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">9,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">4,685<span></span>
</td>
<td class="nump">6,795<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">12,896<span></span>
</td>
<td class="nump">22,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">32,748<span></span>
</td>
<td class="nump">29,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">3,670<span></span>
</td>
<td class="nump">3,864<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">49,314<span></span>
</td>
<td class="nump">56,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value: authorized 200,000,000 shares; issued and outstanding 20,699,546 and 20,699,546, as of December&#160;31, 2021, respectively, and issued and outstanding 23,816,193 and 20,297,704, as of December&#160;31, 2020, respectively.</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">101,905<span></span>
</td>
<td class="nump">84,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained deficit</a></td>
<td class="num">(53,903)<span></span>
</td>
<td class="num">(44,035)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">48,272<span></span>
</td>
<td class="nump">40,752<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 97,586<span></span>
</td>
<td class="nump">$ 96,991<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentHeldForSaleOrRental">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents medical equipment held for sale or rental as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentHeldForSaleOrRental</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents medical equipment in rental service, net of accumulated depreciation, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502249677320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock,, authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">20,699,546<span></span>
</td>
<td class="nump">23,816,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">20,699,546<span></span>
</td>
<td class="nump">20,297,704<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248373784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Operations and Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">$ 102,382<span></span>
</td>
<td class="nump">$ 97,388<span></span>
</td>
<td class="nump">$ 81,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="nump">42,185<span></span>
</td>
<td class="nump">38,629<span></span>
</td>
<td class="nump">34,233<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">60,197<span></span>
</td>
<td class="nump">58,759<span></span>
</td>
<td class="nump">46,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">791<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">4,262<span></span>
</td>
<td class="nump">4,285<span></span>
</td>
<td class="nump">4,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">10,777<span></span>
</td>
<td class="nump">9,661<span></span>
</td>
<td class="nump">9,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">42,261<span></span>
</td>
<td class="nump">35,195<span></span>
</td>
<td class="nump">28,986<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total selling, general and administrative</a></td>
<td class="nump">57,377<span></span>
</td>
<td class="nump">49,932<span></span>
</td>
<td class="nump">43,357<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">2,820<span></span>
</td>
<td class="nump">8,827<span></span>
</td>
<td class="nump">3,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,377)<span></span>
</td>
<td class="num">(1,255)<span></span>
</td>
<td class="num">(1,904)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">1,257<span></span>
</td>
<td class="nump">7,543<span></span>
</td>
<td class="nump">1,524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from (provision for) income taxes</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">9,789<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,420<span></span>
</td>
<td class="nump">$ 17,332<span></span>
</td>
<td class="nump">$ 1,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">20,519,958<span></span>
</td>
<td class="nump">20,106,940<span></span>
</td>
<td class="nump">19,731,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">22,049,659<span></span>
</td>
<td class="nump">21,717,216<span></span>
</td>
<td class="nump">20,839,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,420<span></span>
</td>
<td class="nump">$ 17,332<span></span>
</td>
<td class="nump">$ 1,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent', window );">Unrealized gain on hedges</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent', window );">Provision for income tax on unrealized hedge gain</a></td>
<td class="num">(87)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net comprehensive income</a></td>
<td class="nump">$ 1,688<span></span>
</td>
<td class="nump">$ 17,332<span></span>
</td>
<td class="nump">$ 1,361<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242027944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid in Capital</div></th>
<th class="th"><div>Retained Deficit</div></th>
<th class="th"><div>Other Comprehensive Income</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,096,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,518,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2018</a></td>
<td class="nump">$ 20,441<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 83,167<span></span>
</td>
<td class="num">$ (62,728)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Stock-based shares issued upon vesting - gross (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Stock-based shares issued upon vesting - gross</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="nump">33,742<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Employee stock purchase plan</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation (in shares)</a></td>
<td class="num">(121,607)<span></span>
</td>
<td class="num">(122,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</a></td>
<td class="num">$ (717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">1,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,401,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,518,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2019</a></td>
<td class="nump">22,334<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">83,699<span></span>
</td>
<td class="num">(61,367)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Stock-based shares issued upon vesting - gross (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Stock-based shares issued upon vesting - gross</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="nump">30,012<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Employee stock purchase plan</a></td>
<td class="nump">$ 190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation (in shares)</a></td>
<td class="num">(146,763)<span></span>
</td>
<td class="num">(147,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</a></td>
<td class="num">$ (1,714)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,714)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock - issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">17,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,816,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,518,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2020</a></td>
<td class="nump">40,752<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">84,785<span></span>
</td>
<td class="num">(44,035)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Stock-based shares issued upon vesting - gross (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Stock-based shares issued upon vesting - gross</a></td>
<td class="nump">812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 6,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="nump">31,624<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Employee stock purchase plan</a></td>
<td class="nump">$ 348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation (in shares)</a></td>
<td class="num">(57,067)<span></span>
</td>
<td class="num">(59,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</a></td>
<td class="num">$ (1,172)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,172)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury stock (in shares)</a></td>
<td class="num">(3,500,000)<span></span>
</td>
<td class="num">(3,518,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,518,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,728<span></span>
</td>
<td class="num">(10,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common stock repurchased as part of share repurchase program (in shares)</a></td>
<td class="num">(33,469)<span></span>
</td>
<td class="num">(33,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock repurchased as part of share repurchase program</a></td>
<td class="num">$ (560)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(560)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">1,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2021</a></td>
<td class="nump">$ 48,272<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 101,905<span></span>
</td>
<td class="num">$ (53,903)<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502249512584">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,420<span></span>
</td>
<td class="nump">$ 17,332<span></span>
</td>
<td class="nump">$ 1,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77<span></span>
</td>
<td class="nump">791<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,363<span></span>
</td>
<td class="nump">9,740<span></span>
</td>
<td class="nump">7,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on disposal of and reserve adjustments for medical equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,029<span></span>
</td>
<td class="nump">418<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Gain on sale of medical equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,545)<span></span>
</td>
<td class="num">(3,577)<span></span>
</td>
<td class="num">(1,453)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,262<span></span>
</td>
<td class="nump">4,285<span></span>
</td>
<td class="nump">4,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred debt issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">151<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,404<span></span>
</td>
<td class="nump">2,610<span></span>
</td>
<td class="nump">997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(153)<span></span>
</td>
<td class="num">(10,071)<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets - decrease/(increase):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">829<span></span>
</td>
<td class="num">(2,631)<span></span>
</td>
<td class="num">(1,560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(864)<span></span>
</td>
<td class="num">(102)<span></span>
</td>
<td class="num">(645)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(133)<span></span>
</td>
<td class="num">(740)<span></span>
</td>
<td class="num">(290)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(161)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Changes in liabilities - (decrease)/increase:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,363)<span></span>
</td>
<td class="nump">2,394<span></span>
</td>
<td class="nump">2,436<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY OPERATING ACTIVITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,316<span></span>
</td>
<td class="nump">20,280<span></span>
</td>
<td class="nump">13,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisitions of businesses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,976)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireMedicalEquipment', window );">Purchase of medical equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(15,676)<span></span>
</td>
<td class="num">(15,820)<span></span>
</td>
<td class="num">(19,669)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(980)<span></span>
</td>
<td class="num">(1,094)<span></span>
</td>
<td class="num">(2,926)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from sale of medical equipment, property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,317<span></span>
</td>
<td class="nump">4,752<span></span>
</td>
<td class="nump">2,952<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(21,315)<span></span>
</td>
<td class="num">(12,162)<span></span>
</td>
<td class="num">(19,643)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(81,660)<span></span>
</td>
<td class="num">(37,180)<span></span>
</td>
<td class="num">(4,868)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Cash proceeds from long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">76,191<span></span>
</td>
<td class="nump">37,587<span></span>
</td>
<td class="nump">9,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(386)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,172)<span></span>
</td>
<td class="num">(1,714)<span></span>
</td>
<td class="num">(717)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchased as part of share repurchase program</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(560)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Cash proceeds from stock plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,124<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,463)<span></span>
</td>
<td class="num">(1,117)<span></span>
</td>
<td class="nump">4,097<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,462)<span></span>
</td>
<td class="nump">7,001<span></span>
</td>
<td class="num">(1,671)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,648<span></span>
</td>
<td class="nump">2,647<span></span>
</td>
<td class="nump">4,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents, end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">186<span></span>
</td>
<td class="nump">9,648<span></span>
</td>
<td class="nump">2,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURES</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,113<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">1,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">171<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>NON-CASH TRANSACTIONS</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Additions to medical equipment and property</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,590<span></span>
</td>
<td class="nump">793<span></span>
</td>
<td class="nump">2,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration', window );">Additions to contingent consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">750<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_NoncashActivitiesProceedsFromStockPlans', window );">Additions to cash proceeds from stock plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts consist of current liabilities for medical equipment and property that have not been included in investing activities. These amounts have not been paid for as of December 31, 2021, 2020 and 2019, respectively, but will be included as a cash outflow from investing activities for purchases of medical equipment and property when paid.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amount consists of current liabilities for contingent consideration that have not been included in financing activities. These amounts have not been paid for as of December 31, 2021, but will be included as a cash outflow from financing activities for contingent consideration when paid.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Amount consists of receivables for cash proceeds from stock plans that have not been included in financing activities. These amounts have not been received as of December 31, 2021, but will be included as a cash inflow from financing activities for cash proceeds from stock plans when received.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_NoncashActivitiesProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Activities, Proceeds from Stock Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_NoncashActivitiesProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash or Part Noncash Acquisition, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_PaymentsToAcquireMedicalEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cash paid during the period to acquire medical equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_PaymentsToAcquireMedicalEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246285912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Nature of Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation and Nature of Operations</a></td>
<td class="text">Basis of Presentation and Nature of Operations<div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InfuSystem Holdings, Inc. and its consolidated subsidiaries (the &#8220;Company&#8221;) are a leading national provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from seven locations in the United States and Canada. The Company provides products and services to hospitals, oncology practices and facilities and other alternate site health care providers. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support, and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada. InfuSystem Inc. (&#8220;ISI&#8221;) and First Biomedical, Inc. ("First Biomedical") are both operating subsidiaries of the Company.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s core service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics to be utilized in the treatment of a variety of cancers including colorectal cancer, pain management and other disease states. The majority of the Company&#8217;s pumps are electronic infusion pumps. Smiths Medical, Inc. and Moog Medical Devices Group each supplied more than 10% of the ambulatory pumps purchased by the Company in 2021. The Company has a supply agreement in place with each of these suppliers. Certain &#8220;spot&#8221; purchases are made on the open market subject to individual negotiation. The Company also supplies Negative Pressure Wound Therapy (&#8220;NPWT&#8221;) medical equipment, as well as related disposables and ancillary supplies. Cardinal Health, Inc. supplied more than 10% of the NPWT medical equipment purchased by the Company in 2021. The Company has a supply agreement in place with Cardinal Health, Inc.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company sells or rents new and pre-owned pole-mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. The Company also provides these products and services to customers in the hospital market.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases new and pre-owned pole-mounted and ambulatory infusion pumps from a variety of sources on a non-exclusive basis. The Company repairs, refurbishes and provides biomedical certification for the devices as needed. The pumps are then available for sale, rental or to be used within the Company&#8217;s ambulatory infusion pump management service.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246360200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and all wholly owned organizations. All intercompany transactions and account balances have been eliminated in consolidation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in two reportable segments, Integrated Therapy Services (&#8220;ITS&#8221;) and Durable Medical Equipment Services (&#8220;DME Services&#8221;) based on management's view of its business for purpose of evaluating performance and making operating decisions. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s approach is to make operational decisions and assess performance based on delivering products and services that together provide solutions to its customer base utilizing a functional management structure. Based upon this business model, the Company&#8217;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker, reviews segment financial information. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e717b65c1e3405d850ef6e342b20071_1859" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for segment disclosures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates, assumptions and judgments that affect the amounts reported in the financial statements, including the notes thereto. The Company considers critical accounting policies to be those that require more significant judgments and estimates in the preparation of its consolidated financial statements, including the following: revenue recognition, leases, accounts receivable and allowance for doubtful accounts, income taxes, equity compensation valuations, and long-lived asset valuations. Management relies on </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">historical experience and other assumptions believed to be reasonable in making its judgments and estimates. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for all business combinations using the acquisition method of accounting, which allocates the fair value of the purchase consideration to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions. The Company may utilize third-party valuation specialists to assist the Company in the allocation. For intangible assets, the Company typically uses the income approach to determine their estimated fair values.  Key estimates and assumptions in that approach include the amount and timing of projected future cash flow, the discount rate selected to measure the risks inherent in those cash flows and the assessment of the asset's useful life.  Initial purchase price allocations are subject to revision within the measurement period, not to exceed one year from the date of acquisition. Acquisition-related expenses and transaction costs associated with business combinations are expensed as incurred.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company maintains substantially all of its cash and cash equivalents primarily with two financial institutions that are insured with the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). At times throughout the year, cash and cash equivalents balances might exceed FDIC insurance limits. Accounts at banks with an aggregate excess of the amount of outstanding checks over the cash balances are included in accounts payable in current liabilities in the consolidated balance sheet.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts billed that have not yet been collected that also meet the conditions for unconditional right to payment are presented as accounts receivable. Accounts receivable related to rental service and delivery of products are reported at their estimated transaction prices, inclusive of adjustments for variable consideration, based on the amounts expected to be collected from payers. The Company writes off accounts receivable once collection efforts have been exhausted and an account is deemed to be uncollectible. An allowance for doubtful accounts is established as a result of an adverse change in the Company&#8217;s payers&#8217; ability to pay outstanding billings. The allowance for doubtful accounts was $1.1 million and $1.0 million as of December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s inventories consist of disposable medical supplies, replacement parts and other supplies used in conjunction with medical equipment and are stated at the lower of cost (first-in, first-out basis) or net realizable value. Cost primarily represents the purchase price paid for the items on hand. The Company periodically performs an analysis of slow-moving inventory and records an adjustment to reflect the recoverable amount.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Equipment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment (&#8220;Equipment&#8221;) consists of equipment that the Company purchases from third-parties and is (1) for sale or rent, and (2) used in service to generate rental revenue. Equipment, once placed into service, is depreciated using the straight-line method over the estimated useful lives of the equipment which is typically seven years. The Company does not depreciate Equipment held for sale or rent. When Equipment in rental service assets are sold, or otherwise disposed, the cost and related accumulated depreciation are removed from the accounts and a gain or loss is recorded in the current period. The Company periodically performs an analysis to identify potentially missing  Equipment and records a reserve equal to the underlying net book value, which was $1.1 million and $0.9 million as of December&#160;31, 2021 and 2020, respectively. The Company performs a similar analysis of slow-moving Equipment for sale or rent and records a reserve, which was less than $0.1 million as of both December&#160;31, 2021 and 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation of Medical Equipment in the Consolidated Statements</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases medical equipment directly for sale as well as medical equipment that is purchased for either rental or sale and that is unallocated at the time of purchase (&#8220;Unallocated Assets&#8221;). Management believes that the predominant source of revenues and cash flows from the Unallocated Assets is from rentals and most equipment purchased is likely to be rented prior to being sold. The Company concluded that (i) the assets specifically supporting its two primary revenue streams should be separately disclosed on the balance sheet; (ii) the purchase and sale of Unallocated Assets should be classified solely </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in investing cash flows based on their predominant source while medical equipment purchased specifically for sales activity should be classified in operating cash flows; and (iii) other activities ancillary to the rental process should be consistently classified.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at acquired cost and depreciated using the straight-line method over the estimated useful lives of the related assets, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY3ODU_89ea2bad-0ac3-4d89-9bff-0b3592eb4de5">three</span> to seven years. Externally purchased information technology software and hardware are depreciated over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY4ODI_16fecb86-c446-4994-8930-6e54f72298e6">three</span> and five years, respectively. Leasehold improvements are amortized using the straight-line method over the life of the asset or the remaining term of the lease, whichever is shorter. Maintenance and minor repairs are charged to operations as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is recorded in the current period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually or when events occur or circumstances change that trigger a review. Management has the option to first assess qualitative factors such as current performance and overall economic conditions to determine whether or not it is necessary to perform a quantitative goodwill impairment test. If the Company chooses that option, then the Company would not be required to perform a quantitative goodwill impairment test unless the Company determines that, based on a qualitative assessment, it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company determines that an impairment is more likely than not, or if the Company chooses not to perform a qualitative assessment, the Company will then proceed with the quantitative assessment. Under the quantitative test, if the fair value of a reporting unit exceeds its carrying amount, then goodwill of the reporting unit is considered to not be impaired. If the carrying amount of the reporting unit exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess, up to the value of the goodwill. The Company performed its annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that there was no impairment. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of trade names, physician and customer relationships, unpatented technology, non-competition agreements and software. The Company amortizes the value assigned to the physician and customer relationships on a straight-line basis over the period of expected benefit, which ranges from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzc2NzA_787bbc1d-efca-48b5-9bc6-20acf41ccb09">fifteen</span> to twenty years. The acquired physician and customer relationship base represents a valuable asset of the Company due to the expectation of future business opportunities to be leveraged from the existing relationship with each physician and customer. The Company has long-standing relationships with numerous oncology clinics, physicians, home care and home infusion providers, skilled nursing facilities, pain centers and others. The useful lives of these relationships are based on the expected attrition rates. Acquired software is amortized on a straight-line basis over the period of expected benefit, which ranges from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzgzMTA_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1">three</span> to five years. Acquired unpatented technology arose from recent acquisitions and is amortized on a straight-line basis over the period of expected benefit, which is seven years. This asset represents acquired knowledge of repair solutions that will be leveraged into opportunities into the acute care market. The non-competition agreements arose from recent acquisitions and are amortized on a straight-line basis over the terms of the agreements, which is five years. Trade names associated with the original acquisition of InfuSystem are not amortized.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management tests indefinite life trade names for impairment annually or more frequently if deemed necessary. Management has the option of first performing the impairment test for intangible assets with indefinite lives on a qualitative basis, by evaluating factors to determine whether it is more likely than not that an impairment exists. If it is more likely than not that an impairment exists, then a quantitative impairment test is performed. Impairment exists when the carrying amount of the intangible asset exceeds its fair value. If the carrying value of the intangible assets exceeds the fair value, an impairment loss is recognized in an amount equal to that excess. The Company performed its annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that the fair value of the trade names with indefinite lives was greater than their carrying value, resulting in no impairment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software Capitalization and Depreciation</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software project, external direct costs of materials and services and interest costs while developing the software. Capitalized software costs are included in intangible assets, net and are amortized using the straight-line method over the estimated useful life of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzODg_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1">three</span> to five years. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs, are </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expensed in the period in which they are incurred. The Company capitalized $0.3 million of internal-use software for the year ended December&#160;31, 2021 and did not capitalize any internal-use software for the year ended  December&#160;31, 2020. Amortization expense for capitalized software was $1.6 million in 2021, $1.9 million in 2020 and $2.0 million in 2019.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses impairment indicators related to its internally-developed, internal-use software, specifically looking at the effectiveness and useful lives of each project and sub-project to determine if impairment indicators are present. For the year ended December&#160;31, 2021, the Company assessed the impairment indicators and found none to be present.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets held for use, which includes medical equipment in rental service, property and equipment and amortizable intangible assets, are reviewed for impairment when events or changes in circumstances indicate that their carrying value may not be recoverable. If an impairment indicator exists, the Company assesses the asset or asset group for recoverability. Recoverability of these assets is determined based upon the expected undiscounted future net cash flows from the operations to which the assets relate, utilizing management&#8217;s best estimates, appropriate assumptions and projections at the time. If the carrying value is determined not to be recoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair market value of the asset or asset group. For the years ended December&#160;31, 2021, 2020 and 2019, respectively, the Company assessed the impairment indicators and found none to be present.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019 (the &#8220;Effective Date&#8221;), the Company adopted Accounting Standards Codification ("ASC") Topic 842, Leases,("Topic 842"),  using a modified retrospective transition approach. Under Topic 842, lessees are required to recognize a lease liability and right-of-use asset (&#8220;ROU asset&#8221;) for all leases and to disclose key information about leasing arrangements. Additionally, leases are classified as either financing or operating; the classification determines the pattern of expense recognition and classification within the statement of operations. The Company elected to apply its lease accounting policy only to leases with a term greater than twelve months.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic 842 provides several optional practical expedients that the Company adopted at transition. The Company elected the &#8220;package of practical expedients&#8221;, which does not require it to reassess its prior conclusions regarding lease identification, lease classification and initial direct costs. The Company did not elect the practical expedient of hindsight to the evaluation of lease options (e.g. renewal).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic 842 also provides practical expedients for an entity&#8217;s ongoing accounting. The Company elected the &#8220;combining lease and non-lease components&#8221; practical expedient and also elected to apply the short-term lease recognition exemption to certain leases; therefore, the Company did not recognize ROU assets and lease liabilities for these leases.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In adopting Topic 842, the Company determined and will continue to determine whether an arrangement is a lease at inception. The Company&#8217;s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next ten years. The Company&#8217;s leases do not contain any restrictive covenants. The Company&#8217;s office leases generally contain renewal options for periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEzNTUy_9f2fcc91-aee1-47c3-a7b5-103597d961a0">one</span> to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company&#8217;s office leases do not contain any material residual value guarantees. The Company&#8217;s equipment leases generally do not contain renewal options. The Company is not reasonably certain to exercise the renewal options for those equipment leases that do contain renewal options, thus, the options are not considered in determining the lease term and payments associated with the option years are excluded from lease payments.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s equipment leases, the Company used and will use the implicit rate in the lease as the discount rate, when available. Otherwise, the Company uses its incremental borrowing rate as the discount rate. For the Company&#8217;s office leases, the implicit rate is typically not available, so the Company used and will use its incremental borrowing rate as the discount rate. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The Company&#8217;s lease agreements include both lease and non-lease components. The Company elected the practical expedient that allows it to combine lease and non-lease components for all of its leases.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments due under the Company&#8217;s operating leases include fixed payments as well as variable payments. For the Company&#8217;s office leases, variable payments include amounts for the Company&#8217;s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company&#8217;s equipment leases, variable payments may consist of sales taxes, property taxes and other fees.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized at the time and in an amount that reflects the consideration expected to be received for the performance obligations that have been provided. ASC Topic 606 &#8211; Revenue from Contracts with Customers (&#8220;ASC 606&#8221;) defines contracts as written, oral and through customary business practice. Under this definition, the Company considers contracts to be created at the time that the rental service is authorized or an order to purchase product is agreed upon regardless of whether or not there is a written contract.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three separate and distinct performance obligations offered to its customers: a rental service performance obligation, a product sale performance obligation and a service performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is defined as the unit of account for revenue recognition under ASC 606. These performance obligations are related to separate revenue streams and at no point are they combined into a single transaction. Sources of net revenues include commercial insurance payers, government insurance payers, medical facilities and patients.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue from the rental of infusion pumps to its customers and a minority of its revenue from product sales and services. For the rental service performance obligation, revenue is based on its standalone price, determined by using reimbursement rates established by third-party payer or other contracts. Revenue is recognized in the period in which the related performance obligation is satisfied, which is typically at the point in time that a patient concludes a treatment, or in certain arrangements, based on the number of pumps that a facility has onsite. The Company&#8217;s revenues related to product sales are recognized at the time that control of the product has been transferred to the customer; either at the time the product is shipped or the time the product has been received by the customer, depending on the delivery terms. The Company does not commit to long-term contracts to sell customers a certain minimum quantity of products. The Company's revenues related to services are recognized at the time that the service work has been completed.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company employs certain significant judgments to estimate the dollar amount of revenue, and related concessions, allocated to the rental service. These judgments include, among others, the estimation of variable consideration. Variable consideration, specifically related to the Company&#8217;s third-party payer rental revenues, is estimated as implied price concessions resulting from differences between the rates charged for services performed and the expected reimbursements for commercial payers and other implied customer concessions. The estimates for variable consideration are based on historical collections with similar payers, aged accounts receivable by payer class and payer correspondence using the portfolio approach, which provide a reasonable basis for estimating the variable portion of a transaction. The Company doesn&#8217;t believe it is probable that a significant reversal of revenue will occur in future periods because (i) there is no significant uncertainty about the amount of considerations that are expected to be collected based on collection history and (ii) the large number of sufficiently similar contracts allows the Company to adequately estimate the component of variable consideration.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues are adjusted when changes in estimates of variable consideration occur. Changes in estimates typically arise as a result of new information obtained, such as actual payment receipt or denial, or pricing adjustments by payers. Subsequent changes to estimates of transaction prices are recorded as adjustments to net revenue in the period of the change. Subsequent changes that are determined to be the result of an adverse change in the payer&#8217;s ability to pay are recorded as an allowance for doubtful accounts.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the industry and the reimbursement environment in which the Company operates, certain estimates are required to record net revenues and accounts receivable at their net realizable values. Inherent in these estimates is the risk that the estimates will have to be revised or updated as additional information becomes available. Specifically, the complexity of many third-party billing arrangements and the uncertainty of reimbursement amounts for certain services from certain payers may result in adjustments to amounts originally recorded. Due to continuing changes in the health care industry and third-party reimbursement, it is possible that management&#8217;s estimates could change in the near term, which could have a material impact on the Company&#8217;s results of operations and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenues</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues include the costs of servicing and maintaining pumps, products and services sold, shipping and other direct and indirect costs related to net revenues. Shipping and handling costs incurred after control over a product has transferred to a customer are accounted for as a fulfillment cost.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Concentration</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had contracts with nearly 770 third-party payer networks, an increase of 6% over the prior year period. Material terms of contracts with third-party payer organizations are typically a pre-negotiated fee </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">schedule rate or a then-current proprietary fee schedule rate for equipment and supplies provided. The majority of these contracts generally provide for a term of one year, with automatic one-year renewals, unless the Company or the contracted payer elect not to renew. The Company also contracts with various other third-party payer organizations, Medicaid, commercial Medicare replacement plans, self-insured plans, facilities of its Medicare patients and numerous other insurance carriers. No single payer or customer represented more than 10% of the Company's net revenue in 2021, 2020 or 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred&#160;income tax liabilities and assets based on (i) the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and (ii) the tax credit carryforwards. Deferred income tax (expense) benefit results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all of any deferred tax assets will not be realized.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for federal, state and foreign taxes are calculated based on reported pre-tax earnings based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities.&#160;Certain items of income and expense are recognized in different time periods for financial reporting than for income tax purposes; thus, such provisions differ from the amounts currently receivable or payable.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows a two-step approach for recognizing uncertain tax positions. First, it evaluates the tax position for recognition by determining if the weight of available evidence indicates it is more-likely-than-not that the position will be sustained upon examination. Second, for positions that are determined are more-likely-than-not to be sustained, it recognizes the tax benefits as the largest benefit that has a greater than 50% likelihood of being sustained. The Company establishes a reserve for uncertain tax positions liability that is comprised of unrecognized tax benefits and related interest and penalties. The Company adjusts this liability in the period in which an uncertain tax position is effectively settled, the statute of limitations expires for the relevant taxing authority to examine the tax position, or more information becomes available.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted Accounting Standards Update ("ASU") 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, in the fourth quarter of 2019. This guidance simplifies various aspects related to accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. The guidance was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption was permitted, including adoption in any interim period for which financial statements had not yet been issued. Certain amendments may have been applied on a retrospective, modified retrospective or prospective basis. As permitted, the Company elected to early adopt this guidance for the year ended December&#160;31, 2019. The adoption of this guidance did not have a significant impact on the Company&#8217;s financial statements and primarily resulted in the reclassification of an immaterial amount from non-income tax expense to income tax expense related to the accounting for franchise taxes, with no impact to the Company&#8217;s consolidated net income, equity or cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically repurchases shares of its common stock. These repurchases take place either as part of a board-authorized program, which may include open market transactions or privately negotiated transactions and may be made under a Rule 10b5-1 plan, or in targeted stock purchase agreements approved by the board. Treasury stock is accounted for using the par value method. In 2021, the Company retired the approximately 3,500,000 shares that were previously held in treasury.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Payments</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of stock option awards, restricted stock awards and stock appreciation rights (collectively, &#8220;Share-Based Awards&#8221;) on the date of grant using either the grant date price of the Company's common stock or option-pricing models which are affected by the Company&#8217;s stock price, as well as assumptions regarding a number of other inputs using the Black-Scholes pricing model. These variables include the Company&#8217;s expected stock price volatility over the expected term of the Share-Based Awards, actual and projected employee stock option exercise behaviors, risk-free interest rates and expected dividends. The expected volatility is based on the historical volatility. The expected term represents the period over which the Share-Based Awards are expected to be outstanding. The dividend yield is an estimate of the expected dividend yield on the Company&#8217;s stock. The risk-free rate is based on U.S. Treasury yields in effect at the time of the grant for the expected term of the Share-Based Awards. Forfeitures are recognized as they occur. All Share-Based Awards are amortized based on their graded vesting over the requisite service period of the awards. Compensation costs are recognized over the requisite service period using the accelerated method and included in general and administrative expenses.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company also determines the fair value of performance-based restricted stock units (&#8220;PSUs&#8221;) based upon the type of performance measure. These awards typically vest after the Company&#8217;s achievement of either a specific Company performance metric or when the market value of the Company&#8217;s stock meets a specific metric such as when the closing price of the Company's stock reaches a target value for a minimum number of consecutive trading days. Under Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC Topic 718, the provisions of the PSUs that vest upon achievement of a target market value are considered a market condition, and therefore the effect of that market condition is reflected in the grant date fair value for this type of award. A third-party valuation expert was engaged to complete a &#8220;Monte Carlo simulation&#8221; to account for the market condition. That simulation takes into account the beginning stock price of the Company&#8217;s common stock, the expected volatilities for the Company&#8217;s stock price and the expected risk-free rate of return. The single grant-date fair value computed by this valuation method is recognized by the Company in accounting for the awards regardless of the actual future outcome of the market condition. Compensation costs are accelerated if the market condition is satisfied prior to the end of the service period derived under the Monte Carlo simulation. The grant date fair value of the other PSUs is calculated as the closing price of the Company&#8217;s common stock on the grant date multiplied by the number of shares estimated to be delivered subject to the award terms. Company performance measure goals are considered a performance condition and the timing and amount of compensation cost for those PSUs corresponds with management&#8217;s expectation of the probable outcome of the performance conditions as of the grant date and during the vesting period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Debt Issuance Costs</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized debt issuance costs as of December&#160;31, 2021 and 2020 relate to the Company&#8217;s credit facility. The costs related to the agreement are netted against current and non-current debt. The Company amortizes these costs using the interest method through the maturity date of the underlying debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its earnings per share in accordance with ASU 2017-11, Earnings Per Share (Topic 260), which requires the presentation of both basic and diluted earnings per share on the statements of operations. The diluted weighted average common shares include adjustments for the potential effects of outstanding stock options but only in the periods in which such effect is dilutive under the treasury stock method. Included in our basic and diluted weighted average common shares are those stock options and restricted stock awards due to participants granted from the 2014 and 2021 stock incentive plans. Anti-dilutive stock awards are comprised of stock options and unvested restricted stock awards, which would have been anti-dilutive in the application of the treasury stock method in accordance with ASU 2017-11, Earnings Per Share (Topic 260). In periods where the Company records a net loss, the diluted per share amount is the same as the basic per share amount.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with this topic, the following table reconciles income and share amounts utilized to calculate basic and diluted net income per common share:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:58.176%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerator (in thousands):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income:</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,519,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,106,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,731,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dilutive effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,529,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,610,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,107,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,049,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,717,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,839,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options of 368,056, 18,321 and 25,669 shares were not included in the calculation for the years ended December&#160;31, 2021, 2020 and 2019, respectively, because they would have an anti-dilutive effect.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes all derivative financial instruments as cash flow hedges which are shown as either assets or liabilities on the Company&#8217;s consolidated balance sheets at fair value. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in fair value of the derivative is recorded to accumulated other comprehensive income (&#8220;AOCI&#8221;) in the consolidated balance sheets. The underlying hedge transaction is realized when the interest payments </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on debt are accrued; the applicable amount of gain or loss included in AOCI is reclassified into earnings in the consolidated statements of operations on the same line as the gain or loss on the hedged item attributable to the hedged risk. The cash flows from derivatives are classified as operating activities.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a policy of requiring that all derivative instruments be governed by an International Swaps and Derivatives Association Master Agreement and settles on a net basis.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s derivative financial instruments are categorized as Level 2 of the fair value hierarchy as the values are derived using the market approach based on observable market inputs including quoted prices of similar instruments and interest rate forward curves.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported in the consolidated balance sheets as of December&#160;31, 2021 and 2020 for cash, accounts receivable, accounts payable and other current liabilities approximate fair value because of the short-term nature of these instruments (Level I). The carrying value of the Company&#8217;s long-term debt with variable interest rates approximates fair value based on instruments with similar terms (Level II).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted ASC 820, Fair Value Measurements, which defines fair value, establishes a framework for assets and liabilities being measured and reported at fair value and appends disclosures about fair value measurements.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial assets and liabilities measured at fair value on a recurring basis, fair value is the price the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction with a market participant at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value as follows:</span></div><div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Level I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;&#160;&#160;quoted prices in active markets for identical instruments;</span></div><div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Level II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;&#160;&#160;quoted prices in active markets for similar instruments, quoted prices for identical instruments in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the instrument; and</span></div><div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Level III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;&#160;&#160;significant inputs to the valuation model are unobservable.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements and Developments</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has adopted ASU 2020-04, Reference Rate Reform (Topic 848), which contains optional expedients for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Inter-bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope." This ASU clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition.  The Company has elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2016, the FASB issued ASU No. 2016-13, &#8220;Financial Instruments (Topic 326) Credit Losses&#8221;. Topic 326 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. Topic 326 was originally effective as of January 1, 2020, although in November 2019, the FASB delayed the effective date until fiscal years beginning after December 15, 2022 for SEC filers eligible as of the FASB's deferral date to be smaller reporting companies under the SEC&#8217;s definition. The Company qualified as a smaller reporting company in November 2019 when the FASB delayed the effective date of Topic 326. Early adoption is permitted. The Company is currently evaluating the impact of Topic 326 on its consolidated balance sheets, statements of operations, statements of cash flows and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246139640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions Accounted for Using the Purchase Method</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;31, 2021, the Company acquired the business and the majority of the assets of FilAMed, a privately-held biomedical services company based in Bakersfield, California. In becoming a part of the Company's Durable Medical Equipment Services ("DME Services") segment, this acquisition will supplement the Company&#8217;s existing biomedical recertification, maintenance and repair services for acute care facilities and other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;18, 2021, the Company acquired the business and substantially all of the assets of OB Healthcare Corporation (&#8220;OB Healthcare&#8221;), a privately-held biomedical services company based in Austin, Texas. OB Healthcare specializes in on-site repair, preventative maintenance, and device physical inventory management to hospitals and healthcare systems nationwide. The acquisition further develops and expands InfuSystem&#8217;s DME Services segment and complements the Company&#8217;s purchase of FilAMed.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FilAMed and OB Healthcare&#8217;s results of operations are included in the Company&#8217;s consolidated statements of operations from the respective closing dates. Revenues and earnings from these acquisitions have not been significant through December&#160;31, 2021.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC Topic 805, &#8220;Business Combinations,&#8221; the purchase price for each of the acquisitions was allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the respective acquisition dates. The purchase price allocations were primarily based upon a valuation using management&#8217;s estimates and assumptions. The purchase price allocation was completed for FilAMed and OB Healthcare as of December 31, 2021. The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">FilAMed</span></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consideration</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,250&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,650&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Working capital adjustment, paid in cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FilAMed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment held for sale or rental</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(288)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - purchase price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of acquisition costs for both transactions was $0.2 million and is included in general and administrative expenses for the year ended December&#160;31, 2021.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, the Company updated the valuation of OB Healthcare based on further analysis of the final working capital with an immaterial decrease in the consideration transferred and a corresponding decrease to accounts receivable. There was no impact to the consolidated statement of operations. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company fully paid all consideration for FilAMed as of December&#160;31, 2021. On the OB Healthcare acquisition date, the Company made an initial cash payment of $6.1&#160;million with subsequent cash payments of $0.4 million during the year and had an additional estimated amount due to the seller for contingent consideration of $0.8&#160;million, which was recorded in the balance sheet under the heading for other current liabilities. The contingent consideration arrangement requires the Company to pay OB Healthcare $0.8&#160;million if certain customer contracts are executed by December 31, 2021. In December 2021, the Company extended this date to February 28, 2022. The Company expects to further extend this deadline and for OB Healthcare to satisfy this requirement. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the breakdown of the identified intangible assets acquired into major intangible asset classes for both acquisitions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Thousands)</span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted-Average</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization Period</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Years)</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,300&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unpatented technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total intangible assets (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.2</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) There was no residual value, renewal terms or extensions associated with any intangible assets acquired.</span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill acquired consists of expected synergies from combining operations of FilAMed and OB Healthcare with the DME Services segment as well as their respective assembled workforce who have specialized knowledge and experience. All of the goodwill is deductible for tax purposes. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information in the table below summarizes the combined results of operations of the Company, FilAMed and OB Healthcare as though the companies&#8217; businesses had been combined as of January 1, 2020. The pro forma financial information for the year ended December&#160;31, 2021 has been adjusted by $0.5&#160;million for the tax effected amount of acquisition costs and non-recurring expenses directly attributable to the FilAMed and OB Healthcare acquisitions. The year ended December&#160;31, 2020 also included these charges. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place at the beginning of each period presented nor is it indicative of future results. The following pro forma financial information presented also includes the pro forma depreciation and amortization charges from acquired tangible and intangible assets for the years ended December&#160;31 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 77.57pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">103,152&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100,032&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246209368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s disaggregated revenue by offering type (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-Party Payer Rentals</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,847&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,266&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,510&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct Payer Rentals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102,382&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97,388&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-Party Payer Rentals are entirely attributed to revenues of the ITS segment. For the year ended December&#160;31, 2021, $12.5 million and $16.8 million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the year ended December&#160;31, 2020, $11.8 million and $16.7 million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the year ended December&#160;31, 2019, $11.0 million and $13.1 million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the year ended December&#160;31, 2021, $0.2 million and $15.3 million of Product Sales were attributed to the ITS and DME Services segments, respectively. For the years ended December&#160;31, 2020 and 2019 all Product Sales were entirely attributed to revenues of the DME Services segment. For the years ended December&#160;31, 2021, 2020 and 2019, all Services revenues were entirely attributed to the DME Services segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246169384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentAbstract', window );"><strong>Medical Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentAndPropertyDisclosureTextBlock', window );">Medical Equipment</a></td>
<td class="text">Medical Equipment<div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical equipment consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment for sale or rental</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment for sale or rental - pump reserve</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment for sale or rental - net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,603&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment in rental service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment in rental service - pump reserve</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,074)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(50,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment in rental service - net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,871&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,214&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for medical equipment for the years ended December&#160;31, 2021, 2020 and 2019 was $9.4 million, $8.9 million and $7.5 million, respectively, which were recorded in &#8220;cost of revenues&#8221; for each period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentAndPropertyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for medical equipment and property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentAndPropertyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246647176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment<div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.164%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture, fixtures, and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,528)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,018)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Automobiles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,843)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,523&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,979)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,296&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for property and equipment for each of the years ended December&#160;31, 2021, 2020 and 2019 was $0.9 million, $0.8 million and $0.5 million, respectively. This expense was recorded in &#8220;general and administrative expenses&#8221; for each period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246285064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill and Intangible Assets<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying value of goodwill by segment are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services (a)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) The ITS segment has no recorded goodwill. </span></div></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the indicators of goodwill impairment as part of its annual impairment test, as of October 1, 2021, and through December 31, 2021, by performing a qualitative assessment of goodwill. In performing the qualitative assessment, the Company evaluated events and circumstances since the last impairment analysis, recent operating performance, changes in the business climate and company-specific factors. The results of the qualitative assessment indicated that it was more likely than not that the estimated fair value of each reporting unit exceeded its carrying value amount as of the test date. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount and accumulated amortization of intangible assets were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonamortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physician and customer relationships</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(31,401)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28,924)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpatented technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total nonamortizable and amortizable intangible assets</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,802&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(42,872)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,930&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,787&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38,610)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets for the years ended December&#160;31, 2021, 2020 and 2019 was $4.3&#160;million, $4.3&#160;million and $4.4&#160;million, respectively, which was recorded in "amortization of intangibles expenses" for each period. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected remaining annual amortization expense for the next five years for intangible assets recorded as of December&#160;31, 2021 is as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.643%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2027 and <br/>thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246119080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;5, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company entered into a Credit Agreement (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 Credit Agreement&#8221;) with JPMorgan Chase Bank, N.A., as administrative agent (the &#8220;Agent&#8221;), sole bookrunner and sole lead arranger, and the lenders party thereto. The borrowers under the 2021 Credit Agreement are the Company, InfuSystem Holdings USA, Inc. (&#8220;Holdings&#8221;), ISI, First Biomedical, and IFC LLC (&#8220;IFC&#8221; and, collectively with the Company, Holdings, ISI and First Biomedical, the &#8220;Borrowers&#8221;).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement provides for a revolving credit facility (the &#8220;Revolving Facility&#8221;) of $75.0 million, maturing on February 5, 2026. The Revolving Facility may be increased by $25.0 million, subject to certain conditions, including the consent of the Agent and obtaining necessary commitments. The lenders under the 2021 Credit Agreement may issue up to $7.0 million in letters of credit subject to the satisfaction of certain conditions. On February&#160;5, 2021, the Borrowers made an initial borrowing of $30.0 million under the Revolving Facility. Proceeds from the loan, along with approximately $8.2 million in cash, were used to repay all amounts due under the Company&#8217;s then existing credit facility dated March 23, 2015 (the &#8220;2015 Credit Agreement&#8221;).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement has customary representations and warranties. The ability to borrow under the facility is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations on indebtedness, liens, mergers, acquisitions, investments, asset sales, affiliate transactions and restricted payments, as well as financial covenants, including the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a minimum fixed charge coverage ratio (defined as the ratio of consolidated EBITDA (as defined in the 2021 Credit Agreement) less 50% of depreciation expense), to consolidated fixed charges (as defined in the 2021 Credit Agreement)) for the prior four most recently ended calendar quarters of 1.20 to 1.00; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a maximum leverage ratio (defined as total indebtedness to EBITDA for the prior four most recently ended calendar quarters) of 3.50 to 1.00.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement includes customary events of default. The occurrence of an event of default will permit the lenders to terminate commitments to lend under the Revolving Facility and accelerate payment of all amounts outstanding thereunder.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Simultaneous with the execution of the 2021 Credit Agreement, the Company entered into a Pledge and Security Agreement to secure repayment of the obligations of the Borrowers. Under the Pledge and Security Agreement, each Borrower has granted to the Agent, for the benefit of various secured parties, a first priority security interest in substantially all of the personal property assets of each of the Borrowers, including the shares of each of Holdings, ISI and First Biomedical and the equity interests of IFC.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;5, 2021, in connection with the execution and closing of the 2021 Credit Agreement, the Company, along with its wholly owned subsidiaries as borrowers, terminated the 2015 Credit Agreement. All outstanding loans under the 2015 Credit Agreement have been repaid and all liens under the 2015 Credit Agreement have been released, except that a letter of credit originally issued under the 2015 Credit Agreement in the amount of approximately $0.8 million was transferred to the 2021 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement was accounted for as a debt modification that resulted in a small increase to deferred debt issuance costs. As of December&#160;31, 2021, the Company was in compliance with all debt-related covenants under the 2021 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the 2015 Credit Agreement, which would have matured on November 9, 2024, included three term notes totaling $37.9 million, with varying required quarterly amortization payments, and an undrawn $11.8 million revolving line of credit. The availability under the line of credit was reduced by outstanding letters of credit and reserves totaling $1.0 million and was subject to a borrowing base limitation as defined by the agreement. The borrowing base was approximately $15.6 million at December&#160;31, 2020. At December&#160;31, 2020 and on the date of the refinancing, the Company </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was in compliance with all affirmative and negative covenants, as outlined in the agreement, which included maintenance of a maximum leverage ratio and a minimum fixed charge coverage ratio, as defined in the agreement. Interest on the facility was payable at the Company&#8217;s option as a (i) Eurodollar Loan, which bore interest at a per annum rate equal to the applicable 30-day LIBOR plus an applicable margin ranging from 2.00% to 3.00% or (ii) CB Floating Rate (&#8220;CBFR&#8221;) Loan, which bore interest at a per annum rate equal to the greater of (a) the lender&#8217;s prime rate or (b) LIBOR plus 2.50%, in each case, plus a margin ranging from -1.00% to 0.25% based on the Company's leverage ratio. The actual Eurodollar Loan rate at December&#160;31, 2020 was 2.19% (LIBOR of 0.19% plus 2.00%). The actual CBFR Loan rate at December&#160;31, 2020 was 2.25% (lender&#8217;s prime rate of 3.25% minus 1.00%).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;15, 2019, the Company sold for $2.0 million and immediately leased back certain medical equipment in rental service to a third party specializing in such transactions. The leaseback term is 36 months. Because the arrangement contains a purchase option that the Company is reasonably certain to exercise, this transaction did not qualify for the sale-leaseback accounting under ASC 842. The medical equipment remains recorded on the accompanying condensed consolidated balance sheet and the proceeds received have been classified as an other financing liability, which is being paid off monthly over the term of the lease. During the fourth quarter of 2021, the Company recorded an additional $0.2&#160;million of interest expense to reflect the amount expected to be paid upon the exercise of the purchase option at the end of its other financing transaction. The balance of other financing as of December&#160;31, 2021 was $0.4 million.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As referenced above, the Company executed and closed the 2021 Credit Agreement during the first quarter of 2021, and in connection with entering into that agreement, terminated the 2015 Credit Agreement. For the following tables, the figures related to the December&#160;31, 2021 revolving credit facility balances relate to the 2021 Credit Agreement, while the December&#160;31, 2020 revolving credit facility balances relate to the now-terminated 2015 Credit Agreement. The following table illustrates the net availability under the revolving credit facilities as of the applicable balance sheet date (in thousands):</span></div><div style="margin-top:10pt;text-indent:27pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Facility:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross availability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding draws</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Landlord reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Availability on Revolving Facility</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,426&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,788&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had future maturities of its long-term debt as of December&#160;31, 2021 as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.582%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2027 and <br/>thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a breakdown of the Company&#8217;s current and long-term debt (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.581%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment line</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019 equipment line</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,397&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,427&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized value of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">349&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,748&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,097&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,423&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,378&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,801&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span>December&#160;31, 2021, amounts outstanding under the Revolving Facility provided under the 2021 Credit Agreement bear interest at a variable rate equal to, at the Company&#8217;s election, a LIBO Rate for Eurodollar loans or an Alternative Base Rate for ABR loans, as defined by the 2021 Credit Agreement, plus a spread that will vary depending upon the Company&#8217;s leverage ratio. The spread ranges from 2.00% to 3.00% for Eurodollar Loans and 1.00% to 2.00% for base rate loans. The weighted-average Eurodollar loan rate at December&#160;31, 2021 was 2.11% (LIBO of 0.11% plus 2.00%). The actual ABR loan rate at December&#160;31, 2021 was 4.25% (lender&#8217;s prime rate of 3.25% plus 1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246327976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments and Hedging Activities</a></td>
<td class="text">Derivative Financial Instruments and Hedging Activities<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company adopted a derivative investment policy which provides guidelines and objectives related to managing financial and operational exposures arising from market changes in short term interest rates. In accordance with this policy, the Company can enter into interest rate swaps or similar instruments, will endeavor to evaluate all the risks inherent in a transaction before entering into a derivative financial instrument and will not enter into derivative financial instruments for speculative or trading purposes. Hedging relationships are formally documented at the inception of the hedge and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to interest rate risk related to its variable rate debt obligations under the 2021 Credit Agreement. In order to manage the volatility in interest rate markets, in February 2021, the Company entered into two interest rate swap agreements to manage exposure arising from this risk. On a combined basis, the agreements have a constant notional amount over a 5-year term that ends on February 5, 2026. The agreements both pay the Company 30-day LIBOR on the notional amount and the Company pays a fixed rate of interest equal to 0.73%. These derivative instruments are considered cash flow hedges. The Company does not have any other derivative financial instruments.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the location and gross fair value amounts of the Company's derivative financial instruments and the associated notional amounts designated as cash flow hedges (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December&#160;31, 2021 (a)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair Value Derivative Assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 32.57pt 0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">355</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:40.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) No derivative instruments existed at December&#160;31, 2020.</span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the effect of our derivative financial instruments designated as hedging instruments in AOCI (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.100%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December&#160;31, 2021 (a)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Gain on cash flow hedges - interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unrealized gain recognized in AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">249</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amounts reclassified to interest expense (b)(c)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">106</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(87)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">268</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="9" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) No derivative instruments existed for the years ended December&#160;31, 2020 and December&#160;31, 2019.</span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(b) Positive amounts represented interest expense. Total interest expense as presented in the consolidated statement of operations for the years ended December&#160;31, 2021, 2020 and 2019 were $1.4 million, $1.3 million and $1.9 million, respectively.</span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(c) $0.1 million of expense is expected to be reclassified into earnings within the next 12 months.</span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not incur any hedge ineffectiveness during the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246627656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s income before income taxes (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,543&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,524&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s components of the consolidated benefit from (provision for) income taxes (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S Federal income tax benefit&#160;(expense)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. Federal income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total state and local income tax (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit (expense)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,789&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity related to the Company&#8217;s valuation allowance (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance at the Beginning of Period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,250)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,370)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance at the End of Period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,250)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes a reconciliation of the Company&#8217;s effective income tax rate to the U.S. federal statutory rate:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at the statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the temporary differences and carryforwards that give rise to deferred tax assets and liabilities (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Federal tax assets &#8211;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt reserves</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research &amp; development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred Federal tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,132&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,997&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Federal tax liabilities &#8211;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and asset basis differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,423)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,393)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(937)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred Federal tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,402)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,330)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred Federal tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,730&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,667&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred state and local tax assets (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,033&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,967&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) At December&#160;31, 2021 and 2020, this includes state and local net operating losses of $1.3 million and $1.2 million, respectively.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. federal net operating loss carryforward for tax purposes was $38.2 million at December&#160;31, 2021, resulting in a federal deferred tax asset of $8.0 million. Approximately $31.3 million of the Company&#8217;s U.S. federal net operating loss carryforwards will begin to expire in various years beginning in 2029. $6.9 million of U.S. federal net operating loss carryforwards have an indefinite life. The Company&#8217;s state net operating loss carryforward of approximately $1.3 million is comprised of various jurisdictions. These state net operating losses can be used for a period of 5 to 20 years and vary by state, and if unused, begin to expire in 2022, though a substantial portion expires beyond 2022. Approximately $0.1 million of the state net operating loss carryforwards have an indefinite life. Tax benefits of operating loss and tax credit carryforwards are evaluated on an ongoing basis, including a review of historical and projected future operating results, the eligible carryforward period, and other circumstances.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to monitor shifts in past ownership (as defined under Section 382 of the Code). The Company is subject to an annual limitation of $1.8 million on its use of remaining pre-ownership change net operating loss carryforwards of $4.5 million (and certain other pre-change tax attributes).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2020, it was determined that the valuation allowance against the U.S. federal and state deferred taxes was no longer required and the valuation allowance of $11.2 million that existed was released. The Company&#8217;s realization of its deferred tax assets is dependent upon many factors, including, but not limited to, the Company&#8217;s ability to generate sufficient taxable income. Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets. At December&#160;31, 2021 and 2020, cumulative income in recent years and projected future taxable income is the basis for the Company&#8217;s assessment that the deferred tax assets do not require a valuation allowance.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no uncertain tax positions for the years ended December&#160;31, 2021 and 2020.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to taxation for Federal and various state jurisdictions in the United States and Canada. The Federal income tax returns of the Company for the years 2018 through 2021 are open to examination by the Internal Revenue Service. The Company was under audit with the Internal Revenue Service in relation to the Company&#8217;s 2018 federal income tax return and the audit was closed on December&#160;15, 2021. The state income tax returns and other state tax filings of the Company </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are subject to examination by the state taxing authorities, for various periods generally up to four years after they are filed. Canadian income tax returns of the Company for the years 2017 through 2021 are subject to examination by the Canada Revenue Agency.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the&#160;Coronavirus Aid, Relief, and Economic Security ("CARES") Act was enacted in response to the COVID-19 pandemic. The&#160;CARES Act among other things,&#160;allows employers to defer the deposit and payment of the employer's share of Social Security taxes. The Company, under the CARES Act, deferred paying $0.7 million of applicable gross payroll taxes as of December&#160;31, 2020, which was included in other liabilities. The $0.7 million balance of the deferred Social Security taxes was expected to be paid in two equal annual installments during the years ending December 31, 2021 and 2022, respectively. In December 2021, the Company made the first of these two equal annual installment payments. On April&#160;15, 2020, the Company received a $4.1 million loan under the Federal Paycheck Protection Program (&#8220;PPP&#8221;) created under the CARES Act. In response to revised eligibility guidelines announced by the U.S. Small Business Administration shortly thereafter, the Company repaid this loan in full on May 7, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502247785192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time in the ordinary course of its business, the Company may be involved in legal and regulatory proceedings, the outcomes of which may not be determinable. The results of litigation and regulatory proceedings are inherently unpredictable. Any claims against the Company, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. The Company is not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable, primarily for the following reasons: (i) many of the relevant legal proceedings are in preliminary stages, and until such proceedings develop further, there is often uncertainty regarding the relevant facts and circumstances at issue and potential liability; and (ii) many of these proceedings involve matters of which the outcomes are inherently difficult to predict. The Company has insurance policies covering potential losses where such coverage is cost effective.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not at this time involved in any proceedings that the Company believes could have a material effect on the Company&#8217;s financial condition, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246223096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically entered into a number of lease agreements under which the Company is the lessee for equipment and office leases.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s operating lease costs consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs for the year ended December&#160;31, 2021 of approximately $1.5 million and $0.1 million, were recorded to G&amp;A expenses and cost of revenues, respectively. Lease costs for the year ended December&#160;31, 2020 of approximately $1.3 million and $0.6 million, were recorded to G&amp;A expenses and cost of revenues, respectively. Lease costs for the year ended December&#160;31, 2019 of approximately $1.2 million and $1.0 million, were recorded to G&amp;A expenses and cost of revenues, respectively.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information and non-cash activity related to the Company&#8217;s leases are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities and ROU assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions to ROU assets resulting from reductions to lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease terms and discount rates for the Company&#8217;s operating leases are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8%</span></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future maturities of lease liabilities as of December&#160;31, 2021 are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:83.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,434)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The long-term portion of the lease liabilities included in the amounts above is $3.7 million with the remainder included in other current liabilities in the Consolidated Balance Sheet.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502247778824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Compensation</a></td>
<td class="text">Share-based Compensation<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Incentive Plan</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various stock option and stock-based incentive plans and agreements whereby equity based awards are granted to certain employees, directors and others approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) or Compensation Committee. Grants may be made in the form of stock options, restricted stock awards ("RSUs" or "RSAs"), performance-based restricted stock units ("PSU's), unrestricted common stock, stock appreciation rights (&#8220;SARs&#8221;) in addition to other award types. Stock options are granted with an exercise price at, or above, fair market value on the date of grant, generally expire in 5 to 10 years from the grant date and generally become exercisable over a period of up to 3 years. RSUs generally become vested over a period of up to 3 years. PSUs generally become vested over a period of up to 3 years based on the performance of a specific achievement. Awards typically vest and are issued only if the participants remain employed by the Company through the vesting date. Common stock issued under these awards are issued from shares reserved under the Company&#8217;s plan described below. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 18, 2021, the Company&#8217;s Board adopted the 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). The 2021 Plan was approved by the Company&#8217;s shareholders at the 2021 Annual Meeting on May 18, 2021 and became effective at that time. The 2021 plan supersedes the 2014 Amended and Restated Stock Incentive Plan (the "2014 Plan"). The 2021 Plan provided for the issuance of a maximum of 2,500,000 shares of common stock in connection with the grant of stock-based or stock-denominated awards. As of December&#160;31, 2021, a total of 1,766,769 common shares remained available for future grant under the 2021 Plan.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2014, the Company&#8217;s Board adopted the 2014 Plan. The 2014 Plan was approved by the Company&#8217;s shareholders at the 2014 Annual Meeting and became effective as of the date it was adopted by the Board of Directors. The 2014 Plan provided for the issuance of a maximum of 2,000,000 shares of common stock in connection with the grant of stock-based or stock-denominated awards. On July 19, 2018, the Company&#8217;s stockholders approved the reservation of an additional 1,000,000 shares to be issued under the 2014 Plan. On May 15, 2019, the Company&#8217;s stockholders approved the reservation of an additional 1,000,000 shares to be issued under the 2014 Plan. The 2021 Plan replaces and supersedes the 2014 Plan, so as of the adoption date of the 2021 Plan, no common shares remained available for future grant under the 2014 Plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation expense</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stock option awards are amortized based on their graded vesting over the requisite service period of the awards. Compensation costs are recognized over the requisite service period using the accelerated method and included in general and administrative expenses.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total stock-based compensation expense, which is included in selling, general and administrative expenses (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option and SARs expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit related to stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Forgone to Satisfy Minimum Statutory Withholdings</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021, 2020 and 2019, shares of common stock were issued to employees and directors as their restricted stock awards vested or stock options were exercised. Under the terms of the Company&#8217;s stock plans, at the election of each employee, the Company can authorize a net settlement of distributable shares to employees in order to satisfy an individual employees' tax withholding obligations. For the years ended December&#160;31, 2021, 2020 and 2019, the Company received 57,067 shares, 146,763 shares and 121,607 shares, respectively, from employees for tax withholding obligations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards entitle the holder to receive, upon meeting certain time-based vesting criteria, a specified number of shares of the Company&#8217;s common stock. Stock-based compensation cost of restricted stock awards is measured by the market value of the Company&#8217;s common stock on the date of grant.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s restricted share activity, excluding the Company&#8217;s employee stock purchase plan:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>grant<br/>date fair<br/>value</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested shares forgone to satisfy minimum statutory withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.61&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of awards granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares forgone to satisfy minimum statutory withholding</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, there was $2.9 million of pre-tax total unrecognized compensation cost related to non-vested restricted stock awards, which will be adjusted for future forfeitures, if any. The Company expects to recognize such cost over a weighted average period of two years</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance-Based Restricted Stock Units</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company granted approximately 127,476 PSUs. During the year ended December&#160;31, 2020, the Company granted approximately 232,500 PSUs. PSUs entitle the holder to receive, upon meeting certain performance-based vesting criteria, a specified number of shares of the Company&#8217;s common stock. These awards typically vest after the Company&#8217;s achievement of either a Company-based performance metric, such as the achievement of a certain amount of net revenue during a specified period, coupled with a time-based vesting criteria or based on a market based metric of the Company&#8217;s stock, such as when the trading price reaches a target value for a minimum number of consecutive trading days. All of the PSUs granted in 2021 are earned based on specified Company-based performance measure conditions. Approximately three-fourths of the PSUs granted in 2020 are earned based on the market-based metric, while the other one-fourth are earned based on specified Company-based performance metric conditions. In the case of the market-based metric, awards are paid in stock immediately upon achievement of the performance condition or expire without any payment after the third anniversary of the grant date. In the case of the specified Company-based performance measure, awards can be earned at an amount that varies by award between 93% to 100% of the target number of shares for achieving a minimum threshold below the target or up to 200% of the target number of shares for exceeding the target, with a linear adjustment between threshold and target or between target and stretch performance goals.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s PSU activity:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>grant <br/>date fair value</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested shares forgone to satisfy minimum statutory withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,629)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,976&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.74&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of awards granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares forgone to satisfy minimum statutory withholding</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, there was $1.2 million of pre-tax total unrecognized compensation cost related to non-vested PSUs, which will be adjusted for future forfeitures and changes to management&#8217;s expectations of the probable outcomes of the performance conditions, if any. The Company expects to recognize such cost over a weighted average period of 1 year.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2014, the Company received approval from stockholders to adopt an employee stock purchase plan ("ESPP") effective October 2014 (collectively the &#8220;Original ESPP&#8221;). Under the Original ESPP, 200,000 shares of common stock were authorized for purchase by eligible employees at a 15% discount through payroll deductions during the six-month offering periods. Shares were purchased in whole numbers and generally would be the last day of the offering period. In September 2016, the Company received approval from shareholders for an additional 350,000 shares. No employee may purchase more than $25,000 worth of fair market value shares in any calendar year. As allowed under the ESPP, a participant may elect to withdraw from the plan, effective for the purchase period in progress at the time of the election with all accumulated payroll deductions returned to the participant at the time of withdrawal. As of December&#160;31, 2021, there were 156,052 shares remaining available for future issuance. The following table summarizes the activity relating to the Company&#8217;s ESPP program:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of stock sold to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value per ESPP award</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates the fair value of stock option awards using the Black-Scholes option pricing model, which incorporates various assumptions including volatility, expected term, risk-free interest rates and dividend yields. The expected volatility assumption is based on historical volatility of the Company&#8217;s common stock over the most recent period commensurate with the expected life of the stock option granted. The Company uses historical volatility because management believes such volatility is representative of prospective trends. The risk-free interest rate assumption is based upon observed interest rates appropriate for the expected life of the stock option awarded. The Company uses historical exercise data to determine the expected lives. Dividend yields have not been a factor in determining fair value of stock options granted as the Company has never issued cash dividends and does not anticipate issuing cash dividends in the future.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables detail the various stock option activity:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:44.061%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2014 Plan (Options)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>of Authorized<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term (in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,449,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279,904)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised shares forgone to satisfy minimum statutory withholding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cashless exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,051,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478,357&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.99&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.36</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,274,817&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:44.061%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 Plan (Options)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>of Authorized<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term (in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021 (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.38</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021 (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,770&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Aggregate Intrinsic Value - no options were in-the-money as of December 31, 2021</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.</span></div><div style="margin-top:5pt;text-indent:27pt"><span><br/></span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the average fair value per share estimated on the date of grant and the assumptions used for options granted:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock Options:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43% to 46%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42% to 51%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36% to 38%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.31% to 0.54%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.20% to 1.56%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.80% to 2.36%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected lives at date of grant (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.63</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average fair value of options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6.56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.87</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.61</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intrinsic value of options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,248,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,377,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2021, the Company's Board of Directors approved a stock repurchase program (the &#8220;Share Repurchase Program&#8221;) authorizing the Company to repurchase up to $20.0 million of the Company&#8217;s outstanding common stock through June 30, 2024. The Share Repurchase Program will be subject to market conditions, the periodic capital needs of the Company&#8217;s operating activities, and the continued satisfaction of all covenants under the Company&#8217;s existing 2021 Credit Agreement. Repurchases under the program may take place in the open market or in privately negotiated transactions and may be made under a Rule 10b5-1 plan. The Share Repurchase program does not obligate the Company to repurchase shares and may be suspended, terminated, or modified at any time. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had repurchased approximately $0.6 million, or 33,469 shares, of the Company's outstanding common stock under the Share Repurchase Program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502247776040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment Information</a></td>
<td class="text">Business Segment Information<div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments are organized based on service platforms, with the ITS segment reflecting higher margin rental revenues that generally include payments made by third-party and direct payers and the DME Services segment reflecting lower margin product sales, direct payer rental and services revenues. Resources are allocated and performance is assessed for these segments by the Company&#8217;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker. The Company believes that reporting performance at the gross profit level is the best indicator of segment performance. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial information summarized below is presented by reportable segment:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DME Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,753)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DME Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate/<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,370)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DME Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate/<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,788)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,788)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246262120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Other<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plans and Other</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Employee Benefit Plans and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span>The Company has a defined contribution plan in which the Company makes discretionary matching contributions for a certain percentage of employee contributions. For the years ended December&#160;31, 2021, 2020 and 2019, the Company&#8217;s matching contributions were $0.9 million, $0.8 million and $0.7 million, respectively. The Company does not provide other post-retirement or post-employment benefits to its employees. As of December&#160;31, 2021 and 2020, accrued payroll liabilities included in Other current liabilities were $1.3 million and $2.8 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246655208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVID-19<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_Covid19Abstract', window );"><strong>Covid-19 [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_EffectOfCovid19PandemicTextBlock', window );">COVID-19</a></td>
<td class="text">COVID-19On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which spread globally and throughout the United States. With the exception of in-person visits to customer facilities by the Company's sales <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">staff, the Company continued to operate despite stay-at-home orders and other government mandated shutdowns across the United States and Canada under exceptions allowed by those orders for the healthcare industry.&#160;</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company took a number of precautionary and preemptive steps to protect the safety and well-being of its employees while ensuring continuity of service to its clients, including, transitioning employees to a remote work environment, suspending employee travel, canceling participation in industry events and in-person group meetings, promoting social distancing and enhanced cleaning and sanitization efforts across office locations, and implementing protocols to quarantine employees who may have been exposed to COVID-19, or show relevant symptoms. The Company also executed preparedness plans at its facilities to maintain continuity of operations, which provided for flexible work arrangements without any significant disruptions to its business or control processes. The Company's management team is continuing to actively monitor the situation and continuously communicates with employees, customers and vendors. Other specific actions the Company took included purchasing additional inventory of supplies and pumps, as well as purchasing personal protective equipment for employees. While the Company&#8217;s business is considered critical, the Company is unable to predict the impact that the COVID-19 pandemic will have on future periods due to numerous uncertainties. While the COVID-19 pandemic has not had any material unfavorable effects to the Company's financial results for the year ended December&#160;31, 2021, the extent of the impact in the future, if any, will depend on future developments, which are highly uncertain, cannot be predicted and could have a material adverse impact on the Company's financial position, operating results and cash flows. A prolonged outbreak could, among other things, strain the Company's business continuity plans, create delays in the Company's growth and strategic initiatives, reduce the Company's sales and marketing activities, limit the Company's access to financing on favorable terms, increase the Company's exposure to potential impairment charges related to long-lived and intangible assets, hinder the Company's ability to support its clients and operate its business effectively, heighten the risk of disruption to the Company's information and reporting systems and internal controls, including those over financial reporting and other risk management systems, or require the Company to incur substantial costs. The Company continues to closely monitor the impact of the COVID-19 pandemic on all aspects of its business and may take further actions as may be required by federal, state or local authorities, or that the Company determines are in the best interests of its employees, customers and partners. As the conditions surrounding the COVID-19 pandemic continue to evolve rapidly, the Company will continue to actively manage its response in collaboration with customers, government officials and stakeholders, and assess any potential impacts to the Company's financial position and operating results, as well as adverse developments in its business.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_Covid19Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Covid-19</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_Covid19Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_EffectOfCovid19PandemicTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for effects of COVID-19 pandemic.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_EffectOfCovid19PandemicTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248407480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and all wholly owned organizations. All intercompany transactions and account balances have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in two reportable segments, Integrated Therapy Services (&#8220;ITS&#8221;) and Durable Medical Equipment Services (&#8220;DME Services&#8221;) based on management's view of its business for purpose of evaluating performance and making operating decisions. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s approach is to make operational decisions and assess performance based on delivering products and services that together provide solutions to its customer base utilizing a functional management structure. Based upon this business model, the Company&#8217;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker, reviews segment financial information. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i9e717b65c1e3405d850ef6e342b20071_1859" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 14</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for segment disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates, assumptions and judgments that affect the amounts reported in the financial statements, including the notes thereto. The Company considers critical accounting policies to be those that require more significant judgments and estimates in the preparation of its consolidated financial statements, including the following: revenue recognition, leases, accounts receivable and allowance for doubtful accounts, income taxes, equity compensation valuations, and long-lived asset valuations. Management relies on </span></div>historical experience and other assumptions believed to be reasonable in making its judgments and estimates. Actual results could differ materially from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for all business combinations using the acquisition method of accounting, which allocates the fair value of the purchase consideration to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions. The Company may utilize third-party valuation specialists to assist the Company in the allocation. For intangible assets, the Company typically uses the income approach to determine their estimated fair values.  Key estimates and assumptions in that approach include the amount and timing of projected future cash flow, the discount rate selected to measure the risks inherent in those cash flows and the assessment of the asset's useful life.  Initial purchase price allocations are subject to revision within the measurement period, not to exceed one year from the date of acquisition. Acquisition-related expenses and transaction costs associated with business combinations are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company maintains substantially all of its cash and cash equivalents primarily with two financial institutions that are insured with the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). At times throughout the year, cash and cash equivalents balances might exceed FDIC insurance limits. Accounts at banks with an aggregate excess of the amount of outstanding checks over the cash balances are included in accounts payable in current liabilities in the consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts billed that have not yet been collected that also meet the conditions for unconditional right to payment are presented as accounts receivable. Accounts receivable related to rental service and delivery of products are reported at their estimated transaction prices, inclusive of adjustments for variable consideration, based on the amounts expected to be collected from payers. The Company writes off accounts receivable once collection efforts have been exhausted and an account is deemed to be uncollectible. An allowance for doubtful accounts is established as a result of an adverse change in the Company&#8217;s payers&#8217; ability to pay outstanding billings. The allowance for doubtful accounts was $1.1 million and $1.0 million as of December&#160;31, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s inventories consist of disposable medical supplies, replacement parts and other supplies used in conjunction with medical equipment and are stated at the lower of cost (first-in, first-out basis) or net realizable value. Cost primarily represents the purchase price paid for the items on hand. The Company periodically performs an analysis of slow-moving inventory and records an adjustment to reflect the recoverable amount.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentPolicyTextBlock', window );">Medical Equipment</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Equipment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment (&#8220;Equipment&#8221;) consists of equipment that the Company purchases from third-parties and is (1) for sale or rent, and (2) used in service to generate rental revenue. Equipment, once placed into service, is depreciated using the straight-line method over the estimated useful lives of the equipment which is typically seven years. The Company does not depreciate Equipment held for sale or rent. When Equipment in rental service assets are sold, or otherwise disposed, the cost and related accumulated depreciation are removed from the accounts and a gain or loss is recorded in the current period. The Company periodically performs an analysis to identify potentially missing  Equipment and records a reserve equal to the underlying net book value, which was $1.1 million and $0.9 million as of December&#160;31, 2021 and 2020, respectively. The Company performs a similar analysis of slow-moving Equipment for sale or rent and records a reserve, which was less than $0.1 million as of both December&#160;31, 2021 and 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation of Medical Equipment in the Consolidated Statements</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases medical equipment directly for sale as well as medical equipment that is purchased for either rental or sale and that is unallocated at the time of purchase (&#8220;Unallocated Assets&#8221;). Management believes that the predominant source of revenues and cash flows from the Unallocated Assets is from rentals and most equipment purchased is likely to be rented prior to being sold. The Company concluded that (i) the assets specifically supporting its two primary revenue streams should be separately disclosed on the balance sheet; (ii) the purchase and sale of Unallocated Assets should be classified solely </span></div>in investing cash flows based on their predominant source while medical equipment purchased specifically for sales activity should be classified in operating cash flows; and (iii) other activities ancillary to the rental process should be consistently classified.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at acquired cost and depreciated using the straight-line method over the estimated useful lives of the related assets, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY3ODU_89ea2bad-0ac3-4d89-9bff-0b3592eb4de5">three</span> to seven years. Externally purchased information technology software and hardware are depreciated over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY4ODI_16fecb86-c446-4994-8930-6e54f72298e6">three</span> and five years, respectively. Leasehold improvements are amortized using the straight-line method over the life of the asset or the remaining term of the lease, whichever is shorter. Maintenance and minor repairs are charged to operations as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is recorded in the current period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">GoodwillGoodwill is tested for impairment annually or when events occur or circumstances change that trigger a review. Management has the option to first assess qualitative factors such as current performance and overall economic conditions to determine whether or not it is necessary to perform a quantitative goodwill impairment test. If the Company chooses that option, then the Company would not be required to perform a quantitative goodwill impairment test unless the Company determines that, based on a qualitative assessment, it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company determines that an impairment is more likely than not, or if the Company chooses not to perform a qualitative assessment, the Company will then proceed with the quantitative assessment. Under the quantitative test, if the fair value of a reporting unit exceeds its carrying amount, then goodwill of the reporting unit is considered to not be impaired. If the carrying amount of the reporting unit exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess, up to the value of the goodwill. The Company performed its annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that there was no impairment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of trade names, physician and customer relationships, unpatented technology, non-competition agreements and software. The Company amortizes the value assigned to the physician and customer relationships on a straight-line basis over the period of expected benefit, which ranges from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzc2NzA_787bbc1d-efca-48b5-9bc6-20acf41ccb09">fifteen</span> to twenty years. The acquired physician and customer relationship base represents a valuable asset of the Company due to the expectation of future business opportunities to be leveraged from the existing relationship with each physician and customer. The Company has long-standing relationships with numerous oncology clinics, physicians, home care and home infusion providers, skilled nursing facilities, pain centers and others. The useful lives of these relationships are based on the expected attrition rates. Acquired software is amortized on a straight-line basis over the period of expected benefit, which ranges from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzgzMTA_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1">three</span> to five years. Acquired unpatented technology arose from recent acquisitions and is amortized on a straight-line basis over the period of expected benefit, which is seven years. This asset represents acquired knowledge of repair solutions that will be leveraged into opportunities into the acute care market. The non-competition agreements arose from recent acquisitions and are amortized on a straight-line basis over the terms of the agreements, which is five years. Trade names associated with the original acquisition of InfuSystem are not amortized.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management tests indefinite life trade names for impairment annually or more frequently if deemed necessary. Management has the option of first performing the impairment test for intangible assets with indefinite lives on a qualitative basis, by evaluating factors to determine whether it is more likely than not that an impairment exists. If it is more likely than not that an impairment exists, then a quantitative impairment test is performed. Impairment exists when the carrying amount of the intangible asset exceeds its fair value. If the carrying value of the intangible assets exceeds the fair value, an impairment loss is recognized in an amount equal to that excess. The Company performed its annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that the fair value of the trade names with indefinite lives was greater than their carrying value, resulting in no impairment.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizationOfInternalCostsPolicy', window );">Software Capitalization and Depreciation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software Capitalization and Depreciation</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software project, external direct costs of materials and services and interest costs while developing the software. Capitalized software costs are included in intangible assets, net and are amortized using the straight-line method over the estimated useful life of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzODg_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1">three</span> to five years. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs, are </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expensed in the period in which they are incurred. The Company capitalized $0.3 million of internal-use software for the year ended December&#160;31, 2021 and did not capitalize any internal-use software for the year ended  December&#160;31, 2020. Amortization expense for capitalized software was $1.6 million in 2021, $1.9 million in 2020 and $2.0 million in 2019.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses impairment indicators related to its internally-developed, internal-use software, specifically looking at the effectiveness and useful lives of each project and sub-project to determine if impairment indicators are present. For the year ended December&#160;31, 2021, the Company assessed the impairment indicators and found none to be present.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets held for use, which includes medical equipment in rental service, property and equipment and amortizable intangible assets, are reviewed for impairment when events or changes in circumstances indicate that their carrying value may not be recoverable. If an impairment indicator exists, the Company assesses the asset or asset group for recoverability. Recoverability of these assets is determined based upon the expected undiscounted future net cash flows from the operations to which the assets relate, utilizing management&#8217;s best estimates, appropriate assumptions and projections at the time. If the carrying value is determined not to be recoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair market value of the asset or asset group. For the years ended December&#160;31, 2021, 2020 and 2019, respectively, the Company assessed the impairment indicators and found none to be present.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019 (the &#8220;Effective Date&#8221;), the Company adopted Accounting Standards Codification ("ASC") Topic 842, Leases,("Topic 842"),  using a modified retrospective transition approach. Under Topic 842, lessees are required to recognize a lease liability and right-of-use asset (&#8220;ROU asset&#8221;) for all leases and to disclose key information about leasing arrangements. Additionally, leases are classified as either financing or operating; the classification determines the pattern of expense recognition and classification within the statement of operations. The Company elected to apply its lease accounting policy only to leases with a term greater than twelve months.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic 842 provides several optional practical expedients that the Company adopted at transition. The Company elected the &#8220;package of practical expedients&#8221;, which does not require it to reassess its prior conclusions regarding lease identification, lease classification and initial direct costs. The Company did not elect the practical expedient of hindsight to the evaluation of lease options (e.g. renewal).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Topic 842 also provides practical expedients for an entity&#8217;s ongoing accounting. The Company elected the &#8220;combining lease and non-lease components&#8221; practical expedient and also elected to apply the short-term lease recognition exemption to certain leases; therefore, the Company did not recognize ROU assets and lease liabilities for these leases.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In adopting Topic 842, the Company determined and will continue to determine whether an arrangement is a lease at inception. The Company&#8217;s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next ten years. The Company&#8217;s leases do not contain any restrictive covenants. The Company&#8217;s office leases generally contain renewal options for periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEzNTUy_9f2fcc91-aee1-47c3-a7b5-103597d961a0">one</span> to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company&#8217;s office leases do not contain any material residual value guarantees. The Company&#8217;s equipment leases generally do not contain renewal options. The Company is not reasonably certain to exercise the renewal options for those equipment leases that do contain renewal options, thus, the options are not considered in determining the lease term and payments associated with the option years are excluded from lease payments.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s equipment leases, the Company used and will use the implicit rate in the lease as the discount rate, when available. Otherwise, the Company uses its incremental borrowing rate as the discount rate. For the Company&#8217;s office leases, the implicit rate is typically not available, so the Company used and will use its incremental borrowing rate as the discount rate. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The Company&#8217;s lease agreements include both lease and non-lease components. The Company elected the practical expedient that allows it to combine lease and non-lease components for all of its leases.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments due under the Company&#8217;s operating leases include fixed payments as well as variable payments. For the Company&#8217;s office leases, variable payments include amounts for the Company&#8217;s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company&#8217;s equipment leases, variable payments may consist of sales taxes, property taxes and other fees.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized at the time and in an amount that reflects the consideration expected to be received for the performance obligations that have been provided. ASC Topic 606 &#8211; Revenue from Contracts with Customers (&#8220;ASC 606&#8221;) defines contracts as written, oral and through customary business practice. Under this definition, the Company considers contracts to be created at the time that the rental service is authorized or an order to purchase product is agreed upon regardless of whether or not there is a written contract.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three separate and distinct performance obligations offered to its customers: a rental service performance obligation, a product sale performance obligation and a service performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is defined as the unit of account for revenue recognition under ASC 606. These performance obligations are related to separate revenue streams and at no point are they combined into a single transaction. Sources of net revenues include commercial insurance payers, government insurance payers, medical facilities and patients.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue from the rental of infusion pumps to its customers and a minority of its revenue from product sales and services. For the rental service performance obligation, revenue is based on its standalone price, determined by using reimbursement rates established by third-party payer or other contracts. Revenue is recognized in the period in which the related performance obligation is satisfied, which is typically at the point in time that a patient concludes a treatment, or in certain arrangements, based on the number of pumps that a facility has onsite. The Company&#8217;s revenues related to product sales are recognized at the time that control of the product has been transferred to the customer; either at the time the product is shipped or the time the product has been received by the customer, depending on the delivery terms. The Company does not commit to long-term contracts to sell customers a certain minimum quantity of products. The Company's revenues related to services are recognized at the time that the service work has been completed.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company employs certain significant judgments to estimate the dollar amount of revenue, and related concessions, allocated to the rental service. These judgments include, among others, the estimation of variable consideration. Variable consideration, specifically related to the Company&#8217;s third-party payer rental revenues, is estimated as implied price concessions resulting from differences between the rates charged for services performed and the expected reimbursements for commercial payers and other implied customer concessions. The estimates for variable consideration are based on historical collections with similar payers, aged accounts receivable by payer class and payer correspondence using the portfolio approach, which provide a reasonable basis for estimating the variable portion of a transaction. The Company doesn&#8217;t believe it is probable that a significant reversal of revenue will occur in future periods because (i) there is no significant uncertainty about the amount of considerations that are expected to be collected based on collection history and (ii) the large number of sufficiently similar contracts allows the Company to adequately estimate the component of variable consideration.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues are adjusted when changes in estimates of variable consideration occur. Changes in estimates typically arise as a result of new information obtained, such as actual payment receipt or denial, or pricing adjustments by payers. Subsequent changes to estimates of transaction prices are recorded as adjustments to net revenue in the period of the change. Subsequent changes that are determined to be the result of an adverse change in the payer&#8217;s ability to pay are recorded as an allowance for doubtful accounts.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the industry and the reimbursement environment in which the Company operates, certain estimates are required to record net revenues and accounts receivable at their net realizable values. Inherent in these estimates is the risk that the estimates will have to be revised or updated as additional information becomes available. Specifically, the complexity of many third-party billing arrangements and the uncertainty of reimbursement amounts for certain services from certain payers may result in adjustments to amounts originally recorded. Due to continuing changes in the health care industry and third-party reimbursement, it is possible that management&#8217;s estimates could change in the near term, which could have a material impact on the Company&#8217;s results of operations and cash flows.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock', window );">Cost of Revenues</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenues</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues include the costs of servicing and maintaining pumps, products and services sold, shipping and other direct and indirect costs related to net revenues. Shipping and handling costs incurred after control over a product has transferred to a customer are accounted for as a fulfillment cost.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Customer Concentration</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Concentration</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had contracts with nearly 770 third-party payer networks, an increase of 6% over the prior year period. Material terms of contracts with third-party payer organizations are typically a pre-negotiated fee </span></div>schedule rate or a then-current proprietary fee schedule rate for equipment and supplies provided. The majority of these contracts generally provide for a term of one year, with automatic one-year renewals, unless the Company or the contracted payer elect not to renew. The Company also contracts with various other third-party payer organizations, Medicaid, commercial Medicare replacement plans, self-insured plans, facilities of its Medicare patients and numerous other insurance carriers. No single payer or customer represented more than 10% of the Company's net revenue in 2021, 2020 or 2019.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred&#160;income tax liabilities and assets based on (i) the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and (ii) the tax credit carryforwards. Deferred income tax (expense) benefit results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all of any deferred tax assets will not be realized.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for federal, state and foreign taxes are calculated based on reported pre-tax earnings based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities.&#160;Certain items of income and expense are recognized in different time periods for financial reporting than for income tax purposes; thus, such provisions differ from the amounts currently receivable or payable.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows a two-step approach for recognizing uncertain tax positions. First, it evaluates the tax position for recognition by determining if the weight of available evidence indicates it is more-likely-than-not that the position will be sustained upon examination. Second, for positions that are determined are more-likely-than-not to be sustained, it recognizes the tax benefits as the largest benefit that has a greater than 50% likelihood of being sustained. The Company establishes a reserve for uncertain tax positions liability that is comprised of unrecognized tax benefits and related interest and penalties. The Company adjusts this liability in the period in which an uncertain tax position is effectively settled, the statute of limitations expires for the relevant taxing authority to examine the tax position, or more information becomes available.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted Accounting Standards Update ("ASU") 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, in the fourth quarter of 2019. This guidance simplifies various aspects related to accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. The guidance was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption was permitted, including adoption in any interim period for which financial statements had not yet been issued. Certain amendments may have been applied on a retrospective, modified retrospective or prospective basis. As permitted, the Company elected to early adopt this guidance for the year ended December&#160;31, 2019. The adoption of this guidance did not have a significant impact on the Company&#8217;s financial statements and primarily resulted in the reclassification of an immaterial amount from non-income tax expense to income tax expense related to the accounting for franchise taxes, with no impact to the Company&#8217;s consolidated net income, equity or cash flows.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_TreasuryStockPolicyPolicyTextBlock', window );">Treasury Stock</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically repurchases shares of its common stock. These repurchases take place either as part of a board-authorized program, which may include open market transactions or privately negotiated transactions and may be made under a Rule 10b5-1 plan, or in targeted stock purchase agreements approved by the board. Treasury stock is accounted for using the par value method. In 2021, the Company retired the approximately 3,500,000 shares that were previously held in treasury.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Payments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Payments</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of stock option awards, restricted stock awards and stock appreciation rights (collectively, &#8220;Share-Based Awards&#8221;) on the date of grant using either the grant date price of the Company's common stock or option-pricing models which are affected by the Company&#8217;s stock price, as well as assumptions regarding a number of other inputs using the Black-Scholes pricing model. These variables include the Company&#8217;s expected stock price volatility over the expected term of the Share-Based Awards, actual and projected employee stock option exercise behaviors, risk-free interest rates and expected dividends. The expected volatility is based on the historical volatility. The expected term represents the period over which the Share-Based Awards are expected to be outstanding. The dividend yield is an estimate of the expected dividend yield on the Company&#8217;s stock. The risk-free rate is based on U.S. Treasury yields in effect at the time of the grant for the expected term of the Share-Based Awards. Forfeitures are recognized as they occur. All Share-Based Awards are amortized based on their graded vesting over the requisite service period of the awards. Compensation costs are recognized over the requisite service period using the accelerated method and included in general and administrative expenses.</span></div>Additionally, the Company also determines the fair value of performance-based restricted stock units (&#8220;PSUs&#8221;) based upon the type of performance measure. These awards typically vest after the Company&#8217;s achievement of either a specific Company performance metric or when the market value of the Company&#8217;s stock meets a specific metric such as when the closing price of the Company's stock reaches a target value for a minimum number of consecutive trading days. Under Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC Topic 718, the provisions of the PSUs that vest upon achievement of a target market value are considered a market condition, and therefore the effect of that market condition is reflected in the grant date fair value for this type of award. A third-party valuation expert was engaged to complete a &#8220;Monte Carlo simulation&#8221; to account for the market condition. That simulation takes into account the beginning stock price of the Company&#8217;s common stock, the expected volatilities for the Company&#8217;s stock price and the expected risk-free rate of return. The single grant-date fair value computed by this valuation method is recognized by the Company in accounting for the awards regardless of the actual future outcome of the market condition. Compensation costs are accelerated if the market condition is satisfied prior to the end of the service period derived under the Monte Carlo simulation. The grant date fair value of the other PSUs is calculated as the closing price of the Company&#8217;s common stock on the grant date multiplied by the number of shares estimated to be delivered subject to the award terms. Company performance measure goals are considered a performance condition and the timing and amount of compensation cost for those PSUs corresponds with management&#8217;s expectation of the probable outcome of the performance conditions as of the grant date and during the vesting period.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Debt Issuance Costs</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Debt Issuance Costs</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized debt issuance costs as of December&#160;31, 2021 and 2020 relate to the Company&#8217;s credit facility. The costs related to the agreement are netted against current and non-current debt. The Company amortizes these costs using the interest method through the maturity date of the underlying debt.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its earnings per share in accordance with ASU 2017-11, Earnings Per Share (Topic 260), which requires the presentation of both basic and diluted earnings per share on the statements of operations. The diluted weighted average common shares include adjustments for the potential effects of outstanding stock options but only in the periods in which such effect is dilutive under the treasury stock method. Included in our basic and diluted weighted average common shares are those stock options and restricted stock awards due to participants granted from the 2014 and 2021 stock incentive plans. Anti-dilutive stock awards are comprised of stock options and unvested restricted stock awards, which would have been anti-dilutive in the application of the treasury stock method in accordance with ASU 2017-11, Earnings Per Share (Topic 260). In periods where the Company records a net loss, the diluted per share amount is the same as the basic per share amount.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes all derivative financial instruments as cash flow hedges which are shown as either assets or liabilities on the Company&#8217;s consolidated balance sheets at fair value. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in fair value of the derivative is recorded to accumulated other comprehensive income (&#8220;AOCI&#8221;) in the consolidated balance sheets. The underlying hedge transaction is realized when the interest payments </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on debt are accrued; the applicable amount of gain or loss included in AOCI is reclassified into earnings in the consolidated statements of operations on the same line as the gain or loss on the hedged item attributable to the hedged risk. The cash flows from derivatives are classified as operating activities.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a policy of requiring that all derivative instruments be governed by an International Swaps and Derivatives Association Master Agreement and settles on a net basis.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s derivative financial instruments are categorized as Level 2 of the fair value hierarchy as the values are derived using the market approach based on observable market inputs including quoted prices of similar instruments and interest rate forward curves.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported in the consolidated balance sheets as of December&#160;31, 2021 and 2020 for cash, accounts receivable, accounts payable and other current liabilities approximate fair value because of the short-term nature of these instruments (Level I). The carrying value of the Company&#8217;s long-term debt with variable interest rates approximates fair value based on instruments with similar terms (Level II).</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted ASC 820, Fair Value Measurements, which defines fair value, establishes a framework for assets and liabilities being measured and reported at fair value and appends disclosures about fair value measurements.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial assets and liabilities measured at fair value on a recurring basis, fair value is the price the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction with a market participant at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value as follows:</span></div><div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Level I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;&#160;&#160;quoted prices in active markets for identical instruments;</span></div><div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Level II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;&#160;&#160;quoted prices in active markets for similar instruments, quoted prices for identical instruments in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the instrument; and</span></div><div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Level III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:&#160;&#160;&#160;&#160;significant inputs to the valuation model are unobservable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements and Developments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements and Developments</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has adopted ASU 2020-04, Reference Rate Reform (Topic 848), which contains optional expedients for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Inter-bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope." This ASU clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition.  The Company has elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2016, the FASB issued ASU No. 2016-13, &#8220;Financial Instruments (Topic 326) Credit Losses&#8221;. Topic 326 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. Topic 326 was originally effective as of January 1, 2020, although in November 2019, the FASB delayed the effective date until fiscal years beginning after December 15, 2022 for SEC filers eligible as of the FASB's deferral date to be smaller reporting companies under the SEC&#8217;s definition. The Company qualified as a smaller reporting company in November 2019 when the FASB delayed the effective date of Topic 326. Early adoption is permitted. The Company is currently evaluating the impact of Topic 326 on its consolidated balance sheets, statements of operations, statements of cash flows and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for medical equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_RevenueRecognitionCostOfRevenuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the cost of revenue for servicing and maintaining products sold including shipping and handling costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_RevenueRecognitionCostOfRevenuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_TreasuryStockPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for policy of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_TreasuryStockPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizationOfInternalCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for capitalizing internal costs associated with exploration and production activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 360<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123726384&amp;loc=d3e516343-122869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123726172&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizationOfInternalCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246114792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with this topic, the following table reconciles income and share amounts utilized to calculate basic and diluted net income per common share:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:58.176%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerator (in thousands):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income:</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,519,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,106,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,731,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dilutive effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,529,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,610,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,107,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,049,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,717,216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,839,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248698872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text">The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">FilAMed</span></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consideration</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,250&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,650&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Working capital adjustment, paid in cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FilAMed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment held for sale or rental</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(288)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - purchase price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">FilAMed</span></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consideration</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,250&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,650&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Working capital adjustment, paid in cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FilAMed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment held for sale or rental</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(288)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - purchase price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the breakdown of the identified intangible assets acquired into major intangible asset classes for both acquisitions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Thousands)</span></div></td><td colspan="3" style="padding:0 1pt 0 32.57pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted-Average</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization Period</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Years)</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,300&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unpatented technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total intangible assets (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.2</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) There was no residual value, renewal terms or extensions associated with any intangible assets acquired.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text">The following pro forma financial information presented also includes the pro forma depreciation and amortization charges from acquired tangible and intangible assets for the years ended December&#160;31 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 77.57pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">103,152&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100,032&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246335656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s disaggregated revenue by offering type (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-Party Payer Rentals</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,847&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,266&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,510&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct Payer Rentals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102,382&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97,388&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246146488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentAbstract', window );"><strong>Medical Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ScheduleOfMedicalEquipmentTableTextBlock', window );">Schedule of Medical Equipment</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical equipment consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment for sale or rental</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment for sale or rental - pump reserve</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment for sale or rental - net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,603&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment in rental service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment in rental service - pump reserve</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,074)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(50,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Equipment in rental service - net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,871&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,611&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,214&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ScheduleOfMedicalEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of medical equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ScheduleOfMedicalEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246214840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.164%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated<br/>Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture, fixtures, and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,528)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,018)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Automobiles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,843)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,523&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,979)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,296&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502247786552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying value of goodwill by segment are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services (a)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) The ITS segment has no recorded goodwill. </span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock', window );">Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount and accumulated amortization of intangible assets were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonamortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physician and customer relationships</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(31,401)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28,924)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpatented technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11,258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total nonamortizable and amortizable intangible assets</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,802&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(42,872)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,930&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,787&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38,610)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected remaining annual amortization expense for the next five years for intangible assets recorded as of December&#160;31, 2021 is as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.643%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2027 and <br/>thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount and accumulated amortization of identifiable intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248321032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Line of Credit Facilities</a></td>
<td class="text">The following table illustrates the net availability under the revolving credit facilities as of the applicable balance sheet date (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Facility:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross availability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding draws</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Landlord reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Availability on Revolving Facility</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,426&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,788&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had future maturities of its long-term debt as of December&#160;31, 2021 as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.582%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2027 and <br/>thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a breakdown of the Company&#8217;s current and long-term debt (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.581%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term<br/>Portion</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment line</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019 equipment line</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,974&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,397&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,427&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized value of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">349&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,748&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,097&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,423&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,378&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,801&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502247404424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the location and gross fair value amounts of the Company's derivative financial instruments and the associated notional amounts designated as cash flow hedges (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December&#160;31, 2021 (a)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair Value Derivative Assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 32.57pt 0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">355</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:40.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) No derivative instruments existed at December&#160;31, 2020.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the effect of our derivative financial instruments designated as hedging instruments in AOCI (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.100%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December&#160;31, 2021 (a)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Gain on cash flow hedges - interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unrealized gain recognized in AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">249</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amounts reclassified to interest expense (b)(c)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">106</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(87)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">268</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="9" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) No derivative instruments existed for the years ended December&#160;31, 2020 and December&#160;31, 2019.</span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(b) Positive amounts represented interest expense. Total interest expense as presented in the consolidated statement of operations for the years ended December&#160;31, 2021, 2020 and 2019 were $1.4 million, $1.3 million and $1.9 million, respectively.</span></div></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(c) $0.1 million of expense is expected to be reclassified into earnings within the next 12 months.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246518184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income Before Income Tax, Domestic and Foreign</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s income before income taxes (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,543&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,524&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s components of the consolidated benefit from (provision for) income taxes (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S Federal income tax benefit&#160;(expense)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. Federal income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total state and local income tax (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit (expense)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,789&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity related to the Company&#8217;s valuation allowance (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance at the Beginning of Period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,250)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,370)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance at the End of Period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,250)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes a reconciliation of the Company&#8217;s effective income tax rate to the U.S. federal statutory rate:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at the statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the temporary differences and carryforwards that give rise to deferred tax assets and liabilities (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Federal tax assets &#8211;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt reserves</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research &amp; development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred Federal tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,132&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,997&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Federal tax liabilities &#8211;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and asset basis differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,423)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,393)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(937)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred Federal tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,402)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,330)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred Federal tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,730&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,667&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred state and local tax assets (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,033&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,967&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) At December&#160;31, 2021 and 2020, this includes state and local net operating losses of $1.3 million and $1.2 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502247417480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s operating lease costs consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information and non-cash activity related to the Company&#8217;s leases are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities and ROU assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions to ROU assets resulting from reductions to lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease terms and discount rates for the Company&#8217;s operating leases are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future maturities of lease liabilities as of December&#160;31, 2021 are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:83.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,434)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246407368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total stock-based compensation expense, which is included in selling, general and administrative expenses (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option and SARs expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit related to stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Nonvested Restricted Stock Shares Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s restricted share activity, excluding the Company&#8217;s employee stock purchase plan:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>grant<br/>date fair<br/>value</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested shares forgone to satisfy minimum statutory withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.61&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of awards granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares forgone to satisfy minimum statutory withholding</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock', window );">Share-based Payment Arrangement, Performance Shares, Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s PSU activity:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>average<br/>grant <br/>date fair value</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested shares forgone to satisfy minimum statutory withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,629)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,976&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.74&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of awards granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares forgone to satisfy minimum statutory withholding</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock', window );">Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity</a></td>
<td class="text">The following table summarizes the activity relating to the Company&#8217;s ESPP program:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares of stock sold to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value per ESPP award</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables detail the various stock option activity:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:44.061%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2014 Plan (Options)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>of Authorized<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term (in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,449,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279,904)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised shares forgone to satisfy minimum statutory withholding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cashless exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.93</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,051,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478,357&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.99&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.36</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,274,817&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:44.061%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 Plan (Options)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>of Authorized<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term (in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021 (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.38</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021 (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,770&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Aggregate Intrinsic Value - no options were in-the-money as of December 31, 2021</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the average fair value per share estimated on the date of grant and the assumptions used for options granted:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock Options:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43% to 46%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42% to 51%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36% to 38%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.31% to 0.54%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.20% to 1.56%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.80% to 2.36%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected lives at date of grant (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.63</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average fair value of options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6.56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.87</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.61</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intrinsic value of options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,248,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,377,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of employee stock purchase plan activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246245800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial information summarized below is presented by reportable segment:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DME Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,753)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,377)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DME Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate/<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,370)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DME Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate/<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,788)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,788)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248407256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Nature of Operations (Details) - Minimum - Cost of Goods and Service, Product and Service Benchmark - Supplier Concentration Risk<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=infu_AmbulatoryPumpsMember', window );">Ambulatory Pumps | Smiths Medical, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=infu_NPWTMedicalEquipmentMember', window );">NPWT Medical Equipment | Cardinal Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=infu_AmbulatoryPumpsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=infu_AmbulatoryPumpsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=infu_SmithsMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=infu_SmithsMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=infu_NPWTMedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=infu_NPWTMedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=infu_CardinalHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=infu_CardinalHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502241370536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>lease </div>
<div>network </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>financialInstitution</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_NumberOfFinancialInstitutions', window );">Number of financial institutions | financialInstitution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for credit loss, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServicesUsefulLife', window );">Medical equipment in rental services, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServicesReserve', window );">Medical equipment in rental services reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,074<span></span>
</td>
<td class="nump">893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentForSaleOrRentalReserve', window );">Medical equipment for sale or rental, reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Capitalized computer software, amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, operating lease, expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_NumberOfContractsWithThirdParties', window );">Number of contracts with third parties | network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PercentageIncreaseInNumberOfContracts', window );">Percentage increase in number of contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock, shares, retired (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets held-for-use</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember', window );">Unpatented technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=infu_InformationTechnologySoftwareMember', window );">Information Technology Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, operating lease, renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Physician and customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentForSaleOrRentalReserve', window );">Medical equipment for sale or rental, reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, operating lease, renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Physician and customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentForSaleOrRentalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of reserve associated with medical equipment for sale or rental, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentForSaleOrRentalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServicesReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of medical equipment in rental services reserve, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServicesReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServicesUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the useful life of medical equipment in rental services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServicesUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_NumberOfContractsWithThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Contracts With Third Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_NumberOfContractsWithThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_NumberOfFinancialInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of financial institutions where the entity maintains its cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_NumberOfFinancialInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_PercentageIncreaseInNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Increase in Number of Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_PercentageIncreaseInNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=infu_InformationTechnologySoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=infu_InformationTechnologySoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=infu_PhysicianAndCustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=infu_PhysicianAndCustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502249590360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Income and Share Amounts Utilized to Calculate Basic and Diluted Net Income Per Common Share (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,420<span></span>
</td>
<td class="nump">$ 17,332<span></span>
</td>
<td class="nump">$ 1,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">20,519,958<span></span>
</td>
<td class="nump">20,106,940<span></span>
</td>
<td class="nump">19,731,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of common stock equivalents (in shares)</a></td>
<td class="nump">1,529,701<span></span>
</td>
<td class="nump">1,610,276<span></span>
</td>
<td class="nump">1,107,898<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">22,049,659<span></span>
</td>
<td class="nump">21,717,216<span></span>
</td>
<td class="nump">20,839,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">368,056<span></span>
</td>
<td class="nump">18,321<span></span>
</td>
<td class="nump">25,669<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502241314728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 18, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition costs and non-recurring expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,976<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember', window );">OB Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses, gross</a></td>
<td class="nump">$ 6,100<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember', window );">OB Healthcare | Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense', window );">Pro forma acquisition cost and non-recurring expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma acquisition cost and non-recurring expense for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242547848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Purchase Price Allocation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments', window );">Cash</a></td>
<td class="nump">$ 7,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_WorkingCapital', window );">Working capital adjustment, paid in cash</a></td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total - consideration</a></td>
<td class="nump">8,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember', window );">FilAMed</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments', window );">Cash</a></td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_WorkingCapital', window );">Working capital adjustment, paid in cash</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total - consideration</a></td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember', window );">OB Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments', window );">Cash</a></td>
<td class="nump">6,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_WorkingCapital', window );">Working capital adjustment, paid in cash</a></td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total - consideration</a></td>
<td class="nump">$ 7,325<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Business, Excluding Working Capital Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of working capital adjustments incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242228728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Apr. 18, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">$ 725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental', window );">Medical equipment held for sale or rental</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">4,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets</a></td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Operating lease liabilities</a></td>
<td class="num">(288)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total - purchase price</a></td>
<td class="nump">$ 8,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember', window );">FilAMed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental', window );">Medical equipment held for sale or rental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total - purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember', window );">OB Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental', window );">Medical equipment held for sale or rental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total - purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of medical equipment in rental service recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating lease right of use asset recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242489848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Intangible Assets Acquired (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquisition date fair value</a></td>
<td class="nump">$ 4,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">11 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquisition date fair value</a></td>
<td class="nump">$ 2,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Unpatented technology</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquisition date fair value</a></td>
<td class="nump">$ 943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquisition date fair value</a></td>
<td class="nump">$ 472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquisition date fair value</a></td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248109944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Pro Forma Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 103,152<span></span>
</td>
<td class="nump">$ 100,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,936<span></span>
</td>
<td class="nump">$ 16,498<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502241343736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 102,382<span></span>
</td>
<td class="nump">$ 97,388<span></span>
</td>
<td class="nump">$ 81,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=infu_DirectPayerRentalsMember', window );">Direct Payer Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">29,302<span></span>
</td>
<td class="nump">28,525<span></span>
</td>
<td class="nump">24,116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=infu_DirectPayerRentalsMember', window );">Direct Payer Rentals | ITS Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">11,800<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=infu_DirectPayerRentalsMember', window );">Direct Payer Rentals | DME Services Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">16,800<span></span>
</td>
<td class="nump">16,700<span></span>
</td>
<td class="nump">13,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">15,514<span></span>
</td>
<td class="nump">$ 17,357<span></span>
</td>
<td class="nump">$ 14,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Sales | ITS Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Sales | DME Services Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 15,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=infu_DirectPayerRentalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=infu_DirectPayerRentalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502249660984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 102,382<span></span>
</td>
<td class="nump">$ 97,388<span></span>
</td>
<td class="nump">$ 81,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=infu_ThirdPartyPayerRentalMember', window );">Third-Party Payer Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">52,847<span></span>
</td>
<td class="nump">49,266<span></span>
</td>
<td class="nump">40,510<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=infu_DirectPayerRentalsMember', window );">Direct Payer Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">29,302<span></span>
</td>
<td class="nump">28,525<span></span>
</td>
<td class="nump">24,116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">15,514<span></span>
</td>
<td class="nump">17,357<span></span>
</td>
<td class="nump">14,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 4,719<span></span>
</td>
<td class="nump">$ 2,240<span></span>
</td>
<td class="nump">$ 2,153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Third-Party Payer Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">51.60%<span></span>
</td>
<td class="nump">50.60%<span></span>
</td>
<td class="nump">49.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Direct Payer Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">28.60%<span></span>
</td>
<td class="nump">29.30%<span></span>
</td>
<td class="nump">29.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Product Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">15.20%<span></span>
</td>
<td class="nump">17.80%<span></span>
</td>
<td class="nump">17.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Customer Concentration Risk | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=infu_ThirdPartyPayerRentalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=infu_ThirdPartyPayerRentalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=infu_DirectPayerRentalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=infu_DirectPayerRentalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248575144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Equipment (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentAbstract', window );"><strong>Medical Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DepreciationExpenseRelatedToMedicalEquipment', window );">Depreciation expense related to medical equipment</a></td>
<td class="nump">$ 9.4<span></span>
</td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DepreciationExpenseRelatedToMedicalEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of depreciation expense related to medical equipment recorded during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DepreciationExpenseRelatedToMedicalEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248766824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Equipment - Summary of Medical Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentAbstract', window );"><strong>Medical Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentHeldForSaleOrRentalGross', window );">Medical Equipment for sale or rental</a></td>
<td class="nump">$ 1,788<span></span>
</td>
<td class="nump">$ 1,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentForSaleOrRentalReserve', window );">Medical Equipment for sale or rental - pump reserve</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentHeldForSaleOrRental', window );">Medical Equipment for sale or rental - net</a></td>
<td class="nump">1,742<span></span>
</td>
<td class="nump">1,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServicesGross', window );">Medical Equipment in rental service</a></td>
<td class="nump">91,891<span></span>
</td>
<td class="nump">83,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServicesReserve', window );">Medical Equipment in rental service - pump reserve</a></td>
<td class="num">(1,074)<span></span>
</td>
<td class="num">(893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(50,946)<span></span>
</td>
<td class="num">(46,907)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation', window );">Medical Equipment in rental service - net</a></td>
<td class="nump">39,871<span></span>
</td>
<td class="nump">35,611<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentNet', window );">Total</a></td>
<td class="nump">$ 41,613<span></span>
</td>
<td class="nump">$ 37,214<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentForSaleOrRentalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of reserve associated with medical equipment for sale or rental, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentForSaleOrRentalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentHeldForSaleOrRental">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents medical equipment held for sale or rental as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentHeldForSaleOrRental</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentHeldForSaleOrRentalGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents medical equipment held for sale or rental as of the balance sheet date, before reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentHeldForSaleOrRentalGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents medical equipment in rental service, net of accumulated depreciation, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of accumulated depreciation related to medical equipment in rental services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServicesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the gross amount of medical equipment in rental services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServicesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServicesReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of medical equipment in rental services reserve, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServicesReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the net amount of medical equipment, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242584808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Assets</a></td>
<td class="nump">$ 8,366<span></span>
</td>
<td class="nump">$ 7,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="num">(3,843)<span></span>
</td>
<td class="num">(2,979)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">4,523<span></span>
</td>
<td class="nump">4,296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Assets</a></td>
<td class="nump">4,812<span></span>
</td>
<td class="nump">3,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="num">(2,528)<span></span>
</td>
<td class="num">(2,018)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">2,284<span></span>
</td>
<td class="nump">1,724<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Assets</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="num">(103)<span></span>
</td>
<td class="num">(102)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Assets</a></td>
<td class="nump">3,444<span></span>
</td>
<td class="nump">3,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="num">(1,212)<span></span>
</td>
<td class="num">(859)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">$ 2,232<span></span>
</td>
<td class="nump">$ 2,557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502249708792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationNonproduction', window );">Depreciation, nonproduction</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationNonproduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationNonproduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502240008280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,710<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">$ 4,262<span></span>
</td>
<td class="nump">$ 4,285<span></span>
</td>
<td class="nump">$ 4,402<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242586056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Goodwill (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">3,710,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember', window );">DME Services Segment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">3,710,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">3,710,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember', window );">ITS Segment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242456280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Trade names</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(42,872)<span></span>
</td>
<td class="num">(38,610)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total nonamortizable and amortizable intangible assets, gross</a></td>
<td class="nump">53,802<span></span>
</td>
<td class="nump">49,787<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total nonamortizable and amortizable intangible assets, net</a></td>
<td class="nump">10,930<span></span>
</td>
<td class="nump">11,177<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross assets</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=infu_PhysicianAndCustomerRelationshipsMember', window );">Physician and customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross assets</a></td>
<td class="nump">38,834<span></span>
</td>
<td class="nump">36,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(31,401)<span></span>
</td>
<td class="num">(28,924)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">7,433<span></span>
</td>
<td class="nump">7,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Unpatented technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross assets</a></td>
<td class="nump">943<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(123)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">820<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross assets</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(67)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">405<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross assets</a></td>
<td class="nump">11,530<span></span>
</td>
<td class="nump">11,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(11,258)<span></span>
</td>
<td class="num">(9,663)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 272<span></span>
</td>
<td class="nump">$ 1,567<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=infu_PhysicianAndCustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=infu_PhysicianAndCustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502341646808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 2,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">2027 and thereafter</a></td>
<td class="nump">$ 3,122<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502239093752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details Textual)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 15, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,397,000<span></span>
</td>
<td class="nump">$ 33,397,000<span></span>
</td>
<td class="nump">$ 38,867,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,974,000<span></span>
</td>
<td class="nump">32,974,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit facility, current borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="nump">11,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,974,000<span></span>
</td>
<td class="nump">$ 32,974,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PercentageOfTotalDepreciationExpense', window );">Percentage of total depreciation expense</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio', window );">Debt instrument, covenant, minimum fixed coverage ratio</a></td>
<td class="nump">1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt instrument, covenant, maximum leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.11%<span></span>
</td>
<td class="nump">2.11%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LIBORRate', window );">LIBOR rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.11%<span></span>
</td>
<td class="nump">0.11%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | ABR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LenderPrimeRate', window );">Lender prime rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | London Interbank Offered Rate (LIBOR) | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Base Rate | ABR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Minimum | London Interbank Offered Rate (LIBOR) | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Minimum | Base Rate | ABR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Maximum | London Interbank Offered Rate (LIBOR) | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Maximum | Base Rate | ABR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Revolving Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions', window );">Revolving credit facility</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Borrowings under revolving credit facility</a></td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2015CreditAgreementMember', window );">The 2015 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2015CreditAgreementMember', window );">The 2015 Credit Agreement | Revolving Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayments</a></td>
<td class="nump">$ 8,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember', window );">Three Term Notes Associated With the 2015 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Term notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember', window );">Credit Facility | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LIBORRate', window );">LIBOR rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.19%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember', window );">Credit Facility | CB Floating Rate Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember', window );">Credit Facility | London Interbank Offered Rate (LIBOR) | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember', window );">Credit Facility | London Interbank Offered Rate (LIBOR) | CB Floating Rate Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate', window );">Debt instrument, basis spread on variable rate, before margin rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember', window );">Credit Facility | CB Floating Rate | CB Floating Rate Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LenderPrimeRate', window );">Lender prime rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember', window );">Credit Facility | Minimum | London Interbank Offered Rate (LIBOR) | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember', window );">Credit Facility | Minimum | Greater of Prime Rate or LIBOR Plus 2.5% | CB Floating Rate Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember', window );">Credit Facility | Maximum | London Interbank Offered Rate (LIBOR) | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember', window );">Credit Facility | Maximum | Greater of Prime Rate or LIBOR Plus 2.5% | CB Floating Rate Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember', window );">Credit Facility | Revolving Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LineOfCreditFacilityBorrowingBase', window );">Line of credit facility, borrowing base</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember', window );">Other financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 423,000<span></span>
</td>
<td class="nump">$ 423,000<span></span>
</td>
<td class="nump">$ 947,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember', window );">Other financing | Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points, excluding the margin rate, added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DebtInstrumentCovenantMaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum leverage ratio required by the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DebtInstrumentCovenantMaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum fixed coverage ratio required by the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DebtInstrumentCovenantMinimumFixedCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LIBORRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the LIBOR rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LIBORRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LenderPrimeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the lender's prime rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LenderPrimeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional borrowing capacity under the credit facility subject to certain conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LineOfCreditFacilityBorrowingBase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of money that a lender is willing to loan a company calculated as the sum of the company's eligible accounts receivable and eligible inventory as define by the credit agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LineOfCreditFacilityBorrowingBase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_PercentageOfTotalDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of total depreciation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_PercentageOfTotalDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=infu_EurodollarLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=infu_EurodollarLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=infu_ABRLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=infu_ABRLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_The2015CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_The2015CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=infu_CBFloatingRateLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=infu_CBFloatingRateLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=infu_CBFloatingRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=infu_CBFloatingRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=infu_GreaterOfPrimeRateOrLIBORPlus25Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=infu_GreaterOfPrimeRateOrLIBORPlus25Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollateralAxis=infu_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollateralAxis=infu_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248417416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details) - Revolving Facility - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Gross availability</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 11,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding draws</a></td>
<td class="num">(32,974)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit</a></td>
<td class="num">(600)<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LandlordReserves', window );">Landlord reserves</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(162)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Availability on Revolving Facility</a></td>
<td class="nump">$ 41,426<span></span>
</td>
<td class="nump">$ 10,788<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LandlordReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of landlord reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LandlordReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242207864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Summary of Future Maturities of Loans (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">32,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2027 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">33,397<span></span>
</td>
<td class="nump">$ 38,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember', window );">Other financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2027 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">947<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">32,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2027 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 32,974<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502238986600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Summary of Company's Current and Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongtermDebtGrossCurrent', window );">Current Portion</a></td>
<td class="nump">$ 423<span></span>
</td>
<td class="nump">$ 9,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtGrossNoncurrent', window );">Long-Term Portion</a></td>
<td class="nump">32,974<span></span>
</td>
<td class="nump">29,427<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">33,397<span></span>
</td>
<td class="nump">38,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_UnamortizedDebtIssuanceExpenseCurrent', window );">Unamortized value of debt issuance costs</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_UnamortizedDebtIssuanceExpenseNoncurrent', window );">Unamortized value of the debt issuance costs, long-term debt</a></td>
<td class="num">(226)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized value of the debt issuance costs, total</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">9,423<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">32,748<span></span>
</td>
<td class="nump">29,378<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">33,097<span></span>
</td>
<td class="nump">38,801<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember', window );">Other financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongtermDebtGrossCurrent', window );">Current Portion</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtGrossNoncurrent', window );">Long-Term Portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">947<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=infu_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongtermDebtGrossCurrent', window );">Current Portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtGrossNoncurrent', window );">Long-Term Portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,305<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongtermDebtGrossCurrent', window );">Current Portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtGrossNoncurrent', window );">Long-Term Portion</a></td>
<td class="nump">32,974<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">32,974<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=infu_EquipmentLineMember', window );">Equipment Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongtermDebtGrossCurrent', window );">Current Portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtGrossNoncurrent', window );">Long-Term Portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=infu_The2019EquipmentLineMember', window );">The 2019 Equipment Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongtermDebtGrossCurrent', window );">Current Portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtGrossNoncurrent', window );">Long-Term Portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LongTermDebtGrossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt, excluding the current portion. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LongTermDebtGrossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LongtermDebtGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of the current portion of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LongtermDebtGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_UnamortizedDebtIssuanceExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of unamortized debt issuance expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_UnamortizedDebtIssuanceExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_UnamortizedDebtIssuanceExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of unamortized debt issuance expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_UnamortizedDebtIssuanceExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=infu_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=infu_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=infu_EquipmentLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=infu_EquipmentLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=infu_The2019EquipmentLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=infu_The2019EquipmentLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502251265224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities (Details Textual) - Interest Rate Swap - Designated as Hedging Instrument - Cash Flow Hedging<br></strong></div></th>
<th class="th">
<div>Feb. 05, 2021 </div>
<div>numberOfAgreement</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Interest rate swap</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed interest rate</a></td>
<td class="nump">0.73%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502241964584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details) - Cash Flow Hedging - Interest Rate Swap - Designated as Hedging Instrument - Other Noncurrent Assets<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Fair value derivative assets</a></td>
<td class="nump">$ 355<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248344104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities - Designated as Hedging Instruments in AOCI (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances</a></td>
<td class="nump">$ 40,752<span></span>
</td>
<td class="nump">$ 22,334<span></span>
</td>
<td class="nump">$ 20,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances</a></td>
<td class="nump">48,272<span></span>
</td>
<td class="nump">40,752<span></span>
</td>
<td class="nump">22,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1,377<span></span>
</td>
<td class="nump">1,255<span></span>
</td>
<td class="nump">$ 1,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Reclassified within twelve months</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gain/(loss) on cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Unrealized gain recognized in AOCI</a></td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified to interest expense</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Tax provision</a></td>
<td class="num">(87)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances</a></td>
<td class="nump">$ 268<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242344200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 15, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_NetOperatingLossCarryforwardsLimitationOnUse', window );">Net operating loss carryforwards limitation on use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RemainingPreownershipNetOperatingLossCarryforwards', window );">Remaining preownership net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance, deferred tax asset, increase (decrease), amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Cash proceeds from long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,191<span></span>
</td>
<td class="nump">37,587<span></span>
</td>
<td class="nump">$ 9,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_PaycheckProtectionProgramCaresActMember', window );">Paycheck Protection Program CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Cash proceeds from long-term debt</a></td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards, total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_OperatingLossCarryforwardsWithADefiniteLife', window );">Operating loss carryforwards with a definite life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards, total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,200<span></span>
</td>
<td class="nump">38,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,022<span></span>
</td>
<td class="nump">8,022<span></span>
</td>
<td class="nump">7,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_OperatingLossCarryforwardsWithADefiniteLife', window );">Operating loss carryforwards with a definite life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,300<span></span>
</td>
<td class="nump">31,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_OperatingLossCarryforwardsWithIndefiniteLife', window );">Operating loss carryforwards with indefinite life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent', window );">Accrued payroll taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_OperatingLossCarryforwardsExpirationPeriods', window );">Operating loss carryforwards expiration periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_OperatingLossCarryforwardsExpirationPeriods', window );">Operating loss carryforwards expiration periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_NetOperatingLossCarryforwardsLimitationOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The annual limitations on use applicable to net operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_NetOperatingLossCarryforwardsLimitationOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_OperatingLossCarryforwardsExpirationPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The duration of operating loss carryforwards before expiration begins.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_OperatingLossCarryforwardsExpirationPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_OperatingLossCarryforwardsWithADefiniteLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of operating loss carryforwards that have an indefinite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_OperatingLossCarryforwardsWithADefiniteLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_OperatingLossCarryforwardsWithIndefiniteLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of operating loss carryforwards that have an indefinite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_OperatingLossCarryforwardsWithIndefiniteLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_RemainingPreownershipNetOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of remaining preownership net operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_RemainingPreownershipNetOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_PaycheckProtectionProgramCaresActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_PaycheckProtectionProgramCaresActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502247697528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S income</a></td>
<td class="nump">$ 1,033<span></span>
</td>
<td class="nump">$ 6,623<span></span>
</td>
<td class="nump">$ 1,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Non-U.S. income</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">920<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">$ 1,257<span></span>
</td>
<td class="nump">$ 7,543<span></span>
</td>
<td class="nump">$ 1,524<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502241889400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>U.S Federal income tax benefit&#160;(expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">8,346<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Total U.S. Federal income tax benefit (expense)</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">8,335<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>State and local income tax (expense) benefit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current</a></td>
<td class="num">(167)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">Total state and local income tax (expense) benefit</a></td>
<td class="num">(164)<span></span>
</td>
<td class="nump">1,659<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Foreign income tax expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">177<span></span>
</td>
<td class="num">(205)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="nump">$ 163<span></span>
</td>
<td class="nump">$ 9,789<span></span>
</td>
<td class="num">$ (163)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502247594920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Valuation Allowance (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance at the Beginning of Period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (11,250)<span></span>
</td>
<td class="num">$ (11,370)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DeferredTaxAssetsValuationAllowanceExpense', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DeferredTaxAssetsValuationAllowanceIncrease', window );">Increase in valuation allowance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DeferredTaxAssetsValuationAllowanceRelease', window );">Release of valuation allowance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,250<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance at the End of Period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (11,250)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DeferredTaxAssetsValuationAllowanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the valuation allowance for deferred tax assets charged to income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DeferredTaxAssetsValuationAllowanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DeferredTaxAssetsValuationAllowanceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Valuation Allowance, Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DeferredTaxAssetsValuationAllowanceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DeferredTaxAssetsValuationAllowanceRelease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the valuation allowance for deferred tax assets due to the release of valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DeferredTaxAssetsValuationAllowanceRelease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246375960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax expense at the statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income tax expense</a></td>
<td class="nump">10.30%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign income tax</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent', window );">Permanent differences</a></td>
<td class="num">(36.70%)<span></span>
</td>
<td class="num">(8.40%)<span></span>
</td>
<td class="num">(5.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Decrease in valuation allowance</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(149.20%)<span></span>
</td>
<td class="num">(7.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other adjustments</a></td>
<td class="num">(8.50%)<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="num">(12.90%)<span></span>
</td>
<td class="num">(129.80%)<span></span>
</td>
<td class="nump">10.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the permanent differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502249646840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Carry Forwards (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 10,033<span></span>
</td>
<td class="nump">$ 9,967<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Bad debt reserves</a></td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">1,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="nump">656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">8,022<span></span>
</td>
<td class="nump">7,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">980<span></span>
</td>
<td class="nump">1,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Accrued compensation</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventories</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Goodwill and intangible assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research &amp; development credits</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther', window );">Other credits</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred Federal tax assets</a></td>
<td class="nump">13,132<span></span>
</td>
<td class="nump">12,997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciation and asset basis differences</a></td>
<td class="num">(3,423)<span></span>
</td>
<td class="num">(3,393)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DeferredTaxLiabilitiesRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="num">(891)<span></span>
</td>
<td class="num">(937)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(88)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred Federal tax liabilities</a></td>
<td class="num">(4,402)<span></span>
</td>
<td class="num">(4,330)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">8,730<span></span>
</td>
<td class="nump">8,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred Federal tax assets</a></td>
<td class="nump">$ 1,303<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DeferredTaxLiabilitiesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DeferredTaxLiabilitiesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible tax credit carryforwards, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502249546008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, cost, total</a></td>
<td class="nump">$ 1,559<span></span>
</td>
<td class="nump">$ 1,932<span></span>
</td>
<td class="nump">$ 2,239<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, cost, total</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, cost, total</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502246500520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 1,316<span></span>
</td>
<td class="nump">$ 1,617<span></span>
</td>
<td class="nump">$ 1,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 1,559<span></span>
</td>
<td class="nump">$ 1,932<span></span>
</td>
<td class="nump">$ 2,239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248033592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flow from operating leases</a></td>
<td class="nump">$ 1,271<span></span>
</td>
<td class="nump">$ 1,603<span></span>
</td>
<td class="nump">$ 1,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="nump">4,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations', window );">Operating leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of reductions to right-of-use assets resulting from reductions to lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248255400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Weighted Average Table (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term:</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate:</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248405336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 1,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">1,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">1,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">1,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">2027</a></td>
<td class="nump">1,783<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">7,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(2,434)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 4,668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502240879896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 18, 2021</div></th>
<th class="th"><div>May 15, 2019</div></th>
<th class="th"><div>Jul. 19, 2018</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>May 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Apr. 23, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for tax withholding obligation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,067<span></span>
</td>
<td class="nump">146,763<span></span>
</td>
<td class="nump">121,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Cost not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP', window );">Employee stock ownership plan (ESOP) (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_EmployeeStockPurchasePlanDiscountRate', window );">Employee stock purchase plan discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum', window );">ESOP purchase per employee maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance', window );">Stock issued during period shares employee stock ownership plan number of remaining shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchased during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=infu_A2021EquityIncentivePlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Share-based payment award, shares purchased for award (in shares)</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,766,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=infu_A2014EquityIncentivePlanMember', window );">2014 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based compensation arrangement, equity instruments other than options, grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Nonvested award, excluding option, cost not yet recognized, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based compensation arrangement, equity instruments other than options, grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,476<span></span>
</td>
<td class="nump">232,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Nonvested award, excluding option, cost not yet recognized, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Cost not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Share-based Payment Arrangement, Exceeding Minimum Threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned', window );">Share-based compensation arrangement by share-based payment award percentage of target number of shares to be earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Share-based Payment Arrangement, Achieving Minimum Threshold | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned', window );">Share-based compensation arrangement by share-based payment award percentage of target number of shares to be earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Share-based Payment Arrangement, Achieving Minimum Threshold | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned', window );">Share-based compensation arrangement by share-based payment award percentage of target number of shares to be earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum threshold, per employee, of purchases made in the employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_EmployeeStockPurchasePlanDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The discount rate applied to an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_EmployeeStockPurchasePlanDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of target number of shares to be earned under share based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares employee stock ownership plan number of remaining shares available for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the number of shares provided to the Employee Stock Ownership Plan (ESOP) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=infu_A2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=infu_A2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=infu_A2014EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=infu_A2014EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502247820904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Stock-based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockExpense', window );">Restricted share expense</a></td>
<td class="nump">$ 4,491<span></span>
</td>
<td class="nump">$ 1,687<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option and SARs expense</a></td>
<td class="nump">1,913<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">6,404<span></span>
</td>
<td class="nump">2,610<span></span>
</td>
<td class="nump">997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to stock-based compensation</a></td>
<td class="nump">$ 2,234<span></span>
</td>
<td class="nump">$ 1,652<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242119688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Summary of Restricted Share Activity, Excluding Company's Employee Stock Purchase Plan (Details) - Restricted Stock - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, number of shares (in shares)</a></td>
<td class="nump">145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based compensation arrangement, equity instruments other than options, grants in period (in shares)</a></td>
<td class="nump">213,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, number of shares (in shares)</a></td>
<td class="num">(54,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod', window );">Vested shares forgone to satisfy minimum statutory withholding, number of shares (in shares)</a></td>
<td class="num">(1,901)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeitures, number of shares (in shares)</a></td>
<td class="num">(11,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, number of shares (in shares)</a></td>
<td class="nump">290,942<span></span>
</td>
<td class="nump">145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 9.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">18.85<span></span>
</td>
<td class="nump">$ 10.12<span></span>
</td>
<td class="nump">$ 7.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">12.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue', window );">Vested shares forgone to satisfy minimum statutory withholding, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">12.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeitures, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">17.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 15.61<span></span>
</td>
<td class="nump">$ 9.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested, aggregate fair value</a></td>
<td class="nump">$ 920,125<span></span>
</td>
<td class="nump">$ 367,273<span></span>
</td>
<td class="nump">$ 712,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue', window );">Vested shares forgone to satisfy minimum statutory withholding, aggregate fair value</a></td>
<td class="nump">$ 32,282<span></span>
</td>
<td class="nump">$ 62,479<span></span>
</td>
<td class="nump">$ 422,779<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that expired during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards expired during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards expired during the period, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502238972376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - PSU Activity (Details) - Performance Shares - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, number of shares (in shares)</a></td>
<td class="nump">232,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based compensation arrangement, equity instruments other than options, grants in period (in shares)</a></td>
<td class="nump">127,476<span></span>
</td>
<td class="nump">232,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, number of shares (in shares)</a></td>
<td class="num">(66,371)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone', window );">Vested shares forgone (in shares)</a></td>
<td class="num">(53,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, number of shares (in shares)</a></td>
<td class="nump">239,976<span></span>
</td>
<td class="nump">232,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 9.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">19.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 8.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue', window );">Vested shares forgone to satisfy minimum statutory withholding (in shares)</a></td>
<td class="nump">8.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 14.74<span></span>
</td>
<td class="nump">$ 9.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of shares vested</a></td>
<td class="nump">$ 1,335,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue', window );">Total fair value of shares forgone to satisfy minimum statutory withholding</a></td>
<td class="nump">1,078,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Shares Forgone</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Shares Forgone, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value Shares Forgone, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248641512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Summary of Activity Relating to Company's ESPP Program (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense', window );">Compensation expense</a></td>
<td class="nump">$ 173,561<span></span>
</td>
<td class="nump">$ 108,589<span></span>
</td>
<td class="nump">$ 43,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares of stock sold to employees (in shares)</a></td>
<td class="nump">31,624<span></span>
</td>
<td class="nump">30,012<span></span>
</td>
<td class="nump">33,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased', window );">Weighted average fair value per ESPP award (in dollars per share)</a></td>
<td class="nump">$ 16.95<span></span>
</td>
<td class="nump">$ 7.43<span></span>
</td>
<td class="nump">$ 3.94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average purchase price of shares purchased under the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of plan compensation cost recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502242259672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - 2014 and 2021 Plan Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=infu_A2014EquityIncentivePlanMember', window );">2014 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Authorized Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, number of authorized shares (in shares)</a></td>
<td class="nump">1,959,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based compensation arrangement, options, grants in period (in shares)</a></td>
<td class="nump">56,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised, number of authorized shares (in shares)</a></td>
<td class="num">(279,904)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Exercised shares forgone to satisfy minimum statutory withholding, number of authorized shares (in shares)</a></td>
<td class="num">(1,537)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_CashlessExerciseOfStockOptionsShares', window );">Cashless exercise, number of authorized shares (in shares)</a></td>
<td class="num">(566)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited, number of authorized shares (in shares)</a></td>
<td class="num">(1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, number of authorized shares (in shares)</a></td>
<td class="nump">1,731,841<span></span>
</td>
<td class="nump">1,959,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-based compensation arrangement, options, exercisable, number (in shares)</a></td>
<td class="nump">1,478,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 4.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based compensation arrangements, options, grants in period, weighted average exercise price (in usd per share)</a></td>
<td class="nump">18.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-based compensation arrangements, options, exercises in period, weighted average exercise price (in usd per share)</a></td>
<td class="nump">2.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Share-based compensation arrangements, options, expirations in period, weighted average exercise price (in usd per share)</a></td>
<td class="nump">2.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice', window );">Cashless exercise, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">2.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Share-based compensation arrangements, options, forfeitures in period, weighted average exercise price (in usd per share)</a></td>
<td class="nump">18.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">4.92<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based compensation arrangement, options, exercisable, weighted average exercise price (in usd per share)</a></td>
<td class="nump">$ 3.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Options, Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, Weighted average remaining contractual term</a></td>
<td class="text">3 years 11 months 4 days<span></span>
</td>
<td class="text">4 years 5 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Weighted average remaining contractual term</a></td>
<td class="text">3 years 4 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 21,051,101<span></span>
</td>
<td class="nump">$ 28,449,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 19,274,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=infu_A2021EquityIncentivePlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Authorized Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, number of authorized shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based compensation arrangement, options, grants in period (in shares)</a></td>
<td class="nump">288,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited, number of authorized shares (in shares)</a></td>
<td class="num">(15,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, number of authorized shares (in shares)</a></td>
<td class="nump">273,269<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-based compensation arrangement, options, exercisable, number (in shares)</a></td>
<td class="nump">78,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based compensation arrangements, options, grants in period, weighted average exercise price (in usd per share)</a></td>
<td class="nump">19.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Share-based compensation arrangements, options, forfeitures in period, weighted average exercise price (in usd per share)</a></td>
<td class="nump">19.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">19.47<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based compensation arrangement, options, exercisable, weighted average exercise price (in usd per share)</a></td>
<td class="nump">$ 19.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Options, Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, Weighted average remaining contractual term</a></td>
<td class="text">9 years 4 months 17 days<span></span>
</td>
<td class="text">0 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Weighted average remaining contractual term</a></td>
<td class="text">6 years 7 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_CashlessExerciseOfStockOptionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares exercised in a cashless transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_CashlessExerciseOfStockOptionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of awarded shares exercised in the period in a cashless transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=infu_A2014EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=infu_A2014EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=infu_A2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=infu_A2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502241966504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Schedule of Share-based Compensation Expense Based on Fair Value of Options (Details) - Stock Options - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility rate, minimum</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility rate, maximum</a></td>
<td class="nump">46.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">0.31%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="nump">0.54%<span></span>
</td>
<td class="nump">1.56%<span></span>
</td>
<td class="nump">2.36%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected lives at date of grant (in years)</a></td>
<td class="text">3 years 7 months 13 days<span></span>
</td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">4 years 7 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Weighted average fair value of options granted (in usd per share)</a></td>
<td class="nump">$ 6.56<span></span>
</td>
<td class="nump">$ 3.87<span></span>
</td>
<td class="nump">$ 1.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="nump">$ 4,248,401<span></span>
</td>
<td class="nump">$ 3,377,730<span></span>
</td>
<td class="nump">$ 624,462,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502241657336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesExternal', window );">Net revenues - external</a></td>
<td class="nump">$ 102,382<span></span>
</td>
<td class="nump">$ 97,388<span></span>
</td>
<td class="nump">$ 81,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesInternal', window );">Net revenues - internal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net revenues</a></td>
<td class="nump">102,382<span></span>
</td>
<td class="nump">97,388<span></span>
</td>
<td class="nump">81,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">60,197<span></span>
</td>
<td class="nump">58,759<span></span>
</td>
<td class="nump">46,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Selling, general and administrative expenses</a></td>
<td class="nump">57,377<span></span>
</td>
<td class="nump">49,932<span></span>
</td>
<td class="nump">43,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,377)<span></span>
</td>
<td class="num">(1,255)<span></span>
</td>
<td class="num">(1,904)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">9,789<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">1,420<span></span>
</td>
<td class="nump">17,332<span></span>
</td>
<td class="nump">1,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">97,586<span></span>
</td>
<td class="nump">96,991<span></span>
</td>
<td class="nump">79,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireMedicalEquipment', window );">Purchases of medical equipment</a></td>
<td class="nump">15,676<span></span>
</td>
<td class="nump">15,820<span></span>
</td>
<td class="nump">19,669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">14,625<span></span>
</td>
<td class="nump">14,025<span></span>
</td>
<td class="nump">12,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=infu_CorporateAndEliminationsMember', window );">Corporate and Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesExternal', window );">Net revenues - external</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesInternal', window );">Net revenues - internal</a></td>
<td class="num">(5,753)<span></span>
</td>
<td class="num">(5,370)<span></span>
</td>
<td class="num">(3,788)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net revenues</a></td>
<td class="num">(5,753)<span></span>
</td>
<td class="num">(5,370)<span></span>
</td>
<td class="num">(3,788)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Selling, general and administrative expenses</a></td>
<td class="nump">57,377<span></span>
</td>
<td class="nump">49,932<span></span>
</td>
<td class="nump">43,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,377)<span></span>
</td>
<td class="num">(1,255)<span></span>
</td>
<td class="num">(1,904)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">9,789<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireMedicalEquipment', window );">Purchases of medical equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember', window );">ITS Segment | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesExternal', window );">Net revenues - external</a></td>
<td class="nump">65,598<span></span>
</td>
<td class="nump">61,072<span></span>
</td>
<td class="nump">51,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesInternal', window );">Net revenues - internal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net revenues</a></td>
<td class="nump">65,598<span></span>
</td>
<td class="nump">61,072<span></span>
</td>
<td class="nump">51,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">42,046<span></span>
</td>
<td class="nump">39,773<span></span>
</td>
<td class="nump">33,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">60,970<span></span>
</td>
<td class="nump">68,472<span></span>
</td>
<td class="nump">54,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireMedicalEquipment', window );">Purchases of medical equipment</a></td>
<td class="nump">10,533<span></span>
</td>
<td class="nump">9,583<span></span>
</td>
<td class="nump">14,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">10,886<span></span>
</td>
<td class="nump">10,708<span></span>
</td>
<td class="nump">9,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember', window );">DME Services Segment | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesExternal', window );">Net revenues - external</a></td>
<td class="nump">36,784<span></span>
</td>
<td class="nump">36,316<span></span>
</td>
<td class="nump">29,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesInternal', window );">Net revenues - internal</a></td>
<td class="nump">5,753<span></span>
</td>
<td class="nump">5,370<span></span>
</td>
<td class="nump">3,788<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net revenues</a></td>
<td class="nump">42,537<span></span>
</td>
<td class="nump">41,686<span></span>
</td>
<td class="nump">33,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">18,151<span></span>
</td>
<td class="nump">18,986<span></span>
</td>
<td class="nump">13,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">34,616<span></span>
</td>
<td class="nump">26,519<span></span>
</td>
<td class="nump">22,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireMedicalEquipment', window );">Purchases of medical equipment</a></td>
<td class="nump">5,143<span></span>
</td>
<td class="nump">6,237<span></span>
</td>
<td class="nump">5,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">$ 3,739<span></span>
</td>
<td class="nump">$ 3,317<span></span>
</td>
<td class="nump">$ 2,885<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_PaymentsToAcquireMedicalEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cash paid during the period to acquire medical equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_PaymentsToAcquireMedicalEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_RevenuesExternal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of external net revenues recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_RevenuesExternal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_RevenuesInternal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of internal net revenues recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_RevenuesInternal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=infu_CorporateAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=infu_CorporateAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140502248561480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Other (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Contributions by employer</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee-related liabilities, current</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>infu-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:infu="http://infusystem.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="infu-20211231.xsd" xlink:type="simple"/>
    <context id="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib7b671a11ff144cdb841c10e00e545b2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i71d72a1442944b90bab79e5eb66f6ea8_I20220307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2022-03-07</instant>
        </period>
    </context>
    <context id="iadf344ba2bca42ada453fc7ff77944bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6b8b5e5eab5d411ab7c41bbd0a191163_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibfdec380605a4b47bc98e52a196722c4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibe974377c6e747c1a5ca843447269847_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i08a5c3d39ecd4a888c2f856ced55d19a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i157f7776f6f34785bf30f4235c8d11bc_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i488a17cbb36b421597c4f159595f4b31_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i67545d7705224bc6be52955d497ead2a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie2affbe3d3694f7286adc05cd2ef1a5f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i68d542ad3a9045d9a04429f3568a9113_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib332759d305f4dc8b9ccc96ac2c5af1a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24ee4273907446b1ba9e85ec18226b50_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icc90323890a347a6a803d6e29739a07a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5306a01245a74e03ab4033c4fe19fc15_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i36d6369b86a9480192a2232dd6e20776_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5eec6c22b6b342eab7efdb046682bff8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i264313229b604d5dbaa260791106aae8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icdf6be04bef848a3be60bd50bbe09ea3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9e4706fa4334283bce0bd814b6d4abe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7a10bd1ab424f0d9abf84a729cab56e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if9fc97e52018419aac6e451ce020e3c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9f3ba1490534187962e956028423a05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibba59ce2bece4e15bb0877c92494fe88_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ef36744ffb64ea58b479667d4a1410c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iffdd24f84ee6404c8449edf03c2c03b9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i60447bb6297b410f8726ce5432f5690a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i33bade00e83b4d3fa491f7a2b7f67333_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d0ded68cb484345bb92203314eb3670_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iafc46bb5055c4ecfb796ab2b26d1f201_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9e7686a6c9a4fb996fb64830470a5d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide4509120e7e42d29953cf1e80b08d9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i954290189efa49729f89a0332d6eed3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34393106918541a2afdfacc9dc70598f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:AmbulatoryPumpsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">infu:SmithsMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9f484679bbfa45cc82f4383cd151aeae_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:NPWTMedicalEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">infu:CardinalHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i273cf9bfb6db4d47a691a81cafdaae1a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic449570e790a4e16996815fc2fe98242_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i936cbf63d246476db743dd2b8af1f17c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3f83755b9294a7fbbea649f435470f7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i29ae89039c7d4439ae9da620e9a76622_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">infu:InformationTechnologySoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iff2484e23bda4759a180d34049f89085_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icec29a20da85434a84ef9a1fe876a262_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9cbd2ba5629b4065967778d18fce6cc6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icff6cc8b05334e9aa94fdb2166c5189e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3805c0f8aa0b4495a88f1333effc915e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iafb98485af7044f4b4e5556491802f9f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie95c2bd801aa4bb288bad94f285a3474_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1ef1975dd83440c2b7903b64c216e6f5_D20211001-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="i00d66cb681ad4fb9820d60af76680b44_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9465d698b48a4cb89adc9870e948bf77_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie66a45b985ad4079b2542a584a5b7264_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4884e729c62d490e9c7039f04d149a94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf5fd049ceed45b68799835682190196_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia683a1cdfea841359642a861af2182de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibad2abb0e5fe4e9398ad4ae3632f3fbc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i05190bb32cd04e68951f01b2c1a8198a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:FilAMedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia1369ea7cfa4428a8a0535746cc8e915_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:FilAMedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i24d9edd536944e538abc2437af99d50f_I20210418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-18</instant>
        </period>
    </context>
    <context id="i1d555f047a9d4a98bcdde0ca522a6c33_D20210418-20210418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-18</startDate>
            <endDate>2021-04-18</endDate>
        </period>
    </context>
    <context id="i3540294de93b4071b8f2e1e40e99745e_D20210419-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i40c6769d29844b238f82f52eec98cc12_I20210418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-18</instant>
        </period>
    </context>
    <context id="ic33f271dada5450ba5170593f412ee83_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i233a685f88ec410c8dc45a29274c0b7b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9117e35a7b704846add5b6cf91320364_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ef27ca6d720458d8890b7403ee50d2f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i441702431efa453d9ae697b4ed1bf9f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac70b116e25d46d6943dcd912146fc65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if05acd9bb129444c859314fc90a675b8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iee74bd21a9164ffa92cd63e1a7f77a5b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iac7342c282ec477da6afb686717858a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i68bd4d8cc58b4fe4b8a77002f54a62e4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i44173ad083b247b4a3a2827ae4199ffe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0797ce13f2f84bccb9643bb465b72539_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0b8592ae240046e2ae1d7bba300944f3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:ThirdPartyPayerRentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9b8bca74bc6643a39beeb55eb9ee5829_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6c9b6408c306478397ff75df2204b657_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i780ffb81ffd74c41a647d4101deb7fed_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i55869796670c49c2b3cd162096936a33_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8c13d15fc1e3436490201fc54a7ebe45_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i777a8534320c4ad2a3ca66b33e628c6d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ide3e566a68504537bf76d20a1a6e221e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i38bb3cacf11d424c8a9bf2b293ac90bc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i806896b65be24eb8a8d565e1ead9dfbc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i94248c02936a4257911be7191534390c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie795f19734ba4ea0ad822d0aa14b10e9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib0ec252312564b5b9a317bfa1d062542_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic85e0dd291c74ec88ceca6c455d9099e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie2db72027cda42008cbdb85b30ce7435_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iabc7ebe2911f4b8ead87bc9344dbecbf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8cec8dd30c2a446b991de51c91e34f4c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib93c9a20502d4745907b197f7456558c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iea2e191999e8474dac4c6c90b1ebd6ea_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0fca34364019406e99032d7e62aa8549_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if47ce6b2f6bd4668ac4fd139af7095f7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i99e9f20c6321440d8bbc7f2097999db8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i24689dc260664972bc304c938065d32c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9eab4726eabd4666a158889e4ca9f089_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i136bd725ae5d499aa73f5dbdcc3d0538_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1702a843f4c243c393e12054224e80e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe177a89508b4e398be3e3549eb93a26_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2a29108335024c84a565385b792cd555_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4fddcf470fec4bef906869caf2a1aee9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifb9b60051f3d464abf97f4d754be3921_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i901347f42a9240abb769c4ca3db405e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0e87b8645294c95b18cfe1e1938f796_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9f56e398e372492d8641d88cd8b01cff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e2ca571a5714cb889e214a572d2aa67_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9649d301729547c5b2196154dc65a224_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b7bb29ceaad4f8da8ce9a75bfa49f10_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i680eb364512840a7b20a8bfda742ab6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i972c98c27e6f4a3999d5e2e73d5e2a77_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i02810325b2664b7997154ec528092ae9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0629bca191f34f1caf750d54c8ebd131_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if63340937f6a47b08decf2e320428890_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9e0342993b94444b974026bddb99c28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45d3cf60b6544e0d862fa72ac5fa656b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i109995ede010411299c74fcc87e3829a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7678f2cb51f54e08941b9dfcf63bace0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d86c2941c0e4ddfa25d123e33722fa3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i749458dfcda84fcba057ba09cfc9c14f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec609ab7f9cc482f878e37ae4b232f06_I20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="i9c000588f48b4e20af3b977ce4231e48_I20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="ib6e13bc56eba44a085dd386fb4a920de_D20210205-20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="i033b71a678134cd586b4202ce9eb994e_D20210205-20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2015CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="i28416998ed494697b9e63887fde6fd11_D20210205-20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="if5d269b502c94e90b66e4c4b94a9c2ed_I20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="i452ae0b2df354385976aa6108ccf6fb9_I20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2015CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="id2da90a2b53f464d83f01bf20f29c091_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:ThreeTermNotesAssociatedWithThe2015CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9523dc8728f4f108564fbb8f67d46a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8ae56ca359cf4788a118a9f206ace640_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i29c501e886e64e9c963a67b76eb4cd46_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i223aaee1de9843719aacfcb115ef4cb2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i32f4cc53746a4a8cba9ea7b91c877b3b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">infu:GreaterOfPrimeRateOrLIBORPlus25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4bb191034086475081b1b2d7260fba3c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">infu:GreaterOfPrimeRateOrLIBORPlus25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib19aee4251c0421a88d27487e974e24e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i86348f84097549aea76b5e34c1abceab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4249c9895bc145b5be2fa0d810ad324b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2958795320034b74ba5d1eff1f005813_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">infu:CBFloatingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48cdf09f16b649aba0ae191e5967f0ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:CBFloatingRateLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">infu:CBFloatingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic70163d2c2154132b876d363ae1420b5_I20190415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-15</instant>
        </period>
    </context>
    <context id="ia8c78e4c1e864bd5a5b27f93ca59061e_D20190415-20190415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-15</startDate>
            <endDate>2019-04-15</endDate>
        </period>
    </context>
    <context id="i4b550170313246b389a63672f1b2683f_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i262345c59e314575bff01a7f8cda11fe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i57c0ab7efbce44e3a190303cafd12765_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0bac56a13b8a4a839f394785fb03bcca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a3117f913484a4686356512d23fcd5a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i26945b82dabf4e67b225a0c6d08752e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib56fe4590048490aac40ada7ae6400c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6540674abce4c21a0ef51335bdd4b29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">infu:EquipmentLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c407a2ed2ae458a8df6a05548246659_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">infu:EquipmentLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4facded32a743d880e4713f269f8b0a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">infu:The2019EquipmentLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i987ef74564c541748397735c98c6eef8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">infu:The2019EquipmentLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ab9a73eeba346ee8122c590dbcbff5c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd19a01ade284855af47b1b4373ea548_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifb66c8f537fd4b868b21fad8bb3d0370_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5ad0860c58864013aaca9c0803749cc1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i753ef5726f0d46c09a8a2930b70f0ae4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibbe15e51fb3c431391c39b3871874755_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5cd65086be1a4f03b35066f3c49722b5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id680c7f9eb53497f8afe704e06188d0d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id41bcfe45ebb4131bad97991e1bcf070_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie04daf42f32244b687b1b4a179069060_I20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="i3f5f66be8c4042dfbc78b5ce658083c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3212a9cabfa9493096f98169ff09dde2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i262ff830a2bd433899876342da3eb117_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i15476ca71552472d8a12c8939898580d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07f3da9e713d4c489ebdd0e68b443b18_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i055937925234444eb13527b2e0cb4ae9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf34a521c00b474b8c705fb5db98af8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice5d9a455230467faf56b669a8015a3e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib0c7b74dd3b642bd83f8f8f69155e38a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i856c610b2fe549e0b8bc1e612a43b96c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if64f71b0d53e48e3a2c1aa091fd31365_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i439fd912ad054d238616616e9babc7fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idfedd81ba6944a6985fc391bcc412d7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2150414dae3f42f68c21d9adaf756de4_D20200415-20200415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:PaycheckProtectionProgramCaresActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-15</startDate>
            <endDate>2020-04-15</endDate>
        </period>
    </context>
    <context id="i7eb9d27f65dd4491a35f0b273d413655_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie0c917cfe5e042599ce26f2256dff1ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib2b9762869f5424c88544abd7900c8d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c5b6e5d34b445c1b9f13378f83a9a8b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia8ac411300664a70b0331e7b8a64e151_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3aecccce92b14a9c9084a4f31af83e6c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i450379ae7a724e1eb2a0f5753d483e22_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7e697973a46d4d5d9d02a7da49fa4e3b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1562a53301a84c6f86d2e5026a162d32_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icbca7ff14ebb4795b34515b88d7092ba_D20210518-20210518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-18</startDate>
            <endDate>2021-05-18</endDate>
        </period>
    </context>
    <context id="i2b64b934b737430092de595691e27b69_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b2880103789464c83dd09c03f90e4c9_I20140423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-04-23</instant>
        </period>
    </context>
    <context id="i3ee8e04870e34b48a26a7940cc7e9b5c_D20180719-20180719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-19</startDate>
            <endDate>2018-07-19</endDate>
        </period>
    </context>
    <context id="i85e14e2aedee40cd9f3d83472a6a4224_D20190515-20190515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-15</startDate>
            <endDate>2019-05-15</endDate>
        </period>
    </context>
    <context id="i93a156af54c948df8919aacc5b640f4b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idad1a9e99df642878fbca1cdddf632e2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8b8108f7576e4800a4821616a2f4206c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2970496b363049a4989e1475da130d29_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2975cbac6e1d4d30a4131dcbc1127282_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4a81f3c1031c41d6be1e69e4807e648a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">infu:SharebasedPaymentArrangementAchievingMinimumThresholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a5e593bf0f4482cbd136bb082362baf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">infu:SharebasedPaymentArrangementAchievingMinimumThresholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id71f0e9811ac46ee9b2694dfddb5b84c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">infu:SharebasedPaymentArrangementExceedingMinimumThresholdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i579ba4102b384a248e9ea9ecb23a50df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3deaf1a379a149fd8aca28bd274ab8e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63aa50be007746b6b60d96242969200f_D20140501-20140531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <startDate>2014-05-01</startDate>
            <endDate>2014-05-31</endDate>
        </period>
    </context>
    <context id="ib5fd5a9607e8406696c8241935b20eea_I20140531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2014-05-31</instant>
        </period>
    </context>
    <context id="i337469ad875742708ce9ddae6c4a0f49_D20160901-20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <startDate>2016-09-01</startDate>
            <endDate>2016-09-30</endDate>
        </period>
    </context>
    <context id="id664e22f92654bd6835e8960b88f906e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i09a35f534ba14f4d9e18f538cbfa8254_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iec83287d77134edda3de6abc4cfa02ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2014EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5e7c1a7074da4ca6b240f0057300c46c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7e33f7d1e2e5453ea11e60d4febe0678_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if119c5c4f07e4e6fb8be547a3dfead4e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e5609e12fdd4bcc9d3cac4d8aa1ae1a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6cd1956173c44262a83ed2582407f25b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">infu:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4d33e010b93943a0a1b9d74ec3a67b16_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8879dd04a8a42e3aa243ab1446763cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i90ee66b33a414ffb93ffa9dcf1afd8e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9928856516d548d1aba6381436cf7644_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b70e2ce104146f5ab103c7d119b5bb6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9f6184d5208e4826bebce3c6df68d12f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4bb2db6241c24063b31cb809b4d00a65_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i72387201e71d4834ad096602f0745428_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i297307e995f4423482791be08ae954b0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia6d80d3950ca42f0aa2a881eb9e20226_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6c666a090afb4d4088d45f15b60baf48_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i99dd14e3f4d04b82a5f72adea8821e1f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="lease">
        <measure>infu:lease</measure>
    </unit>
    <unit id="financialinstitution">
        <measure>infu:financialInstitution</measure>
    </unit>
    <unit id="network">
        <measure>infu:network</measure>
    </unit>
    <unit id="numberofagreement">
        <measure>infu:numberOfAgreement</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV80L2ZyYWc6M2U2Yjg5MmUxNmJkNDRkNGFhNDNmZmQ2ODI4ZjgxNDAvdGFibGU6OTY4NTQ2ZjdjNzc0NGRiOWIzY2E0ZWVlZWM5ZGM2MzIvdGFibGVyYW5nZTo5Njg1NDZmN2M3NzQ0ZGI5YjNjYTRlZWVlYzlkYzYzMl8zLTEtMS0xLTUwNjIy_8d4bab73-4ca6-44f4-836a-bf36cbc6765b">0001337013</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV80L2ZyYWc6M2U2Yjg5MmUxNmJkNDRkNGFhNDNmZmQ2ODI4ZjgxNDAvdGFibGU6OTY4NTQ2ZjdjNzc0NGRiOWIzY2E0ZWVlZWM5ZGM2MzIvdGFibGVyYW5nZTo5Njg1NDZmN2M3NzQ0ZGI5YjNjYTRlZWVlYzlkYzYzMl8xOC0xLTEtMS01MDYyMg_e135dde0-358e-466a-a03c-3885cd01f475">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV80L2ZyYWc6M2U2Yjg5MmUxNmJkNDRkNGFhNDNmZmQ2ODI4ZjgxNDAvdGFibGU6OTY4NTQ2ZjdjNzc0NGRiOWIzY2E0ZWVlZWM5ZGM2MzIvdGFibGVyYW5nZTo5Njg1NDZmN2M3NzQ0ZGI5YjNjYTRlZWVlYzlkYzYzMl8xOS0xLTEtMS01MDYyMg_7cbbd274-2178-4c2f-b65a-3a99fe8bfc97">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV80L2ZyYWc6M2U2Yjg5MmUxNmJkNDRkNGFhNDNmZmQ2ODI4ZjgxNDAvdGFibGU6OTY4NTQ2ZjdjNzc0NGRiOWIzY2E0ZWVlZWM5ZGM2MzIvdGFibGVyYW5nZTo5Njg1NDZmN2M3NzQ0ZGI5YjNjYTRlZWVlYzlkYzYzMl8yMC0xLTEtMS01MDYyMg_bbcd77c3-1fd9-42d5-a838-61ca91439981">false</dei:AmendmentFlag>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i936cbf63d246476db743dd2b8af1f17c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY3ODU_89ea2bad-0ac3-4d89-9bff-0b3592eb4de5">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i29ae89039c7d4439ae9da620e9a76622_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY4ODI_16fecb86-c446-4994-8930-6e54f72298e6">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="icec29a20da85434a84ef9a1fe876a262_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzc2NzA_787bbc1d-efca-48b5-9bc6-20acf41ccb09">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="icff6cc8b05334e9aa94fdb2166c5189e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzgzMTA_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="icff6cc8b05334e9aa94fdb2166c5189e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzODg_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i4884e729c62d490e9c7039f04d149a94_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEzNTUy_9f2fcc91-aee1-47c3-a7b5-103597d961a0">P1Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i6cd1956173c44262a83ed2582407f25b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8yMDUxL2ZyYWc6NTVmNTg5OWQ5MTQyNGI1MWE3NGQzMTAxYjIwYWY3NDEvdGFibGU6ZDg2YjRiZjZmZTNhNDdlMmFhYTIzYmFlZTNiYmFiZTYvdGFibGVyYW5nZTpkODZiNGJmNmZlM2E0N2UyYWFhMjNiYWVlM2JiYWJlNl8xLTEtMS0xLTg4MDQ5_51d35fd5-6d83-45bb-99b4-4ccf54d292c2">P0Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <dei:DocumentType
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDI4_62ba0d14-218d-472e-88a8-2618fe17c2a4">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6ZDcyOGE0NTYxNGMwNGQ2N2E2ZDIxMjk4NmM0MmU0MWIvdGFibGVyYW5nZTpkNzI4YTQ1NjE0YzA0ZDY3YTZkMjEyOTg2YzQyZTQxYl8wLTAtMS0xLTYzMTUx_28023b1f-43d0-4529-9b67-90a0d4ea8fac">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MTAx_6563f86d-3451-42dd-b83d-38b1102dc05e">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MTAx_34d3a8b2-08c7-4861-9531-d3fe37ef1969">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YTVhMTExNjU3YTM3NDY2ZTkxNjRkNmRkZTg3NGIyOGMvdGFibGVyYW5nZTphNWExMTE2NTdhMzc0NjZlOTE2NGQ2ZGRlODc0YjI4Y18wLTAtMS0xLTYzMjU4_889806ce-8a4c-4637-bf45-bc5c6309a9bb">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDI5_80d08857-11e9-47b4-afb0-a1475f3d232f">001-35020</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDI3_ba8dd0b7-5fa2-4aeb-bd6c-daa70ed56edc">INFUSYSTEM HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YmQwYzc1MTNiYzI2NGYzNzgyYzQ1OWExZDQ2YjM3ZjQvdGFibGVyYW5nZTpiZDBjNzUxM2JjMjY0ZjM3ODJjNDU5YTFkNDZiMzdmNF8wLTAtMS0xLTYzMTQ3_c1b3720b-7dbe-4e7b-abc9-351bc8e0594b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YmQwYzc1MTNiYzI2NGYzNzgyYzQ1OWExZDQ2YjM3ZjQvdGFibGVyYW5nZTpiZDBjNzUxM2JjMjY0ZjM3ODJjNDU5YTFkNDZiMzdmNF8wLTEtMS0xLTYzMTQ5_ae87809f-ec33-4b64-b3a2-da3ff21c802c">20-3341405</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDMx_adffb46b-6612-431a-b04e-ffc79b5f1b2e">3851 West Hamlin Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDMy_05d5b741-c84b-49df-9fba-dbebef5afd24">Rochester Hills</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDM1_8db2f495-baee-4854-bd9f-fe941cf60de7">MI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDM3_a0bdfa05-4c0a-4984-acea-4515cbe4c5df">48309</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDQ0_4f9fe551-4a89-471d-bde3-723657d638a0">(248)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDUw_73fde81e-c349-44d2-b3c0-db79c0fec568">291-1210</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YTM5ODY2NzNhN2Y0NDY2NGI0ZDMwNTYzNDEwZDhhODcvdGFibGVyYW5nZTphMzk4NjY3M2E3ZjQ0NjY0YjRkMzA1NjM0MTBkOGE4N18xLTAtMS0xLTYzMTk1_3abcecf8-fceb-486c-8217-c908057a0342">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YTM5ODY2NzNhN2Y0NDY2NGI0ZDMwNTYzNDEwZDhhODcvdGFibGVyYW5nZTphMzk4NjY3M2E3ZjQ0NjY0YjRkMzA1NjM0MTBkOGE4N18xLTEtMS0xLTYzMTk3_4854b768-3fad-4aa9-a4e5-2fbfffdaed5c">INFU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6YTM5ODY2NzNhN2Y0NDY2NGI0ZDMwNTYzNDEwZDhhODcvdGFibGVyYW5nZTphMzk4NjY3M2E3ZjQ0NjY0YjRkMzA1NjM0MTBkOGE4N18xLTItMS0xLTYzMTk5_d0b7d2a9-258d-4e43-8501-e8b3ed6a4598">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV8zMjk4NTM0ODg3NjEx_ea868d75-e1b5-4a0d-b97c-c8c8694a0d32">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV8zMjk4NTM0ODg3NjEz_51a7dd3e-e45a-4c3c-8762-a3d0b345c6d8">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDY1_b5c90036-af44-44d4-ba48-c10c62d5afbb">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDY2_f8d3e252-aaf3-49ec-a373-f71f90456d0f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6N2MzMjdhMmM4MzUwNGY3MmFjNDNjZTkyNTk1Y2IxMWEvdGFibGVyYW5nZTo3YzMyN2EyYzgzNTA0ZjcyYWM0M2NlOTI1OTVjYjExYV8wLTQtMS0xLTYzNDAx_20eb027f-2c10-4775-b6a9-27858d933ad6">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6N2MzMjdhMmM4MzUwNGY3MmFjNDNjZTkyNTk1Y2IxMWEvdGFibGVyYW5nZTo3YzMyN2EyYzgzNTA0ZjcyYWM0M2NlOTI1OTVjYjExYV8wLTctMS0xLTYzNDAz_f61c215c-aa82-47f0-99b7-c79a25c3cabe">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGFibGU6N2MzMjdhMmM4MzUwNGY3MmFjNDNjZTkyNTk1Y2IxMWEvdGFibGVyYW5nZTo3YzMyN2EyYzgzNTA0ZjcyYWM0M2NlOTI1OTVjYjExYV8yLTEtMS0xLTYzNDA1_e5f74350-9767-4be4-a89f-d8b6b56734cc">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDcx_6259b3ec-9670-4d69-b6d8-d7acceb559e3">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80OTQ3ODAyMzI5MDky_909e15e6-8f7b-4f9a-804b-5e6fbd4d9c94">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ib7b671a11ff144cdb841c10e00e545b2_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV8zMjk4NTM0ODg3NTk4_949184ab-2e07-4712-9d01-bd1f1c6a68ea"
      unitRef="usd">370281189</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i71d72a1442944b90bab79e5eb66f6ea8_I20220307"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV8xMDk5NTExNjMxODg5_9e38d330-024b-42f7-9f06-1529fb1f7ee5"
      unitRef="shares">20547517</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xL2ZyYWc6ZGU5YzMxOGIyNzRmNGM2M2JiZTU4MWRjMGE2ZDQ0NDkvdGV4dHJlZ2lvbjpkZTljMzE4YjI3NGY0YzYzYmJlNTgxZGMwYTZkNDQ0OV80Mzk4MDQ2NTE1MjI2_3dca1406-834f-4dd7-b692-64c814783bc6">Portions of the registrant&#x2019;s definitive proxy statement to be filed with the Securities and Exchange Commission in connection with the solicitation of proxies for its 2022 Annual Meeting of Stockholders are incorporated by reference in Part III of this Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV83OS9mcmFnOjQxMzAzZWRkMmMwMDRhMzdiZjk1MmVjN2Y1Y2Y4OGRiL3RhYmxlOmIxMDA0NzIzN2JlNTQ2OWQ4ZjMxZTE1YmNjMDI0NGQ5L3RhYmxlcmFuZ2U6YjEwMDQ3MjM3YmU1NDY5ZDhmMzFlMTViY2MwMjQ0ZDlfMS0wLTEtMS04ODUzMC90ZXh0cmVnaW9uOmNkOTRiNmViYmI0OTQxZDdiMDdhNjY0NmIzYTRiNzE5XzMyOTg1MzQ4ODM0MzY_4354a7c7-7f86-4e7c-8684-3c35ccccae2b">243</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84Mi9mcmFnOjA3ZjU4NzBkZTdjMjQ3ZTRiZjE3M2IzOGVkZTE2ZGQ5L3RleHRyZWdpb246MDdmNTg3MGRlN2MyNDdlNGJmMTczYjM4ZWRlMTZkZDlfMzI5ODUzNDg5MDQ3Mg_ba16c75f-ed4e-420f-a290-6467388259c6">BDO USA, LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84Mi9mcmFnOjA3ZjU4NzBkZTdjMjQ3ZTRiZjE3M2IzOGVkZTE2ZGQ5L3RleHRyZWdpb246MDdmNTg3MGRlN2MyNDdlNGJmMTczYjM4ZWRlMTZkZDlfMzI5ODUzNDg5MDQ3Mw_f301903f-1042-4430-ac3e-dd9e6e0b587f">Troy, Michigan</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNC0yLTEtMS01MDYyMg_093275d1-6e89-48fe-99bd-a1d25fe21a83"
      unitRef="usd">186000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNC00LTEtMS01MDYyMg_18e0169b-2590-4d3c-9df2-b80b6e7d1c1b"
      unitRef="usd">9648000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNS0yLTEtMS01MDYyMg_e84b0e46-8231-45ce-9949-95ff5d7ea4c4"
      unitRef="usd">15405000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNS00LTEtMS01MDYyMg_f9a63c9a-0a8c-4df5-a488-606aa55afde9"
      unitRef="usd">14720000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNi0yLTEtMS01MDYyMg_0abcca9e-c9cf-4d9a-8719-86c8e249c0b2"
      unitRef="usd">3939000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNi00LTEtMS01MDYyMg_8f6b8ff6-cffc-4186-beae-3ae289ea7f5c"
      unitRef="usd">3001000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNy0yLTEtMS01MDYyMg_4a9ae445-9af7-4db8-955a-65d852105351"
      unitRef="usd">2535000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNy00LTEtMS01MDYyMg_53e016da-efb1-48af-8489-3630cc0ce9a9"
      unitRef="usd">2402000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfOS0yLTEtMS01MDYyMg_5647e8cf-dc90-4c90-b1d8-42e56481b3e9"
      unitRef="usd">22065000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfOS00LTEtMS01MDYyMg_903c45e7-ec4f-4536-9f6d-f338576214f9"
      unitRef="usd">29771000</us-gaap:AssetsCurrent>
    <infu:MedicalEquipmentHeldForSaleOrRental
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTAtMi0xLTEtNTA2MjI_61c39d96-aabc-4b31-ba61-ba8a01d1fa79"
      unitRef="usd">1742000</infu:MedicalEquipmentHeldForSaleOrRental>
    <infu:MedicalEquipmentHeldForSaleOrRental
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTAtNC0xLTEtNTA2MjI_fb448d08-6852-445f-a615-73c38374c308"
      unitRef="usd">1603000</infu:MedicalEquipmentHeldForSaleOrRental>
    <infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTEtMi0xLTEtNTA2MjI_4d097177-d6b9-44ff-9208-0a60f73a36d9"
      unitRef="usd">39871000</infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation>
    <infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTEtNC0xLTEtNTA2MjI_8693f20e-3753-40ee-b99d-99474e548c72"
      unitRef="usd">35611000</infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTItMi0xLTEtNTA2MjI_5178fc56-540f-41d7-bc3e-82a4406d37fe"
      unitRef="usd">4523000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTItNC0xLTEtNTA2MjI_d7ef229f-a0ef-4a67-8fa0-9bc3f2f91888"
      unitRef="usd">4296000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTMtMi0xLTEtNTA3MjA_aaca9ab1-52be-41df-9b99-245acef4a960"
      unitRef="usd">3710000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTMtNC0xLTEtNTA3MjA_e0444e23-4765-4fc4-8e6e-9b45e7aefcab"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTMtMi0xLTEtNTA2MjI_58640abf-7007-4769-bd13-ebd3b0ae028a"
      unitRef="usd">10930000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTMtNC0xLTEtNTA2MjI_351fcf0c-e6bb-45d5-8316-bfdf3b6ba479"
      unitRef="usd">11177000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTQtMi0xLTEtNTA2MjI_4cd101b5-964c-4cab-904c-f651ea6e14d0"
      unitRef="usd">4241000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTQtNC0xLTEtNTA2MjI_ec276d68-4c2f-48e5-9acb-58f0e630fdb0"
      unitRef="usd">4461000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTUtMi0xLTEtNTA2MjI_90b189bb-9c0c-4b64-873a-e75d849787fd"
      unitRef="usd">10033000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTUtNC0xLTEtNTA2MjI_1f3cd0ca-0f3d-447c-8097-c2b6613bdd3e"
      unitRef="usd">9967000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTYtMi0xLTEtNTA2MjI_51faf067-ae29-4a01-a132-c2c028c77e2e"
      unitRef="usd">471000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTYtNC0xLTEtNTA2MjI_5763aa8d-21df-4b16-bd89-f50cc98cc6bf"
      unitRef="usd">105000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTgtMi0xLTEtNTA2MjI_abb1b112-3439-41fa-8ff9-e37212b2e83c"
      unitRef="usd">97586000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMTgtNC0xLTEtNTA2MjI_02a0a6db-6f15-43ea-bc68-1e7309582b9f"
      unitRef="usd">96991000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjItMi0xLTEtNTA2MjI_0736c3ec-b0f3-4b32-8759-8011239421b9"
      unitRef="usd">7862000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjItNC0xLTEtNTA2MjI_3420129e-8b06-4802-9b48-3f41f0fd440d"
      unitRef="usd">6779000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjMtMi0xLTEtNTA2MjI_a55bc4c6-0876-4b4f-86a4-103c05f557fd"
      unitRef="usd">349000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjMtNC0xLTEtNTA2MjI_a96c6513-c8c9-4ba3-a418-75d5cb68b600"
      unitRef="usd">9423000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjQtMi0xLTEtNTA2MjI_6dae1647-cc69-4b5e-94ee-2b0dc32fc980"
      unitRef="usd">4685000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjQtNC0xLTEtNTA2MjI_5b3612bb-2735-470a-b20e-e2e37cc1f988"
      unitRef="usd">6795000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjYtMi0xLTEtNTA2MjI_a4b30119-445f-49f0-ad0a-fea50bd20a73"
      unitRef="usd">12896000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjYtNC0xLTEtNTA2MjI_eb86f687-47e6-4552-9fd4-edb7623f70bd"
      unitRef="usd">22997000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjgtMi0xLTEtNTA2MjI_4690dfd2-4861-4a9d-918c-81a6bb42cc6f"
      unitRef="usd">32748000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMjgtNC0xLTEtNTA2MjI_7e2cbd28-0c16-495c-9750-972474e4df9c"
      unitRef="usd">29378000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzAtMi0xLTEtNTA2MjI_a1f24058-9444-4037-818a-37f127e64887"
      unitRef="usd">3670000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzAtNC0xLTEtNTA2MjI_b28d1075-d1e7-45be-8af0-c41a5a3b1708"
      unitRef="usd">3864000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzItMi0xLTEtNTA2MjI_6b9e3dc5-cede-4b0f-a9d1-43ed1cf65b45"
      unitRef="usd">49314000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzItNC0xLTEtNTA2MjI_48be518a-ed64-4c71-974e-baf43a42b51a"
      unitRef="usd">56239000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODU1_77954786-1259-45f1-99c8-2b741a5d6f00"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODU1_bac1e78b-ea5b-4f22-a5ea-65467cfcaba7"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODY0_b5562687-0cbb-4b5e-8f42-8adbf6a8da51"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODY0_c588c729-d62b-41bd-b834-972d8470e362"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODc2_0c476de8-710b-406e-a3cf-2520ca5f24a1"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMC0xLTEtNTA3ODgvdGV4dHJlZ2lvbjo3NTA3ODkyNmE3N2U0ZWE0YjNmOGU5ZjI5N2E0NGQxN18xMDk5NTExNjI3ODc2_f5084e4b-3175-492a-90ad-6a582d2d2888"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtMi0xLTEtNTA2MjI_eff1fa27-6476-441c-a360-2826ffb755a5"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzUtNC0xLTEtNTA2MjI_ca00a416-140c-4983-9c86-a6bbf8410376"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDI1_1c3afd9c-7ea3-4cf8-aff4-61ddc0391dce"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDI1_8b4915e0-1916-44a6-8b87-7abbe6514b54"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDM1_9d2d4457-3863-46b2-9f27-e517144a3017"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDM1_a37638eb-ad61-47c7-a925-4ee9c0711078"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDQ5_b2fc03fc-8893-4b68-a5a8-df5d9623b34e"
      unitRef="shares">20699546</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MDYy_b34f4c6c-a247-49a9-bdb2-37a58cc5a8b8"
      unitRef="shares">20699546</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MTE1_cc196865-9b29-49ce-b1ec-29eb1f76fdf9"
      unitRef="shares">23816193</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMC0xLTEtNTA4MDgvdGV4dHJlZ2lvbjpmM2E3NzM1ZjlhZTE0MzU3OTEzMDY5NDExZGFlZmFlMl8xMDk5NTExNjI4MTI4_8319b14a-d35a-46d6-b4c6-5f5ea2197713"
      unitRef="shares">20297704</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtMi0xLTEtNTA2MjI_7e8a2f22-8f1b-499e-a3ba-361dee0c5046"
      unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzYtNC0xLTEtNTA2MjI_b804fb95-5647-4f07-a64a-311429a1a88b"
      unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzctMi0xLTEtNTA2MjI_033fb916-ad73-49ce-9a2a-d3a986bbcb7e"
      unitRef="usd">101905000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzctNC0xLTEtNTA2MjI_23160d14-eb57-4aed-aecb-c4b3c832dd20"
      unitRef="usd">84785000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzktMi0xLTEtNTA3MzQ_6a1bea1f-d34e-49f0-a736-aa258f572bf9"
      unitRef="usd">268000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzktNC0xLTEtNTA3MzQ_3f1e7593-4c9e-4b64-8c8a-aaebb5973ab3"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzgtMi0xLTEtNTA2MjI_3317fe61-0cb7-44f2-9827-23e6774838ee"
      unitRef="usd">-53903000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfMzgtNC0xLTEtNTA2MjI_a8e9531f-f868-495f-97c5-700609126797"
      unitRef="usd">-44035000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNDAtMi0xLTEtNTA2MjI_adc42703-ced4-41dd-ac4a-959f4baee0cd"
      unitRef="usd">48272000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNDAtNC0xLTEtNTA2MjI_072c4e44-411c-4a76-888a-d7825f2935da"
      unitRef="usd">40752000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNDItMi0xLTEtNTA2MjI_c69f86a8-ae12-4c26-88ca-16cb6a8df7d3"
      unitRef="usd">97586000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV84NS9mcmFnOmNlMTFlM2FiMWJjODQ0NjQ5MWE3NTNkOGI1M2VkYzNiL3RhYmxlOjkzMTAzYTM3MDMzNzRjYTBhYTI2ZmMwOWE5YTcyZGU2L3RhYmxlcmFuZ2U6OTMxMDNhMzcwMzM3NGNhMGFhMjZmYzA5YTlhNzJkZTZfNDItNC0xLTEtNTA2MjI_b19ed822-1119-4729-a71e-1cfeb3f6fec0"
      unitRef="usd">96991000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yLTItMS0xLTUxMDQ5_8f4167ae-94f5-4fea-960b-f34bb206e5b7"
      unitRef="usd">102382000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yLTQtMS0xLTUxMDQ5_7d5a9fcc-74ab-4d8a-87c4-9443e2f86609"
      unitRef="usd">97388000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yLTYtMS0xLTUxMDcy_67311fcd-34bf-4afd-9d17-955701dadb6d"
      unitRef="usd">81115000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zLTItMS0xLTUxMDQ5_91b22a8e-7431-48f3-bb94-3cbe8ae1c443"
      unitRef="usd">42185000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zLTQtMS0xLTUxMDQ5_a07abc2a-a01f-4f75-a9f7-4a6634a20370"
      unitRef="usd">38629000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zLTYtMS0xLTUxMDcy_b64f3c06-fa71-4db0-9f31-8e2e5b28dc42"
      unitRef="usd">34233000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV80LTItMS0xLTUxMDQ5_a74e55db-b59d-467d-9d64-b6861205dc84"
      unitRef="usd">60197000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV80LTQtMS0xLTUxMDQ5_e173d8e6-6e61-4005-9036-c2764fc95896"
      unitRef="usd">58759000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV80LTYtMS0xLTUxMDcy_bae5ca41-45c2-4888-bdad-09a6c6f0ba55"
      unitRef="usd">46882000</us-gaap:GrossProfit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV83LTItMS0xLTUxMDQ5_6b1b3ead-af2a-49c4-a544-c9ec6fa3fa27"
      unitRef="usd">77000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV83LTQtMS0xLTUxMDQ5_97117259-27b2-4786-8a22-dbf27acf35d2"
      unitRef="usd">791000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV83LTYtMS0xLTUxMDg0_e00130a0-bb7b-4e8a-bd6e-adc949d53956"
      unitRef="usd">37000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV84LTItMS0xLTUxMDQ5_294d94cf-3569-4c27-9a8d-2cc9a30ed364"
      unitRef="usd">4262000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV84LTQtMS0xLTUxMDQ5_1703ce8d-4072-4997-b31a-71cc1f536c0e"
      unitRef="usd">4285000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV84LTYtMS0xLTUxMDg0_57bdd440-119f-48ff-8119-7a9f49b31573"
      unitRef="usd">4402000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV85LTItMS0xLTUxMDQ5_e4b2e4c5-9638-47dd-9a5f-73c6a9303444"
      unitRef="usd">10777000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV85LTQtMS0xLTUxMDQ5_e9bf320c-5205-4481-81db-a59c3638cc24"
      unitRef="usd">9661000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV85LTYtMS0xLTUxMDg0_bab3228a-eb09-4c6c-90da-72767bc66c5a"
      unitRef="usd">9932000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMC0yLTEtMS01MTA0OQ_a5726f0b-c395-46cc-a40f-072172659006"
      unitRef="usd">42261000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMC00LTEtMS01MTA0OQ_054e7cc9-6d24-4dd6-8654-f43bc4dd7fb8"
      unitRef="usd">35195000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMC02LTEtMS01MTA4NA_8f26fb0f-2587-4351-ba1e-446a7d193d69"
      unitRef="usd">28986000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMi0yLTEtMS01MTA0OQ_97d8e2ad-a07d-4404-85a7-310b4aacfac3"
      unitRef="usd">57377000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMi00LTEtMS01MTA0OQ_09c503f7-f85d-40a0-83a3-2cb8d07aab96"
      unitRef="usd">49932000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xMi02LTEtMS01MTA4NA_f32328ff-d81c-43a1-b62b-20a8981c888c"
      unitRef="usd">43357000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNC0yLTEtMS01MTA0OQ_7af1dbbb-07c5-4687-b8e6-8759912b543c"
      unitRef="usd">2820000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNC00LTEtMS01MTA0OQ_1fc2b292-3294-411a-b0bb-ec763509d3ea"
      unitRef="usd">8827000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNC02LTEtMS01MTA5Ng_837d0480-9e38-4738-8672-5118a30d71c4"
      unitRef="usd">3525000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNi0yLTEtMS01MTA0OQ_c2563b90-e798-4a4d-9419-8179cb740467"
      unitRef="usd">1377000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNi00LTEtMS01MTA0OQ_b3b33301-14ad-4b8e-9136-33a86ea2d3d4"
      unitRef="usd">1255000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNi02LTEtMS01MTEwNA_12c3fed8-3223-4891-8272-cf990dee4241"
      unitRef="usd">1904000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNy0yLTEtMS01MTA0OQ_71eccff6-f374-4bc6-87f3-16bf87b65654"
      unitRef="usd">-186000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNy00LTEtMS01MTA0OQ_28383af3-5d8a-43e7-a359-d255a17ed35e"
      unitRef="usd">-29000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xNy02LTEtMS01MTEwNA_c3f427dc-1bd3-45e2-a311-36ce1c208134"
      unitRef="usd">-97000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xOS0yLTEtMS01MTA0OQ_dd876be2-bcdb-4b88-a0ee-c9130c352ab0"
      unitRef="usd">1257000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xOS00LTEtMS01MTA0OQ_fa10657e-d78a-4fa6-941a-89a3617e42b3"
      unitRef="usd">7543000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8xOS02LTEtMS01MTExOA_121a8427-e20f-4dfa-bab0-60bc668fd7a6"
      unitRef="usd">1524000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMC0yLTEtMS01MTA0OQ_5b1585be-8e8c-48be-913a-f3388ef7ddd0"
      unitRef="usd">-163000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMC00LTEtMS01MTA0OQ_d8194290-a369-4715-8e48-80523262d2ab"
      unitRef="usd">-9789000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMC02LTEtMS01MTExMQ_94666e9e-27ad-4057-9934-538f31610288"
      unitRef="usd">163000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMS0yLTEtMS01MTA0OQ_d4781426-597e-41e1-b864-6f20f3621b61"
      unitRef="usd">1420000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMS00LTEtMS01MTA0OQ_a815cc32-ec60-4e17-93b5-ac6e9fa70de2"
      unitRef="usd">17332000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMS02LTEtMS01MTEyNg_8fa1451b-d45b-4f62-8f18-47eef68f6c50"
      unitRef="usd">1361000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMy0yLTEtMS01MTA0OQ_7f9718b7-56e7-4846-bfe5-9c6ab779b3fe"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMy00LTEtMS01MTA0OQ_d648fd22-7b1a-476b-a476-cd941be24b03"
      unitRef="usdPerShare">0.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yMy02LTEtMS01MTEzOQ_56ef97a8-35d4-432c-8f0a-4fcd381b70c7"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNC0yLTEtMS01MTA0OQ_9674e000-b1d6-4841-ab97-b6b02b24000e"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNC00LTEtMS01MTA0OQ_8d8d432d-49bb-4440-bd5a-f90c0d1afa8d"
      unitRef="usdPerShare">0.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNC02LTEtMS01MTEzOQ_f75f5d29-7754-483d-8677-e90e21a42d50"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNi0yLTEtMS01MTA0OQ_975dd14a-d805-4240-8c94-8be3e35c173e"
      unitRef="shares">20519958</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNi00LTEtMS01MTA0OQ_45dfd4a4-afcb-42e0-baeb-d19efa2eb4eb"
      unitRef="shares">20106940</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNi02LTEtMS01MTEzOQ_e9aa1279-dc96-4e44-a4c5-c9176710cbde"
      unitRef="shares">19731498</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNy0yLTEtMS01MTA0OQ_5cb7addb-21ad-43aa-8fe9-e31b5452d7f4"
      unitRef="shares">22049659</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNy00LTEtMS01MTA0OQ_fe23ad67-0b82-4fc8-9f63-d3404cdc4107"
      unitRef="shares">21717216</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8yNy02LTEtMS01MTEzOQ_15841361-c812-4375-9952-7fa9701a9c74"
      unitRef="shares">20839396</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMC0yLTEtMS01MTA0OQ_a4cfec2f-4b96-47af-a159-7c7a8cb5a96e"
      unitRef="usd">1420000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMC00LTEtMS01MTA0OQ_3fe96813-5e64-4403-9eeb-ad50bb21d896"
      unitRef="usd">17332000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMC02LTEtMS01MTE0Ng_e8e0a771-b8d3-4e9e-b6ec-a31432f89568"
      unitRef="usd">1361000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMi0yLTEtMS01MTA0OQ_1c96cfb2-31e1-4326-9c13-b34351c8e759"
      unitRef="usd">355000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMi00LTEtMS01MTA0OQ_991bffd0-bc1d-435e-9483-e58942fcb639"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMi02LTEtMS01MTE0Ng_e598bd73-3420-4b5e-a012-5fe01fb83ea2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMy0yLTEtMS01MTA0OQ_05a8a8ea-c5dc-4ec3-bc47-7497bad33555"
      unitRef="usd">87000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMy00LTEtMS01MTA0OQ_6afa4026-9def-42e1-9a27-e8894dbfdb10"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zMy02LTEtMS01MTE0Ng_e62575ef-36c4-484a-a270-cd6e12aca43d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zNC0yLTEtMS01MTA0OQ_0259570c-a588-4201-987e-ecf01748052a"
      unitRef="usd">1688000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zNC00LTEtMS01MTA0OQ_813e118e-ed59-4c49-8312-39bde056ca12"
      unitRef="usd">17332000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjg4L2ZyYWc6Yjk4NGEzMDMxOWNlNDkyNWI4ZGRmYjJhMWNmNmY3N2EvdGFibGU6NWE0NWEzODM1YjkzNDRkY2JlNzBkMDQzMTg3YzMzOGEvdGFibGVyYW5nZTo1YTQ1YTM4MzViOTM0NGRjYmU3MGQwNDMxODdjMzM4YV8zNC02LTEtMS01MTE0Ng_f02f2acc-f572-4d64-af71-b207a68836f6"
      unitRef="usd">1361000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i6b8b5e5eab5d411ab7c41bbd0a191163_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTItMS0xLTUxMzk1_4afedbeb-31e4-436c-995c-069377ff6f3a"
      unitRef="shares">23096000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6b8b5e5eab5d411ab7c41bbd0a191163_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTQtMS0xLTUxMzk1_f6469212-c5ca-48f7-a43f-609d4f779f3e"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibfdec380605a4b47bc98e52a196722c4_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTYtMS0xLTUxMzk1_2b6a3013-7605-40cb-acb0-260d12756a9b"
      unitRef="usd">83167000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe974377c6e747c1a5ca843447269847_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTgtMS0xLTUxMzk1_375ec498-ebde-4806-8dc8-5b6f63fb5f7f"
      unitRef="usd">-62728000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i08a5c3d39ecd4a888c2f856ced55d19a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTEwLTEtMS01MTM5NQ_a4037ee1-6439-485f-b763-08d6bb5cdd1f"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i157f7776f6f34785bf30f4235c8d11bc_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTEyLTEtMS01MTM5NQ_ea41bfed-cba0-40e6-9aac-c9c78978f288"
      unitRef="shares">3518000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i157f7776f6f34785bf30f4235c8d11bc_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTE0LTEtMS01MTM5NQ_4f505498-6ba5-429b-8854-5ce4196d653c"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i488a17cbb36b421597c4f159595f4b31_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTE2LTEtMS01MTM5NQ_0b069fa7-8930-4bb3-8ae0-5c686160b9f1"
      unitRef="usd">20441000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="i67545d7705224bc6be52955d497ead2a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zLTItMS0xLTUxMzk1_b9b74f94-cd02-459d-8077-7a657faf897c"
      unitRef="shares">394000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="ie2affbe3d3694f7286adc05cd2ef1a5f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zLTYtMS0xLTUxMzk1_585158fe-cc3c-4d30-877d-6e7effdd10c5"
      unitRef="usd">139000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zLTE2LTEtMS01MTM5NQ_a6f27841-32d5-434b-840f-7f32771ff7f3"
      unitRef="usd">139000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie2affbe3d3694f7286adc05cd2ef1a5f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV80LTYtMS0xLTUxMzk1_970a8391-7ce4-4ebf-85ef-37ed78be221b"
      unitRef="usd">997000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV80LTE2LTEtMS01MTM5NQ_ffd8aaf8-a68b-4332-a921-68b1b414559e"
      unitRef="usd">997000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i67545d7705224bc6be52955d497ead2a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTItMS0xLTUxMzk1_d9f66e2b-a67a-4fab-b351-f9c6bdaa1681"
      unitRef="shares">33000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ie2affbe3d3694f7286adc05cd2ef1a5f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTYtMS0xLTUxMzk1_83947b98-54bd-4b19-9452-4dbadc15f56d"
      unitRef="usd">113000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTE2LTEtMS01MTM5NQ_ebd52702-cb4e-4167-a89c-1d3b8851977b"
      unitRef="usd">113000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i67545d7705224bc6be52955d497ead2a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTItMS0xLTUxMzk1_8f02859f-cbd3-4cc4-8ce7-a9eb4108ebf2"
      unitRef="shares">122000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie2affbe3d3694f7286adc05cd2ef1a5f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTYtMS0xLTUxMzk1_6a5b8ec2-cabf-4d95-b2b8-b0e68ab03ea0"
      unitRef="usd">717000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTE2LTEtMS01MTM5NQ_5e9a1f86-f609-4d5c-9229-a3b6ffbad21a"
      unitRef="usd">717000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i68d542ad3a9045d9a04429f3568a9113_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV85LTgtMS0xLTUxMzk1_4f301403-aa8e-4086-b592-cbcb562b8ee6"
      unitRef="usd">1361000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV85LTE2LTEtMS01MTM5NQ_92c7080a-057f-4c12-92f6-8b7fedaad364"
      unitRef="usd">1361000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ib332759d305f4dc8b9ccc96ac2c5af1a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTItMS0xLTUxMjg3_e027bdfc-dca9-4c5f-98cd-da768e462cc5"
      unitRef="shares">23401000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib332759d305f4dc8b9ccc96ac2c5af1a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTQtMS0xLTUxMjg3_066ece9d-e792-4889-ae37-dac7e125818e"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i24ee4273907446b1ba9e85ec18226b50_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTYtMS0xLTUxMjg3_a5999d4a-a3d7-4d46-8c6b-c26fbeec155a"
      unitRef="usd">83699000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icc90323890a347a6a803d6e29739a07a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTgtMS0xLTUxMjg3_59813209-afd3-4da9-9347-6f88c3b57301"
      unitRef="usd">-61367000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5306a01245a74e03ab4033c4fe19fc15_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTEwLTEtMS01MTI4Nw_c53854d2-8a55-49bf-921e-57adbd809ab8"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i36d6369b86a9480192a2232dd6e20776_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTEyLTEtMS01MTI4Nw_dac36a93-67b2-4d0f-8b90-c0fb7a1f0292"
      unitRef="shares">3518000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i36d6369b86a9480192a2232dd6e20776_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTE0LTEtMS01MTI4Nw_fb9c24d7-cb64-4458-b565-60f62700e012"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yLTE2LTEtMS01MTI4Nw_d5577346-6b25-4232-93d3-931142081ac8"
      unitRef="usd">22334000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="i264313229b604d5dbaa260791106aae8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zLTItMS0xLTUxMjg3_1c3264f6-9e3d-4ca9-abca-6a25164158e5"
      unitRef="shares">505000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zLTE2LTEtMS01MTI4Nw_2354db3b-90d2-496b-a6e8-e16ce50f85b5"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icdf6be04bef848a3be60bd50bbe09ea3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV80LTYtMS0xLTUxMjg3_996405e0-2270-4660-8d36-7e2f1fe60819"
      unitRef="usd">2610000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV80LTE2LTEtMS01MTI4Nw_706e931f-cad7-4914-82ad-10c84658c772"
      unitRef="usd">2610000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i264313229b604d5dbaa260791106aae8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTItMS0xLTUxMjg3_ef79705f-ff20-40f4-80e3-1636e9462b3a"
      unitRef="shares">29000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="icdf6be04bef848a3be60bd50bbe09ea3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTYtMS0xLTUxMjg3_ce50a205-2d3f-409c-badc-fd19b36ef3c1"
      unitRef="usd">190000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV81LTE2LTEtMS01MTI4Nw_72bbf9e6-d934-403d-a746-bfccba6c6567"
      unitRef="usd">190000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i264313229b604d5dbaa260791106aae8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTItMS0xLTUxMjg3_81a23c8a-3068-4cbb-8fb5-8edb9672bbbc"
      unitRef="shares">147000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="icdf6be04bef848a3be60bd50bbe09ea3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTYtMS0xLTUxMjg3_8dad3e21-fd52-457b-a900-565d080a78fb"
      unitRef="usd">1714000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV82LTE2LTEtMS01MTI4Nw_ce4b9b74-df06-45e1-acdd-896e0819fa50"
      unitRef="usd">1714000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i264313229b604d5dbaa260791106aae8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOS0yLTEtMS04ODYzNw_7fb1cb98-35e5-478f-83e3-270d66b3b395"
      unitRef="shares">28000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="if9e4706fa4334283bce0bd814b6d4abe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV85LTgtMS0xLTUxMjg3_9e54ad9f-a9a1-42ef-ab39-849154f7e93b"
      unitRef="usd">17332000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV85LTE2LTEtMS01MTI4Nw_bba3dc1c-7560-409f-bccd-f50c24222760"
      unitRef="usd">17332000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="ic7a10bd1ab424f0d9abf84a729cab56e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC0yLTEtMS01MTI4Nw_c86cfa6e-517e-49a7-892a-e870e0b2e894"
      unitRef="shares">23816000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic7a10bd1ab424f0d9abf84a729cab56e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC00LTEtMS01MTI4Nw_4299d1c7-5e87-4540-9302-59d7e8c036aa"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if9fc97e52018419aac6e451ce020e3c4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC02LTEtMS01MTI4Nw_53fde545-98a9-46e5-8d1d-a274836740a4"
      unitRef="usd">84785000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic9f3ba1490534187962e956028423a05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC04LTEtMS01MTI4Nw_3fcbe3ba-7df9-4552-9699-89fd3df6feeb"
      unitRef="usd">-44035000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibba59ce2bece4e15bb0877c92494fe88_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC0xMC0xLTEtNTEyODc_91f2153d-d658-4c23-b518-7b39550d03ff"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i3ef36744ffb64ea58b479667d4a1410c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC0xMi0xLTEtNTEyODc_c5e90422-2c90-4019-a0b5-604430e7fb47"
      unitRef="shares">3518000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3ef36744ffb64ea58b479667d4a1410c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC0xNC0xLTEtNTEyODc_96b2038c-ecf0-436f-8a63-93a1bd4e3fe5"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMC0xNi0xLTEtNTEyODc_1a72a6e2-b324-45a6-b87b-2ae0a22efb2a"
      unitRef="usd">40752000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMS0yLTEtMS01MTI4Nw_270e7408-a78d-4a8b-8cb2-a90623b27eee"
      unitRef="shares">462000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMS02LTEtMS01MTI4Nw_46ec49a6-acc3-4540-9e80-4e2792054b0b"
      unitRef="usd">812000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMS0xNi0xLTEtNTEyODc_28bb7edf-fd1f-4062-a02e-887e84d50223"
      unitRef="usd">812000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMi02LTEtMS01MTI4Nw_7d86338c-c25f-4a32-93e7-2e642ffa1382"
      unitRef="usd">6404000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMi0xNi0xLTEtNTEyODc_0b294957-d43e-4320-aa60-9df33d3559e4"
      unitRef="usd">6404000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMy0yLTEtMS01MTI4Nw_0dba7817-4324-46e6-b687-0f89e724d0ca"
      unitRef="shares">32000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMy02LTEtMS01MTI4Nw_aab1d31e-fa59-4049-83a4-eb90af889ba6"
      unitRef="usd">348000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xMy0xNi0xLTEtNTEyODc_baeb7f61-82fd-47f1-ad77-010b4eed8395"
      unitRef="usd">348000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNC0yLTEtMS01MTI4Nw_d6e7e6f3-1b4a-4bcd-abb2-2597da47220b"
      unitRef="shares">59000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNC02LTEtMS01MTI4Nw_ccdcf8ff-b990-4723-a708-885d902b9a12"
      unitRef="usd">1172000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNC0xNi0xLTEtNTEyODc_c783ba63-2397-4b95-ac6c-d0c64dbe7e62"
      unitRef="usd">1172000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yNy0yLTEtMS02ODE2Nw_ed4be597-222b-43fd-a509-d10b92959cbc"
      unitRef="shares">3518000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ica3870a97302464c89dd8c4818ec589c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yNy02LTEtMS02ODE2Nw_982fa560-b672-4fa2-bb6e-36bb75ef625f"
      unitRef="usd">-10728000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="iffdd24f84ee6404c8449edf03c2c03b9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yNy04LTEtMS02ODE2Nw_f698737a-5efc-4389-9a17-a03b30fd5cae"
      unitRef="usd">10728000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i60447bb6297b410f8726ce5432f5690a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yNy0xMi0xLTEtNjgxNjc_df477a26-686d-477a-862b-0c1c09a539e9"
      unitRef="shares">3518000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yNy0xNi0xLTEtNjgxNjc_3804f4ae-0ee8-49b5-adf9-3cb2c9102879"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i50e0df5e0be34267a8e241c9ea31fe20_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yOC0yLTEtMS02ODE2Nw_f993c311-c277-4a90-b7f1-21a34fcf6cd9"
      unitRef="shares">33000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="iffdd24f84ee6404c8449edf03c2c03b9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yOC04LTEtMS02ODE2Nw_2ff41a81-48cc-4e32-8b09-7e54ea7ef617"
      unitRef="usd">560000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8yOC0xNi0xLTEtNjgxNjc_4e83bf5d-0874-4bc4-9164-5c343394de9c"
      unitRef="usd">560000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i33bade00e83b4d3fa491f7a2b7f67333_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNi0xMC0xLTEtNTEyODc_25fb555f-3b48-4acd-ad85-0d857b03b9ad"
      unitRef="usd">268000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8zMC0xNi0xLTEtNjgzMDY_5156b983-2015-4568-9e64-426b4950f01a"
      unitRef="usd">268000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="iffdd24f84ee6404c8449edf03c2c03b9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNy04LTEtMS01MTI4Nw_d11958cf-c6f6-4579-a304-ff5da70dec57"
      unitRef="usd">1420000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xNy0xNi0xLTEtNTEyODc_94820500-0e26-47ee-92af-7a3425f89545"
      unitRef="usd">1420000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i6d0ded68cb484345bb92203314eb3670_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC0yLTEtMS01MTI4Nw_d1bda45c-2ab4-4ee0-9315-6392cbd18f2d"
      unitRef="shares">20700000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6d0ded68cb484345bb92203314eb3670_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC00LTEtMS01MTI4Nw_8fd260d8-7e77-4f5e-9135-61cd04392246"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iafc46bb5055c4ecfb796ab2b26d1f201_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC02LTEtMS01MTI4Nw_524526cb-1a31-47fb-85c2-69658b37a4fe"
      unitRef="usd">101905000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if9e7686a6c9a4fb996fb64830470a5d8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC04LTEtMS01MTI4Nw_4a93075c-04af-4c11-b18a-c59001e85aba"
      unitRef="usd">-53903000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ide4509120e7e42d29953cf1e80b08d9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC0xMC0xLTEtNTEyODc_bca628d4-1814-461a-bbb3-8a8c185966ac"
      unitRef="usd">268000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i954290189efa49729f89a0332d6eed3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC0xMi0xLTEtNTEyODc_25d196df-0b15-443d-b5a2-350753da4f98"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i954290189efa49729f89a0332d6eed3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC0xNC0xLTEtNTEyODc_3f7ec1bc-74e0-44c5-b449-932926aba666"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzE1L2ZyYWc6ZWIwZjEzOTE0NjA1NGRlZDljNzFjZmZjZmY3YmZjNjcvdGFibGU6MTgwNzI2ZTk3NzY0NGQwMmIyZTYwMjgxZDBjODJhNzUvdGFibGVyYW5nZToxODA3MjZlOTc3NjQ0ZDAyYjJlNjAyODFkMGM4MmE3NV8xOC0xNi0xLTEtNTEyODc_52787eeb-45db-4816-a904-0bc07dff9bfe"
      unitRef="usd">48272000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yLTItMS0xLTUxNTYy_25544050-8926-4f82-9b03-4fe626bbf0ff"
      unitRef="usd">1420000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yLTQtMS0xLTUxNTYy_98cff91f-3c75-43c6-a9a6-6c02d3de5e4a"
      unitRef="usd">17332000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yLTYtMS0xLTUxNTgz_88517c16-1add-43b2-8114-c1bc42bda2cd"
      unitRef="usd">1361000</us-gaap:NetIncomeLoss>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF80LTItMS0xLTUxNTYy_78fb4d16-1346-40d3-b08e-330abc6f61df"
      unitRef="usd">77000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF80LTQtMS0xLTUxNTYy_b56b39c0-8858-4f88-812a-9ca08e28ed74"
      unitRef="usd">791000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF80LTYtMS0xLTUxNTkw_d2a703fc-e6e0-4bd1-95ea-c4e96b24feaa"
      unitRef="usd">37000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:Depreciation
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF81LTItMS0xLTUxNTYy_93c79c11-5d13-4d17-80a6-f4cc662fc372"
      unitRef="usd">10363000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF81LTQtMS0xLTUxNTYy_91c6cf7e-b4a4-4200-8c25-00f81e3a11eb"
      unitRef="usd">9740000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF81LTYtMS0xLTUxNTkw_c0f1a4a0-382e-4ae5-8904-a0d9100e55a6"
      unitRef="usd">7940000</us-gaap:Depreciation>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF82LTItMS0xLTUxNTYy_b48e7b60-65b8-4d24-848a-cb16773a9bdf"
      unitRef="usd">1029000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF82LTQtMS0xLTUxNTYy_f33f16a5-2f0c-4ce8-b8c4-afa1b482fa69"
      unitRef="usd">418000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF82LTYtMS0xLTUxNTkw_b36f3b4a-c1d3-4f8e-a1b2-8b4ff39ee3c4"
      unitRef="usd">638000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF83LTItMS0xLTUxNTYy_b16c4f18-8946-40a0-95c5-7d23622b0145"
      unitRef="usd">2545000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF83LTQtMS0xLTUxNTYy_53fc8f33-fbf1-47e5-94a0-eb65548fdec3"
      unitRef="usd">3577000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF83LTYtMS0xLTUxNTk3_a6b23225-1b82-45cc-a883-eb37ea2f99a3"
      unitRef="usd">1453000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF84LTItMS0xLTUxNTYy_e65bb164-46b7-4c3d-aa11-e150ad3f0724"
      unitRef="usd">4262000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF84LTQtMS0xLTUxNTYy_a8dc7fb0-5313-4c01-adf8-02ba493b0c38"
      unitRef="usd">4285000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF84LTYtMS0xLTUxNjA0_7f23c5a3-4797-4660-b79f-fc4ba41e1788"
      unitRef="usd">4402000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF85LTItMS0xLTUxNTYy_a20f9359-0d59-4318-9928-2c0058686d76"
      unitRef="usd">151000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF85LTQtMS0xLTUxNTYy_f1ff84db-7581-4f82-a354-c8c3acbb2919"
      unitRef="usd">17000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF85LTYtMS0xLTUxNjA0_22f4e59f-bf30-4b8d-9772-e592779089ce"
      unitRef="usd">37000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ShareBasedCompensation
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMC0yLTEtMS01MTU2Mg_2e6c90b8-9845-4282-aad5-99bce8a53169"
      unitRef="usd">6404000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMC00LTEtMS01MTU2Mg_cab7cbf4-5656-4ea8-af29-70da4e9c7931"
      unitRef="usd">2610000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMC02LTEtMS01MTYwNA_af77e871-c7ff-47a2-b282-bf62457f0d5d"
      unitRef="usd">997000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMS0yLTEtMS01MTU2Mg_242b1156-a325-4614-a59a-3c214f441a35"
      unitRef="usd">-153000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMS00LTEtMS01MTU2Mg_675a79d0-e513-4407-be20-373b45cd0afc"
      unitRef="usd">-10071000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMS02LTEtMS01MTYwNA_ac7cd41c-6dfa-45cb-b019-34f322ad7e45"
      unitRef="usd">104000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMy0yLTEtMS01MTU2Mg_b59968fc-f0c6-4245-aa37-db107888128f"
      unitRef="usd">-829000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMy00LTEtMS01MTU2Mg_7e20eb9c-5499-4d10-891d-a1e9b1f7f0c0"
      unitRef="usd">2631000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xMy02LTEtMS01MTYxMQ_879dfe6b-2860-43ac-84f8-23ffb55d0803"
      unitRef="usd">1560000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNC0yLTEtMS01MTU2Mg_a22f1c52-3f8d-4c19-80c3-7c7f3476ec34"
      unitRef="usd">864000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNC00LTEtMS01MTU2Mg_2e2ab89d-118a-4c7d-8a55-0c4511962e61"
      unitRef="usd">102000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNC02LTEtMS01MTYxMQ_c4a12b8f-1cde-4d63-a091-ca885e6bf705"
      unitRef="usd">645000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNS0yLTEtMS01MTU2Mg_b19cf96a-7307-4b3b-a41c-7cd95d7a0aae"
      unitRef="usd">133000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNS00LTEtMS01MTU2Mg_56c71b5c-a5f8-4411-941d-331dad1d652e"
      unitRef="usd">740000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNS02LTEtMS01MTYxMQ_0d8d42c6-e5b2-4abe-94c0-5e30e1e9fd2c"
      unitRef="usd">290000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNi0yLTEtMS01MTU2Mg_7ae39a6d-5933-483c-b8c2-c72f21af3387"
      unitRef="usd">161000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNi00LTEtMS01MTU2Mg_8b7f6569-da27-47e4-b69a-2defdf8f36e1"
      unitRef="usd">186000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xNi02LTEtMS01MTYxMQ_ea5e02a3-56da-424e-9c93-418b8d17ccd8"
      unitRef="usd">129000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOC0yLTEtMS01MTU2Mg_e185e5f3-7a6c-40a9-b3b2-9462e94b2acf"
      unitRef="usd">-2363000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOC00LTEtMS01MTU2Mg_83b28c84-2bac-4e77-b27f-827185875e4b"
      unitRef="usd">2394000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOC02LTEtMS01MTYxOA_a939f12f-f6ef-4b11-88be-3516489e01cd"
      unitRef="usd">2436000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOS0yLTEtMS01MTU2Mg_65f732d3-c4e5-4555-b81b-cbf9a6112c59"
      unitRef="usd">18316000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOS00LTEtMS01MTU2Mg_db675857-d0a9-4234-a78d-b5a9a236b4be"
      unitRef="usd">20280000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8xOS02LTEtMS01MTYxOA_795f55e3-519a-4591-bb76-23b1743fdbf2"
      unitRef="usd">13875000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMi0yLTEtMS01MTU2Mg_2710b5ca-7159-44da-aa45-a8c61d0c396e"
      unitRef="usd">7976000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMi00LTEtMS01MTU2Mg_08b5a472-e826-424a-9922-b9dba562610a"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMi02LTEtMS01MTYyNQ_9c2f05d0-5768-4ed6-9406-040f05ee7ce5"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMy0yLTEtMS01MTU2Mg_7d0cf1c5-9123-4759-9c6f-e92a944a1cf7"
      unitRef="usd">15676000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMy00LTEtMS01MTU2Mg_e0f10eed-03db-4f3a-94d2-04b6125b9543"
      unitRef="usd">15820000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yMy02LTEtMS01MTYyNQ_af741965-85a8-4ab1-b920-43bc68247e08"
      unitRef="usd">19669000</infu:PaymentsToAcquireMedicalEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNC0yLTEtMS01MTU2Mg_578bc7f7-0e42-429a-8f8d-12dd7083a760"
      unitRef="usd">980000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNC00LTEtMS01MTU2Mg_343a3050-049d-411a-af73-05d5236532c3"
      unitRef="usd">1094000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNC02LTEtMS01MTYyNQ_ea94e357-1cca-42fb-93fd-edc3f23ce234"
      unitRef="usd">2926000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNS0yLTEtMS01MTU2Mg_32d53e5a-7c4d-456a-a25a-3f114ca2a535"
      unitRef="usd">3317000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNS00LTEtMS01MTU2Mg_ae197c89-6043-45c4-b65c-32487f593ff2"
      unitRef="usd">4752000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNS02LTEtMS01MTYyNQ_e95432c9-fa57-4147-a561-784566de7c1e"
      unitRef="usd">2952000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNi0yLTEtMS01MTU2Mg_35614f0d-1c82-437f-bfa0-b2d9dfdabcba"
      unitRef="usd">-21315000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNi00LTEtMS01MTU2Mg_458c5aeb-ff0f-47b1-bba1-ec54fdd5f7ec"
      unitRef="usd">-12162000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yNi02LTEtMS01MTYyNQ_fd6097d5-af4a-4ae6-8cdf-770214176176"
      unitRef="usd">-19643000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yOS0yLTEtMS01MTU2Mg_9dac47d7-0207-4f6c-8384-c06b43aa5c6e"
      unitRef="usd">81660000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yOS00LTEtMS01MTU2Mg_825a167b-8ed2-4840-9acf-0cf82c2df5b7"
      unitRef="usd">37180000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8yOS02LTEtMS01MTYzMg_ae79571a-f5e7-4598-bc36-302c26f23971"
      unitRef="usd">4868000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMC0yLTEtMS01MTU2Mg_00135cdf-d0ec-4560-ba6a-5d49d39b4f5d"
      unitRef="usd">76191000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMC00LTEtMS01MTU2Mg_22ad46b9-51d6-4038-a5ac-5cb3f6e8da05"
      unitRef="usd">37587000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMC02LTEtMS01MTYzMg_4e84db69-d04e-40e9-b6f2-4524142d234e"
      unitRef="usd">9436000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMS0yLTEtMS01MTU2Mg_9cbd051f-703c-4b0e-8b0b-8f842a0e87c5"
      unitRef="usd">386000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMS00LTEtMS01MTU2Mg_94370ccb-6c19-4b72-8294-65296f4f4afa"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMS02LTEtMS01MTYzMg_2098f6b9-2d5b-4836-a04b-8dd14183fd9d"
      unitRef="usd">6000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMi0yLTEtMS01MTU2Mg_3940450b-60ee-4b90-aa4f-8e7e5dcef947"
      unitRef="usd">1172000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMi00LTEtMS01MTU2Mg_43f326fc-5b1c-4a84-a08b-622a90759eee"
      unitRef="usd">1714000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMi02LTEtMS01MTYzMg_a32b2167-c88f-4fea-8ef2-80b6726cfb2d"
      unitRef="usd">717000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNC0yLTEtMS02ODI5MA_18529b1a-2963-430c-9a49-2312d3514800"
      unitRef="usd">560000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNC00LTEtMS02ODI5MA_5578a8ad-0f9e-43c3-b766-a581d4cd248b"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNC02LTEtMS02ODI5MA_ca9e5bab-a2d2-4a7a-b63b-7d12599958be"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMy0yLTEtMS01MTU2Mg_60c9ea30-b523-4868-840d-024bc183e85f"
      unitRef="usd">1124000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMy00LTEtMS01MTU2Mg_b1858c71-d3ef-41d7-8974-0aa3a9a45398"
      unitRef="usd">190000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zMy02LTEtMS01MTYzMg_bddbf593-f511-43be-b9ee-979bb8527bf8"
      unitRef="usd">252000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNS0yLTEtMS01MTU2Mg_e5fe66b0-0650-4145-9523-2c56e3522682"
      unitRef="usd">-6463000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNS00LTEtMS01MTU2Mg_5bb8d52f-9a9e-4e45-9d33-e0345ac7ff4a"
      unitRef="usd">-1117000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNS02LTEtMS01MTYzMg_d18647fa-38cc-454e-a1b8-cca2981360c6"
      unitRef="usd">4097000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNy0yLTEtMS01MTU2Mg_eb4727a9-fb64-4e5f-8282-71e7b3e0f86f"
      unitRef="usd">-9462000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNy00LTEtMS01MTU2Mg_bf058a08-8349-4845-a12d-368bb23fa1ff"
      unitRef="usd">7001000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zNy02LTEtMS01MTYzMg_5488dca5-3d21-4735-a13b-44cf1a3117ff"
      unitRef="usd">-1671000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOC0yLTEtMS01MTU2Mg_1df5d426-7a7a-4791-83fb-03630073c4ca"
      unitRef="usd">9648000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOC00LTEtMS01MTU2Mg_54480862-248f-4f4b-bb42-effd2aad5578"
      unitRef="usd">2647000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i488a17cbb36b421597c4f159595f4b31_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOC02LTEtMS01MTYzMg_3304fb0b-2d31-487b-9779-c0c89f7cd689"
      unitRef="usd">4318000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOS0yLTEtMS01MTU2Mg_849abb78-c52f-416e-8168-1f39fef6e29d"
      unitRef="usd">186000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOS00LTEtMS01MTU2Mg_cc764ace-773f-4332-91db-7b0338fc45b7"
      unitRef="usd">9648000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YWQ0M2I5MzY5OGM3NDEwZmIwNDUyODI2YmVjNzgzNWQvdGFibGVyYW5nZTphZDQzYjkzNjk4Yzc0MTBmYjA0NTI4MjZiZWM3ODM1ZF8zOS02LTEtMS01MTYzMg_e494871c-251d-4d78-b323-fa92f839d77a"
      unitRef="usd">2647000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV8zLTItMS0xLTUxNTYy_6505f19e-d837-4899-9cfe-1069e82dc01c"
      unitRef="usd">1113000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV8zLTQtMS0xLTUxNTYy_081298ec-739f-4626-8aae-3adc99a264a9"
      unitRef="usd">1214000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV80LTYtMS0xLTU4NTgz_9a9682b3-039f-47b3-a576-fa2bfe1940da"
      unitRef="usd">1705000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV80LTItMS0xLTUxNTYy_d90a404a-8238-4db5-b4af-5b0d5bb04964"
      unitRef="usd">171000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV80LTQtMS0xLTUxNTYy_fc107106-01f2-41e1-b688-01cf431717b1"
      unitRef="usd">102000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV81LTYtMS0xLTU4NTgz_20e06869-47e5-4942-8432-b3bd01aae203"
      unitRef="usd">111000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTItMS0xLTUxNTYy_481006d8-1084-4727-894a-60249e6a0acf"
      unitRef="usd">1590000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTQtMS0xLTUxNTYy_85944c39-89c5-482e-9458-11163ccd9b31"
      unitRef="usd">793000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV83LTYtMS0xLTU4NTgz_8836808c-e83c-441d-9439-13331421e05d"
      unitRef="usd">2773000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <infu:NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTMtMS0xLTY4ODgz_40e6085e-e2f2-4deb-adba-1604628105b6"
      unitRef="usd">750000</infu:NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration>
    <infu:NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTUtMS0xLTY4ODc2_c111bee4-d840-4aa3-92a0-bac2910ee946"
      unitRef="usd">0</infu:NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration>
    <infu:NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTctMS0xLTY4ODY5_e5423472-a3f2-41f8-bf6a-49f647b5d1ed"
      unitRef="usd">0</infu:NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration>
    <infu:NoncashActivitiesProceedsFromStockPlans
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTMtMS0xLTcxODUy_6838e1f4-e58f-4c76-a61b-10f7c982034d"
      unitRef="usd">36000</infu:NoncashActivitiesProceedsFromStockPlans>
    <infu:NoncashActivitiesProceedsFromStockPlans
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTUtMS0xLTcxODU5_02a6b5f6-3c05-4ee2-b77c-626b8dbafc75"
      unitRef="usd">0</infu:NoncashActivitiesProceedsFromStockPlans>
    <infu:NoncashActivitiesProceedsFromStockPlans
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTctMS0xLTcxODY2_8cf1827d-43b3-49fd-9ca8-720fd3e1ef15"
      unitRef="usd">0</infu:NoncashActivitiesProceedsFromStockPlans>
    <us-gaap:BasisOfAccounting
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDMvZnJhZzo4OGUwZTEzMjZmNDk0YzY1YTViOTg2ZWI1MDQxM2RiYi90ZXh0cmVnaW9uOjg4ZTBlMTMyNmY0OTRjNjVhNWI5ODZlYjUwNDEzZGJiXzMwMzE_f3e878a6-7eda-4da9-8dbb-c55cca857cd7">Basis of Presentation and Nature of Operations&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;InfuSystem Holdings, Inc. and its consolidated subsidiaries (the &#x201c;Company&#x201d;) are a leading national provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from seven locations in the United States and Canada. The Company provides products and services to hospitals, oncology practices and facilities and other alternate site health care providers. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support, and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada. InfuSystem Inc. (&#x201c;ISI&#x201d;) and First Biomedical, Inc. ("First Biomedical") are both operating subsidiaries of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s core service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics to be utilized in the treatment of a variety of cancers including colorectal cancer, pain management and other disease states. The majority of the Company&#x2019;s pumps are electronic infusion pumps. Smiths Medical, Inc. and Moog Medical Devices Group each supplied more than 10% of the ambulatory pumps purchased by the Company in 2021. The Company has a supply agreement in place with each of these suppliers. Certain &#x201c;spot&#x201d; purchases are made on the open market subject to individual negotiation. The Company also supplies Negative Pressure Wound Therapy (&#x201c;NPWT&#x201d;) medical equipment, as well as related disposables and ancillary supplies. Cardinal Health, Inc. supplied more than 10% of the NPWT medical equipment purchased by the Company in 2021. The Company has a supply agreement in place with Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company sells or rents new and pre-owned pole-mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. The Company also provides these products and services to customers in the hospital market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company purchases new and pre-owned pole-mounted and ambulatory infusion pumps from a variety of sources on a non-exclusive basis. The Company repairs, refurbishes and provides biomedical certification for the devices as needed. The pumps are then available for sale, rental or to be used within the Company&#x2019;s ambulatory infusion pump management service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccounting>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i34393106918541a2afdfacc9dc70598f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDMvZnJhZzo4OGUwZTEzMjZmNDk0YzY1YTViOTg2ZWI1MDQxM2RiYi90ZXh0cmVnaW9uOjg4ZTBlMTMyNmY0OTRjNjVhNWI5ODZlYjUwNDEzZGJiXzE0NDI_4e76d407-fd9d-43f0-bffd-43312a54a156"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9f484679bbfa45cc82f4383cd151aeae_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDMvZnJhZzo4OGUwZTEzMjZmNDk0YzY1YTViOTg2ZWI1MDQxM2RiYi90ZXh0cmVnaW9uOjg4ZTBlMTMyNmY0OTRjNjVhNWI5ODZlYjUwNDEzZGJiXzE4NDU_cc01f02a-bffe-49a1-8a04-364f4633a9c2"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzU0OTc1NTgxNzQ5MjY_1e25f7ad-1d90-4864-bf65-51a63bf6afd9">Summary of Significant Accounting Policies&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and all wholly owned organizations. All intercompany transactions and account balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in two reportable segments, Integrated Therapy Services (&#x201c;ITS&#x201d;) and Durable Medical Equipment Services (&#x201c;DME Services&#x201d;) based on management's view of its business for purpose of evaluating performance and making operating decisions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s approach is to make operational decisions and assess performance based on delivering products and services that together provide solutions to its customer base utilizing a functional management structure. Based upon this business model, the Company&#x2019;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker, reviews segment financial information. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i9e717b65c1e3405d850ef6e342b20071_1859" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 14&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for segment disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates, assumptions and judgments that affect the amounts reported in the financial statements, including the notes thereto. The Company considers critical accounting policies to be those that require more significant judgments and estimates in the preparation of its consolidated financial statements, including the following: revenue recognition, leases, accounts receivable and allowance for doubtful accounts, income taxes, equity compensation valuations, and long-lived asset valuations. Management relies on &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;historical experience and other assumptions believed to be reasonable in making its judgments and estimates. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for all business combinations using the acquisition method of accounting, which allocates the fair value of the purchase consideration to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions. The Company may utilize third-party valuation specialists to assist the Company in the allocation. For intangible assets, the Company typically uses the income approach to determine their estimated fair values.  Key estimates and assumptions in that approach include the amount and timing of projected future cash flow, the discount rate selected to measure the risks inherent in those cash flows and the assessment of the asset's useful life.  Initial purchase price allocations are subject to revision within the measurement period, not to exceed one year from the date of acquisition. Acquisition-related expenses and transaction costs associated with business combinations are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company maintains substantially all of its cash and cash equivalents primarily with two financial institutions that are insured with the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). At times throughout the year, cash and cash equivalents balances might exceed FDIC insurance limits. Accounts at banks with an aggregate excess of the amount of outstanding checks over the cash balances are included in accounts payable in current liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts billed that have not yet been collected that also meet the conditions for unconditional right to payment are presented as accounts receivable. Accounts receivable related to rental service and delivery of products are reported at their estimated transaction prices, inclusive of adjustments for variable consideration, based on the amounts expected to be collected from payers. The Company writes off accounts receivable once collection efforts have been exhausted and an account is deemed to be uncollectible. An allowance for doubtful accounts is established as a result of an adverse change in the Company&#x2019;s payers&#x2019; ability to pay outstanding billings. The allowance for doubtful accounts was $1.1 million and $1.0 million as of December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s inventories consist of disposable medical supplies, replacement parts and other supplies used in conjunction with medical equipment and are stated at the lower of cost (first-in, first-out basis) or net realizable value. Cost primarily represents the purchase price paid for the items on hand. The Company periodically performs an analysis of slow-moving inventory and records an adjustment to reflect the recoverable amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Medical Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment (&#x201c;Equipment&#x201d;) consists of equipment that the Company purchases from third-parties and is (1) for sale or rent, and (2) used in service to generate rental revenue. Equipment, once placed into service, is depreciated using the straight-line method over the estimated useful lives of the equipment which is typically seven years. The Company does not depreciate Equipment held for sale or rent. When Equipment in rental service assets are sold, or otherwise disposed, the cost and related accumulated depreciation are removed from the accounts and a gain or loss is recorded in the current period. The Company periodically performs an analysis to identify potentially missing  Equipment and records a reserve equal to the underlying net book value, which was $1.1 million and $0.9 million as of December&#160;31, 2021 and 2020, respectively. The Company performs a similar analysis of slow-moving Equipment for sale or rent and records a reserve, which was less than $0.1 million as of both December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Presentation of Medical Equipment in the Consolidated Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company purchases medical equipment directly for sale as well as medical equipment that is purchased for either rental or sale and that is unallocated at the time of purchase (&#x201c;Unallocated Assets&#x201d;). Management believes that the predominant source of revenues and cash flows from the Unallocated Assets is from rentals and most equipment purchased is likely to be rented prior to being sold. The Company concluded that (i) the assets specifically supporting its two primary revenue streams should be separately disclosed on the balance sheet; (ii) the purchase and sale of Unallocated Assets should be classified solely &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in investing cash flows based on their predominant source while medical equipment purchased specifically for sales activity should be classified in operating cash flows; and (iii) other activities ancillary to the rental process should be consistently classified.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is stated at acquired cost and depreciated using the straight-line method over the estimated useful lives of the related assets, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY3ODU_89ea2bad-0ac3-4d89-9bff-0b3592eb4de5"&gt;three&lt;/span&gt; to seven years. Externally purchased information technology software and hardware are depreciated over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY4ODI_16fecb86-c446-4994-8930-6e54f72298e6"&gt;three&lt;/span&gt; and five years, respectively. Leasehold improvements are amortized using the straight-line method over the life of the asset or the remaining term of the lease, whichever is shorter. Maintenance and minor repairs are charged to operations as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is recorded in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment annually or when events occur or circumstances change that trigger a review. Management has the option to first assess qualitative factors such as current performance and overall economic conditions to determine whether or not it is necessary to perform a quantitative goodwill impairment test. If the Company chooses that option, then the Company would not be required to perform a quantitative goodwill impairment test unless the Company determines that, based on a qualitative assessment, it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company determines that an impairment is more likely than not, or if the Company chooses not to perform a qualitative assessment, the Company will then proceed with the quantitative assessment. Under the quantitative test, if the fair value of a reporting unit exceeds its carrying amount, then goodwill of the reporting unit is considered to not be impaired. If the carrying amount of the reporting unit exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess, up to the value of the goodwill. The Company performed its annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that there was no impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of trade names, physician and customer relationships, unpatented technology, non-competition agreements and software. The Company amortizes the value assigned to the physician and customer relationships on a straight-line basis over the period of expected benefit, which ranges from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzc2NzA_787bbc1d-efca-48b5-9bc6-20acf41ccb09"&gt;fifteen&lt;/span&gt; to twenty years. The acquired physician and customer relationship base represents a valuable asset of the Company due to the expectation of future business opportunities to be leveraged from the existing relationship with each physician and customer. The Company has long-standing relationships with numerous oncology clinics, physicians, home care and home infusion providers, skilled nursing facilities, pain centers and others. The useful lives of these relationships are based on the expected attrition rates. Acquired software is amortized on a straight-line basis over the period of expected benefit, which ranges from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzgzMTA_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1"&gt;three&lt;/span&gt; to five years. Acquired unpatented technology arose from recent acquisitions and is amortized on a straight-line basis over the period of expected benefit, which is seven years. This asset represents acquired knowledge of repair solutions that will be leveraged into opportunities into the acute care market. The non-competition agreements arose from recent acquisitions and are amortized on a straight-line basis over the terms of the agreements, which is five years. Trade names associated with the original acquisition of InfuSystem are not amortized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management tests indefinite life trade names for impairment annually or more frequently if deemed necessary. Management has the option of first performing the impairment test for intangible assets with indefinite lives on a qualitative basis, by evaluating factors to determine whether it is more likely than not that an impairment exists. If it is more likely than not that an impairment exists, then a quantitative impairment test is performed. Impairment exists when the carrying amount of the intangible asset exceeds its fair value. If the carrying value of the intangible assets exceeds the fair value, an impairment loss is recognized in an amount equal to that excess. The Company performed its annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that the fair value of the trade names with indefinite lives was greater than their carrying value, resulting in no impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software Capitalization and Depreciation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software project, external direct costs of materials and services and interest costs while developing the software. Capitalized software costs are included in intangible assets, net and are amortized using the straight-line method over the estimated useful life of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzODg_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1"&gt;three&lt;/span&gt; to five years. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs, are &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expensed in the period in which they are incurred. The Company capitalized $0.3 million of internal-use software for the year ended December&#160;31, 2021 and did not capitalize any internal-use software for the year ended  December&#160;31, 2020. Amortization expense for capitalized software was $1.6 million in 2021, $1.9 million in 2020 and $2.0 million in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses impairment indicators related to its internally-developed, internal-use software, specifically looking at the effectiveness and useful lives of each project and sub-project to determine if impairment indicators are present. For the year ended December&#160;31, 2021, the Company assessed the impairment indicators and found none to be present.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets held for use, which includes medical equipment in rental service, property and equipment and amortizable intangible assets, are reviewed for impairment when events or changes in circumstances indicate that their carrying value may not be recoverable. If an impairment indicator exists, the Company assesses the asset or asset group for recoverability. Recoverability of these assets is determined based upon the expected undiscounted future net cash flows from the operations to which the assets relate, utilizing management&#x2019;s best estimates, appropriate assumptions and projections at the time. If the carrying value is determined not to be recoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair market value of the asset or asset group. For the years ended December&#160;31, 2021, 2020 and 2019, respectively, the Company assessed the impairment indicators and found none to be present.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2019 (the &#x201c;Effective Date&#x201d;), the Company adopted Accounting Standards Codification ("ASC") Topic 842, Leases,("Topic 842"),  using a modified retrospective transition approach. Under Topic 842, lessees are required to recognize a lease liability and right-of-use asset (&#x201c;ROU asset&#x201d;) for all leases and to disclose key information about leasing arrangements. Additionally, leases are classified as either financing or operating; the classification determines the pattern of expense recognition and classification within the statement of operations. The Company elected to apply its lease accounting policy only to leases with a term greater than twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Topic 842 provides several optional practical expedients that the Company adopted at transition. The Company elected the &#x201c;package of practical expedients&#x201d;, which does not require it to reassess its prior conclusions regarding lease identification, lease classification and initial direct costs. The Company did not elect the practical expedient of hindsight to the evaluation of lease options (e.g. renewal).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Topic 842 also provides practical expedients for an entity&#x2019;s ongoing accounting. The Company elected the &#x201c;combining lease and non-lease components&#x201d; practical expedient and also elected to apply the short-term lease recognition exemption to certain leases; therefore, the Company did not recognize ROU assets and lease liabilities for these leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In adopting Topic 842, the Company determined and will continue to determine whether an arrangement is a lease at inception. The Company&#x2019;s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next ten years. The Company&#x2019;s leases do not contain any restrictive covenants. The Company&#x2019;s office leases generally contain renewal options for periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEzNTUy_9f2fcc91-aee1-47c3-a7b5-103597d961a0"&gt;one&lt;/span&gt; to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company&#x2019;s office leases do not contain any material residual value guarantees. The Company&#x2019;s equipment leases generally do not contain renewal options. The Company is not reasonably certain to exercise the renewal options for those equipment leases that do contain renewal options, thus, the options are not considered in determining the lease term and payments associated with the option years are excluded from lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s equipment leases, the Company used and will use the implicit rate in the lease as the discount rate, when available. Otherwise, the Company uses its incremental borrowing rate as the discount rate. For the Company&#x2019;s office leases, the implicit rate is typically not available, so the Company used and will use its incremental borrowing rate as the discount rate. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The Company&#x2019;s lease agreements include both lease and non-lease components. The Company elected the practical expedient that allows it to combine lease and non-lease components for all of its leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments due under the Company&#x2019;s operating leases include fixed payments as well as variable payments. For the Company&#x2019;s office leases, variable payments include amounts for the Company&#x2019;s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company&#x2019;s equipment leases, variable payments may consist of sales taxes, property taxes and other fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized at the time and in an amount that reflects the consideration expected to be received for the performance obligations that have been provided. ASC Topic 606 &#x2013; Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;) defines contracts as written, oral and through customary business practice. Under this definition, the Company considers contracts to be created at the time that the rental service is authorized or an order to purchase product is agreed upon regardless of whether or not there is a written contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has three separate and distinct performance obligations offered to its customers: a rental service performance obligation, a product sale performance obligation and a service performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is defined as the unit of account for revenue recognition under ASC 606. These performance obligations are related to separate revenue streams and at no point are they combined into a single transaction. Sources of net revenues include commercial insurance payers, government insurance payers, medical facilities and patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates the majority of its revenue from the rental of infusion pumps to its customers and a minority of its revenue from product sales and services. For the rental service performance obligation, revenue is based on its standalone price, determined by using reimbursement rates established by third-party payer or other contracts. Revenue is recognized in the period in which the related performance obligation is satisfied, which is typically at the point in time that a patient concludes a treatment, or in certain arrangements, based on the number of pumps that a facility has onsite. The Company&#x2019;s revenues related to product sales are recognized at the time that control of the product has been transferred to the customer; either at the time the product is shipped or the time the product has been received by the customer, depending on the delivery terms. The Company does not commit to long-term contracts to sell customers a certain minimum quantity of products. The Company's revenues related to services are recognized at the time that the service work has been completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company employs certain significant judgments to estimate the dollar amount of revenue, and related concessions, allocated to the rental service. These judgments include, among others, the estimation of variable consideration. Variable consideration, specifically related to the Company&#x2019;s third-party payer rental revenues, is estimated as implied price concessions resulting from differences between the rates charged for services performed and the expected reimbursements for commercial payers and other implied customer concessions. The estimates for variable consideration are based on historical collections with similar payers, aged accounts receivable by payer class and payer correspondence using the portfolio approach, which provide a reasonable basis for estimating the variable portion of a transaction. The Company doesn&#x2019;t believe it is probable that a significant reversal of revenue will occur in future periods because (i) there is no significant uncertainty about the amount of considerations that are expected to be collected based on collection history and (ii) the large number of sufficiently similar contracts allows the Company to adequately estimate the component of variable consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues are adjusted when changes in estimates of variable consideration occur. Changes in estimates typically arise as a result of new information obtained, such as actual payment receipt or denial, or pricing adjustments by payers. Subsequent changes to estimates of transaction prices are recorded as adjustments to net revenue in the period of the change. Subsequent changes that are determined to be the result of an adverse change in the payer&#x2019;s ability to pay are recorded as an allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the nature of the industry and the reimbursement environment in which the Company operates, certain estimates are required to record net revenues and accounts receivable at their net realizable values. Inherent in these estimates is the risk that the estimates will have to be revised or updated as additional information becomes available. Specifically, the complexity of many third-party billing arrangements and the uncertainty of reimbursement amounts for certain services from certain payers may result in adjustments to amounts originally recorded. Due to continuing changes in the health care industry and third-party reimbursement, it is possible that management&#x2019;s estimates could change in the near term, which could have a material impact on the Company&#x2019;s results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenues include the costs of servicing and maintaining pumps, products and services sold, shipping and other direct and indirect costs related to net revenues. Shipping and handling costs incurred after control over a product has transferred to a customer are accounted for as a fulfillment cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer Concentration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had contracts with nearly 770 third-party payer networks, an increase of 6% over the prior year period. Material terms of contracts with third-party payer organizations are typically a pre-negotiated fee &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;schedule rate or a then-current proprietary fee schedule rate for equipment and supplies provided. The majority of these contracts generally provide for a term of one year, with automatic one-year renewals, unless the Company or the contracted payer elect not to renew. The Company also contracts with various other third-party payer organizations, Medicaid, commercial Medicare replacement plans, self-insured plans, facilities of its Medicare patients and numerous other insurance carriers. No single payer or customer represented more than 10% of the Company's net revenue in 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes deferred&#160;income tax liabilities and assets based on (i) the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and (ii) the tax credit carryforwards. Deferred income tax (expense) benefit results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all of any deferred tax assets will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions for federal, state and foreign taxes are calculated based on reported pre-tax earnings based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities.&#160;Certain items of income and expense are recognized in different time periods for financial reporting than for income tax purposes; thus, such provisions differ from the amounts currently receivable or payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows a two-step approach for recognizing uncertain tax positions. First, it evaluates the tax position for recognition by determining if the weight of available evidence indicates it is more-likely-than-not that the position will be sustained upon examination. Second, for positions that are determined are more-likely-than-not to be sustained, it recognizes the tax benefits as the largest benefit that has a greater than 50% likelihood of being sustained. The Company establishes a reserve for uncertain tax positions liability that is comprised of unrecognized tax benefits and related interest and penalties. The Company adjusts this liability in the period in which an uncertain tax position is effectively settled, the statute of limitations expires for the relevant taxing authority to examine the tax position, or more information becomes available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted Accounting Standards Update ("ASU") 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, in the fourth quarter of 2019. This guidance simplifies various aspects related to accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. The guidance was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption was permitted, including adoption in any interim period for which financial statements had not yet been issued. Certain amendments may have been applied on a retrospective, modified retrospective or prospective basis. As permitted, the Company elected to early adopt this guidance for the year ended December&#160;31, 2019. The adoption of this guidance did not have a significant impact on the Company&#x2019;s financial statements and primarily resulted in the reclassification of an immaterial amount from non-income tax expense to income tax expense related to the accounting for franchise taxes, with no impact to the Company&#x2019;s consolidated net income, equity or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company periodically repurchases shares of its common stock. These repurchases take place either as part of a board-authorized program, which may include open market transactions or privately negotiated transactions and may be made under a Rule 10b5-1 plan, or in targeted stock purchase agreements approved by the board. Treasury stock is accounted for using the par value method. In 2021, the Company retired the approximately 3,500,000 shares that were previously held in treasury.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of stock option awards, restricted stock awards and stock appreciation rights (collectively, &#x201c;Share-Based Awards&#x201d;) on the date of grant using either the grant date price of the Company's common stock or option-pricing models which are affected by the Company&#x2019;s stock price, as well as assumptions regarding a number of other inputs using the Black-Scholes pricing model. These variables include the Company&#x2019;s expected stock price volatility over the expected term of the Share-Based Awards, actual and projected employee stock option exercise behaviors, risk-free interest rates and expected dividends. The expected volatility is based on the historical volatility. The expected term represents the period over which the Share-Based Awards are expected to be outstanding. The dividend yield is an estimate of the expected dividend yield on the Company&#x2019;s stock. The risk-free rate is based on U.S. Treasury yields in effect at the time of the grant for the expected term of the Share-Based Awards. Forfeitures are recognized as they occur. All Share-Based Awards are amortized based on their graded vesting over the requisite service period of the awards. Compensation costs are recognized over the requisite service period using the accelerated method and included in general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, the Company also determines the fair value of performance-based restricted stock units (&#x201c;PSUs&#x201d;) based upon the type of performance measure. These awards typically vest after the Company&#x2019;s achievement of either a specific Company performance metric or when the market value of the Company&#x2019;s stock meets a specific metric such as when the closing price of the Company's stock reaches a target value for a minimum number of consecutive trading days. Under Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC Topic 718, the provisions of the PSUs that vest upon achievement of a target market value are considered a market condition, and therefore the effect of that market condition is reflected in the grant date fair value for this type of award. A third-party valuation expert was engaged to complete a &#x201c;Monte Carlo simulation&#x201d; to account for the market condition. That simulation takes into account the beginning stock price of the Company&#x2019;s common stock, the expected volatilities for the Company&#x2019;s stock price and the expected risk-free rate of return. The single grant-date fair value computed by this valuation method is recognized by the Company in accounting for the awards regardless of the actual future outcome of the market condition. Compensation costs are accelerated if the market condition is satisfied prior to the end of the service period derived under the Monte Carlo simulation. The grant date fair value of the other PSUs is calculated as the closing price of the Company&#x2019;s common stock on the grant date multiplied by the number of shares estimated to be delivered subject to the award terms. Company performance measure goals are considered a performance condition and the timing and amount of compensation cost for those PSUs corresponds with management&#x2019;s expectation of the probable outcome of the performance conditions as of the grant date and during the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Debt Issuance Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized debt issuance costs as of December&#160;31, 2021 and 2020 relate to the Company&#x2019;s credit facility. The costs related to the agreement are netted against current and non-current debt. The Company amortizes these costs using the interest method through the maturity date of the underlying debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its earnings per share in accordance with ASU 2017-11, Earnings Per Share (Topic 260), which requires the presentation of both basic and diluted earnings per share on the statements of operations. The diluted weighted average common shares include adjustments for the potential effects of outstanding stock options but only in the periods in which such effect is dilutive under the treasury stock method. Included in our basic and diluted weighted average common shares are those stock options and restricted stock awards due to participants granted from the 2014 and 2021 stock incentive plans. Anti-dilutive stock awards are comprised of stock options and unvested restricted stock awards, which would have been anti-dilutive in the application of the treasury stock method in accordance with ASU 2017-11, Earnings Per Share (Topic 260). In periods where the Company records a net loss, the diluted per share amount is the same as the basic per share amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with this topic, the following table reconciles income and share amounts utilized to calculate basic and diluted net income per common share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.176%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Numerator (in thousands):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,519,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,106,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,731,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dilutive effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,529,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,610,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,107,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,049,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,717,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,839,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options of 368,056, 18,321 and 25,669 shares were not included in the calculation for the years ended December&#160;31, 2021, 2020 and 2019, respectively, because they would have an anti-dilutive effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes all derivative financial instruments as cash flow hedges which are shown as either assets or liabilities on the Company&#x2019;s consolidated balance sheets at fair value. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in fair value of the derivative is recorded to accumulated other comprehensive income (&#x201c;AOCI&#x201d;) in the consolidated balance sheets. The underlying hedge transaction is realized when the interest payments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on debt are accrued; the applicable amount of gain or loss included in AOCI is reclassified into earnings in the consolidated statements of operations on the same line as the gain or loss on the hedged item attributable to the hedged risk. The cash flows from derivatives are classified as operating activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a policy of requiring that all derivative instruments be governed by an International Swaps and Derivatives Association Master Agreement and settles on a net basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s derivative financial instruments are categorized as Level 2 of the fair value hierarchy as the values are derived using the market approach based on observable market inputs including quoted prices of similar instruments and interest rate forward curves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts reported in the consolidated balance sheets as of December&#160;31, 2021 and 2020 for cash, accounts receivable, accounts payable and other current liabilities approximate fair value because of the short-term nature of these instruments (Level I). The carrying value of the Company&#x2019;s long-term debt with variable interest rates approximates fair value based on instruments with similar terms (Level II).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has adopted ASC 820, Fair Value Measurements, which defines fair value, establishes a framework for assets and liabilities being measured and reported at fair value and appends disclosures about fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial assets and liabilities measured at fair value on a recurring basis, fair value is the price the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction with a market participant at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Level I&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&#160;&#160;&#160;&#160;quoted prices in active markets for identical instruments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Level II&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&#160;&#160;&#160;&#160;quoted prices in active markets for similar instruments, quoted prices for identical instruments in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the instrument; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Level III&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&#160;&#160;&#160;&#160;significant inputs to the valuation model are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements and Developments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has adopted ASU 2020-04, Reference Rate Reform (Topic 848), which contains optional expedients for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Inter-bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope." This ASU clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition.  The Company has elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &#x201c;Financial Instruments (Topic 326) Credit Losses&#x201d;. Topic 326 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. Topic 326 was originally effective as of January 1, 2020, although in November 2019, the FASB delayed the effective date until fiscal years beginning after December 15, 2022 for SEC filers eligible as of the FASB's deferral date to be smaller reporting companies under the SEC&#x2019;s definition. The Company qualified as a smaller reporting company in November 2019 when the FASB delayed the effective date of Topic 326. Early adoption is permitted. The Company is currently evaluating the impact of Topic 326 on its consolidated balance sheets, statements of operations, statements of cash flows and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODcz_5bb113f2-8e55-4e83-b13f-fa80b97b542d">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and all wholly owned organizations. All intercompany transactions and account balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODU2_d85befe6-fba2-415c-b984-87562493ca0c">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in two reportable segments, Integrated Therapy Services (&#x201c;ITS&#x201d;) and Durable Medical Equipment Services (&#x201c;DME Services&#x201d;) based on management's view of its business for purpose of evaluating performance and making operating decisions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s approach is to make operational decisions and assess performance based on delivering products and services that together provide solutions to its customer base utilizing a functional management structure. Based upon this business model, the Company&#x2019;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker, reviews segment financial information. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i9e717b65c1e3405d850ef6e342b20071_1859" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 14&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for segment disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzNjc_7ecdc0f5-4594-4587-ab9f-532fac70d5f8"
      unitRef="lease">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:UseOfEstimates
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODc2_b69bc5a5-0f6e-4766-8e77-1807792bb13b">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates, assumptions and judgments that affect the amounts reported in the financial statements, including the notes thereto. The Company considers critical accounting policies to be those that require more significant judgments and estimates in the preparation of its consolidated financial statements, including the following: revenue recognition, leases, accounts receivable and allowance for doubtful accounts, income taxes, equity compensation valuations, and long-lived asset valuations. Management relies on &lt;/span&gt;&lt;/div&gt;historical experience and other assumptions believed to be reasonable in making its judgments and estimates. Actual results could differ materially from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODU3_b19492ce-c925-45e8-a30d-ceb6629d9373">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for all business combinations using the acquisition method of accounting, which allocates the fair value of the purchase consideration to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions. The Company may utilize third-party valuation specialists to assist the Company in the allocation. For intangible assets, the Company typically uses the income approach to determine their estimated fair values.  Key estimates and assumptions in that approach include the amount and timing of projected future cash flow, the discount rate selected to measure the risks inherent in those cash flows and the assessment of the asset's useful life.  Initial purchase price allocations are subject to revision within the measurement period, not to exceed one year from the date of acquisition. Acquisition-related expenses and transaction costs associated with business combinations are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODcx_2c9ee54e-9746-49d5-8b77-b676ba4e3384">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company maintains substantially all of its cash and cash equivalents primarily with two financial institutions that are insured with the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). At times throughout the year, cash and cash equivalents balances might exceed FDIC insurance limits. Accounts at banks with an aggregate excess of the amount of outstanding checks over the cash balances are included in accounts payable in current liabilities in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <infu:NumberOfFinancialInstitutions
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzQyMDg_5611fa11-29dd-4704-94aa-b444296c1876"
      unitRef="financialinstitution">2</infu:NumberOfFinancialInstitutions>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODU4_6e7ec44b-6f35-4254-9d18-9a76f4c760c7">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts billed that have not yet been collected that also meet the conditions for unconditional right to payment are presented as accounts receivable. Accounts receivable related to rental service and delivery of products are reported at their estimated transaction prices, inclusive of adjustments for variable consideration, based on the amounts expected to be collected from payers. The Company writes off accounts receivable once collection efforts have been exhausted and an account is deemed to be uncollectible. An allowance for doubtful accounts is established as a result of an adverse change in the Company&#x2019;s payers&#x2019; ability to pay outstanding billings. The allowance for doubtful accounts was $1.1 million and $1.0 million as of December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzUxNjk_a08c18a2-0a1a-4690-8388-d573fbe2d1b0"
      unitRef="usd">1100000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzUxNzY_5f46cf2d-a858-444f-8bf8-3dea97df029d"
      unitRef="usd">1000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODc0_81cbcd31-178c-4aac-a5ab-eacf6a7a167c">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s inventories consist of disposable medical supplies, replacement parts and other supplies used in conjunction with medical equipment and are stated at the lower of cost (first-in, first-out basis) or net realizable value. Cost primarily represents the purchase price paid for the items on hand. The Company periodically performs an analysis of slow-moving inventory and records an adjustment to reflect the recoverable amount.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <infu:MedicalEquipmentPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODgw_ad5788c4-c033-4334-b545-29cd23add1ce">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Medical Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment (&#x201c;Equipment&#x201d;) consists of equipment that the Company purchases from third-parties and is (1) for sale or rent, and (2) used in service to generate rental revenue. Equipment, once placed into service, is depreciated using the straight-line method over the estimated useful lives of the equipment which is typically seven years. The Company does not depreciate Equipment held for sale or rent. When Equipment in rental service assets are sold, or otherwise disposed, the cost and related accumulated depreciation are removed from the accounts and a gain or loss is recorded in the current period. The Company periodically performs an analysis to identify potentially missing  Equipment and records a reserve equal to the underlying net book value, which was $1.1 million and $0.9 million as of December&#160;31, 2021 and 2020, respectively. The Company performs a similar analysis of slow-moving Equipment for sale or rent and records a reserve, which was less than $0.1 million as of both December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Presentation of Medical Equipment in the Consolidated Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company purchases medical equipment directly for sale as well as medical equipment that is purchased for either rental or sale and that is unallocated at the time of purchase (&#x201c;Unallocated Assets&#x201d;). Management believes that the predominant source of revenues and cash flows from the Unallocated Assets is from rentals and most equipment purchased is likely to be rented prior to being sold. The Company concluded that (i) the assets specifically supporting its two primary revenue streams should be separately disclosed on the balance sheet; (ii) the purchase and sale of Unallocated Assets should be classified solely &lt;/span&gt;&lt;/div&gt;in investing cash flows based on their predominant source while medical equipment purchased specifically for sales activity should be classified in operating cash flows; and (iii) other activities ancillary to the rental process should be consistently classified.</infu:MedicalEquipmentPolicyTextBlock>
    <infu:MedicalEquipmentInRentalServicesUsefulLife
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzU5Njg_7c3b36aa-fae4-40df-aa1d-3152c6dc0277">P7Y</infu:MedicalEquipmentInRentalServicesUsefulLife>
    <infu:MedicalEquipmentInRentalServicesReserve
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5MjY3MDY_647d1714-2dfb-4a3f-8a7a-32a56f9e1297"
      unitRef="usd">1100000</infu:MedicalEquipmentInRentalServicesReserve>
    <infu:MedicalEquipmentInRentalServicesReserve
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5MjY2OTY_c4559a07-142b-4dce-ae94-79b4a9a97859"
      unitRef="usd">900000</infu:MedicalEquipmentInRentalServicesReserve>
    <infu:MedicalEquipmentForSaleOrRentalReserve
      contextRef="i273cf9bfb6db4d47a691a81cafdaae1a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTM5OTYxOTc_0c5f62d0-07a5-4ebd-aa6d-b74c0857d21d"
      unitRef="usd">100000</infu:MedicalEquipmentForSaleOrRentalReserve>
    <infu:MedicalEquipmentForSaleOrRentalReserve
      contextRef="ic449570e790a4e16996815fc2fe98242_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTM5OTYxOTc_caba9030-52d8-4000-8e16-5d67b28c8472"
      unitRef="usd">100000</infu:MedicalEquipmentForSaleOrRentalReserve>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODc3_ad923ca9-9d2b-49de-9775-7bcffd6ea217">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is stated at acquired cost and depreciated using the straight-line method over the estimated useful lives of the related assets, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY3ODU_89ea2bad-0ac3-4d89-9bff-0b3592eb4de5"&gt;three&lt;/span&gt; to seven years. Externally purchased information technology software and hardware are depreciated over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY4ODI_16fecb86-c446-4994-8930-6e54f72298e6"&gt;three&lt;/span&gt; and five years, respectively. Leasehold improvements are amortized using the straight-line method over the life of the asset or the remaining term of the lease, whichever is shorter. Maintenance and minor repairs are charged to operations as incurred. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is recorded in the current period.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id3f83755b9294a7fbbea649f435470f7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY3OTE_768e3bb9-c55d-4997-95c2-863efd27b36d">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iff2484e23bda4759a180d34049f89085_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzY4ODk_ffbe0b1b-6280-4203-98c4-18e6f2f98533">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5ODQzODM_f19a8d22-06dc-4eb0-8294-f98be21c4ef9">GoodwillGoodwill is tested for impairment annually or when events occur or circumstances change that trigger a review. Management has the option to first assess qualitative factors such as current performance and overall economic conditions to determine whether or not it is necessary to perform a quantitative goodwill impairment test. If the Company chooses that option, then the Company would not be required to perform a quantitative goodwill impairment test unless the Company determines that, based on a qualitative assessment, it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company determines that an impairment is more likely than not, or if the Company chooses not to perform a qualitative assessment, the Company will then proceed with the quantitative assessment. Under the quantitative test, if the fair value of a reporting unit exceeds its carrying amount, then goodwill of the reporting unit is considered to not be impaired. If the carrying amount of the reporting unit exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess, up to the value of the goodwill. The Company performed its annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that there was no impairment.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODU5_9defb300-47a8-4af0-96da-93cb1ab6d151">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of trade names, physician and customer relationships, unpatented technology, non-competition agreements and software. The Company amortizes the value assigned to the physician and customer relationships on a straight-line basis over the period of expected benefit, which ranges from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzc2NzA_787bbc1d-efca-48b5-9bc6-20acf41ccb09"&gt;fifteen&lt;/span&gt; to twenty years. The acquired physician and customer relationship base represents a valuable asset of the Company due to the expectation of future business opportunities to be leveraged from the existing relationship with each physician and customer. The Company has long-standing relationships with numerous oncology clinics, physicians, home care and home infusion providers, skilled nursing facilities, pain centers and others. The useful lives of these relationships are based on the expected attrition rates. Acquired software is amortized on a straight-line basis over the period of expected benefit, which ranges from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzgzMTA_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1"&gt;three&lt;/span&gt; to five years. Acquired unpatented technology arose from recent acquisitions and is amortized on a straight-line basis over the period of expected benefit, which is seven years. This asset represents acquired knowledge of repair solutions that will be leveraged into opportunities into the acute care market. The non-competition agreements arose from recent acquisitions and are amortized on a straight-line basis over the terms of the agreements, which is five years. Trade names associated with the original acquisition of InfuSystem are not amortized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management tests indefinite life trade names for impairment annually or more frequently if deemed necessary. Management has the option of first performing the impairment test for intangible assets with indefinite lives on a qualitative basis, by evaluating factors to determine whether it is more likely than not that an impairment exists. If it is more likely than not that an impairment exists, then a quantitative impairment test is performed. Impairment exists when the carrying amount of the intangible asset exceeds its fair value. If the carrying value of the intangible assets exceeds the fair value, an impairment loss is recognized in an amount equal to that excess. The Company performed its annual impairment analysis by using a qualitative assessment as of the first day of October 2021 and determined that the fair value of the trade names with indefinite lives was greater than their carrying value, resulting in no impairment.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9cbd2ba5629b4065967778d18fce6cc6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzc2NzY_672f8879-b672-498f-bb01-b16be49bb636">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3805c0f8aa0b4495a88f1333effc915e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2NjI5OTY_d870549a-f5be-42a5-b4ad-98382c05e175">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iafb98485af7044f4b4e5556491802f9f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2NjM1MTA_104b8724-9ba0-4254-a9fe-6d561d45ab62">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie95c2bd801aa4bb288bad94f285a3474_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2NjMyNTE_769e9806-2bc9-4ecc-bfa8-d5f29a02a32b">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i1ef1975dd83440c2b7903b64c216e6f5_D20211001-20211031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5Nzc4NjE_d0507614-480e-477b-97ee-cb16668ce6fd"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:CapitalizationOfInternalCostsPolicy
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODYy_2b57a5ed-74bd-4f78-b7f0-fcc5d846ab9a">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software Capitalization and Depreciation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software project, external direct costs of materials and services and interest costs while developing the software. Capitalized software costs are included in intangible assets, net and are amortized using the straight-line method over the estimated useful life of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzODg_deb5ce52-5ef8-4e88-8ad7-c0f61b0b6cc1"&gt;three&lt;/span&gt; to five years. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs, are &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expensed in the period in which they are incurred. The Company capitalized $0.3 million of internal-use software for the year ended December&#160;31, 2021 and did not capitalize any internal-use software for the year ended  December&#160;31, 2020. Amortization expense for capitalized software was $1.6 million in 2021, $1.9 million in 2020 and $2.0 million in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses impairment indicators related to its internally-developed, internal-use software, specifically looking at the effectiveness and useful lives of each project and sub-project to determine if impairment indicators are present. For the year ended December&#160;31, 2021, the Company assessed the impairment indicators and found none to be present.&lt;/span&gt;&lt;/div&gt;</us-gaap:CapitalizationOfInternalCostsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3805c0f8aa0b4495a88f1333effc915e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQzOTU_d870549a-f5be-42a5-b4ad-98382c05e175">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQ0NzU_60966a6e-ddfb-469b-8f4c-1096c48ad32d"
      unitRef="usd">300000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5MjY2ODE_0912a9c0-f036-4709-ace8-c85991fa7065"
      unitRef="usd">0</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwMTYw_6ea9e547-a0bb-4137-a147-bdc205689a8a"
      unitRef="usd">1600000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwMTcz_a1b35939-4b6c-4db4-9fde-ea35cce68029"
      unitRef="usd">1900000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzE2NDkyNjc0ODQ0Mjg_93c030f9-5b50-447a-9db7-a76fcea9786a"
      unitRef="usd">2000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i00d66cb681ad4fb9820d60af76680b44_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTQwMDg0Nzc_23cee1dc-18a6-4042-8164-900c7ddba80e"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODc4_3c807485-7e39-4e7b-80aa-fb726726c33a">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets held for use, which includes medical equipment in rental service, property and equipment and amortizable intangible assets, are reviewed for impairment when events or changes in circumstances indicate that their carrying value may not be recoverable. If an impairment indicator exists, the Company assesses the asset or asset group for recoverability. Recoverability of these assets is determined based upon the expected undiscounted future net cash flows from the operations to which the assets relate, utilizing management&#x2019;s best estimates, appropriate assumptions and projections at the time. If the carrying value is determined not to be recoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair market value of the asset or asset group. For the years ended December&#160;31, 2021, 2020 and 2019, respectively, the Company assessed the impairment indicators and found none to be present.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i9465d698b48a4cb89adc9870e948bf77_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5Nzc4NjQ_678dd726-f417-4588-b2c3-d3371b8d8370"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ie66a45b985ad4079b2542a584a5b7264_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5Nzc4NjQ_6b618754-66f3-4d71-bb50-4afa9b283b11"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i00d66cb681ad4fb9820d60af76680b44_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5Nzc4NjQ_c40aa25b-6cfd-4a60-aa5c-2b973a5989a9"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODYz_e72c0881-06e1-4e25-a3e5-ae11f0adeb38">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2019 (the &#x201c;Effective Date&#x201d;), the Company adopted Accounting Standards Codification ("ASC") Topic 842, Leases,("Topic 842"),  using a modified retrospective transition approach. Under Topic 842, lessees are required to recognize a lease liability and right-of-use asset (&#x201c;ROU asset&#x201d;) for all leases and to disclose key information about leasing arrangements. Additionally, leases are classified as either financing or operating; the classification determines the pattern of expense recognition and classification within the statement of operations. The Company elected to apply its lease accounting policy only to leases with a term greater than twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Topic 842 provides several optional practical expedients that the Company adopted at transition. The Company elected the &#x201c;package of practical expedients&#x201d;, which does not require it to reassess its prior conclusions regarding lease identification, lease classification and initial direct costs. The Company did not elect the practical expedient of hindsight to the evaluation of lease options (e.g. renewal).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Topic 842 also provides practical expedients for an entity&#x2019;s ongoing accounting. The Company elected the &#x201c;combining lease and non-lease components&#x201d; practical expedient and also elected to apply the short-term lease recognition exemption to certain leases; therefore, the Company did not recognize ROU assets and lease liabilities for these leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In adopting Topic 842, the Company determined and will continue to determine whether an arrangement is a lease at inception. The Company&#x2019;s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next ten years. The Company&#x2019;s leases do not contain any restrictive covenants. The Company&#x2019;s office leases generally contain renewal options for periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEzNTUy_9f2fcc91-aee1-47c3-a7b5-103597d961a0"&gt;one&lt;/span&gt; to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company&#x2019;s office leases do not contain any material residual value guarantees. The Company&#x2019;s equipment leases generally do not contain renewal options. The Company is not reasonably certain to exercise the renewal options for those equipment leases that do contain renewal options, thus, the options are not considered in determining the lease term and payments associated with the option years are excluded from lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s equipment leases, the Company used and will use the implicit rate in the lease as the discount rate, when available. Otherwise, the Company uses its incremental borrowing rate as the discount rate. For the Company&#x2019;s office leases, the implicit rate is typically not available, so the Company used and will use its incremental borrowing rate as the discount rate. The incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The Company&#x2019;s lease agreements include both lease and non-lease components. The Company elected the practical expedient that allows it to combine lease and non-lease components for all of its leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments due under the Company&#x2019;s operating leases include fixed payments as well as variable payments. For the Company&#x2019;s office leases, variable payments include amounts for the Company&#x2019;s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company&#x2019;s equipment leases, variable payments may consist of sales taxes, property taxes and other fees.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2NjE1OTk_3dc77626-ad95-4441-96f8-3b58c610981e">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ic449570e790a4e16996815fc2fe98242_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEzNTU4_267a32a4-6085-44d1-a1b3-8dec2f8c4481">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODgx_889e03a4-0741-4ef4-afd8-a2b02ca262e0">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized at the time and in an amount that reflects the consideration expected to be received for the performance obligations that have been provided. ASC Topic 606 &#x2013; Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;) defines contracts as written, oral and through customary business practice. Under this definition, the Company considers contracts to be created at the time that the rental service is authorized or an order to purchase product is agreed upon regardless of whether or not there is a written contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has three separate and distinct performance obligations offered to its customers: a rental service performance obligation, a product sale performance obligation and a service performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is defined as the unit of account for revenue recognition under ASC 606. These performance obligations are related to separate revenue streams and at no point are they combined into a single transaction. Sources of net revenues include commercial insurance payers, government insurance payers, medical facilities and patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates the majority of its revenue from the rental of infusion pumps to its customers and a minority of its revenue from product sales and services. For the rental service performance obligation, revenue is based on its standalone price, determined by using reimbursement rates established by third-party payer or other contracts. Revenue is recognized in the period in which the related performance obligation is satisfied, which is typically at the point in time that a patient concludes a treatment, or in certain arrangements, based on the number of pumps that a facility has onsite. The Company&#x2019;s revenues related to product sales are recognized at the time that control of the product has been transferred to the customer; either at the time the product is shipped or the time the product has been received by the customer, depending on the delivery terms. The Company does not commit to long-term contracts to sell customers a certain minimum quantity of products. The Company's revenues related to services are recognized at the time that the service work has been completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company employs certain significant judgments to estimate the dollar amount of revenue, and related concessions, allocated to the rental service. These judgments include, among others, the estimation of variable consideration. Variable consideration, specifically related to the Company&#x2019;s third-party payer rental revenues, is estimated as implied price concessions resulting from differences between the rates charged for services performed and the expected reimbursements for commercial payers and other implied customer concessions. The estimates for variable consideration are based on historical collections with similar payers, aged accounts receivable by payer class and payer correspondence using the portfolio approach, which provide a reasonable basis for estimating the variable portion of a transaction. The Company doesn&#x2019;t believe it is probable that a significant reversal of revenue will occur in future periods because (i) there is no significant uncertainty about the amount of considerations that are expected to be collected based on collection history and (ii) the large number of sufficiently similar contracts allows the Company to adequately estimate the component of variable consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues are adjusted when changes in estimates of variable consideration occur. Changes in estimates typically arise as a result of new information obtained, such as actual payment receipt or denial, or pricing adjustments by payers. Subsequent changes to estimates of transaction prices are recorded as adjustments to net revenue in the period of the change. Subsequent changes that are determined to be the result of an adverse change in the payer&#x2019;s ability to pay are recorded as an allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the nature of the industry and the reimbursement environment in which the Company operates, certain estimates are required to record net revenues and accounts receivable at their net realizable values. Inherent in these estimates is the risk that the estimates will have to be revised or updated as additional information becomes available. Specifically, the complexity of many third-party billing arrangements and the uncertainty of reimbursement amounts for certain services from certain payers may result in adjustments to amounts originally recorded. Due to continuing changes in the health care industry and third-party reimbursement, it is possible that management&#x2019;s estimates could change in the near term, which could have a material impact on the Company&#x2019;s results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <infu:RevenueRecognitionCostOfRevenuePolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODc5_600e41fa-1e05-4014-9954-8154be5b23c9">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenues include the costs of servicing and maintaining pumps, products and services sold, shipping and other direct and indirect costs related to net revenues. Shipping and handling costs incurred after control over a product has transferred to a customer are accounted for as a fulfillment cost.&lt;/span&gt;&lt;/div&gt;</infu:RevenueRecognitionCostOfRevenuePolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODY3_5e197900-5bd5-4be2-b537-e5ef35bc7ba4">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer Concentration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had contracts with nearly 770 third-party payer networks, an increase of 6% over the prior year period. Material terms of contracts with third-party payer organizations are typically a pre-negotiated fee &lt;/span&gt;&lt;/div&gt;schedule rate or a then-current proprietary fee schedule rate for equipment and supplies provided. The majority of these contracts generally provide for a term of one year, with automatic one-year renewals, unless the Company or the contracted payer elect not to renew. The Company also contracts with various other third-party payer organizations, Medicaid, commercial Medicare replacement plans, self-insured plans, facilities of its Medicare patients and numerous other insurance carriers. No single payer or customer represented more than 10% of the Company's net revenue in 2021, 2020 or 2019.</us-gaap:ConcentrationRiskCreditRisk>
    <infu:NumberOfContractsWithThirdParties
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTM5OTk1MDc_dd129a3f-f07e-46bc-9d29-39ba4b336c48"
      unitRef="network">770</infu:NumberOfContractsWithThirdParties>
    <infu:PercentageIncreaseInNumberOfContracts
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTM5OTk1NDY_68043fe9-6358-42db-a32f-812505e7458e"
      unitRef="number">0.06</infu:PercentageIncreaseInNumberOfContracts>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODY4_0545c81d-c36e-47dc-9b8c-cf2b53163715">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes deferred&#160;income tax liabilities and assets based on (i) the differences between the financial statement carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and (ii) the tax credit carryforwards. Deferred income tax (expense) benefit results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all of any deferred tax assets will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions for federal, state and foreign taxes are calculated based on reported pre-tax earnings based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities.&#160;Certain items of income and expense are recognized in different time periods for financial reporting than for income tax purposes; thus, such provisions differ from the amounts currently receivable or payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows a two-step approach for recognizing uncertain tax positions. First, it evaluates the tax position for recognition by determining if the weight of available evidence indicates it is more-likely-than-not that the position will be sustained upon examination. Second, for positions that are determined are more-likely-than-not to be sustained, it recognizes the tax benefits as the largest benefit that has a greater than 50% likelihood of being sustained. The Company establishes a reserve for uncertain tax positions liability that is comprised of unrecognized tax benefits and related interest and penalties. The Company adjusts this liability in the period in which an uncertain tax position is effectively settled, the statute of limitations expires for the relevant taxing authority to examine the tax position, or more information becomes available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted Accounting Standards Update ("ASU") 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, in the fourth quarter of 2019. This guidance simplifies various aspects related to accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. The guidance was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption was permitted, including adoption in any interim period for which financial statements had not yet been issued. Certain amendments may have been applied on a retrospective, modified retrospective or prospective basis. As permitted, the Company elected to early adopt this guidance for the year ended December&#160;31, 2019. The adoption of this guidance did not have a significant impact on the Company&#x2019;s financial statements and primarily resulted in the reclassification of an immaterial amount from non-income tax expense to income tax expense related to the accounting for franchise taxes, with no impact to the Company&#x2019;s consolidated net income, equity or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <infu:TreasuryStockPolicyPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODYw_601c4021-c1c2-42a1-b36d-464a98409259">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company periodically repurchases shares of its common stock. These repurchases take place either as part of a board-authorized program, which may include open market transactions or privately negotiated transactions and may be made under a Rule 10b5-1 plan, or in targeted stock purchase agreements approved by the board. Treasury stock is accounted for using the par value method. In 2021, the Company retired the approximately 3,500,000 shares that were previously held in treasury.&lt;/span&gt;&lt;/div&gt;</infu:TreasuryStockPolicyPolicyTextBlock>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzYwNDczMTQwNDU5NjM_a3a0c704-5a9a-4551-998d-420d4474e76c"
      unitRef="shares">3500000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODY0_09597774-8c6c-402d-9899-1c61058183ca">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of stock option awards, restricted stock awards and stock appreciation rights (collectively, &#x201c;Share-Based Awards&#x201d;) on the date of grant using either the grant date price of the Company's common stock or option-pricing models which are affected by the Company&#x2019;s stock price, as well as assumptions regarding a number of other inputs using the Black-Scholes pricing model. These variables include the Company&#x2019;s expected stock price volatility over the expected term of the Share-Based Awards, actual and projected employee stock option exercise behaviors, risk-free interest rates and expected dividends. The expected volatility is based on the historical volatility. The expected term represents the period over which the Share-Based Awards are expected to be outstanding. The dividend yield is an estimate of the expected dividend yield on the Company&#x2019;s stock. The risk-free rate is based on U.S. Treasury yields in effect at the time of the grant for the expected term of the Share-Based Awards. Forfeitures are recognized as they occur. All Share-Based Awards are amortized based on their graded vesting over the requisite service period of the awards. Compensation costs are recognized over the requisite service period using the accelerated method and included in general and administrative expenses.&lt;/span&gt;&lt;/div&gt;Additionally, the Company also determines the fair value of performance-based restricted stock units (&#x201c;PSUs&#x201d;) based upon the type of performance measure. These awards typically vest after the Company&#x2019;s achievement of either a specific Company performance metric or when the market value of the Company&#x2019;s stock meets a specific metric such as when the closing price of the Company's stock reaches a target value for a minimum number of consecutive trading days. Under Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC Topic 718, the provisions of the PSUs that vest upon achievement of a target market value are considered a market condition, and therefore the effect of that market condition is reflected in the grant date fair value for this type of award. A third-party valuation expert was engaged to complete a &#x201c;Monte Carlo simulation&#x201d; to account for the market condition. That simulation takes into account the beginning stock price of the Company&#x2019;s common stock, the expected volatilities for the Company&#x2019;s stock price and the expected risk-free rate of return. The single grant-date fair value computed by this valuation method is recognized by the Company in accounting for the awards regardless of the actual future outcome of the market condition. Compensation costs are accelerated if the market condition is satisfied prior to the end of the service period derived under the Monte Carlo simulation. The grant date fair value of the other PSUs is calculated as the closing price of the Company&#x2019;s common stock on the grant date multiplied by the number of shares estimated to be delivered subject to the award terms. Company performance measure goals are considered a performance condition and the timing and amount of compensation cost for those PSUs corresponds with management&#x2019;s expectation of the probable outcome of the performance conditions as of the grant date and during the vesting period.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODcy_8932d52b-894c-42b0-8d6d-f063a6ebe5da">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Debt Issuance Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized debt issuance costs as of December&#160;31, 2021 and 2020 relate to the Company&#x2019;s credit facility. The costs related to the agreement are netted against current and non-current debt. The Company amortizes these costs using the interest method through the maturity date of the underlying debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzQ5NDc4MDIzNjgzNTM_ba8ccc13-6407-43bc-9667-e5472a36f3a9">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its earnings per share in accordance with ASU 2017-11, Earnings Per Share (Topic 260), which requires the presentation of both basic and diluted earnings per share on the statements of operations. The diluted weighted average common shares include adjustments for the potential effects of outstanding stock options but only in the periods in which such effect is dilutive under the treasury stock method. Included in our basic and diluted weighted average common shares are those stock options and restricted stock awards due to participants granted from the 2014 and 2021 stock incentive plans. Anti-dilutive stock awards are comprised of stock options and unvested restricted stock awards, which would have been anti-dilutive in the application of the treasury stock method in accordance with ASU 2017-11, Earnings Per Share (Topic 260). In periods where the Company records a net loss, the diluted per share amount is the same as the basic per share amount.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5MjY2ODA_ec92a8bd-0c64-4295-8514-f0389d349862">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with this topic, the following table reconciles income and share amounts utilized to calculate basic and diluted net income per common share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.176%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Numerator (in thousands):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,519,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,106,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,731,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dilutive effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,529,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,610,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,107,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,049,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,717,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,839,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzMtMS0xLTEtNjUyNTA_b35738b0-236f-4433-bfdf-3ab4cd5a5414"
      unitRef="usd">1420000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzMtMy0xLTEtNjUyNTA_d729afd8-4474-4852-8330-1a077582085f"
      unitRef="usd">17332000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzMtNS0xLTEtNjUyNTA_8aa93029-4fc6-4bfa-b6aa-e149d21fa771"
      unitRef="usd">1361000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzYtMS0xLTEtNjUyNTA_15b3a122-d220-4b8d-ae9d-847a47089811"
      unitRef="shares">20519958</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzYtMy0xLTEtNjUyNTA_6e643be1-5cdc-4e5f-b7dd-99cccc5e01fc"
      unitRef="shares">20106940</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzYtNS0xLTEtNjUyNTA_1d59476e-c389-4161-bc44-7a34c4a11b08"
      unitRef="shares">19731498</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzctMS0xLTEtNjUyNTA_027e8a99-0add-4fce-aade-646cb83e52ab"
      unitRef="shares">1529701</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzctMy0xLTEtNjUyNTA_1f57ba60-ca18-4ec6-9aa1-27ff5d481dce"
      unitRef="shares">1610276</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzctNS0xLTEtNjUyNTA_d65112fb-42f5-430f-bfd3-5bda64a66bcb"
      unitRef="shares">1107898</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzgtMS0xLTEtNjUyNTA_a66a0a58-3e89-42da-84e1-20633897507f"
      unitRef="shares">22049659</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzgtMy0xLTEtNjUyNTA_d0a2862c-990a-4146-b97f-a52ef32c8119"
      unitRef="shares">21717216</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90YWJsZTo2NmZmZDhjNTgwOTI0NDJmYTcxMzgyNTE3ZDgwMTA4My90YWJsZXJhbmdlOjY2ZmZkOGM1ODA5MjQ0MmZhNzEzODI1MTdkODAxMDgzXzgtNS0xLTEtNjUyNTA_92d3b37b-82e2-49ce-baaa-2fe648abb937"
      unitRef="shares">20839396</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icf5fd049ceed45b68799835682190196_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2Njc2OTQ_93b81280-56e0-4157-bfde-d980aa309589"
      unitRef="shares">368056</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia683a1cdfea841359642a861af2182de_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2MzY2NTAz_31e7ed4c-8ab3-4cf5-9bef-94abefdd5795"
      unitRef="shares">18321</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibad2abb0e5fe4e9398ad4ae3632f3fbc_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzEwOTk1MTE2MzY2NTEx_a31423f7-fd42-49b2-94d7-85220fc0f243"
      unitRef="shares">25669</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMyOTg1MzQ5MzgyOTI_3f7f5331-c418-4cd2-a2fd-14b1c0719845">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes all derivative financial instruments as cash flow hedges which are shown as either assets or liabilities on the Company&#x2019;s consolidated balance sheets at fair value. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in fair value of the derivative is recorded to accumulated other comprehensive income (&#x201c;AOCI&#x201d;) in the consolidated balance sheets. The underlying hedge transaction is realized when the interest payments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on debt are accrued; the applicable amount of gain or loss included in AOCI is reclassified into earnings in the consolidated statements of operations on the same line as the gain or loss on the hedged item attributable to the hedged risk. The cash flows from derivatives are classified as operating activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a policy of requiring that all derivative instruments be governed by an International Swaps and Derivatives Association Master Agreement and settles on a net basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s derivative financial instruments are categorized as Level 2 of the fair value hierarchy as the values are derived using the market approach based on observable market inputs including quoted prices of similar instruments and interest rate forward curves.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODY5_882b05dc-5563-442d-a4bb-6d13b7d1c635">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts reported in the consolidated balance sheets as of December&#160;31, 2021 and 2020 for cash, accounts receivable, accounts payable and other current liabilities approximate fair value because of the short-term nature of these instruments (Level I). The carrying value of the Company&#x2019;s long-term debt with variable interest rates approximates fair value based on instruments with similar terms (Level II).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has adopted ASC 820, Fair Value Measurements, which defines fair value, establishes a framework for assets and liabilities being measured and reported at fair value and appends disclosures about fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial assets and liabilities measured at fair value on a recurring basis, fair value is the price the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction with a market participant at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Level I&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&#160;&#160;&#160;&#160;quoted prices in active markets for identical instruments;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Level II&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&#160;&#160;&#160;&#160;quoted prices in active markets for similar instruments, quoted prices for identical instruments in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the instrument; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:108pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Level III&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&#160;&#160;&#160;&#160;significant inputs to the valuation model are unobservable.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMDkvZnJhZzo0NTY0ZDQ2MzhiMGY0Y2I5ODgyZGIyNjU0ODRjYzcwYy90ZXh0cmVnaW9uOjQ1NjRkNDYzOGIwZjRjYjk4ODJkYjI2NTQ4NGNjNzBjXzMxODY1_9d6ba4b2-6e81-4ba9-9f96-e2f59dac2251">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements and Developments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has adopted ASU 2020-04, Reference Rate Reform (Topic 848), which contains optional expedients for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Inter-bank Offered Rate ("LIBOR") or another reference rate expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope." This ASU clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition.  The Company has elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &#x201c;Financial Instruments (Topic 326) Credit Losses&#x201d;. Topic 326 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. Topic 326 was originally effective as of January 1, 2020, although in November 2019, the FASB delayed the effective date until fiscal years beginning after December 15, 2022 for SEC filers eligible as of the FASB's deferral date to be smaller reporting companies under the SEC&#x2019;s definition. The Company qualified as a smaller reporting company in November 2019 when the FASB delayed the effective date of Topic 326. Early adoption is permitted. The Company is currently evaluating the impact of Topic 326 on its consolidated balance sheets, statements of operations, statements of cash flows and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18zMjk4NTM0ODg4OTc0_4f67787a-bca4-41b7-98b3-464a6df342c6">Business Combinations&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions Accounted for Using the Purchase Method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;31, 2021, the Company acquired the business and the majority of the assets of FilAMed, a privately-held biomedical services company based in Bakersfield, California. In becoming a part of the Company's Durable Medical Equipment Services ("DME Services") segment, this acquisition will supplement the Company&#x2019;s existing biomedical recertification, maintenance and repair services for acute care facilities and other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;18, 2021, the Company acquired the business and substantially all of the assets of OB Healthcare Corporation (&#x201c;OB Healthcare&#x201d;), a privately-held biomedical services company based in Austin, Texas. OB Healthcare specializes in on-site repair, preventative maintenance, and device physical inventory management to hospitals and healthcare systems nationwide. The acquisition further develops and expands InfuSystem&#x2019;s DME Services segment and complements the Company&#x2019;s purchase of FilAMed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FilAMed and OB Healthcare&#x2019;s results of operations are included in the Company&#x2019;s consolidated statements of operations from the respective closing dates. Revenues and earnings from these acquisitions have not been significant through December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to ASC Topic 805, &#x201c;Business Combinations,&#x201d; the purchase price for each of the acquisitions was allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the respective acquisition dates. The purchase price allocations were primarily based upon a valuation using management&#x2019;s estimates and assumptions. The purchase price allocation was completed for FilAMed and OB Healthcare as of December 31, 2021. The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;FilAMed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Working capital adjustment, paid in cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;FilAMed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Acquisition Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment held for sale or rental&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of acquisition costs for both transactions was $0.2 million and is included in general and administrative expenses for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended December 31, 2021, the Company updated the valuation of OB Healthcare based on further analysis of the final working capital with an immaterial decrease in the consideration transferred and a corresponding decrease to accounts receivable. There was no impact to the consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company fully paid all consideration for FilAMed as of December&#160;31, 2021. On the OB Healthcare acquisition date, the Company made an initial cash payment of $6.1&#160;million with subsequent cash payments of $0.4 million during the year and had an additional estimated amount due to the seller for contingent consideration of $0.8&#160;million, which was recorded in the balance sheet under the heading for other current liabilities. The contingent consideration arrangement requires the Company to pay OB Healthcare $0.8&#160;million if certain customer contracts are executed by December 31, 2021. In December 2021, the Company extended this date to February 28, 2022. The Company expects to further extend this deadline and for OB Healthcare to satisfy this requirement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the breakdown of the identified intangible assets acquired into major intangible asset classes for both acquisitions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Acquisition Date&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;(Thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;(Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unpatented technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total intangible assets (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) There was no residual value, renewal terms or extensions associated with any intangible assets acquired.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill acquired consists of expected synergies from combining operations of FilAMed and OB Healthcare with the DME Services segment as well as their respective assembled workforce who have specialized knowledge and experience. All of the goodwill is deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Financial Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma financial information in the table below summarizes the combined results of operations of the Company, FilAMed and OB Healthcare as though the companies&#x2019; businesses had been combined as of January 1, 2020. The pro forma financial information for the year ended December&#160;31, 2021 has been adjusted by $0.5&#160;million for the tax effected amount of acquisition costs and non-recurring expenses directly attributable to the FilAMed and OB Healthcare acquisitions. The year ended December&#160;31, 2020 also included these charges. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place at the beginning of each period presented nor is it indicative of future results. The following pro forma financial information presented also includes the pro forma depreciation and amortization charges from acquired tangible and intangible assets for the years ended December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 77.57pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;103,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;100,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;16,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18zMjk4NTM0ODg4OTc1_b60fe30e-f964-42f3-8acc-cf35643d7235">The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;FilAMed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Working capital adjustment, paid in cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;FilAMed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Acquisition Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment held for sale or rental&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18zMjk4NTM0ODg4OTc1_d1f721f6-1874-44eb-8b7d-e5619c53b6d4">The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;FilAMed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Working capital adjustment, paid in cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;FilAMed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Acquisition Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment held for sale or rental&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments
      contextRef="i05190bb32cd04e68951f01b2c1a8198a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8xLTEtMS0xLTUyMDAy_5fcb3dd6-78a9-44af-88d4-c0e37f3b2518"
      unitRef="usd">1400000</infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments>
    <infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments
      contextRef="ia1369ea7cfa4428a8a0535746cc8e915_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8xLTMtMS0xLTUyMDAy_90cd5b35-1923-403e-811f-6ef3e6452a33"
      unitRef="usd">6250000</infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments>
    <infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8xLTUtMS0xLTUyMDAy_9baa8219-e6b3-4c7f-b1dc-36d69a5829d4"
      unitRef="usd">7650000</infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments>
    <infu:WorkingCapital
      contextRef="i05190bb32cd04e68951f01b2c1a8198a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8yLTEtMS0xLTUyMDAy_47ed83fd-254b-47a4-9584-0898839d3014"
      unitRef="usd">0</infu:WorkingCapital>
    <infu:WorkingCapital
      contextRef="ia1369ea7cfa4428a8a0535746cc8e915_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8yLTMtMS0xLTUyMDAy_342a3d7f-c22f-4b90-833a-7ae750c0e78c"
      unitRef="usd">325000</infu:WorkingCapital>
    <infu:WorkingCapital
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8yLTUtMS0xLTUyMDAy_c40748e3-2adb-47e3-8e52-6e0f44c86495"
      unitRef="usd">325000</infu:WorkingCapital>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i05190bb32cd04e68951f01b2c1a8198a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8zLTEtMS0xLTUyMDAy_661207b1-13fb-4c6e-bc82-69784bd7bebd"
      unitRef="usd">0</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="ia1369ea7cfa4428a8a0535746cc8e915_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8zLTMtMS0xLTUyMDAy_2764d4cd-e78c-4419-8a45-85c8ebc3d101"
      unitRef="usd">750000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF8zLTUtMS0xLTUyMDAy_8d3ae938-18d5-41b4-9a4a-b201ab0cb30e"
      unitRef="usd">750000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i05190bb32cd04e68951f01b2c1a8198a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF80LTEtMS0xLTUyMDAy_5ce8c25f-ee61-4735-9bc5-426b899b78ae"
      unitRef="usd">1400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia1369ea7cfa4428a8a0535746cc8e915_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF80LTMtMS0xLTUyMDAy_ce7f265f-eea0-494f-a87d-cf08b989ec9e"
      unitRef="usd">7325000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NDM0YTI2MWRmMjAxNDg0NWIwMjk0N2FmZTE5NTM1ZTAvdGFibGVyYW5nZTo0MzRhMjYxZGYyMDE0ODQ1YjAyOTQ3YWZlMTk1MzVlMF80LTUtMS0xLTUyMDAy_f09e5142-7237-4d9a-a519-b2127c9f319a"
      unitRef="usd">8725000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8xLTItMS0xLTUyMDAy_1dc5d3c8-6456-4291-9b97-e61fd98e8638"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i24d9edd536944e538abc2437af99d50f_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8xLTQtMS0xLTUyMDAy_d19772e2-1a31-4585-95ae-e36140fe94c9"
      unitRef="usd">725000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8xLTYtMS0xLTUyMDAy_8890ee90-8ec0-4e99-9908-2e92199edb64"
      unitRef="usd">725000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8yLTItMS0xLTUyMDAy_74b33550-d1cc-4a6b-ace3-fc3c29bcf26e"
      unitRef="usd">74000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i24d9edd536944e538abc2437af99d50f_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8yLTQtMS0xLTUyMDAy_8c51f3c2-e280-450b-87b8-c17a37990c88"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8yLTYtMS0xLTUyMDAy_1f23f4b7-792b-4376-a24c-1904fc5f4458"
      unitRef="usd">74000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental
      contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8zLTItMS0xLTUyMDAy_97f10a14-70ec-4a1a-bf16-5209383ea651"
      unitRef="usd">40000</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental
      contextRef="i24d9edd536944e538abc2437af99d50f_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8zLTQtMS0xLTUyMDAy_044b735d-a671-42a5-8472-79eba51e1018"
      unitRef="usd">0</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF8zLTYtMS0xLTUyMDAy_6ac6e938-21dc-4264-bfc4-e75c9be4c4d3"
      unitRef="usd">40000</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF80LTItMS0xLTUyMDAy_31c85e2b-888d-40c6-94c1-75367a1cdab4"
      unitRef="usd">102000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i24d9edd536944e538abc2437af99d50f_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF80LTQtMS0xLTUyMDAy_7ea85d0d-f822-4d00-b320-4d0b83e9ae5d"
      unitRef="usd">59000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF80LTYtMS0xLTUyMDAy_66651ff9-d725-48aa-915c-7b8e857daadf"
      unitRef="usd">161000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF81LTItMS0xLTUyMDAy_d1600d45-e446-48d0-abf6-b604b0015e38"
      unitRef="usd">1015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i24d9edd536944e538abc2437af99d50f_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF81LTQtMS0xLTUyMDAy_c496cba4-a9c1-4278-8fb9-796f5375389a"
      unitRef="usd">3000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF81LTYtMS0xLTUyMDAy_f0ecf6e1-5852-47a5-a197-2c7048226928"
      unitRef="usd">4015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF82LTItMS0xLTUyMDAy_27f4e346-e922-42c9-a372-293c880c35ae"
      unitRef="usd">169000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i24d9edd536944e538abc2437af99d50f_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF82LTQtMS0xLTUyMDAy_c3c832b9-55b7-4da4-aaa7-15ca8432a7f9"
      unitRef="usd">3541000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF82LTYtMS0xLTUyMDAy_977bfad7-df6b-427c-b30d-ebf3c35e1b6c"
      unitRef="usd">3710000</us-gaap:Goodwill>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF83LTItMS0xLTUyMDAy_3227a59d-bcee-4433-a8da-899e9dfb1dda"
      unitRef="usd">281000</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="i24d9edd536944e538abc2437af99d50f_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF83LTQtMS0xLTUyMDAy_ea716fcc-50a1-4dbd-89f9-d173cc0b4b6e"
      unitRef="usd">7000</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF83LTYtMS0xLTUyMDAy_8df4c399-c759-44b8-84e4-65a2a53ede54"
      unitRef="usd">288000</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF84LTItMS0xLTUyMDAy_2ce198d9-4bf6-43ea-8c1e-3056af0c1dc5"
      unitRef="usd">281000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i24d9edd536944e538abc2437af99d50f_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF84LTQtMS0xLTUyMDAy_21e91e82-0b8b-4c6e-905e-695678c793a5"
      unitRef="usd">7000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF84LTYtMS0xLTUyMDAy_ec52b65e-88e9-4154-9da6-7ecabc3c98ca"
      unitRef="usd">288000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="id0eaa7080b554ccf815d4876c8bd0bb8_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF85LTItMS0xLTUyMDAy_ea3a6a45-c73c-4638-887d-88e307d6fdc4"
      unitRef="usd">1400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i24d9edd536944e538abc2437af99d50f_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF85LTQtMS0xLTUyMDAy_033951a1-fec3-491d-a86c-788c4d803a87"
      unitRef="usd">7325000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NmNlYWU0NTVkMjhkNGM5ODk3ZjNlNTNhMGViMTdiMWQvdGFibGVyYW5nZTo2Y2VhZTQ1NWQyOGQ0Yzk4OTdmM2U1M2EwZWIxN2IxZF85LTYtMS0xLTUyMDAy_4e40b8b5-481f-49d9-959d-34d7b099e4b9"
      unitRef="usd">8725000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xMDk5NTExNjMzMjA3_0b04c18a-6cc7-4429-be7e-f1467b1a6f3c"
      unitRef="usd">200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i1d555f047a9d4a98bcdde0ca522a6c33_D20210418-20210418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xMDk5NTExNjMzMjE0_720c5c89-8fd4-4259-b8ee-1ffa7657fdbd"
      unitRef="usd">6100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i3540294de93b4071b8f2e1e40e99745e_D20210419-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xNjQ5MjY3NDQ3ODE1_58e3840d-c2db-460d-8cc5-66069e97a783"
      unitRef="usd">400000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i40c6769d29844b238f82f52eec98cc12_I20210418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xMDk5NTExNjMzMjU3_6c1d5187-31a7-4c57-ac0c-03e379e904fe"
      unitRef="usd">800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i40c6769d29844b238f82f52eec98cc12_I20210418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xMDk5NTExNjMzMjY0_6c1d5187-31a7-4c57-ac0c-03e379e904fe"
      unitRef="usd">800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18zMjk4NTM0ODg4OTc4_13abd2bb-8b5f-45ca-b070-5844bba57880">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the breakdown of the identified intangible assets acquired into major intangible asset classes for both acquisitions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Acquisition Date&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;(Thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;(Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unpatented technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total intangible assets (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) There was no residual value, renewal terms or extensions associated with any intangible assets acquired.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic33f271dada5450ba5170593f412ee83_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8xLTItMS0xLTUyMDAy_d117f002-64d7-44d6-a744-06639dce2667"
      unitRef="usd">2300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i233a685f88ec410c8dc45a29274c0b7b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8xLTQtMS0xLTUyMDAy_347c659a-7e86-4047-816b-88af2934353a">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9117e35a7b704846add5b6cf91320364_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8yLTItMS0xLTUyMDAy_58784513-dccf-4e8d-99dc-2dde727e66d8"
      unitRef="usd">943000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9ef27ca6d720458d8890b7403ee50d2f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8yLTQtMS0xLTUyMDAy_ca8433e1-5cc1-4586-8100-e9ffd74afeba">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i441702431efa453d9ae697b4ed1bf9f8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8zLTItMS0xLTUyMDAy_5f86cb3a-a51b-4643-a472-1f93e9bae8ff"
      unitRef="usd">472000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie95c2bd801aa4bb288bad94f285a3474_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV8zLTQtMS0xLTUyMDAy_a2b2ad0d-0780-4181-8a80-abd0379e5f29">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iac70b116e25d46d6943dcd912146fc65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV80LTItMS0xLTUyMDAy_b79ebc0b-f5a0-4393-9388-6f1ef84c620f"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i00d66cb681ad4fb9820d60af76680b44_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV80LTQtMS0xLTUyMDAy_ae3375fe-16ec-4976-a664-8e0d36662b8f">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV82LTItMS0xLTUyMDAy_29de0439-98c9-4719-87a8-0021086b608b"
      unitRef="usd">4015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6ZTJiMTVmNzQ0MzIwNDQ1Y2I0NDIzOTMyYWFhZWFmMGEvdGFibGVyYW5nZTplMmIxNWY3NDQzMjA0NDVjYjQ0MjM5MzJhYWFlYWYwYV82LTQtMS0xLTUyMDAy_89afead1-b05a-439e-a855-354ff83d1f8c">P11Y2M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <infu:BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense
      contextRef="if05acd9bb129444c859314fc90a675b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18xMDk5NTExNjMzMzI1_ea424379-d15e-40b5-bec9-20f7a5839c65"
      unitRef="usd">500000</infu:BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGV4dHJlZ2lvbjplYTBjMGIyYTAxYjQ0OGJhYmU0OGZhZGQ4MzFlOWVjM18zMjk4NTM0ODg4OTc3_254651ab-16ea-49ee-8d86-5d1c470fd624">The following pro forma financial information presented also includes the pro forma depreciation and amortization charges from acquired tangible and intangible assets for the years ended December&#160;31 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 77.57pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;103,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;100,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;16,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NzY3OGIxYTY4OGU3NDY5MDkxYjg1MWE1YTA4Njk0MGEvdGFibGVyYW5nZTo3Njc4YjFhNjg4ZTc0NjkwOTFiODUxYTVhMDg2OTQwYV8yLTUtMS0xLTUyMDAy_d5467395-74bd-49cd-902f-53dda64adfba"
      unitRef="usd">103152000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NzY3OGIxYTY4OGU3NDY5MDkxYjg1MWE1YTA4Njk0MGEvdGFibGVyYW5nZTo3Njc4YjFhNjg4ZTc0NjkwOTFiODUxYTVhMDg2OTQwYV8yLTctMS0xLTUyMDAy_9ba357c8-3168-4009-93a5-afdb4191e82a"
      unitRef="usd">100032000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NzY3OGIxYTY4OGU3NDY5MDkxYjg1MWE1YTA4Njk0MGEvdGFibGVyYW5nZTo3Njc4YjFhNjg4ZTc0NjkwOTFiODUxYTVhMDg2OTQwYV8zLTUtMS0xLTUyMDAy_b1d16329-83df-49d1-8ad3-389becefead4"
      unitRef="usd">1936000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzY1L2ZyYWc6ZWEwYzBiMmEwMWI0NDhiYWJlNDhmYWRkODMxZTllYzMvdGFibGU6NzY3OGIxYTY4OGU3NDY5MDkxYjg1MWE1YTA4Njk0MGEvdGFibGVyYW5nZTo3Njc4YjFhNjg4ZTc0NjkwOTFiODUxYTVhMDg2OTQwYV8zLTctMS0xLTUyMDAy_15f29198-478d-4b34-996d-7fe38c1ffbd7"
      unitRef="usd">16498000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8zMjk4NTM0ODgzOTc3_401371c5-16b3-4939-b96b-337224f52e7d">Revenue Recognition&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s disaggregated revenue by offering type (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Percentage of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Percentage of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Percentage of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Third-Party Payer Rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Direct Payer Rentals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;97,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Third-Party Payer Rentals are entirely attributed to revenues of the ITS segment. For the year ended December&#160;31, 2021, $12.5 million and $16.8 million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the year ended December&#160;31, 2020, $11.8 million and $16.7 million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the year ended December&#160;31, 2019, $11.0 million and $13.1 million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the year ended December&#160;31, 2021, $0.2 million and $15.3 million of Product Sales were attributed to the ITS and DME Services segments, respectively. For the years ended December&#160;31, 2020 and 2019 all Product Sales were entirely attributed to revenues of the DME Services segment. For the years ended December&#160;31, 2021, 2020 and 2019, all Services revenues were entirely attributed to the DME Services segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8zMjk4NTM0ODgzOTc4_eed96776-0475-40dc-9930-18d91fb9e40d">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s disaggregated revenue by offering type (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Percentage of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Percentage of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Percentage of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Third-Party Payer Rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Direct Payer Rentals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;97,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="iee74bd21a9164ffa92cd63e1a7f77a5b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTEtMS0xLTUxOTA2_387b99c4-6bca-4e12-a12c-9e1513d75ba1"
      unitRef="usd">52847000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iac7342c282ec477da6afb686717858a7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTMtMS0xLTUxOTA2_2ad233b0-00b5-469e-9523-172790146e59"
      unitRef="number">0.516</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i68bd4d8cc58b4fe4b8a77002f54a62e4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTUtMS0xLTUxOTA2_e81a8d0e-1cff-4833-8cb6-ee842a314df6"
      unitRef="usd">49266000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i44173ad083b247b4a3a2827ae4199ffe_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTctMS0xLTUxOTA2_1adabeee-90e5-4f95-b836-04ce5802326e"
      unitRef="number">0.506</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i0797ce13f2f84bccb9643bb465b72539_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTktMS0xLTUxOTM4_f5bf2293-7632-40ee-ac3c-71da68f0b126"
      unitRef="usd">40510000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0b8592ae240046e2ae1d7bba300944f3_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18yLTExLTEtMS01MTkzOA_302c4ffd-5e4c-484d-a0a2-2ef75c03e180"
      unitRef="number">0.499</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i9b8bca74bc6643a39beeb55eb9ee5829_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTEtMS0xLTUxOTA2_ce979eaf-ada6-4f9d-9b4e-a0ea1952d100"
      unitRef="usd">29302000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6c9b6408c306478397ff75df2204b657_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTMtMS0xLTUxOTA2_8984f565-2fa5-4a3b-bcb2-f774db57a22d"
      unitRef="number">0.286</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i780ffb81ffd74c41a647d4101deb7fed_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTUtMS0xLTUxOTA2_efd2a237-82e9-4dfd-a4db-034c108b82a0"
      unitRef="usd">28525000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i55869796670c49c2b3cd162096936a33_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTctMS0xLTUxOTA2_15e2074b-87c8-4be1-b8de-0c3ab1b48c8c"
      unitRef="number">0.293</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i8c13d15fc1e3436490201fc54a7ebe45_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTktMS0xLTUxOTM4_2a670777-5530-46cd-82ed-ab0f7b4eac47"
      unitRef="usd">24116000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i777a8534320c4ad2a3ca66b33e628c6d_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y18zLTExLTEtMS01MTkzOA_33d6427a-05c0-424f-bfae-1ad93bd71cd8"
      unitRef="number">0.297</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="ide3e566a68504537bf76d20a1a6e221e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTEtMS0xLTUxOTA2_3341c018-85d5-4466-8950-02267dd029ac"
      unitRef="usd">15514000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i38bb3cacf11d424c8a9bf2b293ac90bc_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTMtMS0xLTUxOTA2_7846febe-65c2-4665-a90e-820bea8de843"
      unitRef="number">0.152</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i806896b65be24eb8a8d565e1ead9dfbc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTUtMS0xLTUxOTA2_445fa2ff-61fd-4cf9-8efc-63e6327679da"
      unitRef="usd">17357000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i94248c02936a4257911be7191534390c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTctMS0xLTUxOTA2_a6384071-ec26-4970-931a-066d34644ece"
      unitRef="number">0.178</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="ie795f19734ba4ea0ad822d0aa14b10e9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTktMS0xLTUxOTM4_051d421c-f6b5-47fb-b979-026ffe1ef3b1"
      unitRef="usd">14336000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib0ec252312564b5b9a317bfa1d062542_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y180LTExLTEtMS01MTkzOA_aad25969-6921-4dcc-a0b7-1dd5a33ae8e0"
      unitRef="number">0.177</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="ic85e0dd291c74ec88ceca6c455d9099e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTEtMS0xLTg3NjM2_c33fea76-72dd-4364-a22b-6f273e01d6c3"
      unitRef="usd">4719000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie2db72027cda42008cbdb85b30ce7435_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTMtMS0xLTg3NjQ0_8857eb25-da31-4661-9118-94cc747678b5"
      unitRef="number">0.046</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="iabc7ebe2911f4b8ead87bc9344dbecbf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTUtMS0xLTg3Njgx_b579ff07-1fd0-40b4-9fa2-bcca1fd82e52"
      unitRef="usd">2240000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8cec8dd30c2a446b991de51c91e34f4c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTctMS0xLTg3Njgx_f09ed934-18d1-4f8f-9543-83e00ce14532"
      unitRef="number">0.023</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="ib93c9a20502d4745907b197f7456558c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTktMS0xLTg3Njgx_5d594838-26f8-4e4e-93c1-bb063b92381a"
      unitRef="usd">2153000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iea2e191999e8474dac4c6c90b1ebd6ea_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTExLTEtMS04NzY4MQ_66479709-01de-4bcc-9776-551008a42eb0"
      unitRef="number">0.027</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTEtMS0xLTUxOTA2_d10b3dfb-0419-46e9-bf14-1e67ca18c239"
      unitRef="usd">102382000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0fca34364019406e99032d7e62aa8549_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTMtMS0xLTUxOTA2_9d86979d-00bc-4f7e-b835-611b1e1a0b21"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTUtMS0xLTUxOTA2_506a2341-ebf2-4981-9d76-f22c30424b27"
      unitRef="usd">97388000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if47ce6b2f6bd4668ac4fd139af7095f7_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTctMS0xLTUxOTA2_ff6af4f8-6d02-432f-889b-d703388a0973"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTktMS0xLTUxOTM4_f497de3f-601c-48c2-989a-6963c80cea32"
      unitRef="usd">81115000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i99e9f20c6321440d8bbc7f2097999db8_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGFibGU6YjY2MWVjZjFmY2M3NGQyNzk5YzU3MmRhMDM0ZTdhNWMvdGFibGVyYW5nZTpiNjYxZWNmMWZjYzc0ZDI3OTljNTcyZGEwMzRlN2E1Y182LTExLTEtMS01MTkzOA_d7f22935-3b6e-458a-88ef-3470ccca8d30"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i24689dc260664972bc304c938065d32c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8zMTg_7d802c12-1ef6-4094-99e1-7d77d2cef140"
      unitRef="usd">12500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9eab4726eabd4666a158889e4ca9f089_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8zMjU_b03b3153-07e3-466f-9b58-f74acb579af1"
      unitRef="usd">16800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i136bd725ae5d499aa73f5dbdcc3d0538_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml80NDM_58f45648-02f4-4e77-be1f-9155ac471d90"
      unitRef="usd">11800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1702a843f4c243c393e12054224e80e8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml80NTA_e3c38427-cf4c-40d3-ae78-f77c142076df"
      unitRef="usd">16700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibe177a89508b4e398be3e3549eb93a26_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8xMDk5NTExNjI4NDEw_fafeabcf-c063-4d05-9b51-c36307d104aa"
      unitRef="usd">11000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2a29108335024c84a565385b792cd555_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml8xMDk5NTExNjI4NDE3_b7b62a30-8a93-452c-910e-13731455e92e"
      unitRef="usd">13100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fddcf470fec4bef906869caf2a1aee9_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml82MDQ3MzEzOTUzNDY5_380c17d5-5fbd-4dfb-8ee9-39ee2d89a5aa"
      unitRef="usd">200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifb9b60051f3d464abf97f4d754be3921_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzQ5L2ZyYWc6OTBmNmU5NTQzYTQ5NDIxM2JkODliNzBjOTAwZjJiNTIvdGV4dHJlZ2lvbjo5MGY2ZTk1NDNhNDk0MjEzYmQ4OWI3MGM5MDBmMmI1Ml82MDQ3MzEzOTUzNDc4_fd58056e-fac9-4c1c-875a-947c9152a550"
      unitRef="usd">15300000</us-gaap:Revenues>
    <infu:MedicalEquipmentAndPropertyDisclosureTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90ZXh0cmVnaW9uOjViMmEyNjc3NjYyMjQ0ZDBiNTAwZjNhYjhhNDc0ZGE4XzI1NQ_8d83cadb-83b1-42f2-9681-c6550eab6f46">Medical Equipment&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment for sale or rental&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment for sale or rental - pump reserve&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment for sale or rental - net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment in rental service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment in rental service - pump reserve&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(50,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(46,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment in rental service - net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for medical equipment for the years ended December&#160;31, 2021, 2020 and 2019 was $9.4 million, $8.9 million and $7.5 million, respectively, which were recorded in &#x201c;cost of revenues&#x201d; for each period.&lt;/span&gt;&lt;/div&gt;</infu:MedicalEquipmentAndPropertyDisclosureTextBlock>
    <infu:ScheduleOfMedicalEquipmentTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90ZXh0cmVnaW9uOjViMmEyNjc3NjYyMjQ0ZDBiNTAwZjNhYjhhNDc0ZGE4XzI1Ng_b6d2078a-54af-41b1-983b-5257db3380ad">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment for sale or rental&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment for sale or rental - pump reserve&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment for sale or rental - net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment in rental service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment in rental service - pump reserve&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(50,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(46,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical Equipment in rental service - net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</infu:ScheduleOfMedicalEquipmentTableTextBlock>
    <infu:MedicalEquipmentHeldForSaleOrRentalGross
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzEtMS0xLTEtNTA2MjI_63eeca07-8ec9-475e-ae36-870e5ecba6e6"
      unitRef="usd">1788000</infu:MedicalEquipmentHeldForSaleOrRentalGross>
    <infu:MedicalEquipmentHeldForSaleOrRentalGross
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzEtMy0xLTEtNTA2MjI_f1dbc924-f541-48fa-81b7-e3efa955832d"
      unitRef="usd">1636000</infu:MedicalEquipmentHeldForSaleOrRentalGross>
    <infu:MedicalEquipmentForSaleOrRentalReserve
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzItMS0xLTEtNTA2MjI_63195ae0-1d66-4d86-988c-7de42f52b084"
      unitRef="usd">46000</infu:MedicalEquipmentForSaleOrRentalReserve>
    <infu:MedicalEquipmentForSaleOrRentalReserve
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzItMy0xLTEtNTA2MjI_3230c58c-ec9b-4654-8d41-98251dc71f51"
      unitRef="usd">33000</infu:MedicalEquipmentForSaleOrRentalReserve>
    <infu:MedicalEquipmentHeldForSaleOrRental
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzMtMS0xLTEtNTA2MjI_e7399c0a-de67-466b-acc7-b0bd35a91dbc"
      unitRef="usd">1742000</infu:MedicalEquipmentHeldForSaleOrRental>
    <infu:MedicalEquipmentHeldForSaleOrRental
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzMtMy0xLTEtNTA2MjI_feb5d2f8-30ce-4b54-b758-8271d5eede92"
      unitRef="usd">1603000</infu:MedicalEquipmentHeldForSaleOrRental>
    <infu:MedicalEquipmentInRentalServicesGross
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzUtMS0xLTEtNTA2MjI_47bdb3a8-70ff-4bc1-902e-e8ade49ed971"
      unitRef="usd">91891000</infu:MedicalEquipmentInRentalServicesGross>
    <infu:MedicalEquipmentInRentalServicesGross
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzUtMy0xLTEtNTA2MjI_3a7c7985-2f82-4565-ac5e-f72e1e8e9b64"
      unitRef="usd">83411000</infu:MedicalEquipmentInRentalServicesGross>
    <infu:MedicalEquipmentInRentalServicesReserve
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzYtMS0xLTEtNTA2MjI_2ef4c96e-b7c2-4810-8427-9167c61bbccc"
      unitRef="usd">1074000</infu:MedicalEquipmentInRentalServicesReserve>
    <infu:MedicalEquipmentInRentalServicesReserve
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzYtMy0xLTEtNTA2MjI_d040e948-ab0d-4e7b-9525-5bf40eee4366"
      unitRef="usd">893000</infu:MedicalEquipmentInRentalServicesReserve>
    <infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzctMS0xLTEtNTA2MjI_90010a7e-4183-4c7e-8f63-061d8c674a44"
      unitRef="usd">50946000</infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation>
    <infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzctMy0xLTEtNTA2MjI_2930ae43-934e-4c89-93e3-7d656ac14721"
      unitRef="usd">46907000</infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation>
    <infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzgtMS0xLTEtNTA2MjI_be00911d-038c-4068-b984-f973521ea465"
      unitRef="usd">39871000</infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation>
    <infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzgtMy0xLTEtNTA2MjI_fa39f253-a81a-4c56-9737-b4b490748dc3"
      unitRef="usd">35611000</infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation>
    <infu:MedicalEquipmentNet
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzEwLTEtMS0xLTUwNjIy_9c207c3c-fedc-421e-b2bf-506ffcbe3cc9"
      unitRef="usd">41613000</infu:MedicalEquipmentNet>
    <infu:MedicalEquipmentNet
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90YWJsZToxMTY5ODNiYWE0NWM0ZWY2YmM2ODY1NmVlNDhkYzQ0NS90YWJsZXJhbmdlOjExNjk4M2JhYTQ1YzRlZjZiYzY4NjU2ZWU0OGRjNDQ1XzEwLTMtMS0xLTUwNjIy_7b264706-9967-47c7-b73f-07cf7a0bc4bc"
      unitRef="usd">37214000</infu:MedicalEquipmentNet>
    <infu:DepreciationExpenseRelatedToMedicalEquipment
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90ZXh0cmVnaW9uOjViMmEyNjc3NjYyMjQ0ZDBiNTAwZjNhYjhhNDc0ZGE4XzE3Mw_f087b2a1-f738-4de7-9133-a14a3f1a7f0e"
      unitRef="usd">9400000</infu:DepreciationExpenseRelatedToMedicalEquipment>
    <infu:DepreciationExpenseRelatedToMedicalEquipment
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90ZXh0cmVnaW9uOjViMmEyNjc3NjYyMjQ0ZDBiNTAwZjNhYjhhNDc0ZGE4XzE4MA_05040b5f-bc4c-4168-bc83-8ddc56f81451"
      unitRef="usd">8900000</infu:DepreciationExpenseRelatedToMedicalEquipment>
    <infu:DepreciationExpenseRelatedToMedicalEquipment
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMTgvZnJhZzo1YjJhMjY3NzY2MjI0NGQwYjUwMGYzYWI4YTQ3NGRhOC90ZXh0cmVnaW9uOjViMmEyNjc3NjYyMjQ0ZDBiNTAwZjNhYjhhNDc0ZGE4XzEwOTk1MTE2MjgxMDM_dc9ec529-55cd-43b2-9684-c099e1b5a3aa"
      unitRef="usd">7500000</infu:DepreciationExpenseRelatedToMedicalEquipment>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90ZXh0cmVnaW9uOmE5ODM4YmFhZTg0MzRmODU5MDg3MGNjZmEwYTg0MmVlXzMwNQ_5e9b43ca-eb7c-4012-a2bd-3d6c40fbc967">Property and Equipment&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated&lt;br/&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated&lt;br/&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture, fixtures, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Automobiles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for property and equipment for each of the years ended December&#160;31, 2021, 2020 and 2019 was $0.9 million, $0.8 million and $0.5 million, respectively. This expense was recorded in &#x201c;general and administrative expenses&#x201d; for each period.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90ZXh0cmVnaW9uOmE5ODM4YmFhZTg0MzRmODU5MDg3MGNjZmEwYTg0MmVlXzMwNg_2d98362a-0e9f-4cf1-b51c-77c74271d140">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated&lt;br/&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated&lt;br/&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture, fixtures, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Automobiles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,979)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i901347f42a9240abb769c4ca3db405e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItMS0xLTEtNTA2MjI_89953161-4ceb-41c8-a620-d309092e2639"
      unitRef="usd">4812000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i901347f42a9240abb769c4ca3db405e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItMy0xLTEtNTA2MjI_62e17b24-8a0a-4d5f-bc84-0e93a916a7af"
      unitRef="usd">2528000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i901347f42a9240abb769c4ca3db405e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItNS0xLTEtNTA2MjI_e1e20b01-3516-452f-833b-1806d87a5458"
      unitRef="usd">2284000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia0e87b8645294c95b18cfe1e1938f796_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItNy0xLTEtNTE2OTI_0ea647de-736b-4e1f-aef8-50252d94bda0"
      unitRef="usd">3742000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia0e87b8645294c95b18cfe1e1938f796_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItOS0xLTEtNTE2OTI_d6dcd598-8c35-4609-96a6-79fd76417749"
      unitRef="usd">2018000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia0e87b8645294c95b18cfe1e1938f796_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzItMTEtMS0xLTUxNjky_caef10ce-ac43-42d2-bbb6-4d37bbe7132e"
      unitRef="usd">1724000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9f56e398e372492d8641d88cd8b01cff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtMS0xLTEtNTA2MjI_fa2f0146-abdc-46c4-bff4-d72a91e58416"
      unitRef="usd">110000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9f56e398e372492d8641d88cd8b01cff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtMy0xLTEtNTA2MjI_4a32bc1f-5c68-4243-adbb-d2f93acc4540"
      unitRef="usd">103000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9f56e398e372492d8641d88cd8b01cff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtNS0xLTEtNTA2MjI_398d7b05-efd5-4f4c-9a1c-0c18763748d6"
      unitRef="usd">7000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1e2ca571a5714cb889e214a572d2aa67_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtNy0xLTEtNTE2OTI_ce240b04-66c9-456d-974c-0aa799a65f3e"
      unitRef="usd">117000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i1e2ca571a5714cb889e214a572d2aa67_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtOS0xLTEtNTE2OTI_52155130-e2d1-4a3c-a468-797a1a314b0d"
      unitRef="usd">102000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1e2ca571a5714cb889e214a572d2aa67_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzMtMTEtMS0xLTUxNjky_cf03e6e5-f130-4187-a6b2-38fe118f7935"
      unitRef="usd">15000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9649d301729547c5b2196154dc65a224_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtMS0xLTEtNTA2MjI_1a1b990c-e307-4f3c-a03e-b804bef827b4"
      unitRef="usd">3444000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9649d301729547c5b2196154dc65a224_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtMy0xLTEtNTA2MjI_a196e61a-ea24-4941-836e-44a61753b411"
      unitRef="usd">1212000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9649d301729547c5b2196154dc65a224_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtNS0xLTEtNTA2MjI_a766cd9c-3232-483d-aec4-3c1e2548f575"
      unitRef="usd">2232000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3b7bb29ceaad4f8da8ce9a75bfa49f10_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtNy0xLTEtNTE2OTI_56904136-7935-48eb-98f6-a97d2d275689"
      unitRef="usd">3416000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i3b7bb29ceaad4f8da8ce9a75bfa49f10_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtOS0xLTEtNTE2OTI_d60fc2ef-4da2-4f05-9351-2886fb4f3aae"
      unitRef="usd">859000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3b7bb29ceaad4f8da8ce9a75bfa49f10_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzQtMTEtMS0xLTUxNjky_c28515fd-cafd-4c87-b4c1-1a4adaa4c535"
      unitRef="usd">2557000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtMS0xLTEtNTA2MjI_24b10440-db8e-4a48-ae4a-8f5dfcaeeddc"
      unitRef="usd">8366000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtMy0xLTEtNTA2MjI_66ada9d8-4ac9-477a-9d09-9f82b9b899ee"
      unitRef="usd">3843000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtNS0xLTEtNTA2MjI_2fc1d217-4fbd-4160-8ca6-78d44baa3bd4"
      unitRef="usd">4523000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtNy0xLTEtNTE2OTI_a4cd9ce7-d4a0-4043-9b29-c8ad9c6c50f5"
      unitRef="usd">7275000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtOS0xLTEtNTE2OTI_2f98f7f5-5c5a-4987-91cb-86977800fd95"
      unitRef="usd">2979000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90YWJsZTpjYmM3YjBjMmE2ODE0OWFmODM1ZWMwMDIyYTM1MTg4Zi90YWJsZXJhbmdlOmNiYzdiMGMyYTY4MTQ5YWY4MzVlYzAwMjJhMzUxODhmXzYtMTEtMS0xLTUxNjky_f672b55d-fca8-42db-92b6-9d270fb46f39"
      unitRef="usd">4296000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationNonproduction
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90ZXh0cmVnaW9uOmE5ODM4YmFhZTg0MzRmODU5MDg3MGNjZmEwYTg0MmVlXzE5OA_2d3788c4-e0cf-42a6-9214-1909776bb1ab"
      unitRef="usd">900000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90ZXh0cmVnaW9uOmE5ODM4YmFhZTg0MzRmODU5MDg3MGNjZmEwYTg0MmVlXzIwNQ_da639b76-9f55-4096-ae2f-a29549816ddc"
      unitRef="usd">800000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjEvZnJhZzphOTgzOGJhYWU4NDM0Zjg1OTA4NzBjY2ZhMGE4NDJlZS90ZXh0cmVnaW9uOmE5ODM4YmFhZTg0MzRmODU5MDg3MGNjZmEwYTg0MmVlXzEwOTk1MTE2MjgxODI_34e83340-aa5a-42de-b7c3-4ed7c4820e49"
      unitRef="usd">500000</us-gaap:DepreciationNonproduction>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzkwMg_f79490bf-e5a2-4c41-9315-dcc9b4c4220f">Goodwill and Intangible Assets&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying value of goodwill by segment are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;DME Services (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) The ITS segment has no recorded goodwill. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the indicators of goodwill impairment as part of its annual impairment test, as of October 1, 2021, and through December 31, 2021, by performing a qualitative assessment of goodwill. In performing the qualitative assessment, the Company evaluated events and circumstances since the last impairment analysis, recent operating performance, changes in the business climate and company-specific factors. The results of the qualitative assessment indicated that it was more likely than not that the estimated fair value of each reporting unit exceeded its carrying value amount as of the test date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount and accumulated amortization of intangible assets were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nonamortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Physician and customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(31,401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(28,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unpatented technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total nonamortizable and amortizable intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(42,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(38,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for intangible assets for the years ended December&#160;31, 2021, 2020 and 2019 was $4.3&#160;million, $4.3&#160;million and $4.4&#160;million, respectively, which was recorded in "amortization of intangibles expenses" for each period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected remaining annual amortization expense for the next five years for intangible assets recorded as of December&#160;31, 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2027 and &lt;br/&gt;thereafter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzMyOTg1MzQ4ODYzNzQ_31879b41-0b65-4efb-afc6-6e209c430757">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying value of goodwill by segment are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;DME Services (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) The ITS segment has no recorded goodwill. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i680eb364512840a7b20a8bfda742ab6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTplN2I0N2I1MWU3ODk0YTgwYWZmZWUyNGRjMGM5ZjU2Ni90YWJsZXJhbmdlOmU3YjQ3YjUxZTc4OTRhODBhZmZlZTI0ZGMwYzlmNTY2XzEtMi0xLTEtNTM3OTU_74c5ce8b-0bd0-401c-bbf6-190570bfbfac"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i972c98c27e6f4a3999d5e2e73d5e2a77_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTplN2I0N2I1MWU3ODk0YTgwYWZmZWUyNGRjMGM5ZjU2Ni90YWJsZXJhbmdlOmU3YjQ3YjUxZTc4OTRhODBhZmZlZTI0ZGMwYzlmNTY2XzItMi0xLTEtNTM3OTU_7999516e-ee9b-4798-95e8-1d771e0e14ec"
      unitRef="usd">3710000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i02810325b2664b7997154ec528092ae9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTplN2I0N2I1MWU3ODk0YTgwYWZmZWUyNGRjMGM5ZjU2Ni90YWJsZXJhbmdlOmU3YjQ3YjUxZTc4OTRhODBhZmZlZTI0ZGMwYzlmNTY2XzMtMi0xLTEtNTM3OTU_2103105e-8a1e-404f-b803-6bfe81d91e4f"
      unitRef="usd">3710000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0629bca191f34f1caf750d54c8ebd131_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTplN2I0N2I1MWU3ODk0YTgwYWZmZWUyNGRjMGM5ZjU2Ni90YWJsZXJhbmdlOmU3YjQ3YjUxZTc4OTRhODBhZmZlZTI0ZGMwYzlmNTY2XzUtMC0xLTEtNTM3OTUvdGV4dHJlZ2lvbjpkYzM4NDM5ZjdlMzk0MDNjYjc2NDAyMDZiNzI0YjgxOF8xMDk5NTExNjI3ODI4_cf060714-9260-4686-8b0c-838a76d05235"
      unitRef="usd">0</us-gaap:Goodwill>
    <infu:CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzkwMw_db56bc6b-d667-4e86-a894-adde74c37e7c">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount and accumulated amortization of intangible assets were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nonamortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Physician and customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(31,401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(28,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unpatented technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(11,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total nonamortizable and amortizable intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(42,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(38,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</infu:CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzMtMS0xLTEtNTA2MjI_14cf45b0-00f7-43a3-a60c-016e174e5d16"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzMtNS0xLTEtNTA2MjI_0e469b9a-6aab-456f-bc4d-c59016101850"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzMtNy0xLTEtNTE3Mzk_c8488371-4f94-4973-9679-ae886f6ec07d"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzMtMTEtMS0xLTUxNzM5_a71456cd-c970-492f-860f-5d6c542c4e0e"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if63340937f6a47b08decf2e320428890_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtMS0xLTEtNTA2MjI_ba2fb6fb-110d-4d17-88d6-88095e39d5b9"
      unitRef="usd">23000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if63340937f6a47b08decf2e320428890_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtMy0xLTEtNTA2MjI_a9a6cfeb-aefa-4f3c-87a3-5533a9de8460"
      unitRef="usd">23000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if63340937f6a47b08decf2e320428890_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtNS0xLTEtNTA2MjI_5f3630df-663e-46a8-b680-783469c49a2c"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib9e0342993b94444b974026bddb99c28_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtNy0xLTEtNTE3Mzk_13d836e6-eae1-4f96-8f7d-179c535935ea"
      unitRef="usd">23000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib9e0342993b94444b974026bddb99c28_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtOS0xLTEtNTE3Mzk_abae8aa5-ff09-49bd-990f-46d20f0102b7"
      unitRef="usd">23000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib9e0342993b94444b974026bddb99c28_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzUtMTEtMS0xLTUxNzM5_09eea431-fd6c-46ed-ba2f-d3b4ef67a336"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i45d3cf60b6544e0d862fa72ac5fa656b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtMS0xLTEtNTA2MjI_3809df3c-7aae-4916-89f6-d8840eaee0d6"
      unitRef="usd">38834000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i45d3cf60b6544e0d862fa72ac5fa656b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtMy0xLTEtNTA2MjI_271ca23b-c0a3-40cf-bf1f-b5ee201ecc7d"
      unitRef="usd">31401000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i45d3cf60b6544e0d862fa72ac5fa656b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtNS0xLTEtNTA2MjI_163c110d-ac7e-43d8-afd5-63b4884976bf"
      unitRef="usd">7433000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i109995ede010411299c74fcc87e3829a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtNy0xLTEtNTE3Mzk_0d7ada21-dd63-461b-ad62-c925c160b393"
      unitRef="usd">36534000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i109995ede010411299c74fcc87e3829a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtOS0xLTEtNTE3Mzk_5c866b64-7a0a-45cf-9864-74da1df8d632"
      unitRef="usd">28924000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i109995ede010411299c74fcc87e3829a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzYtMTEtMS0xLTUxNzM5_2cf42bf6-631d-4bab-ad45-5a965fc97ec9"
      unitRef="usd">7610000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9117e35a7b704846add5b6cf91320364_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMS0xLTEtNTkzNDA_ff2041f4-c2fc-4fee-a233-6cf377639b3b"
      unitRef="usd">943000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9117e35a7b704846add5b6cf91320364_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMy0xLTEtNTkzNDA_0671cc2b-c64c-4443-b68b-0305a66035d8"
      unitRef="usd">123000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9117e35a7b704846add5b6cf91320364_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNS0xLTEtNTkzNDA_7e1ad88a-9e53-4b75-bb86-3c659094a806"
      unitRef="usd">820000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7678f2cb51f54e08941b9dfcf63bace0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNy0xLTEtNTkzNDA_4e5c134d-0f23-4365-a215-c9dee1875fca"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7678f2cb51f54e08941b9dfcf63bace0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctOS0xLTEtNTkzNDA_2121c7bd-4db9-4674-9130-7e31854b500b"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7678f2cb51f54e08941b9dfcf63bace0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMTEtMS0xLTU5MzQw_8af0faed-60c6-4886-81fa-26bd23d16d65"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i441702431efa453d9ae697b4ed1bf9f8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMS0xLTEtNTM5OTE_aeec5ec0-98d3-409b-9625-83c5628a48fe"
      unitRef="usd">472000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i441702431efa453d9ae697b4ed1bf9f8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMy0xLTEtNTM5OTE_0faae2a5-907b-4e22-a5b6-d09dd1580612"
      unitRef="usd">67000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i441702431efa453d9ae697b4ed1bf9f8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNS0xLTEtNTM5OTE_bcceeeff-07b7-4905-aae8-01788e0bdb07"
      unitRef="usd">405000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3d86c2941c0e4ddfa25d123e33722fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNy0xLTEtNTM5OTE_5000b6ee-3d6d-42a4-b124-1e9e40207f9f"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3d86c2941c0e4ddfa25d123e33722fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctOS0xLTEtNTM5OTE_307ec891-f757-42e8-a9b7-43de1f0b10e3"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3d86c2941c0e4ddfa25d123e33722fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMTEtMS0xLTUzOTkx_a60a55e6-b762-47fb-beef-0cc8f4b2b888"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iac70b116e25d46d6943dcd912146fc65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMS0xLTEtNTA2MjI_aa0c409d-81fc-4c45-b894-6dfe48c8b7c1"
      unitRef="usd">11530000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iac70b116e25d46d6943dcd912146fc65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMy0xLTEtNTA2MjI_f95c7172-bdfc-4aac-b0f3-bf1f29742616"
      unitRef="usd">11258000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iac70b116e25d46d6943dcd912146fc65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNS0xLTEtNTA2MjI_29c66d2b-beb8-4f3f-97c3-8311ed421ee8"
      unitRef="usd">272000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i749458dfcda84fcba057ba09cfc9c14f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctNy0xLTEtNTE3Mzk_7562ff30-998d-49f4-a900-c9a798b275f3"
      unitRef="usd">11230000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i749458dfcda84fcba057ba09cfc9c14f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctOS0xLTEtNTE3Mzk_fade2691-a868-40d0-a779-28e1bdb82d5d"
      unitRef="usd">9663000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i749458dfcda84fcba057ba09cfc9c14f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzctMTEtMS0xLTUxNzM5_4ecfc45c-b684-404a-9380-47dc5f0b14e7"
      unitRef="usd">1567000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktMS0xLTEtNTA2MjI_df254b3d-7ec2-4fe2-8aab-fb0af2aac7ff"
      unitRef="usd">53802000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktMy0xLTEtNTA2MjI_c3528783-855e-4f9e-a153-db733a566267"
      unitRef="usd">42872000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktNS0xLTEtNTA2MjI_857c20c8-b29d-415b-9767-06891fac4b0c"
      unitRef="usd">10930000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktNy0xLTEtNTE3Mzk_95090632-50a0-478d-8788-98a52fad8e34"
      unitRef="usd">49787000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktOS0xLTEtNTE3Mzk_f40d19de-8333-4935-b6b2-4039e587f02a"
      unitRef="usd">38610000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZToxYjI4OTJjOTA2MTE0YzVmYTE0MDBhNTE5YmE5M2E2Yi90YWJsZXJhbmdlOjFiMjg5MmM5MDYxMTRjNWZhMTQwMGE1MTliYTkzYTZiXzktMTEtMS0xLTUxNzM5_2f9b9d2d-1e74-4130-92a2-c65571f285e7"
      unitRef="usd">11177000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzEwOTk1MTE2MzA3MDk_67df1d17-5cfe-43c3-98d5-dcd159a38453"
      unitRef="usd">4300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzEwOTk1MTE2MzA3MTc_da4bafd8-7a7d-4922-8b11-4ad98a9ca9cd"
      unitRef="usd">4300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzEwOTk1MTE2MzA4NDg_d9e7015c-a252-482c-97bd-970486e428a1"
      unitRef="usd">4400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90ZXh0cmVnaW9uOjk0Y2NhNDJmODZiMjRmYzNiNzU2OGE5OGE0NDFhOWZjXzkwNA_38f57f7a-f4d0-4194-8ca3-659cf28ca241">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected remaining annual amortization expense for the next five years for intangible assets recorded as of December&#160;31, 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2027 and &lt;br/&gt;thereafter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtMS0xLTEtNTA2MjI_552a1e78-f749-4116-af37-bbd3ddd611d6"
      unitRef="usd">2494000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtMy0xLTEtNTA2MjI_5e4f66bb-649b-4df1-b622-80d723f30da2"
      unitRef="usd">990000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtNS0xLTEtNTA2MjI_f58d085f-46fa-4dcc-ad59-6ccf9071f813"
      unitRef="usd">990000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtNy0xLTEtNTA2MjI_3c2cad41-739c-4c07-b778-d29bbefecfa2"
      unitRef="usd">810000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtOS0xLTEtNTA2MjI_a54af78f-a34e-4d56-8616-1b20bd65ee39"
      unitRef="usd">524000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMjQvZnJhZzo5NGNjYTQyZjg2YjI0ZmMzYjc1NjhhOThhNDQxYTlmYy90YWJsZTpkYTdlMDhhOTFiZGI0YTcyODdhNTgxYTBmZWM2MDIyMC90YWJsZXJhbmdlOmRhN2UwOGE5MWJkYjRhNzI4N2E1ODFhMGZlYzYwMjIwXzEtMTEtMS0xLTUwNjIy_f1f6d9ab-d6de-4935-a9fd-964e08177a8b"
      unitRef="usd">3122000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzY1MDg_65668fe0-2292-4cda-8b75-d592ae6ccfb1">Debt&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;February&#160;5, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company entered into a Credit Agreement (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021 Credit Agreement&#x201d;) with JPMorgan Chase Bank, N.A., as administrative agent (the &#x201c;Agent&#x201d;), sole bookrunner and sole lead arranger, and the lenders party thereto. The borrowers under the 2021 Credit Agreement are the Company, InfuSystem Holdings USA, Inc. (&#x201c;Holdings&#x201d;), ISI, First Biomedical, and IFC LLC (&#x201c;IFC&#x201d; and, collectively with the Company, Holdings, ISI and First Biomedical, the &#x201c;Borrowers&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement provides for a revolving credit facility (the &#x201c;Revolving Facility&#x201d;) of $75.0 million, maturing on February 5, 2026. The Revolving Facility may be increased by $25.0 million, subject to certain conditions, including the consent of the Agent and obtaining necessary commitments. The lenders under the 2021 Credit Agreement may issue up to $7.0 million in letters of credit subject to the satisfaction of certain conditions. On February&#160;5, 2021, the Borrowers made an initial borrowing of $30.0 million under the Revolving Facility. Proceeds from the loan, along with approximately $8.2 million in cash, were used to repay all amounts due under the Company&#x2019;s then existing credit facility dated March 23, 2015 (the &#x201c;2015 Credit Agreement&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement has customary representations and warranties. The ability to borrow under the facility is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations on indebtedness, liens, mergers, acquisitions, investments, asset sales, affiliate transactions and restricted payments, as well as financial covenants, including the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;a minimum fixed charge coverage ratio (defined as the ratio of consolidated EBITDA (as defined in the 2021 Credit Agreement) less 50% of depreciation expense), to consolidated fixed charges (as defined in the 2021 Credit Agreement)) for the prior four most recently ended calendar quarters of 1.20 to 1.00; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;a maximum leverage ratio (defined as total indebtedness to EBITDA for the prior four most recently ended calendar quarters) of 3.50 to 1.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement includes customary events of default. The occurrence of an event of default will permit the lenders to terminate commitments to lend under the Revolving Facility and accelerate payment of all amounts outstanding thereunder.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Simultaneous with the execution of the 2021 Credit Agreement, the Company entered into a Pledge and Security Agreement to secure repayment of the obligations of the Borrowers. Under the Pledge and Security Agreement, each Borrower has granted to the Agent, for the benefit of various secured parties, a first priority security interest in substantially all of the personal property assets of each of the Borrowers, including the shares of each of Holdings, ISI and First Biomedical and the equity interests of IFC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;5, 2021, in connection with the execution and closing of the 2021 Credit Agreement, the Company, along with its wholly owned subsidiaries as borrowers, terminated the 2015 Credit Agreement. All outstanding loans under the 2015 Credit Agreement have been repaid and all liens under the 2015 Credit Agreement have been released, except that a letter of credit originally issued under the 2015 Credit Agreement in the amount of approximately $0.8 million was transferred to the 2021 Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement was accounted for as a debt modification that resulted in a small increase to deferred debt issuance costs. As of December&#160;31, 2021, the Company was in compliance with all debt-related covenants under the 2021 Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the 2015 Credit Agreement, which would have matured on November 9, 2024, included three term notes totaling $37.9 million, with varying required quarterly amortization payments, and an undrawn $11.8 million revolving line of credit. The availability under the line of credit was reduced by outstanding letters of credit and reserves totaling $1.0 million and was subject to a borrowing base limitation as defined by the agreement. The borrowing base was approximately $15.6 million at December&#160;31, 2020. At December&#160;31, 2020 and on the date of the refinancing, the Company &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was in compliance with all affirmative and negative covenants, as outlined in the agreement, which included maintenance of a maximum leverage ratio and a minimum fixed charge coverage ratio, as defined in the agreement. Interest on the facility was payable at the Company&#x2019;s option as a (i) Eurodollar Loan, which bore interest at a per annum rate equal to the applicable 30-day LIBOR plus an applicable margin ranging from 2.00% to 3.00% or (ii) CB Floating Rate (&#x201c;CBFR&#x201d;) Loan, which bore interest at a per annum rate equal to the greater of (a) the lender&#x2019;s prime rate or (b) LIBOR plus 2.50%, in each case, plus a margin ranging from -1.00% to 0.25% based on the Company's leverage ratio. The actual Eurodollar Loan rate at December&#160;31, 2020 was 2.19% (LIBOR of 0.19% plus 2.00%). The actual CBFR Loan rate at December&#160;31, 2020 was 2.25% (lender&#x2019;s prime rate of 3.25% minus 1.00%).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;15, 2019, the Company sold for $2.0 million and immediately leased back certain medical equipment in rental service to a third party specializing in such transactions. The leaseback term is 36 months. Because the arrangement contains a purchase option that the Company is reasonably certain to exercise, this transaction did not qualify for the sale-leaseback accounting under ASC 842. The medical equipment remains recorded on the accompanying condensed consolidated balance sheet and the proceeds received have been classified as an other financing liability, which is being paid off monthly over the term of the lease. During the fourth quarter of 2021, the Company recorded an additional $0.2&#160;million of interest expense to reflect the amount expected to be paid upon the exercise of the purchase option at the end of its other financing transaction. The balance of other financing as of December&#160;31, 2021 was $0.4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As referenced above, the Company executed and closed the 2021 Credit Agreement during the first quarter of 2021, and in connection with entering into that agreement, terminated the 2015 Credit Agreement. For the following tables, the figures related to the December&#160;31, 2021 revolving credit facility balances relate to the 2021 Credit Agreement, while the December&#160;31, 2020 revolving credit facility balances relate to the now-terminated 2015 Credit Agreement. The following table illustrates the net availability under the revolving credit facilities as of the applicable balance sheet date (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving Facility:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross availability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding draws&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(32,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Letters of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Landlord reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Availability on Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had future maturities of its long-term debt as of December&#160;31, 2021 as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2027 and &lt;br/&gt;thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a breakdown of the Company&#x2019;s current and long-term debt (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Current&lt;br/&gt;Portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-Term&lt;br/&gt;Portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Current&lt;br/&gt;Portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-Term&lt;br/&gt;Portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2019 equipment line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unamortized value of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;December&#160;31, 2021, amounts outstanding under the Revolving Facility provided under the 2021 Credit Agreement bear interest at a variable rate equal to, at the Company&#x2019;s election, a LIBO Rate for Eurodollar loans or an Alternative Base Rate for ABR loans, as defined by the 2021 Credit Agreement, plus a spread that will vary depending upon the Company&#x2019;s leverage ratio. The spread ranges from 2.00% to 3.00% for Eurodollar Loans and 1.00% to 2.00% for base rate loans. The weighted-average Eurodollar loan rate at December&#160;31, 2021 was 2.11% (LIBO of 0.11% plus 2.00%). The actual ABR loan rate at December&#160;31, 2021 was 4.25% (lender&#x2019;s prime rate of 3.25% plus 1.00%</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iec609ab7f9cc482f878e37ae4b232f06_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgxMzg_521b448c-c9f6-4d44-a530-5222828ef662"
      unitRef="usd">75000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <infu:LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions
      contextRef="iec609ab7f9cc482f878e37ae4b232f06_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgxNzc_28e32224-1b37-448b-8f16-ab947f3b1be8"
      unitRef="usd">25000000</infu:LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9c000588f48b4e20af3b977ce4231e48_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgxOTc_5d8f55f7-efe4-49e3-8961-e293b885ed84"
      unitRef="usd">7000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ib6e13bc56eba44a085dd386fb4a920de_D20210205-20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgyMzU_1587a1ec-a735-4297-b38b-abe521506a1b"
      unitRef="usd">30000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i033b71a678134cd586b4202ce9eb994e_D20210205-20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgyNTU_64a0ed1f-f9e9-4548-8a69-ae9713a7d5a7"
      unitRef="usd">8200000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <infu:PercentageOfTotalDepreciationExpense
      contextRef="i28416998ed494697b9e63887fde6fd11_D20210205-20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgyODg_c3d3e7d5-606f-4e57-b425-32ae0b20d332"
      unitRef="number">0.50</infu:PercentageOfTotalDepreciationExpense>
    <infu:DebtInstrumentCovenantMinimumFixedCoverageRatio
      contextRef="if5d269b502c94e90b66e4c4b94a9c2ed_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgyODE_2c5a8fa4-9425-4719-abe8-cd1956061153"
      unitRef="number">1.20</infu:DebtInstrumentCovenantMinimumFixedCoverageRatio>
    <infu:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="if5d269b502c94e90b66e4c4b94a9c2ed_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgyNzQ_ee792094-8868-4b07-987e-75e09bb14e17"
      unitRef="number">3.50</infu:DebtInstrumentCovenantMaximumLeverageRatio>
    <us-gaap:LineOfCredit
      contextRef="i452ae0b2df354385976aa6108ccf6fb9_I20210205"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgzMTQ_da095831-ace3-4e8e-9208-23164669a109"
      unitRef="usd">800000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id2da90a2b53f464d83f01bf20f29c091_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgzNTM_81e9088c-ecc9-4c05-82c8-0104182fca93"
      unitRef="usd">37900000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic9523dc8728f4f108564fbb8f67d46a3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgzNzI_e87c02f3-f950-47ab-bc64-23103e7941bb"
      unitRef="usd">11800000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ic9523dc8728f4f108564fbb8f67d46a3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgzOTE_e21c2a6f-cd78-4636-bbf6-4cd73b894178"
      unitRef="usd">1000000</us-gaap:LettersOfCreditOutstandingAmount>
    <infu:LineOfCreditFacilityBorrowingBase
      contextRef="ic9523dc8728f4f108564fbb8f67d46a3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg0NTM_f3f58bc6-9d32-40cd-b768-b4c5453e4737"
      unitRef="usd">15600000</infu:LineOfCreditFacilityBorrowingBase>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8ae56ca359cf4788a118a9f206ace640_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1NjE_93eb789f-c0da-4329-80cc-487134fc9c29"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i29c501e886e64e9c963a67b76eb4cd46_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1Njk_33ef38f6-5652-4d81-9da7-4bf88ff715a0"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <infu:DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate
      contextRef="i223aaee1de9843719aacfcb115ef4cb2_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1Nzc_6cd182e5-013b-48dc-b332-53e31448dc5a"
      unitRef="number">0.0250</infu:DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i32f4cc53746a4a8cba9ea7b91c877b3b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1ODU_98ee8b7c-450e-4725-8db6-1ffc55f9947b"
      unitRef="number">-0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i4bb191034086475081b1b2d7260fba3c_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1OTU_5bc2f542-d220-4351-a5df-da88e835684d"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ib19aee4251c0421a88d27487e974e24e_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg0ODg_fdbebbd5-0b50-4de7-9f2a-40feab3dc18c"
      unitRef="number">0.0219</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <infu:LIBORRate
      contextRef="ib19aee4251c0421a88d27487e974e24e_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg0ODA_0eda2429-f385-443b-a75b-718651152790"
      unitRef="number">0.0019</infu:LIBORRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i86348f84097549aea76b5e34c1abceab_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg0NzI_79475c80-d57e-4676-9e9b-03bb98002bf7"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i4249c9895bc145b5be2fa0d810ad324b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1MTM_16dadeaf-d72c-4902-84b7-ab41e47deee7"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <infu:LenderPrimeRate
      contextRef="i2958795320034b74ba5d1eff1f005813_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg0OTY_a37bb903-0464-4d74-bd73-e50b6090c0e8"
      unitRef="number">0.0325</infu:LenderPrimeRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i48cdf09f16b649aba0ae191e5967f0ad_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg1MDQ_d6c51510-ed8f-4547-8f46-85537d35dd76"
      unitRef="number">-0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic70163d2c2154132b876d363ae1420b5_I20190415"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg2NDQ_5c7d6919-706c-4e63-994c-a7d71156512e"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ia8c78e4c1e864bd5a5b27f93ca59061e_D20190415-20190415"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDg2NjI_990a8158-f666-4025-861d-7ceabdcea462">P36M</us-gaap:DebtInstrumentTerm>
    <us-gaap:InterestExpenseDebt
      contextRef="i4b550170313246b389a63672f1b2683f_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzMyOTg1MzQ5MDUxNTQ_db873641-438a-4b83-aced-f72f345fc375"
      unitRef="usd">200000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i262345c59e314575bff01a7f8cda11fe_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDgwOTg_9f838c7e-c29b-44ff-8a16-f0ea7000b601"
      unitRef="usd">400000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzY1MDk_3785de61-e090-4a73-878d-4d70c59b700f">The following table illustrates the net availability under the revolving credit facilities as of the applicable balance sheet date (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving Facility:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross availability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding draws&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(32,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Letters of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Landlord reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Availability on Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzItMS0xLTEtNTA2MjI_63bf27ed-dd3e-485e-9269-2df25977bb3e"
      unitRef="usd">75000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzItMy0xLTEtNTA2MjI_95452266-b561-476b-9db0-af9567806115"
      unitRef="usd">11750000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzMtMS0xLTEtNTA2MjI_8ca2e919-63d4-45bc-9a3c-7eca771e5bb9"
      unitRef="usd">32974000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzMtMy0xLTEtNTA2MjI_85b08632-1381-4e36-9711-9bb24d1b89ad"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzQtMS0xLTEtNTA2MjI_516280f7-4b77-4998-b9c1-6edc5ca01d73"
      unitRef="usd">600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzQtMy0xLTEtNTA2MjI_04089b18-cdc5-4f1e-b990-19312f2e3bd2"
      unitRef="usd">800000</us-gaap:LettersOfCreditOutstandingAmount>
    <infu:LandlordReserves
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzUtMS0xLTEtNTA2MjI_97e33960-2e7e-4622-a658-7b2b6c52dee8"
      unitRef="usd">0</infu:LandlordReserves>
    <infu:LandlordReserves
      contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzUtMy0xLTEtNTA2MjI_8747dbd0-5ca8-4177-b9cb-2c6bec2d08c4"
      unitRef="usd">162000</infu:LandlordReserves>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzYtMS0xLTEtNTA2MjI_4f10f5fa-9232-4c8a-9691-43cb3285cb37"
      unitRef="usd">41426000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo0MWIxOTM0OGVmYjY0YzhhYTE3YzMzOWQ3Yjk2ODk1ZS90YWJsZXJhbmdlOjQxYjE5MzQ4ZWZiNjRjOGFhMTdjMzM5ZDdiOTY4OTVlXzYtMy0xLTEtNTA2MjI_692f8705-7582-46ec-8e3d-a5b31f8772d9"
      unitRef="usd">10788000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzY1MTA_3f8edc03-a80f-4169-9d93-69d8e752d11d">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had future maturities of its long-term debt as of December&#160;31, 2021 as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2027 and &lt;br/&gt;thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtMS0xLTEtNTA2MjI_b3b9aeb8-07a9-471b-9125-83fe9cc2965c"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtMy0xLTEtNTA2MjI_b251681f-db78-44a8-bbf5-13c169fd1576"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtNS0xLTEtNTA2MjI_998a8474-392e-4a75-90e9-7adbb3b443d3"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtNy0xLTEtNTA2MjI_e499a164-2522-45eb-925e-0b4ead2a9eb6"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtOS0xLTEtNTIzMzU_e585eca5-9cf1-4f03-89e3-b7986d5cba80"
      unitRef="usd">32974000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtOS0xLTEtNTA2MjI_64e5aafc-2ef6-4ad7-816f-767d4f5d188f"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzEtMTEtMS0xLTUwNjIy_862d28a3-b893-4cfa-9050-8ea15ffd3cbe"
      unitRef="usd">32974000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtMS0xLTEtNTA2MjI_707aff14-ce8d-4225-8b73-cf1efbf16556"
      unitRef="usd">423000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtMy0xLTEtNTA2MjI_d9229e2a-e61d-46a0-b22b-cd39c2025fc6"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtNS0xLTEtNTA2MjI_c45a1ed2-0184-4bf7-8053-cc5f2668fa1d"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtNy0xLTEtNTA2MjI_18166d2b-655d-4bc1-b8e4-c8bf54fc60d4"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzItOS0xLTEtNTIzMzU_ed1d2de5-3e2d-4fdc-988a-628cd42bd223"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtOS0xLTEtNTA2MjI_42c73043-ac5a-4f04-91a0-8ffc139837b5"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzUtMTEtMS0xLTUwNjIy_ed0ac7b0-6595-4bb8-b7d5-d3f4f0b8b3cf"
      unitRef="usd">423000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtMS0xLTEtNTA2MjI_96d94881-a25c-4909-9e86-c744eb0b2b78"
      unitRef="usd">423000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtMy0xLTEtNTA2MjI_2de7967e-2fc9-476a-ac28-22eed10a8b45"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtNS0xLTEtNTA2MjI_ad27b6e5-54c3-4d98-a597-1ecf555341b5"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtNy0xLTEtNTA2MjI_0255f0dd-f0ec-4bfa-97e7-154c54bbc382"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzMtOS0xLTEtNTIzMzU_ac5c8e07-fdd8-41f9-b0d1-2c6a041cbd82"
      unitRef="usd">32974000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtOS0xLTEtNTA2MjI_98fbc766-d60a-436b-a30f-2076faa81b69"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTowMmYxYjBkOTZjOGY0MTg3OTcxMzYwZWZhZjU5MjAxZS90YWJsZXJhbmdlOjAyZjFiMGQ5NmM4ZjQxODc5NzEzNjBlZmFmNTkyMDFlXzYtMTEtMS0xLTUwNjIy_6d28437a-38a9-48ac-adc0-77fe997a3416"
      unitRef="usd">33397000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzY1MTE_4fe3b81e-b5d9-444e-8fc3-b973edd295b9">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a breakdown of the Company&#x2019;s current and long-term debt (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Current&lt;br/&gt;Portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-Term&lt;br/&gt;Portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Current&lt;br/&gt;Portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-Term&lt;br/&gt;Portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2019 equipment line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unamortized value of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <infu:LongtermDebtGrossCurrent
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMS0xLTEtNTI0NzE_696b06ae-d424-40b2-a372-f82e7007f0b4"
      unitRef="usd">0</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMy0xLTEtNTI0NzE_89e223b8-460a-4f2b-86d6-5cb83b70caf4"
      unitRef="usd">32974000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i57c0ab7efbce44e3a190303cafd12765_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItNS0xLTEtNTI0NzE_47a42365-e1f7-446c-a5d4-f7fd0c59b9f0"
      unitRef="usd">32974000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItNy0xLTEtNTI0NzE_37b38d13-e5fe-4ff8-9baa-7dd5d20b8862"
      unitRef="usd">0</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItOS0xLTEtNTI0NzE_81346e36-4f21-42dd-9a4c-35d91f58b54d"
      unitRef="usd">0</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0bac56a13b8a4a839f394785fb03bcca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMTEtMS0xLTUyNDcx_c0c83e55-9b0a-43c2-987b-2d28d873869f"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i26945b82dabf4e67b225a0c6d08752e0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMS0xLTEtNTA2MjI_1d3da8ff-6d5a-4ff7-b368-8060d034a0f2"
      unitRef="usd">0</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i26945b82dabf4e67b225a0c6d08752e0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMy0xLTEtNTA2MjI_2d638613-a739-4dd9-94d1-5d61f0662c55"
      unitRef="usd">0</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i26945b82dabf4e67b225a0c6d08752e0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItNS0xLTEtNTA2MjI_d0a78fb6-c367-4b24-96c3-9a1368450294"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="ib56fe4590048490aac40ada7ae6400c3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItNy0xLTEtNTA2MjI_addb79d8-a405-4b01-adb9-776810ed7dc7"
      unitRef="usd">4615000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="ib56fe4590048490aac40ada7ae6400c3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItOS0xLTEtNTA2MjI_6f70fbec-9674-4bbd-81ea-e3b35d086185"
      unitRef="usd">17305000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib56fe4590048490aac40ada7ae6400c3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzItMTEtMS0xLTUwNjIy_7fa4d94e-d98d-4cd3-956a-cec6e48c9d19"
      unitRef="usd">21920000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="ib6540674abce4c21a0ef51335bdd4b29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtMS0xLTEtNTA2MjI_d662567d-e105-43a1-919b-fb147aaca962"
      unitRef="usd">0</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="ib6540674abce4c21a0ef51335bdd4b29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtMy0xLTEtNTA2MjI_db276abd-04ee-4453-9cfc-c9761a98c119"
      unitRef="usd">0</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib6540674abce4c21a0ef51335bdd4b29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtNS0xLTEtNTA2MjI_efdbaafb-3eb8-4009-a889-3ea0d37f480b"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i3c407a2ed2ae458a8df6a05548246659_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtNy0xLTEtNTA2MjI_75e2e72f-515d-443c-a58e-2895f7bb73a1"
      unitRef="usd">1600000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i3c407a2ed2ae458a8df6a05548246659_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtOS0xLTEtNTA2MjI_f76ea076-0d17-4907-be56-849594c0c1fb"
      unitRef="usd">4400000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3c407a2ed2ae458a8df6a05548246659_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzMtMTEtMS0xLTUwNjIy_f1ed471e-82c6-4732-82f2-802bb3e0dc21"
      unitRef="usd">6000000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="ib4facded32a743d880e4713f269f8b0a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtMS0xLTEtNTA2MjI_7ae7b089-0af6-4271-9cc9-9358ffcbbd58"
      unitRef="usd">0</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="ib4facded32a743d880e4713f269f8b0a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtMy0xLTEtNTA2MjI_5f4f7e3d-e86c-4f37-ba75-053571d65f4d"
      unitRef="usd">0</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib4facded32a743d880e4713f269f8b0a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtNS0xLTEtNTA2MjI_7cb7bb3a-99cc-4676-82de-d1cf6190ee00"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i987ef74564c541748397735c98c6eef8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtNy0xLTEtNTA2MjI_dedd3bd6-20c7-41ac-8c52-0cb9a34b14ef"
      unitRef="usd">2500000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i987ef74564c541748397735c98c6eef8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtOS0xLTEtNTA2MjI_e91ccb56-6d4e-439a-b6e9-467973c52497"
      unitRef="usd">7500000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i987ef74564c541748397735c98c6eef8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzQtMTEtMS0xLTUwNjIy_a9d21d24-2cdd-4967-b30d-a7cd3c417784"
      unitRef="usd">10000000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtMS0xLTEtNTA2MjI_c28799ea-6c1e-4892-af3d-1b20c944331f"
      unitRef="usd">423000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtMy0xLTEtNTA2MjI_6b364d1c-a958-4370-8ef0-8216c6944197"
      unitRef="usd">0</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7a3117f913484a4686356512d23fcd5a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtNS0xLTEtNTA2MjI_3e52584c-d619-4bde-8fde-b46630102949"
      unitRef="usd">423000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i2ab9a73eeba346ee8122c590dbcbff5c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtNy0xLTEtNTA2MjI_76407969-0974-439a-ac54-ddd3a6088fe5"
      unitRef="usd">725000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i2ab9a73eeba346ee8122c590dbcbff5c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtOS0xLTEtNTA2MjI_b2237881-257a-4452-bfce-f131523f7c7a"
      unitRef="usd">222000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2ab9a73eeba346ee8122c590dbcbff5c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzYtMTEtMS0xLTUwNjIy_a20ad1fb-c447-4959-a42b-645596f0e88f"
      unitRef="usd">947000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctMS0xLTEtNTA2MjI_4b271bb4-58bf-4dbe-9f09-80b4bc6bab01"
      unitRef="usd">423000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctMy0xLTEtNTA2MjI_9ccb7252-1f30-4989-be27-8788c09f0ce9"
      unitRef="usd">32974000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctNS0xLTEtNTA2MjI_4400b7a6-50be-466b-b3af-4c54382a28b1"
      unitRef="usd">33397000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctNy0xLTEtNTA2MjI_8c475910-0d1a-4d37-9101-b0bec29ee200"
      unitRef="usd">9440000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctOS0xLTEtNTA2MjI_d82a92d4-f43c-4d81-941b-1c3a643edac9"
      unitRef="usd">29427000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzctMTEtMS0xLTUwNjIy_9426ed28-3423-45d6-9352-d2bad73b33b3"
      unitRef="usd">38867000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:UnamortizedDebtIssuanceExpenseCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMS0xLTEtNTI0MzI_efa7b317-db5a-4ef4-950a-e64d709f4c10"
      unitRef="usd">74000</infu:UnamortizedDebtIssuanceExpenseCurrent>
    <infu:UnamortizedDebtIssuanceExpenseNoncurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMy0xLTEtNTI0MzI_ca767227-b125-4b3a-9d2a-797a8baea6d5"
      unitRef="usd">226000</infu:UnamortizedDebtIssuanceExpenseNoncurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktNS0xLTEtNTI0MzI_74b8bd17-de28-4d68-9caa-26e4b6d0084e"
      unitRef="usd">300000</us-gaap:UnamortizedDebtIssuanceExpense>
    <infu:UnamortizedDebtIssuanceExpenseCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktNy0xLTEtNTI0MzI_543c1855-23a8-4e16-8812-7c06f35373b2"
      unitRef="usd">17000</infu:UnamortizedDebtIssuanceExpenseCurrent>
    <infu:UnamortizedDebtIssuanceExpenseNoncurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktOS0xLTEtNTI0MzI_c8bd6254-d9b3-4805-89d8-6dc9ff435eb9"
      unitRef="usd">49000</infu:UnamortizedDebtIssuanceExpenseNoncurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMTEtMS0xLTUyNDMy_38c55ac9-2e0e-477b-b2d1-fc869c51b6e1"
      unitRef="usd">66000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebtCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMS0xLTEtNTI0NTE_e91e6fc5-ae20-4faf-9e81-477f9ceb44a4"
      unitRef="usd">349000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMy0xLTEtNTI0NTE_649b8173-f726-40a8-be78-3e317ada63aa"
      unitRef="usd">32748000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktNS0xLTEtNTI0NTE_998e4ac5-89e5-4ebf-ad8c-6d513fa1c0a8"
      unitRef="usd">33097000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktNy0xLTEtNTI0NTE_538229fa-e5db-4497-9d10-37a0f30cf1c1"
      unitRef="usd">9423000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktOS0xLTEtNTI0NTE_d5b28bac-0398-4fe9-b8b1-8e4e1e6a3347"
      unitRef="usd">29378000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90YWJsZTo4N2VhOWY5YWMyMzk0ZWVjOTZhZGI1ZDFmNGVlMzI2Yi90YWJsZXJhbmdlOjg3ZWE5ZjlhYzIzOTRlZWM5NmFkYjVkMWY0ZWUzMjZiXzktMTEtMS0xLTUyNDUx_d1ecc78a-e9c0-4511-80d3-838abae44dac"
      unitRef="usd">38801000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="idd19a01ade284855af47b1b4373ea548_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0NTc_62956b56-6165-4985-8ad6-23f69c0f60d0"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ifb66c8f537fd4b868b21fad8bb3d0370_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0NjU_2d772833-b3c7-4e85-a222-2a78765762fd"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5ad0860c58864013aaca9c0803749cc1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0NzM_1d3117d5-6119-480e-a30e-5c7d20f8ddd9"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i753ef5726f0d46c09a8a2930b70f0ae4_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0ODE_b8f55e1f-08bf-494e-b06a-53cbab4259f7"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ibbe15e51fb3c431391c39b3871874755_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0MDk_9a0b416d-7664-48b3-9c12-20a46f018005"
      unitRef="number">0.0211</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <infu:LIBORRate
      contextRef="ibbe15e51fb3c431391c39b3871874755_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0MTc_ec4299c3-ef43-42bf-94ff-d6e20557d762"
      unitRef="number">0.0011</infu:LIBORRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5cd65086be1a4f03b35066f3c49722b5_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0MjU_c7c0bfb3-1835-416e-8986-43f1d049868b"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="id680c7f9eb53497f8afe704e06188d0d_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0NDk_39dd246e-360e-4013-94f0-3d7598f4a60d"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <infu:LenderPrimeRate
      contextRef="id680c7f9eb53497f8afe704e06188d0d_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0MzM_1a1577a1-6bae-40db-a5e0-4f60fdde6ee3"
      unitRef="number">0.0325</infu:LenderPrimeRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id41bcfe45ebb4131bad97991e1bcf070_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzAvZnJhZzpkNmY4YzZlMjA3Mzc0Y2QwOWQ4YzU4MDUxZmJlNDc0YS90ZXh0cmVnaW9uOmQ2ZjhjNmUyMDczNzRjZDA5ZDhjNTgwNTFmYmU0NzRhXzEwOTk1MTE2NDc0NDE_a7974ec5-b44b-421f-ab18-02eccc2d189a"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGV4dHJlZ2lvbjplYjIyODYxM2Y4MjM0ODY0OTQyNWI3MzFhOGRjYzkwYV8zMjk4NTM0ODg1MzM4_e379b0cf-6177-4d13-97b5-a044ba1007c2">Derivative Financial Instruments and Hedging Activities&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company adopted a derivative investment policy which provides guidelines and objectives related to managing financial and operational exposures arising from market changes in short term interest rates. In accordance with this policy, the Company can enter into interest rate swaps or similar instruments, will endeavor to evaluate all the risks inherent in a transaction before entering into a derivative financial instrument and will not enter into derivative financial instruments for speculative or trading purposes. Hedging relationships are formally documented at the inception of the hedge and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to interest rate risk related to its variable rate debt obligations under the 2021 Credit Agreement. In order to manage the volatility in interest rate markets, in February 2021, the Company entered into two interest rate swap agreements to manage exposure arising from this risk. On a combined basis, the agreements have a constant notional amount over a 5-year term that ends on February 5, 2026. The agreements both pay the Company 30-day LIBOR on the notional amount and the Company pays a fixed rate of interest equal to 0.73%. These derivative instruments are considered cash flow hedges. The Company does not have any other derivative financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the location and gross fair value amounts of the Company's derivative financial instruments and the associated notional amounts designated as cash flow hedges (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December&#160;31, 2021 (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Fair Value Derivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;padding-left:40.57pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) No derivative instruments existed at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the effect of our derivative financial instruments designated as hedging instruments in AOCI (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December&#160;31, 2021 (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Gain on cash flow hedges - interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unrealized gain recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;249&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amounts reclassified to interest expense (b)(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;106&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;268&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) No derivative instruments existed for the years ended December&#160;31, 2020 and December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(b) Positive amounts represented interest expense. Total interest expense as presented in the consolidated statement of operations for the years ended December&#160;31, 2021, 2020 and 2019 were $1.4 million, $1.3 million and $1.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(c) $0.1 million of expense is expected to be reclassified into earnings within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not incur any hedge ineffectiveness during the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="ie04daf42f32244b687b1b4a179069060_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGV4dHJlZ2lvbjplYjIyODYxM2Y4MjM0ODY0OTQyNWI3MzFhOGRjYzkwYV8xMTIx_4b1b9c5b-f65d-4f0d-8018-8b3ddb119802"
      unitRef="numberofagreement">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ie04daf42f32244b687b1b4a179069060_I20210205"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGV4dHJlZ2lvbjplYjIyODYxM2Y4MjM0ODY0OTQyNWI3MzFhOGRjYzkwYV8xNDQz_b753e542-9bad-40e3-856c-65debc7646cf"
      unitRef="number">0.0073</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGV4dHJlZ2lvbjplYjIyODYxM2Y4MjM0ODY0OTQyNWI3MzFhOGRjYzkwYV80Mzk4MDQ2NTEzMTEy_0eadfba2-54a6-4a54-830a-5a072a017e5f">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the location and gross fair value amounts of the Company's derivative financial instruments and the associated notional amounts designated as cash flow hedges (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December&#160;31, 2021 (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Fair Value Derivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;padding-left:40.57pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) No derivative instruments existed at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3f5f66be8c4042dfbc78b5ce658083c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6YmU0NjgwZTJjZTQyNDUwNmI1ZGY3ZjQzNmJjN2I4MTcvdGFibGVyYW5nZTpiZTQ2ODBlMmNlNDI0NTA2YjVkZjdmNDM2YmM3YjgxN180LTQtMS0xLTU0Mzc4_d139dc0f-9399-4031-8539-6904504d3d55"
      unitRef="usd">20000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i3f5f66be8c4042dfbc78b5ce658083c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6YmU0NjgwZTJjZTQyNDUwNmI1ZGY3ZjQzNmJjN2I4MTcvdGFibGVyYW5nZTpiZTQ2ODBlMmNlNDI0NTA2YjVkZjdmNDM2YmM3YjgxN180LTYtMS0xLTU0Mzc4_12218d50-85d0-4b99-8e63-0cc45efcc460"
      unitRef="usd">355000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGV4dHJlZ2lvbjplYjIyODYxM2Y4MjM0ODY0OTQyNWI3MzFhOGRjYzkwYV8zMjk4NTM0ODg1MzM3_c1887770-e317-4803-9859-76e0024ad005">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the effect of our derivative financial instruments designated as hedging instruments in AOCI (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December&#160;31, 2021 (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Gain on cash flow hedges - interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unrealized gain recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;249&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amounts reclassified to interest expense (b)(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;106&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;268&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) No derivative instruments existed for the years ended December&#160;31, 2020 and December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(b) Positive amounts represented interest expense. Total interest expense as presented in the consolidated statement of operations for the years ended December&#160;31, 2021, 2020 and 2019 were $1.4 million, $1.3 million and $1.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(c) $0.1 million of expense is expected to be reclassified into earnings within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i3212a9cabfa9493096f98169ff09dde2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV8zLTItMS0xLTU0Mzc4_9db9a7aa-9d66-4dbd-8cd0-3bd1a17f0bdc"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i262ff830a2bd433899876342da3eb117_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV80LTItMS0xLTU0Mzc4_e38b0ac2-34a9-4911-aa84-d8802120c9e9"
      unitRef="usd">249000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i262ff830a2bd433899876342da3eb117_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV81LTItMS0xLTU0Mzc4_eaa2045b-9d44-4f4a-9049-507ca9a07cf8"
      unitRef="usd">-106000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i262ff830a2bd433899876342da3eb117_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV82LTItMS0xLTU0Mzc4_7a046de8-447e-4b09-bfae-84337a3f24f2"
      unitRef="usd">87000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity
      contextRef="i15476ca71552472d8a12c8939898580d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV83LTItMS0xLTU0Mzc4_b66f5f69-389c-4da6-89a6-f88ae7519342"
      unitRef="usd">268000</us-gaap:StockholdersEquity>
    <us-gaap:InterestExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV8xMC0wLTEtMS01NDM3OC90ZXh0cmVnaW9uOmM1Y2Y1ZWY0YTgxMzQ4MmQ4OTkwMmYxMTc1N2EyNWE2XzE2NA_248410dd-2ce0-4c30-9330-ee08a8af9c73"
      unitRef="usd">1400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV8xMC0wLTEtMS01NDM3OC90ZXh0cmVnaW9uOmM1Y2Y1ZWY0YTgxMzQ4MmQ4OTkwMmYxMTc1N2EyNWE2XzE3MQ_63e7034b-ecee-45cb-a461-65b89c64228c"
      unitRef="usd">1300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV8xMC0wLTEtMS01NDM3OC90ZXh0cmVnaW9uOmM1Y2Y1ZWY0YTgxMzQ4MmQ4OTkwMmYxMTc1N2EyNWE2XzE2NDkyNjc0NDE4NzU_256f67ef-ac39-4fdc-8f51-6b9d11c6bca4"
      unitRef="usd">1900000</us-gaap:InterestExpense>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i07f3da9e713d4c489ebdd0e68b443b18_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODI4L2ZyYWc6ZWIyMjg2MTNmODIzNDg2NDk0MjViNzMxYThkY2M5MGEvdGFibGU6MmMyYzM5YTg2MTlmNDdmZjk4YzhhMGI3ODIzN2Y5NGUvdGFibGVyYW5nZToyYzJjMzlhODYxOWY0N2ZmOThjOGEwYjc4MjM3Zjk0ZV8xMS0wLTEtMS01NDM3OC90ZXh0cmVnaW9uOmQ3ZGVmMjZkYmQ3NDQ0YTdhYjZhNzkzYzkyZmE2NzUyXzk_d2c1ac64-f747-4ed8-95df-c10b64505aef"
      unitRef="usd">-100000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwODE_9524b444-faad-4d8c-bbac-091ce1c6232c">Income Taxes&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s income before income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-U.S. income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s components of the consolidated benefit from (provision for) income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S Federal income tax benefit&#160;(expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. Federal income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total state and local income tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity related to the Company&#x2019;s valuation allowance (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance at the Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Release of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance at the End of Period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes a reconciliation of the Company&#x2019;s effective income tax rate to the U.S. federal statutory rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense at the statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the temporary differences and carryforwards that give rise to deferred tax assets and liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred Federal tax assets &#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred Federal tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred Federal tax liabilities &#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and asset basis differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred Federal tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred Federal tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred state and local tax assets (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) At December&#160;31, 2021 and 2020, this includes state and local net operating losses of $1.3 million and $1.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s U.S. federal net operating loss carryforward for tax purposes was $38.2 million at December&#160;31, 2021, resulting in a federal deferred tax asset of $8.0 million. Approximately $31.3 million of the Company&#x2019;s U.S. federal net operating loss carryforwards will begin to expire in various years beginning in 2029. $6.9 million of U.S. federal net operating loss carryforwards have an indefinite life. The Company&#x2019;s state net operating loss carryforward of approximately $1.3 million is comprised of various jurisdictions. These state net operating losses can be used for a period of 5 to 20 years and vary by state, and if unused, begin to expire in 2022, though a substantial portion expires beyond 2022. Approximately $0.1 million of the state net operating loss carryforwards have an indefinite life. Tax benefits of operating loss and tax credit carryforwards are evaluated on an ongoing basis, including a review of historical and projected future operating results, the eligible carryforward period, and other circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to monitor shifts in past ownership (as defined under Section 382 of the Code). The Company is subject to an annual limitation of $1.8 million on its use of remaining pre-ownership change net operating loss carryforwards of $4.5 million (and certain other pre-change tax attributes).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2020, it was determined that the valuation allowance against the U.S. federal and state deferred taxes was no longer required and the valuation allowance of $11.2 million that existed was released. The Company&#x2019;s realization of its deferred tax assets is dependent upon many factors, including, but not limited to, the Company&#x2019;s ability to generate sufficient taxable income. Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets. At December&#160;31, 2021 and 2020, cumulative income in recent years and projected future taxable income is the basis for the Company&#x2019;s assessment that the deferred tax assets do not require a valuation allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no uncertain tax positions for the years ended December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to taxation for Federal and various state jurisdictions in the United States and Canada. The Federal income tax returns of the Company for the years 2018 through 2021 are open to examination by the Internal Revenue Service. The Company was under audit with the Internal Revenue Service in relation to the Company&#x2019;s 2018 federal income tax return and the audit was closed on December&#160;15, 2021. The state income tax returns and other state tax filings of the Company &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;are subject to examination by the state taxing authorities, for various periods generally up to four years after they are filed. Canadian income tax returns of the Company for the years 2017 through 2021 are subject to examination by the Canada Revenue Agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the&#160;Coronavirus Aid, Relief, and Economic Security ("CARES") Act was enacted in response to the COVID-19 pandemic. The&#160;CARES Act among other things,&#160;allows employers to defer the deposit and payment of the employer's share of Social Security taxes. The Company, under the CARES Act, deferred paying $0.7 million of applicable gross payroll taxes as of December&#160;31, 2020, which was included in other liabilities. The $0.7 million balance of the deferred Social Security taxes was expected to be paid in two equal annual installments during the years ending December 31, 2021 and 2022, respectively. In December 2021, the Company made the first of these two equal annual installment payments. On April&#160;15, 2020, the Company received a $4.1 million loan under the Federal Paycheck Protection Program (&#x201c;PPP&#x201d;) created under the CARES Act. In response to revised eligibility guidelines announced by the U.S. Small Business Administration shortly thereafter, the Company repaid this loan in full on May 7, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwODI_68db86da-44af-4fc5-9380-d62dd0e9f23e">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s income before income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-U.S. income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzEtMS0xLTEtNTA2MjI_fa04d515-babf-43f8-9d77-025612edb5bb"
      unitRef="usd">1033000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzItMy0xLTEtNzU2MTY_1958b3e3-a0e0-41be-a5c2-030e05ccaac2"
      unitRef="usd">6623000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzEtMy0xLTEtNTA2MjI_e09f4b1f-c4a7-4d87-84fe-789af5bb252b"
      unitRef="usd">1413000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzItMS0xLTEtNTA2MjI_75b48040-7070-4044-8c7a-7c8a06cea866"
      unitRef="usd">224000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzMtMy0xLTEtNzU2MjE_4f5f5f2c-74af-4a0d-bc67-a1b7df443e5b"
      unitRef="usd">920000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzItMy0xLTEtNTA2MjI_8c778894-8f44-437b-863d-42fbf3d59e26"
      unitRef="usd">111000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzMtMS0xLTEtNTA2MjI_d8a7d098-722d-458e-8701-93020fa666d1"
      unitRef="usd">1257000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzQtMy0xLTEtNzU2MjE_fb36b8f2-402c-4642-b825-454fecdb6985"
      unitRef="usd">7543000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2MTM5NTdlM2FiYWI0MDY2YTI3MDI4ZGIzNDU5ZmU1OS90YWJsZXJhbmdlOjYxMzk1N2UzYWJhYjQwNjZhMjcwMjhkYjM0NTlmZTU5XzMtMy0xLTEtNTA2MjI_27be57fe-d019-4245-8db9-049ba5402467"
      unitRef="usd">1524000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwODM_9a87d772-91eb-42d7-b858-7773521ece18">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s components of the consolidated benefit from (provision for) income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S Federal income tax benefit&#160;(expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. Federal income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total state and local income tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzItMS0xLTEtNTA2MjI_9bf2bac8-c145-4bda-94ee-ff8342f14879"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzMtMy0xLTEtNzU2Mzk_0c8080f5-b3ed-49e5-968e-79470af334b4"
      unitRef="usd">11000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzItMy0xLTEtNTA2MjI_48598244-7c15-45df-bb21-b863df4d92fb"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzMtMS0xLTEtNTA2MjI_f96032f7-615e-4a7b-ad65-7de5f4fdecd9"
      unitRef="usd">-150000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzQtMy0xLTEtNzU2Mzk_a7686907-2ccd-4090-a238-55ca8626171b"
      unitRef="usd">-8346000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzMtMy0xLTEtNTA2MjI_5ee7f6cf-1d67-4702-a2bc-4519521cee75"
      unitRef="usd">104000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzQtMS0xLTEtNTA2MjI_8842f802-4f05-42f3-81fd-fd546f7bfdf4"
      unitRef="usd">-150000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzUtMy0xLTEtNzU2Mzk_dd27b296-a3e2-4f30-9026-277a3ef95860"
      unitRef="usd">-8335000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzQtMy0xLTEtNTA2MjI_f3289d1a-64fe-4e36-b248-2a8d29adec30"
      unitRef="usd">104000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzYtMS0xLTEtNTA2MjI_bdc170b3-d9b3-41e0-b4c7-cbf8a5b15158"
      unitRef="usd">167000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzctMy0xLTEtNzU2Mzk_e4178941-b667-4f25-94ec-db1bfe9737b3"
      unitRef="usd">66000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzYtMy0xLTEtNTA2MjI_b1d474d8-d5b7-46af-9f94-8ece2cd39a75"
      unitRef="usd">29000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzctMS0xLTEtNTA2MjI_f20a6dd3-3f43-40fa-8513-811fef9976c0"
      unitRef="usd">-3000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzgtMy0xLTEtNzU2Mzk_4e71b1f1-4292-489d-9958-016f22b80708"
      unitRef="usd">-1725000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzctMy0xLTEtNTA2MjI_e3ccf6aa-3d80-466a-be07-9ec070da1d03"
      unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzgtMS0xLTEtNTA2MjI_a9e8ce2b-9fed-4589-a1e8-f4053499ebd7"
      unitRef="usd">164000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzktMy0xLTEtNzU2Mzk_3f7d39bb-d4d3-467e-a98b-4f7254eb313c"
      unitRef="usd">-1659000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzgtMy0xLTEtNTA2MjI_490aeb35-b5c8-4177-aa82-5c8fa05a2e14"
      unitRef="usd">29000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzEwLTEtMS0xLTUwNjIy_68cbb4c8-71ae-4fa2-8fda-0b848088ce89"
      unitRef="usd">-177000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzExLTMtMS0xLTc1NjM5_236b1f2d-2137-45b7-bcf1-4ce58ddc235d"
      unitRef="usd">205000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzEwLTMtMS0xLTUwNjIy_5e1652eb-8ba3-4480-97ed-47d63a5221bb"
      unitRef="usd">30000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzExLTEtMS0xLTUwNjIy_aeb003f4-a1b7-4b21-9bc1-56bbfe226918"
      unitRef="usd">-163000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzEyLTMtMS0xLTc1NjM5_38b5a0f0-d99f-4303-8a13-55d52a4d83f2"
      unitRef="usd">-9789000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZToxMzhhOTAwNjg2MjA0NDhjYjk3ZWY4OGI4MDAxMWM5Mi90YWJsZXJhbmdlOjEzOGE5MDA2ODYyMDQ0OGNiOTdlZjg4YjgwMDExYzkyXzExLTMtMS0xLTUwNjIy_8a486ae6-d554-4289-bf6b-e2d7b07c19cf"
      unitRef="usd">163000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwODQ_3fd72bfe-f04d-4d88-88b1-026983cd4b94">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity related to the Company&#x2019;s valuation allowance (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance at the Beginning of Period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Release of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance at the End of Period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzEtMS0xLTEtNTA2MjI_fcfd42ee-30e0-4989-8907-7dfd7e51237e"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzItMy0xLTEtNzU3MjE_52c9722e-2034-403a-aaa8-4cccb92ca00d"
      unitRef="usd">11250000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i488a17cbb36b421597c4f159595f4b31_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzEtMy0xLTEtNTA2MjI_420176b4-fb66-4b31-b2f5-41066fd4b91b"
      unitRef="usd">11370000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <infu:DeferredTaxAssetsValuationAllowanceExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzItMS0xLTEtNTA2MjI_042f341f-8f5a-46bd-a2ce-878123d1196c"
      unitRef="usd">0</infu:DeferredTaxAssetsValuationAllowanceExpense>
    <infu:DeferredTaxAssetsValuationAllowanceExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzMtMy0xLTEtNzU3MjE_d7f4f197-e766-4396-95c8-278758c61834"
      unitRef="usd">0</infu:DeferredTaxAssetsValuationAllowanceExpense>
    <infu:DeferredTaxAssetsValuationAllowanceExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzItMy0xLTEtNTA2MjI_ab73ba97-9c96-4245-804c-6cb94df5885f"
      unitRef="usd">0</infu:DeferredTaxAssetsValuationAllowanceExpense>
    <infu:DeferredTaxAssetsValuationAllowanceIncrease
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzQtMS0xLTEtNzU3MTI_6cd5393e-4511-4564-b787-76db1380694c"
      unitRef="usd">0</infu:DeferredTaxAssetsValuationAllowanceIncrease>
    <infu:DeferredTaxAssetsValuationAllowanceIncrease
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzQtMy0xLTEtNzU3MjY_899563e8-c658-4808-9e23-dc4ca15eb204"
      unitRef="usd">0</infu:DeferredTaxAssetsValuationAllowanceIncrease>
    <infu:DeferredTaxAssetsValuationAllowanceIncrease
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzQtNS0xLTEtNzU4Mjc_18879b2a-5ec0-4127-9045-76e03a7a1715"
      unitRef="usd">0</infu:DeferredTaxAssetsValuationAllowanceIncrease>
    <infu:DeferredTaxAssetsValuationAllowanceRelease
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzMtMS0xLTEtNTA2MjI_9e7673c0-d0ae-43f2-b662-c85c2cd323e0"
      unitRef="usd">0</infu:DeferredTaxAssetsValuationAllowanceRelease>
    <infu:DeferredTaxAssetsValuationAllowanceRelease
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzUtMy0xLTEtNzU3MjE_d6a5381f-f156-48c4-9d7b-d496eb0e27cc"
      unitRef="usd">11250000</infu:DeferredTaxAssetsValuationAllowanceRelease>
    <infu:DeferredTaxAssetsValuationAllowanceRelease
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzMtMy0xLTEtNTA2MjI_f3b283d7-1099-4e8d-ab7c-e8f680b9f633"
      unitRef="usd">120000</infu:DeferredTaxAssetsValuationAllowanceRelease>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzQtMS0xLTEtNTA2MjI_c14582d1-6285-479a-819e-86790e87da70"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzYtMy0xLTEtNzU3MjE_8d007ecc-b87c-4b12-8b09-637f4c4a5971"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTpkZDFiOTE1M2FjM2M0Yzc2YTZlODI3Y2QyYmFlNDI3NS90YWJsZXJhbmdlOmRkMWI5MTUzYWMzYzRjNzZhNmU4MjdjZDJiYWU0Mjc1XzQtMy0xLTEtNTA2MjI_5e7a28d6-7aeb-4a44-aefe-f4565461c1e5"
      unitRef="usd">11250000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwNzk_8ca04d20-0fc8-4178-9a01-bf42db737f3f">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes a reconciliation of the Company&#x2019;s effective income tax rate to the U.S. federal statutory rate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense at the statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzEtMS0xLTEtNTA2MjI_e90aa149-6e49-4e18-9100-f45002e006ad"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzItMy0xLTEtNzU4NTA_79295ec4-3091-41ff-aa3e-5c836c6ebcf2"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzEtMy0xLTEtNTA2MjI_0849c139-6fb9-4882-ab8e-75a67cffed0b"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzItMS0xLTEtNTA2MjI_3eeae136-97c0-46ce-bccd-1dc27871da32"
      unitRef="number">0.103</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzMtMy0xLTEtNzU4NTA_fb9ac512-f55d-45c8-b12c-d74aafa937b7"
      unitRef="number">0.051</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzItMy0xLTEtNTA2MjI_f595a02f-4f6d-43a1-bac9-2c4c89a93b00"
      unitRef="number">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzMtMS0xLTEtNTA2MjI_1ae7a701-64d5-4e4c-9953-0ac351db7427"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzQtMy0xLTEtNzU4NTA_4069ac4d-a86c-465d-9a96-51f6fc35b6fa"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzMtMy0xLTEtNTA2MjI_6752f2c4-741e-4683-bdf4-dd90b6744c36"
      unitRef="number">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <infu:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzQtMS0xLTEtNTA2MjI_58f60e21-8014-449a-9332-ae0f6685a7ea"
      unitRef="number">-0.367</infu:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <infu:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzUtMy0xLTEtNzU4NTA_068cf96b-ad90-43ae-b7b1-1b526db80e42"
      unitRef="number">-0.084</infu:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <infu:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzQtMy0xLTEtNTA2MjI_2edeaf5b-1888-4f5c-8dc9-e2849002144f"
      unitRef="number">-0.058</infu:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzUtMS0xLTEtNTA2MjI_1d36594b-fb0c-45b8-85e0-7d0382d5aa0b"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzYtMy0xLTEtNzU4NTA_2d8586ff-75e2-42f9-98cf-22dd2cf4265a"
      unitRef="number">-1.492</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzUtMy0xLTEtNTA2MjI_390d737f-3987-4734-91d0-15102a02e2fd"
      unitRef="number">-0.079</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzYtMS0xLTEtNTA2MjI_bc10a94d-6b75-459a-bc27-5428ab716f73"
      unitRef="number">-0.085</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzctMy0xLTEtNzU4NTA_97135bc3-8fd2-4e3f-8f5c-9e2500612901"
      unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzYtMy0xLTEtNTA2MjI_ef14cf06-8e86-4f60-bc02-fcc1e38fd21a"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzctMS0xLTEtNTA2MjI_501de19e-32a7-401f-8f15-55a8b2fd9a2e"
      unitRef="number">-0.129</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzgtMy0xLTEtNzU4NTA_ce9ef043-7c89-4922-a713-f973de130f25"
      unitRef="number">-1.298</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo2ZmU1MTg5OTZhYjc0Y2EwYjZkMGU0OTY0ODQ0N2FmZS90YWJsZXJhbmdlOjZmZTUxODk5NmFiNzRjYTBiNmQwZTQ5NjQ4NDQ3YWZlXzctMy0xLTEtNTA2MjI_66b1fb45-daff-4be7-8ad0-f85b92244f02"
      unitRef="number">0.107</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzUwODA_0c477615-f797-4d4a-ad4e-e309930760e7">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the temporary differences and carryforwards that give rise to deferred tax assets and liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred Federal tax assets &#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred Federal tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred Federal tax liabilities &#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and asset basis differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred Federal tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred Federal tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred state and local tax assets (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) At December&#160;31, 2021 and 2020, this includes state and local net operating losses of $1.3 million and $1.2 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzItMS0xLTEtNTA2MjI_0954d888-b566-45fc-b35b-00c9ea27a5d6"
      unitRef="usd">1576000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzItMy0xLTEtNTA2MjI_639ba675-103c-4afb-9796-619429796e7e"
      unitRef="usd">1570000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzMtMS0xLTEtNTA2MjI_83fb4b56-6248-489e-8cc8-28951d7cb0e8"
      unitRef="usd">1350000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzMtMy0xLTEtNTA2MjI_9ed90dcc-3aeb-49d5-96d9-b764123d7df1"
      unitRef="usd">656000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzQtMS0xLTEtNTA2MjI_61d539c4-5f2b-48f1-9a80-3a988a4f071c"
      unitRef="usd">8022000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzQtMy0xLTEtNTA2MjI_c5df9217-3e4a-454a-8294-70f9013c2fc0"
      unitRef="usd">7337000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <infu:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzUtMS0xLTEtNTA2MjI_5774628f-70e5-4305-bc0d-8822ec5f54ad"
      unitRef="usd">980000</infu:DeferredTaxAssetsOperatingLeaseLiabilities>
    <infu:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzUtMy0xLTEtNTA2MjI_da429433-0992-448d-9320-bbb74dda8e53"
      unitRef="usd">1014000</infu:DeferredTaxAssetsOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzYtMS0xLTEtNTA2MjI_717101f1-1e8c-442b-ba18-60114786523a"
      unitRef="usd">253000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzYtMy0xLTEtNTA2MjI_8b46c68b-3245-436f-b260-c6fc78909e5f"
      unitRef="usd">757000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzctMS0xLTEtNTA2MjI_d7ff6d52-48bc-42c1-b602-35affae6fd0e"
      unitRef="usd">246000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzctMy0xLTEtNTA2MjI_f8919848-640f-47ed-b9ad-c2327c33d8b8"
      unitRef="usd">214000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzgtMS0xLTEtNTA2MjI_9f87538d-cfe4-4491-b643-4c0cc7636f47"
      unitRef="usd">21000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzgtMy0xLTEtNTA2MjI_319d3673-9327-4b6a-bbd3-582d4581ad4e"
      unitRef="usd">832000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzktMS0xLTEtNTA2MjI_d51e403f-980e-4945-a70b-042bd5d0dac5"
      unitRef="usd">533000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzktMy0xLTEtNTA2MjI_cc1a4bb5-8b05-4171-86a7-154af7400e3d"
      unitRef="usd">533000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzEwLTEtMS0xLTUwNjIy_5de7b75f-c09f-414a-b226-db0b481eb879"
      unitRef="usd">62000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzEwLTMtMS0xLTUwNjIy_ae0bd824-1e4b-4c33-8eb6-bdd7e3104e04"
      unitRef="usd">30000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzExLTEtMS0xLTUwNjIy_15273c46-3210-4e89-adf3-e7a82d650ba7"
      unitRef="usd">89000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzExLTMtMS0xLTUwNjIy_08c78fe3-7942-455b-b5a7-8b9cca432873"
      unitRef="usd">54000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzEyLTEtMS0xLTUwNjIy_63c572ea-aba8-4303-a716-1532d0626e60"
      unitRef="usd">13132000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzEyLTMtMS0xLTUwNjIy_03500a12-5d61-40b5-96b2-4a8a8c0a0d66"
      unitRef="usd">12997000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE2LTEtMS0xLTUwNjIy_048b0067-c1ce-4e75-afe5-db0e31085257"
      unitRef="usd">3423000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE2LTMtMS0xLTUwNjIy_d609f66d-ec0a-4948-8c27-1f08891dc9df"
      unitRef="usd">3393000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <infu:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE3LTEtMS0xLTUwNjIy_4fb63502-226e-476b-b2b7-6a0941a29ffe"
      unitRef="usd">891000</infu:DeferredTaxLiabilitiesRightOfUseAssets>
    <infu:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE3LTMtMS0xLTUwNjIy_c73211b8-fc66-4ecb-b04b-486d6945d5d7"
      unitRef="usd">937000</infu:DeferredTaxLiabilitiesRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE4LTEtMS0xLTc3OTk3_58cf4706-173c-4389-8a5f-2ef03547c497"
      unitRef="usd">88000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE4LTMtMS0xLTc4MDA2_2143a368-2f03-4bb8-b3b4-425bd22eb448"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE4LTEtMS0xLTUwNjIy_30071222-74b0-468c-b560-f11d17d8b133"
      unitRef="usd">4402000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE4LTMtMS0xLTUwNjIy_9bc016ba-03c8-4167-accd-a431bb98ebe5"
      unitRef="usd">4330000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE5LTEtMS0xLTUwNjIy_7a891d90-6812-4921-95f8-e67ceac0bd42"
      unitRef="usd">8730000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i055937925234444eb13527b2e0cb4ae9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzE5LTMtMS0xLTUwNjIy_1c550172-3585-446c-99b1-36906b013d2b"
      unitRef="usd">8667000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ibf34a521c00b474b8c705fb5db98af8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzIwLTEtMS0xLTUwNjIy_659c57a5-3b45-4924-8767-0549c983c9fb"
      unitRef="usd">1303000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ice5d9a455230467faf56b669a8015a3e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzIwLTMtMS0xLTUwNjIy_a8590ff0-a210-4165-b197-6ec346b28f56"
      unitRef="usd">1300000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzIzLTEtMS0xLTUwNjIy_114166eb-ca6b-4dd7-ba41-1a5a8e40fd7a"
      unitRef="usd">10033000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90YWJsZTo0MmQ0NDUzMjdhZGQ0MWU2OGViYzc1YzJjYzJiNWM1OC90YWJsZXJhbmdlOjQyZDQ0NTMyN2FkZDQxZTY4ZWJjNzVjMmNjMmI1YzU4XzIzLTMtMS0xLTUwNjIy_9231a49d-06d7-4a5f-ac39-a54b4a273ee4"
      unitRef="usd">9967000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ibf34a521c00b474b8c705fb5db98af8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzc5Nw_adda0269-4566-48f7-a657-d745ea20430f"
      unitRef="usd">1300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ice5d9a455230467faf56b669a8015a3e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzgwNA_f51e51fe-f136-4417-8e2e-c59a187e4b1f"
      unitRef="usd">1200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzkwMg_22663f5f-b2e9-4166-a383-4c61b81598d3"
      unitRef="usd">38200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzk1Nw_72e862aa-f32d-4c37-9991-c52bc2646dd6"
      unitRef="usd">8000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <infu:OperatingLossCarryforwardsWithADefiniteLife
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzk3NQ_df4453ae-de24-4868-8d14-e7824d78a667"
      unitRef="usd">31300000</infu:OperatingLossCarryforwardsWithADefiniteLife>
    <infu:OperatingLossCarryforwardsWithIndefiniteLife
      contextRef="ideeb6ace10874638aa6f3b1683d9f2fa_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzEwOTg_2664e57e-9e93-4b5c-be59-e9ea66506760"
      unitRef="usd">6900000</infu:OperatingLossCarryforwardsWithIndefiniteLife>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ibf34a521c00b474b8c705fb5db98af8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzEyNDQ_50c3c643-e04f-4f31-a7c4-06e79e6130e9"
      unitRef="usd">1300000</us-gaap:OperatingLossCarryforwards>
    <infu:OperatingLossCarryforwardsExpirationPeriods
      contextRef="ib0c7b74dd3b642bd83f8f8f69155e38a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzEzNDc_31a9ea0c-2750-4758-b695-44a6c7ab1ac4">P5Y</infu:OperatingLossCarryforwardsExpirationPeriods>
    <infu:OperatingLossCarryforwardsExpirationPeriods
      contextRef="i856c610b2fe549e0b8bc1e612a43b96c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzEzNTM_cfc51c7b-7f09-43fe-b4f8-04dcb0646cf2">P20Y</infu:OperatingLossCarryforwardsExpirationPeriods>
    <infu:OperatingLossCarryforwardsWithADefiniteLife
      contextRef="ibf34a521c00b474b8c705fb5db98af8d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzE0Nzk_aa4afd67-75d3-4b96-b807-bfd0cf00e85f"
      unitRef="usd">100000</infu:OperatingLossCarryforwardsWithADefiniteLife>
    <infu:NetOperatingLossCarryforwardsLimitationOnUse
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzIxMTA_6eec4ea7-7bff-4c60-b1f3-7736464199b6"
      unitRef="usd">1800000</infu:NetOperatingLossCarryforwardsLimitationOnUse>
    <infu:RemainingPreownershipNetOperatingLossCarryforwards
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzIxOTQ_89faa46d-6d3d-4968-bed3-175dc623c272"
      unitRef="usd">4500000</infu:RemainingPreownershipNetOperatingLossCarryforwards>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="if64f71b0d53e48e3a2c1aa091fd31365_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzI0MTg_b86272d9-a224-495f-8bfd-7d66c4067c78"
      unitRef="usd">-11200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzMwMDA_bfc53e00-f168-4f19-a007-a980faa2ca44"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzMwMDA_ee10e418-fc4e-493d-878d-aeb61af864b6"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent
      contextRef="i439fd912ad054d238616616e9babc7fe_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzQ1Mjc_20f1bd4c-2679-4013-8795-a32a69603e6a"
      unitRef="usd">700000</us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent>
    <us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent
      contextRef="idfedd81ba6944a6985fc391bcc412d7d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzYwNDczMTM5NTgxNTc_cd80ffc1-e546-4386-acae-16babe9dd3d9"
      unitRef="usd">700000</us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i2150414dae3f42f68c21d9adaf756de4_D20200415-20200415"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xMzYvZnJhZzpkOTQzNmRjYjg2NmY0ZTk2OGJjNjQyNmFjZjIwOTkyZS90ZXh0cmVnaW9uOmQ5NDM2ZGNiODY2ZjRlOTY4YmM2NDI2YWNmMjA5OTJlXzQ4MTk_32a775b8-aa1b-449f-ba2c-a5522b994bf3"
      unitRef="usd">4100000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNDIvZnJhZzphODBjYWE3ZWRlZGE0ODcwYjYxMDI0MmVhMmUxMTcwYy90ZXh0cmVnaW9uOmE4MGNhYTdlZGVkYTQ4NzBiNjEwMjQyZWEyZTExNzBjXzEzMjU_54f00b79-9b73-468d-bb3e-e490ae47c787">Commitments and Contingencies&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time in the ordinary course of its business, the Company may be involved in legal and regulatory proceedings, the outcomes of which may not be determinable. The results of litigation and regulatory proceedings are inherently unpredictable. Any claims against the Company, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. The Company is not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable, primarily for the following reasons: (i) many of the relevant legal proceedings are in preliminary stages, and until such proceedings develop further, there is often uncertainty regarding the relevant facts and circumstances at issue and potential liability; and (ii) many of these proceedings involve matters of which the outcomes are inherently difficult to predict. The Company has insurance policies covering potential losses where such coverage is cost effective.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not at this time involved in any proceedings that the Company believes could have a material effect on the Company&#x2019;s financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8zMjk4NTM0ODg0NTg5_866365c6-6f29-4b24-a20c-b703f767a9a6">Leases&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has historically entered into a number of lease agreements under which the Company is the lessee for equipment and office leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company&#x2019;s operating lease costs consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs for the year ended December&#160;31, 2021 of approximately $1.5 million and $0.1 million, were recorded to G&amp;amp;A expenses and cost of revenues, respectively. Lease costs for the year ended December&#160;31, 2020 of approximately $1.3 million and $0.6 million, were recorded to G&amp;amp;A expenses and cost of revenues, respectively. Lease costs for the year ended December&#160;31, 2019 of approximately $1.2 million and $1.0 million, were recorded to G&amp;amp;A expenses and cost of revenues, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information and non-cash activity related to the Company&#x2019;s leases are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities and ROU assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flow from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reductions to ROU assets resulting from reductions to lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease terms and discount rates for the Company&#x2019;s operating leases are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future maturities of lease liabilities as of December&#160;31, 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The long-term portion of the lease liabilities included in the amounts above is $3.7 million with the remainder included in other current liabilities in the Consolidated Balance Sheet.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8zMjk4NTM0ODg0NzIz_d6fa1705-6d28-4b10-9207-55d5f19a9791">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company&#x2019;s operating lease costs consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information and non-cash activity related to the Company&#x2019;s leases are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities and ROU assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flow from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reductions to ROU assets resulting from reductions to lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease terms and discount rates for the Company&#x2019;s operating leases are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8yLTItMS0xLTU1MDk0_30516491-a31a-4e4d-a0c9-dedd272a0233"
      unitRef="usd">1316000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8yLTQtMS0xLTU1MDk0_43f99280-192f-445f-95b2-70a9a6c12bfb"
      unitRef="usd">1617000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8yLTYtMS0xLTU1MTEx_8800990a-2f87-4fe7-a619-f5bd9a8f576c"
      unitRef="usd">1948000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8zLTItMS0xLTU1MDk0_676523e6-4c60-4055-907f-4d73a3336394"
      unitRef="usd">243000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8zLTQtMS0xLTU1MDk0_2a84b0bf-1631-4966-819e-1d73113ec283"
      unitRef="usd">315000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl8zLTYtMS0xLTU1MTEx_21ba8e56-ce2a-47c3-93da-90856bed7bf4"
      unitRef="usd">291000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl80LTItMS0xLTU1MDk0_8ab8abab-8e31-4f3e-9711-7fb647d80d5e"
      unitRef="usd">1559000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl80LTQtMS0xLTU1MDk0_15500f69-a35b-497d-8642-fd3aa44105e3"
      unitRef="usd">1932000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6YjJjNDk5MTZjNWNjNDllNzlhNzY2ODQ0YzYzYzhlYzYvdGFibGVyYW5nZTpiMmM0OTkxNmM1Y2M0OWU3OWE3NjY4NDRjNjNjOGVjNl80LTYtMS0xLTU1MTEx_e05f6a59-59b4-4a22-979a-aebb83468af8"
      unitRef="usd">2239000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="if05acd9bb129444c859314fc90a675b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8zODA_670bb305-e7e5-490d-b6ce-60349f9c81af"
      unitRef="usd">1500000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i7eb9d27f65dd4491a35f0b273d413655_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8zODc_c4e0dd71-bc8b-4f47-9188-d4ecce5d1725"
      unitRef="usd">100000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ie0c917cfe5e042599ce26f2256dff1ae_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl81MDg_d520e842-a89f-48fb-b66e-41cd7c2f8d8f"
      unitRef="usd">1300000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ib2b9762869f5424c88544abd7900c8d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl81MTU_f8677ba2-a1ad-45b2-a1f2-08ff00ac8969"
      unitRef="usd">600000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i5c5b6e5d34b445c1b9f13378f83a9a8b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8xNjQ5MjY3NDQyODg1_a4dff78c-ecfe-4a11-b160-6ca76eb5a414"
      unitRef="usd">1200000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ia8ac411300664a70b0331e7b8a64e151_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8xNjQ5MjY3NDQyODkx_7f7402e1-8510-49c2-9d1f-01419164e5a4"
      unitRef="usd">1000000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF8zLTItMS0xLTU1MDk0_cda39ae6-bc26-4dc9-b384-adde9def1c1a"
      unitRef="usd">1271000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF8zLTQtMS0xLTU1MDk0_510ba883-937e-4a0b-9842-d4fe087f9388"
      unitRef="usd">1603000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF8zLTYtMS0xLTU1MjI4_3dfab787-375f-4718-a20a-2b286e0ed2de"
      unitRef="usd">1610000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF82LTItMS0xLTU1MDk0_619e861b-b507-4982-9ca8-e45f0adb5072"
      unitRef="usd">926000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF82LTQtMS0xLTU1MDk0_3a437f29-a8d8-4cde-9c10-faac7cb3892d"
      unitRef="usd">264000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF82LTYtMS0xLTU1MjM1_27ec2068-8936-40f8-ab8f-89ab7c0281e2"
      unitRef="usd">4545000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <infu:ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF85LTItMS0xLTU1MDk0_14538a6f-1624-41e9-bb80-5da6104e5f4c"
      unitRef="usd">0</infu:ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations>
    <infu:ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF85LTQtMS0xLTU1MDk0_951544c3-f8ae-42f7-92d8-9df82ea036e6"
      unitRef="usd">0</infu:ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations>
    <infu:ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6OGRmNmE2YjIwZDM3NDhiMGI1YWU3ZGNiZWVkOWJiNzgvdGFibGVyYW5nZTo4ZGY2YTZiMjBkMzc0OGIwYjVhZTdkY2JlZWQ5YmI3OF85LTYtMS0xLTU1MjQy_1132d890-08e8-4cdb-ab7e-375a8f660952"
      unitRef="usd">22000</infu:ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6N2NmZWI1NDg1MGJhNGFmZmE2NzA2NWEyZTcwNjVmZGEvdGFibGVyYW5nZTo3Y2ZlYjU0ODUwYmE0YWZmYTY3MDY1YTJlNzA2NWZkYV8yLTItMS0xLTU1MDk0_51a99b60-3708-4e35-989f-94ab9b4986af">P6Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6N2NmZWI1NDg1MGJhNGFmZmE2NzA2NWEyZTcwNjVmZGEvdGFibGVyYW5nZTo3Y2ZlYjU0ODUwYmE0YWZmYTY3MDY1YTJlNzA2NWZkYV8yLTQtMS0xLTU1MDk0_0ad9992c-9b57-450d-89b7-8e98c216315b">P7Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6N2NmZWI1NDg1MGJhNGFmZmE2NzA2NWEyZTcwNjVmZGEvdGFibGVyYW5nZTo3Y2ZlYjU0ODUwYmE0YWZmYTY3MDY1YTJlNzA2NWZkYV80LTItMS0xLTU1MDk0_62a3960b-1a15-4276-bc77-81b290ac0d3c"
      unitRef="number">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6N2NmZWI1NDg1MGJhNGFmZmE2NzA2NWEyZTcwNjVmZGEvdGFibGVyYW5nZTo3Y2ZlYjU0ODUwYmE0YWZmYTY3MDY1YTJlNzA2NWZkYV80LTQtMS0xLTU1MDk0_6b27670c-b8ad-4ce0-81f3-d124317d8f15"
      unitRef="number">0.078</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl8zMjk4NTM0ODg0NTkz_a75043bb-26e6-4d35-902f-a2bb15a5df65">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future maturities of lease liabilities as of December&#160;31, 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.673%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl8xLTItMS0xLTU1MDk0_9fe75f7c-7839-4b75-ac0c-045c063ef653"
      unitRef="usd">1224000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl8yLTItMS0xLTU1MDk0_92c1db47-ae5c-420d-8170-8e7f9058b24f"
      unitRef="usd">1065000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl8zLTItMS0xLTU1MDk0_6638ed4f-7855-4416-826e-0833dcb91349"
      unitRef="usd">1060000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl80LTItMS0xLTU1MDk0_70fcd45d-49b4-4268-b6e5-9e2c2c05c557"
      unitRef="usd">1029000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl81LTItMS0xLTU1MDk0_dcadfe7e-021b-4929-ad3b-fe8924d6355f"
      unitRef="usd">941000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl82LTItMS0xLTU1MDk0_50390b7a-7a50-47c3-b3b0-fdae62650ce6"
      unitRef="usd">1783000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl83LTItMS0xLTU1MDk0_d088066f-34da-4828-ab69-171b3e83b949"
      unitRef="usd">7102000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl84LTItMS0xLTU1MDk0_be12c1eb-c6b1-4afc-97af-d45fc984ba4e"
      unitRef="usd">2434000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGFibGU6MzFhNjZmM2IwYmVhNGE3Mjk1ZGEwNTljNTI0ZDYzOTYvdGFibGVyYW5nZTozMWE2NmYzYjBiZWE0YTcyOTVkYTA1OWM1MjRkNjM5Nl85LTItMS0xLTU1MDk0_e78bad23-ba9f-4879-b76d-0a85732fcd92"
      unitRef="usd">4668000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODQyL2ZyYWc6NTI2NDRmNDFiMTIyNGY1Zjk4NDk3Mzg1ZjhjMGM2YjYvdGV4dHJlZ2lvbjo1MjY0NGY0MWIxMjI0ZjVmOTg0OTczODVmOGMwYzZiNl85ODc_e8dfcab7-8667-40a4-a294-b02bfc939e77"
      unitRef="usd">3700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV80OTQ3ODAyMzQ2Mjk0_f90b2af8-b5ac-4b5f-8cd1-6c712fcfdc0b">Share-based Compensation&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various stock option and stock-based incentive plans and agreements whereby equity based awards are granted to certain employees, directors and others approved by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) or Compensation Committee. Grants may be made in the form of stock options, restricted stock awards ("RSUs" or "RSAs"), performance-based restricted stock units ("PSU's), unrestricted common stock, stock appreciation rights (&#x201c;SARs&#x201d;) in addition to other award types. Stock options are granted with an exercise price at, or above, fair market value on the date of grant, generally expire in 5 to 10 years from the grant date and generally become exercisable over a period of up to 3 years. RSUs generally become vested over a period of up to 3 years. PSUs generally become vested over a period of up to 3 years based on the performance of a specific achievement. Awards typically vest and are issued only if the participants remain employed by the Company through the vesting date. Common stock issued under these awards are issued from shares reserved under the Company&#x2019;s plan described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 18, 2021, the Company&#x2019;s Board adopted the 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;). The 2021 Plan was approved by the Company&#x2019;s shareholders at the 2021 Annual Meeting on May 18, 2021 and became effective at that time. The 2021 plan supersedes the 2014 Amended and Restated Stock Incentive Plan (the "2014 Plan"). The 2021 Plan provided for the issuance of a maximum of 2,500,000 shares of common stock in connection with the grant of stock-based or stock-denominated awards. As of December&#160;31, 2021, a total of 1,766,769 common shares remained available for future grant under the 2021 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2014, the Company&#x2019;s Board adopted the 2014 Plan. The 2014 Plan was approved by the Company&#x2019;s shareholders at the 2014 Annual Meeting and became effective as of the date it was adopted by the Board of Directors. The 2014 Plan provided for the issuance of a maximum of 2,000,000 shares of common stock in connection with the grant of stock-based or stock-denominated awards. On July 19, 2018, the Company&#x2019;s stockholders approved the reservation of an additional 1,000,000 shares to be issued under the 2014 Plan. On May 15, 2019, the Company&#x2019;s stockholders approved the reservation of an additional 1,000,000 shares to be issued under the 2014 Plan. The 2021 Plan replaces and supersedes the 2014 Plan, so as of the adoption date of the 2021 Plan, no common shares remained available for future grant under the 2014 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All stock option awards are amortized based on their graded vesting over the requisite service period of the awards. Compensation costs are recognized over the requisite service period using the accelerated method and included in general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total stock-based compensation expense, which is included in selling, general and administrative expenses (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted share expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock option and SARs expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit related to stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shares Forgone to Satisfy Minimum Statutory Withholdings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2021, 2020 and 2019, shares of common stock were issued to employees and directors as their restricted stock awards vested or stock options were exercised. Under the terms of the Company&#x2019;s stock plans, at the election of each employee, the Company can authorize a net settlement of distributable shares to employees in order to satisfy an individual employees' tax withholding obligations. For the years ended December&#160;31, 2021, 2020 and 2019, the Company received 57,067 shares, 146,763 shares and 121,607 shares, respectively, from employees for tax withholding obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock awards entitle the holder to receive, upon meeting certain time-based vesting criteria, a specified number of shares of the Company&#x2019;s common stock. Stock-based compensation cost of restricted stock awards is measured by the market value of the Company&#x2019;s common stock on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s restricted share activity, excluding the Company&#x2019;s employee stock purchase plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;grant&lt;br/&gt;date fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested shares forgone to satisfy minimum statutory withholding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of awards granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares forgone to satisfy minimum statutory withholding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, there was $2.9 million of pre-tax total unrecognized compensation cost related to non-vested restricted stock awards, which will be adjusted for future forfeitures, if any. The Company expects to recognize such cost over a weighted average period of two years&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance-Based Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, the Company granted approximately 127,476 PSUs. During the year ended December&#160;31, 2020, the Company granted approximately 232,500 PSUs. PSUs entitle the holder to receive, upon meeting certain performance-based vesting criteria, a specified number of shares of the Company&#x2019;s common stock. These awards typically vest after the Company&#x2019;s achievement of either a Company-based performance metric, such as the achievement of a certain amount of net revenue during a specified period, coupled with a time-based vesting criteria or based on a market based metric of the Company&#x2019;s stock, such as when the trading price reaches a target value for a minimum number of consecutive trading days. All of the PSUs granted in 2021 are earned based on specified Company-based performance measure conditions. Approximately three-fourths of the PSUs granted in 2020 are earned based on the market-based metric, while the other one-fourth are earned based on specified Company-based performance metric conditions. In the case of the market-based metric, awards are paid in stock immediately upon achievement of the performance condition or expire without any payment after the third anniversary of the grant date. In the case of the specified Company-based performance measure, awards can be earned at an amount that varies by award between 93% to 100% of the target number of shares for achieving a minimum threshold below the target or up to 200% of the target number of shares for exceeding the target, with a linear adjustment between threshold and target or between target and stretch performance goals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s PSU activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;grant &lt;br/&gt;date fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested shares forgone to satisfy minimum statutory withholding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of awards granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,335,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares forgone to satisfy minimum statutory withholding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, there was $1.2 million of pre-tax total unrecognized compensation cost related to non-vested PSUs, which will be adjusted for future forfeitures and changes to management&#x2019;s expectations of the probable outcomes of the performance conditions, if any. The Company expects to recognize such cost over a weighted average period of 1 year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2014, the Company received approval from stockholders to adopt an employee stock purchase plan ("ESPP") effective October 2014 (collectively the &#x201c;Original ESPP&#x201d;). Under the Original ESPP, 200,000 shares of common stock were authorized for purchase by eligible employees at a 15% discount through payroll deductions during the six-month offering periods. Shares were purchased in whole numbers and generally would be the last day of the offering period. In September 2016, the Company received approval from shareholders for an additional 350,000 shares. No employee may purchase more than $25,000 worth of fair market value shares in any calendar year. As allowed under the ESPP, a participant may elect to withdraw from the plan, effective for the purchase period in progress at the time of the election with all accumulated payroll deductions returned to the participant at the time of withdrawal. As of December&#160;31, 2021, there were 156,052 shares remaining available for future issuance. The following table summarizes the activity relating to the Company&#x2019;s ESPP program:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of stock sold to employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value per ESPP award&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company calculates the fair value of stock option awards using the Black-Scholes option pricing model, which incorporates various assumptions including volatility, expected term, risk-free interest rates and dividend yields. The expected volatility assumption is based on historical volatility of the Company&#x2019;s common stock over the most recent period commensurate with the expected life of the stock option granted. The Company uses historical volatility because management believes such volatility is representative of prospective trends. The risk-free interest rate assumption is based upon observed interest rates appropriate for the expected life of the stock option awarded. The Company uses historical exercise data to determine the expected lives. Dividend yields have not been a factor in determining fair value of stock options granted as the Company has never issued cash dividends and does not anticipate issuing cash dividends in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables detail the various stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2014 Plan (Options)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of Authorized&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,449,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised shares forgone to satisfy minimum statutory withholding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cashless exercise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,051,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.36&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,274,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 Plan (Options)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of Authorized&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Aggregate Intrinsic Value - no options were in-the-money as of December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the average fair value per share estimated on the date of grant and the assumptions used for options granted:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock Options:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43% to 46%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42% to 51%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36% to 38%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.31% to 0.54%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.20% to 1.56%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.80% to 2.36%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected lives at date of grant (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.63&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$6.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.61&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intrinsic value of options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,248,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,377,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2021, the Company's Board of Directors approved a stock repurchase program (the &#x201c;Share Repurchase Program&#x201d;) authorizing the Company to repurchase up to $20.0 million of the Company&#x2019;s outstanding common stock through June 30, 2024. The Share Repurchase Program will be subject to market conditions, the periodic capital needs of the Company&#x2019;s operating activities, and the continued satisfaction of all covenants under the Company&#x2019;s existing 2021 Credit Agreement. Repurchases under the program may take place in the open market or in privately negotiated transactions and may be made under a Rule 10b5-1 plan. The Share Repurchase program does not obligate the Company to repurchase shares and may be suspended, terminated, or modified at any time. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had repurchased approximately $0.6 million, or 33,469 shares, of the Company's outstanding common stock under the Share Repurchase Program.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i3aecccce92b14a9c9084a4f31af83e6c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQxOTYx_d9039ca9-1269-4dfa-b81b-afb83ab64e98">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i450379ae7a724e1eb2a0f5753d483e22_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQxOTY4_48b56d2f-2c0b-45fa-b7c4-98995ba601e3">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7e697973a46d4d5d9d02a7da49fa4e3b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQyMTEy_beb75152-75cd-4368-9ec8-4cb94b6cacf1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1562a53301a84c6f86d2e5026a162d32_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ5MDI3_feb80639-f916-48d4-af79-2bc24e18330e">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="icbca7ff14ebb4795b34515b88d7092ba_D20210518-20210518"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ0ODM3_2c9c1eb9-5631-42df-b3a7-c6358fa70782"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i2b64b934b737430092de595691e27b69_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ0MzA1_b0cfc2a2-e2bf-495c-9bb4-e406df8f0598"
      unitRef="shares">1766769</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i0b2880103789464c83dd09c03f90e4c9_I20140423"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQzMDEw_e41724d5-39a3-414a-975a-98018100d04d"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i3ee8e04870e34b48a26a7940cc7e9b5c_D20180719-20180719"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQzMTg3_701b7060-1e73-4aeb-98c0-ea022562f9f8"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i85e14e2aedee40cd9f3d83472a6a4224_D20190515-20190515"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQzMzA5_9c23e72a-b39d-41e5-b801-21c9b2de7f35"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zMjk4NTM0OTA0NjQ3_286cea86-86a5-4ada-a7b9-3be58b0e9374">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total stock-based compensation expense, which is included in selling, general and administrative expenses (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted share expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock option and SARs expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit related to stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:RestrictedStockExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8xLTItMS0xLTU1ODgw_ecccd673-8d42-4599-bd86-96d10393819c"
      unitRef="usd">4491000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8xLTQtMS0xLTU1ODgw_4c20d863-e47a-4217-8b13-2ebd810d3314"
      unitRef="usd">1687000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8yLTYtMS0xLTY2MzQx_05d87bb5-4489-46c1-91df-68d3fcd409d0"
      unitRef="usd">190000</us-gaap:RestrictedStockExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8yLTItMS0xLTU1ODgw_dad242ca-b6c9-482a-b0b7-210b200e1256"
      unitRef="usd">1913000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8yLTQtMS0xLTU1ODgw_82e92c8a-4a2f-4d25-b0c3-64d1f68a2ad6"
      unitRef="usd">923000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8zLTYtMS0xLTY2MzQx_71adf704-5a0e-4d79-89dc-63d501e86e28"
      unitRef="usd">807000</us-gaap:StockOptionPlanExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8zLTItMS0xLTU1ODgw_de96465c-feb6-4fea-97e6-8df94d95717b"
      unitRef="usd">6404000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl8zLTQtMS0xLTU1ODgw_4b0bb436-0494-4ce7-8704-5caeadf04d01"
      unitRef="usd">2610000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl80LTYtMS0xLTY2MzQx_b67f8ebf-1c24-46d7-ba05-26f81b497e79"
      unitRef="usd">997000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl82LTItMS0xLTg3ODQ3_5c401128-86fc-47dc-9dab-46219c08891f"
      unitRef="usd">2234000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl82LTQtMS0xLTg3ODU0_f2a1afbb-294e-4490-8a45-73706bf2fbe2"
      unitRef="usd">1652000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MWUyZTJmYzg4NzBiNDBjZDkyM2M5ODQ2NDIyMTIyZTYvdGFibGVyYW5nZToxZTJlMmZjODg3MGI0MGNkOTIzYzk4NDY0MjIxMjJlNl82LTYtMS0xLTg3ODYx_893bcdbf-81ec-4fbc-97a6-3a550ec15033"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8yODE0_62635520-499b-404c-8219-78d32634d336"
      unitRef="shares">57067</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82NTk3MDY5Nzk4NDgz_1c848967-0174-49a6-9e1c-1ee476e14e0a"
      unitRef="shares">146763</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82NTk3MDY5Nzk4NDkx_74abaf01-206c-4b2e-b2e1-17931978a9e0"
      unitRef="shares">121607</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zMjk4NTM0OTA0NjQ4_22c01604-8ce9-47d8-9b9e-0d40da90c068">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s restricted share activity, excluding the Company&#x2019;s employee stock purchase plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;grant&lt;br/&gt;date fair&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested shares forgone to satisfy minimum statutory withholding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of awards granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;920,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares forgone to satisfy minimum statutory withholding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i93a156af54c948df8919aacc5b640f4b_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF85LTEtMS0xLTU1Njg5_ce5950bb-97bf-4856-acce-07e8bde8754a"
      unitRef="shares">145000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i93a156af54c948df8919aacc5b640f4b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF85LTMtMS0xLTU1Njg5_3c53ef04-73ee-4372-92fb-02b2b7f4616a"
      unitRef="usdPerShare">9.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMC0xLTEtMS01NTY4OQ_cb379ef2-b460-4544-9f6d-22ceaa92f592"
      unitRef="shares">213027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMC0zLTEtMS01NTY4OQ_f0c31bc1-78e9-4522-96f0-bc611db31ba3"
      unitRef="usdPerShare">18.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMS0xLTEtMS01NTY4OQ_25a024bc-c46f-4926-b748-dceb87bd953c"
      unitRef="shares">54184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMS0zLTEtMS01NTY4OQ_8ecf4e97-a207-4792-a060-8f243720f0a2"
      unitRef="usdPerShare">12.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMi0xLTEtMS01NTY4OQ_45895b3b-9f05-4d89-96b7-6f1c3c92b565"
      unitRef="shares">1901</infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod>
    <infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMi0zLTEtMS01NTY4OQ_de7afc32-689d-493e-9760-705f3f0ccbd4"
      unitRef="usdPerShare">12.29</infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMy0xLTEtMS01NTY4OQ_91986f84-9f68-476d-9f9d-54ea090c6f31"
      unitRef="shares">11000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xMy0zLTEtMS01NTY4OQ_0ea9787c-5048-42af-9a05-071148a4f3d3"
      unitRef="usdPerShare">17.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="idad1a9e99df642878fbca1cdddf632e2_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xNC0xLTEtMS01NTY4OQ_85a44e17-156e-47fc-9918-079061f3ab77"
      unitRef="shares">290942</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="idad1a9e99df642878fbca1cdddf632e2_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6YTFjZDI4MjNlMmRjNGViMGIyYjRkMmMxYjEyMGU4NzQvdGFibGVyYW5nZTphMWNkMjgyM2UyZGM0ZWIwYjJiNGQyYzFiMTIwZTg3NF8xNC0zLTEtMS01NTY4OQ_7a1b88c3-f13b-4729-b77d-035f2f3c103a"
      unitRef="usdPerShare">15.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF8xMC0xLTEtMS01NTcyOQ_f0c31bc1-78e9-4522-96f0-bc611db31ba3"
      unitRef="usdPerShare">18.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8b8108f7576e4800a4821616a2f4206c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF8zLTMtMS0xLTc2MDcz_209027a8-ab41-4135-a620-ab92e7f662e9"
      unitRef="usdPerShare">10.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2970496b363049a4989e1475da130d29_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF8xMC0zLTEtMS01NTcyOQ_7e380e26-b1e0-43a5-bbf9-65ed2a269f77"
      unitRef="usdPerShare">7.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF8xMS0xLTEtMS01NTcyOQ_f3c5a2fe-4a84-46c5-8eda-276d13081f2d"
      unitRef="usd">920125</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i8b8108f7576e4800a4821616a2f4206c_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF80LTMtMS0xLTc2MDc2_6765c560-536b-44bd-8fa6-a0e0a8274d61"
      unitRef="usd">367273</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i2970496b363049a4989e1475da130d29_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF8xMS0zLTEtMS01NTcyOQ_f902ccd4-d948-4e66-b029-c1cc3bad2e0d"
      unitRef="usd">712969</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <infu:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue
      contextRef="i70536e94e85c431eba31912dac7f7c14_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF80LTEtMS0xLTU1NzY4_1db1dbd9-9485-405e-aeee-e9262912e20a"
      unitRef="usd">32282</infu:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue>
    <infu:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue
      contextRef="i8b8108f7576e4800a4821616a2f4206c_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF81LTMtMS0xLTc2MDc2_ab0fe384-0f13-4882-ac2d-44f2c6f6b4fd"
      unitRef="usd">62479</infu:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue>
    <infu:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue
      contextRef="i2970496b363049a4989e1475da130d29_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZDE1NmE5MjU2NDA5NGY4OTliZmQ4N2E3ZjEyMjNhMWQvdGFibGVyYW5nZTpkMTU2YTkyNTY0MDk0Zjg5OWJmZDg3YTdmMTIyM2ExZF80LTMtMS0xLTU1NzY1_1802e5c0-891f-427b-89fc-142880c560fd"
      unitRef="usd">422779</infu:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="idad1a9e99df642878fbca1cdddf632e2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zNTMy_53b2fb5b-dbb9-40c6-b89a-25b99a9706df"
      unitRef="usd">2900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82MDQ3MzEzOTc0Nzcw_4c055a4b-1e75-4b90-b558-5690c4c50f5e">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zODYx_e8c48af3-80af-4ae0-8b48-4b20efd9b77a"
      unitRef="shares">127476</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2975cbac6e1d4d30a4131dcbc1127282_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ4ODEx_16112154-ed37-4027-96f6-de33efdbe506"
      unitRef="shares">232500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned
      contextRef="i4a81f3c1031c41d6be1e69e4807e648a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zMjk4NTM0OTE2NjEy_5e40feeb-73d5-4468-852d-0872b3010159"
      unitRef="number">0.93</infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned>
    <infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned
      contextRef="i8a5e593bf0f4482cbd136bb082362baf_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV80ODQz_e4a141f9-46dd-41f5-84b1-e2520c75f7ff"
      unitRef="number">1</infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned>
    <infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned
      contextRef="id71f0e9811ac46ee9b2694dfddb5b84c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV80OTIw_c9a0bf36-1342-4fe7-95a0-988d31125c3c"
      unitRef="number">2</infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zMjk4NTM0OTA0NjQ5_a5ed2953-24f8-49eb-a003-48b9569dbf89">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s PSU activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;grant &lt;br/&gt;date fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested shares forgone to satisfy minimum statutory withholding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of awards granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,335,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares forgone to satisfy minimum statutory withholding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i579ba4102b384a248e9ea9ecb23a50df_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF8yLTEtMS0xLTU1Njg5_f75110c5-d0ab-41c0-bafe-446dd3789f77"
      unitRef="shares">232500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i579ba4102b384a248e9ea9ecb23a50df_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF8yLTMtMS0xLTU1Njg5_be310568-3cc1-463a-a70b-eacb0c702f4e"
      unitRef="usdPerShare">9.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF8zLTEtMS0xLTU1Njg5_9c6a8198-edc4-4f68-8a66-2e959401d269"
      unitRef="shares">127476</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF8zLTMtMS0xLTU1Njg5_02c52769-057b-43d2-9bbc-5ee117dbb1b3"
      unitRef="usdPerShare">19.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF80LTEtMS0xLTcyMzc1_2c78f1f9-acad-41d6-9071-e80b0bd3b647"
      unitRef="shares">66371</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF80LTMtMS0xLTcyMzgy_c1593659-f2a9-4a0e-b08c-6216aa9c1880"
      unitRef="usdPerShare">8.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF81LTEtMS0xLTcyMzg5_04d11f82-b8f6-4202-aedc-c958101e4ab1"
      unitRef="shares">53629</infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone>
    <infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF81LTMtMS0xLTcyMzk2_d47bc040-1cfb-4f17-9899-75bbe523d9aa"
      unitRef="shares">8.79</infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3deaf1a379a149fd8aca28bd274ab8e5_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF80LTEtMS0xLTU1Njg5_13ee449b-ab0c-461d-a282-56826171ff31"
      unitRef="shares">239976</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3deaf1a379a149fd8aca28bd274ab8e5_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MmY5ZjQ4ODRmNjE4NDBiOGE5ZGQ5M2E0NjFlYWRlYmQvdGFibGVyYW5nZToyZjlmNDg4NGY2MTg0MGI4YTlkZDkzYTQ2MWVhZGViZF80LTMtMS0xLTU1Njg5_3f3e442c-2e6e-4a92-bd3a-d57c3402a399"
      unitRef="usdPerShare">14.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MDBlYWZkODI1MDg3NGJmNTkyNmJmOTIxMjVhZDhlZmMvdGFibGVyYW5nZTowMGVhZmQ4MjUwODc0YmY1OTI2YmY5MjEyNWFkOGVmY18zLTEtMS0xLTU1ODMz_02c52769-057b-43d2-9bbc-5ee117dbb1b3"
      unitRef="usdPerShare">19.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i579ba4102b384a248e9ea9ecb23a50df_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MDBlYWZkODI1MDg3NGJmNTkyNmJmOTIxMjVhZDhlZmMvdGFibGVyYW5nZTowMGVhZmQ4MjUwODc0YmY1OTI2YmY5MjEyNWFkOGVmY18zLTMtMS0xLTc2NjY1_be310568-3cc1-463a-a70b-eacb0c702f4e"
      unitRef="usdPerShare">9.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MDBlYWZkODI1MDg3NGJmNTkyNmJmOTIxMjVhZDhlZmMvdGFibGVyYW5nZTowMGVhZmQ4MjUwODc0YmY1OTI2YmY5MjEyNWFkOGVmY180LTEtMS0xLTU1ODMz_125c540f-0f77-40ca-b5d8-31cde2b84aa8"
      unitRef="usd">1335053</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MDBlYWZkODI1MDg3NGJmNTkyNmJmOTIxMjVhZDhlZmMvdGFibGVyYW5nZTowMGVhZmQ4MjUwODc0YmY1OTI2YmY5MjEyNWFkOGVmY181LTEtMS0xLTU1ODMz_927e2e45-c8fd-4baa-b56f-6661cba29fa7"
      unitRef="shares">1078747</infu:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i3deaf1a379a149fd8aca28bd274ab8e5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82MzYz_6e1a0602-e5cc-4dfe-818a-39b561d62f0a"
      unitRef="usd">1200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ4ODQ1_605b1f67-5e42-4fe5-91a6-352da40e5165">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeStockOwnershipPlanESOPSharesContributedToESOP
      contextRef="i63aa50be007746b6b60d96242969200f_D20140501-20140531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82ODg2_541d741e-1614-4fe1-be40-5dd1d9f34e4f"
      unitRef="shares">200000</us-gaap:EmployeeStockOwnershipPlanESOPSharesContributedToESOP>
    <infu:EmployeeStockPurchasePlanDiscountRate
      contextRef="ib5fd5a9607e8406696c8241935b20eea_I20140531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82OTY4_fae8423a-a8bc-4f51-afdd-d65519addd57"
      unitRef="number">0.15</infu:EmployeeStockPurchasePlanDiscountRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i337469ad875742708ce9ddae6c4a0f49_D20160901-20160930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV83MjE4_fd08c621-242a-47a7-bb39-cbeb2faa8f51"
      unitRef="shares">350000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <infu:EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum
      contextRef="i63aa50be007746b6b60d96242969200f_D20140501-20140531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV83MjY0_81f706e5-d9d7-4906-af55-95ff183cd2a1"
      unitRef="usd">25000</infu:EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum>
    <infu:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV83NTkx_41876165-dce5-4f84-9595-101456934b7c"
      unitRef="shares">156052</infu:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8zMjk4NTM0OTA0NjUw_f29f2708-a131-4aaa-8eb0-19d988bb580f">The following table summarizes the activity relating to the Company&#x2019;s ESPP program:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares of stock sold to employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value per ESPP award&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8xLTEtMS0xLTU1Njg5_8c9e5fdc-8a1c-486a-af57-5ba9712a816c"
      unitRef="usd">173561</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8xLTMtMS0xLTU1Njg5_fe462af7-16a9-40bd-add9-31f527ac3170"
      unitRef="usd">108589</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8yLTUtMS0xLTY2MzY0_fcc4ec47-ccee-4be4-88d4-7d70d70a62d5"
      unitRef="usd">43030</us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8yLTEtMS0xLTU1Njg5_619f8169-2637-4b74-b823-45bab25ab4ed"
      unitRef="shares">31624</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8yLTMtMS0xLTU1Njg5_d449ac89-0f5e-40ed-a409-0cccd576bb99"
      unitRef="shares">30012</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8zLTUtMS0xLTY2MzY0_0dd655ff-743e-4c13-8691-264c6ebe7534"
      unitRef="shares">33742</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <infu:EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8zLTEtMS0xLTU1Njg5_abc021b6-63bb-4793-86aa-da5c41436d46"
      unitRef="usdPerShare">16.95</infu:EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased>
    <infu:EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV8zLTMtMS0xLTU1Njg5_dafb9c88-b900-446d-8782-2edd75ac8ef3"
      unitRef="usdPerShare">7.43</infu:EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased>
    <infu:EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OWFlZjM0Njk5ZWFkNGI5YzllNWMyYWZiZGZiYzUzMTUvdGFibGVyYW5nZTo5YWVmMzQ2OTllYWQ0YjljOWU1YzJhZmJkZmJjNTMxNV80LTUtMS0xLTY2MzY0_6e1e937d-51c4-479b-8337-e7fab2811886"
      unitRef="usdPerShare">3.94</infu:EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV81NDk3NTU4MTYwMTk4_4313e815-1bb5-48e9-b1d7-55583b5e5078">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables detail the various stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2014 Plan (Options)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of Authorized&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,449,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised shares forgone to satisfy minimum statutory withholding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cashless exercise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,051,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.36&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,274,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 Plan (Options)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of Authorized&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.38&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Aggregate Intrinsic Value - no options were in-the-money as of December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate Intrinsic Value = Excess of market value over the option exercise price of all in-the-money stock options.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id664e22f92654bd6835e8960b88f906e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF85LTItMS0xLTU1Njg5_2ecee513-33f3-4b64-9686-edf656622a5a"
      unitRef="shares">1959348</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id664e22f92654bd6835e8960b88f906e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF85LTQtMS0xLTU1Njg5_695e02f9-2721-418f-af3c-7b98becddd70"
      unitRef="usdPerShare">4.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i09a35f534ba14f4d9e18f538cbfa8254_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF85LTYtMS0xLTU1Njg5_3d14d204-0b93-400d-b6a6-19ef16e46347">P4Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="id664e22f92654bd6835e8960b88f906e_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF85LTgtMS0xLTU1Njg5_9eb49249-ca1e-43a9-a3d6-2a3dec8f209b"
      unitRef="usd">28449362</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xMy0yLTEtMS01NTY4OQ_d1bdb1d6-cf42-4ed9-9340-8854013edcee"
      unitRef="shares">56000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xMy00LTEtMS01NTY4OQ_8aad563c-5da5-440d-bc51-5bbd8995ca5b"
      unitRef="usdPerShare">18.44</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNC0yLTEtMS01NTY4OQ_f754154d-4fa3-42cc-b2f1-902f40328f16"
      unitRef="shares">279904</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNC00LTEtMS01NTY4OQ_73b97669-4ce0-4720-8984-6bc60a05b6d9"
      unitRef="usdPerShare">2.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNS0yLTEtMS01NTY4OQ_9ad47207-4358-44e4-b002-1313501fa9a0"
      unitRef="shares">1537</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNS00LTEtMS01NTY4OQ_bc407b7e-06ff-412a-978d-c3df0d136faa"
      unitRef="usdPerShare">2.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <infu:CashlessExerciseOfStockOptionsShares
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNi0yLTEtMS01NTY4OQ_70355217-6963-411a-b31e-13ac248947a3"
      unitRef="shares">566</infu:CashlessExerciseOfStockOptionsShares>
    <infu:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNi00LTEtMS01NTY4OQ_066f464a-1249-4237-ad5e-0437da3f482d"
      unitRef="usdPerShare">2.15</infu:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNy0yLTEtMS01NTY4OQ_c7deefd9-29ba-42fb-a775-d90d2548bfb2"
      unitRef="shares">1500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xNy00LTEtMS01NTY4OQ_06034334-9981-4a07-91c0-82bdecfd28c8"
      unitRef="usdPerShare">18.44</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xOS0yLTEtMS01NTY4OQ_b9be69c2-f656-4119-85be-0d7474be8e52"
      unitRef="shares">1731841</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xOS00LTEtMS01NTY4OQ_67ff611d-b64d-43a8-97c6-e34d42fbd899"
      unitRef="usdPerShare">4.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xOS02LTEtMS01NTY4OQ_68e5dee9-b168-4385-a656-02f195823c6b">P3Y11M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xOS04LTEtMS01NTY4OQ_b3cd67b1-733c-424f-9fb8-a7546ab7fd45"
      unitRef="usd">21051101</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8yMS0yLTEtMS01NTY4OQ_04349146-b05d-42d6-99b8-2c8bcef210db"
      unitRef="shares">1478357</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8yMS00LTEtMS01NTY4OQ_dc292593-fd5e-4cb3-bde8-ab7cafa914a7"
      unitRef="usdPerShare">3.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xMS02LTEtMS03MjE1OA_5384214b-7855-4d82-814d-32c1eb63a86f">P3Y4M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="iec83287d77134edda3de6abc4cfa02ae_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6OGViZGJmMzM3MTNkNGI1NDgxMDUzNWJmZDM5MWFhMGQvdGFibGVyYW5nZTo4ZWJkYmYzMzcxM2Q0YjU0ODEwNTM1YmZkMzkxYWEwZF8xMS04LTEtMS03MjE4MQ_4bda2ab8-9790-4d06-92bf-98035fae4ea7"
      unitRef="usd">19274817</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5e7c1a7074da4ca6b240f0057300c46c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xLTItMS0xLTcyMDk5_124a995a-ffdf-42ea-a94e-693a103c56d3"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5e7c1a7074da4ca6b240f0057300c46c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xLTQtMS0xLTcyMTA2_635119b6-cca7-4f08-a839-e6689a2b0bae"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i5e7c1a7074da4ca6b240f0057300c46c_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xLTgtMS0xLTcyMjAy_b44fc4dd-071f-439d-9c31-8f94f92d27ed"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18yLTItMS0xLTcyMjA5_85ba38fb-7676-46fc-8cfc-e4e5d04410ce"
      unitRef="shares">288269</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18yLTQtMS0xLTcyMjE2_7ff95dc1-4cd5-4e7e-b792-9003bd0aa990"
      unitRef="usdPerShare">19.47</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN182LTItMS0xLTcyMjk3_c67dd809-8a92-4ffd-8813-6a34352f3973"
      unitRef="shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN182LTQtMS0xLTcyMjk3_8317b9d5-1481-4bcc-94ed-c079d968f8f2"
      unitRef="usdPerShare">19.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2b64b934b737430092de595691e27b69_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN184LTItMS0xLTcyMzA0_a86c4d17-0eae-4d0b-b973-146151d79fdd"
      unitRef="shares">273269</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2b64b934b737430092de595691e27b69_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN184LTQtMS0xLTcyMzA0_7131c675-c67c-45f3-b872-df08f05ba466"
      unitRef="usdPerShare">19.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN184LTYtMS0xLTcyMzA0_d2d4ea20-e0d6-4450-8498-4df0ba92bfae">P9Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i2b64b934b737430092de595691e27b69_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN184LTgtMS0xLTcyMzA0_a6f8945a-3d4d-460f-a204-accf4721ec53"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i2b64b934b737430092de595691e27b69_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xMC0yLTEtMS03MjMxMQ_33605ab8-027f-4a67-b13a-16b2ee3a88d9"
      unitRef="shares">78770</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i2b64b934b737430092de595691e27b69_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xMC00LTEtMS03MjMxMQ_ce06ac0d-a282-489f-b875-73650cfbfd43"
      unitRef="usdPerShare">19.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i11266eecea6f4c9fa4fc2b1567cd2c41_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xMC02LTEtMS03MjMxMQ_3873cadc-21f9-4f64-8a27-2ffdda6d9351">P6Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i2b64b934b737430092de595691e27b69_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6ZjAyYzY4NmVkMjQwNDRlYWJjOGMxMTkyMmJhM2Y1MzcvdGFibGVyYW5nZTpmMDJjNjg2ZWQyNDA0NGVhYmM4YzExOTIyYmEzZjUzN18xMC04LTEtMS03MjMxMQ_3ae7fa02-1bb9-41ee-a552-f662f0c394b3"
      unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV81NDk3NTU4MTYwMTk2_e9f0dbfd-b2d2-478d-b098-d7845af1a90d">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the average fair value per share estimated on the date of grant and the assumptions used for options granted:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock Options:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43% to 46%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42% to 51%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36% to 38%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.31% to 0.54%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.20% to 1.56%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.80% to 2.36%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected lives at date of grant (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.63&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$6.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.61&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intrinsic value of options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,248,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,377,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTItMS0xLTYzNDYwL3RleHRyZWdpb246NDQxYzU2YzVhODRhNDFiOTgwYzEyYjdmNDc4ZTNmMzBfMjc0ODc3OTA2OTQ2MA_04b5923f-800c-4aab-9e41-2459fe58c70f"
      unitRef="number">0.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTItMS0xLTYzNDYwL3RleHRyZWdpb246NDQxYzU2YzVhODRhNDFiOTgwYzEyYjdmNDc4ZTNmMzBfMjc0ODc3OTA2OTQ1NA_3fcc87a1-7288-4507-b21c-c6553dff5a6b"
      unitRef="number">0.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTQtMS0xLTYzNDY2L3RleHRyZWdpb246MDYzZTViZjA2NTc1NGRlMjg3OGYxZGU2Y2I2ZTg5YTlfMjc0ODc3OTA2OTQ1NA_6c21b9b3-b04e-4806-bc1f-1595ca3f2a18"
      unitRef="number">0.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTQtMS0xLTYzNDY2L3RleHRyZWdpb246MDYzZTViZjA2NTc1NGRlMjg3OGYxZGU2Y2I2ZTg5YTlfMTA5OTUxMTYyNzc5OQ_4d1ab108-b774-4061-bf20-de6a84838e26"
      unitRef="number">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTYtMS0xLTY2MjU3L3RleHRyZWdpb246MDJmNWNiMWM4NTk3NDRkNGI3OTYzMDIzYmFjMmNkYjdfMTA5OTUxMTYyNzc4OA_6497b2eb-89e6-40c4-b613-301c5cc242f3"
      unitRef="number">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8yLTYtMS0xLTY2MjU3L3RleHRyZWdpb246MDJmNWNiMWM4NTk3NDRkNGI3OTYzMDIzYmFjMmNkYjdfMTA5OTUxMTYyNzc5Mg_87a45001-720d-483d-852c-53df7eb945bc"
      unitRef="number">0.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTItMS0xLTY2MjMyL3RleHRyZWdpb246MTA3YTZhZGJjYjUyNDBkYWE1OTZjYTc2ZjAzNGE3MjlfMTA5OTUxMTYyNzc5NA_c15d17f0-8b71-4eea-ade8-03937c0f0ddb"
      unitRef="number">0.0031</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTItMS0xLTY2MjMyL3RleHRyZWdpb246MTA3YTZhZGJjYjUyNDBkYWE1OTZjYTc2ZjAzNGE3MjlfMTA5OTUxMTYyNzgwMg_1f00798f-6a87-4216-b130-e6ff909b71b5"
      unitRef="number">0.0054</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTQtMS0xLTY2MjE4L3RleHRyZWdpb246NmEyMTQxNDhiYjk3NDNhOTgyNzg3NWJkMTU1YjBjZTFfMTA5OTUxMTYyNzc5OQ_e5587c42-88ad-47d7-8751-b90b44b0a400"
      unitRef="number">0.0020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTQtMS0xLTY2MjE4L3RleHRyZWdpb246NmEyMTQxNDhiYjk3NDNhOTgyNzg3NWJkMTU1YjBjZTFfMTA5OTUxMTYyNzgwNw_093c6653-9545-40ed-b24f-cd0ad8912e31"
      unitRef="number">0.0156</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTYtMS0xLTY2Mjc0L3RleHRyZWdpb246NzRkYWM0ZTZhMDljNGNiM2FlYmU2ZjNhYzc4YzlhZjFfMTA5OTUxMTYyNzc4OA_04e17fee-7825-4e55-b428-121c296a8f85"
      unitRef="number">0.0180</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTYtMS0xLTY2Mjc0L3RleHRyZWdpb246NzRkYWM0ZTZhMDljNGNiM2FlYmU2ZjNhYzc4YzlhZjFfMTA5OTUxMTYyNzc5Mg_05471f2c-7b6c-4cba-b338-d7fa56fa25e7"
      unitRef="number">0.0236</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTItMS0xLTU1Njg5_de360c18-2aa2-4693-b865-1d8ac1a40715">P3Y7M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV8zLTQtMS0xLTU1Njg5_d6e63691-899b-42c7-85e5-18a6b65bf9e8">P3Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV80LTYtMS0xLTY2Mjkx_c0690c22-b8e6-498f-af71-7ef3f5cc84b4">P4Y7M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i7e33f7d1e2e5453ea11e60d4febe0678_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV80LTItMS0xLTU1Njg5_bc6f95ed-774e-4648-938f-77bcb8a9fb88"
      unitRef="usdPerShare">6.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="if119c5c4f07e4e6fb8be547a3dfead4e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV80LTQtMS0xLTU1Njg5_12df93c9-4d0e-4ea2-b523-5485d46cc050"
      unitRef="usdPerShare">3.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i5e5609e12fdd4bcc9d3cac4d8aa1ae1a_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV81LTYtMS0xLTY2Mjk5_1438cf56-6d7b-4460-a9d7-488db605bf4e"
      unitRef="usdPerShare">1.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i916acf9d0f104707870dd85b845fdad2_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV82LTItMS0xLTYzNTg5_45da3ca4-b550-4594-becf-966802c18e4b"
      unitRef="usd">4248401</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i27ffb228641a453da9cdf6c4ccb7c4e7_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV82LTQtMS0xLTYzNTg5_31b2743b-05d8-4e83-bf5b-1b86e0e42bb5"
      unitRef="usd">3377730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i1d35c2bc82cd469984699c6e06799255_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGFibGU6MzFkZDAzYWI4M2JhNDMyN2EwMjc1NjQwMzA2M2U5MWUvdGFibGVyYW5nZTozMWRkMDNhYjgzYmE0MzI3YTAyNzU2NDAzMDYzZTkxZV82LTYtMS0xLTc2ODQx_a76782f2-6b47-4fa0-8c39-ec493ec3d1f5"
      unitRef="usd">624462000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ib7b671a11ff144cdb841c10e00e545b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV8xMDk5NTExNjQ5MDYw_af44981c-3d3b-456b-95cc-8a25325f556b"
      unitRef="usd">20000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82MDQ3MzEzOTgwNDgw_1287e19c-ac2a-4b35-b7fc-8eb4226b58e4"
      unitRef="usd">600000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODc1L2ZyYWc6YWRmODE2YzM0ZjllNDEwYzkzYTk2YjIxZTQzNWI0MTkvdGV4dHJlZ2lvbjphZGY4MTZjMzRmOWU0MTBjOTNhOTZiMjFlNDM1YjQxOV82MDQ3MzEzOTg2MDYy_9c3f2cf7-f7e7-470e-9af3-86abd0ef5ed7"
      unitRef="shares">33469</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGV4dHJlZ2lvbjoxNTA0MzEwNjkzOGY0ZTFiYTIwMTM1Yjc5NjQ4ZmM5YV80OTQ3ODAyMzI2OTMz_dc1b0542-eb96-4cf2-9399-e2f419e4a4fe">Business Segment Information&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reportable segments are organized based on service platforms, with the ITS segment reflecting higher margin rental revenues that generally include payments made by third-party and direct payers and the DME Services segment reflecting lower margin product sales, direct payer rental and services revenues. Resources are allocated and performance is assessed for these segments by the Company&#x2019;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker. The Company believes that reporting performance at the gross profit level is the best indicator of segment performance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial information summarized below is presented by reportable segment:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ITS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;DME Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Corporate/&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues - external&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues - internal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;57,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;57,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;97,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases of medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ITS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DME Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues - external&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues - internal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ITS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DME Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues - external&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues - internal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGV4dHJlZ2lvbjoxNTA0MzEwNjkzOGY0ZTFiYTIwMTM1Yjc5NjQ4ZmM5YV80Mzk4MDQ2NTEyMDUy_b461644f-b970-4137-9a1f-5ee3b54a843d">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial information summarized below is presented by reportable segment:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ITS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;DME Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Corporate/&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues - external&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues - internal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;57,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;57,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;97,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases of medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ITS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DME Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues - external&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues - internal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ITS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DME Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues - external&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues - internal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <infu:RevenuesExternal
      contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8yLTItMS0xLTU1NjIx_78d16ef9-8d5b-4f04-baef-e32a8dd2e949"
      unitRef="usd">65598000</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8yLTQtMS0xLTU1NjIx_23c295c6-7e53-4415-84ef-b22680bdfc25"
      unitRef="usd">36784000</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8yLTYtMS0xLTU1NjIx_550ba259-db5d-4361-872d-5c35b8c178d8"
      unitRef="usd">0</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8yLTgtMS0xLTU1NjIx_7ce9f181-852b-4d6e-913e-33a2d0dbef08"
      unitRef="usd">102382000</infu:RevenuesExternal>
    <infu:RevenuesInternal
      contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8zLTItMS0xLTU1NjIx_4abc5cd6-258d-44f2-a5dc-045544dcfafe"
      unitRef="usd">0</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8zLTQtMS0xLTU1NjIx_25f9cbd7-193a-4a51-b413-c180f8d9eec4"
      unitRef="usd">5753000</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8zLTYtMS0xLTU1NjIx_9ba4a9c2-ffd9-49b0-ac86-7646f322bf29"
      unitRef="usd">-5753000</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8zLTgtMS0xLTU1NjIx_582cb305-275f-4905-8be2-56595b6ad136"
      unitRef="usd">0</infu:RevenuesInternal>
    <us-gaap:Revenues
      contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV80LTItMS0xLTU1NjIx_6026b02d-20d4-4d62-aa50-f2ab33d20f05"
      unitRef="usd">65598000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV80LTQtMS0xLTU1NjIx_09f3d5bf-4136-4bf3-9a09-921dfdc856ee"
      unitRef="usd">42537000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV80LTYtMS0xLTU1NjIx_974550ed-6dd0-4f4a-9063-3d03a73b8a3d"
      unitRef="usd">-5753000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV80LTgtMS0xLTU1NjIx_ecfd4df5-4be2-4196-afcd-25dc7095f914"
      unitRef="usd">102382000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV81LTItMS0xLTU1NjIx_8d9ab61e-3414-41eb-829d-d474cfcdbef2"
      unitRef="usd">42046000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV81LTQtMS0xLTU1NjIx_649294e5-56e0-4c66-97e9-ee2ef2bf02c1"
      unitRef="usd">18151000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV81LTYtMS0xLTU1NjIx_86976381-7ae8-4b9e-af03-7671cd3211a7"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV81LTgtMS0xLTU1NjIx_7e0afd24-dbd1-443d-b4b9-0d1034379be5"
      unitRef="usd">60197000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses
      contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV83LTYtMS0xLTU1NjIx_1d26a4ae-86e7-4ca6-9531-9805720be531"
      unitRef="usd">57377000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV83LTgtMS0xLTU1NjIx_aa1a9cbc-ca6a-4dd8-8cf1-fd8f61ff977e"
      unitRef="usd">57377000</us-gaap:OperatingExpenses>
    <us-gaap:InterestExpense
      contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV84LTYtMS0xLTU1NjIx_f78b385f-352b-402e-adec-402416ff2cc6"
      unitRef="usd">1377000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV84LTgtMS0xLTU1NjIx_b2caeaff-4830-4de6-ab46-b51f68f731a3"
      unitRef="usd">1377000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV85LTYtMS0xLTU1NjIx_284fd301-c8de-4838-b5cf-3a215c06ef08"
      unitRef="usd">-186000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV85LTgtMS0xLTU1NjIx_82f79476-b9bb-4221-93d3-49ff28467373"
      unitRef="usd">-186000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xMC02LTEtMS01NTYyMQ_8c52f1c6-5703-4407-ba73-552a3f1fa38e"
      unitRef="usd">-163000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xMC04LTEtMS01NTYyMQ_04f2fa41-80cf-4f65-b99f-a33be3dc1768"
      unitRef="usd">-163000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xMi04LTEtMS01NTYyMQ_62c2ccc1-9c84-4527-9f78-d3030c3dda02"
      unitRef="usd">1420000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets
      contextRef="i4d33e010b93943a0a1b9d74ec3a67b16_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNC0yLTEtMS01NTYyMQ_7335b9cd-7ca2-45bd-b137-2cacbea5a493"
      unitRef="usd">60970000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie8879dd04a8a42e3aa243ab1446763cf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNC00LTEtMS01NTYyMQ_5ab43c45-47ad-4d4e-8313-12f77ac50ca2"
      unitRef="usd">34616000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i90ee66b33a414ffb93ffa9dcf1afd8e9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNC02LTEtMS01NTYyMQ_7cae8fbb-9925-4063-bad1-ff43da6ce8c9"
      unitRef="usd">2000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNC04LTEtMS01NTYyMQ_95f5d828-60ed-46ca-92eb-995e3f2aaa3b"
      unitRef="usd">97586000</us-gaap:Assets>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNS0yLTEtMS01NTYyMQ_c6bde9ea-d068-453a-a234-e4690440d68c"
      unitRef="usd">10533000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNS00LTEtMS01NTYyMQ_8ce36f45-e90c-493c-8b5a-c6de0c1d589e"
      unitRef="usd">5143000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNS02LTEtMS01NTYyMQ_327e89ba-0942-4988-83dc-1a33c23ad9e7"
      unitRef="usd">0</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNS04LTEtMS01NTYyMQ_01d2230a-4a63-41fa-a3ac-dbcd12255b88"
      unitRef="usd">15676000</infu:PaymentsToAcquireMedicalEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="id3735e06759b4fafa67d70b97cbabc4d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNi0yLTEtMS01NTYyMQ_b848f734-7c35-40dd-85cb-b20aa938701f"
      unitRef="usd">10886000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="idbcb37fc1839477a99d0ea17cac181bf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNi00LTEtMS01NTYyMQ_e4ad0f16-9c7c-4446-811d-b404e5bf1f46"
      unitRef="usd">3739000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i58e4bffb06634bbc9b6085897831a0a2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNi02LTEtMS01NTYyMQ_fc3b2672-560a-4ac3-8671-8fecaba0a291"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6ODE3YzlhNjJiZWU1NDJkY2I1N2U0NTQxMjExZjhkNDkvdGFibGVyYW5nZTo4MTdjOWE2MmJlZTU0MmRjYjU3ZTQ1NDEyMTFmOGQ0OV8xNi04LTEtMS01NTYyMQ_85ac6686-fa84-44ef-b062-64349d3db53a"
      unitRef="usd">14625000</us-gaap:DepreciationAndAmortization>
    <infu:RevenuesExternal
      contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18yLTItMS0xLTU1NjIx_ed0a107d-a54a-40e9-a40f-f81368460569"
      unitRef="usd">61072000</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18yLTQtMS0xLTU1NjIx_3564f8cd-fc4a-458b-a05b-8f581d05debc"
      unitRef="usd">36316000</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18yLTYtMS0xLTU1NjIx_f131f9aa-72ff-4c48-b6eb-430edce5f5a5"
      unitRef="usd">0</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18yLTgtMS0xLTU1NjIx_bc49bef3-0af4-4178-ae49-93515960851d"
      unitRef="usd">97388000</infu:RevenuesExternal>
    <infu:RevenuesInternal
      contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18zLTItMS0xLTU1NjIx_20679fbb-66e6-426c-a8b2-516846071553"
      unitRef="usd">0</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18zLTQtMS0xLTU1NjIx_26a78f82-2771-4008-97a0-87b42e642fb3"
      unitRef="usd">5370000</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18zLTYtMS0xLTU1NjIx_43f4e452-9a03-4043-a67b-c8c4da79e254"
      unitRef="usd">-5370000</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18zLTgtMS0xLTU1NjIx_14895756-2595-43e1-a24b-941aafe6bb0d"
      unitRef="usd">0</infu:RevenuesInternal>
    <us-gaap:Revenues
      contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY180LTItMS0xLTU1NjIx_427d358a-354d-4688-832b-03ee391e0757"
      unitRef="usd">61072000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY180LTQtMS0xLTU1NjIx_525c44cd-2ecc-4c55-af4e-43129562eb92"
      unitRef="usd">41686000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY180LTYtMS0xLTU1NjIx_3d4c1403-c280-4ea3-b6a5-2482f1ce3324"
      unitRef="usd">-5370000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY180LTgtMS0xLTU1NjIx_b06a1c8e-76a6-4170-b43e-642dd30aef37"
      unitRef="usd">97388000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY181LTItMS0xLTU1NjIx_9a76cec1-5bc3-4057-a0b2-d73d9ec5bb01"
      unitRef="usd">39773000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY181LTQtMS0xLTU1NjIx_ef248a4e-fae9-4602-b9d0-0400adca1b72"
      unitRef="usd">18986000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY181LTYtMS0xLTU1NjIx_7aa06f0b-72a8-41f7-9d6d-9f01f99af599"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY181LTgtMS0xLTU1NjIx_2949512b-1563-447a-830e-7205c708132d"
      unitRef="usd">58759000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses
      contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY183LTYtMS0xLTU1NjIx_d99bc9bd-8817-4c56-9799-6cc48bfe6d3f"
      unitRef="usd">49932000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY183LTgtMS0xLTU1NjIx_273d94af-c81c-4a9b-9e3d-2ff09761ad7b"
      unitRef="usd">49932000</us-gaap:OperatingExpenses>
    <us-gaap:InterestExpense
      contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY184LTYtMS0xLTU1NjIx_ba4706c4-a7b2-43d6-8cdb-41501a276545"
      unitRef="usd">1255000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY184LTgtMS0xLTU1NjIx_07c577db-4260-4c90-bf2b-5015143edb39"
      unitRef="usd">1255000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY185LTYtMS0xLTU1NjIx_d0c0a61e-d789-4785-8f6f-8ed9e92f17f0"
      unitRef="usd">-29000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY185LTgtMS0xLTU1NjIx_9c3fefbb-8751-4423-be2b-416066742d8e"
      unitRef="usd">-29000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xMC02LTEtMS01NTYyMQ_76b7be42-b772-40d2-add4-c4d405187b81"
      unitRef="usd">-9789000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xMC04LTEtMS01NTYyMQ_3845aa68-dd03-4e49-bc5d-f69948eba10f"
      unitRef="usd">-9789000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xMi04LTEtMS01NTYyMQ_d4d6f888-917d-4336-a2f7-1bd3f88a79a4"
      unitRef="usd">17332000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets
      contextRef="i9b70e2ce104146f5ab103c7d119b5bb6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNC0yLTEtMS01NTYyMQ_09e843f7-114b-4745-824d-9088b952631a"
      unitRef="usd">68472000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9f6184d5208e4826bebce3c6df68d12f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNC00LTEtMS01NTYyMQ_b4f79575-d238-4960-a2e3-2b4fbc7f8bd0"
      unitRef="usd">26519000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4bb2db6241c24063b31cb809b4d00a65_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNC02LTEtMS01NTYyMQ_f1652ca8-2a27-4735-9d43-1f466186d2a8"
      unitRef="usd">2000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNC04LTEtMS01NTYyMQ_7510c37f-eb98-4184-8a57-537dd6eb3a02"
      unitRef="usd">96991000</us-gaap:Assets>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNS0yLTEtMS01NTYyMQ_4defaf30-60b0-4d50-a350-cc448c18633c"
      unitRef="usd">9583000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNS00LTEtMS01NTYyMQ_2fab3449-e3db-42d1-8cf4-d33bcd0cc051"
      unitRef="usd">6237000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNS02LTEtMS01NTYyMQ_ca6f9890-0fc3-4844-a563-57065a2f492a"
      unitRef="usd">0</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNS04LTEtMS01NTYyMQ_9165d76f-f72a-4eb9-9f59-d7a58f3e7ecc"
      unitRef="usd">15820000</infu:PaymentsToAcquireMedicalEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="ibb4a4915856147e3be64632aa43447d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNi0yLTEtMS01NTYyMQ_b7b967ef-2cff-421d-934f-0f4e391c0667"
      unitRef="usd">10708000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i7e33097725ab4d7597ef420d057c09f0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNi00LTEtMS01NTYyMQ_e544179c-bfdd-4a98-8eab-b83db3818c97"
      unitRef="usd">3317000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9928856516d548d1aba6381436cf7644_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNi02LTEtMS01NTYyMQ_8e28386f-4621-4a4c-b800-09b18082c781"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6YWMwYWY4ZjhmN2YxNGVjMmJjOTRlZTI1MGM4ZGYzMmMvdGFibGVyYW5nZTphYzBhZjhmOGY3ZjE0ZWMyYmM5NGVlMjUwYzhkZjMyY18xNi04LTEtMS01NTYyMQ_6034b5b0-93c6-480c-91bf-dbde77a07077"
      unitRef="usd">14025000</us-gaap:DepreciationAndAmortization>
    <infu:RevenuesExternal
      contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8yLTItMS0xLTU1NjI3_f0aef593-8b3d-42ee-aa87-f787f89e4f50"
      unitRef="usd">51540000</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8yLTQtMS0xLTU1NjI3_15b40a96-b3c8-45e1-ad05-07dc636393b9"
      unitRef="usd">29575000</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8yLTYtMS0xLTU1NjI3_43930026-5a8b-4966-a473-c16bf67a78c2"
      unitRef="usd">0</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8yLTgtMS0xLTU1NjI3_6a532e39-686c-45e6-8803-052e0de58c2d"
      unitRef="usd">81115000</infu:RevenuesExternal>
    <infu:RevenuesInternal
      contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8zLTItMS0xLTU1NjI3_ba0b4447-c44b-4905-ac88-ec2a6908d4d6"
      unitRef="usd">0</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8zLTQtMS0xLTU1NjI3_99caa796-5451-4d47-aab3-827e3c2a5c37"
      unitRef="usd">3788000</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8zLTYtMS0xLTU1NjI3_0dd2a914-1451-4814-9f81-c28efd053811"
      unitRef="usd">-3788000</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8zLTgtMS0xLTU1NjI3_a8a0809b-807f-4ddc-819b-5e5fa26f46ab"
      unitRef="usd">0</infu:RevenuesInternal>
    <us-gaap:Revenues
      contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF80LTItMS0xLTU1NjI3_b37a2c6d-328d-498f-ba61-a9a0e8aaaee3"
      unitRef="usd">51540000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF80LTQtMS0xLTU1NjI3_09756ac8-b27e-427a-8f0d-c54567e68e68"
      unitRef="usd">33363000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF80LTYtMS0xLTU1NjI3_e25c0e5a-56e4-4bca-acea-d02ad34d62e2"
      unitRef="usd">-3788000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF80LTgtMS0xLTU1NjI3_7c93ab54-b4d1-4cab-9769-4b6f910aa05e"
      unitRef="usd">81115000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF81LTItMS0xLTU1NjI3_ba6a4ee8-a40c-43d8-9d97-976ce0721dc1"
      unitRef="usd">33063000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF81LTQtMS0xLTU1NjI3_d909ced9-7a08-4f87-9fce-14caa44e80b2"
      unitRef="usd">13819000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF81LTYtMS0xLTU1NjI3_b1160f9f-584c-4947-9ed1-1074ed3f9d22"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF81LTgtMS0xLTU1NjI3_8901b993-6ef0-4193-acd6-331431da24f2"
      unitRef="usd">46882000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses
      contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF83LTYtMS0xLTU1NjI3_89bc9737-248b-4b72-a441-97dccb3f9a58"
      unitRef="usd">43357000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF83LTgtMS0xLTU1NjI3_7b7a8f96-b8ea-4bd4-abe8-ca06ac851740"
      unitRef="usd">43357000</us-gaap:OperatingExpenses>
    <us-gaap:InterestExpense
      contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF84LTYtMS0xLTU1NjI3_b9674132-1e36-486e-971f-1d6fdfa128c8"
      unitRef="usd">1904000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF84LTgtMS0xLTU1NjI3_f86e6150-84b1-42c9-bfc2-8306df438189"
      unitRef="usd">1904000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF85LTYtMS0xLTU1NjI3_8dbe6a0c-fbb9-4ac5-a587-70661a859357"
      unitRef="usd">-97000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF85LTgtMS0xLTU1NjI3_baf08796-ee45-4169-930a-b4b31620bfc5"
      unitRef="usd">-97000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xMC02LTEtMS01NTYyNw_128754cc-af4f-47b1-8ffa-f28919a05954"
      unitRef="usd">163000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xMC04LTEtMS01NTYyNw_c0ff8abe-d2d0-4ecc-a3db-529ebf38bb7e"
      unitRef="usd">163000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xMi04LTEtMS01NTYyNw_7af693b9-3c83-409e-af96-9e2c1250fc06"
      unitRef="usd">1361000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets
      contextRef="ia6d80d3950ca42f0aa2a881eb9e20226_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNC0yLTEtMS01NTYyNw_029b9b66-e9ff-4ed0-abf3-2b1d5de0089d"
      unitRef="usd">54292000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6c666a090afb4d4088d45f15b60baf48_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNC00LTEtMS01NTYyNw_5d2e2b24-e0e7-4c92-9e7f-9a4c3f89dbfb"
      unitRef="usd">22932000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i99dd14e3f4d04b82a5f72adea8821e1f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNC02LTEtMS01NTYyNw_fde92176-a537-4ea9-b7bd-154d89a41c18"
      unitRef="usd">2000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5eec6c22b6b342eab7efdb046682bff8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNC04LTEtMS01NTYyNw_df933276-3b14-40ce-bbb3-7d5ce6e9684b"
      unitRef="usd">79224000</us-gaap:Assets>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNS0yLTEtMS01NTYyNw_71f47965-0b2e-4f97-a1a5-3e1bb51d55ff"
      unitRef="usd">14216000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNS00LTEtMS01NTYyNw_6a9e59c3-7cec-4671-8f51-b87bc1aa56a1"
      unitRef="usd">5453000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNS02LTEtMS01NTYyNw_774efa56-06d8-4945-9683-211be0774ed5"
      unitRef="usd">0</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNS04LTEtMS01NTYyNw_edf0465e-9eda-4004-9c10-e78b864ee9de"
      unitRef="usd">19669000</infu:PaymentsToAcquireMedicalEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="i05913e99eab84124bc8b9426cbdbd7e2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNi0yLTEtMS01NTYyNw_32aa719d-d229-4ec0-8608-55e7be788250"
      unitRef="usd">9457000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i72387201e71d4834ad096602f0745428_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNi00LTEtMS01NTYyNw_549f424d-fdf0-4c51-b569-8e3e2734505a"
      unitRef="usd">2885000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i297307e995f4423482791be08ae954b0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNi02LTEtMS01NTYyNw_57638886-333f-4069-8ff1-871f0ab654ca"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xODU5L2ZyYWc6MTUwNDMxMDY5MzhmNGUxYmEyMDEzNWI3OTY0OGZjOWEvdGFibGU6OTA2ODliZGQ2MmNmNDRkZWFkMTQyODMwNjNlODUxZjAvdGFibGVyYW5nZTo5MDY4OWJkZDYyY2Y0NGRlYWQxNDI4MzA2M2U4NTFmMF8xNi04LTEtMS01NTYyNw_ffb50ea0-8bed-4046-9a1d-c04bc4083831"
      unitRef="usd">12342000</us-gaap:DepreciationAndAmortization>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzUwNg_b86def30-4ed0-4e15-948e-302ad3776247">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"&gt;Employee Benefit Plans and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;The Company has a defined contribution plan in which the Company makes discretionary matching contributions for a certain percentage of employee contributions. For the years ended December&#160;31, 2021, 2020 and 2019, the Company&#x2019;s matching contributions were $0.9 million, $0.8 million and $0.7 million, respectively. The Company does not provide other post-retirement or post-employment benefits to its employees. As of December&#160;31, 2021 and 2020, accrued payroll liabilities included in Other current liabilities were $1.3 million and $2.8 million, respectively.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzI3Mw_84614398-5d46-42bd-8024-a801201df347"
      unitRef="usd">900000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i2b7303800b234b62b753517f5ca97efb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzI4MA_8cc27574-b754-42ee-8bf8-faf22a45c167"
      unitRef="usd">800000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i00c80232edc34b2caf7e182c534419e6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzYwNDczMTM5NTM1Mjg_69138330-1496-4cad-8ee4-a8054b6d3b29"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iadf344ba2bca42ada453fc7ff77944bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzQ4Mw_e1b32cab-69b6-407c-93b4-9b3c9a4224b8"
      unitRef="usd">1300000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjAvZnJhZzpiMjViMDkxOTgwY2E0ZjFlYTZiMjVhZTNlMTZiYjIzNS90ZXh0cmVnaW9uOmIyNWIwOTE5ODBjYTRmMWVhNmIyNWFlM2UxNmJiMjM1XzQ5MA_efb36ef9-feb0-4934-b196-3c48896bc73e"
      unitRef="usd">2800000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <infu:EffectOfCovid19PandemicTextBlock
      contextRef="i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNjMvZnJhZzoxN2E0NzcwOTA0NDM0NDk1OTUxMzc4NTA0MTI2OWE2NS90ZXh0cmVnaW9uOjE3YTQ3NzA5MDQ0MzQ0OTU5NTEzNzg1MDQxMjY5YTY1XzMzNDI_c6c3223c-0cd6-4f90-95c8-be020889b115">COVID-19On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, which spread globally and throughout the United States. With the exception of in-person visits to customer facilities by the Company's sales &lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;staff, the Company continued to operate despite stay-at-home orders and other government mandated shutdowns across the United States and Canada under exceptions allowed by those orders for the healthcare industry.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company took a number of precautionary and preemptive steps to protect the safety and well-being of its employees while ensuring continuity of service to its clients, including, transitioning employees to a remote work environment, suspending employee travel, canceling participation in industry events and in-person group meetings, promoting social distancing and enhanced cleaning and sanitization efforts across office locations, and implementing protocols to quarantine employees who may have been exposed to COVID-19, or show relevant symptoms. The Company also executed preparedness plans at its facilities to maintain continuity of operations, which provided for flexible work arrangements without any significant disruptions to its business or control processes. The Company's management team is continuing to actively monitor the situation and continuously communicates with employees, customers and vendors. Other specific actions the Company took included purchasing additional inventory of supplies and pumps, as well as purchasing personal protective equipment for employees. While the Company&#x2019;s business is considered critical, the Company is unable to predict the impact that the COVID-19 pandemic will have on future periods due to numerous uncertainties. While the COVID-19 pandemic has not had any material unfavorable effects to the Company's financial results for the year ended December&#160;31, 2021, the extent of the impact in the future, if any, will depend on future developments, which are highly uncertain, cannot be predicted and could have a material adverse impact on the Company's financial position, operating results and cash flows. A prolonged outbreak could, among other things, strain the Company's business continuity plans, create delays in the Company's growth and strategic initiatives, reduce the Company's sales and marketing activities, limit the Company's access to financing on favorable terms, increase the Company's exposure to potential impairment charges related to long-lived and intangible assets, hinder the Company's ability to support its clients and operate its business effectively, heighten the risk of disruption to the Company's information and reporting systems and internal controls, including those over financial reporting and other risk management systems, or require the Company to incur substantial costs. The Company continues to closely monitor the impact of the COVID-19 pandemic on all aspects of its business and may take further actions as may be required by federal, state or local authorities, or that the Company determines are in the best interests of its employees, customers and partners. As the conditions surrounding the COVID-19 pandemic continue to evolve rapidly, the Company will continue to actively manage its response in collaboration with customers, government officials and stakeholders, and assess any potential impacts to the Company's financial position and operating results, as well as adverse developments in its business.&lt;/span&gt;&lt;/div&gt;</infu:EffectOfCovid19PandemicTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTUtMS0xLTY4ODc2_c111bee4-d840-4aa3-92a0-bac2910ee946"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTUtMS0xLTY4ODc2_c111bee4-d840-4aa3-92a0-bac2910ee946"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTctMS0xLTY4ODY5_e5423472-a3f2-41f8-bf6a-49f647b5d1ed"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTctMS0xLTY4ODY5_e5423472-a3f2-41f8-bf6a-49f647b5d1ed"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTMtMS0xLTY4ODgz_40e6085e-e2f2-4deb-adba-1604628105b6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTMtMS0xLTY4ODgz_40e6085e-e2f2-4deb-adba-1604628105b6"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY4_b48ecc6c-d3a8-4b35-9611-7794e88fc0c0" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY4_b48ecc6c-d3a8-4b35-9611-7794e88fc0c0" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amount consists of current liabilities for contingent consideration that have not been included in financing activities. These amounts have not been paid for as of December 31, 2021, but will be included as a cash outflow from financing activities for contingent consideration when paid.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTUtMS0xLTY4ODc2_c111bee4-d840-4aa3-92a0-bac2910ee946"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY4_b48ecc6c-d3a8-4b35-9611-7794e88fc0c0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTctMS0xLTY4ODY5_e5423472-a3f2-41f8-bf6a-49f647b5d1ed"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY4_b48ecc6c-d3a8-4b35-9611-7794e88fc0c0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV84LTMtMS0xLTY4ODgz_40e6085e-e2f2-4deb-adba-1604628105b6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY4_b48ecc6c-d3a8-4b35-9611-7794e88fc0c0"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTUtMS0xLTcxODU5_02a6b5f6-3c05-4ee2-b77c-626b8dbafc75"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTUtMS0xLTcxODU5_02a6b5f6-3c05-4ee2-b77c-626b8dbafc75"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTctMS0xLTcxODY2_8cf1827d-43b3-49fd-9ca8-720fd3e1ef15"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTctMS0xLTcxODY2_8cf1827d-43b3-49fd-9ca8-720fd3e1ef15"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTMtMS0xLTcxODUy_6838e1f4-e58f-4c76-a61b-10f7c982034d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTMtMS0xLTcxODUy_6838e1f4-e58f-4c76-a61b-10f7c982034d"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY5_da598c6c-1ff0-44c6-a475-798637b014e3" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY5_da598c6c-1ff0-44c6-a475-798637b014e3" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amount consists of receivables for cash proceeds from stock plans that have not been included in financing activities. These amounts have not been received as of December 31, 2021, but will be included as a cash inflow from financing activities for cash proceeds from stock plans when received.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTUtMS0xLTcxODU5_02a6b5f6-3c05-4ee2-b77c-626b8dbafc75"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY5_da598c6c-1ff0-44c6-a475-798637b014e3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTctMS0xLTcxODY2_8cf1827d-43b3-49fd-9ca8-720fd3e1ef15"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY5_da598c6c-1ff0-44c6-a475-798637b014e3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV85LTMtMS0xLTcxODUy_6838e1f4-e58f-4c76-a61b-10f7c982034d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY5_da598c6c-1ff0-44c6-a475-798637b014e3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV83LTYtMS0xLTU4NTgz_8836808c-e83c-441d-9439-13331421e05d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV83LTYtMS0xLTU4NTgz_8836808c-e83c-441d-9439-13331421e05d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTItMS0xLTUxNTYy_481006d8-1084-4727-894a-60249e6a0acf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTItMS0xLTUxNTYy_481006d8-1084-4727-894a-60249e6a0acf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTQtMS0xLTUxNTYy_85944c39-89c5-482e-9458-11163ccd9b31"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTQtMS0xLTUxNTYy_85944c39-89c5-482e-9458-11163ccd9b31"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY3_26951cf3-5524-42c9-b7eb-b73b54eb1668" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY3_26951cf3-5524-42c9-b7eb-b73b54eb1668" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts consist of current liabilities for medical equipment and property that have not been included in investing activities. These amounts have not been paid for as of December 31, 2021, 2020 and 2019, respectively, but will be included as a cash outflow from investing activities for purchases of medical equipment and property when paid.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV83LTYtMS0xLTU4NTgz_8836808c-e83c-441d-9439-13331421e05d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY3_26951cf3-5524-42c9-b7eb-b73b54eb1668"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTItMS0xLTUxNTYy_481006d8-1084-4727-894a-60249e6a0acf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY3_26951cf3-5524-42c9-b7eb-b73b54eb1668"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGFibGU6YjMyODNlNWI2M2Y4NDI2N2FlZjhlMjhmMjExYzViMzkvdGFibGVyYW5nZTpiMzI4M2U1YjYzZjg0MjY3YWVmOGUyOGYyMTFjNWIzOV82LTQtMS0xLTUxNTYy_85944c39-89c5-482e-9458-11163ccd9b31"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjllNzE3YjY1YzFlMzQwNWQ4NTBlZjZlMzQyYjIwMDcxL3NlYzo5ZTcxN2I2NWMxZTM0MDVkODUwZWY2ZTM0MmIyMDA3MV8xNzMzL2ZyYWc6ODk3NGQ4OGFjZjAxNDU1MTllNzIzNjYwMGU2NmRjYWUvdGV4dHJlZ2lvbjo4OTc0ZDg4YWNmMDE0NTUxOWU3MjM2NjAwZTY2ZGNhZV8zMjk4NTM0ODg3NDY3_26951cf3-5524-42c9-b7eb-b73b54eb1668"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>97
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M'40: [B_$D*_;<Q@Z[YCTG]02P,$%     @ /'MO5*DU"#KN!0  &AD  !@
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M26L@,A*KR%)>WO<4?%S-644=8UT=F$ZQ$#6;^L$U,Q/1%/O.0/O.0.V 9&#
M:59FJSEMP&LQ2<TRJVGS!F1<9#M_"S#\':  )J[Z[8:-VF'E2GA_AG"01D$0
MG$SN^PG90!S"I(_3B.,]<7P<\2/(3G=#A7VR 2%09SISH'3$N8U(,(QB'75A
MH\81BE&BPRYMF#EU/H0V:60_::0-P0.3)MI.-A %K\64M9_>R(O#N0;\>\/*
M$@@EV&9U_I^GU<+]R4-OQ=JSC*6BY%VG@:)I-N)HLQ;7^CUM>+&Z$VO/7<T:
MK2%=_1?:;962P:Z*]ARCG\C1U6J1Q0OBU&@C/T8C'N^)QT<3%TN+\#!-UKH
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M#W%2I:'@C&_VWOAVN/=&FS.R5DK9"2G=.^,V> TJ 86$2%:6/!H!9DYF:N"
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MI31B?^_G#LN6QQ*,IG7%,J;)?#W(*%C,'6Q8'98<QIT+9>4H\8&]C98(E!5
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MC^1T&J[>S#H%N_?=,B9;MT" J^)=EP<-V)DNA/UJ?YT^2;?(S?9T%[^0KE)
MJFF!HWN[SY^-A$OWV_02;!/OE)B"D"[Q)P9.)"QOP/>%M:%[807]/QF._P%0
M2P,$%     @ /'MO5*=B4+)=*@  )H8  !@   !X;"]W;W)K<VAE971S+W-H
M965T.2YX;6S-?>ESVTB6Y[^"T,YLVQ&0+,FV?)8C9-DUX]VJ+D?)[HZ-C?T
M$DD291!@XY"L^NOG_=Z1!PA*U34S$?O!,@D"F2]?OOM(O+UMNV_]QKDA^[ZM
MF_Z'H\TP[%X_>=(O-VY;]"?MSC7TRZKMML5 7[OUDW[7N:+DA[;UD_/3TXLG
MVZ)JCMZ]Y6N?NW=OVW&HJ\9][K)^W&Z+[NZ]J]O;'X[.CNS"K]5Z,^#"DW=O
M=\7:7;OAZ^YS1]^>^%'*:NN:OFJ;K'.K'XXNSUZ_?X;[^8:_5>ZVCSYG6,FB
M;;_ARZ?RAZ-3 .1JMQPP0D'_W;@K5]<8B,#XAXYYY*?$@_%G&_U'7CNM95'T
M[JJM_UZ5P^:'HY='6>E6Q5@/O[:W_^YT/<\QWK*M>_Z;W<J]SYX>9<NQ']JM
M/DP0;*M&_B^^*QZB!UZ>'GC@7!\X9[AE(H;R0S$4[]YV[6W6X6X:#1]XJ?PT
M 5<UV)3KH:-?*WIN>'<MFY&UJ^RZ6C?5JEH6S9!=+I?MV Q5L\X^MW6UK%S_
M]LE \^&I)TL=^[V,?7Y@[+/S[.>V&39]]K$I79D.\(0 ]=">&[3OS^\=\8-;
MGF1/S_+L_/3\[)[QGOK5/^7QGAX8;V:9V?^]7/1#1]3R_^Z9X)F?X!E/\.R_
M!;WWC@UV?=WOBJ7[X8CXL7?=C3OZ)R;,/G=5LZQV-7VDNZ_:IJ=?RH*9Y<O&
M94M_Q979JFH*NKNHLWZ@"\260Y_1\_58NFR@NPN9@<?"]ZMVNRN:NZQHRJRH
MB:PW;5T37+<-C49"I&BJWWFN_B2[I-^K9G#=4A\B_#=]P7S;RP@R.C%@36 0
MQ)OBQF4+YYK,U17Q!0-9-1'0].Q)=NW6 NJ7""22:!W=#_BSX;8EV;)KNZ%8
MU"[K]?X\^T3PK#L>EI[MBMT=#=;=5)C\T?_\'R_/ST_??/IRS9_.WCQF*#^,
M'8_RLRL)[77V\1]CM<-X^X]^^/FCO^C'@'@AY#3$X U)1#SYESZ[@6PCK%:T
MC,78$Q7T?4;B.-N-W:[M'7YS-T4]%KR_M#B6U80F!FI;?,-E630^E6Y9]8+X
M""L XNS%&T+W;M>UQ7*357TVM'C<V<-M0XORC\O&]#W B2?UJRAI:VY<QT!U
M;3DN!WFF-V0,FV*@.=:."*;#/3<541/MWR@[3]-CT2(&G8C?C'ZKJ]\Q:)&M
MQF:I8 64$85V--?8N9/L/<,R[@B:85-%^-NV!%T>4ZI'P-6F<JOLXW>W'*$Q
MLE]6Q$2NRT'"VX2V-T5/BR2Z)0*D:0C<A1.(>8A]E!\#FS12Y["IO9%;Q%U5
M(XI6J==E?VT'EYT]XPVWV\NJ7]9M3RND/?PJ%/"Q'ZHM4S4VE03"KI MPX\'
MN!?<@NFJX8[4SK#)_NWR\C,!1V1+0\<H-4)P-DN.G1^WN\"BOXVE\AIO:[%:
MD>(5T; 5R2!\)GR*ZW-0Y2I4@#7<T[0#$XKKW- F!,NL3O32$;J[:F"&*X*8
MVYF8DUT9-N 4ADS71R1 ?_I(2(858#U^J0;N!*>\SP^)R.ER5B0$VUOZ]AHT
MX)K1T?_+EF# L'E6.R)8(->D*?WJJAN6*BI)VUOF,M!#V8Z+837Z=<MTQ"K9
M4'S',%CI $QMR8CK!725% 1YSD/6;;,^!J,*,P_1#2?9SX$$.N)FJ(HF(T8:
MVHX1[KX3C5?.9$W+C!Q3Q@)/W7CF(+NQ)W;%<JK&1!,P>0#WI!N(DVDBHD>R
MLX#QL2Z) 8BZN@RW=(1PTBNKCGD3FQP]_-[8G6AF 27!,,5$Y!$-?$)/>0FQ
MC!_!Q;7J.<)IS]N5;4EPM26((1 >Q$1%TA,[M2R4>+-5476,6&?ZD83W<@-Y
M9F0LNT-HPJ]#T:PKVW12C?XK=J@7(#KL&#:P*A8D$@?L#J.>KGL93(/1S(:2
M,@)$Q;_[OL1J[X>J)3$^68<]0O?2?;3T557$$$X JYB4VZYD,LO6;5O>5G5]
MDOU]XQHO1#V;I-/\P57GL<2"N.H3]@X,K8K+B#05*]OB3G4,Y$75E<?$]<1$
MGBVR?N? YL0%+%UH)/J8* :5&$H#+,O)A]C?R$0!9</=#DQ%U#SV2C?*SEXG
MTW1>X=R_M__;W1U>L0 (*>V5?6S*L;SF9P;85FOL =WW&PET3#-"MV;+HM]D
M*Q)'L@CH)'X,-E,F;I>P_99X'@_@KJ[JOV%VR'.ZE\$ S_K!!%2&@BT+WDLE
M3L;97\",#D*OKE:DX3]!=)* \)2[(\D4HYY&A)P?%[^Q/FI9^;)/"96G.Z4P
M\FR0:"T1$ZD>W X&85YRV9TK.I,TM&(LE'G?2P2(*__EF"0F[PN$9-/K+D2F
M+3$92(B6U1(]X4Y6PO,2"(O0@9B#:,/&CICA)+L"[C T?X#-232P9_0&;0DI
MMR%GE>BLKNAN")@;(A41OPP"2?=U)585[;4P&6]"YZ WV:<C>JX!I0AVWD 7
MYI[R%$B_HF70/I!V; :1V@#%5*FM8CH2-I1<FJI6&P46>VPO$8T/9B\R27=@
M&^RFXA-[]:.#+*NS#V2"T.X0U= -K$>O6C*B5<R9<?[CAT]79I33E@Y@ V;(
MKAW7FW849@<UY/? [7V5+2(#1D<86^#CZ>&\#*SF5 \5<'*:;[H119,5ZW7G
MUJ"U5%0KE](W @@X92-CN7%+>M@+;(;*0R*X84YG*\QKOUUQ9TJ9R8H&3J2W
M<$EB[NB@&<<>H@7\FEHLEXG%\L$L%G_[I1J'-%<->8$M9.<.['='Y@@[>4NR
MFU2@\![7/>2*&PRLLA(*P!SD$]@%& Z,?")26B*S-W# _G(S""?-V%K1<B(#
MS/B990C1<VV>#"]4O9T[%9;J[G0NF+W%L">R8VG @LLLQAZ>!X1+^=MHK(G%
MW1 G,#")@LX3A>\-;L@+D\+@48]$EF&$$!('*:/>$K,SKZ]F3= 6^ZC# &2W
M(IB&Q!O_OBD(8%72A2<Q& "E<UL/#'9)QA%\-P_9MAB!$$=P5$1RLG-J%C*B
M:("2\ ]ELB$MZXQHI^Z=+%N_9D+C=TH@"2N!(NE_Q=!#T-T2//]R=G)&W$Z/
M(=Y(ZZ<+I^$"L^X'PN9V0=QI82R^D3Z<PBV$:0&GL[Z#9B,' 8:VZV<=]2KZ
MG:FA9T20(B89Q]NUU3A$/^YV,-XQPZXNEJKGBDX--3';[2[H5XNE_*8.MD@C
M&\_YN 9O,M3K4 0*)Y?BEL8C6*#@LD>KJNN'XXJH5#Y!@!*]5OUC*)'&P;<@
M<^IWAIGM%U)J>#)(?H);6+9/S511]KN"E!BVA4TF<KW$32'@4NH6S:XVEH8L
M>J8<DA1W!!!@[@GZXVU[PYZ)HEC"6&+ R@.>+44:K&IS=G$3D:'(/^;#DYEX
MT/X5TSW^BH\*Z=XR< 'S$CN)%Z<XZ<U",=.U4LN#EO?H[+$$$@HP<\=B3+S
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M%V6 >&+KW[KZQHJ\3L)&6WE^SSE6U%*)2\PQ<@32K1RXK$(1^!S]<NS7".O
M@@)G[(KE-Q*:4E2S/XT2B.E3G^6U&N]*\_,:.*ZDG QJKI4J&PA3E%=U[!((
M\JR>=5E$1=G3S1++7&H/8V-^DG96P]+Y^H"956!QM/%E;Z5*+ )#O2G]+""T
MJ@T>N9/U"<P#=UO4C^--XL(HOU.S&\.L1!H?KGLH)B%SI65>\83SX-9(>6)
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M=3M(V><*8;(E.>)C[32] $P3-,VQ;T3B@AXW(+:X?S\;9TDIEV_##_'1+Y,
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M/?MS?^(VF83Q$4E;+_!$9O26Z>&P0#]X6:)I3FQ)4EGWG#0!3UEM6O$V]:0
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M&8$\)=,Z*)%*IT0N4VT@@HKFMN"+]R8H!X\K >GP3P5BZV&RU-0925! @$B
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;*55VV[;.!#]E8$V6"2
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M:&5E=#$U+GAM;*5::W/;NA']*QC7:>491B8IV;+SFK&=N-<=YR83)^V'3C]
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M8?1X,.I?KIH'M@@)Z(G>&8I9$NY+%Z630B,9_>X<WV$S!%DFS48N2W$<11U
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MRM$&K$^M#?6 %#3_#CC]'U!+ P04    "  \>V]4@!EH[6L+  !4'P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6RM6=MRVT82_94IK9.EJF"* 'B-
M+U62[>SJ(;'*<K*UM;4/0V! 3@Q@Z,% $O/U>[H' $&*HA77/I"X3=^[3_<
MK^^-_5*ME7+BH<C+ZLW9VKG-3Q<75;)6A:R&9J-*/,F,+:3#I5U=5!NK9,I$
M17X1C4;3BT+J\NSM:[YW8]^^-K7+=:ENK*CJHI!V>Z5R<__F+#QK;WS2J[6C
M&Q=O7V_D2MTJ]]OFQN+JHN.2ZD*5E3:EL"I[<W89_G0UIO6\X'>M[JO>N2!+
MEL9\H8OK],W9B!12N4H<<9 XW*EW*L^)$=3XVO \ZT028?^\Y?XSVPY;EK)2
M[TS^+YVZ]9NS^9E(52;KW'TR]_]4C3T3XI>8O.)_<>_7QO&92.K*F:(AA@:%
M+OU1/C1^Z!',1T\01 U!Q'I[0:SE>^GDV]?6W M+J\&-3MA4IH9RNJ2@W#J+
MIQIT[NUUF9A"B<_R056O+QPXTOV+I*&^\M31$]1A)'XQI5M7XD.9JG2?P054
MZ?2)6GVNHI,<WZMD*.(P$-$H"D_PBSO[8N87?],^\5Y726ZJVBKQG\MEY2PR
MXK\G1(P[$6,6,?Y.%SZ?6GQ>*Y&9')6BRY5P<IFKIESTGWCL\/B=*3:RW/[X
MMWD4SEY50GOZI4*!JO;*,;>!+D%BZDJ6:77^D_BWDK:)E("?5;%4MO,U_8WP
M%R[$;\/;EM$+$0:C.,9Q&DRCF*_'82Q^->5++!NVZZ)H+!:@#\-07#^M$9%'
MDQF.LV R]NPF(/T.N\%U8TI5NDJ8C%<DIJQ,KE/I8-]2E2K33F36%&*PL>9.
M,XY I_/_GY=^5JFR,N\Q[ 0/U . LU+GXEUM+?2$L:Q\] IG@S \[]UXKS*%
M1:D()R,Q#^+Q%"M&XW/QV3BP9T\_2U9#'T\:^EL';PA8)G*3[!/OB%HVK:*#
M<#H[%X/I%'_1XGRG78QPS:))I[;7KOHK,L ;:H7!=++PS(&M0,ZR3]40=?J$
MLQG6CB90)QZU/CGI!N35E+)K$<SF"W;W-#[_5I9Q@]!NBUZ3<PXY<S3S[F1>
M2]]2B)<L$_7=2?3[$5[2L=@KM=)E29HBOV^4U28]3"'4TNB\.8UG.+U^[,26
MX/"(I6CB%17H48N>HON$ADID4.H4F5=.A##TA(UPT!/6';'S6^%#W  !B<ZU
ME]; PF'X5)8I'@7Z*60IA9MX<[5E3;51<M?.V"TO>7Y@CT2BL7F?HXC"X4C\
M<' X4;8MMW TC+%R,@R)C*F.E))G-QI&W2+XNI"$FR+5\ 0*+"$0C*?#F?@!
M%38?CODX&<[I"!N?E28_($[C!<D![6RXH.-'F&N%3/_ &%,P4H/[A)Z$=!"#
MT7!*5Q^>C,@@C#PKG"R\0K ;BCZG8SB%#F$Q:>Y92DY-I+5;=()[:5-:B\BL
M2+S5%6=!V@(>*2*K2CE/A\Q:(KV</M(V'B?#X9W1#DA;+._Q9T>&K\253"%_
MZ9#-E;)W3=.<S*;-<83D,,F7ES2*IMP%D0X^*@ !E-QT,A6_8IK'W X?DG<P
M]%3H"J,H0MN-XYGXN'O$L>W;M9B/J.>'8W&9)+8^E!%-8C%#![\N[Q!18XDD
M0KN*0/ /8])[G>?L*UTZ6:XTQ:6Q$"Z9QQ$ I$(-)6OQHRPVKV#K'78&&\H/
M@51+-59.,''0SR=0>W<:B7C4W .J3\9-)TA/>#6,@Q RPRA8+&;'_=\WO@W"
M>X4=3M+@"%G#[&C\U]5!W03C**;&%,0+''E3\])D+^NJLWLP7Z#9#Q;QK"V)
MP7Q^?M!$CQJQEV_C8#R*SND84Q>D$)^R?![,8IH%IM/9H8C#AMVC&DAJSO$H
MYO_1OI3>.N3BJ!D,%\$"(HCPTAVI A)#R1^@6C2/JWF=PIY#)<I'*:MXLGL1
M N<*9%4;"MR(VAL!5<G&@T>^'3(J'.+]'IP_EK('!C0>LIF;VFX,:7 O86P\
MWXDD&']D)>N!?2 Q!2[(3MYCW[%-<T!QPV\H+C<83Q\T=IBP <+Z!C_1P_Z*
M3;"!:G))XP2!&QJ(M@V>H^W6E=AR3UMV\P8>P:C%4+R8 GU[JOPUL6MY1P$&
M.WA!E]H1T&3J>)1\.GPK/-!![GNK[RSM=P6$XJF?3[Q]?]2XE6I^#5"Q^$H]
M*5"1R!+>$#6QH8208N,'%/"<D L!Y=YGE(]WU&&66\\P\-B7B;HD\N"8V^';
M*.#>L5J#=U5C+RI+I^%3]"N&'+^88K(UOGZB1WDR0N<_2)-G.?%48';#--?>
M 1<RC?+8 _(!4PGCE)\0R/M4J_A?&:)FW R:VJ<;-*O=T2L;" $J4!\A#" !
ML/$/%#2YOG:T5]\IX6NL"MA6E6O?7?82Q ?*1\'X[J%M4A?D8>#U7N[1AA%\
M:QH7C"@,'(%@5VN=.<(IL9$5''E?*HM[&R!<)=A?4*V&YZRX;=XLQ?-H5ZBI
M.M^7@JQ$B,DF$B/),64-8W-=:-=-JDCD^2Z<B UTJ/V8;16]7",'H"F]W"F4
MK-%@GQ%NXC[&P-5R'_ (I*P#U\9)Q+AAQT#EG-7+VJD*MER7;%EF:NO6XFLM
MK0,%F'I41R+<LV=PMV#G\#Q%),?F1;F"U,H]'K1)*9^_?<QL$+@T, S:63CC
M:ZWI(2?C$T+8G[TVX552#\@T4!)#ZW<QZ7$PPL2;ZS^[V% LCC5!F@441J.4
M9I=Z@\4%!3S#1M+8?KX#!FH'(YP/.F\M@Z/ [OO]EC)EA4+D(;BJLTPGFH1
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M0@T9"0_X')R]N_STX?8,>Y+$1U"5DF&#LZ,"5E?=^YYW'W^_?O\R7*#A(]'
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MQCE3\.E:(2\L+<#SS" :S04)Z#ZDO_T?4$L#!!0    ( #Q[;U20@%TJ- 0
M )T)   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;*U66V_;-A3^*X0&
M#!U@1+:2KD'J&,AEQ?90(&AW>1CV0%-'$E&*=$DJKO]]OT/*BKPU>=CV8I/4
M.=_YSI5<[YW_%#JB*+[TQH;KHHMQ=U660774RW#F=F3QI7&^EQ%;WY9AYTG6
M2:DW9;5<_ECV4MMBLTYG#WZS=D,TVM*#%V'H>^D/MV3<_KI8%<>##[KM(A^4
MF_5.MO21XF^[!X]=.:'4NB<;M+/"4W-=W*RN;B]8/@G\KFD?9FO!GFR=^\2;
M7^KK8LF$R)"*C"#Q]TAW9 P#@<;G$;.83++B?'U$?Y=\AR];&>C.F3]T';OK
MXK(0-35R,/&#V_],HS^O&4\Y$]*OV&?9UU4AU!"BZT=E,.BUS?_RRQB'F<+E
M\AF%:E2H$N]L*+&\EU%NUM[MA6=IH/$BN9JT04Y;3LK'Z/%50R]N[ES?ZX@H
MQR"DK<6=LU';EJS2%-9EA D6+-4(=YOAJF?@5I5X#X0NB)]L3?4I0 EN$\'J
M2/"V>A'QGM29.%\M1+6L5B_@G4\.GR>\\W_CL+C701D7!D_BSYMMB!Y5\]<+
M5B\FJQ?)ZL7_%>;_ "?>>=>+B-81T>5_;47L2#A?:XO6$\H-/F#?" V$[1"
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MU0'&)[CS1FL\!5Y@OHR*7U!+ P04    "  \>V]4H #HN:L'  #.$0  &0
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M^ZS;.;!QV?4L/6@E^C/12"H1E 98B9#3<WB0B>;+^OT.4HI,PZ%3NE%V]<8
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MH#1;L$WR(F2@:(9,*P[%X/;\^4K81V]0M"=Q3M1;]+ F+$ !BRCJ+Y#81[I
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M+ _CXX@#;=X^,57(*M2^5?6&>)726UF/2=Q6L\$RK/R%KCS%:&)$IIAX 0!
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M/(P:G,W3B=A0-I_ZD]:8=>;%:_D4C#1[8P-=Y_<8:O>6Q"$"C_1!N+KHI*L
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MVYHCJK%"9:6G:&1"4H79I?ST2,CPW>.+% ^)Z#[H=?8-&"P/V:CP!;WCJ$>
MMDO ]9U'$303G=<&H$$8-P7Z3-WM3?8"KXZ(COO7\'9!;UE9 V8\H#/-OJY:
MDJ+<NK%JVB.%!IK-U=<7%FI[AO=F19MDGWFWXSQ8].9B+1*/+HS>A:C]7$&.
M'($B/#]925-"(!Q^,90,?8TN*,UKX<;!"*-B=VK;CF^H0<6OC7="17#:D9CD
MA*TSM$K>H&X39E0&16:XQ6SB%T$6W.A_G7&_YWG%9S\I&KEBK PCAGV$T24O
MP(P/H[,:BI<J?-]E+T<BD*UEEN,"K@[]Y3DPRU2FO[)%/G>5"=DZ&]UX]&%8
MTM;RI0X\<T&S?K[!3O'@+XJT $LAL?(P.&'12-R'U&AT$1U +N F+VID%354
M51(]"P"^8O(TA  C21Y/80KSP$45<[B7H1SJ ,))?1+:U^</-9[#>8NS[>_;
MIFY0H!#4VAL9^7A<N_R+GW%"@OW!JN+\\MM9]L%I35SV 3+^@^/I]H]LQ,R+
MQZ$866TI/X%I/-X'$W0 %[]$7$NLN;%X&\T)$SAA^DE_9S(4/'J)*UYB&%<*
MX!7?R)K.,FO/5[!QRK\T==&H=7:.%UKB9?+<COU!"BA^>??ZMP]GCZ6E7&@W
MK-#*ZRZ36#0/ Y'1.9+5LD%J(;OU\_7M:\VB&TJOSB_IQ[,'<?HRNUV2^7IQ
M)D46N#N4,TACI6Y["MD2V_>%$[X\@E;69K"3>$_RQ3KVJ$EL;<_/XTR-C4AA
M<_#(."U0VN1<I8-G1UM*&U 7\<0V]GG\(&D9;IJ,/\66^7S/,04:XT$B/T)>
MWSS$39-\E=1Z:;V$-&&I.Y(D7:U&3 P(LBN6&Z\"L$IC!ILUK$D,TZ.2M,M!
M[*1S\<ZM3GHZO!>?2E2^PEINE_-[^,(-!Z\-8O*5GB$MP!/0M=)!$Q=6&V$)
M9CDQ81+G6_OR+O$\DSZ240.%*E_-6X!WAIJ#7L^G&>=OS07_>G[UU*<MIZUG
M9:&G\^>/LQL)>__2@#;41;>A9'1!U+.4#' 4-;#B4BT,N9^R?#SSJ9+S ,0O
MYT +6*>E6C,9; ;NW305$\'DPE)58:\_SOSHL+&:3>K^$XO+8NFA/D/"E/'P
M2>>[A7G6M$Y[/]+^-_&&44TH5(Q9SP)Y7'RL0QTD6Z\7% Y]#7&<,^2E^,U(
MOJ:;]7N*'^%\!M]#/O(/\J33\6@[8S.N..?U8\I A574&A0"3.);)2,S8>BC
M'8B13N?UM^9.'"\9(.K)F8@JWVN)0UB0DQR0=E52%O9@5=B<S^'V[0W=5J'=
MR56E#?8U!.*QWUBU/L8!:HH(Q:9;VABK."LD7K)0X#>(>@*FY:.8@HUU284(
M3_,/ ;IC"^\/4!-"6P^AA[;CC^:@&*Z,2L92R,JXHCEZQT0JX,*AZ]B)$Z[U
M[&C4:_S+Z&7VIKPBIVO2K'S"SWE#-N]//VQ=NW8WY/-P*UA-%A]:0/RWL$[0
M@?7R>G[VA.X,E__TPRY?NU_S=@U;K'(KNO7RXKMG9U(&8A_Z9H<ED1_JFRW_
MN7$Y'3TNH-]7#;D"^@$/X*X9@/?3?P%02P,$%     @ /'MO5$P%D@$U P
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M8 \*=%665&TO62$WDT[0V1U\Y:O<V(/^=+RF*S9GYMOZ0>&NWZ!DO&1"<RE
ML>6D,PLN+H?VOKOP)V<;?; &:\E"RN]V<Y=-.KXEQ J6&HM <7IB5ZPH+!#2
M^/&"V6E46L'#]0[]UMF.MBRH9E>R^(MG)I]TD@YD;$FKPGR5F]_9BST#BY?*
M0KL1-O7=>-2!M-)&EB_"R*#DHI[I\XL?#@02_X0 >1$@CG>MR+&\IH9.QTIN
M0-G;B&87SE0GC>2XL$&9&X5?.<J9Z6<ILPTO"J B@SMAJ%CQ1<%@IC4S&KJ/
M%'>Z-^X;5&9%^ND+\&4-3$X !P3NI3"YAAN1L>PU0!]9-E3)CNHE:46\9NDY
MA($'Q"=!"U[8F!XZO/#_F7[-=5I(72D&?\\6VBA\0/^TJ(T:M9%3&YU0.\>\
MRBK4(Y>PHW#,O:TH-E<O])JF;-+!9-1,/;'.]#%GD.9H!]/ !1B[I4IMN5C!
M$RTJIW.U,WNQ!<U6F& &*!I)-2QE@4F*47?"LM+H&=V[@.O[&YBC"IXB<)?V
MX)(65*1.!A$Q,*Q<,+4+C@]G\.LO"0G(;[!W<OJCXHIE$'IQX/\$(4"$^I[5
M9LVZ>YPW;',4$A)+0BH5/JW&HG-H"<^@"<^@-3Q7.X?-2EE9U^#CF*5I558%
M-:@,CY7A_U)74Y#Z78:4^)+;/'G_BHX%ME5_2V!WQ.B>&#T@1M\0XWLNM'[1
M&_:3,+^+POO(?E92ZUV*G/3+%_R;?/SF%REVY"W;]\0?%<T8X"5\?F= /-\_
M?&+[DWI^>S[[,#8)H4O"7H/P=O^0;S5/.17.^75U1N<H5CAC=,[7&L+$2\((
MNNBRR ]Z$'M1&$(X] ;VE"3>B$3V=(BO^YM8HTN$]8IA:2YD(5=;&$6H-["*
M$[(WY^V,7ON4RG+-#*__;RO%F,T/#5%,H#N,>Q#Y@Y/R<[DT&YOX08#4,--P
M)H.D!P2E[=J>C;SA$'G@C6$,C]+0 C/O5;3<,VSU\!D,0B_Q"2ZZ$?&2F/1P
M&?C>*+1!BT9>G,3V(WH.G>(^!EX0QVWI/&S2>?CA:GO+!3?LTQ_8!API^![<
M5L96^U?O\^89VQ_-CN5QJ^+C>6S14AMMQ6S#Y+)9B J]^BI[6:T4$U6Y(B[8
MLX$ETH8MHTJ[\_=^;NKAJ9K*=5OVXQ5BA] .D1T&=AC:(:[+X#&.-LNB483S
M:.0W8Q+8<4 B5\@#1#X6R_Y!WX*)M'+=F8;4UK>ZA6E.FP9P5O<]^^MU]WA/
MU8H+#05;HJA_'F.5575'5F^,7+LN:"$-9JU;YMC$,F4OX/>EE&:WL0J:MGCZ
M'U!+ P04    "  \>V]4U2[7B$$$   F"P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6R=5FUOXS8,_BM$5@PIX#5^BYWTD@!]N=L&M+BB[6T?AGU0
M;"413I9RDIQ<]^M'RH[7KDE:W!=:;WQ(B0]I3K;:?+4KSAU\KZ2RT][*N?7Y
M8&"+%:^8/=-KKG!GH4W%'$[-<F#7AK/2*U5R$(=A-JB84+W9Q*_=F=E$UTX*
MQ>\,V+JJF'FZY%)OI[VHMUNX%\N5HX7!;+)F2_[ W9?UG<'9H$,I1<65%5J!
MX8MI[R(ZO\SHO#_PA^!;^VP,=).YUE]I\GLY[87D$)>\<(3 \+/A5UQ* D(W
MOK68O<XD*3X?[] _^;OC7>;,\BLM_Q2E6TU[HQZ4?,%JZ>[U]C?>WF=(>(66
MUDO8-F=3M%C4UNFJ5<9Y)53S9=_;=WBF, H/*,2M0NS];@QY+Z^98[.)T5LP
M=!K1:."OZK71.:$H* _.X*Y /3>[YG,'_4<VE]R>3@8.(6EC4+3JEXUZ?$ ]
MBN%6*[>R\%&5O'P),$!?.H?BG4.7\5'$:UZ<01(%$(=Q= 0OZ2Z8>+SDV 6O
MA2VDMK7A\-?%W#J#9/C["'C:@:<>/#T _H Y4M:2@U[ #>[1]\KP4CCXQ HA
MA1/<[GO5H["4B.=VS0H^[6&F66XVO#=[7'%8:(E9)-02'$4,A)0UW<9Q"P[W
M%68QVS AV9R,/T&-43%^R_"-EAM2+1H'%YV#P"PY3J?8>BU%X;'G3#)5<&AJ
M0XDVH"\4GM*U9:JTI^> L>+5' WLXO5J)83[SF[[(D_G\*O1UKYT] 3R81"&
M(0ZB*,B'(7RNG75HB%1+P[86^DD<C//T%'[^:11'\0>XX<YQXYUO+]7/PO 4
M^B.2-Z@LM2FA?4+;Z?6C+#Z%B^?VL4"\]A2=2:,@C3/R*@SRT0B.D&;8D6;X
M;M+<,E>;)@A$(:V6O^"-*B#6[N/-4>3#O+G2U9JI)UBQ$A:UHSRH7E@6SH+L
MK)>4,PTI7H<8UQL:VE=\P/V81$(B)3$DD9'( 0_!HW9,[G_I77#>&C4DV+?T
M&1EL8"$4\I; 4W1D=^BM+YUMG#OQXQ_Q(@F2<7Z,(5G'D.S=##G$A*,([ZD@
M C,0YO@C_UKJK=H5@)8I_E;Y!XN_(&.X<CYX_R/(CU2#JQ;.,_V1H)I'/[3^
M!E.Z*.P)Q^N1QY6:J<,L"+)H"%$>)"$R-PK&Z/+';[585^0</?)!U2C TH,
M*<K,5[(XC,; WZ<=!T/4R+W$2D/JQ]A,XYR2"_-MG.9^WCY!R\)QD*;H GXP
M\Y)1,,IR^*)8I8T3__ 2-DS6GE\^E,+:VA?[0ENL!'TJLOTXSE FOJ!&.8IT
MC"+#Q5VB).FX>?L\'34)$*+I$S+N4PC-)[G?00?":&]J#)[U+A4W2]^A(>]T
MK5S3QG2K71-XT?0^_QUO.LA;9I9"82'C"U0-SW*LEJ;IRIJ)TVO?"<VUP[[*
M#U?8R')#!W!_H;7;3<A UQK/_@502P,$%     @ /'MO5%[]0#LQ!   A@H
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M/,TMX;.D01$M"]!Y;HQ?+]A!-WI._@-02P,$%     @ /'MO5+@:F\IV!@
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M.T3AIR%J'"]3W$?5W&/%<0J'.?4T6J9MM!]HZ?-P\4<SC*K1K$SQP+]-W"-
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M@'-'LGD\KJ%1NZ<+W+Q^I5_YP]O#+*B&"\E_L,P4D^@T0AGDM.;F3JX^P_I
M \=+)=?^$ZV:M:-AA-):&UFN@VT&)1/--WU>%V(C@.P*(.L XO-N-O)97E)#
MIV,E5TBYU9;F+OQ1?;1-C@FGRMPH>Y?9.#.=U=K.:(TN9+E@@KI2:72,KH6A
M8LD6'-"YUF T.D\?:Z8@0Q\NP5#&]2$Z0$R@;X6L-169'L?&)N2P<;K>?-9L
M3G9LC@FZD<(4&GT2&61_ F)[DO8XY/4X,Q(D7D)Z@GKX")&$X/OY)?IP<!C
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M5+U.H)3UR N]G6'!UH6Q!C]--G0-#V >-W.%)[]CR1D'H9D41,%JY(W#V^G
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M"BF#WB?4I)K)T1R,W+CF6TJ#K>RV!0Y;4-8![U=2FMW!!NC&=_H'4$L#!!0
M   ( #Q[;U1J/TMJ>@,  %8.   9    >&PO=V]R:W-H965T<R]S:&5E=#0U
M+GAM;+5778^;.!3]*Q;J0RMU!VP^0JHD4F=HM2/M2-%DNONPZH,';@@JX-1V
MDJFT/WZ-(4" H#127A(,]]R/<Z(3[NS ^ ^Q 9#H+4MS,3<V4FX_F:8(-Y!1
M<<>VD*LG:\8S*M61QZ;8<J"1!F6I22S+,S.:Y,9BIN\M^6+&=C)-<EAR)'99
M1OFO>TC986Y@XWCC.8DWLKAA+F9;&L,*Y+?MDJN366>)D@QRD; <<5C/C<_X
M4T!( = 1?R=P$*UK5(SRRMB/XO 8S0VKZ A2"&61@JJO/3Q FA:95!\_JZ1&
M7;, MJ^/V;_JX=4PKU3  TO_22*YF1N^@2)8TUTJG]GA3Z@&<HM\(4N%_D2'
M,M:S#13NA&19!58=9$E>?M.WBH@6 'MG *0"D"[ .0.P*X!]*<"I (YFIAQ%
M\Q!021<SS@Z(%]$J6W&AR=1H-7Z2%[JO)%=/$X63BV?80[X#] PAB_-$:_$^
M $F35* 7>),[FGY ?Z!OJP"]?_<!O4-)CEXV;"=H'HF9*54/128SK.K=E_7(
MF7J8H">6RXU 7_((HM,$IFJ^GH <)[@GHQD#".^0C3\B8A$\T-##Y7!K !Y<
M#,?3D6GL6@];Y[//Y4L$C6,.,=52L#4Z*O3O7RH4/4K(Q/>10DY=R-&%G''A
M!R4LD:Y&%L:Q7V"+V#Z9F?LVL?VPZ<3V_=.HH!_E8XS=.NJD>[?NWAWM/DBX
M,@ZTI+^ *X9R25,Q0HI7I_5NR_ZD+C2YFOT2Z;4((U/;ZI(_$.6[Q.V0/Q#E
M8.P-D^_7S?N_33[Z#SV^K- *8O6G($<8FM9%IK>5 EN-!5I7BU%!VPQBXEI6
M1XVA,.QWPX+!,*L5=CI!R\3Q-8H$3U^4(GR?A" ND :3IAZYL3B-'V+[>G'L
M/IU>C_6'P;!)7YR!,!N?%:<Q6CSNM$O.HIU29T73[ABG&1OSP^Z-Z6\,$7O7
MT^_U"7-=['3I]_I_)Q/;G73I'PAS;/N,5^'&:?&XU9[0?[%-X<8,L7]C,1I+
MQ-/KQ9CVK?[<;Y<TUDC&K;%+WF\Z"FD<C.#;LD@:\R+D:A8KZ,F/T+5[/)JM
M%^X,>*P7%X%"MLME^>9:WZV7H\]Z)>C<OU=+4[GB-&G*C>N)\CC)!4IAK5):
M=Q/5$R^7F/(@V5:_UK\RJ98$?;E1BQ_P(D ]7S,FCX>B0+U*+OX'4$L#!!0
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M64AC9]%O*RNOJ)R#O5]*:;:&"S (=O8/4$L#!!0    ( #Q[;U0RX)@>V (
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M$!X[(-#YUVR<-\D?V)'_ME;7_]_R80B] 98AS(M<Z ^X[%X_U!\CMXAO2"$
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M4&)>;)F*"\GV^:YCS:3:P^2G.[7-)%P/4,\CQN3;A=[(5!O7^5]02P,$%
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MNG/6+.N2"#(><;8%7*EE-G70U*:)EJO)*W4;[P275W,9)\:7]%& ,W"WNXN
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M)Z%%(@OFLJ1!B/T@O)>_3U (,W!R+^+>SL*;T!!K&N*?IB$^3D.+! V=E=5
MQ*\ 1'S\I= B2=SV- _Q"WG8Q@U]EDP)#,UF#'K;@6HO]@_"%WE5@X+.95QX
MGL@$?+>]N3L1;-7L$#XR(5C9'"XIF5&N!/+ZG#'Q?*(V';M-YO%_4$L#!!0
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MS.\3*:(N16121$=2/(]FJH@ZS5#Y+#8V6-U!7C/?"\/4?>T?Z6%0D@1[0?D
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M<G1^H4L2S11N-HK7=BXMN-)3SBY+?7&!, #]?<FYVFY,@NXJ3/\!4$L#!!0
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MBD83VX*Z[>HV0-7XQM@HM&WFA[5]"$&[!+N^50I/@>NU_FDM7@!02P,$%
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M%>5J@/S^EC&QO5 O9-0O0YW]"U!+ P04    "  \>V]4O_6A]-H"  !0"
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M2:<W4/GPHGX5'<EVYD5?,ZGJ@VFFJN0#UP UOV%,GCHZ0/4G8O(/4$L#!!0
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M<F%^8=/$^@ZDE9"L:, J@X*6]9-L&R$. &'O B!L .$)($@N *(&$%V[0MP
M8J-,78K184HD&0\YVP#7T8I--XR8!JW*IZ7>]YGD:I8JG!S/EH3CK58N@P=6
MJ.,DB-F06YBI,Y95.0*;P\6P]UO=1IB8*37P@5 .WTA>&=R7E8X2<#-%26@N
MWFA>R=*7=N86OLZF<//7FZ$G53TZ*R]M<I_4N8<7<@]"^,Q*N13POLPP.R;P
ME!"M&N%>C4EH99QBZD(4O(70#X..A!ZNA_L=\.G5\.#.4DW4[FUD^*+_N[?W
MG)-R@>KUE?"\.]K<1[(SP_<;PC/X[Y.BA(\2"_'#DE#<)A2;A.(+">G#DDJU
MRIKE*I.<RAUP(O&M/MFTJ(JN,V"GC"/7]__NVJI7<.$%W-2.B_KGN",M>JT6
MO3_5@FPO:6&GC#MRJ[6PXWK!)2WLN&CPBA;]5HN^E>B)BA>8<T2@I42.0KY^
M+.R,OAL%G4J\!@N[A;## G=@U2%I=4C^4(?+1\+.Z+N]N%,'.RQP>_U.'>RP
MT(U.84<Z#%H=!M>]&[GR! *(A$S)H.^3A?KCDG!#2]@AX:+STK!S1S42$BCJ
MNR.(%/M.=(ET'5/4,'7I96>(SW)).G(YDO"NE?#.2OW=&!XE(5DC5P8.YOI>
M7N_O9=;<OD9/%:45K40&*U2>4%\'G<K62P[,DMI0KL=]=5"&WOI0M/.@R!TD
MQT'3\Z# [0=MT%')@?_;R_C6HO]EDN3ZW>%4&=/TO%S<(D^I./4*C=FHR7L'
M2<5A/(C]X*3"CL H2I(D\D^J[ CLAW'<5Z;</ZG5.[!P!?*%L<("4E:5LO8O
M[6AKM^^-R3P9GV@;;JSA;YK:PW\F?*%T@1SGBM)W$Y47KVUQW9%L98SB,Y/*
M=IKF4GU*(-<!:G[.F-QW] +MQ\GX%U!+ P04    "  \>V]4_H-W,O@&   X
M)0  &0   'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6R]FEMOVS88AO\*8?2B
M!=I:/.A4) &:J-L"K&O0M-O%L O%IFVA.K@BG63#?OPHR1$M\A-E;^UN$EMY
M>7CU27Q>*CI[J.HO8L.Y1(]%7HKSV4;*[9OY7"PVO$C%ZVK+2_675547J51?
MZ_5<;&N>+MM&13XGGA?,BS0K9Q=G[;&;^N*LVLD\*_E-C<2N*-+ZSTN>5P_G
M,SQ[.O Q6V]D<V!^<;9-U_R6R\_;FUI]F_>]++."ER*K2E3SU?GL+7Z3L*!I
MT"I^S?B#./B,&BMW5?6E^7*]/)]YS8QXSA>RZ2)5O^[Y%<_SIB<UCZ_[3F?]
MF$W#P\]/O?_0FE=F[E+!KZK\MVPI-^>S:(:6?)7N<OFQ>OB)[PWY37^+*A?M
M3_30:0,V0XN=D%6Q;ZQF4&1E]SM]W)^(@P8X&&E ]@V(V6!L!+IO0(]MP/8-
M6'MF.BOM>4A2F5Z<U=4#JANUZJWYT)[,MK6RGY5-W6]EK?Z:J7;RXG(GU!$A
MT"U?JW)*=%UV%U-3E.<)EVF6BQ?H%?I\FZ#GSUZ@9R@KT:=-M1-IN11G<ZDF
MT70U7^P'O.P&)",#8H+>5Z7<"/2N7/+EL(.YFGUO@3Q9N"3.'A.^>(TH?HF(
M1S PH:OCFWM \^3HYCAVN*%]06C;'QWI[ZD.'_FVJF56K@<5^?UG)4?7DA?B
M#\=@K!^,M8.QD<%^40M+S>]YN>-"U9@_2EZ7:0Y5M>O(;SMJ%I/["^P1&I&S
M^?WAN;9E<4BC:*A*;%6$,?9[U<",WYOQ3S&3E>-FNHZ"@_$]P\>D(G$I!O,/
M^OD'SOE_JF2:H_+ !33UP!H6K(,M@^I@JQQU"'L?H=/'CW6EUI-M7:TR"3D(
MK4$#=>N$A@%;Y4>A'QL&;!4+HH.3,3 0]08BIX%;12%UX[U$:U[R6M5$K70H
M7:K5-Q.R3AM0J5M%D5? )8KLJ8<T- W:*A;'U*AC J@H]4/88-P;C)T&KYM;
M@POYY (R$5L#O\*V"4A%?-\P :EBC\$FL*?1Y3EM?) ;7KL\[-L/!XX"PP.D
M(N:%!HGBD3+@ _ABIX-+=8&INP2MZJI0"]:B*CB2Z2-\6>W[&MSZ 37-V*(X
MC"PWMNK585]#.T3;(9,K<.<"G#^QY\^(N?!"JI!:]P4DHP$><:#AB^D1:W J
M!)=P#2AP>GW[D@)D01QCTX0M"V-"QFX,377LQOK-KEYL5!@6J%JA@B^SA3+%
MO^ZR;1,M0%_,/IU^$%J^(%EDUC"!9'$0Q".^-."QF_ )5WN;1=9%H791+IJ,
M]%=W0'E5S$_+=7:7<U<-;7)C%A#?] K)/%.60#)"V0B"L X#V)T&KJI:!<!4
M\M;HNSQ3^&E]"D?NPYK1./S^,1-KHF(W4D\(FMA&GK5&3$H2IV1H0E,3N[%Y
M0L#$ /+\T+=6:TA&0\L,(*/A09H;[ILT0(D;H,<E3@*@#_ "RFPOD,SA1:.4
MN%$ZE3J)C3SSLIJ6)$[)<.::FL1-S?\:-XF-0BAO C(H<$*R\<1)-%F)FZS'
M9$YB\Q *G:#,3IV@;#1V$DU7XJ;K9.PD-OZ V FIK-@)B<9B)]$<)6Z.GA0[
M"0 X*W8"(B!V JKQV$DT*LDQ&^=QX!-[FTL\S[K[CU$E4ZJA!8UCXMXSGY[8
MB+WUM1Q-2A*G9.A%LYZX6?]M4AJ9C@'3DL0I&?K3,8!,[)X_W?9/2_]&'[:\
M6:-5@-H?<^4SJM%,O>^?SZBF)W73\X1\1FT$!KX?&X^6KB 9]D(3-X#,QSX;
M*1+54*736]$CLQJUB6=>:=.2Q"D9FCAX%'S,;G0JGU&;<V!! !E4$%OF*HBF
M)G53<RJ?49MTC'C,I"8@HW$84M,%(*/>&&JH)B=UDW,*-=0F7.#%9@B^@F01
MLVMARWQ&XI&])=7 I&Y@GDX;"CUV]JD9 P!9[$=6<8#.&,'!B"T-4>J&Z+<!
M#[61B+W(BF^@+/3,)^R +&9C:9IJQM()QKY_IWA3WV<++OXUC#3Q:/P__$]*
MLX^YMZ6G_%?*WDW2((R842Q01K%1TP20D5AM=>%J,4U7=A)=73!B  _MO3:D
MLK?:@&I\I\TT6ID;K<=1B0'[2*(F:3H!9#@P[[8$D%%*Q]9SI@G+W(2=HA*S
M:8@C[&/3!22+;1> C$9XY+DH._@OKINM4U1B  U98%[^5X",!#XV=W&0C!P^
M2!BZT&QE;K:>3B4&\!$SZV8!8$O,"S&!^F+^V 6F4<O<J/TV3-H/X@_N9!J;
M1@$5Q9916T6BR%SCY@>OE!2\7K>OY@BTJ':E[%[-Z(_VK_^\;5]Z,8Y?XC=)
M]Q*/[J9[I^A]6J^S4J"<KU27WNM03:GN7M/IOLAJV[ZX<E=)617MQPU/E[QN
M!.KOJZJ23U^: ?J7I2[^ 5!+ P04    "  \>V]44FRAC8<"  !?!@  &0
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M05..62@_U"S0X SE+, \Q2QT2FPA='E8[]D\Q2QTVOV;ISW9?GA?PJ64*+_
M5UC87_"JF!OF7]HUA5&2^I5>JZ:J+F'?C?JD>?G\CZ#G?S-]^ ]02P,$%
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M^C=02P$"% ,4    "  \>V]4!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #Q[;U0S:VP"[P   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( #Q[;U297)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ /'MO5#8V_[%N!@  SQD  !@
M         ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( #Q[;U3Z"J9X%@(  &$%   8              " @;(.  !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  \>V]4D*?@;1L&  !=&
M&               @('^$   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!
M A0#%     @ /'MO5#PV' R] @  TP@  !@              ("!3Q<  'AL
M+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( #Q[;U2I-0@Z[@4
M !H9   8              " @4(:  !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6Q02P$"% ,4    "  \>V]4O@NFH_D&   1)0  &               @(%F
M(   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ /'MO5-Y&
MM3;2"0  MRL  !@              ("!E2<  'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+ 0(4 Q0    ( #Q[;U2M9,%8F08  ' 0   8
M  " @9TQ  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  \
M>V]4IV)0LETJ   FA@  &               @(%L.   >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&UL4$L! A0#%     @ /'MO5*U9TPF]"@  ^1L  !D
M         ("!_V(  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M    "  \>V]4-!)9+*8#  "$"@  &0              @('S;0  >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( #Q[;U2X,0YZ$ ,  # '
M   9              " @=!Q  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L! A0#%     @ /'MO5)GZCLLV P  #P<  !D              ("!%W4
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  \>V]4W+:V
MVDX%  #M#   &0              @(&$>   >&PO=V]R:W-H965T<R]S:&5E
M=#$T+GAM;%!+ 0(4 Q0    ( #Q[;U1G&G-BT0P  +$C   9
M  " @0E^  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @
M/'MO5"[X/X54!@  &A   !D              ("!$8L  'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6Q02P$"% ,4    "  \>V]4@!EH[6L+  !4'P  &0
M            @(&<D0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4
M Q0    ( #Q[;U20@%TJ- 0  )T)   9              " @3Z=  !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ /'MO5#390B"?!
MVPL  !D              ("!J:$  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"% ,4    "  \>V]4S+WJQ+81    -P  &0              @(%_
MI@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( #Q[;U1@
MQFSCLP4  ,4.   9              " @6RX  !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&UL4$L! A0#%     @ /'MO5!:=C0?^ 0  F 0  !D
M     ("!5KX  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
M"  \>V]4H #HN:L'  #.$0  &0              @(&+P   >&PO=V]R:W-H
M965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( #Q[;U29'? 7CBH  .*.   9
M              " @6W(  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L!
M A0#%     @ /'MO5$P%D@$U P  A 8  !D              ("!,O,  'AL
M+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  \>V]4N)>8M(H%
M  #W$   &0              @(&>]@  >&PO=V]R:W-H965T<R]S:&5E=#(V
M+GAM;%!+ 0(4 Q0    ( #Q[;U1\9$%6! ,  *@&   9              "
M@5_\  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ /'MO
M5*>2N%FY @  8P8  !D              ("!FO\  'AL+W=O<FMS:&5E=',O
M<VAE970R."YX;6Q02P$"% ,4    "  \>V]4I(T9>- "   +!@  &0
M        @(&* @$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0
M   ( #Q[;U1GQ!*[6P0  "(+   9              " @9$% 0!X;"]W;W)K
M<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ /'MO5-4NUXA!!   )@L
M !D              ("!(PH! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q0
M2P$"% ,4    "  \>V]47OU .S$$  "&"@  &0              @(&;#@$
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( #Q[;U2X&IO*
M=@8  $T2   9              " @0,3 0!X;"]W;W)K<VAE971S+W-H965T
M,S,N>&UL4$L! A0#%     @ /'MO5',%83X6!   _PD  !D
M ("!L!D! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  \
M>V]45,L7XX4'  ![%@  &0              @(']'0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( #Q[;U3U;YBTMP0  $P,   9
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M970T,"YX;6Q02P$"% ,4    "  \>V]4@W4U61L#   ^"P  &0
M    @(&W.P$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (
M #Q[;U1X@HKD: 0  +(3   9              " @0D_ 0!X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L! A0#%     @ /'MO5!K%NL5$ P  K@P  !D
M             ("!J$,! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"
M% ,4    "  \>V]4HCJRVV0"  #*!0  &0              @($C1P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( #Q[;U1J/TMJ>@,
M %8.   9              " @;Y) 0!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&UL4$L! A0#%     @ /'MO5'?/(A9B!   /Q8  !D              ("!
M;TT! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    "  \>V]4
MC)R"[%8"  "\!0  &0              @($(4@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;%!+ 0(4 Q0    ( #Q[;U0RX)@>V (  '$)   9
M      " @954 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%
M  @ /'MO5$:">69N P  K@T  !D              ("!I%<! 'AL+W=O<FMS
M:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "  \>V]4=K:1R%4"  "W!0
M&0              @(%)6P$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+
M 0(4 Q0    ( #Q[;U17E,'F:P(  $(&   9              " @=5= 0!X
M;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ /'MO5-Z+#OB3
M @  00@  !D              ("!=V ! 'AL+W=O<FMS:&5E=',O<VAE970U
M,BYX;6Q02P$"% ,4    "  \>V]4^%Y%M&,$  "[%   &0
M@(%!8P$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( #Q[
M;U1!RK&48@(  $(&   9              " @=MG 0!X;"]W;W)K<VAE971S
M+W-H965T-30N>&UL4$L! A0#%     @ /'MO5&^47GUO"   *3D  !D
M         ("!=&H! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
M    "  \>V]4BN"C/<0"  !'!P  &0              @($:<P$ >&PO=V]R
M:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( #Q[;U1M'5#Z;@,  ,0.
M   9              " @15V 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL
M4$L! A0#%     @ /'MO5#JA=+F)!   <!8  !D              ("!NGD!
M 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    "  \>V]4W#3\
MU#$"  #!!   &0              @(%Z?@$ >&PO=V]R:W-H965T<R]S:&5E
M=#4Y+GAM;%!+ 0(4 Q0    ( #Q[;U0[-*/67 (  /X$   9
M  " @>*  0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @
M/'MO5&*,&4W) P  D P  !D              ("!=8,! 'AL+W=O<FMS:&5E
M=',O<VAE970V,2YX;6Q02P$"% ,4    "  \>V]4OYCL%-$$  #A%   &0
M            @(%UAP$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4
M Q0    ( #Q[;U1$O [*FP(  #<'   9              " @7V, 0!X;"]W
M;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ /'MO5+H'(CU9 P
MY@L  !D              ("!3X\! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX
M;6Q02P$"% ,4    "  \>V]4W7P@2M("  #Q"   &0              @('?
MD@$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( #Q[;U1S
M[JJ&/0,   4,   9              " @>B5 0!X;"]W;W)K<VAE971S+W-H
M965T-C8N>&UL4$L! A0#%     @ /'MO5.&MX=EM!   &1$  !D
M     ("!7)D! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #Q[;U0-&_@\D@(  &X'   9              "
M@=:H 0!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ /'MO
M5'*Y683%!@  &"4  !D              ("!GZL! 'AL+W=O<FMS:&5E=',O
M<VAE970W,RYX;6Q02P$"% ,4    "  \>V]4O_6A]-H"  !0"   &0
M        @(&;L@$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0
M   ( #Q[;U2A"0VV0@0  'D0   9              " @:RU 0!X;"]W;W)K
M<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ /'MO5(G8'(:T P  /@T
M !D              ("!);H! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q0
M2P$"% ,4    "  \>V]4=ZUN@NX"  "U!P  &0              @($0O@$
M>&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( #Q[;U1=.H80
M# 8  !8A   9              " @37! 0!X;"]W;W)K<VAE971S+W-H965T
M-S@N>&UL4$L! A0#%     @ /'MO5++.<G"X P  J P  !D
M ("!>,<! 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    "  \
M>V]4_H-W,O@&   X)0  &0              @(%GRP$ >&PO=V]R:W-H965T
M<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( #Q[;U12;*&-AP(  %\&   9
M          " @9;2 0!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#
M%     @ /'MO5$O*??4= P  ,!(   T              ( !5-4! 'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    "  \>V]4EXJ[',     3 @  "P
M    @ &<V $ 7W)E;',O+G)E;'-02P$"% ,4    "  \>V]4(5\"8RD&  !1
M-0  #P              @ &%V0$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ /'MO5*N<,4MN @  VB\  !H              ( !V]\! 'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ /'MO5$3DWU@> @  ERX
M !,              ( !@>(! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/ %D 60!F&   T.0!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>245</ContextCount>
  <ElementCount>519</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>75</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - Consolidated Statement of Operations and Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome</Role>
      <ShortName>Consolidated Statement of Operations and Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation and Nature of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BasisofPresentationandNatureofOperations</Role>
      <ShortName>Basis of Presentation and Nature of Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2115104 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2119105 - Disclosure - Medical Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/MedicalEquipment</Role>
      <ShortName>Medical Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2123106 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2127107 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2133108 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2139109 - Disclosure - Derivative Financial Instruments and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2144110 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2152111 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2153112 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2160113 - Disclosure - Share-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SharebasedCompensation</Role>
      <ShortName>Share-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2169114 - Disclosure - Business Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessSegmentInformation</Role>
      <ShortName>Business Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2172115 - Disclosure - Employee Benefit Plans and Other</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/EmployeeBenefitPlansandOther</Role>
      <ShortName>Employee Benefit Plans and Other</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2174116 - Disclosure - COVID-19</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/COVID19</Role>
      <ShortName>COVID-19</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://infusystem.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Summary of Significant Accounting Policies - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SummaryofSignificantAccountingPoliciesEarningsPerShareTables</Role>
      <ShortName>Summary of Significant Accounting Policies - Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/BusinessCombinations</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/RevenueRecognition</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - Medical Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/MedicalEquipmentTables</Role>
      <ShortName>Medical Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/MedicalEquipment</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2324305 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/PropertyandEquipment</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2328306 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2334307 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/Debt</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - Derivative Financial Instruments and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2345309 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/IncomeTaxes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2354310 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/Leases</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2361311 - Disclosure - Share-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SharebasedCompensationTables</Role>
      <ShortName>Share-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/SharebasedCompensation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2370312 - Disclosure - Business Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessSegmentInformationTables</Role>
      <ShortName>Business Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/BusinessSegmentInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Basis of Presentation and Nature of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails</Role>
      <ShortName>Basis of Presentation and Nature of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/BasisofPresentationandNatureofOperations</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/SummaryofSignificantAccountingPoliciesEarningsPerShareTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Summary of Income and Share Amounts Utilized to Calculate Basic and Diluted Net Income Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Income and Share Amounts Utilized to Calculate Basic and Diluted Net Income Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Business Combinations (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsDetailsTextual</Role>
      <ShortName>Business Combinations (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/BusinessCombinationsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Business Combinations - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails</Role>
      <ShortName>Business Combinations - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Business Combinations - Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Business Combinations - Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Business Combinations - Intangible Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails</Role>
      <ShortName>Business Combinations - Intangible Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Business Combinations - Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails</Role>
      <ShortName>Business Combinations - Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Revenue Recognition (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/RevenueRecognitionDetailsTextual</Role>
      <ShortName>Revenue Recognition (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/RevenueRecognitionTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails</Role>
      <ShortName>Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - Medical Equipment (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/MedicalEquipmentDetailsTextual</Role>
      <ShortName>Medical Equipment (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/MedicalEquipmentTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2422412 - Disclosure - Medical Equipment - Summary of Medical Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails</Role>
      <ShortName>Medical Equipment - Summary of Medical Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2426414 - Disclosure - Property and Equipment (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/PropertyandEquipmentDetailsTextual</Role>
      <ShortName>Property and Equipment (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - Goodwill and Intangible Assets (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual</Role>
      <ShortName>Goodwill and Intangible Assets (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2431417 - Disclosure - Goodwill and Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2432418 - Disclosure - Goodwill and Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2435419 - Disclosure - Debt (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DebtDetailsTextual</Role>
      <ShortName>Debt (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/DebtTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails</Role>
      <ShortName>Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2437421 - Disclosure - Debt - Summary of Future Maturities of Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails</Role>
      <ShortName>Debt - Summary of Future Maturities of Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2438422 - Disclosure - Debt - Summary of Company's Current and Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails</Role>
      <ShortName>Debt - Summary of Company's Current and Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Derivative Financial Instruments and Hedging Activities (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - Derivative Financial Instruments and Hedging Activities - Designated as Hedging Instruments in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities - Designated as Hedging Instruments in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2447427 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Income Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2448428 - Disclosure - Income Taxes - Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/IncomeTaxesComponentsDetails</Role>
      <ShortName>Income Taxes - Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2449429 - Disclosure - Income Taxes - Valuation Allowance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/IncomeTaxesValuationAllowanceDetails</Role>
      <ShortName>Income Taxes - Valuation Allowance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2450430 - Disclosure - Income Taxes - Effective Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails</Role>
      <ShortName>Income Taxes - Effective Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2451431 - Disclosure - Income Taxes - Carry Forwards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/IncomeTaxesCarryForwardsDetails</Role>
      <ShortName>Income Taxes - Carry Forwards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2455432 - Disclosure - Leases (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LeasesDetailsTextual</Role>
      <ShortName>Leases (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/LeasesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2456433 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2457434 - Disclosure - Leases - Supplemental Cash Flow (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LeasesSupplementalCashFlowDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2458435 - Disclosure - Leases - Weighted Average Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LeasesWeightedAverageTableDetails</Role>
      <ShortName>Leases - Weighted Average Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2459436 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2462437 - Disclosure - Share-based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SharebasedCompensationNarrativeDetails</Role>
      <ShortName>Share-based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2463438 - Disclosure - Share-based Compensation - Stock-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails</Role>
      <ShortName>Share-based Compensation - Stock-based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2464439 - Disclosure - Share-based Compensation - Summary of Restricted Share Activity, Excluding Company's Employee Stock Purchase Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails</Role>
      <ShortName>Share-based Compensation - Summary of Restricted Share Activity, Excluding Company's Employee Stock Purchase Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2465440 - Disclosure - Share-based Compensation - PSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SharebasedCompensationPSUActivityDetails</Role>
      <ShortName>Share-based Compensation - PSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2466441 - Disclosure - Share-based Compensation - Summary of Activity Relating to Company's ESPP Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SharebasedCompensationSummaryofActivityRelatingtoCompanysESPPProgramDetails</Role>
      <ShortName>Share-based Compensation - Summary of Activity Relating to Company's ESPP Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2467442 - Disclosure - Share-based Compensation - 2014 and 2021 Plan Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails</Role>
      <ShortName>Share-based Compensation - 2014 and 2021 Plan Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2468443 - Disclosure - Share-based Compensation - Schedule of Share-based Compensation Expense Based on Fair Value of Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails</Role>
      <ShortName>Share-based Compensation - Schedule of Share-based Compensation Expense Based on Fair Value of Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2471444 - Disclosure - Business Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessSegmentInformationDetails</Role>
      <ShortName>Business Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/BusinessSegmentInformationTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="infu-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2473445 - Disclosure - Employee Benefit Plans and Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/EmployeeBenefitPlansandOtherDetails</Role>
      <ShortName>Employee Benefit Plans and Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/EmployeeBenefitPlansandOther</ParentRole>
      <Position>81</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="infu-20211231.htm">infu-20211231.htm</File>
    <File>infu-20211231.xsd</File>
    <File>infu-20211231_cal.xml</File>
    <File>infu-20211231_def.xml</File>
    <File>infu-20211231_lab.xml</File>
    <File>infu-20211231_pre.xml</File>
    <File>infu-20211231xexx211.htm</File>
    <File>infu-20211231xexx231.htm</File>
    <File>infu-20211231xexx311.htm</File>
    <File>infu-20211231xexx312.htm</File>
    <File>infu-20211231xexx321.htm</File>
    <File>infu-20211231xexx322.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>infu-20211231_g1.jpg</File>
    <File>infu-20211231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1013">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>103
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "infu-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 26,
   "contextCount": 245,
   "dts": {
    "calculationLink": {
     "local": [
      "infu-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "infu-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "infu-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "infu-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "infu-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "infu-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 644,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 7,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 11
   },
   "keyCustom": 68,
   "keyStandard": 451,
   "memberCustom": 32,
   "memberStandard": 42,
   "nsprefix": "infu",
   "nsuri": "http://infusystem.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://infusystem.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Business Combinations",
     "role": "http://infusystem.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115104 - Disclosure - Revenue Recognition",
     "role": "http://infusystem.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:MedicalEquipmentAndPropertyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119105 - Disclosure - Medical Equipment",
     "role": "http://infusystem.com/role/MedicalEquipment",
     "shortName": "Medical Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:MedicalEquipmentAndPropertyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123106 - Disclosure - Property and Equipment",
     "role": "http://infusystem.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127107 - Disclosure - Goodwill and Intangible Assets",
     "role": "http://infusystem.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133108 - Disclosure - Debt",
     "role": "http://infusystem.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139109 - Disclosure - Derivative Financial Instruments and Hedging Activities",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities",
     "shortName": "Derivative Financial Instruments and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144110 - Disclosure - Income Taxes",
     "role": "http://infusystem.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152111 - Disclosure - Commitments and Contingencies",
     "role": "http://infusystem.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153112 - Disclosure - Leases",
     "role": "http://infusystem.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://infusystem.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160113 - Disclosure - Share-based Compensation",
     "role": "http://infusystem.com/role/SharebasedCompensation",
     "shortName": "Share-based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2169114 - Disclosure - Business Segment Information",
     "role": "http://infusystem.com/role/BusinessSegmentInformation",
     "shortName": "Business Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2172115 - Disclosure - Employee Benefit Plans and Other",
     "role": "http://infusystem.com/role/EmployeeBenefitPlansandOther",
     "shortName": "Employee Benefit Plans and Other",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:EffectOfCovid19PandemicTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2174116 - Disclosure - COVID-19",
     "role": "http://infusystem.com/role/COVID19",
     "shortName": "COVID-19",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:EffectOfCovid19PandemicTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Summary of Significant Accounting Policies - Earnings Per Share (Tables)",
     "role": "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesEarningsPerShareTables",
     "shortName": "Summary of Significant Accounting Policies - Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Business Combinations (Tables)",
     "role": "http://infusystem.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - Revenue Recognition (Tables)",
     "role": "http://infusystem.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:ScheduleOfMedicalEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - Medical Equipment (Tables)",
     "role": "http://infusystem.com/role/MedicalEquipmentTables",
     "shortName": "Medical Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:ScheduleOfMedicalEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324305 - Disclosure - Property and Equipment (Tables)",
     "role": "http://infusystem.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - Consolidated Balance Sheets",
     "role": "http://infusystem.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328306 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://infusystem.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334307 - Disclosure - Debt (Tables)",
     "role": "http://infusystem.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - Derivative Financial Instruments and Hedging Activities (Tables)",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables",
     "shortName": "Derivative Financial Instruments and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345309 - Disclosure - Income Taxes (Tables)",
     "role": "http://infusystem.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354310 - Disclosure - Leases (Tables)",
     "role": "http://infusystem.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2361311 - Disclosure - Share-based Compensation (Tables)",
     "role": "http://infusystem.com/role/SharebasedCompensationTables",
     "shortName": "Share-based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2370312 - Disclosure - Business Segment Information (Tables)",
     "role": "http://infusystem.com/role/BusinessSegmentInformationTables",
     "shortName": "Business Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i34393106918541a2afdfacc9dc70598f_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Basis of Presentation and Nature of Operations (Details)",
     "role": "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
     "shortName": "Basis of Presentation and Nature of Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i34393106918541a2afdfacc9dc70598f_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Summary of Income and Share Amounts Utilized to Calculate Basic and Diluted Net Income Per Common Share (Details)",
     "role": "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Summary of Income and Share Amounts Utilized to Calculate Basic and Diluted Net Income Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Business Combinations (Details Textual)",
     "role": "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
     "shortName": "Business Combinations (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Business Combinations - Purchase Price Allocation (Details)",
     "role": "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails",
     "shortName": "Business Combinations - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Business Combinations - Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Business Combinations - Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Business Combinations - Intangible Assets Acquired (Details)",
     "role": "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
     "shortName": "Business Combinations - Intangible Assets Acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Business Combinations - Pro Forma Information (Details)",
     "role": "http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails",
     "shortName": "Business Combinations - Pro Forma Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Revenue Recognition (Details Textual)",
     "role": "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
     "shortName": "Revenue Recognition (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i24689dc260664972bc304c938065d32c_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details)",
     "role": "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails",
     "shortName": "Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iee74bd21a9164ffa92cd63e1a7f77a5b_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "infu:DepreciationExpenseRelatedToMedicalEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - Medical Equipment (Details Textual)",
     "role": "http://infusystem.com/role/MedicalEquipmentDetailsTextual",
     "shortName": "Medical Equipment (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "infu:DepreciationExpenseRelatedToMedicalEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "infu:ScheduleOfMedicalEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:MedicalEquipmentHeldForSaleOrRentalGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422412 - Disclosure - Medical Equipment - Summary of Medical Equipment (Details)",
     "role": "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails",
     "shortName": "Medical Equipment - Summary of Medical Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "infu:ScheduleOfMedicalEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:MedicalEquipmentHeldForSaleOrRentalGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)",
     "role": "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails",
     "shortName": "Property and Equipment - Schedule of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - Consolidated Statement of Operations and Comprehensive Income",
     "role": "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome",
     "shortName": "Consolidated Statement of Operations and Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationNonproduction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426414 - Disclosure - Property and Equipment (Details Textual)",
     "role": "http://infusystem.com/role/PropertyandEquipmentDetailsTextual",
     "shortName": "Property and Equipment (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationNonproduction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - Goodwill and Intangible Assets (Details Textual)",
     "role": "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual",
     "shortName": "Goodwill and Intangible Assets (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)",
     "role": "http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i680eb364512840a7b20a8bfda742ab6c_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "infu:CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431417 - Disclosure - Goodwill and Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)",
     "role": "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "infu:CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432418 - Disclosure - Goodwill and Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)",
     "role": "http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435419 - Disclosure - Debt (Details Textual)",
     "role": "http://infusystem.com/role/DebtDetailsTextual",
     "shortName": "Debt (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i28416998ed494697b9e63887fde6fd11_D20210205-20210205",
      "decimals": "INF",
      "lang": "en-US",
      "name": "infu:PercentageOfTotalDepreciationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i57c0ab7efbce44e3a190303cafd12765_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details)",
     "role": "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails",
     "shortName": "Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i57c0ab7efbce44e3a190303cafd12765_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "infu:LandlordReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437421 - Disclosure - Debt - Summary of Future Maturities of Loans (Details)",
     "role": "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
     "shortName": "Debt - Summary of Future Maturities of Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:LongtermDebtGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438422 - Disclosure - Debt - Summary of Company's Current and Long-term Debt (Details)",
     "role": "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
     "shortName": "Debt - Summary of Company's Current and Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:LongtermDebtGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "ie04daf42f32244b687b1b4a179069060_I20210205",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNumberOfInstrumentsHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "numberofagreement",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Derivative Financial Instruments and Hedging Activities (Details Textual)",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
     "shortName": "Derivative Financial Instruments and Hedging Activities (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "ie04daf42f32244b687b1b4a179069060_I20210205",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNumberOfInstrumentsHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "numberofagreement",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i6b8b5e5eab5d411ab7c41bbd0a191163_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i6b8b5e5eab5d411ab7c41bbd0a191163_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i3f5f66be8c4042dfbc78b5ce658083c7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details)",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails",
     "shortName": "Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i3f5f66be8c4042dfbc78b5ce658083c7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - Derivative Financial Instruments and Hedging Activities - Designated as Hedging Instruments in AOCI (Details)",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
     "shortName": "Derivative Financial Instruments and Hedging Activities - Designated as Hedging Instruments in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i07f3da9e713d4c489ebdd0e68b443b18_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "infu:NetOperatingLossCarryforwardsLimitationOnUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://infusystem.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "infu:NetOperatingLossCarryforwardsLimitationOnUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447427 - Disclosure - Income Taxes - Income Before Income Taxes (Details)",
     "role": "http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Income Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448428 - Disclosure - Income Taxes - Components (Details)",
     "role": "http://infusystem.com/role/IncomeTaxesComponentsDetails",
     "shortName": "Income Taxes - Components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i65a1b71990ae4b209d05ce3e9e1f9ab6_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449429 - Disclosure - Income Taxes - Valuation Allowance (Details)",
     "role": "http://infusystem.com/role/IncomeTaxesValuationAllowanceDetails",
     "shortName": "Income Taxes - Valuation Allowance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i488a17cbb36b421597c4f159595f4b31_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450430 - Disclosure - Income Taxes - Effective Tax Rate (Details)",
     "role": "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails",
     "shortName": "Income Taxes - Effective Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsLiabilitiesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451431 - Disclosure - Income Taxes - Carry Forwards (Details)",
     "role": "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails",
     "shortName": "Income Taxes - Carry Forwards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsLiabilitiesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455432 - Disclosure - Leases (Details Textual)",
     "role": "http://infusystem.com/role/LeasesDetailsTextual",
     "shortName": "Leases (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i7eb9d27f65dd4491a35f0b273d413655_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456433 - Disclosure - Leases - Lease Cost (Details)",
     "role": "http://infusystem.com/role/LeasesLeaseCostDetails",
     "shortName": "Leases - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://infusystem.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457434 - Disclosure - Leases - Supplemental Cash Flow (Details)",
     "role": "http://infusystem.com/role/LeasesSupplementalCashFlowDetails",
     "shortName": "Leases - Supplemental Cash Flow (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458435 - Disclosure - Leases - Weighted Average Table (Details)",
     "role": "http://infusystem.com/role/LeasesWeightedAverageTableDetails",
     "shortName": "Leases - Weighted Average Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459436 - Disclosure - Leases - Maturities of Lease Liabilities (Details)",
     "role": "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "iadf344ba2bca42ada453fc7ff77944bb_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i337469ad875742708ce9ddae6c4a0f49_D20160901-20160930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462437 - Disclosure - Share-based Compensation - Narrative (Details)",
     "role": "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
     "shortName": "Share-based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i337469ad875742708ce9ddae6c4a0f49_D20160901-20160930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedStockExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463438 - Disclosure - Share-based Compensation - Stock-based Compensation (Details)",
     "role": "http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails",
     "shortName": "Share-based Compensation - Stock-based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedStockExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i93a156af54c948df8919aacc5b640f4b_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464439 - Disclosure - Share-based Compensation - Summary of Restricted Share Activity, Excluding Company's Employee Stock Purchase Plan (Details)",
     "role": "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails",
     "shortName": "Share-based Compensation - Summary of Restricted Share Activity, Excluding Company's Employee Stock Purchase Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i70536e94e85c431eba31912dac7f7c14_D20210101-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i579ba4102b384a248e9ea9ecb23a50df_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465440 - Disclosure - Share-based Compensation - PSU Activity (Details)",
     "role": "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
     "shortName": "Share-based Compensation - PSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i87b3f7c8f581413484a70a1c9a8f2534_D20210101-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466441 - Disclosure - Share-based Compensation - Summary of Activity Relating to Company's ESPP Program (Details)",
     "role": "http://infusystem.com/role/SharebasedCompensationSummaryofActivityRelatingtoCompanysESPPProgramDetails",
     "shortName": "Share-based Compensation - Summary of Activity Relating to Company's ESPP Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "id664e22f92654bd6835e8960b88f906e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467442 - Disclosure - Share-based Compensation - 2014 and 2021 Plan Activity (Details)",
     "role": "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails",
     "shortName": "Share-based Compensation - 2014 and 2021 Plan Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "id715ae4994c6485bb09a14ef0f5dafc2_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i916acf9d0f104707870dd85b845fdad2_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468443 - Disclosure - Share-based Compensation - Schedule of Share-based Compensation Expense Based on Fair Value of Options (Details)",
     "role": "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails",
     "shortName": "Share-based Compensation - Schedule of Share-based Compensation Expense Based on Fair Value of Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i916acf9d0f104707870dd85b845fdad2_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation and Nature of Operations",
     "role": "http://infusystem.com/role/BasisofPresentationandNatureofOperations",
     "shortName": "Basis of Presentation and Nature of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:RevenuesExternal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471444 - Disclosure - Business Segment Information (Details)",
     "role": "http://infusystem.com/role/BusinessSegmentInformationDetails",
     "shortName": "Business Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:RevenuesExternal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473445 - Disclosure - Employee Benefit Plans and Other (Details)",
     "role": "http://infusystem.com/role/EmployeeBenefitPlansandOtherDetails",
     "shortName": "Employee Benefit Plans and Other (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://infusystem.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20211231.htm",
      "contextRef": "i5671eb8f2ad84cf2863cd043432037a3_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 75,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "verboseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "verboseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "infu_A2014EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2014 Equity Incentive Plan",
        "label": "2014 Equity Incentive Plan [Member]",
        "terseLabel": "2014 Equity Incentive Plan"
       }
      }
     },
     "localname": "A2014EquityIncentivePlanMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_A2021EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Equity Incentive Plan",
        "label": "2021 Equity Incentive Plan [Member]",
        "terseLabel": "2021 Equity Incentive Plan"
       }
      }
     },
     "localname": "A2021EquityIncentivePlanMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_ABRLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the ABR loans.",
        "label": "ABR Loans [Member]",
        "terseLabel": "ABR Loans"
       }
      }
     },
     "localname": "ABRLoansMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_AmbulatoryPumpsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the ambulatory pumps.",
        "label": "Ambulatory Pumps [Member]",
        "terseLabel": "Ambulatory Pumps"
       }
      }
     },
     "localname": "AmbulatoryPumpsMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://infusystem.com/20211231",
     "xbrltype": "stringItemType"
    },
    "infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma acquisition cost and non-recurring expense for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition Pro Forma Acquisition Cost And Nonrecurring Expense",
        "terseLabel": "Pro forma acquisition cost and non-recurring expense"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of medical equipment in rental service recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Medical Equipment Held For Sale Or Rental",
        "terseLabel": "Medical equipment held for sale or rental"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of operating lease right of use asset recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Asset",
        "terseLabel": "Operating lease right of use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_CBFloatingRateLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to the CB Floating Rate Loan.",
        "label": "CB Floating Rate Loan [Member]",
        "terseLabel": "CB Floating Rate Loan"
       }
      }
     },
     "localname": "CBFloatingRateLoanMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_CBFloatingRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding the CB Floating Rate.",
        "label": "CB Floating Rate [Member]",
        "terseLabel": "CB Floating Rate"
       }
      }
     },
     "localname": "CBFloatingRateMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_CardinalHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to Cardinal Health, Inc.",
        "label": "Cardinal Health, Inc. [Member]",
        "terseLabel": "Cardinal Health, Inc."
       }
      }
     },
     "localname": "CardinalHealthIncMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount and accumulated amortization of identifiable intangible assets.",
        "label": "Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets [Table Text Block]",
        "terseLabel": "Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets"
       }
      }
     },
     "localname": "CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_CashlessExerciseOfStockOptionsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares exercised in a cashless transaction.",
        "label": "Cashless Exercise Of Stock Options Shares",
        "negatedLabel": "Cashless exercise, number of authorized shares (in shares)"
       }
      }
     },
     "localname": "CashlessExerciseOfStockOptionsShares",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "infu_CorporateAndEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding corporate and eliminations.",
        "label": "Corporate and Eliminations [Member]",
        "terseLabel": "Corporate and Eliminations"
       }
      }
     },
     "localname": "CorporateAndEliminationsMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_Covid19Abstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covid-19",
        "label": "Covid-19 [Abstract]"
       }
      }
     },
     "localname": "Covid19Abstract",
     "nsuri": "http://infusystem.com/20211231",
     "xbrltype": "stringItemType"
    },
    "infu_CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information about credit facility.",
        "label": "Credit Facility [Member]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_DMEServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding the DME Services segment.",
        "label": "DME Services Segment [Member]",
        "terseLabel": "DME Services Segment"
       }
      }
     },
     "localname": "DMEServicesSegmentMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points, excluding the margin rate, added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument Basis Spread On Variable Rate Before Margin Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate, before margin rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRateBeforeMarginRate",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_DebtInstrumentCovenantMaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum leverage ratio required by the debt agreement.",
        "label": "Debt Instrument Covenant Maximum Leverage Ratio",
        "terseLabel": "Debt instrument, covenant, maximum leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaximumLeverageRatio",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "pureItemType"
    },
    "infu_DebtInstrumentCovenantMinimumFixedCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum fixed coverage ratio required by the debt agreement.",
        "label": "Debt Instrument Covenant Minimum Fixed Coverage Ratio",
        "terseLabel": "Debt instrument, covenant, minimum fixed coverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMinimumFixedCoverageRatio",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "pureItemType"
    },
    "infu_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to operating lease liabilities.",
        "label": "Deferred Tax Assets, Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_DeferredTaxAssetsValuationAllowanceExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the valuation allowance for deferred tax assets charged to income tax expense.",
        "label": "Deferred Tax Assets Valuation Allowance Expense",
        "negatedLabel": "Income tax expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceExpense",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_DeferredTaxAssetsValuationAllowanceIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Valuation Allowance, Increase",
        "label": "Deferred Tax Assets, Valuation Allowance, Increase",
        "negatedTerseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceIncrease",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_DeferredTaxAssetsValuationAllowanceRelease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the valuation allowance for deferred tax assets due to the release of valuation allowance.",
        "label": "Deferred Tax Assets, Valuation Allowance, Release",
        "terseLabel": "Release of valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceRelease",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_DeferredTaxLiabilitiesRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to right-of-use assets.",
        "label": "Deferred Tax Liabilities Right Of Use Assets",
        "negatedTerseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightOfUseAssets",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_DepreciationExpenseRelatedToMedicalEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of depreciation expense related to medical equipment recorded during the period.",
        "label": "Depreciation Expense Related To Medical Equipment",
        "terseLabel": "Depreciation expense related to medical equipment"
       }
      }
     },
     "localname": "DepreciationExpenseRelatedToMedicalEquipment",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_DirectPayerRentalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents direct payer rental revenue.",
        "label": "Direct Payer Rentals [Member]",
        "terseLabel": "Direct Payer Rentals"
       }
      }
     },
     "localname": "DirectPayerRentalsMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_EffectOfCovid19PandemicTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for effects of COVID-19 pandemic.",
        "label": "Effect of Covid-19 Pandemic [Text Block]",
        "terseLabel": "COVID-19"
       }
      }
     },
     "localname": "EffectOfCovid19PandemicTextBlock",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/COVID19"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the permanent differences.",
        "label": "Effective Income Tax Rate Reconciliation, Permanent Differences, Percent",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum threshold, per employee, of purchases made in the employee stock ownership plan.",
        "label": "Employee Stock Ownership Plan ESOP Purchase Per Employee Maximum",
        "terseLabel": "ESOP purchase per employee maximum"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPPurchasePerEmployeeMaximum",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_EmployeeStockPurchasePlanDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The discount rate applied to an employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan Discount Rate",
        "terseLabel": "Employee stock purchase plan discount rate"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanDiscountRate",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average purchase price of shares purchased under the employee stock purchase plan.",
        "label": "Weighted average fair value per ESPP award (in dollars per share)",
        "terseLabel": "Weighted average fair value per ESPP award (in dollars per share)"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanWeightedAveragePurchasePriceOfSharesPurchased",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationSummaryofActivityRelatingtoCompanysESPPProgramDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "infu_EquipmentLineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the equipment line.",
        "label": "Equipment Line [Member]",
        "terseLabel": "Equipment Line"
       }
      }
     },
     "localname": "EquipmentLineMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_EurodollarLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to the Eurodollar Loan.",
        "label": "Eurodollar Loan [Member]",
        "terseLabel": "Eurodollar Loan"
       }
      }
     },
     "localname": "EurodollarLoanMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_FilAMedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to FilAMed.",
        "label": "FilAMed [Member]",
        "terseLabel": "FilAMed"
       }
      }
     },
     "localname": "FilAMedMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_FinancingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the financing agreement (the \"Financing Agreement\").",
        "label": "Financing Agreement [Member]",
        "terseLabel": "Other financing"
       }
      }
     },
     "localname": "FinancingAgreementMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_GreaterOfPrimeRateOrLIBORPlus25Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to the greater of prime rate or LIBOR plus 2.5%.",
        "label": "Greater of Prime Rate or LIBOR Plus 2.5% [Member]",
        "terseLabel": "Greater of Prime Rate or LIBOR Plus 2.5%"
       }
      }
     },
     "localname": "GreaterOfPrimeRateOrLIBORPlus25Member",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_ITSSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding the ITS segment.",
        "label": "ITS Segment [Member]",
        "terseLabel": "ITS Segment"
       }
      }
     },
     "localname": "ITSSegmentMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_InformationTechnologySoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the external information technology software used.",
        "label": "Information Technology Software [Member]",
        "terseLabel": "Information Technology Software"
       }
      }
     },
     "localname": "InformationTechnologySoftwareMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_LIBORRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the LIBOR rate.",
        "label": "LIBOR Rate",
        "terseLabel": "LIBOR rate"
       }
      }
     },
     "localname": "LIBORRate",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_LandlordReserves": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of landlord reserves.",
        "label": "Landlord Reserves",
        "negatedLabel": "Landlord reserves"
       }
      }
     },
     "localname": "LandlordReserves",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_LenderPrimeRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the lender's prime rate.",
        "label": "Lender Prime Rate",
        "terseLabel": "Lender prime rate"
       }
      }
     },
     "localname": "LenderPrimeRate",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional borrowing capacity under the credit facility subject to certain conditions.",
        "label": "Line Of Credit Facility Additional Borrowing Capacity Subject To Certain Conditions",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_LineOfCreditFacilityBorrowingBase": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of money that a lender is willing to loan a company calculated as the sum of the company's eligible accounts receivable and eligible inventory as define by the credit agreement.",
        "label": "Line Of Credit Facility Borrowing Base",
        "terseLabel": "Line of credit facility, borrowing base"
       }
      }
     },
     "localname": "LineOfCreditFacilityBorrowingBase",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_LongTermDebtGrossNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt, excluding the current portion. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long term Debt Gross Noncurrent",
        "verboseLabel": "Long-Term Portion"
       }
      }
     },
     "localname": "LongTermDebtGrossNoncurrent",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_LongtermDebtGrossCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of the current portion of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Longterm Debt Gross Current",
        "verboseLabel": "Current Portion"
       }
      }
     },
     "localname": "LongtermDebtGrossCurrent",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Equipment",
        "label": "Medical Equipment [Abstract]"
       }
      }
     },
     "localname": "MedicalEquipmentAbstract",
     "nsuri": "http://infusystem.com/20211231",
     "xbrltype": "stringItemType"
    },
    "infu_MedicalEquipmentAndPropertyDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for medical equipment and property.",
        "label": "Medical Equipment and Property Disclosure [Text Block]",
        "terseLabel": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentAndPropertyDisclosureTextBlock",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_MedicalEquipmentForSaleOrRentalReserve": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 1.0,
       "parentTag": "infu_MedicalEquipmentHeldForSaleOrRental",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of reserve associated with medical equipment for sale or rental, as of the balance sheet date.",
        "label": "Medical Equipment For Sale Or Rental Reserve",
        "negatedTerseLabel": "Medical Equipment for sale or rental - pump reserve",
        "terseLabel": "Medical equipment for sale or rental, reserve"
       }
      }
     },
     "localname": "MedicalEquipmentForSaleOrRentalReserve",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentHeldForSaleOrRental": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 2.0,
       "parentTag": "infu_MedicalEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents medical equipment held for sale or rental as of the balance sheet date.",
        "label": "Medical equipment for sale or rental",
        "terseLabel": "Medical equipment for sale or rental",
        "totalLabel": "Medical Equipment for sale or rental - net"
       }
      }
     },
     "localname": "MedicalEquipmentHeldForSaleOrRental",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets",
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentHeldForSaleOrRentalGross": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 2.0,
       "parentTag": "infu_MedicalEquipmentHeldForSaleOrRental",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents medical equipment held for sale or rental as of the balance sheet date, before reserves.",
        "label": "Medical Equipment Held For Sale Or Rental Gross",
        "terseLabel": "Medical Equipment for sale or rental"
       }
      }
     },
     "localname": "MedicalEquipmentHeldForSaleOrRentalGross",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 1.0,
       "parentTag": "infu_MedicalEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents medical equipment in rental service, net of accumulated depreciation, as of the balance sheet date.",
        "label": "Medical equipment in rental service, net of accumulated depreciation",
        "terseLabel": "Medical equipment in rental service, net of accumulated depreciation",
        "totalLabel": "Medical Equipment in rental service - net"
       }
      }
     },
     "localname": "MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets",
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 1.0,
       "parentTag": "infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of accumulated depreciation related to medical equipment in rental services.",
        "label": "Medical Equipment In Rental Services Accumulated Depreciation",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "MedicalEquipmentInRentalServicesAccumulatedDepreciation",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentInRentalServicesGross": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 3.0,
       "parentTag": "infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the gross amount of medical equipment in rental services.",
        "label": "Medical Equipment In Rental Services Gross",
        "verboseLabel": "Medical Equipment in rental service"
       }
      }
     },
     "localname": "MedicalEquipmentInRentalServicesGross",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentInRentalServicesReserve": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 2.0,
       "parentTag": "infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of medical equipment in rental services reserve, as of the balance sheet date.",
        "label": "Medical Equipment In Rental Services Reserve",
        "negatedTerseLabel": "Medical Equipment in rental service - pump reserve",
        "terseLabel": "Medical equipment in rental services reserve"
       }
      }
     },
     "localname": "MedicalEquipmentInRentalServicesReserve",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentInRentalServicesUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the useful life of medical equipment in rental services.",
        "label": "Medical Equipment In Rental Services Useful Life",
        "terseLabel": "Medical equipment in rental services, useful life"
       }
      }
     },
     "localname": "MedicalEquipmentInRentalServicesUsefulLife",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "infu_MedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents medical equipment.",
        "label": "Medical Equipment [Member]",
        "terseLabel": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_MedicalEquipmentNet": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the net amount of medical equipment, as of the balance sheet date.",
        "label": "Medical Equipment Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "MedicalEquipmentNet",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for medical equipment.",
        "label": "Medical Equipment [Policy Text Block]",
        "terseLabel": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentPolicyTextBlock",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_NPWTMedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the NPWT medical equipment.",
        "label": "NPWT Medical Equipment [Member]",
        "terseLabel": "NPWT Medical Equipment"
       }
      }
     },
     "localname": "NPWTMedicalEquipmentMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_NetOperatingLossCarryforwardsLimitationOnUse": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The annual limitations on use applicable to net operating loss carryforwards.",
        "label": "Net Operating Loss Carryforwards Limitation On Use",
        "terseLabel": "Net operating loss carryforwards limitation on use"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardsLimitationOnUse",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_NoncashActivitiesProceedsFromStockPlans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Activities, Proceeds from Stock Plans",
        "label": "Noncash Activities, Proceeds from Stock Plans",
        "terseLabel": "Additions to cash proceeds from stock plans"
       }
      }
     },
     "localname": "NoncashActivitiesProceedsFromStockPlans",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash or Part Noncash Acquisition, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration",
        "label": "Noncash or Part Noncash Acquisition, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration",
        "terseLabel": "Additions to contingent consideration"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionContingentConsiderationArrangementsChangeInAmountOfContingentConsideration",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_NumberOfContractsWithThirdParties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Contracts With Third Parties",
        "label": "Number of Contracts With Third Parties",
        "terseLabel": "Number of contracts with third parties"
       }
      }
     },
     "localname": "NumberOfContractsWithThirdParties",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "infu_NumberOfFinancialInstitutions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of financial institutions where the entity maintains its cash and cash equivalents.",
        "label": "Number Of Financial Institutions",
        "terseLabel": "Number of financial institutions"
       }
      }
     },
     "localname": "NumberOfFinancialInstitutions",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "infu_OBHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding the acquisition of OB Healthcare Corporation.",
        "label": "OB Healthcare [Member]",
        "terseLabel": "OB Healthcare"
       }
      }
     },
     "localname": "OBHealthcareMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_OperatingLossCarryforwardsExpirationPeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The duration of operating loss carryforwards before expiration begins.",
        "label": "Operating Loss Carryforwards Expiration Periods",
        "terseLabel": "Operating loss carryforwards expiration periods"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpirationPeriods",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "infu_OperatingLossCarryforwardsWithADefiniteLife": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of operating loss carryforwards that have an indefinite life.",
        "label": "Operating Loss Carryforwards With A Definite Life",
        "terseLabel": "Operating loss carryforwards with a definite life"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsWithADefiniteLife",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_OperatingLossCarryforwardsWithIndefiniteLife": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of operating loss carryforwards that have an indefinite life.",
        "label": "Operating Loss Carryforwards With Indefinite Life",
        "terseLabel": "Operating loss carryforwards with indefinite life"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsWithIndefiniteLife",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_PaycheckProtectionProgramCaresActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents loan designed to provide funds for small businesses to keep their employees on the payroll.",
        "label": "Paycheck Protection Program CARES Act [Member]",
        "terseLabel": "Paycheck Protection Program CARES Act"
       }
      }
     },
     "localname": "PaycheckProtectionProgramCaresActMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Business, Excluding Working Capital Adjustments",
        "label": "Payments to Acquire Business, Excluding Working Capital Adjustments",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_PaymentsToAcquireMedicalEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of cash paid during the period to acquire medical equipment.",
        "label": "Payments To Acquire Medical Equipment",
        "negatedLabel": "Purchase of medical equipment",
        "terseLabel": "Purchases of medical equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireMedicalEquipment",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_PercentageIncreaseInNumberOfContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Increase in Number of Contracts",
        "label": "Percentage Increase in Number of Contracts",
        "terseLabel": "Percentage increase in number of contracts"
       }
      }
     },
     "localname": "PercentageIncreaseInNumberOfContracts",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_PercentageOfTotalDepreciationExpense": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of total depreciation expense.",
        "label": "Percentage Of Total Depreciation Expense",
        "terseLabel": "Percentage of total depreciation expense"
       }
      }
     },
     "localname": "PercentageOfTotalDepreciationExpense",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_PhysicianAndCustomerRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to physician and customer relationships.",
        "label": "Physician and Customer Relationships [Member]",
        "terseLabel": "Physician and customer relationships"
       }
      }
     },
     "localname": "PhysicianAndCustomerRelationshipsMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of reductions to right-of-use assets resulting from reductions to lease obligations.",
        "label": "Reductions to ROU assets resulting from reductions to lease obligations: Operating leases",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "ReductionsToRightOfUseAssetsResultingFromReductionsToLeaseObligations",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_RemainingPreownershipNetOperatingLossCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of remaining preownership net operating loss carryforwards.",
        "label": "Remaining Preownership Net OperatingLoss Carryforwards",
        "terseLabel": "Remaining preownership net operating loss carryforwards"
       }
      }
     },
     "localname": "RemainingPreownershipNetOperatingLossCarryforwards",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_RevenueRecognitionCostOfRevenuePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the cost of revenue for servicing and maintaining products sold including shipping and handling costs.",
        "label": "Revenue Recognition, Cost of Revenue [Policy Text Block]",
        "terseLabel": "Cost of Revenues"
       }
      }
     },
     "localname": "RevenueRecognitionCostOfRevenuePolicyTextBlock",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_RevenuesExternal": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessSegmentInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of external net revenues recognized during the period.",
        "label": "Net revenues - external",
        "terseLabel": "Net revenues - external"
       }
      }
     },
     "localname": "RevenuesExternal",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_RevenuesInternal": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessSegmentInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of internal net revenues recognized during the period.",
        "label": "Net revenues - internal",
        "terseLabel": "Net revenues - internal"
       }
      }
     },
     "localname": "RevenuesInternal",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_ScheduleOfMedicalEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of medical equipment.",
        "label": "Schedule of Medical Equipment [Table Text Block]",
        "terseLabel": "Schedule of Medical Equipment"
       }
      }
     },
     "localname": "ScheduleOfMedicalEquipmentTableTextBlock",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that expired during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expirations In Period",
        "negatedTerseLabel": "Vested shares forgone to satisfy minimum statutory withholding, number of shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsInPeriod",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards expired during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expirations Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested shares forgone to satisfy minimum statutory withholding, weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationsWeightedAverageGrantDateFairValue",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Shares Forgone",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Shares Forgone",
        "negatedTerseLabel": "Vested shares forgone (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgone",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Shares Forgone, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested Shares Forgone, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested shares forgone to satisfy minimum statutory withholding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedSharesForgoneWeightedAverageGrantDateFairValue",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value Shares Forgone, Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value Shares Forgone, Fair Value",
        "terseLabel": "Total fair value of shares forgone to satisfy minimum statutory withholding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFairValueSharesForgoneFairValue",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "infu_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of target number of shares to be earned under share based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Percentage of Target Number of Shares to Be Earned",
        "terseLabel": "Share-based compensation arrangement by share-based payment award percentage of target number of shares to be earned"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfTargetNumberOfSharesToBeEarned",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average exercise price of awarded shares exercised in the period in a cashless transaction.",
        "label": "Cashless exercise, weighted average exercise price (in dollars per share)",
        "terseLabel": "Cashless exercise, weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessWeightedAverageExercisePrice",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "infu_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards expired during the period, to receive or retain shares or units, other instruments, or cash.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Expiration In Period Fair Value",
        "terseLabel": "Vested shares forgone to satisfy minimum statutory withholding, aggregate fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpirationInPeriodFairValue",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_SharebasedPaymentArrangementAchievingMinimumThresholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to the achievement of minimum threshold under the share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Achieving Minimum Threshold [Member]",
        "terseLabel": "Share-based Payment Arrangement, Achieving Minimum Threshold"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementAchievingMinimumThresholdMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_SharebasedPaymentArrangementExceedingMinimumThresholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to exceeding the minimum threshold under the share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exceeding Minimum Threshold [Member]",
        "terseLabel": "Share-based Payment Arrangement, Exceeding Minimum Threshold"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementExceedingMinimumThresholdMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_SmithsMedicalIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to Smiths Medical, Inc.",
        "label": "Smiths Medical, Inc. [Member]",
        "terseLabel": "Smiths Medical, Inc."
       }
      }
     },
     "localname": "SmithsMedicalIncMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares employee stock ownership plan number of remaining shares available for future issuance.",
        "label": "Stock Issued During Period Shares Employee Stock Ownership Plan Number Of Remaining Shares Available For Future Issuance",
        "terseLabel": "Stock issued during period shares employee stock ownership plan number of remaining shares available for future issuance (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlanNumberOfRemainingSharesAvailableForFutureIssuance",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "infu_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the Term Loan.",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_The2015CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the \"2015 Credit Agreement\".",
        "label": "The 2015 Credit Agreement [Member]",
        "terseLabel": "The 2015 Credit Agreement"
       }
      }
     },
     "localname": "The2015CreditAgreementMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_The2019EquipmentLineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding the 2019 Equipment Line.",
        "label": "The 2019 Equipment Line [Member]",
        "terseLabel": "The 2019 Equipment Line"
       }
      }
     },
     "localname": "The2019EquipmentLineMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_The2021CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the \"2021 Credit Agreement\".",
        "label": "The 2021 Credit Agreement [Member]",
        "terseLabel": "The 2021 Credit Agreement"
       }
      }
     },
     "localname": "The2021CreditAgreementMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_ThirdPartyPayerRentalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents third-party payor rental.",
        "label": "Third-Party Payer Rental [Member]",
        "terseLabel": "Third-Party Payer Rentals"
       }
      }
     },
     "localname": "ThirdPartyPayerRentalMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_ThreeTermNotesAssociatedWithThe2015CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding three term notes associated with the 2015 Credit Agreement.",
        "label": "Three Term Notes Associated With the 2015 Credit Agreement [Member]",
        "terseLabel": "Three Term Notes Associated With the 2015 Credit Agreement"
       }
      }
     },
     "localname": "ThreeTermNotesAssociatedWithThe2015CreditAgreementMember",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_TreasuryStockPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for policy of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock, Policy [Policy Text Block]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockPolicyPolicyTextBlock",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_UnamortizedDebtIssuanceExpenseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_UnamortizedDebtIssuanceExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current portion of unamortized debt issuance expense.",
        "label": "Unamortized Debt Issuance Expense Current",
        "negatedTerseLabel": "Unamortized value of debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpenseCurrent",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_UnamortizedDebtIssuanceExpenseNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The noncurrent portion of unamortized debt issuance expense.",
        "label": "Unamortized Debt Issuance Expense Noncurrent",
        "negatedTerseLabel": "Unamortized value of the debt issuance costs, long-term debt"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpenseNoncurrent",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_WorkingCapital": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of working capital adjustments incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Working capital",
        "terseLabel": "Working capital adjustment, paid in cash"
       }
      }
     },
     "localname": "WorkingCapital",
     "nsuri": "http://infusystem.com/20211231",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r115",
      "r162",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r188",
      "r192",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r265",
      "r266",
      "r268",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r115",
      "r162",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r188",
      "r192",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r265",
      "r266",
      "r268",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r276",
      "r311",
      "r365",
      "r367",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r598",
      "r600",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r276",
      "r311",
      "r365",
      "r367",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r598",
      "r600",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r194",
      "r336",
      "r338",
      "r561",
      "r597",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r194",
      "r336",
      "r338",
      "r561",
      "r597",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r276",
      "r311",
      "r347",
      "r365",
      "r367",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r598",
      "r600",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r276",
      "r311",
      "r347",
      "r365",
      "r367",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r598",
      "r600",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r34",
      "r552"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r21",
      "r199",
      "r200"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent": {
     "auth_ref": [
      "r573",
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs.",
        "label": "Accrued Payroll Taxes",
        "terseLabel": "Accrued payroll taxes"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r32",
      "r241"
     ],
     "calculation": {
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated Depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r54",
      "r62",
      "r63",
      "r64",
      "r65",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Gain/(loss) on cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r24",
      "r51",
      "r53",
      "r54",
      "r587",
      "r605",
      "r606"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r50",
      "r54",
      "r62",
      "r63",
      "r64",
      "r117",
      "r118",
      "r119",
      "r484",
      "r601",
      "r602",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r22",
      "r402",
      "r552"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r399",
      "r400",
      "r401",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r369",
      "r371",
      "r405",
      "r406"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r371",
      "r396",
      "r404"
     ],
     "calculation": {
      "http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "totalLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r28",
      "r205",
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance for credit loss, current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r74",
      "r94",
      "r296",
      "r531"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r94",
      "r223",
      "r230"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      },
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangibles",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome",
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r109",
      "r170",
      "r183",
      "r190",
      "r209",
      "r258",
      "r259",
      "r260",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r269",
      "r271",
      "r272",
      "r480",
      "r485",
      "r520",
      "r550",
      "r552",
      "r568",
      "r585"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r47",
      "r109",
      "r209",
      "r258",
      "r259",
      "r260",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r269",
      "r271",
      "r272",
      "r480",
      "r485",
      "r520",
      "r550",
      "r552"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AutomobilesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vehicles that are used primarily for transporting people.",
        "label": "Automobiles [Member]",
        "terseLabel": "Automobiles"
       }
      }
     },
     "localname": "AutomobilesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r372",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r495",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "Basis of Presentation and Nature of Operations"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r364",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r364",
      "r366",
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r454",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r454",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition costs and non-recurring expenses"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r469",
      "r470",
      "r472"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Total - consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r467",
      "r469",
      "r470",
      "r474"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r468",
      "r471",
      "r475"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "auth_ref": [
      "r459"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease obligation assumed in business combination.",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation",
        "negatedLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r459"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r459"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r458",
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Acquisition date fair value"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r458",
      "r459"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r458",
      "r459"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r459"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total - purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSegmentAllocationTable": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about goodwill in a business combination.",
        "label": "Business Combination, Segment Allocation [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "BusinessCombinationSegmentAllocationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r99",
      "r100",
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Additions to medical equipment and property"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizationOfInternalCostsPolicy": {
     "auth_ref": [
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for capitalizing internal costs associated with exploration and production activities.",
        "label": "Capitalization of Internal Costs, Policy [Policy Text Block]",
        "terseLabel": "Software Capitalization and Depreciation"
       }
      }
     },
     "localname": "CapitalizationOfInternalCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r615",
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Capitalized computer software, amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "auth_ref": [
      "r616"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.",
        "label": "Capitalized Computer Software, Gross",
        "terseLabel": "Capitalized computer software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r29",
      "r96"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r89",
      "r96",
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r89",
      "r521"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r510"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "negatedLabel": "Reclassified within twelve months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "NON-CASH TRANSACTIONS"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollateralAxis": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of collateral or no collateral, from lender's perspective.",
        "label": "Collateral Held [Axis]",
        "terseLabel": "Collateral Held [Axis]"
       }
      }
     },
     "localname": "CollateralAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollateralDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of collateral or no collateral, from lender's perspective.",
        "label": "Collateral Held [Domain]",
        "terseLabel": "Collateral Held [Domain]"
       }
      }
     },
     "localname": "CollateralDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r255",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r117",
      "r118",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock,, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20",
      "r552"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value: authorized 200,000,000 shares; issued and outstanding 20,699,546 and 20,699,546, as of December\u00a031, 2021, respectively, and issued and outstanding 23,816,193 and 20,297,704, as of December\u00a031, 2020, respectively."
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r57",
      "r59",
      "r60",
      "r70",
      "r576",
      "r593"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Net comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive income:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r224",
      "r228",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r152",
      "r153",
      "r197",
      "r518",
      "r519",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r152",
      "r153",
      "r197",
      "r518",
      "r519",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r152",
      "r153",
      "r197",
      "r518",
      "r519",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r148",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Customer Concentration"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r152",
      "r153",
      "r197",
      "r518",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r152",
      "r153",
      "r197",
      "r518",
      "r519",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r76",
      "r561"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsProductLineMember": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.",
        "label": "Cost of Goods and Service, Product and Service Benchmark [Member]",
        "terseLabel": "Cost of Goods and Service, Product and Service Benchmark"
       }
      }
     },
     "localname": "CostOfGoodsProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r434",
      "r442"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesComponentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "negatedTerseLabel": "Current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r434"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesComponentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "negatedTerseLabel": "Current"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r434",
      "r442"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesComponentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "negatedTerseLabel": "Current"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r151",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r290",
      "r297",
      "r298",
      "r300",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r108",
      "r115",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r286",
      "r287",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r305",
      "r306",
      "r307",
      "r308",
      "r532",
      "r569",
      "r571",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r16",
      "r301",
      "r571",
      "r584"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding borrowings",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r273",
      "r305",
      "r306",
      "r530",
      "r532",
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Term notes"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r40",
      "r303",
      "r530",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt instrument, interest rate, effective percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r41",
      "r108",
      "r115",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r286",
      "r287",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r305",
      "r306",
      "r307",
      "r308",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r41",
      "r108",
      "r115",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r286",
      "r287",
      "r288",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r299",
      "r305",
      "r306",
      "r307",
      "r308",
      "r313",
      "r314",
      "r315",
      "r316",
      "r529",
      "r530",
      "r532",
      "r533",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Deferred Debt Issuance Costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r435",
      "r442"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesComponentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r94",
      "r110",
      "r435",
      "r442",
      "r443",
      "r444"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r17",
      "r18",
      "r424",
      "r570",
      "r583"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred Federal tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r435",
      "r442"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesComponentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Goodwill and intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r425"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred Federal tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r432",
      "r433"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r432",
      "r433"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r432",
      "r433"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsOther": {
     "auth_ref": [
      "r430",
      "r432",
      "r433"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible tax credit carryforwards, classified as other.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Other",
        "terseLabel": "Other credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r430",
      "r432",
      "r433"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research &amp; development credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r432",
      "r433"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r432",
      "r433"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r432",
      "r433"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Bad debt reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedPeriodEndLabel": "Valuation allowance at the End of Period",
        "negatedPeriodStartLabel": "Valuation allowance at the Beginning of Period"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r432",
      "r433"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r432",
      "r433"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Depreciation and asset basis differences"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r346",
      "r348",
      "r350",
      "r358",
      "r359",
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Contributions by employer"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/EmployeeBenefitPlansandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r94",
      "r239"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r94",
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationNonproduction": {
     "auth_ref": [
      "r94",
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.",
        "label": "Depreciation, Nonproduction",
        "terseLabel": "Depreciation, nonproduction"
       }
      }
     },
     "localname": "DepreciationNonproduction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r488",
      "r489",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Noncurrent",
        "terseLabel": "Fair value derivative assets"
       }
      }
     },
     "localname": "DerivativeAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Fixed interest rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r49",
      "r496",
      "r497",
      "r501",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r511",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Financial Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r493",
      "r496",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r489",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r487",
      "r490",
      "r491",
      "r493",
      "r494",
      "r499",
      "r501",
      "r505",
      "r507",
      "r509",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r487",
      "r490",
      "r493",
      "r494",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r372",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Text Block [Abstract]",
        "terseLabel": "Notes to Financial Statements"
       }
      }
     },
     "localname": "DisclosureTextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r71",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r130",
      "r132",
      "r137",
      "r138",
      "r139",
      "r142",
      "r143",
      "r513",
      "r514",
      "r577",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r71",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r132",
      "r137",
      "r138",
      "r139",
      "r142",
      "r143",
      "r513",
      "r514",
      "r577",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r112",
      "r416",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Income tax expense at the statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r416",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Decrease in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r416",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign income tax"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r416",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r416",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local income tax expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee-related liabilities, current"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/EmployeeBenefitPlansandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Cost not yet recognized, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Nonvested award, excluding option, cost not yet recognized, amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Tax benefit related to stock-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCompensationExpense": {
     "auth_ref": [
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of plan compensation cost recognized during the period.",
        "label": "Employee Stock Ownership Plan (ESOP), Compensation Expense",
        "terseLabel": "Compensation expense"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationSummaryofActivityRelatingtoCompanysESPPProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPSharesContributedToESOP": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the number of shares provided to the Employee Stock Ownership Plan (ESOP) during the period.",
        "label": "Employee Stock Ownership Plan (ESOP), Shares Contributed to ESOP",
        "terseLabel": "Employee stock ownership plan (ESOP) (in shares)"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPSharesContributedToESOP",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r62",
      "r63",
      "r64",
      "r117",
      "r118",
      "r119",
      "r121",
      "r127",
      "r129",
      "r145",
      "r210",
      "r312",
      "r317",
      "r399",
      "r400",
      "r401",
      "r438",
      "r439",
      "r512",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r601",
      "r602",
      "r603",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r516",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r110",
      "r415"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesComponentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "negatedTotalLabel": "Total U.S. Federal income tax benefit (expense)"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "U.S Federal income tax benefit\u00a0(expense)"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible asset, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      },
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "2027 and thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r224",
      "r225",
      "r229",
      "r233",
      "r562",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r229",
      "r563"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Amortizable intangible assets, gross assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r224",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r229",
      "r562"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Foreign income tax expense"
       }
      }
     },
     "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture, fixtures, and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r94",
      "r238",
      "r244"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Gain on sale of medical equipment"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r217",
      "r218",
      "r552",
      "r567"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/ConsolidatedBalanceSheets",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r75",
      "r109",
      "r170",
      "r182",
      "r186",
      "r189",
      "r192",
      "r209",
      "r258",
      "r259",
      "r260",
      "r263",
      "r264",
      "r265",
      "r267",
      "r269",
      "r271",
      "r272",
      "r520"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r493",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r94",
      "r237",
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment of long-lived assets held-for-use"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r94",
      "r236"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Loss on disposal of and reserve adjustments for medical equipment"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r235",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r111",
      "r445"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r68",
      "r170",
      "r182",
      "r186",
      "r189",
      "r192",
      "r566",
      "r574",
      "r579",
      "r595"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome",
      "http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r111",
      "r445"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Non-U.S. income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r245",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r419",
      "r421",
      "r423",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r417",
      "r422",
      "r429",
      "r440",
      "r447",
      "r449",
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r113",
      "r128",
      "r129",
      "r168",
      "r415",
      "r441",
      "r448",
      "r596"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://infusystem.com/role/IncomeTaxesComponentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Benefit from (provision for) income taxes",
        "negatedTerseLabel": "Benefit from income taxes",
        "negatedTotalLabel": "Benefit from income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome",
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r61",
      "r411",
      "r412",
      "r422",
      "r423",
      "r428",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r91",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.",
        "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities",
        "terseLabel": "Accounts payable and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Assets [Abstract]",
        "terseLabel": "Changes in assets - decrease/(increase):"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Liabilities [Abstract]",
        "terseLabel": "Changes in liabilities - (decrease)/increase:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r139"
     ],
     "calculation": {
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of common stock equivalents (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r232"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Total nonamortizable and amortizable intangible assets, gross"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r222",
      "r227"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Total nonamortizable and amortizable intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r66",
      "r164",
      "r528",
      "r531",
      "r578"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r78",
      "r294",
      "r304",
      "r307",
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense, debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r88",
      "r90",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r44",
      "r552"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r45",
      "r105",
      "r144",
      "r214",
      "r215",
      "r216",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r546",
      "r548"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease, cost, total",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesDetailsTextual",
      "http://infusystem.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lessee, operating lease, renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, operating lease, expiration"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "negatedLabel": "Letters of credit",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r37",
      "r109",
      "r184",
      "r209",
      "r258",
      "r259",
      "r260",
      "r263",
      "r264",
      "r265",
      "r267",
      "r269",
      "r271",
      "r272",
      "r481",
      "r485",
      "r486",
      "r520",
      "r550",
      "r551"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r27",
      "r109",
      "r209",
      "r520",
      "r552",
      "r572",
      "r589"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r109",
      "r209",
      "r258",
      "r259",
      "r260",
      "r263",
      "r264",
      "r265",
      "r267",
      "r269",
      "r271",
      "r272",
      "r481",
      "r485",
      "r486",
      "r520",
      "r550",
      "r551",
      "r552"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r16",
      "r571",
      "r584"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "negatedLabel": "Outstanding draws",
        "terseLabel": "Long-term line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of credit facility, current borrowing capacity",
        "totalLabel": "Gross availability"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Availability on Revolving Facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r16",
      "r287",
      "r302",
      "r305",
      "r306",
      "r571",
      "r586"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt",
        "totalLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r115",
      "r256",
      "r292"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "2027 and thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r115",
      "r256",
      "r292"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r115",
      "r256",
      "r292"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r115",
      "r256",
      "r292"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r115",
      "r256",
      "r292"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r115",
      "r256",
      "r292"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r41",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r89",
      "r92",
      "r95"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "NET CASH PROVIDED BY OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r55",
      "r58",
      "r64",
      "r69",
      "r95",
      "r109",
      "r120",
      "r122",
      "r123",
      "r124",
      "r125",
      "r128",
      "r129",
      "r136",
      "r170",
      "r182",
      "r186",
      "r189",
      "r192",
      "r209",
      "r258",
      "r259",
      "r260",
      "r263",
      "r264",
      "r265",
      "r267",
      "r269",
      "r271",
      "r272",
      "r514",
      "r520",
      "r575",
      "r592"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome",
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows",
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements and Developments"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-competition agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Nonvested Restricted Stock Shares Activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "terseLabel": "Unrealized gain recognized in AOCI"
       }
      }
     },
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Selling, general and administrative expenses",
        "totalLabel": "Total selling, general and administrative"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r170",
      "r182",
      "r186",
      "r189",
      "r192"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r540",
      "r548"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r536",
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flow from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r534"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right of use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r545",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate:"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesWeightedAverageTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r544",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term:"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesWeightedAverageTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r430"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards, total"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r46",
      "r552"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent",
        "terseLabel": "Unrealized gain on hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent",
        "negatedLabel": "Provision for income tax on unrealized hedge gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r56",
      "r59",
      "r478",
      "r479",
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": {
     "auth_ref": [
      "r478",
      "r479",
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent",
        "negatedLabel": "Tax provision"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r38",
      "r552"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r495",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Common stock repurchased as part of share repurchase program"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r81",
      "r473"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedTerseLabel": "Acquisitions of businesses",
        "terseLabel": "Payments to acquire businesses, gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r347",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r361",
      "r362",
      "r363",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefit Plans and Other"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/EmployeeBenefitPlansandOther"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r372",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r19",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r19",
      "r552"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Cash proceeds from long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Borrowings under revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from Sale of Productive Assets",
        "terseLabel": "Proceeds from sale of medical equipment, property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Cash proceeds from stock plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product Sales"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r32",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r248",
      "r610",
      "r611",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r31",
      "r240"
     ],
     "calculation": {
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Gross Assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r242",
      "r552",
      "r580",
      "r590"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property &amp; equipment, net of accumulated depreciation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets",
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r30",
      "r242",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r12",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r12",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r73",
      "r212"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      },
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome",
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "negatedLabel": "Amounts reclassified to interest expense"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Principal payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "terseLabel": "Repayments"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockExpense": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.",
        "label": "Restricted Stock or Unit Expense",
        "terseLabel": "Restricted share expense"
       }
      }
     },
     "localname": "RestrictedStockExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r317",
      "r402",
      "r552",
      "r588",
      "r604",
      "r606"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r117",
      "r118",
      "r119",
      "r121",
      "r127",
      "r129",
      "r210",
      "r399",
      "r400",
      "r401",
      "r438",
      "r439",
      "r512",
      "r601",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r152",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer Benchmark"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r106",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r337",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r67",
      "r109",
      "r161",
      "r162",
      "r181",
      "r187",
      "r188",
      "r194",
      "r195",
      "r197",
      "r209",
      "r258",
      "r259",
      "r260",
      "r263",
      "r264",
      "r265",
      "r267",
      "r269",
      "r271",
      "r272",
      "r520",
      "r579"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessSegmentInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "totalLabel": "Total net revenues",
        "verboseLabel": "Net revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r543",
      "r548"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.",
        "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesEarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r224",
      "r228",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income Before Income Tax, Domestic and Foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Line of Credit Facilities"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r32",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r170",
      "r173",
      "r185",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r170",
      "r173",
      "r185",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r372",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of employee stock purchase plan activity.",
        "label": "Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r378",
      "r389",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Option, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r157",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r197",
      "r250",
      "r251",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r157",
      "r159",
      "r160",
      "r170",
      "r174",
      "r186",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, General and Administrative Expense [Abstract]",
        "terseLabel": "Selling, general and administrative expenses:"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeitures, number of shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeitures, weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Share-based compensation arrangement, equity instruments other than options, grants in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted, weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested, number of shares (in shares)",
        "periodStartLabel": "Unvested, number of shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested, weighted average grant date fair value (in dollars per share)",
        "periodStartLabel": "Unvested, weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested, number of shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Vested, aggregate fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Weighted average fair value of options granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Number of shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Options, Additional Disclosures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Share-based compensation arrangement, options, exercisable, number (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Share-based compensation arrangement, options, exercisable, weighted average exercise price (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Exercised shares forgone to satisfy minimum statutory withholding, number of authorized shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited, number of authorized shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Share-based compensation arrangement, options, grants in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r380",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, number of authorized shares (in shares)",
        "periodStartLabel": "Outstanding, number of authorized shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Authorized Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, weighted average exercise price (in dollars per share)",
        "periodStartLabel": "Outstanding, weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": {
     "auth_ref": [
      "r370",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares purchased for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award",
        "terseLabel": "Share-based payment award, shares purchased for award (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r370",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails",
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails",
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails",
      "http://infusystem.com/role/SharebasedCompensationSummaryofRestrictedShareActivityExcludingCompanysEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based compensation arrangements, options, exercises in period, weighted average exercise price (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based compensation arrangements, options, expirations in period, weighted average exercise price (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based compensation arrangements, options, forfeitures in period, weighted average exercise price (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based compensation arrangements, options, grants in period, weighted average exercise price (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r372",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Payments"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.",
        "label": "Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Performance Shares, Activity"
       }
      }
     },
     "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by supplier.",
        "label": "Supplier [Axis]",
        "terseLabel": "Supplier [Axis]"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.",
        "label": "Supplier [Domain]",
        "terseLabel": "Supplier [Domain]"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Share-based payment award, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r394",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected lives at date of grant (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationScheduleofSharebasedCompensationExpenseBasedonFairValueofOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable, Weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average grant date fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding, Weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationPSUActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balances (in shares)",
        "periodStartLabel": "Balances (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedLabel": "Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation (in shares)",
        "terseLabel": "Shares withheld for tax withholding obligation (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r103",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r110",
      "r415",
      "r441"
     ],
     "calculation": {
      "http://infusystem.com/role/IncomeTaxesComponentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.",
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations",
        "negatedTotalLabel": "Total state and local income tax (expense) benefit"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "State and local income tax (expense) benefit"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesCarryForwardsDetails",
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r157",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r197",
      "r220",
      "r246",
      "r250",
      "r251",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsDetailsTextual",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r43",
      "r62",
      "r63",
      "r64",
      "r117",
      "r118",
      "r119",
      "r121",
      "r127",
      "r129",
      "r145",
      "r210",
      "r312",
      "r317",
      "r399",
      "r400",
      "r401",
      "r438",
      "r439",
      "r512",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r601",
      "r602",
      "r603",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r145",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r19",
      "r20",
      "r312",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares of stock sold to employees (in shares)",
        "verboseLabel": "Employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://infusystem.com/role/SharebasedCompensationSummaryofActivityRelatingtoCompanysESPPProgramDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r312",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Common stock - issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Stock-based shares issued upon vesting - gross (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r20",
      "r312",
      "r317",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised, number of authorized shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensation2014and2021PlanActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Stock-based shares issued upon vesting - gross"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionPlanExpense": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for option under share-based payment arrangement.",
        "label": "Stock or Unit Option Plan Expense",
        "terseLabel": "Stock option and SARs expense"
       }
      }
     },
     "localname": "StockOptionPlanExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationStockbasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r19",
      "r20",
      "r312",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Common stock repurchased as part of share repurchase program (in shares)",
        "terseLabel": "Stock repurchased during period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r19",
      "r20",
      "r312",
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Common stock repurchased as part of share repurchase program",
        "terseLabel": "Stock repurchased during period"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r25",
      "r26",
      "r109",
      "r207",
      "r209",
      "r520",
      "r552"
     ],
     "calculation": {
      "http://infusystem.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balances",
        "periodStartLabel": "Balances",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets",
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURES"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationandNatureofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Unpatented technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillandIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r42",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r20",
      "r312",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Retirement of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r20",
      "r312",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "negatedLabel": "Retirement of treasury stock (in shares)",
        "terseLabel": "Treasury stock, shares, retired (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTotalLabel": "Unamortized value of the debt issuance costs, total"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnpatentedTechnologyMember": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based innovations or scientific advances that have not been patented.",
        "label": "Unpatented Technology [Member]",
        "terseLabel": "Unpatented technology"
       }
      }
     },
     "localname": "UnpatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r410",
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits, ending balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r146",
      "r147",
      "r149",
      "r150",
      "r154",
      "r155",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Valuation allowance, deferred tax asset, increase (decrease), amount"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r541",
      "r548"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r131",
      "r139"
     ],
     "calculation": {
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r130",
      "r139"
     ],
     "calculation": {
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/ConsolidatedStatementofOperationsandComprehensiveIncome",
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/SummaryofSignificantAccountingPoliciesSummaryofIncomeandShareAmountsUtilizedtoCalculateBasicandDilutedNetIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(2))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123726172&loc=d3e511914-122862"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123726384&loc=d3e516343-122869"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756"
  },
  "r618": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r619": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r620": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r621": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r622": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r623": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r624": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r625": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r626": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r627": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>104
<FILENAME>0001628280-22-006223-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-006223-xbrl.zip
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M\T2R42X&C+<C@X3V/"T?H(_F<LT?7&6BS&-(W%F":FL=R0-UB4ME'(8X?/G
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M^'B^=2F@F4/<.D.8@DW<.RHLD5Q0HZUB8*4BS C&'9%+ ]-CQJTSQ,=[)VT
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MF4!8#N4$D]I2ZD&C>Y0]*4M^)OQ6M+0\8@W:RESZC0OO!#CBHF$L$N>H\)1
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MN#HJ0W#MJXH(#TE4N>:>*.@LLA.<"=H NO%@E/!1.NF93I8')RU1%";E&%$
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MK$$C5X$X=?%1?ICL>YUX=!8TY5$$82SX& DHXX7@GE8KKV+E)"RZDS!_IHH
M/M?0I<1HH;AQ3B44=&5XM(FE"B1";N?=OZ#ISM='P^->_[,E)YMX=#!LA8W>
MJ#OL5V89D)26:\LDXWF?4G02N&3:,R#!B^DVS OMZ2T2+C-,'$Y<.,EH(,0+
M+;P)FLCD9?36N&0J8-F_ADMI^=>[,<>U[3]'_=8@MD+FZ8IH3@ 9K1/H>7$B
ME$XN2>65LLX0*M'=KK[FS >A&>H0"=IK$2/W2F! 9'@R^$=9=)<!35 %G*R'
MSPA:("&8OY=BI J*$L\22&&!>.,#!4690Z_<JE !B7EH7+]+9)<WY24ID33U
M)$H.P@!W+%#GB*4I<LJ5G$-IC&_OMSG4AA#<IFA1L2*1(C)N%%7X/[#>^:!3
M!:SG/<?F7[><SXMT6E"5S8)C@A@-]4Y9(? O(U/@EOH0!&515\#U7#!H9K@(
MG4HBJ(@.>)[W528PBDYH=$E+%2?9I612OVG\85$Q^F)2PAMW@0T*'][T>T,H
M+1)^.NJ[SH;KPV ]//1 +KEWA:7;I_Y(VC!X&YE.2L8HA*6.RX1NB.919"M2
MI82YL>-Q-:Y[M_YM] ;#G;3GV@^A>O/W"H $2W5 +Q*(8-+: $PEQE!)4Z(.
M*E00\EYPOH)N6;&H&]=C!^,35.MRU'/K_!3O]P +4.=?2]$S;[5B1MDD!1/!
M&(G6TD=M"0DFTF6#^/$T=BYPRB"] AFY\$+(0+U-N:=-,MQ99_RD,N(83FHK
M#^=<-3:7)KPGQ'CJK"!VQJ$'2SDA2@FGB2><4]#>."6 2KIL$#^:QLX'3NX@
MX']@F:=Y,V)+<JVLQ*E#G85*C-4\_.C>^IGKQT\IL=.?MSJG[=X%H 3UPH>=
MTV4=SA.2<&T=:*<9JCAXYDB26J)7C2+"6 5$9.9 ?I=0+N_XG09EM=7<"15%
ME-%&PIR.3MCD!$PV1*NTB.P"VO96&$(LA60E'M^68*68DYP3ZHP(*AD5&4C"
ME*.*1;X$#/(&^JG7[XS'R_((RTI OFD6V >G,:87>9F0MM)S(:GTQD1-T#.9
MSC%*:HKIAT45D#=MUVVXSHW5,[G-X\P\=#GS(SY"/NWAD90%-?=#\L:I/U*M
MVBOA;=XQAFN!08)E$:25RE)@VJL*%#*<*X /5*28&8/LBH&X%4H$PV,D-A">
M+ $12DQH7MS!JX4)%8^,"15YJ)KQ&6#" 0P0832!/%AB'!I#;04)08/ULHR[
MJ"$:0[WIAQ4X7V$\M Y$%]3>)X*^=>H/93L VBWF( (@?M$F'@T7FCGE!&-B
M,B BI[N!R,6=35H<)&UID.Z[08><S?21Y0X]59<D<J(P,1E;[DJ>QS0%2578
M]VXFP<N/F:T9UF\GDBNP HS,=5!R0<L\GAA=T$D'6J4B0//"9?Z>?721.@O6
MQJ0$,]HD=/5IB!&_<S99 [?"[K%<0>,-)29IJ14(0X@3AE%%E6-),**JM$WW
M0NC47&;9F-5$6.6YXOBO$]98=$&TC(YR$IFMT!3,(H XGXD7HSU',V:2-%2,
MMRC1!)G1.I.8Y$M@W;YU3*R2]@UU40;O@@(:1>1(J)33&'Q Q#0SK/J$^M@P
MSF?+:V=HXH$23H.@,9=< V6SB=2@Q&J1PZ..?5^5/LHKSKI'UZ+1\O[>#2"^
M<1=EQF._GU^Y_!B.6Y WJYJ\=?,8FW+<:\=EI!WC)$C+?<*X%%VXX"/ERGMB
M&%?,NU0!>5UNJ?HN=5W>"9ZH:2)@#:4NY%TIK,\[@<44HY?>B"JDF51#7K?.
M T#\25A0:NO1X2+,<W2?F3!@P5D(GG$G24R5';![!)_K08;L> 27J,OI0E38
M%(T+CAD?6=[9S$ %2A<O!""S&^]1W*$F>"!$:Z$\_B'1*B:851;#DM)/H(+(
M\5 !?EBXA75YSDW>,SHO3YU-7KI,43JKT/TW@BAE53!,4,NE9P3 3:9,%Z.[
M;DY0RAFI,D>!L2X:+;5@FI@ -D8'*@B'3N=XD$D1.Y8<_,#) G3%#<E1!;'W
ME)SR5$YFX>DH)8"Q9)F2PD=EN 2#@N2-29:H"BS)7)#)]AF:)6+S2C#)A4>S
ME$2T0/.>0R;XY R3HD*#- LS13N?<1J,(Z0#8:T(2AB)$6_V- ##8!E="E7*
M)%P<).>SN"\8SHR.6E,N "T+^H[*^2!"<H0Y6'Q7<5%X<H8;3H .U&FB170B
M..69((D0J3DA&+978._(14G>FYWM0A50"B" 4TF$G$^/-.>I5#I$%D25]@%;
MJ-38QV<\2Y4+R4:2*!&H9$:3&$T>_L)@P\4JV:Z?>T$4TREYQHP2U F9*Y"&
MF# N"L'K($!7R)U<&"#GXDW2R"62*8;V(6*P:TW^*R@@2EO+QO4BJIU(\>A
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MOCS!^U[N_&7$Z^:[87V/G+]N[HN=S< . Z7HZH HHA&D$,[QPC)'"N\"LY0
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ML_WFP8<&7HLN#=EION4[F^L7Z ;)^N:V.,RUY$FDHF#4Q.S20&$,1OY,49.
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M4]2;TD5ZV>ZY6WL?=D>=(O:&Q>1JC)6PP5#>XV?BJYO)^<T/XM *2XUP:.F
MZ%QCCQ4VHAGPD28:E%,&W-ISKLEOS-#?J+DJ*3K%]?F3VG8744'@.ZWN-/7P
M+DVXC]C_ED5JFD[^F2#6//KCJ96=;13#WEEWK NQA:*)/N"@=/9[98G0_EV7
MY\,8[0URKL_9<:]VG%6!DO_*7G.GU[]J:6\T+$.ZR43!)R7Z_);'[B.,$\SA
M/%>RA/BDUCQN#:YZ9%+-'D/;Z4OF<'$X&DR7!751K08#UT=R0K<$]0)O,\@Y
MH3?OD,/37NG-8&AYVL. )3\(:MVR!F%^0%DYY([7ON*=FZ]R[1W';%!W_7 \
M)GM=[KW+2D7^HAZ/GW=+E36-FCG48F:%\)9XY[4%"5ZII,"94I71Z2#ZNBIO
M-U[>D?I>-K<LEK)7/FKG4Y-7VGV'=I^C!R(;Y=ZH^*S-(WF(SKR)G)."L%R]
MFR5=V$14026SR=.D 63>D.(W*?1ODNK/E?N']IN;Q^KLS9V-=_6M1G,O[PBV
ML_MF9W>]N;59>[%?V]UZN;6[U=C86G"?XA$V"AY\VFL#XHN+W:DST<0'O6BC
MPOU<BD-R68[ZYEN&RD/K)]OLD,> )(::8KA(&"9'C6&R9842P5"A#?=!K=4
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M/?$6$?E.JD?40 +D.NF*9'O5F;E'(STOB]T"<IB]#CAG<?XWV5D#9+,-:UL
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MP\Z*S$+!%8B#R<2LR.Z8.S[U<7K-D!,QSK7)H*#S3%[9+<CE\2B6J=2/,J\
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M2N72[L4,&^A=)E'+Y)474E4NMA%[B'Z9<,EXMBS_3I!FK$,/;;)+5Y)WO_-
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MRE"C:+_#EW>%G")[[1;"3_?N-$%Q*@]_W#"C6_3K&7@$_@+!X<3R&HOMC@=
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MF>TAY"-F#L*]/7AOEK5T(1G:)KY"R5_M,&M3#G9?Z"O8I'JS;4;$_EW4F46
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M+\[JC4[J"+:9MFF]M4</\KAAD:_DF,G(UUHQH+6MT.?28E?K^+?JT$)12SP
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M-.36MMCH)LVY)PZO\AG5-NSQR9UP+6]FL)'S45:4?V&C5-AU(UO7#[*0* L
M\E].<W'4STQ++N\*=%Y5$&\,$6I5?R?1"SI68_G5,4KA,*0;Y&SZ[8E[\4)O
MXX5HUN)8>PHJY=QJ4<Y[0G0"<9:C JJN0.HEA;EW_6B#O>FCB99F ^F8A[^?
M 0<&_$I00.!KEP![.)_5?4D3D/[5QB$P!YCY@V._<>S)B_W-A0NG((G!MIX0
M/(*IO?U<RQS8Z15840L1!(SV1!F%ABR0F3=*00Z;;<TCH/HR9;\R'MG=--]+
M,9M*DWF^3S!G$Z=Y]]S]<._N+]&$4/2T^Z-VO;'I[WX_0_E<*G=)$%$CE9"]
M/G!7 MP^.%UA*7'PZV/PN9O1[N# K+?R2DF:[#NK57&6B#_33B9KG)AFYA:Z
M\ ]%BA4MK,,&I!@#[_3)XT+;2U3XV0?5,YV.@8<)PVN^$K_B[6BB)M;Y9#)
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M3#"*TYRV@\DO^T4)I(@"&+X:SOA(W7;GT'NKPZ+8,#I3<%7D#A0+Z*V8[=I
M>_ORY5NMQ'F_EM& %#($-TZ"4&(F+3D Z5JNG@4ZI\K(&.(O#J)@E" DR?VE
M]3O"4Z9>U%T7K6YL*<2/"/V!I*DB&DE"SC-/41/ID'88342A-;H9  Y.HO+G
M>*64OB!0)0<?1FP!AJ +B1\P@'6OTJS!(:V2JP@L?!J!LVT>J _+[Q#IJZ\
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M(_%,B3K!50"6"F*<K2)#? X(LZ4N0&?6BBJVZ*2NWU9 S:7FB'/HMG,M*6P
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MFZK,R\=!MODARO7F=??@^K$O2:PV>:KXP]KE758"'?0V/TW[19!'X;;:-X]
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M[/+%DZ?-S[RD1EPBL_:>G%V^A"<_I-,H]([:1]Z^I\%$@ANUU8RD ]F.+R6
MGO.;^ :\#<@Y+6-"SP;=2'> Q8Y?>IPR0$ZR.$2Q&V(X/M<-"4DYY!VB'A,6
MCIHB<[=-$%EE:-WR-&QN64;J#:UKAW/KE*B6)]N6/K$Y]3_D$P9P2* ]T,XQ
M>4;BE\4X2\O16%('4 *80/@47XM"D-&_B]2(I/ULQ)UM7>^H/I7[03X2^G\*
M;HQFP&2FJM>FOF/V2PG*%/;L&DAC7*I%Q+7<7FZ#$FQJ?!J]1 /N8YNI$6!
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MB 8F8L)-3\#,G_+HH#AF32WYS W>ROXDTMX)#6R- ")NZ3,R-DHF[4KSJV"
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M>-+% 8,8&T.)B&P")[^@3OI>C3 S![TO[\CYXW8&?AUEDWO4PPG5O+T7KRY
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MUR$VLM,9Z,Y1*]6#'V;0/KPV3?:7GOP0^-AVP[2\Z"9MGX_ZMV8ELF0E,@R
M2$ZA-@$("$6B-P6,0P1XXXB)RQ+$4F\T$*PK\F@IDB,@U45T><?#,Z*?3:L4
MB"8,!1N@!9X; RAS#$B".# ADK;A1M,B)PW5D1 50O0ZA$+V3HLVZ)VC6MOK
MOJ\5PY*V;\[Z/A__62'=<F7(#\F.G]+-[(7/_2'G97HKC][^G,U%L0Y!9!A0
MG%I H^,%%(P_!<Z0U]PCZF 1Z*55VJ3.2*ZH7LE(?C(D3PL5;['@CLL(8AP
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MXW/&GZ8Y;FR_;=WKQ''K3W#>UM"BV0\KC]MFN^D0@D3P'*6*"]$/HP$#);$
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MQ[:*:&O\Q4F\Y?[4<<J)AQU] \6O!(MW<=KM%QF\KWN^K=-1S-]_MMS@>$P
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M!%0X%YT1%H @EFL5!2JE-!50J8N\P_&2$5VZ-Y(1_52(GDY1529$&K: 8<@
MI1)%T>(,T$Q9$D%N+8Z(5G7.\_;'"P9TZ9Y(!O13 7K*"S':$(RE!M[ %"_D
M%BCH-!!8<&$LYY;I!&A%'NV%Y,V1AQ^LNS47,.^-K)0K,C)DY+G-&V;,9%<^
MV9WOOH47J3%0)#RT>[ )]_[\JIG *9D>6**B?N'6 DUA %!@%%]A"D)>%/C
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M%4@6Q<@S!Y4SUV6N6_:.6^:Z97+=M(NI)6+6$@R\Y1!0CZ)<)88!;:.(#5I
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MUWCA)=2GBB/D%/S[C-=,NME#0^;L%1.++Y?/\<BYBN%+E)"7<VK"ZV@S;W$
MU*28N- !:,04$%9H:0W3BOO;JAB60Q\C5&0>66\>R14"5XI'IB-/)'C%)2*
M>4X!I9  Y;T!VC%H#$9.*GYKA<"L0S)_/)8_<M&]E>*/R5 6;!Y]]=)#+42J
MH9P:8*?2^(9[F[I@1R49I&)<WE9T[P8NUB&^4/1CCT]7Z2C#+;KNI5UL63>T
M;B4;/W=Z/M[&I7>U(]WJU"+;'WMWM.1&;@L.Z,3*6>6MHF?WX0N"NA$%O5Y*
MW^K^\;MV]^<?R;KOHZG3+S?#P/<^>=O6_7XKQ"%,MSSLCWF@SS_JGN_DOC,+
M+[.SR>W(*FZ#P8"D?@71OAPH&U6[B;9FR$HOF-IH$,:>UMG/>%RN+[PD/$YJ
MXM Z]PY<^EXWXW1QG$Z[TTHA$X*#P%B4\K:8!XI* CR3BN)@#2<1I__G?R1&
M^/<G\:<S1)?K;F:(5ARB,QXK4](X00"A& )J(D1UI&+ @H<H&$F\QO>$Z+J=
MK_XXV;9YHFMSK<#<E1]0Z/_"&ZB*5[MJA+9(^\B*.@%9_C^8LV;3P2'34DNO
M@67. NIM5/Z6"B"H$D8[$H4_VVC(V=H3,UTGGSWRLFI07'WYGU7%$A Z+?RY
M#IK"Y)8[']*!5 24Q@)X&86_,\$9!$L6_GF=? '"/X-S">"<D?P<,\$B+@FW
MJ7@3U2!B$P+KN$=86TV)6Y;D7]%$PWF;5,^QW3_J&#0<CWE-@R9:"L%7@JUV
MJ[['YPN4.EXO,N&@=']ISAH0$;07(K7G](,RF7U.J6*(F6("6J"9E%%V1:,I
M*3SP-D DJ(0,ZY1^P.5L58!G38/,O)9YK>+>9^:UI^.UF<+'B'B$9"0RQQ2@
MEBH@"<* *.,\9-QJ='OCYJS3,I^M/I^5[K!G/GLZ/IOVP /$47!;"P(3&%#'
M4^6VE#6*H=!1G!$>^/W31'\;Z B5^+=K_6C\._XQGL8GNG?4Z@P;,L.;]&%]
MG%N]IY_V.!W_W_>^%I\^3D#=N8BHK76Z@WCU03=-^0+7.I4M#JV.[MB6;L?[
MB[\XB;?<?W7U^-,/._H&B@MZ^/VTVV^E\7K=\VT]B%/\]Y\M-S@>%R"8^."(
M=.#U1[2)-W$VN/TC51G(5,EO<C@F_TRW6^!3>8&$X<PB3RAD3C+H X\_XSC=
MH$!?D4!L8_RQXZO#[*?ZR /3\_I[G)SQ&5_K]D]]T=_X[>8<BQ-L:NBG1^W6
ML0EA:6,SG.N1LKJ](K#X.JXYOI?>%>])5^9>:L>]Q.[_\VLCB8W&08)YK1MJ
M;]/"$,'P[]]T8P8/P]%N_-OT?FO,FQV5X@<Q=UKO--]]WC_</]C>K?VQ]V%K
MI_E^OU[;:;Y]5=ML;M7V/[_9W]G:V?RTL[U_*QM4Y5'>[C7W]S[L;&T>;,<[
M/XA_[6XW#_9K>^\J?^O[!WMO_S>-__:GJW%^#I(K M'B]]K3W,/\L=C^\_/.
MP>&M)IL TJCT1P'5JP6FT*[Q7MOZM.]?CW_XW;7ZIVU]\;K5*;ZQ^-#OHVN-
M5J7$IU.*M9@?PY>OJ?85'-+M*!8_^N;1RZ^*EZ9\E^%K6+P2F-WZ,GR%'O@:
MH?Q!G[SK9MDKR<42[I5*4OJ]\E>(WOYJU>Z5RX=9ZSGN5?%EC.LRYBN"KS"1
M*W*SJS5A5^=>U2O$[G<_MQ23PO.*2?6Z/Z>#*P_=4[U+H3]L497C-;6XX.O6
M('ZCO7N5+5:O?UZG2"[G?NXL2K<<@?'0L1@<=\_B!5W_7U,B_O8HYB]37]1]
MYLI0<SY-F&S:,/.'XFWWY*3;J>T/NO;[/8*Y]\D 6@P^U1N2S7BOR974[5KA
MZ'W4+5>+Z$D_O]6G:9:5-%++>>NJC__PZ/+- FD[]\T*>:DX/>AYW3_K762D
M3@Y*-V$QX;(8E>-N._J"_?];_&;[OV>MP<6\A*HI#8#1'04E%\EXO-Y%07=N
MH51^6(=56N^SM7>?1UZKH?NH>[6_=/O,%W-P\Z1[UAD\^V*Q$B/WR0]T_*4;
MKKE;/K1LZ_F&[N7,R SFQX.Y]C@@KW0BK[K74+W1;=VQ\7)Z4/N/[ISIJ%10
MO99VRW.OR44'<[$*[MQ(PSSSVC!'$=)&6(J,<5 CA1 G7W>B%>2O<Q8>6)O]
MV3,5+K?1.%/AR]\[/[]\V[[<2YD WS91\_VG]I>M]K?FY;MO7T[BMYT<DL/X
M=_.;O<I4V#TX^MF\W(G7_4Z:EX>P^?[/G^GZ7PX.?^Y^.SK_LO7FV][6?XZ;
MEY^G,Q7.]](]Q&?8.["D^>U/^&5K,S[+?]KQNR_VMMY]WWV_2W=/MDGS+WGQ
MX6 G92F<?SCX?+Y[^1U]I3IX9[Q)=38HH(3;5)G= L@5$2($'HC>:&!2AW.J
MLB\EG#(].^>'<E:^G=VC":-JY+N2S>X?286S25RE\>"$*SET(C/7+<QU?][D
MNL I5QAA8)G5@,H@@*8D  Z5HT$(%8J&N9GF,LUEFKN;YDR(Y$4DY)!I:J@P
M5DG/<"0Y+C"V]#$TE_5>F1QX>),#L>&:0$2 X*EI.+0&:&L@P!PZA 7C6IF-
MAB1UQ&>+*V0BS$2X#D2X2#4:XY6@T56RW LJ+-)16TA**!68*TG%[4S8CX\9
M?\J4^-24>'23$HE@WE(E@3?.1UD(.9#.2L ,#YP$PX((&PV.ZP+/GJF<J3>3
M*2E3TO-J,R@C!Q%'E+>.:BFEQ4$R;KUCS"&ER])F52S9L3(<M/WS^L#0+FNF
M_C:0".\1X)2HR$(L ",X 5 Z;@RSSJ'PZY(=69GE,/Y]M<S<.#YB(@@A> K\
M4B&9"00&B@FSTB%D;([C5X5 +J8(Q&N*3(B,;(V&T;/S'"BM+;#*"JF$#%C*
MC0:I,Y153%8QE5<QI1%15C%+)"$X14(T,,B2+\6-9H!B98"4C )F/46*.\Z(
MS2HFTV"FP7O2()52(V&-(=Q0C)@2EH;X5_Q_H(:@'&BO#!?B*2Z$!G(5M !2
MD51WW1 @M8>1"[GDD6V,"JAH>D_I[34@UHH*5[HEVOT&M\ A,+KOXY 6/E*M
MU>^?Q7^=G48F^.'[@U0N ]3B@_8?UE+JOF5R[W)WYPQLU=S=^>.[8-::8)0Y
M(2##F!K+C6=8,>:H$EX[K!<NN5.8=Z<PZ-99+P[=Q_@473?TAHL_WR33IV,E
MOM,O:D6\[Q5M&S/?+L*WES.);$8908.BP#J( 67* 0F% $+SZ$GH$%W@J#R)
MHC-4NR#?W='28EG2;ZT1/7(6LI4J;:4%)*W'.@3CB2-<T2"PY-I9R*S#/B#-
M0EFD6R3-9\XMDW.GDDF89(C)X(&UQ +JHLR50CC O8B2T#D$+=MH(*(RYZX6
MFC/G9BME*V4K92ME*U7)2L]933>KS*=2F3.15,T#%I(B0+!C@$9[ DEA "(0
M+ 0*(?Y0-9WYHH[;_CJ6:2?F?<V?IY^7TC[GI23KE+D*56\S,ELI6^FYK?2<
M$:E-]^VL/RC*F1]TKRMYI1I>.YU1]:Y",YAIS?#)__>LU6\-_+[O_6A9/Q09
MG[SM'G6*JQ1Z(XN*Q40%G E=*0&U) H!8=.Y=V\"D$7#/.&=D,9CC,Q&0ZG9
M0U 9]I6&?2;G;*5LI6RE;*5LI2I9Z3E#5UF.5DZ.SL2X0G!2ZR"!YM( 2@@&
M6F$$XK^0H8@RIGS5!.D:Y.MMGYRVNQ<^=?KHVN^UT[.>/8X@J9VV=2=GY[VD
M[+RQI8LW?1S9^6,T<P[A+TAO:"8YSZG N<<FDIO0@ 9M@"$,@:"B59W6B$NT
MT2"D0O'[C.>\:_I"K+02D="9W=/Y?-SK'O7TR2]E::;LA2E[*D JB:+"* D8
M-0Y0@Q10E*56IB9."<0"XVZC@5#F[!5C@\S9V4K92ME*V4K92E6RTDH$2+-*
M?6:5.A,W]<8Q+" &UE /*.(":*DL0(X8*1E20IBJZ=0UR T<=?0;1DU[?APW
M=;5!MY:0TP\7M9-6IW5R=A+?I =G@V[OHO:S-3A.10K2$>CQI^<D&.;$PD7-
ML6 5L/(CK\6W)#Y]U^T=Z/._KPT=?S&?6C,[+L:.>";L*@/$DJD0N=$10*VE
M0%H?"5)Y0Q&4W@0<N1'/EKQ?Y8)@+QO)>;=_%:RT2 7I9<9</_FV'GAWT,V<
MNRS.G8J;<LV,]#;J46T"H$XQ8+"1P$#/I3:0> TW&@+-[N-GSJTJFC/G9BME
M*V4K92ME*U7)2HNHS&7&3+/*7+K*G(E[,J\T"I*#P*&*.I-9H#!60!/#HSNA
M'4:Z0CKS%R%/U^J?MO5%ND]_-P7D=^9W5N.=>4KG=[ZP=^8IG=_YPMZ9IW1^
MYPM[YQH<NVKZ0:W5L=V3AQ416NM$JISNEJV4K92MM#Y66B ,RJ5C%&M'M(*4
M.:4AI5@%PKC4"B&R<!@TKE0[Q4+UH2CVF'OJE!;U9#.=FFD@$%%(@-;2 PHE
M!X:IE/II#>/82._Y1@/5"9]MJ),A7&D(9Z+-5LI6RE9:'RL]Y]YM%BU+%"TS
M6[4*6P$EU  R$0"U" .% P?2B."=CF*4T^K)EA=U2&5^'\XWNJT[-EY.#VI;
MWOH3XWLU@NJUA*+G/F1BNCWG>V#0/7V=3-COMENN-AZ2*M/=@CU/YQY ,81@
MP90CD 7JK#3*6JNXMI'T=$"Z:'MZ[W,GN0W]TKJ>3IPX^79$OGJ(A7'! F>U
MBE3' E#2.N"TX-)3CFWJ"(5)G<(7T//TWA!=H2RX=:&=6955&N?,:;6<>65!
M7OGS)J] SN/ZK!SP0F% I51 >R(BK]@HA3&32/K(*YE2,J54B5(P]9YB0104
ME'*#C%9>,F^C\X:Y8? QE))U3)E\<WB3;S132CFJ@29. .IH]-8L-\!B'HR/
M!F1,;S0DJ7,UVW0HDTXFG;))9Y%4_ZA:(,%$*J@)%9IK"8GC'JM(1!J*.X1,
M/SYF_"G3SU/3S]%-^F%*(H)A%#DA'=QWT9=2T92 !RDM,4P0B#8:/(6,2LCO
MS_"O//P70#\CD&N(,&5:4 ^)-A028FGP2(6X<)6E.4+KW#MPZ7O=C/>%\;[]
M\SI&O$.;/[]:1B2C#@.I&0-4F0 41AXPH9UQ$BIMY-7.3E8<F7*>47',C=@2
M[CCARDBN%9618;#&F&"7A <4@N>(;56HYV**>IRV)!J- "Y,JN\+ Y!&06!A
M,$*C +'"&PU29TAFK;$&P%] :Y0&^JPUE@AX. 7X8)3%U E@#:> 4B:!89P!
M#@/'<4[XJ!ZSULB44TG*8=Y;;C$VW!"*O3;"!V<@Y5QB$X+,(=7*\ Z>%AJ,
M"4$H!]S@Z./$A0(HXDC\ R&*H43:1A\'XSHA---.^0DZJW<,;++#_-#KJ+6*
M]DVUL]-($S]\?Y!*Q8):?-!^/Q\56VX_+LPI001C93BDCCFC->90*(0@U]K+
ME(:(X2@-,;+PX_IQS2\=\[Y79"QF,EZ$C"]G\G20)=&:@0/EB0,T)>MH8S7@
M&C/$*6+2LXT&@ZQ""8D9T3GW.ULI6RE;*5LI6RE;*5LI6VDMK;1( J(1!!()
MH<&$&A[_R0A#(K"H^(4/IBR7K6@#?Z?'EL/Y)7ER,V$U3!AUAAB@H,. *I[:
M+'L)/.+6,Q@D,^SV<'X^8/9$\:O)!D8U?YY^?EAQH[4N>9P+4V<K92L]N8ZP
M+G#C(34^2"HU,9Y#XQ@T\9?*:[*PCKAWQT4SK2=^V56QT")Y,Z]$U0%GSD<H
MQ2ED'@*,!024<PBD(QP(CP,*<7)(I#8:N,X1?*SBR*R0N3M;*5LI6RE;*5MI
M?:WTG%&OK%972ZW.Q,@$Y%X1%(#5Z3RO0A1(K!U T$K*F;1"X.KIU37(\-H^
M.6UW+[RO#3N%C_N$UT[;^F%MOO/.0$7SN<:6+M[T<63GC]',.9UK08)#LV67
M@E "L@!"P-$=AR'2&_0$($XB[]&X A(=Z6VV5$'>Z:LTGO-^["I8:27BJ#/[
MLO/YN-<]ZNF37ZK63-D+4_94!#5MS6H,&<".A$C9R@*CG07!(64B:P=BT48#
MJ4?KT<P&F;.SE;*5LI6RE;*5UM=**Q$_S2KUF57J;.04&Q.4Y\ I0J-.)0YH
M03DPP5JCN>6,BZKIU#7(+(P8.>EV1E'3GA_'35UMT*TEY/3#1>VDU6F=G)W$
M-^G!V:#;NZC]; V.TYGW=&AV_.DYZ8DY+7%1<RQ8+*G\R&OQ+8E/WW5[!_K\
M[VM#QU_,I];,CHNQ(YX)NTJD,;%2 P*Y!-0: V0P#$COC.*).8V-W$A+J-&8
MMYDK+6:SE:K"MT\;<_WDVWK@W4'WWIR;-_K+).2IH*ITVA&/$0B.84"9,$ K
M" 'CS*4.3"+2<^JT)-!L@9E,R54%>Z;D;*5LI6RE;*5LI2I9:1$1NLR0:A:A
MSRM"9V*FUE.CC*# !<BC#/4(:.L<D(K[=#(J: 8K)4-_$3!UK?YI6U^D^_1W
M,T1^9WYG-=Z9IW1^YPM[YQH<![BQK05&Q5[S.8"7= X@/F'Q4D[[7U!IGN_M
MPW'O#KJW=7B9=N>#0=8H"0CS#% A Y#$$X %=)P;8HA*_99G&W?D9)U* SBG
M5&4K92ME*V4K92ME*V4K92ME*SUUFFSU B#YG?F=)8?(5B_SN^D'M5;'=D]R
M]=B\KYZME*V4K92M5,:IOZ \%9 '30FA6!)C/31.(FJXH]KXA;<!XDJU4RQ4
M'V8Z .2DDT=M!; /!T=3!7D]H]JI +32"%#LXT^&*""I0HP&X15)F<^B3@BN
M4(6SC.',M-E*V4K92ME*%:E5D%7+$E7+3*JL,9HXBRP0C*?*A5'!&&L=" Q:
M3#'&@L,*ZI87E8HEYF+PC6[KCHV7TX/:EK?^Q/A>C:!Z+<'HN5.R[MU<O6I\
M-W^L%\O7LD*CZ)DA;2BF 3JE39!4"ZRL-HS[KSN+% W8.QOT![J31BRS79GI
M6KMOK]*UK@X&2&Z#YA[$%<H#JK0 4F$-O!0P.MO82T4W&IC4)>(S;#?&W+.H
MIH?L4=T;I"NTS;@NQ#/G&'U9K).20],1)=_K;__WK#6XR,RR.+/ *6:A6"F'
MK  L<@F@C$*@",2 *2>\M)!PG2I 9U+)I%(E4@DJV.BFL4@<DB*EM>6>,F1]
MI!)/+'T,J60M4RKC3'MNC 3G&65 2:T Y9X!Z9 #&@LJ"1<4ZJAE)*T+R3+M
M9-I9.NTL5!-(!6(TH@HR0I$4BF.O&(=84DPT9+?S3C\^9OPI$]"3$Q"=(B 2
MK/'1BD"X$ F(,0P45RIZ5,$1%WCPWFPT**U#,DM ]S]FG0E@50A@ ?P;HYFR
M'AMO/?6(&0.E$%9AJFCP4I:E.W*G^\<@OO@OH;YYL!U?MU\5"A@QXH#C+!5<
MQ 08AB00Z9P;@PZ2$&YO=9]%1^:<IQ,=<T.WQ(<DC6D(AE.OF30T:@\N'(UB
M!$&;0[?5X9[63>ZQS"M(,0;8JK13A130T## (:4$>A&B*3<:I![Y**N--4#^
M FJC--1GM;%,Q#>GU08W&!)I@;<A(I[P *3F!"BBD7'4D^!95AN9<RK).9S%
M22J04E![&N>Q<I!93[SR*"AM>(ZL5HAXIJ0&T@)K[C$P!%- F>; 2&$ UAYJ
MC'TP6&\T**P+EG=TEI"LLWJ'PO8G.GD,'8]1[:3:V6GDB1^^/T@]/T M/FB_
MGP^.+;>@$H,>NL \-)Y0S(66'E-D4[%Y%#R&14XB&N<DHD<65)I?Y/-]KTA?
MS&R\&!OOS^3L8!&=.PHET$(Z0+4T0%J#4V%YCHG!PGL?R9A7*3TQ8SJG@K\0
M*RVRJ:>)%% K02"FG%JIG).62B2]95+9LFCW+]T^\YEU2V7=Z>P"RKVE*@I?
M;2T9Y3-Y&;UPCX7"D%$#S49#HLRZ*X;GS+K92ME*V4K92ME*5;+2 CJ3<8&\
MD0%K)ZD-6')B':2$$@R)&#64RSJSDCIS)M:*I3'"NP""0P'0Z-,##;$'4@HO
MJ6,08U(UH?FB3A_^.J YV9JXYL_3SP^K?97+#>:BD-E*V4HK'92::/QUT-V,
M(Y?N0+=3[^^=SEM]VAKH=B$:S+1H^.3_>];JMP9^W_=^M*P?JHQ/WG:/.L55
M"L&1MW=+E1RMF="6<%$PIK02BUE4')I@H(@7 'M.<0@:$8DW&KQ.X6QWL,P+
ME>:%S-[92ME*V4K92ME*5;+2<P:WLEY=,;TZ$R*#!BNJF ".$@_21 !:<PB4
M"X0XPICRM'J"=0VR_K9/3MO="^]KPWZ)IV<]>QQ!5#MMZT[.\7M).7YC2Q=O
M^CBR\\=HYKP)L###7<RD^$%GM)!()&ZCJ90%!X9+ 6"0R@M,';1ZHU&I H09
MT7GG]858:26"J3,[L/,9N=<]ZNF37PK73-J+D_9T&%5K@QQ!/LY)ID#4G@I(
MHBGP1D$=I%1&\TC:]-&];S,?9-;.5LI6RE;*5LI66E\KK400->O4Y]:I,^%3
MH[T1@2,@<7" BH" =D* :'Y#O7>2*%8UH;H&&881)"?=SBATVO/CX*FK#;JU
M!)U^N*B=M#JMD[.3^"8].!MT>Q>UGZW!<:J&D$Y3CS\])TTQIR<N:HX%"VF5
M'WXMOB41ZKMN[T"?_WUMZ/B+^=R:Z7%!>FS.MD1PW O/ P'(4 VHL0YH8S#
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M5,E&><$EU]RJ"'NC% ^&4TD@%5 S)V^G\5OZ-F0^7SJ?3^]^4ZT(%,P"2'4
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M&QV_>1>O)0N2(SMZ?A'TO'3[HZ/G1Z3G*8,D/A0I<.4H2D@H641HHA01C,5
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MTN_(^<&LC*O(N:/8NU)L-*'8@[.=C4,XFLRP+"38D)S03$1$HA26-HUHDME
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MFTL*$*V(L74#1/[;"B/_E][G+[M_;VW"+W\<])8&N;=$I]-KAKI]=,#\C_E
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M^;& "==E4 T'1I^!QEK$>C)X2GX<O]^#FR)0. )L',P#:YXJ3#WO7W4;A=6
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MW[DU@-W*F+]3#0Q@E?/69!-":Z5%[#4E:,_-6EZ,YCCOT],Y0G=C=4;-^5L
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MR["%(2-,Z(RHP*:A#"2PR_!N8;"8!0D\S80()";R"L9L&,>QL5;Q,#$=\WV
M;EEGN_O?P^W]#]'.MRW,YSW4+ L2R@6QB32$1B(AD@I-.(M9I(+$A%ERG8.^
M194+=3*@;T0JK3(:E3/.)EB?3:7C<JD8OGW=S1,66^^Q1-@LH-1224V2)"GE
M(0LBRVUW\Q[VYFV'R%'"@$J61134.!%X/#'!K2&I3M)0TP3,M>C&$L.\K$1W
M6ZS7%_+[8'@&<NNH2L5%:[[=HPL-?N=JF1+6KB1V6IZ[CWRP9#RJ!";86=_-
MR(NYZZR.FV__=.SJYNN/'HL)=E_SJEO>?8,1;ZE9$ I!I8P8DT)S:B,@AYAF
MM+O[#WSW+W9<)@(WG 5@O4C%09HJ1:05B(!D(RZ"2,21O)[K[D]LYCDD9.=E
MK[%6V]#K<&FV0+_;NRA'YL1=/'0?-I?OUI45J^)5:$47T N+E*I!#N#U],'=
MEF?ANC"'<SE;],?[9,?<UAAJ38S@NE"&:\^$;L;*@UE'GV>=]G81FKD_LJF)
M_S#EO-O><8$U]'VV6CS6@9*%P8Z;G/O3_EUGFY3.?_PS#]8^XVG?^.P.Y.7$
MRPNOFAW$QYNN<5_/[MX5#NQY+_B4^WG^#.IAIEWX:S_O A>CR@>^BB[N!8T5
MVH2R^$*B4QR$#;94\=?!)SM/[_!:!13H(6VN!E6>K^4+C0UYEFC-8DH#$%$9
M#V*94A6%J4EME:$3!K5<"F:*^N(YK*UF5W?M)["7G;SRSM/_F+[^."R^E@O$
M5!M6^96)J4E ?N=2T9UO'PYUD 19&E)"68#]!#-)>&8,43),TY0I.!C]YMU@
M :[R5.SD*8'V3YV/W3=>W[78RQ?3]Q#TZ36'2@XN#B.99"(QFF14:D)MQHC,
M;$"L4@GL=RHD%[/)%B(3U@1A0F4*IQ!8&=HPM3&PSDSHS(CG&%K9JWU)TW?%
MMW%NI4\]-]UHJMJO7AKF:YABY'QV0Z\P^=RS"H5M8%H@;$,YJK+@$(@5#*3^
M\-0S=D]$9%R:QA77;I-X*BZ*(59QPA96/S=-/?QK7>'FR6E_>&%0M!P/?5IL
M70^Z2*%=^-:ZO\H:2%O_YVJ0ZCT@W>HF8#,=G*L60:9 M<1_V1?IM!;J,@B;
MD%%S/]H.R*H5R0P:^H*6-0B],F_MW2.9WZ<N=C[*!5W@8?S.7_D2SW7_ZQ+\
ME3-\'N%(,,W,4[)RW5LG=DC%7URJ[U2/$?3W]$&UKE)OA?95>[GCJ2,S0$YP
M.BXP5]=C3+9X+1QH3?:GV),5:P6+B^9=CFT.$<@27W'2( ? VX]\V]ZF2+[A
M0R<SZ<?(31SK=LM:<VRGJXV^6VUTVM5&K\9<5J4V^L9:YQEUF?%$V2 $RR54
ME-)8,AUQ:8Q4, "C_*HLWAO5[!6LJ6YZK-6MMGV0!G[S;FGX[*+6DZIJA\4:
MZMT@R):%[M]2[G!*P)^*VC#XLQB690<_=@L!'>Q<?CU, YZF(C5$.QRZE$O"
M+%4DA,^!<H2.(XW@0/'56$#8NVNAME\C+[N&@E[&7@,6I'-]%P_43Z+9S3F>
M[G25.I_3%'S=YH?#@(>1X"H@-HA3;.;%B5"&$<42SD,KLB!-%OJ<1BTFTO/]
M1&]YAQ9?HF"]M^$--<^:*P[G!E"+;,&[XFC^E'_K)YE8>R5AQ\RNBM-M[Q^<
M':9&<)/0C("A!QPLC.&G$'Z56D5!DC(NF$ DS?1J#@9B#X]L[6ZXA#*+ [ R
M QG%(/KAUR1.PLPF2O#,6.GN0U#?AULT*^GNP_WO@[H\!+$0)SSF! Y%$:HE
M)=QJ0XR($Z5,RH*(XWVX!E#3WX?@S@BK0:!@]#@R6L&5B)2PF0G!SDU Z0FY
M<0FJ(:^N1,B[*_&X^L[VMZ-#'JL ='1.$ID$A-),$*XEL(PLM0H[V; 4N$5T
M71L;=SM"_NS"[U-)]"XRB<DRK6*N >(=N0!UJZ5;[2+Q, JD\K<B3O<5CN4I
M:*3^</C=Q45])--8ZXO#71HNDM=LSJE/K&VY5LJQ)/7O4W'SW%XQ^58G.]^2
M_%8ZZ'3!6;4_>C8QH/V: =9BC@=WTEJ#0*>IDBD+A::8UQ;!!P'PB13XDJ2+
M\WF6&S?]S>;G1I-+4PP;SA"_.LY0PZ3^!7,^ DM('4:Q,B;48/HP 9IL0"/"
MPA2$!W#U3&LI6&!0DQV8>=;@4\CK2S?ON9OVU#UPUZK)C2@V?<^?_MS=Z-"W
M=C<5/8Q!7F>4)20SJ#"8#*S? -LHR"Q*X7\JCI]EE+25J@,\%<^>N,-_IN5H
M;@%]MX J ZCI03%N,#[JD-XB+-JY9A1K*&,607NYH%^E6OG&R'.Q00_,@07S
M\]7X4Q7X155M[_HH3Y?A5W+$-$D^<[DYO1-Q,2D];WI'N5RIF2+L6B:U<[OF
M)?T4;(K_X:@8CD_=$IHWN+:?Z]A<M_7[I!A$-*"WK40E7P\R/IVM" '9F)<.
MKP0WRM?@8&!U$;)N"V,%F&GCA*Q?Z!62M=YX!!.ZQ$TZ:?+[FL9G$H/#=>P5
M#^H4#[EP[4M@G/')Z22-MU(I_.\3E.&K4M&F%US5L$^?C%]+M<Q%.(]KK2.8
MM'VM2\'KQK"S"6QG-;YC*XVMJ7(:>:#EN>GZ!+E*?9E$HUTBF4^%GLXG6W0O
MIG6G\@;EJ;&74#6>A@%Z',V*TS31*6>2,D&5!+-?*\ZRP'#*I,VRFVRO3K-Z
MH+RTOP[3C&D-TI18&F:$)HP1,(YCHN,X"R73+,Z".W42,&DJ: +:<P):=)!Q
M&2486F94)"BXZ4VNE^ZL'^ZL91JR+*$D32WB+V8AD<[2%E; .;%8AN&=SKJS
MF%;VK!4%73E*)$F5U7#":4"$2!2)),]BD7#@P?P*B^D6K29NLJD>+RWU$PHL
MX[#L.L,)TU$O#TT6J8"QD 2I"<%PBA(B8@/_,6%H Z&-C-ES-)S\(3\W^VAW
MT/LO,1AC5I)3Q4+>>XOJ5=WTLO:Z]39!#:P[9,RH97IXZIHV>(!!5"7WL&)=
M8#>G]T/M/'J.5[]]L['W_LTOO?WA*= :H]&:AWDLU]Z^:3Y[ \,W)1$G[G&#
MB5>C8E@KAICT-*@JG9RF+M1QC=K4&KOOB*^LK*X)!%>C#L,+'-1CKY_7YHI+
M\G+IF4/KO)->K:V[AGS9_>H_:9J H@F$R&1]GT_F4K*&32N,WG=S,84:*R2V
M*L8ONP46K@S=E?6M]S:TAS1#]^=:,V Q!00ORKH/BD7<>54E[39&P^]>IZ\>
MJ/9]"HD+>QN/T/U:U]4.RL9":/*A9P; W-PJW:.LF]7@XQ/3:SK)P_2]&0<[
M >>#=5:CLMIJ,;DEIXXA]H8#W]2D6K#+ Q8>CW.Z#.7,].'L3^!.'Y?/SX5>
MW\L:;Z'LE:X4M5\5ESED?I1@SO\ YZ)SXYM3S_23K>G-P?#5='#%_D\H^52H
M[\(7R"YZ376?:X=(T\:SHANL%'.44V'XX7GZUC.^OTSIK.'"' '1X]'ZLZYZ
M6U:WJ+K2LW?+YV?GF&TYE=(]TU<T][:S:;IB+U@%+@[NJ2YQWQM3MRJB\^DF
M?@K#RIQ_:]:/UM&_8\Y$_Y=G?*= 81U.+M;">^08U:"')S*:='P'+7;H.%%#
MEC?>)#4\D3[EM*+H@7:%T=7IPH.@MDVNU,*#<AX+G/,<IW \!K%VB>, ?M V
M>S+GYJ0!EJQK'#SO^-W#NL%*S;2(JF_/A/,WC-RS[&DQD%=%I-YQY<=^=I=C
M:^ Y!1Y42R@N1&CT+B17(E\G-BZN-,42R(G,<G@.]2U /XPRIW/,:'+5&L=6
M2[3Y!E-YU0IE:"VV^X7M0C]KW?VW0J&YF$*?F?A=7?KH[.A3HK4NTSQ%3B;0
M@06L:USVL/U:J]Y^  =W/9S$'7(0%]D!N_4<G=:S#WN[:S%Y%0FDJP:XHH[^
M0P@_'\9:95D:I41HGA!*:4AX:AF)9<)4&@:<A6 GC&[5I+JYD=4]U!Y<$X]:
MN#)?['=6CN YIVRBFQ9;_)177&M_9ZNQ?%]V7S?@AZND2R-S\)[[G-FR:\:Q
MZ.PO=_:_7AQR&UFE> AV(9J)F8J)R&1"PB!.>*9Y&HK@S3OG(+A54<]=6HC>
M3+M?_*$B"7>$.WMX]#!*,Q%'@I(T8$BM&HXQE#%AVL"&,S@+%EY?N_.'40+-
MK[:XRFN55)2@+DNDL4K\P]F#6E"HW#_A-(8IJEMKH3B4#1Y&"V WGUA)=<6.
MER/XV5I=X%A!O2Q"X? JB8]WX/CFO*H2=+3MQZI'N TC6<"4Z@)'Y$ZY1D !
M'XDY O,=^),Q5PP\$95S3&KF+3.[-JT*WGK[%[*\T3&:PW-3<9(99G'%#/#<
MQO<\O64?WG-3!.M8W$W78EHW')=MK; F12Q4RQ48@PC45U> 5 J7=R[4<5OW
MC34?U18_1-[W(>C=4=7?8NYM994OI@I?"=?OR6%1#,\<\*&/P\Z_8!)IO)::
MUA9-'H:[.*V2S1PZ3CU+T#R'-^S%3TUUWQ4W7_D03&@2;_7V4#$\=[]/ZJ(Q
M3NV^[6!CX IA<+NH$M0]?I2[UG4S=H\AU:: :U2A-IY5E1+A&S5?;^A=;3$N
M,OT\L$S?Q?"]5\$;E.:&MS2>-BP:J=U)SX\:/]>,"#%'QPW0_(W&4GT>+J#4
M9F=-B2A:-2Z;8'+2MR2.N2>;MWF\F\8:GAL(LR0PXP4$P@CM=F2>$[\@S+YR
M,)95_D4%)5HGT(S$.?Z>#\IQ@=DM:WC>)[Z#C9@K=?4=+FMKL $:J%]Q]7+G
M.=W\BC%GIH54[9MR5O.;GF][+F;N!G;5MC=5VV9=M>UJS&55JFUOK)Z=J;9-
MPDQ)'B="RH0:@56S\$ 4J< J(:A^\%9/7WPW](^@'-;NFW] Z+ZO8)R[0"^,
M>7[(&#=!#$9@D%$,]%H*I*P9$9$,(B6B-#+!<PST5J?O$ATKI_1S4T+J)4Q#
MW+62&:NH3 ORSJEMP"]0N_/:;6U_38HF:T^^3SDT+NNVUAS:'9V&$L10G;*)
MXQX+Q#TTI@$CU^N]C;WWE=\Z#5(7>PC#WWOUS)UA5A-?I?/6]%<VX5H< YYN
M@K4.Z<ZXEA35@Z@_%?D(.!IV'A(>RFAT7 S'1\<5+CO&QAO\]TJC-9,F02X?
MTP'HU9V@)K7NU0ZU7^BW1[G YO26-X&^Z7QCYV0?@_E<>-A8YX3'1GV%:X94
M]2;%C=-CCU_BM/@JJ]:'Y%S?)N#=,]VQ7+3$._&K36@F^NSTZEGD? ?X WMX
M*KQ%YLK$$9-?C:Z\BZ 6U]V67-^F^C[]YOH[31W*XB'6X(OU0: &><77?/CK
MAK&  JYZW)T8O.<$'2ZY-P3]L;F@)P:%K6O.UJP8^S#AJ=>OK&*C3?>$"IS;
MTX>N[5?7.0J[6_G@8)7N[0FP'9+S9DQ%;,X:+*\F>)^-T12)-2=4#UR.@#8J
MFQ4(8@!W?)ACR+ P'ENB,A<K &?81K S^E5.B,\ 6^_M#8$N?%G8P&%&N[$G
M=@V:&>BP0E#.VOA 6\!U03C"B-"@2BV>_6-=(3!IC5!9UZ/\67J'VG3C_8*C
M*DWD1'P#GN-3^'.72-]BO2T^Y4 <ZEX2XY/3<HY^JOON.J5>-6";;*81W"9V
MW2UIL)A(MZ;?!+[/]=$0_>' A1W1VFQ7(M0XK(7)3^2X*'V$TV^'@4?A!>6Q
M_R(P_4(3N+>P%G<OFLZM$T:_WELL9*]&36FHXFJJ+^&G$O. 6AC@$R=6)3X\
MN>![&JDBZOM9I6M@DH#H(:&-?,<\AU?<^'/;L=.UZ9X=@S&F\+LL$G_4?O@F
M1(NL%Z7>R"SV,S64V&(!,T=?F*N4$O<RM\/#IFU>_3"^V&D0-?LK)M4.]47\
MO<Z=FAYT2GABKY)3+V<7?J5Y3Z/AR(NIE^"M.C6^84NU:=I@!1*VGT1OW$QB
M2YUI@RS)^\-<TQ?GN9Y2&TKT\[1HJCDN]'J?C$]J0.8+G^/CICO]LO^]>/\G
M4(DW;+W+S:B([VQ8?)]L1@V2]OR0Q:=<EPZH<H*<B9W!7*(2$,ZWL3ZJD@F&
MC9_6GRXZ88L6?G6UQVM3S9J1\$ +\T$-='^J>OOG.5LM0B?OK.36&KX%[Q7>
MXLJK7<VERF]J'%M3VOEZ[^^%G\^47+?NQ"(WVCS;JZ9=7ZJU:1^V*+W+'5D:
M\MOV'K3@HQW[U[G3O5R%FS2C,U/!\GG^6W?4MA,5IH4O7NGLK?*Q*1[NO9<M
MB>]%><N-5\^R48=:$_4$U)2&N;$6;_)T@R.P"T8@[5!50"]]73 VY9RO=0K7
MCJ+IS^T9BQM?UAOM<N9J-[Z;8(%U4D,D'V5:Z*+HC;7#?CYL$F-K45%95DZ5
MK2)X=<<)!]):7:-JG(F#U+MW?9/3*1UKEHL-JHN"=8>PG3],!2\/+Y9NJ$I6
MM*D*;TY1>B6B%MN^*:KK00PT6%7%U1D3LHH+O\U_F9@OH".V!QT/*@+&?%Z7
M;^L*U1KZG#JU6H059M:$K8ZMJ5(<#EHG69VO3QA^F_O9]/IX35LRLARCHSWW
MO0;J4V\9GSX*TC894:/5""\_0C3^*3[3A$*NH?/GQGUWVLJY0\S5W\:N5[4+
M'+:*8"<4>.7J_:59[[U?]%1+32IR'ZX4%1/R5L+95)ZVAT1&1:MN30TG-O;,
MPRN&2*6G(X^8/ "VXI0HY',NG=(MPW.?FHB!E>R-9>E[3S1+:TF3LFJ169.8
MYYH3L5QHSU3;@V-CX,D>SFB7E8KD7[7X[?7=;S</<+??2Z5Z>] /I)%4Z]&:
M-^'*&@E19]&C4B<NYB<^\%?>:;;(=/1P+$<(XE$SOV=W@3<GG0,'PM?OUJTG
M-!Q2Q2#\9K;M"C/XD1?#VLAL&0$U(_ A-)2IM38RN2:+"AH*/6WI.I-K@4AI
M:L;]MQT\+G[N4DFP*\@ N6IE0#@M9/+>W/,JH)_O$X5P\F?'N)TKK_8!_LA+
MKTJ/3W6M$HBFRF&*X("Q#UV+FTFNP%Y+-UEK6&#?G%<Z[HECF"VE1"+,SDQ9
M1;/_;:G@I$W[.-IQSD;[JQ4-IZ#4GU;* X8+*_) @VF:(NO1ZM8\3K7R9+#>
MJVY,%=)P==X3?H43/89# 25!>0S-J5LT6>K4].OV[J=#T%D:2;N@S'UR5LK5
MAD_3\L!4"0.URN"_Y$Y43+*/L/(:#*'A5,/[EH&'FU).5X?XFI*FG/U)2O+0
M1U%';EJN>T1LWK75YUWD9G=3)8=I$!@:6D%"$R2$!B$EG">4,$2J-8F,8L6?
M8^0&SQHO9G7:SZY8KY[_G#O3\\:J#X+G6XX/ M6Y)(H*(MRY;-8:W\!TGX1R
MV$=M!]T?];/>.JJ*<GQ$:*KI0LM>;,L>X-SM48#'Z'Z#4#X!1W=Q_8D[YX?S
M6+?=+#.>'-%R5Q=-(5EE%3IU#C0)"R+@Q#NZRB?N2(,V)&KZR&6^@,A\#^O(
M1_C3J^0K!_%A8D*>\2 @B=3 5Z2)B$SBC)C$V#B1*I."S@;[K90R#F7$K564
M9PG3\&\H9"R5L#%]EJ7"=:"R-W5'GALWVG#<YC:0>,="MZQ>W[<:= U0BZY$
M<P!^@A[&I8" !U,JP(ZSSB>%-R6F;NRC:O49-*O<E U00_#JZ+2&MMM.7/W-
MICK4.HRXB"VQ068(3:4B7$><Q!QH5<8Q(GV_>9=E"T OY]V%U:&6OMT>9L*Z
M8DQ[S35PA[5<..5HZCI\-@62(&C*6]6$M@9S5Z2Y$B1ZY7<"GCE,&6RV-9RD
M<<((C;0D(HXLJ(=1$B0FHPD#1CP/FOR_6IV=7>VP0];TO@KLNEG9%TW;VQF6
ML2CJ=B0&%9"MMXI;7A[$_R #<S0<^6Q_:[K&*'=-U61=JN9JS&554C5O3+V<
MT=Z"-.24*1-P$=%8<$%#1EEDC0R8ECI<Q08GBU=^HQ[ZKE3'1H_[IJK/0&L&
M6-V .','+!*/*&A&F$^&S&CZ^RX&,X4E68Y/,2Q5MG+B]F?2,KR#;L(G)X5=
M=;3'^GE@,!D],@-?<+=6H6R,,;UM!,8/_($X;ES57V&^_L!EC4WY)(LZ\<^]
MS]31* _*4$$;NA&FHT.NTG^&F]<UV-[&O(&WK_6V7=I-KM?:@3S_H7.&GO:%
M\JX\^ D?*$W?$I>^@]/TG[5R=JH4E&:$.G_'EY^@1)A,;I($A%B)N?/D[PSK
MO*,F :2Q3IL.]?!FUUO9P9>$P?^J?<.3</R,[[X%B#@L:JCP.:DT1:P/C @\
M0*_LOCCO/&-@P=+#(*&)8J$F*DZQ3ZX&=5@R16!WP9(-TS@+D^=HD?IS[NUC
M?<MSLT/;G*;)7G&YC,YUY W3W"]P),ZG4#Y<E,3#@#1!WBJT?&5*0@6\A.D:
M#1;23!?S2=0!7^B#[!A%:P&.3":Q5H7OS<#S5'S$ISU@T,<!<-4>>E^A.CNY
MV=BU#ZJ;Z= TCJJ<!\I/%@3#&2)TK8,%7_G86GOTMBJJ^@56/C 6:R8KOWZ3
M_3>)'2 3JW?;/5VMTX5&6Q^WUHS)K1-<GDE0L,J5<P%#%P&^J4-]B3.>% 9Z
M5)/YJ;C05 .)[,LEGUVL\3/*]+*IJ+8& ]_]-7\-*^C; AX8U'5J"!TF^FKL
MO;3-!0?Y-"R<] 8+"3<);A7ZAULT4.LL[MC$6>7\;3F;QR=C;_?4-[3:_'8L
MJ[G'U9W! G!72GN*D4&0KP@,-EVYO>CL9LAEW1/T^RH>EP,%>G'N;Z_#AJE0
MS6;RV?!=%=F,?%9;G57BMK,A:[\_/A,&3MGA=$](H^KUZ<"&L#3=Y0><3H[&
MOV)")S5'J+;4QP+K:.S0)0&Y<.=SNXUMMFN'/I,%-,VS(<@><]JD'S48X7@(
MN*=-'-;O9F448Y9O7I0^E%E!=E5YR.VOM4?S8>.+J?N3>P7+3]S=R3J<#(/F
M/EFJ!E O6\R%>.9"\,!)PUQ\0E7U9L="@'V4H.:YU!!?8&'.!79UK=+.868#
MT%$=QDN]LH5)%JZ5Z\(7#Z=>XO:C)=4:F>+9<EFGZKO,HW+4L.NJK :/9 I$
M+P$MU+TR/Q[Z#!%I<..:%\X4<S>)SU6ZC"E^>*/BBF-L02FZ*>2E"]H7/A'
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M$W'UE(DA'=%>$0F0="R5DZ! ::J!P1!I ZTAT*\:5R\I>% P)UQQ6R.G?C;
MS8;&;3,O0SKE:8PY'<]?<ACY0=;HV2#^4UINJ(XM+Q'\X6Q>HO728A: ]QP!
M*DCJ\&VC&,#<2*6,D-HO*2_Q(9CLB;W(->C6H/L,C><:=)<,NE-VM/4B8)Y!
M5T- %0U 2Q$9(T!IE%3>JJ1Q-Y?GUJ]!MP;=&G17VK=1@^Z207?*S1&@\@Q1
M# 0F E"G--#1L $&(RRL"@0IO;$EF^)Y@>XMGI*J<D.<K;\9I]?YRKP(_\QE
M*6XOC/7H52^4VI2,_$K1"\PW)5]^:88'>FRJI2'(@Y2G8 ]1GD)"M3Z#97BI
MM32NC7_493<6*32P*N?RIVIR//:RIR$TZJH0=5F0FOI6'BK6H]#(6"&_QHZ^
M\"L_X%'_\;N61>'/*V.RK'K?+_MR)V6YKI)2GW2]DU_&0:^U@!(:QJBU02+F
MJ!3<2N.@,?+P?>&7^05WS&SUV$29=Z@?^T?15*JX\N.0IOO//['T-+[SRV>X
MN__WM];)\;?==RVVM_.-?#W9[>SN[QZWWOW=;NV[=NO+AVD/#C[ ?Q]_W?^
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MD([%I7'426N9-#1X:B*H1G,&!T8UQYXN?#"BUK$>!FD_3R*META+!SU -@1
M)2% 6L.!]Y)B31!U@6]L4=7$?$VP=@5T+/3R%*S4JI9H!R4QF I#-=%1V1+:
M4Z14"/X6_J\5K =F>SO)]D@[;;R/:A7T4<$*B@$C24KMM9Y)B GF/BI8\"$4
MK)NYH]:N:NVJUJZFT!4*):Q'). @J;'6*$Z),90S(S C*J$K4B6Z(E5K5T\%
ML]_&8+9%#P,S 6-%@. $ PHCX&I++!#(:2X#- @G[0HV&;IW"]!:NWJ^VA4T
MDBFL/8X/H]S'WY 3QF@"H:(TD%OXO]:N'MIQ_;-T7J/6_K>KO>U# K&E(3C
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M%2U_%*7@O5-@U[ W5 UX-> ]IG50 ][2 :\U"7C"8$X%C,J^2B=_1#KT(T@
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M)V-$+,B .+4<.4(Y(M%$#D>G ''G9JX73G[5G%Q\ZH_E4Q_P-L,J>FT(2DJ
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MFZ55O*)O]M_F[NFUVRS%3N<2@Z=RW[-#I)N5G?S8H$ID!LB6?LZ;@1>J; Z
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MA+^&8OO)%@-WCX26;J>/L$$O!J=M2(QS9ZGSEE,;+!< T"HEI0R\[DI <_&
M?+*)M)'!<*T)LE1XQ TVR$0MD5><1X<==4K/!<?GSDG/(PVM8&K!U 7'U!)9
MGC/$CKFF:8C*2!4133XW.Y$6;%RJ$:4Q!H*M=GQ^EFV!V1<+L_=J%?"B87;6
M$/_3P6P)\<\1:,=#_#90Y6042'#/$ ]&(RN,0B3Z)(1@G,S1A5B ]L4";=%G
MG[T^6W(MYHFSX].'J1 )AX 2CCZG4EED5 2<!=P5<*J>:5IPMN!LP=F7C[.E
M(\)<P79C(O/%>N%UQ JE$/),UV20PX'DF:X6<^)=R&#[$(5Q!6L+UA:L702L
M+1E(#Z'6CF<@&9V<5U*B(+%%G$F'+,,)4:QDLE83)TU1:PO4%JA];E!;^CH\
M6NQK/$],!JHY4Q8QG3O]:^N1#1XCI5(T1EG&B03UE2TSHUX,IEZ?GUH/E?S7
MM7&IJU.FJEX9.SGD%TY75)X3>=+N-O)GWG1B$S[\+5Z.A\S\=.6+PV?&EU^Q
M#AZOW[OY*Q,3<YX(%H2Z/H7SZL^#SN6\G_V(7"?:(U1/$WICFZ?VK+OTK^MC
M.QLM-+:'XX]_XT.F]& /.: B@)9VIS[S-T"[L9,_!6NR"[.6ZJ"3T?>_&B8J
MHIP4GD3&L0A:X)@D_$X=Q5B1/;6T6D_AS4-7WV7@!K7U?_]E5R?FJ0YV>[4>
M!37MF,>888"U3#&F,5B]PJ<Z$9@:A^$5R@S7+)"!L(#OQ/ VPS=)/-O#8!6;
MP+D6%L/*N4E1XB"T24N/-[.XS">NYQ._W^,I,J<)\*P( /^<1Z239\@9Q6((
MU AGGNE\XL$LX3S6JM&M;%6#4FB?MC(S]"[G%]?V@OJM6_E^IP/+KF>BC8TM
M?OGCB!E9H=B\]I&I9:UEK<]IK?INZ[GOB%\BGND\Q]&@^6HT8WX>PRU?S&[@
M629=SC#S<Q;S;<&W[-U )ZCUXC_;G:S[WH&$[K0!KVLCLS,=96]ZV<KY#ZDM
M'%LXMG#LXFYE&2M=QDJ73N&/TBF\T4K].G+?&T;N/W;:W>Y0*+STR#S?I'\?
M;'W=$3M?-\XVSH_P[M>_#[>V=P]V/ZZ3W;4/QYL?_X8UKM.=QG@4:9_M?GTO
M=@^;!SOGZ^=;VY^;NU\WQ.;QAZ.=P[^/-K[NP+6^G&\<[C9R]Y_+(M5U#/NQ
M)XUT6-J( J<<<>PHLDQ1E#2- (DJ83>_YEYE'$(!N0)RU]*3:I#;;+?\-)Q[
MH2'SQP.[L^M@ITVDE#F->)V&E*A#6@:)A'>:.87A&/ESFX10L*Y@W6)B74D1
M>FR\VQQ3[KBRG#(I4"1)(<ZE1U8$CI)* 7MAG$EEY%_!NX)W-=YAV PA+0$%
MP7*KF4G,<*5%<I@Y[P?=\7 Q8)\8X\9T.J8<TX$P%$6*H-,EC8RS%JD01*#8
M:2T?JF*R@-QB\7H!N4<$N3L9L 7G?AKGML9T.4T8EY');+82Q&D(R%CN$1/!
MD"2T$WQ^0S8*SA6<>]TX-[OQ6K#NY_UTEZ4M9["&[WL>>\VB$*#*U?6"GB*C
ME4-YD&G0BFEIGM^0YM<PLS1K!56S;6].-WCU3=BI-%PX38-UB4>I'*7"8B\#
MUDK0B$N<="$@::R"F006K$X)R5#/4$@*.28UTECB@!FW.,W/S"PS%%X!^Q8#
MZK&"?Z->L1+T!L*05<P@'H)!A@>"1) D82FI%V4*2N'@'W-P,0V>)*0UG"6,
MK=+)2>295(@[RI&1GB$#II[47&!JRC#"U\#%3L@4N3 8<\T-MM9S;(-5-DJX
MMF=SC-:4L/2\0C:C9L+!*1,TLASG 4>8(!N<04I)37 ,*GBUM,J7)1&%@PL'
MEURZ16#B\99>,BF<7/0@?E4>^NT"TB1:%)EC E0I232HTT0M,URXN'!QR1);
M&$Z>:"2EDN7!\(B"T0%Q'T"=%M(B'[V,7'L3B%E:I639Y,+CA6'EUU")]?X_
M_<9)9H@JO_=33O4I3_T"44@*CD$0V9RKZBFQ."9!&!,N!# 237&J/SWR;$PX
MU8.45$@54"39$&"6($.,0\D1KD"26#/_W*T%2ELH[#MW]BU.]0?FX#%3/CBJ
MI 7='_,8$><"5 >?//)&26*-]H3,O;%OX> 7R,'%J?Z(7#SN5(\I.&N30RSF
MXCB,#;):&_C3XL!4XAJ[PL6O@(L9&._*TABH!9M>6QV2M%@(KBF74ICB5%\<
M'AZ3Q$I$&A5-2! !1CQGN=9+1T2U$4DYIT"[7EHERQ+?VX8O'/P*.+@XU1^!
MB<>=ZDE)$+E*(AR(RB/C%7)12*2Y$89[[$ER.3+&"Q,7)BX^]<5AY F?>B(Q
M<$4BTM1+Q!6C\%N"'Y@ZQR(.8",MK<IEO%"<_!I2U(%Q3!7O[U=_'=$]GJP/
M,3!J%6=!:QR!JEFBTB3ML"U^]:='GT\3?G5EHW(8#'AL$X /5009[PTR3.B4
MO'-!Z)(D5]CW[NQ;_.H/S,%CUKQ(/*G( HI:>L03 T/ *H&P8$*1(.']^57[
M%@Y^N1Q<_.J/R,7C?G7EG0)MWR(#XA=Q"8:]IB&B0'R2Q. 8,2Y<_ JXV&@5
MD^)"<B\X45PSHQ03WF@OP7C3Q:^^.#P\'N&.(3 7)*+8*\2)]4A[01'VSEC&
M'>$Q@5&Y+.YOR!<.?@4<7/SJC\#$XW[U:(CW3D@D X^(,V.1D]%DD6P4 W;F
M1BVMJL+$A8F+7WV1&'G"KVY-H"10CJ@/ 7$C<Q\&')!5/C /AZHT7UHE>!Z.
M]9*K/A,C;O4.8J=*C99M>5AS25:_"8:4982H9 CCNIZ^*YF0@M! 6?)!W->I
M7B!F!HC9F7">>ZJ5,=$BZ0GH"MI09!,+B#BP  SGC!%0^#EE"Q2W*Q'X1671
MXCA_8.X=,]>E8Y('XI$U0H.FKS#2,<$/2J27P+XD:_HEE;5P\%P<YX5;9^+6
M<0<YBX(*S3T*DH U[D*>80\_')>289*;N9@B:U\XIU+KC%4L1F=SB^.H":5>
M&!R<=RD)?T_G>&'1V5AT/*]<<JR,- B;W.<AN\ZL%QR%$)B56.L4Q=*JHO=N
M\E!8]!6PZ(WJ<.'2F;ATW,'M*&5*:X*H4#;785+DDH\H$48$:#S**[NT2BDM
M7%JXM*B\CVF@3GBP*;:!)(<\Y[G&0QAD.75(<B&,3#B"2%U:-5PM$*O>-R_\
M/B&I^PUO>-8,;4-BG#M+G0<2L<%R <:K2DDI Z^[XBA^/$[V$XYB[J@BSG$D
MM$N(!Q>12=@@C1UW7CKK,)F+\3HK(SRC>'-A[OLS=\DH>0SF'S.+C?<.C%Z*
M2&(8I+@VR$6JD 8MW&/  1_-O$9K%OXO_%^249X> \:]UQQHP"DKD< @^[F4
M#CEF017P@C--+=4.% #&EIFYMS)?,. E8H 4ECA%C,$V@CJ)3<#"1Q9-),E8
M)TM>^.(P_Y@"H#U7PA"<6S58T/Z90O 700ZPP%,3(\VU'6890*+P?N']!^3]
MHO\_ ON/.]P#R'=# T<I=UKB01-D.'&(>&8E9S%8GWLF __3(OL+_S\ _Q?]
M_]%] ..N?,.IC(%JQ#AEB(L@<XL%B@)U-BCF&/P#!H!>UO+9@,!KR%3_ AS4
MAN6<QU!]L\U^K-H)>,SUJD:WV[<M'^'1N[WN*TMA_^6QO9=7SJ%&L>'FO_]^
M$EO=6.(4/P-31U?B%.L8KK<7DU6.$86"RZ-+8^+("&Q1E#PH;!+W!"R5*6[*
M7TM60&'5.[%JR>3Y>6X]N\ZMWBJI*%7($9J'H^7N$8%:I(RRVMEH91 YDT<6
M=BWL>IM=<#O'%CZ=D4\WQZ2JXDZ[W*4U1#  >) :&6\M HN .QDPUCR"[C^E
M"K7PZ8O@T[GX[XH&_""\.B93!6>>:"$0919X-1*)M"84*8]E8H*!J4[SK,+"
MJH55BP;\V-RZ-299/<A527.)B7$,<8T%TGE:L S>I,29B"X7A9G"K85;BP+\
M>(;JI??[;'-MXVR/:2^$]0;1B"/B2CGD:" H>2V-%\3)F%N<+XBA^AI:FV^W
M>[;YDQ&%P<+'@@KWC,\MW ;]]Q-MSF*#\Q,X)Z[F+10KY_Y^_LWM][G)793)
M"V0CQ8@GFY")FF1D3L9'Q[GE2ZMLBN)TKU#D/7GCB9,5"CH6=%QH="P)70\?
M=\GH*;EQFBB&DJ(2<6PU<E%IQ"(C"HY2,FOK@@[%=0'0 J %0)\)@!;8?*@P
M6(9-8W3DUF<7712(1Y>0#=HC&01AR1(/0%K7P.!YU\ 4V"RP66!SKA[3J59Y
M0<^'"4QF]!1,4VJ215$$AS@W"IE ,&+*XL2P3\23NHAHWDT$"G@6\"S@^6#@
M68SVAP\59_P,PE$-E(XP,QKQ% URVA$$.FDD45K&N*JKL)@J1GL!T *@SP5
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M''6*8:8Q=I1Q)VDNSRV(2L);HV)RA<#AD<!-1B14 O>"!8[5/^U)%A6&I4<
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MAJZ;<A8J.)N5CHQ9'%ISFF C0CQAD0LU,*1)"B@%P652+H7$YV)QS*HW+ZA
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MT0:[SUCD/%5(<*JM4T0FQ;)[7E0>M,H]_YKB.2LH>1B4^ E[SBC"A/,,Z13
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M S?VB2ZM4CRQI"5!R3XFT/^SFCLK57VY^%,SP1Z0%7OY)HX#:TBS"[,SV#\
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M =GH)+%)2Y[MF79G8C>;W-X&[1'_+ )F"JCOM"\QKX3,O$&%7V'OBX:PZ\Z
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MEW"6K[FZ,A=Q#Z,;N.R:^U',8@:&,@ [+QR,#2:RG*5:IWWCP5$"B6T7YB0
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M(\*:L>"=(8R;$M,>7!1X_K5$7CM+$Q5+>VV8]J$SZ%:0-D=(FSQS53CYP$5
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M8WOC9R/_OKWS<R\8S(RW!A$J#>(A6>0T<<@FIYEUDD<#EHT8WUZR--ZU_EP
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MB)<H7$GU;N^6_;GU[SA^;C ZSUGMC-A1K<':9TH;+KG7+ 0,M(XE@R/W!:@
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M.2&T^!9*X)_S7HW[QO5ZKQ_7W<985*E_9+];N"JN0]5^>EF#O4YIB\8-OSU
MRW*7'F ^!9?HE:O.E*;/)M8K%^<  F?]-@>#9LFY/U#_:&I0U]6WZT#7ZG;]
MKL$<_+59%(4N*L7?DLM)9&Z8</;[ $^*K\[E7_,0#U',>@>F:G.IU-O^"O?[
M ?_Z[A-[!H\(;=DN;K1='"_;Q<W'7.:E7=POV[^-M(OC/KM'; C&)RZT--$%
MG*(1+"0O9%B;=97E6JO9,U!'RB3TB]CGW:[>O2Y6K"RE?%M*F1]2ZC'8J!QI
M'TT^:]3(.!,1#AP'"R\=2[TDI90[%V<P6QBD,W$7:8]6!;1]H5FOQ*M<1GG@
MFAG]XH [#5P:_09QA6]C&2LG*[I!S<MJ^"Y/V6!8 RS?J6SP8I06K0VX8['S
M]/CC=(NP+M9Z_"A^B:%8#@LS SI5_%Q0U.*G@K0F6V\7OQ6<=U)QUM$(3?%(
MA.8T:MH^,PAQIK=<A8C"[WTJD]WBPT6T*X_6,7XL._ZIY\T+="@[T9]EF"5"
MVB2X-UR'I TQUGHOG.0X<5<TVGRBM_,E391Z38,_-X%)7!3M/':!,+3WCFVS
MEV3?N:6I/71<=M]7[]1V?^_CR<'V9UX]J36J9]].:I_^J5<_?88Y?3NMGE6O
M]D]VKJN?OO/:S=>14]OSX^J/VFGUY.BZ2K]?'WR">_[X?+E_\J5>^P3/=/.Q
M7MW[?'FP=\1J'[7XS][.;2)2[>1('/K<914[AXS*O3JUD"@WD$%81>U"U$KP
MPJTJ)C9A*L-/Y@X95S7\Y*_8<YY/!>[H.\#=@/QL]7A/T1]T&]C.1R [_V2>
M4X+=L\&N>A_LF!<L)K#D%8L1<:8H,C0YA*FC3B4NB02P,QM*SQ'2K4*MPD+8
M@?>_A+@M85FCB<1-8<%D-#QJX3DCT5F6CQN#]2HI3_B+PAAF FG%V^Q\;OY5
MM*8K"=P4,>VJ^F?&LX+$D=K>/M_]>N@=4R8FBAR7&''!.3))!D2IC]8"P E#
MUS8I8>N8SE,UI;+VV8PXSRN1X@W)SWVD*!G0#-#B9@0M$O:,.$^0TODT0U#@
M0#)AY+PD)#CXFV5@\.D-+>8(*U;!I_5/80:LF//JMV4E0;VW69*@F<#:WV,D
MB J+*7<>>2X3XH9*Y!37*/CHM'+!".;7-@5?)WH\(_1?"^S!6G)\6&KZ<Q\C
M2OHS YP8I3\Z^L2C4<A2K!!7AB*+P6S2B69_$$[8YF3+?'Y?^H#>@?X,HBC3
M72+3(/?DK)_(U+E-9!H*P%TQU]$[T:9Z,UW,$ ]WKL[KO7B_TGLT&T"LCQ$G
M+K01CCED$A:(!VW 'G0*R40\\X8Z(471Y0*/-VE\.F\JW4:KPYO>#B1*QC0#
M@!AE3"$JFSRC2&H3P+)B$1D%C G$);&$O7>!3XDQE0ZC9^GXQU8[Q7KWXK&H
MP>6T"I?6:]1_I:7C:$;P=CW&?PPQ6B9=G)EI, AE@)\ Z 2/%AOL90)AV"1D
M8OQ3Z3B:6XA8:L?1$/*7'&@&(#'*@7"T1FGED< <0(+:A$PN9(P5(5Q;GEC(
MAV9J8VJEC$NOT>L#P<EKG$+]N/M^PM"$:KZO*T2_0( YD5(%&X@UT9B0)*=:
MZ>2\)3X$^)W12(NXRO=D4F48^0PALC8>A:2%Y3P2A8B0$7A4\L@8H@$B#98D
M,>N46MND!J\;_NHZAE/7T7=V1KTS&,T=JC\]B'WZ"[2@*/TPK7T95)<A\$L"
MU*-<5EGBM/8,)<(< #4U"* Y(,Q$HHEY@EG.^!$;<MSAOZ@P/:'&XU+DF0NS
M(11=\3SS19LL?=H+>VU2/!$+F@6^'VV[LG.O2&2VZ":E><\RO_HQ,W@.5^U1
M>_<YC[M::_9PLOB*2Q,Q95V%=[_E*IQB#DA_I5_PHU>/KG);Z..NL%V_!-[1
MY&3!,I5[R>W8Q3F>6=6TIH/M'5([VQ'5D^^TMKTE:I_ XMQKU _.8(YTAQUD
MJ_:D!A;LF%5[6MW[3F'L:[!288ZG<,\CL?OCR]G!]A';WPMGN6=!E>Y<'8PE
M0?KKMTUKFK^CW!+ZEASZM-,$ZZ2$DI%KC"W7E.1J!33Q7.CX%[7*2^A;%NB[
MN:MIX2D\Z\TAQ093936RCA/$"1/(2HKA5T.C2E+2: #X\ 8INT>5P+=HP$>-
MPMQ(QR2#_[7<:!,)5R)8PG"@YA?5]TO@6Q;@&TEE+SB?BDSCF#,]2<2(,RN0
M<\D@*6*@EDJ3\I&SVL#SU -T%8)R]EI=VQ@QWOMY73\G)KF_.@%C[I;@V2?8
M2X+C"QMY?3\7MY#@(;!>A>"A-T/RO\>M=^8%V#(1<:LYXM(+I&.PB"H98*/7
M)-&PMFDH7B=TGLJ2O%'X3PE_\_1LSX"_5]KM)?PM'_SA$0N>'DHEA1<2(]@J
M'>+<!:23E<CBB*VFB@=)UC:95.M4C7<V*\&O!+_Y!+]7VNXE^"T?^(U49.EQ
M/X.I]X&C8')N391@SV-JD"?>,V<#C1BXGR)TW<@RPWAN#/G7%F@I7;=+"OO3
MKS7C?HWY[A5E) :X7T+^C/CN4,N)FWU^2(*#_P2# .\%XEA$9&.,*!HJ*4A*
MI+F3+Z/K5)='5B7N+0KN3<O6+W%O*7"/C-GYUN$4F>8()\(0UYHBZVD BS]1
M+Y-T/ '1E72=JWFJ/5CB7HE[;V'FE[BW%+B'[W7=N=DGAT1C&H7'2!N2$*?*
MP4_)(\*IUCA[/C/N<4K7U5P!WX2DP=_O=6A>A"Z_6T5#^D$>56\Q!^4QUG.O
MWG:L7-I.Y7\]0^-?EE",Q*A#;Z??%?COV/Y9]W&R?^\V.;A0\T[AD1C^^Y^M
M3K?6ZNY'F)QO'35A;<+=2+TOC6+!TQ1>+JS"O[SY=6VO>GTHF*/)"8>"<P8,
M-"^1T\8B*IPQ%N!>AK2V23?&E;4"$MS(T@,R=][..;%7E6[A0[IHMF]?#TC3
MW?N#7SK=2CLV;,X!Z;8J,![JUW09[C==-([N98"L5RZ/Z_ZX<@DWJ[A8L>'D
MHK@>WFHE7>2R2/G'086D]4H]56SS>J.R=]>:NA*OSJ/O=O(=;V=6Z5S L,6$
M6@ -%5NY'$U..2^VCOQ\,^[6/C/EZ&]^K7;_HWP=N:<1@#7^0[AH7[9@S-A<
M/34 OOZ556]V;G;W/*[=^,M#[K$0ECM$HA*(.X.1$T(C(0WVW N<1%S;[%ZV
M*M?1MCMC&\436IQG0)_=)E&,^*$.\E'W3]@V0$@*@6CZB JIJWR[T\6_"UW\
M#J+3>>J#S<MVN'W1'O2HSR^J$N^E&4_8'F_QHI]U5K'GY^W6%6P4W=BXKCRO
M:))6CB7E=1*:<,*XYE9AV#F-!:@0;(ZBH5:KA=O+]\O=[?VKPZ@]US8QI+$%
M@FLC4%V7S[(<Q3$%XY3*%36H LM>CN^9?_W]O;-1>89DXNE+)AAQP@.;EI$$
M'ABV()XD>.=!"!75='X"54K)?))D7H&9)FI[.U>UDZ\<[G=U2"2\2R(XBH$I
M8'54Y0PY"8O%&$BIBP)+8'6,KHL)E4[[4IK_!='LUKN-6 AA/MT#IM1C4;'^
M,ZY7+LY!W,YB[&9Y]F!AV7HS\Z;;#:4PWHM(X.**=KT+[]*N ]WJ ">KISK\
MM5E4;1LZ;X2?AH3^__LO38GZ=R=3R;-6LT</"X+7B8,\X>[U>;;M0!?RK2HV
M=?-$)XQA_7$]_BS$,M\&:.-Q0?[ZU_7G._0$\'1Y+USO\46PGO*H(Z/8VT>W
M9V"@%I\U8V:Z/V/S(E9"3]^'G[G'+=?AF2[.&_![/CV%"[JP 3ZP9A4@O+V_
MP!K8"FRZIW"+WB>].3ZT;L6"W3W Y7%L%M=UVS8;SL#>@73"9.&I8/%A$K"?
MP]"]4^#,L^WM<>_=JP)( >IXT04QN!THV&N0FRU@ZOV9%"(TP"Q8GKS35> 5
M5P#UFO#1[?/<+<QC+\)V,MV'.X>"R>9[W</![G$[1I1:%^WN<>>1.>")<\@7
M]U85#:]J88'T-:!52$NK.;C)*YZEVS<D;A_E<V\&'JX=3'WB;/H2G^]\;NO%
M(_4,IOK960SUWDH4>CDBI7G$X3G<WCQ+5LPNLUB(8>NBFTTH&+V ZB%EZA[7
MV[#W-)OPTML=V[X>#'N7QC_Q.9[Q=F^?SP-A=+>+:_.4!MK5/;99.MMUD%9W
MW?L"7-N]C"#8#^Z%S7YMR'M[(;>:].I@$<])D"Z2*$T^TU%1PD;_-GT08'_+
M=4' YMQ->X7R]0I9[J;B>K#U_H@[Q4+<;G.(KMX^=U,].87Y5_'NW@ZMG>Q<
M'XK(<8K1(<4"F&I<:J0%#0AK11W+KTV8M4TS'DGYWWD7>YZH:"NB,,PEG#C7
MU+M F'0.:\HD=3:5HC)'HH)WM[_>'$9NP?9*!G$9 H*?!-+<$12IH-@KD51*
M.5]VG +]]P"Z^GOA&$4IML4"7WL[^V"#S%M0)Q,E *1&ZW)X#/C&Q?GSY2XH
MDG TFA#KN8S1."H-#RD$)YSFOI2[N9*[O<^7AV#D8Y>81&#W4\13!/HM+$9&
MZ\#@#0F?&U32E\I=O/(QAH$%V;MR?< @LQ\$3,J>G[38OP<[XYUHVF88$LK;
MO_<^R7\$BRQV@2T.;]!'+9"GC?M.H#S]+*SUYD4A2/?<0GUG#*<;*M=&/&]U
M"K;QH?#_ H.X*XF8#R&'OM@OJ(COOF)=I]6XZ#[\E;$*6^_D<Y)B9(&&_CV^
MK:AU#FJ$'!#N4U20JP^V<0G4>>WW^VZU>A.-K.'HXS_XD"G-["%[[CT F%;O
MB/7#11.LPGP5S,G.S5PJ(.T G_]5-U$1Y:3P)#*.1= "QR3A9^I  Q4Y5&N;
M>T414-"R/S/R-K.OTXX[<GNKO?D_KOW[YJ37/*(,/?#CWOG@; C&)RXTD$L7
M@+,8P4+R0O;/V^ [,6QEUP85VAD;J/'1<2&(PYQ036(D*6''V>UY_:P.(R9O
M$4-.XA[@%[O"H"+_%J#7SWKWNEC'/9C-'PVP2%8/_H<8ZA:NG7P5AS;GI\/+
M1I0GC3B\?60QSB%!S@AI@DO:K%4B;)GG&<;:%W%M$7SK^70MM1K <(IMJ%=#
M]^(,9@N#="9Z(< .K]B^G'QXREG"@M7G58#1[.$_SUW)6S&CR=*G36AZ55T7
MIMIFH3FU$48WW9JDB[46@\HIQ8[:/W4O?N[YDXH?1VI#EH5*5Z]JZ&-]?QZN
MZ;MBK<XF'O4)99SE!%/'-+>4ZVBB-=$[RJS (1716^]YPK>2G7NJ9_OBH#BJ
M^W96.]GAM>T_ZKN?=L3!IZ^B2G> .'YLP+B-_;/1Z,S6-=SCK+9]Q&N?]FEU
M[PA7/WWF^WN-TX/M?,^OM/KC'R"L_]0//NKK>]DX)T?B,"E!"/8"!6P=XL1C
MY&RNQ)']8TSI7A&EAXX%R[#TN4/&50U+?Z""W,O@KNQ^LQQ@5[T/=BXR@H74
MB'E/$)?,(JNP0]%ZA[W"-'&PM<T&'@_3*2O&S5*Q/TVNZ?XDXO;4.B$+!&=E
M]&"):9,Q[6:,P!DOK29&HQ@\1SQWL=962D2C$89C$J@T#T<?+GSYH%6%B$>*
MA;\.)\J:N4N$%2/\!U,OJ)(&8:' V&.!(N.<1R)&0E1PCKC<)<%LB%>;>F6E
MG6?I^3\3Z^(NN>/JMV4E0/<+BI4$:(J@-E1/QE]7;SPYI%[IE".ZK+<YHBM(
M9+ B*&KLL O,2:[6-J5<9VJ\H^F_%MAWM>3HL-34YSY"E-1G^BA1'4*)H^M#
M3X1A4AB4J#6(6QR1P]HC28FTUGBB-5[;U!OS5X)@R5T_/4V85EG!)3<'WXDQ
MO2Y.^(E@V(LA^]@3@)(S31$-R7W.E U!'@A)FB*GDT0<7CZR,7CD#4@*)I%;
M1]8V!5N7=!P/G\Z92G?1O'"F6<##E-((7@(/)6&:/D0,$Z93>ABX<AYSC(A/
M#O%$%#+:&*2$<U%0%HRUTR%,;^<J&H2$-EM%9/HCP/)65ZZ";^NQ6*V'>]8_
MP:CMA\;U@WD9R$QH7>30X,$S/2EV;FGAG85H$[%,&4NX24%;;ZEV@2K8WG44
MD^MTE9%>2P'H>.R@D+ 8.3<.68<]XI($!.) D9":2J)(2B (FY29=?/Z@\*I
M:^B<QXG-&(KF#M.?'64VQ05:4(Q^V&WY,J N8]26 Z9'SFA98@#3U",:96Z(
M9\!(#\RB()1G'%/+3([GX!MJ6FU-WQ^D)Y1:78K\+V$VA**+D__%-"\G2Y_V
MPEZ;K$;$XF5H%5JPGVL)[-PK3Y>MN4E96+-,?WK,!)[#57O4UGW.XZ[6FCV<
MRU6NV0-K1DR9$/GNMUP%O][ &+@MCGU7\FVD9UR_?MO1Y"C_I<K!HDN<@T67
M/BQG92.2M_\ :_8 QO],JMM'K/;IRUDM-_PX^W*VN_?YJGH"%NOV<>/@K#IJ
M[5Y6/\'?SK[RZLGW2Y@'WC_;)_ ="O\KJB<[U[4?'T]W/_T#G][/7MC=KMZ\
M943R_ 7P+17PE<FG9?)I"77#4'?7_ZT&:[&8R:?3#E5^'05^5WMK,BK4?M]Z
MCN=C*4(V'VD+_7-B'LNK(ZWF;@F>OM%->L3%W>C>(B7G)?W_)H;5WVY>9$5"
M"]YF:\-C+#Z7KQ4<)X23RKTEO$5.!-CIB ^1.I *JX'%KS,FUK$8+[V]/%G(
MKT/Z^<."T>UMOM9K&?G  CH"'^$#K\WG*$WDI6 .<YR=TF<.MUSA7ISYBO4(
M?B,"0<8(A*$JTL@% FD(B#N;"81,2$I)O+/4)*LR@<!*KRNN2@-YZ0E$Z5!X
M.#:J;$/]\JC)L@WU_)?,I]6;_9M#&8G%$E,4A?>(AQ21)MHB9F!K($'2A'-;
MS0TZZS;4N5O<,WM.%QU3_''F'D6+:5 @VZ,AM[7O>PVHBYO?]J4[;[=<K^W$
M11=F=]?V<&*/MO?H;/TBSC9WG:USA]754ZN1GJ!?R:'$PI$D%1*QUY1(($.L
M1$S08#F.@D@!*C:ZX10=:D?:_BQ 4^N!X/4;6/]UT08-[<3*7PW;7+1&UI^;
ME:J]AOV3\/O=@/MM6/OM@']FN[S=RL8V/'*O66N!##:TSHO^B7&P*+V&D>>#
M13F'1:G\MK;S]U]_K?VK C0J^J*OYZ[OMG+$9[YSY;<<;-W[0]%J,U8RO%'\
M[UT@HO4FW#Q_O_B,_/M?&Y7OS=!O&WGO@O5G=BN6S%J!7<18*2X=_#\.1E).
MC304XZ+M'N%8%""4?[A/ 3[7/CZ(27D1=B^;L$K']?,L&#M_[_[5,PES'Z!V
MW5T *.VU\L?+;A.^?/_>W3ZBAX*3H#B)B$B2"U-&@ESD&(D02#")\<A3T?%L
M'4]J.'S7]W>XQR_L6[#3VHON<:M=;.)Y_[T56@>['S#X>MY"!X+=*1J%/K/!
MGA,I"&LD5E%S+*617E-.#!.YIW>TF5N."];]A/A[,C4 FRQ2V_6.STU+OP'7
M6.G.>'1W;Y\?)@MK3/-IN'; \Y(@R*804)!"$ .V6Q#9]A<3&N.%_DKF/G:M
MBZ/CW)^V#9 $[R1<^!ZU"G>-U3OU*P22U#T&J4JQ^+C'>CH;E9Z.]\1K($]%
M(]U+0,W8;[K7XW5'$?"A:"Q]V;HHNCH6HS=L)P<_WC; ';E'T07W[WC>[47,
M@_S(IR%WGM@ N8L6D\U*-FCST\$USTP)9@"8L*9:"<6IPMI'$X*-TG.+$S<%
M<DIL>L@)/S#\"^1\L=]MT"MRZ_99^DW$;G6[Q-<'](953W9 ;P*\/DGA37%J
M$5=6(>>80=Y%1Y,%0B[(VB83C^+K1J76NN, 9R"]MV!ZUFIGP09Q>XY5/KV]
M>1Q$QS;F6U2-[<&%57N53Q=*V7E8=O;QH29)80ET/YB@$#=8 N8*8/\B):*9
M#]3F7' Q670N6^T"0WM'/OVN\[V3G_ZNG=O> Z3E56X&V^X9#)4MP,_<'PXP
M[N*6"?8(H 7HSCZX^GD.(<]R&#.QS%0UGPZ%MKWLP6%A#</K7Q_BI!D5B\]O
MR6O/EH59 )(>P80*$E!T1@42/@#HX@Y9G'MM4F';L-Y?G%WT?  3MI)V!..^
MV?,/%/<;FO+(^(-)VT;QV+]V?N5_GH?E-@"'XLY2YRT@ !AL@B6O4E+*P.=N
MLO]K5,$*Q?K<Z5S$L%WLE#TKNH?%#VO? +V_Q3-;;\+7^N#]T]8;V8,!5OC'
MPBN2A\YNBU(A'U+(VM[IU2$G6DFPME'PH)4\:0ZZ: 0B@)%"&L:=\ID$R74L
M)CB\^FK7'KR-BAV\B&$'5;W_+C8>=?%,HU^H/P:M:<1^)^@Q>O @-2Z;ADYL
M&OK]\C!1DS)A0Y8P@KBU%NGH,"(F&*V=$QJGT;ZQ/BBI@Q R1<.MQU9&S+0S
MAB;8GWT:;3+ZA Z>@VZ=/5=I<5EK8FO/#.L]]+5G'\9.+)[<ZG-B_]Q?/M=B
MI8AS*A<GZWI6+4++%/$E2Q'OE#GB98[XW.2(K^3*3,X$7^I0Q&&669R$-COQ
MA?5P5KU4UU)7XAI-U'N)S?-('L/C;JM[IE!/1I?=/.[%%^[^^ CSJ()%<RH.
M?GP\K7WZ+/9OX+L_JC#F0?W@TT%]_^;[377O^VA\H=C_\<\9S)_N[C4:^S^^
MXOV3Q@E84?"<7XX/SKZ<PG]/P&*ZJL$\QVH?:F^B2,$C;8E'7$N;_5T*"6>-
M(M1J(K-YK=BZD.--0EY55FM92AN6<+@Z<$B=8F!18^PHXT["KX()HI+PH"XQ
MN0(.\0 .?]TLO(3#=X;#D1J#*7));5*(R-P,!;N 0(X-8B0)JJQG1&& 0ZS7
MA9Y6/Y02#DLXG*<'?P8<8NPUIHS&X $.J0?-B413+QCGQ$19G&F:/AP24\+A
M7,/A-<!@'P[W<Z0Q/DS>\^BY0EG$$7>1(ZT#1RHH#/^QD@:QMLG9.F;3JD+S
M-B55E[P.P=^W(6*]V#!8Q>)L]C;T:\6Z0SWO_'C:-N_33Y*'3_R>F 518MM3
ML6W$\I7$)+!N#:*2*< VQ9'3E"$.IJ^CPCH>P]HF(^N2OKJ>]!SGY9<*/WVK
MKE3XN5#X$=LN<&ZLUP;A)(#,X BV'<?PJ_<^""6=R_7C&5Z'%UPJ_%(K_+3M
MEE+AWU_A;\:L%QQRI'Q*2'$&"N\)0UH:>*62>QE=!)3GH/!L7?%Y4OA5.(T<
MJY \5"/E/+9[05)%<>2R[LE2UCUYI#3HZZRO)Z8:C93UO/U3N^X'P9F=P8>A
MA.)G0_&(L66=AW?E))+,.<25R5!L+0I6>$XXDX'+M4TB-\QX-M/"ES I(6O)
M(>N5]F,)67,!6:/FHDW.>*V1,Q@CSF5 6FF*P&@(2H A&1-;VU0;_-55&TO$
M*A'KC1'KE09PB5COCUAXS-Z5D43#5$"">)Y)ED.:,86B2M9138C60++8AIE6
M?\3I=S@<R6I9H!HJO=(I_0)6BU8T9;A*$KPH7V1Z]O*:1HJ7%D_9*IYRT+SH
MHC,H(_!' R0%_>US88#.X*IST/9\P5DKQ,:@6E2]Z5OM\U:[N,U/VZZW+CH5
MV^E<G/46,%_0N,C"5?G9ROE4C7KW>KU?P2GGF<;VV7JE7>^<HM2.$2Z'3V(N
M5%6,F(L1P*K785U#Y;H>&[F007[(VP'N1AVZ;:7>J10%M"OP\W$='K:=Y7;X
MXGZ&[&A2U[U*'$4AJ7S56:]T5@Z!'V3>Y@MCLW.1Y]E+K^T.3ZM13[=9N/?6
MNM\AZGY!JXL./.OD>;KH[47.5;^MKP4?->KQ)WRC*'DU=&T]YT>>P_+!5;;(
M&R[*@[4ZY_TTXFX;UK&_@@^L^<15O#C/I<8<".7/HF3$_7>4BSF <!1-L?IY
MRK]>AT+F?K4.\2JV?1V>/MBNS>?>(6:!J3?CZ%U^YD3_[?N24CFV\,S-5EZQ
M"'<$%? P<DZ:'HR3Y?)AQ;CMYP6+<J^0!>QSE6;,TE$O?,6@:YWC6T'MBVT+
MGB7?'$8H4JB[O?34?,N1RV%"A886.:PC5:?&D70(A?JZS^F&REE\YZU.46CB
M0R]U\6>\2][+[&+HB_W4/WSW%>LZK<9%]^&OC*6"O!/$23FR0$/_'M\V 3P'
M94&N'>TIL@DF^\$V+NUU9^WW^R@.$#ZRAJ./_^!#IC2SA^SM)L#2,J[FEU/4
M$LA7P9SLW,RE<MS.'/2_ZB8JHIP4GD3&L0A:X)@D_$P=6,N*'"K8F7I5_U(E
M%YG*C7K^YW<[GB7;6^W-_W'MWS<GO>:)R;)4:&=LH,9'QX4@#G,"+"E&DA)V
MG(TF#6M%<BE_P9C!/->$<3DD%--D3'+!FULB_E[)X[VHN1X$E?GBO7QQ4ML^
M9;6][W#]_B6,Q0\Y(RQJ(A!Q3J#<>0HY$A020FCF1!18Z='\[P6A<",IZIV\
M7]EZH]@E!B3K_F[:EY(/3\\[?]O\<6,V%%8O21_G? /+EZ9'/Y[GS::?.DUA
MV)?ENK_#9,F&%.5D9S79IZ7[/S%'?&$2<GE1;+3R6W_[^M=T,Y<7:SEZ)80*
M,@/$YZ[L6_%)SVNVRLLS\"JB8CWZOL7*3M_F*SXL/(SE&HVL4?'S;5VJXK>B
M="NP@ NPFO? M*W\!D9E4:1BI35PZ^BH'8_ ]"X6Z7,N;]OL *,O.IY,I73
M<](<YOI@9?>BV^G:9N&JL]U[14TJ3RQ!\?(>%X_%,OYJH9<_RC%(R2,%^Y1*
MP5V0FHFHC<1.ZV2PC).;[$ZSE&E_-Q^2D5J_J/!*!#Y^^J=^\.G+6?6FRJI[
MM7P0!.;HT55U^SM<^^7L8+LJJC\^'E<_?1T]".('/[Z<[I_!W6[\597F@Z#O
M&.Y_6=L#T_;LX+1Z<WJU_V/G\N"C%O_9^WS_Z)J"$D9!&&(L,<2=Y,A(+5$,
M"<BPI-2*W"!BW0BSSKB>=>;6(IULOP(NY@Z:IY?!NN2GX2\#RNEU(Q^'R9&3
M\P&Y+7AMB8_/QL>O(ZE?1L3LMT5448(XT0G9Q#Q2SF@7?0@A9_GS#3JMAN,+
M 8U3H:^+U8/M,8<]-I:))!AWEO#$@XD@)X)I[Y+55/")07W3;=K\,"#<6G%#
M!ERVW^CR=?5Y:ZS8OX\5+! >*.8(.P-<"N. G+02$1,3D9%+QE7&BKL4DK%:
MKB5]*>G++*IOO(RV3&XM/QW:<NLI6:'6L&^'3$?WD<E$QPWE!GE+(N+,&F19
MD(C"O]'K1+%Q:YM4KW,.9IY\=8K;FW"95:C.\:D7'333]O%EEB\@BB+"1FX,
M]Y)KX1S.#5%CPDD$FSS]12;9#!QAQ9OO?&[VTH,_M5N=5<D!?AN0O*I>XT&E
M#U+;V^>[7P\#<<$1P$6?<BO'& PRC&.DM>"8L!@ UM8V<_^("1U=RK3_!06$
M1YP]KT.%YWM].L\"A=+S,UTXP"-PH*T-0C*/X&T+Q'FVY[P@" 0A:&.$MP)8
M$]$;?)FK_BSZ&*M0(V&@^B\CBE,\0EW ?>&W=V>*CU6$&0[4O7W+)1&<)O+7
M_APC@DD)3@0/B"?+$*?>(T<300;3Q#&C.A$)]K(RZP:/8_]8/,P"I?,NN;(O
M PD<P$#) V>$!J,\4#%GE)0&<1\QXHJ"16@T1])YB2T63@8#:+!AIN4WFT<\
M6/0Q5L%;>$L0!KTL@28<M7(J8ZN28::3KBLY)?'LX@RF9KL7W5;[ND@MS;VQ
M<Z!GZ6=<//KX2D?CSM5YO9=X=[NAE/QRJCO*WV/\TMB0MQ&%.!,:<1XY<AA3
M1!AA I-DC<V](]8%4Z]@EW/L5%A.+%@.=CD&!R6_G"X:C/)+YSE63D6$94J(
M$VJ141KT@86$ V$R69OY)7EUP;LY1H1%'V,5W(Q_VLYQ(W8ZMU4S2G?CXO#%
MHO[6X T.,'PW#3L8_^[/H(3TYT%Z?8S@*<R$H$0A:20#2"<6.48B$#SK*=>&
M*\OR2?)XU'#I/)Q;U7U'>E<H[_0]AP,X*!G>=.%@E.%A*1.7W"*2@_ X90K9
M((#P<::"98EK&J;#\.88%!9]C%7P('YLM5.LEQ&'"\7LIN4)[+_\BW8L/8&S
MV1G&0PZ]"H XP2!JG(6=(3EDE1(H&!RHX-HE1PM/X(2(P](3.+=8L R>P EP
M4/+$Z:+!.$_$C#/&D3&:(&ZQ0H9XC#1U\*93H-KK,N)PWL?H$\7!EP? T"^*
M-R=L=A9%:,I)KNXD5\$Z^D4!(U(:33-.TXI>,ZI54(HP'D/(Z8O2.L]]LIC:
M7AKK6YA*99FBF5*CW?&0"6=<E,93E.L298^Z04"2(\)!<<5=U%$4AI("9=2<
M+!\]>K7RSQV</CUK?](C+BBN/6P O@S<RM)"BX-IH^:>5"E)0G*9D)QKP*Q&
M1GF)(N,ANX)REEDN&/+ZP.+Y@[,I<<2YU?R)A8)>Y.,I"P4MON;34<T'NA)B
MT4] :M!\+9#-O ;31(S0E'GIBOY;;"JE@DIJL2+48BJ4HBS[L[ XPT>M)N:#
M5(X@Q9A'G/*$3'(:624X"()*@8NU34K6L2#KL.W,$<]8<B\J@V4)K8O<(66.
MG7_E+-]^EJO@2>V;DD6#H'GTI/9?6[__T"-OKG2USCX_[5942E?KU$G#=77<
MU9I;S1G")7)8!" -02)C@#10KYV/"0S4D.O>K'.EUYD8SU![&6=XELK-N2_V
M]? Q=XC];(OJ>6NPH- Y]][<(?0LO;G3A<U1;V[PU%!A&$HYM)M[QY +$6PM
MI[Q-%A#5JL*G8U80,9\SQG.?:R&P8U[]P0\#Q$/^8%+Z@U]9:O#.'\RJ)SMD
M=^M0,,TIX0XI+03B05.D"0^(44^BD\QJF3)V,#D/_N"2WJP.O9FA1WDZJ'7?
MHTQ*ZW#*4,6'H(I7OQYR%RRU+A]5&PQ0A<$ZI"XAHS$3"7:SF&D.,>M4\75-
M%LH\+%QOOQ<MJ#<?;7"=%>OME97>:SA9&6DV6?G_*SM7/J?GMU(%YGH:NY6?
MQ1]:\-!%9^]^+^]!^G[E/'/_?+EM-"KYT8XC.FLUXW5EN/=W9^,I/;_[2U(V
M_2Z;?B]:'^V%FNQ*-OVFI&SZ73;]+IM^ETV_YV+YRJ;?9=/OA3+D)Q[QBJ@\
ML<"?>;#<6^DHQPECH1C&GDL_+TV_4_T*D.HFMEM+8[\?G&Q=[]_L\]K9/Z?5
M$YC;]K?&_H\O)[N?JE=PW77U[,MQE>X3L-%'[/?SL^KVEY/:R1$]^/'UNK:]
MA6N?_CG>/ZOR_9N=J]V]S]?[9SLW!R??;VI$7]WU^_8P]U-Q2"BWQ@B+4@H)
M<1HMLH9') VS!#,O9&!K8*)K2NB_%Z(-W)0P8X8X,7>87+;+?.(A[LL0\OU2
M<DK4G!)J?KU#S;TM>BB9(,0XB;RW"O&$-;*:&12EU,92AYV-*XF:*\NT^N]Z
MB5]MN2&N\H8XE8WPO1))RJWO%5O?T=W6!_<\=)PGST- 6!$P&)@)R'A&D$Z&
M)T,#53$LUM:W"O'U9=_HMW&A$$*EC-%'*Q/W)EE0%NJ(D,H'ZCDI^T8O&T)>
MWW.IG&R)0RV<93HYI*22B,ODD?;P3^11!,PYP6":;5*MUZF<5NCG/$9VKA@>
M/.PU>"4HE&VC%PH-AEP%)SOT4*5D1/ $<1\$XE%%Y)2AR&#,7,#6&I-;.YD-
M/JW(J'G$@D4?XQ<<<1"^!"\O/G[;\LJ77EF^@G>_LGP%[W[E*K25>EW3@=7N
M2?/,I@/S9Z^N;-.!-V*H]+Z]>LH.O50A:&R0ML!+>4H!:4T8DI9Q)FAB1C%@
MJ&(=OZKGP!QWHEE.*%@&2W55>PZ\'1A\O0\&FA'E#%BJA.>. \Y[9'@$;<#*
M!"-UTHD6YJH8QX*R-=6\C#&56EES9I?/KDY^.<FEF.0JF$:_ZCA0^<T^)1"_
MI$JO.>2C3G)G&'>**<XP-C1$880T)%+EI"F[#BP%.>+W+*6;+7QHM?0\$(5P
MM#&G.CODP#@"KB2)($&9%'+;3L6F<;(W?_3HU8H_=W#Z[#BO)8GF>L#\>QFP
ME1T'%@;/OM[',T48\5()!/]XQ$5BR&E%44A8)RR<Y5).Z6QR_M!L2A1Q;A5_
M8H&I%SEXRH8#"Z_X^_<5/]# HZ4811PDXEQ@I+G10&D2=C:7;\GY"V:#Z:F4
MERIYQ8KPBJGPB3)*? $!YFC$4I))&RXL8B%W,I(X(8 ;CJSWB2M*HA=33RN=
MFR8#\^LXG79A_'*6RS++57">_JK)P#PX3\M& W/C75W11@-OE5E6_?.VT0"K
MGL#87P\9DUCD4I*8JH2XE0HYPBPBTM$8F=4ZF+5-I=>5FM;I\US5S)Y.!NYJ
MEN%]T1HL*&[.O0=WU;H,O"%FXA',]!%+ZW$ ^TI3Q+5)V8<KD&)28)]<"IQ-
M-V!GD2#S.6.L3IN!.? "EVT&W@,\Z"CATHIY&SRB)!G$D^1(6ZH032D$*X-A
M@JQMR@TYG38#);\I^<W[>Y+?H,U Z4I^#4KQ492R4>5N$H@X!RA%8D16"(J2
ME#1ASPQWLZI16+87^,W^J_)PBP%4:;8&70$JE[$=[W<-L$7O@8>[><[G([]_
M1X71S7;R$HG!YE9O!@"J#U3=+MEF48CX_J"/$$)@?B0ZG:@-FOM$M60^Y+:/
MC&*F+'L*(?3',5PTXFZ:;!G^G1^W#Z-Y,7O(V^E<G/4^V\M:L <S^J,!%RXL
M6/[#P__YTCB@C9_NY/SXX-,^K^X=G%1O8(P?W^&:/TYV]VK'NWL']>K)1QBK
M2O9/OE[M_J-);?N4U?:^P_7[ES 6/8PFX0#V&W(T@&6G-/R$C49!:2YL(M9@
MV"8C["_G\!ZZ[8N<)/JP,CTD*F^M77N@):G5:+0N<Q!SO5.HC>U794^VWNZK
MU#EH5.$@AD?LPH8.%D(%-"M?';)N@DX=Y3H6%=L,O3'NA*ER =*7=^1;;#KJ
M%4#Z\!3H$>_0N 08T0;NL:+G=BX1>D,:,9.6%0_?]#4M*\C36E8L\629YC.9
M+'U:CY$G-@-Y1IG^!R\E8O%*^A<P530UJ.P 7(9[!.8YU?P7Y'"T>-YB?Z[T
M-^@/3S#OG^-R>VK]OCF7B:=VHO_EXZ[6FCVEI\-*K@PQ;]X;I+!3U882<PY'
M.U?GT6?*][/5 %.A4>]>SS0TX[U:L PQT#%I?:>E?] MU^Q'0=PS'0V1UB<3
M<"*8*ZRTPB%HX<!&2<&&R2V+9W'T^!%,A\)*'S(J!U+TSZT0?0/3H5IOUL\N
MSFY=<X@NK+G9\\U5;SZ>'FQOW>S_^,RK],LQF)77-;IS63WQI';R];)ZLT6K
M]+NH_O@^VOWSIOKCVVEUNW:\?W)TLW^V@ZLWG]G^WM9U[>8[K<&8U>W]FX.]
MTZN#?X9+7>[?U+;W+__#OC7B__EV?? CG#O*96W[Z]4^?&__YI_CW>UO,(^/
M]=V](YC_#JQ/.*MM>WZP5SNKWOR18&X8GIOM[FW1W;VOM+IUB+D3AK*$-,8>
M<6L=,I&#W'!A4A3:*YS6-CD;<_']=Z7;JBR_V-JK4FSG3&Q);>N0)>^UL@0I
MJC7B BOD*/'(2R%82$E8Z4!LY;C8CCC]RGUMCO8UJE)RE&K)B>7P'JWQ(4G/
MO7?*\Z@*@, #@)AASY=R7WL#@/@Z#!!T%"!ZU_Y3/SC9HK4]N/>G;XWJR1';
M_;1_=? )@ /6XV#O2.SO-28!A/24..,8<IA'Q#66R'F2$!%&>,L2M40#0-!I
M[&N+*+;EOC8'8KNW)7;WOE]5]_;A7E[L?CWD@5A'L$9.*8XXE@2Y1#$*45K-
M-=.1RK5-0<I];9'V-1*8\-1Y37W@TAB=__$R8JF,H4)D@""F#Q#$S 5 E/O:
M2P%BD/>[3ZLGW]DX0'PYJ_VHU:L_JK VIZRV_>VT]NDS[%WP--N?8?R/)]6S
MVBF0X%& X+NPKW&C'(T.:1,E (3GR$G"$,/$"^\IIXFM;;()Q/?Y^]HBBFVY
MK\V=V(KJT2'8:F"DX6ROX0!TC 6D!?4H&VLJ.L.%\R"V^DG[VI2:!RV*6_9;
MO7-:2>V8XWQ@QXN=;J6=VU[/LJ_0#%LQ+?QN_DHW%I\I+&9A^0BR\KDO*N5>
M_G)0O!ER8@$H5J_'0'%O"[Y[<'SPZ<O)_LGWZ]KV'Z?[/W;([M[!R?Z>IV $
MW-0^[;#JR3C9!QO5$Q&(2AAIIPCB,?>!#E$CS Q3'B<0*[>VB3?8!+K_YM[7
M=Q#;<B^?-[$]NH2]G"2,E=$)@4FJ$*=$YHQ1C*),R6 #LNQ$%EO!IVJEEEO7
MNSM8RZUK@3#@ZQ &[/"Q\Y>SG>OJWM>KVO9Q??\D\_D<(7N4=9S5?GPYK>Y]
M)_LG?YP<['V<Y*>*0FB0&(JTML#G55!(*T&0,]AQ[K %:<T80,<3(-_>P5IN
M7:78PM95NSS$AGDI!4-&<($XCCG0FR?D [9!&T(C2,XFV1#3/3@LMZYW]Z&6
M6]<"8<"P*\KC,0RX^09T%>8-%+:ZW3BI?:K5J_1C8__L.U!7N,>-Y_LWC>.#
MD[&M*WM0,8]@=,6(E*:Y.:00R'&J$:'$4P.<-FF1,4!/9>M:/+$MMZZY$]OL
M0<6"*Y*H1\I)C[AW%CG&<F92LD(F2T54:YMT8Y+K?QH^U$<*_BV #_4VM+51
M_PFCVNY(/M-O]68EES7HS+88V>N*N[UK//6C>_C$!,<7.9RFE#O^V(G14A>V
M>'L?TW<8]T@<AL@D]D0C:BU%L,OENN92(!*T]6"V845@6V4;DKY%68O5U+@7
MV<FEQBV*QGT=T3@9)9.&(&V,0YQZA;2(H'':2B>%2R;JK'%4E!HW*XU[$;TO
M-6XA- [?9_2G5X<>2X,]I;"SY>";? 9BDR)(Q<22\%YSQ]<V^89DCVK<BL4O
M#&J-32HX  1\I%K '(<US"$V_:\7U*M4D;&D HDT"F )T1(2)0X\19=Q2\^Z
M7N5DW%K&$I5O!U0C9-QYF8R( 2F5H]\EU\@P0"NEG'?:FN2TSC7F)OBY2_V;
MM?XE0HP7GB>L(H\2WH4#1526A11MX+'0OS?/$BCU[S7Z-T+-"0W),&]ROT+0
MOP@6L1.4(<&U )[H/18X4W,]WN.KU+]9ZQ_82!*;2&@*(3?;-H%YZWG0UA(;
MB<WZ]_;1S*7^O5C_R A1!_WC3/LD)))!@6G,)4;6!(6XUL%)#+8QC_F,1XY'
MUDVE.L2",O6]5M?FBGF# GQC''U08N]E++UL2?:L1UR:0K*OC#R=>F^R =AV
M/C=ABZBW0B'WC[4I6]:^(V\$T/1>-8 ]($A<! N[+@=:)##BPL!/T2=DI-28
M>J(CS_G[ZY3K=8['47KA.Z&68+>D8/?*6,42[)8 [+[>!SM&'%6<.81%T& -
M:H9<$@X1IV7$D5.7 ^;9.E-J7;%IM0PIP:X$NUF#W2NCV^88[%@)=D\$N]LV
MUW1W^^O5H552:9HHDHZ#P9TL1MHS@Z+GAD7/ DD =I+R=2['JZ^\<Q?:^WT!
MQL[PX/<L_O5FKY+ZO:CJO@IQVC/SSUN=>K[F0SOF_/2?\:[F]'_?#\?N5ZS&
M=U^QKM-J7'0?_LJ\1'!+-1)9./3O\6U#WW-[%)%K1WN*;(+)?K"-2WO=6?O]
M?BWP>A.-K.'HXS_XD"G-["%[4@3HT&H7[_P#2%]LYZM@3G9NYE(Y;F= _J^Z
MB8HH)X4GD?',-P2.2<+/U 'K5.10K6T69?^S6R=W>P+YZ?S/[W9SK$C[PTT-
M;EL;#"M##RZU(H+C)!@S&/Z7&R>HLI@F8Y(+WCQ:+7]V4ER,^*$.>T'=/Z4N
M<U$"_UL\OVC[8]AJ*G^U6T=M>_:D'AIT?LK^[S8K7RZ:L<)PKP?(>E&S/V^M
MMGG]OSN5/UJP=1;=0NKMZ+NM=J=BS\_;K9_YL+[?+*-]MPKGO56H_)9'R:U?
M*/[W0TM5_)G\^U\5>]$];K7K-[GQP-#=<R3]T- 7Y_F#1[WY(]3#@90K8@E)
MB7#N@].<>((CQOE4V]'>*3:6#/^J96U^S+L'Z,]_JS_M&+;.8,?IDJ?1!KFP
MM.'%332NJMNGHK:W<P6T0@ UN#RTB7.CB4<L@-'#A73(".]SFS/!J$A"Y.*,
M%&^,FSH5T()&?O,@E$/24O094O_N5%H7W4[7-O-N#^)P=M9J]L6T>PS$X.CX
MGKSSC4IN?/&0B%8NX5X5%RN="W<"XI\EL-]@!B0M%'MQIZ<RYP69S,%?]CRC
M2*498^@\.$FX'# 1IIB?ZB<,%&&<0<N,/FB"BF5VVTE]4>^WJ_&@?$T+F%PI
MP'WB^/&JWBF&+QIH_]F.,-?*UE$[%A1Y8^A1AT<9:.^9!>6SI_!!P_I<4Z3?
M0R<V!T_?:N=/S]OUG[8;&]?PL$>M;KUH!M(%)M[IS;A3/%$>#9;PS(;8OY>M
M?+N [85@)Q#)-VD^\!H&$PHMF&>S!?=U0&ER6/[#.-'K7CU\Y\Y%!Z8>8H W
M%=O (O(\U_,SG,$;2_4,9;E?"8P$T+I1630,W[K7SJG'CP<]G>[A>>78AJ&E
M"CTHORJZN,!+? ZVOJ@UT1W((O$+C U;S? M=F'3"=L78)H=]8RUOGFVNE!*
MJ]M?6?5FYR97PJUM'UT>$JI5),8CZZE%W#&!G$H I=%Q2J43.O*<9ST>QS-
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MU9;3R*RE $:.<"X5F#>I1*%W12$\@D+".LX\%X@K&Q //"+-"$.$)J6L%QC
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M[+ 66<HXBEP:S#D.4OM<<GY=L"7LSEO"U++"U%0;AI<P]=8P->IGTSXRF;A
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ME]"6CCI<G5 [B%-N)XX3Q0F)8^+25^^]%G-\0RE#J2VAU-+*M3R%4J8J]W,
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MS J\,AV>B! $,"U1&#JV)U-BPVPYMH@3SW8<RAV:",93T&'NM8* ;9 *UT&
MYK<:P>5*09<=&S37,-=X9+VUG8A"7<D.O'C3LFYD+DO1T4UODMLLSZI>*7K9
M-VG)[UV95T],QUET@377, ;':OV%\ZY$@<YOCFMY-F;'$LT.9\IU",(HACGT
M;<;Q*'KD,QO\?6J'?A+'$;@.P@W ['!:CKN##6.-(J_,<S"*O&)%GMQAC'P1
MI%@Y)Y "%#GAMHAD8,>"8,*12WU.-E"1]R%G6IT8D%6OL=%6FC%MKO'H?)(M
M)/L+)XR-H[V1YYKL!NQ+!#N?#NZ&GL^IPVPJ'6QMX4DPSFAJT\1+DU10%L1@
MH=%62/CST\6V-"-LQS5XZ<:9T>"5:O"$:9:"SGK4)7; (VIS%H=VE,;,#ASB
M)2G'#G_A1FGP/L34SGMM63[+(MNV8-6F7&,W?>W-2.%74GU6Y$7C?9_D<7$K
M!YPW*'\,RMWI<%D224^0V$ZC*+2YB%U;N(%O^\3SJ C<$+SK5^_#:0_;5!38
M"<U=@B5F-/=E-/=F,DDU)0$6]Y&2NS:G7FB'#A%VQ".'>HR 1>9NCN;N0UCL
MHBR^914J''@?5J;$W>J)[RLN*6"N8=SKE0?(4):OQ?>:WA]D+E4&E8'X8R#^
M_?1HO!OUV=U?E 6^R^/8%BE/;>Z#0QVDJ;!3%H0T%,2%&0-?>L9! Q,+VPEE
M74$LS"CKDI253RAK3-(T$)&T$Y80FTM46R>);)>%,DJ=((I\N4'*NI1<QFV+
MQIAK;,XU]L'JQ[KBVM8W5O[^7&.U)1TV3LA-5X\U&') %FW+?2DJDVVV7-LN
MF[+M?)%ZV(W-=N+ L3D));ADH6>'DL64N22-B8>;FHY'MZR@A;'_S#56?HT1
M879 7).B'W7DE#3OG76HR\N*JI*]E42!GQT\V;@1>[2IL9O6A/"2@"1.Z))8
M<)82(9@( BHC6(\(8]Y?)XL9$8=*](SUL$SKX>R(W$]8#X2%41AYGBW#-+6Y
M3(@MHM2Q6403-Y&$!&'RZKW+6RQ\]FG7S0OG&@KM*(6\V/,\04(BTH@GG 1!
MPMV4NI%'(I'RP%!HK10B$Q1R$R99Q+@MB?1M'H<,W!<_M4/!8R<%!$5I].H]
M8ZW0,10R%-H6"H5ADE NG90GA$<!$V[J,Y%(,(@8E30U%%HKA2:WM--$AHSZ
MGBU<!R@D16A'?I38U.5) "BB,0V 0BV0+P,A Z$M@9 K9>S%C$5>Y' F1>3+
M-(D(][R 16EJ3*'U0F@RG)NDH>,P@) 346YS$DL[BB+']A,WEIX,O8"#*>2'
M+<:F#ZFLCT+[<%+EHE_&;5'!!8O4NI4)WI<E_]//NK<R7TE5XF<G>6_<&"X.
MY5F/N#-07FY_Z0MQCQ)871>',8AC*4^U<!XWLFFHO51J7TV%T7R:<C_T7)M$
M3-H\#7U;4.':CJ11Y-+$==/TU7O*6XQZ&U3TP6#*8.KENF@;3+TTIB;C;)X(
MI1O&8$W&,K:YYV/2MDOM*/"CF KA>H*^>N^VN+N#]>$-I7:44DL[-O(42IGR
MV<\!U&0(SO>Y3 %#-O&2  MHNS9XO([-*$XHOINX.UQ VR!J1Q&UW [HQI!Z
M:4Y-1NEDDA+NN1++^PL;Q(/;84R)+?T@"CPN99C@@9JPY7F;U*9C'S+7/LIN
M"8(NE$JJ^LRW!=S=/_J%(K6RO"?RFPS3_$Q^F]E.67=[M%%Y/<R3PQ%I-1A?
M*L:SJ;"=PX3P:9C8"6,AGHLD=N"1P'9=Z4? \H"YY-7[$/SA9Y=J-3N^!E';
M%K4SB'IY1$VEQO$PY8PG=II@.YH8HW6N%]J!="3S'>X25V!22A LJU^M091!
MU-:$[!Z-*!.O>PZ=)N-UKN\Y01!@=RPG!3\8P92FU Y\FA(1>2Z/Q=+B=89/
MAD_;%J\S)M3+0VHR6)>FD4ND -\N O1SPCT[%!0$F8#WSDG@!#![[REK.7R3
M3A>H8-W;GH@Z$OY,LF_OU<VAG&9Y7XG.K%?@@UI20K#_?4!P3*7#B9L$, BI
M!W]G$2/$IW_!@[UJKHS?JA_J5I0W6:Z/=Z-BU<]B(ZO>,;\!6)8G,N^]L_&5
ME2NT/ZG0#!6:N@?-Q.A9.^O?PI7BB018SZ<R"E(FDH#'*0L\)TX(=[C#B.,+
M!W69T5J7&=6Z/*Z]%S*OM.*JZJ 71=4K92\K)0;;ZSI5U<>LBCM%U2_E-?SV
MATX1?UVSSIZ!+OV9_]+^\Y]N=OKWO[/3CU^_GU_?W/W!CLF??W_J_''])[[>
M_O/ZK',*?X??^N?L*B1__F^;Q+?_SL7O8?\<K@<Z?7=^?>R>?_SP]Q_7E[>G
MO_^[?:9>AWMFOWT_N_T%KG-*__<?X,+-7U'@)3)UB#Y.R"5U[9 'TG8(3('C
M^Q[CON8M2*U,#I%\-(PCT$,9L81S240H&<BJ&[A44.$G,",20-B%.>F5?;D6
M>1M7!,H/7!3\X]MNI[B7TJK%P+KHP"^HP+.2E49 7WC!4_HQP:XQ'5E \4?5
M_$6T?/93_/<$XK1._5!@WE^WI754W,(=WUMM 5,""W0*5T^4Z)59U%=7Z\)\
M65ENW;6SN&WU1KYT*[["4R2@UJCL12Y*?*T7MT$(QJY1J<*IPHH!YP(NU95E
M#(,F;B3N-\A&0L:^<F!]@N_@S]U+45:6A'%.K(\REK>1+/7,.;1E(9+4?XF2
M*;0V6J-WJ6QK_Z=JWIW=R5):__<QYP6>@LL1T\>=-GW4J-?Z@>IQ-'J''^YK
M%2H7,X2\O8/JB7-Z]U? /<J=,+#=!.P76,,3&RQ4;HN @)K0)'4 JN_)P?1V
MHP4ZV8&_M!XE!BP"#]T)"(G /8\\^*?KN-1/W5B$ODPC)0:D$0-BQ&#U8L!/
M#_\*XICYKL]MF \.8B E6+5I .1-&1,<C#U/B4$P5PP41AXC"<_UA8PD+%L2
M_@#O*_[G]/K4/;L^I:=_W_SEA1060S"Y* ^!#K$ .DBIZ.""]B9.Q$(4B^EM
MK"$=2EEU98P]C#OW!];HZID4L [F1<_J8J7P!%8UU;.E"V:P/;2#K:)^22]X
MZJ6HMHVM7F'A'\U:",O?H3I&,WO!JY<Z1EJ6B&,P^!*K*^[+HM.Q.IF(LD[6
MR^"6LCSN]''9A#57MY&)^V6)OSOZJ4>O@ )ARB/!(BQA(A)0*R>-_33U_1!>
MC_#$W"(+7V,:7LJ.Z,GDR_">CO1M&OF>+=^_<ECP)(T<@$UD>V$$(DW\V Z=
MB-MAY,0AS OC$;9;.YC.5'XRZ3Q7T,BG84B$!-*1,"%N+!T92IJ&(E*U:Q99
MZLS$/W7B75CBP+AP/)F&=BHC<!]#!Q8["E1S8AX$H1?%O@,.('M@B9M@V:RP
M2>T2#5R@12,FSI9'3+R#EW%(%W>@5Q2Z48F2QVD*4G">'N&R1<,+ (*\S>+-
MB<^<U@I6P'>.R=D_,2C*(3G[> K__Y6>7__V_?2?&'[OD)Q>G[#SWX_9E(+]
M#?=W_:MS]L^A>_KQ5P+W1.![8!D<_W/VSPV%U[Z?_OV'^\?U'Z!@I_^<?3SY
M*_9BAS$GMDF<>'A:C=BA&P=V) %OH&,1I>YD@"8*//C?)(I=CW%!1$ ]'GA$
M1#05T@O]R0#-T?F_3S[:-)P..TRJWC9&'WX\&N.C!Z99 *9S&@<^X:'K"1F(
M("#<YR%6NQ&OWI_GUJDHX[9%:W=?>_F_%V4GL7Z6HM-K6^?EC<B;3$98+3JB
M!.,'/U;T>U$IQ5<TJ9J1MU3,HUO+?*L.<%1=^%QBW72*2'0Z]VJ-[+7+HG_3
MAHNHB_T&*R1<]ZH'BQ<8:K]G/1T7D=]CV1UF4=I=65;P#^P=HRV\N%_U"IAF
M*Q5Q8WU%]Z/1BO^JK K6MLI:A,GCY3\Y._!=A&L!/P=?>%?BZ@J$_^DN2WKM
M9H]GY(LZG/Z.#+\BHJKH]'OSOS(2H<<(#K@@ZY$ZS!H>'8[1_[8'A5&[XD;:
M:MYMD<+-OA.=.W%?O7H[KE@P51-C./GX<Q\R35?VD%K!08J+4@G NSX(:HF?
M@GL2&W,O5KO$I>C__-@X +_[&C=KE [B*I9C:K&8%FP]VN__.RK?OI\US3.)
M\V."/ #3-4EQU1-I.A:M'&(1>:%;K$E 6=4%Y,#MB7M;].PV-J!2=5EU(%V[
MFS?%-UGFRJV$.TO0LK:J=K^7%'<8<(_+HJJF^:4N<"1R<.,L-:M#C,%[G4YQ
M!Q]5D"JJP8^F=6BVK;@; V:!=PG0K;P_F BJ;\DR]K%?8FQXN+ T$](KBJ^P
M3( / EXXBB[N4XM^$^_&T8-7P&]'U,)=RZY"?;<L>F!:J4M5(I4]_=$[V>F
M&8$_A6O$J,>/ZP\HA\PK?2NU)&3P3?@H/-:W+)9-G"#N9*@^K=K%A\_#79?P
M_(KC^/7A=>$K @S^6[@AZZXHO\)/?,O*0DE*RZKZX GDR>A7\$K@&+2L6.2Q
M[.!;78$;L5FW5KA\,-V6_(8WHAYNN.3AGF_7NI42^P/"7<)HP,_CA:HBSD0'
M-PUZ<'%\!;\I\S;^5 +/)47>O KSF0T.)L@4A*XWD.,B37$XP$A5;\-OJ#N
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M/!R36XG!S[%;J_/CAD\,5Q88$-2^)#I:0@5J,("I/745%Y?ZO5%'>.#)P6?
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M%5FIK+>TTV0)J?2=P4Y5KBS+9A^A:O;#]*[D8'=,8WY^LI69Z,=.]$,XT1N
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M05C&#YB;G'N3CY;V5/W/DZ5]WDD@ZJJ]PC7UN:X]MAE84<>AONE02-4XM77
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M*H/D%@8;;@K&M;F_>EA+*7!5D=^Q[;8.:=:JO/"$3#4O&T[(@75:@#7V38(
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M:I@O6-N)?%U[[LB#S'M.8(":."]LJ"'U]A.ZCT8_KNT]XB<?8UJ&7>+ Q%5
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MTL?SO09EQ^ 'NNJ?0XEP:ZYSKXEO5[(VIX&\F<\*^4_).M)N 8&56E@?,B,
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M>9@\F>8G^60\'2^6]?F?+U:O0:3(6QKP'$.M7:,)MSY",,K2[)-[9_LX0_<
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MK46C(&JA7+969]VG<.J.#8>'=:9:\6&3^?O/>]L4R"U5%?74ZXO)[,M?,7_
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MSS0H?%V>SC&/ER]"JF<#OYUU(EFC7+?@I-\LOXV,B<IDS\"0FPFDO>J!Q9A
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M-LM?QI,):;67M7?MAW&<G&<P:R\FXU.!E%2NFXD%O"*W,A9,-F,R$8]DONY
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MO&VI@,]^7O^I[O%?_O#_ %!+ P04    "  \>V]4[1',CBAX  !$@04 %0
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M90;2Q1Z:]+XKN05M ^I%LUS]"JN+)CV[;*[FJXG23AIJ'.'*4B*E\<2S*%
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M7#../\H06;OQ\2>?>M!)YH=3#[H(;(34 Z=LAJP\23QI(JW.Q&NNB;:X6L/
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M%'<R94NS\&#+R H+)!L:G%(N!=ZN.>6A)XQG_PTH_69HT56P #=+W8#!5?#
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MO7=JD]E%_M6[)+8!\WVWR>RDKGO;)1XCZ_IM,H'QP*TDR@>);IG-)7_<$I8
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M%Z&&4-BX:8SKEDT1ERV5(=IK%(;6E%B%[I!Q8'$G31R@SE79_;B^+^IT5<2
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M*C38C^<<K(H!)%TA:^(NJFWSQQ:XJMH2AY ]CATQA/8>)$0/T5<X(0[B"P!
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MN.IAL/SCET#V>7^UF2J8Z)P3(CI@SCHZ^I*$P"T'M(8R,.=T5FT(=OI*^AI
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MF*5N4]?QFJ?*]/)TIZDR?=RTLXV[.97)AS__>4-F,3@7R9;/;D0F\IP6#]A
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M"-9+0&%<25&J*-I,71^-"<ZK]FBKMB583_H*K(,IHM 4> 0HIG8OZ%J'GB@
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MBY1C@_280 D1P!M*EF(1B?XH9FZ/Q/ PWO;:S>W%CHIE$TKAR5K0!!.RJ&1
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M(DU3<LTQT&*^W#\['+V'<=N[G)(TGT/)4$Q-V=SJ:3!%R(&5P%G)MK3);$;
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MZ'..@:ARMYY='97JB@<%ZJU25L&V-<_1N'LH)]A*7>WT]?G:QU9L;>/DUCA
M>E*NGV-91/>8KKYI81$W,(RL?-$-CUSW\::KN,S%36J UK-0EF"KDTZAEZ^\
MSI"O[R-EIW>7-@4S@K0E'3+&T5G,>YK+-VZ$=3JBRTHJ"!N,CMZI:NG/5A'J
MWUA5>BVQ/2^WV:GG:!,JQ^/( 7BV9QTDX\9^^NE-P6H[M#<;[<K"3,2N1#LM
M&PTI4I,M4QA?1/+8+'_S,+QS!/I"Y@YP%*]FJ'U0>U.P8;"VG'?H)#!Y_3GN
M!!&]I[1#<_\KM$197YQ%["%15%& OUMI?)N"3>N-8<X'D5V3@)#%)&#P-&*8
MGOBD@WTM]Y; ,\.C/:UC8WNH79. 8'?"",DG>R(N)SY9D]3ZL=\<6E/1QLQT
MER"@ANY551\9R#N%)]I]\$FW]Q!FC:9&$1?N[?=P;Y3OLS"*/+9)1W7P<.;H
ME>&6#,R85'UNVAG#QR'!%V0;2&F7!_:\TJM#C\M;6*4.$ZY. M%U1Z"KS<Q(
M6W-?9:2(9'U(66357S=XST%=89Z>>:2FRZJ-(@:O!$ND3U^$7=BZ3>-QT&Z5
M1O;)<>O1IM;1C1/GCKL.SW.(ODN=-]]U5W]A_;UR%?]A%5-'U_-!PQO&3U<&
MKMM15K>J#>[_;A>R++>EM3:Y_=6S<=*S=[D+WSBI7>B[KC6(F01N/]D^"?B]
M73BP4G:@:1*XYUWD_)@EN[(>NG0!IZY[K"[!][1UQ,[M!\TV@'KCGY@$AKJZ
MC2<*L7J9K6_?N-QO,CJTMJ_!O.1B,1P[D834SSEN^BI/'N/6WE)8.E(B)SU;
MW4'*]KEJ3N7+@-;LT>)AZJZ!896&H=":''[W7>,'7\PO;"UMK:F[O+]W59W]
MZ*N1KIU8S<?8I*0Y[O:9+?GM*BWHK,Y7IY:>6^1R<:^SIQG_^*G[.Y/C->"L
MQ8_?N=NH9KM<+Y?.:QXMCG]5"D>-C((FN@"X6+Q^/ ]5-Q@U@>O.SVWE4,,G
MV'M:;D=VF[<>.5<YYDH7L2X;:%X?.-#=VRI/P"8U$#R.^-P.WN^XYE#9F^(M
MV8>.=JEZ?CQOUE>Z\'(_ZFI2OM:*? /VO:/=1ETG=JW[T.7F- F8BD\"\N]"
MBH=1>76J<]\]4ZG-@]Q]YU6"TUO3_G[B:L!$_97SHS=:C[,B.$Y-1B?:#NO=
MJTLI[4[JMGUYXQ!)>ZR/;IIV+> V^G3?R(V(P_/!(2AXY8SZ:-2!4'WC8%_Q
M_KA47RQV=0#EM7A1H6@,DFY\;Q)X4*.8&Y_^#&=O/Y(^ BW T=L^%I[0VY59
ME2U2;C]OOE-5U;/BH>'B,52A\6C;RS279)7$BL0V0D #,EQ=X65[SZZ/(SDO
MTC&7KYIAJHO6>#S-!U32!PD[,SO[UU4/$OH=^M$NG%M5B$HQ\?9G]WO)$IX[
M=^EX6KQ$,+!:FB^%C?K7J<[ZF)=O1&PYCO77+#XIA4Y-C&^JFUCX? <UD^!X
ML='-**/UQ$XU]]S$E'!YMYK<8FR@@^LDD))/>B^_W?I9<?Z0V:.'9K:=SA8F
M^3E>+P.:T3LZ7Y%*RY C.;M)[2((]-N)6R,7](N*SC8M'B*TP+"JK^.3#N+6
M3!0C+*YKNN[I+(I"VU=H/KNTIEQZZ9"X4^O!:]7#<>]UKIU<_DAFY1AUI7KW
MKK5O[\1-<#)'5>&D?E\/Q?<FA"-C>M)594^>&!^[2]FT@M)RHS(WGZ#W\8JJ
MRG%)U,?ZJ,4E#ET?ANK\ZB@[B04$>/,%)7?LW--O8E;)%T#?OE8X,L*LN1]B
M\<$?/J[Z.CQW?<#I_M!;4<&NU@_:CPQ$0SNA5XG=5^\VD;K\\O<[JQH-^HK)
M/^D?CQ C:(H^1*C-'FI@]4$$Z),WADV$(8$"2@GT^7D".JQ[.[0WI4@T-,+7
M66S+S2G6*I$#>L>?-54>K-J>Z1-FVB;==_0ZL.G#3,YMY?;ZOB,5L^B*3QJ/
M]A25G7IHEFZ4AR;>8'<,KPMLN3EZH'(=7$0D"SYTI_3\A_D< \*LI777$8&J
M<2&]UJ.J;^9\7 JM368^7Y_MGCRR>LS"! XW%$Q+,UW'=RY@?N0CU_3T->L9
M0SL0%DFN<O)P1F>QU@E8?UYO?6)-D+QR9Z?.G1%&]KIKPR\=B,QQ^=1;58.R
MH^%Z0COFC>W,@<<ZYIR)CM]^;\2F^@X"=>]%X56-QY<TXNMM+6^H[JAXC'T$
M'T9U>U&#X(X7F[+Z5PV)P%?W+)BXH[A\0T"@Q/!YG6'6>]UDMS5$SLW1[6\E
MA[85#;"*;\(YS]L45+HT!\**!U^X/8-:WQH."\<<&JULVF4'Z;T#%T<S.N:-
MKZG3<GONNH?I:M&W8>4U]4-B[]W&7_IM$>WO&5$VPWR<1Q^->&SB, EXO'!@
M?;@VQ_H,[.1Q&Y6]X_'IM55'19=</['R^KD/W:TF.-2)^CZ/"+C5H0Y=;$>_
M\QU<3*K_QX'; UUN+RU&I7IV'C[7_[ZRO<-C.>0!+&)=VI;+9X>W7\J>F+TY
M>6C[6K3P:6632<#G;;:?\N'5]PCK"3E]JD=&:U8\>53E?Q3N+N%\$JZ?,?*J
MP*S/W+/LSHM)8%:U#)_ 8M%>M2/C6_M%!HX=8YXN/-9O!U_?&8-P<AC?VR.3
M?YP%;?5T)4;'D*+&14;W.R1C%89U5$MCW>"F[Q8;H*,?/0L0F@0TCY=WUS .
MK4UVW4E7SQC?K'D8JOF^M*/0=,%RJ>'M35GE$V,KVSB#T8LM+<1AB("%\!+T
ML4TBOCOH1_K*A]IN]KU9%R[EGN'HN6K%[K*J5:.&W3TG)H'1SNQ68O&=FV^S
M+E2O:B&$R=^955OP"ETC=3 Z_EGUCI'JC\OG:"U[:BSYLE0D*5F165Q.=SOJ
MKW/,?DP%>JOZ.<YQ?N2;]AD!D8JF'7U=+*,7X^\@J9VD;0&7.8?[PQZL3>BS
MM.W8D=3C*'J@]@JD\T;U.Y5USZV'"[7,TE-'!6+V[LF.OWSN7O4'VM%GU3MO
M=HRZWAH]^*Z-W22;BZDK;IT$,,D;NC\(:U[N+ZU&PD_<AYU=K"IW/V /)_EY
M^<U)0(L?Q;HQNL-'Q6S'M5Q;/5>A]DZR9]'\L/!1E+P\4T6^^O:X;&]AM>JY
M2<![WW/2D56WD9<<[)<7"[L^[FOKN;)^M&8(<C]W5XU$\_"2D1Z-MK/KFI[C
MLQX'WGOAV'';4:Z45E:8F]-< /!Q4@<.5IW*6&RTYH@R^_JLN@[SXPK]<\!=
M!!VA-'M59>109;-;ME%3[[WC8957'=YYBAROED<=/5)N0;!XF=A^+5A%(3QD
M7=SH5I7:)YOG:+XZ^.8 >Y?JY,UAXXC+F9O2>[MS+.'#.X9MV[JUTOO&TU]P
M6N3WW!FQO/W.:2)@A/-Z@O-^<T3KQ)5)0-&R;H0T^+XV/7>$5?XRND:U8-2R
M?6CBRNC"GCVM$^O<90XVRK,&JT4BKJE*#1])O?/D+KZ[=!2>/FI9.IK7HD\<
M)>C&ITT"SV+*VX9):D-$>D>=[(?NFUGK%$;<LF_#VX95=/+-KH^A$M>T9!:[
M]74[C4\"A<2(UN$]S;6NVG+8";3=P--12W!@Y..[)=].6+Y[=5LD<3P*E*EU
M_>,KH]M=Q8/IPRU&J GO2>".V1YBPYAL%K*CEY"^GM@ZTG*"9,(J'^W.'^6H
MOZCE]-:(:)'>(P9'M=7S6P87AHQU#]V2>NVJJO#V@V72CC&%KL'R<8Y;AU3W
MB*4EL:7DZ;B4UA Q?_SBF&I_'6I,_^/JEM&:$<M#NR;T. 7E$WIC6JG/S]?=
MF@04VL9;QJYW]$O-UE9$DN*>CW>_KGMI.BRRU?(50?4E)WDBE\ 9FF"E[XD7
M'UU?>[7.-OMF]T@^*G=<_]9XR N2P[NT7I+UV,)#'9/ _-YQSL >NM2PPFCW
M$+%[8NFHS(?SFSI04CW*J/%+^$G@RH<2UHT/JJ');^MTL"V';C8.$Q3'G.2[
MS6X'W$]V18ZIOD<-G<COFP2>@_.W>+2G0]6NHQ^'[H4[383T.XY9P&^,;2V_
MW3V^\.:X[0!)?TBH!\-N&E55?2^B'R;3_Q9T-&.6"1.%XR$COL,U"\UN-0V-
M6Y:\X)3LFC <V]I79WUO7&B -))_&W0S.=C\PHG6AN[QC7>24?DCG.(+/82%
MASYR1B:!,0:( !R17*FX)7IKM#ZTA%N0[I+,WK'=5+<\_G!HXNFH4[[^R#-C
MY/">*ZPJA=$8@DY-]3MB_O-Q55 G"H.UY>]G<J[7-O0^P:T9UZZ[S2HCA'SH
M4L"I(L<M;M_[. ETU-7C[G-Z[UQC; E('1P0>0D"GP0R;KJ)2%FJOB:]Y!![
M2<4U&Y]KI8[@)>YSN@B$KO%X>B?)?#RD>E0A>52DI_;&J-1A+/.I<?#506+\
M)/!TCQ.#?GF/Y6M7TF3'Y,"JFU_.)F0EI0'%?=JZ @*\NV"5M=QS @!8.V,F
M -%VLL$:>: Q"$=+(S7-_9)&NFJ&QI+&AB9&QOLU)"T-=(W4+8TP,+@#PMH2
M(BT!49J2M)DG:9'0J-;'E<W7G1FR-HUQ1PT_\LJ4>;?:"[GEGTX; $#(V<7>
M":./Q3AC,6"6>W0!&* Q1E8H%))70]L)@T X81VGT]Q/=:0+-[^0QVMD[\ZM
ML<\>P^7Y(A/AH@=S1!CO/V(,DE8 !P #0!30!VS /WL #B" 4^ + ](, !<
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M6Y9MTLQ46Z);O%_2+.3%&,WXP:-.D7JQ%EH[PHJB0V2L0N*B%ZTR"$D*6@<
MOGB0:T6J>I%<X+/$E+Q%A*'XC5G+D0>B.]-PYL,1#Y)#-6O#=)(6R"P.D>1@
M5FT)613$!W()D8'XK)0/U?<#"8G&Y1L(WG'7BY@.=Z*I>3AS=@0MFZJ)#'V5
MN0]R+;@],6?EN^!2]D, H!>0@; WI8+H1AJAH *CX,K.2<+4(UYEG,<BC6U3
M=[I"U)*2!-WXQ5]SWKOE+'%*6NN6 _:+"'*9E(CA^6@B^><]2USELN,]V8C
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M25L_3$\_H#F% -"C:(N1V;07I4I4#\VXXSKZ,2W:%X3937T[<Q]V$W79I87
M%Y+HO9?!$I&LY0UTH>"=.A"FY:,I78@9/.^25"2&.RGV%*J/_<"'AD:P;LZX
M@O[(]+I *%?IH:-!H%#-J>8D\!55B+(#FBV_3$Z /9"JBE<@LL7RF#/(.F'3
MVGI4I,!NQ@S4)4[3>9<R09UI]TN@?[5SDP7HK*E%D0?)-,23%D.?:=V+IL%+
M52';'R(&Y W>]Y ATC,V1<B'_!GG;$N'.R_MNEU>TBIH> G\WKA*'@5FUSPE
MVD'M*I\4NL#,%3[;%\*?:=]Z!R+2-?.F7T?:\[K.1I8Z[;+=-:OLY,"$ANG
MQ*Z#LFS0E58=80VDO.%(02KT6PUX&PR^N?*85PM<6R&;7H+ \_+/#)?L/I([
M0BO+VT>NSRN_,5(@-8)B^G+Q8/"-CK/YC=#2YK?19V =#7%>BV OS6^F3X=_
MY:TXD8Y_!!0.D@F%X&VU^PE/("^E%L12& J?3'P#_Y'?3R(AJ=$7R+:H-VON
MD\]A'*T#J(48OV//L<\P&P92<7+,HYHZO >6*7Z%/X1;A@LC9.%.Y'42_N )
M4=>)-81%GI])4039-""YF]!TM CC3GO4UX%Y0N-6+\:J::M%2-QFZC/,!]QG
MZG N&]].U6T]2TBG(CVM"(^IH5,'2#Z4*X<OHNJ%A%YK-%#@8\9A7'D?A!,Q
MC[B'T#78#L[>G!P<CGTN\C+>@_76PPMO9/E.74AXQL >RD!F:>9V:U'NRB^5
MDU#OY-?Y6O2@]#2J",,7W\_>BBT6>42\QBT1F%:#< B^8(H2?XJM/+@<D5%U
MH"L?N=ITU7@&^<%PAU>*&M5^0D:CM6J?K&T8E*(CPA[K*Q.NVH,%2@E3EN%N
MLVD'5L&EK93.8D1>XZF*TTCGVN_<4N2;*A]$%NJLL2V3C.[68[:48\HTYU>M
MQG#5J5:'< O8H?LAL&\#,1UU\*/=UPT_$/1V;XX$&=ZDA'-1+G4Q&7O0LZM$
MX6?0QTW[W#O01PW.5C@LAFVS[QU,M7]]QP)X]NZ)A@3$U $^^PIBM-L1=AFI
M;UN5X8AB-4T)#T('U<]R=T<[&QE609@OK$>[( Q5N;'%F^$/PFE?TK]#W%EX
M^GGH7NA/^C \)AU&'T)<WTRCWT9%NDUBT-&)DS<P=V'$(]MI>U"]S;-H8K18
MTTLKPJ0P=]"V81= 'M/"L+=WPFAQN(8P)0V'3U_I2?N)/S;I&&,ZX<+P8NH,
MRNG& Y3OE$&UCG*78F0LIURC<,!G*;<HS#0\Y1M%O&F$ZDI1N$*H$@II4CY-
M3E$,[B:K>)<;,LD<[AO5##*)\YMVG$SGV()D9#-[>VH>^11+%WJ*_(?YQ:6)
M$LYD39I*W4J_-  F[53<K[<FQ<G]%7M)<5(JE47*$A\#8DDTD4=**6E4<#3D
M-^D37[;B#]F.;SEQE+*&P>M/)N:;IM=^)&8;:N5-Q&R=(P5-A*@KRO%$M7)#
MLH!X5NX8$D&:*D6O*"7-E (F4LB;&)E]:$)E8]182C;5N<AV$_15E\D"0J.)
M5U9%N&1 )YTASM'N#6XC!JN/+']%=%<MF1A%(C,">D\1K+NK:M((T]N/2+_A
M_S1WD@X0)M7K2V\1O*MO)RTBX"M'@A<2:HV/EE,)Y;J$B8[$VXS%O9GXQMU+
MJB_@&P=UTA2\N&>4- _/;']>&H!O:M8FBO!O&C9MU!(6U9*66^-/ZW(L?A*S
M&9/:K@GWE-TP?A?0@+N$O_@4, R_C]<,G5)<QGT/T\6_XN8CE@<]XRY!LI=V
M<S^C8L<R+!V[O/6CP )99+3B?4,E"][PIJ/7XH:Y(9@I17".&/,@WHICB=T=
M-)N]#X=;\H53CCLZEJ341-N6=[QRTDW#92Z1])U_G:,C6V--[!ODI85PMB\Y
M(LZ--41&!\:S$&3]DF36)[)L+!,]H0B:SW.^<-+U=9R9[$&>C!W,!F"$+ XK
ML0#/?,T\N".3B6=&!30P_1D/G8XP=8RQ\P,#2@,TU;,/2F_J=*Q[$@&7R5H@
M7H;.9Y8(!_*AC"N"PE@@ \V/]K_/6,N#.*UE%//&SAMT3QJ@L95U54_1:I@_
MM!0.G>FESD1!&32E3YZ(_E[N%=-"YTAQ_EOH6R0)COWT-/'ML5UO"0W0\("U
MN':MYAAS2Q6/W<[ F-J08[N1X43N(;J?SB4&0#NM_N!WE(91C3C&TT"*U+][
M94,T4]H^1>/,&&T>87VC/VUP0=RGN]2(<N?0M.:4[8FT .-U/S_JW8I^AV_4
M1E7X7U7_D.DQN$A=Q\CM]6%ETTD=+Q$;:,TM53DDVJR&M]NN4COK".M/4].J
M\0Z55!N5U5]5V:!V+(N57E*Z )VI;^1XT"7(*=E$2'FF6-(%_1(U4VR"HWRN
MB&<A>A9R)36(+V,C/Y^PV_1*J4*D2^?+CR%CJ/-DKB@?\ ])&WI>QB%Q&OK[
MUF31%LQUGY7"=JS [I<8@&6.C6$UQ<EDIYA+C)7,DN43R92EDB/$1C! G$:\
MEGY/9$.RBY0()Y!RUE($!22Y'45((H'&>IA. Q@7R@99JT2_I-;,7M(7,86Y
M#C15-(LQM/.'X HC+>(,_R)CJO=COA?]M-ULP1SZ];_/5>$B98E7BP#B!Z)9
MQ&^B;,%SX!3!%_[>G1[\?EY/Q&+>*/>6]T[> F[<@B[>$6[:7V5(D%1IXH4A
M8DN5CN@GI"@.E:\3S).]2\OF799&; %S+XG?>YWDNHEC%D1QVT23_RI]G?BM
MF2'@BM)-7@2\X+2AOXS S]9M3&WG+=5,"[_,7:S*\,KFI"H_S?_#Z9&*Q]5B
M<6G3*?YGX;7ZY_A;@O":TZ6W>,?-@ZESN#S3S/!0CK B:LT3]AZ#V_Q1]GUI
MWE^EVR.>TI/"9PF)'>_Q*?Q;K0&EL;R$1EF*G&M9I]I\F3.IYLL:#MO?[# ?
MR-XJ'3]CRZY5WB\]Q;AJW%XN1MXU6(!\"PYIWX(/)W UUM"HD%<J#JQ[5;3R
M&;QW%DAS![[F?XI\3A9J$L,+&%LK9B'BD1MT!Y&!!2Z:6M2R^'>J ?3TD"*E
M._JY^T4%&D.8Y:_ZC/[PMRVISK@4?YV.UH\0YB#(6C A)C]7G4A0QV]4EA.>
M!Y^4WR>&NN^4+R;"9UDJUQ!7_%62LX93C(TTA0Y"OPEG:3SH^#R9:B[=)8ZH
M\*.]"':7]=(.N-V1/J US[P@5]!:QA5 WR=HHA[1[N0/P_K4#KRCN7U**^Z=
M'5?DB[G3-U9(JS@$-ZQD/R=X9KML/GL\.XB3=4>4D=0%&IS\)&R":H,L-'>:
MPDDRLL-'YB/.W;A"8A:5NRT3#XBR9@HE^_CROTIT1&=7\95B4)_5?X,RE'SM
MI1R"/%<]'%LI12O?;Z@7/U"<7GE6=$UQ>&:9V"0 CJMDK;YN+V69.J%F,Q2@
MG&A69G^1G3:^CW60W#)<VN BWJ&_M1(H\M<MFKE-U"887P%$$[0;VP^1#ZH^
MM=R"R!6&QJ9LABRE3A[3)\FHB0\Z*SI2]7FED["S8NG,Q<+O K^_BLEOGEOJ
MA]E0_Z7L7JEMK2,0E_:@"@?ZO558.0."6-]C7 <=7)9=\1"6/B7-U E;,J[F
M-'Z E:#OU%V!1Y:T5S]%K$ZCFUV1\[=Z&5N1O]>7& ZB3BY;98A$.TZA5:#0
MWG\50].@P96B0VIYN)J2955*W./4MZ8+^(V1715)^*KU 'T)_O?2E[I3!-LI
M)GT)H7%< >K#:'$H64T@#5"<8XZE#J3&&D541N1B@QVU;)U0YT;-65JM15/3
MIG1HA53E7T4OK%O!BT2^JU[.Q17U5V[@M*>8*_#L]Q$:W0]VYCI[[4RVQ=)T
M31A[WI3=ZKO,\W\5[5KM-ED.LK0J5KJPR-.4)SZ98FO0B:01<W5SA#S?8QHK
MP?NEJ]3+A?E33JERV1_'%;A&IN,BOIKUFC.%0\8FM46R27]#&;.E01LO_^"+
M56^09RRU53G*GDUYH)S!L1A7\VKF55U$'#3;5PX74HP+C.#D>/UJ@_^6.(U:
MU^"[0"71Y2TYHH2JJ5.>*0 <R_%*Q?GJW<V9"'+E8,.K0L^*AKJU23]T[=7U
M6RPT-E4>/M>5/RM)2_2*:YII4Q[*@_YK"]/7N[^$6O:YR[]L2B:M[7&Y*-:N
M>3?((IC;\ "<Z;&Q[B4$:#=<KX6 )O!K6F#_J?2><]"$LA.=*V$.F:FM#;#O
M,=^;DN"W@V'UV8C='H&U4<ARNX>UC<B(";^K_-#CJPUF>C<)\ZPLM_T:UC[3
MHB42FQM3U? 2>S!X9>TKG(?'K.JC.);=F^KGN"2+;--WPO@JBF[K<J!DE3YO
M(U/F9V";/I)OQ_C6J\@'-QZMT9./K#Y754X^;_>T*IV\VZ*MX@>E<UR%=WQB
MWR^EMJ:Q/3,F-YYE<;</UH&9'S<BJ@N9TM4R\UHFT.YZY5?F7HO7AB#Z/W\5
MZE''7+&@=&4+6H1([VQX*$S;GE.+%Z1M=*PJY1M6YU3:\4OM+I@&^,R)SKH!
MAM.X4K47J3>6/&G>KSR1#FEP5FS>;E?3+KNSX9+9('VSVLL4)+.RNV%42W9.
M3-&6,\+&55;;59-%27>S1T50^MIZCCYEV[4:2VWM!E7E*TW_JI=&I09CMZOB
MB&QX(E^3R"@<5YYME/H%)7U-H[4+TSWK?E:=VS94G55Y? .QTLWT<=7+BM$*
MI=UYPP?9L8EM:A&#]%>5K]T[L;@OZ\RNT-(9<0\'-66PS<Y]D\N/^+IW/0-^
M<G;J# ;5S%C:O17X$  P3T)V_55EKT<W0M9FG1T)@%R+^SP0!C5NWM*#A4%\
M,SH]X=[.R/9HN'%&?\<SV!, P+0/YS:N3N]^BB[,,@W=0-/B+O>=10]M=NEZ
MC5GH&]\NPY"<Y:T\3,?,Q6W',"X @)%/6C:NFG8A2,"LO,%BDF,<MS>+^#SL
M0R>6>,?7HVT>\9VSLOD#\=O,DI8'Q&L 0$4IM7I<$4:\F=2L=0/.C!MQ*3VV
MC&UA?1VKZ%=]Y[4,T@W.JB8VO7)F<[,7O0, ,(!H@'$5.[Q!L"O+L7\Q_WA<
M>#> =RNLLMV&-\OG9[.<JW V-09R]\U\TMC*&3OCZ67_K]R&J/+?6?/Z(F7'
MXD*Z[*2,,%6;O03D\[ZI0GS?N;%AK63+K&4-.P7/ 0#=W?]7-H,?]3NS%O16
M:I_$A7?NU"2'*5ICU%-\'C4>50TX&^NSE:=FA=3O%/P<4UO_4Z4_!J55+[.<
M>^>:H^+B._I-I#!-2X5QA<_S1NL*B'-WG4JW;%9*'5,X'0#0]ORG3L>!P,7A
MPT\A7J7H^HO0:^4RV3UX 4A%G(&X"Q$7)J-VP,C;0>@Z1)QW.Z89><7F*,X;
M.7 RL^P-/&DH#?@445('!@\@L5(SM 3%P3^$6Z*U!<$(#:9^6Q[R![;"JQMU
M"Y<\_0D&A7U\G%=RG)0[("^[1<JLN0\\2<J1N(#U)#).#DTAM>3/@?TAW8G>
MB8"2)ZTY@EQ%GC1]*>H-B7ET5]$#;ES?@=)IG+AJ^W)K=J[( /S XF+=P:>9
M%W-O0D7,-5%)\,D,L>=SN)[^TAJ#K* -';$KC%#X]KH5DV1)9F:I6$(1SBQG
MBG:AKX(@P@4Y/9#-_)JMN= #O$V>CK!57*=ICQ X5L*APP4 T]+NVT4A!EBE
M?TFRMI]_HBQ1/0W5 (Q4L+/KP4ME/I$,2(/$S:,,\D1T>%HIG,6=>G @[U?3
MW*Y+A:%U6I-[<7+5#]ZNTB03$-E<GF"8FW4,Y*/Y$W$4W*U*6GT!?%+Q<9H%
M;)ASZ,#KO V]4[ML"J@=AXR)1>*6[=R;)>SZFX@39:SJH<P_0'#EY(CEH!>&
M7ZMW@*[K,J=VPN9Q1 ?*<W?M^=W)SO\Q]+2BI_!;KY*[HOA!1RQB0>F-9F1F
M5OF!^N M0I!?3?"J(R" L6DJ&#:'DS/:B9(4Y;9/0C-*1@T@#+SL+6<4FP[\
MA9B)"P/_DYF.7PU]LR61,!.^:]5$PEWD0BL:>3Z2O"<"L1'ZKO4YLA@>I$]'
MH1$P]@ :@]3!9V"0J#T9Y5@X^FXX!I>%>>3NCY^,E5E^)F;@YNW:!_,D %N"
MX0C"@/8BPD#XS@I!#A##H/M19XGJ]'#T(^*KS4C,%=):MS1L+"G$DH"_0@*-
MN$&R6">:#- >EH_&&_:*J6%<1=@S?D-PR!T,VDY7%(XQ(XR-AM#-*^7H0;JG
MY4P<F^8]U $Z+W5K=(6L%1]4[8621'%T$&Q(<!<< ?_*9Z4M0OKR$C8UH3RX
M0:YW4.$<_.0^;"$3-(@#:O2&^D^@/UJP4@J)43O3-D/EBAL@+]AU66>J&V*^
M9##T 7*N>(YK,.(?4<KD$LP=9N, H[RB;E[=3]"4ZN4*!3BI<C(U"F(P/ %&
M0E]JOZ?DPCW5*:'!"">EO\MN^!V%\V17;#23U'^R[&Z'MBX8N+WEJ?PP2-[P
MC8(!GZVU+,="EYGSDFMA$*-?2 ,\2__1)0KV0O-@TB=L-7-G?TI9_O#RVJ'R
MXWV#<F?@[\YOY"/@-:W!96<AA(8/R3.AAVM+0NQ@'=4V*X[";/7"22>P3YD;
MNV"D/X5M53%DAQ('Z6QR4EDJ24,V DM*?Y/?@XN2PBDIT,3@V93+\)G+ =16
MA,N$K_02U(3.1,)Y2)79A^@*FRN^2R3 2XEHXF5$<\E'4B#R86(BJ1,];Z,_
M>37&P7DS^3C&/&& VH&#=SC@+N/DIGOX&/Q"T2A^ "\G;".X$ #%CPA& B:A
MF.A$>+T!1C01MR\SDBR(21/(E%6DU+8A["Q&B1&)U3%6"/UP\^EG<3]P&CJB
MJ /O2G>)3\?OICT.DA(":;5+GQ *:2D3MI'/4T=:B]%:46C%$HR[,)3_&-,G
M6('MQH;P 85&[%7NR[AB')GS3^!1W _.JJ51N&?L4Q.64.QH!UMVH,HT:PU3
MT1-5.-YYM%RAP=1AG&7-!=68_9(K.Q38 K%?X$+L7>'W)7NQ.N$ X!<EF=;:
M#$/BJM;H5Z 6F$:Y+U"U%?/1^]'K=$7YI] WU ]B;V)HRNX  >:E8N62> Q2
M=@IPE\*E:9M.(/:W!.B0R/S&^=Q5R&>U;:@_*$150/X,M)UI;NPJ]%$#SO\7
M9K5^EM-;-$'U"7"4TD7C-&4BPOO2M.\0#[H$'"DRHRT?E8Z\VN2?AT1AZN@Q
M]>AEU5W^)#33S''"HIK4$8 ^RGD:OH;*/ERX4%G%GE_,9VI9QM(#B!!69/GY
MG"&6->C$MO?,#Y"V]736$MC6Q47LO/_ML[3MF)%J'7,(S%0T,K= IS)HC&<P
M,'P=PPP?S3[( "(G;5O 2$<%K=O'(*/][8\QH>CB_^T.A.$J(?TZYK*\F,[#
M"NE9]"#<*M@<^D3<OJQ]M#OXY&A_VE7\HW63:1\).^S]Z ;"ZO\I2J"YF+:0
MMD+F0[U-6T9;0&VD383.I>*I=S)O4@NI!Z)HU&)JNR^.2J&J%IV@WJ>.)X[*
M($H7GRQ=3B'SSE*M*''</^!'E%5<AXPK%$=.]%8Y92U;[]-#"6/;+ J@[&1/
M_ZM,X629XHUD.;E(KJ9,(P?*9H(^D!=*L.F?R3-$WR*ODA<*NWT6DY<+;B\\
M2OI'4/Q7&<FD%F.)>">)8R@C;R2EZCQ!+B1?]:-T7Y*G\GBD+\E?,6UM/6F5
MW&4AG'A4\E^B?TS\I_ZC:(!XJS:9)"$V5@&!6"+>A-C))\(-QR.D1*;NX%HG
M(EC[?>$2PB'9KW%%)E([S:( 8GX;A/B3N+3I>OD=PJ/Z#6F_"1=J'"(6$NY5
M+?+N)!PQF>V&\!]D@W^5ZKQT>H&"\T%L*GJ/?2?"ERXI,0OYY:XI]H)=(-O-
M&P7NX/N>&($;-'+N,5$%=-Z_[RM4-4OL 2)P5@F_@G]C9P@>0TN+3_(_P?8E
M[^2O0%B'R7E*9(C'71X9Y3@W7T!&MOV;L@>4WL(<="1[L2 &,P-CQ]^*.51T
MB5>(A261N6;<HDU7N7-QPQY1G#=XI[D3>52<X6\/%:OY0^1_6-:\'LIRU ?N
M?LJZPA><!Y2@Q&:.)R5RDR>[F9*\^B0;0TF:,\RIHHPG#KD7;SOG%',F-Y&3
MBOS) ;(/%GQF*]@."9]9UUGT4",KDS5]=09K"7/O'"SK&9,S7CU(Y09)1QE)
MG&A)#W(S.U>,+5C&8HM<$Y8S3PG>A7Q@A@L JRXP?O$KYS@Q2WB!XW6 )DZ^
MKI]N8..T"Q!L%E\=D%_";%9&Q(,9'^2"D&1&D2QL%93^C\QA]F.&HVCAN%K"
MWET]2I_*NF[6P)\S[YOL\TXQ/AF$<9<9?KKTX&%ZC^:3^SMZH"9B=@]]MG#\
MIE@RRM[2\I6F914UI<(+F/GU6_)"&/DU2^/2Z%JS+CB%/JVRR+V")JE8-QM.
MVR(\^5=Q23I3@2VA3*,KV@D*5STLP67>5Q:6(;9'*68"8P+7RY> /J^X+O>'
M3+#>H%2#4?^^KPC.9<TOH !_5NT$M@#JE660DLPM\IO0O=MVRXAPRX!1*1WA
MN@(GQ2".67O*[1!;_K;%6:+>BKR)>Z/DH>K++\BOHPLSB+)XC..VZ9+/F$L!
MGN(?6-2*&>)+V%W6BR7'L.2_BKU5V46:C_TM_TG:7G9*ED5"IC=(;I"TT=O$
M(M(^?[E(17J\W"A*(SVQGB#:31Z?E2RH(HNU$^LNZV99E7Z3VC&K=QX1&YC>
M44VB38SC_I.%\0SN<G_!;T;)M->"]_0WXW6 $7FDZ!@&(6T2OBT-D<P4?-II
M)^+S7T99"CUYO_R,@A6\#.>7_'T\X+3K_!+.O''E(D.IP]'O);>5[TIVBX,4
M^6D<89/L\%:@($9:ZC>/'R;1.5?R>B1'IAWA.7"CQNL W=(KIC-HC"3,.+DD
M4*35OTV;)/BB/17Y@J_4+%HOY8G40&=?[G.5[;0![BQN\+A*EQ8VL-#SQ6?J
M,HI/BA94'TV5"TK,:R)9O*^FA/4;N(^-L&5ON ':RFEJ3@1WO/9%D-74Y\,@
M<ZM<"M6YK:8WQ54)2RJ>E@K"T@R.Y;%>#W2_@0<7T_7[02$3[^JJ0:/_4]1S
M^)_5F\J)X*K*4\ 'N;Y&*GA3_+ A"Z(.FZ"C02]XU6JC89<6%VO/PJTF+=',
M@H_?MN.!YAI$&NB-*0RY-,=D^(1\$K]4=Q[5MHFA^8 N]0I7=Z-_+UZOF8S^
M9U*"\C VYJ_"':J<17  K:W81<C+/JW'$8QQ)&T:X5;H*S6=Z+#FHFH#<8?]
M5U4)T7L22KZ/M'U<V1OWTM\">08$?3C;4;>.CMEQ3#.7[A%:JO*E?5M3J'A+
MNV7?K_A,NS9)(OU%,_U56$[%"/]N^0\]DN^?I=1Z\= [ M53N>TA#Y3+N%9K
M%LJ'.=WV4KF).W]2DP3#=!E7LPVWY5?+:;I*V:$L6TV:E!,[HEHEV1H"5H2*
M8ST/R4Z(/MES9$6BNDE'Q6[,H/'J0:]AB_YE^3:=I8Z9>5O=H3D9BU3FJ:>'
M.,J+E%<\"Z3_*"_8>TE%\HV3+HL6,\=G"@:HOU*SJMQ"*ZXB9@K5KI69L8L5
MIXSAP1=DARH6>KI*M^G?V5M)3BLB)ET3)C C_BJ(97M GC)_8DM6@2(YL'&P
MB!E95A]4DNH?4^M0^M5U?<V"<OLY[G74LL:QU'81DO]7@9EML\I"\D::[<NE
M2;\:(H#W(T-KJ\#N_G[5N9!$UY J;ZC]''B-!T0PEMH\D&7C:D$+'=:;%]"H
MA".3='5]"+^(.S43D1/\7IN'D2.N]I4(E.<<1=5<I X 4%?AO/XJ4'73"]R4
MW,Z&B;C$Q%^UJW'&B/(J NZM'[_2![_)Y;;Q%AXT1UNY%O<9 %!YD0K&U<I&
M&164ZU_728U+I%=?IZ[:\M#L0IWDYVT\1_GD8JJ 43[,41@YE(< @.+9?[D2
MN*>!R_F0<[VVGH--7%%UE/UH"[O2FAVW_EI%*^NQ"]2PDG5YCJ)B(FLL+\N/
M_+\JK!^4D'/D-1?$G0EWS4]%/5L"38["7>LYAMU">Y<@_0IA])QZ?1-_+,O+
M;OZ_6EX_4S,K)ZG&1?4YP6CV49K#/QIS%#O7A^H_R7M7/-?ER7?/8>C:1<PQ
MY?J?*G]75VUZF)-276=L2M!7Z@Q?PZ]5U.A3UOOH%^C.KOBI+=<\G=.B;195
M JRE MJ4ORJO=XB4RT_^U$_*3XBJ[I$5VFW(ZSQ8=-!C5[NH9,5B17MXR="4
MS(ZZ$B  H$Q#C/][D.<U*"^YF7RT;T>9192BV[;<?P.TPQI8[/&XU0PJ7/RN
M=1IH9,K[MJF@L?>K6("%_%6Y+P:L(:^2L3U[H8JHK$X$;,N&S6WQ<"N/*\UG
MX(T.\YHGPX]/S6RNAX_-+-E](FU<M?05HJ\EK^A>A%FX]5?[.4S>ADDMK9@1
MCY:F)5AKAP6-:[&64YL:"5A_ $"ZESI_7)7V?"9=2'K>V4;:NW6T+8O4'C3<
M[$LR>D@:U*0:AX7U$I)^ZHMZ'GELEY3L_V\,<SV[;S#?)QWMH#.U6VM;ES/=
M@RH:WS/V>T#KMS*8#BOJ9C&JIKG6GF($  #BA_^IG%]=/X7SDOK;Q0+R5EV+
M$W]WD+#A/G^*1U:=-V_ 857-'?Z2:44UT1S>F/+Y?W6]*U41D=33=E).V:IK
MWBK#!+'KOTOY'MMJ-TF+'.RJ7TEV3R-5.W$7   BX_^K_9VW]55)N]I6Z_9L
MK6V2:^E!W'I?#<LCH0:L\7#PJ9Z@C)VFJ%K&'5MG1(#_U/ZY);8YKSLNE@7D
M]U6\!@87Y?*6@9>7O$&60;Z5EV4-PH9!YR..(K9 9ZT^BW2!W9XV">,.G[=W
M2>&*\O/MVXH%(+9!4KH7LIKSK/P"]"0B G06GIO9!.E&O-QR'!:%2ESU#/8>
MG345C"I% _=$Y:G1C:V<PB686+U5,1GSD8TL[<76P[Z57\!E9M!!Y_"SPT]
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M#8R;XW4 )O>31 0.Y"X2G\EYR'$5G8C'LKV$C6$+666"'N]<YAW!6D<W9JV
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M]D#WJXM1G[$%*GW19=PKY<D$,2%;Z>VO(3Q1[)GUC$!3[!W3YE4PF&F:$HE
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M%;(L,76\_%?D ^H->?,B(/67'#FEC-XM^SJFS=?C?8S;>4P"UW";$$=LTQ\
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M"^D=ET[V ^FE"7*>L[1\3-&?8% K<604<ZKN-LR.J=5-+>ACOM4N2@QAE6I
MP>6L+O4UEW16I&;*!!KGJK)HC JDY]>^(9VF?S/=K: SZ#7B@NF,2]56"3W,
M<./)H!-,GM';^2;CKG'2!#C[M')X3-'OIG':!*02NF?+#^A[>FOSU/Q:^KO&
MR0E+&&GUTB &@U<_S5E*WVRZ/,&';:,<JX%A9NNVE%S'2K3?RMZ4K]<*0+>S
M>[6>T-:8$,U/N*/O>VTZTFN.6/<%^=[\HVX&>O9H5 3"*-4X0IY@-JB;807
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M3ZAZH#4I K,%K"FOP!VJ>)R61QA$.H1L(%FC7SE>(<JPHWXO\4WK0?!4$,,
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M$M.2HI(#4MQ2'=)LTWZEO\]XFGDSZVSVH9QMN:ORNO/K?Z\#7A&Q&%*25YH
M6%+F 9Q=/K'\*^@%^";D)'17Q4I8*UR+X"!1J$)T/"8 .Q]GBQO!/R*<)^XF
M#9$;*#(J@59,CV5X,:<QO[$>LD]Q-G,[>"H^25 L7"9:*)XD_B"Y(=TO6R$W
M*&C*$E6DVD4S3O-<>T:WH;))+S3 C"E5OM73JD=J;IL.U@[5U=1S&J"-*4W^
MS;-;S%N>MUYLV],^U-'0*>^B=D.6Y_3$] ;TN?;/')@P\&/%^\'G0_>';ZR\
MM.KLZA-KCJP]N&[_^GT;]FW<O^G0YJ-;3FV]L.W&]@<[7NT<V6VUQWZOR[Z
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M)A5EYDYM'9W2EC)2NXD*141I[M'8/K'R)?1G]DS!#>: Y?&@*TLH(W8_![K
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M$WC!77=J$;J*JCY<BI@K)P[+X?0\M%\)85*\.W: IZ-\&UZ">?Y/3//!66Z
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M@KX'D?IQMIG*4D6#)53V%7YC1"0VW#/M(U%UP0E5K" V=8_L!"\P<JG8CK/
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MG_F#C"#MHFX^+8CWI.TV;30MMBF<^K&BI*Z;MB!WJVD^K69+DFXG[<>&$25
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MS>#*Y+=8N+[,>;9)!"_&#1-I9S3CC/9:XF[&)<6H$ QSC/"0RSMF$CINY%\
MM]_2L8QY9;=&SV-Z]BSB<!F=K=OQ*D95?6?^*4:)\7UB-H.N^AGBQ=@K-KI<
M8\Y"K^PA2CHP4<VS1$^K9>JOPOB:"^QE_,NXF=B+O!)\Y8XL[E^$]UL6HC:2
M/G@L.Y$B=FY _J)]V,T01Y"532Y" _FE>KQ@#F4CLI[72.FH^<*-I?KF*=&?
MU#N;R]E=-%T0%\'3.<X,>".C9Y B_ :>;APGV F&*G_P'K &8!<NPHJKF<()
M!+YM/XN. _8GG$$N (*@I7 '4.J<!<F!U(%BP5'!*-LMOC_/J#C,/<'UA=9R
M,.B+ZD5H,'M@^P3V(D2<X W_@?,#]T+?(!?G / ;ZUK_9OX9Y=KZ:[R-LL_R
MO9P;DH/@+%0L$F-<V 6"XMP0))NW)=X,)W.6!NZ <I$3SBM +.3;E\6?5AM3
M=Y_+U2?(3G!6:/Q9KNQ;RB55><B ;/0V!=PN>A"_!AKD-P?.!6]PO)TG@:/@
MBEX9C]"85K> \Z4.E?Y!!28!4,J.TM,J>Q!'=>FV2;"C/"IN!/(2?0^X#A;Q
MBIT^LRP(K><S;TS7)BN1PVFMEZ:B"QOV, \@9RP-E7/@;H,T!X .J'?%;0,O
MR:8$6,&)@ERG9ZQD=GX/A]NQ9Z7E.\>OUR0YQ#[4WLMT1,H;Q14B>+.E-&<>
MM$/O$3<)9"F.!)2QCHBF.-UDS4:7MV9I#U3M-:Q6.U=/%FQ6'*])HEZ2L;#6
MTE>2C?B9F?=$8PC-,8OX Z0B/QVW@()UG(".I;UND6N8)):^6C6:](POEC>2
M,ZB+I(7DNZ4!8G<*G!DF^$V-VZ3@':*Y^&WBP/1PQ[_8/@QM\V'U1I:+CJFX
M#NSG]<A ()<2(-D"+"JI$3DR/V1H!5.83S;-XCYB/ES_&QUB?G.<B# !^Z8K
M*F=NGQ:0'^6@7)N4@A:2L\6;V%N*&X6^2&;Z%[X37!9=RYT'T=>/H&-!D>,D
M^!Y+WOA9Z2R+T^AE%R3;./LD8E$U"2<J$L"[W@JV\!K2\WB9G"O1/IP,]OOU
M'/8V^)OC9#@-O-WHI*C1W5,_D2W2>'*FB*\I,<1!89>L>5<0OT[\>.L%;KMP
M:=1Y=)@7MCX)N8SZ.4Z&[D._&YCR!W4I:E^IV/0(S1+'&&*(TX4K-,:B1OY"
MQ9NM&5Q'J6<4 _41)J]W0'*Y(8Y3(";\Q?9%CFNUJ5JD=HWE[..B6];W!+J@
MM3:U: 6O0=N3]H1S4/$SRIU]2;)B_7CX%W_B_REWY)1-*5_=>U<5)+G6<94=
M(T*;2_$_!9OK3A5V\B)J[=.$G'P--O(5FR73^MZ"]PCXCE/ MVRB\6S=E*IL
ML<W4CZD#OAGXU6^J#VFQV-A\;U4*[GBR5+Z:@-D8*[Y."O$N%E13MJ^U<A[0
M'AM]+1^)=6+[VA;2= "CIY.$U4&:/++]CEYE./EI\G+9$LKI\+>B.]0SWF%\
M-GW"VM.<B0S H#6?9!X1E1I%S!+F<5T><Q5&I(YGCMJQ4!' ^)-DE:YA+@I7
M"C\SH[R7\GJ8LK7OT$W,'_J'IA[TF-!H8+ '&2^UV<CNJBNJ&/AR'E:^"9Z>
MM$*R$<H(#Q&N!>O7_>!^8OVP_YMM8:7J5]6>%_<)'NAKA=\8+AI L*EJCA++
MJ]M^3U;&'9?8*B:AI+"/@A+D[KK[W'C8W]Z)/1/DZI#:B>IN0;CNH3*"+E0?
MDYVK9"@&):G;TZ4]PCN)FT2[^<5A_?PASK-U)SG][$WV&Q -I-;^-))-8OX9
MW59#)7V>VDOK6/%'L41Y.?>.=)D,VO)"Y"9V#*/Q7?B[U_5Q_#FK[5.0=3!#
M*S#.;(S@9VG?UI703*JCIL0*OKQ!OS 7*VE2/=XB$AZ26</">$=%T>NLZ&7N
M$?M\^ &R0>MG.-)QD_=':VH)HOFK*FT;*M;(-YD7YBZ21.D^;8D5[E >"YO!
MJY: Z_BHB+_2OA(V(_<D;]I$5>.AP28&)IRPK%Y8+2I>;-;5?,R\:>#AF'$:
M33K!/_B4_!MID0<D+J1L7L/B:6FW)$BKGG 3*F_D$C?B3]6AQ-.[3IH0$BF3
MIZ\F)\:EJR,HR<%&V5MJC0='5$J[L.8"MYM1+%G<0F:0P:<--0Q'?)JUC/YY
M5T)M.?U#YG)='F-NW'A5&",KN$+ZG='CP1=RF.OLYG*>,O\1ZYKSD'=@HBT7
M_H'KM&R'EQ8=,>Z "C(:M(7@^=@V92J8$!PH7<JZXL$3C+"J[9(XOJS%XK^;
M",(,UJ%Z,O\P;K&9R0LM\C1 G+,9ZS406AV;J8#8=L'3)9GPY?]3T_\O8-0$
M!HM$C8<5>UC1=2=E$+;>=%H25[A/?U:T./V"^BS_?>P\^2'NF:#7X@:TSD/
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M)-U5^C=^EZF@IN$X^WK.7GP9+R>&C[T7_/;G8V?$GQSIV&5Y8?\&7,W.:&S
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MU<>CYD+3E!?\'*$Z8M/_J "LLNL&<*,UO:83.-0\&=L&K&H0"Y8#W;6;*AJ
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M"Q>W/Y"=]S_;=%'^R/U.;1<PU?Z,H1 LL'10)T!KJ"_7]8*!)8N'=&!XEMN
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M1J?FMO@YJU/V0'*/4T\KEK[F->1ND<\5;([-5I2*W@3D X^EE4Y\:)W":S"
M?XG_INF6X(-PL?JR:)0H6'I+O$2<084ER1)9[DCI@'1;S'6YA?RO@)F*:PJI
M$Q6\""[HO\F]!#@W@OP9@%I5)5@)_"-9)X3 B=5"T3TP+<=%4@'VQX3*)D(C
M_7?+WT)TIU)P.G2GKY9C0R8WA'*EQ$.E%^\HD2'6"!;AZZOJA8WXI&R^. KC
M1^^6SD:O^@OE5JBG4QY 0Z2]).NXL;K>G^-F\"#]N!K=85$'[[/6K_* 0*T>
MR+HH2E+-BDZ0A)& O[^,CQ]URE#<1)_V;&"N:RJH*V-;-F01E1RR[B_A->YO
ML[YR*G^U<5)6E)#4H5'OQ7KU8__QTKO*I4[)B@K<KF<:XW+WDMK=K)2.2'P'
M>WOK)*$GUZ>QG<+CO:FSR]PC>&SJBZH5C]*/];LCI:A]G>(5(PF_[@%&R.KV
MV@CFSOXWN!M[4?=A01^GH3VGXC,OH^EI9H$@IXX:M5RD-9[VZY..T?QTBI%O
M(>>U/8<[2BX8#\/R\D?(/ABO/,.["0]1N\I9\%T&E'X5L66C*YL0F+?)9R<Z
M5N1O_Q4](O-O_0[&4/<;+H$,^@MX/]C%_,[]%WS(^:ML$ K@+4WWAP8$F2MM
M8&?16A\$OBL-=YB,'%,XM[Q7V/-4^GZ%@G\?VJ/X1VC/^0YXBZI+;P!KQ5O3
MFL%PZ=R('> 'F<DG&;JH<'=8 C\!?C2?D_G)5^@DLG7R2Z!>;J5(Y,R7=RD.
MELY6K  "T_Y2_ 0.1.0#5\!T'SOP$?C9P16V@ :;-DB:L3M:0&J'[0)JI9LP
M-GNZ+!:;4!(O'X$.IA;)GZ*)X4\53Y /R]Z"\Y!:AT!(A#@U[A<GZS@:G?BE
MUJ!8(\$U/%:@U$7M7:R5?E6^3KDH^T"N"E<K9A#%RPX"5=A/AY7@8Q1I^",*
MK[NN/B-Z6>LK_R#6FJ.86LERHWW1&^E2W:^47)FKYDQXA+Q095C6ISA/NC@D
M@DQLJ($IY+5/4_N*;%J&Y%FBHXUW&5_$BKIK1142JOEH\EVIR3 8]EYV42M>
M1BJR5(L<,L )^$##6,'-_K&J@\+:[KNRRR+/#B^&6/2P):CPB_AB0T"R3CJF
MQCEL2%9H&+LL1_Z?>J]#'K"+$)F:5.]*AG"):D;Y!K%:2:MLI)XE;U$Y^<UD
M.B,W,8HXQZ8M+R!R>(.>3_!?HA#; ?RT+,)XFCQ)G8YM)MWI8:(=Q""SF#J7
M<&4K\O[@N[AK$B[@N?SORZ?AHT5,S_/8!:FE[57LL,+*\ (_P$U#A_%LW@'A
M%>R5P*HZ!#,(T;PD+%CT(2$!_261A>Y"S\D6>OZ-'I$_L1N)W@1NZ]^@[Z1<
MI!?ME+D+#J*ILNM5='2\7);;C-Q4V,4?0PXJ[H;2D!W H&<[<AG$[1S0J1!?
M]QU)15!X-[( J><_@1\B9&4#O 4ISET,UR/!\2RX&[$*#83W(!,]Z^ _\&>[
M:*0$OJ=SA!>H3?!8Z*/J,S\(.JRRH;R VI0N.4RHAG2/>P^M)P)"GD+/\3!/
M 9R(^=F5P:=12RT,+32SH7SPC\F.5P]>-N@HR> VW<'L.^!NS=LX''RAGA>R
M$?)2!GI60)N)%782.!7SU7P',YOG@E? B,;%O*G@_+H=%>>!KS4SLZG@>&-Y
MW (P4;<FA 7VJU]Z9D$^R@EV&N@UOE33#!SN(D F\'?[;6X[H&X9J"@%*AH7
M9T\&!+7JV*O 0>/;$'_031?KZ0]>5FGMFJ!V_"X^8&XO$4CS31/+*YC5AK65
MT26G]?E4I_3SVE\,JZ@3FE9V9&"PVI]7[Q:B?"):;JTA-\@2L#?&==6YDCV&
M%!K!.*X?R5A7$J7=P;J77JEA<!VB8+4MOSYPGO*>R-XMGMPH^65]E6A3S,.\
M]/LX<\1/=#JNF3%+F\F?4-RFL1)HTNZKWHF61EDK3XC/!3PG!Z4=;JE$F[S5
M9B&^&MB/EFJ_B->+QVMN2=1T#_4^:7;1)U6WS"$M4VF2CXH\0FKE'P)V$GK%
M1[<,?!"<;I.%78'"D3H-#_(4I:FI$)^&JPJAEJ((93JT/O4-F00=CY03#.AC
M0!-NA*W=\K$S<*&-"K.$6^"[ZD!RG7!0M9),I#Y0KB#V%NXB X@IJ3(B L^-
M3,"IV+8 &!O&YKL58=-0OLU&5(T<AQ-5T8:_A+[*8OU$JH3,U^XO7$&D:,)2
M?N'5JH,K7V ]RN2 ?/0=<<\M'^7A.3:7T(GH*>BZ4E_O(#A(KJTU4T<1 V:R
MX#+>9/1):<>VZ)ZNU&$C-9T!EFBQJM@M#WE+CK1YA_1A?1"L'-DV6U!)6C<_
MKNXBYC7.+!#AHVN?IJ1@BTT'5^:@//U P&CDOL;DEH&HE56V?R%I>)9T64M5
MB1-K?Y-W^?CR@PU6E!<Y075_55]-X)B/T.^NV&!DLN?Y@/KQ/-#IA6:-*-1R
MC8HJ2Y48FW94=;&B&P:H1\N3Z\ST_[(?UK!8(0G>IF6<KA5F_0>^JP^D726\
MYSQ/39/<M)JIC%9,$?_7\(#U@-E2]XY367:HYA7W?7:IZ2J_)OZ288LP?D6N
MSBAV].%K*J4VSB&J>'F&%8N,!?K%R?66PF^,A[7AHA=EH\R9XNM9%XW9DDOQ
M9?HTZ?T5,[4)\G$^>>I(Q4KG+&4BT&>UFV!!LT2#M:N $8PP\PV@K+32^ W8
MDA5L& ?\BONCFPWF+#^K\0"/^(2HHJ%0YRJ2#9VP^HUO@O-%LVH@["=]IVD?
M=J[DA>$1IL@\JON"38]KT4Y%URSO57N@63XN2@HZR5E$K$<.6/OBLQ&)L,VL
MU)RBKS1>UDPJD>A_J2=GYNEF*Y_%A6K\R,/+JU75Q!H?%[(+;W-6$Q,PU+H"
MJT7IPA#3!3.3/M[H9'(L6:&/-P@SEVI3=&#<!#5'4[O<3;E=];?/:'(L^<*Y
M'D>)2=9JS!'S%7PTQ35>I1TT=#:,+_ZLVUG;FG%#L]-T+?:2ZKK!>ODDI9T6
M7O:%4*I>.[?A"\ATZT'T$G:+%='+*=Y8(>WJ+T/R\MNO4BJ2G[;<K"Z/3&SL
MI:L"+]2%LQYZ?#:=Y-'LS^D31!$6X]0?99G,H>Z?E7LK%G?Z5#_,F]:62K=)
M_KLYDHE'^C5,YDP,O%ZSAW?0<[&Q0-CI8*'](=EGH58=4HQB>G4%,0WE+>TD
M>TGN<,LPYU!R<>,03[/R=QTIX 8>-:>(4$\OPV3))H<RS3GY;(O_E#L!+6-;
M!R#P+)_1>ET8F+ND>88H,>EG@[58LG)K[0+)OL!>TTB9C6>@[JZ\VZ%!?10(
MM\PAKX O&0'M(V2'R]I;F/+XG'6-&^1GD@QUIQ6I*\7F2XJW@9#A)C#@&:B]
M M(=]JKN0E&60^0LV)I^JO4JDE 6VIR(I.?D-M0B04EAM9N1V2O]3$?@GX%4
M_27XIV>(YA4RWN&N:BZRR/(-P44\Z:R6%\K^TG^;JI2N.?/JUY#"I)$U)XG.
MB&_&)_BEP&C]:'R!9XS&"F,[_/Y?4]YO98>_0.?0'5J<]?M+-S<.ZPYG7ZU[
MKZ4E'JN9HKX7<=SHIBH.G*,K(E]Y^JL)PNBXE+R#NUBEXP!ZF?:NN;=V<^FJ
M1NN:N.S3=7FFX,3-YE+][8BC!I&V)=!9NTXM\$Q5?5)6._J1'"+?2HS;8=SR
MX;6GBA?F@:L%I==2_?L?5>R-OM#]H>I\**U]@+[ )Z!Y":O#95N=A)=D\]UX
M7!2UI$&;*<LJG[/&3#F8Y['*NNI!ZIB^:IIG]-ZN0L:&4%[;1':Y3TFCD9?@
M\K/FAS#?EFJ@2OJ6NFGFRK^6[5U]EV&;>WE R-R3<K3G %L:K>O8P:6'%K5(
M^"H?5L,LX157+W.[),SVJ-Y5=F/I1O4H0%#&7;60EYT+]NWA"U)HW7,$0]$9
M[3:B":'!3=_%M3ZLNFW24-<<4XE\I-T,W1S%4PM+U1SP:)G-0*U$FAO0&RZU
M2G'J[)5>BI[5NE-6'VK7.""'?)BUH$+I*C;& !UV:5H;\)0%K$R WI7>Z2\"
M:W,G]DP%3Z6,[>"!;Z(^M1B@Z:%3&@@HWD=40X/Z71L,:?!4.[4F'<8LSI%]
M\/O2OKXJ7)[SLGL.'I[\OEV$78BZWUR/I83\J&]$'_B(S#I4X[I5#Z%1=CO5
MO>A8R^GD?.14J;AWM<8YYWI7BAI)?M*V6B6-NMIT1!D?\K;N#.GA0S5=(YQ=
M]^ANX<OM[JMG8#F6D<1J%"[-ZYUO[,^YU+G!H$I^V/I']R#J4M,\[8B0?^NL
MU#X^,I._$G<]I4LEWMA]5G7A-$LVD8S-V)Y7OCW_Q>!_E<7%N8TNU5_*=A+_
MT V54_B_64'4ZK(1W"F,6RG1@BD<6>AM<8& ZL:33Y0\VL8OH5=F#D#EE.J=
M]?<K5]+GX</4I4P1[P=C!OM6J07;C5>0K.=)!3]"BT2SQ/?=HF53Y:Y;A@I1
M3G_?/R4[>2/K>.57^(58=N4KP5'N)=HB44B)"U,N/I%TD3M1R@QY)G@C#W.S
MDKH 69L>Y[V0'>M=4)0M=ZDY6]HC;T"^5;Q2C./T5N<K#,5^]"^ 3=)2]C'@
M:(B,_P+$W$9(*J""C>$Y:_$CW4T%47BDN;1X#W80[BKWP,+8]95GT)-%V;1^
ME)((LM8AOT,6\,<C':Z/Q5L1__5/LBX9AKH*\DSZ6%-HD;WV*E17ND]3Q.JA
MH*KGA>U46*E(^,3<2TX*/LJ+PU6N9\06Z*-U_V2F-%5U%N4Z-%@8,PHNUVX'
M=Y>HS"N9=RI8ADL%/ZK-NI($)>.#^F8PP5VM]''=*>K%"X9_9%AU/^MHSYG4
ML=G0FG^L-06<4JQNO,4,*5?5L0I856=-7Q*6,E+U%<&)7!MUF^N0*)CH'!:D
MQZV9W#$_.V3@NF%6WM<> : NVM\QDG&T['1S<\&4*OMZZ_A3],,F9? TSC;M
M.M=VX7-R>,UM^N3\X;;OC%_%OGHQZT-9)Q#">4OYET'PQU!3\WN$*QBGXR>)
M^SG"P(NR#('(>3V0+QTQE%_UGE+7>H?F4[U8)V%0:'6* E8+<Q1]#^<Y6Y[W
MG4_A38W3BZ8)C@62THGBX\Y=BGRYYZHS%#MV=DMXU2#GE78*;0I/))_(D//_
MT+K88X5->3.YA\21L7<%ZZ63 RW$+^1_.=?(Q<"*0?^RU9(W39LH>=(>M:'J
MK2Q.>I&FE;VA&IEI\J[<($ZLHBPVBL\#O -.B%Z %LZD;!ARZM]?@J*TQHSR
M?#1&M:)R 3I-TE!]!SE=W4D_AQASA*S?2&G,;EXQXAL BB8ATYSETE_PBSYM
MT1[MA0:OTBV:ZTKO"K-ZM[B]2J+25>VG&90%V>>8#TCOF&@NCQ@?$"),POYQ
MYDNIJ+RWOC"N?EI];$EN;3"971YG]A&=KXPWSJH:3\5T'[-#&=\T9Z-?<E:K
M.@(F"M:1*<X,R2OL>L_M L>.&74-Q5&M)41_64035>1(2:]/K614]]4$9FUE
M!!L71^LXD[0O_>\*G%5ZYTH)28SIJ<C/&]A;-Z<(Z'4D%I;*.X.%W17&5B?*
MYZK7C8NS<NDMM>.B@]BXX:K_(/^ 1N1<*EE&_.X<X#7G&VNL^6>++;!;POEE
M6L$1D81RC^(H?DL-S:1(58S]D=_DT1R^[V<@3H ZSH5:I L[RMD#%3?-8[FN
M51"ZG[>!-I%_4A#.T%>D"]^R%V;L$!_F'H]42 \(6GRW*/X2;W6T NOD7NT+
M&9]9<XP[67O8UY#M'#Y7RSO#6\;W*4<$,P6O,^:*K$1[(Z=)"B1#OK#LONR$
MHPNP!G!HW4@SB>T-V0Q"LA!.9%5+OG$'.1G2?\I@'DLVG)XHV"IO7XF)'14=
MO@'2Q\!NQV6*.^!_+675"+Q8/X?6 L=#"QF]< Y'P]H&IY:NXWR&D]*Z^3PX
M=^4TT7R8YCM2.A9&'8,4KG!'<V+E.?4HW53J:%45:$^W5[:Q!YGYY-:21^P]
MQ*FT&;P\_&G$>J$;/L;G@B06F^,8)F] YS1Q*$SS7FU@U593%I!/?6489KUD
M^.GNE02S=FBGIAJY(G5P1+F@4EGFLT&\BF Y1LGG8P6-)RNR6D(T=97#3>,4
M6ZK?U@.L)'ITS<'BU<Q[IK]2IW+VZB,CIO!/:40^)K&M$G6,DVW">8UYY=H>
MMF8!Y44G0^%>[=KZ'_,D3=.46!S(=*OK3MG%66IZ'WZ8'ZUW]2D2[55'.2;)
M2HC<VO6RLGRU,DEVNWBZS%H.ETD8SHI@RIG"S< DJD?R0N S8]>*Y^ OCMC;
M%0X3U-H-(8>D'C5-XOJ*2#))4E;YK]1&&DC5T>-D5HRE!?_)+5C[DS2*Y5QT
MA1* !0SOL>!/<9?=.7B+W-,L%8YE/"+FB*:SCDN6BF=SVFC9$D<>M6"9-%NP
M,O$_V5J1_PHGA8TDSNL)<$-FLGL/'0:FF:)X6X5\["[_C:A!]$ZX2-Q#58BR
M)*OS9>)MTBV)?&F([,+RV[(7BM%>IQ57@2S[R> '\)AQ(6<O\ R]Q9L/9@C?
M\ZE@1[50< 0\G[=%% N-3_A',AI*6LZ1WH=:O;KDWZ!_[>W 4#C38,VV(F.1
M%YPZXKMP"O<G(:OJYXOPZ[E_A/-PGX0,T5NL>;FEY#/ZQPN6!Z'%]H% '[)%
MG\_\QP @3NQ,/5^0S3FKLZK\P<O7K,JE"1:H'>,?B*8J5X4^D;B1MEX,61-N
ML(\';-''NH.,0PUBV,S*J=O W\N^6:.M9''Y)H^<)__+Z%P\6YBG98:VB6O5
MH[QR9#-(A7VN8@_V5)=)_]YA#R]AMK0.\L/9%DVK*9\XN^NK_U>AFFJLXVT%
M>PPW0PO$T[5*+P_IL&J1?86"AN]6OD=9^80"0P.*?G(*4>^RPG((C:1LR_)
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MRK."(\R7U'<)P=P&EF/P=&$+;[?K..EW\9,UNMPW)65M&PLYY:7Z927W*G,
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M/(4B!BD06+ ;/ U=3-\,C81^Q+$@*WA&F"V4"GOZ.T+-<(G[>>@3W.4P!M;
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M7KOXP9_[AB8_#HZ*?1@1&WD_+B'\;E)2Z!U(<O"=M-2@V^FI@;>1D(!;:&C
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MQMY7>,*O*WQ)Y^4AO%EI7/XQ"50T7HJ1#Q51:_H$G/JNS,R6-K:@JYE>VMM
MD0YH2<I!.5XY6$Y0]XF(U3T+Z2]#B:,9D#@X 9FC_PN%2\P#I3OLALJ;>%$5
MR#E=%9TW79E2.E&!E V+2.J^(D9=1RZOM3$CMTO'+NJK9D@&E;2J(0FI:KB$
MK.XO)FMZ%Q(HV[L8E+PS.)B!<GLG4.G@_Z+**?J!VA5ZL]H+?ZG&GW6V.B)[
M1I,H/*I,+Q^1X55=I=2ZIGQVJRX[JTO-R^^7LTL'*YB5P\54Q4@A53603]/T
M+:0_#99;0:F]&:BP<P1R>[^7*D?C_>\"N57K@;VL]Z7/U87Q3^D3\H_6II?U
M*["J5C&Y3B]DMJKS,KHKL_+ZQ1G%0R5<Z4@^4S&2RU0-YC#5?0L)B/YC*+,S
M&FP=@<+.]Y7&WGC_.Z7>KG-#7VWTH5YH">'.MB3DC-7!RKI4:*5!2JRK+J6U
M5A9RNL1YV?W"[,*A_$S)2#9/,9K)40[R.>K^A?0_!MO#0&KC )0V/J^K[2(>
MZQV3[S:Z(J^W>1,O=(4P9CJ3^(,&:&E;-5*ID^/KJB24%DD)JTM8F-F?EY\_
ME)4G&N'E*$8YF<HA#E_=OY#^,HAL#@.9M0-067N_UMJ$/VVP3[S?Z@*_UNV-
MG1L,)QWM2<CH;8:4-NK2JS0JK+Y"1FHIEC"Z\DHS^OC%>8.<HM)A1I%BA)&G
M'&+DJ/H7$A#M60Q*+;8"L?4A(+>R!QI+K[=ZJ]!GS;9Q][J<(5>&?-+/C$=A
M1OOC,]K;4TIT#7"%7(O6E:D(S8)*6B>_@MO+DN0,T$3"(9)(/DP6*@<IA:K^
MA03$_S%(K X!A84=J#'W! T6P<_:;:)O#S@G7IKR2YXY%HX9&([E-74G%ZM;
MT^22!F1M82V^*5-#:6<IV3T4158_7EXTB)'+AK#EJD%\F;I_(?UE*+<P!<HC
MMD!WV/U-\Q'_1SU68=<G7"+GSOC'3IP,0W=.Q'!T@XG"RFY(97$KHB:[$6M@
MUY-;*3IF)U[+[T%5Y_<A-)+^=+6Z'UFIZ5M(0+Q[,2@SWPJD1PX"]2%K4'_0
MY5G'8>_;(U;^%V9= X[/N2?USP;@&X]%<%7C\86B?JA4T(G4\%L(=4P#M8E<
MQVS#Z7@=Z-K<+H2VN!NNK>Q.TVH6%)#L>F?8!N2'#@#M <LWS?L<[O<?=+TT
M;>TR?<$F=/"B([3YK =9/1V8*1J-*<[OAT@S.U$J3BNQEM9$K2<9F(VX!FX+
MNBZK%5E7T(:HD[3!];+VA03*C0;QX:U N=\$U.TQ>]JYQ^K:Q'[K$W.F;D/7
MS*-:KM@@U&=<Z*)C 3F"T=@2OG$/G&ZTDMY!J"89?Q+&V[\.T\1I0#;R&],-
MN4TP@]"8>$&!BIV+0<6!S:!Z]^ZWS3L.W!G>?G#V[$ZSX6O[O%MO'XK77+%"
MBTZ[,/..!>5DC,85LP;3)+1>="6I&Z_$=9(UZ'9Z#;*-I86W<G5I+5EZ2(N@
M+K59N*" =/OB/]Y'J=NV_7'/QAWG3F[:,GIUJW7;PST!FKL'DT27K;"YI]V9
MW.,A68R)A$+*"*STW3L(F'Z<%-E+>O?NP1_O'4"[V*K4S@QU<F>.)JE#L*"
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M>Y.01)BG' FKI@?!]GD^L&\I ]36$.'(1E<PV.8 9CMMP':/!3BIF(+;?B/
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M)C>P.^/^T[;+X[OM-=PWFT'<9YOGN'';,=PK^S>X$8>WN"',N]_ZOPU$]3G
MU%D,7-,UP+/=!ERL"GA[:@#-6Q?(OL9 D%N"1XPMN*8Z@$N.$S@5NP"FTA4<
MZ]W H<G]IWV;QP^[+MQWVQOXKS:/\1]MG^/?VKW"OW!XC7^*>8M_Y/3NMX"
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M!<INL&R2 ZR=; 5;IIK GNGZH#I3&[1F:X'>7#4P_NL@6,S;#[;S]P)FP6[
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M/7=>=)YW7L!_?7(!I[=N^-\PP.61.[@N!9AX#2P#KO^\E0@UX85H&T&(=9&
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M;)/5A/UR&G!F28/X#-J/X/GG$<K_ Z&4!PA%?^-%(2"$_$&"P (%HAMHD)S
M@,L!S+AMP8:'#%1>"W#A,P4//F/PYC> @&5Z$+I,!V*6:T&*@#KDK%"%,D%E
M:!!2@DYA!=B(;1&1A^DE=1[$\\_@Y_\=H>1["(6]0H@-),0" >0&H@0:2!/L
M08E(!DV2.>B33,"4RP"LN'3!CEL+'+DUP)5;#3QX5,";1PD">.0AC%<68GFE
M(8U/$O+YQ*&*;R6LX5\)7?RBL&%)X*A/ D<3+J!C'A8\P+3E R]70?#R$0=F
MN RX)RL"/4\-G*LTP;%9!ZC=>D#9: "444.PWVH$=KN,P>Z@"=B>PBZ9@LU=
M[+D9V,QC"V9@"Z;?L6]V8/:1 N8?E@ T/1(X&7$! V.:\8"W-1_XN@B"C[<X
M>(?* #-1"=RSU8!>K@7.C;I Z]0'QWY#H&XV H=)8Z#L, '*?E.P/VX&]A>Q
M?\S![BGVSASLOYHOVH/Y @7,/E/ 8HX*EF^7 $YX#:X&)/ T^.]/J?B1^2#
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ML5,R8' 9NX>]P-YCWV2^&8+T@B'(?#4 64SN9V"*9Y/UB&"G3P1[(Q)0++B
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MS\F@_(P,JD_)H/;DO]3_#6Q_S%<E ATWMP=>!\N0!%YD;F#2>,&#M1P8P4)
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MZ$25/1$9FCO#"G2G0\H-M@;7&T\&K34=#^PV'PT8L-P<L(4\Q-YA/<@^:C/
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MI"2_P+PPKY*<E]MHFY732<G('G!,RYIT2LDZX)R<=0E[YI2<]9F6G 6.*5E
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M[IK(.H.&B!:C^O!>TYKP(?.JL&T6%6&'K<K#KEJ5A3^W+ W_:E$: >:8V<_
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M '1> FA]%0-UP@=5(@-*1 GDB0;($CV0)B8@))8@(/; )R[ (S[ )6' (4G
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MCU#2]P]04@^N4\)[+RCAG8__80[F3\?\:LS/VPF0> #SCP),/0G@< Y@PL\
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MEGQ(SA+%H.P-2H'9!Y%KR$O\^:M"4!890_X[EW <#N$\V(;;WY$2@&7E8V=
MZ%REZ)UE%%252T!9A2(45>I"?J4%E5UA3\NH<&6DEONPDLJ#1>/+HL1B2Q/%
MHTHS)")*"B1#BRN%P<7-,H%%O7+^18OD?0O7*?@4[E?T+KRBZ%/XAX)/P1<%
MWP(B[YO_+V<3 /9A#387X7JL0.^L'CL# FA&JO"^I$8<\NMD(:=."S+K3:FT
M^DFTI'IG>GR=)S.V-D DJC:<'5X3QPFM2>4&5>=)!%25"_RJ&J6\*[ME/"L'
M9:=6K)5SK]@K[UYQ6=Z]_(6<1]EGA,AYE!+9[YS ^;\+QW\]]G^H%KVO'J 3
MJ4.*40MRFMB0T2R$U!8U2&HU@OA6*RJF=0HMLL6='M[BQPQI"14):HYA^S<E
M<WR;LKG>C2424QOK)=VGS1"Z3AN0=FY8+>/4L$O&L>&BC%/],QFGND\R3K7D
M/_R$-=B*=5\S=@Z%#M[7A-[5C-[3@MXU'=VW@PX),_@0VZ4(T=VZ$-%M :'=
M=E1PMPLMH-N+[M<5Q/3IBF1YSD@0]9B1(>;6623NW%G+<^R8+C&Y8YZD?<=*
M@5W'#H%MQSF!7?L3@5W;1Z%=*_D/>PIQ+F+-AS%[?ANNA7: >LPNG@&0VHON
M.0L@O%\<0N;(0- <#0B8:PR^<ZW >^X4RG.N!\UCKA_=;4XHPV5.+--I3BIK
M<G^^J'U_%=NVOXUCT]\O;C5[F&LY>QMOXNS3W(FS'G$G]OW)F]A+),:SM>+;
M.=0BS)[5!=#:C37 [%S,3IP+$+H _7\1"SP7\\%CL2*X+]$!UR5FX++4%IR6
M.E-3EGI2#DL#:79+(VF3EB;2K9=D,RR7E#$G+&EBF2_I$S%;LDS49,DH<D+4
M9/$#4>.%[]G&@T3,>,&_;$ %6X[]GHO979A;CUI8- \@;1#]?PGZ_Q" &VKB
MY-7B8+]&"FS7J,*D-?I@L]8"K-?:@>5:%Y@XX@T6(\&4^4@,93J21C,>*:09
MCM33#4:ZZ7HCBQBZ(QL9.B-'&#IK[]*U5[]E:*\B3.V5_[(2\Q?T ,Q$-6Z>
M#U"Q"/UW&4#\"H#@-0!340T=-@),'*6#Z58>&&^5 :.M:F"X31\,MEF _G9;
MT-ON KK;?4!G1RAH[8@'S1W9H+&C@E+;T4ZI[IA/*>]<2RGM/$ I[;A)*6U[
M12EN_4Q3W$+^83'FS\:^MV/-JU%'\S [:2U &.9ZH9).V09@N1/ "+5=:S\+
M5'_B@O)/4J#TDPHH'M(!A4.F('_8!N0..X'L82^0.1(*TD<20>IH/@B/UH/@
MZ$R0/#8$_&,[0>+8)> ??0[\PQ^!?XC\P]PYN!:Q[G78]\+5N [0PR.V 'BC
MBSONQOQ]Z. ' 32/ "B>H$#J- OXYSG NR )W ORB#J(7S! )@+GXF00N^@)
M[)]#D200_;D(6)>:@7EI'C NK07ZY0- 7;Z&/$/>_4/W0H"&H6]G0&F; "(Q
MVV<O]O\ UO\0@,$Q /63 /)G 007 ;B_4,"^R@36-2XPKDD"_;H<H& !W- #
MN&D.< LWJ+<]<&,4 G G^=L_RG07)_Q=+/2]]0AVZ-YEW+P]^(<FS"\=^78&
M%(7]]L6_XG@88,)?YS\ JN<!9"\!\*\ <*X#,&\#?AYR3P1_GPOP0!+@H0S
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M;.X%Z<W+0&KS-A!N/@O"34] N.$#"-<3ZCL#73@/L-[-V.=2U-$,['/T<H
MS'5#'[=#+37?C Z,7JRV T!NEPA([>&!<(\T"/:H@.1>'<0$^'NM@;_/"7C[
M?)!PX.Y+!?'])<#9WPIB^^:#Z+X1$-GW$W(3[_\ T;T?D<]_,0O[W38?GP>8
MG8-]3E@#$+P!P&,4P'X;YF.N+JJZZCX V8, DH<I$#\N"J(G>"!R0@I8)Y2
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M&%;$E021.)))W6)JUE"OA5K=;&T /V YOL,XM=91:Q.U=E!K#[4.L=V35+W
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MM]#B/2PT>Z\1-7IO$]7['!+5^9P7U_H\(Z[Q_5!<[?L348@>Y5_4NT/]BY'
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MI*" <Z (B"\&(DJI7T'O5TWO4ZL!YSI=.-89PZ'>'/;UMK"K=X5M@P\6-83
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MT6N?9C[.,(ZS 807GG,\X<]QD,^Q<\K_(?%9^NUSE_E*,W_V _(Y&I7WX8P
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M()9X+#,V*/> 2 ]I9?E3SS@JF9=24N2KB7P_?>3XF2#+SQH9?DY(\_-$JG\
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MI,<>0VULTP:\.@9+ZZC!M;3'/-&ZAA9?3:]>38\W?A_;P!/&W3@,KU<P_1T
M9_+\U BFM! _[?:+@,L&5SP\Z?#DP5$"1R4<]7"TPM&E]=3'.OQ82WRLH;^L
MAFTE)5SAMTO+_/9ISO^@EOK?H-F ^\!S6ASX@18'?:'%P?\&"[K?ZEUNOY"I
MY@RPF^<G,,QNQ9_C3(':$F+6ID"[-@0F:5U0AN:#\K4FN%2K@JNT,KA!*T+:
MM#RD1W,A@UH:.J$EH;-:'+92B\(V:CI\AZ;"S]!DQ,4:C[A>8Q'W:=3T'/A
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MW&W&'P/H6-NHBVW$YE8T]S;:8^O9?(:8V/(@>(/O?*Q^.#M '>U<QD?SC#U
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M?8*.^3,Z]T/4R0>H"D,IO8W">8M.\B:*[I<HL-<)&N\OMNY'OU^(JKM2SU(
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MR#E*#;D*W*V4X&?!^TH)^EP;X5@*YRCI5S<I1S.H-=8]>%W*]2)\<>%+OB5
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MTCSO&E V?$Z^GL)C/*^C*(X57G.)%(9)I@/Y53'AUZ!QZ]#]]4RNC=1%D['
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MZUMD5D,OOP=67X5< ]T'H5W*ZUGVSO4L^]BC8%O/,KT9Z0/E#8#R!H&&@D:
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M+N12;O XU%O%,"[^J:[41(WK;(QYY4;CH-UM&(/O.4W \;[-93[B*=4EA<W
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M?.IOWHG+?W%..]9IFEU8K5^BK70OUI?:=CIUX/\KM6EAJ9I0)5#A(BPEKK9
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M&V6YGL/Z'.<%2TYIBB/7BG<QS$1/EHGHI6)Y""9R5QX"P4CQX[OS$/P9QJQ
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M2X\Y"JV7>G(0\%TY"/2N' 2BGVSLSD' &R@!+ <APT K3]?3RU/UV8^DCL"
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M['Y&CM-'S7-Y205N#[[(Z\ED^=SI'+\[E>]WI8@"KB1)P)6H*'<E:,OM"?I
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MI#V1=NA*"OU 6P9C?RL^>V\+.6=/,RUW=W-VWJZF@KP=3:S\WNA:65^DO7Q
MWV#CP 'F+Z(GE* CYA6A4Y=EH?/7X7]?NBWEE[7[XK_?=N3L-[M/'K][X.SA
M+X]>.'#[U*5]GY^/W_/9Y83=GR8F[?PD-7G'QQDIVS\FI&[[B)RV]18M_<-;
M.>D?W"S,Z(U:W/V08.4 Q-+1+[KDK\$3BM!Q+]#0F:_BT%>7)Z,KWK^(;MAX
MZL\/MQR^OW/'_GO[=N_YY?"^G3\=/[#]Q],'M_YP_O"'WU\^\L'WB4<W?Y=R
M;-.WZ<<W?HL_ON$;THEUW]!.KOTZYU1O%/;U0RP-??N4?/)$=!$Z= P-G3PU
M$YT[)Q%]<^$Y=,4;Q] URPZ@FU;L0K>NWH[N7KL%/;!A,WITTT;TY.8-?YW]
M<-V?%[:L_2-^ZYK?D[:]_WO:]M7W<3O>^XVX<^5OM%TK?LW9W1M9*YY ))U(
MGR*T_P J.F)8!CIU7 +ZTI0SZ&O/'T&7SMN+KEJP UW_VH?HAV]N1'<N78?N
M6[X&/?S.:O3$BE7HF94KT0NK5J"7WWL'35K]-IKV_G(4MV892EJS%*6M?0O-
M7=<;H;FP/A3.B$$+7YN YK\W!\W>N@S-.K#I]ZSC^W^@GCM[AYR<\@D13[J1
M2<WN3,LN:DLIX#0G%@L:X[GBALL"2=U%L:SV@DQ1>TZIK#FK5=6<,:DC9VSJ
MR&F7NO*,3QT\ZU,]3(\9_A<QY %#T8QHM @8"MZ;B^8 0_;^3?<91P]\3S]S
M[DM:8NK'E$S*-0(EKSV3P6I)R^<WIC#%]4D<66T"7U%S6:R*7))JJB\HM57G
MM;JJ<R9]U=E2?>59ESYPWJWS7'#K'R8T'QB8P% ,#(7 D+MU.9J[9_/]G$,'
MOLL^>?X+^N7TC[+2:5?)I()6 IW;E)DKJD\KDM6DL)21))ZF*D&DJ[PL-51<
M4AK#%[6F\ 63.7S>80Y<=)I=(/NEAPLM&-8'+08&%C 4 4,>,.3MVGP_[\#!
M[W*/7;B=?3[C%B,EJX-&*&HAT_@-A!Q);6:!LCJM6%N9PC54) E-\ BSA.(5
MUN EG2UXT6+S7RJUN2Z7VDI!YOB'"RT$!E8/ W/57#1_RW*T8,?F^P5[#WZ7
M?_C"[=PSF3>S$QGM=%QQ$XTJK"-ERR/X?$UE!M,03N.8@RD":WF2I#20H'0$
M+NL=@4M6ARO>9K>#S/&V4D-"Z4.%%@$#&QC870SST(+-R]&BK9OO%^TZ^%WA
M@0NW\T]DWLB]Q&C/3F,UTLGB6BI#647*TX7Q1>9@!ML62!4X DD2IS]!Y?1?
M-CK=\59G:;S584ZP.O0)-KLFT5;Z,*%,8.!,CT8YP%"\<AY:M'$Y6OSAYOO%
MVP]^Q]Q[X7;1D<P;^>>RVW*3V W9^)((/4O=%9\C%MK*<2Q[5UP.B\DEJ%W>
MRUTQKC)3@J5,EV!UJA.M#D62S?XP_8N!^VHW0_'ZY2A[TZ;[G"T'OF/OO'"[
M>'_FC:*3V6WYE]D-N>F2ZFR*)DS/-I=3"DH#^&*G+XWO\B9)/=X$G<<1;_*8
M$DQN;:+9I4RR.&5)5H<DV69_F-!B8.!B#(LFH*P5\U#6VN4H=\.FWWF;]W_/
MVW;^-F=WQ@W6T>RVHG/L^OQD:74N01O*H5O*:7EV/Z&HS)O.\[B3I/ZR!+W?
MU!6#,GH426:W--E2)DZQ.H0I-OO#A+* @0<,/(SAW7DHY_UE*'_MQM\%&_9_
M+_S@W!>"[>DW>0<85]@GV0W,RY+J@@QM*(]J#3!R'%Y2H=N=SO67)<F#YD1M
M4)VD#\B2C=Z2%)-;F&HIXZ=9'=PTF_UAZF+@8PRO3$#9P,!];RDJ?'_#'^)U
M^WXHV7CVRY(/TVZ)=F6U\P\7-W#.EE07)VE#A01+((_N]%#SO,X,3J@T65FE
M3E972%)TY<)4@X^79G)STLUEK RKLSC#9G^84'8/ Q]C>.=%E+]R*2I>M?Y/
MR?M[?I2M.WU'OBGE(]D6:J=D7U&3Z+@HPKNH#K/3S8%BJM/%R [8<*R()D56
M)TY35?'2M4%VAL%7G&GR,'%F5R'.ZBS V>P/4Q># &-8. 'E (/@W;=0R8IU
M?\E7[?Y)N?KD7?6ZI$\TFTC7U#OR6Y0'>76RT_+*DD1#N0!O+RNB!0U9K#HA
M3M+(PBNKBV"H%!#T_GR"T9-',+MR"19G+L'J>)A03@^# &-X^T54]/825/;.
M6E3U[LY?M"N/?VU8'?^Y>2WNIF4SH\.ZF]EL/2JLLUZ2^]7)-H. $!05YM45
M,$J:<FB*2#95$V90]0$&Q>AE4$QN!ME2QB!;'0]3%X,08U@P >4NGX>6+'L3
M52Q;@VJ7;__5^/:1[VPK+GQ9MCKU$]]ZTLWP=D9;Y?&"L/NLS&J.MTH5&>4%
M GHMA2MN(A7(:\BYZ@I*MJZ<PC#X*'23AYIE=E%I%N?#A'+!QQ$!@Q 8^$OG
MH=(EX'LO68T:EVR]7_K6@1_=RT]_$UIY^;.Z#<G7V_:EU=0=R7.%3DG499<L
M;/"_J2IJ)$W.JT\7*&HR6>H*7*$VB,_7^PFY1B\QV^PF,2QE#Q/* P8QQO#R
M!%3XYEQ4OG@QJGM]%6I]??-]]^(]WX67'OZ\<=6)&S?67*KM_)#D:=A7I N=
MDHI<":9""\Y-U)+#2:J"ZGBUHBH)_/U4KC:8SM(',HH,OLP"DP>79W8]3"B_
MAT$T?P(J?GTVJGKU-=3TRKM_E"U<_T/HU2V?-[ZUX^J-I4=K/WXGV7-E?9:N
M9C='5'Y240P,N59\&<%("23K<D/Q.D'HHE83BI?J@HE"?2"9:_"ELHR>M"*3
M^V'J8BB9%H6*@4&Z:!:J>_D5U/[2TI_*7UIUN^&5-1TW%FV+?+[XE.?6TG1=
MR[H<460WKQ@8<MT)1IH=9\=9R.X48P[XVFS_1:/4?TZO#UQ4Z/V72PR^!('1
MF\0UN1\F5 @,DJE1:,F+$U#%_)FH><[\W[RS7O^R=LZ2CAMS5E7?GK_;?>?5
M\_H;;^%$S>MSF9$]O)S@*5F6-U%++,LPI]E)]D0;O>RRM=!UT2IPG;,HW*?,
M)L]9C<ES06[R7"HQN1\F5 0,TF>B4,F\":AV]@S4\=R<;RJGO]1Y;?K"ZMLO
MK'7_\.)^_1>++HJN+\47M6S,R:[=QZ96G!$3RQ,5Z=YT;9*;8+Q41K.<=^19
MSSK8MC..$NM)A]IVS&ZQ'S?9[*<T#Q=: @SR*5&H=,YXU#QCRD^!IZ=?;Y\X
M-7+[F=?=/SR_4?_CBX=$MU^[5'CC'1R][0,ZJ>% $3YREIM6&2]*#*5*L7,'
MY_P4]6EOMO:$MTAWW,/3'?/*=$>\.MU!M]UPT%'V4*%28%!,'HAJIH_^HVSB
MN$\:AX^M^6SL<^X?IKRE__/YS:(?YQ\J^O+-"UD?O9=&N+J5G-YZ*#NY\73!
MY;I+K/.19.Z9J@S!R4J2Z%A%5LF1<)[D4(@E/1 2@A32_6&39$^P3/8PH8JA
M"*IZ:B!JGCCLJZK8(76?Q([T_#!FEOZO*<M$Z*S-13\M.I#UU=NG\9^M3TB]
MM2,]X=IAXH6.4]0S;1<8)YH3<H\VI>4?;L 7'JBG,O?591?OJ2UD[:[ELG?5
MBCD[:]6<';46]L.$_E_LO%=44VOWA[NH8G?;R[8K=E$149'>>PT]"24)"4DH
M 1(20DCH)?3>>^]2I(DBJ%BPH6Y%$0$%!07$7N=9[O\>YPK\;L_%&8QG,+B:
MSWK72M[YF^-=5"Y'H'KC@MF+2Z5N]2^2[)Q9MK'VUX8C^6C^3X9C9E%?E'%!
M[_3)_F\L/5BO\,S?[T'0AFD\RA!#0!KT#79^ZA_J^"0P'#\0%H%]+(RR>Y0@
MM/DG+=KZ84ZTU</B&,L'5?\3J%V*_#X3TW=-2J3ST<*%-3]7_)T/?\LDPS[E
M*) W"/RE:<G]:H+S^6!#<'N'IY"G"'3"I*N'XX2'%_Z5CP]VG,.R&POPM7D9
MS+9^$?'O>P^8D41_BY$TGMEP#L]TN#C@?_&N40JY=5$2.7]K@4C-\P6+\V#E
MWTFP[4 DR)P4@*(Z!W3UO<#,E/;+RHKX'6OG^-49A_M,=K#[2'>R_L @6+YG
MD3"S?B[F[_ADTYE@BLE,A*OQ= S5:"J19C"53M=_F^OVO[C;*H9T7)9 JA^*
MB>1^6;PX$=:NCX!=N_AP7(8-JO(>H*-$!F-U)\!H8\%6WP8<#"V!:&(.KJ:F
MX&9N# P+(V!B#'[Y6>K_#+#2_1ELK?,CW$;[>[2MUO=$.\UO:?;_B_/GQ9#J
M/A$D9P@128"E4F&P824/]FWR ;F=-#BSGP#J,CC0.VX-)O(68'G:%.S.&(&#
MDCX05/2 K*H#-#4M\%#7!&\-#?#55 -_+540:*M J(XR"'45(5[O?U%S&4%R
M_D&0V(^(2"@L%^?"IL6>L.LO%SBX#@]R?]N XG8+T)0V!OU]!F!V4 >L9+0
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MO)YXAWPW\8KKG:1.ZIVD%MJ=I ;ZG:1:M[N)-7\ _%>*@-_?8L"560I!9S9
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M;O[:>F+'U"5%Z;$^;>DG_09R-VY:Z'9>MK>K[W2F%;6X<M+.>H8)J]B)@K+
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M35"IWDFHUY.'3GUYN#0O%QH0I*830?+Z$"3A&8)$P%(1 6R48,'.)738OXH
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MMHVT#S;GZ1^LK[K-6MUWG[(:<1^S&7,?M'_MUH^=<._#37I<Q<\/T% '"NI
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M/4&H\'_E>(X_AN\-''1\\N\<[B+I:4@+^4E(O>N3D&KJT^!RVF!0"6TP<#Z
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M^0E[R_HS]L8\@ /J8+]+#"QE),#AF!2X*JP =XV-X&&T$]RM#@'5\02XT)3
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MM=1,4B6EQ+7,I8%6[-+M5N#RW"V'\I:>[CI%2Z%.NR;29B@)M'<N<;19TER
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M[O"@TZLC T[OCO(_<RO2]]2':+]#7^("=HW&!VT930C9\/D_81W K2Z ,_T
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M..BWW Y]!QW09Z,C>N]R0N]CSNAUV?F+UWV7CUZO7=YY?W-^Y8VN#_R0?RL
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M74)=IT86L%$>/K<KP[,N3<;=Q4;,ZXLYPN>Z/>2/=81H[VN--]_6F&$_4E_
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M 7NZ[7WWK';TWK.+Y[7G%T?/7>^</':@B\=6=/4:05?OM?]V>QK :9K!WB4
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M,64_![I>H%P ;:*.PJ""$C !94 .)X TK442-4$,]4 $34 0K8!)<P%:"V
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M:]:3;!?!/S,#Q&ZEQ<I>3<Y0OIA0I'DNME+W5/0,P^-1<TR/1,RW.!2^Q.I
MV(#-WM -W-VANVUWAIZRVQ9ZUVYSZ%O[D3!T6$^&PM%^( +M5D:B[8IQT(?F
M'T9]+XYZ=]I8YZ+UY"O#VT)MQI,B4^:=0GOVK_G>HA=S(V3/9*:H'$_+TSJ<
M4FJP/ZG&9$]"@\7.N#;K;;'=W,W1R^TV1JUQV!"UE3<<><1I3>0-I]51+YW[
MH]&Y+QJ=>F.0MR06'1?&H@.Q_Q[ZT_PCJ6LE4=?)IG442,'G$CGXJU09[D[1
M95POLV']--E#Y&11J.SA_ 25O;E9VCNSB@RW9E28;4RMLUJ?,IN[-JG#?BAQ
M,6]5_(!S7_R(ZXJX_6Z]<9?X2^+_<EL4_\UM80*Z+DA$Y\Y$=)J7B+SQ,(CF
M'S,V Q' /%'*%X<W99)POU(&;E2IPH4J"^;)2E>1@U,"979/BE'96I2FO3%_
MHM%P;JGY4':US4#F++N5Z6V.O6G=SDM25K@M3!YV[T[>Y=&5?-:S(_F1Y[R4
M+^YS4Y'?FHJN+:GHTIR*SL3I>Q@RM@_4M3*%X'.A(#PL$X3?I@K#C1HQN#1=
M$4Y--V4>JG42WEWE)[.E(E)Y?6FR]E!)CM% 4;'%BOQ*SM*\.OM%.<U.W=F=
MKIV92]WG9@QYMJ5O\YZ3?M*[.>.^=U/&9\^F3/1HR$3^K$QTG9E)KS"9Z/P]
M#),"3*3>G<."OTJ8<*N"!5=JA>#2#.K^,^7AR"PCYIYZ1Z&MTWVDU]>$*P]6
M)FCW3<DT6E9:8+&HI(RSH*C6OK.@P:D]?ZY;2]XBCZ;< :^&G,T^]3E'?>MR
M[OC6Y7[TGIZ'GL1]6BZZU>:B*W'Y'D;064AFP=>) '=*J?=6,^&G.@$X,TL8
MCC=1]Y]MP-C>9"<X,LM3:FA&B%)?;9S6TJHTPY[*B>;SITSBS"VMLF^95._<
M5-SJ-JNHV[.NL,^[MF#$M[K@H-_4@M_\IA:^]YE:B%Z5A>A168#\RGQZM<U'
MU^]A%)W%5(#7A=3]*ZCW3F/"Z5EL.#9;$ ZV2,/.-EW&IA:NP-IF=\G^QB#%
M9?71FCUU*0:=M3GF;57%-LV5%?8-Y75.,Z8TN]66SO><.GFY3_FD]7YE)?O]
M)T_ZE;SUG3P9O4HGH4=I";J7%J,;<?T>QM!9R !X0-W[%^J=Y^H9<'PV"PZV
MLF'W7$G8TJ'%6#?/6F!5FYM$;TO A)[9D1J=#4GZK?599DUU!=8SIY793:^I
M=:JN:G*KJ.SP**U8YEU2OM:OL'R/?T'Y%?+:MZ <O0O+T;.H#-V+2M%M/(RG
MLY -<)?VX5(MP,D&ZCPM3-@]CPE;YXO#^@7J,-AER5[>Z2RV:)Z??&=;N%KK
MG 2]IMD9)O6-$ZUJ9TZVG5I?S9M2-\MUTK2Y'H6U2[PGU@SYYE3O\LNJN4A>
M^F;7H%=.-7KF3D7WO IT&P\3V?!AXC_[<'X&]<YFZGUS ;9U,6##0A$86J0"
M*Q>9L1;W\$3G+_"6;9L?JM(T+U9G1GNJ44UKKD7%G!).Z>Q*AZ+&>N>)#:W\
MG)D+/3/J5_NDU>_P3:D_3U[XI-:C5UH=>J1/0_>,&G3+K/X1I@ \+J*S2/MP
MBF9PH(UZ%_7?D84 @TO9L+)7$9;T&C.[EMD+MRWQE&Y:%*PTHR=:LWI!LD'Y
M_&RS21V%UH5SR^URVZ?S,EOGN*:V=+LGS1GP2IBSS3MNSEGON.9G7G'-Z!G?
MA.Z)LY"?7(^NR3-^-'86[DT&N##]GQGL[@381/E#2P&64_]9-" '70/ZC/9^
MKF!3'U]BQHH A:K>2+4I2Q-T2Q9G&.4ORK?(Z2FU2>^NM4]>T,2+G]_E&C._
MCQ_9N<4]8OYICXC.I^X1'<B/F(=NT:WH&M-,GXIF_^A3[C_[<'H6P'[JWUNI
M_ZZE_)4K 7JH_\Q;*P6MP]J,QK56[+HUSJ)3AWQERU:'*14-Q&GD]:?I9?7E
M&J>NG&21N+S*)K:WP2YR6:=CV+(53B%+-[D$+3OI$K3TB7/08G0.6H3.P=WH
M'-J)3F'S?O24]N%G.HM'YP#LI#U83_VSGSKX8NK <ZF#-FX2@_K-JE"[V919
MN<E!:/)&3XF"D6#YG W1RNGKDS62UV7KQ@\7&T:OK30-7S/3,GAHGDW T');
MOZ&-=KY#)^Q\!A_;>:_Z9N\]@/8^*]'>;QG:^R_YT=TI0*]' /OFT1XLHOZ_
M'&#I*NJ_8_G4 :MWL:%BMSR4[M9G%.WFL/-VN0EG[O*73-D9(9>P(T$I9D>&
M6L3V JV0;>5Z@=MF&/IMG6OBO;77S&/KB+G[UN,6[EL?F_,W?;-TVXC6KAO0
MAK\&;=P'?W259G"D!6![#_7_7NK?U,'G#P/,IOS:G0"3#K @[X@DY!Q5A\RC
MYHR4HX[LA*->PC%'0L0CCL1*AQY.E0\\/%'1[W"9BO>AZ>H>A]JTW XMU7$Y
MM$'7^? Q7>=#CW5Y![X9..Q#(_N]:.RP"TT<=J#I]TXWTCD<VX-E= ;Z 190
M?O-8_BZ R0< <HZS(/&L,,2>EX.8GW0A\B<;1MA/KJS@"WX"_A<BA'TN)(IY
M7LB6Y%\HD7:]4"/G=&&.@N.%Q8KV%]8IV5T\JF1WX9$2]_RHJLU95+<^@YI6
MIU';\M2/#M >;!P[ W0/]*P%:-D$,&TL_R#E4P]//,>$L,M"X'M#''QN*8'W
M+4/P^LV6X?X;G^GV>R#+Y?=H-N^/5$&'/R8*V?Y1(<*YW2!F?7N!N.6=00F+
M._LDS>_>EC3__:.4Z6\H:W(+Y8UOX 2C<;:.G0&Z!Q;3/=!*^=/'\@\!9)\"
MB/\)(.1G *^;;'![+ $NCQ7!Z8DN.#ZQ +NG#@SN4P^&]5^!3,MGT2SS9ZDL
MD^<%;*/G4P4,7C0+ZK]8(J3[<D1(Y]4I(9V7SX2T_T(A[:<HK/44136?H-CW
MUM ]L'00H'TC0-U8_F& K#, <=3#@ZX!N%,7=[@'8/M>'#@?Y,'J@P98?#0$
MTT]68/3)@6'PF<_0'?5G:(]&,#2^)#/5ODYDJGRM8BE]:V4IXG*6 FYER^//
M;/EO;]ER7Y E]YE\^E$OW8/S1@!F4'[I$<H_"Q!#U^Y_ \#U#P NY5N\'?L>
M0!2,4!KT41%TJ/-KH@&HH3E0T0)%= 9Y]&+(8@A#&N,9DIC+$,=*AABV,$5Q
M!5,$MS.%\2I3"-\2_)?.#0 S*;]L+/\<Y5\%\*-K=[H+8/40P/ Y@"X":"&;
M,L4I4P8FX 200U6006V01$.00 L013L00E=@HQ_0AW22P0 L([-)+]E"SI G
MY,T/&NC^FT+SSQ[+OP[@2]?N>!_ _ EE4[[:5P E6H,"D:%U2*$894J""*U%
M$!6 A2J4IT4,B 6Q)^XDF"01>A'$F81N?EQ#]I"C/T ]2P;J$R-B:,U /3LF
M:KDR4<6?A8HQ+%3(8J%<*1MEZT@+64!Z!5!V%5DOB+);R1YR5!#E?A)"N3_(
M4_*>X!C!O\G3<WD4IN?"J( B/]"W8*"Q.0--S<C8<PX3]9R8J.G#0O5(%JJF
MLU&YF(V*-62V "IVDB6"J-A'U@JAXB:R4Q@5#PFCTAERDSPB;\E7853&_Q$A
MHJB$8J@RC@'EFU'_MS!BH*4) \TMF6ALST1#3Q;JA;%0)YF-6OD"J%%)9@FB
M1KL0:O20Y<*HL5H$-=:3K62?*&J<(#^3^^25*&I^$?VFB:)?-5'LBR:*?]%
M"7J4_*#](S2A7$L#!MI0_^;HT^/8]S)CWTNYL= \B(4F\6PTRA% @U)!U)\N
MA/ISA%%_/LUOB2CJ]XFA_AHQU-LDCGJ[Q%'_,/E)@IJ^Q!?]%Q*?##Z+OS=
MB7<&*/56'Z6)S&L#E'UF^".TH'PN]7U[ZM^.V@QTH'4XTBP<:#]L?5G(B1)
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M?\BN+?ZF?4O\&[LY"<AM3D3.[$2T;DI$J\9$M/S>W_M ;[6CU+?N4N^\7L"
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M^J\%'^E_$WZ@AZ+W]%'L3WT4_U,/Q>^2.WHH\3]HH4&WE!*@[01"G=N!UN-
M>V)/^\%U8Z!-(!,MXUBC%EGLC^8E['=FU0)OS&8)OC)K$WQAMD#HF=DRX;_,
M!H2?F*T3?FRV5?BAV0&1!V;G1.Z:WQ7^W?R5Z$VS;^+7S%'RBAE*739#Z4OD
M OG)_/]#&V5 >^K>/.J^SK* ;O1G/LW"E<ZJLR/C,\^;^=8A@O72/H7]EUV^
MP&/;*8(/;*<+W^/.%K[+[1"YS5TD^CMWA>@MSI#8#<XF\>N<O>)7.:<E+G/_
MD/B)^U+J#/>K[$DNRAWGHOQ1+BH<Y:#"(7H\2'_^'[2C:W>BWNLJ0;>T%* /
MK<>']L3' -Y[V3!>>+@Q'O.#6/?<XME_N&8)WG0I$;[N7"5ZQ7FF^"6G5HD+
M3EU2YWE+I,_R^F5.\];)GN)MESO!.R)WC'=5_I#34X5]O%'%W3Q4VLE#Y1UD
M.SW?XH1*F[^#CF/7/I9/G<^/NF<@K2=( =X%:<+3 !.XYV_/^,W?AWG5-Y)]
MT2=5^)SW1+'37F42)SQKI8]Z-,@>]FB3.^C>K;#?O7?"7OZ@XA[^)J5=_'W*
M._CG5+:Z/U#9Z/Y!;8,[JJ\C:]U1;<R@.ZJN_@ZZ4*;'6#YU[V!AP# Q^!0N
M!4_#%.!.J!9<#[.&"V'NS-.A(0+'0A)$#@5E2>P/+)+>$U AM]-_NL)VO]F*
M6WWG*6_V7:BZT6>EV@:?88UUWCLTUWJ?T!SRN:VURN>M5I\/:J_P1:WE_]!<
MZHL:2[Z#?)J!#_6](("/$4QX%,V&.]'"<#=: JY&*\.Y6#,X'NO,/!@3(+@G
M.EIT1V2JY):(/-F-89,5UH=6*0V'U*NL"6Y17QTT7W,@:)E67^"@SHK S;J]
M@8?TE@9>UU\<^%*_)PCUNLF"(-3M"D*=SF#4_AYZB/[S%A-.78?>9GY+9,#5
M) &XG"@"9Y/DX6B*$>Q+<6#N2/81W)P8+KHA/E%J;5R6W&!,H>) ]!25E5'3
MU)='-FHNC9BKLSA\H=["L#Z#[K -AO/#]AEUAETTFAOVEU%[^#?#UG T(/HM
M$:@W)P)UF[^#WM2[ P%>1@/\D0CP,_6-<^DL.)4N"$?396!OEAYLS^(R-V9Z
M" RGAXBN3HV5ZDM.DU^>E*>T-'&2ZJ+XJ1K=<?7:7;$M>ATQ709SHY<;M4:O
M-9D3M=-T=M19T\;HQZ8-T5],9L6@$3&<&8/Z]3&H]SWT90&& CRDSO<KY9_/
M CB1PX##.6S8FR,)VR9JP<A$:^::/#>!@9P T17945)+,I/E%Z9G*W6E%:EU
MI)1KSDV>IM.:U*3?G-AAU)BPQ&16_*#9C/AMYG7Q)RVFQ3\PKTWX;%:3@"8U
MB6A$#.FY074"ZO_/V#Z,1@#\29WO<B;UK3SJ?-0Y]A0P87N!!(P4J<.:8@O&
M0)&S0&^!G^CB_'"I!7D)\ATY&4KMV?EJ+9FE6K,SJO\/8><!%M75A>OO3*,,
M#+TC2K50;& #"R@@O??>$9#>%&F*@F+OO??>N['&)$;3DS_=F!Y-3$S7F.S[
MC6!B_OO?YSYYWIP9@N?;:ZU]SMG?<L_$N2-GEEM[]OR!+5FKW)LRMWE.RSPR
MN"'CVN"ZS$_)0\^Z+.%.!I(!=9G"[5F>UN%C^O];1?0:95SK5]#[5P*'*O2Q
MN\H6VZK=I0W5HQ6K*P/UEI5':19-33;O+LVV[IQ29-]17-&OO:C!N;FPS6UZ
M_KR!#7G+/>KRMGA5YQX:7)E[>4A%[NTAY7F_>57D"0\RB RHR!7]GT7[URWW
MM'5@#EZB][U([5/T?H=K@3VU.MA6;X6-#0.DU?4C%<OJ G07UH1KYE8EF,VN
MS+!N+R^P;YE:UK>IK-:YL:39K79*Y\"JXJ4>Y44;O<J*]@\I*7INZ)2B#X=,
M*?K%:TJ1\""#2HK$P))",8#T?XJ(YES0SD7Z_^?I?<]1_U@#O3_]W_9&.39,
M-\?J)E=I69.W?.'T"3IS&T,-.^KC3-OJTJQFU.3:-5:7]*VKJG:JKFARJRB?
M/;!LZF*/*67KO0K+]@[)+SL_-*_LO2%Y93\/SBL3GOEEPCV_5 PL*!$#GN5/
M+K<^8QU>X=+O<A5S0/U#3<"N9GH.LKK%!,O:G+"P;:AL;NLX54?S9(/6&3$F
M3=-3+!NF9=O6-!0[5-17.I;5-;I.J9TYH+!FH7M>]5JO[*K=@S.KS@[)J'J+
M_.B5624\,BN%>U:E&)A=(09DE__# ^U<R*7OG0I<J&,.J+^/_G/K3.JWT_?,
M,L*"V7W1-=M+-JO#5]DR*U!_>GND45U;HGE5:Z9U>7.A?<F,J?V*FNJ=\Z:W
M]<^>UCTHHW&U1VK#3J_DAM.#DQI>)P^\DNN%!QF44B<&IM:* :3_4[Y+ ?ZC
MK0-S<(9+ST/4W]D!;)A#_4Y@WEP#S)EGAYG=[E+SO%&*QKD!NK5=X885G?&F
M9;/3+(L[\FSS9Y4ZY,RL=<QH;W9);9L[(*EUY:"$ENT>L2TG/6-:7O&,:?[>
M([99N,?.$ /CFL2 ^.FB_[-\G0F\QFOQ4CU])Y?A^V8#6^;2^W;3>],'SEJD
MBY;%5FA:TE^J7^(MKUX\7C5U48AZRL(8HX(%*6:Y\[.M,KN+[=+F53DDS6UR
MC.^:XQ+3N;Q_U)RM R/F'!\4-N?FH+#9]P>&=XB!X;/$ -(_HEVX13[#'>WU
MP&OA'&MPF/'OG$?ONY YX%*\8QF]UPH9ZE:9HGJU$RI6#Y&5K/)5%*X*U,U=
M&6F0M2+1*&UYAEGRL@*KA&7EMC%+&_M$+NGH%[9XB7/(XBTNP8N/N@4NON$6
MN.@[U\ %PC5POG -ZA8N0?/^S;N<BU?K>WJ!VC[8ID7:'A1K0'O4LI;>@UZP
M=),&Q9OL4;AYD)2[>:0L:Y._,FU3J&[RQEAU_,943<R&7-/(]:468>OKK">O
M:[<-7+>H3\#:37TGK#W<;_S:%_N-7W.O[_C5HM^XE<)QW KA.'[YO[G%')SG
M_#_<Q6N1^FN6 PM7LP;4;M@,3*$7S=ZEBXS=YDC;XX*4/4.EQ#U^LK@]@8KH
MW9&JB-U)>J&[LPR"=Q5K)NVJ,?'?V6H^;N<"2[^=&ZS&[#QD/7KG"]:C=]RU
M'K5-V([<(NQ&;A;V(S?]FVN-S 'GP![J;Z E6\K8YVQB#>A#RW<#N;1H"8>!
MZ*,:1!ZU0\2Q 0@[YH.08^.EH&,ALDG'8A7^Q])4XX_EZ_H=J] ?<ZS)8.2Q
M>1J?HVN-AA\[8#SLV//&PXY^8SST\%^F0PX*\\$'A,7@_<+R6;3]R(.L_Q;J
MKZ3^7,;>3$M611]:< A(.0Y$GJ('/*_$A LF&'_! >.><X??<R/@>]$?HR^&
M22,OQLM\+F7)AE\J40R]U* <?&F.RO/2*AWW2WMU!UV^HCOHTE<Z R_\J3_@
MO##H?U88]C\C-,]R=#ZP@_E?0_T%6X#674 U;7+A,2"5UC#J'#")?G3,-1F&
MO*0+KQLF\+S1!QXO#X3[RSYPOSD!@VZ%8L"M1/1_)0=NKU1(+J^T2LZO+I$Y
MOKI#UN^U"[)^KWXNZWOKD=SA9:%PN"&4?5X2JF?93?WUU%],_9G,?2UC+SH)
MI)UG_)<8_U5@-.WRX)M _]<4Z/N./NS>-X;=![:P_< -MA\.A<U'?K#^:#*L
M/TZ U>U<6'Y2#8M/9L/\SEJ8?7H$II^]"M-/?H;IQT(R^8A\(&3/LI'Z2ZG?
ML:>G!U7,V-,8=^0U(.!%8"2U/5\#7-X&[.G)+6XK8?Z-!J9WS6%RKP^,[[E!
M\^T0:+X; \/[05#?CX/^][G0^Z$6N@_F0N?'S5#^>!:*!Y]#]N!/R+X7D'_W
M;U90?\Z>GA[4E+/4OP)$4'L"M;U?!P:] SA2V^83P/1SP.@'"88/]:%^9 2]
M/RR@\X<]%(]=(#WV !Z/) &$#\+'.<"?O/D_9K$?\^)Z?)G<(X(__S=SJ3^-
M^B6L>SICCZ3V>&H/^P]S_Q'0YPYC_P+0? WH/P!T_P240@Z:_-[^@RFQ(GU)
M?S*4C.O=@\&'H> XQ(+>W@,#%%^1Q__JP\S@W"MC[3.N4_]5ZC/NH=1V_12P
M_1(PN0L8W*?NC^#O_S?*9WHAVK%8$\?>/LAH$DHR"!<$@OD0S(<X0]XB'_^-
ML/: L!E(!D!8N$,8#X%0CY*$?)(D$$,R21EI)#/)?+*<K.<PMI+=Y! Y29XC
M+Y+_D*_(3^1/\O_YQX[Z?=P@[%TYCOX09AR3QIOCF" )W4A)*-,XGF))R&I)
M*^DB2\AJLDD2T@X(:3\Y2LZ2:^1UGOES\H \QF..^+&,R(E"2(^5_T;TI;XC
M/6X_1P@'9^9%.P[FPL1/$II021@F24*=)PG]"C*==) %A+G07T>VDMWD$#E%
M+K$\-\DG^$/_>_RF_PB_J(7TBX&0?C9\@NR_$4[4=Z'?=Z'/=>+1@>_MM?49
M!6$9* FS6$F8LA[&):2.,!?&S(7Q8K**;"0[I#^-]TN/C8])CXPO2 ]-7I)^
M,?E(>F#RG73?Y*'TK:F0W3,3LKMF0O[-_T"X47> -;&$<-/"]VZ<&\ZL1[\)
MK%.$).Q2)&%3(/UE4RD]MIXN/;2>)?UF/5_ZU7J9]+/U6NDGZRW2 YO=T@\V
MAV7W;<[*OK.Y+KMK^Y[L2]M[TJ=V#V6?V GYQ_9"\9&]4'[8RP?/( ;90'B:
M$9,>O+3OF0L/+XB!8SB>8.F12[STJW.V]*-3J?2]4YWL.Z<6V3VG3MDW3HMD
M7SFME'WAM%'VN=,.V:=.!V1WG$_);CM?E7WD_([L79>[\C=<'BI?=16J6ZY"
MYV57H7M#B\N_$5[FO*3IO8?1^WIK('SXWH=U&=X?CX9ZXZ?!_KCO&2E]XY$J
M?>%1(/O4HU)VVWV:["/WF?+WW;OE[[HO5;SMOE;QIOM6Q>ON>Y6ONA]3WG*_
MJ+KI\:KJ1<^O=*YY_J9WV5/H7_04Z@N>PN"\%@]A<.X9Q%#&[F, ,8*^<XP:
MPH_C\;7 [Z/[XON1[OAJQ&C<\0G&AS[QTML^V;+7?4KDKWC7*&YZSU#>\)ZM
M>M%[@<[UX<MUKPU?KW=E^ Z]R\,/ZE\<?D9]8?B+ZG/>=]2GO'\R/.XMC(Z0
MP]["^! YR-?/(GP8^RCJ^\D@)J@@_-5XY&^$[\9;XC,_)[P_=BC>&.>/F^.B
M9"^.2Y5?&YNOO#RV7.>B7[WN>;\6_;.^G>K3OHL,3OFN,CPQ9I/FV)@]1D?&
M'#<^-.:*R<$Q[YGL]?W>=)>O,-OA*\RW\[B-;.W!]"EB%+V_7\\6MU\"Z?^#
M9+A#+_Y9@"'>GFB#FX$>N![L)UT.#I&=#TI0G G,4IV85*QW;&*5^O#$:88'
M ]J-]@?,-=[KO\1TM_]:LUT3MIOOF'#(8MN$\Y9;)KQFN='_KM5Z_\=6:_V%
MU>H>+%?Y"XMG$;Z,?3SP, CX@M[SPTAZK@@%7@_5PXU0<UR)Z(_SD2.E4Y&!
MLJ,1T<I#X:FZ^\+R]'>'EAGN#*DUVAXRPV3+Y ZS3<'S+38$K[!:%[3)>DW0
M7IM50:=M5P;=L%L6]*7=DN"'=HN"A>W"8&%#K!?T8/44,4[VI+U]C_H?Q0"O
MQ]/OQ$NX'JO$Y1@3G(ESPK&$X=+!>'_9WOAPY<ZX1-VM,5D&FZ*+C#9$59BL
MC6PP7QW9:KDRHLMZ6?@2FR7AZ^P6A>WLLR#LF$-WV/,.<\,^=>@,_\UA3KCH
M,SM<V,^.$+8\VCR+F,#':3!SP,?MVXG4I^>YDDK/E2S'Z20-CJ0X8'_J8&E7
MZEC9UI00Y<;D.+UU26D&JQ+SC5<DE)HNC:^Q6!379+4@ML.V.V:!?5?,*H<Y
MT=OZ=D0?[C<S^K)C6_1'CBTQ/_=KCA%]21]B3^R([5,$'_<_\/%VF_&_0NUK
M]#SG^<@]R>.1=#7V9=IB1[8[-F>/D:W/"E2NRHS66YZ>;+ X+=MX06JQ67=*
MI657<H/U[*0VNUF)<_NT)2[OVY*PR;$IX8#3M/@+SHT)_W%N2/C1J3Y1]"-]
M21]B3^R>(C@/O^4<>)_^_R7J7J3W/)5/?7J??3FZV)YGA4WY ["V8*1L9?Y$
MY9*\"-V%.0D&\[(SC#NS"LPZ,LLLVS-J;5K2F^UGI,UQF):ZI%]#Z@:GVI2]
M+M4I9UVK4MYPK4S]P;DB53B1?I6IPH'T(?9/T6X]_2J6\Y#^_WGJGZ/W/%8,
M["<["I785&2.M5-<L6**MVQQ\03%_*)0W:[".(..@C3C]OQ<LY:\$LNFW&J;
MQISI]O79'0XU60L=*S/7.I=G[G8MRSCM6I+YBMN4S/LN4S*%4TFFZ$?Z$@?2
MYRD/68?/Z+U?9?XO%S ')?2]9?3^9%.)A#6E)E@^U0F+RX=*W5/'*CK+@G5F
ME4:K6TN2C6849YLU%A59UA=5V-04-MI7%K0[3,V?[UB2M]JY.'>G:V'N2;?\
MW)OD6]?\7.%,' MR15_B0/H\Y<=PS@76X09S<(&^[U@Y:T#OM96LX>MEE<98
M5-T7\ZJ]I#G5OO*958$ZS961ZNGEB9KZJ9FF-64%%I6E4ZVGEM39E4QI=2B:
M,L^QH'BE<V[1=M?LHN-N644ON646W77-+/K+.:M(.&85BK[9A<+A6;Z/XEQ(
M!ZXS!V>GTO-5,P=< FZH!99S";:@UA!SZ^TQN\%=:F\8)9]1/U'56!>N5UL;
M;UA5DV927IUG7EI5:E5<66-;4#&C3VYY9[^LJ<N=,LJVNJ26'75-*7O!-;GL
M:Q[_=$XI%8ZII:)O6JEP2"OYAWMQ/3W)*\S!R2K. _K?;=.8 [*@ >B<IL:L
M)FNTSAB IAD^LH:F"<J:Z2&Z%=-B#,H:4XR*&W+,"NJ++7/K*FVR:J?;I]?.
M[IM:L\0QJ7JS<T+U89>XZN?)5RYQ58^=XJM$O_A*T3>A4C@D5(@^3_DBJ:<G
M^1QS<)3Q[V[B/&AA#>B#.TE;JPYFM%F@L=T%=3.'257M8Q53VX)TIK1%Z1>V
M)AKFM62:9#<7FF?,*+=*;6JP39H^LT_\]$5]8Z9M<(R:=M I<MI5IXC&+YPB
M&OYPC&P0?2/KA4-4G>CS++=9AQ=Y#9QA#0Y.Y[70!JR=2>]-VF9QW3];AMHY
M)JCJZH?R+B^II&NTK*ASHC*O,UPW>TZ<.F-VFB:U(\\DJ:/4/'Y6G57,S#;;
MR/8%]F'MZQQ"VO?WG=QVN5]PVV=]@UL?.4QN$0Z3FT6?D!G"_EG>H16YPKEW
MG/Y[+_4WT8,O[P2Z2--<H))+\M*%ABA>9(O"10.1N]A'REHT7IZ^:+(R96&T
M;N+"9'7<@FQ-]/QBXXCYU6:AW<V6D^?-LPZ<M\9VXKR]=@'S+MKYS[MCY]_U
MT,Y_CK#SGRWL F8+VX".?]#V1<]S_AUB_G?,80[F,0?4G4E;4K>8WI-^-&>%
M+C)7F2-]E3-25P]&TNHQ4OSJ2?+85>'*J%7Q.N&KTO5"5A88!*^LT$Q:,=W$
M?T67V?CEJRS&+M]MZ;O\ KEM.6;I[U9C%@NK,8O(PG^C[4F>Y!S8R_@W=C,'
MBYB#I<P!M<M7 ;GK@*2-0.QF#6(VVR%JRP!$;/%&V)9Q4LB68%GPEFCYI"W)
MRH M.3KC-Y?JC=W<H!ZS>;;AJ,W+-2,V[S3RV7S.V'OS1T;>&WXS'KY>F Y?
M2]8(LV>YH.U'LN[;J+]Z":^%%4#[&J!F/7.PB?YS*_T_;5KP'EU,VFN*B7O[
MPG^?.R;L&XGQ^_TQ=G^HY+L_3C9Z?[I\Y/XBA<_^&N6P_>VJ(?N7Z'CMWZ;K
MN?^TGL?^]W0]]OZB[[Y;J ?M% :#=@C#9SG!.;";^NNIOV0E,)O:C9LY!W8
M6;N!N/W Y$/ 6'K2$2?4\#YA@>$G'3'LI >&GAJ)(:?\,?AT&+Q.)\#C=+8T
MZ/14:>"9)EG_,PMDKF<VR5W.')<[GWE#[GSJ9X73":%T/"Y4CL>$CN/1?SC
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M3?1+ME717]M6QCRVKHP15L2"F%=%"[.G_,(Y^'D8O3]COYQ*[Y_!=78F]=.
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M^;@4(1]/+C/G1ZB_A4OPQ>GT_MH>$)E*<D@:?YZ8"<1F&R(ZQPJ1N4Z(R/5
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M#\&3!K#C1]CQ%/YXVM,2##\;+CV''<\3@#S/9/^"<4DZ#?P"!"]0B1=> !^
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M?CF1"S)XIX,IUL<9$VWRM4+A3((SGUI4T>PM\/3",4SYB_1'K;AF'\8NRCU
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M[T>5'[*5W5%[33GJHDE'O61S-$"FHRS]1UD2CS'!'V/ 'Z.C':-"QS#^Z&&
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MFCD1/S=2W^([+2>3(JBG'^:ZP#G]:2O?B^"GX!5KEN)7UITBQJZ--ZP[-_Z
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M6CZ@XHI%*JI88RJHV&W*JSAIRJFXPY1=\:0IJ^(/IJSR?YJRRLRFK%*S*=M
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M>URBFSP(U[-ZA<;[.=8:G#^UXCEK+F+B5(AL_B/_P$P.IQO>FTV=HN!+A:\
MGBK]GC9Y'=W_&W3_+['C5?SQ<]KE9>QX"3M>Q([G4=(_1G$_0YL\I;L90H_#
M\RH>^5"/X<E'83%@_+[/@[+\UL^U_%]-=*G)^,Z).GG17L%PQ5&/3&POU@NT
MR8_5PG#LI@X#E#T"PV+*7D&9ZW196^D%>_0 *O\^VN1>742W/\24\OS$GIF+
M])+_WI5QZS4V&!?@_$V635BOTC=>1/<_0[]X4A'P),.3"T<9Y==2?BLU[*;\
M =V)'9>PXR)VW(8=MVJ;;J&/WJ03NA%?G*-?G*64T]3H)-XU]C49.'D-KO*_
M:[(,\Y],3 >3\)<3OO*D+H'4(P:>-.S/UP7&R<VJI_Q6RN^F_ &=P8Y3](^3
M6DEOV$C/W(4GCNCP1#;D#BQZ5/OHFWL8O-?1VL;O#EV+KXP?QG*P7$[]+(^/
M,,7<9V-,R=/A=*9./O2P4+@2X,FD#H5P5,+1 $<;'#V,B+EP+-!>+:/,-?2*
MK=H)\P[^8AO>V4)[;,*S&TWO:H/-5UIORSHUZ7O\ ^XW6?:> P^Q[-S!5'LS
M[YUG"3AKZT#=W!CYLW78%*D#-LG::YNCZR85:]?D:NV<TJCM4]JU;>H<;9DZ
MI,W3%FGCM'%MF+9)ZZ;OT9KI)[3:[H)6VCVH%?8O:+G#7[3,\6O &G$-WF,J
M>W4V2\<L^%GVSOFPG/+>89:?0TZV.FCGI#WV,[7+(5C;'6.UQ3%-FYSRM,&I
M3.N=:K5V1K/6.'=IE?. 5CK/UPKG,8VYK-<RE]U:XG*]%KG<HE'7![3 ]07-
M=WM7\]R^U;"[V0(W"_XPVY*#N0_<1!AR?2#AAC^:B^5O.U/^-M=IVNSBJ@VN
ML[36/4*KW!,U[I&EY9Z%&O.LT-*9]5HRLTV+9O9JU&M("[P6:[[W:LWSWJXA
M[\,:]+E1 S[WJM_GQYKC^V?U^GVM'C^S>GR_AW$ZZ8=1+,N1A!A@?P3<O+<Q
M"-V'+6M\;;7*>X:6^WAIJ5^P%L^*U>BL5"V8G:OYLTLTS[]:P_Y-&@SHU-R
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MUSM!+<^+J',F=4Z@SN&+X%\F>8U+KJO1P&ATPB39;)DF;47/;27PVD:@L9U
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MNYZR6RBO2X?41PO,HS<L9DI;A05;M&OB',B9B=TI6QE<QNFEJWLPKF(3,/;
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M*E6U4ZVJG%I5,6..RF?,5^F,E2IVWJ%"%L$"Y]N5Y_RX<IU_IUR7+X"9Y\S
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MK7+(.R[[O#MDE_>T['+_+/O<K^608Y9C-MK?.).69MD+U&C- 16";",'!!)
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M$3&/A<".>60]%V44W!]Y#;%S35ZSN369YHM$;7_JZX%<MU(1NT%_RK^,!1/
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M(K;&$+=&;_$;_*&A)D7EY_%0SPJH'8O<4#[[X=8>U-> 7*?"/\EL8 EL* _
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M8$ELT";?X9]?T_A?T-"?(^P3!+ROE/_O_VSL[!T<G5U<W8PF=P]/+V]?/__
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MS9EYX?",EZ\=F+;LYOYI&V]O'+/Q]IJQVZZN'KO]\E^%M@(=EJ'#2G384BU
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M[#0XO#0.3JQCP]D=5- Z0 *C8WBP/>4)Z+,8\%)W!3]-)PC2=@"JCAU$Z-D
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M*(]ARK*B&)FY+$9)'H/1F$>GM\D9] L)#/K%N-_URQ"Z?C+$(*^)Q!W3(>O
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MMQQK0@8<.BG7'&Y2>NSNA;0Y/ QH='SB6^OT E?A_-IMO "+&-R1,WW IBE
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M]MTT+ZMNMJ]9E\C/N"LUP*BKD&C8W40TN' KP+#C,=ZHZ9F74>/S_Q@PYBB
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M90@07P]AXNL@5D(14B04($=2'DHDUT#M_Q-P\-_7GFK\P-01!*Z>,/B;+H9
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M:0N IZX@L$U$P,M6#-A4*6!Y+P=FI"QXI*\!1JD"N#>N UK7!G#KVPBN>U3
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M[W;H6[\?,[":FC2PG+IO:/G^O8'%VQ\&%F]@01>[$)H81&C77H2ZCR/4=(F
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M5USOH&],SYA?5,]>_\B>*_Y1O2^\8WN_NL7WH7-"'SI^#PL!;M?1#*C['EL
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M4 ?^D0W1=_@@XHDDA/RN!H&_&S*^OUNS/)\Z<]R>>G-=GD[C=7H6S>_P+%G
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M6U-VNC6GG'9K2KTWM3G]O6-+)EJW9J%Y:S::M.:@\60817N0PH%O^6RX5\[
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MK[+Q'=YNXS-\RM9G^4-KW^4?+?R&T,Q_"$V(\62_5@.<;@'8UTO]?S&=@>4
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M< <Y0<[\0\M.@,J)_9_(I]G[WZ39WP.P> R@^PPH%T"5*"(79%&(,L5 '*5
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M!M0/^ YI[O-9H[7'9[/V+I]].CM]SNIN]_Y-=ZOO:^W-?JBQT1]5-P:@\H8
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M\N=1_FRZ]HK-M ?40Q/W (0>H YZA &GDSQ@=UH,;$\K@LT97; ^8PE69YW
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MDNG:0\\#>%P&L*5L(\K6H&SY^P"23P#$/@&(( \(HQ (H!CPHA1P4 $85 -
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M<7DON<J5[B!7%%OABJ)$9,74_T"7B>NG'U=^ .^#6/ TF >>3!.$WP+$X,<
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MQ,S*DXYL+),-:ZA3"&YH5PJJ[U<)J%^MYE<_KNY;?T[=M^YW5;^Z+TK^=:A
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MNKX.EC?VP>+&>9C=>!7FUWZ ^15),+\L"69/2.(H^S:JGT<#5N\&%@T"=<>
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M[G<^K;77^9K6'N>7M7:Z?*6UW>5/K0%72:O?55)NU: 89?CE1]3_BIW<!X'
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MP+I.8KY#;@)SF>=IC->:\1I35W=T_>7^R/K+Z Z1;T=VB?QG+43.Z^D"#XV
MORQ&GI)Q&GE3B/J-)>4C3\AL'7E3*BM:NCZ,9&!#GVT-WJETQ.,)/3><B#>)
M)*FDB-20UO^Y_O!_GY)Y?&1WR+/TZN_1;7^+O^C81]<^_OA?:R!&]/H&EI"4
M%OS):J0<ZATJ\T@(222YI((TD@[217I('W6V4F?G\#Z,/W&$&J?P.R[B5]S$
MSWB%*?J<SO_7X;6.!R-K'@]&^&X$R<0,DJ$)?3Z!FK%D"C2[9/Q)S,AZ4#&U
M:J@SGSJ+\!N6XQ>LH<X&ZO2S2G;Q^@=XS6.LJK/XBKGX L^S!!^Q"G_ Q_SV
MQ\.K0Q(_T?#A",-K'\8JYL( DI8AZ\2<GTY\9#THC)I)U,ME/.74J6=V%^!K
MULF76$&=M?@,&ZDS0(T]O/8A-I^3>)>Y>!NW\0;>PFLLU2N\RLN\VHLC*U6/
M(EGJLQS:S(4"DDH/DKXQR\)<"%.97U?&&4#-&.JE4ZN0.I4L>R-OCS:\@R54
MZ*9.+V_73=383HU]>(&Y>)ZY>!;7<8<W\VV6]";KXTGJW1 E7)?]7R1K)<LQ
M\O(;4Y;#F/E0F>$/W0GX7NF SV0>^% 6BG=E"7A#GH57Y,5X45&-NXHF/*=H
MQS.*I;BC6(G;RG6XJ=R*)Y6[<%UY"%>5IW%9ZPHN:;^ B[J?XIS>;SAK(&&(
MG%:CDG!JA.&7#UMK>,A;^Q<+!7YE.;Y6F>.^GAW>U)N#E_1]\;Q!))XV2,$M
M52Z>5)7BNJH&5U7-N&S8@4N&7;A@M!KGC3;@<:/M.&-T *>-'\,IXR?PF/%S
M.&;R*0Z;_8:#YA(.D/W_A<0N5OT2HN\G 9^Q:_F0M_6[8Q1XQT@?+QF/P3.F
M,_"4^3Q<M0C&)<M8G+-,PUFK?)RV*L-)JUJ<&-."XV,6XNB8Y3@R=BT.C=V,
MP;&[<<#Z"/99/XX]-K>QV^8#;!_WDS P7A+ZR=8)DK#E$:2IFDUOGSFR&YS%
MKIS'Y_CSTQ.T\:2-*9X8;X?')\S!J8D^.&X;CB-VB3ADEXD#DPJQ;U(%]DZJ
MP^Y)K=@Y:3%V3.K&MLGKA?[)VX2MDP\(FR>?%C9.N2YLF/*&L&[J V'M-$E<
M0U:3'@V"FH<SV.W-!M[CD/>".W!K'H<W9\ZU[46<FZ+"R6GC<&2&/09GNF/O
MS"#LLH_&=OL4#-AG8ZM]$3;;5PH;[1N$/H<%PGJ'I4*OPVIAC<-F<;7#'G&5
MPW&QV^$)<87C/=DRIZ]D2YW^DBUQDL3.$1:/\#.[TT^H^XH/_18]^&7RN#=P
MBL/?T5EZ.##+$KOG3,4V9Q=L=?;%1I=P]+G$H]<E'6M<<H4>EQ)AI4NUT.W2
M)"QW62AVN:P0E[BLEW6Z;)<M<CDL6^AR3M[N\JR\S?4S>:O;'_+Y;I*LY;_X
MWH4YH/YS]-_70H!SH9SC\OP0/]L[5XEM<TVQV=T6?1Y.6.OA@1Z/(*STB,9R
MCR2ARR-36.)1("SV*!<7>M2)[1ZM8IO'$EFKQQIYB\=6>;/' 46CQY"BP>.6
MLL[SOK+6\S=%K9<DK]$@J_'4\)6'9A_.K7#@4A3C)X<C@#W!G&?["MC@;82U
M/N.PRG<FEONY8:F?'Q;[A6.A7YS0[I<J+/#+$>;[%HO-OE5BHV^3K-YWH:S.
M=Z6\QG>3HLIWK[+2]Z2RPN^&5IG?^^079:F_I"#R8?PT?,IX7V3LUZ-9!W'T
M.IQZ[(]3KW]PCLERK XPP/+ ,5@2-!6+@IW1'NR-UN!@M 1'"XW!24)]4(90
M%Y0OU@25B55!=;**H#9Y>= R16G0>F5QT"ZMHJ#C6@5!5[7S@]\B/VGE!TO*
MO&!)0>3Y(WS((?XYZEVF]FD.L8=3@-T\;F$YUC ?R\+TL"C,'&UA=I@?[H2F
M<'<TA >@-CQ"J Z/%RK#4X7R\!RQ-*Q8+ FKEA6%S9<7A"U1Y(?U*G/#MFME
MAQW5S@J_K)T9_AKY02LS0E(216;X,'(U[S#6._3_%ZG[6!KG^1GTG/2@&^B%
MNSDM7!2EC=8H$S1%3T!]M#UJHMU0%>V+\NA0E$;'",7124)A=*98$%THYD57
MRG*CF^3948L5F5&KE>E1 UIIT8>U4Z,OZ:1$OZR3'/U .SE&4J9$#Z,8Y76V
M@Z<XY3I'_6-9;(><BO:37I9E*<O5&B='0YP1:N-M4!D_'>7QSBB)]T)1?! *
MXB.%O/@$(2<^7<R.SQ,SX\MDZ?$-\K3X#D5*_"IE4OQ6K<3X@]KQ\1=TXN/O
MZ<3%?\MS28LHB6*4E]@&KS/F,YFLAUSZ+4Y#-Y,>>N&%+%<C?U>=I$)Y\AB4
M)$]&8?(LY">[(S?9']G)X4)F<IR0D9PJI"7GB"G));+DY%IY8G*;(CZY6QF;
MO%DK)GE0.RKY'+FK$YG\-8__:$4E2TJB&.4N\WV96B?5>X'H?[<7LQY(-\];
MF9<:UDMINCX*TRV0EVZ'G P'9&7,14:&+](R0I&:$2,D9R0+B1E98D)&D2PN
MHUH6D]$JCTI?KHA(WZ@5GKY?*RSCK'9HQG/:(1E?\?BW,C1=4J,(&^'I1+8%
M:ATO /9QZDF;AG45;(MES 'S4<ZR%>3H(#O'%)DYXY&6,P.IN2Y(SO5"8FX0
M$G(CA;C<1"$V-T.,SBT0(W,K9>&Y+?+0W"Y%<$Z?,BAWKU9 [I"6?^XSY LM
M_YR_E $YDF*8; TW4WE/YM'W4G]W)>\'VI+5I+,:J&,YBIF3K$(%4@N-D%QH
MC<2B*8@OFH788G?$%/LCJC@<D<5Q0GAQFA!:G">&%)>+0<5-LH"B3KE?T3J%
M3]%NI7?1::57\1WRF=*KZ*'"JU :QKM DJNYQAR<I@4X2/T==:P'6I)NTM'
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M21S)@F8_2BTT>T'4SZ*LH,8:_(T-U.BGQBY>^P!^PW%>_RS]^C5JW!U>>7C
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MQ:$'7\-I^!+:H^8BU@/+D<V<)+ L82E:"$PQ@G^*%?Q2;>&3.A/>J<[P2O6
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M/7CN7^'];VD:;N_7&]CQ!^SX7^QX%3M^BQTOPPQ?A.L^#\M_%I[Y*P+I:;U
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M63.4I );<OO@7E/P ?8$4$\>739RGF@O^TX7V79Z:EQG@,9T1FAT9X)&==*
M.NEP.NLMCIPXF]<K %RS$^[?28;4 3'I('MK)XMK)Y]#_VYT;YP''5_ & %-
MG\EU(N_'#Q*+?):!?;&("L9'WGS?!;OLI]EI]#02GSX&^3X&MCX&N#X&F#X&
MOCXZWCX"N8_@[N/+O7"\7HC[5 C=5$C4E)< 7+,'&WI,.HB>[>A=Q]>6+Z,>
MEO,UKLW0Y KNY2R"?_-Y&';Y0I'<L,T!C!J"1PW!+0?A=(,,\H/P[4$&E@$X
MU0"^&"@#!-$ #AS@AW,A^',AM7,@K?V_83#^!'Q'\)NT9[%E+]#J599U*#-
M)ZA;+16"5!#)9_XK)7=<Z@!& ZV :Z\@\1O&%\-NUC4I)!W#\.UA.M7E^&)Y
MK66R<SG.7&9L]CE$P$$JET!2%W^ PF^!R7P>RX9U_&P#9FZB3\#<1E"ZA3K8
M*D5S#0#NP&&+L08%_=PGP>,ZFF0'.[9@QQ;LV((=6TG$ME(G6QGPMM*Y;:%Q
M;R'@-R^W/(!X$W&YD<QY YGT>AC->I,V;[1,T\S;3I5!15MV4P>$3S84/18$
M O?]Z <RUJ!<!PY="QM \GF(Q.\0=AS&CL,DA]<;21E)P?7$Q6%B\_"0Y4%
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M8&<8]OCB&S=$.[;9:FRKLVQ:W.G$Z,Q;@BV=60L=; L!W$(0M1!8+12F92&
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M^,E,KI-Y/X'[%?@E%Q\E4S^1U$\ ]>:!7YRKQLFVTDFC*QE4*AE<*NG(*FG
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MG]E@K(/X%[[X1$[H\^17(>B*TQ_^'WOO 1;5LJP-UY S0TZ2!50R$D2B 51
M0$%14$!%!1%4! P@8,Y@SI@5,6%"153,.6+ A&)&,2<4 ]^[9D"9-</>Y]Y[
MSKG_^2_]/$V8KNFJKJZNKK=7=R]RH&O N9>I(UT DCD+.4[Q[@3MB[K[@\-@
M=%,"S" 9]:?!+":A]=GHQJ4PGSQ(L0]=>X6V0'/,&93\!GLP%C>0@5D#8%Y[
M7$',LI8,70*N.@M=G 2V.TJ6=!!XJH@\:"_0V6[(L1-R% !U;0?BVPH$N!DX
M-Q]R;(0<ZX&.U\*9K$:?K,2 6@&JI3"@Q<#<S-D3YO[/>75[,&8@,W>1,GM
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M8TMW] -TH@6=J-A+DH*M LG:<$G:1H.D;/5(TM:4Q&TM2<P.AF0')=HQ"Q<
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M;K?A&L0NZ&(K=+$)&',#</]:],E*<@ N=T6M7JC;A_=.D@5 ?_. GN< V^4
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M,OPUVE)+:<P^E%3H ,.W+WX'(;?#,&J-;(ZOZ(R$#8!&&O(1.P^KR[R]*0@
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M7W>!:^6ML3#K*_7OQME"(L[AT)^[0^KWBNR##REB-I'#-@X@&#D OWD NC@
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MU'2L[W\Q/3^_+S]W8?;T25GIHY.'#XT=* C,#P[I;*TC:'/V@A6PK8E(7)"
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M:G]NT,K7!P\I[;,C\8GSG^:]NGVJ8]*7S(FS]$N^_'%[S7*NKS,J6YMU^5S
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MW0F6$G9'EG>B$45&@@38(0Q8MG1QR=OAR.?[ P P_0!8-)-5V1&Y7@2KX_\
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M:UBL[/]AVPE.ZCX^=][98%30=2KON>?0.KEX5DZ1*7KV<Q+UO!@,5?_&M!%
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M0VM%#J=JU(4M:_#S$16TWA7)3LDDLP* S\D]FQ67A26;$6P1YVTY]UWUP"<
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MSS?[D]R[E<YU 0^W8B4 7D-[+V3N$,>LSQ%?/E;NO%NW:_2IKXDU97+FY!<
MQF2ZTWOL_3#Z'&;:;!<<95"5  'P%\/37G1BG=389^L+2*9;OR+,L5$;A@.K
MGZ%X"[MW_9\3D(^I62#,*7SA%(J=;X <KB7\GSX\^S/1[S+)E_L8-Z,9F#<+
MM0BW?/#=>6%A-[*<H";D+Q3MVM[E70(-2+5H>;;'^N5S; -0D3SL6-</7F)C
MV+V';JU_DE5Q1=?9,2L>02?PD(2B'Q#:EV]A<K$0A2:-X!SO1.FV%P&@-)0+
M94(^+>@2_'S3!)3F"+U=J"G)L?4I4_GY]?V=[*D,$8=]*.SWS-/+L_!<>,X%
M+7QH=3Z_Z5B_^HW^.)0F[)T9V8F=G2W/F7DQ:<^#$,0,>QZ]#S';:R_#P5Q#
MMMG=(-GU??7H]A6,_95FS$XL^(<  -FY8,3GMHEZQ\W<,EH$_I5ITXI"PY#%
M8G3?S 5Z-D/U/+P<O]0<GST/0L5K1+M;:_.2^9QRHW^-'@SO[[5G5M=U=YA^
M?MX*2N@'\.PVWMOU86YK;X=2=AD DIF#W.MGWM$MY0T4C=>$$(Q%)GKR_0 $
M=;VMNUF<-B#LZPOX/D7>ABA#!G]F$9>1B.1)]N6ONF[M\PER>9)S$B\NS;1,
M(&]]6@=0OY5//5^]O"E6;M38V''S7!(]XO0NTYYIU(<FD[AQ @!;7?PR+R="
MJ#D3CCFMUAS'FN"W3P#4N.I8T###0/,V(>VT!CF%4QV)8P#PK^R/30]"'%5G
MH>V%@ZE!G5?HYNSY3>33?M:/>.\P:72MY)'6+NLS_GG$("E98QL/_ !L_#DT
MGJZ(XQ!'A/7>\CI-1WL>5, ^A)QM[IR>P( A.5TDDH<H7:.*OI!TKF:2OVB@
M"VW"R%T=9/K:4R]X<?\\9HS9U63X3_*+^.$P6<?NZ58I9!\@M7;>P@?01JGM
MMU?WBY611^M0IY5G,SGJV(8Y;YR%_"X6^T/)7,E^KMY644^"D %JL7S!8-!M
M*6J_5G(PAI(S/0?#_D:WB>!633[V#>-8<L% %Y"8&\]MM*"!L*&[M;3#(EOL
M5(]A<?@%CS$I=(#12O>3!!JS';-M24,80A_"T.DHZ<?I'O<G %+;2VP[IA!3
MDB.Q(_>D;[I(=@ 156?1;G1SV6DTD6"N41)7@V(;\*]&EKEO2FW/P?7HO TZ
M2U#9<P8P8*>2=B/^98_V4>IEKB]5"<XH)Y!NF)+:4PIK7W6]YZ4]FGQZ^S.F
MCG1YW3U?-)=WL21L*$UH"'8T9EP9JB?[V13NA>P,/E<I(07OX%G:=2]?*)'[
M-^EK58M]G%X'T#;WCIA5AL<DO\7YVG_\HDF*W\O_PC&NVB#M#2B31(SUYF(.
M Z%H;)\F=<O2";6J4I,\E,=]L4CGL;H?TWP;66J,L1?CK<=4QO\5C79=G!H/
MIP!H[@:9-G'(M)/(GR1X]_M)/4D:7N7( 8S:=5!$OLT1I:8B?/:866=!6M[<
M%J5S.-_F!6L64OV]Q;\ )A9;>*V%0VCS9*-7<UZ/@[!RV_N.K*.W9OQP&.U:
MWP=P8'W3.WOK5I9DYVN6FO!RR.AC&-"CJRD@=:KYJ;\]^=1:!W;Z@B" &R$<
ME-EXX&L^)GD+_=6]J4*C%ZP+/&)O/BE!M#0#@%7C02JMYE?=?B-)V#&(JSG3
M%_9!8;.Z=N_GZ]6@+T7,PR&^0 T<N!PM97I;AA;< E+?1&/1;CW$]P /9(1:
MW+]ND*JT6S.P)FV1!N!WOKR@3V;HM#D.3QASE([TH,=!*7@4375=$/8#,-4?
M?T,9#)&A^KA.C*I.\+3)B#RE5*^=-U0  8T-C169]1'O;%X_HYLU$9=3"M'=
M%+P%AT;'@L5K;L%WMG0MW#D 5).@]\::<'G[*<40R->+U@KN"12-O,+6:GGF
M!*;.W$5#*T1Z6!833[V;2$'L;$1FK4\ 0$I6YU-A7S*3<S3G?&XM5+R&WRJ5
M8G'8HDGU$NCEWOX:H@A I-]1'&;?!UW1],H8RYW.@,%Y&/Z;8T^P1_TTV)E/
M)V/><_U($\_857XIN.5>2]C1QP ,1W0>;ZQ?\K4"J 65EY@4X686I\J?/H<S
M01RC (!YG%TJMCGW] J *B >ZNK*XZ D_OG>P+@+,,-[U#W5.R%'66*Q81X(
M-@$GU]WGWY$WA35EDV63Z:V#V<I[LO?OO_Y'WW_U7R>$'[, (A0T  4'7'@%
M0Z>ZCSJ/1\2F%1 C-U\BL!U2F9L=$#[6%M'7H,T2$VD/SIB(@QY6(/^<@?LM
MO) A0\;O# Z'5<S37/^MZ619[401(SW\JD:0B#O:),A#/!%3%H](C!P36Q(#
M#2$3&H,P"]$I(+\RP)I3ZT35^;;?J6ZN^"RYNM::WDT3_6*!/U<8!P%Y3UT7
MAWV<J$F.$D \2W;H]<+'E)W"*4SE>%K_C(_Y)8R:[_I2XZS9'/VAX)3_0M#[
M: UUHL(+G?7X!O=>2KC77,_/E$.=H?&5&)[4XB^].@R6=8L+BOZ4NU57[>R^
MZ!AA%_M-61)U,!#]2U$XKY%*+*)2UZ,C]%U]"[<T:T/;MUY+;@\:LSN4;X)Z
MA%*0=E'Q</++HY3PWP?U![YD:21J\TC2T$[W*(-I/VOP% %X,T]R)Z8L#Q!H
M=YXHPII]^0P?]F%%*@Q8(4 Y?%C3X^XL>6E0U+_;-"2D[+R63(;)!LQ)+;%>
M8PQ!LU+@X7)V(K\/EU>;4ES8#7F-$T,@%E6(-[+58UVA?Q2/X@^J'G-4&#)%
MRZ\D/A??50A2Y\C-'XX<.KEM&F(,+![YN$$WP6\8#"K=[)TSXLJVDL:$0JI*
MWV>P6DI3'M%_/BDW\+3/=V&]9(?!S.[3V+MQ!5$,T0BFC#;O;$=JZ_*881U"
MW]C[':U@4U+N[=/;AI0-.O.2K<(3?2G;"#J]N0G]E"Y9;?.V"Q?S?&Z@=5)/
M*_D'$&E_6]_?4,UO:)EAQTW\Z'$1U!N[S51R6'SR6YD5,A\<^6&:2X_D*>Z\
M\]TU\V+5S>MGMM6!QEKKPC8IGWGI\]3DM% "R*-E$C/R2;^NU8;A^L6S_P"(
M5>B)^,K[Z=\.SKN5B5?J$@[*8Y/OF[[+LI3.Q[O-J&=1N=A<2.$V%UE"=>P*
M9KK2-2N?G=P!'60AB%21/,?]\![CM3J=@@M]C&O_M[P R4@C=K-RBLM080)Y
M\O0981]F+K<IK7@QD.!3AH8?@"M1<)-%J/65J0)OR5*BF'G%FX'GM]#.\2JY
M(707U-55";.2LANZ,>=TW[D7&*Z72&=I6]^2:XQU3-BS;A34=DWU2U;38-QD
M=DN^-2 W>,VMY7_:U+[ H=F85''QH=,K70Z>R'JFZOZMP,)@C7GNZ>Z5S5#1
M2IE0V;O&FV9"\*E5M2^+<C!9S=;$&8F^1VQ-IN'7[NID#5I528W!1X6%A77?
M40K36+**.CLGN%3UA3>O!9IX2$4P*)R4+CBTLG#9E[S1UP0)@@I6TVUK%:$U
M[L.JOF2M:*T?5&A^Y[K/<6IG)#B/[A]*4KJ.4<=0!<Y:!M*0773=E]&B/MM9
M3H,(MON9%'%N+985>H?W U^Z:QSQ/B<B.-J&*JM*E7]^L<9PS21<1<B)*:*0
MBK_=>&R%FRD[RO7D!Y!$&\E>< !?4;DPVF:>/9=K66[/,?)1)XWN8J#W\6Z)
M#.Z>K_YDDW&YQ9)V8"G"6.R$#.<,TU,Z%LO2>K%,\7/+X*TQ>?7QN$_2]$)]
MVD)FJ?[$2E/=.%PGG6@^3F*&Q$JC?*]CW_B_+AMA4ZHYJE$KYK^/=$H+:Q\_
M4:RQ9[<W,4!T/S=/U&_PFVYV=AT;BLOCS:&^L/;K=WHH9AJ:_ ' 8(5(/,([
MZ-1H[KTE_4,\\]PM [[D<UJI.)3>^NHR2?*/E&,Q 2T7KH"%4N=,V""^)'K[
M0(?8(C%0?S"Y* [A%>5G[SK?I+5[+=WTDHN=[)7$PN=%D:6]>9(Y/B;GO<XI
M&212'SSO7@6O0G_"QMXZ_$, [3=[Z'-^&!?53KZ]/M(?SDEQ,$29B2D380>0
MI46QDO@TMVX%NV^^@(1U#SJZ<M6:J"VDWEO&=996VE#G?/23>8Z=*MY_C",#
MA?9<S\5E-:643B>_,&EG\Y_*!SWV?_TR)B *UK0PR29O_Y)LMWW^W@&$VK=8
M2'H?#<,9QYE1_;SB&]4[Y,^*=\_*2#Z^%0UP=MGZW5&;=0;A\,;J_1/=G#)?
MYW';1Y09+[L[U'F^EY&F5.?1Y1;CK!_B36FYSQT'5]<)CXL7QIL+?<-947)3
M&77C2[I&LI9=IRG44"T<MD0.[_TE]RU$VN<RU6;'YURC6%/=WW;CJW:K,%=-
MO8FWZ,WH,X$\KE6L\<3WBL^+:#X4,F352?#VJCR6"] I<!/2N;HF4:I)U7C#
MJ?5*;FB!GO0^Q@@*GZ]"!$OT2:12S@3-]5;!H$I4EIPR.15G7_(?LEC=)S8I
M<1 ^2FC\ 33KG#Y<VPS=;I2!S\O33O5!CR\F!AKD^$7?>KB,;@@$J6FHZPG"
M:.\>F9%5WKZM4WEG*4@X=(;.V^1F;\IW[OD#\*G>NO\^E7[9IZ!ID[F9B:*S
MUC*]_-=\^:)3;[EGYRF#4V+L W_]P<!_B>GG^?M$O]WZ"F3&6Y_&Z8-_U; O
M%COS>:D;RVMY)^A4V..#$2;Y>3+$!UO5<T,VH+0I!\'216]QG+!AARAJUV )
M:QJ;LC]R]1LO&CP/J$>YJ*Z06464K#KH7KILH78AK9F?:7>H5>F-N*@Y&A ;
M0?]1UG!VF, *V+2F_^5N7 'G;$Q-?:A1*Y]:'1*]JYM4U4+'@%<S=CB.JFH=
M&&PO/QC-9$2ZG\[^I4%9ZNK:?(6YGT@,<S]$O&Q+RD T?IZ?=!773_Z&6 @[
MY3-ET3@"VP ^QS/AR9"B%"9V>HDAV=>K3?E-\!:ODDR,5[<2I)$=83/0:.12
MN5(X,G\ DJR%=RLN/+^0Y\3S2HA8X1P[J@Z8^U+"_]IQ84JP[UL%S\"&J3[W
MZDJ-?;+PNV5?[\UJ =62]IO'Z%@WB:'.BHABH#S]5\Q!1X@2=(.?H@WB<O S
MPQ7I7,N:Z;"LTL85N#I(U^.H9/M'"F14$N)PWE!*QXHE8\=A9,'H6 _ 6^:1
M;9^&/.QB[[9BC63GHJOWTKJV\7W+AW[U3)._"\M$"<LY)B/89AU+@ U3%A]Q
MF".E(":KQ&)W75E?32TNC[+*D5.<@TOFLR/7[&.&";K52,.;%;46+H[$E6>Q
M19>!GLEA9Q:X>2&O&N_(T(7XHK4N(X[T:>!6_)R_%%ZAV=H+H[7>7 Y8O\K3
M#3JC)Z8^9\%=3\,(=E"H/R:F?P$K0X]<VXZO1,_<_%(0J!77AZ<U&2-1&]-_
MVC>NUL]T*ASU<BK,>RP*%.J'-?IZ%C& -@N5AC6:/"*$A'2?Y]=SP:E'NO$.
MNJ2S8@8RD\.TI<'##9X$[OP O'3C(KS,Y9CS%1,0JP/H5'$(8:)>";LZ4X%=
M=#Y_CM_XBI?^]OZ=:BI'UUZT_D2EU_RC,I_)O!"W6D/1S'9#E1-[Z15$][.]
MLL>K'+G-ZM"(CT6821$DIGI#,[ZBZA@[QM]9!4(5,K.ZC5)C?- G'V:-1V7$
MBMO])$*E51,OWS_3;(Q%D893;A0"]ZL3]D)Z$RWSTL0WS,*4]2F4.UT:?=^!
MC5ZI[JNA%4-R'S)W]Z?+Z>]]!KJ\.%!4.P4,_!Y=,($,N-0,=5^?'R6-GRB
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M5V@P8-V2)!1)?]_*3HQ<D/KXN80;@C:'&C$+SA:].0W@F\]&B_L^D;\+]_*
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M*^KF@3-X%'<^FZ+4!03G3:+7R#FF[J9+TH"-1EYP,&;9CU>/_\B-P,@8GIM
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M9[&S!\.RNOD2/W'LTIG*9^.R#1D H-8_1O9LIG6QE2%@X \ZFL$_9U;]<_B
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M720^TYLZ,3:O1%U!+]92GBXZ\2<+=406M5MR8OS4<$P813""V-S0QAGUGI@
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M*$6;ZBF)FYH'8@RS**Y\P9G,[NU>>3@ZN#^@ FHF1=\_?=XO40/M)#:"S?P
M+%;@:GGU'%H+<@!#SUP'0CHOP)JYYZJ6G8];BG,J\]0D?X5N]PJ_%\O-(:AS
M@\9U1!&5XG'=VR*5B3KM-8\"F7?HK='>Z'39_-!/!6VL D*^Q3&L7Y3CMT,"
MIH2[Z'2U)QMHIRP/M "^CTLB3N(N]@8(O9CT#1.S*HP@C_,JH J<6<,_1T(<
M;::,@-?N%#\YN\HV?,T'I*]__P' &##>BCO+7@SL,Z<^$KJVH^S,/H\ ?7B
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MO_.MUF,^[4N4K8'A[RD;VU3ZO)%NJ#]Y ")8L_(M<__6)E-*,4L<:CR9 ^#
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M8RMALE=0%MKH:>TI^?F5'$VSP;YTDC!K2D2*V'G?03 0)/K^J-9T=$E2<NC
MH_)+\:>R*Z^ H-IONO!0Q/'J_LDSD/XJ)-$:\_JD+,K.T]Q@XX8[\7S7J-V8
M89-S#R#/#^1Y-^VHQ.I\Y5V;B8J8GD6JKBK.3]H\1F$*T49JFU5>1LW$<L_H
MUK\DK7'&ST<B7 )N6=I^I#C<+PAN_>CN[6/"F&B\Q2$C8X*J1BN72*W+Z)XZ
M@$:L(7M,D\ O1U?[E*VOOY.D&HT*&.G=JTM9KWKERJ!0<O0Q_,E&-+=H<EJ*
M:3M%<")QA%FA7MJE-X;G,C[RGJYNV%P+NE0#Z'!53LA=5W83B8@XH5J/*:(?
M@H&^L1)^Y5S&9M151S8%65&>LS=TM'_IC#HGN3P[UG@B'M/[GM\]%=\60RO%
M-4VSCL/ 8!9A,^'-,TX:5BHB;'W;_-$Z=*9M]R7-E;U;'.2>E8.RPI69INN]
M[,(1HN\6_E"=KQ\*J^K)UH:X!+X+<<SGE.8S49#=9@^@B7@]& ;EUV]QM1/=
M-NJW=1?ZKK6Z4]X+W4-*]YW8E_@FFNL P]+%5Q;M4R@D3[-7[CO9NX?CAEIK
MFIK$=BX1?YSO#YQ*FJ&U. \OD#95;W0%8 M_(A&X?B[&K'F;/>\WH70\9$ <
M;-DCB@KLZVW\K%M]>8L0<SY4B+LT)EY]'YPY[KR$HK#B;:5[)V+O)%3].JNY
M+G,1!KU"WLPT X8GVJ,2I_$*H*MDU&74HV:M'P_XH5RZ0$54.NI,UM1:W<J&
M"V<(D'L,P.I"YQ7A%1" G<*LGCD3&O9AW_<V=Q2*RH_5=CFVP SXT&IN)/_<
MA 3)P;<\3-<?RJ%O?]+W9.@Q<_12,K\!+N"@2T-2TK,.:0MNGM\:O#_ZA?#1
M?LW-UL[''LI%14G%JYJ'S=:/>;06PK["R J=3@*"1;HY6CP5[U9!%NK,Z*0Z
MVM(@JF.*5#3M))_[4*,3C>JEL;1;\PB(S-SP&9=.L9Q&$=TM(H,W_/,1S_!L
M!RM.!QYT":JA1 9\Z+/ECGU!I!RDJ4BH^#%-I_ (@&;8CF\2-F[MC=^U4F'<
ME,%[.1H%_*+(W/O[]_DS6*M60V$$B#B(3H[].+B^*?_J4N6JB?\(GV?P_1GJ
MVJ8?)[S<PLSYF+&%" GLIG:T/SKX>*_[0",3>S35A $6 %;Y+KL:ED$.=5&\
M("$[+JMPH:HTC4]IWSL, =X6PZ.^0R>9NDV-E*PL//''P+5F@AS#!?@W-!;(
MDE#?S@.;SH-7;:T)JH&;17.F5%,[#)Z&4SXF"14"MXK-G;J'I3ZPG.(8]JU0
MVEZW],J#V,/=#$ETA-;L_$N8?ZR"*9EL%CM,YP5FRGDY"Q\6JFW,R4WR!0[U
M>\I;]2]'"QU'\-05/'J>:I%V.:?;3I9<6HP^H(1Z'&=]]/_$%ARZY/0+ 25F
MP?/0^^^2\U"B"J_'"\WS*QGK9\XF)GM:*PSI(L(XK7.;DPIG%ZB9<EJIS,+&
MWLUPM%DIN0-&JH.M0?"8P6Z=-KA=7K&&ZDV"$W8CB"FC@P?C$O3G7KXMIH[Z
MR^X3<DV7]U!N96^'F"YN0:6&.>!S!Q1&07P8&H?34<(#@U-=G=X2XQ!<2C6K
MVKU,"V0I?U]G8B_^_1>"$:C4VV!E!/L86;LOM<GC,YA9-M3I#:_^%$9Y*R_C
M<)-#C^!B$[.AH\_1-?9'2[O5-0_WZ+TK>#+$#+RJ6][@@[:5J=!28_HB&7 Y
M&@+W.DT;U=,2"*Y*#Z(.CG$S# 0D[S9&E\O!9Q>UU![XPQO27EW35.:4\VAX
MMOS#++0_#+$ND?>+((<_5K-G-L$"+$[!D\-2$XGJ\-+<Y^3=OAEU'_W75P2*
M5D':$_MF1CML/^.'T[C*OO#0O7);,!@XZ&ONE]&=6P1A8O 2D):>-L:]7^YI
MD7@;SZ#)^Z=SGP./\IJ3@.)I]2P^K4^>F9+,XW+[QCKG</&.+1+-V8L8@AI?
MEZ9GA+<1]-S[-Y<<>7,^$Y?,'<(5C1H)O*5(^DRPN#$>#$TT!B@A3S4I<"-#
M<X=S?U0"&Y+#XEL=CW_"?_(+\%Z3D6XV^X[9LK_!B@.T/H7-R;^XU3 /'[9=
MM&>P*K"UT^N0SCF(Y,< ?7N\RMR^>(62@,GQW939T)_N2#&A2/0=A$4#%V/A
MD[;;&(9K\YIM<:]<2M\SN27:X88UZ33-[92?B+\9Y7RT6^H4P[@U.0%4QN,[
MO&AG<R?TE;'8'O%:.+2 ?V9\LT YOJPR1U5=^P;%/\V.]!7]6_]^677^R+%0
MZJ,U IWN<S?,"UN,D;T.8C.YW*BAGZ0]\KZ8ZX7MH0Y3AJ*-UE4Y2URSZ_-)
MX!%!EED!4Z3]8?=*@%W6Y\3D.L?J14NJ+B<@4EFK5)-FC6N[,U[S;/36_%4#
M:89C$1E+/^5?&95YVP'Z"D1"MK28WGB,_<M(<#"ACW!@12H@N+%%V_*'0$CJ
MOTM1,<5N^!I8B2Y>BY=:WQ"]]>\2SHT?O[;U] $.P&3#TWF ZMD$+KJE&S]K
MZ%@Y$;4)ISZR;^Y)$E[\R(OT^JG<_\Z7?I.L/=[QL[9Q,-059L2/X;:?US6\
MT%-N;=_P_O&YH0S?0%4!B>G<9#3[P>^%Z4P:IY)4'FQ'FQO?^ Y!$W2CP;:G
MBF1VVR_UTLVK-=W $_6,+SN/ER.;9P'N(3-N8\M+,/^_[I9\V;VD2_F]'9#0
MW!3<_F];[)]M8O)3:U^G'<U<Z;3%+'H=MUE!TKQ,VBIR^-FY2=)Y50D.\;ZA
MW@/):E-QVE(/C/@HX="N!91CP/V?BOR+P#0QD[H+Z,F)^="\J#2EBD:TQ5MB
MJ_)N%RQ=C]ZF%_P8]7!AAY:?*VU YR)_D9#/J?WZI20*W;/-/0L'S%D(_B%L
M[@/V=HYMY&8[^,M+)@(]!*Q6/+0'379=Z"9#Z"NCD:8MUT,-F%)L-1M[EI#Q
M6J)(24JUM.LK2VX@ V99%,'MU!X^<*"!\\](.ZUO4P]UKA).9@BLNIMO@O+T
MZBPY-;1&=O?(*J9HK/Q"T *'1B5IAO2WAWLV<!;^G$^;#1+H^CB0;CBW6_KE
MI.Y;1\@LEE%JBOJK $<D)R)1"+__F.#\9UF7IN'%Q6M/H)_)*#'O%DAB ')4
M<HY&2S$$:T8"UXA&\^=<A"7KW V+PSE-@+X!-F>9AQ*N0\ =T!(3U*$=ZKRO
M^?;6181$L5,@+99[_@Y4=_T]=+C# V[#P5\3/Q_C6 .<PIPG^T(QJ%$7?)1T
M;1XX<F@ELF76SJ9;GFYN("!R4>/^W/_9<%&U[K/Q0T8A"M<7>&.?,ST4;(F7
M!)G=5 7+]X6# .W'0#7M)3S0J"E 6Z.KG3XWFB46ETE:@]$,)SAWQ.+'XHW\
MR)_YY [(JFX\!K8Z;DW. ?,M#?0), TO[V*B;NG[K]=4Y1H 1_;:H;07.9C?
M#4]W"2YN]A\SST_6=;M5&;?^]?KEYU\M6NW3G+J;BJ\,K77)#DMWCC[&,S,T
M:T=?<J1;,Y;2RS1>N>-4%:2&N@MPG]ZZDDUK%&VU^H:ZPV$G7P]>.F:XTQW7
M,23.-0 -+.3-VCKZ-=#:>NALRRS?%SA7-8B1=QZUE'A^TJHQ$6]*>KU45PGC
M9*[QGP W,&)4OR,7C>(K12.[=&K [Z><F_QZ9!G>B4K N%ZM2R =YPMX=1_>
MW!IIZ#Y^-Z#5(&$WBL+"G_8GUD<5[%=5S\AS3S5B"@5'\9M71/F^.G],1A<U
MO!7/W0-^(7SFZZCZJDZQ:CGQD;3$R:ZY%(MA>,I6<(HE>MZCP\'<'9K3P9RJ
M#T#1);(@S;4/-=8)V=?= E<!ES$@;LZ)^"VNRFO;#>7U+4Z]_L(?8J71/S47
MV0.W9U$V;[R1C#Q3^./*28R-5\"3#QWVHW:[TY6NE]]"21O9JHGKJQAD4IQK
MP63P!09KDE$(U!D<_>@.[X(9&-@Q>)-:1I.>W]K&U-]WQQ41FZSP%RB[?_ZK
MQU^R'B+9B*)?0KE_R(X^UD"SO2OU%"MH#X(;#QWOU$)]L\3O=%G4=YQ#T9TI
MRN+1'\P'ZB\73RBV0%-T8>,;P,;7:#Y [@&=>DV&['UQ'XCQLL:H3[!?SN+E
M]$UP'/:QJ:=/1?^HR;L&Y,.M2&U TW)='1CMMMQ<I2D?,.M40>TMV0*G,8,1
MW<&:@*/FF,IL-9Y@3U:JL]L.OK]KB6Y2?<!/[+$8988L:O-$'!W[3-3EUAV$
ML21X,0R/-CKZVF0CRGEF24$HP7[E5D3Q+'(W3F,-NKY<V1GT:7\3BI*/!1PJ
M<Q6?KR:)*@)EH!_\0L _'!E.)YS[JT.;?M5?GO<8J7+G11TIFW:!]RUEFRR9
M^\DN<C82M*$D*Q V%)N.'W4!$'*S-3Y',=MNRKZ^GNR' CC,9HE$.TXW"UBR
M^A.Y3PNB?*Q-5;4U2W7^ QW:D>.:1GH<-T [AV7QSTV0Z7U&TGJ]=>-&82?&
ME9@"'1Y'W#Y^]A"E8R:+NY5^*[=<B!#-YJ% UHHAQQFGKFP.8EG<]]V,K[KU
MUTU(_H,M&=%8>!7#A]8D?BU7OC<^67K"'$;U#_0%51$,MAL1.@O30X',8>YA
M'$:0CNO<Q/9_#)1(2S1[ *V- QKP)4@'.:VE%SLP,<PWQKCU*/METUF1%1<_
MV >'5D;T5(4\>A'EX$@*-'EXK!6>:)8Q\;;!D>59O-O,>)/<E$=6,U,3C5U3
MP"Y:+UMG$@H]KP;UDHKO-HO84AR'$U_^N[S1]/@Z&\*$Q,/R$DMQG]<N;"=<
M;A?[5<!5N2(GSILL3!6V(N>:U90_J[KK18/2ON9$8]+>0U<2QU$LY*\I2D4Q
M6J.8ZQ4W_-4AI'\O<##_PS]/36>=#2/=9SXO39&Q0! 57ZK2P88.'2RW9NK\
M:M)G)[9[L%FM$I%_(820FX0BK#TU(\FJI])J.>FK7%;SX <> %B6:LC;"=Z]
M'=$1=S7'NP#:/;"I;2'R,YE';.$E-.-GKBT46?):_$)XUM/JKIA;/_)L3F4G
MEXJV03E[%#QOTF-:H:ZNKPS,<(O2.S0)Y3S:QN^@NP;Z[STE4$W!2UP8!'_;
M&P27(,]<M6X/UM2 RN)E,+JQ34:/E =NUPC](TD$ JB5PI-]H@JK,EC@AEBW
MLU+PU K ]?8AZ?XL<<J4'T]2:8V]I?O($O-(J,E!O'%1TI>M,_=^]M+_89,[
ML.X7@LSA5(ANQ_M7V[:\"'UI%;G]LB2L0\M5;Q#>A@^ O-=W:?EZ6HY2CQC2
MW=H@[XW->@7:5@Q#&SR 7D<OZA)KA(!E3_<H]2H*F)ER&V8G;A#\B\8HS4:;
MQG.>/T_/2+O#PCQ=?@^VL:#!3,\,=18 ^)SD.5\?C51\)&U*J-ILX(#<N>UH
M=$0O#<^=PE-T'@2<F71-YV7AQE,YR]L%,NHWZX^1^=Q=N8FJMB:5-#_#E,K,
MA5M='G>U)=;F9,7#T7B$<X!X?>D[!,$"A8KPQ";DO4&]JTO?CV1W=\B4< M)
M6V";3H_S6_O^R0L-YE&7B!\P*[<._9<MF>,KG]KN,T+_<4<0_2\(S;)HF :S
ME-,!K+"@,A]&&VW>_T*(=_=:H5M.,_ )KZ];XIEH?Z^R)<=[.1/3E@@4YSL3
M"<4HKE <\KA%"$#&]M3U$&MON JN]RF!,P6-NU*^3VU-6DZN3Q)D*JA_>"_P
MK0WNL.6;@=K,A-D(M?\N*##@\A.01EROE'7H/4RE0OGF;ZFH->Z3L*8Q7&Q9
MO(Z1^*R9R6! W%]]FI9"M%FM@+EAZT@YMM:MSGA)86+&S=$[Z:]AXJJ@EN-"
MT?G2%H5[O>4=T__6E8M"G(6%^1CH>.0)M1VM<$A[:9$FQZ.A[L!LUD7%5^<)
M6X7A8>XDV@[?Q4[I-Q=_=X+/ZN@WF0@WOML^<R;*7MQE>4&+,C+4^JK.DT3C
MY[Q 3/17*[>_*Y6%JBP>=OEN'3REGO3'@0:PJVNND#:\LQ9-<ITF8^G[M/+%
M>)EIIH-V84GR78'?_$'_3(=&_S.D3AY#.KM3\$M??MU_IMARS6<#7]9X*[1
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MTOL1<9B)[;H@Q6Q;I(N*-5!K<;&SYM"59@(G)W>'CO]'V5= Q;DLZP[N[C)
M< CNKL'=@[N[>R X!'>'X.ZNP=W=W=V=/++W.>>><]^];ZTWL];,FI[ZN^3K
MZJ[J^:=+N;C2^_23*P7QFX[)F%^];7#L6Z_;GQ92&RQ4- DD3J8[88J-3D]*
M[2&,QY$7M"C2ZT9V.AMYPI=EF;7]WCC9=[TRML[DSP@E#_[53/EJ;OO0+"T/
MH<T'9LWN&_$/XI_ D?7Y7UW^W+S&;"?%1-B'?K\TGA=-F!AYO#S#^.=6ZUWM
MLYF$^&L3.#3GD@/7S&NZ^Y/!UI5*X@N;MA_M+1\?#Z>42*6OK%<&7@8;8UP;
M=436U]RQ/)T_KIN\E[S! ,L$@*7BI/FI1[]3%C:,.Y/ZOM0EJ<ZG! (QC'OS
M/ZBF7\Q[9^6_,TUJY]?=K:@[IAY51]>Z>BO_B%S58K/GB%682YKU^IO5'\ZY
MJCI7*.#R@8"OQH;T1GL?'2S\)]>9F,PSDY2]?-(2NJ)_-/TWBNENIAYWJ3!@
M20NBT\1_*7+DG7EFH8;,)GF3 F$PO:9Z;0L X$^^?US'09LP:(X<6#+FVI$P
MY;(];GP]+M-Q8UP$>N/^:U[I>Z,MX07Q^G_U_T]V5$LO=6%9O:%HP\%M_Z7
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MGU9W.E2^TZ\*TO>&OP$[CDD[^>#(\.+R >#BL;W)Q:\45+*2$";2JY3DGH)
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M!]SR!QQS#(Y(#YTG=2:&QJW1^]!#S%ZAO-DHDW"NJU3>&V\** 7VN 87)J9
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MRI*Z>XY[0! _R_>]UGB@1<D3D= 4J335'9,%K[M,1+U81*24<3([ T<JX#>
M\B/"21JFSGF^Y'%Y9V'[E7<=L9]2?BB:O.9@SF4;H:7=*R/29&,QYW2XU!!"
M2A0!9O;34;"N]V@TF.!P;;6!O>&L'G^R58R8 %(1 7IRV*(LKQ04!H=>T,/%
ML/$(7UQ:D1(&DRB$>C2$$G4/'2N1+(<K*)&HI!+?O16-4K^;.VTU!:O6PE/U
M-LJG-HF=*8&'/RA3^BV?A80H21>Z];W)]<GI<J\1#!*O=2?<DG!>^0WWD"$*
MV#]=TJ?1P%;!@L)29,D2YJW,  1G&F*199/H;W$-&?(DHD@+ST@F@IKO IWF
M"*2$45GQ "/A-I]H&*B22%V^'E=.Q9&?RHUE@P_G",%%$)P5A$S1Y^5I!"%M
M"XOK;\EI"4FN( ',!J+F8I_D]2NTN_BP<P4!QTG*C(P:2PL?@@D>MX"15:2!
M855KA,&6GS#64!K?S"\(%C K3PAV\MJIVR+[^^=<\E)5EU3P?"UI3LV*<2%=
M#3 PDGU-#Y.N+T<"],B+KL&JW3U:HCB&+<'A^0?#S[@6,EU4&>G5CPA%\@P4
M^Z_7MT#N.FD"=_0X/IMJ6!13J/,:C5F+Q'G:MPX$UW;&1 JH!%5Y_ JSA>5;
MOK*S<V%"[76)/R9Y[DW*SV!JVL_1*%.@A7]@FBZ%AQ9?<5DC#8BPN&;*IN'3
MCNP<JEK$?HWM9B/'1C]$/!#CM1LYWM=#C*TNLY^"TC@RX?IUH\:\*%!H5U_G
MJLBQ WKTN9]K(7"S:78]9H/0=["'X2?0C[W_\01#AM*Y8FL+[T.<Z%0T>4^B
M"P+"'K6[0'HI#S4RY_SV%I0);3G),D:PI5CAS=X$DU5(V02G!HOI4EN;@!O,
MJOD<2N5K'%(^_/(MSEDH#2E+(W/2&+\<2IK14;.2$FHI1B( A 0+CGX&1KM\
MXW50:WL^OT53+A<J-8P?([!C<G)U?')A_JF9!:7HW']] Z_-PX%AE%),+^*J
MZ]'R!'_;7.DXZ/'B@E#J$PMYB0\L <J;GO;M3'[M#5MB:9'\$$M0VRIR,8F-
MNFR@AB]+:X*(B;J'RC3[8JA+[/3<U^1RHG)5EKFZLY\%\;[3':G4X%].)"PM
M(FAJ&)2_0*2D1&"H")"EA ( ,*23QK:O,^\6F@&]BE'Z>IMH%K*E:3%Y7GD(
M##V%NP<]/L&P57=C09,]LQD[Z]RY,X,]E+E(/=7S/+2,C25XJR0!+@/D@O&S
M0*)+'[69[:;T4HCZ.EN:FF;8F '<1%<7+M 2/PDN  Y*<&V?K_[HD"%(R4U:
MA"O31SS'0 ";-=I7BWT97O9FI*^-V$-GSQV!(>6FHYC]?$ -V]]ZOJ=L26H,
MW)"MM*["<_EIUO5DO(A[--8[8D/-HK9'6CP?%/_9>^J%V37TN["/BZKF=P7A
M,055;CL+L5\YG$JU))VZRS*H=+F=O[QI=T9B5-%)!(&&NXJ9Z+<+,_AMA',W
M/J1<)/Q=7U2NS.6?FR$(/A/US _D:/I^5N=L"H7DE#\XK8AUB'RRXE^Z?/CY
M)/NI'G(Z@S4,(;$I-E>2G:6:+2H0L$!YX6%*ND;2IH%*1KX^R7#/=L7I,E,F
MPU/4G1!NCD..,K7"04-K>,>PTAO=VR:!6Q*))L/GQUX503*'<'7:U'\!F3%>
M12HL5)!]&1YKW\)R"9Q:>J^D\Q!$^VR0Y-S0L\W"K497N*7N:M"H,7QW^34@
M)-I8*[^7?M>\,&-9@M1!?5W,8/R\/S\E.=' *5:"<P0<5GLU4$5>BAE- ( K
M02$ )L$%J6"P]F'N=UL$#_:>GY9+6+K?S548U51L=,BUX8FCC8$#8G9]S;VH
M63<+:>Q8FL(+HJ,Y'$AC.V&Y<]:6M[2(FO91_MY:4$ZN31Q17V,7+QG.":6>
M6XN'M[78M-L(H5?JJ@%S0)4.@D,;-$?BL\]FY."^*"J<4]NJU3[U>GF/:@^4
M7?AJ<D,&ESI[]4>*T7ZP=</+L%J;JCXT?8#<;2Q!HZ9B BSF7(,EQ)A:V%*,
M[)A=XHX0,]*U6=?(K5>.&C,C=&,6_F!$]\(JWKGWBG-KAB7W-CD@K:&UL)CX
MFMQP(6[(_A89QO<2*1:9YC0H,2Y:4]J[NQ&K 7AJ]<7SC#T5 K16Y)#LVIHB
M4L'IK/W'*(S>/B"-6+"QC?-W]M^ 'PFN@K\!B9"Y!GJ8THG8RL1$L"79@&Q8
M & 2@/OQO%4;SB5 M=S2/3U7XY/R_Y7;XDU_?'X 41MG,Y!;8F4 >"2W<ZDD
M2(N8\ *S+6_!G[C_%M8SMMRMO*8S#-W8('P:<N=05<D.ZF;CE!'2,YAUMH;I
MG]&6(-#2$0_FZ- C =$Y$@"D G<2R:9M))^-.&S!;QX<Z&JH &OSIH.?@A?*
MNV^2 PSIR4BM<!?&/\-')NRX<)@3-.R?0VO&&#D;R&X"XIICI#+C>CX1'@JZ
MVR&A"=H27Y\I!=/&]YX;X9T8.D$][ @OCW3WVB1%]N^\4CO >@CI&S:311)U
MKF.6Y28$"3*,)VP%IBF.. -;8UU!M;"3,P$PFT,VI^02VSZ*5S4M!.2*@KO\
M<XC,,YYAA/<KZB8B7)EZK0QBOP&H)I'\_<.:+PM,8]QUL=RXM:W5)B;<^<FQ
MLD_'KP4RK?B@4[]:V@H2B0-6EH/0W9?$EPW@[:B0R"0B.:V?*29/6&JJ&]"5
M!?.39RPD\.?R$@9+!W=K@:8"A;G2#K#%\XBB4OPPWJ'S')$7KE&T*<K%6^"N
M#MF#;MQP'<O<8.KG=GNU!(E<BR>\6UUKM_!)2;$T"E_RU];\<JC#:ID9050$
M2&,% ,KI^5W\"?<]!&V2Q2TN9I>W^J>PTYHE0*BT?0-]T4A7'*X=M]O[^PF%
M:TLV-CL(ONI$T$KJ]XP]'BY(D=5$$U;2U%C9&MDCSL5FQ-5A?334!&ZRY>O>
MSQCE<!"((,39:'+'P8B'1DBUY.QN.'W>*NVQH5I*!Z@:#0_^G:7%ER\N30@_
MJ-I;0 .>MRQMQ*D74!%, O6$QYM(!_ ;VK$/QVK4%Y>((K%ST5446B2*30RD
MN*OISM774I+CWD!$,4:Z /9(@EH[CV?=&DM+_=-C-$&A^&;4HW(? [.8W!=4
M'$=JZA5BM^IPE%[\K&LI]L+HD7DMIB(/,G*]@*,-U647S]LT+VGV=2T<YGDD
MHO*M8B&W(5\O-^![ AC6E=@W?WK_D$PF*#O\-NQ9A[CUD5D*V\ZD0-Q,1>XG
M-WN4WKG;(!T4HQW@\=XE7?DOQ,S^SE=7TZFFY>HM;"_!) _/)/?52U7".)?/
M[;,-AS8 -I0.U./-8BI+JSP8<F\5+J$O"?B[9:$JX#5+M\PY=M TIS-&%O0D
M&?0LY8*--.5J+MG%+"#*U%$"^LE97Q@_E]'M2^M@IVI*[#7&Y+*YCAN:AL:$
M87XQR)NL*<X7&+D(8GU5?-BI>=F*\$%O?SSM>#34[:/_QDW?@;UP);41^2^"
MGLVL_,61W-5?9>6AZQC&3$74@JD!R&:"DV*Y24^T4TO%IGJ*6A+1AZF'OE>:
ML:SY+0DQ\WDXJY @9P,:1Q%'!/EV=5#][*?K=YY\X9^U&]=UI8^!Z_#%./L+
M_KJFN@8IUIRD%QF\)F$OPNYUD8^[)$2-8&G<SPL=W.F<D,+RKJ(QOP&17&HA
MB<N+G;&+!'!$#0;IZ+Y*E':K7.29VUO3E+D"ZKNQHK A82RUS,@ED+'B.")!
MLB6/8X\2U3B!",:%_C81K0A5!J$%D?L29IQC,8?X%!/RWF+(XSW?G&WWXJ::
M&F5L#PU[:$V:ELC3K$*D[<$Z:=(8*QOT$]9Y?PR:M+2G2NP[EN\EC,8R7J6$
MGFA3M1<>T)7-W-F-;KRT=XK@F'!3\\,BW,1$(H%PFX:?VR,J>MSI6^.5.!/(
M29N/&+G1MQ1.;P [D%YMPPQI7"+6UD9[+VYJN1>2+*DZT]<^!5NL()KX(ZKB
M$IR8;E4 N/I:&"*9A3B/<+XC 6X)T Z*^')#3/4[N1JOAPX7G_G!%*Y*#S_I
MEU3](CB:0$ZD!"%8*:,=AY@*5]PGGR:5^AQI=B5IB)(I.CC\AMH;0M"_EOX2
MOVPXR(2Y1M5#=[F$F-?2F+H6A3H<(F=(8W.?E=ZWQJ]F:O9'DR\I!5R0/UMD
M+T?2XP]Q@S:!;S>MAQ!?/S=JHR]H)=A FX))X/T&!)NZ^>RHGR=IV;<B]2EZ
MTU2]AVR:CVMO*PV "\N B7>Y))\3@VJO*.;4 L%HV']BPYXN;U614IN!N. :
M)1SEVIC#C7S"A6LE%-SB\_ _Y@ARP;LI]:')C#C,!)3G<%168-NFX"ZS4/Q(
MC49DSC"=*H-$L_?T8;$3QIZ?%N]25I/'8#5A49%7#P&DEY_O-_Q &[@7EO%A
M@J(B8RE/;2)>9V55,08UATS!]T/QB-(/$P2.HL+R..0,X2'LBT%\M4-VR$(X
MM"&$Q+&V9]:2P&B!WF;F$L/CB# +50[%,@:M]*/\K/&,WYH*H):#U/2(-E/H
MZNQW]<3+](7-R3L$HW.086+KM& /+O#)1=$CL@;3"-L[#F[&\?AY+JI3Y!F3
M5$*P:_RG@6M<$!8$'6#S&[ IM9BDJ3G*S5@U@OINMHTR3T/,'[L<R^)5LB?'
M<^P=S[8.@K<@<&[VWY%>)1YQH"&@V(N]OR68->1ZR$\R ]IQDS,J>Z2E->PK
M=,K3B;Z)DZCEBJ0"/31_V'EX1PG(&]%1$$([(QEP'[AZJOX&W%IIB;4PYU^)
MN?X&@++(Y3$07:$()Z),O>0MMF5H7)^(X&4V\VS"L^-2NA?)';;#!#P=(Q5M
MXRS:CI>_UGBP37KB$\SZO*D<W=ZT:'[C58[3O[H63;+B=L@2Q;0&F'/RG)U$
MN+-#$4UE58,F\O[L=T;4*K4GPH?]O,)RCM]&--;O.3MRX[-N\ZX#8KP'[C)0
MF*"GM^,YF[D>N:Z)6JS4)L*5<[[KIE,O>P"SM;Z^4*GV7_(^NPGY#E'-_JA,
M<C.N&X^.V&2+HN+ZW)>@N,L.1@16P[)+TJMDT )6$<_C63JR.IS+;B(!X1H4
MMUS.Z5 8N/B^VF 8K>9VR-NB%C>)+9>9_1SY*2/H]7ACA"+7VFO*\N['Z'G<
MZ_7*('\N*8FF&V\&5+W6&Q>*M\)M,,R9"Q.*T$]EVV^X<HBN_TCPC,<'MD1=
M7<5 +AZ8L%Q)1.NA7%<($+9:*U4[#P^;HIQ,I;8C+VZ/G#%</BG;5L]M#*M+
ME/7AI#Q8"CD!-YU='%#Z2&J! I:#//FSME53*^A#9^?QF&"R-PC/-BBM@Z)B
M2([*)!9,KHUJ<8[^<27&T5-J$IS8VV0DZVL\IM-S \G$Z8E1-6H__/VKHYU8
MH<1Y/6%N9@D5>IFK-C(TGXQNK2M3:;]5NV=,^V1JND/=&IEWS)V";4Q$B#;@
MB474/5!R<G6I84!]Y>K,(][FG<J@#^/NG*GZXDQ<>WT,C'"7V>9OYZ3M@0VL
M^-X-?7O-=O433[F8PFU!S)"\)=XJ"!UPPB5(GNZ7]B1LQYKW8]$:W.'P^#4&
MR2_U4?,%RJ:Y?VR\_/-1E%SM0E46K^ =OC WPM-<9Z)L&[V'=IB&?@SN5$4%
ML2\K.U:Z\3(/G**L[^>80/O^-N=YVG*Z//Q8;$427<M/6R/&AGWXMC_$B]].
M$GC+_";LO:T03Q-E!;8>,>/O088,>UJ4S-'8PK0=&S1<2]WQX48T;/$3?P.@
MF\*.H>Z8A(FE\-PJ N.O">HM]W_HENF8.F4=)*X+ON% 7W7V9*$AS.ELOH?F
MU5!RSV&<6HX(+X3*N1F?M()U)E7@9ZTD'5#UX[4GD,1(K!=5&NIJ_ AY$'7J
MH#R_>Q[N<AL$KM8-(R%3-"%JP!'V7<S0RBP"7^N:\2V\B1SR'*BXYWZ> OG\
M2W'ABZ;]^U3/U6CQQ.(Z1#5<@BG<THO(P")S6P CYM D7K@'LX<X"GOXF5@.
MS68T;DF=TO7L>J[7TWMNL\\"?P4#T)6&.E:H&;(XG,Z10\.V*&]'0Y^2560L
M6"(D90^@A^!!PS8/RYW";*_"PSB+A07[)*/D*&G[&V,\X?+N69QAN%-8RLM#
M>>.T#O?6]75(LN]+_Q,0Z5')_:51!S%+N^%A<6/CP.&:F#QD :((HJ./99[Q
M5?1BQ^%E*]P'I?5Q]2,.(.RU>6?_B ,&KO Z(_Y%<+@.%^64AM9>V]1LG A3
M66$<)K)/QN*V+E1&#?(32ARJR$-PIG2O/J*$.,3-%0L1PKWI$Y2%Z#3U,HFD
M_^><1W6I(!^ZA8^U?*LWFE0[A7Y76\4]A K"";GAF%0X=P^1R4L.MSGQ>E])
M+=&=0%WKHBX6TX2'-'TJ])8?K;F' KUT18944WG5+ARLXKG)F$00W!@3Z76K
M'CNA."?MQ$B\(A>W(?^[BUXZPKJ5P*;RM&I.LH?<Y,EAY:DI 7PU[F28"E"&
M@!,SF\>!>C!8F)+SA_^M7!YV$)[Y^X8E!;.U*P^*=>TXSCV)LW8!+ A+<79%
MV?]J".Q&J6J\=-DC>5'REE2)791B$V4D$F8KOU&A>=]J(G/.Z14G=MR.[MP,
M?_&&)"7-LO"<L'%B9W@!4E +@:FD#7C#QXB-_KV''NQW$M>K9N_+?OZ0M5>;
MK]YM;[1]:P3[$,960H=!J@F"X#AF@I !0'!GVBN;D&UV#N,9 Y>IE'*36!AX
M:X@5)JR(A 8)%3)+(654%OC_5=C_#BL-'.@1O?@5C="PO?>XH+VG/0M]=?":
M>)K"$,EGJY;2<M$@>=%HYF=>Q\E5U0O86,_2P)AR.K)&<PQ]H9)]<L5?J.*0
MV4#.?PJMZ\48M<WN@_>_:J6&+2=5_2J,5J_%M"^(,+=ZTT^J?H:A11HY4@?&
M@"#IVPN6=V=@O=U3 ^7)OZL(),YW$ZWAZ.^@HVL9KFE2O4SJYHK<;^]1Z)/N
MY'D_?+A^O7G)W1BYF3B/\J&?X&_A??V[6?:;J!%Y *KX3$Z+:_U='(F%O,0V
M#A9J53'Y]P@HP/]-_V_=D)DOUO('YL4)."/PH.\=W\0QJ. 5$C?\T+5:C[Z(
MZ4OJ'A1?QX72DS=]A0] .)YU01#59#=7Z&AY@=+]A*]N_:LKV,H^PK 4)S L
M5C9'] !2-]/'R?/IF_O;U,7>T\&#6&<T,Z>%13%%:[HTG6K+H?BY\5^M20=9
M:P3O_TZ,6U<A:'PWX&5WD!0=".9TB&.U$FEW<:SS=(K(TZ[S:UT;V.[=UI \
M>^ %%\U>']DU%2W55]B@K96K:]"F#D/\*?X\_%X\SQ@=%X3(XO^I,67&F(0(
M:<8:&/&H&62- ^-21.YI9(5@:[\G%&WQ:J-CM 5^2JL]H](O\VBIKCK>Z$EW
MT=PA6:V JBIC[MS+,V<+)Y"8R%%K0B-G!X1U7BUW55?:U5W<(&M1 6OKBAOS
M4Z!A<U<"6I?W'-<3^\"FP'&\DA@X4\8^;NN2% 05@ZJJMIA%@%G%%G=K"ND,
M&;IJ08ES,5Y ACNEKTK\<1$N]$R%OR<5[I4+"1&J2_QDA$8HEX6[>4RO$;H\
MFR&4IW.S9SKZ,7^89X:^KA?8$M#U/Q;#T;X.4^==0NZ<3B[;TK&DEXQ+K*_E
MB\;5M0C"G[\72$!/)UZAPD>5AWZ=Z;8(?5:?D>IO;4T^K C9EHRMZB(L#B.M
M]/O1(L5H:F(XCX5_N!ND*2'YHY7"@*@EW(9AIIH:5)JYB!;/[-..:<3IL^44
M9_.*5/T=N9^XD3:J().?"UEH&R8&T:$337B9QX_]$3DJ^X6_Q3K6>%I?.'Y(
M60->V2,]&^_[B/*Y.^ZB<9V,8>E^K3U.)*C^?MO.<SEL)BKT><.)E_$HLE_3
MGD&_ \%C@Z>CA)<G6#?/'=%#W%L>G<=0S%:7_BMCA .N@R7ON=9NL%T&C[#$
MF;'@;&%)]+&N] 7B^?[C 85%1E<31]"!)NJ7OJ\VX0%8+&JKW!'KO+G-[;-1
M_;SCG83A[5,98Y7!Y/</.+?U5Y8C%BX5EZOXPI>\MC9H_>Q(V+=W>\J3/1KG
MD8];IP?LJ ^03HKB9C_1XP:9%N4@&8ML+S/O#VS+S@;R@)9-8CYN']'FH Q*
M$6^T:Q3T8*T9& D\>0S2A5TFPM:P&]<O)Q82<1(Z"VU4^H>@QZT-_#9M0>HX
M?'^EB@[MJ\018EGVKD6>^JG%X5 ;M,!TE$5<!U0#^G$E<<&?4 6K;?7#_D5J
M7L;"66B>\MRXO'2M_Q&GFAAL,+=<(V5\OVW-4[QA^^I5,_99L=#8>G^RA*6V
M^A.*MR,#7K/.[48>O+#L"H.PHN+RDL2^]<XL99C%*." S#0^HI#7AB_4D%D)
M_ @L#Q62#QS+]%=#$\;DS^00<BZ0B'DQBF2%.5TV#7>IR/:_@TC%A?'[3K6V
M\<.+'R$^,_3,SXPW(UE$*0LZ9BW/?5DJ/ZVEH4]W#;TA)*#"G2.:OA9OL@S'
M%47;'O.6 \N*=OO=1",'*VU2K+]T!3T2/7!UJ6) "6X/;?+5'6[A!5>GSX\5
M]XEA+RP!QZL^X>:B[W')6:1,.*UT0)]G237.,@%IG"@W>+=:%]<&1ZA*@:85
M-_:'8)HV(!OK.-3*'VF+<R9:3_PWQG/GQU?C\_ 9:S,O6NF55;!@KW/[X^*%
MA2_5N ROW#B./WX&!>$-M+DR:X9Z^G/AB4?YA;5JT0KFQK7VS??:>,&P$( U
M>9-T]24-YO!QGM,7N$/^!FBJY[(8LQ(&NY)EL#*< J<&/4:K+QA/T126)U3N
MR8)M.K*TN[WNH&;MX4_9#U3?U9D9;5/6/B)29&,6$AJ\?#6Y<1WH#AD7N1)V
MU8'4F!6W40S3@NUACI;_#U<9?;(R%)Q<A;*[/MXI^)!H.2(LX]+,4UUA,-I3
MO["&TI-U. X,YS1R<&9YQ(8-'O&0%6?$)5?-;U4SN%9AF#G1:#Z/\'1O+CJ&
M)0@029)N9"T)PR-,GE!?35&;BN$4%RO :S8S4';_'"YXJ29T;<E36"_;.C:0
MC:2\XNOZ$)Q?^ F>V-=%8H.'5_S5</7DZG%D#2>+S/?1BB7K(^FJ8SF/$H!)
M$I_M\?J&*X8H](45GAH)9-2&[!Q)$--0T3FSZ;Z\Z%$XW/(T\D =-4(V^SH"
M.&PZ@GD%54-UY+SZ'YL2S)A/&0O1/H*W<=EH'0%FC-!J_9#KNS-7M%!T&>,Y
M3S4SPUK.?UN9*['#M?ZY?=]5S$M+^#W%/6LJ*E/K"7R\Y49D89[F!MX!UH]2
M5 77D"LJS\VS/=5Y[,^(O.W/'8F.O%1:0=#*;5\<Y#%"=D;),V%!*@[D;XP^
M&LK]:_":8FMJF:0'B]\.&'+TLPZ:#Y4]-#OZ9RD1!HXTK\P,S<8JE,$B,F>[
MC+LE&HX5S^64N;-S>N(H-*2%/Q0G^=>UB74@:JI.U/]R(ABO&&-B',[_:D-0
MT&VF4-X(=7^!)/4O6W[]IRV!JBGUQV!>&=HW73&QPHK]>?N31J3-/,L7'COK
M>\6;(U_T(U_<M-> WQ- *7=Q%,5GKP&>)+(BIV-(U5S-B-4C.HPQD?(J056.
MJ5/C"=-M8E]W>5?[MW4V;YT<+A@J428]Q<I"@YHFS#XR0]/DB4I%3A$D.X+_
M<3J9)SI*DC6)@_J5GRM4DKN7%-IT!05!%%B?-_TY!0+>GHDACC0*_' O/3:;
M$,D5NRT]8_Z SGTZX#RD =T"%C*\.<V3@T3.H%HTMPH=/G4C[XV@JG4%?<72
M+%%?5Y^+>C0XD%2I)V% QB=.5#/-#",O"SXZQ222%<.T-FYNM(@EF70YU3<^
M5I68Y^4S0@G=9W-/"]?(45T:P%5]SDQ0ADRSH2KWGB!O+-/KZ+<MSZ5O)OQV
M[:>=S(1-.O>J0["!A&=L!;X ?K.V]?$CQA2,(W=KF7RHUZ0-G'\GU$V)6J7W
MI Y1^G@MMCSPU"U=-W5R[>OE/TI*><-^VIN(ECZI9-'V-IA@&2!:5BK##V^H
M=UJ_Z^G@]EYO_SJF?*)4]!"%9-(,H\]CZ 3<2:934SKD8[B(W!J7]Y9ZI$A2
MLTGI1BEAE%7*NR_.&&<OB9,C/_!)*L):8@#F>-/LBDU#2.QBG,^PIR7; Z?Z
MUF<=V,Y^BF:T#]O977IH."!W4T(99=STI!32JEN,J"HHN7TD90GKP-5ZX](_
M+6IJR4J; [E7D1W]%>-VK>DJD0EX/3[AY[:(^&?YA-"Y@AOWA5&.;M=[PJEQ
M-F"%(8>\97\&PL1BB!GNT"P_0E<T'6?_AK5VA';JU=X7 2@ &+5X6$\ 6$SB
MH$)P^2J/YD!]7P*B-Z209K>(M]G"L"M'4"9* DF$& *U)WDAM;P+4VXVE+<3
MP7R'QE[-LO*Q]3M8F^-.W!)UYN ) MRQGI@I>>A=,=&UJ1C5++;:!_O<!;O_
M3,<T]UUU!&]Z=JH=D^E@BQW=\MR8&0UHSS3]3%7-H2J"<)211PO)PLA@2P!_
M'O( 2%_ )& 2TO9E' HY&/X(EG=6/"<48[@*RYX(%_2,Q[$('99B41X#TO5+
M1:E,F^0Z81[[T-'(^$P2U\(89N?7MO$C_@G:-O^#_^?T.K&L7_,^:,;3&IPD
MARB2B[]]:?G ]8(Q'$XIIH5:$'/RY]=3_,2O8RJ!8BK;!*4:5Q':&5K-<SBD
M*WGF.[A(M@R#R_&H;D$RGRT-Y$Q9B72US(=:W"'3_2I\61!S"&UX3TQI-I41
M#+V 4"\<#JC=*P+W38A7)U/V!(?C27W U8>4=C,*XK.\.*5^1U6V.Q*);>"-
MX,@\'%TQY )=[@K&WGBD<$7\1PB4KU-J3V]G"CVI7 VP3P^@:BZ[R)AYM#$)
MC3:+D]M!\,Z BFS>OU:01\"*<KJVP&=='S.3;5&V0REM[W7X.1YRB;)(ZASC
ME"O\]XB=B+2>!VWSB+)I=_R?@DD^ON@6$/LHK0F'L9/F9*WE[N#E2!,)M=O>
M\P/!:5;=P*Z++>\2<^35H,88RR9<M4:*0,#XX=AYA2E&3]:JCM!ZHO-_;-",
MU]^T5\Y=,+=P;V\3WHZ,OH=[71\,DCLOI-)U5)O.FW-!;JV=1O"VE5KMN>&)
MGQZ2-"9(6B/<S2PO+.'(W^6:?#!M\\RM+HS>1\WM\H%V. %F3N%,6*QT()\3
M2E4YPAMJ!:6G3G@F<9ZG.7;AFTJ<*=7.&?":0TW?WMQO&13ZOF,,QU':+_X)
M1HJI:UP&+.4LZ?T3W&60]";W%.9S_K%%U/P"ME"%[R^7QYP7N]4@ 4  OX@K
M(H#OY%ZVN=?-.&/WI!^_3VM/.O"461^Y:2^X,'Y:GW&M>;TP;UT2G3^KERDY
M)/%(_;4U;C91;C,%-E.ITI34Q-PPG@=^?0R<=F?V/R]%[ )WK9U&.1&H)+BP
M:9[.7C5<81V7!5V;F=< *SO>)%';:H\112<1W!GW="Q'$$-YG_3D_1_QX<]I
MT@C#OBQ%W<CS--N-OAX<=7=L4;+J;F6;&AF!&$7S'S2L<$$@+T\[$5YL"O]P
M@)R%$ZR4-8JG_\/95P#%\6WI#X'@$-PAP QNP6& X#"X.R2X#SI82(*%H(,[
M@>#N[L'=(;B[:] D\$]^\G;?[GO[W]J:JJGJKCNWNX]\YSOGGMNS71_U]O"U
MT,+/5Y="V6WL-(\ Q9:QO;XQ]K?^5D9>68>'1.]<8C,<R&R.#H^W#:R8/2*B
MYV>$O+0USSQZH^>7MO-UY1)GHKPWXZS[7TR_R9W]*KN.S6$H1.;%'>-\J)S.
M)N7.A=DD?A L4] CJ!R[D.<BV?14A732>UD[L/8%L#I69B/P-T4L]W-_16LS
M]S6>_HGXG$AT=FV4NE?="M0P2,?RDY$I.W"9=/(VN_DSP2]2A[!_CZ>YBNY-
M>'KU!V_3XQ^,Z/&^FZ0\_OR6.UNR:5#([.4K48@5-M_)5:8'R?@]N5_]G:R]
MTRZ;FZB_EYO[_NR+?X5"9\U.C,":NM>NZ,\4A'('5Q\!8<W"6?3 .NZ*\E\F
M"_MELM+E,QS<32J70X[4=S/_$^&XO\*64; %GKZ9&F@<R X $F1;?*S\1=WU
MW7G>&.E3I%.VVPI$1*]LCJ*^TWS_C'[73I9!]9]00_R*:9U*R:C)\D<=[F;$
MYAO9J-.K\=I%%=-WP,:EM:&T#[-O'0):?+!9_RZ]GKQY9K/_60(B4IX'+NUN
M[?BTNW@O"5;IN3E,>Q;1NG3G^9/FD[#ER57>1W$M$Y7C3;)>):24/GL'*L.%
M\!CH),\Y'*5^YNQ?R>7H)10EQO DT:OHLK_.G?#7P[,GS[19U][W['C(/7A!
MMYZ#_TX%!J _Q-R=FM>$O'X2UI<E-+8ZNA(@_C#["U>_H0Q&>3H?KANM]+:-
MOH%O+"_<>X7!FJ;$-\#-*,V?@(X:]!%&HS<<JO^@6>''99(+9"@.K24+%.'7
MDC('[U6\*UM_=UPX776POLUV@I]<7ROP6!9U?@E"G78U_=MM]][EY[U#?6#X
M2Q0/@C?%:0P;WZ]&@_I>G;QM>1\U2L7M\69ER6P=7P=UF?*$BCL>VTY?<'Q!
MYP]::O"O"/Q8Q5T-E9QKD]%.\1CM_)S.KSC29/7/;K1G,+=1%_0(D#EZX[5,
MV&@F-@LE9CU3 E#DB0FZWC/Y%IZ5KK4UF'0XT]780C;KWKCL_NE@[WW-H5*X
M\Z2'G0;-21,O\Y"H#%.(9W+"QX<RX$!0VCNGXY,(2;6H#[;A&G'[(D66)4RE
MP92?$D#3&0C=W ^DL%,X2O5JP6#=*(DC)4IUP775K?4<UKVFN[2L8VEKMNV5
MPA*PP5NP\N\ <YMS'N1T<]F&I:#AB;\T= D]4?'F&*EO%#GZPK>R=5/U8]$[
M=N7_<IJ!BTFML@EUF?RG]B^:,>I#\?WK:.SYN_M=R<URCS]<\AEI<ZO32KNP
M\P/[(\#*A]="4B('=R!F-"7)'7MO2\3N7T:>KIUQ+[K1?8^4<N$P*Y/7PG47
M^VG_5.*^+*/+W^$H^1Q:-O$(.-$00MG7GWT$+') '0IXHQW!\K*,^AKN-0/L
MT#EA%T8+8UM272U=RG%Q),J)M!!)V_6UCJP@; E>J!B9@E]OHH8*Z?K?I$]@
ML?T]SN'+;H^;^MI3<S;VR-"^7_G@0.N,>=1A+@KIN-#=.6(3VE&,J_:Q&U]
M+Z^[K"L88@[&(:9XU5R971TKOS 7.S]BET"&H^J<?G9R]240KH+%^(NMOT:I
M^2237:^Q.%C13QY.^#+IQ.)L3VQU1@@H\U:IK=V[E"K]CV6@'*.K$]S5L5V4
M$F,O[$A%*Y*(PJ>",M$+Y1F_D4_PA^NISK_P\4$*>#?BVFCED8JWM[?VM>.
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M5X2!S+W67?II9FT"KJG_@X,?_(Z&<%&&UKF5P: BAC#=I57RC/-'@(.$=43
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M-X>)TN6:F1':$G;2*,5@W2=B($W$C*N$[I.X=<\Y?;J?34Q6&5FETUI:C6(
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M,5OC_OS(#[ 0$M8^*S'"EP4.F/]YQ(^A[PFG%G>)-VR_,FJ.$X/6.,5S 81
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M:T#AH+WRR)SQ[?NO;92D!13CCMAKA;F@)B<0+T(")X&2!N6;-(+TFH4VR"/
ML)S8T2'YUO$B$C.FTF3MU8HOC#Q$M;0&VF+JEZ+.B^L2I'\%/;.[XSNGBHBO
M3,DK&7]:^BG?_2..<2&O5;T[^+))ZU+KOEM$\=4\I]\'GUJZ:LV%'\5I=^))
MZI\9Z^?F=MR^UM75,^7_;03)%66)DCSMGBSL5&>90KY-1J.# E)0I<VX-)S]
MTH:/VP20"'@]YEDEC:6_//N2O=;'>!UM;5DM-V:V\Q)Z;?^#2<T44IR)[ 0^
M[(C\=[I/!*HZWMCZ,G4?K:5-V\I1\7)EK$48U?PP['P$_!B1EA.UH%Q]!,Q;
MW(SX?/C\/4$-QG1.$TK*1MNT&_AEH'!T@,>;8E5$Q-TKY1BZOY#7GZNL37*[
M_Z;KXM":G4]T8<C>=8(UE?SU"49M=:U2:7PIBWCQ/PRM&PR^+>AI,X*Q>W5
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MA1EHBB6,N2NG; N9E=L5.Q-+S6P82:?+RH6>T,9(4ZWP.CACW[JI\U>?A>'
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MJ$OFC0\]%F;D4WX]=0OI!!9 IVT^3OC2D)>'4\]VBI4-771$G8>+7L2V'!A
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M*A;#1DD09F^&_=YEY81Q)Z0USB4#YJ!E[ I^'A1P@(\?]2"D6W!DSV]^!>;
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M1#/*NHZ23EJEHW3.!*C6D%?.OC9DZ56\"]&C&RR4PS%,3B&Y;JJD(U=[[&*
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MV>;Z^^M?:5?>2[.>MDSG:0XH4 :2R=RCQ%^$.I%XS/50^?WN_13'X?,O?QW
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M2%=-)<Q;(8<A]DDQVHTASIW5T:&@[$1)BJZF[B"PL=NHIACZPUYV>?!%8GJ
ML1]4D6%D2LV,+U^B5)UTF[*3S7ZQN]J&=<:$(B\P>NFU*!N)9(;1'%;HVUVT
M^8Q_/$YL_"94_4%JAV1V;9,_L_55__M(;!VO<]-DNZ$HR<:WU?C]51E!0[7;
MGC .JV)KFE;_[>8)Z?+8<(JOP;XDRGQS9K%>*OC8A1BBGV?;?P&T/6["U76(
M=D2&JZ>Z+OUFS,^+66&0Z*5IZJQ!$O8:$#8=%NOK*@-S[,]/PW]J7?=,LU+
MO*</#DGGAK[1JXC;<++",*2P&V,G$E!DK_9L/.T&#T*?G=6VUFV<]Q!>H[XO
MV/_CO3^5^][77%R BSEW C_4^C/-%IM*T^;3IH,>\:A@R+9/-=P;>K*XY:]W
MR0NZ&-+E8]QF>@E/GTJJ/:I4MGX3+SDPH!F'T#.!NOT")"GT^JYP-E1M<]"D
M;JZ03'8354>;KJ%R!J7H@@UQS!3[YOK9BV/I[/)4%9A(513_3F\J[[]-#'&
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M3B,N_G+SBM-G*H+.%=GK;SC6@"R>9*;K/,+/ILWU-4B+:EVXW;^NPIRAF\%
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M&$2#=RHAS\9YSMW_PNI??Q&GCX[CZ *5"P%P_ER!J2VX$/]BUBXN0<QR*=J
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M2:,=R,ZKIL;4*<^=2U_121V^1$*BL2H11F+#0HV/0S3,)T);[G/^W)#'C%Y
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M"(K0(&*0_[6]!\#BR%G9[-#-:Q)N,1L2.85N6^D#6M\*Z7S:*CK@8?&0]FY
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M+$+>0M &XJ%\V[7>M6,'#[J9Y,&^2<0HU73*]V=916F3UY;EN3FKU1*CH-P
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MQ;[Y3,[H.O5^6=\),;WK(VF,.M\(CEY>38_P%N\=(J*">.+H)C!6X='6X&]
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MU0#[ =Z"B4,YIS"254:B2P&G=T F-T6HFPRHY,K R()=<80R>TM1AY7*YW+
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M8#048YFW+:"S&>(QRMI_VRTE=T81HZ*ZQIBL,BIZ"J[(SY(BAG'_\$H@ B$
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M*T2L;!G/(RG>.W(!C5EY=_[J70L5750 7-M9SP!=0V7Y-'#Y4[0N:(J*($_
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MZ>G?N_6DA2L7MY0?GU<HNR# 0\($!ZP5.Y&;WZ"DL$IA)"FLW.FBZ$KT0H&
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M\1KJN6IJ$]DXQ\)F]!TRLM"HT"[*VG0KEW71PRO/WEE7QDNM 'R"\_,1@7Z
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M=O_#3=HTTCMA4T6/;#L5]+;2GF+Z6"5E2FHL,6@H'^@'.=5W$C-3"G5A3YI
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MEI,7-A.'PS>]+"89K?9A):/3IEG@$^:B32,(_M0WSA^*)W,'ED^=2G4YD'Q
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M&6#)G8VSQ+%C0KW73!#94J*M*OEM%4A<F!$+/_=R('_K_LOEES4H0D@-:/H
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M5/U#&]ZB(Q!ESM;J%[4F=A)U"6CUU"^95XD][947/(";U)$3'V"$0LL  J9
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M!8<^2*>*35#;%X@UX)T0 A:E,.-0MW'IF9^2M/RS' 4HN7_L_G/$M=Z(KB#
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MO9M*1]W2F58PN,6/E7W!,Z:& ("_5N/S28KBU$DADY= 0TV_A@DMT,)1DM(
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M@TB_B98CF6('Z1&0 IEO5HLF28LAFDU!$C)R2INH4W_/"S).,0F3)FSSZQ6
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MQ^@6WX2.2IGE@49^D#(!O<"_V1#;*(1(P): )0O:%JH')I:+Z38TKL]X8'W
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MBC.[ I9#7Z=,^2OK(WE1/<B,O^OQ@#*)_^'>_[NU1&0<("!Q-E&-U\!8VT?
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M# "6K"P*(D9C19;,!6R?>5O'&.=G.\CG'ZV2KNB%7NEQ_TZ"I8!GFP='_;@
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M1;5+RJ0;FF-#'HM*5U,^EYC[)2'KDD0W%CZ/5 >"'."PS<"F5V5/>/E3;IB
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MU/GDN.41V.PV+,Y<9;A@-E$KPL!^53LZ1\:X2'O9R<L/RPY!:)$BD((\6C
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M_>AM'>T4L^<F0>T;_&(4-,5THB#CQ=12/KT?O6\%@S#_7*VI)XX.3++I _,
MXA);%<LM#KA9)7<VT_ZF!D^3WAO38QAG;N$ZA#.7<62LRJ[=TUKA6@MUD6I:
MWI(ZO'.Q;J^(;KG)3C6,Q!8! #W#F;?46E26G[89-ZU,-"V"Y&;F1A4^@#65
MUPRY,J[-U1'ENL,(92E:OI5]OTWS^ECD.(==UP@--@!/XP @"N=,Q3:102/B
M_9O\O0)7$@Z^-<Y);?8D9"+D^^3C<'%T<6(D'':$=5IH^:Q[( $LWHS9&J1D
MW'*EV455[\:>C2>JD[,:ENPWU7LSEQ(^]O>),83>?(.2KG^<11EH0_W<*O[
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MHG>O<0D:26^?$I5OD":0;E*&JL4]\(H)UM(O:3,OIT%1*CUV%;]A96H$\_R
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M<H.7>_!??J2W!$M[WJ]<-_D*R$V*^J>!O$[JK^[.I1+W4LM3$SA[-+#M;A/
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MYQK9'H% R8?E'U=S>?5(\82REH7R23K0ZWR(4!HW56/EWC[U.B7;>SDO=%S
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M]:P+<X1A*68>WIGD)U@868:2\4A;#^ 3, V_<>1A5W+R1<?03Z32=Z[&JAL
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MGE]F/BUMX?5^L!083A1X U.2KM=\/MQ=RLSM[.]]SK.Z'4,AM\9Y"_<$'-,
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M%+0,VPXI]&\^U+'&/'YLXFQQ/^WX%ZA[27LX9_",QQ(\%)NHM1B_XKK1NQB
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MQW'U8.3UQ%0.B>'AT%A)<C#O(3;@\HL4$CYTAVX_N1QOQY/%!M(.'>C%+4K
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MGL!!,N"2T7L7W(/W :#)X-(F:YG6814NK? S,3WNZ08 R\4-:>DU*6+.=)Q
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MD=E U),LID+V5N8*W79!88#D&,A/&#RUB[<W&]>!/<+8"7D[GP#W,JX.SCZ
MGZJC+)KN#(FT/P.S0W-X)P]J)T3.Y02=9Y*WB,N&8CQ8M\>&,\\F:N2HO&&)
M"W3Y8P;9RB3+0C; GW*.*.:E_:!#^SV>0GR&I_5M\$0RMBFSB^GTD-$E-[&6
M%&8T2*JD:@^.@..Z#Y<S!G[,@U\1#'X^B^+]>:A VVE)F&,5-7&]@D9H,5Q
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MNZA"$8ZV'7*YX36HT-,Z\[$V-I)AQ4=X*Z@&_0SH&(!]S,]1P! ,%'I/22C
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M6$:X_PXO_7(QC^=?,GBGU@!<8__IZX429KEFPWJ)!:@12^/:U-5K#.-=9)@
ML57^UIN6] L+NDX="*GTD26?FF$1BAKM)"0[S@;"SPM$8%@"3E5)>(F,F+Q1
MAY']'7;_B[W_BFHJ_-:'T2 @*"#2!82H@"B(B#2I$94F8A0%!(2(*%6(HD+
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M:<+OSI)?":?WL($^3<6S5XG2Z].[&QTX"V=%W.DW[Z<^IH1Q?!E^JOQ#WXC
MX.L.E%F-U(?FXS9T??*>4']3):K/5?^XLF&]].+!U;-<H;P=!T,,'=DK&$8'
M,^*8<L']LAJ,HC8CP@Y?5\D0X4X9\)QHF 47U8UOBGD"J</I80_8:5_LD.JY
M%WGL?F!@SI8D,2G&28N1$"R-J"/29X2!6!:HTZ_.4T(BY,]$**8U[<:NX]+W
M+:A\S>DO"9S,0PHT+L0K+'5!OA$X\UO-SI%1VGMM$FD4]/+SW%"*A4IYG<:U
M1SGOWE:QBYOHM02N9[G6MR.LCX$";_'TH3@PRVHLD QF*P= L4#7NAR5<@!'
M,-E:'+Z/@W5 (MM1,P)>]JF0O\8\,ZN_-DFZ@NWP<.8QH+\J>%0*'*&?)('(
MA#;53._#FV[B/4)!G^1W/WPSKS^S+&3>*S^!EJ$+DWDZ62 )1&NODUAUUDN8
M],9Z,1"YO;)>Z%%HEG9LRC\(>^V6F"EGCCUH?5_U#\]]U P/TP1]D[U^,J@!
M;;HD"^2L F.!;HK,3-?VI)J,]C7;6!US*];LIQ\!1,AE5!\ _IB<M-@4@:E!
M&A3U:Z0%HN:*FG=Q=E*FAH^VMWVW>M,N#1_D$>78A;,/9#:)H-BK&H,ZBE9B
M8C$-^"2F1+=B7&6YH0+BCGGH&:*CE3IMW4HZ8JA.S17[WOG-W%,)]RIV-*8!
M+HM!JM0H1B[S#/U4]NY>AQ409DEFOJY8P&M.9GP=>BM(I35F86;JZ_IJ/_#P
MN\H_>&#;1'_\;W8\LX>]PG34*XI>+XKOLZ6;]:V6^>&$R@6/S=(SQ[H['0;B
M3LJ%8GT,^JL< 3AYHAW"0Q<IHE\"G EZ*H)7QPF[Y1KSAD>3L<WR.5;8E.Y$
M"V%S^11W3M__Z<G^-V@5U(!'L"AJ]M04ZM>3_?6<)D%2X:?@/O21\?)?*(&F
M&'U_(@V_M<.)N"D9*KV96B^IX(ORYWH\\0I5GR^GD#[:@&*CZ#X^01=*$BP%
M[@Q1$J,*+ K7 WOGBF"GQJVZEW;#HC,5,E<>G5/O$.L)'L-7JVY]8,OYC*X>
M<+UB9R/E2-[G>T&)G2Y$@2M3#Z->Z=Q*F^@)3WMH<?0>69W-</8PW]DP#POK
MA!SU07GB<:W$A80E<'S&/B:5&JV:KV4HW?CDM7-1;\Y;4+?]Y8NS#PSWZM.#
MC[&UTT_V8GZD7P7"\6T3P:* ')2<_1ZJEDE;T9[Q5:5Y2'6(!'(FV4,%V:!R
M_-\-&T/QF7(D-)<YG&U,S0H0FWK+ I'3O026!Z6C3' SCXY?X.$Z^BJ6BH\
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M;D09F-%D@]M;OE<!FGS&L;,9T)92_%>%F'9>Z'5_NKC-QD@/GC<8S!S"J0Q
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MX'K!VD'8N8F5S<NR$!:(RU..*=K;?3+;M#=)R&UNN:%<\+L+$?H:+8;8H6*
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M%VN FD7DP:@V!+PBJ>IYW:+,M3DXP3/;(P/7NG-H7\[UBD-["NY%*TF[B(^
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M%4GV*W3875QP6^M>V^6*PN'<TY_OUOCN$@U5#+N\)+($!7177E[EV/(G^$J
M%^<TUZ.=!<Y$*WPW;>:*OYYH;7N=3C3L23;2?UFXGS"*T+!_D:YS5JLBTVD;
M5!NWSJ#+_G6O3#TB+$M3F#G0,ZJ(Z7T[Q5>9GW42: QA*ZKX"-8QW[*&:7'>
MEKNZY*&>?N+K!]4VF0_S&\]M7O0]GR76SO7%Q#?N:R^;_TK4N \R/581<N#9
M4L9A@DAN6:N0Y?_<OOT_"@U8+VQF?,'Y72+.O"$=(]$*D1E^-;JRUO+]9-(Y
MG?&@>UTW!T$M<F_??8W>X13_X']_P_^)_\3_Y0!OS_P74$L#!!0    ( #Q[
M;U3VX^VZ7S8! %/,#  5    :6YF=2TR,#(Q,3(S,5]L86(N>&UL[+W[<]PX
MEB;Z^_P5N#4W;E1'"%5\@*_>F=F09;M&L2[+5U9U;T?%C0P\)6ZGDFJ2*5O]
MUR_ 1R93F<D$F"#%FKL=T2Y;(HGO?" _'  'Y_S;?__^N 3//"_2;/7O/[@_
M.3\ OJ(92U?W__[#;W<?8?S#?_^/?_F7?_N_(/R?[VX_@?<973_R50FN<HY+
MSL"WM'P ?V6\^#L0>?8(_IKE?T^?,83_4=UTE3V]Y.G]0PD\Q_->_S;_<^"@
M@#(60Y_[/D3$Y3"A20B1'^(0(P\A/[FX_S,2GL>C)()A1!%$V/-@3$@ B4]$
MF+ @%E14#UVFJ[__6?U!<,&!-&Y55/_\]Q\>RO+ISS___.W;MY^^DWSY4Y;?
M_^PYCO]S>_4/S>7?]Z[_YE=7NTF2_%S]=G-ID1ZZ4#[6_?E__OKI*WW@CQBF
MJZ+$*ZH:*-(_%]4//V44EQ7G)W&!HU>H?\'V,JA^!%T/^NY/WPOVPW_\"P U
M'7FVY+=< /7?WVZOCS:9_*RN^'G%[U7/?N%YFK&O)<[+3YCPI41?/:U\>>+_
M_D.1/CXM>?NSAYR+PX]=YOG.4Q7*1*%T0X7R7X\U]O,9\"WA+?>Q6@!7F?O9
M%L8^3C];@WLG]8&/#[C3S-F0ZQ?JPXI-]>YNFCH;^OB(;;T668F7$[P6VV8Z
MD)?J!Y_DWYIFU(-ZQ+1JIY'N#E3^O>0KQFNUW'DT2-F__R#_ME@7\![CI\57
MOI2_O?^%KWB.EY<K=LD>TU5:E+D4\F?^X?L37Q7\DJ@?T'+!/1$B1S 8)%P.
M;!Z-(4Y0 D7BH$@@S\/4792;-W[!5_"WKRVX"L$YS?]@P$IYY.O.>9&M<[H=
M%Q^7AP8[.<ZID3'^>84?>?&$FQND#<J%J,WZCP;]!;BO\0.\8@#O6 !X;4+Q
MYW_[>4N"]7Y9OC';RXF(_J5#]"YXT* 'O[?X_[^CC&=T!^E2>2U9_IJXC)Y)
MW%8C"FESQ9K !:G,;IXL*?3<G_FR+-J?0/43Z+B-P_.O R'\O/>*7>:MU3BG
M)_JTN>)GFDD'[ZF$.]VK'&(;])29C;>S[D()^ >0Y8SGTMT_8/S^]U5F].^W
M_$F^H0_2S?R29_<Y?KQ<EP]9GOZ3L\O';+TJW87'$47<#6&"70<BFF"8!(Q"
MW\,^BWPO2$A@)'AZ[<Y.Z11LD&]P@Z<:^ 7 &^@ 5]@-=4ZS'S0%SCZ[8RM;
M1>P6,OC2$KM%#2[[B367,S.:[.J89MO3"I@9(7O*97C[,,GZ3\[NI3Z^YT5Z
MOZJFV>^S1YRN%DCP,/ # F,D*$0DY#"F7@BI3RD1082#)#+1J&,-S4V4&IR@
M Q3\7D,]/O:;4:LG.S8(&UEG!G%E+"RGB+"J)$<;FU0Z3IG\6BM.7C_0GUD_
MR=FI6L/$RRM</'Q<9M^N5R++'ZLV-A.%Q",)CWT!$S^,(/+EO)1P.8LC 6>N
MCSCS'2.MT&QW;M+Q];<O7SY]^/7#Y[O+3^#]]=>K3S=??[O]\-70>=$D7=-Y
ML4_EV,Y+!S%0D('"##J@QYF-F1%EUWW1;'M:]\6,D#WWQ?#V80KU00A.U43N
M>D6S1WZ'O]_BDM]R96.Z3.NFRH^<J=G?UQ*7:_D6O.Q<O' )YH$;$8@PP7(V
MYA%(',^'?L0][B?,C5PC];* :6[*5H,#)?[>+CT!7(+R@8.BQ0_DA)J;*9V-
MSM-3P8F[9&2%W%@#FGZ1$('""'8MNE"=U!@%-E:]OND"?.$2F,VIH$6ZK>JL
M#5R3:K!%(E_KL\U'#]/N3[R4VG4CKG+.TO)7_DAXO@@I"WTL HA#$DI%#BA,
M7$_./4/L)0G%R'&9B1@?:F1NZEIC!)D -4HS%3U(HYXLGDO.R#KWFA?P>PW1
MHM?7QX!5Z3G8T*1:TF?J:W'HO7:@IX;SE9RB%G*P^?J <_XE6Z;TY8Y_+]])
ME']?>$)@ZH0!]$@H/WS!/8A1Y,& 4>)%7APA'AIY8?WMS4T#6KAJ, 858$-?
MZ@2]FGZ2/=+&]H'V^))^3(46_-[\5\$&%6Z+@J')D%VWY42;T[HD>@3LN1N:
MMPU<J%*/?(<+SJZR1S4_J=V7/)>O3#4'??>RO>0+?E$_NOR&<_;A'^NTE%Z-
MG(Q6L7K%C9S4Y'</>'7SI!Y1_(47)6?7JSIR98%$0(3#0^B&<021PUV(A>=!
M)R8B\7W&"0T7>S$ZIU=I)L*O]0'K!339_)AKD!=@M58#C1KP"V5M 7Y,5\U?
M_V2XB#;5"Z&Y"C>G_IUH&4_9 U6T)0-=HT'':D!>0/>ZQG)0F7X!:N-!QWI0
MF0]*:3]H"+@ -05 OBHU"1;7!"?N-KN+BE.!GW95<N(NV5O6G+K]80/BU3K/
M92-JWLXO5TR%4"_EK+T)=WG'5URDY<+S M]'-(3<900B/T(04\)A('#$(M<-
M'!(,&,VT&I_I4-1@-QMM]-C6&RKLD3>-SC=XJ_5%7H7059"KY<4V>N['!O;Q
M0=Q8FHUHLJJK>BU/*HI&9+Q6-+.;AR[U23E\R);L^O$ISYXKH2R:I2I.!4<1
M)3!DL0]1$G@PYHD'0T19@ESL!5R8K?@=;6MND_X-5)!VL)HN_QVG5G<5T IA
MHR\&MEQU88ZR)'B2#LLK@\?;FWB!\*3A^^N$IV\9IAB?>5GO-7S*BF(A0C],
MY-P:<E(=>',2&+LBAB$.G0AAG_A>LB@WAQ].OO([3S=2A2/G.&R^Z1*<G,PH
M=&9*L$L9]L,@41PA'""(',1@(B(F&703%Q/DNJYO(JO#*9M 2.U0IB>7@XD8
M62 5!\W6[H\*VI_ 95GF*5F7F"PY*#,YO>YU;8V5\B 35K5QMX5)U?"@<:_U
M[_!%PQ3OYHFK,PFK^TI4;]5!X!OQ6\$OBX*7BS (L!]Q!D/*,$0!EPI8!:F$
M-$F8_)]@GLGGW-O:W#[O#5BP5&A!?4HZ$V"M E$48D.GJ9]K/1VPQN#(NK E
MKP)Z 2JH,!-0@@456GN2H$6*58GH;W%2R= R_K6$Z-TT<%N$/G"V7O(;\6Y=
MI"M>%)?T'^NT2*L%IW<OG7]M=PJ3$)'0%PYD& <0N2&"Q/4<2#P/"U\="O <
MHV#> 2#F)D"M#4IS6BM UXP+M93=^8'A;L60?M+<>1B9_;%W$4R)![_?5>[.
M*)N_YY!I=VU_")!IU^G/H&IOS?V<9PU3SO=<\#SG[ Y_KX2XV,JT]/2N<)Z_
MB"Q7Z_IR<NHAZG G@M@/Y.34\R,84W5$/Z!(SE>%0P@U$4R#MN>FDVH.DFV=
M-0G73 A-:-?3OY'('%GV6M35*GJ-^P)T'#D)'>Q@MZ=Q PBS*FTF[4^J: .(
M>2UD0QXQ,-KN\6F9O7!^RY=5%I,4DW0I%9(7S7+_PF?42T040L_' B+B!Y X
M<FKIJN,.KA=XR#$*M#W9XMRTJ@4,\QHQ6&XA7P Z9!_P-.MZHF65RY&E:H_&
M3UT:3VVGFL??Z5)C-P+O9*O3QN#IDK 7A:=]HYGLI"NQ[KAIOW*64KQ4(0]/
M:DN@<LFW,Y<XD;/*T$%2>GP,$8]<F"2(PTA$,<4^"Q*2Z$B/4:MSDY_NS*9!
M#C;0]63'C/5^Z1F-RPDGB'LTFDP&SV"6-8D>JU"@Z1G>:7X\IB7 ]1+G@*4%
ME9[].J\X?VPXYZT=/YVO]8.8JO5>W5J)N.LU$F[VL$ED?)!]K90/NWF8%UGO
M;521(>K9;2+.R^]IL:">[PC'19 *(6>]M)K_)AP*@F@0T3!.0J-EPIZVYB;=
MS2[;!BMHP8+?%5S#-"%]).NYBY:H&UFI![-F["-J\&'5.^QK;U*_4,/PUQZA
MSBT#?,&[!^XY;K*1I4_IBC=!2;$?N0DG'%(:(8@0=V",HP F&(<Q$K%T F-M
M[^]X.W,3#8D4**@=[T2!-?!'>CC5\.WL,#6R1APAZ724EQ%;!OZ:'=8F\M!N
M^9-\7!46EW:RI>3\'N<J2WF5L.$ O;9<MM-D]3II/;=/YY:=MF''$=.X?)CK
M]3%=I27_E#ZK(P&E[.54^G7UHN$EE6_3NIK 7SYF>9G^LWZ18X=XA*HL3&X<
M0,0B'R;493!$"6<();''T**;UOBD8V$.0NNK.)G#V>9'T0$*NDC-G+0!W:'G
MNXU$\31R78.'%7JPA;_9L3#FWMC5&TZ?50]P (Q)'</A-+WV%\]XTC A;+=\
MK[)'DM:Y[3K[O<U"YE56E,4B#I@?)D$"J1MZ$ 5>"&/J4^CZ%/, 41%BHRT-
M_:;GYFQV R*H E@=S%EE*YASM;.AG($VA[B9$!ITAYX CD/RR,*W"47IH+[8
M"4-I@(,*N3V],V?+JLX9-#^IOIG3\EK7!CS!3,^*O%S<JD.B[23$(X(@C"'R
MF( H02Z,$?5@0@@C8> (%FN)U:OGSDV)U,I"6I35&O&O'*MEXWIEWBBE[FOR
M^J7E#$K&WJT8RH:V4!RQO4\%Y"T=!9#_>OWUOW[F))_V$4/:[_;8K\\-E/T5
ME^N\VA&]$9^RU?T=SQ_?<_)ZR\?AOBM<.;GRE+^!>!#"! E5L@2';APZ,=7[
M>H<"F-UGWMV&VUB@_J5L@!+"(U!6#(V+U>P6/9=C3+*GW.[LX7FB,%@S_D8*
M@=4$\4;AKV84'0]]-7S.0!WD]VH\NN5/:OZVNJ^S-+W.)4:(CQPO<"%CR('(
MB9CT6N(0ADE( \+]V(G-3@CHM#H[Q:M!&TZ?] C6E#';M(VM735>L $\3<8V
M(YHL5U?2:7GBHDH&9.S74C*Y><"NX?%PV+^FY</E>RZ:U2?!%[Z@R/5C!#E3
MJ]U1(B".I4-&'41]-R3(3[3R19HV/#<=NMD)MP>T"[ZN.(L!:_"#I33 8 _-
MI#\TMB!'8GEDV>H+NP<*.+@$+73P:3R"#78M1R)Z^FU,M6%9%P!3+F[6]ZJ7
M#[@$#_A9Y2 "Z6KGE;>UP3F U]X=3Y/G3;<%.L#*G3W1(?>;#1:,IW(PHLH?
M?OGPG3ZH=8#/\HV2GFE(8^K)H8"02*VL>9#@P(=)% >,^8$07"NVY%@#<Q/_
M%B-H00*%4D^ CI+8K^0VJ!G=T31B15L#3IE^P'DL./WI/GO^6=Y:^8W_0.JO
ML/YK)01''SK)!W_*I/;#/GF=^0?\8556"1%IEDM_LAI3JC"T*R7W^<M5QO@B
M#CR1A-*U8X3Z$,4401Q2%W+",8]\UPN(5FD6S?;F]GG7D,$.YHLFTUZ6@P8Y
M4-#UOWD=WD]+@&4V1U8$&T0:R80!/8-50Z>-R43$P."NIIC<-K?4X!^S7/"T
M7,L7]:]<Y>W@[/)9NC[W_!?Y\/*]-.,C3O._X.6:+X( 15SX"8PC1T#$G! 2
MREP5I2!GK"Q*?!<;K9G-PJRY"68'^P7XUJ 'N(8/[A5^P-1'+Z0%X%F94.48
M9]ERB?,"2,^USC<^FW3C1B^9YKKA+,#.:'28+E7YSOO94@0:CD!%$E L 443
MJ'CZ(V0S']+O?Y!<YT:F_1?)A#ZD.Z?+DSX(W4#?097@OBZ*-6?OURIHKL[-
M7@$O#EOX2ZXR23I^P!#E"<2!X\G1/HQ@$A.U318AFJ XX8@8C?8#@<QM?*[L
M:!2T*?&15E:!]9/4VV=>5,M[4 [5:H5O>/F/H1VG.8).T!U3C'D%J(VXJ(>V
MXN+P$+?]:"\ X2++>6<@LS@^G<FJW1%E*)AIQX S*=M3[7.?-_$<;7](V!3F
M85Y .5;%+) 30^0F#HQIX$$'AV%,A>?P,#([#3,"2BU!F/2X3 -RMQH37I</
M69[^<ZO:TQ=FZNGJD:<]9W;?'V8.<VB6,JNJ2J<[8AZ3BAZ<?XP9PFFBK;G[
M&DW92*?]:J9PRU6X=?M+%4KG+D(6."1),'0B*B!"7@R32"6T0,2-.8H<[AGY
M[*8 YN:K__7U\EG>8FZR<*M@TS^?DW=;HU/TI'U,JJ>++JFS<^^M"FWPUU<
M9<%8";OUJ1LQA[<&B#=,ZZU/47^F;X/G#,G%=DJ/BQ."_.$[SVE:;.7X"A</
M2UZ\7G-IK_N2IY0O8L(]%C$&(ZR*./MN#-7)2TB8_&L8AIR$KGYFMS>Q86XR
MW&(&O$%Y8&.C_15X4A:<M:/QEF]/O]C_0=Z)D<>+_Q^]#B9I]6;_6DR5I.^!
MGWP?U(1>F;Z=S;<75$5T5<SE4\6!^A<&M'WC2LEF@:DRP%J2OS?MM_Z4@6\#
M;<($A&_*_6XZP[>%,G""J?:EZLP7GR7=38+GQ/<\&CL,XL3S('(# A-'SB)=
MBK CB(.CP*@8P,%6YN:CU%O=@PHQ'211<]9W+C5C3^TJ5MI<.%N(%B=O?0S8
MG:$=;&G::5B?L7MSK=Z+SSTD/EROJM.:B] E/G9% %',Y#2), X)"0EDH4L3
MJ1FNU(IAI\?/1#8W8>D>=]99X2YZE[B;0]&&^5GM=;OF/L5;=.;8NQ/3]N,9
M)]HM<3[24?=ST;W1&7A+I!X_'&^K@:%A0DWVW#:)4'LVO,KA'.,P9JX@D#B.
M5'R')9 D#H+R2Y$NHBNX(XPJ=_:V-CL!;[ -RHS=SZMNJ(XEML962$VB!D35
M:!!@.72FK\6)XV,TC-\/@M&Y:<"B_.M<_1^S_"N6\I7?JH6AY2TO>/[,%R()
M$5:E?EV<,.DBQG(09()#[/F^\*((^3C07D37:W-NLO'KZZH20&0Y*/"R.JZ3
M5] O0%Z#-UC)U.P!ZK"04N1#C$,$4>(1&!,A((U%D*CB6(RQ-G;H;OJ.V T(
MNINP/S[T] > X&G]^#1>KVAL#]A_VT>6_7UB)62@,(.;'-2HP>U8C!JLL-MG
M]JVS"33OJ5JVRFA:)>NLTF7L5;0YJ#VX2KJEGDBP;(]R4#QP7I\NLK4Z;L9Y
M[VJVYJ.F6WTVLVUGM=CPUJ$%8//T6;Z:S[QXG9W)IXX(/$<5+8L2B)#/8(()
M@6&@"I?%OAPIM,;GTTW-;5CN(#6MZWJ433TWW@Y'(XMY!^0TJ:U.LV*Y-.O1
MYB:NQ'K*[/W"JR?OF#AR_7,57-VL7!27SSA=JI4(J675*:8%3DC 754@AU(.
MD1<S2&(LH!.$2'A,A%CXDYP7/@%T;A+U>1.TWNQMXQ9Q-8S71X"GCUX_U=V:
MBQDSZ,2QUT'.CV/?O@+-(:?+G5>@LG@&T>R:?3*/D/938/\8<>V:E%L+;M=M
M;]C8HV(<U/^5(_PL'6 YQ9&^;YFG5*6JE[^X7+'='W2NK,,DKE<T5_&F[WG]
M7_GOY5J5BFIS_-S*Z<P'(3@M%V&<.)A&!/HT%! %B$L'./'D*X8#WW681X6S
M*#/I@>N-2-/"-QJG-D:,.$[)N6*3G$H.1BK&JBK14?V%;^TT&YXF?B/T!JWY
M]O/(0YDRY0*H/T''H@NP-;;^I>KWUS_;N:$F ;0L@!];'OYT 394;).=*3)
MS8:]8>YM>M'JX#>Q"9,.B6_3/:\'RC=",33WW,=TR>LA>H$\AF+B<,B<((#(
M#V*(/9I /V8."R.$L:M5DO[0P^<V1:KQ 06P\95-D\=UB.L? \ZE8V2%-F!B
M0/:W?9//3/76>>#$>=WV3=E/XG;@FF%^;;>ZP;;JP2U_JCWKXD9\R=,539_P
M\GKU-X[SNV_9PO$"EL1>"*F'Y0<<X! FQ/>@? >"."8!8E0K4^0Y(.;VH<N7
MR#=S( =1K^<&CDWHR%)1E5>Y:\NK7+3%5UXN@,(*)%A[OM8Y5%GUF 8!F=3O
M.8>JU][+6<\:)G67['^MB[)Z^EUVR5A5; XOO^!4.D)7^"F5$]%J\8"\7GVX
MY75Q.OZ5Y\\IY;7W=,MI=K^JGE)G!%0U+X.(>#!P6 R1I_P:+'PH7,8B)TD0
MB=GBF><DTQ7&L2&;?/-=X",N27:25M'NDF130=-,8D?O<CTYGE,WCBS=EU^N
MKS0R6VVFUZ+*"%RH0C4;F^R)^U3$6QT(1@<]Z: Q51>\'F F:_=MLG#M'<*[
M4^NHURLYW5\5*:W5B? @\HD?0D$CE1F1$HA]1F"( A;[KL]IH%6A84K0<_/K
M*X@@;3$V>8RK BF53=OSO-/FYM)Z 4;>Z1RI6^>_Z[G)WK4Q?9N[2PUN[<LR
MEZ3" SIJ'ENA)L#_&-NB [K"=OXOH[:'YL,AW<:WT#Y\IYRK)>9?TU7ZN'Z\
MD^]9\9 M65-L6DZ3.(GD],D+W00B/_1A+)P >H$;X01A+T9:J?O/!3*W8>BD
M1[VQ!S0&@8U%IME'!G9=_V S98=,.("8]@7XO39'\W36V9UBFM=E_,Z9/A1=
M6I?EC_48G_-E%7U>9M)Q:WM)198_-CU5;GIJO6)530%>AZ\U'=XL4 &\)<=J
M@I;S.N!TEI6!SY\X5<IY+.SG.SGS>0,&P7K;]$9<9<\I<Y,O6+Y-CRGM5+7'
M",4T]F'H!W)RYJ $QJ'C0^J+@#+Y?]_1JFJOU=K<AK.KF[]<OX=N8J"")PG5
M&']LTC3V=FD%54TT*["2*]#"!;_K!+@/8-!@L+#)Y(3INF0K:<X!2PNZS(IU
M7B] \LJ8ZI!1^V)*G:\MLB7NNH3U*OC)ATPGT[KV[&BQ]DT#-[-Y47#^J0YI
M*6B>5O.=3^F*7Y?\L5@PCS/B1#%,8BPG%R%!,*880R9<J<$D#*+(*#O B?;F
M)KHUW(LV^6T',OA=@085:L.\ :<XU]RPML?DV'O39Y)HOD&M1XW=O>@3;4Z[
M[:Q'P-X.L^9M Q/2Y?=XE?ZS&K*NLE61+5-6+\.LV)=ZXE']\T9\3%=X15.\
MW*0Z*"Y)4>98.ZC72ELS^H2Z]ER '8NJ^-RN36I,WE@%MF:!WUO#+'YJ5HFV
MFQ+."K)I4\C9)',OY9S5AP^,)WG,\K+!<".N98NK^Y0L>9T);R$"1()$Q- A
M20A1(@C$"4=0Y10)*6-AF!@Y&_W-S<W7Z*)5WW"ZP6MXS.($RW&"&6+<A=A7
M+ET@5-%7S*#G^PR)D)(PY(8Q-]9XGB9BYCC3@Y*$GN!;,^#%&H=CAZN\(F\+
MM<DE:C$618L3NY$D_4U.&P>B9?Y>%(?>7<,$O$TY=94]$CE*U+$?593'/SF[
M9FJM0*1XT]HE_<<ZS3F30\PG^>-T684LRM^M'^7EKZ!M"FG^DF7L6[I<+@AA
ME#"708HB'R(24X@I#:%@;N2+((@8-DI6/"GZN0TOU^>)W+0]KZ>9L^W/D26X
MM1MT#+\ 6]-!U_9&E4%K?35?Z-@/&@(N]I7\HELDNN7!GKR_2?=9'2VFM6#2
MP>=-.N?U6/8V((8-C=>/3SC-U6SI1JA0_4_ILT12-767O>/OT^))>K;L1BQ$
MZ%(:H!"ZL6"J]*</$\8=**(X<5V?1$)H!6P8MSRW(>F3*J(LO4A6(<3+JO2'
M5*=-ZK-M0&JUZ;"7^LQL"-/O(;WA9Q3>1QXZMI@5V=6IH0IV.TJ4&2 <M-#E
M-?;DWI@NJU*MW_JD,FM,RFN)-'_ ,'G["\XKI:U6A]7Q@T6$A(<\[$(>$PP1
MP@(2(?^6A#A*6.@F@3"J$K#7PMSDJ@78U)>D$J*9 .USJ"<T9S$SLJ!L2&EV
M=Z[Z6#'6C*.66]6&_58FU8"C1K[^UH]?.#2)I."Y])?N\/=:,3I>TV=>+AP4
M!,P1$:0A)Q!Q.?\FOA/ *''B*/"<* Z)24J=$^T9?>\3Y<!A#610XN^#YLVG
M.-93 (O,C:P'+5(@H6Z+"W&+FJ#)A>74DOUM3IQ?4HN _223>K>-4,]:>B%4
MY356R5&^</FFK<I%$,:"(A'#1*C-'LQ#B$-'Y:KED7!]&L4>LE;/^@" N7D7
M>_6L68,92+.XS4+6AWI#<UM]1(['WD$_6<BZQ5\EJ*JR6M&^*:;=4M8]Y$U7
MROH0B/F4LNZAR*B4==]S!FYKK\J4I<NU2N#[E=,F,\.'[RHU%&<?I9GJU-&Z
MW5__@'-525MEE*HBK2^KG.\+C)"#B!M!3"-7>EL\@8GG8ACRD%'/9R+PN-'N
MMPU4<U/)KE&@V%BE3B949@'U4E5I$-;;:!C>F+8M+WS1)MH?G&K73I]K[@U/
MW9-C;R%W.W%K$/BPTXE7NYW86J6$N3YH>@%JRRQN.-LDVNZ^M!5DTVY?VR1S
M;Y?;ZL.M;89?KNJUMVHGHJA2'QA&+IH]=$8?]:%-R6HUO\(..N!'"40<QMO8
MNX%]$-YZ.T^#'HW].)VG3)SO0R7M+%^N5Q+%NLZ,U6[U-:>Y_\*+4FT(=HYR
M?\1I7B> X&Z"W=AW8>(('R(7.Y!PET,DW(C%(N(DF*:RP5EFS,UOJ[%*M^O^
M/J_J@@$AH=:I02;* G+>:Z&GWO/O[)%' 0N90FHJ0(>+;AC*)H](34@WB8CB
M8S;Y0ZQTZ#PRBIQGRA\CQXB5[K*6=<0.FKD-NU51B4T&E5>K,M4OW\N!82NY
MD1,D ?%]R!F6(S$2$8R1*R!BOJM.)2:$&BV(S,:RN0W.%4(U.G][O09=UR-B
MN^-UM6C"LN42YYTEE:E*%5E_S=YZ9!_QY?DO,]C7''4'^[WE^^H2H*CZ@SD"
M _O_#^(;F%KW7\1=&-BITWD00P&>MU36727XGA8+[H0^2X@+A>M@B!).81SP
M!,H!G\4)\F(<&:7%/]+.W ;<S5K9[JJ81&J82N 8KV9KC6>P-=6BH@%1@Y<.
MC] PRAKAZ[;>9#'PB,''5OV.73YPTY32?%V)EH2^O,/?>7&USE7]ZLL5^RP-
MJ?^Q8(2*B/D.# ,D9P',4[E(B",E0B!/^*Z'?+-#P7KMSDTR&M@JF9K"K>+1
MC,\%:S*NN2EIG\>QMQT;"AO(X*Z70O/-0S-"[&X/:K8][0:@&2%[6WR&M]M<
M[I!>494 4=K9%,=43M5OJ^=JW>62ENFS=*_N5##N-A=8C)(XYC&&4<0#B%R4
M0,)% *4C$V&7,L=!6D6Z[$.;FYB=3 ?:,;*IDGL!6M-LK#,,ZM]S%@K&[K4)
M9_K&'09^K^P:I\:\?;HGF%@/@C>#F?$YM.I-;<]J87B=XH_+[-M_<G:O\IK6
M68 11H@G40Q=&JD"]XC#&,DN)DX2AI&<G+I18"+F!UN9FRY7M5T52M# -*_O
MN\^DGFR>S<_("KA'S>FTU(.*V![EP'JMV?V6)B\)>]380Y5;CU\\).'^8UH^
M%+_6!XJO5[1Y5WV'H(@[,>2.PR"*&(9Q$"+Y_<<N=T(4LDCK3&-/&W/[YFN4
MH(%9U9DZGL!5F\C^C]X2/6,[/0>8&92,_C!%)GGFSZ9JHH3!UX?SQAN]8X89
MX'NIZ4_N?OC6"?.V]V+?3<G>?^G@;.OILRIAG3UR.;]6!R)4>HT539=IZXU)
M5TR^-N]3>;6<;5->M">&?!$(5R0QC.(02ZF,$XAQ%$&?8$R3(/:BT#5,QCX8
MS-PT=0,5L"U6X[3CP_M&0WTG9'QDF=Y8 FI3JI.GRABP:TTU26VZI6/0Z9->
M]OO'.&O\)/TTT1C1(%-[]IFHBH5L/Q) >/F-<S5X/&5Y'=]7]:DZ?MW4,P4_
M$K[B(BW_5(67JY_2DU?6)X+D5>0%X*>GY4M;Q.3IT*=J-X/]V9VGD>!^>!M3
MY[\_FXT#Z?'/?^9(L7+%L?WYZH\[V:K*OBL_C\_R@WF?/>)TM7#BF'M!'$"*
MDP@BEW-(:!)"YHK8<7#L<-=NV-L D',;<"ND0$$%O]<(#3?21^G)<Q:,I^N?
ML7?=#+K&?E36&=Q-&V U!.@,5H3M4&T<]G1.6V92SWBZ^"3?P^67AVS%/Z^K
MJ7N$L!\AUX&1XX1R[H,1C /D0#]T Y\F?L"(ED0?>OC<I+7"!RJ H$:HIZP'
MB>M7Q'/I&%G)#)C0%K(^DP\(4,'I3_?9\\_RMDI[_H'47V']UTIP#CYP$J'H
M,Z7]P'NO&;A]DW.6EA^Q<O?*EV;D=1/?#9/$A=C!TH>*I?L4NSR 8< P=07S
MA="J%-?7R-P^U!HC:$$.=(0.TJFYA7,F26/OX)CR8[Y_TT. W>V;0PU-NWO3
M8^K>YDW?M0.#!^M\O^W1>I>2)$YB#WI)C" 2F,(X#D(8<<$8$D'DQUIKD8<?
M/[</_?+KUP]W7PUC_W8)T_N@A],P]IRB3E8[1AZ!PS;;#=;;;6+:F+R#YNV%
MWAV^:N(#A<U)A4O&JIACO'R_J4&Y?9.1$[ X"AV(/:KB-*@'"4<^C*G /(Q]
MXKM&:>1&13LW)=F<K]JB!AW8$YWHT^IG2VLI4_7>V%O3YY^\.]'WHXCK)-TS
MCX-Q6HCGM8!C@WQK!]B,&AU8^S9;W=_Q_/$])^6ON&QR2-WRIEY]<2.^Y.F*
MID]JQ_UO'.>JUCE?<.EINM@7T/<#7\XM?0033AU(4>@*Z@>">T;.YC 8<QM*
MY/>##,O@#J-?;R 8G]31%YM6]U!9 )0)%Z QXN4"*+2@@FNQ8NY9=-DMI#L,
MRK3U=<^B:Z_L[GE/>QNO_,-WGM.T4('8S=HN1]+7]@2"3I!P52H\@#%W*0R<
M@% <N(CS<$I/? _AW"2SZYS1KA.'NR<KLM9/XUM[+L"JLFAX^E+[W3^-@WY6
MI_Z!G/(/W<ZVM=DP>B?,RO7>1_F'<K>/DFS;Q3[>T+F5 +*BN)):]B*R7+57
M?&HKR2_"A N'QW*$"-4&:A@)B(7O03]A. K\.!+$J 2:1IMS4_].0GI5!FT'
M-/A=P085;L/]&QWV]:3:,J<CB^_Y=)Z1T/\D02/E\#_>[ANE[3])Q/%,_:=O
M'2A'*O%-I]1)<_J".$SXH1?!*%!I7K'2(I$@**)$_@:[&'FQD0(=;&9VHE/E
MUNK -!27PUQJZLG9#(TM(:_)&>&(7S\)=F7B<%/3*D.ON7MBT'_UT")G>?J,
MZQ#A33:LRQ5KCA(V1XIE:]L%QNV1?RQP%/F^#QU$/8@"UX=8'0]$TEE)D.\'
MCF-4@?P<,'/3DJTMX&.ZPBN:XN5.(C\5G=\>EMU:9EH^[8S>T].EJ?ID9/7J
M=,?I3NCL](#?1\G+8(-5RR7<S@ T<7VW\ZG;+_YFX9GS3BB\"/T$AY3(SH^Q
M"Q%Q*$RP)Z"/*2(T\2@F1ALS4P&?F[#KK4OR.G-KVM&:;)NY=;-J>;_)W/I4
M&?L&2Y:F[]'(*YDCOAWS7^ <F.]W!FN? [MM'DNBIN#_&"NE [ODK9+LGCF.
M_I)E[%NZ7,I1^WI52FPI6?(Z4N^0\XMBGXF$!"KZ7?W!(A@G'H<>0IQZC#DN
M,EIB-6M^;F-:B[[RA[?XFPK%9@.184?H#2?CT3ORH-#/[/@3C6'$695E0PB3
MBNLP>EY+Y,"G##S1HRQ;E7DEP[=I\?=MQ@!WP3U!'!P&LAL2#!%3H;Y!0B!!
M(<4!CG@<&Y7GZFML;B*V@Q7D$NR%\JH;N(;G?/I(UI,L6]2-+%"[K-U6K'TY
MS9KYZ1\-.NR> NIK<-K30!JF[YT*TKEGF(!\R9M2]U]+J49UE1<:N8Q%R(/,
M$P(B5R"8A!Z# ?-0%,E?1&;EY@^T,3>YV$ $A<)X ?YOYR?'<5SPA)M*/G\&
M>%T^9'GZ3WF1>R%_J?[?3,__&UBIDZYI4:SY\0F8=@?H:<J9M(XL)5M&O]:,
M5@ OP'4_1\92TL."504YU,ZDPM%CZ&N]Z+MTJ$QD<O0L7U2> )537$WGGM0\
M[DNV3.E+)[%WDOC"#WV8N,2%R'<0Q"3$,$C<P'5#CA-.S+1#K^'Y"4J-NW+U
M-Z!-I4&3=%V]L$_EZ")20Y9>B *]2Z;\804<_-[\=Y0YDREKED5'L_&)E<B,
MDGUY,KS_;<*V;]9E(>=O+%W=-W&[OG 8)X$#21 Z$'&"8<)<#JE'G<#A' 4Q
M7=1K]U]+G)<C[YT<PVGR ;]&.V+(R!;F)B8[$UVOJO:EWBY0>[_#A2MB%U'I
M!!/I#B/A!C )7 HY1I[C"XZ%($V'?UBQ/TQWMUC_3V=W.WODO2P;W3?_3:O-
MMM3.&S"WJ/RCG3"/+:BC*/\8>TVG2+8=E7^\H6&.PUV.&5?9T-J@38\B&B$N
MYS.AD,. E\004SFSB8D7D<AQ.?>,%E)?-S"WR4N%#U17F(GR'G-ZFGH.'R-+
M8DU%A6V$$-=CAEN5H;U&)E618R:^%H&CUPW[AF]YB=,59Q]POI*ZT+Z/#@D1
M]C&'3'ZZ$+F^!V/793"*'>I&CD=%:%2JYG S<_N>6Y3@/1<I30V7(8Y0J?=I
MGT_0R!_XAIL6X0B?>3\)5C_V(TU-^LGWF_OZPS]Q]=!(=E)N@TVJ.K\N2@)$
MU93=">4@'G$YB'N>G,OS$'L(AR[SC3[]_2;F]MDKA)WPL4%5DP\0J??AGT?/
MR!^](3,#(KJ/&6\Y3GNOF8FCKX^9N1]3??3* ?58:B__1EQEJRJY3?'7M'RX
M>TAS.3O(563V(HI90&(20T+4ZHWP78A](?_I)]P/$R>*F);'KM?<W#[\SYL%
M%]I"!M\D9E JT&I/4_]TB2;A_:)@G\:1!6++X 8M4'!!A1=\&8%!@T(G5IF<
MJ)3)F8R:%1/1)JBW7,CIITQ7$$3;HIV2'_IW#0T_>WQ,R_: C&I%>G!\18\<
M,B.44)[0$/I^Y*M4!@'$COPGB;V(>L0-26!4KL.L^;FI= =]M;&Y@]\T0LVH
M'_0\N/'8'5F\>XD=/\IV&&^6P]V,($P< #>$GOV0N$%/&;B33!\X6R_YC;B4
M[;!TN5:G []RVN0?^_"=+M>,LX_2V*NJ>E8UF-Z(=D[[A>?5"G95C'D1)L1C
MF#L0AR2"B%(.$P\'D#G<\SS*<,*U*J>. V]N,ME:IUR'KGU@:R!H+03J=0,=
M&]5-FX4=:6:]==5463>M>V3W+=#<;GRSOAU[K_$-NM5\GW$4]NUN,MJ%..T.
MXRCT[FTOCM/*P*%$163>\B?Y&3VH[4PY>-WR,LTY>R_AK.[KXV]U&'#LN7$<
M!2Y$,680R8$"8C]T(7=\+R%!@@(1+%;\7I4.OC,8+O0A:.E%4NO%'I!Q'3PI
M E6HMBI_V5H"<%$M;BAYJ()*.K\$3WEVG^-'0\TWZ"[/Y8(F<D2/$C>!R$$<
MRI'<AR%B(8U=BA-FEM33<C]-.6;O]0RK(#<'V\?K \U!=1QFQQXQ*U)ONZ^[
MG-PTP$&-O#D#WD3;6QP(S1FS.\H9M#_M$&9.S-[X-. 1PP:?ZQ7-N6SB/:__
M>[VZI#1;RSG4+:<\?:[\4L]AG',W@CY3V9M(A"&A+(9)Z+M4OJ0!"U [ZN@)
MF4ZS T::D36LQ2AEK 5IIEM:;.L)EC4&IU&J%B[XL07\)Y6?8L/H[6E&C17*
MA"*KTJ35\*2:9$+%:S$RNG?@HC%^2DN\_* *C[.T5%4J9*MK=5[IW;K\G)5_
MX^47G+*%+Y K/WH"74\X4HF"!)*(>I QSXD21F,:&Z5ET&UX;MY46]BC &4&
M'CE+56U-WAZ:J+R I^9(A>&RL6Y/:"X8C\#OV$O%-630Q0Q:T("L2R!A@Q=>
M @7<XAJQ(55V5X=U&Y]V7=B0DKT58=/[!P86IO</Y8WXK:AS.MR0.GKI>O7A
MNW3?5O?\8Y9O,_4J"6VS=+XLY*3=]T,2PS *A2J'DT#LH0 2P5GH.SQVF5GT
MX7 L<].X;4[JI<)IN/]U3J?H:=M$5(\L=Y45,!-0VE%GG0&M)<I!:VT!(LM!
M)TMXY<MM[+$8%WD^J7:#)\_ ,VV$Y?G$[85A6GCD,$5]MRYD2T5QE3V2=%7G
MN. TNU^I<V+73+HXJ4CQ)HG.)96>3UY-DSOYC^7OUH\*[K.\/LM?%B%#'F*$
M0>$A.8VED0N3P'-DU\=R?LN$R\V2WXR"<FXJW (S#D 8IP_UI/G->V9DT6[M
M QT#+\#61-"UL<TEUEI9S0ZZ>=H;0R_ QE1[>CYJ3UA5^G&03CH&C$KVZ]%A
MW,;.&S>JQHIJAOPES^0P]8BO5T+]1_UH&_44$(\3=81;N+%*AX:#>CDAHDXB
M*&;<Q<F0$4&S_;EI_496.O@O@+0 5": C@W#Q@+=?C%3^1'8GDJ_3Q/=1#",
MD\ED((.CZ*XNAC=15$."CFFEZ6/.C4U[WR1]NL/?&Q7>4=_JS=I^=5R$0809
M@XD@!"(B8ODWWX<XC(6/B!=&'AL6A&:$8VZJV U+:@T!TI+6KWKE3@V-(#/K
M*\U=[?%[8.P=;C/R1U7+,]D<*<;+#,L;!7,-(NQXU-:PQTU6 :FML#Y>"9W7
M-=QG\*4.KZ#3&O.V]7->4_K6Y7,V>.9>/><U<1:*Y^P]TG**RD_;4JHBQLQU
M"8Q0Y*FJ-R$D@CER+A@P1P@O2JA1A-[I)N?FWO0F5#RCE*H&^7KR:)?2D570
M IOV\E'N$31-)LIML_/(0;E'@W;VR?T[S82(\73Q856FY<M?^7+Y/U;9M]57
MCHM,[:*HI,?Y@CL41]2)8%!%=?.00>*'' KL<1[[5- HTM&?DRW-379JL$"A
MA7]7<$&+M\X'?3PUG"'#_2)CE;>1M64X9=J2HDW' 24I./WI/GO^63ZC$I%_
M(/576/^U4H[33Y]$,+2-;'5"_X8STM(6*A+E8Y;+.8TZDOV0+57V.OF#P[GP
M%CYU&0HI@PEVE7*X%)($A=#! 8L))3Q"B5E0[A 86I_'I$&Z1T^"E!E0F OQ
M A[35?JX?I07X7*M]AVJ7!B-K:"]^U 1O_.2DYKV<<#CF#@B@ YSD.SC((0X
M#KC*4D8<+W1\/S)*G3Y:#T]=7[%.7O+ EZP*3"GQ]]T>),OT_BTZ3'-9;N1N
M&'M-[E"NUVYQRZ:+_MKM(K5FU[$3W&RZR'(.V(&\VD_S:@ID^DRN ZDZF*QU
MZ+-&S#)BN QG],P9?8[ZN2U&6&@;1-KTB2W>9C%M$#F#TEJ<N6!690:ZY8\X
M5:>;O^1<>KAR*'](GS[S<AOBEQ7%%<[S%ZGG*M=RL< 842Y=$>@AGD 4TP@F
M2/92[&%.PB2,-+,@#VQ_;J[)Q@+PU#$!K'@)LFTPL[0"T*X9!CG#!O11O_A-
MP/S(\K<EO8L>?%:!S%W\X&HZS@T2MXW+_429W"X?U7DPM4>;#_L$?K*4Y6TX
MF[UIWP8\=KH\<,-MWDD,=\9CSBW&H^JCJL'M<[;BCT_+[(7SKSQ_3BDO[N2T
MHI #FWQ]W[U\73\]+5.>5SEG?4H33P0$,L\E$$6AG)+$5+H'(@AP&+)(,&$\
M-QX,9VY#48MM4(;?,WO&8!(\"=]C3X<UJ3ZCI,DY#(U4OV00I#<J5G(.?<<K
MDYSUU',C^[[R>S6NW_*G+%?BW DCE"W6OZR3BKD,2Y<<4^C&B0^10S$D:MF8
M^MA+,$]\+S'*L#D P^S$L1-4UN $&RNZP;<756FCYHHZM&QH>)]^AVG*Y[C=
M,+9FGM$#HT3T&9,X4C2?/HXWBN0S)NIX%)_YHVSEN+DI'WA^I0Z"K\HZ@'#A
M>T[(A/0?F0ACB+ 7P<0)'.B&+H^=).8H<L_-<;/?[/RVSRJ,@-8@ :Y0GIOD
MY@#=>B)GC<(W37)34]J ;@*7Q\QR<YRCD;/<'&CXC;/<'*?B=):;GGN'Z="G
M="55[RKG+"T_8EH=E-[,NM]E>9Y]DW^YPO+M4ED(L!<G*(H%I %U5,&*0"VN
M)C#T$ MCWT>^:W1<V:SYN?ELE\\X73:GR]4._2U_SI;/REMH;3%3*</.T-.K
M\2@>6;D4\*H00P5]0ZDZ4]RNYVW@@Q:_/0T;QIM5-3.$,*FN#:/GM<(-?,JY
MIR8^IM_5 5^I$;PH;Z4'L_"P$#$.!4Q4O!)* A?&:NLH]I(P=%S?B4)D5G;K
M:%MS4[$*H/0):H0@EQ!-BV\=YU5/HRRQ-;(@;5%>@)JT%BBX[2/MC),B1^D8
MZ23(?GMO=-+CJ.''3W(<OV687+S.J_T.%RF5'A#U_3@AD#.10.3Y#HP%BR$E
MC/$PBKF3&"WQ'VQE;A)1@:K"UEBV7.*\4!F2ZQ VPPBVPZ3JJ<395(VL#_NI
M_B] A=&>,O128%43#K<TJ1KT&OM:!_HO'A!Z\J%=/U=AMU^:B%UU&N.O7.6@
MXNSRF>?XGF]^E:=4+2#5@6=MA.^"> 0YC%'( ^9"Y,N_)1Q1&$<^"=W$9SS1
M.LQE$=/<U*4%#W"-'@B<YN!999*N=.;#UR]? %;;NV=)D,U>[1>L-^JKD>7M
M#]A-!C$OTW?71'$P=P\<?'O==9UR$]*,32&* FR/)JQ74BA!*>]N=Q*;\PO;
M>V4[MH)D[-+?&SACJ:GI@FGL<K,38&/YT0/7('E1<'XD:V,3S%^\7_._<9S?
MR:[EBR22@ZD:1=V Q! YCG3"W=B!#&,4XC#R<&"4<ML8P=R&4/F6(\.U1F/2
M-9<;QZ1R[!7'"OO%ZYRR%]NDLA?JQ!;A59KM"Z!L )41%I<=A_)G=^71&,6T
MBX]#2=I;?QS\H $SBN-1B^ITRK4<;T6Z2DL)0/"%<!&GF"<P0"&#2/  XMCU
M8$*%(W_B4JJ7&-:XY;E)VTU/B&Y=+CS=X =+:8"!FVG4(QH^_U@\CZQ[';W;
M"TJOJU]OH8-/(U)LX*^/1?5$7ODM?Y*/J\Y'*1<;;X+5^R+2Y:6X! _2B0=X
M]?JUM^6)#R&VU]\V>N!T7O40.W=\YT$/&%C-@3_SU9K7I1_K&NFJC:NUG)$]
M\GR;@L\3?BQ"ET'72U0Z<8QAC(,(1BZ.&2$"\\@U*MV@V?#<!HT&=YM^VCP[
MK#;C>E[Q&#R./"BT%#9%;6O0]8#;PAZI,KDI67:+*^@V/FTE!4-*]LHFF-X_
M3*<^-H+W7&W$R;<IW>;:?E0!E?^LAM6J^$W!+X64 N59?Y0W+(B/<$!\%WJ1
M"G94#B]A(8)Q2).8>AS%H5&FUS.PS$W-Y*L:5<>H5?07QPJJF9J=TR]Z C<1
MVR-K7FT%K,P 6SOJ^,B+JOP65<NH79,N0-4A]6* LL>>$%H@U:HVGH-G4KFT
M0-QK!;7QR'//)':35722F[Q[V5[2K%E<*C]4I8PK7SH)+JOHT;L'O+IYJ@KU
M?<Y6S[R0+_3G]2/A^8)%E*+("V&2) Y$0>+")!(^="DFH2N8%\?AHJZ-_+7$
M>:DGQ)/A-Q&2UU:,IRF_-1@OP*I"V=EL.2\/T"2O1.0)2AGBD$4A@2CD&!(A
MWPN/A=P)8A0BC)M7XL/*)*?7/%^(UH;_\SH<?AWTG(%9=O#(KD,W 577ZFX6
MJNK<V*%$5<KV"U!;OY.INCZF44H"0,/ !=AP(/]:L3#&Z=Z).FZD@\!CHW^C
M,\,3=<KQX\53 1@X^\QRGMZOKE=4SFGO\/?&%WO'5URD99VE:)VN[IN%.]G^
M)AN7GP0\]K$#/8^[$$5^#.. (D@HQ?++#T(_,#K7,AS*W.:>C24@K4RILAKR
MVAC#*>CPSM&<@4Y"^=@3T(;MVHHJ06%C!_BQL>1/%V!K#-A:,THJM?-)M3L!
M'0YGVOGGV;3M33_/?^+ X)QL=7_'\\?WG)2_XG*=5V41;OE3LSE^([[D4AO2
M)[R\7GWFW\N[;WSYS'^5B!Z*11 (EQ W@E'LJ%+2GI"ZR@G$Q(L"%CF4"Z-2
M!F>AF9NTRI?<,PS:.:LS- -XIJ)X[& >:0=4A@!ER05H;'EIPG9N5C:#=FQP
M9C> YRQ$TP;SV"!O+[#'RD.'2>9O\K6L5@0Y4\VK=.Q8,M%(]H(QGB2>CV&4
M"$=J8A)"S!TID;Z(&8MCYI--5H>[K,1+/6GL;U7KP]Q-ZK!M>\S5D WH)I(\
M$U5 !),F@+2Q ="L* L5>R<1F2GFB;[0DT0+U$ZC>5TZ%5+00FV]2'N2I\>)
M54T[T>2DHJ5G_FM5TKSKW$1<7_*,K6G9+>-997%R0NY%+F.2X(1#Y L."1$)
M)#Y-'!%& H5&T2$G6YR;Q]5-\=1 /E#7UC0SX4G>-5=-;;(Y]FKGF42>D17K
M!#DCY< ZUNH;9;PZ0<+Q_%:G;AR:S:H^==T(F=*V121$',6^@,0C 43(C2'&
M:C/1=Z+$%;'G.D9U0@ZT,3=YV:0#:%;(+BHWQC13U3Z5>OIQ)D$C*\:&FP\M
M-^_[N!F0<NJH]98S3.VW,W%"J:.&[N>/.G[I@/,+OW*64KS<5**[7MVJ0.EE
MDV%4Y646EY2N']=+-7]XKT*<:=I4AN(T\),D@G+RXT$4N XD(?,A#T,?>2$+
M$ZQ54^Y<('.3C,84P#?U&-,5R"MK0%&;<U%G*A< ;TV2PK*UR2 :_YPN#&*?
M,X8]&+N)%'2.8]F%,9(N)">((3_@PE^4IR>LDW;A!'/8M@L_'.]" %4?3M1/
M_:/%E.R//*3\@;X=@X,M$_7-].=<'BUTUP7 1;M$1/"R6MHH'KB\B<EK;1V!
ML= %O2=BSGG^= =D++"P<U[&QO,&)GY+"WQ_G_.ZMMN-:*+AJYG/]B1'G'@,
MQZ$/<>@E$$7RCQB%$8PC5=H0A0[A6BZ*4:MS\T=V0:M/K8%MF!).BW&]>8UU
M'D<>EHY2V*R*@%$.S1BQ9#=[G%;+T^:1,R%C+Z.<T<T#UVI5OHTZ"$IEVVBW
M([!'&*;$AYX?.1"A0$ <XQ *%',1A(2X+#!:H#W8S-PTIT()L@IF=<SEZ^5M
M,2S*Z BOF@NP9[,U]JIK350.?ENE91,0"A14^]L[_5S8760]W-2T*ZN]YNXM
MI_9?/4&@S>9TEN]'/@J(!VD2>1 YPI5."W*@%R$OB@*DEF!'"["9\7FY<,3
M&L.C<:-3.K+JG BDL7OD[2RRWBZ"YFV.N9U%UED1,V<>;:OF@Y_D4+^45]]R
M-?OGQ<))>!@Y+H-".%++(AI!+)P01D(5EF?4=>0$3*O<R<'G#PB!&5FG6H0@
M;R :K$;ML:>Q[#>(D8E$IJ7BU@(5!JMMYU R>2'3Y>OWQ=:"US$6>E>Q]FZ:
M;FGJ&-Z=]::C%PWSS]ZMBW3%B^(J>R3IJNKS)KO(/SF[9O(]2$6*MX>"Z3_6
M:<[9Y8JU"<6DG,K?R5>F<X*X6%#A,<Q="B/'BR B.( D%#X4@1,&OA\@[#@F
M'MQ(..?FXU6XBRJS2[7VV\E&:^;ZC=6O>L[A#'IK9&5O+00=$R_ UDC0M;*I
M1 5:.ZOE@(ZEH#%5%6 XF*K!8A&KD;O&JK,Z%M9)W=F1"7_M\([=W "7^#T7
M/)=MW.'O=:-_D7I6G[9<+K-O:KNKK0FVB-S8I2(1, I]'U9%N>+8"Z&#2!3%
MCA/&KMB$D6L&5ABT/\";OILD!*LI=Y>NJL&@7H/'+7H#K]*D+S1\;]O43E7R
MID9=G42L<5^ #7*P@7X!6O C,6S@TH_$]$3>OD7&S>8  VCKG1Z8/&^ZF<,
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M3\IF\*.\=ETP=7V=8,.PAM7$;YC><##?]V;DP40G"T>AFX;C0_=]:C-QM$2
MAHG-5:#BPG)ZCLG[T'[2CNE,F#Z5Q^3=<S#!Q_0H!@[&/'^63VFB87R"<>1&
M 0P<)L?*A#J0^#R$CA<X":6A'#V-(HAVGCZ[H:P&9[ABLDN8IO0/I6%L9:YQ
MC1 [=-!BNSJVT\*T,G/(N#T5.'C1P".AV:KRM4I^V9X&+IH7D'.7>DD202IH
M %'D^3".!85Q$E//)5$0.&9'/X\V-;?/5R*%-=2T=D W> T/>AXG5^_KMD/9
MR)_Z%B38HASAPS]-AMT#F,>;F_:@Y4FS]PY4GKYCF%A<,E9]$'BIUF:N5U?X
M*2WQ<B'<(,:N'\$P=!!$7"204.Q!-XXI]:*$^I'1H<DC[<Q-)K8PP9/$">6T
M@=9(S63B&*UZ&F&!K)$%HL.3@JBF5U<G>#(6AQ,L6%6&8VU-*@LG#'ZM":<N
M/V='H5K5>\\+FJ?5+.-.U=1:X(11-T(,JDQB$%$N8,(9@A[%D7 $=A@Q<OA[
MVIJ;,+1KW,W*=@<N^+T";!A:W$>SR8;!V>1-M#<P@+>!FP"]C(RPWG^XO3=8
MVN\U_/ J?O\MX\0&;U(&N"*A5#@Q%-+9D&KB$XCCV(,"!8D3$X2]R$Q--!N>
MG;1<7[Z[_E0EG0&7G]^#KW<W5__C/V\^O?]P^[6-$O[P__YV??<WNU'"AKD;
MQJ!W;/$Y&#4\2B8'4W8F#21^FQP/II28!A9;2AWSGN?I,U9A&Y\V9WJ\P/<#
MX5'(O5C.?HB+8(PD[QYED>]&L0@CH]BQ VW,386V$,\X,'6(2SUU.9.AD87$
ME)P!,;-'S;<<^+K?SL31JT<-W0]!/7[IL$_]/SF[5\D0^++:9"D>TJ?WV2-.
M5POFTT0(]:U3XD(48Q]B$3J0\HAXL2\(]XT61H^V-+?/O@$*NDC![S56PX__
M.+MZ$F"%LY&%8!A=QG)PD@JKHG"\M4FEX:31KP7B] U#D\G)+X\7I8K>_/H-
M/S7K^R0)N4=H "GR8XBB2"V)4A^2(/)BDCB^0XWF*X>;F9M M"CK:&:%TS1I
MW$$R]23A?(I&UH-]=D;8)>EGP7*"N(--39P;KL_<_;1PO5</R A7S314N3W.
MWJ]S*3!U6$45A+$YW5)==/-M);] *3M5T8:U:OA&W/+'.I]5?</E,TZ7:EGE
M8Y9_7)?KG+>5_!:R:>1Q)X:A%V#I>7@>C+'#8!2''J(A"H-(/[7[5*CGID^5
M255A2E6DLK*\B1QLJVWQ]KA;=?P:9*WYX$G5,%E5!*CB7'E+07LC;DD (LN!
MJ&C8EL!488?UA9KQAM.^7/T".]M79F2]KM^6VF90&]W$!=;QA,7V<&1]Z<9R
M4%>\J=^6&P$VUK<W;NQ7%:Y!S<"F2.T<WQ"#5(-S?%,F2EWX5OIB*^'AU%W7
MFT!Q,C#3)62<FM^=!(^3-SXP;%1^I/QRQ3[)5W6Y.1S7'"-NS@U?9:LR7:TE
MF.9HB9S0;;>*,(LQI2%TDJBJ01I"+#P$7<*"0"0>)8%1UH9S <W/"5+3#[7%
MH=1 =D!]"+7$W\&/3:GN/P%2VV48P'INU^E-]*;LD-%=C+8O*F.Z!X+;2O4_
M-A;]2:5I:(T"6ZM&V:&R1;'=N-QS04T;RFN)PKWH7UO//;-X0MW&/5_1ESH2
M)8H2%GJ1"S%) HC\((3$%P0B.6_%@N$$,Z/L@D=;FIN@=C[:#M1AH3['Z=5=
M!+- VNCK8(/X&EXPX1@7XY1+V&OM;8HE'#/Z:*F$HS<,*92 \_Q%U6YYS-:K
M4JK5)943L/42JZ-&CUE>IO^L,QR(:R:G9:E(58NO,Q!6,.[X]_*=M/#O"\?W
ML4LYE0(3*%FA!";<32#R'!P0)Q0AT3IN.QK"N0E3:R.HC:S\C(Z9H&NGFG1V
M+=U/Y&E2L6",[M=8I'KK3AU9..WV9R.X0%D**E.-BE*,T<4F!2W>N*NGJNR(
MB;0I!VQ;6TAVK*I\0=N7 6]?!MQY&?"KER'MO@SI]F7 %1'62F:,V"W]Y3;&
M:'C"4ATC\K9;YF/,AH:6"*GVY7"5#ND]+O'5.L]EVPL:NXG'0@<RAW&(&*,P
MCJC\ _F,(R_R@I";U0HYW-#<QNVF0D8'+%!H00/7M'S($7;[QU.;G(T\+ ZE
M:T!ID7XNSJPQ<N3A$Q<;Z3=QO^K(B>L'G@OH%%#_%9?KO(KLO>5/3<J@&_$E
M3U<T?<++2R';W^3/8E$DL(LPY$Y (7(3 K$?1S#Q7<R$+Q!UM;;)SP4R-TF1
M+UQ4N0@JI1S'"JKA 8&A/:*W;C$%SR/+D#(!*AN ,N("-&:\7("*[E$RF9W)
MFMV#!4/!3'O0X$S*]@X>G/L\Z_5>NEY<LRQ<-2I?]$7"" N)'T$6Q@Y$ 5+.
ME!>IFMXDQL+W!-;RJ,Z#,4-Q#*P5>^FC7T\+QR=U9"7L+0AS4>ULT=?K%6VF
M1PEBDB(Q&DQ.53:F#\I<"LEHT&506D;G:6:Z6.3EXE?9X./ZL0D:1A'WY921
MP(#X4NI0Y01&/G2XS]V$^K&7:"6EV'ORW-2K :<G8/L\]6O26=:/+#,-+HM!
MU$>M[9,">5-'!N2_7DO _E,G^:J/&M-^J,<O&+#C\S[-I:A_P2\\OU7+HLLV
MTQ%%/,&.<"&*0B'_( @2%WM08,\-F.=@U]4*Q^EM96[?9(T35$!!@]1@<?TH
MF1I[(#8H&OG#/<3.D,+81VDRV$>P0=?TA;%9S>!3Q6!>X9;_>>:KM;58T%/$
M]*[&'[UYNA7U4_AW5L5/7CQLEO9+GA7%ESP3:;G@).)2[&(8!;XJ?"TB&!.'
M0X$B1Y# )\)+3*K<=9YMI'X3%+2KH(&G"IO9O*I+&,(B85$2P" *"428$!@+
M(JESN!/+66L2(:-S]4,)FV"XL$.8WNQR( TC#PDU U_Z&3">_QVPU>JDKOO\
M26=J!PQ[/?TZ=,GX=4/NOF6+@/'$0RB KA\G<N858(B%*R!)0AI'+HX9,TH'
M:-C^W#YN^>[XXU4-481K+K&/1^/8*^M#:H9($]ZF9$B'NS>K&*(PS+9@2(>@
M<^J%=!\S-/O8BM^(JYPS.7K**Q!W8Q<FD4IW[",.E<<&7<KB)/%B4W>C^_"Y
M25*U556JK:JE2E"3"4 KG*8YPSKT$>(Z82AG^-P/.$2>J\HM< ]&H73AF(=8
M$L:+%;]7<28C$9C4!'8;&8_"FW59E'C%E!JQ''\S3 V]PYVF?@]\H:;8]JS>
MI4_-NW35_RX-2)>V;[CEE&B=!B9.>[9OVGYJLP/7#%BANWO@RO[Z09O,T,V*
MB4O=)'+D9(LQBJ'\6C&, ^6XA9X($?*Y(%KJ=[*EN4FAQ H4V.:MW:8P-UB'
MZF568\G.%E\C?^E'J1JR=M?+F<'ZG2WN)EK#NUZ)+'^L@W)S7D?J2M=5!?3^
M<)#;'VRMY^D0U;NFU_N Z=;U=.S86=O3NF&8 _D.+]6)YZ\/G)?J/)[JUC9)
MG!,APN2LEX:N!Q'A/DQ"'T%*!'<#&GMN:#0)/M[4W!2U00HJJ*#%.C!/7 _#
M>EZ3'=Y&5M:AE!F[4J?9L.I8]30WJ9MUVNS73I?&'<,DXTO>%$:O,BTTN136
MY4.6I__D;!'[?H0HE8HA6"3]L)C!Q'$3Z&,OB"+$W,BLE$9_<W.3C@W:.CW*
M!< ;J.8IE#09UY,1>SR.+"5;"K_6%+89AS9@[:F)'BE6%>5$DY.JBI[YKY5%
M\ZYAZO+;*N<TNU^I1]WA[TTZ@&+!<>P1'!,8)&IQ*^%(RDI"H$@<SX]Q$G/F
MF<C*D7;FIB==F%6"DR:MB:H>6R_=D%KGS13E&,MZ4F*!NY$U9(<V=4R_Q6A/
M.DZ08%4SCK4UJ5B<,/BU2IRZ?*CSD5'.6?%1PON*EUP%IV=L71W>J2,S%X'C
MQL)' >2.2FY-(A?&2>#!(&1^E=K:<8P2UYYN<FZBT2(&JA-!(3&K1<U'.7M4
M&7KX/];IDYI 7JC]^B>>ER_5N9K-STV=DY,]HNN@V.1Y=">E2_'7AN(MX%,9
M!P9X*KKL6/963C8[L<>B2\.^UZ)]Y]#*&K57),6N?EX5O[ @V/68RQ(8$N9#
M%#D.Q,2/(64X#%%"$^QCDZBIP\T82= $ 51WJ@W 6D_^(Y<\RA\H#P8;Y.(X
MP:V>L)S/V,ABT@*L/)4:X@6H0-HLN=%'@N6J&P>;FKCP1I^Y^[4W>J\^,\]8
M,S<J7YIEO\1/>)"(&,:>[ZM$V Y,J)] @AFC@N$@](R.L!UK:&YN22=KU@;I
MP$75H]SJ*8(-QD;6A&%D#<\P=H2)<1*,O6[L;?*+'3'Y:'JQ8]</V,G^\O!2
MI#3%J\L5NUH7I6P@[Q;V:(\!(.R[2/@".C$6$/ER0H-1+*#KA@R[G,AA-=3>
MU-9L=&ZRL8%=S5)H [S>>VR1&VS;ZE+?KR1C$3KVM&6'RQ;S3GV?0>=8=$DU
MV!8?@=SI3[FDG<UR-=-N,J*7&7C2>*MM;9P;4MF[AZ[[K.FVTPVMV]E9-[UW
M:'JHJ^SQ,5MUULL[P7<+'K#$"[P$\C#V5#4V)?(N@AY/8D^X2/Z?+YYY3C+]
M-%%]#9I\,MUFQ_MBFOQ'->A7VSX=X*9IHWI9[]=W^TR.K.SG4C@@E90.,V<F
ME.IM8N*T4CKF[B>7TKIK@ =Y^:C2*LHN>OFR?MR,K[[K"X%% ,/$"2#BW(.8
M4Q<R5W@TX)XK_Z+M+QYL8F[>X18DJ% :."V'*=3P^\XF9F0M>,W)$(_N,#D&
M_MO9)+U]/"/>\OBD;+#EC_52T^M]';YS.E^K%_F.9]5_Y5 _ZI(QV?=%54'@
M)O^29\^IJNT4Q!@1(<4N#N4?B+L88B+_8/)/)GS?";%67NU3#<U-_)I!OP$K
MQ_NJ&$>6@Q:PJ<=TA%]=7^E\UJ;QD@80-L _ZF?C3,_HR,,G]HGZ3=SWADY<
M/\ /^K7>U?[0;EY_YN6""QP2EB10\ A!E" *<1R$D,:8.3YCS*>^SI;;L09F
MN=EF,+8?XDS#[3F3B9$_[08=V, #$M^9I!BX.V>2,_W2E')P5KQLDZ\?#A#!
M19NLO0DS T45X,WD]VO+&^IAKM<7.G3?=)Y0#^H=/ZCONF'[BE=94=Z(7[*,
M%4T$PZ=TQ1L'/4*AGR!5N"A(?(AB&D#LLQ &OH?"F.$@]A.3O<6^QN;F#2FL
MZG6MT%;+JE]Y_IQ2?M$&YG1_J$("Z<,CSO]NMO782[_>]J,M4D=6U*%\CE 3
M7(<QJUN5O0U.NEVI8_KK+4NM>\Z+<MKNBE8!$VJT1#3R>1PR&& _A(@Z$8RQ
M%\)(SLUBS_63Q#,JGW:\J;DISR: 9UN)D@^,<#K JYZHV&%K9$G9$-4-;V@"
MGOK<M<'A3L?9&"7DZ4!S;Q+V=-SL8Z%//7<,34U2)SU)>=%45-C6MU4UT'C"
M(>/8E4*1,$C<P(6NA[#K$#=!L5EZI:--S4TH&GA@N47\9].T&T=IU=,).V2-
MK!,=D!=M%911RL2>9L-RGHZCS4V<M>.4V?LY/$[>,7JAE.O5M@P 0HR$.(8H
M# 1$+G%AS%  $R)$1*.8<+V<O&>AF)NZF%<!&$:^IM",3>G8&G2T&LH(>?[/
M(NNMBJ!TD,RU LH^66>4/SGPL(%9=?E*'8=0M>O88[I*E9"J<RA-)8$%#F.7
M"*86L%5U6()53C?LP3CAH1\'*C6E40VH$^W-3<<:N'5!R!W AJEE3]"LIV,6
MR1M9L;J\[6(%#5B+B6GU6+&;K/9$F],FL-4C8"^IK>9M [;".I$,=YP^K+)E
M=O_R-1/E-YRW"Y2>GV#&(@YIJ-9H$AI#XL72;XHI=ES'%=37SY*FT>#<I*4;
M[;'%#%K0!OM%.FQK;*I9YG!DA3E!WY! (QT>#?;A+//Y-OMR_+O\%E92R?\W
M>6_:'#EN90W_%<0S;\RT(Q(>+N "SR=U+79%5)<4U64[)OI#!E:)SZ0R-61F
M=<F__@&X9#(W$F""%#O>66RI1!+W'I '%\#%N>W\\>T![Z+!>U<([FH?S@*Y
MSGTYD^=,MT]GX=71OIW-?4-7TNGV_;XH]J&$N!]Y$</2@WZB]0MD'$*L:S\E
M)*(Q2_PH"2*[9?2+[<R-F;69MDOFEP$T72^_&9;1%\OI%AQ,!+^9U+D?L%+>
MB8/C9?++;4V\1M[I\/D">??EPS[^\_,(F&(?29+ R N0GO-IZ5J"88(\PJ)$
M8"_ARQ>19QO^ZY;D6[./_Z8C"Z>MC?>JUV)UQ7"-M'-  ^;Q-.:*/1DF*M0-
MN8IR/0PY]U(2^X*(N 'TP]I0T=L!G$U;?RPPS3AUS@=D*ML6;@_#]#KNE#[?
MZ A,KY.GE.GJH,O1\WXF*M9]MWG6T^0R++O+<]6_I13NSZ^'2^H:"W<J3N/W
M+^5!O@\_1,ZR@M"5^*?('I^V@M]]5[/P1U'_13SD&1/+A%.4".9![#,!$2(Q
M5&]5 #$G?A1+1)/0:E]R(KOG%LF5/D&JG0*LY3@@!\\78%/YN%"3G;V7"_![
M[2<@E:/-7P5XT:Z6E+8KN#Y,6U';$&:;X%6RX,MYO2!3L'#];K1]!BVG 7T%
M[>MJQT'IN:ZA4[\X']HO3N,_J %H_BI "8%CJI^NS]P/(!/8/OVP-%V'7!SL
M)FQ^X!#*G@3?:=4S;>5F7>UL[9-^ZM7G6J3QFS;F,)].$XFE\%7X'#!?2Z]J
MO2*&(&%A%#$A0]\S.EWEP);9#76U*V71F+TS^K=6@EOM$/BI=LEVR+JAZPR'
MH6DZ9.RA95!?@-]*A\ H:RL.@'7+_S?8,RVGWP[<&4\[>*0K8<C-AO^>K?0F
MX*>UFB(]9JJU6BN5$(Y8&B?0"P769!M"(G$($R])I"\E3<U.\ ]I?&[LVIA:
M;FAG>V,=*4AV=(+I"O(XT(Z^K'Q);;(-]<%XYS*V0S ;69RRPX WEJSLAZ9?
MR-+@&0-9;;\F7C%J$_E^K304]!&4XBSP+0ZA"0ID@EB"52RIS^PGC$.*"89A
M2.*0\$1&Q$C:SI$]<^.^:Q-E2]:[L9,,B7 ZZ"=<GM@O.[16)D;:@G.#GUN>
MO-&F::G3#8!G;.KHL;<4+2\+"!</FU7&7@_?9<!DR*2G)819#%'*F7IIB<[E
MBF@<)DDH/*LHL:.MN1%C9>20<N27H32C.$< C4Q?39GQRD[P6V7I.'-; T1&
M*!Y^N;TW*!3>Z?CEHN#=MPPCB3O&M'Q#MGXLGYN)8G\<+!9>ZB,58"6I5 $6
M$8H>O#2!,0Z]2$@_2?W$AB.N-S4WBCA8"AI330Z/V0)LQAQN8!N9. 8B9DT:
M_6 XY8R.YB:EC'ZW3QG#X(X;]M)I_W8%O;)=T=K5/]FN^"J>*WGC=YMU:>F.
MK/3!FF I$N:)2' 8!3[3HB04DI2K7YF4H4YJC)A1TOD;^C WBFNYT-K[;#;-
M\\8-P Y^ %WB?L!N^<0OB\7.^7Q?@3_0+OKE-ZG91=^C 5IP@&]=;]*P'?6W
MZ4OWN^L3^S']3OO;=-3%7?<W,F7H+E">?2^/>GU:JY&\/%7R-2O^Y^Y'5BP%
M182%E$"91@*B&*GY/$Y#R"@GF(8B#)'=8FA'8W,;R@ZV@H.Q*OI4IEK&ZIT0
MF^[IN %N]#V< 9@-V*SI!\/QYDQ'@Q-OQO2[?K[Y8G#/P*A=Z\=_*HJ=X.]W
MN9X55*GY9:+M%_%[^:=B*6/$)4GUH0&:0(2B!&*F3Q,$,5=Q=D)08%7ZU*S9
MN1%*70.A+, .(,A*^V](AC?#WC!N=8[HV*%FB6)E,:A,!I7-37D)K=SU>W6%
MPXUB.Z#<QG%F34\;>EG!<18MV=T]C*.^[/2AR'OY5;QL\JU.H/E5/)8[(DL2
M^SZBA$-:JO5X(8<I"U-(19B(E!"$B-5VQ?6FYL9%E:4Z"2W?VPJ*VE@['NK
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M>;D@NM!.7L\+;YB#7X)<>(D"%B4P$8PHR!&&A$8<4IY0#X4R"'&PW&[4I6\
M^;[9*9<_SB$'$*S%+763+P$_8#'I1C@G6DB:\.6]8?'H1BRG7S@Z7RIZ4BY<
M>EO?8IFH TZK):)+SWF[Y:$.KSJ7AKKNNT%540W)[T7UWY_6^[,_U>B^7[)
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MZN& J3]&=E)-1JW.C5FTM>6\NPR3Q<%N2]$5(\3-",8YCB,3S1["\H>6R0M
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M+;$0_>T7RFR%.,A+PRU&?V/P#8*C,2 =F2G.T2P7+Y350)L-[G-0&0Y*R\<
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MUZ66&#&/!JD/J0P"->@$#&(5E<,P0BSRA*11% Z1B')OJA%Q3:\DU2SE\5J
M2$^N'S?KLEJK]KJ0K^!93:QUIKIZ*[8[Q3"OX/=L^_2DIM<E7:UW.ONZG,+O
MMD^;//O7X6G#E8U&>%FF&;J&]OT?;]!J>7K8 )G/:-71$;,:IR[9^8<:H3J
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MVALMM*3< 5OR ]#*DW__-S_V_NLG4;EGN:%X0W^939&GZ861 XH&_,H+H-P
MM1_@I]J3/S6C@W8&'+P913_F=E#=*BD/-V=:%>6;83M34+[]B4-K<!;9XUJ?
M7K\K_B;X8RDBH)Y<ADIUS38:R@A1RF <A!(BCB7$S(LAX6D<2QJ0,+ J%&W0
MYMR8\V"RKN%;&PT.5MN6W^P'W8P5'4,Y,OWUH>BPMMX @!Q7UNQO=^*:FL9
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M) 1*)A.(O 1!(GT"<1#$'!,O#IG1@8V>=N9&#-I24)L*]K9:1!P=D!H$;6Z
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MM '$)>?.AOR+%PW[7C\+]3!Q_R)RHB76/PNB!L-&!K<^&5Z\WXDECWW?0T+
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MD4"!%Z<QMRH>9=+H[**OQF8]F]I;#1JS39:9AW> 81#F&-:QHZ[;$1VN(&<
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MO% ].FU)(Y:QU),/)\14;6@\'ZMN,!2&G"0!B9&/(ZU245=),343IM8#*$5
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M: ],>5N!VPWN#-0R@S?;N/%.[/,=2(QIS@PGI^2F.?6HE&8&QR&1&=YM&1'
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M@@E,?8PA8P2QF-/43XRB<JZ49VKT4*M3'S5M]&E+^9EM@:]=)KT=\8C@#TQ
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MN<]9@"*?0>0%TF3 20PQ$C&D?HI"'(HLHD;UWO>'G]IK5Y^M*?' GXV IKW
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MO?6&M 8:KZ:0B5Y[=8.,;K2UXP0O"L[>/>#BGI?U6=O+=C.")$4'+. P]N)
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M;L4=_CGG<>HAA##$7AA!%&4)S(C/88##0,11RH+(J-QOSUQ&MN88]7UY57\
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M4[$((N6!W'XS#Q*/>)!FA(9^%"(2Z%?GGY9N4Z/;1H>NCH)HM% GG@JF4KR
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M2OUZ3M(D23SL09\'<AO&Y/_@**60)K&(?<SBQ-,RJJZ28FKDTRG1T ]8=6J
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MZ?OUF@8_D<B7-'_""]!)#.37?B%EABKU#3 IM6DE_#,PZW'$5="-50U_BY4
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MI_8-Z,0&6[E!*SAX=_/MPW<@13=PQNABK^%Y&P#1@?E7"\S+O2KM435P3@V
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M9P8;F**X7>5C=N(+UW?,SUK,I=9J^<D*^-6E93J^].4$0R'R#*9 Y56L/N>
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M=LZL[,[@;_9O?_V/]4_L'\+Z'7_]C_\'4$L#!!0    ( #Q[;U1I&7TC@;\
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MSR\FL/W>V1SRO_ZI_"HNR!GCZ^7^Y_H7?[U9]6(."P3*BLL/^(W-[Y=5=J4
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MD]G."FHI1*+%:C1,9L1R[XBR(2JN#%CC]D+/#D2TX,'TCZI:6FC@T/H\GUW
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MG&R535-4A2R5K7/V[D;GL&FG&A"KJ*<&3!3NG>_C!:KGW6S^9G89EOERLGV
M/T)+RX)*GAAM46Q)*F)3J6DTB@.C&)^8.DTTGJ-JX'O BFAXV%>U']4T +.3
M\]E\.?ZOE9H^Y?O]'$?6.6Y9L,0(;<LH2TNLXI+@]X)/S#'OZR2BGJ=KX'O
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M7$9O4\N[8[=]4>TD^ /LB_T@T<2%]#/G\"@I!=H*C"^ST43FK(DW.A.3E7!
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MR)#;X"SQ5)3N)T9S;WC,4'&D^!X4#]X7_KC8K*W3%@[6Q_E<S<=[CLV<C D
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MTM?>\3 @HAKPM-:FI$@%A?[-__C[>'E6](&V!K_QN(!&QGN'"G 8N0L@4H2
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M+#[/)N-8NF7>X:';PX..G]S#>X-]>.CIF<'#96Y&^/@LJ#>"Y!Q\>9;GB*6
M)Z27T5.GJ%!U]NC3-!T<*#XGWV\HTE>3TC@Y^I1Q8WCB4LQ$*FZ(<PGWG!<*
M#W;EO*S3:[@;?</:J9X0\R"HZU\U+]E@U3=<QS=@0QDR*@QG@3&2,B L 8.W
M +CYL@,9%:,4\?G"#-F=-SFK#[^ZV2/>YV!,Z3=EH.R19(GWG!(#*5(EG#*B
MCOEZCJIFC=8NZ'C$M^I'#0WXZU_AM%0[?X&+V?Q:4%?WF=(8PUCK(@'A2]V
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ML4"D!$Y*-Q"B+$]&\423J#2#[6FBN@'LI5T6]*6%!@!U/;CP_L;(:%FEC9:
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MKS!)Z+:B&1]E7Q(M*A(:Q*KG02+6,DXH9<P&)BFKE,OO1-[ 4XZJ8Z]_'34
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M\@[;=.9[AJC>--:>@G\)4'M*H0= 72O81TNZUKB:NZ1S(K&+VNY:D#ODHV#
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MS]#5J9&U)PJ&@FR\2#H V!-9&O3Y&6X%MLJOOJPW%\O_W7[_R<4OHE8Q%>:
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M(/@, V\OIT,T0BBS[0M:_7HMP2>%(*22O$YH5Z%-FO(0ZGI)_I@K.K*?F#J
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M4IP#,FZLS!X+CQ/ 9^3Q=?3<\D8(VI/1\X/HAE_/+V_AG!79"0'&U_E.6]]
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M,@G!7/-6FB>>!#@&12\F 8Z01@<G]X\FD[_\S^7RXGOMJ[=>;5E7/76K0DV
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MU,U^7= &@E/+I0>L_=A6OY2"Z>)'A)C85VMPR"->K]+R;+E=[X-]Y1(32=D
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MVM5A>@P@[B.@4\,? 0H7QB"3U97'VGA8:6X@."<AJ>"4,DY'TZKT;R2I745
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MP=FQ>W9^<]YT3XMJV5%.1-<_YXOYU<U5;8JP_K3\G+;6-,:BB\\.7)!UD&Q
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M-A57Q"1EE,Z)6:=:SL,Z(Z47<UL^B9VR)0RGH*8#'9.QK$51C,+OC&2]'#.
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M39RID4:,0GB2DPH^]*4;!]/8^<XP,'J'4IZV4/I.E R_;#CC=<&L)8(5)I(
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M8NW,KZ($1T0 1ELHGD3-0IN3O@?+V M ?K( .I[E'1BA-^MUOE[/DO*&%2?
M.>U :>7)B,8(M8\QED3LX6T<ZMOW[W>6QR8+D2.X//8IWJ[A]8?EF_C?-_-5
M_F=.\XB?W](WO]=/9@893U&Y.KNU=L!V$M#2%V6%T\5KEAZ/*GSF6._55^T'
MCXF>]0[+Z Y,RH^9WASGM_)9I#=7E6O_N_EV5@H/Z+2!:,IF[A(9QL E1 R&
M\9@BVC8;T@N+V@]=TSM&'EH>?5:][)KJ;MVVVJYWC8NT"14>KGR_@I<7GS=
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M[L0RT*.C2'>?"!-+94KT<\2IE0Q(*;2**<%CPYX & D!:6'VKS_&4YY/B+T
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M?XWC=_QUQ?1R!=)OI8#Y?K65>>P/&9[^?[/UMR5Y=PCDZD4!I+G]K=LIQX(
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M"7<LLD<,NL$QR!C,DL$=47.2,EV[>1*L@+/(6$H]"%Y?R [O\KDN/=1P2(Z
MI!0.YT?6H8WG8:,55&&X)!G:"<<-2YO9XPUAIPH?4FX+QIW!NJ&Q1%!V]'TH
M\)0B KUZ._OO#UWSF^'6WQ-N.-0OPZ>WX(NVX#-?@Z_JM.8(B]*8($B5<<PC
M9$;.21KG=X4V+(%+*2A6:5W%EY%7!0(C)LB** :15)E4Q.D_M-+>'G3J]: _
ME$E&TL*MPCYJHA*U+IEB\P)0@^%Q474PY-%RH];N#MM]#0^I7 E&%\Q:2,S;
M@U:G_]IB/4,P+J1*( QJOT$LE0.[8$0!0^,H8ABQ9(Y@-\*J[7/A%H!3AKB:
M#7Z;#%G#"G$N!.*(*\'1Y!4W2T=7[,^<*V8[H]Y.#9LS:$/8.J2?I.&YRQ7V
M=90P?L*\21=LDW1AM]'$0&L@B;.VZA*.I^A'4D8[0@0(MTG#4R>MM!ABPA7:
MEBFFK1552R9" +(AD$2@C3I#LW29?3%/21K9]RB0NB'#J<)=N2B=D!DK,TQ_
M 8.W3TZT7 88,L=SL*;.I<*4KV$F"))IUMO\Z%.N,T&*'D]=/!U3?RUK+HV1
MB177?[3Y&Q&QKJLNX4KR>D[H=KUVT+:C@L'YP-"-XO44X;DIPC=TE];L>-W@
M97+@A2_2OBK6:Q^W_GVI#2]H["?6=T"48"#<&L-W4FE4-@P9H;;"].K9$X3;
M74NP> ?Q$NS__V"[R(PPD5U%@O=$8?$*6^[X/K?D-1:OUTU7O\Z+[;+[C[PJ
M1XZ?RJ^W!TUL,>X)YV?3Z4>XFXW'5^,M1_=,U\#Z6]D+G#VVKLN2:V09XB(%
MI[ !Y&<%>6?:<V?DG"A5X*S!F& _'MC7A=UPR5D,%Y_ZXDTY'.W"Z+O^]%GW
M>_%2^EEG_.)>F\GR8M]3.-$9_LAV;KK/V>GZ7_#,0N:8HKG99?G&Y7C]+*_J
M[D^#T[\!4$L! A0#%     @ /'MO5/@BU]^'7P, !-(C !$
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M=2TR,#(Q,3(S,5]G,2YJ<&=02P$"% ,4    "  \>V]4ZZYU#"/5  "B+P$
M%               @ 'ZT P :6YF=2TR,#(Q,3(S,5]G,BYJ<&=02P$"% ,4
M    "  \>V]4]N/MNE\V 0!3S P %0              @ %/I@T :6YF=2TR
M,#(Q,3(S,5]L86(N>&UL4$L! A0#%     @ /'MO5&D9?2.!OP  COD( !4
M             ( !X=P. &EN9G4M,C R,3$R,S%?<')E+GAM;%!+ 0(4 Q0
M   ( #Q[;U0AK\9&E@,  %,<   8              "  96<#P!I;F9U+3(P
M,C$Q,C,Q>&5X>#(Q,2YH=&U02P$"% ,4    "  \>V]4SK;H1>8#  # #@
M&               @ %AH \ :6YF=2TR,#(Q,3(S,7AE>'@R,S$N:'1M4$L!
M A0#%     @ /'MO5/Y9EQ#Z!P  LB8  !@              ( !?:0/ &EN
M9G4M,C R,3$R,S%X97AX,S$Q+FAT;5!+ 0(4 Q0    ( #Q[;U2SS:66\ <
M )PF   8              "  :VL#P!I;F9U+3(P,C$Q,C,Q>&5X>#,Q,BYH
M=&U02P$"% ,4    "  \>V]4]W%IOY($  "B$   &               @ '3
MM \ :6YF=2TR,#(Q,3(S,7AE>'@S,C$N:'1M4$L! A0#%     @ /'MO5,S:
MIC>%!   CQ   !@              ( !F[D/ &EN9G4M,C R,3$R,S%X97AX
=,S(R+FAT;5!+!08     #@ . +(#  !6O@\    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
